PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Oh, E; Maejima, T; Liu, C; Deneris, E; Herlitze, S				Oh, Eugene; Maejima, Takashi; Liu, Chen; Deneris, Evan; Herlitze, Stefan			Substitution of 5-HT1A Receptor Signaling by a Light-activated G Protein-coupled Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HIPPOCAMPAL-NEURONS; TRANSGENIC XENOPUS-LAEVIS; FLUORESCENT PROTEIN; SEROTONIN RECEPTOR; DARK-ADAPTATION; FUSION PROTEIN; MUTANT MICE; K+ CHANNELS; TRANSDUCTION; LOCALIZATION	Understanding serotonergic (5-HT) signaling is critical for understanding human physiology, behavior, and neuropsychiatric disease. 5-HT mediates its actions via ionotropic and metabotropic 5-HT receptors. The 5-HT1A receptor is a metabotropic G protein-coupled receptor linked to the G(i/o) signaling pathway and has been specifically implicated in the pathogenesis of depression and anxiety. To understand and precisely control 5-HT1A signaling, we created a light-activated G protein-coupled receptor that targets into 5-HT1A receptor domains and substitutes for endogenous 5-HT1A receptors. To induce 5-HT1A-like targeting, vertebrate rhodopsin was tagged with the C-terminal domain (CT) of 5-HT1A (Rh-CT5-HT1A). Rh-CT5-HT1A activates G protein-coupled inward rectifying K+ channels in response to light and causes membrane hyperpolarization in hippocampal neurons, similar to the agonist-induced responses of the 5-HT1A receptor. The intracellular distribution of Rh-CT5-HT1A resembles that of the 5-HT1A receptor; Rh-CT5-HT1A localizes to somatodendritic sites and is efficiently trafficked to distal dendritic processes. Additionally, neuronal expression of Rh-CT5-HT1A, but not Rh, decreases 5-HT1A agonist sensitivity, suggesting that Rh-CT5-HT1A and 5-HT1A receptors compete to interact with the same trafficking machinery. Finally, Rh-CT5-HT1A is able to rescue 5-HT1A signaling of 5-HT1A KO mice in cultured neurons and in slices of the dorsal raphe showing that Rh-CT5-HT1A is able to functionally compensate for native 5-HT1A. Thus, as an optogenetic tool, Rh-CT5-HT1A has the potential to directly correlate in vivo 5-HT1A signaling with 5-HT neuron activity and behavior in both normal animals and animal models of neuropsychiatric disease.	[Maejima, Takashi; Herlitze, Stefan] Ruhr Univ Bochum, Dept Gen Zool & Neurobiol, D-44780 Bochum, Germany; Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA	Ruhr University Bochum; Case Western Reserve University	Herlitze, S (corresponding author), Ruhr Univ Bochum, Dept Gen Zool & Neurobiol, D-44780 Bochum, Germany.	stefan.herlitze@rub.de		Liu, Chen/0000-0002-5922-0951	National Institutes of Health [RO1 MH062723, R01 MH081127, SBIR R43 MH083302]; National Research Service Award [F30 MH084371]; Medical Scientist Training Program [2T32 GM007250-29]; Neurosciences Training Grant [5T32 AG000271-07]; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062723, R01MH081127, F30MH084371, R43MH083302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neurosciences Training Grant; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 MH062723 (to E. D.), R01 MH081127 (to S. H.), and SBIR R43 MH083302 (to LucCell, Inc.). This work was also supported by National Research Service Award F30 MH084371, Medical Scientist Training Program Training Grant 2T32 GM007250-29, Neurosciences Training Grant 5T32 AG000271-07 (to E. O.), and Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad (to T. M.).	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Brueggemann LI, 2002, J GEN PHYSIOL, V119, P593, DOI 10.1085/jgp.20018495; Carrel D, 2008, J NEUROSCI, V28, P8063, DOI 10.1523/JNEUROSCI.4487-07.2008; CORNWALL MC, 1994, J PHYSIOL-LONDON, V480, P261, DOI 10.1113/jphysiol.1994.sp020358; CORNWALL MC, 1995, J GEN PHYSIOL, V106, P543, DOI 10.1085/jgp.106.3.543; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Fain GL, 1996, TRENDS NEUROSCI, V19, P502, DOI 10.1016/S0166-2236(96)10056-4; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Herlitze S, 2007, CURR OPIN NEUROBIOL, V17, P87, DOI 10.1016/j.conb.2006.12.002; Jin S, 2003, FEBS LETT, V542, P142, DOI 10.1016/S0014-5793(03)00368-5; Kia HK, 1996, J COMP NEUROL, V365, P289; Kim J, 2004, J NEUROSCI METH, V133, P81, DOI 10.1016/j.jneumeth.2003.09.029; Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lanfumey L, 2004, CNS NEUROL DISORD-DR, V3, P1, DOI 10.2174/1568007043482570; Leone M, 1998, NEUROREPORT, V9, P2605, DOI 10.1097/00001756-199808030-00033; Lerch-Haner JK, 2008, NAT NEUROSCI, V11, P1001, DOI 10.1038/nn.2176; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Li X, 2005, J BIOL CHEM, V280, P23945, DOI 10.1074/jbc.M414078200; Li ZZ, 1999, PHOTOCHEM PHOTOBIOL, V69, P500, DOI 10.1562/0031-8655(1999)069<0500:DORTPF>2.3.CO;2; Mark MD, 2000, EUR J BIOCHEM, V267, P5830, DOI 10.1046/j.1432-1327.2000.01670.x; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Moritz OL, 2001, J BIOL CHEM, V276, P28242, DOI 10.1074/jbc.M101476200; Parsons LH, 2001, J NEUROCHEM, V77, P607, DOI 10.1046/j.1471-4159.2001.00254.x; Pei Y, 2008, PHYSIOLOGY, V23, P313, DOI 10.1152/physiol.00025.2008; Perkins BD, 2004, METHOD CELL BIOL, V76, P315; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; Riad N, 2000, J COMP NEUROL, V417, P181, DOI 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A; Scott-McKean Jonah J, 2008, Open Neuropsychopharmacol J, V1, P24; SELETTI B, 1995, NEUROPSYCHOPHARMACOL, V13, P93; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SOTELO C, 1990, EUR J NEUROSCI, V2, P1144, DOI 10.1111/j.1460-9568.1990.tb00026.x; Stamford JA, 2000, TRENDS NEUROSCI, V23, P459, DOI 10.1016/S0166-2236(00)01631-3; Wittemann S, 2000, J BIOL CHEM, V275, P37807, DOI 10.1074/jbc.M004653200; Xie M, 2007, J CELL BIOL, V178, P489, DOI 10.1083/jcb.200702072; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	39	95	96	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30825	30836		10.1074/jbc.M110.147298	http://dx.doi.org/10.1074/jbc.M110.147298			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20643652	Green Published, hybrid			2022-12-25	WOS:000282135500050
J	Suram, S; Gangelhoff, TA; Taylor, PR; Rosas, M; Brown, GD; Bonventre, JV; Akira, S; Uematsu, S; Williams, DL; Murphy, RC; Leslie, CC				Suram, Saritha; Gangelhoff, Todd A.; Taylor, Philip R.; Rosas, Marcela; Brown, Gordon D.; Bonventre, Joseph V.; Akira, Shizuo; Uematsu, Satoshi; Williams, David L.; Murphy, Robert C.; Leslie, Christina C.			Pathways Regulating Cytosolic Phospholipase A(2) Activation and Eicosanoid Production in Macrophages by Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCAN RECEPTOR; C-TYPE LECTIN; PATTERN-RECOGNITION RECEPTOR; CELL-WALL; PROSTAGLANDIN SYNTHESIS; SCAVENGER RECEPTORS; INNATE IMMUNITY; DECTIN-1; BINDING; DOMAIN	Resident tissue macrophages are activated by the fungal pathogen Candida albicans to release eicosanoids, which are important modulators of inflammation and immune responses. Our objective was to identify the macrophage receptors engaged by C. albicans that mediate activation of group IVA cytosolic phospholipase A(2) (cPLA(2)alpha), a regulatory enzyme that releases arachidonic acid (AA) for production of prostaglandins and leukotrienes. A comparison of peritoneal macrophages from wild type and knock-out mice demonstrates that the beta-glucan receptor Dectin-1 and MyD88 regulate early release of AA and eicosanoids in response to C. albicans. However, cyclooxygenase 2 (COX2) expression and later phase eicosanoid production are defective in MyD88(-/-) but not Dectin-1(-/-) macrophages. Furthermore, C. albicans-stimulated activation of MAPK and phosphorylation of cPLA(2)alpha on Ser-505 are regulated by MyD88 and not Dectin-1. In contrast, Dectin-1 mediates MAPK activation, cPLA(2)alpha phosphorylation, and COX2 expression in response to particulate beta-glucan suggesting that other receptors engaged by C. albicans preferentially mediate these responses. Results also implicate the mannan-binding receptor Dectin-2 in regulating cPLA(2)alpha. C. albicans-stimulated MAPK activation and AA release are blocked by D-mannose and Dectin-2-specific antibody, and overexpression of Dectin-2 in RAW264.7 macrophages enhances C. albicans-stimulated MAPK activation, AA release, and COX2 expression. In addition, calcium mobilization is enhanced in RAW264.7 macrophages overexpressing Dectin-1 or -2. The results demonstrate that C. albicans engages both beta-glucan and mannan-binding receptors on macrophages that act with MyD88 to regulate the activation of cPLA(2)alpha and eicosanoid production.	[Suram, Saritha; Gangelhoff, Todd A.; Leslie, Christina C.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Taylor, Philip R.; Rosas, Marcela] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales; [Brown, Gordon D.] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 22D, Scotland; [Bonventre, Joseph V.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Akira, Shizuo; Uematsu, Satoshi] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Williams, David L.] E Tennessee State Univ, James H Quillen Coll Med, Dept Surg, Johnson City, TN 37614 USA; [Murphy, Robert C.; Leslie, Christina C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Leslie, Christina C.] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA	National Jewish Health; Cardiff University; University of Aberdeen; Harvard University; Brigham & Women's Hospital; Osaka University; East Tennessee State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Leslie, CC (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.	lesliec@njhealth.org	brown, gordon/B-4249-2012; Murphy, Robert/AAO-5349-2020; Rosas Nexticapa, Marcela/HGU-1088-2022; Akira, Shizuo/C-3134-2009	Murphy, Robert/0000-0002-9430-6515; Taylor, Philip/0000-0003-0163-1421; brown, gordon/0000-0002-0287-5383	National Institutes of Health [HL34303, DK54741, GM53522]; United Kingdom Medical Research Council [G0601617]; Wellcome Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072381, R56DK054741, R01DK054741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053522] Funding Source: NIH RePORTER; MRC [G0601617] Funding Source: UKRI; Medical Research Council [G0601617] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HL34303 (to R. C. M. and C. C. L.), DK54741 (to J. V. B.), and GM53522 (to D. L. W.). This work was also supported by a United Kingdom Medical Research Council Senior Fellowship G0601617 (to P. R. T.) and the Wellcome Trust (to G. D. B.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barrett NA, 2009, J IMMUNOL, V182, P1119, DOI 10.4049/jimmunol.182.2.1119; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Cambi A, 2008, J BIOL CHEM, V283, P20590, DOI 10.1074/jbc.M709334200; DECARVALHO MS, 1993, ARCH BIOCHEM BIOPHYS, V306, P534, DOI 10.1006/abbi.1993.1549; ENSLEY HE, 1994, CARBOHYD RES, V258, P307, DOI 10.1016/0008-6215(94)84098-9; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Gijon MA, 2007, J LIPID RES, V48, P716, DOI 10.1194/jlr.M600508-JLR200; Girotti M, 2004, J BIOL CHEM, V279, P19113, DOI 10.1074/jbc.M313867200; Graham LM, 2009, CYTOKINE, V48, P148, DOI 10.1016/j.cyto.2009.07.010; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; Heinsbroek SEM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000218; Hernanz-Falcon P, 2009, EUR J IMMUNOL, V39, P507, DOI 10.1002/eji.200838687; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Jouault T, 2006, J IMMUNOL, V177, P4679, DOI 10.4049/jimmunol.177.7.4679; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lee SH, 2007, BIOCHEM BIOPH RES CO, V364, P996, DOI 10.1016/j.bbrc.2007.10.111; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Masuoka J, 2004, CLIN MICROBIOL REV, V17, P281, DOI 10.1128/CMR.17.2.281-310.2004; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Miyazato A, 2009, INFECT IMMUN, V77, P3056, DOI 10.1128/IAI.00840-08; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Parti RP, 2010, AM J RESP CELL MOL, V42, P415, DOI 10.1165/rcmb.2009-0110OC; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Poulain D, 2004, CURR OPIN MICROBIOL, V7, P342, DOI 10.1016/j.mib.2004.06.011; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Rice PJ, 2002, J LEUKOCYTE BIOL, V72, P140; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rosas M, 2008, J IMMUNOL, V181, P3549, DOI 10.4049/jimmunol.181.5.3549; Rouzer CA, 2004, J BIOL CHEM, V279, P34256, DOI 10.1074/jbc.M402594200; Rouzer CA, 2006, BIOCHEM J, V399, P91, DOI 10.1042/BJ20060615; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Suram S, 2006, J BIOL CHEM, V281, P5506, DOI 10.1074/jbc.M509824200; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2005, EUR J IMMUNOL, V35, P2163, DOI 10.1002/eji.200425785; Taylor PR, 2004, J IMMUNOL, V172, P1157, DOI 10.4049/jimmunol.172.2.1157; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Tucker DE, 2009, J BIOL CHEM, V284, P9596, DOI 10.1074/jbc.M807299200; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; Valera I, 2008, J IMMUNOL, V180, P5727, DOI 10.4049/jimmunol.180.8.5727; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; WILLIAMS DL, 1991, CARBOHYD RES, V219, P203, DOI 10.1016/0008-6215(91)89052-H; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Xia Y, 1999, J IMMUNOL, V162, P2281; Zimmerman JW, 1998, J BIOL CHEM, V273, P22014, DOI 10.1074/jbc.273.34.22014	65	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30676	30685		10.1074/jbc.M110.143800	http://dx.doi.org/10.1074/jbc.M110.143800			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20643646	Green Published, hybrid			2022-12-25	WOS:000282135500036
J	Kim, YM; Shin, HT; Seo, YH; Byun, HO; Yoon, SH; Lee, IK; Hyun, DH; Chung, HY; Yoon, G				Kim, You-Mie; Shin, Hyun-Taek; Seo, Yong-Hak; Byun, Hae-Ok; Yoon, Soo-Han; Lee, In-Kyu; Hyun, Dong-Hoon; Chung, Hae-Young; Yoon, Gyesoon			Sterol Regulatory Element-binding Protein (SREBP)-1-mediated Lipogenesis Is Involved in Cell Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHESIS; ATP CITRATE LYASE; TRANSCRIPTION FACTOR; HUMAN FIBROBLASTS; OXIDATIVE STRESS; MITOCHONDRIAL MASS; LIPID-SYNTHESIS; GROWTH; DNA; INHIBITORS	Increased cell mass is one of the characteristics of senescent cells, but this event has not been clearly defined. When subcellular organellar mass was estimated with organelle-specific fluorescence dyes, we observed that most membranous organelles progressively increase in mass during cell senescence. This increase was accompanied by an increase in membrane lipids and augmented expression of lipogenic enzymes, such as fatty acid synthase (FAS), ATP citrate lyase, and acetyl-CoA carboxylase. The mature form of sterol regulatory element-binding protein (SREBP)-1 was also elevated. Increased expression of these lipogenic effectors was further observed in the liver tissues of aging Fischer 344 rats. Ectopic expression of mature form of SREBP-1 in both Chang cells and primary young human diploid fibroblasts was enough to induce senescence. Blocking lipogenesis with FAS inhibitors (cerulenin and C75) and via siRNA-mediated silencing of SREBP-1 and ATP citrate lyase significantly attenuated H2O2-induced senescence. Finally, old human diploid fibroblasts were effectively reversed to young-like cells by challenging with FAS inhibitors. Our results suggest that enhanced lipogenesis is not only a common event, but also critically involved in senescence via SREBP-1 induction, thereby contributing to the increase in organelle mass (as a part of cell mass), a novel indicator of senescence.	[Yoon, Gyesoon] Ajou Univ, Dept Biochem & Mol Biol, Sch Med, Suwon 443721, South Korea; [Yoon, Soo-Han] Ajou Univ, Dept Neurosurg, Sch Med, Suwon 443721, South Korea; [Kim, You-Mie; Shin, Hyun-Taek; Seo, Yong-Hak; Byun, Hae-Ok; Yoon, Soo-Han; Yoon, Gyesoon] Ajou Univ, Dept Mol Sci & Technol, Grad Sch, Suwon 443721, South Korea; [Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu 700721, South Korea; [Hyun, Dong-Hoon] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea; [Chung, Hae-Young] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea	Ajou University; Ajou University; Ajou University; Kyungpook National University; Ewha Womans University; Pusan National University	Yoon, G (corresponding author), Ajou Univ, Dept Biochem & Mol Biol, Sch Med, Suwon 443721, South Korea.	ypeace@ajou.ac.kr	Lee, In-Kyu/AAR-6374-2021		Korean government [R13-2003-019-01007-0]	Korean government(Korean Government)	This work was supported by Korean Science and Engineering Foundation Grant R13-2003-019-01007-0 funded by the Korean government.	Assmus B, 2003, CIRC RES, V92, P1049, DOI 10.1161/01.RES.0000070067.64040.7C; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2; Chondrogianni N, 2004, BIOGERONTOLOGY, V5, P55, DOI 10.1023/B:BGEN.0000017687.55667.42; Chondrogianni N, 2002, BIOGERONTOLOGY, V3, P121, DOI 10.1023/A:1015236203379; CRISTOFA.VJ, 1969, MED EXP, V19, P313; Demoulin JB, 2004, J BIOL CHEM, V279, P35392, DOI 10.1074/jbc.M405924200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; GREENBERG SB, 1977, IN VITRO CELL DEV B, V13, P297; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hwang ES, 2009, CELL MOL LIFE SCI, V66, P2503, DOI 10.1007/s00018-009-0034-2; Inoue N, 2005, MOL CELL BIOL, V25, P8938, DOI 10.1128/MCB.25.20.8938-8947.2005; Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200; Kim KH, 2004, J BIOL CHEM, V279, P51999, DOI 10.1074/jbc.M405522200; KUPKE IR, 1978, J CHROMATOGR, V146, P261, DOI 10.1016/S0378-4347(00)81892-7; Kurz T, 2008, BBA-GEN SUBJECTS, V1780, P1291, DOI 10.1016/j.bbagen.2008.01.009; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978; Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6; LIPETZ J, 1972, J ULTRA MOL STRUCT R, V39, P43, DOI 10.1016/S0022-5320(72)80005-4; Maeda M, 2009, LIFE SCI, V84, P119, DOI 10.1016/j.lfs.2008.11.009; Nakakuki M, 2007, FEBS J, V274, P4440, DOI 10.1111/j.1742-4658.2007.05973.x; OMURA S, 1976, BACTERIOL REV, V40, P681, DOI 10.1128/MMBR.40.3.681-697.1976; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Pizer ES, 1998, CANCER RES, V58, P4611; Porstmann T, 2009, BIOCHEM SOC T, V37, P278, DOI 10.1042/BST0370278; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Schmucker DL, 2002, ARCH GERONTOL GERIAT, V34, P249, DOI 10.1016/S0167-4943(01)00218-7; Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004; Tahara S, 2001, MECH AGEING DEV, V122, P415, DOI 10.1016/S0047-6374(00)00257-8; Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wei YH, 2001, ANN NY ACAD SCI, V928, P97; Yoon G, 2002, BIOCHEM J, V366, P613, DOI 10.1042/BJ20011445; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753	43	60	61	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29069	29077		10.1074/jbc.M110.120386	http://dx.doi.org/10.1074/jbc.M110.120386			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20615871	Green Published, hybrid			2022-12-25	WOS:000281740100008
J	Zhang, C; Browne, A; Child, D; Tanzi, RE				Zhang, Can; Browne, Andrew; Child, Daniel; Tanzi, Rudolph E.			Curcumin Decreases Amyloid-beta Peptide Levels by Attenuating the Maturation of Amyloid-beta Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; IN-VIVO; SECRETASE CLEAVAGE; TRANSGENIC MOUSE; APP METABOLISM; GENERATION; HYPOTHESIS; EXPRESSION; OLIGOMERS; PATHOLOGY	Alzheimer disease (AD) is a devastating neurodegenerative disease with no cure. The pathogenesis of AD is believed to be driven primarily by amyloid-beta (A beta), the principal component of senile plaques. A beta is an similar to 4-kDa peptide generated via cleavage of the amyloid-beta precursor protein (APP). Curcumin is a compound in the widely used culinary spice, turmeric, which possesses potent and broad biological activities, including anti-inflammatory and antioxidant activities, chemopreventative effects, and effects on protein trafficking. Recent in vivo studies indicate that curcumin is able to reduce A beta-related pathology in transgenic AD mouse models via unknown molecular mechanisms. Here, we investigated the effects of curcumin on A beta levels and APP processing in various cell lines and mouse primary cortical neurons. We show for the first time that curcumin potently lowers A beta levels by attenuating the maturation of APP in the secretory pathway. These data provide a mechanism of action for the ability of curcumin to attenuate amyloid-beta pathology.	[Tanzi, Rudolph E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med,MassGen Inst Neurodegenerat Dis, Dept Neurol,Genet & Aging Res Unit, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Tanzi, RE (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,MassGen Inst Neurodegenerat Dis, Dept Neurol,Genet & Aging Res Unit, 114 16th St, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Child, Daniel/0000-0002-4309-0144	Cure Alzheimer's Fund; Massachusetts General Hospital; Harvard NeuroDiscovery Center; Massachusetts Alzheimer's Disease Research Center	Cure Alzheimer's Fund; Massachusetts General Hospital(General Electric); Harvard NeuroDiscovery Center; Massachusetts Alzheimer's Disease Research Center	This work was supported by the Cure Alzheimer's Fund, the Funds for Medical Discovery from Massachusetts General Hospital, and a Neurodegenerative Disease Pilot Study Grant from the Harvard NeuroDiscovery Center and Massachusetts Alzheimer's Disease Research Center.	Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Antczak C, 2009, COMB CHEM HIGH T SCR, V12, P258, DOI 10.2174/138620709787581729; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Calabrese V, 2003, AMINO ACIDS, V25, P437, DOI 10.1007/s00726-003-0048-2; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gandy S, 2007, J NEUROCHEM, V102, P619, DOI 10.1111/j.1471-4159.2007.04587.x; Ganguli M, 2000, ARCH NEUROL-CHICAGO, V57, P824, DOI 10.1001/archneur.57.6.824; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hiltunen M, 2006, J BIOL CHEM, V281, P32240, DOI 10.1074/jbc.M603106200; Hong HS, 2009, J NEUROCHEM, V108, P1097, DOI 10.1111/j.1471-4159.2008.05866.x; Huttunen HJ, 2007, J BIOL CHEM, V282, P28285, DOI 10.1074/jbc.M702951200; Kelloff GJ, 1997, PROG CLIN BIOL RES, V396, P159; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shimmyo Y, 2008, NEUROREPORT, V19, P1329, DOI 10.1097/WNR.0b013e32830b8ae1; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Teijido O, 2004, HUM MOL GENET, V13, P2581, DOI 10.1093/hmg/ddh291; Tesco G, 2003, J BIOL CHEM, V278, P46074, DOI 10.1074/jbc.M307809200; Thomas P, 2009, MUTAT RES-FUND MOL M, V661, P25, DOI 10.1016/j.mrfmmm.2008.10.016; Walsh DM, 2003, BIOCHEMISTRY-US, V42, P6664, DOI 10.1021/bi027375c; Wang YJ, 2009, NEUROTOX RES, V15, P3, DOI 10.1007/s12640-009-9000-x; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Xie ZC, 2005, J BIOL CHEM, V280, P15413, DOI 10.1074/jbc.M414353200; Xie ZC, 2007, J BIOL CHEM, V282, P4318, DOI 10.1074/jbc.M609293200; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; ZHANG C, J BIOL CHEM, V285, P8515; ZHANG C, CURR ALZHEIMER RES, V7, P21; Zhang C, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-15; Zhang Can, 2007, Discov Med, V7, P113	39	137	144	4	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28472	28480		10.1074/jbc.M110.133520	http://dx.doi.org/10.1074/jbc.M110.133520			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20622013	Green Published, hybrid			2022-12-25	WOS:000281594000010
J	Frost, JM; Udayashankar, R; Moore, HD; Moore, GE				Frost, Jennifer M.; Udayashankar, Ramya; Moore, Harry D.; Moore, Gudrun E.			Telomeric NAP1L4 and OSBPL5 of the KCNQ1 Cluster, and the DECORIN Gene Are Not Imprinted in Human Trophoblast Stem Cells	PLOS ONE			English	Article							REPRESSIVE HISTONE METHYLATION; PLACENTA; DOMAIN; LINES	Background: Genomic imprinting of the largest known cluster, the Kcnq1/KCNQ1 domain on mChr7/hChr11, displays significant differences between mouse and man. Of the fourteen transcripts in this cluster, imprinting of six is ubiquitous in mice and humans, however, imprinted expression of the other eight transcripts is only found in the mouse placenta. The human orthologues of the latter eight transcripts are biallelically expressed, at least from the first trimester onwards. However, as early development is less divergent between species, placental specific imprinting may be present in very early gestation in both mice and humans. Methodology/Principal Findings: Human embryonic stem (hES) cells can be differentiated to embryoid bodies and then to trophoblast stem (EB-TS) cells. Using EB-TS cells as a model of post-implantation invading cytotrophoblast, we analysed allelic expression of two telomeric transcripts whose imprinting is placental specific in the mouse, as well as the ncRNA KCNQ1OT1, whose imprinted expression is ubiquitous in early human and mouse development. KCNQ1OT1 expression was monoallelic in all samples but OSBPL5 and NAP1L4 expression was biallelic in EB-TS cells, as well as undifferentiated hES cells and first trimester human fetal placenta. DCN on hChr12, another gene imprinted in the mouse placenta only, was also biallelically expressed in EB-TS cells. The germline maternal methylation imprint at the KvDMR was maintained in both undifferentiated hES cells and EB-TS cells. Conclusions/Significance: The question of placental specific imprinting in the human has not been answered fully. Using a model of human trophoblast very early in gestation we show a lack of imprinting of two telomeric genes in the KCNQ1 region and of DCN, whose imprinted expression is placental specific in mice, providing further evidence to suggest that humans do not exhibit placental specific imprinting. The maintenance of both differential methylation of the KvDMR and monoallelic expression of KCNQ1OT1 indicates that the region is appropriately regulated epigenetically in vitro. Human gestational load is less than in the mouse, resulting in reduced need for maternal resource competition, and therefore maybe also a lack of placental specific imprinting. If genomic imprinting exists to control fetal acquisition of maternal resources driven by the placenta, placenta-specific imprinting may be less important in the human than the mouse.	[Frost, Jennifer M.; Moore, Gudrun E.] UCL, Clin & Mol Genet Unit, Inst Child Hlth, London, England; [Frost, Jennifer M.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Udayashankar, Ramya; Moore, Harry D.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of London; University College London; Imperial College London; University of Sheffield	Frost, JM (corresponding author), UCL, Clin & Mol Genet Unit, Inst Child Hlth, London, England.	j.frost@ich.ucl.ac.uk	Moore, Gudrun/A-2092-2009; Frost, Jennifer/D-1867-2015	Frost, Jennifer/0000-0002-3057-6313	MRC; Wellcome Trust; SPARKS; Wellbeing of Women; Infertility Research Trust; Sheffield Hospitals Charitable Trust; MRC [G0801059] Funding Source: UKRI; Medical Research Council [G0801059] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); SPARKS; Wellbeing of Women(Wellbeing of Women (WoW)); Infertility Research Trust; Sheffield Hospitals Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JMF was an MRC PhD Student. The work in GEM research group at ICH laboratory is supported by the MRC, Wellcome Trust, SPARKS and Wellbeing of Women. RU is grateful to the Infertility Research Trust for her studentship. Aspects of the study in Sheffield were also supported by the Medical Research Council and Sheffield Hospitals Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero S, 2008, J MED GENET, V45, P193, DOI 10.1136/jmg.2007.053017; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Bischof JM, 2007, HUM MOL GENET, V16, P2713, DOI 10.1093/hmg/ddm225; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Harun R, 2006, HUM REPROD, V21, P1349, DOI 10.1093/humrep/del017; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; King A, 2000, PLACENTA, V21, pS113, DOI 10.1053/plac.1999.0526; Knox K, 2008, GENOME RES, V18, P695, DOI 10.1101/gr.071407.107; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Mancini-DiNardo D, 2003, HUM MOL GENET, V12, P283, DOI 10.1093/hmg/ddg024; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Mizuno Y, 2002, BIOCHEM BIOPH RES CO, V290, P1499, DOI 10.1006/bbrc.2002.6370; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Redrup L, 2009, DEVELOPMENT, V136, P525, DOI 10.1242/dev.031328; Schulz LC, 2008, PLACENTA, V29, pS10, DOI 10.1016/j.placenta.2007.10.009; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467	19	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11595	10.1371/journal.pone.0011595	http://dx.doi.org/10.1371/journal.pone.0011595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644730	Green Accepted, Green Published, gold			2022-12-25	WOS:000279884900026
J	Leuner, B; Glasper, ER; Gould, E				Leuner, Benedetta; Glasper, Erica R.; Gould, Elizabeth			Sexual Experience Promotes Adult Neurogenesis in the Hippocampus Despite an Initial Elevation in Stress Hormones	PLOS ONE			English	Article							DENTATE GYRUS; MALE-RATS; CELL-PROLIFERATION; STIMULATED NEUROGENESIS; ENHANCES NEUROGENESIS; PYRAMIDAL NEURONS; APICAL DENDRITES; SPATIAL MEMORY; BEHAVIOR; ANXIETY	Aversive stressful experiences are typically associated with increased anxiety and a predisposition to develop mood disorders. Negative stress also suppresses adult neurogenesis and restricts dendritic architecture in the hippocampus, a brain region associated with anxiety regulation. The effects of aversive stress on hippocampal structure and function have been linked to stress-induced elevations in glucocorticoids. Normalizing corticosterone levels prevents some of the deleterious consequences of stress, including increased anxiety and suppressed structural plasticity in the hippocampus. Here we examined whether a rewarding stressor, namely sexual experience, also adversely affects hippocampal structure and function in adult rats. Adult male rats were exposed to a sexually-receptive female once (acute) or once daily for 14 consecutive days (chronic) and levels of circulating glucocorticoids were measured. Separate cohorts of sexually experienced rats were injected with the thymidine analog bromodeoxyuridine in order to measure cell proliferation and neurogenesis in the hippocampus. In addition, brains were processed using Golgi impregnation to assess the effects of sexual experience on dendritic spines and dendritic complexity in the hippocampus. Finally, to evaluate whether sexual experience alters hippocampal function, rats were tested on two tests of anxiety-like behavior: novelty suppressed feeding and the elevated plus maze. We found that acute sexual experience increased circulating corticosterone levels and the number of new neurons in the hippocampus. Chronic sexual experience no longer produced an increase in corticosterone levels but continued to promote adult neurogenesis and stimulate the growth of dendritic spines and dendritic architecture. Chronic sexual experience also reduced anxiety-like behavior. These findings suggest that a rewarding experience not only buffers against the deleterious actions of early elevated glucocorticoids but actually promotes neuronal growth and reduces anxiety.	[Leuner, Benedetta; Glasper, Erica R.; Gould, Elizabeth] Princeton Univ, Dept Psychol, Inst Neurosci, Princeton, NJ 08544 USA	Princeton University	Leuner, B (corresponding author), Princeton Univ, Dept Psychol, Inst Neurosci, Princeton, NJ 08544 USA.	goulde@princeton.edu	GLASPER, ERICA/GOK-0082-2022	GLASPER, ERICA/0000-0003-1938-2144	National Alliance for Research on Schizophrenia and Depression; National Institute of Mental Health [MH084148, MH54970]; National Institute on Aging; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH084148, R01MH054970, K99MH084148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG033461] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression(NARSAD); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by a Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression (B. L.), grants from the National Institute of Mental Health (MH084148 to B. L. and MH54970 to E. G.) and a Ruth L. Kirschstein postdoctoral NRSA fellowship from the National Institute on Aging (E. R. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antzoulatos E, 2008, HORM BEHAV, V54, P735, DOI 10.1016/j.yhbeh.2008.08.001; Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; Belke TW, 2005, BEHAV PROCESS, V68, P165, DOI 10.1016/j.beproc.2004.12.006; Bonilla-Jaime H, 2006, HORM BEHAV, V49, P376, DOI 10.1016/j.yhbeh.2005.08.005; Brene S, 2007, PHYSIOL BEHAV, V92, P136, DOI 10.1016/j.physbeh.2007.05.015; Brown DA, 2007, J APPL PHYSIOL, V103, P1979, DOI 10.1152/japplphysiol.00706.2007; Calvo N, 1998, BRAIN RES, V800, P227, DOI 10.1016/S0006-8993(98)00515-0; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Conrad Cheryl D, 2006, Behav Cogn Neurosci Rev, V5, P41, DOI 10.1177/1534582306289043; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Droste SK, 2007, NEUROENDOCRINOLOGY, V86, P26, DOI 10.1159/000104770; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Edinger KL, 2007, PHYSIOL BEHAV, V92, P443, DOI 10.1016/j.physbeh.2007.04.018; Eisch AJ, 2006, HIPPOCAMPUS, V16, P271, DOI 10.1002/hipo.20161; EVERITT BJ, 1987, J COMP PSYCHOL, V101, P395, DOI 10.1037/0735-7036.101.4.395; Flanagan-Cato LM, 2006, J NEUROENDOCRINOL, V18, P857, DOI 10.1111/j.1365-2826.2006.01483.x; Gould E, 1997, J NEUROSCI, V17, P2492; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Hull EM, 2007, HORM BEHAV, V52, P45, DOI 10.1016/j.yhbeh.2007.03.030; HUNDT AG, 1963, SCIENCE, V142, P1087, DOI 10.1126/science.142.3595.1087; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Neumann ID, 2009, FRONT NEUROENDOCRIN, V30, P483, DOI 10.1016/j.yfrne.2009.04.012; Paredes RG, 2009, ILAR J, V50, P15, DOI 10.1093/ilar.50.1.15; PITCHERS KK, 2009, BIOL PSYCHI IN PRESS; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Rodriguez-Manzo G, 1999, PHYSIOL BEHAV, V67, P651, DOI 10.1016/S0031-9384(99)00119-5; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Spritzer MD, 2009, BEHAV BRAIN RES, V200, P106, DOI 10.1016/j.bbr.2009.01.003; Stranahan AM, 2007, HIPPOCAMPUS, V17, P1017, DOI 10.1002/hipo.20348; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Takahashi T, 2009, NEUROSCIENCE, V158, P402, DOI 10.1016/j.neuroscience.2008.10.048; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; Tenk CM, 2009, HORM BEHAV, V55, P93, DOI 10.1016/j.yhbeh.2008.08.012; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Waldherr M, 2007, P NATL ACAD SCI USA, V104, P16681, DOI 10.1073/pnas.0705860104; Waldherr M, 2010, HORM BEHAV, V57, P222, DOI 10.1016/j.yhbeh.2009.11.006; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A	49	116	118	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11597	10.1371/journal.pone.0011597	http://dx.doi.org/10.1371/journal.pone.0011597			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644737	Green Published, Green Submitted, gold			2022-12-25	WOS:000279884900027
J	Xu, CF; Yu, CH; Xu, L; Miao, M; Li, YM				Xu, Chengfu; Yu, Chaohui; Xu, Lei; Miao, Min; Li, Youming			High Serum Uric Acid Increases the Risk for Nonalcoholic Fatty Liver Disease: A Prospective Observational Study	PLOS ONE			English	Article							METABOLIC SYNDROME; OXIDATIVE STRESS; PREVALENCE; STEATOHEPATITIS; INDIVIDUALS; ASSOCIATION; POPULATION; MORTALITY; GLUCOSE	Nonalcoholic fatty liver disease (NAFLD) is a common form of chronic liver disease, and serum uric acid is observed to be significantly elevated in NAFLD patients. However, whether this elevation is causal, a bystander, or a consequence of NAFLD remains unclear. We performed a population-based prospective study among the employees of Zhenhai Refining & Chemical Company Ltd., Ningbo, China to investigate whether the elevation of serum uric acid has a casual role for NAFLD. A total of 6890 initially NAFLD-free subjects were followed up for 3 years. Overall, 11.80% (813/6890) subjects developed NAFLD over 3 years of follow-up. The cumulative incidence of NAFLD increased with progressively higher baseline serum uric acid levels (the cumulative incidence was 7.2%, 9.5%, 11.5%, 13.8%, and 17.2% in quintile 1, quintile 2, 3, 4 and 5, respectively; P value for trend <0.001). Cox proportional hazards regression analyses showed that serum uric acid levels were independently and positively associated with the risk for incident NAFLD; the age-, gender- and metabolic syndrome adjusted hazard ratio (95% CI) for the subjects in quintile 2, 3, 4 and 5 versus quintile 1 was 1.18 (0.91-1.54), 1.32 (1.03-1.70), 1.39 (1.09-1.78) and 1.50 (1.18-1.92), respectively. Taken together, our prospective observational study showed that elevation of serum uric acid levels independently predicts increase risk for incident NAFLD.	[Xu, Chengfu; Yu, Chaohui; Xu, Lei; Li, Youming] Zhejiang Univ, Affiliated Hosp 1, Dept Gastroenterol, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Lei; Miao, Min] Ningbo 1 Hosp, Dept Gastroenterol, Ningbo, Zhejiang, Peoples R China	Zhejiang University	Li, YM (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Gastroenterol, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	xiaofu@zju.edu.cn		Ma, Han/0000-0001-9985-3035	Chinese State Key Project for High-tech [2006AA02A308]; National Science & Technology Pillar Program [2008BAI52B03]; National Natural Science Foundation of China [30871154]; Science & Technology Foundation of Zhejiang Province [2008C13027-1]	Chinese State Key Project for High-tech; National Science & Technology Pillar Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Foundation of Zhejiang Province	This study was supported by Chinese State Key Project for High-tech (No. 2006AA02A308), National Science & Technology Pillar Program (No. 2008BAI52B03), National Natural Science Foundation of China (No. 30871154) and Science & Technology Foundation of Zhejiang Province (No. 2008C13027-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Baskol G, 2007, CLIN BIOCHEM, V40, P776, DOI 10.1016/j.clinbiochem.2007.02.006; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cerda C, 2007, J HEPATOL, V47, P412, DOI 10.1016/j.jhep.2007.04.012; Choi HK, 2007, AM J MED, V120, P442, DOI 10.1016/j.amjmed.2006.06.040; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Hjortnaes J, 2007, J RHEUMATOL, V34, P1882; Jankowska EA, 2009, JAMA-J AM MED ASSOC, V301, P1892, DOI 10.1001/jama.2009.639; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Li YM, 2009, J HEPATOL, V50, P1029, DOI 10.1016/j.jhep.2008.11.021; Mahmoodi BK, 2009, JAMA-J AM MED ASSOC, V301, P1790, DOI 10.1001/jama.2009.565; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X; Suzuki A, 2005, J HEPATOL, V43, P1060, DOI 10.1016/j.jhep.2005.06.008; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; XU CF, 2010, HEPATOLOGY IN PRESS, DOI DOI 10.1002/HEP.23798; Yoo TW, 2005, CIRC J, V69, P928, DOI 10.1253/circj.69.928; Zhou M, 2009, EUR J ENDOCRINOL, V161, P723, DOI 10.1530/EJE-09-0585	33	105	118	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11578	10.1371/journal.pone.0011578	http://dx.doi.org/10.1371/journal.pone.0011578			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644649	gold, Green Submitted, Green Published			2022-12-25	WOS:000279884900017
J	Pajalunga, D; Puggioni, EMR; Mazzola, A; Leva, V; Montecucco, A; Crescenzi, M				Pajalunga, Deborah; Puggioni, Eleonora M. R.; Mazzola, Alessia; Leva, Valentina; Montecucco, Alessandra; Crescenzi, Marco			DNA Replication Is Intrinsically Hindered in Terminally Differentiated Myotubes	PLOS ONE			English	Article							CELL-CYCLE; HISTONE H2AX; S-PHASE; REGENERATION; REQUIREMENT; PROGRESSION; CHECKPOINT; INDUCTION; INFECTION; REENTRY	Background: Terminally differentiated (TD) cells permanently exit the mitotic cycle while acquiring specialized characteristics. Although TD cells can be forced to reenter the cell cycle by different means, they cannot be made to stably proliferate, as attempts to induce their replication constantly result in cell death or indefinite growth arrest. There is currently no biological explanation for this failure. Principal Findings: Here we show that TD mouse myotubes, reactivated by depletion of the p21 and p27 cell cycle inhibitors, are unable to complete DNA replication and sustain heavy DNA damage, which triggers apoptosis or results in mitotic catastrophe. In striking contrast, quiescent, non-TD fibroblasts and myoblasts, reactivated in the same way, fully replicate their DNA, do not suffer DNA damage, and proliferate even in the absence of growth factors. Similar results are obtained when myotubes and fibroblasts are reactivated by forced expression of E1A or cyclin D1 and cdk4. Conclusions: We conclude that the inability of myotubes to complete DNA replication must be ascribed to peculiar features inherent in their TD state, rather than to the reactivation method. On reviewing the literature concerning reactivation of other TD cell types, we propose that similar mechanisms underlie the general inability of all kinds of TD cells to proliferate in response to otherwise mitogenic stimuli. These results define an unexpected basis for the well known incompetence of mammalian postmitotic cells to proliferate. Furthermore, this trait might contribute to explain the inability of these cells to play a role in tissue repair, unlike their counterparts in extensively regenerating species.	[Pajalunga, Deborah; Puggioni, Eleonora M. R.; Mazzola, Alessia; Crescenzi, Marco] Natl Inst Hlth, Dept Cell Biol & Neurosci, Rome, Italy; [Leva, Valentina; Montecucco, Alessandra] Inst Mol Genet, Natl Res Council, Pavia, Italy	Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR)	Pajalunga, D (corresponding author), Natl Inst Hlth, Dept Cell Biol & Neurosci, Rome, Italy.	marco.crescenzi@iss.it	Crescenzi, Marco/J-3603-2018; Montecucco, Alessandra/B-8041-2015; pajalunga, deborah/K-2423-2018	Crescenzi, Marco/0000-0003-0156-1494; Montecucco, Alessandra/0000-0002-9388-9149; pajalunga, deborah/0000-0003-4892-8396	Telethon Italy [GGP05006]	Telethon Italy(Fondazione Telethon)	This study has been funded by Telethon Italy (http://www.telethon.it), grant no. GGP05006. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Banerjee NS, 2006, J VIROL, V80, P6517, DOI 10.1128/JVI.02499-05; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Boye Erik, 2009, V521, P55, DOI [10.1007/978-1-60327-815-7_4, 10.1007/978-1-60327-817-5_4]; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Campa VM, 2008, J CELL BIOL, V183, P129, DOI 10.1083/jcb.200806104; CONNOLLY JA, 1986, EUR J CELL BIOL, V39, P341; CRESCENZI M, 1995, J CELL PHYSIOL, V162, P26, DOI 10.1002/jcp.1041620105; CRESCENZI M, 1995, ANN NY ACAD SCI, V752, P9, DOI 10.1111/j.1749-6632.1995.tb17402.x; CRESCENZI M, 2002, REACTIVATION CELL CY; Endo T, 1998, J CELL SCI, V111, P1081; Endo T., 1989, CELLULAR MOL BIOL MU, P95; FEDDERSEN RM, 1992, NEURON, V9, P955, DOI 10.1016/0896-6273(92)90247-B; FOGEL M, 1967, P NATL ACAD SCI USA, V58, P967, DOI 10.1073/pnas.58.3.967; Gottifredi V, 2005, SEMIN CELL DEV BIOL, V16, P355, DOI 10.1016/j.semcdb.2005.02.011; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HJIANTONIOU E, 2007, DIFFERENTIATION; Kirshenbaum LA, 1996, DEV BIOL, V179, P402, DOI 10.1006/dbio.1996.0270; Latella L, 2000, CELL DEATH DIFFER, V7, P145, DOI 10.1038/sj.cdd.4400592; Latella L, 2001, MOL CELL BIOL, V21, P5631, DOI 10.1128/MCB.21.16.5631-5643.2001; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Pajalunga D, 1999, ONCOGENE, V18, P5054, DOI 10.1038/sj.onc.1202897; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; SACCO A, 2002, MOL B INT U, V17, P45; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Smith DS, 2000, CELL GROWTH DIFFER, V11, P625; SULG M, 2009, J NEUROCHEM; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Tanaka EM, 2003, CELL, V113, P559, DOI 10.1016/S0092-8674(03)00395-7; Tanaka T, 2007, CELL PROLIFERAT, V40, P1; TASSIN AM, 1985, J CELL BIOL, V100, P35, DOI 10.1083/jcb.100.1.35; Tiainen M, 1996, CELL GROWTH DIFFER, V7, P1039; Tiainen M, 1996, MOL CELL BIOL, V16, P5302; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Vitolo B, 2005, EUR J HISTOCHEM, V49, P349; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; YAFFE D, 1967, NATURE, V215, P421, DOI 10.1038/215421a0	42	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11559	10.1371/journal.pone.0011559	http://dx.doi.org/10.1371/journal.pone.0011559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644635	Green Published, gold, Green Submitted			2022-12-25	WOS:000279822300013
J	Cahill, MJ; Koser, CU; Ross, NE; Archer, JAC				Cahill, Matt J.; Koser, Claudio U.; Ross, Nicholas E.; Archer, John A. C.			Read Length and Repeat Resolution: Exploring Prokaryote Genomes Using Next-Generation Sequencing Technologies	PLOS ONE			English	Article							BACTERIAL GENOMES; ALGORITHMS; ALIGNMENT; GENETICS; IMPACT	Background: There are a growing number of next-generation sequencing technologies. At present, the most cost-effective options also produce the shortest reads. However, even for prokaryotes, there is uncertainty concerning the utility of these technologies for the de novo assembly of complete genomes. This reflects an expectation that short reads will be unable to resolve small, but presumably abundant, repeats. Methodology/Principal Findings: Using a simple model of repeat assembly, we develop and test a technique that, for any read length, can estimate the occurrence of unresolvable repeats in a genome, and thus predict the number of gaps that would need to be closed to produce a complete sequence. We apply this technique to 818 prokaryote genome sequences. This provides a quantitative assessment of the relative performance of various lengths. Notably, unpaired reads of only 150nt can reconstruct approximately 50% of the analysed genomes with fewer than 96 repeat-induced gaps. Nonetheless, there is considerable variation amongst prokaryotes. Some genomes can be assembled to near contiguity using very short reads while others require much longer reads. Conclusions: Given the diversity of prokaryote genomes, a sequencing strategy should be tailored to the organism under study. Our results will provide researchers with a practical resource to guide the selection of the appropriate read length.	[Cahill, Matt J.; Koser, Claudio U.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Ross, Nicholas E.] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3EH, England; [Archer, John A. C.] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Div Chem & Biol Engn, Thuwal, Saudi Arabia	University of Cambridge; University of Cambridge; King Abdullah University of Science & Technology	Cahill, MJ (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	john.archer@kaust.edu.sa	Archer, John/D-5200-2012; Archer, John/AAW-1990-2021; Köser, Claudio/I-3740-2013	Archer, John/0000-0002-3302-3933; Köser, Claudio/0000-0002-0232-846X	Cambridge European Trust; Clare Hall, Cambridge	Cambridge European Trust; Clare Hall, Cambridge	CUK is a recipient of a Gates Cambridge Scholarship and received additional funding from the Cambridge European Trust and Clare Hall, Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2003, GENETICS, V164, P1279; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bryant DW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-69; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Farrer RA, 2009, FEMS MICROBIOL LETT, V291, P103, DOI 10.1111/j.1574-6968.2008.01441.x; Fraser CM, 2002, J BACTERIOL, V184, P6403, DOI 10.1128/JB.184.23.6403-6405.2002; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Haubold B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-541; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LANDER E S, 1988, Genomics, V2, P231; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Mardis E, 2002, GENOME RES, V12, P669, DOI 10.1101/gr.032102; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Salzberg SL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000186; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI 10.1099/00207713-52-3-1043; Treangen TJ, 2009, FEMS MICROBIOL REV, V33, P539, DOI 10.1111/j.1574-6976.2009.00169.x; Wendl MC, 2002, GENOME RES, V12, P1943, DOI 10.1101/gr.655102; Whiteford N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni170; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	29	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11518	10.1371/journal.pone.0011518	http://dx.doi.org/10.1371/journal.pone.0011518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634954	Green Published, gold, Green Submitted			2022-12-25	WOS:000279781600006
J	Jugessur, A; Shi, M; Gjessing, HK; Lie, RT; Wilcox, AJ; Weinberg, CR; Christensen, K; Boyles, AL; Daack-Hirsch, S; Nguyen, TT; Christiansen, L; Lidral, AC; Murray, JC				Jugessur, Astanand; Shi, Min; Gjessing, Hakon Kristian; Lie, Rolv Terje; Wilcox, Allen James; Weinberg, Clarice Ring; Christensen, Kaare; Boyles, Abee Lowman; Daack-Hirsch, Sandra; Nguyen, Truc Trung; Christiansen, Lene; Lidral, Andrew Carl; Murray, Jeffrey Clark			Maternal Genes and Facial Clefts in Offspring: A Comprehensive Search for Genetic Associations in Two Population-Based Cleft Studies from Scandinavia	PLOS ONE			English	Article							MILLER-DIEKER-SYNDROME; SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; TUMOR-SUPPRESSOR GENE; CANDIDATE-GENE; ORAL CLEFTS; SKELETAL DEVELOPMENT; GENOME-SCAN; PALATE; LIP; MICE	Background: Fetal conditions can in principle be affected by the mother's genotype working through the prenatal environment. Methodology/Principal Findings: Genotypes for 1536 SNPs in 357 cleft candidate genes were available from a previous analysis in which we focused on fetal gene effects [1]. After data-cleaning, genotypes for 1315 SNPs in 334 autosomal genes were available for the current analysis of maternal gene effects. Two complementary statistical methods, TRIMM and HAPLIN, were used to detect multi-marker effects in population-based samples from Norway (562 case-parent and 592 control-parent triads) and Denmark (235 case-parent triads). We analyzed isolated cleft lip with or without cleft palate (iCL/P) and isolated cleft palate only (iCP) separately and assessed replication by looking for genes detected in both populations by both methods. In iCL/P, neither TRIMM nor HAPLIN detected more genes than expected by chance alone; furthermore, the selected genes were not replicated across the two methods. In iCP, however, FLNB was identified by both methods in both populations. Although HIC1 and ZNF189 did not fully satisfy our stringency criterion for replication, they were strongly associated with iCP in TRIMM analyses of the Norwegian triads. Conclusion/Significance: Except for FLNB, HIC1 and ZNF189, maternal genes did not appear to influence the risk of clefting in our data. This is consistent with recent epidemiological findings showing no apparent difference between mother-to-offspring and father-to-offspring recurrence of clefts in these two populations. It is likely that fetal genes make the major genetic contribution to clefting risk in these populations, but we cannot rule out the possibility that maternal genes can affect risk through interactions with specific teratogens or fetal genes.	[Jugessur, Astanand; Gjessing, Hakon Kristian] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Jugessur, Astanand] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Shi, Min; Weinberg, Clarice Ring] NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA; [Gjessing, Hakon Kristian; Lie, Rolv Terje] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Lie, Rolv Terje; Nguyen, Truc Trung] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway; [Wilcox, Allen James; Boyles, Abee Lowman] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [Christensen, Kaare; Christiansen, Lene; Murray, Jeffrey Clark] Univ So Denmark, Dept Epidemiol, Odense, Denmark; [Daack-Hirsch, Sandra] Univ Iowa, Coll Nursing, Iowa City, IA 52242 USA; [Lidral, Andrew Carl; Murray, Jeffrey Clark] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Lidral, Andrew Carl; Murray, Jeffrey Clark] Univ Iowa, Dept Epidemiol, Iowa City, IA USA; [Lidral, Andrew Carl; Murray, Jeffrey Clark] Univ Iowa, Dept Biol Sci, Iowa City, IA USA	Norwegian Institute of Public Health (NIPH); Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Bergen; Norwegian Institute of Public Health (NIPH); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Southern Denmark; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Jugessur, A (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway.	jeff-murray@uiowa.edu	Christensen, Kaare/C-2360-2009; Wilcox, Allen J/C-7723-2019; Gjessing, Hakon K/A-5871-2012; Shi, Min/GXM-3977-2022	Christensen, Kaare/0000-0002-5429-5292; Wilcox, Allen J/0000-0002-3376-1311; Weinberg, Clarice/0000-0002-7713-8556; Boyles, Abee/0000-0002-8711-2077; Daack-Hirsch, Sandra/0000-0003-1192-7154	National Institutes of Health (NIH) [N01-HG-65403, DE08559, P60 DE13076, NIH P30 ES05605, RO1 DE-11948-04]; National Institute of Environmental Health Sciences; Norwegian Research Council [NFR 177522]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P60DE013076, R01DE008559, R01DE011948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605, ZIAES045005, ZIAES049027] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Center for Inherited Disease Research (CIDR) is fully funded through a federal contract from the National Institutes of Health (NIH) to The Johns Hopkins University, Contract Number N01-HG-65403. This research was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences; by NIH grants DE08559, P60 DE13076, NIH P30 ES05605, and RO1 DE-11948-04; and by the Norwegian Research Council (NFR 177522). We also thank the US National Institute of Dental and Craniofacial Research (NIDCR) for underwriting a significant proportion of the genotyping costs by CIDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bille C, 2005, CLEFT PALATE-CRAN J, V42, P255, DOI 10.1597/03-139.1; BINGLE GJ, 1977, AM J HUM GENET, V29, P605; Boyles AL, 2009, GENET EPIDEMIOL, V33, P247, DOI 10.1002/gepi.20376; Brunetti-Pierri N, 2008, AM J MED GENET A, V146A, P2804, DOI 10.1002/ajmg.a.32530; Carter MG, 2000, HUM MOL GENET, V9, P413, DOI 10.1093/hmg/9.3.413; Castanet M, 2002, HUM MOL GENET, V11, P2051, DOI 10.1093/hmg/11.17.2051; Chong SS, 1997, HUM MOL GENET, V6, P147, DOI 10.1093/hmg/6.2.147; Christensen K, 2004, BRIT MED J, V328, P1405, DOI 10.1136/bmj.38106.559120.7C; Farrington-Rock C, 2008, HUM MOL GENET, V17, P631, DOI 10.1093/hmg/ddm188; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fisher R.A., 1958, STAT METHODS RES WOR; GJESSING HK, 2006, ANN HUM GENET, P1; Grimm C, 1999, HUM MOL GENET, V8, P697, DOI 10.1093/hmg/8.4.697; GROSEN D, 2009, J MED GENET; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; Hirotsune S, 1997, GENOME RES, V7, P625, DOI 10.1101/gr.7.6.625; Isidor B, 2008, AM J MED GENET A, V146A, P1593, DOI 10.1002/ajmg.a.32217; Jugessur A, 2005, CURR OPIN GENET DEV, V15, P270, DOI 10.1016/j.gde.2005.03.003; Jugessur A, 2009, ORAL DIS, V15, P437, DOI 10.1111/j.1601-0825.2009.01577.x; Jugessur A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005385; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Lu J, 2007, HUM MOL GENET, V16, P1661, DOI 10.1093/hmg/ddm114; Mansilla MA, 2006, CLEFT PALATE-CRAN J, V43, P21, DOI 10.1597/04-169R.1; Marazita ML, 2009, HUM HERED, V68, P151, DOI 10.1159/000224636; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Marazita ML, 2004, AM J MED GENET A, V126A, P111, DOI 10.1002/ajmg.a.20564; Moreno LM, 2009, HUM MOL GENET, V18, P4879, DOI 10.1093/hmg/ddp444; Mossey PA, 2002, CLEFT LIP PALATE ORI; POPLIKER M, 1987, DEV BIOL, V119, P38, DOI 10.1016/0012-1606(87)90204-1; R Development Core Team, 2006, R LANG ENV STAT COMP; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; SCHWEDER T, 1982, BIOMETRIKA, V69, P493; Shi M, 2007, AM J HUM GENET, V81, P53, DOI 10.1086/518670; Shi M, 2007, AM J HUM GENET, V80, P76, DOI 10.1086/510518; Shi Min, 2008, Birth Defects Research, V84, P16, DOI 10.1002/bdrc.20117; Sivertsen A, 2008, BRIT MED J, V336, P432, DOI 10.1136/bmj.39458.563611.AE; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Wilcox AJ, 1998, AM J EPIDEMIOL, V148, P893; Wilcox AJ, 2007, BMJ-BRIT MED J, V334, P464, DOI 10.1136/bmj.39079.618287.0B; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104; Zhu JL, 2002, BRIT J CANCER, V87, P524, DOI 10.1038/sj.bjc.6600488	47	31	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11493	10.1371/journal.pone.0011493	http://dx.doi.org/10.1371/journal.pone.0011493			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634891	gold, Green Published			2022-12-25	WOS:000279715300008
J	Dehghani, N; Cash, SS; Chen, CC; Hagler, DJ; Huang, MX; Dale, AM; Halgren, E				Dehghani, Nima; Cash, Sydney S.; Chen, Chih C.; Hagler, Donald J., Jr.; Huang, Mingxiong; Dale, Anders M.; Halgren, Eric			Divergent Cortical Generators of MEG and EEG during Human Sleep Spindles Suggested by Distributed Source Modeling	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; HIGH-RESOLUTION; BRAIN ACTIVITY; PREFRONTAL CORTEX; MAGNETOENCEPHALOGRAPHY; LOCALIZATION; OSCILLATIONS; SEGMENTATION; WAVES; FMRI	Background: Sleep spindles are similar to 1-second bursts of 10-15 Hz activity, occurring during normal stage 2 sleep. In animals, sleep spindles can be synchronous across multiple cortical and thalamic locations, suggesting a distributed stable phase-locked generating system. The high synchrony of spindles across scalp EEG sites suggests that this may also be true in humans. However, prior MEG studies suggest multiple and varying generators. Methodology/Principal Findings: We recorded 306 channels of MEG simultaneously with 60 channels of EEG during naturally occurring spindles of stage 2 sleep in 7 healthy subjects. High-resolution structural MRI was obtained in each subject, to define the shells for a boundary element forward solution and to reconstruct the cortex providing the solution space for a noise-normalized minimum norm source estimation procedure. Integrated across the entire duration of all spindles, sources estimated from EEG and MEG are similar, diffuse and widespread, including all lobes from both hemispheres. However, the locations, phase and amplitude of sources simultaneously estimated from MEG versus EEG are highly distinct during the same spindles. Specifically, the sources estimated from EEG are highly synchronous across the cortex, whereas those from MEG rapidly shift in phase, hemisphere, and the location within the hemisphere. Conclusions/Significance: The heterogeneity of MEG sources implies that multiple generators are active during human sleep spindles. If the source modeling is correct, then EEG spindles are generated by a different, diffusely synchronous system. Animal studies have identified two thalamo-cortical systems, core and matrix, that produce focal or diffuse activation and thus could underlie MEG and EEG spindles, respectively. Alternatively, EEG spindles could reflect overlap at the sensors of the same sources as are seen from the MEG. Although our results generally match human intracranial recordings, additional improvements are possible and simultaneous intra-and extra-cranial measures are needed to test their accuracy.	[Dehghani, Nima; Hagler, Donald J., Jr.; Huang, Mingxiong; Dale, Anders M.; Halgren, Eric] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Dehghani, Nima; Cash, Sydney S.; Chen, Chih C.] Harvard Univ, Sch Med, Martinos Ctr Biomed Imaging, Boston, MA USA; [Dehghani, Nima] CNRS, UNIC, Lab Computat Neurosci, Gif Sur Yvette, France; [Cash, Sydney S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Chen, Chih C.] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Dale, Anders M.; Halgren, Eric] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA	University of California System; University of California San Diego; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Massachusetts General Hospital; National Taiwan University; National Taiwan University Hospital; University of California System; University of California San Diego	Dehghani, N (corresponding author), Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA.	ehalgren@ucsd.edu		Dehghani, Nima/0000-0003-2032-8903	National Institutes of Health (NIH) [EB009282, NS18741, NS44623]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018741, R01NS044623] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants EB009282, NS18741, and NS44623. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors SP, 2010, HUM BRAIN MAPP, V31, P140, DOI 10.1002/hbm.20851; Anderer P, 2001, NEUROSCIENCE, V103, P581, DOI 10.1016/S0306-4522(01)00028-8; [Anonymous], [No title captured]; Asano E, 2007, CLIN NEUROPHYSIOL, V118, P1360, DOI 10.1016/j.clinph.2007.02.021; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Benesty J, 2005, IEEE SIGNAL PROC LET, V12, P827, DOI 10.1109/LSP.2005.859517; Buchner Helmut, 1995, Brain Topography, V8, P137, DOI 10.1007/BF01199777; Buzsaki G., 2006, RHYTHMS BRAIN; CADERAS M, 1982, CLIN ELECTROENCEPHAL, V13, P216, DOI 10.1177/155005948201300402; COHEN D, 1983, ELECTROEN CLIN NEURO, V56, P38, DOI 10.1016/0013-4694(83)90005-6; Contreras D, 1997, J NEUROSCI, V17, P1179; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dale AM, 2001, CURR OPIN NEUROBIOL, V11, P202, DOI 10.1016/S0959-4388(00)00197-5; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; DEHGHANI N, 2010, J NEUROPHYSIOL; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Destexhe A, 2003, PHYSIOL REV, V83, P1401, DOI 10.1152/physrev.00012.2003; Destexhe A, 1998, J NEUROPHYSIOL, V79, P999; Dhond RP, 2001, J NEUROSCI, V21, P3564, DOI 10.1523/JNEUROSCI.21-10-03564.2001; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Gibbs F., 1950, ATLAS ELECTROENCEPHA; Gumenyuk V, 2009, J SLEEP RES, V18, P245, DOI 10.1111/j.1365-2869.2008.00717.x; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Huang MX, 2007, NEUROIMAGE, V37, P731, DOI 10.1016/j.neuroimage.2007.06.002; HUGHES JR, 1976, ELECTROEN CLIN NEURO, V40, P261, DOI 10.1016/0013-4694(76)90150-4; Ishii R, 2003, NEUROSCI LETT, V340, P25, DOI 10.1016/S0304-3940(03)00048-X; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; KIM U, 1995, J NEUROPHYSIOL, V74, P1301, DOI 10.1152/jn.1995.74.3.1301; Komssi S, 2004, CLIN NEUROPHYSIOL, V115, P534, DOI 10.1016/j.clinph.2003.10.034; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; Liu AK, 1998, P NATL ACAD SCI USA, V95, P8945, DOI 10.1073/pnas.95.15.8945; LOOMIS ALFRED L., 1935, SCIENCE, V81, P597, DOI 10.1126/science.81.2111.597; Lutkenhoner B, 2003, J PHYSIOL-PARIS, V97, P641, DOI 10.1016/j.jphysparis.2004.01.020; Malow BA, 1999, CLIN NEUROPHYSIOL, V110, P687, DOI 10.1016/S1388-2457(99)00008-5; Manshanden I, 2002, CLIN NEUROPHYSIOL, V113, P1937, DOI 10.1016/S1388-2457(02)00304-8; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MEIJS JWH, 1987, ELECTROEN CLIN NEURO, V66, P286, DOI 10.1016/0013-4694(87)90078-2; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; Nakabayashi T, 2001, PSYCHIAT CLIN NEUROS, V55, P57, DOI 10.1046/j.1440-1819.2001.00785.x; Nakamura M, 2003, NEUROSCI RES, V45, P419, DOI 10.1016/S0168-0102(03)00007-5; NAKASATO N, 1990, ELECTROEN CLIN NEURO, V76, P123, DOI 10.1016/0013-4694(90)90210-B; Nunez PL, 2000, BRAIN TOPOGR, V13, P79, DOI 10.1023/A:1026683200895; Ramon C, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-10; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Shih JJ, 2000, J CLIN NEUROPHYSIOL, V17, P224, DOI 10.1097/00004691-200003000-00011; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P50, DOI 10.1152/jn.1961.24.1.50; Traub RD, 2005, J NEUROPHYSIOL, V93, P2194, DOI 10.1152/jn.00983.2004; Urakami Y, 2008, J CLIN NEUROPHYSIOL, V25, P13, DOI 10.1097/WNP.0b013e318162a8a4; WOLTERS CH, 2005, NEUROIMAGE; Yoshida H, 1996, BRAIN TOPOGR, V8, P303, DOI 10.1007/BF01184789; Zepelin H, 1994, PRINCIPLES PRACTICE, P91; Zikopoulos B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000848; Zygierewicz J, 1999, CLIN NEUROPHYSIOL, V110, P2136, DOI 10.1016/S1388-2457(99)00175-3	57	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11454	10.1371/journal.pone.0011454	http://dx.doi.org/10.1371/journal.pone.0011454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628643	Green Published, gold			2022-12-25	WOS:000279589300005
J	Riede, T; Fisher, JH; Goller, F				Riede, Tobias; Fisher, John H.; Goller, Franz			Sexual Dimorphism of the Zebra Finch Syrinx Indicates Adaptation for High Fundamental Frequencies in Males	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; SYSTEM CONTROLLING SONG; ANDROGEN RECEPTOR; VOCAL MUSCLES; SONGBIRDS; SELECTION; BRAIN; LATERALIZATION; MODULATION; EXPRESSION	Background: In many songbirds the larger vocal repertoire of males is associated with sexual dimorphism of the vocal control centers and muscles of the vocal organ, the syrinx. However, it is largely unknown how these differences are translated into different acoustic behavior. Methodology/Principal Findings: Here we show that the sound generating structures of the syrinx, the labia and the associated cartilaginous framework, also display sexual dimorphism. One of the bronchial half rings that position and tense the labia is larger in males, and the size and shape of the labia differ between males and females. The functional consequences of these differences were explored by denervating syringeal muscles. After denervation, both sexes produced equally low fundamental frequencies, but the driving pressure generally increased and was higher in males. Denervation strongly affected the relationship between driving pressure and fundamental frequency. Conclusions/Significance: The syringeal modifications in the male syrinx, in concert with dimorphisms in neural control and muscle mass, are most likely the foundation for the potential to generate an enhanced frequency range. Sexually dimorphic vocal behavior therefore arises from finely tuned modifications at every level of the motor cascade. This sexual dimorphism in frequency control illustrates a significant evolutionary step towards increased vocal complexity in birds.	[Riede, Tobias; Goller, Franz] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Riede, Tobias] Univ Utah, Natl Ctr Voice & Speech, Salt Lake City, UT USA; [Fisher, John H.] Univ Utah, Dept Physiol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Riede, T (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	t.riede@utah.edu	Riede, Tobias/J-9092-2012	Riede, Tobias/0000-0001-6875-0017; Riede, Tobias/0000-0001-9606-0742	NIH [DC04390, DC06876]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004390, R01DC006876] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by NIH grant DC04390 and DC06876. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador A, 2008, J NEUROPHYSIOL, V99, P2383, DOI 10.1152/jn.01002.2007; CATCHPOLE CK, 1980, BEHAVIOUR, V74, P149, DOI 10.1163/156853980X00366; CHAMBERLAIN DR, 1968, AUK, V85, P244; Chan RW, 2007, ANN BIOMED ENG, V35, P1471, DOI 10.1007/s10439-007-9314-x; Cooke B, 1998, FRONT NEUROENDOCRIN, V19, P323, DOI 10.1006/frne.1998.0171; ECKEL HE, 1996, INT C SERIES, P382; Elemans CPH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002581; Fay R. R., 1988, HEARING VERTEBRATES; Fee MS, 2002, J COMP PHYSIOL A, V188, P829, DOI 10.1007/s00359-002-0349-z; Fine ML, 2008, T AM FISH SOC, V137, P627, DOI 10.1577/T04-134.1; Floody OR, 1997, HORM BEHAV, V31, P25, DOI 10.1006/hbeh.1997.1368; GAUNT AS, 1982, BIRD RESP, P71; Goller F, 2004, ANN NY ACAD SCI, V1016, P130, DOI 10.1196/annals.1298.009; Goller F, 1996, J NEUROPHYSIOL, V75, P867, DOI 10.1152/jn.1996.75.2.867; Goller F, 1996, J NEUROPHYSIOL, V76, P287, DOI 10.1152/jn.1996.76.1.287; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; Larsen ON, 2002, J EXP BIOL, V205, P25; LUINE V, 1980, BRAIN RES, V192, P89, DOI 10.1016/0006-8993(80)91011-2; Luther D, 2010, P R SOC B, V277, P469, DOI 10.1098/rspb.2009.1571; Mindlin GB, 2005, PHYS BIRDSONG; MISKIMEN MILDR D., 1951, AUK, V68, P493; Morse P.M., 1948, VIBRATION SOUND; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; NEGUS V. E., 1949, COMP ANATOMY PHYSL L; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; Price T, 1998, PHILOS T R SOC B, V353, P251, DOI 10.1098/rstb.1998.0207; Riebel K, 2003, ADV STUD BEHAV, V33, P49, DOI 10.1016/S0065-3454(03)33002-5; Riede T, 2006, P NATL ACAD SCI USA, V103, P5543, DOI 10.1073/pnas.0601262103; Riede T, 2010, J MORPHOL, V271, P1, DOI 10.1002/jmor.10774; Riede T, 2010, J ANAT, V216, P23, DOI 10.1111/j.1469-7580.2009.01161.x; RYAN MJ, 1988, AM ZOOL, V28, P885; Schmidt MF, 2004, ANN NY ACAD SCI, V1016, P171, DOI 10.1196/annals.1298.014; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; Suthers RA, 2004, ANN NY ACAD SCI, V1016, P109, DOI 10.1196/annals.1298.041; Suthers RA, 1999, DESIGN OF ANIMAL COMMUNICATION, P37; Tang YP, 2009, DEV NEUROBIOL, V69, P462, DOI 10.1002/dneu.20721; TITZE IR, 1989, J ACOUST SOC AM, V85, P1699, DOI 10.1121/1.397959; Veney SL, 2005, J COMP PHYSIOL A, V191, P97, DOI 10.1007/s00359-004-0577-5; Veney SL, 2004, GEN COMP ENDOCR, V136, P192, DOI 10.1016/j.ygcen.2003.12.017; VICARIO DS, 1995, J NEUROPHYSIOL, V73, P2602, DOI 10.1152/jn.1995.73.6.2602; VICARIO DS, 1991, J NEUROBIOL, V22, P63, DOI 10.1002/neu.480220107; Wade J, 2000, J COMP NEUROL, V426, P154; Wade J, 2002, BRAIN RES, V929, P191, DOI 10.1016/S0006-8993(01)03389-3; Wild JM, 2004, ANN NY ACAD SCI, V1016, P438, DOI 10.1196/annals.1298.016; Williams H, 2004, ANN NY ACAD SCI, V1016, P1, DOI 10.1196/annals.1298.029; WILLIAMS H, 1992, J NEUROBIOL, V23, P1006, DOI 10.1002/neu.480230807; WILLIAMS H, 1989, J COMP PSYCHOL, V103, P366, DOI 10.1037/0735-7036.103.4.366; Wind J., 1970, PHYLOGENY ONTOGENY H; ZANN R, 1984, Z TIERPSYCHOL, V66, P328; Zann RA., 1996, ZEBRA FINCH SYNTHESI	50	33	33	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11368	10.1371/journal.pone.0011368	http://dx.doi.org/10.1371/journal.pone.0011368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20614010	Green Published, Green Submitted, gold			2022-12-25	WOS:000279369900017
J	Nagy, NT; Sakamoto, T; Takacs, B; Gyimesi, M; Hazai, E; Bikadi, Z; Sellers, JR; Kovacs, M				Nagy, Nikolett T.; Sakamoto, Takeshi; Takacs, Balazs; Gyimesi, Mate; Hazai, Eszter; Bikadi, Zsolt; Sellers, James R.; Kovacs, Mihaly			Functional adaptation of the switch-2 nucleotide sensor enables rapid processive translocation by myosin-5	FASEB JOURNAL			English	Article						actomyosin; kinetics; nucleotide exchange; single molecule; sliding speed	HAND-OVER-HAND; MUSCLE-CONTRACTION; KINETIC MECHANISM; STEP-SIZE; MOLECULAR-MECHANISM; TRYPTOPHAN RESIDUE; PHOSPHATE RELEASE; FLUORESCENT-PROBE; MOTOR-ACTIVITY; NECK LENGTH	Active site loops that are conserved across superfamilies of myosins, kinesins, and G proteins play key roles in allosteric coupling of NTP hydrolysis to interaction with track filaments or effector proteins. In this study, we investigated how the class-specific natural variation in the switch-2 active site loop contributes to the motor function of the intracellular transporter myosin-5. We used single-molecule, rapid kinetic and spectroscopic experiments and semiempirical quantum chemical simulations to show that the class-specific switch-2 structure including a tyrosine (Y439) in myosin-5 enables rapid processive translocation along actin filaments by facilitating Mg2(+)-dependent ADP release. Using wild-type control and Y439 point mutant myosin-5 proteins, we demonstrate that the translocation speed precisely correlates with the kinetics of nucleotide exchange. Switch-2 variants can thus be used to fine-tune translocation speed while maintaining high processivity. The class-specific variation of switch-2 in various NTPase superfamilies indicates its general role in the kinetic tuning of Mg2(+)-dependent nucleotide exchange.-Nagy, N.T., Sakamoto, T., Takacs, B., Gyimesi, M., Hazai, E., Bikadi, Z., Sellers, J.R., Kovacs, M. Functional adaptation of the switch-2 nucleotide sensor enables rapid processive translocation by myosin-5. FASEB J. 24, 4480-4490 (2010). www.fasebj.org	[Nagy, Nikolett T.; Takacs, Balazs; Gyimesi, Mate; Kovacs, Mihaly] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Sakamoto, Takeshi; Sellers, James R.] NHLBI, Lab Mol Physiol, Bethesda, MD 20892 USA; [Hazai, Eszter; Bikadi, Zsolt] VirtuaDrug Ltd, Budapest, Hungary	Eotvos Lorand University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kovacs, M (corresponding author), Eotvos Lorand Univ, Dept Biochem, Pazmany P Stny 1-C, H-1117 Budapest, Hungary.	kovacsm@elte.hu	Kovacs, Mihaly/A-6841-2011; Gyimesi, Mate/I-2639-2017	Kovacs, Mihaly/0000-0002-1200-4741; Gyimesi, Mate/0000-0002-7195-1925	Fogarty International Center; National Heart, Lung, and Blood Institute [1 R01-TW007241]; Hungarian Scientific Research Fund (OTKA) [K71915, NNF78783]; European Molecular Biology Organization-Howard Hughes Medical Institute; FOGARTY INTERNATIONAL CENTER [R01TW007241] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004229] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Molecular Biology Organization-Howard Hughes Medical Institute(Howard Hughes Medical InstituteEuropean Molecular Biology Organization (EMBO)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Fogarty International Center and the National Heart, Lung, and Blood Institute (grant 1 R01-TW007241), Hungarian Scientific Research Fund (OTKA) grants K71915 and NNF78783, and a European Molecular Biology Organization-Howard Hughes Medical Institute startup grant to M.K.M.K. is a Bolyai Fellow of the Hungarian Academy of Sciences. The authors declare that they have no competing financial interests.	BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Dewar M.J.S., 1985, J AM CHEM SOC, P107; Durrwang U, 2006, J CELL SCI, V119, P550, DOI 10.1242/jcs.02774; Flores S, 2006, NUCLEIC ACIDS RES, V34, pD296, DOI 10.1093/nar/gkj046; Forgacs E, 2009, J BIOL CHEM, V284, P2138, DOI 10.1074/jbc.M805530200; Fujita-Becker S, 2005, J BIOL CHEM, V280, P6064, DOI 10.1074/jbc.M412473200; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Gyimesi M, 2008, J BIOL CHEM, V283, P8153, DOI 10.1074/jbc.M708863200; Hannemann DE, 2005, BIOCHEMISTRY-US, V44, P8826, DOI 10.1021/bi0473509; Kull FJ, 1998, J MUSCLE RES CELL M, V19, P877, DOI 10.1023/A:1005489907021; Libby RT, 2004, J CELL SCI, V117, P4509, DOI 10.1242/jcs.01316; Malnasi-Csizmadia A, 2001, BIOCHEMISTRY-US, V40, P12727, DOI 10.1021/bi010963q; Malnasi-Csizmadia A, 2001, J BIOL CHEM, V276, P19483, DOI 10.1074/jbc.M010886200; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Murphy CT, 2001, NAT CELL BIOL, V3, P311, DOI 10.1038/35060110; Reck-Peterson SL, 2001, J CELL BIOL, V153, P1121, DOI 10.1083/jcb.153.5.1121; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sasaki N, 1998, J BIOL CHEM, V273, P20334, DOI 10.1074/jbc.273.32.20334; Sellers J. R., 1999, MYOSINS; Sellers JR, 2006, CURR OPIN CELL BIOL, V18, P68, DOI 10.1016/j.ceb.2005.12.014; Snyder GE, 2004, BIOPHYS J, V87, P1776, DOI 10.1529/biophysj.103.036897; Sweeney HL, 2004, PHILOS T R SOC B, V359, P1829, DOI 10.1098/rstb.2004.1576; Takagi Y, 2008, J BIOL CHEM, V283, P8527, DOI 10.1074/jbc.M709150200; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; Toth J, 2005, J BIOL CHEM, V280, P30594, DOI 10.1074/jbc.M505209200; TRENTHAM DR, 1972, BIOCHEM J, V126, P635, DOI 10.1042/bj1260635; Tsiavaliaris G, 2008, J BIOL CHEM, V283, P4520, DOI 10.1074/jbc.M708113200; Urbanke C, 2001, BIOCHEM J, V358, P165, DOI 10.1042/0264-6021:3580165; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Wagner WG, 2003, J CELL BIOL, V163, P1193, DOI 10.1083/jcb.200311077; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Yang Y, 2006, P NATL ACAD SCI USA, V103, P5746, DOI 10.1073/pnas.0509935103; Yang YT, 2007, STRUCTURE, V15, P553, DOI 10.1016/j.str.2007.03.010; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v; Yengo CM, 2002, BIOCHEMISTRY-US, V41, P8508, DOI 10.1021/bi015969u; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	52	11	11	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4480	4490		10.1096/fj.10-163998	http://dx.doi.org/10.1096/fj.10-163998			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20631329	Green Published			2022-12-25	WOS:000283861100033
J	Obican, SG; Finnell, RH; Mills, JL; Shaw, GM; Scialli, AR				Obican, Sarah G.; Finnell, Richard H.; Mills, James L.; Shaw, Gary M.; Scialli, Anthony R.			Folic acid in early pregnancy: a public health success story	FASEB JOURNAL			English	Article						folate; neural tube defects; congenital malformations; epidemiology; teratology	NEURAL-TUBE DEFECTS; METHYLENETETRAHYDROFOLATE REDUCTASE MTHFR; CONOTRUNCAL HEART-DEFECTS; AMNIOTIC-FLUID; VITAMIN SUPPLEMENTATION; PERICONCEPTIONAL USE; FOLATE METABOLISM; MULTIVITAMIN USE; DIETARY-FOLATE; MICE DEFICIENT	Folate is a water-soluble B vitamin that must be obtained in the diet or through supplementation. For >50 yr, it has been known that folate plays an integral role in embryonic development. In mice, inactivation of genes in the folate pathway results in malformations of the neural tube, heart, and craniofacial structures. It has been shown that diets and blood levels of women who had a fetus with a neural tube defect are low for several micronutrients, particularly folate. Periconceptional use of folic acid containing supplements decreased recurrent neural tube defects in the offspring of women with a previously affected child and the occurrence of a neural tube defect and possibly other birth defects in the offspring of women with no prior history. Based on these findings, the U. S. Public Health Service recommended that all women at risk take folic acid supplements, but many did not. Mandatory food fortification programs were introduced in numerous countries, including the United States, to improve folate nutritional status and have resulted in a major decrease in neural tube defect prevalence. The success story of folate represents the cooperation of embryologists, experimentalists, epidemiologists, public health scientists, and policymakers.-Obic. an, S. G., Finnell, R. H., Mills, J. L., Shaw, G. M., Scialli, A. R. Folic acid in early pregnancy: a public health success story. FASEB J. 24, 4167-4174 (2010). www.fasebj.org	[Scialli, Anthony R.] Tetra Tech Sci, Arlington, VA 22201 USA; [Obican, Sarah G.; Scialli, Anthony R.] George Washington Univ, Sch Med, Dept Obstet & Gynecol, Washington, DC USA; [Finnell, Richard H.] Univ Texas Austin, Dept Nutr, Austin, TX 78712 USA; [Mills, James L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Epidemiol Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD USA; [Shaw, Gary M.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	George Washington University; University of Texas System; University of Texas Austin; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Stanford University	Scialli, AR (corresponding author), Tetra Tech Sci, 2200 Wilson Blvd,Ste 400, Arlington, VA 22201 USA.	ascialli@sciences.com	Finnell, Richard/D-8174-2018	Finnell, Richard/0000-0002-5962-8754; Mills, James/0000-0003-4496-332X; Shaw, Gary/0000-0001-7438-4914	National Institutes of Health (NIH), National Institute of Child Health and Human Development; NIH [DE016315, NS050249]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050249] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Intramural Research Program, National Institutes of Health (NIH), National Institute of Child Health and Human Development, and in part by funds from NIH grants DE016315 and NS050249.	[Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; [Anonymous], 1996, FED REG, V61, P44; Arabelovic S, 2007, J AM COLL NUTR, V26, P453, DOI 10.1080/07315724.2007.10719635; Beaty TH, 2001, ANN EPIDEMIOL, V11, P434, DOI 10.1016/S1047-2797(01)00222-8; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Blencowe H, 2010, INT J EPIDEMIOL, V39, P110, DOI 10.1093/ije/dyq028; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Botto LD, 1996, PEDIATRICS, V98, P911; Botto LD, 2006, BIRTH DEFECTS RES A, V76, P693, DOI 10.1002/bdra.20307; BOWER C, 1989, MED J AUSTRALIA, V150, P613, DOI 10.5694/j.1326-5377.1989.tb136723.x; Bukowski R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000061; Canfield MA, 2005, BIRTH DEFECTS RES A, V73, P679, DOI 10.1002/bdra.20210; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P962; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Christianson A., 2006, GLOBAL REPORT BIRTH; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Czeizel AE, 1996, TERATOLOGY, V53, P345, DOI 10.1002/(SICI)1096-9926(199606)53:6&lt;345::AID-TERA5&gt;3.0.CO;2-Z; Czeizel AE, 1997, FOLIA PHONIATR LOGO, V49, P111, DOI 10.1159/000266446; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; De Marco P, 2003, EUR J HUM GENET, V11, P245, DOI 10.1038/sj.ejhg.5200946; Deng L, 2008, MOL GENET METAB, V94, P336, DOI 10.1016/j.ymgme.2008.03.004; Di Pietro E, 2002, MOL CELL BIOL, V22, P4158, DOI 10.1128/MCB.22.12.4158-4166.2002; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; ECONOMIDES DL, 1992, BRIT J OBSTET GYNAEC, V99, P23, DOI 10.1111/j.1471-0528.1992.tb14386.x; Elmore CL, 2007, MOL GENET METAB, V91, P85, DOI 10.1016/j.ymgme.2007.02.001; GARDIKIKOUIDOU P, 1988, CLIN GENET, V33, P441; GELINEAUVANWAES J, 2007, CHEM BIOL PTERIDINES, P483; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; Gorman EB, 2009, PTERIDINES, V20, P156; Greene NDE, 2009, PRENATAL DIAG, V29, P303, DOI 10.1002/pd.2206; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Hernandez-Diaz S, 2000, NEW ENGL J MED, V343, P1608, DOI 10.1056/NEJM200011303432204; Hirsch S, 2009, EUR J GASTROEN HEPAT, V21, P346, DOI 10.1097/MEG.0b013e328306ccdb; HOLMESSIEDLE M, 1982, LANCET, V1, P276; Honein MA, 2001, JAMA-J AM MED ASSOC, V285, P2981, DOI 10.1001/jama.285.23.2981; KIRKE PN, 1993, Q J MED, V86, P703; LAURENCE KM, 1981, BRIT MED J, V282, P1509, DOI 10.1136/bmj.282.6275.1509; Loffredo LCM, 2001, CLEFT PALATE-CRAN J, V38, P76, DOI 10.1597/1545-1569(2001)038<0076:OCAVS>2.0.CO;2; Logan RFA, 2008, GASTROENTEROLOGY, V134, P29, DOI 10.1053/j.gastro.2007.10.014; LUCOCK MD, 1994, BIOCHEM MED METAB B, V52, P101, DOI 10.1006/bmmb.1994.1040; Maberly G., 2008, Morbidity and Mortality Weekly Report, V57, P8; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; Mason JB, 2007, CANCER EPIDEM BIOMAR, V16, P1325, DOI 10.1158/1055-9965.EPI-07-0329; Matsui EC, 2009, J ALLERGY CLIN IMMUN, V123, P1253, DOI 10.1016/j.jaci.2009.03.007; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; Mills JL, 2003, AM J CLIN NUTR, V77, P1474, DOI 10.1093/ajcn/77.6.1474; MILUNSKY A, 1989, JAMA-J AM MED ASSOC, V262, P2847, DOI 10.1001/jama.262.20.2847; MULINARE J, 1988, JAMA-J AM MED ASSOC, V260, P3141, DOI 10.1001/jama.260.21.3141; MUNGER RG, 2002, CLEFT LIP PALATE ORI, P170; Piedrahita JA, 1999, NAT GENET, V23, P228, DOI 10.1038/13861; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; Salbaum JM, 2009, BIRTH DEFECTS RES A, V85, P303, DOI 10.1002/bdra.20537; Selhub J, 1999, ANN INTERN MED, V131, P331, DOI 10.7326/0003-4819-131-5-199909070-00003; SELLER MJ, 1984, J MED GENET, V21, P325, DOI 10.1136/jmg.21.5.325; SHAW GM, 1995, LANCET, V346, P393, DOI 10.1016/S0140-6736(95)92778-6; SHAW GM, 1995, EPIDEMIOLOGY, V6, P219, DOI 10.1097/00001648-199505000-00005; SHAW GM, 1995, AM J MED GENET, V59, P536, DOI 10.1002/ajmg.1320590428; SMITHELLS RW, 1976, ARCH DIS CHILD, V51, P944, DOI 10.1136/adc.51.12.944; SMITHELLS RW, 1983, LANCET, V1, P1027; SMITHELLS RW, 1981, ARCH DIS CHILD, V56, P911, DOI 10.1136/adc.56.12.911; Spiegelstein O, 2004, DEV DYNAM, V231, P221, DOI 10.1002/dvdy.20107; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; Swanson DA, 2001, MOL CELL BIOL, V21, P1058, DOI 10.1128/MCB.21.4.1058-1065.2001; Takacs P, 2005, INT J GYNECOL OBSTET, V89, P301, DOI 10.1016/j.ijgo.2004.11.036; van Rooij IALM, 2004, PREV MED, V39, P689, DOI 10.1016/j.ypmed.2004.02.036; vanderPut NMJ, 1997, QJM-INT J MED, V90, P505, DOI 10.1093/qjmed/90.8.505; VERGEL RG, 1990, PRENATAL DIAG, V10, P149, DOI 10.1002/pd.1970100303; Waes JGV, 2008, BIRTH DEFECTS RES A, V82, P494, DOI 10.1002/bdra.20453; WALLIS D, 2009, FOLATE HLTH DIS, P156; WEEKES EW, 1992, BIOL NEONATE, V61, P226; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Weisberg IS, 2001, ATHEROSCLEROSIS, V156, P409, DOI 10.1016/S0021-9150(00)00671-7; Wen SW, 2008, CAN MED ASSOC J, V179, P1263, DOI 10.1503/cmaj.080859; Wen SW, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.067; Werler MM, 1999, AM J EPIDEMIOL, V150, P675, DOI 10.1093/oxfordjournals.aje.a010070; WERLER MM, 1993, JAMA-J AM MED ASSOC, V269, P1257, DOI 10.1001/jama.269.10.1257; Whitrow MJ, 2009, AM J EPIDEMIOL, V170, P1486, DOI 10.1093/aje/kwp315; WILD J, 1993, BRIT J OBSTET GYNAEC, V100, P546, DOI 10.1111/j.1471-0528.1993.tb15306.x; Williams LJ, 2002, TERATOLOGY, V66, P33, DOI 10.1002/tera.10060; Wlodarczyk B, 2001, TOXICOL APPL PHARM, V177, P238, DOI 10.1006/taap.2001.9303; YATES JRW, 1987, CLIN GENET, V31, P279; Zhao RB, 2001, J BIOL CHEM, V276, P10224, DOI 10.1074/jbc.C000905200; Zhu HP, 2007, BIRTH DEFECTS RES A, V79, P257, DOI 10.1002/bdra.20347	83	60	66	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4167	4174		10.1096/fj.10-165084	http://dx.doi.org/10.1096/fj.10-165084			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20631328	Green Published			2022-12-25	WOS:000283861100004
J	Rudrabhatla, P; Grant, P; Jaffe, H; Strong, MJ; Pant, HC				Rudrabhatla, Parvathi; Grant, Philip; Jaffe, Howard; Strong, Michael J.; Pant, Harish C.			Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ	FASEB JOURNAL			English	Article						neurofilament-M/H; phosphorylation sites; iTRAQ; MS/MS mass spectrometry; TiO2; proline-directed kinases	PAIRED HELICAL FILAMENTS; AMYOTROPHIC LATERAL SCLEROSIS; WEIGHT NEUROFILAMENT PROTEIN; CEREBROSPINAL-FLUID; AXONAL-TRANSPORT; PHOSPHORYLATION; ANTIBODIES; SUBUNIT; IDENTIFICATION; ACCUMULATION	Aberrant hyperphosphorylation of neuronal cytoskeletal proteins is one of the major pathological hallmarks of neurodegenerative disorders such as Alzheimer disease (AD), amyotrophic lateral sclerosis (ALS), and Parkinson's disease (PD). Human NFM/H display a large number of multiple KSP repeats in the carboxy-terminal tail domain, which are phosphorylation sites of proline-directed serine/threonine (pSer/Thr-Pro, KS/T-P) kinases. The phosphorylation sites of NF-M/H have not been characterized in AD brain. Here, we use quantitative phosphoproteomic methodology, isobaric tag for relative and absolute quantitation (iTRAQ), for the characterization of NFM/H phosphorylation sites in AD brain. We identified 13 hyperphosphorylated sites of NF-M; 9 Lys-Ser-Pro (KSP) sites; 2 variant motifs, Glu-Ser-Pro (ESP) Ser-736 and Leu-Ser-Pro (LSP) Ser-837; and 2 non-S/T-P motifs, Ser-783 and Ser-788. All the Ser/Thr residues are phosphorylated at significantly greater abundance in AD brain compared with control brain. Ten hyperphosphorylated KSP sites have been identified on the C-terminal tail domain of NF-H, with greater abundance of phosphorylation in AD brain compared with control brain. Our data provide the direct evidence that NFM/H are hyperphosphorylated in AD compared with control brain and suggest the role of both proline-directed and non-proline-directed protein kinases in AD. This study represents the first comprehensive iTRAQ analyses and quantification of phosphorylation sites of human NF-M and NF-H from AD brain and suggests that aberrant hyperphosphorylation of neuronal intermediate filament proteins is involved in AD.-Rudrabhatla, P., Grant, P., Jaffe, H., Strong, M. J., Pant, H. C. Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ. FASEB J. 24, 4396-4407 (2010). www.fasebj.org	[Pant, Harish C.] NINDS, Cytoskeletal Regulatory Prot Sect, Neurochem Lab, NIH, Bethesda, MD 20892 USA; [Jaffe, Howard] NINDS, Prot Peptide Sequencing Facil, NIH, Bethesda, MD 20892 USA; [Strong, Michael J.] Univ Western Ontario, Mol Brain Res Grp, Robarts Res Inst, London, ON, Canada; [Strong, Michael J.] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Western University (University of Western Ontario); Western University (University of Western Ontario)	Pant, HC (corresponding author), NINDS, Cytoskeletal Regulatory Prot Sect, Neurochem Lab, NIH, Bldg 49,Rm 2A28, Bethesda, MD 20892 USA.	panth@ninds.nih.gov	Strong, Michael/AAU-5699-2020; Strong, Michael J/H-9689-2012	Strong, Michael/0000-0003-1988-6262; Rudrabhatla, Parvathi/0000-0002-7537-3130	National Institutes of Health of the National Institute of Neurological Diseases and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002725] Funding Source: NIH RePORTER	National Institutes of Health of the National Institute of Neurological Diseases and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health Intramural research programs of the National Institute of Neurological Diseases and Stroke. The authors thank the Harvard Brain Resource Center (Boston, MA, USA) and the National Institute of Child Health and Human Development Brain and Tissue Bank (Bethesda, MD, USA) for providing human brain tissue.	Brettschneider J, 2006, DEMENT GERIATR COGN, V21, P291, DOI 10.1159/000091436; COOK LC, 1986, J NEUROPATHOL EXP NE, V45, P56; DAHL D, 1982, J NEUROSCI, V2, P113; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Dosemeci A, 2010, BIOCHEM BIOPH RES CO, V391, P78, DOI 10.1016/j.bbrc.2009.10.167; ELHANANY E, 1994, J NEUROCHEM, V63, P2324; EYER J, 1994, NEURON, V12, P389, DOI 10.1016/0896-6273(94)90280-1; FORNO LS, 1986, NEUROSCI LETT, V64, P253, DOI 10.1016/0304-3940(86)90337-X; Ghoshal N, 1999, AM J PATHOL, V155, P1163, DOI 10.1016/S0002-9440(10)65219-4; GOLDSTEIN ME, 1987, J NEUROIMMUNOL, V14, P149, DOI 10.1016/0165-5728(87)90049-X; Griffin TJ, 2007, J PROTEOME RES, V6, P4200, DOI 10.1021/pr070291b; Jaffe H, 1998, BIOCHEMISTRY-US, V37, P3931, DOI 10.1021/bi972518u; JULIEN JP, 1983, J BIOL CHEM, V258, P4019; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; KRINKS MH, 1988, J NEUROSCI, V8, P2172; LEE VMY, 1987, J NEUROSCI, V7, P3474; LEES JF, 1988, EMBO J, V7, P1947, DOI 10.1002/j.1460-2075.1988.tb03032.x; LEWIS SE, 1988, J CELL BIOL, V107, P2689, DOI 10.1083/jcb.107.6.2689; Lewis SB, 2008, J CEREBR BLOOD F MET, V28, P1261, DOI 10.1038/jcbfm.2008.12; MANETTO V, 1988, J NEUROPATH EXP NEUR, V47, P642, DOI 10.1097/00005072-198811000-00007; MATA M, 1992, RANVIER NEUROCYTOLOG, V21, P199; MILLER CCJ, 1986, EMBO J, V5, P269, DOI 10.1002/j.1460-2075.1986.tb04209.x; MORRISON JH, 1987, BRAIN RES, V416, P331, DOI 10.1016/0006-8993(87)90914-0; MUNOZ DG, 1988, J NEUROPATH EXP NEUR, V47, P9, DOI 10.1097/00005072-198801000-00002; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; NUKINA N, 1987, P NATL ACAD SCI USA, V84, P3415, DOI 10.1073/pnas.84.10.3415; OHARA O, 1993, J CELL BIOL, V121, P387, DOI 10.1083/jcb.121.2.387; Pant AC, 1997, BRAIN RES, V765, P259, DOI 10.1016/S0006-8993(97)00561-1; Pant HC, 1995, BIOCHEM CELL BIOL, V73, P575, DOI 10.1139/o95-063; PANT HC, 1988, BIOCHEM J, V256, P665, DOI 10.1042/bj2560665; PERRY G, 1988, LANCET, V2, P746; POLLANEN MS, 1994, ACTA NEUROPATHOL, V88, P1, DOI 10.1007/BF00294352; Rudrabhatla P, 2009, J NEUROSCI, V29, P14869, DOI 10.1523/JNEUROSCI.4469-09.2009; Shea TB, 2004, J NEUROSCI RES, V76, P795, DOI 10.1002/jnr.20099; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOBUE G, 1990, ACTA NEUROPATHOL, V79, P402, DOI 10.1007/BF00308716; STERNBERGER NH, 1985, P NATL ACAD SCI USA, V82, P4274, DOI 10.1073/pnas.82.12.4274; Stone K. L., 1993, PRACTICAL GUIDE PROT, P43; Tannu NS, 2006, PROG BRAIN RES, V158, P41, DOI 10.1016/S0079-6123(06)58003-3; Thangavel R, 2009, NEUROSCIENCE, V160, P427, DOI 10.1016/j.neuroscience.2009.02.037; Veeranna, 2008, J NEUROCHEM, V107, P35, DOI 10.1111/j.1471-4159.2008.05547.x; Vickers JC, 1996, EXP NEUROL, V141, P1, DOI 10.1006/exnr.1996.0133; WONG PC, 1995, J CELL BIOL, V130, P1413, DOI 10.1083/jcb.130.6.1413; Wu J, 2007, J PROTEOME RES, V6, P4684, DOI 10.1021/pr070481m; YAMASAKI H, 1991, ACTA NEUROPATHOL, V82, P427, DOI 10.1007/BF00293376; ZHANG H, 1989, P NATL ACAD SCI USA, V86, P8045, DOI 10.1073/pnas.86.20.8045	46	51	53	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4396	4407		10.1096/fj.10-157859	http://dx.doi.org/10.1096/fj.10-157859			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20624930	Green Published			2022-12-25	WOS:000283861100026
J	Bussmann, M; Baumgart, M; Bott, M				Bussmann, Michael; Baumgart, Meike; Bott, Michael			RosR (Cg1324), a Hydrogen Peroxide-sensitive MarR-type Transcriptional Regulator of Corynebacterium glutamicum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE S-TRANSFERASES; DNA-BINDING SITES; ESCHERICHIA-COLI; ANAEROBIC GROWTH; 2-COMPONENT SYSTEM; MOLECULAR ANALYSIS; RESPIRATORY-CHAIN; CRYSTAL-STRUCTURE; EXPRESSION; REPRESSOR	The cg1324 gene (rosR) of Corynebacterium glutamicum encodes a MarR-type transcriptional regulator. By a comparative transcriptome analysis with DNA microarrays of a Delta rosR mutant and the wild type and subsequent EMSAs with purified RosR protein, direct target genes of RosR were identified. The narKGHJI operon, which encodes a nitrate/nitrite transporter and the dissimilatory nitrate reductase complex, was activated by RosR. All other target genes were repressed by RosR. They encode four putative monooxygenases, two putative FMN reductases, a protein of the glutathione S-transferase family, a putative polyisoprenoid-binding protein, and RosR itself. The DNA binding site of RosR was characterized as an 18-bp inverted repeat with the consensus sequence TTGTTGAY-RYRTCAACWA. The in vitro DNA binding activity of RosR was reversibly inhibited by the oxidant H2O2. Mutational analysis of the three cysteine residues present in RosR (Cys-64, Cys-92, and Cys-151) showed that these are responsible for the inhibition of DNA binding by H2O2. Adeletion mutant (Delta cg1322) lacking the putative polyisoprenoid-binding protein showed an increased sensitivity to H2O2, supporting the role of RosR in the oxidative stress response of C. glutamicum.	[Bussmann, Michael; Baumgart, Meike; Bott, Michael] Forschungszentrum Julich, Inst Biotechnol 1, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Bott, M (corresponding author), Forschungszentrum Julich, Inst Biotechnol 1, D-52425 Julich, Germany.	m.bott@fz-juelich.de	Bott, Michael/E-8004-2011; Baumgart, Meike/GWC-5464-2022; Baumgart, Meike/ABA-7414-2020	Bott, Michael/0000-0002-4701-8254; Baumgart, Meike/0000-0002-9874-1151	Health & Nutrition business unit of Evonik Degussa GmbH; German Ministry of Education and Research (BMBF)	Health & Nutrition business unit of Evonik Degussa GmbH; German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Health & Nutrition business unit of Evonik Degussa GmbH and the German Ministry of Education and Research (BMBF).	Bott M, 2003, J BIOTECHNOL, V104, P129, DOI 10.1016/S0168-1656(03)00144-5; Brocker M, 2006, FEMS MICROBIOL LETT, V264, P205, DOI 10.1111/j.1574-6968.2006.00456.x; Brocker M, 2009, J BACTERIOL, V191, P3869, DOI 10.1128/JB.00113-09; Brune I, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-86; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DEN HENGST CD, 2008, BBA-GEN SUBJECTS, V1780, P1201; Ehira S, 2009, J BIOL CHEM, V284, P16736, DOI 10.1074/jbc.M109.009027; Engels S, 2005, MOL MICROBIOL, V57, P576, DOI 10.1111/j.1365-2958.2005.04710.x; Engels S, 2004, MOL MICROBIOL, V52, P285, DOI 10.1111/j.1365-2958.2003.03979.x; Engels V, 2008, J BACTERIOL, V190, P8033, DOI 10.1128/JB.00705-08; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Frunzke J, 2008, MOL MICROBIOL, V67, P305, DOI 10.1111/j.1365-2958.2007.06020.x; Gerstmeir R, 2003, J BIOTECHNOL, V104, P99, DOI 10.1016/S0168-1656(03)00167-6; Handa N, 2005, PROTEIN SCI, V14, P1004, DOI 10.1110/ps.041183305; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Kalinowski J., 2005, HDB CORYNEBACTERIUM, V1 edn., P37, DOI [10.1201/9781420039696.pt3, DOI 10.1201/9781420039696.PT3]; KEILHAUER C, 1993, J BACTERIOL, V175, P5595, DOI 10.1128/JB.175.17.5595-5603.1993; Kertesz MA, 1999, J BACTERIOL, V181, P1464, DOI 10.1128/JB.181.5.1464-1473.1999; Kinoshita S., 1957, J GEN APPL MICROBIOL, V3, P193, DOI [10.2323/jgam.3.193, DOI 10.2323/JGAM.3.193]; Kocan M, 2006, J BACTERIOL, V188, P724, DOI 10.1128/JB.188.2.724-732.2006; Kohl TA, 2008, J BIOTECHNOL, V135, P340, DOI 10.1016/j.jbiotec.2008.05.011; Korshunov S, 2006, J BACTERIOL, V188, P6326, DOI 10.1128/JB.00554-06; KRONEMEYER W, 1995, J BACTERIOL, V177, P1152, DOI 10.1128/jb.177.5.1152-1158.1995; Krug A, 2005, J BIOL CHEM, V280, P585, DOI 10.1074/jbc.M408271200; Lange C, 2003, APPL ENVIRON MICROB, V69, P2521, DOI 10.1128/AEM.69.5.2521-2532.2003; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Leelakriangsak M, 2008, MOL MICROBIOL, V67, P1108, DOI 10.1111/j.1365-2958.2008.06110.x; Liebl W, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P796, DOI 10.1007/0-387-30743-5_30; Moker N, 2004, MOL MICROBIOL, V54, P420, DOI 10.1111/j.1365-2958.2004.04249.x; Nakunst D, 2007, J BACTERIOL, V189, P4696, DOI 10.1128/JB.00382-07; Newton GL, 2002, ARCH MICROBIOL, V178, P388, DOI 10.1007/s00203-002-0469-4; Niebisch A, 2001, ARCH MICROBIOL, V175, P282, DOI 10.1007/s002030100262; Nishimura T, 2008, J BACTERIOL, V190, P3264, DOI 10.1128/JB.01801-07; Nishimura T, 2007, APPL MICROBIOL BIOT, V75, P889, DOI 10.1007/s00253-007-0879-y; Okada K, 1996, BBA-LIPID LIPID MET, V1302, P217, DOI 10.1016/0005-2760(96)00064-1; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pop SM, 2004, J BIOL CHEM, V279, P49910, DOI 10.1074/jbc.M409435200; Pop SM, 2006, J BIOL CHEM, V281, P26382, DOI 10.1074/jbc.M602158200; Russo S, 2009, J BIOL CHEM, V284, P5208, DOI 10.1074/jbc.M806591200; Sambrook J, 2001, MOL CLONING LAB MANU; Schaaf S, 2007, J BACTERIOL, V189, P5002, DOI 10.1128/JB.00121-07; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schaffer S, 2001, ELECTROPHORESIS, V22, P4404, DOI 10.1002/1522-2683(200112)22:20<4404::AID-ELPS4404>3.0.CO;2-2; Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Suvarna K, 1998, J BACTERIOL, V180, P2782, DOI 10.1128/JB.180.10.2782-2787.1998; Takeno S, 2007, APPL MICROBIOL BIOT, V75, P1173, DOI 10.1007/s00253-007-0926-8; Towe S, 2007, MOL MICROBIOL, V66, P40, DOI 10.1111/j.1365-2958.2007.05891.x; Vasicova P, 1998, BIOTECHNOL TECH, V12, P743, DOI 10.1023/A:1008827609914; Vuilleumier S, 2002, APPL MICROBIOL BIOT, V58, P138, DOI 10.1007/s00253-001-0836-0; Vuilleumier S, 1997, J BACTERIOL, V179, P1431, DOI 10.1128/jb.179.5.1431-1441.1997; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; Wendisch VF, 2006, J BIOTECHNOL, V124, P74, DOI 10.1016/j.jbiotec.2005.12.002; Wennerhold J, 2006, J BACTERIOL, V188, P2907, DOI 10.1128/JB.188.8.2907-2918.2006; Wennerhold J, 2005, J BIOL CHEM, V280, P40500, DOI 10.1074/jbc.M508693200; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	61	45	47	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29305	29318		10.1074/jbc.M110.156372	http://dx.doi.org/10.1074/jbc.M110.156372			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20643656	Green Published, hybrid			2022-12-25	WOS:000281740100033
J	Lee, SB; Kwon, IS; Park, J; Lee, KH; Ahn, Y; Lee, C; Kim, J; Choi, SY; Cho, SW; Ahn, JY				Lee, Sang Bae; Kwon, Il-Sun; Park, Jihye; Lee, Kyung-Hoon; Ahn, Younghee; Lee, Cheolju; Kim, Joon; Choi, Soo Young; Cho, Sung-Woo; Ahn, Jee-Yin			Ribosomal Protein S3, a New Substrate of Akt, Serves as a Signal Mediator between Neuronal Apoptosis and DNA Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYMPATHETIC NEURONS; CELL-DEATH; GENOTOXIC STRESS; SURVIVAL; DAMAGE; PHOSPHORYLATION; PATHWAY; TRANSLOCATION; EXPRESSION; ACTIVATION	RPS3, a conserved, eukaryotic ribosomal protein of the 40 S subunit, is required for ribosome biogenesis. Because ribosomal proteins are abundant and ubiquitous, they may have additional extraribosomal functions. Here, we show that human RPS3 is a physiological target of Akt kinase and a novel mediator of neuronal apoptosis. NGF stimulation resulted in phosphorylation of threonine 70 of RPS3 by Akt, and this phosphorylation was required for Akt binding to RPS3. RPS3 induced neuronal apoptosis, up-regulating proapoptotic proteins Dp5/Hrk and Bim by binding to E2F1 and acting synergistically with it. Akt-dependent phosphorylation of RPS3 inhibited its proapoptotic function and perturbed its interaction with E2F1. These events coincided with nuclear translocation and accumulation of RPS3, where it functions as an endonuclease. Nuclear accumulation of RPS3 results in an increase in DNA repair activity to some extent, thereby sustaining neuronal survival. Abolishment of Akt-mediated RPS3 phosphorylation through mutagenesis accelerated apoptotic cell death and severely compromised nuclear translocation of RPS3. Thus, our findings define an extraribosomal role of RPS3 as a molecular switch that accommodates apoptotic induction to DNA repair through Akt-mediated phosphorylation.	[Lee, Sang Bae; Kwon, Il-Sun; Park, Jihye; Ahn, Jee-Yin] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea; [Lee, Kyung-Hoon] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Anat, Suwon 440746, South Korea; [Kwon, Il-Sun; Lee, Kyung-Hoon; Ahn, Jee-Yin] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Ctr Mol Med, Suwon 440746, South Korea; [Ahn, Younghee; Lee, Cheolju] Korea Inst Sci & Technol, Div Life Sci, Seoul 136791, South Korea; [Kim, Joon] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Choi, Soo Young] Hallym Univ, Dept Biomed Sci, Chunchon 200702, South Korea; [Choi, Soo Young] Hallym Univ, Res Inst Biosci & Biotechnol, Chunchon 200702, South Korea; [Cho, Sung-Woo] Univ Ulsan, Coll Med, Dept Biochem & Mol Biol, Seoul 138736, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung; Sungkyunkwan University (SKKU); Korea Institute of Science & Technology (KIST); Korea University; Hallym University; Hallym University; University of Ulsan	Ahn, JY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea.	jyahn@med.skku.ac.kr		LEE, SANG BAE/0000-0002-4031-8051	Ministry of Education, Science and Technology, Republic of Korea [NI-1:22-2009-00-010-00]	Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Grant NI-1:22-2009-00-010-00 from the Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Education, Science and Technology, Republic of Korea (to J.-Y. A.).	AHMED NN, 1993, ONCOGENE, V8, P1957; Ahn JY, 2006, EMBO J, V25, P2083, DOI 10.1038/sj.emboj.7601111; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Bavelloni A, 1999, J CELL SCI, V112, P631; Besirli CG, 2003, CELL DEATH DIFFER, V10, P1045, DOI 10.1038/sj.cdd.4401259; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deshmukh M, 1997, MOL PHARMACOL, V51, P897, DOI 10.1124/mol.51.6.897; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; GRABOWSKI DT, 1991, NUCLEIC ACIDS RES, V19, P4297, DOI 10.1093/nar/19.15.4297; Hegde V, 2007, DNA REPAIR, V6, P94, DOI 10.1016/j.dnarep.2006.09.004; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Hu YX, 2005, EMBO J, V24, P3543, DOI 10.1038/sj.emboj.7600823; Ianari A, 2009, CANCER CELL, V15, P184, DOI 10.1016/j.ccr.2009.01.026; Imaizumi K, 1997, J BIOL CHEM, V272, P18842, DOI 10.1074/jbc.272.30.18842; KIM J, 1995, J BIOL CHEM, V270, P13620, DOI 10.1074/jbc.270.23.13620; Kim SH, 2005, BIOCHEM BIOPH RES CO, V328, P962, DOI 10.1016/j.bbrc.2005.01.045; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Morrison RS, 2003, NEUROCHEM RES, V28, P15, DOI 10.1023/A:1021687810103; Naora H, 1998, J CELL BIOL, V141, P741, DOI 10.1083/jcb.141.3.741; Nguyen TLX, 2006, BIOCHEM BIOPH RES CO, V349, P789, DOI 10.1016/j.bbrc.2006.08.120; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Quevedo C, 2007, CURR BIOL, V17, P286, DOI 10.1016/j.cub.2006.12.038; Radyuk SN, 2006, FREE RADICAL BIO MED, V41, P757, DOI 10.1016/j.freeradbiomed.2006.05.021; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Tan JH, 2003, CANCER RES, V63, P7663; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Wyttenbach A, 2006, J NEUROCHEM, V96, P1213, DOI 10.1111/j.1471-4159.2005.03676.x; Yadavilli S, 2007, DNA REPAIR, V6, P1453, DOI 10.1016/j.dnarep.2007.04.009; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x	35	51	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29457	29468		10.1074/jbc.M110.131367	http://dx.doi.org/10.1074/jbc.M110.131367			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20605787	Green Published, hybrid			2022-12-25	WOS:000281740100048
J	Oh, KJ; Singh, P; Lee, K; Foss, K; Lee, S; Park, M; Lee, S; Aluvila, S; Park, M; Singh, P; Kim, RS; Symersky, J; Walters, DE				Oh, Kyoung Joon; Singh, Pawan; Lee, Kyungro; Foss, Kelly; Lee, Shinyoub; Park, Minji; Lee, Steffi; Aluvila, Sreevidya; Park, Matthew; Singh, Puja; Kim, Ryung-Suk; Symersky, Jindrich; Walters, D. Eric			Conformational Changes in BAK, a Pore-forming Proapoptotic Bcl-2 Family Member, upon Membrane Insertion and Direct Evidence for the Existence of BH3-BH3 Contact Interface in BAK Homo-oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER MITOCHONDRIAL-MEMBRANE; LABELED SIDE-CHAINS; CYTOCHROME-C; T4 LYSOZYME; LIPID-BILAYERS; X-RAY; PROTEIN-STRUCTURE; DIPHTHERIA-TOXIN; BH3 DOMAIN; CELL-DEATH	During apoptosis, the pro-apoptotic Bcl-2 family proteins BAK and BAX form large oligomeric pores in the mitochondrial outer membrane. Apoptotic factors, including cytochrome c, are released through these pores from the mitochondrial intermembrane space into the cytoplasm where they initiate the cascade of events leading to cell death. To better understand this pivotal step toward apoptosis, a method was developed to induce membrane permeabilization by BAK in the membrane without using the full-length protein. Using a soluble form of BAK with a hexahistidine tag at the C terminus and a liposomal system containing the Ni2+-nitrilotriacetic acid lipid analog that can bind hexahistidine-tagged proteins, BAK oligomers were formed in the presence of the activator protein p7/p15Bid. In this system, we determined the conformational changes in BAK upon membrane insertion by applying the site-directed spin labeling method of EPR to 13 different amino acid locations. Upon membrane insertion, the BH3 domains were reorganized, and the alpha 5-alpha 6 helical hairpin structure was partially exposed to the membrane environment. The monomer-monomer interface in the oligomeric structure was also mapped by measuring the distance-dependent spin-spin interactions for each residue location. Spin labels attached in the BH3 domain were juxtaposed within 5-10 angstrom distance in the oligomeric form in the membrane. These results are consistent with the current hypothesis that BAK or BAX forms homodimers, and these homodimers assemble into a higher order oligomeric pore. Detailed analyses of the data provide new insights into the structure of the BAX or BAK homodimer.	[Oh, Kyoung Joon; Singh, Pawan; Lee, Kyungro; Foss, Kelly; Lee, Shinyoub; Park, Minji; Lee, Steffi; Aluvila, Sreevidya; Park, Matthew; Singh, Puja; Symersky, Jindrich; Walters, D. Eric] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA; [Kim, Ryung-Suk] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Yeshiva University; Albert Einstein College of Medicine	Oh, KJ (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Biochem & Mol Biol, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	kyoung.oh@rosalindfranklin.edu	Walters, D. Eric/C-9626-2010	Walters, D. Eric/0000-0002-1513-3522; OH, KYOUNG JOON/0000-0002-4729-9674	American Heart Association [0835026G]; Rosalind Franklin University of Medicine and Science	American Heart Association(American Heart Association); Rosalind Franklin University of Medicine and Science	This work was supported in part by the Scientist Development Grant from the American Heart Association (0835026G) and the Start-up fund from the Rosalind Franklin University of Medicine and Science.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; ALTENBACH C, 1990, SCIENCE, V248, P1088, DOI 10.1126/science.2160734; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Barnes JP, 1999, BIOPHYS J, V76, P3298, DOI 10.1016/S0006-3495(99)77482-5; Billeter S.R., 1996, GROMOS96 MANUAL USER; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Bleicken S, 2009, J BIOENERG BIOMEMBR, V41, P29, DOI 10.1007/s10863-009-9202-1; Bottcher CJF, 1961, ANAL CHIM ACTA, V24, P203; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Culmsee C, 2007, EMBO REP, V8, P129, DOI 10.1038/sj.embor.7400892; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeSensi SC, 2008, BIOPHYS J, V94, P3798, DOI 10.1529/biophysj.107.125419; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; FARAHBAKHSH ZT, 1992, PHOTOCHEM PHOTOBIOL, V56, P1019, DOI 10.1111/j.1751-1097.1992.tb09725.x; FEIX JB, 1998, BIO MAGN RE, V14, P251; Gross A, 1999, BIOCHEMISTRY-US, V38, P10324, DOI 10.1021/bi990856k; HUBBELL WL, 1987, REV SCI INSTRUM, V58, P1879, DOI 10.1063/1.1139536; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Hubbell WL, 1994, MEMBRANE PROTEIN STR, P244; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P229; Jeschke G, 2002, CHEMPHYSCHEM, V3, P927, DOI 10.1002/1439-7641(20021115)3:11<927::AID-CPHC927>3.0.CO;2-Q; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kinnally KW, 2007, APOPTOSIS, V12, P857, DOI 10.1007/s10495-007-0722-z; Klare JP, 2009, PHOTOSYNTH RES, V102, P377, DOI 10.1007/s11120-009-9490-7; Klug CS, 2008, METHOD CELL BIOL, V84, P617, DOI 10.1016/S0091-679X(07)84020-9; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P1; Kucerka N, 2008, BIOPHYS J, V95, P2356, DOI 10.1529/biophysj.108.132662; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Langen R, 2000, BIOCHEMISTRY-US, V39, P8396, DOI 10.1021/bi000604f; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Martinez-Caballero S, 2009, J BIOL CHEM, V284, P12235, DOI 10.1074/jbc.M806610200; Mchaourab HS, 1999, BIOCHEMISTRY-US, V38, P2947, DOI 10.1021/bi9826310; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Minn AJ, 1999, EMBO J, V18, P632, DOI 10.1093/emboj/18.3.632; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; Oh KJ, 1996, SCIENCE, V273, P810, DOI 10.1126/science.273.5276.810; Oh KJ, 2000, METH MOL B, V145, P147; Oh KJ, 2006, J BIOL CHEM, V281, P36999, DOI 10.1074/jbc.M602341200; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; Roy SS, 2009, EMBO REP, V10, P1341, DOI 10.1038/embor.2009.219; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Tristram-Nagle S, 2004, CHEM PHYS LIPIDS, V127, P3, DOI 10.1016/j.chemphyslip.2003.09.002; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhang Z, 2010, J BIOL CHEM, V285, P17614, DOI 10.1074/jbc.M110.113456	76	72	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28924	28937		10.1074/jbc.M110.135293	http://dx.doi.org/10.1074/jbc.M110.135293			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20605789	Green Published, hybrid			2022-12-25	WOS:000281594000057
J	Schliep, M; Crossett, B; Willows, RD; Chen, M				Schliep, Martin; Crossett, Ben; Willows, Robert D.; Chen, Min			O-18 Labeling of Chlorophyll d in Acaryochloris marina Reveals That Chlorophyll a and Molecular Oxygen Are Precursors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC PROKARYOTE; RHODOBACTER-SPHAEROIDES; PHOTOSYSTEM-II; BIOSYNTHESIS; BACTERIOCHLOROPHYLL; DERIVATION; PATHWAYS; 3-ACETYL; ORIGIN; IDENTIFICATION	The cyanobacterium Acaryochloris marina was cultured in the presence of either H-2 O-18 or O-18(2), and the newly synthesized chlorophylls (Chl a and Chl d) were isolated using high performance liquid chromatography and analyzed by mass spectroscopy. In the presence of H-2 O-18, newly synthesized Chl a and d, both incorporated up to four isotopic O-18 atoms. Time course H-2 O-18 labeling experiments showed incorporation of isotopic O-18 atoms originating from H-2 O-18 into Chl a, with over 90% of Chl a O-18-labeled at 48 h. The incorporation of isotopic O-18 atoms into Chl d upon incubation in H-2 O-18 was slower compared with Chl a with similar to 50% O-18-labeled Chl d at 115 h. The rapid turnover of newly synthesized Chl a suggested that Chl a is the direct biosynthetic precursor of Chl d. In the presence of O-18(2) gas, one isotopic O-18 atom was incorporated into Chl a with approximately the same kinetic incorporation rate observed in the H-2 O-18 labeling experiment, reaching over 90% labeling intensity at 48 h. The incorporation of two isotopic O-18 atoms derived from molecular oxygen (O-18(2)) was observed in the extracted Chl d, and the percentage of double isotopic O-18-labeled Chl d increased in parallel with the decrease of non-isotopic-labeled Chl d. This clearly indicated that the oxygen atom in the C3(1)-formyl group of Chl d is derived from dioxygen via an oxygenase-type reaction mechanism.	Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Crossett, Ben] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Willows, Robert D.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia	University of Sydney; University of Sydney; Macquarie University	Chen, M (corresponding author), Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia.	min.chen@sydney.edu.au	Willows, Robert/C-1537-2010; Crossett, Ben/G-2316-2011	Willows, Robert/0000-0002-0731-2950; Chen, Min/0000-0001-8070-3248	Australian Research Council [DP0665169, DP0986581]	Australian Research Council(Australian Research Council)	This work was supported, in whole or in part, by Australian Research Council Grants DP0665169 and DP0986581. The mass spectrometry was facilitated by access to the Sydney University Proteome Research Unit, established under the Australian Government's Major National Research Facilities program and supported by the University of Sydney.	Akiyama M, 2002, PHOTOSYNTH RES, V74, P97, DOI 10.1023/A:1020915506409; Akiyama M, 2001, ANAL SCI, V17, P205, DOI 10.2116/analsci.17.205; Beale SI, 1999, PHOTOSYNTH RES, V60, P43, DOI 10.1023/A:1006297731456; Bjorn L, 2009, PHOTOSYNTH RES, V99, P85, DOI 10.1007/s11120-008-9395-x; Blankenship RE, 1998, TRENDS BIOCHEM SCI, V23, P94, DOI 10.1016/S0968-0004(98)01186-4; Chen M, 2005, PHOTOCH PHOTOBIO SCI, V4, P1060, DOI 10.1039/b507057k; Chen M, 2002, FEBS LETT, V514, P149, DOI 10.1016/S0014-5793(02)02315-3; Gloag RS, 2007, BBA-BIOENERGETICS, V1767, P127, DOI 10.1016/j.bbabio.2006.11.014; Gough SP, 2000, P NATL ACAD SCI USA, V97, P6908, DOI 10.1073/pnas.97.12.6908; HAYAISHI O, 1974, MOL MECHANISMS OXYGE, P1; Hu Q, 1998, P NATL ACAD SCI USA, V95, P13319, DOI 10.1073/pnas.95.22.13319; Kuhl Michael, 2007, V11, P101; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Mimuro M, 2004, FEBS LETT, V556, P95, DOI 10.1016/S0014-5793(03)01383-8; Mimuro M, 2000, BBA-BIOENERGETICS, V1456, P27, DOI 10.1016/S0005-2728(99)00095-X; Mimuro M, 2008, PHOTOSYNTH RES, V97, P167, DOI 10.1007/s11120-008-9311-4; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; Oster U, 2000, PLANT J, V21, P305, DOI 10.1046/j.1365-313x.2000.00672.x; Porra RJ, 1998, EUR J BIOCHEM, V257, P185, DOI 10.1046/j.1432-1327.1998.2570185.x; PORRA RJ, 1993, FEBS LETT, V323, P31, DOI 10.1016/0014-5793(93)81442-3; Porra RJ, 2000, PHOTOSYNTH RES, V66, P159, DOI 10.1023/A:1010631505071; PORRA RJ, 1995, FEBS LETT, V371, P21, DOI 10.1016/0014-5793(95)00854-3; Porra RJ, 1996, EUR J BIOCHEM, V239, P85, DOI 10.1111/j.1432-1033.1996.0085u.x; Raymond J, 2004, GEOBIOLOGY, V2, P199, DOI 10.1111/j.1472-4677.2004.00037.x; Razeghifard MR, 2005, BIOCHEMISTRY-US, V44, P11178, DOI 10.1021/bi048314c; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Schiller H, 1997, FEBS LETT, V410, P433, DOI 10.1016/S0014-5793(97)00620-0; SCHNEEGURT MA, 1992, BIOCHEMISTRY-US, V31, P11677, DOI 10.1021/bi00162a002; Swingley WD, 2008, P NATL ACAD SCI USA, V105, P2005, DOI 10.1073/pnas.0709772105; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; Tomo T, 2007, P NATL ACAD SCI USA, V104, P7283, DOI 10.1073/pnas.0701847104; WALKER CJ, 1989, BIOCHEM J, V257, P599, DOI 10.1042/bj2570599; Willows RD, 2003, NAT PROD REP, V20, P327, DOI 10.1039/b110549n	33	49	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28450	28456		10.1074/jbc.M110.146753	http://dx.doi.org/10.1074/jbc.M110.146753			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20610399	hybrid, Green Published			2022-12-25	WOS:000281594000008
J	Wu, D; Haruta, A; Wei, QZ				Wu, Di; Haruta, Akiko; Wei, Qize			GIPC1 Interacts with MyoGEF and Promotes MDA-MB-231 Breast Cancer Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; DOMAIN-CONTAINING PROTEIN; PDZ DOMAIN; RHO-GTPASES; MYOSIN-VI; C-TERMINUS; CYTOPLASMIC DOMAIN; BINDING-PROTEIN; MIGRATION; RECEPTOR	GIPC1/synectin, a single PDZ domain-containing protein, binds to numerous proteins and is involved in multiple biological processes, including cell migration. We reported previously that MyoGEF, a guanine nucleotide exchange factor, plays a role in regulating breast cancer cell polarization and invasion. Here, we identify GIPC1 as an interacting partner of MyoGEF. Both in vitro and in vivo binding assays show that the GIPC1 PDZ domain binds to the PDZ-binding motif at the C terminus of MyoGEF. Immunofluorescence analysis shows that GIPC1 and MyoGEF colocalize to the cell leading edge. Depletion of GIPC1 by RNAi in MDA-MB-231 cells causes cells to shift from a polarized to a rounded morphology. Matrigel invasion assays show that RNAi-mediated depletion of GIPC1 dramatically decreases MDA-MB-231 cell invasion. Notably, an anti-MyoGEF peptide antibody, whose epitope is located at the C terminus of MyoGEF, interferes with GIPC1-MyoGEF complex formation. Treatment of MDA-MB-231 cells with the anti-MyoGEF peptide antibody disrupts cell polarization and invasion. Thus, our results suggest that GIPC1-MyoGEF complex formation plays an important role in regulating MDA-MB-231 breast cancer cell polarization and invasion.	[Wu, Di; Haruta, Akiko; Wei, Qize] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	Kansas State University	Wei, QZ (corresponding author), Kansas State Univ, Dept Biochem, 141 Chalmers Hall, Manhattan, KS 66506 USA.	weiq@ksu.edu			National Center for Research Resources, National Institutes of Health [P20 RR015563]; Terry C. Johnson Center for Basic Cancer Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015563] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Terry C. Johnson Center for Basic Cancer Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20 RR015563 from the National Center for Research Resources. This work was also supported by the Terry C. Johnson Center for Basic Cancer Research. This is Contribution 10-211-J from the Kansas Agricultural Experiment Station (Manhattan, KS).	Asiedu M, 2009, MOL BIOL CELL, V20, P1428, DOI 10.1091/mbc.E08-01-0001; Awan A, 2002, BIOCHEM BIOPH RES CO, V290, P1030, DOI 10.1006/bbrc.2001.6288; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Bohlson SS, 2005, J LEUKOCYTE BIOL, V77, P80, DOI 10.1189/jlb.0504305; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Buss F, 2002, TRAFFIC, V3, P851, DOI 10.1034/j.1600-0854.2002.31201.x; Cai HB, 1999, J NEUROSCI, V19, P6519; CARSBERG CJ, 1995, J CELL SCI, V108, P2905; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chittenden TW, 2006, DEV CELL, V10, P783, DOI 10.1016/j.devcel.2006.03.012; D'Angelo R, 2007, MOL BIOL CELL, V18, P4780, DOI 10.1091/mbc.E06-12-1144; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; Wu D, 2006, CELL CYCLE, V5, P1234, DOI 10.4161/cc.5.11.2815; El Mourabit H, 2002, MATRIX BIOL, V21, P207, DOI 10.1016/S0945-053X(01)00198-6; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Hirakawa T, 2003, J BIOL CHEM, V278, P49348, DOI 10.1074/jbc.M306557200; Hu LYA, 2003, J BIOL CHEM, V278, P26295, DOI 10.1074/jbc.M212352200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jeanneteau F, 2004, MOL BIOL CELL, V15, P696, DOI 10.1091/mbc.E03-05-0293; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kato H, 2004, FEBS LETT, V572, P123, DOI 10.1016/j.febslet.2004.07.017; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Le Roy C, 2005, DEV CELL, V9, P167, DOI 10.1016/j.devcel.2005.07.007; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Liu ML, 2006, MOL BIOL CELL, V17, P1880, DOI 10.1091/mbc.E06-01-0002; Liu TF, 2001, J BIOL CHEM, V276, P35768, DOI 10.1074/jbc.M103585200; Lou XJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134918; Lou XJ, 2001, MOL BIOL CELL, V12, P615, DOI 10.1091/mbc.12.3.615; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Mellor H, 2004, CURR BIOL, V14, pR434, DOI 10.1016/j.cub.2004.05.038; MYERS KA, 1994, J BIOL CHEM, V269, P9319; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Park E, 2003, J BIOL CHEM, V278, P19220, DOI 10.1074/jbc.M301052200; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rousset R, 1998, ONCOGENE, V16, P643, DOI 10.1038/sj.onc.1201567; Rudchenko S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-248; Seipel K, 2001, J CELL SCI, V114, P389; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Tkachenko E, 2006, CIRC RES, V98, P1398, DOI 10.1161/01.RES.0000225283.71490.5a; Ulrich F, 2009, TRAFFIC, V10, P811, DOI 10.1111/j.1600-0854.2009.00929.x; Vanni C, 2004, ONCOGENE, V23, P4098, DOI 10.1038/sj.onc.1207509; Wang LH, 1999, J BIOL CHEM, V274, P14137, DOI 10.1074/jbc.274.20.14137; Wei QZ, 2005, J BIOL CHEM, V280, P37790, DOI 10.1074/jbc.M502974200; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; Wu JL, 2006, DEVELOPMENT, V133, P3651, DOI 10.1242/dev.02547; Yonemura S, 2004, EXP CELL RES, V295, P300, DOI 10.1016/j.yexcr.2004.01.005; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	58	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28643	28650		10.1074/jbc.M110.107649	http://dx.doi.org/10.1074/jbc.M110.107649			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20634288	Green Published, hybrid			2022-12-25	WOS:000281594000028
J	Komaba, S; Coluccio, LM				Komaba, Shigeru; Coluccio, Lynne M.			Localization of Myosin 1b to Actin Protrusions Requires Phosphoinositide Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; RAT-LIVER; MECHANICAL TRANSDUCTION; ATPASE SITE; MYO1C; IDENTIFICATION; MICROVILLUS; ADAPTATION; MOTOR	Myosin 1b (Myo1b), a class I myosin, is a widely expressed, single-headed, actin-associated molecular motor. Transient kinetic and single-molecule studies indicate that it is kinetically slow and responds to tension. Localization and subcellular fractionation studies indicate that Myo1b associates with the plasma membrane and certain subcellular organelles such as endosomes and lysosomes. Whether Myo1b directly associates with membranes is unknown. We demonstrate here that full-length rat Myo1b binds specifically and with high affinity to phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphatidylinositol 3,4,5-triphosphate (PIP3), two phosphoinositides that play important roles in cell signaling. Binding is not Ca2+-dependent and does not involve the calmodulin-binding IQ region in the neck domain of Myo1b. Furthermore, the binding site is contained entirely within the C-terminal tail region, which contains a putative pleckstrin homology domain. Single mutations in the putative pleckstrin homology domain abolish binding of the tail domain of Myo1b to PIP2 and PIP3 in vitro. These same mutations alter the distribution of Myc-tagged Myo1b at membrane protrusions in HeLa cells where PIP2 localizes. In addition, we found that motor activity is required for Myo1b localization in filopodia. These results suggest that binding of Myo1b to phosphoinositides plays an important role in vivo by regulating localization to actin-enriched membrane projections.	[Komaba, Shigeru; Coluccio, Lynne M.] Boston Biomed Res Inst, Watertown, MA 02472 USA	Boston Biomedical Research Institute	Coluccio, LM (corresponding author), Boston Biomed Res Inst, 64 Grove St, Watertown, MA 02472 USA.	coluccio@bbri.org			National Institutes of Health [DC08793-01, DC08793-01S1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008793, R55DC008793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC08793-01 and DC08793-01S1 (to L. M. C.).	Balish MF, 1999, ARCH BIOCHEM BIOPHYS, V370, P285, DOI 10.1006/abbi.1999.1409; Batters C, 2004, EMBO J, V23, P1433, DOI 10.1038/sj.emboj.7600169; Benesh AE, 2010, MOL BIOL CELL, V21, P970, DOI 10.1091/mbc.E09-07-0638; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Brzeska H, 2008, J BIOL CHEM, V283, P32014, DOI 10.1074/jbc.M804828200; Brzeska H, 2010, J BIOL CHEM, V285, P5738, DOI 10.1074/jbc.M109.066910; Coluccio L.M., 2008, MYOS SUP MOL MOT, P95; COLUCCIO LM, 1989, J CELL BIOL, V108, P495, DOI 10.1083/jcb.108.2.495; Coluccio LR, 1999, J BIOL CHEM, V274, P21575, DOI 10.1074/jbc.274.31.21575; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; Gillespie PG, 2004, PHILOS T ROY SOC B, V359, P1945, DOI 10.1098/rstb.2004.1564; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; Hagan GN, 2008, MOL CELL BIOL, V28, P4215, DOI 10.1128/MCB.00867-07; HAYDEN SM, 1990, J CELL BIOL, V111, P443, DOI 10.1083/jcb.111.2.443; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hokanson DE, 2006, P NATL ACAD SCI USA, V103, P3118, DOI 10.1073/pnas.0505685103; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Huang SH, 2004, MOL CELL BIOL, V24, P9102, DOI 10.1128/MCB.24.20.9102-9123.2004; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; JONTES JD, 1995, NATURE, V378, P751, DOI 10.1038/378751a0; Jontes JD, 1997, J CELL BIOL, V139, P683, DOI 10.1083/jcb.139.3.683; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Loomis PA, 2003, J CELL BIOL, V163, P1045, DOI 10.1083/jcb.200309093; MATSUDAIRA PT, 1979, J CELL BIOL, V83, P667, DOI 10.1083/jcb.83.3.667; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McConnell RE, 2009, J CELL BIOL, V185, P1285, DOI 10.1083/jcb.200902147; McDonough AA, 2009, AM J PHYSIOL-CELL PH, V297, pC1331, DOI 10.1152/ajpcell.00423.2009; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Olety B, 2010, FEBS LETT, V584, P493, DOI 10.1016/j.febslet.2009.11.096; Patino-Lopez G, 2010, J BIOL CHEM, V285, P8675, DOI 10.1074/jbc.M109.086959; Perreault-Micale C, 2000, J BIOL CHEM, V275, P21618, DOI 10.1074/jbc.M000363200; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Raposo G, 1999, MOL BIOL CELL, V10, P1477, DOI 10.1091/mbc.10.5.1477; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; RUPPERT C, 1993, J CELL BIOL, V120, P1393, DOI 10.1083/jcb.120.6.1393; RUPPERT C, 1995, J CELL SCI, V108, P3775; Salas-Cortes L, 2005, J CELL SCI, V118, P4823, DOI 10.1242/jcs.02607; Sasaki N, 1998, ADV BIOPHYS, V35, P1; Sharma VP, 2008, J LEUKOCYTE BIOL, V84, P440, DOI 10.1189/jlb.0907636; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Takamoto N, 2006, ARCH BIOCHEM BIOPHYS, V456, P194, DOI 10.1016/j.abb.2006.09.026; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; Tang NY, 2001, CURR BIOL, V11, P1131, DOI 10.1016/S0960-9822(01)00320-7; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.e04-12-1116; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Wagner MC, 2005, AM J PHYSIOL-CELL PH, V289, pC120, DOI 10.1152/ajpcell.00569.2003; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; WILLIAMS R, 1994, CELL MOTIL CYTOSKEL, V27, P41, DOI 10.1002/cm.970270105; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	57	49	49	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27686	27693		10.1074/jbc.M109.087270	http://dx.doi.org/10.1074/jbc.M109.087270			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20610386	Green Published, hybrid			2022-12-25	WOS:000281404100024
J	Talsky, KB; Collins, K				Talsky, Kristin Benjamin; Collins, Kathleen			Initiation by a Eukaryotic RNA-dependent RNA Polymerase Requires Looping of the Template End and Is Influenced by the Template-tailing Activity of an Associated Uridyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOGENESIS	A conserved family of eukaryotic RNA-dependent RNA polymerases (RDRs) initiates or amplifies the production of small RNAs to provide sequence specificity for gene regulation by Argonaute/Piwi proteins. RDR-dependent silencing processes affect the genotype-phenotype relationship in many eukaryotes, but the principles that underlie the specificity of RDR template selection and product synthesis are largely unknown. Here, we characterize the initiation specificity of the Tetrahymena RDR, Rdr1, as a heterologously expressed single subunit and in the context of its biologically assembled multisubunit complexes (RDRCs). Truncation analysis of recombinant Rdr1 revealed domain requirements different from those of the only other similarly characterized RDR, suggesting that there are subfamilies of the RDR enzyme with distinct structural requirements for activity. We demonstrate an apparently obligate Rdr1 mechanism of initiation in which the template end is looped to provide the hydroxyl group priming the synthesis of dsRNA. RDRC subunits with poly(U) polymerase activity can act on the template end prior to looping to increase the duplex length of product, thus impacting the small RNA sequences generated by the RDRC-coupled Dicer. Overall, our findings give new perspective on mechanisms of RDR initiation and demonstrate that non-RDR subunits of an RDRC can affect the specificity of product synthesis.	[Talsky, Kristin Benjamin; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Collins, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kcollins@berkeley.edu			National Institutes of Health [GM54198]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54198 (to K. C.).; Supported by a National Science Foundation predoctoral fellowship.	Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Couvillion MT, 2009, GENE DEV, V23, P2016, DOI 10.1101/gad.1821209; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Lee SR, 2006, GENE DEV, V20, P28, DOI 10.1101/gad.1377006; Lee SR, 2007, NAT STRUCT MOL BIOL, V14, P604, DOI 10.1038/nsmb1262; Lee SR, 2009, RNA, V15, P1363, DOI 10.1261/rna.1630309; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Zong J, 2009, GENE, V447, P29, DOI 10.1016/j.gene.2009.07.004	21	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27614	27623		10.1074/jbc.M110.142273	http://dx.doi.org/10.1074/jbc.M110.142273			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20622019	hybrid, Green Published			2022-12-25	WOS:000281404100017
J	Desch, P; Asslaber, D; Kern, D; Schnidar, H; Mangelberger, D; Alinger, B; Stoecher, M; Hofbauer, SW; Neureiter, D; Tinhofer, I; Aberger, F; Hartmann, TN; Greil, R				Desch, P.; Asslaber, D.; Kern, D.; Schnidar, H.; Mangelberger, D.; Alinger, B.; Stoecher, M.; Hofbauer, S. W.; Neureiter, D.; Tinhofer, I.; Aberger, F.; Hartmann, T. N.; Greil, R.			Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells	ONCOGENE			English	Article						chronic lymphocytic leukemia; apoptosis; hedgehog; stromal cells; GLI transcription factors	HEDGEHOG SIGNALING PATHWAY; MARROW STROMAL CELLS; SONIC HEDGEHOG; B-CELLS; ZAP-70 EXPRESSION; CD38 EXPRESSION; NEURAL-TUBE; STEM-CELLS; IN-VITRO; CANCER	The Hedgehog (Hh) pathway regulates cell proliferation and survival and contributes to tumorigenesis. We investigated the expression and function of this pathway in B-cell chronic lymphocytic leukemia (CLL) cells and in healthy B lymphocytes. Profiling of cognate Hh pathway members revealed reduced expression of two key Hh signaling effectors, Smoothened (SMOH) and GLI, in CLL cells, whereas transcription levels of other investigated members resembled normal B-lymphocyte levels. Examining the functional role of SMOH and GLI in cell survival, we found that CLL cells were hardly sensitive toward specific SMOH inhibition, but showed an unspecific decline in cell viability in response to high concentrations of the SMOH antagonist cyclopamine. In contrast, treatment with the novel GLI antagonist GANT61 reduced expression of the target gene Patched and preferentially decreased the viability of malignant cells. Specific RNA interference knockdown experiments in a CLL-derived cell line confirmed the autonomous role of GLI in malignant cell survival. GANT61-induced apoptosis in primary leukemic cells was partly attenuated by protective stromal cells, but not soluble sonic hedgehog ligand. In summary, our data show a downregulation of the classical Hh pathway in CLL and suggest an intrinsic SMOH-independent role of GLI in the ex vivo survival of CLL cells. Oncogene (2010) 29, 4885-4895; doi: 10.1038/onc.2010.243; published online 5 July 2010	[Desch, P.; Asslaber, D.; Stoecher, M.; Hofbauer, S. W.; Tinhofer, I.; Hartmann, T. N.; Greil, R.] Paracelsus Med Univ, Lab Immunol & Mol Canc Res, Med Dept Hematol Med Oncol Hemostaseol Rheumatol, A-5020 Salzburg, Austria; [Kern, D.; Schnidar, H.; Mangelberger, D.; Aberger, F.] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Alinger, B.; Neureiter, D.] Paracelsus Med Univ, Inst Pathol, A-5020 Salzburg, Austria; [Tinhofer, I.] Charite, Translat Radiobiol & Radiooncol Res Lab, Clin Dept Radiotherapy CCM CVK, Berlin, Germany	Paracelsus Private Medical University; Salzburg University; Paracelsus Private Medical University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hartmann, TN (corresponding author), Paracelsus Med Univ, Lab Immunol & Mol Canc Res, Med Dept Hematol Med Oncol Hemostaseol Rheumatol, A-5020 Salzburg, Austria.	t.hartmann@salk.at; r.greil@salk.at	Hartmann, Tanja Nicole/C-9345-2017; Greil, Richard F/C-7673-2017; Aberger, Fritz/B-6357-2012; Hartmann, Tanja Nicole/AAA-6735-2020; Hartmann, Tanja Nicole/C-9345-2017	Hartmann, Tanja Nicole/0000-0002-0377-7179; Greil, Richard F/0000-0002-4462-3694; Aberger, Fritz/0000-0003-2009-6305; Hartmann, Tanja Nicole/0000-0002-0377-7179; Asslaber, Daniela/0000-0002-8711-016X; Tinhofer, Ingeborg/0000-0002-0512-549X; Hartmann, Tanja Nicole/0000-0002-2633-7301	Klinische Malignom und Zytokinforschung Salzburg-Innsbruck GmbH [P021]; ONB [13420]; PFIZER corporation Austria; Province of Salzburg; Austrian Science Fund (FWF) [W1213, P20652]; Austrian Genome programme Gen-AU	Klinische Malignom und Zytokinforschung Salzburg-Innsbruck GmbH; ONB; PFIZER corporation Austria; Province of Salzburg; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Genome programme Gen-AU	This work was supported by the Klinische Malignom und Zytokinforschung Salzburg-Innsbruck GmbH, SFB program P021 to RG, ONB research Grant 13420 to TNH., an unrestricted grant from PFIZER corporation Austria Ges.m.b.H, Vienna, and grants from the province of Salzburg. We thank Dr Reinhard Vlasak for help with the production of recombinant Shh protein. FA was supported by Austrian Science Fund (FWF) Grants W1213, P20652 and by the Austrian Genome programme Gen-AU.	Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Burger M, 2005, BLOOD, V106, P1824, DOI 10.1182/blood-2004-12-4918; Caligaris-Cappio F, 2003, BRIT J HAEMATOL, V123, P380, DOI 10.1046/j.1365-2141.2003.04679.x; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dierks C, 2008, CANCER CELL, V14, P238, DOI 10.1016/j.ccr.2008.08.003; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; DOHNER H, 1995, BLOOD, V85, P1580, DOI 10.1182/blood.V85.6.1580.bloodjournal8561580; Dohner H, 1999, J MOL MED-JMM, V77, P266, DOI 10.1007/s001090050350; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Ecke I, 2008, MOL CARCINOGEN, V47, P361, DOI 10.1002/mc.20394; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Gao J, 2009, CELL STEM CELL, V4, P548, DOI 10.1016/j.stem.2009.03.015; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Hegde GV, 2008, MOL CANCER RES, V6, P1928, DOI 10.1158/1541-7786.MCR-08-0142; Hofmann I, 2009, CELL STEM CELL, V4, P559, DOI 10.1016/j.stem.2009.03.016; Ikram MS, 2004, J INVEST DERMATOL, V122, P1503, DOI 10.1111/j.0022-202X.2004.22612.x; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jaganathan BG, 2007, STEM CELLS, V25, P1966, DOI 10.1634/stemcells.2007-0167; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kasper Maria, 2007, V397, P67; KNUUTILA S, 1986, NEW ENGL J MED, V314, P865, DOI 10.1056/NEJM198604033141401; Lagneaux L, 1998, BLOOD, V91, P2387, DOI 10.1182/blood.V91.7.2387.2387_2387_2396; Lauth M, 2007, ONCOGENE, V26, P5163, DOI 10.1038/sj.onc.1210321; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Lee J, 1997, DEVELOPMENT, V124, P2537; Lindemann RK, 2008, CANCER RES, V68, P961, DOI 10.1158/0008-5472.CAN-07-5500; Lowrey JA, 2002, J IMMUNOL, V169, P1869, DOI 10.4049/jimmunol.169.4.1869; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; Matsenko NU, 2008, B EXP BIOL MED+, V145, P240, DOI 10.1007/s10517-008-0060-3; Messmer BT, 2005, J CLIN INVEST, V115, P755, DOI 10.1172/JCI23409; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Panayiotidis P, 1996, BRIT J HAEMATOL, V92, P97, DOI 10.1046/j.1365-2141.1996.00305.x; Patten PEM, 2008, BLOOD, V111, P5173, DOI 10.1182/blood-2007-08-108605; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Pleyer L, 2009, NAT REV CLIN ONCOL, V6, P405, DOI 10.1038/nrclinonc.2009.72; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Sacedon R, 2005, J IMMUNOL, V174, P1456, DOI 10.4049/jimmunol.174.3.1456; Seiffert M, 2007, LEUKEMIA, V21, P1977, DOI 10.1038/sj.leu.2404863; Sheng T, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-29; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zanotti R, 2007, LEUKEMIA, V21, P102, DOI 10.1038/sj.leu.2404458; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	60	61	68	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2010	29	35					4885	4895		10.1038/onc.2010.243	http://dx.doi.org/10.1038/onc.2010.243			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	646XP	20603613				2022-12-25	WOS:000281578700003
J	Feng, ZJ; Gao, SB; Wu, Y; Xu, XF; Hua, X; Jin, GH				Feng, Z-J; Gao, S-B; Wu, Y.; Xu, X-F; Hua, X.; Jin, G-H			Lung cancer cell migration is regulated via repressing growth factor PTN/RPTP beta/zeta signaling by menin	ONCOGENE			English	Article						lung cancer; migration; Men1; pleiotrophin; RPTP beta/zeta	FOCAL-ADHESION KINASE; TYROSINE-PHOSPHATASE BETA/ZETA; UP-REGULATION; GENE; PLEIOTROPHIN; INTEGRIN; FAK; METASTASIS; INVASION; PATHWAY	Menin encoded by the multiple endocrine neoplasia type 1 (MEN1) gene is associated with chromatin and the nuclear matrix and exerts multiple biological functions including regulation of cell proliferation and adhesion. Men1 mutations increase the likelihood of lung cancer development in mice. Menin expression is reduced in certain human non-small cell lung cancer cells, and reduction of menin is closely correlated with increased lung cancer metastasis to lymph nodes. However, it is poorly understood whether menin affects migration of lung cancer cells. In this study, we show that meninregulated A549 lung cancer cell migration, which was mediated by growth factor pleiotrophin (PTN) and its cell surface receptor, protein tyrosine phosphatase beta/zeta (RPTP beta/zeta). Ectopic menin expression significantly repressed PTN transcription, but indirectly inhibited RPTP beta/zeta expression through repressing PTN expression. Further studies revealed that menin-regulated cell migration through PTN/RPTP beta/zeta, in conjunction with integrin alpha(v)beta(3), focal adhesion kinase, phosphatidylinositol 3-kinase and phosphorylated extracellular signal regulated kinase 1/2. These findings provide mechanistic insights into the molecular basis for menin/PTN-mediated regulation of A549 lung cancer cell migration. Oncogene (2010) 29, 5416-5426; doi: 10.1038/onc.2010.282; published online 19 July 2010	[Feng, Z-J; Gao, S-B; Wu, Y.; Jin, G-H] Xiamen Univ, Dept Basic Med Sci, Coll Med, Xiamen 361005, Fujian, Peoples R China; [Xu, X-F] Xiamen Second Hosp, Dept Pathol, Xiamen, Fujian, Peoples R China; [Hua, X.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA	Xiamen University; University of Pennsylvania	Jin, GH (corresponding author), Xiamen Univ, Dept Basic Med Sci, Coll Med, Daxue Rd 168, Xiamen 361005, Fujian, Peoples R China.	huax@mail.med.upenn.edu; ghjin@xmu.edu.cn		Feng, Zijie/0000-0002-5633-3686	NFSC [30701003]; National Cancer Institute [R01CA113962]; NATIONAL CANCER INSTITUTE [R01CA113962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097555] Funding Source: NIH RePORTER	NFSC(National Natural Science Foundation of China (NSFC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by an NFSC grant (No. 30701003, GH Jin) and a National Cancer Institute grant (R01CA113962, XH). We appreciate the valuable comments from other members of our laboratories.	Baillat G, 2008, BBA-MOL CELL RES, V1783, P2323, DOI 10.1016/j.bbamcr.2008.08.008; Carelli S, 2006, LUNG CANCER, V53, P263, DOI 10.1016/j.lungcan.2006.06.001; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen JS, 2009, HEPATOL RES, V39, P177, DOI 10.1111/j.1872-034X.2008.00449.x; Chen YJ, 2009, J CELL PHYSIOL, V221, P98, DOI 10.1002/jcp.21835; Debelenko LV, 2000, GENE CHROMOSOME CANC, V28, P58, DOI 10.1002/(SICI)1098-2264(200005)28:1<58::AID-GCC7>3.0.CO;2-2; Debelenko LV, 1997, HUM MOL GENET, V6, P2285, DOI 10.1093/hmg/6.13.2285; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Duces A, 2008, MOL CANCER THER, V7, P2817, DOI 10.1158/1535-7163.MCT-08-0301; Gao SB, 2008, ANN ENDOCRINOL-PARIS, V69, P426, DOI 10.1016/j.ando.2008.06.001; Gao SB, 2009, ONCOGENE, V28, P4095, DOI 10.1038/onc.2009.273; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Jager R, 2002, BRIT J CANCER, V86, P858, DOI 10.1038/sj.bjc.6600202; Jin GH, 2007, INT J CANCER, V121, P2539, DOI 10.1002/ijc.22708; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Klein CA, 2008, SCIENCE, V321, P1785, DOI 10.1126/science.1164853; Lemos MC, 2008, HUM MUTAT, V29, P22, DOI 10.1002/humu.20605; Liu GY, 2008, CELL BIOL INT, V32, P663, DOI 10.1016/j.cellbi.2008.01.292; Lu KV, 2005, J BIOL CHEM, V280, P26953, DOI 10.1074/jbc.M502614200; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Meng XN, 2009, BRIT J CANCER, V101, P327, DOI 10.1038/sj.bjc.6605154; Mikelis C, 2009, FASEB J, V23, P1459, DOI 10.1096/fj.08-117564; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Molloy T, 2008, CURR OPIN GENET DEV, V18, P35, DOI 10.1016/j.gde.2008.01.019; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Pannett AAJ, 1999, ENDOCR-RELAT CANCER, V6, P449, DOI 10.1677/erc.0.0060449; Pariser H, 2005, BIOCHEM BIOPH RES CO, V332, P664, DOI 10.1016/j.bbrc.2005.05.007; Pei XH, 2007, CANCER RES, V67, P3162, DOI 10.1158/0008-5472.CAN-06-4517; Perez-Pinera P, 2007, CELL CYCLE, V6, P2877, DOI 10.4161/cc.6.23.5090; Petzmann S, 2001, HUM PATHOL, V32, P333, DOI 10.1053/hupa.2001.22762; Polykratis A, 2005, J BIOL CHEM, V280, P22454, DOI 10.1074/jbc.M414407200; Schnepp RW, 2006, CANCER RES, V66, P5707, DOI 10.1158/0008-5472.CAN-05-4518; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; Tamura M, 1999, JNCI-J NATL CANCER I, V91, P1820, DOI 10.1093/jnci/91.21.1820; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Weng TT, 2009, J BIOL CHEM, V284, P28021, DOI 10.1074/jbc.M109.052530; Wu Xinjiang, 2008, Curr Mol Med, V8, P805, DOI 10.2174/156652408786733702; Yan J, 2009, ONCOGENE, V28, P973, DOI 10.1038/onc.2008.435	42	38	44	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	39					5416	5426		10.1038/onc.2010.282	http://dx.doi.org/10.1038/onc.2010.282			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664EZ	20639902	hybrid, Green Published			2022-12-25	WOS:000282944500008
J	Marin, I				Marin, Ignacio			Diversification and Specialization of Plant RBR Ubiquitin Ligases	PLOS ONE			English	Article							LINEAGE-SPECIFIC EXPANSION; GENE FAMILY; COMPARATIVE GENOMICS; ARABIDOPSIS; EXPRESSION; RING; PROTEINS; COMPLEX; PARKIN; DESTRUCTION	Background: RBR ubiquitin ligases are components of the ubiquitin-proteasome system present in all eukaryotes. They are characterized by having the RBR (RING-IBR-RING) supradomain. In this study, the patterns of emergence of RBR genes in plants are described. Methodology/Principal Findings: Phylogenetic and structural data confirm that just four RBR subfamilies (Ariadne, ARA54, Plant I/Helicase and Plant II) exist in viridiplantae. All of them originated before the split that separated green algae from the rest of plants. Multiple genes of two of these subfamilies (Ariadne and Plant II) appeared in early plant evolution. It is deduced that the common ancestor of all plants contained at least five RBR genes and the available data suggest that this number has been increasing slowly along streptophyta evolution, although losses, especially of Helicase RBR genes, have also occurred in several lineages. Some higher plants (e. g. Arabidopsis thaliana, Oryza sativa) contain a very large number of RBR genes and many of them were recently generated by tandem duplications. Microarray data indicate that most of these new genes have low-level and sometimes specific expression patterns. On the contrary, and as occurs in animals, a small set of older genes are broadly expressed at higher levels. Conclusions/Significance: The available data suggests that the dynamics of appearance and conservation of RBR genes is quite different in plants from what has been described in animals. In animals, an abrupt emergence of many structurally diverse RBR subfamilies in early animal history, followed by losses of multiple genes in particular lineages, occurred. These patterns are not observed in plants. It is also shown that while both plants and animals contain a small, similar set of essential RBR genes, the rest evolves differently. The functional implications of these results are discussed.	CSIC, Inst Biomed Valencia, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Marin, I (corresponding author), CSIC, Inst Biomed Valencia, Valencia, Spain.	imarin@ibv.csic.es	Marin, Ignacio/A-9524-2009	Marin, Ignacio/0000-0002-1315-8961	Programa Nacional de Biotecnologia; Ministerio de Ciencia e Innovacion. Spain [BIO2008-05067]	Programa Nacional de Biotecnologia; Ministerio de Ciencia e Innovacion. Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by grant BIO2008-05067 (Programa Nacional de Biotecnologia; Ministerio de Ciencia e Innovacion. Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Capili AD, 2004, J MOL BIOL, V340, P1117, DOI 10.1016/j.jmb.2004.05.035; Craig A, 2009, J EXP BOT, V60, P1123, DOI 10.1093/jxb/erp059; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gingerich DJ, 2007, PLANT CELL, V19, P2329, DOI 10.1105/tpc.107.051300; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haerizadeh F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-25; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jiao YL, 2009, NAT GENET, V41, P258, DOI 10.1038/ng.282; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lucas JI, 2006, J MOL BIOL, V357, P9, DOI 10.1016/j.jmb.2005.12.068; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Marin I, 2009, J MOL EVOL, V69, P54, DOI 10.1007/s00239-009-9252-3; Marrocco K, 2003, PLANT MOL BIOL, V52, P715, DOI 10.1023/A:1025056008926; Mladek C, 2003, PLANT PHYSIOL, V131, P27, DOI 10.1104/pp.012781; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Paterson AH, 2006, TRENDS GENET, V22, P597, DOI 10.1016/j.tig.2006.09.003; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Sokal R. R., 1981, BIOMETRY; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; SWOFFORD DL, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Xu GX, 2009, P NATL ACAD SCI USA, V106, P835, DOI 10.1073/pnas.0812043106; Yang XH, 2008, PLANT PHYSIOL, V148, P1189, DOI 10.1104/pp.108.121921; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	44	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11579	10.1371/journal.pone.0011579	http://dx.doi.org/10.1371/journal.pone.0011579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644651	gold, Green Published			2022-12-25	WOS:000279884900018
J	Stachon, P; Missiou, A; Walter, C; Varo, N; Colberg, C; Wolf, D; Buchner, M; von zur Muhlen, C; Zirlik, K; Bode, C; Zirlik, A				Stachon, Peter; Missiou, Anna; Walter, Carina; Varo, Nerea; Colberg, Christian; Wolf, Dennis; Buchner, Maike; von zur Muehlen, Constantin; Zirlik, Katja; Bode, Christoph; Zirlik, Andreas			Tumor Necrosis Factor Receptor Associated Factor 6 Is Not Required for Atherogenesis in Mice and Does Not Associate with Atherosclerosis in Humans	PLOS ONE			English	Article							FACTOR-KAPPA-B; SIGNALING PATHWAY; APOLIPOPROTEIN-E; DEFICIENT MICE; CD40 LIGAND; DEFECTIVE INTERLEUKIN-1; REDUCES ATHEROSCLEROSIS; FACTORS TRAFS; ACTIVATION; CELLS	Background: Tumor necrosis factor receptor-associated factors (TRAFs) are important signaling molecules for a variety of pro-atherogenic cytokines including CD40L, TNF alpha, and IL1 beta. Several lines of evidence identified TRAF6 as a pro-inflammatory signaling molecule in vitro and we previously demonstrated overexpression of TRAF6 in human and Murine atherosclerotic plaques. This study investigated the role of TRAF6-deficiency in mice developing atherosclerosis, a chronic inflammatory disease. Methodology/Principal Findings: Lethally irradiated low density lipoprotein receptor-deficient mice (TRAF6(+/+)/LDLR(-/-)) were reconstituted with TRAF6-deficient fetal liver cells (FLC) and consumed high cholesterol diet for 18 weeks to assess the relevance of TRAF6 in hematopoietic cells for atherogenesis. Additionally, TRAF6(+/-)/LDLR(-/-) mice received TRAF6-deficient FLC to gain insight into the role of TRAF6 deficiency in resident cells. Surprisingly, atherosclerotic lesion size did not differ between the three groups in both aortic roots and abdominal aortas. Similarly, no significant differences in plaque composition could be observed as assessed by immunohistochemistry for macrophages, lipids, smooth muscle cells, T-cells, and collagen. In accord, in a small clinical study TRAF6/GAPDH total blood RNA ratios did not differ between groups of patients with stable coronary heart disease (0.034 +/- 0.0021, N = 178), acute coronary heart disease (0.029 +/- 0.0027, N = 70), and those without coronary heart disease (0.032 +/- 0.0016, N = 77) as assessed by angiography. Conclusion: Our study demonstrates that TRAF6 is not required for atherogenesis in mice and does not associate with clinical disease in humans. These data suggest that pro- and anti-inflammatory features of TRAF6 signaling outweigh each other in the context of atherosclerosis.	[Stachon, Peter; Missiou, Anna; Walter, Carina; Colberg, Christian; Wolf, Dennis; von zur Muehlen, Constantin; Bode, Christoph; Zirlik, Andreas] Univ Freiburg, Dept Cardiol, Freiburg, Germany; [Missiou, Anna; Zirlik, Andreas] Univ Freiburg, Spemann Grad Sch Biol & Med, Freiburg, Germany; [Missiou, Anna] Univ Freiburg, Fac Biol, Freiburg, Germany; [Varo, Nerea] Univ Navarra, Dept Clin Chem, E-31080 Pamplona, Spain; [Buchner, Maike; Zirlik, Katja] Univ Freiburg, Dept Hematol & Oncol, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Navarra; University of Freiburg	Stachon, P (corresponding author), Univ Freiburg, Dept Cardiol, Freiburg, Germany.	andreas.zirlik@uniklinik-freiburg.de	Zirlik, Andreas/A-6400-2011; Wolf, Dennis/S-9217-2018; Wolf, Dennis/G-8299-2012; Varo, Nerea/AAB-3569-2019	Zirlik, Andreas/0000-0001-6290-3297; Wolf, Dennis/0000-0003-1525-4348; Varo, Nerea/0000-0002-2362-9472	German Research Foundation [DFG ZI743/3-1, 3-2, DFG GSC-4]	German Research Foundation(German Research Foundation (DFG))	This work was supported by research grants from the German Research Foundation to AZ (DFG ZI743/3-1 and 3-2). AM was partly funded by the Excellence Initiative of the German Research Foundation (DFG GSC-4, Spemann Graduate School). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bavendiek U, 2005, ARTERIOSCL THROM VAS, V25, P1244, DOI 10.1161/01.ATV.0000161420.55482.ef; Bishop GA, 2007, ADV EXP MED BIOL, V597, P131; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Donners MMPC, 2008, BLOOD, V111, P4596, DOI 10.1182/blood-2007-05-088906; Funakoshi-Tago M, 2008, CELL SIGNAL, V20, P1679, DOI 10.1016/j.cellsig.2008.05.013; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Kawai T, 2000, NAT MED, V6, P114, DOI 10.1038/72162; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lloyd-Jones D., CIRCULATION, V121, pe46; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; LUTGENS E, J EXP MED, V207, P391; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Missiou A, 2010, CIRCULATION, V121, P2033, DOI 10.1161/CIRCULATIONAHA.109.895037; Miyahara T, 2004, CARDIOVASC RES, V64, P154, DOI 10.1016/j.cardiores.2004.06.014; Mukundan L, 2005, J IMMUNOL, V174, P1081, DOI 10.4049/jimmunol.174.2.1081; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Schiller NK, 2001, ARTERIOSCL THROM VAS, V21, P1674, DOI 10.1161/hq1001.096724; Schonbeck U, 2000, P NATL ACAD SCI USA, V97, P7458, DOI 10.1073/pnas.97.13.7458; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Xu LG, 2004, J BIOL CHEM, V279, P17278, DOI 10.1074/jbc.C400063200; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zirlik A, 2007, ARTERIOSCL THROM VAS, V27, P1101, DOI 10.1161/ATVBAHA.107.140566; Zirlik A, 2007, CIRCULATION, V115, P1571, DOI 10.1161/CIRCULATIONAHA.106.683201	36	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11589	10.1371/journal.pone.0011589	http://dx.doi.org/10.1371/journal.pone.0011589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644648	gold, Green Published, Green Submitted			2022-12-25	WOS:000279884900024
J	Kashiyama, T; Murayama, T; Suzuki, E; Allen, PD; Ogawa, Y				Kashiyama, Taku; Murayama, Takashi; Suzuki, Erika; Allen, Paul D.; Ogawa, Yasuo			Frog alpha- and beta-Ryanodine Receptors Provide Distinct Intracellular Ca2+ Signals in a Myogenic Cell Line	PLOS ONE			English	Article							CHICKEN SKELETAL-MUSCLE; INDUCED CALCIUM-RELEASE; MICE LACKING; SARCOPLASMIC-RETICULUM; PROTEIN ISOFORMS; SPARKS; EXPRESSION; CHANNELS; FIBERS; GENERATION	Background: In frog skeletal muscle, two ryanodine receptor (RyR) isoforms, alpha-RyR and beta-RyR, are expressed in nearly equal amounts. However, the roles and significance of the two isoforms in excitation-contraction (E-C) coupling remains to be elucidated. Methodology/Principal Findings: In this study, we expressed either or both alpha-RyR and beta-RyR in 1B5 RyR-deficient myotubes using the herpes simplex virus 1 helper-free amplicon system. Immunological characterizations revealed that alpha-RyR and beta-RyR are appropriately expressed and targeted at the junctions in 1B5 myotubes. In Ca2+ imaging studies, each isoform exhibited caffeine-induced Ca2+ transients, an indicative of Ca2+-induced Ca2+ release (CICR). However, the fashion of Ca2+ release events was fundamentally different: alpha-RyR mediated graded and sustained Ca2+ release observed uniformly throughout the cytoplasm, whereas beta-RyR supported all-or-none type regenerative Ca2+ oscillations and waves. alpha-RyR but not beta-RyR exhibited Ca2+ transients triggered by membrane depolarization with high [K+](o) that were nifedipine-sensitive, indicating that only alpha-RyR mediates depolarization-induced Ca2+ release. Myotubes co-expressing alpha-RyR and beta-RyR demonstrated high [K+](o)-induced Ca2+ transients which were indistinguishable from those with myotubes expressing alpha-RyR alone. Furthermore, procaine did not affect the peak height of high [K+](o)-induced Ca2+ transients, suggesting minor amplification of Ca2+ release by beta-RyR via CICR in 1B5 myotubes. Conclusions/Significance: These findings suggest that alpha-RyR and beta-RyR provide distinct intracellular Ca2+ signals in a myogenic cell line. These distinct properties may also occur in frog skeletal muscle and will be important for E-C coupling.	[Kashiyama, Taku; Murayama, Takashi; Suzuki, Erika; Ogawa, Yasuo] Juntendo Univ, Sch Med, Dept Pharmacol, Tokyo 113, Japan; [Allen, Paul D.] Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, Boston, MA 02115 USA	Juntendo University; Harvard University; Brigham & Women's Hospital	Kashiyama, T (corresponding author), Juntendo Univ, Sch Med, Dept Pharmacol, Tokyo 113, Japan.	takashim@juntendo.ac.jp			Grants-in-Aid for Scientific Research, Japan Society for Promotion of Science; National Institutes of Health (NIH) [R01 AR43140]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043140] Funding Source: NIH RePORTER	Grants-in-Aid for Scientific Research, Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by Grants-in-Aid for Scientific Research, Japan Society for Promotion of Science and National Institutes of Health (NIH) R01 AR43140 (PDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIREY JA, 1993, DEV DYNAM, V197, P189, DOI 10.1002/aja.1001970304; AIREY JA, 1990, J BIOL CHEM, V265, P14187; Brum G, 2003, BIOPHYS J, V85, P245, DOI 10.1016/S0006-3495(03)74470-1; Chawla S, 2001, J PHYSIOL-LONDON, V536, P351, DOI 10.1111/j.1469-7793.2001.0351c.xd; Cheng H, 1996, AM J PHYSIOL-CELL PH, V270, pC148; Cheng H, 1996, CELL CALCIUM, V20, P129, DOI 10.1016/S0143-4160(96)90102-5; Chugun A, 2003, AM J PHYSIOL-REG I, V285, pR601, DOI 10.1152/ajpregu.00419.2002; Conklin MW, 2000, BIOPHYS J, V78, P1777, DOI 10.1016/S0006-3495(00)76728-2; ENDO M, 1977, PHYSIOL REV, V57, P71, DOI 10.1152/physrev.1977.57.1.71; ENDO M, 1981, MECHANISM GATED CALC, P257; Endo M, 2009, PHYSIOL REV, V89, P1153, DOI 10.1152/physrev.00040.2008; Felder E, 2002, P NATL ACAD SCI USA, V99, P1695, DOI 10.1073/pnas.032657599; Fessenden JD, 2000, BIOPHYS J, V79, P2509, DOI 10.1016/S0006-3495(00)76492-7; Franck JPC, 1998, AM J PHYSIOL-CELL PH, V275, pC401, DOI 10.1152/ajpcell.1998.275.2.C401; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gonzalez A, 2000, J GEN PHYSIOL, V115, P139, DOI 10.1085/jgp.115.2.139; HEISTRACHER P, 1969, J PHYSIOL-LONDON, V201, P627, DOI 10.1113/jphysiol.1969.sp008776; HODGKIN AL, 1960, J PHYSIOL-LONDON, V153, P386, DOI 10.1113/jphysiol.1960.sp006541; Kirsch WG, 2001, J PHYSIOL-LONDON, V537, P379, DOI 10.1111/j.1469-7793.2001.00379.x; KLEIN MG, 1992, J PHYSIOL-LONDON, V453, P341, DOI 10.1113/jphysiol.1992.sp019232; Kurebayashi N, 2003, BIOCHEM BIOPH RES CO, V310, P1266, DOI 10.1016/j.bbrc.2003.09.146; Legrand C, 2008, J PHYSIOL-LONDON, V586, P441, DOI 10.1113/jphysiol.2007.145862; LUTTGAU HC, 1968, J PHYSIOL-LONDON, V194, P51; LUTTGAU HC, 1979, J PHYSIOL-LONDON, V296, P411; Moore RA, 1998, J CELL BIOL, V140, P843, DOI 10.1083/jcb.140.4.843; Murayama T, 2000, BIOPHYS J, V78, P1810, DOI 10.1016/S0006-3495(00)76731-2; Murayama T, 2002, TRENDS CARDIOVAS MED, V12, P305, DOI 10.1016/S1050-1738(02)00179-2; Murayama T, 2001, J BIOL CHEM, V276, P2953, DOI 10.1074/jbc.M005809200; OBRIEN J, 1993, BIOPHYS J, V65, P2418, DOI 10.1016/S0006-3495(93)81303-1; Ogawa Y, 2002, FRONT BIOSCI-LANDMRK, V7, pD1184, DOI 10.2741/ogawa; OGAWA Y, 1994, CRIT REV BIOCHEM MOL, V29, P229, DOI 10.3109/10409239409083482; Ottini L, 1996, BIOCHEM J, V315, P207, DOI 10.1042/bj3150207; OYAMADA H, 1994, J BIOL CHEM, V269, P17206; Pouvreau S, 2007, P NATL ACAD SCI USA, V104, P5235, DOI 10.1073/pnas.0700748104; Protasi F, 1998, J CELL BIOL, V140, P831, DOI 10.1083/jcb.140.4.831; Rios E, 2004, BIOL RES, V37, P583; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; Schneider MF, 1999, J GEN PHYSIOL, V113, P365, DOI 10.1085/jgp.113.3.365; SCHNEIDER MF, 1994, ANNU REV PHYSIOL, V56, P463, DOI 10.1146/annurev.ph.56.030194.002335; Shirokova N, 1998, J PHYSIOL-LONDON, V512, P377, DOI 10.1111/j.1469-7793.1998.377be.x; Shirokova N, 1999, J GEN PHYSIOL, V113, P377, DOI 10.1085/jgp.113.3.377; Sorrentino V, 1999, TRENDS CARDIOVAS MED, V9, P54, DOI 10.1016/S1050-1738(99)00003-1; Sorrentino V, 1995, Adv Pharmacol, V33, P67, DOI 10.1016/S1054-3589(08)60666-3; Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027; TAKESHIMA H, 1995, EMBO J, V14, P2999, DOI 10.1002/j.1460-2075.1995.tb07302.x; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Takeshima H, 1996, J BIOL CHEM, V271, P19649, DOI 10.1074/jbc.271.33.19649; THORENS S, 1975, P JPN ACAD, V51, P473, DOI 10.2183/pjab1945.51.473; Wang Y, 2000, AM J PHYSIOL-CELL PH, V278, pC619, DOI 10.1152/ajpcell.2000.278.3.C619; Yang DM, 2001, J BIOL CHEM, V276, P40210, DOI 10.1074/jbc.M106944200; Zhou JS, 1998, J BIOL CHEM, V273, P25503, DOI 10.1074/jbc.273.39.25503	51	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11526	10.1371/journal.pone.0011526	http://dx.doi.org/10.1371/journal.pone.0011526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634947	Green Published, gold, Green Submitted			2022-12-25	WOS:000279781600011
J	Kerr, B; Silva, PA; Walz, K; Young, JI				Kerr, Bredford; Silva, Pamela A.; Walz, Katherina; Young, Juan I.			Unconventional Transcriptional Response to Environmental Enrichment in a Mouse Model of Rett Syndrome	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; BDNF TRANSCRIPTION; MECP2; MICE; EXPRESSION; DEFICIENCY; PHOSPHORYLATION; PHENOTYPE; BEHAVIOR; DISEASE	Background: Rett syndrome (RTT) is an X-linked postnatal neurodevelopmental disorder caused by mutations in the gene encoding methyl-CpG binding protein 2 (MeCP2) and one of the leading causes of mental retardation in females. RTT is characterized by psychomotor retardation, purposeless hand movements, autistic-like behavior and abnormal gait. We studied the effects of environmental enrichment (EE) on the phenotypic manifestations of a RTT mouse model that lacks MeCP2 (Mecp2(-/y)). Principal Findings: We found that EE delayed and attenuated some neurological alterations presented by Mecp2(-/y) mice and prevented the development of motor discoordination and anxiety-related abnormalities. To define the molecular correlate of this beneficial effect of EE, we analyzed the expression of several synaptic marker genes whose expression is increased by EE in several mouse models. Conclusions/Significance: We found that EE induced downregulation of several synaptic markers, suggesting that the partial prevention of RTT-associated phenotypes is achieved through a non-conventional transcriptional program.	[Kerr, Bredford; Silva, Pamela A.; Walz, Katherina; Young, Juan I.] Ctr Estudios Cient, Dept Biol, Valdivia, Chile; [Silva, Pamela A.; Walz, Katherina] Univ Austral Chile, Dept Biochem, Valdivia, Chile; [Walz, Katherina; Young, Juan I.] CIN Ctr Ingn Innovac CECS, Valdivia, Chile; [Walz, Katherina; Young, Juan I.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Dept Human Genet, Miami, FL 33136 USA	Universidad Austral de Chile; University of Miami	Kerr, B (corresponding author), Ctr Estudios Cient, Dept Biol, Valdivia, Chile.	Jyoung3@med.miami.edu		Kerr, Bredford/0000-0001-8714-8726	Fondo Nacional de Desarrollo Cientifico y Tecnologico-FONDECYT [1061067, 1051079, 11070237]; Chilean Government; Conicyt	Fondo Nacional de Desarrollo Cientifico y Tecnologico-FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Chilean Government; Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico-FONDECYT (grants 1061067, 1051079 and 11070237). The Centro de Estudios Cientificos (CECS) is funded by the Chilean Government through the Millennium Science Initiative and the Centers of Excellence Base Financing Program of Conicyt. CECS is also supported by a group of private companies which at present includes Antofagasta Minerals, Arauco, Empresas CMPC, Indura, Naviera Ultragas and Telefonica del Sur. Centro de Ingenieria para la Innovacion-CIN is funded by Conicyt and the Gobierno Regional de Los Rios. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Saavedra M, 2007, HUM MOL GENET, V16, P2315, DOI 10.1093/hmg/ddm185; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Deng V, 2007, HUM MOL GENET, V16, P640, DOI 10.1093/hmg/ddm007; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; Kondo M, 2008, EUR J NEUROSCI, V27, P3342, DOI 10.1111/j.1460-9568.2008.06305.x; Laurvick CL, 2006, J PEDIATR-US, V148, P347, DOI 10.1016/j.jpeds.2005.10.037; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lewis MH, 2004, MENT RETARD DEV D R, V10, P91, DOI 10.1002/mrdd.20017; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Miyano M, 2008, J CELL MOL MED, V12, P1188, DOI 10.1111/j.1582-4934.2008.00377.x; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Mount RH, 2002, J CHILD PSYCHOL PSYC, V43, P1099, DOI 10.1111/1469-7610.00236; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Nag N, 2009, BEHAV BRAIN RES, V196, P44, DOI 10.1016/j.bbr.2008.07.008; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Nithianantharajah J, 2004, NEUROBIOL LEARN MEM, V81, P200, DOI 10.1016/j.nlm.2004.02.002; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; RETT A, 1986, AM J MED GENET, V24, P21; Sale A, 2009, TRENDS NEUROSCI, V32, P233, DOI 10.1016/j.tins.2008.12.004; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; van D.A., 2000, NATURE, V404, P721, DOI DOI 10.1038/35008142; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	37	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11534	10.1371/journal.pone.0011534	http://dx.doi.org/10.1371/journal.pone.0011534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634955	gold, Green Published, Green Submitted			2022-12-25	WOS:000279781600014
J	Zeller, SL; Kalinina, O; Brunner, S; Keller, B; Schmid, B				Zeller, Simon L.; Kalinina, Olena; Brunner, Susanne; Keller, Beat; Schmid, Bernhard			Transgene x Environment Interactions in Genetically Modified Wheat	PLOS ONE			English	Article							UBIQUITIN PROMOTER; RUST RESISTANCE; BREAD WHEAT; EXPRESSION; MARKER; TRANSFORMATION; PLASTICITY; SELECTION; ECOLOGY; CLONING	Background: The introduction of transgenes into plants may cause unintended phenotypic effects which could have an impact on the plant itself and the environment. Little is published in the scientific literature about the interrelation of environmental factors and possible unintended effects in genetically modified (GM) plants. Methods and Findings: We studied transgenic bread wheat Triticum aestivum lines expressing the wheat Pm3b gene against the fungus powdery mildew Blumeria graminis f.sp. tritici. Four independent offspring pairs, each consisting of a GM line and its corresponding non-GM control line, were grown under different soil nutrient conditions and with and without fungicide treatment in the glasshouse. Furthermore, we performed a field experiment with a similar design to validate our glasshouse results. The transgene increased the resistance to powdery mildew in all environments. However, GM plants reacted sensitive to fungicide spraying in the glasshouse. Without fungicide treatment, in the glasshouse GM lines had increased vegetative biomass and seed number and a twofold yield compared with control lines. In the field these results were reversed. Fertilization generally increased GM/control differences in the glasshouse but not in the field. Two of four GM lines showed up to 56% yield reduction and a 40-fold increase of infection with ergot disease Claviceps purpurea compared with their control lines in the field experiment; one GM line was very similar to its control. Conclusions: Our results demonstrate that, depending on the insertion event, a particular transgene can have large effects on the entire phenotype of a plant and that these effects can sometimes be reversed when plants are moved from the glasshouse to the field. However, it remains unclear which mechanisms underlie these effects and how they may affect concepts in molecular plant breeding and plant evolutionary ecology.	[Zeller, Simon L.; Kalinina, Olena; Schmid, Bernhard] Univ Zurich, Inst Evolutionary Ecol & Environm Studies, Zurich, Switzerland; [Brunner, Susanne; Keller, Beat] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland	University of Zurich; University of Zurich	Zeller, SL (corresponding author), Univ Zurich, Inst Evolutionary Ecol & Environm Studies, Zurich, Switzerland.	simon.zeller@ieu.uzh.ch; bkeller@botinst.uzh.ch	Keller, Beat/K-3093-2019; Brunner, Susanne/AAX-1457-2021; Kalinina, Olena/J-5986-2019; Schmid, Bernhard/C-8625-2009; Kalinina, Olena/H-6275-2011	Keller, Beat/0000-0003-2379-9225; Brunner, Susanne/0000-0002-4473-3199; Schmid, Bernhard/0000-0002-8430-3214; 	Swiss National Science Foundation [SNF 405940-115607]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was supported by the Swiss National Science Foundation and is part of the wheat-cluster. ch, a sub-unit of the national research programme NRP 59 (SNF 405940-115607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; BAINBRIDGE A, 1974, PLANT PATHOL, V23, P160, DOI 10.1111/j.1365-3059.1974.tb01842.x; Barros E, 2010, PLANT BIOTECHNOL J, V8, P436, DOI 10.1111/j.1467-7652.2009.00487.x; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; BERGELSON J, 1996, PLANT PATHOL, V148, P536; Brown JKM, 2002, CURR OPIN PLANT BIOL, V5, P339, DOI 10.1016/S1369-5266(02)00270-4; Cellini F, 2004, FOOD CHEM TOXICOL, V42, P1089, DOI 10.1016/j.fct.2004.02.003; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Coll A, 2009, TRANSGENIC RES, V18, P801, DOI 10.1007/s11248-009-9266-z; Conner AJ, 2003, PLANT J, V33, P19, DOI 10.1046/j.0960-7412.2002.001607.x; CONNER AJ, 1994, BIOCONTROL SCI TECHN, V4, P463, DOI 10.1080/09583159409355358; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; EFSA, 2006, EFSA J, V4, DOI 10.2903/j.efsa.2006.99; Elmore RW, 2001, AGRON J, V93, P408, DOI 10.2134/agronj2001.932408x; Eyal Z., 1987, SEPTORIA DIS WHEAT C; Filipecki M, 2006, J APPL GENET, V47, P277, DOI 10.1007/BF03194637; GERTZ JM, 1999, P 1999 BRIGHT C WEED, V835, P340; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; GRIFFEY CA, 1986, CROP SCI, V26, P489, DOI 10.2135/cropsci1986.0011183X002600030010x; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; HENIKOFF S, 1979, GENETICS, V93, P105; Hill Ryan A., 2003, Environmental Biosafety Research, V2, P81, DOI 10.1051/ebr:2003004; Jones HD, 2005, J CEREAL SCI, V41, P137, DOI 10.1016/j.jcs.2004.08.009; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; LARKIN PJ, 1981, THEOR APPL GENET, V60, P443; LAST FT, 1953, ANN APPL BIOL, V40, P312, DOI 10.1111/j.1744-7348.1953.tb01085.x; Masci S, 2003, MOL BREEDING, V12, P209, DOI 10.1023/A:1026346823301; McCullagh P., 1989, GENERALISED LINEAR M; Ortelli S, 1996, CROP SCI, V36, P1590, DOI 10.2135/cropsci1996.0011183X003600060030x; Pellegrineschi A, 2002, GENOME, V45, P421, DOI 10.1139/G01-154; PETER M, 2010, PEDOBIOLOGI IN PRESS; PURRINGTON CB, 1995, TRENDS ECOL EVOL, V10, P340, DOI 10.1016/S0169-5347(00)89124-7; Reed J, 2001, IN VITRO CELL DEV-PL, V37, P127; Rooke L, 2000, ANN APPL BIOL, V136, P167, DOI 10.1111/j.1744-7348.2000.tb00022.x; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; SCHMID B, 1992, EVOL TREND PLANT, V6, P45; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Snow AA, 2005, ECOL APPL, V15, P377, DOI 10.1890/04-0539; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; Stam M, 1998, MOL CELL BIOL, V18, P6165, DOI 10.1128/MCB.18.11.6165; Stoger E, 1999, TRANSGENIC RES, V8, P73, DOI 10.1023/A:1008801929494; SULTAN SE, 1987, EVOL BIOL, V21, P127; SULTAN SE, 2001, PHENOTYPIC PLASTICIT; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Travella S, 2006, PLANT PHYSIOL, V142, P6, DOI 10.1104/pp.106.084517; von Burg S, 2010, BASIC APPL ECOL, V11, P257, DOI 10.1016/j.baae.2010.02.003; Waines JG, 2003, CROP SCI, V43, P451, DOI 10.2135/cropsci2003.0451; Wolfenbarger LL, 2000, SCIENCE, V290, P2088, DOI 10.1126/science.290.5499.2088; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; Yu L, 2005, J INTEGR PLANT BIOL, V47, P214, DOI 10.1111/j.1744-7909.2005.00030.x; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x	53	56	60	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11405	10.1371/journal.pone.0011405	http://dx.doi.org/10.1371/journal.pone.0011405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20635001	Green Published, gold			2022-12-25	WOS:000279781600001
J	Zhao, RY; Liang, D; Li, G; Larrimore, CW; Mirkin, BL				Zhao, Richard Y.; Liang, Dong; Li, Ge; Larrimore, Christopher W.; Mirkin, Bernard L.			Anti-Cancer Effect of HIV-1 Viral Protein R on Doxorubicin Resistant Neuroblastoma	PLOS ONE			English	Article							CELL-CYCLE; MULTIDRUG-RESISTANCE; NMR STRUCTURE; VPR ARRESTS; VIRUS; APOPTOSIS; P53; YEAST; EXPRESSION; LINES	Several unique biological features of HIV-1 Vpr make it a potentially powerful agent for anti-cancer therapy. First, Vpr inhibits cell proliferation by induction of cell cycle G2 arrest. Second, it induces apoptosis through multiple mechanisms, which could be significant as it may be able to overcome apoptotic resistance exhibited by many cancerous cells, and, finally, Vpr selectively kills fast growing cells in a p53-independent manner. To demonstrate the potential utility of Vpr as an anti-cancer agent, we carried out proof-of-concept studies in vitro and in vivo. Results of our preliminary studies demonstrated that Vpr induces cell cycle G2 arrest and apoptosis in a variety of cancer types. Moreover, the same Vpr effects could also be detected in some cancer cells that are resistant to anti-cancer drugs such as doxorubicin (DOX). To further illustrate the potential value of Vpr in tumor growth inhibition, we adopted a DOX-resistant neuroblastoma model by injecting SK-N-SH cells into C57BL/6N and C57BL/6J-scid/scid mice. We hypothesized that Vpr is able to block cell proliferation and induce apoptosis regardless of the drug resistance status of the tumors. Indeed, production of Vpr via adenoviral delivery to neuroblastoma cells caused G2 arrest and apoptosis in both drug naive and DOX-resistant cells. In addition, pre-infection or intratumoral injection of vpr-expressing adenoviral particles into neuroblastoma tumors in SCID mice markedly inhibited tumor growth. Therefore, Vpr could possibly be used as a supplemental viral therapeutic agent for selective inhibition of tumor growth in anti-cancer therapy especially when other therapies stop working.	[Zhao, Richard Y.; Liang, Dong; Li, Ge; Larrimore, Christopher W.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Zhao, Richard Y.] Univ Maryland, Sch Med, Dept Microbiol Immunol, Baltimore, MD 21201 USA; [Zhao, Richard Y.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Mirkin, Bernard L.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Childrens Mem Inst Educ & Res, Chicago, IL 60611 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Northwestern University; Feinberg School of Medicine	Zhao, RY (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.	rzhao@som.umaryland.edu		Zhao, Richard Y./0000-0003-3424-2852	Chicago Medical Research Council, Illinois Department of Public Aid and US Department of Human Health Services; University of Maryland Medical Center	Chicago Medical Research Council, Illinois Department of Public Aid and US Department of Human Health Services; University of Maryland Medical Center	This study was supported in part by the Chicago Medical Research Council, Illinois Department of Public Aid and US Department of Human Health Services and the University of Maryland Medical Center (to RYZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MR, 2008, CULT HEALTH SEX, V10, P1, DOI 10.1080/13691050701516363; Bartz SR, 1996, J VIROL, V70, P2324, DOI 10.1128/JVI.70.4.2324-2331.1996; Benko Z, 2004, J VIROL, V78, P11016, DOI 10.1128/JVI.78.20.11016-11029.2004; Bogenmann E, 1996, INT J CANCER, V67, P379, DOI 10.1002/(SICI)1097-0215(19960729)67:3<379::AID-IJC12>3.0.CO;2-3; Broberg EK, 2005, CURR GENE THER, V5, P523, DOI 10.2174/156652305774329267; Chu F, 2005, CANCER RES, V65, P10183, DOI 10.1158/0008-5472.CAN-05-2002; Elder RT, 2002, FRONT BIOSCI-LANDMRK, V7, pD349, DOI 10.2741/elder; Elder RT, 2001, VIROLOGY, V287, P359, DOI 10.1006/viro.2001.1007; ELDER RT, 2003, CANC CTR J NW U, V9, P26; EPSTEIN AL, 1978, CANCER, V42, P2379, DOI 10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO;2-4; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Heilman DW, 2005, CELL CYCLE, V4, P560; HELSON L, 1975, CANCER RES, V35, P2594; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Karpinich NO, 2006, J CELL PHYSIOL, V208, P55, DOI 10.1002/jcp.20638; Li G, 2007, J BIOL CHEM, V282, P7287, DOI 10.1074/jbc.M607951200; Li G, 2009, CURR HIV RES, V7, P178, DOI 10.2174/157016209787581436; Liang D, 2007, MOL MED, V13, P229, DOI 10.2119/2007-00004.Liang; Lothstein L, 2001, DRUG RESIST UPDATE, V4, P169, DOI 10.1054/drup.2001.0201; LOUIE KG, 1985, CANCER RES, V45, P2110; Mahalingam S, 1997, DNA CELL BIOL, V16, P137, DOI 10.1089/dna.1997.16.137; MATLASHEWSKI G, 1986, EUR J BIOCHEM, V154, P665, DOI 10.1111/j.1432-1033.1986.tb09449.x; McCray AN, 2007, CANCER BIOL THER, V6, P1269; McCray AN, 2006, MOL THER, V14, P647, DOI 10.1016/j.ymthe.2006.06.010; Moon HS, 2006, MOL CELLS, V21, P7; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Muthumani K, 2002, ONCOGENE, V21, P4613, DOI 10.1038/sj.onc.1205549; Muthumani Karupplah, 2004, Current Drug Delivery, V1, P335, DOI 10.2174/1567201043334614; Ostrakhovitch EA, 2007, J CELL BIOCHEM, V102, P1571, DOI 10.1002/jcb.21381; Pang S, 2001, CLIN CANCER RES, V7, P3567; PONS G, 1982, CANCER RES, V42, P3719; Qian F, 2005, BIOMED PHARMACOTHER, V59, P64, DOI 10.1016/j.biopha.2005.01.002; RE F, 1995, J VIROL, V69, P6859, DOI 10.1128/JVI.69.11.6859-6864.1995; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Schuler W, 1999, J MOL BIOL, V285, P2105, DOI 10.1006/jmbi.1998.2381; Sherman MP, 2002, VIROLOGY, V302, P95, DOI 10.1006/viro.2002.1576; Smardova J, 2005, ONCOL REP, V14, P901; Smith PJ, 2002, AM J PHYSIOL-CELL PH, V283, pC609, DOI 10.1152/ajpcell.00439.2001; Suzuki K, 2003, INT J ONCOL, V23, P1263; Suzuki K, 2006, AUTOPHAGY, V2, P349; Tan M, 2002, BIOMETRICS, V58, P612, DOI 10.1111/j.0006-341X.2002.00612.x; Valentiner U, 2008, TUMOR BIOL, V29, P152, DOI 10.1159/000143401; Vodicka MA, 1998, GENE DEV, V12, P175, DOI 10.1101/gad.12.2.175; WEI Q, 2006, CHINA J EXP DIAG, V10, P725; WEI Q, 2006, SHANGHAI MED PHARM J, V27, P308; Yeung MC, 1998, AIDS, V12, P349, DOI 10.1097/00002030-199804000-00002; Zelivianski S, 2006, APOPTOSIS, V11, P377, DOI 10.1007/s10495-006-4030-9; Zeman SM, 1998, P NATL ACAD SCI USA, V95, P11561, DOI 10.1073/pnas.95.20.11561; Zhang BR, 2001, J NANOSCI NANOTECHNO, V1, P263, DOI 10.1166/jnn.2001.047; Zhao RY, 2005, INDIAN J MED RES, V121, P270; Zhao YQ, 1996, J VIROL, V70, P5821, DOI 10.1128/JVI.70.9.5821-5826.1996; [No title captured]	53	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11466	10.1371/journal.pone.0011466	http://dx.doi.org/10.1371/journal.pone.0011466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628645	gold, Green Published, Green Submitted			2022-12-25	WOS:000279589300012
J	Subramanyam, MA; Ackerson, LK; Subramanian, SV				Subramanyam, Malavika A.; Ackerson, Leland K.; Subramanian, S. V.			Patterning in Birthweight in India: Analysis of Maternal Recall and Health Card Data	PLOS ONE			English	Article							POPULATION; PREGNANCY; NUTRITION; COHORT; WOMEN; SIZE; AGE	Background: National data on birthweight from birth certificates or medical records are not available in India. The third Indian National Family Health Survey included data on birthweight of children obtained from health cards and maternal recall. This study aims to describe the population that these data represent and compares the birthweight obtained from health cards with maternal recall data in terms of its socioeconomic patterning and as a risk factor for childhood growth failure. Methodology/Principal Findings: The analytic sample consisted of children aged 0 to 59 months with birthweight data obtained from health cards (n = 3227) and maternal recall (n = 16787). The difference between the card sample and the maternal recall sample in the distribution across household wealth, parental education, caste, religion, gender, and urban residence was compared using multilevel models. We also assessed the ability of birthweight to predict growth failure in infancy and childhood in the two groups. The survey contains birthweight data from a majority of household wealth categories (>5% in every category for recall), both genders, all age groups, all caste groups, all religion groups, and urban and rural dwellers. However, children from the lowest quintile of household wealth were under-represented (4.73% in card and 8.62% in recall samples). Comparison of data across health cards and maternal recall revealed similar social patterning of low birthweight and ability of birthweight to predict growth failure later in life. Children were less likely to be born with low birthweight if they had mothers with over 12 years of education compared to 1-5 years of education with relative risk (RR) of 0.79 (95% confidence interval [CI]: 0.52, 1.2) in the card sample and 0.70 (95% CI: 0.59, 0.84) in the recall sample. A 100 gram difference in a child's birthweight was associated with a decreased likelihood of underweight in both the card (RR: 0.95; 95% CI: 0.94, 0.96) and recall (RR: 0.96; 95% CI: 0.96, 0.97) samples. Conclusions: Our results suggest that in the absence of other sources, the data on birthweight in the third Indian National Family Health Survey is valuable for epidemiologic research.	[Subramanyam, Malavika A.] Univ Michigan, Sch Publ Hlth, Ctr Integrat Approaches Hlth Dispar, Ann Arbor, MI 48109 USA; [Ackerson, Leland K.] Univ Massachusetts Lowell, Dept Community Hlth & Sustainabil, Lowell, MA USA; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	University of Michigan System; University of Michigan; University of Massachusetts System; University of Massachusetts Lowell; Harvard University; Harvard T.H. Chan School of Public Health	Subramanyam, MA (corresponding author), Univ Michigan, Sch Publ Hlth, Ctr Integrat Approaches Hlth Dispar, Ann Arbor, MI 48109 USA.	svsubram@hsph.harvard.edu			National Institutes of Health [NHLBI K25 HL081275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	No direct funding was available for this study. SVS is supported by a National Institutes of Health Career Development Award (NHLBI K25 HL081275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri B, 2008, INDIAN J PEDIATR, V75, P111, DOI 10.1007/s12098-008-0066-x; Antonisamy B, 1994, Indian Pediatr, V31, P931; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bisai S, 2007, ANN HUM BIOL, V34, P91, DOI 10.1080/03014460601080728; Blanc AK, 2005, B WORLD HEALTH ORGAN, V83, P178; Carmines E. G., 1979, RELIABILITY VALIDITY, DOI DOI 10.4135/9781412985642; CHITNIS S, 1997, POLITICS BACKWARDNES, P88; Deshmukh J S, 1998, Indian Pediatr, V35, P33; DHARMALINGAM A, 2009, MATERN CHILD HLTH J; Dwarkanath P, 2007, ASIA PAC J CLIN NUTR, V16, P704; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; George K, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-5; Gupta PC, 2004, BMJ-BRIT MED J, V328, P1538, DOI 10.1136/bmj.38113.687882.EB; Hirve S S, 1994, Indian Pediatr, V31, P1221; IIPS and Macro International, 2007, NAT FAM HLTH SURV NF, V1; IIPS and ORC Macro, 2007, NAT FAM HLTH SURV 20; International Institute of Population Sciences (IIPS) & Macro International, 2007, NAT FAM HLTH SURV NF, VII; Kanade AN, 2008, J AM COLL NUTR, V27, P137, DOI 10.1080/07315724.2008.10719685; Kulkarni B, 2006, EUR J CLIN NUTR, V60, P1341, DOI 10.1038/sj.ejcn.1602461; MATHAI M, 1992, BRIT J OBSTET GYNAEC, V99, P342, DOI 10.1111/j.1471-0528.1992.tb13736.x; Misra M, 1995, J TROP PEDIATRICS, V41, P374, DOI 10.1093/tropej/41.6.374; Muthayya S, 2006, EUR J CLIN NUTR, V60, P791, DOI 10.1038/sj.ejcn.1602383; Muthayya S, 2006, PUBLIC HEALTH NUTR, V9, P896, DOI 10.1017/PHN2006943; Nair N. Sreekumaran, 2000, Indian Journal of Pediatrics, V67, P9, DOI 10.1007/BF02802625; Patel V, 2006, BRIT J PSYCHIAT, V188, P284, DOI 10.1192/bjp.bp.105.012096; Prasad K N, 1994, Indian Pediatr, V31, P836; Rao S, 2009, INT J EPIDEMIOL, V38, P1094, DOI 10.1093/ije/dyp223; Rehman AM, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-44; Sarkar N. C., 2000, Indian Journal of Pediatrics, V67, P419, DOI 10.1007/BF02859458; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1245, DOI 10.1093/ije/30.6.1245; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; World Health Organization (WHO), 2004, LOW BIRTH WEIGHT COU; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	34	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11424	10.1371/journal.pone.0011424	http://dx.doi.org/10.1371/journal.pone.0011424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625399	gold, Green Published, Green Submitted			2022-12-25	WOS:000279465700011
J	Yao, W; Dai, WW; Shahnazari, M; Pham, A; Chen, ZQ; Chen, HY; Guan, M; Lane, NE				Yao, Wei; Dai, Weiwei; Shahnazari, Mohammad; Pham, Aaron; Chen, Zhiqiang; Chen, Haiyan; Guan, Min; Lane, Nancy E.			Inhibition of the Progesterone Nuclear Receptor during the Bone Linear Growth Phase Increases Peak Bone Mass in Female Mice	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; DEPOT MEDROXYPROGESTERONE ACETATE; GLUCOCORTICOID-TREATED MICE; ESTROGEN-DEFICIENT MICE; PROSTATE-CANCER CELLS; OSTEOBLAST-LIKE CELLS; KNOCKOUT PRKO MICE; OXIDATIVE STRESS; CALCIUM SUPPLEMENTATION; ANDROGEN RECEPTOR	Augmentation of the peak bone mass (PBM) may be one of the most effective interventions to reduce the risk of developing osteoporosis later in life; however treatments to augment PBM are currently limited. Our study evaluated whether a greater PBM could be achieved either in the progesterone nuclear receptor knockout mice (PRKO) or by using a nuclear progesterone receptor (nPR) antagonist, RU486 in mice. Compared to their wild type (WT) littermates the female PRKO mice developed significantly higher cancellous and cortical mass in the distal femurs, and this was associated with increased bone formation. The high bone mass phenotype was partially reproduced by administering RU486 in female WT mice from 1-3 months of age. Our results suggest that the inhibition of the nPR during the rapid bone growth period (1-3 months) increases osteogenesis, which results in acquisition of higher bone mass. Our findings suggest a crucial role for progesterone signaling in bone acquisition and inhibition of the nPR as a novel approach to augment bone mass, which may have the potential to reduce the burden of osteoporosis.	[Yao, Wei; Dai, Weiwei; Shahnazari, Mohammad; Pham, Aaron; Chen, Zhiqiang; Chen, Haiyan; Guan, Min; Lane, Nancy E.] Univ Calif Davis, Med Ctr, Dept Internal Med, Ctr Healthy Aging, Sacramento, CA 95817 USA	University of California System; University of California Davis	Yao, W (corresponding author), Univ Calif Davis, Med Ctr, Dept Internal Med, Ctr Healthy Aging, Sacramento, CA 95817 USA.	wei.yao@ucdmc.ucdavis.edu	Yao, Wei/O-8187-2019; Chen, Haiyan/HGB-6216-2022; yao, wei/GVS-3913-2022; Shahnazari, Mohammad Reza/AAU-8573-2020	Yao, Wei/0000-0002-1198-1161; yao, wei/0000-0002-1198-1161; Shahnazari, Mohammad Reza/0000-0001-8647-5426; Guan, Min/0000-0003-3851-8553	National Institute of Child Health and Human Development (NICHD) [NIAMS- 5R21AR057515, NIAMS- R01 AR043052-07, K24-AR-048841, 1K12HD05195801]; Office of Research on Women's Health (ORWH); Office of Dietary Supplements (ODS); National Institute of Aging (NIA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR057515, K24AR048841, R01AR043052] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of Research on Women's Health (ORWH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	NIAMS- 5R21AR057515 (to WY), NIAMS- R01 AR043052-07, K24-AR-048841 (to NEL), 1K12HD05195801 that is co-funded by National Institute of Child Health and Human Development (NICHD), the Office of Research on Women's Health (ORWH), the Office of Dietary Supplements (ODS) and the National Institute of Aging (NIA).	ABE T, 1992, BONE MINER, V19, P225, DOI 10.1016/0169-6009(92)90872-B; Abplanalp W, 2001, GYNECOL OBSTET INVES, V51, P81, DOI 10.1159/000052898; Azizi G, 2003, ENDOCR RES, V29, P133, DOI 10.1081/ERC-120022294; Bachrach LK, 2000, PEDIATRICS, V106, P1137, DOI 10.1542/peds.106.5.1137; BARENGOLTS EI, 1995, BONE, V17, P21, DOI 10.1016/8756-3282(95)00138-4; BARENGOLTS EI, 1990, J BONE MINER RES, V5, P1143; Bonjour JP, 2001, LANCET, V358, P1208, DOI 10.1016/S0140-6736(01)06342-5; Boonyaratanakornkit V, 2008, STEROIDS, V73, P922, DOI 10.1016/j.steroids.2008.01.010; Boonyaratanakornkit V, 2007, SEMIN REPROD MED, V25, P139, DOI 10.1055/s-2007-973427; Boonyaratanakornkit V, 2007, MOL ENDOCRINOL, V21, P359, DOI 10.1210/me.2006-0337; Brosens JJ, 2006, J MOL ENDOCRINOL, V36, P389, DOI 10.1677/jme.1.02060; Brouwers JEM, 2007, J ORTHOP RES, V25, P1325, DOI 10.1002/jor.20439; Burger HG, 1998, CLIN ENDOCRINOL, V48, P809; Cao JJ, 2007, J BONE MINER RES, V22, P1271, DOI 10.1359/JBMR.070506; Chappell PE, 1999, ENDOCRINOLOGY, V140, P3653, DOI 10.1210/en.140.8.3653; Chappell PE, 1997, ENDOCRINOLOGY, V138, P4147, DOI 10.1210/en.138.10.4147; Chen L, 1997, J Tongji Med Univ, V17, P72; Conneely OM, 2001, MOL CELL ENDOCRINOL, V179, P97, DOI 10.1016/S0303-7207(01)00465-8; Courteix D, 2005, INT J SPORTS MED, V26, P332, DOI 10.1055/s-2004-821040; Crofton PM, 1997, CLIN ENDOCRINOL, V46, P109, DOI 10.1046/j.1365-2265.1997.d01-1744.x; Cromer BA, 2006, J ADOLESCENT HEALTH, V39, P296, DOI 10.1016/j.jadohealth.2006.03.011; Cundy T, 1997, AM J OBSTET GYNECOL, V176, P1116, DOI 10.1016/S0002-9378(97)70415-0; Cundy T, 1996, J CLIN ENDOCR METAB, V81, P1014, DOI 10.1210/jc.81.3.1014; Cundy T, 1998, OBSTET GYNECOL, V92, P569, DOI 10.1016/S0029-7844(98)00270-1; CUNDY T, 1991, BRIT MED J, V303, P13, DOI 10.1136/bmj.303.6793.13; Danilovich N, 2000, ENDOCRINOLOGY, V141, P4295, DOI 10.1210/en.141.11.4295; de Kretser DM, 2001, MOL CELL ENDOCRINOL, V180, P87, DOI 10.1016/S0303-7207(01)00502-0; de Kretser DM, 2000, MOL CELL ENDOCRINOL, V161, P43, DOI 10.1016/S0303-7207(99)00222-1; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fan WQ, 2007, J BIOL CHEM, V282, P7329, DOI 10.1074/jbc.M610447200; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; Frye CA, 2006, PSYCHOPHARMACOLOGY, V185, P423, DOI 10.1007/s00213-005-0300-4; GALLAGHER JC, 1991, AM J MED, V90, P171; Gellersen B, 2009, HUM REPROD UPDATE, V15, P119, DOI 10.1093/humupd/dmn044; Grassi F, 2007, P NATL ACAD SCI USA, V104, P15087, DOI 10.1073/pnas.0703610104; Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Grosse B, 2000, J CELL BIOCHEM, V79, P334, DOI 10.1002/1097-4644(20001101)79:2<334::AID-JCB160>3.3.CO;2-D; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; HOROWITZ M, 1993, CLIN ENDOCRINOL, V39, P649, DOI 10.1111/j.1365-2265.1993.tb02422.x; HSIAO EC, 2008, P NATL ACAD SCI US; Huang HJ, 2004, J BIOL CHEM, V279, P13866, DOI 10.1074/jbc.M314143200; Iqbal J, 2006, P NATL ACAD SCI USA, V103, P14925, DOI 10.1073/pnas.0606805103; Ishida Y, 1996, J BONE MINER RES, V11, P921; Ishida Y, 1997, BONE, V20, P17, DOI 10.1016/S8756-3282(96)00315-8; Ishida Y, 1997, OSTEOPOROSIS INT, V7, P323, DOI 10.1007/BF01623772; JOHNSTON CC, 1993, OSTEOPOROSIS INT, V3, pS54, DOI 10.1007/BF01621864; KALU DN, 1991, BONE MINER, V15, P109, DOI 10.1016/0169-6009(91)90002-H; Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984; Labied S, 2006, MOL ENDOCRINOL, V20, P35, DOI 10.1210/me.2005-0275; Lane NE, 2006, J BONE MINER RES, V21, P466, DOI 10.1359/JBMR.051103; Lane NE, 2005, J BONE MINER RES, V20, P58, DOI 10.1359/JBMR.041017; Le Mellay V, 2000, J CELL BIOCHEM, V79, P173, DOI 10.1002/1097-4644(20001101)79:2<173::AID-JCB10>3.0.CO;2-3; Lengyel F, 2007, STEROIDS, V72, P422, DOI 10.1016/j.steroids.2007.03.001; Li PF, 2003, MOL CELL BIOL, V23, P104, DOI 10.1128/MCB.23.1.104-118.2003; Liang M, 2003, ENDOCR RES, V29, P483, DOI 10.1081/ERC-120026954; Liu JH, 2005, AM J OBSTET GYNECOL, V192, P1316, DOI 10.1016/j.ajog.2004.12.067; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; MacNamara P, 1998, CALCIFIED TISSUE INT, V63, P39; MACNAMARA P, 1995, CALCIFIED TISSUE INT, V57, P436, DOI 10.1007/BF00301947; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; Markovic V, 2005, AM J CLIN NUTR, V81, P175; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; Matsumoto M, 2005, CELL METAB, V1, P215, DOI 10.1016/j.cmet.2005.03.008; Meehan T, 2000, DEV BIOL, V220, P225, DOI 10.1006/dbio.2000.9625; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; PENSLER JM, 1990, J BONE MINER RES, V5, P797; Perrien DS, 2007, ENDOCRINOLOGY, V148, P1654, DOI 10.1210/en.2006-0848; Petitti DB, 2000, OBSTET GYNECOL, V95, P736, DOI 10.1016/S0029-7844(00)00782-1; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; PRIOR JC, 1994, AM J MED, V96, P521, DOI 10.1016/0002-9343(94)90092-2; Ramara A, 2007, BRAIN RES, V1176, P71, DOI 10.1016/j.brainres.2007.08.036; Reddy DS, 2005, NEUROPHARMACOLOGY, V48, P14, DOI 10.1016/j.neuropharm.2004.09.002; Rickard DJ, 2008, ENDOCRINOLOGY, V149, P2383, DOI 10.1210/en.2007-1247; Roemer SC, 2008, NUCLEIC ACIDS RES, V36, P3655, DOI 10.1093/nar/gkn249; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; SANCHEZCRIADO JE, 1992, J ENDOCRINOL, V134, P51, DOI 10.1677/joe.0.1340051; SANCHEZCRIADO JE, 1992, J ENDOCRINOL, V134, P43, DOI 10.1677/joe.0.1340043; SCHEVEN BAA, 1992, BIOCHEM BIOPH RES CO, V186, P54, DOI 10.1016/S0006-291X(05)80774-0; Schneider JS, 2005, ENDOCRINOLOGY, V146, P4340, DOI 10.1210/en.2005-0490; Schneider JS, 2003, P NATL ACAD SCI USA, V100, P2951, DOI 10.1073/pnas.0130100100; SLOOTWEG MC, 1992, J ENDOCRINOL, V133, pR5, DOI 10.1677/joe.0.133R005; Stirone C, 2005, MOL PHARMACOL, V68, P959, DOI 10.1124/mol.105.014662; Sudoh N, 2001, CIRCULATION, V103, P724; Sur P, 2003, BRAIN RES, V971, P178, DOI 10.1016/S0006-8993(03)02349-7; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Turgeon JL, 2001, ENDOCRINOLOGY, V142, P3108, DOI 10.1210/en.142.7.3108; WANG JD, 1994, CONTRACEPTION, V49, P245, DOI 10.1016/0010-7824(94)90042-6; Wang JP, 2008, J NANOELECTRON OPTOE, V3, P12, DOI 10.1166/jno.2008.006; Ward EC, 2008, ENDOCRINOLOGY, V149, P1942, DOI 10.1210/en.2007-0756; Ward KA, 2007, BONE, V41, P496, DOI 10.1016/j.bone.2007.06.007; WEI LL, 1993, BIOCHEM BIOPH RES CO, V195, P525, DOI 10.1006/bbrc.1993.2077; Welt CK, 1999, J CLIN ENDOCR METAB, V84, P105, DOI 10.1210/jc.84.1.105; Yao W, 2005, OSTEOPOROSIS INT, V16, P1939, DOI 10.1007/s00198-005-1969-2; Yao W, 2008, ARTHRITIS RHEUM, V58, P3485, DOI 10.1002/art.23954; Yao W, 2008, ARTHRITIS RHEUM, V58, P1674, DOI 10.1002/art.23454	97	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2010	5	7							e11410	10.1371/journal.pone.0011410	http://dx.doi.org/10.1371/journal.pone.0011410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YF	20625385	Green Published, Green Submitted, gold			2022-12-25	WOS:000279465500003
J	Bergerot, B; Julliard, R; Baguette, M				Bergerot, Benjamin; Julliard, Romain; Baguette, Michel			Metacommunity Dynamics: Decline of Functional Relationship along a Habitat Fragmentation Gradient	PLOS ONE			English	Article							COTESIA-GLOMERATA; PARASITOID WASP; HOST; CONSERVATION; CATERPILLARS; COMMUNITIES; POPULATIONS; BUTTERFLIES; DISTANCES; BEHAVIOR	Background: The metacommunity framework is crucial to the study of functional relations along environmental gradients. Changes in resource grain associated with increasing habitat fragmentation should generate uncoupled responses of interacting species with contrasted dispersal abilities. Methodology/Principal Findings: Here we tested whether the intensity of parasitism was modified by increasing habitat fragmentation in the well know predator-prey system linking the parasitoid Cotesia glomerata (Hymenoptera: Braconidae) to its main host Pieris brassicae (Lepidoptera: Pieridae). We collected information on herbivorous abundance and parasitism rate along an urbanization gradient from the periphery to the centre of Paris. We showed that butterfly densities were not influenced by habitat fragmentation, whereas parasitism rate sharply decreased along this gradient. Conclusions/Significance: Our results provide novel insights into the mechanisms underlying the persistence of species in highly fragmented areas. They suggest that differential dispersal abilities could alter functional relationships between prey and predator, notably by a lack of natural predators.	[Bergerot, Benjamin; Julliard, Romain] UPMC, CNRS, MNHN, UMR CERSP 7204, Paris, France; [Baguette, Michel] MNHN, CNRS, UMR 7179, MAOAC, Brunoy, France; [Baguette, Michel] CNRS, USR 2936, Stn Ecol Expt, Moulis, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS)	Bergerot, B (corresponding author), UPMC, CNRS, MNHN, UMR CERSP 7204, Paris, France.	bergerot@mnhn.fr	Baguette, Michel/HHZ-3609-2022; bergerot, benjamin/AAD-4591-2021; Baguette, Michel/E-4754-2011	bergerot, benjamin/0000-0003-4313-4925	French National Museum of Natural History; Centre National de la Recherches Scientifiques (CNRS); ANR; SCALE (Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal and Ecological Scales)	French National Museum of Natural History; Centre National de la Recherches Scientifiques (CNRS)(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); SCALE (Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal and Ecological Scales)	The different field work projects of the authors were supported by the French National Museum of Natural History, the Centre National de la Recherches Scientifiques (CNRS), a grant from the ANR (ANR blanc DIAME Dispersal and MEtapopulation, 2008-2011) and the SCALE project (Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal and Ecological Scales).	AKAIKE H, 1981, CC/ENG TECH APPL SCI, P22; Askew R.R., 1986, P225; Baguette M, 2007, LANDSCAPE ECOL, V22, P1117, DOI 10.1007/s10980-007-9108-4; BRODEUR J, 1994, ANIM BEHAV, V48, P187, DOI 10.1006/anbe.1994.1225; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; COHEN JE, 1990, BIOMATHEMATICS BERLI, V20, P1; ECOMOS, 2003, EC SOIL OCC MOD; Elzinga JA, 2007, BASIC APPL ECOL, V8, P75, DOI 10.1016/j.baae.2006.04.003; Esch S, 2005, OECOLOGIA, V146, P218, DOI 10.1007/s00442-005-0214-1; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; FAHRIG L, 1994, CONSERV BIOL, V8, P50, DOI 10.1046/j.1523-1739.1994.08010050.x; Feltwell J., 1982, LARGE WHITE BUTTERFL; Geervliet JBF, 2000, OECOLOGIA, V124, P55, DOI 10.1007/s004420050024; Hanski I, 1999, METAPOPULATION DYNAM; Hardy PB, 1999, BIODIVERS CONSERV, V8, P1261, DOI 10.1023/A:1008984905413; Hill JK, 2006, BIOL LETTERS, V2, P152, DOI 10.1098/rsbl.2005.0401; Holt RD, 2002, ECOL RES, V17, P261, DOI 10.1046/j.1440-1703.2002.00485.x; Kolligs Detlef, 2000, Faunistisch-Oekologische Mitteilungen Supplement, V28, P1; Kozlov MV, 1996, ENTOMOL FENNICA, V7, P137, DOI 10.33338/ef.83902; Kruess A, 2003, ECOGRAPHY, V26, P283, DOI 10.1034/j.1600-0587.2003.03402.x; KRUESS A, 1994, SCIENCE, V264, P1581, DOI 10.1126/science.264.5165.1581; Marzluff JM, 2001, RESTOR ECOL, V9, P280, DOI 10.1046/j.1526-100x.2001.009003280.x; Moss JE, 1933, J ANIM ECOL, V2, P210, DOI 10.2307/959; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Muratet A, 2007, ECOSYSTEMS, V10, P661, DOI 10.1007/s10021-007-9047-6; OHSAKI N, 1990, ECOL ENTOMOL, V15, P169, DOI 10.1111/j.1365-2311.1990.tb00798.x; Poelman EH, 2009, FUNCT ECOL, V23, P951, DOI 10.1111/j.1365-2435.2009.01570.x; Rand TA, 2007, OIKOS, V116, P1353, DOI [10.1111/j.2007.0030-1299.15871.x, 10.1111/j.0030-1299.2007.15871.x]; Roland J, 1997, NATURE, V386, P710, DOI 10.1038/386710a0; TAKABAYASHI J, 1994, J CHEM ECOL, V20, P1329, DOI 10.1007/BF02059811; Tanaka S, 2006, ECOL RES, V21, P570, DOI 10.1007/s11284-006-0153-2; Thies C, 2003, OIKOS, V101, P18, DOI 10.1034/j.1600-0706.2003.12567.x; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2002, ECOL RES, V17, P229, DOI 10.1046/j.1440-1703.2002.00482.x; Tscharntke T, 2002, ECOL APPL, V12, P354, DOI 10.1890/1051-0761(2002)012[0354:COSHFT]2.0.CO;2; van Nouhuys S, 2002, J ANIM ECOL, V71, P639, DOI 10.1046/j.1365-2656.2002.00627.x; van Nouhuys S, 2005, ANN ZOOL FENN, V42, P433; Vos M, 1998, J ANIM ECOL, V67, P774, DOI 10.1046/j.1365-2656.1998.00239.x; Wanner H, 2006, PHYSIOL ENTOMOL, V31, P127, DOI 10.1111/j.1365-3032.2006.00494.x; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Zabel J, 1998, OECOLOGIA, V116, P419, DOI 10.1007/s004420050605	43	23	26	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11294	10.1371/journal.pone.0011294	http://dx.doi.org/10.1371/journal.pone.0011294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613976	gold, Green Published, Green Submitted			2022-12-25	WOS:000279370000005
J	Najera, JL; Gomez, CE; Garcia-Arriaza, J; Sorzano, CO; Esteban, M				Luis Najera, Jose; Elena Gomez, Carmen; Garcia-Arriaza, Juan; Oscar Sorzano, Carlos; Esteban, Mariano			Insertion of Vaccinia Virus C7L Host Range Gene into NYVAC-B Genome Potentiates Immune Responses against HIV-1 Antigens	PLOS ONE			English	Article							CD8(+) T-CELL; POXVIRUS VECTORS MVA; IN-VITRO EXPRESSION; REPLICATION-COMPETENT; VIRAL VECTORS; DNA VACCINE; IMMUNOGENICITY; MEMORY; CANDIDATES; PROTEIN	Background: The highly attenuated vaccinia virus strain NYVAC expressing HIV-1 components has been evaluated as a vaccine candidate in preclinical and clinical trials with encouraging results. We have previously described that the presence of C7L in the NYVAC genome prevents the induction of apoptosis and renders the vector capable of replication in human and murine cell lines while maintaining an attenuated phenotype in mice. Methodology/Principal Findings: In an effort to improve the immunogenicity of NYVAC, we have developed a novel poxvirus vector by inserting the VACV host-range C7L gene into the genome of NYVAC-B, a recombinant virus that expresses four HIV-1 antigens from clade B (Env, Gag, Pol and Nef) (referred as NYVAC-B-C7L). In the present study, we have compared the in vitro and in vivo behavior of NYVAC-B and NYVAC-B-C7L. In cultured cells, NYVAC-B-C7L expresses higher levels of heterologous antigen than NYVAC-B as determined by Western blot and fluorescent-activated cell sorting to score Gag expressing cells. In a DNA prime/poxvirus boost approach with BALB/c mice, both recombinants elicited robust, broad and multifunctional antigen-specific T-cell responses to the HIV-1 immunogens expressed from the vectors. However, the use of NYVAC-B-C7L as booster significantly enhanced the magnitude of the T cell responses, and induced a more balanced cellular immune response to the HIV-1 antigens in comparison to that elicited in animals boosted with NYVAC-B. Conclusions/Significance: These findings demonstrate the possibility to enhance the immunogenicity of the highly attenuated NYVAC vector by the insertion of the host-range gene C7L and suggest the use of this modified vector as an improved vaccine candidate against HIV/AIDS.	[Luis Najera, Jose; Elena Gomez, Carmen; Garcia-Arriaza, Juan; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Oscar Sorzano, Carlos] CSIC, Ctr Nacl Biotecnol, Biocomp Unit, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Najera, JL (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Ciudad Univ Cantoblanco, Madrid, Spain.	mesteban@cnb.csic.es	NAJERA, Jose Luis/W-8177-2019; Sorzano, Carlos Oscar S S./F-2639-2016; S. Sorzano, Carlos Oscar/ABE-4884-2021; Gomez, Carmen Elena/K-1940-2014; GARCIA-ARRIAZA, JUAN/Q-6243-2017; Esteban, Mariano/ABG-5375-2020	Sorzano, Carlos Oscar S S./0000-0002-9473-283X; S. Sorzano, Carlos Oscar/0000-0002-9473-283X; Gomez, Carmen Elena/0000-0002-5414-7935; GARCIA-ARRIAZA, JUAN/0000-0002-5167-5724; Esteban, Mariano/0000-0003-0846-2827; Najera, jose Luis/0000-0001-7798-3330	Ministry of Science and Innovation [SAF2008-02036]; Foundation Botin of Spain;  [FIPSE-36551/06]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Foundation Botin of Spain; 	This investigation was supported by grants from FIPSE-36551/06, the Ministry of Science and Innovation (SAF2008-02036) and Foundation Botin of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara RR, 2002, J VIROL, V76, P7625, DOI 10.1128/JVI.76.15.7625-7631.2002; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Bachmann MF, 2005, J IMMUNOL, V175, P4677, DOI 10.4049/jimmunol.175.7.4677; Backes S, 2010, J GEN VIROL, V91, P470, DOI 10.1099/vir.0.015347-0; Bartlett N, 2002, J GEN VIROL, V83, P1965, DOI 10.1099/0022-1317-83-8-1965; Brave A, 2007, MOL THER, V15, P1724, DOI 10.1038/sj.mt.6300235; Corbett M, 2008, P NATL ACAD SCI USA, V105, P2046, DOI 10.1073/pnas.0705191105; Critchfield JW, 2007, J VIROL, V81, P5460, DOI 10.1128/JVI.02535-06; Dai KF, 2008, VACCINE, V26, P5062, DOI 10.1016/j.vaccine.2008.06.011; Didierlaurent A, 2004, VACCINE, V22, P3395, DOI 10.1016/j.vaccine.2004.02.025; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Esteban M, 2009, HUM VACCINES, V5, P867, DOI 10.4161/hv.9693; Ferrier-Rembert A, 2008, VACCINE, V26, P1794, DOI 10.1016/j.vaccine.2007.12.059; Gedey R, 2006, J VIROL, V80, P8676, DOI 10.1128/JVI.00935-06; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Gomez CE, 2007, J GEN VIROL, V88, P2473, DOI 10.1099/vir.0.83018-0; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Hovav AH, 2007, J VIROL, V81, P12793, DOI 10.1128/JVI.01519-07; Huang XX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004180; Jacobs BL, 2009, ANTIVIR RES, V84, P1, DOI 10.1016/j.antiviral.2009.06.006; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Koff WC, 2008, BIOLOGICALS, V36, P277, DOI 10.1016/j.biologicals.2008.04.004; LEE MS, 1992, J VIROL, V66, P2617, DOI 10.1128/JVI.66.5.2617-2630.1992; Liniger M, 2007, EXPERT REV VACCINES, V6, P255, DOI 10.1586/14760584.6.2.255; Liu JY, 2007, VACCINE, V25, P2951, DOI 10.1016/j.vaccine.2006.05.081; Liu JY, 2006, VACCINE, V24, P3332, DOI 10.1016/j.vaccine.2006.01.017; Loffredo JT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001152; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola LR, 2000, AIDS, V14, pS167; Meng XZ, 2009, J VIROL, V83, P10627, DOI 10.1128/JVI.01260-09; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Mooij P, 2008, J VIROL, V82, P2975, DOI 10.1128/JVI.02216-07; Mooij P, 2009, J VIROL, V83, P5881, DOI 10.1128/JVI.02345-08; Najera JL, 2006, J VIROL, V80, P6033, DOI 10.1128/JVI.02108-05; Narayan S, 2007, EUR J IMMUNOL, V37, P406, DOI 10.1002/eji.200535688; OGUIURA N, 1993, J GEN VIROL, V74, P1409, DOI 10.1099/0022-1317-74-7-1409; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; PERKUS ME, 1990, VIROLOGY, V179, P276, DOI 10.1016/0042-6822(90)90296-4; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Pulendran B, 2004, CURR BIOL, V14, pR30, DOI 10.1016/j.cub.2003.12.020; Radcliffe JN, 2006, J IMMUNOL, V177, P6626, DOI 10.4049/jimmunol.177.10.6626; Ramanathan VD, 2009, AIDS RES HUM RETROV, V25, P1107, DOI 10.1089/aid.2009.0096; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; RODRIGUEZ JF, 1988, P NATL ACAD SCI USA, V85, P1667, DOI 10.1073/pnas.85.5.1667; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rouder JN, 2005, PSYCHON B REV, V12, P573, DOI 10.3758/BF03196750; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; TARTAGLIA J, 1992, VIROLOGY, V188, P217, DOI 10.1016/0042-6822(92)90752-B; Vijaysri S, 2008, VACCINE, V26, P664, DOI 10.1016/j.vaccine.2007.11.045; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Wherry EJ, 1999, J IMMUNOL, V163, P3735; Wherry EJ, 2002, J IMMUNOL, V168, P4455, DOI 10.4049/jimmunol.168.9.4455; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wyatt LS, 2008, VACCINE, V26, P486, DOI 10.1016/j.vaccine.2007.11.036; Zhang XG, 2007, J VIROL, V81, P7022, DOI 10.1128/JVI.02654-06; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102; zur Megede J, 2000, J VIROL, V74, P2628, DOI 10.1128/JVI.74.6.2628-2635.2000	65	53	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11406	10.1371/journal.pone.0011406	http://dx.doi.org/10.1371/journal.pone.0011406			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613977	Green Published, gold			2022-12-25	WOS:000279370000030
J	Gold, S; Monaghan, P; Mertens, P; Jackson, T				Gold, Sarah; Monaghan, Paul; Mertens, Peter; Jackson, Terry			A Clathrin Independent Macropinocytosis-Like Entry Mechanism Used by Bluetongue Virus-1 during Infection of BHK Cells	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; ENDOCYTIC PATHWAY; EPITHELIAL-CELLS; VACCINIA VIRUS; FUNCTIONAL-CHARACTERIZATION; MEDIATED ENDOCYTOSIS; CAVEOLAR ENDOCYTOSIS; ACTIN POLYMERIZATION; MEMBRANE DOMAINS; EARLY ENDOSOMES	Acid dependent infection of Hela and Vero cells by BTV-10 occurs from within early-endosomes following virus uptake by clathrin-mediated endocytosis (Forzan et al., 2007: J Virol 81: 4819-4827). Here we report that BTV-1 infection of BHK cells is also dependent on a low endosomal pH; however, virus entry and infection were not inhibited by dominant-negative mutants of Eps15, AP180 or the 'aa' splice variant of dynamin-2, which were shown to inhibit clathrin-mediated endocytosis. In addition, infection was not inhibited by depletion of cellular cholesterol, which suggests that virus entry is not mediated by a lipid-raft dependent process such as caveolae-mediated endocytosis. Although virus entry and infection were not inhibited by the dominant-negative dynamin-2 mutant, entry was inhibited by the general dynamin inhibitor, dynasore, indicating that virus entry is dynamin dependent. During entry, BTV-1 co-localised with LAMP-1 but not with transferrin, suggesting that virus is delivered to late-endosomal compartments without first passing through early-endosomes. BTV-1 entry and infection were inhibited by EIPA and cytochalasin-D, known macropinocytosis inhibitors, and during entry virus co-localised with dextran, a known marker for macropinocytosis/fluid-phase uptake. Our results extend earlier observations with BTV-10, and show that BTV-1 can infect BHK cells via an entry mechanism that is clathrin and cholesterol-independent, but requires dynamin, and shares certain characteristics in common with macropinocytosis.	[Gold, Sarah; Monaghan, Paul; Mertens, Peter; Jackson, Terry] AFRC, Inst Anim Hlth, Pirbright Lab, Woking GU24 0NF, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Pirbright Institute	Gold, S (corresponding author), AFRC, Inst Anim Hlth, Pirbright Lab, Woking GU24 0NF, Surrey, England.	terry.jackson@bbsrc.ac.uk	Monaghan, Paul/H-1973-2013	Mertens, Peter/0000-0002-3438-3738	Biotechnology and Biological Sciences Research Council [DTABB/B511951/1]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001442] Funding Source: researchfish; BBSRC [BBS/E/I/00001442] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Sarah Gold was supported by Biotechnology and Biological Sciences Research Council DTABB/B511951/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstutz B, 2008, EMBO J, V27, P956, DOI 10.1038/emboj.2008.38; BARRATTBOYES SM, 1992, J GEN VIROL, V73, P1953, DOI 10.1099/0022-1317-73-8-1953; Beer C, 2005, J VIROL, V79, P10776, DOI 10.1128/JVI.79.16.10776-10787.2005; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Cao H, 2007, J CELL SCI, V120, P4167, DOI 10.1242/jcs.010686; Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Delaney KA, 2002, J BIOL CHEM, V277, P33439, DOI 10.1074/jbc.M205293200; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; EATON BT, 1990, CURR TOP MICROBIOL, V162, P89; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Forzan M, 2004, P NATL ACAD SCI USA, V101, P2100, DOI 10.1073/pnas.0306448101; Forzan M, 2007, J VIROL, V81, P4819, DOI 10.1128/JVI.02284-06; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Hassan SH, 2001, J VIROL, V75, P8356, DOI 10.1128/JVI.75.18.8356-8367.2001; Hassan SS, 1999, J VIROL, V73, P9832, DOI 10.1128/JVI.73.12.9832-9842.1999; HEMATI B, 2009, J VIROL; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; Huang CY, 2008, J VIROL, V82, P7988, DOI 10.1128/JVI.00894-08; HUISMANS H, 1987, VIROLOGY, V157, P180, DOI 10.1016/0042-6822(87)90327-8; Huss M, 2009, J EXP BIOL, V212, P341, DOI 10.1242/jeb.024067; HYATT AD, 1993, VIROLOGY, V193, P592, DOI 10.1006/viro.1993.1167; Jones AT, 2007, J CELL MOL MED, V11, P670, DOI 10.1111/j.1582-4934.2007.00062.x; Kalia M, 2006, MOL BIOL CELL, V17, P3689, DOI 10.1091/mbc.E05-10-0980; Karjalainen M, 2008, MOL BIOL CELL, V19, P2857, DOI 10.1091/mbc.E07-10-1094; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Khan AG, 2010, J VIROL, V84, P3984, DOI 10.1128/JVI.01693-09; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Liberali P, 2008, EMBO J, V27, P970, DOI 10.1038/emboj.2008.59; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Locker JK, 2000, MOL BIOL CELL, V11, P2497, DOI 10.1091/mbc.11.7.2497; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; Marechal V, 2001, J VIROL, V75, P11166, DOI 10.1128/JVI.75.22.11166-11177.2001; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Martin CSS, 2004, J VIROL, V78, P2310, DOI 10.1128/JVI.78.5.2310-2318.2004; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Mertens PPC, 1996, VIROLOGY, V217, P582, DOI 10.1006/viro.1996.0153; MERTENS PPC, 1987, VIROLOGY, V157, P375, DOI 10.1016/0042-6822(87)90280-7; Misinzo G, 2009, VIRUS RES, V139, P1, DOI 10.1016/j.virusres.2008.09.005; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Moriyama T, 2007, J VIROL, V81, P8552, DOI 10.1128/JVI.00924-07; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Nishi K, 2007, J BIOL CHEM, V282, P27503, DOI 10.1074/jbc.M703810200; Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x; O'Donnell V, 2008, J VIROL, V82, P9075, DOI 10.1128/JVI.00732-08; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Quirin K, 2008, VIROLOGY, V378, P21, DOI 10.1016/j.virol.2008.04.046; RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011; Raghu H, 2009, J VIROL, V83, P4895, DOI 10.1128/JVI.02498-08; Rojek JM, 2008, J VIROL, V82, P7677, DOI 10.1128/JVI.00560-08; Rojek JM, 2008, J VIROL, V82, P1505, DOI 10.1128/JVI.01331-07; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; Schwartz-Cornil I, 2008, VET RES, V39, DOI 10.1051/vetres:2008023; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Smith JL, 2008, J VIROL, V82, P9505, DOI 10.1128/JVI.01014-08; Spoden G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003313; Suksanpaisan L, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-17; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Takamatsu H, 2003, J GEN VIROL, V84, P227, DOI 10.1099/vir.0.18705-0; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; Van Hamme E, 2008, J GEN VIROL, V89, P2147, DOI 10.1099/vir.0.2008/001602-0; Vidricaire G, 2007, J MOL BIOL, V368, P1267, DOI 10.1016/j.jmb.2007.03.003; Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15	86	63	65	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11360	10.1371/journal.pone.0011360	http://dx.doi.org/10.1371/journal.pone.0011360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613878	Green Published, gold, Green Submitted			2022-12-25	WOS:000279369900009
J	Viswanath, K; Ackerson, LK; Sorensen, G; Gupta, PC				Viswanath, K.; Ackerson, Leland K.; Sorensen, Glorian; Gupta, Prakash C.			Movies and TV Influence Tobacco Use in India: Findings from a National Survey	PLOS ONE			English	Article							SMOKING; YOUTH; MORTALITY	Background: Exposure to mass media may impact the use of tobacco, a major source of illness and death in India. The objective is to test the association of self-reported tobacco smoking and chewing with frequency of use of four types of mass media: newspapers, radio, television, and movies. Methodology/Principal Findings: We analyzed data from a sex-stratified nationally-representative cross-sectional survey of 123,768 women and 74,068 men in India. All models controlled for wealth, education, caste, occupation, urbanicity, religion, marital status, and age. In fully-adjusted models, monthly cinema attendance is associated with increased smoking among women (relative risk [RR]: 1.55; 95% confidence interval [CI]: 1.04-2.31) and men (RR: 1.17; 95% CI: 1.12-1.23) and increased tobacco chewing among men (RR: 1.15; 95% CI: 1.11-1.20). Daily television and radio use is associated with higher likelihood of tobacco chewing among men and women, while daily newspaper use is related to lower likelihood of tobacco chewing among women. Conclusion/Significance: In India, exposure to visual mass media may contribute to increased tobacco consumption in men and women, while newspaper use may suppress the use of tobacco chewing in women. Future studies should investigate the role that different types of media content and media play in influencing other health behaviors.	[Viswanath, K.; Sorensen, Glorian] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Viswanath, K.; Sorensen, Glorian] Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA; [Ackerson, Leland K.] Univ Massachusetts Lowell, Dept Community Hlth & Sustainabil, Lowell, MA USA; [Gupta, Prakash C.] Healis Sekhsaria Inst Publ Hlth, Navi Mumbai, India	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; University of Massachusetts System; University of Massachusetts Lowell	Viswanath, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	vish_viswanath@dfci.harvard.edu			American Legacy Foundation; National Cancer Institute	American Legacy Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	K. Viswanath acknowledges the support of the Dana-Farber Harvard Cancer Center and the Tobacco Research Network on Disparities (TReND) funded by the American Legacy Foundation (http://www.legacyforhealth.org/) and the National Cancer Institute (http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, GLOBAL BURDEN DIS CO; Arora M, 2008, AM J HEALTH BEHAV, V32, P283; DiFranza JR, 2006, PEDIATRICS, V117, pE1237, DOI 10.1542/peds.2005-1817; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; FINNEGAN J, 2008, HLTH BEHAV HLTH ED T; Green MC, 2006, J COMMUN, V56, pS163, DOI 10.1111/j.1460-2466.2006.00288.x; Gupta PC, 2005, INT J EPIDEMIOL, V34, P1395, DOI 10.1093/ije/dyi196; Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x; GUPTA PC, 1986, LANCET, V1, P1235; GUPTA S, 2006, UICC HDB; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; John RM, 2009, TOB CONTROL, V18, P138, DOI 10.1136/tc.2008.027466; National Cancer Institute, 2008, TOB CONTR MON, V19; Pednekar MS, 2007, PREV MED, V44, P496, DOI 10.1016/j.ypmed.2007.02.017; Reddy KS, 2004, REPORT TOBACCO CONTR; Sargent JD, 2007, PEDIATRICS, V119, pE1167, DOI 10.1542/peds.2006-2897; Sauvaget C, 2008, INT J EPIDEMIOL, V37, P1242, DOI 10.1093/ije/dyn097; Shah PB, 2008, ASIAN PAC J CANCER P, V9, P637; Smith KC, 2008, TOB CONTROL, V17, P17, DOI 10.1136/tc.2007.020495; Subramanian SV, 2006, AM J PUBLIC HEALTH, V96, P818, DOI 10.2105/AJPH.2004.060103; Thankappan KR, 2007, INDIAN J MED RES, V126, P300; Wakefield M, 2003, ADDICTION, V98, P79, DOI 10.1046/j.1360-0443.98.s1.6.x; Wakefield M, 2003, J HEALTH COMMUN, V8, P229, DOI 10.1080/10810730305686; Wellman RJ, 2006, ARCH PEDIAT ADOL MED, V160, P1285, DOI 10.1001/archpedi.160.12.1285; *WHO, 2007, TOB HLTH GLOB STAT R; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	28	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11365	10.1371/journal.pone.0011365	http://dx.doi.org/10.1371/journal.pone.0011365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	618QD	20614005	gold, Green Submitted, Green Published			2022-12-25	WOS:000279369900014
J	Bianchi, MT; Cash, SS; Mietus, J; Peng, CK; Thomas, R				Bianchi, Matt T.; Cash, Sydney S.; Mietus, Joseph; Peng, Chung-Kang; Thomas, Robert			Obstructive Sleep Apnea Alters Sleep Stage Transition Dynamics	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; DAYTIME SLEEPINESS; HEART HEALTH; SCALE; FRAGMENTATION; NEUROBIOLOGY; WAKEFULNESS; DISORDERS; PATTERNS; MODEL	Introduction: Enhanced characterization of sleep architecture, compared with routine polysomnographic metrics such as stage percentages and sleep efficiency, may improve the predictive phenotyping of fragmented sleep. One approach involves using stage transition analysis to characterize sleep continuity. Methods and Principal Findings: We analyzed hypnograms from Sleep Heart Health Study (SHHS) participants using the following stage designations: wake after sleep onset (WASO), non-rapid eye movement (NREM) sleep, and REM sleep. We show that individual patient hypnograms contain insufficient number of bouts to adequately describe the transition kinetics, necessitating pooling of data. We compared a control group of individuals free of medications, obstructive sleep apnea (OSA), medical co-morbidities, or sleepiness (n = 374) with mild (n = 496) or severe OSA (n = 338). WASO, REM sleep, and NREM sleep bout durations exhibited multi-exponential temporal dynamics. The presence of OSA accelerated the "decay'' rate of NREM and REM sleep bouts, resulting in instability manifesting as shorter bouts and increased number of stage transitions. For WASO bouts, previously attributed to a power law process, a multi-exponential decay described the data well. Simulations demonstrated that a multi-exponential process can mimic a power law distribution. Conclusion and Significance: OSA alters sleep architecture dynamics by decreasing the temporal stability of NREM and REM sleep bouts. Multi-exponential fitting is superior to routine mono-exponential fitting, and may thus provide improved predictive metrics of sleep continuity. However, because a single night of sleep contains insufficient transitions to characterize these dynamics, extended monitoring of sleep, probably at home, would be necessary for individualized clinical application.	[Bianchi, Matt T.; Cash, Sydney S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Mietus, Joseph; Peng, Chung-Kang] Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Thomas, Robert] Beth Israel Deaconess Med Ctr, Sleep Div, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Bianchi, MT (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.	mtbianchi@partners.org	Thomas, Robert/AAC-9694-2021; Peng, Chung-Kang/N-1308-2019; Peng, Chung-Kang/E-1489-2011	Thomas, Robert/0000-0002-5575-3953; Peng, Chung-Kang/0000-0003-3666-9833; Peng, Chung-Kang/0000-0003-3666-9833	Department of Neurology, Massachusetts General Hospital; Harvard/MIT Health Sciences and Technology; Beth Israel Deaconess Medical Center; Pfizer, Inc.; Merck Co.;  [R21HL079248]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL079248] Funding Source: NIH RePORTER	Department of Neurology, Massachusetts General Hospital; Harvard/MIT Health Sciences and Technology; Beth Israel Deaconess Medical Center; Pfizer, Inc.(Pfizer); Merck Co.(Merck & Company); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Fudning: R21HL079248 (RJT); Department of Neurology, Massachusetts General Hospital, and the Clinical Investigator Training Program: Harvard/MIT Health Sciences and Technology, Beth Israel Deaconess Medical Center, in collaboration with Pfizer, Inc. and Merck & Co. (MTB). This paper represents the work of the authors and not the SHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Behn CGD, 2008, J NEUROPHYSIOL, V99, P3090, DOI 10.1152/jn.01243.2007; Benbadis SR, 1999, ANN INTERN MED, V130, P289, DOI 10.7326/0003-4819-130-4-199902160-00014; Blumberg MS, 2005, P NATL ACAD SCI USA, V102, P14860, DOI 10.1073/pnas.0506340102; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; CARSKADON MA, 1982, NEUROBIOL AGING, V3, P321, DOI 10.1016/0197-4580(82)90020-3; Chervin RD, 2005, AM J RESP CRIT CARE, V171, P652, DOI 10.1164/rccm.200408-1056OC; Chervin RD, 1999, NEUROLOGY, V52, P125, DOI 10.1212/WNL.52.1.125; Espana RA, 2004, SLEEP, V27, P811; Fuller PM, 2006, J BIOL RHYTHM, V21, P482, DOI 10.1177/0748730406294627; Gottlieb DJ, 1999, AM J RESP CRIT CARE, V159, P502, DOI 10.1164/ajrccm.159.2.9804051; Joho RH, 2006, EUR J NEUROSCI, V23, P1567, DOI 10.1111/j.1460-9568.2006.04672.x; Kaplan KA, 2009, SLEEP MED REV, V13, P275, DOI 10.1016/j.smrv.2008.09.001; KEMP B, 1986, SLEEP, V9, P405, DOI 10.1093/sleep/9.3.405; Kim JW, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.178104; Kishi A, 2008, AM J PHYSIOL-REG I, V294, pR1980, DOI 10.1152/ajpregu.00925.2007; Klerman EB, 2004, SLEEP, V27, P793, DOI 10.1093/sleep/27.4.793; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; Lombardi C, 2008, J SLEEP RES, V17, P263, DOI 10.1111/j.1365-2869.2008.00659.x; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Mahowald MW, 2005, NATURE, V437, P1279, DOI 10.1038/nature04287; Mediano O, 2007, EUR RESPIR J, V30, P110, DOI 10.1183/09031936.00009506; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; Norman RG, 2006, SLEEP, V29, P1625, DOI 10.1093/sleep/29.12.1625; Ohayon MM, 2008, SLEEP MED REV, V12, P129, DOI 10.1016/j.smrv.2008.01.001; Quan SF, 1997, SLEEP, V20, P1077; Saper CB, 2005, J COMP NEUROL, V493, P92, DOI 10.1002/cne.20770; Siegel JM, 2009, NAT REV NEUROSCI, V10, P747, DOI 10.1038/nrn2697; Swihart BJ, 2008, J CLIN SLEEP MED, V4, P349; Togo F, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2425; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Weaver EM, 2004, ARCH OTOLARYNGOL, V130, P453, DOI 10.1001/archotol.130.4.453; Wesensten NJ, 1999, J SLEEP RES, V8, P237, DOI 10.1046/j.1365-2869.1999.00161.x; YANG MCK, 1973, BIOMETRICS, V29, P667, DOI 10.2307/2529133	34	70	70	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11356	10.1371/journal.pone.0011356	http://dx.doi.org/10.1371/journal.pone.0011356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596541	Green Submitted, Green Published, gold			2022-12-25	WOS:000279259900024
J	Fujii, T; Ueda, T; Nagata, S; Fukunaga, R				Fujii, Toshihiro; Ueda, Takeshi; Nagata, Shigekazu; Fukunaga, Rikiro			Essential Role of p400/mDomino Chromatin-remodeling ATPase in Bone Marrow Hematopoiesis and Cell-cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE VARIANT EXCHANGE; C-MYC; ACETYLTRANSFERASE COMPLEX; CHROMOSOME STABILITY; DNA; TIP60; PROTEIN; ACETYLATION; TARGET; GENES	p400/mDomino is an ATP-dependent chromatin-remodeling protein that catalyzes the deposition of histone variant H2A.Z into nucleosomes to regulate gene expression. We previously showed that p400/mDomino is essential for embryonic development and primitive hematopoiesis. Here we generated a conditional knock-out mouse for the p400/mDomino gene and investigated the role of p400/mDomino in adult bone marrow hematopoiesis and in the cell-cycle progression of embryonic fibroblasts. The Mx1-Cre-mediated deletion of p400/mDomino resulted in an acute loss of nucleated cells in the bone marrow, including committed myeloid and erythroid cells as well as hematopoietic progenitor and stem cells. A hematopoietic colony assay revealed a drastic reduction in colony-forming activity after the deletion of p400/mDomino. Moreover, the loss of p400/mDomino in mouse embryonic fibroblasts (MEFs) resulted in strong growth inhibition. Cell-cycle analysis revealed that the mDomino-deficient MEFs exhibited a pleiotropic cellcycle defect at the S and G2/M phases, and polyploid and multinucleated cells with micronuclei emerged. DNA microarray analysis revealed that the p400/mDomino deletion from MEFs caused the impaired expression of many cell-cycle-regulatory genes, including G2/M-specific genes targeted by the transcription factors FoxM1 and c-Myc. These results indicate that p400/mDomino plays a key role in cellular proliferation by controlling the expression of cell-cycle-regulatory genes.	[Fujii, Toshihiro; Nagata, Shigekazu; Fukunaga, Rikiro] Kyoto Univ, Dept Med Chem, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Fujii, Toshihiro; Ueda, Takeshi; Nagata, Shigekazu; Fukunaga, Rikiro] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Nagata, Shigekazu; Fukunaga, Rikiro] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Osaka University; Japan Science & Technology Agency (JST)	Fukunaga, R (corresponding author), Kyoto Univ, Dept Med Chem, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.	rfukunaga@mfour.med.kyoto-u.ac.jp	Fukunaga, Rikiro/CAG-2891-2022; Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426; Ueda, Takeshi/0000-0001-9823-6764	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Cai Y, 2005, J BIOL CHEM, V280, P13665, DOI 10.1074/jbc.M500001200; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Herceg Z, 2001, NAT GENET, V29, P206, DOI 10.1038/ng725; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; Iida S, 2005, J LEUKOCYTE BIOL, V78, P481, DOI 10.1189/jlb.0904515; Jin JJ, 2005, TRENDS BIOCHEM SCI, V30, P680, DOI 10.1016/j.tibs.2005.10.003; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; Martinato F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003650; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Menssen A, 2007, CELL CYCLE, V6, P339, DOI 10.4161/cc.6.3.3808; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Ogawa H, 2003, GENES CELLS, V8, P325, DOI 10.1046/j.1365-2443.2003.00636.x; Ruhf ML, 2001, DEVELOPMENT, V128, P1429; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Svotelis A, 2009, BIOCHEM CELL BIOL, V87, P179, DOI 10.1139/O08-138; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Tyteca S, 2006, EMBO J, V25, P1680, DOI 10.1038/sj.emboj.7601066; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Ueda T, 2007, GENES CELLS, V12, P581, DOI 10.1111/j.1365-2443.2007.01080.x; VAN ATTIKUM H, 2005, NAT REV MOL CELL BIO, V6, P757; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Williams-Simons L, 1999, TRANSGENIC RES, V8, P253, DOI 10.1023/A:1008994831937	44	21	21	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30214	30223		10.1074/jbc.M110.104513	http://dx.doi.org/10.1074/jbc.M110.104513			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20610385	Green Published, hybrid			2022-12-25	WOS:000281984300058
J	Reinehr, R; Gohlke, H; Sommerfeld, A; vom Dahl, S; Haussinger, D				Reinehr, Roland; Gohlke, Holger; Sommerfeld, Annika; vom Dahl, Stephan; Haeussinger, Dieter			Activation of Integrins by Urea in Perfused Rat Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-VOLUME; FORCE-FIELD; PROTEIN; INVOLVEMENT; PROTEOLYSIS; SRC; METABOLISM; SIMULATION; RESTRAINTS; STABILITY	High concentrations of urea were shown to induce a paradoxical regulatory volume decrease response with K+ channel opening and subsequent hepatocyte shrinkage (Hallbrucker, C., vom Dahl, S., Ritter, M., Lang, F., and Haussinger, D. (1994) Pflugers Arch. 428, 552-560), although the hepatocyte plasma membrane is thought to be freely permeable to urea. The underlying mechanisms remained unclear. As shown in the present study, urea (100 mmol/liter) induced within 1 min an activation of beta(1) integrins followed by an activation of focal adhesion kinase, c-Src, p38(MAPK), extracellular signal-regulated kinases, and c-Jun N-terminal kinase. Because alpha(5)beta(1) integrin is known to act as a volume/osmosensor in hepatocytes, which becomes activated in response to hepatocyte swelling, the findings suggest that urea at high concentrations induces a nonosmotic activating perturbation of this osmosensor, thereby triggering a volume regulatory K+ efflux. In line with this, similar to hypo-osmotic hepatocyte swelling, urea induced an inhibition of hepatic proteolysis, which was sensitive to p38MAPK inhibition. Molecular dynamics simulations of a three-dimensional model of the ectodomain of alpha(5)beta(1) integrin in water, urea, or thiourea solutions revealed significant conformational changes of alpha(5)beta(1) integrin in urea and thiourea solutions, in contrast to the simulation of alpha(5)beta(1) in water. These changes lead to an unbending of the integrin structure around the genu, which may suggest activation, whereas the structures of single domains remained essentially unchanged. It is concluded that urea at high concentrations affects hepatic metabolism through direct activation of the alpha(5)beta(1) integrin system.	[Reinehr, Roland; Sommerfeld, Annika; vom Dahl, Stephan; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany; [Gohlke, Holger] Univ Dusseldorf, Dept Math & Nat Sci, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Haussinger, D (corresponding author), Univ Klinikum Dusseldorf, Klin Gastroenterol Hepatol & Infektiol, Moorenstr 5, D-40225 Dusseldorf, Germany.	haeussin@uni-duesseldorf.de	Reinehr, Roland/G-6118-2016; Dahl, Stephan vom/AAF-8456-2021	Dahl, Stephan vom/0000-0003-0481-0601	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 575]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 575 "Experimentelle Hepatologie" (Dusseldorf, Germany).	Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; GORDON JA, 1968, J BIOL CHEM, V243, P5663; GORDON JA, 1963, BIOCHEMISTRY-US, V2, P47, DOI 10.1021/bi00901a011; HALLBRUCKER C, 1994, PFLUG ARCH EUR J PHY, V428, P552, DOI 10.1007/BF00374577; HALLBRUCKER C, 1993, EUR J BIOCHEM, V211, P449, DOI 10.1111/j.1432-1033.1993.tb17570.x; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HAUSSINGER D, 1990, EUR J BIOCHEM, V188, P689, DOI 10.1111/j.1432-1033.1990.tb15451.x; Haussinger D, 2003, GASTROENTEROLOGY, V124, P1476, DOI 10.1016/S0016-5085(03)00274-9; Haussinger D, 1999, GASTROENTEROLOGY, V116, P921, DOI 10.1016/S0016-5085(99)70076-4; HAUSSINGER D, 1990, BIOCHEM J, V272, P239, DOI 10.1042/bj2700039; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schliess F, 2004, J BIOL CHEM, V279, P21294, DOI 10.1074/jbc.M313901200; Sies H, 1978, Methods Enzymol, V52, P48; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; Singh LR, 2009, J BIOSCIENCES, V34, P321, DOI 10.1007/s12038-009-0036-0; VOLPES R, 1993, AM J PATHOL, V142, P1483; VOM DAHL S, 2003, J BIOL CHEM, V278, P27088; VOM DAHL S, 2001, CELL PHYSIOL BIOCHEM, V11, P285; VOMDAHL S, 1991, BIOCHEM J, V280, P105, DOI 10.1042/bj2800105; VONHIPPEL PH, 1964, SCIENCE, V145, P577, DOI 10.1126/science.145.3632.577; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zou Q, 1998, PROTEINS, V31, P107, DOI 10.1002/(SICI)1097-0134(19980501)31:2<107::AID-PROT1>3.0.CO;2-J	34	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29348	29356		10.1074/jbc.M110.155135	http://dx.doi.org/10.1074/jbc.M110.155135			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20643649	Green Published, hybrid			2022-12-25	WOS:000281740100037
J	Riemer, AB; Keskin, DB; Zhang, GL; Handley, M; Anderson, KS; Brusic, V; Reinhold, B; Reinherz, EL				Riemer, Angelika B.; Keskin, Derin B.; Zhang, Guanglan; Handley, Maris; Anderson, Karen S.; Brusic, Vladimir; Reinhold, Bruce; Reinherz, Ellis L.			A Conserved E7-derived Cytotoxic T Lymphocyte Epitope Expressed on Human Papillomavirus 16-transformed HLA-A2(+) Epithelial Cancers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HLA CLASS-I; CERVICAL INTRAEPITHELIAL NEOPLASIA; MAJOR HISTOCOMPATIBILITY COMPLEX; TYPE-16 E6; HIGH-GRADE; IMMUNE-RESPONSES; CTL EPITOPES; E5 PROTEIN; ANTIGEN PRESENTATION; BINDING PREDICTION	Human Papillomavirus 16 (HPV-16) has been identified as the causative agent of 50% of cervical cancers and many other HPV-associated tumors. The transforming potential/tumor maintenance capacity of this high risk HPV is mediated by two viral oncoproteins, E6 and E7, making them attractive targets for therapeutic vaccines. Of 21 E6 and E7 peptides computed to bind HLA-A*0201, 10 were confirmed through TAP-deficient T2 cell HLA stabilization assay. Those scoring positive were investigated to ascertain which were naturally processed and presented by surface HLA molecules for CTL recognition. Because IFN gamma ELISpot frequencies from healthy HPV-exposed blood donors against HLA-A*0201-binding peptides were unable to identify specificities for tumor targeting, their physical presence among peptides eluted from HPV-16-transformed epithelial tumor HLA-A*0201 immunoprecipitates was analyzed by MS3 Poisson detection mass spectrometry. Only one epitope (E7(11-19)) highly conserved among HPV-16 strains was detected. This 9-mer serves to direct cytolysis by T cell lines, whereas a related 10-mer (E7(11-20)), previously used as a vaccine candidate, was neither detected by MS3 on HPV-transformed tumor cells nor effectively recognized by 9-mer specific CTL. These data underscore the importance of precisely defining CTL epitopes on tumor cells and offer a paradigm for T cell-based vaccine design.	[Riemer, Angelika B.; Keskin, Derin B.; Handley, Maris; Reinhold, Bruce; Reinherz, Ellis L.] Harvard Univ, Sch Med, Immunobiol Lab, Dana Farber Canc Inst,Dept Med Oncol, Boston, MA 02115 USA; [Riemer, Angelika B.; Zhang, Guanglan; Handley, Maris; Anderson, Karen S.; Brusic, Vladimir; Reinhold, Bruce; Reinherz, Ellis L.] Harvard Univ, Sch Med, Canc Vaccine Ctr, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Reinherz, EL (corresponding author), Harvard Univ, Sch Med, Immunobiol Lab, Dana Farber Canc Inst,Dept Med Oncol, HIM 419,4 Blackfan Circle, Boston, MA 02115 USA.	ellis_reinherz@dfci.harvard.edu	Brusic, Vladimir/B-1478-2008	Brusic, Vladimir/0000-0003-0523-5266; Anderson, Karen/0000-0002-3870-5730; Riemer, Angelika/0000-0002-5865-0714	Erwin Schrodinger Fellowship	Erwin Schrodinger Fellowship	Supported by an Erwin Schrodinger Fellowship of the Austrian Science Fund. Present address: Dept. of Dermatology, Medical University of Vienna, 1090 Vienna, Austria.	[Anonymous], [No title captured]; ARNOLD D, 1992, NATURE, V360, P171, DOI 10.1038/360171a0; Ashrafi GH, 2006, INT J CANCER, V119, P2105, DOI 10.1002/ijc.22089; BENACERRAF B, 1992, NOBEL LECT PHYSL MED, P597; Berzofsky JA, 2004, J CLIN INVEST, V114, P450, DOI 10.1172/JCI200422674; Boon T, 1997, IMMUNOL TODAY, V18, P267, DOI 10.1016/S0167-5699(97)80020-5; BOURGAULT VI, 2004, CANCER RES, V64, P8761; Brady CS, 2000, TISSUE ANTIGENS, V55, P401, DOI 10.1034/j.1399-0039.2000.550502.x; Brusic V, 2005, EXPERT REV VACCINES, V4, P407, DOI 10.1586/14760584.4.3.407; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Cento V, 2009, J MED VIROL, V81, P1627, DOI 10.1002/jmv.21552; Davy CE, 2005, J VIROL, V79, P3998, DOI 10.1128/JVI.79.7.3998-4011.2005; Davy CE, 2006, VIROLOGY, V349, P230, DOI 10.1016/j.virol.2006.02.024; DE GROOT AS, 2004, METHODS, V34, P425; Derkay CS, 2005, ANN OTO RHINOL LARYN, V114, P730, DOI 10.1177/000348940511400913; Devaraj K, 2003, CRIT REV ORAL BIOL M, V14, P345, DOI 10.1177/154411130301400505; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Einstein MH, 2007, GYNECOL ONCOL, V106, P453, DOI 10.1016/j.ygyno.2007.04.038; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Fiander AN, 2006, INT J GYNECOL CANCER, V16, P1075, DOI 10.1111/j.1525-1438.2006.00598.x; Frazer IH, 2004, NAT REV IMMUNOL, V4, P46, DOI 10.1038/nri1260; Gallagher KME, 2007, J GEN VIROL, V88, P1470, DOI 10.1099/vir.0.82558-0; Gao Su-qing, 2009, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V26, P228, DOI 10.3760/cma.j.issn.1003-9406.2009.02.025; Garcia-Hernandez E, 2006, CANCER GENE THER, V13, P592, DOI 10.1038/sj.cgt.7700937; Georgopoulos NT, 2000, ONCOGENE, V19, P4930, DOI 10.1038/sj.onc.1203860; Hallez S, 2004, CANCER IMMUNOL IMMUN, V53, P642, DOI 10.1007/s00262-004-0501-4; Hara M, 2005, INT J ONCOL, V27, P1371; HAUSEN HZ, 1977, CURR TOP MICROBIOL, P1; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Kabsch K, 2002, J VIROL, V76, P12162, DOI 10.1128/JVI.76.23.12162-12172.2002; Kadish AS, 1997, J NATL CANCER I, V89, P1285, DOI 10.1093/jnci/89.17.1285; Kanodia S, 2007, CURR CANCER DRUG TAR, V7, P79, DOI 10.2174/156800907780006869; KAST WM, 1994, J IMMUNOL, V152, P3904; KAST WM, 1993, J IMMUNOTHER, V14, P115, DOI 10.1097/00002371-199308000-00006; Kather A, 2003, INT J CANCER, V104, P345, DOI 10.1002/ijc.10940; Kaufmann AM, 2002, CLIN CANCER RES, V8, P3676; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Lee JH, 2004, P NATL ACAD SCI USA, V101, P2094, DOI 10.1073/pnas.0308615100; Lee KW, 2005, TISSUE ANTIGENS, V65, P437, DOI 10.1111/j.1399-0039.2005.00386.x; Leggatt GR, 2007, CURR OPIN IMMUNOL, V19, P232, DOI 10.1016/j.coi.2007.01.004; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; McIntosh PB, 2008, J VIROL, V82, P8196, DOI 10.1128/JVI.00509-08; Meijers R, 2005, J MOL BIOL, V345, P1099, DOI 10.1016/j.jmb.2004.11.023; MOMBURG F, 1992, NATURE, V360, P174, DOI 10.1038/360174a0; Morishima S, 2007, INT J CANCER, V120, P594, DOI 10.1002/ijc.22312; Moscicki AB, 2006, VACCINE, V24, P42, DOI 10.1016/j.vaccine.2006.06.018; Muderspach L, 2000, CLIN CANCER RES, V6, P3406; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Nakagawa M, 2004, CLIN DIAGN LAB IMMUN, V11, P889, DOI 10.1128/CDLI.11.5.889-896.2004; Nakagawa M, 2007, J VIROL, V81, P1412, DOI 10.1128/JVI.01768-06; O'Brien PM, 2002, VIRUS RES, V88, P103, DOI 10.1016/S0168-1702(02)00123-5; Oerke S, 2005, INT J CANCER, V114, P766, DOI 10.1002/ijc.20794; Palefsky JM, 2006, AIDS, V20, P1151, DOI 10.1097/01.aids.0000226955.02719.26; PARKIN J, 1906, ANN ROY BOT GARD, V3, P11; PATTILLO R A, 1977, Science (Washington D C), V196, P1456, DOI 10.1126/science.867042; Peng SW, 2007, CLIN CANCER RES, V13, P2479, DOI 10.1158/1078-0432.CCR-06-2916; Piersma SJ, 2008, INT J CANCER, V122, P486, DOI 10.1002/ijc.23162; Printz Carrie, 2009, Cancer, V115, P5130, DOI 10.1002/cncr.24728; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Ramqvist T, 2007, EXPERT OPIN BIOL TH, V7, P997, DOI 10.1517/14712598.7.7.997; RESSING ME, 1995, J IMMUNOL, V154, P5934; Ressing ME, 2000, J IMMUNOTHER, V23, P255, DOI 10.1097/00002371-200003000-00010; Rinaudo CD, 2009, J CLIN INVEST, V119, P2515, DOI 10.1172/JCI38330; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; Roden RBS, 2004, HUM PATHOL, V35, P971, DOI 10.1016/j.humpath.2004.04.007; Rudolf MP, 2001, CLIN CANCER RES, V7, p788S; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sarkar AK, 2005, GYNECOL ONCOL, V99, pS251, DOI 10.1016/j.ygyno.2005.07.099; Schiller JT, 2008, VACCINE, V26, pK53, DOI 10.1016/j.vaccine.2008.06.002; Schultze JL, 1997, J CLIN INVEST, V100, P2757, DOI 10.1172/JCI119822; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Sidney J, 1996, IMMUNOL TODAY, V17, P261, DOI 10.1016/0167-5699(96)80542-1; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Stanley MA, 2007, BIOCHEM SOC T, V35, P1456, DOI 10.1042/BST0351456; Steger G, 1997, J VIROL, V71, P50, DOI 10.1128/JVI.71.1.50-58.1997; Steller MA, 1998, CLIN CANCER RES, V4, P2103; Tindle RW, 2002, NAT REV CANCER, V2, P59, DOI 10.1038/nrc700; VAN DEN HENDE M, 2008, INT J CANCER, V123, P146; VAN DER BURG SH, 2001, INT J CANCER, V91, P612; VAN DRIEL WJ, 1999, EUR J CANCER, V35, P946; Vetter KM, 2007, J WOMENS HEALTH, V16, P1258, DOI 10.1089/jwh.2007.0493; Villada IB, 2000, EUR J IMMUNOL, V30, P2281, DOI 10.1002/1521-4141(2000)30:8<2281::AID-IMMU2281>3.0.CO;2-N; Wang JH, 2002, MOL IMMUNOL, V38, P1039, DOI 10.1016/S0161-5890(02)00033-0; Warrino DE, 2004, CLIN CANCER RES, V10, P3301, DOI 10.1158/1078-0432.CCR-03-0498; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; Yao Y, 2009, TISSUE ANTIGENS, V73, P561, DOI 10.1111/j.1399-0039.2009.01237.x; Zhang BY, 2003, VIROLOGY, V310, P100, DOI 10.1016/S0042-6822(03)00103-X; Zhong WM, 2003, J BIOL CHEM, V278, P45135, DOI 10.1074/jbc.M307417200	94	53	59	5	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29608	29622		10.1074/jbc.M110.126722	http://dx.doi.org/10.1074/jbc.M110.126722			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20615877	Green Published, hybrid			2022-12-25	WOS:000281740100062
J	Harrington, JM; Widener, J; Stephens, N; Johnson, T; Francia, M; Capewell, P; Macleod, A; Hajduk, SL				Harrington, John M.; Widener, Justin; Stephens, Natalie; Johnson, Thomas; Francia, Maria; Capewell, Paul; Macleod, Annette; Hajduk, Stephen L.			The Plasma Membrane of Bloodstream-form African Trypanosomes Confers Susceptibility and Specificity to Killing by Hydrophobic Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; VARIANT SURFACE GLYCOPROTEIN; HAPTOGLOBIN-RELATED PROTEIN; HUMAN-SERUM; LYTIC FACTOR; BRUCEI; ENDOCYTOSIS; CAPACITY; ANCHOR; ROLES	Trypanosoma brucei is the causative agent of both a veterinary wasting disease and human African trypanosomiasis, or sleeping sickness. The cell membrane of the developmental stage found within the mammalian host, the bloodstream form (BSF), is highly dynamic, exhibiting rapid rates of endocytosis and lateral flow of glycosylphosphatidylinositol-anchored proteins. Here, we show that the cell membrane of these organisms is a target for killing by small hydrophobic peptides that increase the rigidity of lipid bilayers. Specifically, we have derived trypanocidal peptides that are based upon the hydrophobic N-terminal signal sequences of human apolipoproteins. These peptides selectively partitioned into the plasma membrane of BSF trypanosomes, resulting in an increase in the rigidity of the bilayer, dramatic changes in cell motility, and subsequent cell death. No killing of the developmental stage found within the insect midgut, the procyclic form, was observed. Additionally, the peptides exhibited no toxicity toward mammalian cell lines and did not induce hemolysis. Studies with model liposomes indicated that bilayer fluidity dictates the susceptibility of membranes to manipulation by hydrophobic peptides. We suggest that the composition of the BSF trypanosome cell membrane confers a high degree of fluidity and unique susceptibility to killing by hydrophobic peptides and is therefore a target for the development of trypanocidal drugs.	[Harrington, John M.; Widener, Justin; Stephens, Natalie; Johnson, Thomas; Francia, Maria; Hajduk, Stephen L.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Capewell, Paul; Macleod, Annette] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Glasgow Biomed Res Ctr, Fac Vet Med, Glasgow G12 8TA, Lanark, Scotland	University System of Georgia; University of Georgia; University of Glasgow	Hajduk, SL (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, B129 Life Sci Bldg,120 Green St, Athens, GA 30602 USA.	shajduk@bmb.uga.edu	Capewell, Paul/R-1935-2017	Capewell, Paul/0000-0002-8803-5034; Francia, Maria/0000-0001-9664-9573	National Institutes of Health [AI039033]; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI039033, R01AI039033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI039033 (to S.L.H.).; Supported by a National Research Service Award from NIAID.	Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Benach J, 2003, J BIOL CHEM, V278, P3628, DOI 10.1074/jbc.M205992200; BRIGGS MS, 1986, SCIENCE, V233, P206, DOI 10.1126/science.2941862; Brun R, 2001, TROP MED INT HEALTH, V6, P906, DOI 10.1046/j.1365-3156.2001.00775.x; BULOW R, 1988, BIOCHEMISTRY-US, V27, P2384; Cantor RS, 1998, TOXICOL LETT, V101, P451, DOI 10.1016/S0378-4274(98)00220-3; Delgado M, 2009, CELL DEATH DIFFER, V16, P406, DOI 10.1038/cdd.2008.161; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4963; Field MC, 2009, NAT REV MICROBIOL, V7, P775, DOI 10.1038/nrmicro2221; FIELD MC, 1991, EMBO J, V10, P2731, DOI 10.1002/j.1460-2075.1991.tb07821.x; HAGER KM, 1994, J CELL BIOL, V126, P155, DOI 10.1083/jcb.126.1.155; Haines LR, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000373; HAJDUK SL, 1989, J BIOL CHEM, V264, P5210; Harrington JM, 2009, J BIOL CHEM, V284, P13505, DOI 10.1074/jbc.M900151200; Kamaraju K, 2008, BIOCHEMISTRY-US, V47, P10540, DOI 10.1021/bi801092g; Koynova R, 1998, BBA-REV BIOMEMBRANES, V1376, P91, DOI 10.1016/S0304-4157(98)00006-9; LANGRETH SG, 1975, J PROTOZOOL, V22, P40, DOI 10.1111/j.1550-7408.1975.tb00943.x; Lanteri CA, 2006, MOL PHARMACOL, V70, P1585, DOI 10.1124/mol.106.024653; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; McGwire BS, 2003, J INFECT DIS, V188, P146, DOI 10.1086/375747; Morgan GW, 2001, J CELL SCI, V114, P2605; Oberholzer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000739; Ochsenreiter T, 2006, EMBO REP, V7, P1128, DOI 10.1038/sj.embor.7400817; RIFKIN MR, 1978, P NATL ACAD SCI USA, V75, P3450, DOI 10.1073/pnas.75.7.3450; Rodriguez JA, 2009, P NATL ACAD SCI USA, V106, P19322, DOI 10.1073/pnas.0907001106; Shiflett AM, 2005, J BIOL CHEM, V280, P32578, DOI 10.1074/jbc.M503510200; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; Sorenson RC, 1999, ARTERIOSCL THROM VAS, V19, P2214, DOI 10.1161/01.ATV.19.9.2214; Tyler KM, 2009, J CELL SCI, V122, P859, DOI 10.1242/jcs.037721; Vanhollebeke B, 2007, P NATL ACAD SCI USA, V104, P4118, DOI 10.1073/pnas.0609902104; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; Widener J, 2007, PLOS PATHOG, V3, P1250, DOI 10.1371/journal.ppat.0030129	34	13	14	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28659	28666		10.1074/jbc.M110.151886	http://dx.doi.org/10.1074/jbc.M110.151886			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20615879	Green Published, hybrid			2022-12-25	WOS:000281594000030
J	Zwolak, A; Uruno, T; Piszczek, G; Hammer, JA; Tjandra, N				Zwolak, Adam; Uruno, Takehito; Piszczek, Grzegorz; Hammer, John A., III; Tjandra, Nico			Molecular Basis for Barbed End Uncapping by CARMIL Homology Domain 3 of Mouse CARMIL-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-CAPPING PROTEIN; NMR CHEMICAL-SHIFTS; STRUCTURAL BASIS; MULTIDIMENSIONAL NMR; FILAMENT NUCLEATION; CELL MORPHOLOGY; ARP2/3 COMPLEX; BINDING SITE; MYOSIN-I; IDENTIFICATION	Capping protein (CP) is a ubiquitously expressed, 62-kDa heterodimer that binds the barbed end of the actin filament with similar to 0.1 nM affinity to prevent further monomer addition. CARMIL is a multidomain protein, present from protozoa to mammals, that binds CP and is important for normal actin dynamics in vivo. The CARMIL CP binding site resides in its CAH3 domain (CARMIL homology domain 3) located at or near the protein's C terminus. CAH3 binds CP with similar to 1 nM affinity, resulting in a complex with weak capping activity (30-200 nM). Solution assays and single-molecule imaging show that CAH3 binds CP already present on the barbed end, causing a 300-fold increase in the dissociation rate of CP from the end (i.e. uncapping). Here we used nuclear magnetic resonance (NMR) to define the molecular interaction between the minimal CAH3 domain (CAH3a/b) of mouse CARMIL-1 and CP. Specifically, we show that the highly basic CAH3a subdomain is required for the high affinity interaction of CAH3 with a complementary "acidic groove" on CP opposite its actin-binding surface. This CAH3a-CP interaction orients the CAH3b subdomain, which we show is also required for potent anti-CP activity, directly adjacent to the basic patch of CP, shown previously to be required for CP association to and high affinity interaction with the barbed end. The importance of specific residue interactions between CP and CAH3a/b was confirmed by site-directed mutagenesis of both proteins. Together, these results offer a mechanistic explanation for the barbed end uncapping activity of CARMIL, and they identify the basic patch on CP as a crucial regulatory site.	[Uruno, Takehito; Hammer, John A., III] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Piszczek, Grzegorz] NHLBI, Biophys Core Facil, NIH, Bethesda, MD 20892 USA; [Zwolak, Adam] NYU, Sch Med, Sackler Inst Biomed Sci, New York, NY 10016 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); New York University	Hammer, JA (corresponding author), NHLBI, Cell Biol Lab, NIH, 50 S Dr,Bldg 50,Rm 2306, Bethesda, MD 20892 USA.	hammerj@nhlbi.nih.gov; tjandran@nhlbi.nih.gov	Uruno, Takehito/AAF-7998-2019; Piszczek, Grzegorz/GYU-2029-2022	Uruno, Takehito/0000-0002-2812-9645; Hammer, John/0000-0002-2496-5179	NHLBI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006120, ZIAHL001048, ZICHL000338] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, NHLBI (to J. A. H. and N. T.).	Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; AMATRUDA JF, 1990, NATURE, V344, P352, DOI 10.1038/344352a0; AMATRUDA JF, 1992, J CELL BIOL, V119, P1151, DOI 10.1083/jcb.119.5.1151; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bhattacharya N, 2006, J BIOL CHEM, V281, P31021, DOI 10.1074/jbc.M606278200; Bruck S, 2006, J BIOL CHEM, V281, P19196, DOI 10.1074/jbc.M600166200; Canton DA, 2005, MOL CELL BIOL, V25, P3519, DOI 10.1128/MCB.25.9.3519-3534.2005; Canton DA, 2006, J BIOL CHEM, V281, P36347, DOI 10.1074/jbc.M607595200; Clore GM, 2003, J AM CHEM SOC, V125, P2902, DOI 10.1021/ja028893d; COOPER JA, 1984, J CELL BIOL, V99, P217, DOI 10.1083/jcb.99.1.217; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Fujiwara I, 2010, J BIOL CHEM, V285, P2707, DOI 10.1074/jbc.M109.031203; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P2517, DOI 10.1021/bi962924y; Hernandez-Valladares M, 2010, NAT STRUCT MOL BIOL, V17, P497, DOI 10.1038/nsmb.1792; HUG C, 1995, CELL, V81, P591, DOI 10.1016/0092-8674(95)90080-2; Hutchings NJ, 2003, J BIOL CHEM, V278, P22396, DOI 10.1074/jbc.M302540200; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim K, 2004, J CELL BIOL, V164, P567, DOI 10.1083/jcb.200308061; Kim K, 2007, J BIOL CHEM, V282, P5871, DOI 10.1074/jbc.M609850200; KOUYAMA T, 1980, EUR J BIOCHEM, V105, P279, DOI 10.1111/j.1432-1033.1980.tb04499.x; Kuhn JR, 2007, J BIOL CHEM, V282, P28014, DOI 10.1074/jbc.M705287200; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lee WL, 1999, J BIOL CHEM, V274, P35159, DOI 10.1074/jbc.274.49.35159; Liang Y, 2009, MOL BIOL CELL, V20, P5290, DOI 10.1091/mbc.E08-10-1071; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Matsuzaka Y, 2004, GENE, V343, P291, DOI 10.1016/j.gene.2004.09.004; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Miyoshi T, 2006, J CELL BIOL, V175, P947, DOI 10.1083/jcb.200604176; Narita A, 2006, EMBO J, V25, P5626, DOI 10.1038/sj.emboj.7601395; Narita A, 2007, J MOL BIOL, V365, P480, DOI 10.1016/j.jmb.2006.06.056; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Remmert K, 2004, J BIOL CHEM, V279, P3068, DOI 10.1074/jbc.M308829200; Remmert K, 2009, PROTEIN EXPRES PURIF, V67, P113, DOI 10.1016/j.pep.2009.05.002; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sizonenko GI, 1996, MOL BIOL CELL, V7, P1; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; Uruno T, 2006, J BIOL CHEM, V281, P10635, DOI 10.1074/jbc.M513186200; Vanderzalm PJ, 2009, DEVELOPMENT, V136, P1201, DOI 10.1242/dev.026666; Wear MA, 2003, CURR BIOL, V13, P1531, DOI 10.1016/S0960-9822(03)00559-1; Wear MA, 2004, TRENDS BIOCHEM SCI, V29, P418, DOI 10.1016/j.tibs.2004.06.003; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; XU P, 1995, J BIOL CHEM, V270, P25316, DOI 10.1074/jbc.270.43.25316; Xu P, 1997, P NATL ACAD SCI USA, V94, P3685, DOI 10.1073/pnas.94.8.3685; Yamashita A, 2003, EMBO J, V22, P1529, DOI 10.1093/emboj/cdg167; Yang CS, 2005, DEV CELL, V9, P209, DOI 10.1016/j.devcel.2005.06.008; Zwolak A, 2010, J BIOL CHEM, V285, P25767, DOI 10.1074/jbc.M110.135848	56	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					29014	29026		10.1074/jbc.M110.134221	http://dx.doi.org/10.1074/jbc.M110.134221			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20630878	Green Published, hybrid			2022-12-25	WOS:000281594000066
J	Kim, TH; Sebastian, S; Pinkham, JT; Ross, RA; Blalock, LT; Kasper, DL				Kim, Tae-Hyun; Sebastian, Shite; Pinkham, Jessica T.; Ross, Robin A.; Blalock, LeeAnn T.; Kasper, Dennis L.			Characterization of the O-antigen Polymerase (Wzy) of Francisella tularensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVE VACCINE STRAIN; ESCHERICHIA-COLI; OUTER-MEMBRANE; PSEUDOMONAS-AERUGINOSA; SALMONELLA-TYPHIMURIUM; SHIGELLA-FLEXNERI; CHAIN-LENGTH; GENE-CLUSTER; FUNCTIONAL-CHARACTERIZATION; CAPSULAR POLYSACCHARIDES	The O-antigen polymerase of Gram-negative bacteria has been difficult to characterize. Herein we report the biochemical and functional characterization of the protein product (Wzy) of the gene annotated as the putative O-antigen polymerase, which is located in the O-antigen biosynthetic locus of Francisella tularensis. In silico analysis (homology searching, hydropathy plotting, and codon usage assessment) strongly suggested that Wzy is an O-antigen polymerase whose function is to catalyze the addition of newly synthesized O-antigen repeating units to a glycolipid consisting of lipid A, inner core polysaccharide, and one repeating unit of the O-polysaccharide (O-PS). To characterize the function of the Wzy protein, a non-polar deletion mutant of wzy was generated by allelic replacement, and the banding pattern of O-PS was observed by immunoblot analysis of whole-cell lysates obtained by SDS-PAGE and stained with an O-PS-specific monoclonal antibody. These immunoblot analyses showed that O-PS of the wzy mutant expresses only one repeating unit of O-antigen. Further biochemical characterization of the subcellular fractions of the wzy mutant demonstrated that (as is characteristic of O-antigen polymerase mutants) the low molecular weight O-antigen accumulates in the periplasm of the mutant. Site-directed mutagenesis based on protein homology and topology, which was carried out to locate a catalytic residue of the protein, showed that modification of specific residues (Gly(176), Asp(177), Gly(323), and Tyr(324)) leads to a loss of O-PS polymerization. Topology models indicate that these amino acids most likely lie in close proximity on the bacterial surface.	[Kim, Tae-Hyun; Sebastian, Shite; Pinkham, Jessica T.; Blalock, LeeAnn T.; Kasper, Dennis L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Kim, Tae-Hyun; Sebastian, Shite; Ross, Robin A.; Kasper, Dennis L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kasper, DL (corresponding author), 200 Longwood Ave, Boston, MA 02115 USA.	dennis_kasper@hms.harvard.edu			National Institutes of Health New England Regional Center of Excellence [R01-AI47484]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007061] Funding Source: NIH RePORTER	National Institutes of Health New England Regional Center of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health New England Regional Center of Excellence Grant R01-AI47484.	ALEXANDER DC, 1994, J BACTERIOL, V176, P7079, DOI 10.1128/JB.176.22.7079-7084.1994; Amor PA, 1997, MOL MICROBIOL, V26, P145, DOI 10.1046/j.1365-2958.1997.5631930.x; Baron G S, 1995, Methods Mol Biol, V47, P149; BATCHELOR RA, 1992, J BACTERIOL, V174, P5228, DOI 10.1128/JB.174.16.5228-5236.1992; Belanger M, 1999, MICROBIOL-UK, V145, P3505, DOI 10.1099/00221287-145-12-3505; Bengoechea JA, 2002, J BACTERIOL, V184, P4277, DOI 10.1128/JB.184.15.4277-4287.2002; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Brandon LD, 2001, J BACTERIOL, V183, P951, DOI 10.1128/JB.183.3.951-958.2001; Burrows LL, 1996, MOL MICROBIOL, V22, P481, DOI 10.1046/j.1365-2958.1996.1351503.x; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Daniels C, 1998, MOL MICROBIOL, V28, P1211, DOI 10.1046/j.1365-2958.1998.00884.x; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Dreisbach VC, 2000, INFECT IMMUN, V68, P1988, DOI 10.1128/IAI.68.4.1988-1996.2000; Drummelsmith J, 2000, EMBO J, V19, P57, DOI 10.1093/emboj/19.1.57; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; FORSMAN M, 1990, APPL ENVIRON MICROB, V56, P949, DOI 10.1128/AEM.56.4.949-955.1990; FORSMAN M, 1994, INT J SYST BACTERIOL, V44, P38, DOI 10.1099/00207713-44-1-38; Francis E, 1925, J AMER MED ASSOC, V84, P1243, DOI 10.1001/jama.1925.02660430001001; Genevrois S, 2003, EMBO J, V22, P1780, DOI 10.1093/emboj/cdg174; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; GROSJEAN H, 1982, GENE, V18, P199, DOI 10.1016/0378-1119(82)90157-3; Gunn JS, 2007, ANN NY ACAD SCI, V1105, P202, DOI 10.1196/annals.1409.006; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Huntley JF, 2007, J BACTERIOL, V189, P561, DOI 10.1128/JB.01505-06; JANN K, 1982, EUR J BIOCHEM, V127, P157, DOI 10.1111/j.1432-1033.1982.tb06850.x; Kawula TH, 2004, APPL ENVIRON MICROB, V70, P6901, DOI 10.1128/AEM.70.11.6901-6904.2004; Keenleyside WJ, 1996, J BIOL CHEM, V271, P28581, DOI 10.1074/jbc.271.45.28581; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; KNIREL YA, 1985, EUR J BIOCHEM, V150, P541, DOI 10.1111/j.1432-1033.1985.tb09055.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lauriano CM, 2003, FEMS MICROBIOL LETT, V229, P195, DOI 10.1016/S0378-1097(03)00820-6; Lehrer J, 2007, J BACTERIOL, V189, P2618, DOI 10.1128/JB.01905-06; Li J, 2007, MICROBIOL-SGM, V153, P3141, DOI 10.1099/mic.0.2007/006460-0; MCGRATH BC, 1991, J BACTERIOL, V173, P649, DOI 10.1128/jb.173.2.649-654.1991; MILNE JJ, 1995, BIOCHEM J, V311, P1015, DOI 10.1042/bj3111015; Morner T., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P1123; MORONA R, 1994, J BACTERIOL, V176, P733, DOI 10.1128/jb.176.3.733-747.1994; MULFORD CA, 1983, P NATL ACAD SCI-BIOL, V80, P1159, DOI 10.1073/pnas.80.5.1159; OSBORN MJ, 1972, J BIOL CHEM, V247, P3973; Prior JL, 2003, J MED MICROBIOL, V52, P845, DOI 10.1099/jmm.0.05184-0; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Raynaud C, 2007, INFECT IMMUN, V75, P536, DOI 10.1128/IAI.01429-06; ROBBINS PW, 1967, SCIENCE, V158, P1536, DOI 10.1126/science.158.3808.1536; Sambrook J., 2002, MOL CLONING LAB MANU; Sebastian S, 2007, INFECT IMMUN, V75, P2591, DOI 10.1128/IAI.01789-06; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran AX, 2008, J BIOL CHEM, V283, P20342, DOI 10.1074/jbc.M802503200; VanDenBosch L, 1997, MOL MICROBIOL, V23, P765, DOI 10.1046/j.1365-2958.1997.2541625.x; Vinogradov E, 2002, EUR J BIOCHEM, V269, P6112, DOI 10.1046/j.1432-1033.2002.03321.x; VINOGRADOV EV, 1991, CARBOHYD RES, V214, P289, DOI 10.1016/0008-6215(91)80036-M; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Whitfield C, 1997, MOL MICROBIOL, V23, P629, DOI 10.1046/j.1365-2958.1997.2571614.x; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; Wong DKH, 1999, MICROBIOL-UK, V145, P2443, DOI 10.1099/00221287-145-9-2443; YAO ZJ, 1994, J BACTERIOL, V176, P4133, DOI 10.1128/JB.176.13.4133-4143.1994	60	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27839	27849		10.1074/jbc.M110.143859	http://dx.doi.org/10.1074/jbc.M110.143859			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20605777	hybrid, Green Published			2022-12-25	WOS:000281404100039
J	Bear, A; Simons, A; Westerman, E; Monteiro, A				Bear, Ashley; Simons, Ariel; Westerman, Erica; Monteiro, Antonia			The Genetic, Morphological, and Physiological Characterization of a Dark Larval Cuticle Mutation in the Butterfly, Bicyclus anynana	PLOS ONE			English	Article							JUVENILE-HORMONE; TOBACCO HORNWORM; CUTICULAR MELANIZATION; FEMALE REPRODUCTION; COMMON CUTWORM; MANDUCA-SEXTA; L LEPIDOPTERA; PIGMENTATION; INSECT; PYRIPROXYFEN	Studies on insect melanism have greatly contributed to our understanding of natural selection and the ultimate factors influencing the evolution of darkly pigmented phenotypes. Research on several species of melanic lepidopteran larvae have found that low levels of circulating juvenile hormone (JH) titers are associated with a melanic phenotype, suggesting that genetic changes in the JH biosynthetic pathway give rise to increased deposition of melanin granules in the cuticle in this group. But does melanism arise through different molecular mechanisms in different species? The present study reports on a Bicyclus anynana (Lepidoptera: Nymphalidae) dark larvae single locus mutation, in which larvae exhibit a darker cuticle relative to wild type. Unlike other lepidopteran melanic larvae mutations, this one is autosomal recessive and does not appear to involve a deficiency in JH titers. Unlike JH deficiency mutants, dark larvae mutants display similar growth rates and sexual behaviors as wild type, and topical application of a JH analogue failed to rescue the wild type cuticular coloration. Finally, transmission electron microscopy showed that sclerotization or deposition of diffuse melanin, rather than deposition of melanin granules, produces the dark coloration found in the cuticle of this species. We conclude that different molecular mechanisms underlie larval melanism in different species of Lepidoptera.	[Bear, Ashley; Simons, Ariel; Westerman, Erica; Monteiro, Antonia] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	Yale University	Bear, A (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	ashley.bear@yale.edu	Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X	National Science Foundation [IOB 0653399]; Yale University	National Science Foundation(National Science Foundation (NSF)); Yale University	This work was funded by National Science Foundation award IOB 0653399 (http://www.nsf.gov/) and by Yale University research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	FESCEMYER HW, 1988, J INSECT PHYSIOL, V34, P29, DOI 10.1016/0022-1910(88)90037-6; Futahashi R, 2008, SCIENCE, V319, P1061, DOI 10.1126/science.1149786; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Geister TL, 2008, J EXP BIOL, V211, P1587, DOI 10.1242/jeb.016725; HIRUMA K, 1993, INT J INSECT MORPHOL, V22, P103, DOI 10.1016/0020-7322(93)90003-J; HIRUMA K, 1985, J COMP PHYSIOL B, V155, P659, DOI 10.1007/BF00694579; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; HUBBARD J, 2010, CELL, V39, P231; IKEMOTO H, 1983, APPL ENTOMOL ZOOL, V18, P57, DOI 10.1303/aez.18.57; Joron M, 2003, NATURE, V424, P191, DOI 10.1038/nature01713; KAYSERWEGMANN I, 1976, CELL TISSUE RES, V171, P513; Llopart A, 2002, EVOLUTION, V56, P2262; Majerus M, 1998, MELANISM EVOLUTION A; Marcus JM, 2004, P ROY SOC B-BIOL SCI, V271, pS263, DOI 10.1098/rsbl.2004.0175; MORITA M, 1988, J INSECT PHYSIOL, V34, P751, DOI 10.1016/0022-1910(88)90148-5; Nijhout H.F., 1998, INSECT HORMONES, P280; Pool JE, 2007, MOL ECOL, V16, P2844, DOI 10.1111/j.1365-294X.2007.03324.x; Rajpurohit Subhash, 2008, Entomological Research, V38, P49, DOI 10.1111/j.1748-5967.2008.00129.x; Saccheri IJ, 1996, EVOLUTION, V50, P2000, DOI 10.1111/j.1558-5646.1996.tb03587.x; SAFRANEK L, 1975, J INSECT PHYSIOL, V21, P1931, DOI 10.1016/0022-1910(75)90225-5; Steigenga MJ, 2006, ENTOMOL SCI, V9, P269, DOI 10.1111/j.1479-8298.2006.00173.x; Takahashi A, 2007, GENETICS, V177, P1233, DOI 10.1534/genetics.107.075283; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; TRUMAN JW, 1973, J INSECT PHYSIOL, V19, P195, DOI 10.1016/0022-1910(73)90232-1; Tsugehara T, 2007, COMP BIOCHEM PHYS B, V147, P358, DOI 10.1016/j.cbpb.2006.10.112; Westerlund SA, 2004, ANAL BIOANAL CHEM, V379, P540, DOI 10.1007/s00216-004-2598-x; Windig JJ, 1999, HEREDITY, V82, P57, DOI 10.1038/sj.hdy.6884510; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wu MC, 2008, ARCH INSECT BIOCHEM, V68, P232, DOI 10.1002/arch.20257; Zufelato MS, 2000, ARTHROPOD STRUCT DEV, V29, P111, DOI 10.1016/S1467-8039(00)00023-2	31	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11563	10.1371/journal.pone.0011563	http://dx.doi.org/10.1371/journal.pone.0011563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644735	gold, Green Published, Green Submitted			2022-12-25	WOS:000279884900011
J	Christoforou, N; Oskouei, BN; Esteso, P; Hill, CM; Zimmet, JM; Bian, WN; Bursac, N; Leong, KW; Hare, JM; Gearhart, JD				Christoforou, Nicolas; Oskouei, Behzad N.; Esteso, Paul; Hill, Christine M.; Zimmet, Jeffrey M.; Bian, Weining; Bursac, Nenad; Leong, Kam W.; Hare, Joshua M.; Gearhart, John D.			Implantation of Mouse Embryonic Stem Cell-Derived Cardiac Progenitor Cells Preserves Function of Infarcted Murine Hearts	PLOS ONE			English	Article							SMOOTH-MUSCLE; TERATOMA FORMATION; ES CELLS; CARDIOMYOCYTES; TRANSPLANTATION; MULTIPOTENT; MYOCARDIUM; HOST; DIFFERENTIATION; ENGRAFTMENT	Stem cell transplantation holds great promise for the treatment of myocardial infarction injury. We recently described the embryonic stem cell-derived cardiac progenitor cells (CPCs) capable of differentiating into cardiomyocytes, vascular endothelium, and smooth muscle. In this study, we hypothesized that transplanted CPCs will preserve function of the infarcted heart by participating in both muscle replacement and neovascularization. Differentiated CPCs formed functional electromechanical junctions with cardiomyocytes in vitro and conducted action potentials over cm-scale distances. When transplanted into infarcted mouse hearts, CPCs engrafted long-term in the infarct zone and surrounding myocardium without causing teratomas or arrhythmias. The grafted cells differentiated into cross-striated cardiomyocytes forming gap junctions with the host cells, while also contributing to neovascularization. Serial echocardiography and pressure-volume catheterization demonstrated attenuated ventricular dilatation and preserved left ventricular fractional shortening, systolic and diastolic function. Our results demonstrate that CPCs can engraft, differentiate, and preserve the functional output of the infarcted heart.	[Christoforou, Nicolas; Bian, Weining; Bursac, Nenad; Leong, Kam W.] Duke Univ, Dept Biomed Engn, Pratt Sch Engn, Durham, NC 27706 USA; [Oskouei, Behzad N.; Hare, Joshua M.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Esteso, Paul; Hill, Christine M.; Gearhart, John D.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Zimmet, Jeffrey M.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Duke University; University of Miami; University of Pennsylvania; University of California System; University of California San Francisco	Christoforou, N (corresponding author), Duke Univ, Dept Biomed Engn, Pratt Sch Engn, Durham, NC 27706 USA.	nc28@duke.edu	Leong, Kam/O-9302-2019; Bursac, Nenad/AAU-5548-2021; Leong, Kam W/A-7270-2009; Zimmet, Jeffrey/AAI-7806-2020; Bian, Weining/G-3146-2011	Leong, Kam/0000-0002-8133-4955; Bursac, Nenad/0000-0002-5688-6061; Leong, Kam W/0000-0002-8133-4955; 	Institute for Cell Engineering at Johns Hopkins University; National Heart, Lung and Blood Institute [HL083342]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL083342] Funding Source: NIH RePORTER	Institute for Cell Engineering at Johns Hopkins University; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded with resources from the Institute for Cell Engineering at Johns Hopkins University. National Heart, Lung and Blood Institute grant HL083342 to N.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Bursac N, 2006, CARDIOVASC RES, V69, P381, DOI 10.1016/j.cardiores.2005.09.014; Bursac N, 2004, P NATL ACAD SCI USA, V101, P15530, DOI 10.1073/pnas.0400984101; Bursac N, 2002, CIRC RES, V91, pE45, DOI 10.1161/01.RES.0000047530.88338.EB; Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Ferrarini M, 2006, CIRC RES, V98, P954, DOI 10.1161/01.RES.0000217342.83731.89; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Fujikawa T, 2005, AM J PATHOL, V166, P1781, DOI 10.1016/S0002-9440(10)62488-1; Gude NA, 2008, CIRC RES, V102, P1025, DOI 10.1161/CIRCRESAHA.107.164749; Hayashi M, 2004, CELL TRANSPLANT, V13, P639, DOI 10.3727/000000004783983558; Iravanian S, 2003, AM J PHYSIOL-HEART C, V285, pH449, DOI 10.1152/ajpheart.00896.2002; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lien CL, 1999, DEVELOPMENT, V126, P75; Menasche P, 2009, MOL THER, V17, P758, DOI 10.1038/mt.2009.40; Min JY, 2002, J APPL PHYSIOL, V92, P288, DOI 10.1152/jappl.2002.92.1.288; Min JY, 2003, J THORAC CARDIOV SUR, V125, P361, DOI 10.1067/mtc.2003.101; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Nelson TJ, 2006, ANAT REC PART A, V288A, P1216, DOI 10.1002/ar.a.20388; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Park KJ, 2006, AM J PHYSIOL-CELL PH, V290, pC1411, DOI 10.1152/ajpcell.00447.2005; Pouzet B, 2001, ANN THORAC SURG, V71, P844, DOI 10.1016/S0003-4975(00)01785-9; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Rubart M, 2003, CIRC RES, V92, P1217, DOI 10.1161/01.RES.0000075089.39335.8C; Rubart M, 2007, NAT BIOTECHNOL, V25, P993, DOI 10.1038/nbt0907-993; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; SOONPAA MH, 1994, SCIENCE, V264, P98, DOI 10.1126/science.8140423; Swijnenburg RJ, 2005, CIRCULATION, V112, pI166, DOI 10.1161/CIRCULATIONAHA.104.525824; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tambara K, 2003, CIRCULATION, V108, P259, DOI 10.1161/01.cir.0000087430.17543.b8; van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yamanaka S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003896; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yasuda T, 2005, J THORAC CARDIOV SUR, V129, P904, DOI 10.1016/j.jtcvs.2004.06.027; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zuppinger C, 2000, Heart Fail Rev, V5, P251, DOI 10.1023/A:1009809520194	51	51	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11536	10.1371/journal.pone.0011536	http://dx.doi.org/10.1371/journal.pone.0011536			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634944	Green Published, Green Submitted, gold			2022-12-25	WOS:000279781600016
J	Marella, M; Seo, BB; Thomas, BB; Matsuno-Yagi, A; Yagi, T				Marella, Mathieu; Seo, Byoung Boo; Thomas, Biju B.; Matsuno-Yagi, Akemi; Yagi, Takao			Successful Amelioration of Mitochondrial Optic Neuropathy Using the Yeast NDI1 Gene in a Rat Animal Model	PLOS ONE			English	Article							NADH-QUINONE OXIDOREDUCTASE; COMPLEX-I DEFECTS; OPTIMIZED ALLOTOPIC EXPRESSION; SACCHAROMYCES-CEREVISIAE; DEHYDROGENASE NDI1; SUBUNIT; THERAPY; CELLS; DEATH; UBIQUINONE	Background: Leber's hereditary optic neuropathy (LHON) is a maternally inherited disorder with point mutations in mitochondrial DNA which result in loss of vision in young adults. The majority of mutations reported to date are within the genes encoding the subunits of the mitochondrial NADH-quinone oxidoreductase, complex I. Establishment of animal models of LHON should help elucidate mechanism of the disease and could be utilized for possible development of therapeutic strategies. Methodology/Principal Findings: We established a rat model which involves injection of rotenone-loaded microspheres into the optic layer of the rat superior colliculus. The animals exhibited the most common features of LHON. Visual loss was observed within 2 weeks of rotenone administration with no apparent effect on retinal ganglion cells. Death of retinal ganglion cells occurred at a later stage. Using our rat model, we investigated the effect of the yeast alternative NADH dehydrogenase, Ndi1. We were able to achieve efficient expression of the Ndi1 protein in the mitochondria of all regions of retinal ganglion cells and axons by delivering the NDI1 gene into the optical layer of the superior colliculus. Remarkably, even after the vision of the rats was severely impaired, treatment of the animals with the NDI1 gene led to a complete restoration of the vision to the normal level. Control groups that received either empty vector or the GFP gene had no effects. Conclusions/Significance: The present study reports successful manifestation of LHON-like symptoms in rats and demonstrates the potential of the NDI1 gene therapy on mitochondrial optic neuropathies. Our results indicate a window of opportunity for the gene therapy to be applied successfully after the onset of the disease symptoms.	[Marella, Mathieu; Seo, Byoung Boo; Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Thomas, Biju B.] Univ So Calif, Keck Sch Med, Doheny Eye Inst, Los Angeles, CA 90033 USA	Scripps Research Institute; Doheny Eye Institute; University of Southern California	Marella, M (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yagi@scripps.edu			U.S. Public Health Service [R01NS048441, R01DK053244]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048441] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. Public Health Service Grants R01NS048441 and R01DK053244 (to T.Y. and A.M.-Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahadorani S, 2010, AGING CELL, V9, P191, DOI 10.1111/j.1474-9726.2010.00546.x; Bai YD, 2001, J BIOL CHEM, V276, P38808, DOI 10.1074/jbc.M106363200; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Barber-Singh J, 2009, REJUV RES, V12, P259, DOI 10.1089/rej.2009.0854; Bonnet C, 2008, BBA-MOL CELL RES, V1783, P1707, DOI 10.1016/j.bbamcr.2008.04.018; Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611; Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; DeCorby A, 2007, BBA-BIOENERGETICS, V1767, P1157, DOI 10.1016/j.bbabio.2007.07.003; DiMauro S, 2009, BBA-MOL BASIS DIS, V1792, P1159, DOI 10.1016/j.bbadis.2008.10.015; Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013; Escobar-Khondiker M, 2007, J NEUROSCI, V27, P7827, DOI 10.1523/JNEUROSCI.1644-07.2007; HART J, 1994, MICROCONTAMINATION, V12, P63; Howell N, 1997, VISION RES, V37, P3495, DOI 10.1016/S0042-6989(96)00167-8; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Levin LA, 2007, CAN J OPHTHALMOL, V42, P403, DOI 10.3129/i07-046; Ludtke H, 1999, GRAEF ARCH CLIN EXP, V237, P207, DOI 10.1007/s004170050220; MAAS MF, 2010, J MOL BIOL; MACKEY D, 1992, AM J HUM GENET, V51, P1218; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162; Marella M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001433; Marella M, 2007, J BIOL CHEM, V282, P24146, DOI 10.1074/jbc.M701819200; Marella M, 2009, J BIOENERG BIOMEMBR, V41, P493, DOI 10.1007/s10863-009-9249-z; Martin KRG, 2004, EYE, V18, P1049, DOI 10.1038/sj.eye.6701579; Nikoskelainen EK, 1996, OPHTHALMOLOGY, V103, P504; Park SH, 2007, IET OPTOELECTRON, V1, P42, DOI 10.1049/iet-opt:20060058; Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102; Pezzi PP, 1998, PEDIATR NEUROL, V19, P308, DOI 10.1016/S0887-8994(98)00060-5; Qi XP, 2003, ANN NEUROL, V53, P198, DOI 10.1002/ana.10426; Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107; Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167; Seo BB, 2000, J BIOL CHEM, V275, P37774, DOI 10.1074/jbc.M007033200; Seo BB, 1999, BBA-BIOENERGETICS, V1412, P56, DOI 10.1016/S0005-2728(99)00051-1; Seo BB, 2004, HUM GENE THER, V15, P887, DOI 10.1089/1043034041839217; Seo BB, 2002, MOL THER, V6, P336, DOI 10.1006/mthe.2002.0674; Seo BB, 2006, FEBS LETT, V580, P6105, DOI 10.1016/j.febslet.2006.10.008; Seo BB, 2006, J BIOL CHEM, V281, P14250, DOI 10.1074/jbc.M600922200; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; STONE EM, 1992, J CLIN NEURO-OPHTHAL, V12, P10; Thomas BB, 2004, J NEUROSCI METH, V138, P7, DOI 10.1016/j.jneumeth.2004.03.007; WAKAKURA M, 1995, BRIT J OPHTHALMOL, V79, P442, DOI 10.1136/bjo.79.5.442; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Yagi T, 2006, REJUV RES, V9, P191, DOI 10.1089/rej.2006.9.191; Yagi T, 2006, BBA-BIOENERGETICS, V1757, P708, DOI 10.1016/j.bbabio.2006.01.011; Zanna C, 2005, APOPTOSIS, V10, P997, DOI 10.1007/s10495-005-0742-5; Zhang X, 2002, NEUROSCI LETT, V326, P97, DOI 10.1016/S0304-3940(02)00327-0	49	68	74	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11472	10.1371/journal.pone.0011472	http://dx.doi.org/10.1371/journal.pone.0011472			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628600	Green Published, Green Submitted, gold			2022-12-25	WOS:000279637100005
J	Larsen, PE; Trivedi, G; Sreedasyam, A; Lu, V; Podila, GK; Collart, FR				Larsen, Peter E.; Trivedi, Geetika; Sreedasyam, Avinash; Lu, Vincent; Podila, Gopi K.; Collart, Frank R.			Using Deep RNA Sequencing for the Structural Annotation of the Laccaria Bicolor Mycorrhizal Transcriptome	PLOS ONE			English	Article							PROTEIN FUNCTION; ECTOMYCORRHIZAL SYMBIOSIS; DNA-SEQUENCES; GENOME; GENE; SEQ; PREDICTION; ACCURACY; FUNGI; TOOL	Background: Accurate structural annotation is important for prediction of function and required for in vitro approaches to characterize or validate the gene expression products. Despite significant efforts in the field, determination of the gene structure from genomic data alone is a challenging and inaccurate process. The ease of acquisition of transcriptomic sequence provides a direct route to identify expressed sequences and determine the correct gene structure. Methodology: We developed methods to utilize RNA-seq data to correct errors in the structural annotation and extend the boundaries of current gene models using assembly approaches. The methods were validated with a transcriptomic data set derived from the fungus Laccaria bicolor, which develops a mycorrhizal symbiotic association with the roots of many tree species. Our analysis focused on the subset of 1501 gene models that are differentially expressed in the free living vs. mycorrhizal transcriptome and are expected to be important elements related to carbon metabolism, membrane permeability and transport, and intracellular signaling. Of the set of 1501 gene models, 1439 (96%) successfully generated modified gene models in which all error flags were successfully resolved and the sequences aligned to the genomic sequence. The remaining 4% (62 gene models) either had deviations from transcriptomic data that could not be spanned or generated sequence that did not align to genomic sequence. The outcome of this process is a set of high confidence gene models that can be reliably used for experimental characterization of protein function. Conclusions: 69% of expressed mycorrhizal JGI "best'' gene models deviated from the transcript sequence derived by this method. The transcriptomic sequence enabled correction of a majority of the structural inconsistencies and resulted in a set of validated models for 96% of the mycorrhizal genes. The method described here can be applied to improve gene structural annotation in other species, provided that there is a sequenced genome and a set of gene models.	[Larsen, Peter E.; Lu, Vincent; Collart, Frank R.] Argonne Natl Lab, Biosci Div, Lemont, IL USA; [Trivedi, Geetika; Sreedasyam, Avinash; Podila, Gopi K.] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Alabama System; University of Alabama Huntsville	Larsen, PE (corresponding author), Argonne Natl Lab, Biosci Div, Lemont, IL USA.	fcollart@anl.gov		Collart, Frank/0000-0001-6942-4483	US Department of Energy (DOE) Office of Biological and Environmental Research	US Department of Energy (DOE) Office of Biological and Environmental Research(United States Department of Energy (DOE))	The submitted manuscript has been created by UChicago Argonne, LLC, Operator of Argonne National Laboratory ("Argonne''). Argonne, a U.S. Department of Energy Office of Science laboratory, is operated under Contract No. DE-AC02-06CH11357. The authors have been supported by the US Department of Energy (DOE) Office of Biological and Environmental Research (http://www.sc.doe.gov/ober/ober_top.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brent MR, 2008, NAT REV GENET, V9, P62, DOI 10.1038/nrg2220; Cseke L.J., 2004, HDB MOL CELLULAR MET; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; Guigo R, 2000, GENOME RES, V10, P1631, DOI 10.1101/gr.122800; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Harley J.L., 1983, MYCORRHIZAL SYMBIOSI; Ho EC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-334; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang XQ, 1997, GENOMICS, V46, P37, DOI 10.1006/geno.1997.4984; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Jones CE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-170; Kim SJ, 1998, GENE, V222, P203, DOI 10.1016/S0378-1119(98)00483-1; Koide RT, 2008, NEW PHYTOL, V178, P230, DOI 10.1111/j.1469-8137.2008.02401.x; Kupfer DM, 2004, EUKARYOT CELL, V3, P1088, DOI 10.1128/EC.3.5.1088-1100.2004; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nehls U, 2008, J EXP BOT, V59, P1097, DOI 10.1093/jxb/erm334; Nehls U, 2007, PHYTOCHEMISTRY, V68, P82, DOI 10.1016/j.phytochem.2006.09.024; Raes J, 2007, CURR OPIN STRUC BIOL, V17, P362, DOI 10.1016/j.sbi.2007.05.010; Reese MG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s1; Sadowski MI, 2009, CURR OPIN STRUC BIOL, V19, P357, DOI 10.1016/j.sbi.2009.03.008; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stajich JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r223; Stothard P, 2006, CURR OPIN MICROBIOL, V9, P505, DOI 10.1016/j.mib.2006.08.002; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valencia A, 2005, CURR OPIN STRUC BIOL, V15, P267, DOI 10.1016/j.sbi.2005.05.010; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WILHELM BT, 2009, METHODS	31	20	20	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e9780	10.1371/journal.pone.0009780	http://dx.doi.org/10.1371/journal.pone.0009780			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625404	Green Published, gold, Green Submitted			2022-12-25	WOS:000279522500001
J	Scheper, J; Guerra-Rebollo, M; Sanclimens, G; Moure, A; Masip, I; Gonzalez-Ruiz, D; Rubio, N; Crosas, B; Meca-Cortes, O; Loukili, N; Plans, V; Morreale, A; Blanco, J; Ortiz, AR; Messeguer, A; Thomson, TM				Scheper, Johanna; Guerra-Rebollo, Marta; Sanclimens, Gloria; Moure, Alejandra; Masip, Isabel; Gonzalez-Ruiz, Domingo; Rubio, Nuria; Crosas, Bernat; Meca-Cortes, Oscar; Loukili, Noureddine; Plans, Vanessa; Morreale, Antonio; Blanco, Jeronimo; Ortiz, Angel R.; Messeguer, Angel; Thomson, Timothy M.			Protein-Protein Interaction Antagonists as Novel Inhibitors of Non-Canonical Polyubiquitylation	PLOS ONE			English	Article							NF-KAPPA-B; UBIQUITIN-CONJUGATING ENZYME; PROSTATE-CANCER CELLS; RING FINGER PROTEIN; CHIRAL SIDE-CHAINS; DNA-REPAIR; LYSINE-63 POLYUBIQUITINATION; CRYSTAL-STRUCTURE; DRUG-RESISTANCE; ACTIVATION	Background: pathways that control cell survival under stress, namely RNF8-dependent DNA damage recognition and repair, PCNA-dependent DNA damage tolerance and activation of NF-kappa B by extrinsic signals, are regulated by the tagging of key proteins with lysine 63-based polyubiquitylated chains, catalyzed by the conserved ubiquitin conjugating heterodimeric enzyme Ubc13-Uev. Methodology/Principal Findings: By applying a selection based on in vivo protein-protein interaction assays of compounds from a combinatorial chemical library followed by virtual screening, we have developed small molecules that efficiently antagonize the Ubc13-Uev1 protein-protein interaction, inhibiting the enzymatic activity of the heterodimer. In mammalian cells, they inhibit lysine 63-type polyubiquitylation of PCNA, inhibit activation of NF-kappa B by TNF-alpha and sensitize tumor cells to chemotherapeutic agents. One of these compounds significantly inhibited invasiveness, clonogenicity and tumor growth of prostate cancer cells. Conclusions/Significance: This is the first development of pharmacological inhibitors of non-canonical polyubiquitylation that show that these compounds produce selective biological effects with potential therapeutic applications.	[Scheper, Johanna; Guerra-Rebollo, Marta; Crosas, Bernat; Meca-Cortes, Oscar; Loukili, Noureddine; Plans, Vanessa; Thomson, Timothy M.] CSIC, IBMB, Inst Mol Biol, Dept Cell Biol, Barcelona, Spain; [Sanclimens, Gloria; Moure, Alejandra; Masip, Isabel; Messeguer, Angel] CSIC, IQAC, Inst Adv Chem Catalonia, Dept Biol Organ Chem, Barcelona, Spain; [Gonzalez-Ruiz, Domingo; Morreale, Antonio; Ortiz, Angel R.] CSIC, UAM, CBM, Ctr Biol Mol Severo Ochoa,Bioinformat Unit, Madrid, Spain; [Rubio, Nuria; Blanco, Jeronimo] CSIC, CIC, Catalan Ctr Cardiovasc Res, Barcelona, Spain; [Rubio, Nuria; Blanco, Jeronimo] CIBER Bioingn Biomat & Nanomed, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Scheper, J (corresponding author), CSIC, IBMB, Inst Mol Biol, Dept Cell Biol, Barcelona, Spain.	titbmc@cid.csic.es	Blanco, Jeronimo/H-2764-2015; Thomson, Timothy/Z-6271-2019; Meca-Cortés, Oscar/H-3257-2015; Guerra-Rebollo, Marta/H-3199-2015; Rubio, Nuria/H-3156-2015	Blanco, Jeronimo/0000-0003-3765-0640; Thomson, Timothy/0000-0002-4670-9440; Meca-Cortés, Oscar/0000-0002-7389-9956; Guerra-Rebollo, Marta/0000-0002-3731-4527; Rubio, Nuria/0000-0003-2471-4684; Messeguer, Angel/0000-0002-8358-9425	Consejo Superior de Investigaciones Cientificas [PIF200580]; Ministerio de Educacion y Ciencia [SAF2005-05109-CO2-01, CTQ2005-00995, GEN2003-20642-C09-09, BIO2005-0576, GEN2003-206420-C09-08]; Comunidad de Madrid [GR/SAL/0306/2004, 200520M157]; Fundacion Ramon Areces; Ministerio de Educacion y Ciencia; Consejo Superior de Investigaciones Cientificas	Consejo Superior de Investigaciones Cientificas; Ministerio de Educacion y Ciencia(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Fundacion Ramon Areces; Ministerio de Educacion y Ciencia(Spanish Government); Consejo Superior de Investigaciones Cientificas	This work was funded by grants from the Consejo Superior de Investigaciones Cientificas (PIF200580 to T.M.T., A.R.O. and A. Messeguer), the Ministerio de Educacion y Ciencia (SAF2005-05109-CO2-01 to T.M.T.; CTQ2005-00995 and GEN2003-20642-C09-09 to A. Messeguer; BIO2005-0576, and GEN2003-206420-C09-08 to A.R.O.), the Comunidad de Madrid (GR/SAL/0306/2004 and 200520M157 to A.R.O.), and an institutional grant from the Fundacion Ramon Areces. J.S. and M. G. R. are receipients of fellowships from the Ministerio de Educacion y Ciencia, and A. Moure of a I3P fellowship from the Consejo Superior de Investigaciones Cientificas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PL, 2005, J CELL BIOL, V170, P745, DOI 10.1083/jcb.200502113; Armand P, 1998, P NATL ACAD SCI USA, V95, P4309, DOI 10.1073/pnas.95.8.4309; Banerjee R, 2002, CHEMBIOCHEM, V3, P1263, DOI 10.1002/1439-7633(20021202)3:12<1263::AID-CBIC1263>3.0.CO;2-O; Bianchi K, 2009, MOL CELL, V36, P736, DOI 10.1016/j.molcel.2009.11.029; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chiu RK, 2006, PLOS GENET, V2, P1070, DOI 10.1371/journal.pgen.0020116; Didier C, 2003, MOL CELL BIOL, V23, P5331, DOI 10.1128/MCB.23.15.5331-5345.2003; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Fojo T, 2003, ONCOGENE, V22, P7512, DOI 10.1038/sj.onc.1206951; Fry DC, 2005, J MOL MED, V83, P955, DOI 10.1007/s00109-005-0705-x; Fukushima T, 2007, P NATL ACAD SCI USA, V104, P6371, DOI 10.1073/pnas.0700548104; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Grunwald V, 2002, CANCER RES, V62, P6141; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang H, 2001, J BIOL CHEM, V276, P38830, DOI 10.1074/jbc.M103632200; Huen MSY, 2008, MOL CELL BIOL, V28, P6104, DOI 10.1128/MCB.00987-08; Jang HJ, 2005, ORG LETT, V7, P1951, DOI 10.1021/ol050371q; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lay JD, 2007, CANCER RES, V67, P3878, DOI 10.1158/0008-5472.CAN-06-3191; Linusson A, 1998, MOL DIVERS, V4, P103, DOI 10.1023/A:1026416430656; Masip I, 2005, BIOORGAN MED CHEM, V13, P1923, DOI 10.1016/j.bmc.2005.01.024; McKenna S, 2003, BIOCHEMISTRY-US, V42, P7922, DOI 10.1021/bi034480t; McKenna S, 2003, J BIOL CHEM, V278, P13151, DOI 10.1074/jbc.M212353200; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; Mondesire WH, 2004, CLIN CANCER RES, V10, P7031, DOI 10.1158/1078-0432.CCR-04-0361; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Pastushok L, 2005, J BIOL CHEM, V280, P17891, DOI 10.1074/jbc.M410469200; Perez C, 2001, J MED CHEM, V44, P3768, DOI 10.1021/jm010141r; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Rubio N, 1998, LAB INVEST, V78, P1315; Sanborn TJ, 2002, BIOPOLYMERS, V63, P12, DOI 10.1002/bip.1058; Sancho E, 1998, MOL CELL BIOL, V18, P576, DOI 10.1128/MCB.18.1.576; Shukla S, 2004, CLIN CANCER RES, V10, P3169, DOI 10.1158/1078-0432.CCR-03-0586; Sillerud LO, 2005, CURR PROTEIN PEPT SC, V6, P151, DOI 10.2174/1389203053545462; SIMON RJ, 1992, P NATL ACAD SCI USA, V89, P9367, DOI 10.1073/pnas.89.20.9367; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sun HY, 2004, J AM CHEM SOC, V126, P16686, DOI 10.1021/ja047438+; TAI KY, 2008, ONCOGENE; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; THOMSON TM, BIOCH SOC T, V38, P116; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; Ulrich HD, 2007, BIOCHEM SOC T, V35, P1334, DOI 10.1042/BST0351334; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037	62	29	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11403	10.1371/journal.pone.0011403	http://dx.doi.org/10.1371/journal.pone.0011403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613989	Green Published, gold, Green Submitted			2022-12-25	WOS:000279370000028
J	Brown, ME; Rondon, E; Rajesh, D; Mack, A; Lewis, R; Feng, XZ; Zitur, LJ; Learish, RD; Nuwaysir, EF				Brown, Matthew E.; Rondon, Elizabeth; Rajesh, Deepika; Mack, Amanda; Lewis, Rachel; Feng, Xuezhu; Zitur, Laura Jo; Learish, Randall D.; Nuwaysir, Emile F.			Derivation of Induced Pluripotent Stem Cells from Human Peripheral Blood T Lymphocytes	PLOS ONE			English	Article							CANCER REGRESSION; GENERATION; DIFFERENTIATION; CULTURE	Induced pluripotent stem cells (iPSCs) hold enormous potential for the development of personalized in vitro disease models, genomic health analyses, and autologous cell therapy. Here we describe the generation of T lymphocyte-derived iPSCs from small, clinically advantageous volumes of non-mobilized peripheral blood. These T-cell derived iPSCs ("TiPS'') retain a normal karyotype and genetic identity to the donor. They share common characteristics with human embryonic stem cells (hESCs) with respect to morphology, pluripotency-associated marker expression and capacity to generate neurons, cardiomyocytes, and hematopoietic progenitor cells. Additionally, they retain their characteristic T-cell receptor (TCR) gene rearrangements, a property which could be exploited for iPSC clone tracking and T-cell development studies. Reprogramming T-cells procured in a minimally invasive manner can be used to characterize and expand donor specific iPSCs, and control their differentiation into specific lineages.	[Brown, Matthew E.; Rondon, Elizabeth; Rajesh, Deepika; Mack, Amanda; Lewis, Rachel; Feng, Xuezhu; Zitur, Laura Jo; Learish, Randall D.; Nuwaysir, Emile F.] Cellular Dynam Int Inc, Dept Res & Dev, Madison, WI USA		Brown, ME (corresponding author), Cellular Dynam Int Inc, Dept Res & Dev, Madison, WI USA.	enuwaysir@cellulardynamics.com	feng, xuezhu/F-3223-2013	ZITUR, LAURA/0000-0002-1238-2726; Rajesh, Deepika/0000-0002-8820-4328	Cellular Dynamics International, Inc.	Cellular Dynamics International, Inc.	This study was supported by research funding from Cellular Dynamics International, Inc. to all authors. The funder had a role in the decision to publish the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Appelbaum F, 2009, THOMAS HEMATOPOIETIC; Berger C, 2003, BLOOD, V101, P476, DOI 10.1182/blood-2002-07-2142; Chatenoud L, 2005, CURR OPIN IMMUNOL, V17, P632, DOI 10.1016/j.coi.2005.09.011; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kleeberger CA, 1999, CLIN DIAGN LAB IMMUN, V6, P14, DOI 10.1128/CDLI.6.1.14-19.1999; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Lichtman M, 2006, WILLIAMS HEMATOLOGY, Vseventh; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Saito H, 2006, NAT PROTOC, V1, P2178, DOI 10.1038/nprot.2006.344; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; van Lent AU, 2007, J IMMUNOL, V179, P4959, DOI 10.4049/jimmunol.179.8.4959; YE Z, 2009, BLOOD; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	30	107	120	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11373	10.1371/journal.pone.0011373	http://dx.doi.org/10.1371/journal.pone.0011373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20617191	gold, Green Submitted, Green Published			2022-12-25	WOS:000279369900021
J	Sheppard Brennand, H; Soars, N; Dworjanyn, SA; Davis, AR; Byrne, M				Sheppard Brennand, Hannah; Soars, Natalie; Dworjanyn, Symon A.; Davis, Andrew R.; Byrne, Maria			Impact of Ocean Warming and Ocean Acidification on Larval Development and Calcification in the Sea Urchin Tripneustes gratilla	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; EMBRYONIC-DEVELOPMENT; CLIMATE-CHANGE; TEMPERATURE; FERTILIZATION; ECOLOGY; CARBON; CO2; ECHINODERMATA; SURVIVAL	Background: As the oceans simultaneously warm, acidify and increase in P-CO2, prospects for marine biota are of concern. Calcifying species may find it difficult to produce their skeleton because ocean acidification decreases calcium carbonate saturation and accompanying hypercapnia suppresses metabolism. However, this may be buffered by enhanced growth and metabolism due to warming. Methodology/Principal Findings: We examined the interactive effects of near-future ocean warming and increased acidification/P-CO2 on larval development in the tropical sea urchin Tripneustes gratilla. Larvae were reared in multifactorial experiments in flow-through conditions in all combinations of three temperature and three pH/P-CO2 treatments. Experiments were placed in the setting of projected near future conditions for SE Australia, a global change hot spot. Increased acidity/P-CO2 and decreased carbonate mineral saturation significantly reduced larval growth resulting in decreased skeletal length. Increased temperature (+3 degrees C) stimulated growth, producing significantly bigger larvae across all pH/P-CO2 treatments up to a thermal threshold (+6 degrees C). Increased acidity (-0.3-0.5 pH units) and hypercapnia significantly reduced larval calcification. A +3 degrees C warming diminished the negative effects of acidification and hypercapnia on larval growth. Conclusions and Significance: This study of the effects of ocean warming and CO2 driven acidification on development and calcification of marine invertebrate larvae reared in experimental conditions from the outset of development (fertilization) shows the positive and negative effects of these stressors. In simultaneous exposure to stressors the dwarfing effects of acidification were dominant. Reduction in size of sea urchin larvae in a high P-CO2 ocean would likely impair their performance with negative consequent effects for benthic adult populations.	[Sheppard Brennand, Hannah; Soars, Natalie; Byrne, Maria] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Dworjanyn, Symon A.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Davis, Andrew R.] Univ Wollongong, Inst Conservat Biol, Wollongong, NSW, Australia; [Byrne, Maria] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia; [Byrne, Maria] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney; Southern Cross University; University of Wollongong; University of Sydney; University of Sydney	Sheppard Brennand, H (corresponding author), Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia.	mbyrne@anatomy.usyd.edu.au	Dworjanyn, Symon A/O-5633-2017; Davis, Andy/H-3607-2011; Soars, Natalie A/M-7476-2013; Sheppard-Brennand, Hannah/N-7120-2013; Byrne, Maria/K-6355-2016	Dworjanyn, Symon A/0000-0002-6690-8033; Davis, Andy/0000-0002-8146-7424; Sheppard-Brennand, Hannah/0000-0002-2063-1905; Byrne, Maria/0000-0002-8902-9808	Australian Research Council	Australian Research Council(Australian Research Council)	The study was funded by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Contribution #, Institute for Conservation Biology and # from Sydney Institute of Marine Science.	Allen JD, 2008, BIOL BULL-US, V214, P42, DOI 10.2307/25066658; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; Byrne M, 2008, FUNCT ECOL, V22, P643, DOI 10.1111/j.1365-2435.2008.01427.x; BYRNE M, 2010, DEEP SEA 2 IN PRESS; Byrne M, 2010, CLIMATE ALERT: CLIMATE CHANGE MONITORING AND STRATEGY, P169; Byrne M, 2010, MAR BIOL, V157, P2061, DOI 10.1007/s00227-010-1474-9; Byrne M, 2010, MAR ENVIRON RES, V69, P234, DOI 10.1016/j.marenvres.2009.10.014; Byrne M, 2009, P ROY SOC B-BIOL SCI, V276, P1883, DOI 10.1098/rspb.2008.1935; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Clark D, 2009, MAR BIOL, V156, P1125, DOI 10.1007/s00227-009-1155-8; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dubois P., 1989, Echinoderm Studies, V3, P109; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; Dupont S, 2008, MAR ECOL PROG SER, V373, P285, DOI 10.3354/meps07800; Dworjanyn SA, 2007, AQUACULTURE, V273, P624, DOI 10.1016/j.aquaculture.2007.08.023; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Findlay HS, 2010, MAR BIOL, V157, P725, DOI 10.1007/s00227-009-1356-1; FUJISAWA H, 1989, BIOL BULL, V176, P96, DOI 10.2307/1541576; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hendriks IE, 2010, ESTUAR COAST SHELF S, V86, P157, DOI 10.1016/j.ecss.2009.11.022; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Juinio-Menez Marie Antonette, 1998, Canadian Special Publication of Fisheries and Aquatic Sciences, V125, P393; KOIKE I, 1987, Ecological Research, V2, P19, DOI 10.1007/BF02348616; Kurihara H, 2004, MAR ECOL PROG SER, V274, P161, DOI 10.3354/meps274161; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Lamare MD, 1999, MAR ECOL PROG SER, V180, P197, DOI 10.3354/meps180197; LAWRENCE JM, 2007, BIOL ECOLOGY EDIBLE, P499; Lawrence JM, 2007, DEV AQUAC FISH SCI, V37, P499; Marshall DJ, 2006, INTEGR COMP BIOL, V46, P643, DOI 10.1093/icb/icl013; Miles H, 2007, MAR POLLUT BULL, V54, P89, DOI 10.1016/j.marpolbul.2006.09.021; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; Morse JW, 2007, CHEM REV, V107, P342, DOI 10.1021/cr050358j; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; O'Donnell MJ, 2010, MAR ECOL PROG SER, V398, P157, DOI 10.3354/meps08346; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Pierrot D., 2006, ORNLCDIAC105A US DEP; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; Rahman S, 2009, BIOLOGIA, V64, P768, DOI 10.2478/s11756-009-0135-2; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rodolfo-Metalpa R, 2010, MAR ECOL-EVOL PERSP, V31, P447, DOI 10.1111/j.1439-0485.2009.00354.x; RUPP JH, 1973, MAR BIOL, V23, P183, DOI 10.1007/BF00389483; Sewell MA, 1999, J EXP MAR BIOL ECOL, V236, P291, DOI 10.1016/S0022-0981(98)00210-X; SHIRAYAMA Y, 2005, J GEOPHYS RES, pS908; Soars NA, 2009, MAR ECOL PROG SER, V383, P113, DOI 10.3354/meps07848; Todgham AE, 2009, J EXP BIOL, V212, P2579, DOI 10.1242/jeb.032540; Tyrrell T, 2008, J PLANKTON RES, V30, P141, DOI 10.1093/plankt/fbm105; Unsworth RKF, 2010, OCEAN COAST MANAGE, V53, P218, DOI 10.1016/j.ocecoaman.2010.04.002; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Whalan S, 2008, CORAL REEFS, V27, P783, DOI 10.1007/s00338-008-0400-9; Widdicombe S, 2008, J EXP MAR BIOL ECOL, V366, P187, DOI 10.1016/j.jembe.2008.07.024; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343	57	177	179	3	245	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11372	10.1371/journal.pone.0011372	http://dx.doi.org/10.1371/journal.pone.0011372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613879	gold, Green Published, Green Submitted			2022-12-25	WOS:000279369900020
J	Diaz-Hernandez, M; Gomez-Ramos, A; Rubio, A; Gomez-Villafuertes, R; Naranjo, JR; Miras-Portugal, MT; Avila, J				Diaz-Hernandez, Miguel; Gomez-Ramos, Alberto; Rubio, Alicia; Gomez-Villafuertes, Rosa; Naranjo, Jose R.; Teresa Miras-Portugal, M.; Avila, Jesus			Tissue-nonspecific Alkaline Phosphatase Promotes the Neurotoxicity Effect of Extracellular Tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; PROTEIN-TAU; NEURONAL CELLS; MICE; PATHOLOGY; BRAIN; POLYMERIZATION; LOCALIZATION	There is solid evidence indicating that hyperphosphorylated tau protein, the main component of intracellular neurofibrillary tangles present in the brain of Alzheimer disease patients, plays a key role in progression of this disease. However, it has been recently reported that extracellular unmodified tau protein may also induce a neurotoxic effect on hippocampal neurons by activation of M1 and M3 muscarinic receptors. In the present work we show an essential component that links both effects, which is tissue-nonspecific alkaline phosphatase (TNAP). This enzyme is abundant in the central nervous system and is mainly required to keep control of extracellular levels of phosphorylated compounds. TNAP dephosphorylates the hyperphosphorylated tau protein once it is released upon neuronal death. Only the dephosphorylated tau protein behaves as an agonist of muscarinic M1 and M3 receptors, provoking a robust and sustained intracellular calcium increase finally triggering neuronal death. Interestingly, activation of muscarinic receptors by dephosphorylated tau increases the expression of TNAP in SH-SY5Y neuroblastoma cells. An increase in TNAP activity together with increases in protein and transcript levels were detected in Alzheimer disease patients when they were compared with healthy controls.	[Teresa Miras-Portugal, M.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain; [Gomez-Ramos, Alberto; Rubio, Alicia; Naranjo, Jose R.; Avila, Jesus] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28049, Spain; [Teresa Miras-Portugal, M.] Univ Complutense Madrid, Fac Vet, Dept Bioquim, E-28040 Madrid, Spain; [Naranjo, Jose R.] Consejo Super Invest, Ctr Nacl Biotecnol, Madrid 28049, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBERNED; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Avila, J (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	javila@cbm.uam.es	Gomez-Ramos, Alberto/K-3907-2014; Avila, Jesus/I-2610-2015; Miras-Portugal, Maria Teresa/L-7137-2014; Gomez-Villafuertes, Rosa/L-7181-2014; NARANJO, Jose R/K-1950-2014; rubio, alicia/I-7487-2018	Gomez-Ramos, Alberto/0000-0001-9502-9241; Avila, Jesus/0000-0002-6288-0571; Gomez-Villafuertes, Rosa/0000-0002-7064-0906; NARANJO, Jose R/0000-0002-0270-3469; rubio, alicia/0000-0003-0897-4806; Diaz-Hernandez, Miguel/0000-0002-1952-4600	Spanish Ministry of Health [SAF 2006-02424]; CIBERNED [CB06/05/0035]; Noscira [2008/285]; Comunidad de Madrid [SAL/0202/2006, S-SAL-0253-2006]; Spanish Ministry of Science and Education [BFU2008-02699]; Fundacion Marcelino Botin; UCM-Santander Central Hispano Bank [911585-670]; Fundacion R. Areces; Consolider SICI [CSD2008-00005]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); CIBERNED(Instituto de Salud Carlos III); Noscira; Comunidad de Madrid(Comunidad de Madrid); Spanish Ministry of Science and Education(Spanish Government); Fundacion Marcelino Botin; UCM-Santander Central Hispano Bank; Fundacion R. Areces(Instituto de Salud Carlos III); Consolider SICI	This work was supported by Spanish Ministry of Health Grant SAF 2006-02424, CIBERNED Grant CB06/05/0035, Noscira Grant 2008/285, Comunidad de Madrid Grants SAL/0202/2006 and S-SAL-0253-2006, Spanish Ministry of Science and Education Grant BFU2008-02699, by the Fundacion Marcelino Botin, Consolider SICI "Spanish Ion Channel Initiative" Grant CSD2008-00005, UCM-Santander Central Hispano Bank Grant 911585-670, and by an institutional grant from Fundacion R. Areces.	Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; BIEDLER JL, 1978, CANCER RES, V38, P3751; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; BONDAREFF W, 1989, NEUROBIOL AGING, V10, P709, DOI 10.1016/0197-4580(89)90007-9; BRAAK H, 1985, ACTA NEUROPATHOL, V68, P325, DOI 10.1007/BF00690836; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CORREAS I, 1992, J BIOL CHEM, V267, P15721; CRAS P, 1995, ACTA NEUROPATHOL, V89, P291; Diaz-Hernandez M, 2001, EUR J NEUROSCI, V14, P918, DOI 10.1046/j.0953-816x.2001.01703.x; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Engel T, 2006, NEUROBIOL AGING, V27, P1258, DOI 10.1016/j.neurobiolaging.2005.06.010; Fonta C, 2004, CEREB CORTEX, V14, P595, DOI 10.1093/cercor/bhh021; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; FUKUTANI Y, 1995, NEUROSCI LETT, V200, P57, DOI 10.1016/0304-3940(95)12083-G; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; de Barreda EG, 2010, NEUROBIOL DIS, V37, P622, DOI 10.1016/j.nbd.2009.11.017; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Gomez-Ramos A, 2004, BRAIN RES, V1007, P57, DOI 10.1016/j.brainres.2004.01.071; Gomez-Ramos A, 2006, FEBS LETT, V580, P4842, DOI 10.1016/j.febslet.2006.07.078; Gomez-Ramos A, 2009, EUR NEUROPSYCHOPHARM, V19, P708, DOI 10.1016/j.euroneuro.2009.04.006; Gong CX, 2008, CURR MED CHEM, V15, P2321, DOI 10.2174/092986708785909111; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HENTHORN PS, 1992, P NATL ACAD SCI USA, V89, P9924, DOI 10.1073/pnas.89.20.9924; Iwata N, 2002, J NEUROSCI RES, V70, P493, DOI 10.1002/jnr.10390; OGATA S, 1988, J BIOL CHEM, V263, P10489; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Perez M, 1996, J NEUROCHEM, V67, P1183; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309; Zimmermann Herbert, 2006, Novartis Found Symp, V276, P113	38	125	129	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32539	32548		10.1074/jbc.M110.145003	http://dx.doi.org/10.1074/jbc.M110.145003			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20634292	Green Published, hybrid			2022-12-25	WOS:000282683000068
J	Schwindinger, WF; Mihalcik, LJM; Giger, KE; Betz, KS; Stauffer, AM; Linden, J; Herve, D; Robishaw, JD				Schwindinger, William F.; Mihalcik, Lauren J. Murphree; Giger, Kathryn E.; Betz, Kelly S.; Stauffer, Anna Maria; Linden, Joel; Herve, Denis; Robishaw, Janet D.			Adenosine A(2A) Receptor Signaling and G(olf) Assembly Show a Specific Requirement for the gamma(7) Subtype in the Striatum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; TRANSLATIONAL PROFILING APPROACH; CNS CELL-TYPES; DOPAMINE-RECEPTOR; MICE LACKING; PARKINSONS-DISEASE; ADENYLYL-CYCLASE; DEFICIENT MICE; KNOCKOUT MICE; FUNCTIONAL SPECIFICITY	The adenosine A(2A) receptor (A(2A)R) is increasingly recognized as a novel therapeutic target in Parkinson disease. In striatopallidal neurons, the G-protein alpha(olf) subtype is required to couple this receptor to adenylyl cyclase activation. It is now well established that the beta gamma dimer also performs an active role in this signal transduction process. In principal, sixty distinct beta gamma dimers could arise from combinatorial association of the five known beta and 12 gamma subunit genes. However, key questions regarding which beta gamma subunit combinations exist and whether they perform specific signaling roles in the context of the organism remain to be answered. To explore these questions, we used a gene targeting approach to specifically ablate the G-protein gamma(7) subtype. Revealing a potentially new signaling paradigm, we show that the level of the gamma(7) protein controls the hierarchial assembly of a specific G-protein alpha(olf)beta(2)gamma(7) heterotrimer in the striatum. Providing a probable basis for the selectivity of receptor signaling, we further demonstrate that loss of this specific G-protein heterotrimer leads to reduced A(2A)R activation of adenylyl cyclase. Finally, substantiating an important role for this signaling pathway in pyschostimulant responsiveness, we show that mice lacking the G-protein gamma(7) subtype exhibit an attenuated behavioral response to caffeine. Collectively, these results further support the A(2A)R G-protein alpha(olf)beta(2)gamma(7) interface as a possible therapeutic target for Parkinson disease.	[Robishaw, Janet D.] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA; [Mihalcik, Lauren J. Murphree] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Betz, Kelly S.] Columbia Univ, Div Digest & Liver Dis, Dept Med, Irving Canc Res Ctr, New York, NY 10032 USA; [Linden, Joel] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Herve, Denis] INSERM, UMR S839, F-75005 Paris, France; [Herve, Denis] Univ Paris 06, F-75005 Paris, France; [Herve, Denis] Inst Fer Moulin, F-75005 Paris, France	University of Virginia; Columbia University; La Jolla Institute for Immunology; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Robishaw, JD (corresponding author), 100 N Acad Ave, Danville, PA 17822 USA.	jrobishaw@geisinger.edu	HERVE, Denis/E-2929-2017; Linden, Joel/AAH-5690-2020	HERVE, Denis/0000-0003-1376-1522; 	National Institutes of Health [GM39867, HL37942]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R55HL037942, R01HL037942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039867, R29GM039867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM39867 (to J. D. R.) and HL37942 (to J. L.).	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Aoyama S, 2000, J NEUROSCI, V20, P5848, DOI 10.1523/JNEUROSCI.20-15-05848.2000; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Bara-Jimenez W, 2003, NEUROLOGY, V61, P293, DOI 10.1212/01.WNL.0000073136.00548.D4; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P772, DOI 10.1016/j.bbamem.2006.12.002; Borgkvist A, 2007, NEUROSCI BIOBEHAV R, V31, P79, DOI 10.1016/j.neubiorev.2006.03.003; CALI JJ, 1992, J BIOL CHEM, V267, P24023; Cauli O, 2005, BEHAV PHARMACOL, V16, P63, DOI 10.1097/00008877-200503000-00001; Charalambous C, 2008, J BIOL CHEM, V283, P9276, DOI 10.1074/jbc.M706275200; Chen JF, 2001, P NATL ACAD SCI USA, V98, P1970, DOI 10.1073/pnas.98.4.1970; Clifford JJ, 1998, NEUROPHARMACOLOGY, V37, P1595, DOI 10.1016/S0028-3908(98)00116-6; Corvol JC, 2001, J NEUROCHEM, V76, P1585, DOI 10.1046/j.1471-4159.2001.00201.x; Corvol JC, 2007, NEUROPSYCHOPHARMACOL, V32, P1109, DOI 10.1038/sj.npp.1301230; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; FOSTER KA, 1990, AM J PHYSIOL, V259, pH432, DOI 10.1152/ajpheart.1990.259.2.H432; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2005, ANNU REV PHARMACOL, V45, P385, DOI 10.1146/annurev.pharmtox.45.120403.095731; Gao X, 2007, J BIOL CHEM, V282, P294, DOI 10.1074/jbc.M607522200; GROSS W, 1991, MOL PHARMACOL, V39, P524; HANSEN CA, 1994, J CELL BIOL, V126, P811, DOI 10.1083/jcb.126.3.811; Hauser RA, 2008, MOVEMENT DISORD, V23, P2177, DOI 10.1002/mds.22095; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Herve D, 2001, J NEUROSCI, V21, P4390, DOI 10.1523/JNEUROSCI.21-12-04390.2001; HERVE D, 1993, J NEUROSCI, V13, P2237, DOI 10.1523/jneurosci.13-05-02237.1993; Hildebrandt JD, 1997, BIOCHEM PHARMACOL, V54, P325, DOI 10.1016/S0006-2952(97)00269-4; Holmes A, 2004, NEUROPHARMACOLOGY, V47, P1117, DOI 10.1016/j.neuropharm.2004.07.034; Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; Kelly MA, 2008, GENES BRAIN BEHAV, V7, P568, DOI 10.1111/j.1601-183X.2008.00392.x; Kelly MA, 1998, J NEUROSCI, V18, P3470; Kull B, 2000, MOL PHARMACOL, V58, P771, DOI 10.1124/mol.58.4.771; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Lee KW, 2002, J NEUROSCI, V22, P7931; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lindskog M, 2002, NATURE, V418, P774, DOI 10.1038/nature00817; Lobanova ES, 2008, J NEUROSCI, V28, P3510, DOI 10.1523/JNEUROSCI.0338-08.2008; LOHSE MJ, 1991, MOL PHARMACOL, V39, P517; Lukov GL, 2006, J BIOL CHEM, V281, P22261, DOI 10.1074/jbc.M601590200; LUTHIN DR, 1995, MOL PHARMACOL, V47, P307; LUTHIN DR, 1995, J NEUROCHEM, V65, P2072; MARIN EP, 1995, BIOCHEM J, V309, P377, DOI 10.1042/bj3090377; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; MUNTZ KH, 1992, MOL BIOL CELL, V3, P49, DOI 10.1091/mbc.3.1.49; Murphree LJ, 2002, MOL PHARMACOL, V61, P455, DOI 10.1124/mol.61.2.455; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Offermanns S, 2001, ONCOGENE, V20, P1635, DOI 10.1038/sj.onc.1204189; Popoli P, 2000, NEUROPSYCHOPHARMACOL, V22, P522, DOI 10.1016/S0893-133X(99)00144-X; Rehm A, 1997, J CELL BIOL, V137, P305, DOI 10.1083/jcb.137.2.305; Richardson M, 1999, J BIOL CHEM, V274, P13525, DOI 10.1074/jbc.274.19.13525; Robishaw JD, 2004, CURR OPIN CELL BIOL, V16, P206, DOI 10.1016/j.ceb.2004.02.007; Salamone John D, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS130, DOI 10.1016/j.parkreldis.2008.04.017; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Schwindinger WF, 2004, MOL CELL BIOL, V24, P7758, DOI 10.1128/MCB.24.17.7758-7768.2004; Schwindinger WF, 2003, J BIOL CHEM, V278, P6575, DOI 10.1074/jbc.M211132200; Schwindinger WF, 2009, AM J PHYSIOL-REG I, V297, pR1494, DOI 10.1152/ajpregu.00308.2009; SIMONDS WF, 1991, J BIOL CHEM, V266, P5363; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Stacy M, 2008, NEUROLOGY, V70, P2233, DOI 10.1212/01.wnl.0000313834.22171.17; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Svenningsson P, 1998, NEUROSCIENCE, V84, P223, DOI 10.1016/S0306-4522(97)00510-1; Tang XD, 2002, BEHAV BRAIN RES, V136, P555, DOI 10.1016/S0166-4328(02)00228-0; TOLKOVSKY AM, 1982, P NATL ACAD SCI-BIOL, V79, P213, DOI 10.1073/pnas.79.2.213; Wang Q, 1999, J BIOL CHEM, V274, P17365, DOI 10.1074/jbc.274.24.17365; Wang Q, 1997, J BIOL CHEM, V272, P26040, DOI 10.1074/jbc.272.41.26040; Wang Q, 2001, J BIOL CHEM, V276, P39386, DOI 10.1074/jbc.M104981200; WATSON JB, 1994, J NEUROSCI RES, V39, P108, DOI 10.1002/jnr.490390113; Wells CA, 2006, J BIOL CHEM, V281, P20221, DOI 10.1074/jbc.M602409200; Zahniser NR, 2000, J NEUROSCI, V20, P5949, DOI 10.1523/JNEUROSCI.20-16-05949.2000	73	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29787	29796		10.1074/jbc.M110.142620	http://dx.doi.org/10.1074/jbc.M110.142620			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20639202	hybrid, Green Published			2022-12-25	WOS:000281984300014
J	Sen, A; O'Malley, K; Wang, Z; Raj, GV; DeFranco, DB; Hammes, SR				Sen, Aritro; O'Malley, Katherine; Wang, Zhou; Raj, Ganesh V.; DeFranco, Donald B.; Hammes, Stephen R.			Paxillin Regulates Androgen- and Epidermal Growth Factor-induced MAPK Signaling and Cell Proliferation in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; EXTRANUCLEAR STEROID-RECEPTORS; FOCAL ADHESION KINASE; PLASMA-MEMBRANE; SERTOLI-CELLS; C-SRC; EPITHELIAL MORPHOGENESIS; LNCAP CELLS; STEM-CELLS; CROSS-TALK	Although transcriptional effects of androgens have been extensively studied, mechanisms regulating transcription-independent (nongenomic) androgen actions are poorly understood. Previously, we have shown that paxillin, a multidomain adaptor protein, is a critical regulator of testosterone-induced MAPK-signaling during Xenopus oocyte maturation. Here we examine the nongenomic effects of dihydrotestosterone (DHT) in prostate cancer cells, focusing on how paxillin mediates Erk signaling and downstream physiologic actions. We show that in LnCAP cells DHT functions as a growth factor that indirectly activates the EGF-receptor (EGFR) via androgen receptor binding and matrix metalloproteinase-mediated release of EGFR ligands. Interestingly, siRNA-mediated knockdown of paxillin expression in androgen-dependent LnCAP cells as well as in androgen-independent PC3 cells abrogates DHT- and/or EGF-induced Erk signaling. Furthermore, EGFR-induced Erk activation requires Src-mediated phosphorylation of paxillin on tyrosines 31/118. In contrast, paxillin is not required for PKC-induced Erk signaling. However, Erk-mediated phosphorylation of paxillin on serines 83/126/130 is still needed for both EGFR and PKC-mediated cellular proliferation. Thus, paxillin serves as a specific upstream regulator of Erk in response to receptor-tyrosine kinase signaling but as a general regulator of downstream Erk actions regardless of agonist. Importantly, Erk-mediated serine phosphorylation of paxillin is also required for DHT-induced prostate-specific antigen mRNA expression in LnCAP cells as well as EGF-induced cyclin D1 mRNA expression in PC3 cells, suggesting that paxillin may regulate prostate cancer proliferation by serving as a liaison between extra-nuclear kinase signaling and intra-nuclear transcriptional signals. Thus, paxillin may prove to be a novel diagnostic or therapeutic target in prostate cancer.	[Sen, Aritro; Hammes, Stephen R.] Univ Rochester, Med Ctr, Div Endocrinol, Dept Med, Rochester, NY 14642 USA; [O'Malley, Katherine; Wang, Zhou] Univ Pittsburgh, Dept Urol, Pittsburgh, PA 15232 USA; [Wang, Zhou; DeFranco, Donald B.] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15232 USA; [Wang, Zhou; DeFranco, Donald B.] Univ Pittsburgh, Dept Biol Chem, Pittsburgh, PA 15232 USA; [Raj, Ganesh V.] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75310 USA	University of Rochester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hammes, SR (corresponding author), Univ Rochester, Div Endocrinol & Metab, Sch Med & Dent, 601 Elmwood Ave, Rochester, NY 14642 USA.	Stephen_Hammes@urmc.rochester.edu		Sen, Aritro/0000-0001-8038-3715	National Institutes of Health [DK59913]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059913, R01DK078394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK59913 (to S. R. H.).	Arnold JT, 2005, AM J PHYSIOL-ENDOC M, V288, pE573, DOI 10.1152/ajpendo.00454.2004; Askari MDF, 2005, J CANCER RES CLIN, V131, P639, DOI 10.1007/s00432-005-0002-7; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Cai XM, 2006, MOL CELL BIOL, V26, P2857, DOI 10.1128/MCB.26.7.2857-2868.2006; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Carey AM, 2007, INT J CANCER, V121, P520, DOI 10.1002/ijc.22715; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Cheng J, 2007, ENDOCRINOLOGY, V148, P2066, DOI 10.1210/en.2006-1465; Cinar B, 2007, J BIOL CHEM, V282, P29584, DOI 10.1074/jbc.M703310200; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Dobkin-Bekman M, 2009, MOL ENDOCRINOL, V23, P1850, DOI 10.1210/me.2008-0260; Evaul K, 2008, J BIOL CHEM, V283, P27525, DOI 10.1074/jbc.M803867200; Festuccia C, 2009, PROSTATE, V69, P1529, DOI 10.1002/pros.20995; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Fix C, 2004, P NATL ACAD SCI USA, V101, P10919, DOI 10.1073/pnas.0404278101; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Franco OE, 2003, PROSTATE, V56, P319, DOI 10.1002/pros.10258; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Gamble SC, 2004, ONCOGENE, V23, P2996, DOI 10.1038/sj.onc.1207444; Goi T, 2000, EMBO J, V19, P623, DOI 10.1093/emboj/19.4.623; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Ishibe S, 2003, MOL CELL, V12, P1275, DOI 10.1016/S1097-2765(03)00406-4; IWATA KK, 2004, P AM ASSOC CANC RES, V9, P142; Jamnongjit M, 2005, P NATL ACAD SCI USA, V102, P16257, DOI 10.1073/pnas.0508521102; Kasai M, 2003, CANCER RES, V63, P4927; Ku H, 2000, J BIOL CHEM, V275, P11333, DOI 10.1074/jbc.275.15.11333; Lange CA, 2007, ANNU REV PHYSIOL, V69, P171, DOI 10.1146/annurev.physiol.69.031905.160319; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Li Z, 2007, J BIOL CHEM, V282, P3428, DOI 10.1074/jbc.C600277200; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; Lu SY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000127; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Migliaccio A, 2006, ANN NY ACAD SCI, V1089, P194, DOI 10.1196/annals.1386.006; Nishiyama T, 2007, J UROLOGY, V178, P1282, DOI 10.1016/j.juro.2007.05.138; O'Malley BW, 2009, CANCER RES, V69, P8217, DOI 10.1158/0008-5472.CAN-09-2223; Peterziel H, 1999, ONCOGENE, V18, P6322, DOI 10.1038/sj.onc.1203032; Qi WQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-142; Rasar M, 2006, J BIOL CHEM, V281, P39455, DOI 10.1074/jbc.M608959200; Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200; Ripple MO, 1997, JNCI-J NATL CANCER I, V89, P40, DOI 10.1093/jnci/89.1.40; Robinson MJ, 1996, J BIOL CHEM, V271, P29734, DOI 10.1074/jbc.271.47.29734; Sastry KSR, 2006, J BIOL CHEM, V281, P27367, DOI 10.1074/jbc.M511485200; Seong JH, 2009, CHEM BIOL, V16, P48, DOI 10.1016/j.chembiol.2008.11.007; Suzuki H, 2003, ENDOCR-RELAT CANCER, V10, P209, DOI 10.1677/erc.0.0100209; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Tremblay L, 1996, INT J CANCER, V68, P164, DOI 10.1002/(SICI)1097-0215(19961009)68:2<169::AID-IJC4>3.0.CO;2-W; Unni E, 2004, CANCER RES, V64, P7156, DOI 10.1158/0008-5472.CAN-04-1121; Varricchio L, 2007, MOL CANCER RES, V5, P1213, DOI 10.1158/1541-7786.MCR-07-0150; Wade R, 2002, ONCOGENE, V21, P96, DOI 10.1038/sj.onc.1205013; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; Webb DJ, 2005, J CELL SCI, V118, P4925, DOI 10.1242/jcs.02563; Woodrow MA, 2003, EXP CELL RES, V287, P325, DOI 10.1016/S0014-4827(03)00122-8; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Zhang L, 2009, CANCER LETT, V285, P58, DOI 10.1016/j.canlet.2009.04.041; Zheng Z, 2006, J BIOL CHEM, V281, P4002, DOI 10.1074/jbc.M509260200; Zhu ML, 2008, ENDOCR-RELAT CANCER, V15, P841, DOI 10.1677/ERC-08-0084	62	72	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28787	28795		10.1074/jbc.M110.134064	http://dx.doi.org/10.1074/jbc.M110.134064			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20628053	Green Published, hybrid			2022-12-25	WOS:000281594000044
J	Zhang, Y; Liang, J; Li, YY; Xuan, CH; Wang, F; Wang, DD; Shi, L; Zhang, D; Shang, YF				Zhang, Yu; Liang, Jing; Li, Yanyan; Xuan, Chenghao; Wang, Feng; Wang, Dandan; Shi, Lei; Zhang, Di; Shang, Yongfeng			CCCTC-binding Factor Acts Upstream of FOXA1 and Demarcates the Genomic Response to Estrogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-REGULATED TRANSCRIPTION; ENHANCER-BLOCKING ACTIVITY; BETA-GLOBIN LOCUS; BREAST-CANCER; PROTEIN CTCF; ENDOMETRIAL CARCINOGENESIS; CHROMOSOME CONFORMATION; GENE; METHYLATION; INSULATORS	Transcription activation by estrogen receptor (ER) is rapid and dynamic. How the prompt and precise ER response is established and maintained is still not fully understood. Here, we report that two boundary elements surrounding the well defined ER alpha target TFF1 locus are occupied by the CCCTC-binding factor (CTCF). These elements are separated by 40 kb but cluster in the nuclear space depending on CTCF but independent of estrogen and transcription. In contrast, in estrogen non-responsive breast cancer cells, the spatial proximity of these two elements is lost and the entire locus instead displays a polycomb repressive complex 2-controlled heterochromatin characteristic. We showed that CTCF acts upstream of the "pioneer" factor FOXA1 in determining the genomic response to estrogen. We propose that the CTCF-bound boundary elements demarcate active versus inactive regions, building a framework of adjacent chromosome territory that predisposes ER alpha-regulated transcription.	[Zhang, Yu; Liang, Jing; Li, Yanyan; Xuan, Chenghao; Wang, Feng; Wang, Dandan; Shi, Lei; Zhang, Di; Shang, Yongfeng] Peking Univ, Hlth Sci Ctr, Key Lab Carcinogenesis & Translat Res, Dept Biochem & Mol Biol,Minist Educ, Beijing 100191, Peoples R China	Peking University	Shang, YF (corresponding author), 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	yshang@hsc.pku.edu.cn	Zhang, Di/AAD-6936-2021; Zhang, Di/AAE-2027-2021		National Natural Science Foundation of China [30830032, 30921062]; Ministry of Science and Technology of China [2005CB522404, 2007CB914503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China Grants 30830032 and 30921062 (to Y. S.) and 973 Program Grants 2005CB522404 and 2007CB914503 (to Y. S.) from the Ministry of Science and Technology of China.	Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chambon P, 2004, NAT MED, V10, P1027, DOI 10.1038/nm1004-1027; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Giamarchi C, 1999, ONCOGENE, V18, P533, DOI 10.1038/sj.onc.1202317; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; JELTSCH JM, 1987, NUCLEIC ACIDS RES, V15, P1401, DOI 10.1093/nar/15.4.1401; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Li RF, 2009, EMBO J, V28, P2763, DOI 10.1038/emboj.2009.211; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; O'Malley BW, 2005, MOL ENDOCRINOL, V19, P1402, DOI 10.1210/me.2004-0480; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shang YF, 2006, NAT REV CANCER, V6, P360, DOI 10.1038/nrc1879; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Sun LY, 2009, P NATL ACAD SCI USA, V106, P10195, DOI 10.1073/pnas.0901864106; Tan-Wong SM, 2008, P NATL ACAD SCI USA, V105, P5160, DOI 10.1073/pnas.0801048105; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhang Y, 2007, EMBO J, V26, P2645, DOI 10.1038/sj.emboj.7601710	43	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28604	28613		10.1074/jbc.M110.149658	http://dx.doi.org/10.1074/jbc.M110.149658			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20610384	hybrid, Green Published			2022-12-25	WOS:000281594000024
J	Cantero-Recasens, G; Gonzalez, JR; Fandos, C; Duran-Tauleria, E; Smit, LAM; Kauffmann, F; Anto, JM; Valverde, MA				Cantero-Recasens, Gerard; Gonzalez, Juan R.; Fandos, Cesar; Duran-Tauleria, Enric; Smit, Lidwien A. M.; Kauffmann, Francine; Anto, Josep M.; Valverde, Miguel A.			Loss of Function of Transient Receptor Potential Vanilloid 1 (TRPV1) Genetic Variant Is Associated with Lower Risk of Active Childhood Asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY INFLAMMATION; ION-CHANNEL; EXPRESSION; CAPSAICIN	Transient receptor potential cation channels of the vanilloid subfamily (TRPV) participate in the generation of Ca2+ signals at different locations of the respiratory system, thereby controlling its correct functioning. TRPV1 expression and activity appear to be altered under pathophysiological conditions such as chronic cough and airway hypersensitivity, whereas TRPV4 single nucleotide polymorphisms (SNP) are associated with chronic obstructive pulmonary disease. However, to date, there is no information about the genetic impact of either TRPV1 or TRPV4 on asthma pathophysiology. We now report on the association of two functional SNPs, TRPV1-I585V and TRPV4-P19S, with childhood asthma. Both SNPs were genotyped in a population of 470 controls without respiratory symptoms and 301 asthmatics. Although none of the SNPs modified the risk of suffering from asthma, carriers of the TRPV1-I585V genetic variant showed a lower risk of current wheezing (odds ratio = 0.51; p = 0.01), a characteristic of active asthma, or cough (odds ratio = 0.57; p = 0.02). Functional analysis of TRPV1-I585V, using the Ca2+-sensitive dye fura-2 to measure intracellular [Ca2+] concentrations, revealed a decreased channel activity in response to two typical TRPV1 stimuli, heat and capsaicin. On the other hand, TRPV4-P19S, despite its loss-of-channel function, showed no significant association with asthma or the presence of wheezing. Our data suggest that genetically determined level of TRPV1 activity is relevant for asthma pathophysiology.	[Cantero-Recasens, Gerard; Fandos, Cesar; Valverde, Miguel A.] Univ Pompeu Fabra, Lab Mol Physiol & Channelopathies, Dept Expt & Hlth Sci, Barcelona 08003, Spain; [Gonzalez, Juan R.; Anto, Josep M.] Ctr Res Environm Epidemiol CREAL, Barcelona 08003, Spain; [Duran-Tauleria, Enric] Inst Prestac Assistencia Med Personal Muncipal PA, Barcelona 08015, Spain; [Duran-Tauleria, Enric; Anto, Josep M.] IMIM Hosp Mar, Inst Municipal Invest Med, Barcelona 08003, Spain; [Smit, Lidwien A. M.] Univ Utrecht, Inst Risk Assessment Sci, NL-3508 TC Utrecht, Netherlands; [Kauffmann, Francine] INSERM, U1018, F-94807 Villejuif, France	Pompeu Fabra University; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Utrecht University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Valverde, MA (corresponding author), Univ Pompeu Fabra, Lab Mol Physiol & Channelopathies, Dept Expt & Hlth Sci, Parc Recerca Biomed Barcelona,Rm 343 C Dr Aiguade, Barcelona 08003, Spain.	miguel.valverde@upf.edu	Cantero-Recasens, Gerard/AAH-1697-2019; Smit, Lidwien AM/AFC-8689-2022; Gonzalez, Juan R/B-7860-2018; Cantero-Recasens, Gerard/AAE-9003-2022; Anto, J M/H-2676-2014	Cantero-Recasens, Gerard/0000-0001-6452-782X; Smit, Lidwien AM/0000-0003-0292-0946; Gonzalez, Juan R/0000-0003-3267-2146; Anto, J M/0000-0002-4736-8529; Fandos, Cesar/0000-0001-7348-1376; Valverde, Miguel A./0000-0002-6961-3361	Spanish Ministry of Science and Innovation; Plan E [SAF2009-09848, Red HERACLES RD06/0009]; Generalitat de Catalunya [2009SGR-1369]; Fundacio la Marato de TV3 [080430]; Institucio Catalana de Recerca i Estudis Avancats (ICREA)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Plan E; Generalitat de Catalunya(Generalitat de Catalunya); Fundacio la Marato de TV3; Institucio Catalana de Recerca i Estudis Avancats (ICREA)(ICREA)	This work was supported by grants from the Spanish Ministry of Science and Innovation, Fondos Europeos de Desarrollo Regional (FEDER) Funds, and Plan E (Grants SAF2009-09848 and Red HERACLES RD06/0009); Generalitat de Catalunya (Grant 2009SGR-1369); and Fundacio la Marato de TV3 (Grant 080430).; The recipient of an Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia Award.	Alvarez DF, 2006, CIRC RES, V99, P988, DOI 10.1161/01.RES.0000247065.11756.19; Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Delany NS, 2001, PHYSIOL GENOMICS, V4, P165, DOI 10.1152/physiolgenomics.2001.4.3.165; Doherty MJ, 2000, THORAX, V55, P643, DOI 10.1136/thorax.55.8.643; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Geppetti P, 2006, EUR J PHARMACOL, V533, P207, DOI 10.1016/j.ejphar.2005.12.063; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Groneberg DA, 2004, AM J RESP CRIT CARE, V170, P1276, DOI 10.1164/rccm.200402-174OC; Guler AD, 2002, J NEUROSCI, V22, P6408; Hayes P, 2000, PAIN, V88, P205, DOI 10.1016/S0304-3959(00)00353-5; Jia YL, 2004, AM J PHYSIOL-LUNG C, V287, pL272, DOI 10.1152/ajplung.00393.2003; Lee LY, 2009, CURR OPIN PHARMACOL, V9, P243, DOI 10.1016/j.coph.2009.02.002; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; McLeod Robbie L, 2006, Cough, V2, P10, DOI 10.1186/1745-9974-2-10; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Tian W, 2009, P NATL ACAD SCI USA, V106, P14034, DOI 10.1073/pnas.0904084106; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe N, 2006, NEUROSCIENCE, V141, P1533, DOI 10.1016/j.neuroscience.2006.04.073; Weiland SK, 2004, EUR RESPIR J, V24, P406, DOI 10.1183/09031936.04.00090303; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zhang GF, 2008, J PHYSIOL-LONDON, V586, P5771, DOI 10.1113/jphysiol.2008.161042; Zhu GH, 2009, HUM MOL GENET, V18, P2053, DOI 10.1093/hmg/ddp111	28	85	91	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27532	27535		10.1074/jbc.C110.159491	http://dx.doi.org/10.1074/jbc.C110.159491			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20639579	Green Published, hybrid			2022-12-25	WOS:000281404100007
J	McAllister-Lucas, LM; Jin, XH; Gu, SF; Siu, K; McDonnell, S; Ruland, J; Delekta, PC; Van Beek, M; Lucas, PC				McAllister-Lucas, Linda M.; Jin, Xiaohong; Gu, Shufang; Siu, Katy; McDonnell, Scott; Ruland, Juergen; Delekta, Phillip C.; Van Beek, Matthew; Lucas, Peter C.			The CARMA3-Bcl10-MALT1 Signalosome Promotes Angiotensin II-dependent Vascular Inflammation and Atherogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; T-CELL-ACTIVATION; MALT1; ATHEROSCLEROSIS; LYMPHOCYTES; CARMA1; PATHOGENESIS; SYSTEM; BCL10	The CARMA1, Bcl10, and MALT1 proteins together constitute a signaling complex (CBM signalosome) that mediates antigen-dependent activation of NF-kappa B in lymphocytes, thereby representing a cornerstone of the adaptive immune response. Although CARMA1 is restricted to cells of the immune system, the analogous CARMA3 protein has a much wider expression pattern. Emerging evidence suggests that CARMA3 can substitute for CARMA1 in non-immune cells to assemble a CARMA3-Bcl10-MALT1 signalosome and mediate G protein-coupled receptor activation of NF-kappa B. Here we show that one G protein-coupled receptor, the type 1 receptor for angiotensin II, utilizes this mechanism for activation of NF-kappa B in endothelial and vascular smooth muscle cells, thereby inducing pro-inflammatory signals within the vasculature, a key factor in atherogenesis. Further, we demonstrate that Bcl10-deficient mice are protected from developing angiotensin-dependent atherosclerosis and aortic aneurysms. By uncovering a novel vascular role for the CBM signalosome, these findings illustrate that CBM-dependent signaling has functions outside the realm of adaptive immunity and impacts pathobiology more broadly than previously known.	[Jin, Xiaohong; Siu, Katy; McDonnell, Scott; Delekta, Phillip C.; Van Beek, Matthew; Lucas, Peter C.] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA; [McAllister-Lucas, Linda M.; Gu, Shufang] Univ Michigan, Dept Pediat & Communicable Dis, Sch Med, Ann Arbor, MI 48109 USA; [Ruland, Juergen] Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, D-81675 Munich, Germany; [Ruland, Juergen] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Lab Signaling Immune Syst, D-85764 Neuherberg, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lucas, PC (corresponding author), Univ Michigan, Dept Pathol, Sch Med, 3510 MSRB 1,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	plucas@umich.edu	Nuñez, Gabriel/A-7160-2014; Ruland, Jürgen/Q-6680-2018	Ruland, Jürgen/0000-0002-8381-3597; Lucas, Peter/0000-0003-4880-7172	National Institutes of Health [R01-HL082914, R01-DK079973]; Anatomic Pathology Division of the Pathology Department at The University of Michigan Medical School; Nathan Shock Center [AG013283]; Shirley K. Schlafer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anatomic Pathology Division of the Pathology Department at The University of Michigan Medical School; Nathan Shock Center; Shirley K. Schlafer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL082914 and R01-DK079973 (to P. C. L.). This work was also supported by a grant from the Anatomic Pathology Division of the Pathology Department at The University of Michigan Medical School, a grant from the Nathan Shock Center (National Institutes of Health Grant AG013283), and the Shirley K. Schlafer Foundation.	Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; Boisvert WA, 2004, TRENDS CARDIOVAS MED, V14, P161, DOI 10.1016/j.tcm.2004.02.006; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Fraser CC, 2008, INT REV IMMUNOL, V27, P320, DOI 10.1080/08830180802262765; Fukuda D, 2008, PHARMACOL THERAPEUT, V118, P268, DOI 10.1016/j.pharmthera.2008.02.007; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Hassan GS, 2009, TRENDS IMMUNOL, V30, P165, DOI 10.1016/j.it.2009.01.004; Hellenthal FAMVI, 2009, NAT REV CARDIOL, V6, P464, DOI 10.1038/nrcardio.2009.80; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li XC, 2008, CURR OPIN NEPHROL HY, V17, P37, DOI 10.1097/MNH.0b013e3282f2903c; Marchesi C, 2008, TRENDS PHARMACOL SCI, V29, P367, DOI 10.1016/j.tips.2008.05.003; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Sagaert X, 2007, LEUKEMIA, V21, P389, DOI 10.1038/sj.leu.2404517; Stilo R, 2004, J BIOL CHEM, V279, P34323, DOI 10.1074/jbc.M402244200; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Surmi BK, 2010, VASC PHARMACOL, V52, P27, DOI 10.1016/j.vph.2009.12.004; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Thome M, 2008, NAT REV IMMUNOL, V8, P495, DOI 10.1038/nri2338; WEGENER E, 2007, SCI STKE, pPE21; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	24	52	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25880	25884		10.1074/jbc.C110.109421	http://dx.doi.org/10.1074/jbc.C110.109421			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20605784	hybrid, Green Published			2022-12-25	WOS:000280921000002
J	Wang, XL; Hang, SY; Prazak, L; Gergen, JP				Wang, Xiaoling; Hang, Saiyu; Prazak, Lisa; Gergen, J. Peter			NELF Potentiates Gene Transcription in the Drosophila Embryo	PLOS ONE			English	Article							POLYMERASE-II ELONGATION; RNA-POLYMERASE; FUSHI-TARAZU; CELL FATE; IN-VIVO; EXPRESSION; MELANOGASTER; SEGMENTATION; COFACTOR; PROMOTER	A hallmark of genes that are subject to developmental regulation of transcriptional elongation is association of the negative elongation factor NELF with the paused RNA polymerase complex. Here we use a combination of biochemical and genetic experiments to investigate the in vivo function of NELF in the Drosophila embryo. NELF associates with different gene promoter regions in correlation with the association of RNA polymerase II (Pol II) and the initial activation of gene expression during the early stages of embryogenesis. Genetic experiments reveal that maternally provided NELF is required for the activation, rather than the repression of reporter genes that emulate the expression of key developmental control genes. Furthermore, the relative requirement for NELF is dictated by attributes of the flanking cis-regulatory information. We propose that NELF-associated paused Pol II complexes provide a platform for high fidelity integration of the combinatorial spatial and temporal information that is central to the regulation of gene expression during animal development.	[Wang, Xiaoling; Hang, Saiyu; Gergen, J. Peter] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Wang, Xiaoling; Hang, Saiyu; Gergen, J. Peter] SUNY Stony Brook, Ctr Dev Genet, Grad Program Biochem & Struct Biol, Stony Brook, NY 11794 USA; [Prazak, Lisa] SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wang, XL (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA.	pgergen@life.bio.sunysb.edu	Wang, Xiaoling/D-4208-2013		National Science Foundation [MCB 0344486, MCB 0721430]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation research grants MCB 0344486 and MCB 0721430 (JPG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Amleh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005034; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006918; Chopra VS, 2009, CURR BIOL, V19, P688, DOI 10.1016/j.cub.2009.02.055; Chou TB, 1996, GENETICS, V144, P1673; Crocker J, 2008, PLOS BIOL, V6, P2576, DOI 10.1371/journal.pbio.0060263; Fujioka M, 1999, DEVELOPMENT, V126, P2527; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; HIROMI Y, 1985, CELL, V43, P603, DOI 10.1016/0092-8674(85)90232-6; IBNSOUDA S, 1993, DEVELOPMENT, V119, P471; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; KLINGLER M, 1993, MECH DEVELOP, V43, P3, DOI 10.1016/0925-4773(93)90019-T; KRAUSE HM, 1988, GENE DEV, V2, P1021, DOI 10.1101/gad.2.8.1021; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; McChesney PA, 2006, CANCER RES, V66, P1346, DOI 10.1158/0008-5472.CAN-05-3593; Midorikawa Y, 2002, JPN J CANCER RES, V93, P636, DOI 10.1111/j.1349-7006.2002.tb01301.x; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; NECHAEV S, SCIENCE, V327, P335; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Sullivan E, 2001, GENE DEV, V15, P173, DOI 10.1101/gad.862801; Sun JL, 2008, J CELL BIOCHEM, V103, P1798, DOI 10.1002/jcb.21568; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; THUMMEL CS, 1988, GENE, V74, P445, DOI 10.1016/0378-1119(88)90177-1; TSAI CC, 1994, DEVELOPMENT, V120, P1671; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wang XL, 2007, GENE DEV, V21, P1031, DOI 10.1101/gad.1521207; WEINER AJ, 1984, CELL, V37, P843, DOI 10.1016/0092-8674(84)90419-7; Wheeler JC, 2002, NAT GENET, V32, P206, DOI 10.1038/ng942; Wu CH, 2005, NUCLEIC ACIDS RES, V33, P1269, DOI 10.1093/nar/gki274; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; YUNG TM, 2009, EXP CELL RES; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	44	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11498	10.1371/journal.pone.0011498	http://dx.doi.org/10.1371/journal.pone.0011498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634899	Green Published, gold, Green Submitted			2022-12-25	WOS:000279715300011
J	Salgado-Luarte, C; Gianoli, E				Salgado-Luarte, Cristian; Gianoli, Ernesto			Herbivory on Temperate Rainforest Seedlings in Sun and Shade: Resistance, Tolerance and Habitat Distribution	PLOS ONE			English	Article							RESOURCE AVAILABILITY; SIMULATED HERBIVORY; INSECT HERBIVORY; TROPICAL FOREST; NATIVE CRUCIFER; CHILOE ISLAND; PLANT DEFENSE; GROWTH; LIGHT; TREE	Differential herbivory and/or differential plant resistance or tolerance in sun and shade environments may influence plant distribution along the light gradient. Embothrium coccineum is one of the few light-demanding tree species in the temperate rainforest of southern South America, and seedlings are frequently attacked by insects and snails. Herbivory may contribute to the exclusion of E. coccineum from the shade if 1) herbivory pressure is greater in the shade, which in turn can result from shade plants being less resistant or from habitat preferences of herbivores, and/or 2) consequences of damage are more detrimental in the shade, i.e., shade plants are less tolerant. We tested this in a field study with naturally established seedlings in treefall gaps (sun) and forest understory (shade) in a temperate rainforest of southern Chile. Seedlings growing in the sun sustained nearly 40% more herbivore damage and displayed half of the specific leaf area than those growing in the shade. A palatability test showed that a generalist snail consumed ten times more leaf area when fed on shade leaves compared to sun leaves, i.e., plant resistance was greater in sun-grown seedlings. Herbivore abundance (total biomass) was two-fold greater in treefall gaps compared to the forest understory. Undamaged seedlings survived better and showed a slightly higher growth rate in the sun. Whereas simulated herbivory in the shade decreased seedling survival and growth by 34% and 19%, respectively, damaged and undamaged seedlings showed similar survival and growth in the sun. Leaf tissue lost to herbivores in the shade appears to be too expensive to replace under the limiting light conditions of forest understory. Following evaluations of herbivore abundance and plant resistance and tolerance in contrasting light environments, we have shown how herbivory on a light-demanding tree species may contribute to its exclusion from shade sites. Thus, in the shaded forest understory, where the seedlings of some tree species are close to their physiological tolerance limit, herbivory could play an important role in plant establishment.	[Salgado-Luarte, Cristian; Gianoli, Ernesto] Univ Concepcion, Dept Bot, Concepcion, Chile; [Gianoli, Ernesto] Univ La Serena, Dept Biol, La Serena, Chile; [Gianoli, Ernesto] Pontificia Univ Catolica Chile, Ctr Adv Studies Ecol & Biodivers, Santiago, Chile	Universidad de Concepcion; Universidad de La Serena; Pontificia Universidad Catolica de Chile	Salgado-Luarte, C (corresponding author), Univ Concepcion, Dept Bot, Concepcion, Chile.	egianoli@userena.cl	Gianoli, Ernesto/A-7984-2015	Gianoli, Ernesto/0000-0003-4246-8640	FONDECYT [1070503]; CONICYT (Consejo Nacional de Investigacion Cientifica y Tecnologica) [21050805]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT (Consejo Nacional de Investigacion Cientifica y Tecnologica)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This study received partial financial support from FONDECYT (www.fondecyt.cl) grant 1070503. CS-L thanks CONICYT (Consejo Nacional de Investigacion Cientifica y Tecnologica) for doctoral fellowship 21050805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDE TM, 1990, ECOLOGY, V71, P1412, DOI 10.2307/1938278; [Anonymous], 2007, HDB FUNCTIONAL PLANT; Ayres MP, 2000, SCI TOTAL ENVIRON, V262, P263, DOI 10.1016/S0048-9697(00)00528-3; Baraza E, 2004, CAN J BOT, V82, P357, DOI [10.1139/b04-004, 10.1139/B04-004]; Bazzaz F. A., 1996, PLANTS CHANGING ENV; BAZZAZ FA, 1987, BIOSCIENCE, V37, P58, DOI 10.2307/1310178; Blundell AG, 2001, J ECOL, V89, P608, DOI 10.1046/j.0022-0477.2001.00581.x; Calvo-Irabien LM, 1999, AM J BOT, V86, P1108, DOI 10.2307/2656973; Chacon P, 2006, OECOLOGIA, V146, P555, DOI 10.1007/s00442-005-0244-8; Choong MF, 1996, FUNCT ECOL, V10, P668, DOI 10.2307/2390178; Coley P.D., 1991, PLANT ANIMAL INTERAC, P25; COLEY PD, 1983, ECOLOGY, V64, P426, DOI 10.2307/1939960; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Collantes HG, 1998, PHYTOCHEMISTRY, V49, P1921, DOI 10.1016/S0031-9422(98)00444-0; COLLINGE SK, 1988, OECOLOGIA, V75, P559, DOI 10.1007/BF00776420; Crawley Michael J., 1997, P401; Crone EE, 1999, J CHEM ECOL, V25, P635, DOI 10.1023/A:1020966206840; Dalling JW, 2009, OECOLOGIA, V161, P361, DOI 10.1007/s00442-009-1385-y; DENSLOW JS, 1990, ECOLOGY, V71, P165, DOI 10.2307/1940257; DENSLOW JS, 1987, ANNU REV ECOL SYST, V18, P431, DOI 10.1146/annurev.es.18.110187.002243; Diaz MF, 2007, REV CHIL HIST NAT, V80, P13; Dirzo R, 1995, SEASONALLY DRY TROPI, P305; Dorsch K, 2003, THESIS L MAXIMILIANS; DUDT JF, 1994, ECOLOGY, V75, P86, DOI 10.2307/1939385; Elger A, 2009, OIKOS, V118, P767, DOI 10.1111/j.1600-0706.2009.17206.x; Figueroa JA, 2001, NEW PHYTOL, V152, P483, DOI 10.1046/j.0028-646X.2001.00282.x; Finzi AC, 2000, FOREST ECOL MANAG, V131, P153, DOI 10.1016/S0378-1127(99)00206-6; Gianoli E, 2010, J VEG SCI, V21, P66, DOI 10.1111/j.1654-1103.2009.01124.x; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63, DOI 10.1071/PP9880063; HARRISON S, 1987, OECOLOGIA, V72, P65, DOI 10.1007/BF00385046; Henriksson J, 2003, OIKOS, V103, P3, DOI 10.1034/j.1600-0706.2003.12306.x; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; JING SW, 1990, OIKOS, V58, P369, DOI 10.2307/3545228; KNAPP R, 1986, ECOLOGY, V67, P598, DOI 10.2307/1937683; LARSSON S, 1986, OIKOS, V47, P205, DOI 10.2307/3566047; LEI TT, 1990, OECOLOGIA, V84, P224, DOI 10.1007/BF00318275; Lentz KA, 1998, PLANT ECOL, V139, P125, DOI 10.1023/A:1009762603019; LINCOLN DE, 1984, OECOLOGIA, V64, P173, DOI 10.1007/BF00376867; Louda SM, 1996, J ECOL, V84, P229, DOI 10.2307/2261358; Lusk CH, 2006, OIKOS, V112, P131, DOI 10.1111/j.0030-1299.2006.13922.x; Lusk CH, 2002, OECOLOGIA, V132, P188, DOI 10.1007/s00442-002-0974-9; Lusk CH, 2002, AUSTRAL ECOL, V27, P173, DOI 10.1046/j.1442-9993.2002.01168.x; Lusk CH, 1999, J ECOL, V87, P973, DOI 10.1046/j.1365-2745.1999.00408.x; MACGARVIN M, 1986, OIKOS, V47, P135, DOI 10.2307/3566038; MAIORANA VC, 1981, BIOL J LINN SOC, V15, P151, DOI 10.1111/j.1095-8312.1981.tb00754.x; Marquis R. J., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P301; MCGRAW JB, 1990, TREE PHYSIOL, V7, P247, DOI 10.1093/treephys/7.1-2-3-4.247; Molina-Montenegro MA, 2006, ACTA OECOL, V30, P147, DOI 10.1016/j.actao.2006.02.008; Muth NZ, 2008, ECOSCIENCE, V15, P182, DOI 10.2980/15-2-3095; NICHOLSORIANS CM, 1991, OECOLOGIA, V86, P552, DOI 10.1007/BF00318322; NIESENBAUM RA, 1992, AM MIDL NAT, V128, P270, DOI 10.2307/2426460; Niesenbaum RA, 2006, ENVIRON ENTOMOL, V35, P600, DOI 10.1603/0046-225X-35.3.600; Norghauer JM, 2008, J ECOL, V96, P103, DOI 10.1111/j.1365-2745.2007.01325.x; NUNEZFARFAN J, 1988, OIKOS, V51, P274, DOI 10.2307/3565308; Onoda Y, 2008, ANN BOT-LONDON, V101, P727, DOI 10.1093/aob/mcn013; Pearson TRH, 2003, J ECOL, V91, P785, DOI 10.1046/j.1365-2745.2003.00803.x; PIERSON EA, 1990, OECOLOGIA, V84, P534, DOI 10.1007/BF00328171; Richards LA, 2007, J TROP ECOL, V23, P169, DOI 10.1017/S0266467406003907; Richards LA, 2007, OIKOS, V116, P31, DOI 10.1111/j.2006.0030-1299.15043.x; Roberts MR, 2006, NEW PHYTOL, V170, P677, DOI 10.1111/j.1469-8137.2006.01707.x; Rogers WE, 2002, BASIC APPL ECOL, V3, P297, DOI 10.1078/1439-1791-00120; Rosenthal G. A, 1991, HERBIVORES THEIR INT; Sipura M, 2000, OIKOS, V91, P550, DOI 10.1034/j.1600-0706.2000.910317.x; Sousa WP, 2003, OECOLOGIA, V137, P436, DOI 10.1007/s00442-003-1350-0; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; VANDERMEIJDEN E, 1988, OIKOS, V51, P355, DOI 10.2307/3565318; Wise MJ, 2007, AM NAT, V169, P443, DOI 10.1086/512044; Yamasaki M, 2003, OECOLOGIA, V137, P226, DOI 10.1007/s00442-003-1337-x; ZANGERL AR, 1993, ECOLOGY, V74, P47, DOI 10.2307/1939500	70	42	43	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11460	10.1371/journal.pone.0011460	http://dx.doi.org/10.1371/journal.pone.0011460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628638	Green Published, gold, Green Submitted			2022-12-25	WOS:000279589300008
J	Hung, MS; Lin, YC; Mao, JH; Kim, IJ; Xu, ZD; Yang, CT; Jablons, DM; You, LA				Hung, Ming-Szu; Lin, Yu-Ching; Mao, Jian-Hua; Kim, Il-Jin; Xu, Zhidong; Yang, Cheng-Ta; Jablons, David M.; You, Liang			Functional Polymorphism of the CK2 alpha Intronless Gene Plays Oncogenic Roles in Lung Cancer	PLOS ONE			English	Article							PROTEIN-KINASE CK2; PML TUMOR-SUPPRESSOR; II SUBUNIT-ALPHA; PSEUDOGENE; IDENTIFICATION; TUMORIGENESIS; DEGRADATION; EXPRESSION; ORIGINS; GENOME	Protein kinase CK2 is frequently up-regulated in human cancers, although the mechanism of CK2 activation in cancer remains unknown. In this study, we investigated the role of the CK2 alpha intronless gene (CSNK2A1P, a presumed CK2 alpha pseudogene) in the pathogenesis of human cancers. We found evidence of amplification and over-expression of the CSNK2A1P gene in non-small cell lung cancer and leukemia cell lines and 25% of the lung cancer tissues studied. The mRNA expression levels correlated with the copy numbers of the CSNK2A1P gene. We also identified a novel polymorphic variant (398T/C, I133T) of the CSNK2A1P gene and showed that the 398T allele is selectively amplified over the 398C allele in 101 non-small cell lung cancer tissue samples compared to those in 48 normal controls (p = 0.013<0.05). We show for the first time CSNK2A1P protein expression in transfected human embryonic kidney 293T and mouse embryonic fibroblast NIH-3T3 cell lines. Both alleles are transforming in these cell lines, and the 398T allele appears to be more transforming than the 398C allele. Moreover, the 398T allele degrades PML tumor suppressor protein more efficiently than the 398C allele and shows a relatively stronger binding to PML. Knockdown of the CSNK2A1P gene expression with specific siRNA increased the PML protein level in lung cancer cells. We report, for the first time, that the CSNK2A1P gene is a functional proto-oncogene in human cancers and its functional polymorphism appears to degrade PML differentially in cancer cells. These results are consistent with an important role for the 398T allele of the CSNK2A1P in human lung cancer susceptibility.	[Hung, Ming-Szu; Kim, Il-Jin; Xu, Zhidong; Jablons, David M.; You, Liang] Univ Calif San Francisco, Dept Surg, Ctr Comprehens Canc, Thorac Oncol Lab, San Francisco, CA 94143 USA; [Hung, Ming-Szu; Lin, Yu-Ching; Yang, Cheng-Ta] Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Chiayi, Taiwan; [Hung, Ming-Szu] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Mao, Jian-Hua] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Yang, Cheng-Ta] Chang Gung Univ, Coll Med, Dept Resp Care, Tao Yuan, Taiwan	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Chang Gung Memorial Hospital; Chang Gung University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Chang Gung University	Hung, MS (corresponding author), Univ Calif San Francisco, Dept Surg, Ctr Comprehens Canc, Thorac Oncol Lab, San Francisco, CA 94143 USA.	jablonsd@surgery.ucsf.edu; Liang.You@ucsfmedctr.org	Mao, Jian-Hua/EIZ-8595-2022	Mao, Jian-Hua/0000-0001-9320-6021; Yang, Cheng-Ta/0000-0003-1846-1027	National Institutes of Health [093708-01A3]; Larry Hall and Zygielbaum Memorial Trust; Kazan, McClain, Edises, Abrams, Fernandez, Lyons and Farrise Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry Hall and Zygielbaum Memorial Trust; Kazan, McClain, Edises, Abrams, Fernandez, Lyons and Farrise Foundation	This work was partially supported by the National Institutes of Health (093708-01A3) and the Larry Hall and Zygielbaum Memorial Trust, and the Kazan, McClain, Edises, Abrams, Fernandez, Lyons and Farrise Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTISTUTTA R, 2009, CELL MOL LIFE SCI; Berger IR, 2005, CANCER GENET CYTOGEN, V159, P155, DOI 10.1016/j.cancergencyto.2004.10.010; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Harrison PM, 2002, GENOME RES, V12, P272, DOI 10.1101/gr.207102; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hwang SL, 2005, EUR SURG RES, V37, P100, DOI 10.1159/000084540; Jemal A, 2009, CA CANC J CLIN; LaFramboise T, 2005, PLOS COMPUT BIOL, V1, P507, DOI 10.1371/journal.pcbi.0010065; Landesman-Bollag E, 2001, MOL CELL BIOCHEM, V227, P153, DOI 10.1023/A:1013108822847; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; Piazza FA, 2006, BLOOD, V108, P1698, DOI 10.1182/blood-2005-11-013672; PINNA LA, 2009, CELL MOL LIFE SCI; Prudent R, 2009, CHEM BIOL, V16, P112, DOI 10.1016/j.chembiol.2009.01.004; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sarno S, 2008, MOL BIOSYST, V4, P889, DOI 10.1039/b805534c; Scaglioni PP, 2008, MOL CELL BIOCHEM, V316, P149, DOI 10.1007/s11010-008-9812-7; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; Singh LS, 2002, BIOCHEMISTRY-US, V41, P8935, DOI 10.1021/bi025791r; Sun C, 2008, BIOCHEM BIOPH RES CO, V377, P215, DOI 10.1016/j.bbrc.2008.09.113; TREMBLEY JH, 2009, CELL MOL LIFE SCI; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; WIRKNER U, 1992, BIOCHIM BIOPHYS ACTA, V1131, P220, DOI 10.1016/0167-4781(92)90083-C; WIRKNER U, 1994, GENOMICS, V19, P257, DOI 10.1006/geno.1994.1056	31	21	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11418	10.1371/journal.pone.0011418	http://dx.doi.org/10.1371/journal.pone.0011418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625391	gold, Green Submitted, Green Published			2022-12-25	WOS:000279465700006
J	Shah, P; Gilchrist, MA				Shah, Premal; Gilchrist, Michael A.			Is Thermosensing Property of RNA Thermometers Unique?	PLOS ONE			English	Article							MESSENGER-RNA; ESCHERICHIA-COLI; SECONDARY STRUCTURE; SIGMA(32); PREDICTION; INDUCTION	A large number of studies have been dedicated to identify the structural and sequence based features of RNA thermometers, mRNAs that regulate their translation initiation rate with temperature. It has been shown that the melting of the ribosome-binding site (RBS) plays a prominent role in this thermosensing process. However, little is known as to how widespread this melting phenomenon is as earlier studies on the subject have worked with a small sample of known RNA thermometers. We have developed a novel method of studying the melting of RNAs with temperature by computationally sampling the distribution of the RNA structures at various temperatures using the RNA folding software Vienna. In this study, we compared the thermosensing property of 100 randomly selected mRNAs and three well known thermometers rpoH, ibpA and agsA sequences from E. coli. We also compared the rpoH sequences from 81 mesophilic proteobacteria. Although both rpoH and ibpA show a higher rate of melting at their RBS compared with the mean of non-thermometers, contrary to our expectations these higher rates are not significant. Surprisingly, we also do not find any significant differences between rpoH thermometers from other gamma-proteobacteria and E. coli non-thermometers.	[Shah, Premal; Gilchrist, Michael A.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Shah, Premal; Gilchrist, Michael A.] Natl Inst Math & Biol Synth, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Shah, P (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	pshah1@utk.edu	Gilchrist, Michael A/A-8209-2008; Taylor, Graham/A-4027-2012	Gilchrist, Michael A/0000-0002-6936-0771; Shah, Premal/0000-0002-8424-4218	Department of Ecology and Evolutionary Biology at the University of Tennessee, Knoxville; National Institute for Mathematical and Biological Synthesis (NIMBioS)	Department of Ecology and Evolutionary Biology at the University of Tennessee, Knoxville; National Institute for Mathematical and Biological Synthesis (NIMBioS)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The funding was provided by the Department of Ecology and Evolutionary Biology at the University of Tennessee, Knoxville (http://eeb.bio.utk.edu/). P. S. was supported by the National Institute for Mathematical and Biological Synthesis (NIMBioS) Graduate Research Assistantship (http://nimbios.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avihoo A, 2005, IEEE COMP SYST BIOIN, P235; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Chowdhury S, 2003, J BIOL CHEM, V278, P47915, DOI 10.1074/jbc.M306874200; Chowdhury S, 2006, EMBO J, V25, P2487, DOI 10.1038/sj.emboj.7601128; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Hambraeus G, 2003, MOL GENET GENOMICS, V269, P706, DOI 10.1007/s00438-003-0883-6; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hughes T A, 2006, Comput Math Methods Med, V7, P37, DOI 10.1080/10273660600906416; Huynen M, 1997, J MOL BIOL, V267, P1104, DOI 10.1006/jmbi.1997.0889; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Morita MT, 1999, GENE DEV, V13, P655, DOI 10.1101/gad.13.6.655; NAKAHIGASHI K, 1995, NUCLEIC ACIDS RES, V23, P4383; Narberhaus F, 2006, FEMS MICROBIOL REV, V30, P3, DOI 10.1111/j.1574-6976.2005.004.x; R Core Team, 2022, R LANG ENV STAT COMP; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Shultzaberger RK, 2001, J MOL BIOL, V313, P215, DOI 10.1006/jmbi.2001.5040; Voss B, 2004, BIOINFORMATICS, V20, P1573, DOI 10.1093/bioinformatics/bth129; Waldminghaus T, 2005, BIOL CHEM, V386, P1279, DOI 10.1515/BC.2005.145; Waldminghaus T, 2007, MOL GENET GENOMICS, V278, P555, DOI 10.1007/s00438-007-0272-7; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7; YUZAWA H, 1993, NUCLEIC ACIDS RES, V21, P5449, DOI 10.1093/nar/21.23.5449	24	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11308	10.1371/journal.pone.0011308	http://dx.doi.org/10.1371/journal.pone.0011308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625392	Green Submitted, Green Published, gold			2022-12-25	WOS:000279465700002
J	Yan, D; Ng, WL; Zhang, XM; Wang, P; Zhang, ZB; Mo, YY; Mao, H; Hao, CH; Olson, JJ; Curran, WJ; Wang, Y				Yan, Dan; Ng, Wooi Loon; Zhang, Xiangming; Wang, Ping; Zhang, Zhaobin; Mo, Yin-Yuan; Mao, Hui; Hao, Chunhai; Olson, Jeffrey J.; Curran, Walter J.; Wang, Ya			Targeting DNA-PKcs and ATM with miR-101 Sensitizes Tumors to Radiation	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; STRAND BREAK REPAIR; MICRORNA-101; GLIOMA; RECOMBINATION; EXPRESSION; SUBUNIT; MIR-31	Background: Radiotherapy kills tumor-cells by inducing DNA double strand breaks (DSBs). However, the efficient repair of tumors frequently prevents successful treatment. Therefore, identifying new practical sensitizers is an essential step towards successful radiotherapy. In this study, we tested the new hypothesis: identifying the miRNAs to target DNA DSB repair genes could be a new way for sensitizing tumors to ionizing radiation. Principal Findings: Here, we chose two genes: DNA-PKcs (an essential factor for non-homologous end-joining repair) and ATM (an important checkpoint regulator for promoting homologous recombination repair) as the targets to search their regulating miRNAs. By combining the database search and the bench work, we picked out miR-101. We identified that miR-101 could efficiently target DNA-PKcs and ATM via binding to the 3'- UTR of DNA-PKcs or ATM mRNA. Up-regulating miR-101 efficiently reduced the protein levels of DNA-PKcs and ATM in these tumor cells and most importantly, sensitized the tumor cells to radiation in vitro and in vivo. Conclusions: These data demonstrate for the first time that miRNAs could be used to target DNA repair genes and thus sensitize tumors to radiation. These results provide a new way for improving tumor radiotherapy.	[Yan, Dan; Ng, Wooi Loon; Zhang, Xiangming; Wang, Ping; Curran, Walter J.; Wang, Ya] Emory Univ, Sch Med, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA 30322 USA; [Zhang, Zhaobin; Olson, Jeffrey J.] Emory Univ, Sch Med, Dept Neurosurg, Winship Canc Inst, Atlanta, GA USA; [Mo, Yin-Yuan] So Illinois Univ, Sch Med, Springfield, IL USA; [Mao, Hui] Emory Univ, Sch Med, Dept Radiol, Winship Canc Inst, Atlanta, GA 30322 USA; [Hao, Chunhai] Emory Univ, Sch Med, Dept Pathol & Lab Med, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University; Southern Illinois University System; Southern Illinois University; Emory University; Emory University	Yan, D (corresponding author), Emory Univ, Sch Med, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA 30322 USA.	ywang94@emory.edu	Yan, Dan/B-1793-2012; Mo, Yin-Yuan/R-8255-2019; Mo, Yin-Yuan/B-6141-2011	Yan, Dan/0000-0001-7531-5814; 	NIH [GM80771]; Emory University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080771] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM80771 (to Y.W.) and an Emory University startup fund (to Y.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Golding SE, 2004, J BIOL CHEM, V279, P15402, DOI 10.1074/jbc.M314191200; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Jackson SP, 1996, CANCER SURV, V28, P261; JEGGO PA, 1995, BIOESSAYS, V17, P949, DOI 10.1002/bies.950171108; Kaur B, 2009, CANCER RES, V69, P1212, DOI 10.1158/0008-5472.CAN-08-1166; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P927, DOI 10.1038/nrm2598; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Li S, 2009, HEPATOLOGY, V49, P1194, DOI 10.1002/hep.22757; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y L, 1989, Zhonghua Zhong Liu Za Zhi, V11, P1; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang FZ, 2008, J VIROL, V82, P9065, DOI 10.1128/JVI.00961-08; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858	28	182	198	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2010	5	7							e11397	10.1371/journal.pone.0011397	http://dx.doi.org/10.1371/journal.pone.0011397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YF	20617180	gold, Green Published, Green Submitted			2022-12-25	WOS:000279465500001
J	Fukuda, A; Cao, F; Morita, S; Yamada, K; Jincho, Y; Tane, S; Sotomaru, Y; Kono, T				Fukuda, Atsushi; Cao, Feng; Morita, Shinnosuke; Yamada, Kaori; Jincho, Yuko; Tane, Shouji; Sotomaru, Yusuke; Kono, Tomohiro			Identification of Inappropriately Reprogrammed Genes by Large-Scale Transcriptome Analysis of Individual Cloned Mouse Blastocysts	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; NUCLEAR TRANSFER; EXPRESSION PROFILES; CHROMATIN-STRUCTURE; CYCLE REGULATION; X-CHROMOSOME; DONOR CELLS; MICE; EMBRYOS; METHYLATION	Although cloned embryos generated by somatic/embryonic stem cell nuclear transfer (SECNT) certainly give rise to viable individuals, they can often undergo embryonic arrest at any stage of embryogenesis, leading to diverse morphological abnormalities. In an effort to gain further insights into reprogramming and the properties of SECNT embryos, we performed a large-scale gene expression profiling of 87 single blastocysts using GeneChip microarrays. Sertoli cells, cumulus cells, and embryonic stem cells were used as donor cells. The gene expression profiles of 87 blastocysts were subjected to microarray analysis. Using principal component analysis and hierarchical clustering, the gene expression profiles were clearly classified into 3 clusters corresponding to the type of donor cell. The results revealed that each type of SECNT embryo had a unique gene expression profile that was strictly dependent upon the type of donor cells, although there was considerable variation among the individual profiles within each group. This suggests that the reprogramming process is distinct for embryos cloned from different types of donor cells. Furthermore, on the basis of the results of comparison analysis, we identified 35 genes that were inappropriately reprogrammed in most of the SECNT embryos; our findings demonstrated that some of these genes, such as Asz1, Xlr3a and App, were appropriately reprogrammed only in the embryos with a transcriptional profile that was the closest to that of the controls. Our findings provide a framework to further understand the reprogramming in SECNT embryos.	[Fukuda, Atsushi; Cao, Feng; Morita, Shinnosuke; Yamada, Kaori; Jincho, Yuko; Tane, Shouji; Kono, Tomohiro] Tokyo Univ Agr, Dept Biosci, Tokyo, Japan; [Sotomaru, Yusuke] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima, Japan	Tokyo University of Agriculture; Hiroshima University	Fukuda, A (corresponding author), Tokyo Univ Agr, Dept Biosci, Tokyo, Japan.	tomohiro@nodai.ac.jp	Sotomaru, Yusuke/G-5508-2019	Tane, Shoji/0000-0002-0209-347X	Ministry of Education, Science, Sports and Culture of Japan [18208024]; Ministry of Agriculture, Forestry and Fisheries of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan to T.K. (No. 18208024), and from the Ministry of Agriculture, Forestry and Fisheries of Japan (Development of stable production technology of cloned animals by somatic cell nuclear transfer) to T.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artus J, 2008, MOL CELL ENDOCRINOL, V282, P78, DOI 10.1016/j.mce.2007.11.008; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bao SQ, 2005, EMBO REP, V6, P748, DOI 10.1038/sj.embor.7400461; Beyhan Z, 2007, DEV BIOL, V305, P637, DOI 10.1016/j.ydbio.2007.01.041; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Chung YG, 2003, BIOL REPROD, V69, P146, DOI 10.1095/biolreprod.102.014076; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Gurdon John, 2008, Cell Stem Cell, V2, P135, DOI 10.1016/j.stem.2008.01.009; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Humphreys D, 2002, P NATL ACAD SCI USA, V99, P12889, DOI 10.1073/pnas.192433399; Inoue K, 2005, CURR BIOL, V15, P1114, DOI 10.1016/j.cub.2005.05.021; Iwamori N, 2002, FEBS LETT, V526, P119, DOI 10.1016/S0014-5793(02)03121-6; Jincho Y, 2008, BIOL REPROD, V78, P568, DOI 10.1095/biolreprod.107.064634; Kawahara M, 2008, NAT PROTOC, V3, P197, DOI 10.1038/nprot.2007.531; Kishigami S, 2006, NAT PROTOC, V1, P125, DOI 10.1038/nprot.2006.21; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Li XP, 2006, CLONING STEM CELLS, V8, P214, DOI 10.1089/clo.2006.8.214; Li XP, 2005, MOL REPROD DEV, V72, P152, DOI 10.1002/mrd.20346; Muller C, 2004, J BIOL CHEM, V279, P7353, DOI 10.1074/jbc.M312709200; Ng K, 2007, EMBO REP, V8, P34, DOI 10.1038/sj.embor.7400871; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Nolen LD, 2005, DEV BIOL, V279, P525, DOI 10.1016/j.ydbio.2005.01.016; Ogawa H, 2003, REPRODUCTION, V126, P549, DOI 10.1530/rep.0.1260549; Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; Ogura A, 2000, BIOL REPROD, V62, P1579, DOI 10.1095/biolreprod62.6.1579; Oishi M, 2006, MOL REPROD DEV, V73, P404, DOI 10.1002/mrd.20345; Ono Y, 2001, REPRODUCTION, V122, P731, DOI 10.1530/reprod/122.5.731; Ono Y, 2006, BIOL REPROD, V75, P210, DOI 10.1095/biolreprod.105.049171; PAI SR, 1994, ANTICANCER RES, V14, P2501; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Renard JP, 1999, LANCET, V353, P1489, DOI 10.1016/S0140-6736(98)12173-6; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Shimozawa N, 2002, GENESIS, V34, P203, DOI 10.1002/gene.10143; Smith SL, 2005, P NATL ACAD SCI USA, V102, P17582, DOI 10.1073/pnas.0508952102; Somers J, 2006, REPRODUCTION, V131, P1073, DOI 10.1530/rep.1.00967; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262; Tong GQ, 2006, CELL TISSUE RES, V325, P231, DOI 10.1007/s00441-006-0189-1; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Waes JGV, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-156; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Wee G, 2006, J BIOL CHEM, V281, P6048, DOI 10.1074/jbc.M511340200; Wee G, 2007, REPRODUCTION, V134, P781, DOI 10.1530/REP-07-0338; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang HS, 2001, ONCOGENE, V20, P3134, DOI 10.1038/sj.onc.1204338; Zhang M, 2009, J BIOL CHEM, V284, P24981, DOI 10.1074/jbc.M109.011973	63	37	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11274	10.1371/journal.pone.0011274	http://dx.doi.org/10.1371/journal.pone.0011274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614022	gold, Green Submitted, Green Published			2022-12-25	WOS:000279370000004
J	Jonker, RM; Eichhorn, G; van Langevelde, F; Bauer, S				Jonker, Rudy M.; Eichhorn, Goetz; van Langevelde, Frank; Bauer, Silke			Predation Danger Can Explain Changes in Timing of Migration: The Case of the Barnacle Goose	PLOS ONE			English	Article							OPTIMAL AVIAN MIGRATION; HEART-RATE; OXYGEN-CONSUMPTION; SPRING MIGRATION; BRANTA-LEUCOPSIS; RANGE EXPANSION; CLIMATE-CHANGE; STOPOVER SITE; TRADE-OFF; GEESE	Understanding stopover decisions of long-distance migratory birds is crucial for conservation and management of these species along their migratory flyway. Recently, an increasing number of Barnacle geese breeding in the Russian Arctic have delayed their departure from their wintering site in the Netherlands by approximately one month and have reduced their staging duration at stopover sites in the Baltic accordingly. Consequently, this extended stay increases agricultural damage in the Netherlands. Using a dynamic state variable approach we explored three hypotheses about the underlying causes of these changes in migratory behavior, possibly related to changes in (i) onset of spring, (ii) potential intake rates and (iii) predation danger at wintering and stopover sites. Our simulations showed that the observed advance in onset of spring contradicts the observed delay of departure, whereas both increased predation danger and decreased intake rates in the Baltic can explain the delay. Decreased intake rates are expected as a result of increased competition for food in the growing Barnacle goose population. However, the effect of predation danger in the model was particularly strong, and we hypothesize that Barnacle geese avoid Baltic stopover sites as a response to the rapidly increasing number of avian predators in the area. Therefore, danger should be considered as an important factor influencing Barnacle goose migratory behavior, and receive more attention in empirical studies.	[Jonker, Rudy M.; van Langevelde, Frank] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands; [Eichhorn, Goetz] Univ Strasbourg, DEPE, IPHC, Strasbourg, France; [Eichhorn, Goetz] CNRS, Strasbourg, France; [Jonker, Rudy M.; Bauer, Silke] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Maarssen, Netherlands; [Bauer, Silke] Swiss Ornithol Inst, Sempach, Switzerland	Wageningen University & Research; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Swiss Ornithological Institute	Jonker, RM (corresponding author), Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands.	rudy.jonker@wur.nl	Eichhorn, Götz/R-8136-2016; Bauer, Silke/C-3524-2008; Jonker, Rudy/I-3979-2012; Bauer, Silke/M-9811-2019	Eichhorn, Götz/0000-0003-2151-8856; Bauer, Silke/0000-0002-0844-164X; Bauer, Silke/0000-0002-0844-164X; Van Langevelde, Frank/0000-0001-8870-0797	Dutch Faunafonds; Koninklijke Nederlandse Jagersvereniging; ESF; 'Marianne und Dr. Fritz Walter-Fischer Stiftung', Germany; Groningen University; The Netherlands Organisation [816.01.007]	Dutch Faunafonds; Koninklijke Nederlandse Jagersvereniging; ESF(European Commission); 'Marianne und Dr. Fritz Walter-Fischer Stiftung', Germany; Groningen University; The Netherlands Organisation(Netherlands Organization for Scientific Research (NWO))	Rudy Jonker was funded by the Dutch Faunafonds and the Koninklijke Nederlandse Jagersvereniging. Gotz Eichhorn was supported by ESF travel grants and scholarships from the 'Marianne und Dr. Fritz Walter-Fischer Stiftung', Germany, and the 'Ubbo Emmius Programme' of Groningen University. Silke Bauer received support from The Netherlands Organisation for Scientific Research, Earth & Life Sciences (NWO-ALW) project grant 816.01.007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T., 1990, P331; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Bauer S, 2008, J ANIM ECOL, V77, P654, DOI 10.1111/j.1365-2656.2008.01381.x; Beekman JH, 2002, ARDEA, V90, P437; Both C, 2007, SCIENCE, V315, DOI 10.1126/science.1136148; Bruinzeel L.W., 1997, PATCHWORK PATCH USE, P111; Butler PJ, 2000, COMP BIOCHEM PHYS A, V126, P379, DOI 10.1016/S1095-6433(00)00221-X; Clark CW, 2000, OX ECOL EV; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Dierschke V, 2003, J AVIAN BIOL, V34, P24, DOI 10.1034/j.1600-048X.2003.03049.x; Eichhorn G., 2008, THESIS U GRONINGEN G; Eichhorn G, 2009, J ANIM ECOL, V78, P63, DOI 10.1111/j.1365-2656.2008.01485.x; Eichhorn G, 2006, ARDEA, V94, P667; *FAUN, 2009, DORDR AGR DAM BARN G; FORSLUND P, 1991, ARDEA, V79, P342; Fransson T, 1997, BEHAV ECOL SOCIOBIOL, V41, P75, DOI 10.1007/s002650050366; Ganter B., 1999, GOOSE POPULATIONS W, P270; Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568; Gordo O, 2007, CLIM RES, V35, P37, DOI 10.3354/cr00713; HELANDER B, 2000, P INT C BJORK SWED 1; HERMANN C, 2009, POPULATION DEV BALTI; Houston AI, 1998, J AVIAN BIOL, V29, P395, DOI 10.2307/3677158; Houston AI, 1999, MODELS ADAPTIVE BEHA; Jones T, 2010, J ANIM ECOL, V79, P98, DOI 10.1111/j.1365-2656.2009.01610.x; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Jonzen N, 2007, P ROY SOC B-BIOL SCI, V274, P269, DOI 10.1098/rspb.2006.3719; Klaassen M, 2006, J APPL ECOL, V43, P92, DOI 10.1111/j.1365-2664.2005.01109.x; Lank DB, 2003, OIKOS, V103, P303, DOI 10.1034/j.1600-0706.2003.12314.x; Lank DB, 2003, J AVIAN BIOL, V34, P225, DOI 10.1034/j.1600-048X.2003.03250.x; Leito Aivar, 1996, Estonia Maritima, V1, P1; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; MCNAMARA JM, 1994, AM NAT, V144, P978, DOI 10.1086/285721; NOLET BA, 1992, PHYSIOL ZOOL, V65, P1188, DOI 10.1086/physzool.65.6.30158275; Pomeroy AC, 2006, OIKOS, V112, P629, DOI 10.1111/j.0030-1299.2006.14403.x; Pomeroy AC, 2006, BEHAV ECOL, V17, P1041, DOI 10.1093/beheco/arl043; Prins Herbert H. T., 2008, V195, P1; Prop J, 2003, OIKOS, V103, P403, DOI 10.1034/j.1600-0706.2003.12042.x; R Development Core Team, 2009, R FDN STAT COMP; Roder Frank E., 2008, Takkeling, V16, P100; Stervander M, 2005, J AVIAN BIOL, V36, P210, DOI 10.1111/j.0908-8857.2005.03360.x; Sutherland WJ, 1998, J AVIAN BIOL, V29, P441, DOI 10.2307/3677163; Tombre IM, 2008, J AVIAN BIOL, V39, P691, DOI 10.1111/j.1600-048X.2008.04440.x; van der Graaf AJ, 2007, BASIC APPL ECOL, V8, P354, DOI 10.1016/j.baae.2006.07.001; van der Graaf SAJ, 2006, ARDEA, V94, P567; Van Der Jeugd HP, 2009, GLOBAL CHANGE BIOL, V15, P1057, DOI 10.1111/j.1365-2486.2008.01804.x; van der Jeugd HP, 2003, POLAR BIOL, V26, P700, DOI 10.1007/s00300-003-0535-7; VANDERGRAAF AJ, 2006, THESIS RIJKSUNIVERSI; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Ward S, 2002, J EXP BIOL, V205, P3347; Weber TP, 1998, EVOL ECOL, V12, P377, DOI 10.1023/A:1006560420310; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8; YDENBERG RC, 1981, J APPL ECOL, V18, P443, DOI 10.2307/2402405; Ydenberg RC, 2007, J AVIAN BIOL, V38, P523, DOI 10.1111/j.2007.0908-8857.04202.x	54	46	47	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11369	10.1371/journal.pone.0011369	http://dx.doi.org/10.1371/journal.pone.0011369			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614027	Green Published, gold			2022-12-25	WOS:000279370000007
J	Kowarsch, A; Marr, C; Schmidl, D; Ruepp, A; Theis, FJ				Kowarsch, Andreas; Marr, Carsten; Schmidl, Daniel; Ruepp, Andreas; Theis, Fabian J.			Tissue-Specific Target Analysis of Disease-Associated MicroRNAs in Human Signaling Pathways	PLOS ONE			English	Article							REL/NF-KAPPA-B; MESSENGER-RNA; C-FOS; CANCER; GENE; IDENTIFICATION; EXPRESSION; GROWTH; CELLS; TRANSCRIPTION	MicroRNAs are a large class of post-transcriptional regulators that bind to the 39 untranslated region of messenger RNAs. They play a critical role in many cellular processes and have been linked to the control of signal transduction pathways. Recent studies indicate that microRNAs can function as tumor suppressors or even as oncogenes when aberrantly expressed. For more general insights of disease-associated microRNAs, we analyzed their impact on human signaling pathways from two perspectives. On a global scale, we found a core set of signaling pathways with enriched tissue-specific microRNA targets across diseases. The function of these pathways reflects the affinity of microRNAs to regulate cellular processes associated with apoptosis, proliferation or development. Comparing cancer and non-cancer related microRNAs, we found no significant differences between both groups. To unveil the interaction and regulation of microRNAs on signaling pathways locally, we analyzed the cellular location and process type of disease-associated microRNA targets and proteins. While disease-associated proteins are highly enriched in extracellular components of the pathway, microRNA targets are preferentially located in the nucleus. Moreover, targets of disease-associated microRNAs preferentially exhibit an inhibitory effect within the pathways in contrast to disease proteins. Our analysis provides systematic insights into the interaction of disease-associated microRNAs and signaling pathways and uncovers differences in cellular locations and process types of microRNA targets and disease-associated proteins.	[Kowarsch, Andreas; Marr, Carsten; Schmidl, Daniel; Ruepp, Andreas; Theis, Fabian J.] Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Schmidl, Daniel; Theis, Fabian J.] Tech Univ Munich, Inst Math Sci, D-8046 Garching, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Kowarsch, A (corresponding author), Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany.	andreas.kowarsch@helmholtz-muenchen.de; fabian.theis@helmholtz-muenchen.de	Marr, Carsten/B-3696-2013; Theis, Fabian J/ABD-5212-2021	Marr, Carsten/0000-0003-2154-4552; Theis, Fabian J/0000-0002-2419-1943	Federal Ministry of Education and Research (BMBF); MedSys initiative; Helmholtz Alliance on Systems Biology	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); MedSys initiative; Helmholtz Alliance on Systems Biology	This work was supported by the Federal Ministry of Education and Research (BMBF) and its MedSys initiative (project 'LungSys') and the Helmholtz Alliance on Systems Biology (project 'CoReNe'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bruning JC, 2000, P NATL ACAD SCI USA, V97, P2462, DOI 10.1073/pnas.97.6.2462; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chiao PJ, 2002, CANCER, V95, P1696, DOI 10.1002/cncr.10829; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; CUI Q, 2006, MOL SYSTEMS BIOL, P1; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Evangelisti C, 2009, FASEB J, V23, P4276, DOI 10.1096/fj.09-134965; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; George D, 2003, ADV EXP MED BIOL, V532, P141; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Griffen TD, 2004, J INDO-EUR STUD, V32, P11; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Irminger-Finger I, 2006, NAT REV CANCER, V6, P382, DOI 10.1038/nrc1878; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jovanovic M, 2006, ONCOGENE, V25, P6176, DOI 10.1038/sj.onc.1209912; KABNICK KS, 1988, MOL CELL BIOL, V8, P3244, DOI 10.1128/MCB.8.8.3244; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Klamt S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000385; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; LEGEWIE S, 2008, MOL SYSTEMS BIOL, P1; LEUCHT C, 2008, NAT NEUROSCI; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Lutter D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-224; Ricarte JCM, 2009, TRANSL ONCOL, V2, P236, DOI 10.1593/tlo.09151; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Perrone G, 2007, MODERN PATHOL, V20, P344, DOI 10.1038/modpathol.3800743; ROSS R, 1974, P NATL ACAD SCI USA, V71, P1207, DOI 10.1073/pnas.71.4.1207; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; SCHAEFER CF, 2008, NUCL ACIDS RES; Seigel GM, 2007, MOL VIS, V13, P823; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Wu EX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003794; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Yeilding NM, 1996, MOL CELL BIOL, V16, P3511; 2009, TARGETSPY	57	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11154	10.1371/journal.pone.0011154	http://dx.doi.org/10.1371/journal.pone.0011154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614023	Green Published, gold, Green Submitted			2022-12-25	WOS:000279370000002
J	Shi, YC; Lin, S; Wong, IPL; Baldock, PA; Aljanova, A; Enriquez, RF; Castillo, L; Mitchell, NF; Ye, JM; Zhang, L; Macia, L; Yulyaningsih, E; Nguyen, AD; Riepler, SJ; Herzog, H; Sainsbury, A				Shi, Yan-Chuan; Lin, Shu; Wong, Iris P. L.; Baldock, Paul A.; Aljanova, Aygul; Enriquez, Ronaldo F.; Castillo, Lesley; Mitchell, Natalie F.; Ye, Ji-Ming; Zhang, Lei; Macia, Laurence; Yulyaningsih, Ernie; Nguyen, Amy D.; Riepler, Sabrina J.; Herzog, Herbert; Sainsbury, Amanda			NPY Neuron-Specific Y2 Receptors Regulate Adipose Tissue and Trabecular Bone but Not Cortical Bone Homeostasis in Mice	PLOS ONE			English	Article							NEUROPEPTIDE-Y; BODY-WEIGHT; PEPTIDE-YY; PARAVENTRICULAR NUCLEUS; OBESITY SYNDROME; KNOCKOUT MICE; ZUCKER RATS; OB/OB MICE; LEPTIN; STRESS	Background: Y2 receptor signalling is known to be important in neuropeptide Y (NPY)-mediated effects on energy homeostasis and bone physiology. Y2 receptors are located post-synaptically as well as acting as auto receptors on NPY-expressing neurons, and the different roles of these two populations of Y2 receptors in the regulation of energy homeostasis and body composition are unclear. Methodology/Principal Findings: We thus generated two conditional knockout mouse models, Y2(lox/lox) and NPYCre/+;Y2(lox/lox), in which Y2 receptors can be selectively ablated either in the hypothalamus or specifically in hypothalamic NPY-producing neurons of adult mice. Specific deletion of hypothalamic Y2 receptors increases food intake and body weight compared to controls. Importantly, specific ablation of hypothalamic Y2 receptors on NPY-containing neurons results in a significantly greater adiposity in female but not male mice, accompanied by increased hepatic triglyceride levels, decreased expression of liver cartinine palmitoyltransferase (CPT1) and increased expression of muscle phosphorylated acetyl-CoA carboxylase (ACC). While food intake, body weight, femur length, bone mineral content, density and cortical bone volume and thickness are not significantly altered, trabecular bone volume and number were significantly increased by hypothalamic Y2 deletion on NPY-expressing neurons. Interestingly, in situ hybridisation reveals increased NPY and decreased proopiomelanocortin ( POMC) mRNA expression in the arcuate nucleus of mice with hypothalamus-specific deletion of Y2 receptors in NPY neurons, consistent with a negative feedback mechanism between NPY expression and Y2 receptors on NPY-ergic neurons. Conclusions/Significance: Taken together these data demonstrate the anti-obesogenic role of Y2 receptors in the brain, notably on NPY-ergic neurons, possibly via inhibition of NPY neurons and concomitant stimulation of POMC-expressing neurons in the arcuate nucleus of the hypothalamus, reducing lipogenic pathways in liver and/or skeletal muscle in females. These data also reveal as an anti-osteogenic effect of Y2 receptors on hypothalamic NPY-expressing neurons on trabecular but not on cortical bone.	[Shi, Yan-Chuan; Lin, Shu; Wong, Iris P. L.; Baldock, Paul A.; Aljanova, Aygul; Enriquez, Ronaldo F.; Castillo, Lesley; Mitchell, Natalie F.; Zhang, Lei; Macia, Laurence; Yulyaningsih, Ernie; Nguyen, Amy D.; Riepler, Sabrina J.; Herzog, Herbert; Sainsbury, Amanda] Garvan Inst Med Res, Neurosci Res Program, Sydney, NSW, Australia; [Ye, Ji-Ming] Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW, Australia; [Baldock, Paul A.; Herzog, Herbert] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Sainsbury, Amanda] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	Garvan Institute of Medical Research; Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney	Shi, YC (corresponding author), Garvan Inst Med Res, Neurosci Res Program, Sydney, NSW, Australia.	a.sainsbury-salis@garvan.org.au	/E-2900-2010; Herzog, Herbert/B-8294-2008; /A-4361-2010; Nguyen, Amy D/K-2588-2019; Baldock, Paul/B-3840-2012; /B-6258-2012; Salis, Amanda/A-3187-2011; Macia, laurence/D-5983-2016; /A-6021-2011	Nguyen, Amy D/0000-0003-4603-564X; Salis, Amanda/0000-0001-9176-1574; Macia, laurence/0000-0003-0835-851X; /0000-0003-2110-2017; , Herbert/0000-0002-1713-1029; lin, shu/0000-0002-4239-2028	National Health and Medical Research Council (NHMRC) of Australia [427661, 427606]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by the National Health and Medical Research Council (NHMRC) of Australia grants # 427661 & # 427606, and AS, HH and PB are supported by NHMRC Fellowships (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Goycolea C, 2005, J NEUROSCI, V25, P7406, DOI 10.1523/JNEUROSCI.1008-05.2005; Allison SJ, 2006, J BIOL CHEM, V281, P23436, DOI 10.1074/jbc.M604839200; Baldock PA, 2005, J BONE MINER RES, V20, P1851, DOI 10.1359/JBMR.050523; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI14588; Baldock PA, 2006, J BONE MINER RES, V21, P1600, DOI 10.1359/JBMR.060705; Baldock PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008415; Baraban SC, 1998, REV NEUROSCIENCE, V9, P117; Baran K, 2002, DIABETES, V51, P152, DOI 10.2337/diabetes.51.1.152; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; BECK B, 1993, J NUTR, V123, P1168; BILLINGTON CJ, 1994, AM J PHYSIOL, V266, pR1765, DOI 10.1152/ajpregu.1994.266.6.R1765; Blomqvist AG, 1997, TRENDS NEUROSCI, V20, P294, DOI 10.1016/S0166-2236(96)01057-0; Boey D, 2006, DIABETOLOGIA, V49, P1360, DOI 10.1007/s00125-006-0237-0; Boey D, 2008, NEUROPEPTIDES, V42, P19, DOI 10.1016/j.npep.2007.11.003; Broberger C, 1997, NEUROENDOCRINOLOGY, V66, P393, DOI 10.1159/000127265; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Dowell P, 2005, ANNU REV BIOCHEM, V74, P515, DOI 10.1146/annurev.biochem.73.011303.074027; Ellacott KLJ, 2004, RECENT PROG HORM RES, V59, P395, DOI 10.1210/rp.59.1.395; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Fetissov SO, 2004, J COMP NEUROL, V470, P256, DOI 10.1002/cne.11047; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; KALRA SP, 1991, P NATL ACAD SCI USA, V88, P10931, DOI 10.1073/pnas.88.23.10931; King PJ, 2000, EUR J PHARMACOL, V396, pR1, DOI 10.1016/S0014-2999(00)00230-2; Kotz CM, 1998, AM J PHYSIOL-REG I, V275, pR471, DOI 10.1152/ajpregu.1998.275.2.R471; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; LEIBOWITZ SF, 1991, PEPTIDES, V12, P1251, DOI 10.1016/0196-9781(91)90203-2; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; Lin S, 2007, ENDOCRINOLOGY, V148, P2056, DOI 10.1210/en.2006-1408; Marin MT, 2007, PHYSIOL BEHAV, V90, P29, DOI 10.1016/j.physbeh.2006.08.021; MCKIBBIN PE, 1991, DIABETES, V40, P1423, DOI 10.2337/diabetes.40.11.1423; McLean J., 1987, ANIMAL HUMAN CALORIM; Naveilhan P, 2002, PEPTIDES, V23, P1087, DOI 10.1016/S0196-9781(02)00042-6; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Parker RMC, 1999, EUR J NEUROSCI, V11, P1431, DOI 10.1046/j.1460-9568.1999.00553.x; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; Pierroz DD, 1996, ENDOCRINOLOGY, V137, P3, DOI 10.1210/en.137.1.3; Playford RJ, 1996, TRENDS PHARMACOL SCI, V17, P436, DOI 10.1016/S0165-6147(96)01008-5; Pralong FP, 2002, FASEB J, V16, P712, DOI 10.1096/fj.01-0754fje; Redrobe JP, 2004, J MOL NEUROSCI, V22, P159, DOI 10.1385/JMN:22:3:159; Sainsbury A, 2006, DIABETES, V55, P19; Sainsbury A, 1997, DIABETES, V46, P209, DOI 10.2337/diabetes.46.2.209; Sainsbury A, 2003, MOL CELL BIOL, V23, P5225, DOI 10.1128/MCB.23.15.5225-5233.2003; Sainsbury A, 2002, P NATL ACAD SCI USA, V99, P8938, DOI 10.1073/pnas.132043299; Sainsbury A, 2002, DIABETES, V51, P3420, DOI 10.2337/diabetes.51.12.3420; STANLEY BG, 1989, PHYSIOL BEHAV, V46, P173, DOI 10.1016/0031-9384(89)90251-5; Tasan RO, 2010, J NEUROSCI, V30, P6282, DOI 10.1523/JNEUROSCI.0430-10.2010; Tschenett A, 2003, EUR J NEUROSCI, V18, P143, DOI 10.1046/j.1460-9568.2003.02725.x; WILLIAMS G, 1988, DIABETES, V37, P763, DOI 10.2337/diabetes.37.6.763; Ye JM, 2003, AM J PHYSIOL-ENDOC M, V284, pE531, DOI 10.1152/ajpendo.00299.2002; Zafar HM, 1997, BRAIN RES BULL, V44, P289, DOI 10.1016/S0361-9230(97)00140-8; ZARJEVSKI N, 1993, ENDOCRINOLOGY, V133, P1753, DOI 10.1210/en.133.4.1753	57	53	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11361	10.1371/journal.pone.0011361	http://dx.doi.org/10.1371/journal.pone.0011361			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613867	Green Published, gold			2022-12-25	WOS:000279369900010
J	Kivela, R; Silvennoinen, M; Lehti, M; Rinnankoski-Tuikka, R; Purhonen, T; Ketola, T; Pullinen, K; Vuento, M; Mutanen, N; Sartor, MA; Reunanen, H; Koch, LG; Britton, SL; Kainulainen, H				Kivela, Riikka; Silvennoinen, Mika; Lehti, Maarit; Rinnankoski-Tuikka, Rita; Purhonen, Tatja; Ketola, Tarmo; Pullinen, Katri; Vuento, Meri; Mutanen, Niina; Sartor, Maureen A.; Reunanen, Hilkka; Koch, Lauren G.; Britton, Steven L.; Kainulainen, Heikki			Gene expression centroids that link with low intrinsic aerobic exercise capacity and complex disease risk	FASEB JOURNAL			English	Article						skeletal muscle; complex metabolic disease; oxygen metabolism; mitochondria; lipid metabolism	ENDURANCE RUNNING CAPACITY; HUMAN SKELETAL-MUSCLE; OXIDATIVE-PHOSPHORYLATION; ARTIFICIAL SELECTION; RATS; MITOCHONDRIAL; INTERLEUKIN-6; MORTALITY; NETWORKS; MODELS	A strong link exists between low aerobic exercise capacity and complex metabolic diseases. To probe this linkage, we utilized rat models of low and high intrinsic aerobic endurance running capacity that differ also in the risk for metabolic syndrome. We investigated in skeletal muscle gene-phenotype relationships that connect aerobic endurance capacity with metabolic disease risk factors. The study compared 12 high capacity runners (HCRs) and 12 low capacity runners (LCRs) from generation 18 of selection that differed by 615% for maximal treadmill endurance running capacity. On average, LCRs were heavier and had increased blood glucose, insulin, and triglycerides compared with HCRs. HCRs were higher for resting metabolic rate, voluntary activity, serum high density lipoproteins, muscle capillarity, and mitochondrial area. Bioinformatic analysis of skeletal muscle gene expression data revealed that many genes up-regulated in HCRs were related to oxidative energy metabolism. Seven mean mRNA expression centroids, including oxidative phosphorylation and fatty acid metabolism, correlated significantly with several exercise capacity and disease risk phenotypes. These expression-phenotype correlations, together with diminished skeletal muscle capillarity and mitochondrial area in LCR rats, support the general hypothesis that an inherited intrinsic aerobic capacity can underlie disease risks.-Kivela, R., Silvennoinen, M., Lehti, M., Rinnankoski-Tuikka, R., Purhonen, T., Ketola, T., Pullinen, K., Vuento, M., Mutanen, N., Sartor, M. A., Reunanen, H., Koch, L. G., Britton, S. L., Kainulainen, H. Gene expression centroids that link with low intrinsic aerobic exercise capacity and complex disease risk. FASEB J. 24, 4565-4574 (2010). www.fasebj.org	[Kivela, Riikka; Silvennoinen, Mika; Rinnankoski-Tuikka, Rita; Pullinen, Katri; Vuento, Meri; Mutanen, Niina; Kainulainen, Heikki] Univ Jyvaskyla, Dept Biol Phys Act, Neuromuscular Res Ctr, Jyvaskyla 40014, Finland; [Purhonen, Tatja; Ketola, Tarmo; Reunanen, Hilkka] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla 40014, Finland; [Kivela, Riikka; Silvennoinen, Mika; Lehti, Maarit; Rinnankoski-Tuikka, Rita; Kainulainen, Heikki] Res Ctr Sport & Hlth Sci, Liikunnan Ja Kansaterveyden Edistamissaatio LIKES, Jyvaskyla, Finland; [Sartor, Maureen A.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Koch, Lauren G.; Britton, Steven L.] Univ Michigan, Dept Anesthesiol, Sch Med, Ann Arbor, MI 48109 USA	University of Jyvaskyla; University of Jyvaskyla; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kainulainen, H (corresponding author), Univ Jyvaskyla, Dept Biol Phys Act, Neuromuscular Res Ctr, POB 35, Jyvaskyla 40014, Finland.	heikki.kainulainen@sport.jyu.fi	Kivelä, Riikka/I-2859-2016; Lehti, Maarit/T-3824-2019; Sartor, Maureen/L-2902-2019; Lehti, Maarit/ABB-1812-2021; Ketola, Tarmo/AAD-2609-2019; Kivelä, Riikka/AAD-9636-2020	Kivelä, Riikka/0000-0002-2686-8890; Ketola, Tarmo/0000-0001-5151-7980; Kivelä, Riikka/0000-0002-2686-8890; Silvennoinen, Mika/0000-0002-5389-8251; Lehti, Maarit/0000-0002-9063-6541; Kainulainen, Heikki/0000-0001-5102-4350	LIKES Foundation for Promotion of Sport and Health Sciences; Ministry of Education of Finland; Academy of Finland; National Center for Research Resources of the National Institutes of Health (NIH), U.S. Department of Health and Human Services [RR17718]; NIH [1R01DK077200]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077200] Funding Source: NIH RePORTER	LIKES Foundation for Promotion of Sport and Health Sciences; Ministry of Education of Finland; Academy of Finland(Academy of Finland); National Center for Research Resources of the National Institutes of Health (NIH), U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was financially supported by LIKES Foundation for Promotion of Sport and Health Sciences, the Ministry of Education of Finland, and the Academy of Finland. L.G.K. and S.L.B. were supported by grant RR17718 from the National Center for Research Resources of the National Institutes of Health (NIH), U.S. Department of Health and Human Services. M.A.S. was supported by NIH grant 1R01DK077200. The authors acknowledge the expert care of the LCR/HCR rat colony provided by Lori Gilligan and Nathan Kanner. The authors thank Raija Vassinen, Virpi Miettinen, Veijo Kinnunen, Leena Salminen, and Sira Torvinen for help in the cutting and analysis of EM samples. The authors thank Paavo Niutanen for help with electron micrographs. Microarray experiments were conducted at the Finnish DNA Microarray Center at Turku Center for Biotechnology. The microarray data accession number in GEO is GSE17190.	Andersen JL, 2000, MUSCLE NERVE, V23, P1095; Bray MS, 2009, MED SCI SPORT EXER, V41, P34, DOI 10.1249/MSS.0b013e3181844179; BROOKE MH, 1970, J HISTOCHEM CYTOCHEM, V18, P670, DOI 10.1177/18.9.670; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Glund S, 2007, DIABETES, V56, P1630, DOI 10.2337/db06-1733; HENDRIX LJ, 1982, BIOMETRICS, V38, P641, DOI 10.2307/2530045; Howlett RA, 2003, J APPL PHYSIOL, V94, P1682, DOI 10.1152/japplphysiol.00556.2002; Howlett RA, 2009, J APPL PHYSIOL, V106, P1819, DOI 10.1152/japplphysiol.00914.2007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; Lessard SJ, 2009, ENDOCRINOLOGY, V150, P4883, DOI 10.1210/en.2009-0158; Liu Zhenqi, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P38; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Naples SP, 2010, APPL PHYSIOL NUTR ME, V35, P151, DOI 10.1139/H09-139; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; Novak CM, 2010, HORM BEHAV, V58, P355, DOI 10.1016/j.yhbeh.2010.03.013; Novak CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005869; Packard GC, 1999, COMP BIOCHEM PHYS A, V122, P37, DOI 10.1016/S1095-6433(98)10170-8; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thyfault JP, 2009, J PHYSIOL-LONDON, V587, P1805, DOI 10.1113/jphysiol.2009.169060; Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009; Ways JA, 2002, GENOMICS, V80, P13, DOI 10.1006/geno.2002.6797; Ways JA, 2007, PHYSIOL GENOMICS, V29, P91, DOI 10.1152/physiolgenomics.00027.2006; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Wright DC, 2007, APPL PHYSIOL NUTR ME, V32, P840, DOI 10.1139/H07-062; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167	35	43	43	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2010	24	11					4565	4574		10.1096/fj.10-157313	http://dx.doi.org/10.1096/fj.10-157313			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20643908	Green Published, hybrid			2022-12-25	WOS:000283861100041
J	Mukherjee, A; Soyal, SM; Li, J; Ying, Y; He, B; DeMayo, FJ; Lydon, JP				Mukherjee, Atish; Soyal, Selma M.; Li, Jie; Ying, Yan; He, Bin; DeMayo, Francesco J.; Lydon, John P.			Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression	FASEB JOURNAL			English	Article						progesterone receptor knockout; cell-type specific expression; doxycycline; induction-deinduction; minichromosome maintenance protein	CYCLIN D1 EXPRESSION; NORMAL HUMAN BREAST; GLAND DEVELOPMENT; OSTEOPROTEGERIN-LIGAND; DNA-REPLICATION; TRANSGENIC MICE; PROLIFERATION; ESTROGEN; DIFFERENTIATION; ABNORMALITIES	Despite support for receptor of activated NF-kappa B ligand (RANKL) as a mediator of mammary progesterone action, the extent to which this cytokine can functionally contribute to established progesterone-induced mammary morphogenetic responses in the absence of other presumptive effectors is still unclear. To address this uncertainty, we developed an innovative bigenic system for the doxycycline-inducible expression of RANKL in the mammary epithelium of the progesterone receptor knockout (PRKO) mouse. In response to acute doxycycline exposure, RANKL is specifically expressed in the estrogen receptor alpha (ER) positive/progesterone receptor negative (ER+/PR-) cell type in the PRKO mammary epithelium, a cell type that is equivalent to the ER+/PR+ cell type in the wild-type (WT) mammary epithelium. Notably, the ER+/PR+ mammary cell normally expresses RANKL in the WT mammary epithelium during pregnancy. In this PRKO bigenic system, acute doxycycline-induced expression of RANKL results in ordered mammary ductal side branching and alveologenesis, morphological changes that normally occur in the parous WT mouse. This mammary epithelial expansion is accompanied by significant RANKL-induced luminal epithelial proliferation, which is driven, in part, by indirect induction of cyclin D1. Collectively, our findings support the conclusion that RANKL represents a critical mediator of mammary PR action and that restricted expression of this effector to the ER+/PR+ mammary cell-type is necessary for a spatially ordered morphogenetic response to progesterone.-Mukherjee, A., Soyal, S. M., Li, J., Ying, Y., He, B., DeMayo, F. J., Lydon, J. P. Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. FASEB J. 24, 4408-4419 (2010). www.fasebj.org	[Mukherjee, Atish; Soyal, Selma M.; Li, Jie; Ying, Yan; He, Bin; DeMayo, Francesco J.; Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Lydon, JP (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Rm 733A,1 Baylor Plaza, Houston, TX 77030 USA.	jlydon@bcm.tmc.edu	DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336	U.S. National Institutes of Health [CA077530]; NATIONAL CANCER INSTITUTE [R29CA077530, R01CA077530] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Jie Han for her technical expertise, and the Darwin Transgenic Core Facility, Baylor College of Medicine, for its DNA microinjection services. The authors also thank Dr. Daniel Medina (Baylor College of Medicine) for his expertise in mammary histopathology. The authors are grateful to Dr. Lewis A. Chodosh (Department of Cancer Biology, Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, PA, USA) for providing the p-Tet-Splice cloning vector, as well as for the transgenic MTB and TZA reporter mouse. This research was funded by U.S. National Institutes of Health grant CA077530 (to J.P.L.).	Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Aupperlee MD, 2007, ENDOCRINOLOGY, V148, P2290, DOI 10.1210/en.2006-1721; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; BRANSTETTER D, 2008, SAN ANT BREAST CANC; Brisken C, 2000, GENE DEV, V14, P650; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Clarke RB, 1997, CANCER RES, V57, P4987; Davies CR, 2006, PROTEOMICS, V6, P5694, DOI 10.1002/pmic.200600202; Endl E, 2001, J PATHOL, V195, P457, DOI 10.1002/path.978; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fernandez-Valdivia R, 2008, ENDOCRINOLOGY, V149, P6236, DOI 10.1210/en.2008-0768; Fernandez-Valdivia R, 2009, DEV BIOL, V328, P127, DOI 10.1016/j.ydbio.2009.01.019; Gonzalez-Suarez E, 2007, MOL CELL BIOL, V27, P1442, DOI 10.1128/MCB.01298-06; Graham JD, 2009, ENDOCRINOLOGY, V150, P3318, DOI 10.1210/en.2008-1630; Grimm SL, 2002, MOL ENDOCRINOL, V16, P2675, DOI 10.1210/me.2002-0239; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Ha SA, 2004, CLIN CANCER RES, V10, P8386, DOI 10.1158/1078-0432.CCR-04-1029; Ismail PM, 2004, J ENDOCRINOL, V180, P287, DOI 10.1677/joe.0.1800287; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kim HJ, 2002, J BIOL CHEM, V277, P5339, DOI 10.1074/jbc.M108342200; Kim NS, 2006, MOL CELL BIOL, V26, P1002, DOI 10.1128/MCB.26.3.1002-1013.2006; Lydon JP, 2009, ENDOCRINOLOGY, V150, P2988, DOI 10.1210/en.2009-0383; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; MADINE MA, 1995, NATURE, V375, P421, DOI 10.1038/375421a0; Mukherjee A, 2007, GENESIS, V45, P639, DOI 10.1002/dvg.20336; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; Pan HY, 2006, P NATL ACAD SCI USA, V103, P14021, DOI 10.1073/pnas.0601271103; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; Rosen Jeffrey M, 2003, Breast Dis, V18, P3; Russo J, 1999, BREAST CANCER RES TR, V53, P217, DOI 10.1023/A:1006186719322; Said TK, 1997, ENDOCRINOLOGY, V138, P3933, DOI 10.1210/en.138.9.3933; Satoh K, 2007, ONCOGENE, V26, P7526, DOI 10.1038/sj.onc.1210555; Seagroves TN, 2000, MOL ENDOCRINOL, V14, P359, DOI 10.1210/me.14.3.359; Shyamala G, 2000, P NATL ACAD SCI USA, V97, P3044, DOI 10.1073/pnas.97.7.3044; Shyamala G, 1998, P NATL ACAD SCI USA, V95, P696, DOI 10.1073/pnas.95.2.696; Soling A, 2005, CLIN CANCER RES, V11, P249; Srivastava S, 2003, J BIOL CHEM, V278, P46171, DOI 10.1074/jbc.M308545200; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Walsh MC, 2003, CYTOKINE GROWTH F R, V14, P251, DOI 10.1016/S1359-6101(03)00027-3	41	65	66	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2010	24	11					4408	4419		10.1096/fj.10-157982	http://dx.doi.org/10.1096/fj.10-157982			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20605949	Green Published			2022-12-25	WOS:000283861100027
J	Sisquella, X; de Pourcq, K; Alguacil, J; Robles, J; Sanz, F; Anselmetti, D; Imperial, S; Fernandez-Busquets, X				Sisquella, Xavier; de Pourcq, Karel; Alguacil, Javier; Robles, Jordi; Sanz, Fausto; Anselmetti, Dario; Imperial, Santiago; Fernandez-Busquets, Xavier			A single-molecule force spectroscopy nanosensor for the identification of new antibiotics and antimalarials	FASEB JOURNAL			English	Article						malaria; 2-C-methyl-D-erythritol-4-phosphate pathway; 1-deoxy-D-xylulose 5-phosphate synthase; pyruvate; glyceraldehyde-3-phosphate; drug discovery	1-DEOXY-D-XYLULOSE 5-PHOSPHATE SYNTHASE; ESCHERICHIA-COLI; ISOPRENOID BIOSYNTHESIS; THIOREDOXIN CATALYSIS; NONMEVALONATE PATHWAY; ALZHEIMERS-DISEASE; PHOSPHATE-PATHWAY; INHIBITORS; ENZYME; MICROSCOPY	An important goal of nanotechnology is the application of individual molecule handling techniques to the discovery of potential new therapeutic agents. Of particular interest is the search for new inhibitors of metabolic routes exclusive of human pathogens, such as the 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway essential for the viability of most human pathogenic bacteria and of the malaria parasite. Using atomic force microscopy single-molecule force spectroscopy (SMFS), we have probed at the single-molecule level the interaction of 1-deoxy-D-xylulose 5-phosphate synthase (DXS), which catalyzes the first step of the MEP pathway, with its two substrates, pyruvate and glyceraldehyde-3-phosphate. The data obtained in this pioneering SMFS analysis of a bisubstrate enzymatic reaction illustrate the substrate sequentiality in DXS activity and allow for the calculation of catalytic parameters with single-molecule resolution. The DXS inhibitor fluoropyruvate has been detected in our SMFS competition experiments at a concentration of 10 mu M, improving by 2 orders of magnitude the sensitivity of conventional enzyme activity assays. The binding of DXS to pyruvate is a 2-step process with dissociation constants of k(off) = 6.1 x 10(-4) +/- 7.5 x 10(-3) and 1.3 x 10(-2) +/- 1.0 x 10(-2) s(-1), and reaction lengths of x(beta) = 3.98 +/- 0.33 and 0.52 +/- 0.23 angstrom. These results constitute the first quantitative report on the use of nanotechnology for the biodiscovery of new antimalarial enzyme inhibitors and open the field for the identification of compounds represented only by a few dozens of molecules in the sensor chamber.-Sisquella, X., de Pourcq, K., Alguacil, J., Robles, J., Sanz, F., Anselmetti, D., Imperial, S., Fernandez-Busquets, X. A single-molecule force spectroscopy nanosensor for the identification of new antibiotics and antimalarials. FASEB J. 24, 4203-4217 (2010). www.fasebj.org	[Fernandez-Busquets, Xavier] Inst Bioengn Catalonia, Nanobioengn Grp, E-08028 Barcelona, Spain; [Sisquella, Xavier] Barcelona Sci Pk, Nanotechnol Platform, Barcelona, Spain; [Imperial, Santiago] Univ Barcelona, Dept Biochem & Mol Biol, Nanosci & Nanotechnol Inst, Barcelona, Spain; [Alguacil, Javier; Robles, Jordi] Univ Barcelona, Dept Organ Chem, Nanosci & Nanotechnol Inst, Barcelona, Spain; [Sanz, Fausto] Univ Barcelona, Dept Phys Chem, Nanosci & Nanotechnol Inst, Barcelona, Spain; [Imperial, Santiago; Fernandez-Busquets, Xavier] Univ Barcelona, Biomol Interact Team, Nanosci & Nanotechnol Inst, Barcelona, Spain; [Anselmetti, Dario] Univ Bielefeld, Bielefeld, Germany	Barcelona Institute of Science & Technology; Catalan Institute of Nanoscience & Nanotechnology (ICN2); Institut de Bioenginyeria de Catalunya; University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; University of Bielefeld	Fernandez-Busquets, X (corresponding author), Inst Bioengn Catalonia, Nanobioengn Grp, Baldiri Reixac 10-12, E-08028 Barcelona, Spain.	xfernandez_busquets@ub.edu	Robles, Jordi/K-6653-2014; imperial, santiago/K-4963-2017; Anselmetti, Dario/F-1664-2011; Fernàndez-Busquets, Xavier/K-1323-2014	Robles, Jordi/0000-0002-8583-4930; imperial, santiago/0000-0001-8749-1428; Anselmetti, Dario/0000-0002-8720-4369; Fernàndez-Busquets, Xavier/0000-0002-4622-9631; Alguacil, Javier/0000-0002-5681-0323	Ministerio de Ciencia e Innovacion, Spain [BIO2002-00128, BIO2002-04419-C02-02, BIO2005-01591, BIO2008-01184, CSD2007-00036, CSD2006-00012]; Generalitat de Catalunya, Spain [2009SGR-760, 2009SGR-0026, 2005SGR-00914]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya, Spain(Generalitat de Catalunya)	This work was supported by grants BIO2002-00128, BIO2002-04419-C02-02, BIO2005-01591, BIO2008-01184, CSD2007-00036, and CSD2006-00012 from the Ministerio de Ciencia e Innovacion, Spain, which included FEDER funds, and by grants 2009SGR-760, 2009SGR-0026, and 2005SGR-00914 from the Generalitat de Catalunya, Spain. We thank the Nanotechnology Platform of the Barcelona Scientific Park and Marta Taules (Scientific and Technical Services of the University of Barcelona) for technical assistance.	Allen S, 1997, BIOCHEMISTRY-US, V36, P7457, DOI 10.1021/bi962531z; Altincicek B, 2000, FEMS MICROBIOL LETT, V190, P329, DOI 10.1111/j.1574-6968.2000.tb09307.x; Anselmetti D., 2000, Single Molecules, V1, P53, DOI 10.1002/(SICI)1438-5171(200004)1:1<53::AID-SIMO53>3.0.CO;2-U; Bartels FW, 2003, J STRUCT BIOL, V143, P145, DOI 10.1016/S1047-8477(03)00127-8; BEYTIA ED, 1976, ANNU REV BIOCHEM, V45, P113, DOI 10.1146/annurev.bi.45.070176.000553; Bizzarri AR, 2010, CHEM SOC REV, V39, P734, DOI 10.1039/b811426a; Bonanni B, 2006, J PHYS CHEM B, V110, P14574, DOI 10.1021/jp0610315; Borrmann S, 2006, ANTIMICROB AGENTS CH, V50, P2713, DOI 10.1128/AAC.00392-06; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustamante C, 2000, NAT REV MOL CELL BIO, V1, P130, DOI 10.1038/35040072; Eckel R, 2005, ANGEW CHEM INT EDIT, V44, P3921, DOI 10.1002/anie.200500152; Eisenreich W, 2001, TRENDS PLANT SCI, V6, P78, DOI 10.1016/S1360-1385(00)01812-4; Eubanks LM, 2003, BIOCHEMISTRY-US, V42, P1140, DOI 10.1021/bi0205303; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; FINBERG JPM, 1995, ACTA PSYCHIAT SCAND, V91, P8, DOI 10.1111/j.1600-0447.1995.tb05918.x; Fiorini M, 2001, BIOPHYS J, V80, P2471, DOI 10.1016/S0006-3495(01)76215-7; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Frey BL, 1996, ANAL CHEM, V68, P3187, DOI 10.1021/ac9605861; Frisoni GB, 2001, J NEUROL, V248, P551, DOI 10.1007/s004150170131; Funari G, 2010, J MOL RECOGNIT, V23, P343, DOI 10.1002/jmr.999; Garcia-Manyes S, 2006, J BIOL CHEM, V281, P5992, DOI 10.1074/jbc.M507878200; Ghosh AK, 2002, CURR MED CHEM, V9, P1135, DOI 10.2174/0929867023370149; Green JBD, 1999, APPL PHYS LETT, V74, P1489, DOI 10.1063/1.123590; HEGNER M, 1993, SURF SCI, V291, P39, DOI 10.1016/0039-6028(93)91474-4; Hibbert H, 1929, J AM CHEM SOC, V51, P3115, DOI 10.1021/ja01385a034; Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477; Hoeffler JF, 2002, EUR J BIOCHEM, V269, P4446, DOI 10.1046/j.1432-1033.2002.03150.x; Jain KK, 2005, DRUG DISCOV TODAY, V10, P1435, DOI 10.1016/S1359-6446(05)03573-7; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kamper SG, 2007, LANGMUIR, V23, P12561, DOI 10.1021/la702148v; Kaubisch A, 2000, CANCER J, V6, P192; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Kuhner F, 2004, BIOPHYS J, V87, P2683, DOI 10.1529/biophysj.104.048968; Lebon F, 2000, CURR MED CHEM, V7, P455, DOI 10.2174/0929867003375146; Lois LM, 1998, P NATL ACAD SCI USA, V95, P2105, DOI 10.1073/pnas.95.5.2105; LYUBCHENKO Y, 1993, P NATL ACAD SCI USA, V90, P2137, DOI 10.1073/pnas.90.6.2137; Maki T, 2007, LANGMUIR, V23, P2668, DOI 10.1021/la0627011; Mao JL, 2008, BIOORG MED CHEM LETT, V18, P5320, DOI 10.1016/j.bmcl.2008.08.034; Mathijssen RHJ, 2002, CURR CANCER DRUG TAR, V2, P103, DOI 10.2174/1568009023333890; Meadows PY, 2003, LANGMUIR, V19, P9566, DOI 10.1021/la035217w; Menard J, 2001, ADV PROTEIN CHEM, V56, P13; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; Moghadasian MH, 1999, LIFE SCI, V65, P1329, DOI 10.1016/S0024-3205(99)00199-X; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; Nair V, 2002, REV MED VIROL, V12, P179, DOI 10.1002/rmv.350; Neuert G, 2006, FEBS LETT, V580, P505, DOI 10.1016/j.febslet.2005.12.052; OLANOW CW, 1993, ADV NEUROL, V60, P666; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Perez-Jimenez R, 2009, NAT STRUCT MOL BIOL, V16, P890, DOI 10.1038/nsmb.1627; Porter-Peden L, 2008, LANGMUIR, V24, P11556, DOI 10.1021/la801477a; Prendergast GC, 2000, SEMIN CANCER BIOL, V10, P443, DOI 10.1006/scbi.2000.0335; Querol J, 2001, BIOCHEM BIOPH RES CO, V289, P155, DOI 10.1006/bbrc.2001.5957; Ralph SA, 2001, DRUG RESIST UPDATE, V4, P145, DOI 10.1054/drup.2001.0205; Rico F, 2007, J MOL RECOGNIT, V20, P495, DOI 10.1002/jmr.841; Rief M, 2002, CHEMPHYSCHEM, V3, P255, DOI 10.1002/1439-7641(20020315)3:3<255::AID-CPHC255>3.0.CO;2-M; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; Rohdich F, 2001, CURR OPIN CHEM BIOL, V5, P535, DOI 10.1016/S1367-5931(00)00240-4; Santos-Magalhaes NS, 2010, ADV DRUG DELIVER REV, V62, P560, DOI 10.1016/j.addr.2009.11.024; Sauret-Gueto S, 2006, FEBS LETT, V580, P736, DOI 10.1016/j.febslet.2005.12.092; Schmidt D, 1999, CLIN EXP ALLERGY, V29, P99; Schurmann M, 2002, J MOL CATAL B-ENZYM, V19, P247, DOI 10.1016/S1381-1177(02)00174-1; Schurmann M., 2001, THESIS U DUSSELDORF; Schwesinger F, 2000, P NATL ACAD SCI USA, V97, P9972, DOI 10.1073/pnas.97.18.9972; Simpson ER, 2002, RECENT PROG HORM RES, V57, P317, DOI 10.1210/rp.57.1.317; Sletmoen M, 2005, CARBOHYD RES, V340, P2782, DOI 10.1016/j.carres.2005.09.020; Sodhi RNS, 2004, ANALYST, V129, P483, DOI 10.1039/b402607c; Takahashi S, 1998, P NATL ACAD SCI USA, V95, P9879, DOI 10.1073/pnas.95.17.9879; Taranta M, 2008, J MOL RECOGNIT, V21, P63, DOI 10.1002/jmr.869; Thomas T, 2000, NEUROBIOL AGING, V21, P343, DOI 10.1016/S0197-4580(00)00100-7; Vane JR, 1998, INFLAMM RES, V47, pS77; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Wiesner J, 2003, PARASITOL RES, V90, pS71, DOI 10.1007/s00436-002-0770-9; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Wilkinson TA, 2000, J PEPT RES, V55, P140, DOI 10.1034/j.1399-3011.2000.00164.x; Xiang S, 2007, J BIOL CHEM, V282, P2676, DOI 10.1074/jbc.M610235200; Yingge Z, 2001, J PHARMACOL EXP THER, V297, P798; Zlatanova J, 2000, PROG BIOPHYS MOL BIO, V74, P37, DOI 10.1016/S0079-6107(00)00014-6	78	23	23	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4203	4217		10.1096/fj.10-155507	http://dx.doi.org/10.1096/fj.10-155507			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20634351	Bronze			2022-12-25	WOS:000283861100009
J	Borompokas, N; Papachatzaki, MM; Kanavouras, K; Mastorodemos, V; Zaganas, I; Spanaki, C; Plaitakis, A				Borompokas, Nikolas; Papachatzaki, Maria-Martha; Kanavouras, Konstantinos; Mastorodemos, Vasileios; Zaganas, Ioannis; Spanaki, Cleanthe; Plaitakis, Andreas			Estrogen Modification of Human Glutamate Dehydrogenases Is Linked to Enzyme Activation State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; BASAL ACTIVITY; GLUD2; GENE; MECHANISMS; NEURONS; DIETHYLSTILBESTROL; MITOCHONDRIA; ASTROCYTES; MUTATIONS	Mammalian glutamate dehydrogenase (GDH) is a housekeeping enzyme central to the metabolism of glutamate. Its activity is potently inhibited by GTP (IC50 = 0.1-0.3 mu M) and thought to be controlled by the need of the cell in ATP. Estrogens are also known to inhibit mammalian GDH, but at relatively high concentrations. Because, in addition to this housekeeping human (h) GDH1, humans have acquired via a duplication event an hGDH2 isoform expressed in human cortical astrocytes, we tested here the interaction of estrogens with the two human isoenzymes. The results showed that, under base-line conditions, diethylstilbestrol potently inhibited hGDH2 (IC50 = 0.08 +/- 0.01 mu M) and with similar to 18-fold lower affinity hGDH1 (IC50 = 1.67 +/- 0.06 mu M; p < 0.001). Similarly, 17 beta-estradiol showed a similar to 18-fold higher affinity for hGDH2 (IC50 = 1.53 +/- 0.24 mu M) than for hGDH1 (IC50 = 26.94 +/- 1.07 mu M; p < 0.001). Also, estriol and progesterone were more potent inhibitors of hGDH2 than hGDH1. Structure/function analyses revealed that the evolutionary R443S substitution, which confers low basal activity, was largely responsible for sensitivity of hGDH2 to estrogens. Inhibition of both human GDHs by estrogens was inversely related to their state of activation induced by ADP, with the slope of this correlation being steeper for hGDH2 than for hGDH1. Also, the study of hGDH1 and hGDH2 mutants displaying different states of activation revealed that the affinity of estrogen for these enzymes correlated inversely (R = 0.99; p = 0.0001) with basal catalytic activity. Because astrocytes are known to synthesize estrogens, these hormones, by interacting potently with hGDH2 in its closed state, may contribute to regulation of glutamate metabolism in brain.	[Borompokas, Nikolas; Papachatzaki, Maria-Martha; Kanavouras, Konstantinos; Mastorodemos, Vasileios; Zaganas, Ioannis; Spanaki, Cleanthe; Plaitakis, Andreas] Univ Crete, Neurol Lab, Sch Hlth Sci, Fac Med, Iraklion 71003, Crete, Greece	University of Crete	Plaitakis, A (corresponding author), Univ Crete, Neurol Lab, Sch Hlth Sci, Fac Med, Iraklion 71003, Crete, Greece.	plaitakis@yahoo.com	Zaganas, Ioannis/AAE-5441-2020; MASTORODIMOS, VASILEIOS/AAK-7838-2021	Zaganas, Ioannis/0000-0002-0774-5772	European Community; Ministry of Development/General Secretariat for Research and Technology [PENED 2003/03ED576]; Association for the Advancement of Research and Treatment of Neurologic Disorders of Crete EY ZHN	European Community(European Commission); Ministry of Development/General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); Association for the Advancement of Research and Treatment of Neurologic Disorders of Crete EY ZHN	This work was supported by European Community and the Ministry of Development/General Secretariat for Research and Technology Contract Grant PENED 2003/03ED576 and by Association for the Advancement of Research and Treatment of Neurologic Disorders of Crete EY ZHN.	Amantea D, 2005, PHARMACOL RES, V52, P119, DOI 10.1016/j.phrs.2005.03.002; Ba F, 2004, NEUROCHEM INT, V45, P31, DOI 10.1016/j.neuint.2003.12.013; Bao XD, 2009, J NEUROSCI, V29, P13929, DOI 10.1523/JNEUROSCI.4413-09.2009; Blutstein T, 2006, J NEUROENDOCRINOL, V18, P692, DOI 10.1111/j.1365-2826.2006.01466.x; Burki F, 2004, NAT GENET, V36, P1061, DOI 10.1038/ng1431; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; HAUKKAMAA M, 1977, CLIN ENDOCRINOL, V7, P111, DOI 10.1111/j.1365-2265.1977.tb01302.x; Hertz L, 1999, J NEUROSCI RES, V57, P417, DOI 10.1002/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.3.CO;2-E; Hill RA, 2009, MOL CELL NEUROSCI, V41, P1, DOI 10.1016/j.mcn.2008.12.009; KALLOS J, 1971, P NATL ACAD SCI USA, V68, P916, DOI 10.1073/pnas.68.5.916; Kanavouras K, 2007, J NEUROSCI RES, V85, P1101, DOI 10.1002/jnr.21197; Kanavouras K, 2009, J NEUROCHEM, V109, P167, DOI 10.1111/j.1471-4159.2009.05914.x; Mastorodemos V, 2009, BIOCHEM CELL BIOL, V87, P505, DOI [10.1139/O09-008, 10.1139/o09-008]; MAVROTHALASSITIS G, 1988, P NATL ACAD SCI USA, V85, P3494, DOI 10.1073/pnas.85.10.3494; MCENERY MW, 1986, J BIOL CHEM, V261, P1745; MCENERY MW, 1989, J BIOL CHEM, V264, P12029; Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200; Peterson PE, 1999, STRUCTURE, V7, P769, DOI 10.1016/S0969-2126(99)80101-4; Plaitakis A, 2000, J NEUROCHEM, V75, P1862, DOI 10.1046/j.1471-4159.2000.0751862.x; Plaitakis A, 2001, J NEUROSCI RES, V66, P899, DOI 10.1002/jnr.10054; Plaitakis A, 2010, EUR J HUM GENET, V18, P336, DOI 10.1038/ejhg.2009.179; PONS M, 1978, EUR J BIOCHEM, V84, P257, DOI 10.1111/j.1432-1033.1978.tb12164.x; Quesada A, 2008, DEV NEUROBIOL, V68, P632, DOI 10.1002/dneu.20609; SHASHIDHARAN P, 1994, J BIOL CHEM, V269, P16971; Simpson E, 1999, ENDOCR-RELAT CANCER, V6, P131, DOI 10.1677/erc.0.0060131; SMITH EL, 1979, P AM PHILOS SOC, V123, P73; Sonnewald U, 1997, GLIA, V21, P56, DOI 10.1002/(SICI)1098-1136(199709)21:1<56::AID-GLIA6>3.0.CO;2-#; Spanaki C, 2010, J BIOL CHEM, V285, P16748, DOI 10.1074/jbc.M109.092999; Stanley CA, 2000, DIABETES, V49, P667, DOI 10.2337/diabetes.49.4.667; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; WARREN JC, 1964, BIOCHEM J, V93, P409, DOI 10.1042/bj0930409; YIELDING KL, 1960, P NATL ACAD SCI USA, V46, P1483, DOI 10.1073/pnas.46.11.1483; Zaganas I, 2002, J BIOL CHEM, V277, P46552, DOI 10.1074/jbc.M208596200; Zaganas I, 2002, J BIOL CHEM, V277, P26422, DOI 10.1074/jbc.M200022200; Zaganas I, 2009, NEUROCHEM INT, V55, P52, DOI 10.1016/j.neuint.2009.03.001; Zwain IH, 1999, ENDOCRINOLOGY, V140, P3843, DOI 10.1210/en.140.8.3843	38	16	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31380	31387		10.1074/jbc.M110.146084	http://dx.doi.org/10.1074/jbc.M110.146084			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20628048	hybrid, Green Published			2022-12-25	WOS:000282764600032
J	Pancholi, V; Boel, G; Jin, H				Pancholi, Vijay; Boel, Gregory; Jin, Hong			Streptococcus pyogenes Ser/Thr Kinase-regulated Cell Wall Hydrolase Is a Cell Division Plane-recognizing and Chain-forming Virulence Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; RHEUMATIC HEART-DISEASE; GRAM-POSITIVE BACTERIA; BINDING-PROTEIN; SERINE/THREONINE KINASE; FUNCTIONAL-ANALYSIS; RESPONSE REGULATOR; SURFACE-PROTEINS; GENE; IDENTIFICATION	Cell division and cell wall synthesis are closely linked complex phenomena and play a crucial role in the maintenance and regulation of bacterial virulence. Eukaryotic-type Ser/Thr kinases reported in prokaryotes, including that in group A Streptococcus (GAS) (Streptococcus pyogenes Ser/Thr kinase (SP-STK)), regulate cell division, growth, and virulence. The mechanism of this regulation is, however, unknown. In this study, we demonstrated that SP-STK-controlled cell division is mediated under the positive regulation of secretory protein that possesses a cysteine and histidine-dependent aminohydrolases/peptidases (CHAP) domain with functionally active cell wall hydrolase activity (henceforth named as CdhA (CHAP-domain-containing and chain-forming cell wall hydrolase). Deletion of the CdhA-encoding gene resulted in severe cell division and growth defects in GAS mutants. The mutant expressing the truncated CdhA (devoid of the CHAP domain), although displayed no such defects, it became attenuated for virulence in mice and highly susceptible to cell wall-acting antibiotics, as observed for the mutant lacking CdhA. When CdhA was overexpressed in the wild-type GAS as well as in heterologous strains, Escherichia coli and Staphylococcus aureus, we observed a distinct increase in bacterial chain length. Our data reveal that CdhA is a multifunctional protein with a major function of the N-terminal region as a cell division plane-recognizing domain and that of the C-terminal CHAP domain as a virulence-regulating domain. CdhA is thus an important therapeutic target.	[Pancholi, Vijay; Boel, Gregory; Jin, Hong] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Pancholi, V (corresponding author), 420 W 12th Ave,TMRF 288A, Columbus, OH 43210 USA.	vijay.pancholi@osumc.edu	Boel, Gregory/N-4623-2016; Pancholi, Vijay/E-3810-2011	Boel, Gregory/0000-0001-9900-6493; 	National Institutes of Health [AI64912]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI64912 (to V. P.).	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Barendt SM, 2009, J BACTERIOL, V191, P3024, DOI 10.1128/JB.01505-08; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Beltramini AM, 2009, INFECT IMMUN, V77, P1406, DOI 10.1128/IAI.01499-08; Boel G, 2005, INFECT IMMUN, V73, P6237, DOI 10.1128/IAI.73.10.6237-6248.2005; Borges F, 2005, J BACTERIOL, V187, P2737, DOI 10.1128/JB.187.8.2737-2746.2005; Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205; Carapetis JR, 2008, CIRCULATION, V118, P2748, DOI 10.1161/CIRCULATIONAHA.108.774307; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carlsson F, 2006, NATURE, V442, P943, DOI 10.1038/nature05021; Chaffin DO, 1998, GENE, V219, P91, DOI 10.1016/S0378-1119(98)00396-5; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; CONE LA, 1987, NEW ENGL J MED, V317, P146, DOI 10.1056/NEJM198707163170305; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; Fagan PK, 2001, INFECT IMMUN, V69, P4851, DOI 10.1128/IAI.69.8.4851-4857.2001; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; FISCHETTI VA, 2006, GRAM POSITIVE PATHOG, P12; Hoe NP, 2002, P NATL ACAD SCI USA, V99, P7646, DOI 10.1073/pnas.112039899; Humann J, 2009, J INNATE IMMUN, V1, P88, DOI 10.1159/000181181; Ji YD, 1996, INFECT IMMUN, V64, P503, DOI 10.1128/IAI.64.2.503-510.1996; Jin H, 2006, J MOL BIOL, V357, P1351, DOI 10.1016/j.jmb.2006.01.020; Jin H, 2005, J MOL BIOL, V350, P27, DOI 10.1016/j.jmb.2005.04.063; JOHNSON DR, 1992, J INFECT DIS, V166, P374, DOI 10.1093/infdis/166.2.374; JONES KF, 1986, J EXP MED, V164, P1226, DOI 10.1084/jem.164.4.1226; Krause RM, 2002, INDIAN J MED RES, V115, P215; Le Breton Y, 2002, CURR MICROBIOL, V45, P434, DOI 10.1007/s00284-002-3714-3; Lepeuple AS, 1998, APPL ENVIRON MICROB, V64, P4142; Liu MY, 2006, MICROBIOL-SGM, V152, P967, DOI 10.1099/mic.0.28706-0; Lock RL, 2008, NAT REV DRUG DISCOV, V7, P324, DOI 10.1038/nrd2510; Loughman JA, 2007, MOL MICROBIOL, V64, P269, DOI 10.1111/j.1365-2958.2007.05663.x; Loughman JA, 2006, EMBO J, V25, P5414, DOI 10.1038/sj.emboj.7601393; Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Mattos-Graner RO, 2001, INFECT IMMUN, V69, P6931, DOI 10.1128/IAI.69.11.6931-6941.2001; McDonald M, 2004, LANCET INFECT DIS, V4, P240, DOI 10.1016/S1473-3099(04)00975-2; Musser JM, 1998, BIOMED RES REP, P185; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Ng WL, 2004, MOL MICROBIOL, V53, P1161, DOI 10.1111/j.1365-2958.2004.04196.x; Ng WL, 2003, MOL MICROBIOL, V50, P1647, DOI 10.1046/j.1365-2958.2003.03806.x; PANCHOLI V, 2006, GRAM POSITIVE PATHOG, P100; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Reinscheid DJ, 2003, FEMS MICROBIOL LETT, V221, P73, DOI 10.1016/S0378-1097(03)00167-8; Reinscheid DJ, 2001, J BACTERIOL, V183, P1175, DOI 10.1128/JB.183.4.1175-1183.2001; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; Rodriguez-Iturbe B, 2008, J AM SOC NEPHROL, V19, P1855, DOI 10.1681/ASN.2008010092; Rosch JW, 2007, MOL MICROBIOL, V64, P257, DOI 10.1111/j.1365-2958.2007.05667.x; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Saskova L, 2007, J BACTERIOL, V189, P4168, DOI 10.1128/JB.01616-06; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Schubert K, 2000, ARCH MICROBIOL, V173, P21, DOI 10.1007/s002030050003; Scott JR, 2006, ANNU REV MICROBIOL, V60, P397, DOI 10.1146/annurev.micro.60.080805.142256; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Shah IM, 2010, MOL MICROBIOL, V75, P1232, DOI 10.1111/j.1365-2958.2010.07046.x; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Smith DJ, 2003, INFECT IMMUN, V71, P1179, DOI 10.1128/IAI.71.3.1179-1184.2003; Steer AC, 2002, J PAEDIATR CHILD H, V38, P229, DOI 10.1046/j.1440-1754.2002.00772.x; STEVENS DL, 1995, EMERG INFECT DIS, V1, P69, DOI 10.3201/eid0103.950301; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOLLERMAN GH, 1957, J EXP MED, V106, P345, DOI 10.1084/jem.106.3.345; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Teng F, 2003, INFECT IMMUN, V71, P5033, DOI 10.1128/IAI.71.9.5033-5041.2003	67	28	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30861	30874		10.1074/jbc.M110.153825	http://dx.doi.org/10.1074/jbc.M110.153825			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20643653	Green Published, hybrid			2022-12-25	WOS:000282135500053
J	Chen, QF; Westfall, CS; Hicks, LM; Wang, SP; Jez, JM				Chen, Qingfeng; Westfall, Corey S.; Hicks, Leslie M.; Wang, Shiping; Jez, Joseph M.			Kinetic Basis for the Conjugation of Auxin by a GH3 Family Indole-acetic Acid-Amido Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX PROTEIN TIR1; GENE-EXPRESSION; SALICYLIC-ACID; STEADY-STATE; PHYSCOMITRELLA-PATENS; PSEUDOMONAS-SYRINGAE; ARABIDOPSIS-THALIANA; DEFENSE RESPONSES; ESCHERICHIA-COLI; COA SYNTHETASE	The GH3 family of acyl-acid-amido synthetases catalyze the ATP-dependent formation of amino acid conjugates to modulate levels of active plant hormones, including auxins and jasmonates. Initial biochemical studies of various GH3s show that these enzymes group into three families based on sequence relationships and acyl-acid substrate preference (I, jasmonate-conjugating; II, auxin- and salicylic acid-conjugating; III, benzoate-conjugating); however, little is known about the kinetic and chemical mechanisms of these enzymes. Here we use GH3-8 from Oryza sativa (rice; OsGH3-8), which functions as an indoleacetic acid (IAA)-amido synthetase, for detailed mechanistic studies. Steady-state kinetic analysis shows that the OsGH3-8 requires either Mg2+ or Mn2+ for maximal activity and is specific for aspartate but accepts asparagine as a substrate with a 45-fold decrease in catalytic efficiency and accepts other auxin analogs, including phenylacetic acid, indole butyric acid, and naphthaleneacetic acid, as acyl-acid substrates with 1.4-9-fold reductions in k(cat)/K-m relative to IAA. Initial velocity and product inhibition studies indicate that the enzyme uses a Bi Uni Uni Bi Ping Pong reaction sequence. In the first half-reaction, ATP binds first followed by IAA. Next, formation of an adenylated IAA intermediate results in release of pyrophosphate. The second half-reaction begins with binding of aspartate, which reacts with the adenylated intermediate to release IAA-Asp and AMP. Formation of a catalytically competent adenylated-IAA reaction intermediate was confirmed by mass spectrometry. These mechanistic studies provide insight on the reaction catalyzed by the GH3 family of enzymes to modulate plant hormone action.	[Westfall, Corey S.; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Hicks, Leslie M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Washington University (WUSTL); Huazhong Agricultural University; Donald Danforth Plant Science Center	Jez, JM (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu	Hicks, Leslie M/E-8015-2010; chen, qingfeng/J-6844-2017	Hicks, Leslie M/0000-0002-8008-3998; 	Huazhong Agricultural University-Donald Danforth Plant Science Center Joint Laboratory [B07041]; National Natural Science Foundation of China [30930063]	Huazhong Agricultural University-Donald Danforth Plant Science Center Joint Laboratory; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the 111 Program (B07041) for the Huazhong Agricultural University-Donald Danforth Plant Science Center Joint Laboratory. This work was also supported by National Natural Science Foundation of China Grant 30930063 (to S. W.).	ALLENDE CC, 1970, J BIOL CHEM, V245, P93; Bierfreund NM, 2004, J PLANT PHYSIOL, V161, P823, DOI 10.1016/j.jplph.2003.12.010; Black PN, 2000, J BIOL CHEM, V275, P38547, DOI 10.1074/jbc.M006413200; Bovee ML, 2003, BIOCHEMISTRY-US, V42, P15102, DOI 10.1021/bi0355701; Chen QF, 2009, ANAL BIOCHEM, V390, P149, DOI 10.1016/j.ab.2009.04.027; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Domingo C, 2009, MOL PLANT MICROBE IN, V22, P201, DOI 10.1094/MPMI-22-2-0201; Fan F, 2007, BIOCHEMISTRY-US, V46, P11421, DOI 10.1021/bi7011492; HAGEN G, 1984, PLANTA, V162, P147, DOI 10.1007/BF00410211; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; HAGEN G, 1985, MOL CELL BIOL, V5, P1197, DOI 10.1128/MCB.5.6.1197; Jagadeeswaran G, 2007, PLANT J, V51, P234, DOI 10.1111/j.1365-313X.2007.03130.x; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P36, DOI 10.1007/s10142-005-0142-5; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Khan S, 2007, PLANTA, V226, P21, DOI 10.1007/s00425-006-0462-2; Khan S, 2007, PLANT SIGNAL BEHAV, V2, P483, DOI 10.4161/psb.2.6.4498; KIM YS, 1994, BIOCHEM J, V297, P327, DOI 10.1042/bj2970327; Lahey KA, 2004, MOL PLANT MICROBE IN, V17, P1394, DOI 10.1094/MPMI.2004.17.12.1394; LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200; Liu KD, 2005, PLANT MOL BIOL, V58, P447, DOI 10.1007/s11103-005-6505-4; Ljung K, 2002, PLANT MOL BIOL, V50, P309, DOI 10.1023/A:1016024017872; Ludwig-Muller J, 2009, NEW PHYTOL, V181, P323, DOI 10.1111/j.1469-8137.2008.02677.x; Nakazawa M, 2001, PLANT J, V25, P213, DOI 10.1046/j.1365-313x.2001.00957.x; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; Okrent RA, 2009, J BIOL CHEM, V284, P9742, DOI 10.1074/jbc.M806662200; PAPAS TS, 1971, J BIOL CHEM, V246, P5924; Park JE, 2007, PLANT CELL PHYSIOL, V48, P1236, DOI 10.1093/pcp/pcm086; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; PFLEIDERER G, 1960, BIOCHEM Z, V333, P302; Rampey RA, 2004, PLANT PHYSIOL, V135, P978, DOI 10.1104/pp.104.039677; Reddy SM, 2006, NEW PHYTOL, V170, P391, DOI 10.1111/j.1469-8137.2006.01677.x; Roux C, 1997, FEBS LETT, V419, P131, DOI 10.1016/S0014-5793(97)01447-6; Segel IH, 1975, ENZYME KINETICS BEHA; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Takase T, 2004, PLANT J, V37, P471, DOI 10.1046/j.1365-313X.2003.01973.x; Tanaka S, 2002, PLANT CELL PHYSIOL, V43, P281, DOI 10.1093/pcp/pcf033; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Terol J, 2006, GENE, V371, P279, DOI 10.1016/j.gene.2005.12.014; Wang H, 2008, PLANT GROWTH REGUL, V56, P225, DOI 10.1007/s10725-008-9313-4; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Zhang SW, 2009, PLANT PHYSIOL, V151, P1889, DOI 10.1104/pp.109.146803; Zhang ZQ, 2007, PLANT PHYSIOL, V145, P450, DOI 10.1104/pp.107.106021; Zhang ZQ, 2008, PLANT SIGNAL BEHAV, V3, P537, DOI 10.4161/psb.3.8.5748; Zheng RJ, 2001, BIOCHEMISTRY-US, V40, P12904, DOI 10.1021/bi011522+	50	65	67	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29780	29786		10.1074/jbc.M110.146431	http://dx.doi.org/10.1074/jbc.M110.146431			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20639576	Green Published, hybrid			2022-12-25	WOS:000281984300013
J	Okuyama, T; Inoue, H; Ookuma, S; Satoh, T; Kano, K; Honjoh, S; Hisamoto, N; Matsumoto, K; Nishida, E				Okuyama, Tetsuya; Inoue, Hideki; Ookuma, Sadatsugu; Satoh, Takayuki; Kano, Kei; Honjoh, Sakiko; Hisamoto, Naoki; Matsumoto, Kunihiro; Nishida, Eisuke			The ERK-MAPK Pathway Regulates Longevity through SKN-1 and Insulin-like Signaling in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS-RESPONSE; C-ELEGANS; LIFE-SPAN; GENE-EXPRESSION; KINASE; CELLS; DAF-2; MITOGEN; PROTEIN; ACTIVATION	It has not been determined yet whether the ERK-MAPK pathway regulates longevity of metazoans. Here, we show that the Caenorhabditis elegans ERK cascade promotes longevity through the two longevity-promoting transcription factors, SKN-1 and DAF-16. We find that RNAi of three genes, which constitute the ERK cascade (lin-45/RAF1, mek-2/MEK1/2, and mpk-1/ERK1/2), results in reduction of life span. Moreover, RNAi of lip-1, the gene encoding a MAPK phosphatase that inactivates MPK-1, increases life span. Epistasis analyses show that the ERK (MPK-1) cascade-mediated life span extension requires SKN-1, whose function is mediated, at least partly, through DAF-2/DAF-16 insulin-like signaling. MPK-1 phosphorylates SKN-1 on the key sites that are required for SKN-1 nuclear accumulation. Our results also show that one mechanism by which SKN-1 regulates insulin-like signaling is through the regulation of expression of insulin-like peptides. Our findings thus identify a novel ERK-MAPK-mediated signaling pathway that promotes longevity.	[Nishida, Eisuke] Kyoto Univ, Dept Cell & Dev Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Hisamoto, Naoki; Matsumoto, Kunihiro] Nagoya Univ, Dept Mol Biol, Grad Sch Sci, Inst Adv Res,Chikusa Ku, Nagoya, Aichi 4648602, Japan	Kyoto University; Nagoya University	Nishida, E (corresponding author), Kyoto Univ, Dept Cell & Dev Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan.	nishida@lif.kyoto-u.ac.jp		Inoue, Hideki/0000-0002-4301-1936	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institutes of Health NCRR; Grants-in-Aid for Scientific Research [21227004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to E.N.).; C. elegans strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health NCRR. We thank members of the Nishida laboratory for technical comments and helpful discussions.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; BRENNER S, 1974, GENETICS, V77, P71; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fukazawa H, 2002, MOL CANCER THER, V1, P303; Gems D, 1998, GENETICS, V150, P129; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Ikeyama S, 2002, FASEB J, V16, pA1163, DOI 10.1096/fj.01-0409fje; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kuida K, 2004, J BIOCHEM, V135, P653, DOI 10.1093/jb/mvh078; Lackner MR, 1998, GENETICS, V150, P103; LACKNER MR, 1994, GENE DEV, V8, P160, DOI 10.1101/gad.8.2.160; Lee MH, 2006, EMBO J, V25, P88, DOI 10.1038/sj.emboj.7600901; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Madsen MA, 2004, BIOCHEM BIOPH RES CO, V318, P998, DOI 10.1016/j.bbrc.2004.04.126; Manning Gerard, 2005, WormBook, P1; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Sundaram Meera V, 2006, WormBook, P1; Tresini M, 2007, J BIOL CHEM, V282, P4136, DOI 10.1074/jbc.M604955200; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083	38	64	74	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30274	30281		10.1074/jbc.M110.146274	http://dx.doi.org/10.1074/jbc.M110.146274			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20624915	hybrid, Green Published			2022-12-25	WOS:000281984300063
J	Schmid, A; Sutto, Z; Schmid, N; Novak, L; Ivonnet, P; Horvath, G; Conner, G; Fregien, N; Salathe, M				Schmid, Andreas; Sutto, Zoltan; Schmid, Nathalie; Novak, Lisa; Ivonnet, Pedro; Horvath, Gabor; Conner, Gregory; Fregien, Nevis; Salathe, Matthias			Decreased Soluble Adenylyl Cyclase Activity in Cystic Fibrosis Is Related to Defective Apical Bicarbonate Exchange and Affects Ciliary Beat Frequency Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY EPITHELIAL-CELLS; CARBONIC-ANHYDRASE; BRONCHIAL EPITHELIUM; SUBMUCOSAL GLANDS; LIQUID SECRETION; INTRACELLULAR PH; HCO3-TRANSPORT; EXPRESSION; CFTR; MICE	Human airway cilia contain soluble adenylyl cyclase (sAC) that produces cAMP upon HCO3-/CO2 stimulation to increase ciliary beat frequency (CBF). Because apical HCO3-exchange depends on cystic fibrosis transmembrane conductance regulator (CFTR), malfunctioning CFTR might impair sAC-mediated CBF regulation in cells from patients with cystic fibrosis (CF). By Western blot, sAC isoforms are equally expressed in normal and CF airway epithelial cells, but CBF decreased more in CF than normal cells upon increased apical HCO3-/CO2 exposure in part because of greater intracellular acidification from unbalanced CO2 influx (estimated by 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF) fluorescence). Importantly, ciliated cell-specific cAMP production (estimated by FRET fluorescence ratio changes of tagged cAMP-dependent protein kinase (PKA) subunits expressed under a ciliated cell-specific promoter) in response to increased apical HCO3-/CO2 perfusion was higher in normal compared with CF cells. Inhibition of bicarbonate influx via CFTR (CFTR(inh)172) and inhibition of sAC (KH7) and PKA activation (H89) led to larger CBF declines in normal cells, now comparable with changes seen in CF cells. These inhibitors also reduced FRET changes in normal cells to the level of CF cells with the expected exception of H89, which does not prevent dissociation of the fluorescently tagged PKA subunits. Basolateral permeabilization and subsequent perfusion with HCO3-/CO2 rescued CBF and FRET changes in CF cells to the level of normal cells. These results suggest that CBF regulation by sAC-produced cAMP could be impaired in CF, thereby possibly contributing to mucociliary dysfunction in this disease, at least during disease exacerbations when airway acidification is common.	[Schmid, Andreas; Sutto, Zoltan; Schmid, Nathalie; Novak, Lisa; Ivonnet, Pedro; Horvath, Gabor; Conner, Gregory; Salathe, Matthias] Univ Miami, Div Pulm & Crit Care, Miami, FL 33136 USA; [Conner, Gregory; Fregien, Nevis] Univ Miami, Dept Cell Biol & Anat, Miami, FL 33136 USA; [Sutto, Zoltan; Horvath, Gabor] Semmelweis Univ, Dept Resp Med, H-1125 Budapest, Hungary	University of Miami; University of Miami; Semmelweis University	Schmid, A (corresponding author), 1600 NW 10th Ave,RMSB 7051, Miami, FL 33136 USA.	aschmid@med.miami.edu	Conner, Gregory/AAI-1285-2021	Conner, Gregory/0000-0003-2217-2252; Salathe, Matthias/0000-0001-9092-4861	National Institutes of Health [R01 HL89399, HL-60644]; FAMRI; James and Esther King Florida Biomedical Research Program Team Science Project Grant from the State of Florida; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060644, R01HL089399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAMRI; James and Esther King Florida Biomedical Research Program Team Science Project Grant from the State of Florida; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL89399 and HL-60644. This work was also supported by FAMRI and by a James and Esther King Florida Biomedical Research Program Team Science Project Grant from the State of Florida.	Ballard ST, 1999, AM J PHYSIOL-LUNG C, V277, pL694, DOI 10.1152/ajplung.1999.277.4.L694; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Chang MH, 2009, J BIOL CHEM, V284, P28306, DOI 10.1074/jbc.M109.001669; Chen JH, 2009, J BIOL CHEM, V284, P35495, DOI 10.1074/jbc.M109.072678; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DE PALMA M, 2002, METHOD ENZYMOL, V346, P514; Dubin PJ, 2007, AM J PHYSIOL-LUNG C, V292, pL519, DOI 10.1152/ajplung.00312.2006; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Fragoso MA, 2004, J PHYSIOL-LONDON, V561, P183, DOI 10.1113/jphysiol.2004.071548; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; Han H, 2005, J EXP MED, V202, P353, DOI 10.1084/jem.20050778; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; KHURI RN, 1974, PFLUG ARCH EUR J PHY, V349, P295, DOI 10.1007/BF00588415; KJALLQUIST A, 1969, ACTA PHYSIOL SCAND, V76, P485; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Kreindler JL, 2009, AM J PHYSIOL-LUNG C, V296, pL257, DOI 10.1152/ajplung.00344.2007; Leinonen JS, 2004, J HISTOCHEM CYTOCHEM, V52, P1107, DOI 10.1369/jhc.4a6282.2004; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Loriol C, 2008, CELL PHYSIOL BIOCHEM, V22, P15, DOI 10.1159/000149780; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Morse DM, 2001, AM J PHYSIOL-CELL PH, V280, pC1485, DOI 10.1152/ajpcell.2001.280.6.C1485; Nlend MC, 2002, AM J RESP CELL MOL, V27, P436, DOI 10.1165/rcmb.2002-0012OC; Nomura M, 2006, CELL MOTIL CYTOSKEL, V63, P582, DOI 10.1002/cm.20147; Okamura HO, 1996, HISTOCHEM CELL BIOL, V106, P257; Ostrowski LE, 2007, GENE THER, V14, P1492, DOI 10.1038/sj.gt.3302994; Ostrowski LE, 2003, MOL THER, V8, P637, DOI 10.1016/S1525-0016(03)00221-1; Paradiso AM, 2003, J PHYSIOL-LONDON, V548, P203, DOI 10.1113/jphysiol.2002.034447; Reddy M M, 2001, JOP, V2, P212; Reddy MM, 2003, NATURE, V423, P756, DOI 10.1038/nature01694; RIORDAN JR, 1989, SCIENCE, V245, P1066; RUTLAND J, 1981, THORAX, V36, P654, DOI 10.1136/thx.36.9.654; SAHLIN K, 1978, J APPL PHYSIOL, V45, P474, DOI 10.1152/jappl.1978.45.3.474; Salathe M, 1999, J PHYSIOL-LONDON, V520, P851, DOI 10.1111/j.1469-7793.1999.00851.x; SALATHE M, 1993, AM J RESP CELL MOL, V9, P306, DOI 10.1165/ajrcmb/9.3.306; Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253; Schmid A, 2007, J GEN PHYSIOL, V130, P99, DOI 10.1085/jgp.200709784; Schmid A, 2006, J CELL SCI, V119, P4176, DOI 10.1242/jcs.03181; Singh AK, 2000, J PHARMACOL EXP THER, V292, P778; SPICER SS, 1982, J HISTOCHEM CYTOCHEM, V30, P864, DOI 10.1177/30.9.6813372; Steegborn C, 2005, J BIOL CHEM, V280, P31754, DOI 10.1074/jbc.M507144200; Steegborn C, 2005, NAT STRUCT MOL BIOL, V12, P32, DOI 10.1038/nsmb880; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Sun XC, 2003, AM J PHYSIOL-CELL PH, V284, pC1114, DOI 10.1152/ajpcell.00400.2002; Sutto Z, 2004, J PHYSIOL-LONDON, V560, P519, DOI 10.1113/jphysiol.2004.068171; Trout L, 1998, AM J PHYSIOL-LUNG C, V275, pL1095, DOI 10.1152/ajplung.1998.275.6.L1095; Wang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1145, DOI 10.1152/ajpcell.00627.2004; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	54	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29998	30007		10.1074/jbc.M110.113621	http://dx.doi.org/10.1074/jbc.M110.113621			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20639512	Green Published, hybrid			2022-12-25	WOS:000281984300037
J	Garcia-Mata, C; Wang, JW; Gajdanowicz, P; Gonzalez, W; Hills, A; Donald, N; Riedelsberger, J; Amtmann, A; Dreyer, I; Blatt, MR				Garcia-Mata, Carlos; Wang, Jianwen; Gajdanowicz, Pawel; Gonzalez, Wendy; Hills, Adrian; Donald, Naomi; Riedelsberger, Janin; Amtmann, Anna; Dreyer, Ingo; Blatt, Michael R.			A Minimal Cysteine Motif Required to Activate the SKOR K+ Channel of Arabidopsis by the Reactive Oxygen Species H2O2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; VOLTAGE SENSOR; SODIUM INFLUX; XYLEM; IDENTIFICATION; NITROSYLATION; ACCUMULATION; RESPONSES; STRESS; EFFLUX	Reactive oxygen species (ROS) are essential for development and stress signaling in plants. They contribute to plant defense against pathogens, regulate stomatal transpiration, and influence nutrient uptake and partitioning. Although both Ca2+ and K+ channels of plants are known to be affected, virtually nothing is known of the targets for ROS at a molecular level. Here we report that a single cysteine (Cys) residue within the Kv-like SKOR K+ channel of Arabidopsis thaliana is essential for channel sensitivity to the ROS H2O2. We show that H2O2 rapidly enhanced current amplitude and activation kinetics of heterologously expressed SKOR, and the effects were reversed by the reducing agent dithiothreitol (DTT). Both H2O2 and DTT were active at the outer face of the membrane and current enhancement was strongly dependent on membrane depolarization, consistent with a H2O2-sensitive site on the SKOR protein that is exposed to the outside when the channel is in the open conformation. Cys substitutions identified a single residue, Cys(168) located within the S3 alpha-helix of the voltage sensor complex, to be essential for sensitivity to H2O2. The same Cys residue was a primary determinant for current block by covalent Cys S-methioylation with aqueous methanethiosulfonates. These, and additional data identify Cys168 as a critical target for H2O2, and implicate ROS-mediated control of the K+ channel in regulating mineral nutrient partitioning within the plant.	[Amtmann, Anna; Blatt, Michael R.] Univ Glasgow, Fac Biomed & Life Sci Plant Sci, Lab Plant Physiol & Biophys, Glasgow G12 8QQ, Lanark, Scotland; [Wang, Jianwen] Soochow Univ, Sch Pharmaceut Sci, Suzhou 215123, Peoples R China; [Gajdanowicz, Pawel; Riedelsberger, Janin; Dreyer, Ingo] Univ Potsdam, Inst Biochem & Biol, Heisenberg Grp BPMPB, D-14476 Golm, Germany; [Gonzalez, Wendy] Univ Talca, Ctr Bioinformat & Simulac Mol, Talca, Chile	University of Glasgow; Soochow University - China; University of Potsdam; Universidad de Talca	Blatt, MR (corresponding author), Univ Glasgow, Fac Biomed & Life Sci Plant Sci, Lab Plant Physiol & Biophys, Glasgow G12 8QQ, Lanark, Scotland.	m.blatt@bio.gla.ac.uk	Wang, Jian Wen/B-3254-2009; García-Mata, Carlos/AAF-9251-2019; Wang, Jian Wen/AAE-4412-2020; Dreyer, Ingo/N-4747-2014	Wang, Jian Wen/0000-0002-3095-7394; García-Mata, Carlos/0000-0003-4243-0554; Wang, Jian Wen/0000-0002-3095-7394; Dreyer, Ingo/0000-0002-2781-0359; Amtmann, Anna/0000-0001-8533-121X; Riedelsberger, Janin/0000-0002-4687-7495; Blatt, Michael R/0000-0003-1361-4645; Gonzalez, Wendy/0000-0002-7535-6883; Gajdanowicz, Pawel/0000-0003-3075-5992	National Science Foundation of China [30772731]; Heisenberg Fellowship; Deutsche Akademische Austausch Dienst/Consejo Nacional de Investigaciones Cientificas y Tecnicas; Max Planck Research School; Biotechnology and Biological Sciences Research Council [BB/D001528/1]; John Simon Guggenheim Memorial Fellowship; Biotechnology and Biological Sciences Research Council [BB/D006775/1, P12750, BB/C500595/1, BB/F001673/1, BB/F001630/1, BB/H009817/1] Funding Source: researchfish; BBSRC [BB/D001528/1, BB/H009817/1, BB/D006775/1, BB/F001673/1, BB/F001630/1] Funding Source: UKRI	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heisenberg Fellowship(German Research Foundation (DFG)); Deutsche Akademische Austausch Dienst/Consejo Nacional de Investigaciones Cientificas y Tecnicas(Deutscher Akademischer Austausch Dienst (DAAD)Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Max Planck Research School(Max Planck Society); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Simon Guggenheim Memorial Fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Science Foundation of China Grant 30772731 (to J. W.), a Heisenberg Fellowship (to I. D.), Deutsche Akademische Austausch Dienst/Consejo Nacional de Investigaciones Cientificas y Tecnicas Grant "NiaPoc" (to I. D. and W. G.), a Max Planck Research School "Primary Metabolism and Plant Growth" studentship (to J. R.), Biotechnology and Biological Sciences Research Council Grant BB/D001528/1, and a John Simon Guggenheim Memorial Fellowship (to M. R. B.).	AMTMANN A, 2007, PLANT SOLUTE TRANSPO, P99; Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Armengaud P, 2004, PLANT PHYSIOL, V136, P2556, DOI 10.1104/pp.104.046482; Berthomieu P, 2003, EMBO J, V22, P2004, DOI 10.1093/emboj/cdg207; Boursiac Y, 2008, PLANT J, V56, P207, DOI 10.1111/j.1365-313X.2008.03594.x; Coelho SM, 2002, PLANT CELL, V14, P2369, DOI 10.1105/tpc.003285; Cuin TA, 2007, PLANT CELL ENVIRON, V30, P875, DOI 10.1111/j.1365-3040.2007.01674.x; Davenport RJ, 2007, PLANT CELL ENVIRON, V30, P497, DOI 10.1111/j.1365-3040.2007.01637.x; Demidchik V, 2010, J CELL SCI, V123, P1468, DOI 10.1242/jcs.064352; Dreyer I, 2004, BIOPHYS J, V87, P858, DOI 10.1529/biophysj.103.037671; Dreyer I, 2009, TRENDS PLANT SCI, V14, P383, DOI 10.1016/j.tplants.2009.04.001; Essah PA, 2003, PLANT PHYSIOL, V133, P307, DOI 10.1104/pp.103.022178; FOHR KJ, 1993, METHOD ENZYMOL, V221, P149, DOI 10.1016/0076-6879(93)21014-Y; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Gajdanowicz P, 2009, NEW PHYTOL, V182, P380, DOI 10.1111/j.1469-8137.2008.02749.x; Gaymard F, 1998, CELL, V94, P647, DOI 10.1016/S0092-8674(00)81606-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johansson I, 2006, PLANT J, V46, P269, DOI [10.1111/j.1365-313X.2006.02690.x, 10.1111/j.1365-313X.2006.02690.X]; Kaddour R, 2009, CR BIOL, V332, P784, DOI 10.1016/j.crvi.2009.05.003; Kohler B, 2003, PLANT PHYSIOL, V131, P385, DOI 10.1104/pp.016014; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lai HC, 2005, NEURON, V47, P395, DOI 10.1016/j.neuron.2005.06.019; Latorre R, 2003, J GEN PHYSIOL, V122, P459, DOI 10.1085/jgp.200308818; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Maathuis FJM, 2006, J EXP BOT, V57, P1137, DOI 10.1093/jxb/erj001; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pilot G, 2003, PLANT MOL BIOL, V51, P773, DOI 10.1023/A:1022597102282; Riedelsberger J, 2010, MOL PLANT, V3, P236, DOI 10.1093/mp/ssp096; Salsbury FR, 2008, PROTEIN SCI, V17, P299, DOI 10.1110/ps.073096508; Schachtman DP, 2007, ANNU REV PLANT BIOL, V58, P47, DOI 10.1146/annurev.arplant.58.032806.103750; Shabala S, 2010, PLANT J, V61, P839, DOI 10.1111/j.1365-313X.2009.04110.x; Shin R, 2004, P NATL ACAD SCI USA, V101, P8827, DOI 10.1073/pnas.0401707101; Sokolovski S, 2004, PLANT PHYSIOL, V136, P4275, DOI 10.1104/pp.104.050344; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Sunarpi, 2005, PLANT J, V44, P928, DOI 10.1111/j.1365-313X.2005.02595.x; Tang XZ, 2004, PHYS PLASMAS, V11, P171, DOI 10.1063/1.1630574; Tombola F, 2005, NEURON, V48, P719, DOI 10.1016/j.neuron.2005.11.024; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Wang B, 2006, J EXP BOT, V57, P1161, DOI 10.1093/jxb/erj116; Wang PT, 2008, NEW PHYTOL, V178, P703, DOI 10.1111/j.1469-8137.2008.02431.x; Wilkinson S, 2002, PLANT CELL ENVIRON, V25, P195, DOI 10.1046/j.0016-8025.2001.00824.x; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xue T, 2002, J BIOL CHEM, V277, P46233, DOI 10.1074/jbc.M204915200	46	93	96	0	39	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29286	29294		10.1074/jbc.M110.141176	http://dx.doi.org/10.1074/jbc.M110.141176			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20605786	Green Published, hybrid			2022-12-25	WOS:000281740100031
J	Joseph, PRB; Sarmiento, JM; Mishra, AK; Das, ST; Garofalo, RP; Navarro, J; Rajarathnam, K				Joseph, Prem Raj B.; Sarmiento, Jose M.; Mishra, Anurag K.; Das, Sandhya T.; Garofalo, Roberto P.; Navarro, Javier; Rajarathnam, Krishna			Probing the Role of CXC Motif in Chemokine CXCL8 for High Affinity Binding and Activation of CXCR1 and CXCR2 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; IMPROVED SENSITIVITY; LIGAND SELECTIVITY; STRUCTURAL BASIS; CC-CHEMOKINE; FACTOR-I; INTERLEUKIN-8; DIMER; MONOMER; OLIGOMERIZATION	All chemokines share a common structural scaffold that mediate a remarkable variety of functions from immune surveillance to organogenesis. Chemokines are classified as CXC or CC on the basis of conserved cysteines, and the two subclasses bind distinct sets of GPCR class of receptors and also have markedly different quaternary structures, suggesting that the CXC/CC motif plays a prominent role in both structure and function. For both classes, receptor activation involves interactions between chemokine N-loop and receptor N-domain residues (Site-I), and between chemokine N-terminal and receptor extracellular/transmembrane residues (Site-II). We engineered a CC variant (labeled as CC-CXCL8) of the chemokine CXCL8 by deleting residue X (CXC -> CC), and found its structure is essentially similar to WT. In stark contrast, CC-CXCL8 bound poorly to its cognate receptors CXCR1 and CXCR2 (K-i > 1 mu M). Further, CC-CXCL8 failed to mobilize Ca2+ in CXCR2-expressing HL-60 cells or recruit neutrophils in a mouse lung model. However, most interestingly, CC-CXCL8 mobilizes Ca2+ in neutrophils and in CXCR1-expressing HL-60 cells. Compared with the WT, CC-CXCL8 binds CXCR1 N-domain with only similar to 5-fold lower affinity indicating that the weak binding to intact CXCR1 must be due to its weak binding at Site-II. Nevertheless, this level of binding is sufficient for receptor activation indicating that affinity and activity are separable functions. We propose that the CXC motif functions as a conformational switch that couples Site-I and Site-II interactions for both receptors, and that this coupling is critical for high affinity binding but differentially regulates activation.	[Rajarathnam, Krishna] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Sarmiento, Jose M.; Navarro, Javier] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Garofalo, Roberto P.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Garofalo, Roberto P.; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Navarro, Javier; Rajarathnam, Krishna] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Rajarathnam, K (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	krrajara@utmb.edu	DAS, SANDHYA/I-1763-2018; Garofalo, Roberto P./AAF-7385-2022; Garofalo, Roberto P./ABL-2322-2022	Navarro, Javier/0000-0001-7098-4373	National Institutes of Health [R01AI069152]; John Sealy Endowment Fund [R01GM081798]; McLaughlin Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Sealy Endowment Fund; McLaughlin Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI069152, the John Sealy Endowment Fund (to K. R.), R01GM081798 (to J. N.), and a McLaughlin Fellowship (to S. T. D.). J. M. S. is on leave from the Instituto de Fisiologia, Universidad Austral de Chile, Valdivia, Chile.	Ahuja SK, 1996, J BIOL CHEM, V271, P225, DOI 10.1074/jbc.271.1.225; BALDWIN ET, 1991, P NATL ACAD SCI USA, V88, P502, DOI 10.1073/pnas.88.2.502; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; BURROWS SD, 1994, BIOCHEMISTRY-US, V33, P12741, DOI 10.1021/bi00209a002; Case D, 2006, AMBER 9; CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Das ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011754; DELANO WL, 2002, PYMOL USERS MANUAL D; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Fernando H, 2007, FEBS J, V274, P241, DOI 10.1111/j.1742-4658.2006.05579.x; Frevert CW, 2003, AM J RESP CELL MOL, V28, P464, DOI 10.1165/rcmb.2002-0084OC; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; Jin HJ, 2007, J BIOL CHEM, V282, P27976, DOI 10.1074/jbc.M702654200; Kagiampakis I, 2008, BIOCHEMISTRY-US, V47, P10637, DOI 10.1021/bi702288a; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Lee MC, 2005, BIOPHYS J, V88, P3133, DOI 10.1529/biophysj.104.058446; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Lowman HB, 1997, PROTEIN SCI, V6, P598; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Rajagopalan L, 2004, J BIOL CHEM, V279, P30000, DOI 10.1074/jbc.M313883200; Rajagopalan L, 2007, BIOPHYS J, V93, P2129, DOI 10.1529/biophysj.107.108761; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; RAJARATHNAM K, 1995, BIOCHEMISTRY-US, V34, P12983, DOI 10.1021/bi00040a008; Rajarathnam K, 1999, BIOCHEMISTRY-US, V38, P7653, DOI 10.1021/bi990033v; Rajarathnam K, 2001, J BIOL CHEM, V276, P4909, DOI 10.1074/jbc.M005085200; Rajarathnam K, 2006, BIOCHEMISTRY-US, V45, P7882, DOI 10.1021/bi0605944; Ravindran A, 2009, BIOCHEMISTRY-US, V48, P8795, DOI 10.1021/bi901194p; Suetomi K, 1999, J BIOL CHEM, V274, P11768, DOI 10.1074/jbc.274.17.11768; Swaminathan GJ, 2003, STRUCTURE, V11, P521, DOI 10.1016/S0969-2126(03)00070-4; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095; Xanthou G, 2003, EUR J IMMUNOL, V33, P2927, DOI 10.1002/eji.200324235; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	42	35	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29262	29269		10.1074/jbc.M110.146555	http://dx.doi.org/10.1074/jbc.M110.146555			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20630874	hybrid, Green Published			2022-12-25	WOS:000281740100028
J	Cooke, A; Prigge, A; Wickens, M				Cooke, Amy; Prigge, Andrew; Wickens, Marvin			Translational Repression by Deadenylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DEADENYLATION; CCR4-NOT COMPLEX; TRANSCRIPTION FACTOR; MEIOTIC MATURATION; CAF1 PROTEINS; IN-VITRO; YEAST; INITIATION; DEGRADATION; POLYMERASE	The CCR4-CAF1-NOT complex is a major cytoplasmic deadenylation complex in yeast and mammals. This complex associates with RNA-binding proteins and microRNAs to repress translation of target mRNAs. We sought to determine how CCR4 and CAF1 participate in repression and control of maternal mRNAs using Xenopus laevis oocytes. We show that Xenopus CCR4 and CAF1 enzymes are active deadenylases and repress translation of an adenylated mRNA. CAF1 also represses translation independent of deadenylation. The deadenylation-independent repression requires a 5' cap structure on the mRNA; however, deadenylation does not. We suggest that mere recruitment of CAF1 is sufficient for repression, independent of deadenylation.	[Cooke, Amy; Prigge, Andrew; Wickens, Marvin] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Cooke, Amy] Univ Wisconsin, Cellular & Mol Biol Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wickens, M (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	wickens@biochem.wisc.edu		Prigge, Andrew/0000-0003-4454-5152	National Institutes of Health [GM31892, GM50942]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031892, R01GM031892, R01GM050942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31892 and GM50942 (to M. W.). This work was also supported by an National Institutes of Health Molecular Biosciences Training Grant (to A. C.).	Barkoff AF, 2000, DEV BIOL, V220, P97, DOI 10.1006/dbio.2000.9613; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Beilharz TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006783; Berthet C, 2004, MOL CELL BIOL, V24, P5808, DOI 10.1128/MCB.24.13.5808-5820.2004; Bianchin C, 2005, RNA, V11, P487, DOI 10.1261/rna.7135305; Chen JJ, 2001, J MOL BIOL, V314, P683, DOI 10.1006/jmbi.2001.5162; Chritton JJ, 2010, RNA, V16, P1217, DOI 10.1261/rna.2070110; Daugeron MC, 2001, NUCLEIC ACIDS RES, V29, P2448, DOI 10.1093/nar/29.12.2448; Denis CL, 2003, PROG NUCLEIC ACID RE, V73, P221, DOI 10.1016/S0079-6603(03)01007-9; Dickson KS, 2001, J BIOL CHEM, V276, P41810, DOI 10.1074/jbc.M103030200; Dlakic M, 2000, TRENDS BIOCHEM SCI, V25, P272, DOI 10.1016/S0968-0004(00)01582-6; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Finoux AL, 2006, J BIOL CHEM, V281, P25940, DOI 10.1074/jbc.M600132200; FOX CA, 1989, GENE DEV, V3, P2151, DOI 10.1101/gad.3.12b.2151; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Gorgoni B, 2005, RNA, V11, P1030, DOI 10.1261/rna.7281305; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Hook BA, 2007, J BIOL CHEM, V282, P15430, DOI 10.1074/jbc.M611253200; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Kwak JE, 2004, P NATL ACAD SCI USA, V101, P4407, DOI 10.1073/pnas.0400779101; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Minshall N, 2007, J BIOL CHEM, V282, P37389, DOI 10.1074/jbc.M704629200; Molin L, 2005, GENE, V358, P73, DOI 10.1016/j.gene.2005.05.023; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Morita M, 2007, MOL CELL BIOL, V27, P4980, DOI 10.1128/MCB.02304-06; Morris JZ, 2005, DEVELOPMENT, V132, P1165, DOI 10.1242/dev.01672; Nakamura T, 2004, NAT GENET, V36, P528, DOI 10.1038/ng1344; Omer AD, 2009, MOL CELL, V35, P739, DOI 10.1016/j.molcel.2009.09.003; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Piao XH, 2010, MOL CELL BIOL, V30, P1486, DOI 10.1128/MCB.01481-09; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Semotok JL, 2005, CURR BIOL, V15, P284, DOI 10.1016/j.cub.2005.01.048; Standart N, 2007, GENE DEV, V21, P1975, DOI 10.1101/gad.1591507; Suzuki A, 2010, P NATL ACAD SCI USA, V107, P3594, DOI 10.1073/pnas.0908664107; Temme C, 2004, EMBO J, V23, P2862, DOI 10.1038/sj.emboj.7600273; Thompson SR, 2000, MOL CELL BIOL, V20, P2129, DOI 10.1128/MCB.20.6.2129-2137.2000; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Viswanathan P, 2004, J BIOL CHEM, V279, P23988, DOI 10.1074/jbc.M402803200; Wagner E, 2007, MOL CELL BIOL, V27, P1686, DOI 10.1128/MCB.01483-06; Wakiyama M, 2010, PROG MOL SUBCELL BIO, V50, P85, DOI 10.1007/978-3-642-03103-8_6; Westmoreland TJ, 2004, EUKARYOT CELL, V3, P430, DOI 10.1128/EC.3.2.430-446.2004; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wickens M, 2000, COLD SPRING HARBOR M, V39, P295; Wickens M, 2003, SCIENCE, V300, P753, DOI 10.1126/science.1084512; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	53	92	97	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28506	28513		10.1074/jbc.M110.150763	http://dx.doi.org/10.1074/jbc.M110.150763			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20634287	Green Published, hybrid			2022-12-25	WOS:000281594000014
J	Gauthier, K; Billon, C; Bissler, M; Beylot, M; Lobaccaro, JM; Vanacker, JM; Samarut, J				Gauthier, Karine; Billon, Cyrielle; Bissler, Marie; Beylot, Michel; Lobaccaro, Jean-Marc; Vanacker, Jean-Marc; Samarut, Jacques			Thyroid Hormone Receptor beta (TR beta) and Liver X Receptor (LXR) Regulate Carbohydrate-response Element-binding Protein (ChREBP) Expression in a Tissue-selective Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; LIPOGENIC ENZYMES; DEUTERATED WATER; OB/OB MICE; GLUCOSE; ALPHA; INSULIN; RAT; CHOLESTEROL; DEFICIENCY	Thyroid hormone (TR) and liver X (LXR) receptors are transcription factors involved in lipogenesis. Both receptors recognize the same consensus DNA-response element in vitro. It was previously shown that their signaling pathways interact in the control of cholesterol elimination in the liver. In the present study, carbohydrate-response element-binding protein (ChREBP), a major transcription factor controlling the activation of glucose-induced lipogenesis in liver, is characterized as a direct target of thyroid hormones (TH) in liver and white adipose tissue (WAT), the two main lipogenic tissues in mice. Using genetic and molecular approaches, ChREBP is shown to be specifically regulated by TR beta but not by TR alpha in vivo, even in WAT where both TR isoforms are expressed. However, this isotype specificity is not found in vitro. This TR beta specific regulation correlates with the loss of TH-induced lipogenesis in TR beta(-/-) mice. Fasting/refeeding experiments show that TR beta is not required for the activation of ChREBP expression particularly marked in WAT following refeeding. However, TH can stimulate ChREBP expression in WAT even under fasting conditions, suggesting completely independent pathways. Because ChREBP has been described as an LXR target, the interaction of LXR and TR beta in ChREBP regulation was assayed both in vitro and in vivo. Each receptor recognizes a different response element on the ChREBP promoter, located only 8 bp apart. There is a cross-talk between LXR and TR beta signaling on the ChREBP promoter in liver but not in WAT where LXR does not regulate ChREBP expression. The molecular basis for this cross-talk has been determined in in vitro systems.	[Gauthier, Karine] Univ Lyon 1, Ecole Normale Super Lyon, INRA, CNRS,IGFL,UMR5242, F-69364 Lyon 07, France; [Beylot, Michel] Univ Lyon 1, Fac Rockefeller, INSERM, ERI 22 EA4173, F-69373 Lyon, France; [Lobaccaro, Jean-Marc] Clermont Univ, CNRS, UMR 6247, Ctr Rech Nutr Humaine Auvergne, F-63177 Aubiere, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS)	Gauthier, K (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, INRA, CNRS,IGFL,UMR5242, 46 Allee Italie, F-69364 Lyon 07, France.	kgauthie@ens-lyon.fr	LOBACCARO, Jean-Marc/L-6151-2015; Lobaccaro, Jean-Marc/Q-3926-2019; Samarut, Jacques/AAD-2587-2019	Lobaccaro, Jean-Marc/0000-0001-9890-2392; 	SIGNATOR [ANR-06-BLAN-0232-01]; Crescendo [LSHM-CT-2005-018652]; Cascade [FOOD-CT2004-506319]; Fondation pour la Recherche Medicale [INE2000407031/1]; Fondation BNP-Paribas	SIGNATOR; Crescendo(European Commission); Cascade(European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation BNP-Paribas	This work was supported by SIGNATOR Grant ANR-06-BLAN-0232-01, Crescendo Contract LSHM-CT-2005-018652, Cascade, Contract FOOD-CT2004-506319, the Fondation pour la Recherche Medicale Grant INE2000407031/1, and the Fondation BNP-Paribas.	Berkenstam A, 2004, MECH AGEING DEV, V125, P707, DOI 10.1016/j.mad.2004.05.005; BLENNEMANN B, 1995, MOL CELL ENDOCRINOL, V110, P1, DOI 10.1016/0303-7207(95)03509-6; Boelen A, 2006, J ENDOCRINOL, V190, P537, DOI 10.1677/joe.1.06872; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; CORREZE C, 1982, EUR J BIOCHEM, V122, P387, DOI 10.1111/j.1432-1033.1982.tb05893.x; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Diraison F, 1997, J MASS SPECTROM, V32, P81, DOI 10.1002/(SICI)1096-9888(199701)32:1<81::AID-JMS454>3.0.CO;2-2; Diraison F, 1996, METABOLISM, V45, P817, DOI 10.1016/S0026-0495(96)90152-3; Flamant F, 2007, MOL ENDOCRINOL, V21, P321, DOI 10.1210/me.2006-0035; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Gauthier K, 1999, EMBO J, V18, P623, DOI 10.1093/emboj/18.3.623; Gauthier K, 2001, MOL CELL BIOL, V21, P4748, DOI 10.1128/MCB.21.14.4748-4760.2001; Hashimoto K, 2006, J BIOL CHEM, V281, P295, DOI 10.1074/jbc.M507877200; Hashimoto K, 2007, ENDOCRINOLOGY, V148, P4667, DOI 10.1210/en.2007-0150; Hashimoto K, 2009, ENDOCRINOLOGY, V150, P3417, DOI 10.1210/en.2009-0059; He ZB, 2004, AM J PHYSIOL-ENDOC M, V287, pE424, DOI 10.1152/ajpendo.00568.2003; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Kratzer A, 2009, J LIPID RES, V50, P312, DOI 10.1194/jlr.M800376-JLR200; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; MARIASH CN, 1980, J CLIN INVEST, V65, P1126, DOI 10.1172/JCI109766; Plateroti M, 2001, MOL CELL BIOL, V21, P4761, DOI 10.1128/MCB.21.14.4761-4772.2001; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Radenne A, 2008, AM J PHYSIOL-ENDOC M, V295, pE884, DOI 10.1152/ajpendo.90438.2008; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; SCHWARTZ HL, 1994, J BIOL CHEM, V269, P24777; Uyeda K, 2002, BIOCHEM PHARMACOL, V63, P2075, DOI 10.1016/S0006-2952(02)01012-2; Weiss RE, 1998, ENDOCRINOLOGY, V139, P4945, DOI 10.1210/en.139.12.4945; Winter H, 2006, J CELL SCI, V119, P2975, DOI 10.1242/jcs.03013	34	50	54	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28156	28163		10.1074/jbc.M110.146241	http://dx.doi.org/10.1074/jbc.M110.146241			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20615868	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000281404100058
J	Singh, N; Thangaraju, M; Prasad, PD; Martin, PM; Lambert, NA; Boettger, T; Offermanns, S; Ganapathy, V				Singh, Nagendra; Thangaraju, Muthusamy; Prasad, Puttur D.; Martin, Pamela M.; Lambert, Nevin A.; Boettger, Thomas; Offermanns, Stefan; Ganapathy, Vadivel			Blockade of Dendritic Cell Development by Bacterial Fermentation Products Butyrate and Propionate through a Transporter (Slc5a8)-dependent Inhibition of Histone Deacetylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; NICOTINIC-ACID; COLON-CANCER; SLC5A8; RELEVANCE; RECEPTOR; GENE; DIFFERENTIATION; IDENTIFICATION; ACTIVATION	Mammalian colon harbors trillions of bacteria, yet there is no undue inflammatory response by the host against these bacteria under normal conditions. The bacterial fermentation products acetate, propionate, and butyrate are believed, at least in part, to be responsible for these immunosuppressive effects. Dendritic cells play an essential role in presentation of antigens to T lymphocytes and initiation of adaptive immune responses. Here we report that butyrate and propionate block the generation of dendritic cells from bone marrow stem cells, without affecting the generation of granulocytes. This effect is dependent on the Na+-coupled monocarboxylate transporter Slc5a8, which transports butyrate and propionate into cells, and on the ability of these two bacterial metabolites to inhibit histone deacetylases. Acetate, which is also a substrate for Slc5a8 but not an inhibitor of histone deacetylases, does not affect dendritic cell development, indicating the essential role of histone deacetylase inhibition in the process. The blockade of dendritic cell development by butyrate and propionate is associated with decreased expression of the transcription factors PU.1 and RelB. Butyrate also elicits its biologic effects through its ability to activate the G-protein-coupled receptor Gpr109a, but this mechanism is not involved in butyrate-induced blockade of dendritic cell development. The participation of Slc5a8 and the non-involvement of Gpr109a in butyrate effects have been substantiated using bone marrow cells obtained from Slc5a8(-/-) and Gpr109a(-/-) mice. These findings uncover an important mechanism underlying the anti-inflammatory functions of the bacterial fermentation products butyrate and propionate.	[Singh, Nagendra; Thangaraju, Muthusamy; Prasad, Puttur D.; Martin, Pamela M.; Ganapathy, Vadivel] Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Lambert, Nevin A.] Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Boettger, Thomas] Max Planck Inst Herz & Lundgenforsch, Dept Cardiac Dev & Remodeling, D-61231 Bad Nauheim, Germany; [Offermanns, Stefan] Heidelberg Univ, Inst Pharmacol, D-69120 Heidelberg, Germany	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Max Planck Society; Ruprecht Karls University Heidelberg	Ganapathy, V (corresponding author), Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA.	vganapat@mail.mcg.edu	Boettger, Thomas/E-3406-2012; Offermanns, Stefan/L-3313-2017	Boettger, Thomas/0000-0003-4280-8449; Offermanns, Stefan/0000-0001-8676-6805				Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bordonaro M, 2008, CELL CYCLE, V7, P1178, DOI 10.4161/cc.7.9.5818; Cejas PJ, 2005, MOL CELL BIOL, V25, P7900, DOI 10.1128/MCB.25.17.7900-7916.2005; Cresci GA, 2010, J GASTROINTEST SURG, V14, P449, DOI 10.1007/s11605-009-1045-x; Cunliffe VT, 2008, CURR OPIN GENET DEV, V18, P404, DOI 10.1016/j.gde.2008.10.001; Dehm SM, 2004, MOL CELL BIOL, V24, P2296, DOI 10.1128/MCB.24.6.2296-2307.2004; Dong XY, 2005, P NATL ACAD SCI USA, V102, P16007, DOI 10.1073/pnas.0506516102; Feagins LA, 2009, NAT REV GASTRO HEPAT, V6, P297, DOI 10.1038/nrgastro.2009.44; Frank H, 2008, J BIOL CHEM, V283, P24729, DOI 10.1074/jbc.M802681200; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Ganapathy V, 2008, AAPS J, V10, P193, DOI 10.1208/s12248-008-9022-y; Gopal E, 2005, BIOCHEM J, V388, P309, DOI 10.1042/BJ20041916; Gopal E, 2007, PHARM RES-DORDR, V24, P575, DOI 10.1007/s11095-006-9176-1; Gupta N, 2006, LIFE SCI, V78, P2419, DOI 10.1016/j.lfs.2005.10.028; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jones PL, 2003, CURR TOP MICROBIOL, V274, P237; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaisho T, 2003, CURR MOL MED, V3, P759, DOI 10.2174/1566524033479366; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Koski GK, 2001, CRIT REV IMMUNOL, V21, P179; Kostyniuk CL, 2002, ONCOGENE, V21, P6340, DOI 10.1038/sj.onc.1205787; Laribee RN, 2005, BBA-GENE STRUCT EXPR, V1730, P226, DOI 10.1016/j.bbaexp.2005.08.003; Larsson M, 2004, SEMIN IMMUNOL, V16, P147, DOI 10.1016/j.smim.2004.02.002; Li H, 2003, P NATL ACAD SCI USA, V100, P8412, DOI 10.1073/pnas.1430846100; Miyauchi S, 2004, J BIOL CHEM, V279, P13293, DOI 10.1074/jbc.C400059200; Nencioni A, 2007, CLIN CANCER RES, V13, P3933, DOI 10.1158/1078-0432.CCR-06-2903; Onai N, 2008, IMMUNITY, V28, P490, DOI 10.1016/j.immuni.2008.03.006; Rada-Iglesias A, 2007, GENOME RES, V17, P708, DOI 10.1101/gr.5540007; Sebastian C, 2008, J IMMUNOL, V180, P5898, DOI 10.4049/jimmunol.180.9.5898; Smith CL, 2008, BIOESSAYS, V30, P15, DOI 10.1002/bies.20687; Sousa CRE, 2004, CURR OPIN IMMUNOL, V16, P21, DOI 10.1016/j.coi.2003.11.007; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Thangaraju M, 2008, J GASTROINTEST SURG, V12, P1773, DOI 10.1007/s11605-008-0573-0; Thangaraju M, 2006, CANCER RES, V66, P11560, DOI 10.1158/0008-5472.CAN-06-1950; Thangaraju M, 2009, CANCER, V115, P4655, DOI 10.1002/cncr.24532; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Trifilo MJ, 2006, J INFECT DIS, V194, pS3, DOI 10.1086/505355; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; van Kooyk Y, 2003, TRENDS MOL MED, V9, P153, DOI 10.1016/S1471-4914(03)00027-3; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620	51	161	166	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27601	27608		10.1074/jbc.M110.102947	http://dx.doi.org/10.1074/jbc.M110.102947			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20601425	hybrid, Green Published			2022-12-25	WOS:000281404100015
J	Anderson, MG; Ferree, CE				Anderson, Mark G.; Ferree, Charles E.			Conserving the Stage: Climate Change and the Geophysical Underpinnings of Species Diversity	PLOS ONE			English	Article							BIODIVERSITY; CONSERVATION; PATTERNS; HETEROGENEITY; AREA	Conservationists have proposed methods for adapting to climate change that assume species distributions are primarily explained by climate variables. The key idea is to use the understanding of species-climate relationships to map corridors and to identify regions of faunal stability or high species turnover. An alternative approach is to adopt an evolutionary timescale and ask ultimately what factors control total diversity, so that over the long run the major drivers of total species richness can be protected. Within a single climatic region, the temperate area encompassing all of the Northeastern U. S. and Maritime Canada, we hypothesized that geologic factors may take precedence over climate in explaining diversity patterns. If geophysical diversity does drive regional diversity, then conserving geophysical settings may offer an approach to conservation that protects diversity under both current and future climates. Here we tested how well geology predicts the species diversity of 14 US states and three Canadian provinces, using a comprehensive new spatial dataset. Results of linear regressions of species diversity on all possible combinations of 23 geophysical and climatic variables indicated that four geophysical factors; the number of geological classes, latitude, elevation range and the amount of calcareous bedrock, predicted species diversity with certainty (adj. R-2 = 0.94). To confirm the species-geology relationships we ran an independent test using 18,700 location points for 885 rare species and found that 40% of the species were restricted to a single geology. Moreover, each geology class supported 5-95 endemic species and chi-square tests confirmed that calcareous bedrock and extreme elevations had significantly more rare species than expected by chance (P<0.0001), strongly corroborating the regression model. Our results suggest that protecting geophysical settings will conserve the stage for current and future biodiversity and may be a robust alternative to species-level predictions.	[Anderson, Mark G.; Ferree, Charles E.] Nature Conservancy, Boston, MA USA	Nature Conservancy	Anderson, MG (corresponding author), Nature Conservancy, Boston, MA USA.	manderson@tnc.org						Anderson MG, 2008, SAVING BIOLOGICAL DIVERSITY: BALANCING PROTECTION OF ENDANGERED SPECIES AND ECOSYSTEMS, P119, DOI 10.1007/978-0-387-09565-3_10; ANDERSON MG, 1999, THESIS U NEW HAMPSHI; Baldi A, 2008, J BIOGEOGR, V35, P675, DOI 10.1111/j.1365-2699.2007.01825.x; Baldwin BG, 2005, EVOLUTION, V59, P2473; Begon M., 2009, ECOLOGY INDIVIDUALS; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; CURRIE DJ, 1987, NATURE, V329, P326, DOI 10.1038/329326a0; Duellman WE, 1999, PATTERNS DISTRIBUTIO; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; HARNER RF, 1976, ECOLOGY, V57, P1254, DOI 10.2307/1935049; HUNTER ML, 1988, CONSERV BIOL, V2, P375, DOI 10.1111/j.1523-1739.1988.tb00202.x; Hutchinson G. E., 1965, ECOLOGICAL THEATER E; Ibanez I, 2006, ECOLOGY, V87, P1896, DOI 10.1890/0012-9658(2006)87[1896:PBCOTC]2.0.CO;2; Kintsch JA, 2002, CONSERV BIOL, V16, P936, DOI 10.1046/j.1523-1739.2002.00542.x; Kruckeberg A.R., 2002, GEOLOGY PLANT LIFE; KRUCKEBERG AR, 1986, SYST BOT, V11, P455, DOI 10.2307/2419082; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; *NATURESERVE EXPL, 2008, ONL ENC PLANTS AN EC; Nichols WF, 1998, CONSERV BIOL, V12, P371, DOI 10.1046/j.1523-1739.1998.96237.x; PACALA SW, 1993, BIOTIC INTERACTIONS, P53; Partel M, 2002, ECOLOGY, V83, P2361, DOI 10.1890/0012-9658(2002)083[2361:LPDPAE]2.0.CO;2; PLATT RB, 1951, ECOL MONOGR, V21, P269, DOI 10.2307/1948652; PURDY BG, 1994, AM J BOT, V81, P904, DOI 10.2307/2445771; Robinson G.R., 1997, 97154 US GEOL SURV; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rouget M, 2003, DIVERS DISTRIB, V9, P191, DOI 10.1046/j.1472-4642.2003.00025.x; Schauffler M, 2002, J ECOL, V90, P235, DOI 10.1046/j.1365-2745.2001.00656.x; Svenning JC, 2008, SCIENCE, V322, P206, DOI 10.1126/science.1164542; Wessels KJ, 1999, BIOL CONSERV, V89, P21, DOI 10.1016/S0006-3207(98)00133-5; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; *WORLDCLIM, 2005, INT J CLIMATOLOGY, V25, P1965	34	185	188	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11554	10.1371/journal.pone.0011554	http://dx.doi.org/10.1371/journal.pone.0011554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644646	Green Published, gold			2022-12-25	WOS:000279884900010
J	Topp, SM; Chipukuma, JM; Giganti, M; Mwango, LK; Chiko, LM; Tambatamba-Chapula, B; Wamulume, CS; Reid, S				Topp, Stephanie M.; Chipukuma, Julien M.; Giganti, Mark; Mwango, Linah K.; Chiko, Like M.; Tambatamba-Chapula, Bushimbwa; Wamulume, Chibesa S.; Reid, Stewart			Strengthening Health Systems at Facility-Level: Feasibility of Integrating Antiretroviral Therapy into Primary Health Care Services in Lusaka, Zambia	PLOS ONE			English	Article							ALMA-ATA; IMPLEMENTATION; COUNTRIES; LESSONS; REBIRTH; TIME; COST	Introduction: HIV care and treatment services are primarily delivered in vertical antiretroviral (ART) clinics in sub-Saharan Africa but there have been concerns over the impact on existing primary health care services. This paper presents results from a feasibility study of a fully integrated model of HIV and non-HIV outpatient services in two urban Lusaka clinics. Methods: Integration involved three key modifications: i) amalgamation of space and patient flow; ii) standardization of medical records and iii) introduction of routine provider initiated testing and counseling (PITC). Assessment of feasibility included monitoring rates of HIV case-finding and referral to care, measuring median waiting and consultation times and assessing adherence to clinical care protocols for HIV and non-HIV outpatients. Qualitative data on patient/provider perceptions was also collected. Findings: Provider and patient interviews at both sites indicated broad acceptability of the model and highlighted a perceived reduction in stigma associated with integrated HIV services. Over six months in Clinic 1, PITC was provided to 2760 patients; 1485 (53%) accepted testing, 192 (13%) were HIV positive and 80 (42%) enrolled. Median OPD patient-provider contact time increased 55% (6.9 vs. 10.7 minutes; p<0.001) and decreased 1% for ART patients (27.9 vs. 27.7 minutes; p = 0.94). Median waiting times increased by 36 (p<0.001) and 23 minutes (p<0.001) for ART and OPD patients respectively. In Clinic 2, PITC was offered to 1510 patients, with 882 (58%) accepting testing, 208 (24%) HIV positive and 121 (58%) enrolled. Median OPD patient-provider contact time increased 110% (6.1 vs. 12.8 minutes; p<0.001) and decreased for ART patients by 23% (23 vs. 17.7 minutes; p<0.001). Median waiting times increased by 47 (p<0.001) and 34 minutes (p<0.001) for ART and OPD patients, respectively. Conclusions: Integrating vertical ART and OPD services is feasible in the low-resource and high HIV-prevalence setting of Lusaka, Zambia. Integration enabled shared use of space and staffing that resulted in increased HIV case finding, a reduction in stigma associated with vertical ART services but resulted in an overall increase in patient waiting times. Further research is urgently required to assess long-term clinical outcomes and cost effectiveness in order to evaluate scalability and generalizability.	[Topp, Stephanie M.; Chipukuma, Julien M.; Giganti, Mark; Mwango, Linah K.; Reid, Stewart] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Topp, Stephanie M.; Giganti, Mark; Reid, Stewart] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Topp, Stephanie M.; Giganti, Mark; Reid, Stewart] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA; [Chiko, Like M.; Wamulume, Chibesa S.] Lusaka Dist Hlth Management Team, Lusaka, Zambia; [Tambatamba-Chapula, Bushimbwa] Minist Hlth, Lusaka, Zambia	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Topp, SM (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.	stephanie.topp@cidrz.org	Topp, Stephanie M/H-3923-2019	Topp, Stephanie M/0000-0002-3448-7983; Reid, Stewart/0000-0001-7779-4820	U.S. Centers for Disease Control and Prevention [U62/CCU12354]	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The program described in this manuscript was supported by a multi-country grant to the Elizabeth Glaser Pediatric AIDS Foundation from the U.S. Centers for Disease Control and Prevention (U62/CCU12354); www.pedaids.org/www.cdc.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bleich SN, 2009, B WORLD HEALTH ORGAN, V87, P271, DOI 10.2471/BLT.07.050401; Bond V, 2006, J COMMUNITY APPL SOC, V16, P452, DOI 10.1002/casp.893; BRIGGS CJ, 2006, COCHRANE DATABASE SY, V2; Cahn P, 2008, LANCET, V372, P265, DOI 10.1016/S0140-6736(08)61085-5; Chi BH, 2005, JAIDS-J ACQ IMM DEF, V40, P350, DOI 10.1097/01.qai.0000162419.16114.39; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; England R, 2007, BRIT MED J, V335, P565, DOI 10.1136/bmj.39335.520463.94; England R, 2007, BMJ-BRIT MED J, V334, P344, DOI 10.1136/bmj.39113.402361.94; Fenton Kevin A, 2007, Top HIV Med, V15, P146; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Garrett L, 2007, FOREIGN AFF, V86, P14; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Haines A, 2004, B WORLD HEALTH ORGAN, V82, P724; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Harris JB, 2008, INT J TUBERC LUNG D, V12, P773; Laurence J, 2007, AIDS READ, V17, P476; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; Levine R, 2009, JAIDS-J ACQ IMM DEF, V52, pS3, DOI 10.1097/QAI.0b013e3181bbc807; Lewin S, 2008, LANCET, V372, P928, DOI 10.1016/S0140-6736(08)61403-8; Oomman N., 2008, SEIZING OPPORTUNITY; Pfeiffer J, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-3; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Valdiserri RO, 2007, PLOS MED, V4, P975, DOI 10.1371/journal.pmed.0040200; Wanyenze RK, 2008, B WORLD HEALTH ORGAN, V86, P302, DOI 10.2471/BLT.07.042580; WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; *ZAMB CSO, 2009, ZAMB DEM HLTH SURV 2	30	58	59	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11522	10.1371/journal.pone.0011522	http://dx.doi.org/10.1371/journal.pone.0011522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	624MG	20644629	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000279822300005
J	Guadalupe-Grau, A; Rodriguez-Gonzalez, FG; Ponce-Gonzalez, JG; Dorado, C; Olmedillas, H; Fuentes, T; Perez-Gomez, J; Sanchis-Moysi, J; Diaz-Chico, BN; Calbet, JAL				Guadalupe-Grau, Amelia; German Rodriguez-Gonzalez, Francisco; Gustavo Ponce-Gonzalez, Jesus; Dorado, Cecilia; Olmedillas, Hugo; Fuentes, Teresa; Perez-Gomez, Jorge; Sanchis-Moysi, Joaquin; Nicolas Diaz-Chico, Bonifacio; Calbet, Jose A. L.			Bone Mass and the CAG and GGN Androgen Receptor Polymorphisms in Young Men	PLOS ONE			English	Article							IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; REPEAT POLYMORPHISM; MINERAL DENSITY; GENETIC-DETERMINANTS; RANCHO-BERNARDO; SEX STEROIDS; WOMEN; OSTEOPOROSIS; METABOLISM; ADULTS	Background: To determine whether androgen receptor (AR) CAG (polyglutamine) and GGN (polyglycine) polymorphisms influence bone mineral density (BMD), osteocalcin and free serum testosterone concentration in young men. Methodology/Principal Findings: Whole body, lumbar spine and femoral bone mineral content (BMC) and BMD, Dual X-ray Absorptiometry (DXA), AR repeat polymorphisms (PCR), osteocalcin and free testosterone (ELISA) were determined in 282 healthy men (28.6 +/- 7.6 years). Individuals were grouped as CAG short (CAG(S)) if harboring repeat lengths of <= 21 or CAG long (CAG(L)) if CAG>21, and GGN was considered short (GGN(S)) or long (GGN(L)) if GGN <= 23 or >23. There was an inverse association between logarithm of CAG and GGN length and Ward's Triangle BMC (r = -0.15 and -0.15, P<0.05, age and height adjusted). No associations between CAG or GGN repeat length and regional BMC or BMD were observed after adjusting for age. Whole body and regional BMC and BMD values were similar in men harboring CAG(S), CAG(L), GGN(S) or GGN(L) AR repeat polymorphisms. Men harboring the combination CAG(L)+GGN(L) had 6.3 and 4.4% higher lumbar spine BMC and BMD than men with the haplotype CAG(S)+GGN(S) (both P<0.05). Femoral neck BMD was 4.8% higher in the CAG(S)+GGN(S) compared with the CAG(L)+GGN(S) men (P<0.05). CAG(S), CAG(L), GGN(S), GGN(L) men had similar osteocalcin concentration as well as the four CAG-GGN haplotypes studied. Conclusion: AR polymorphisms have an influence on BMC and BMD in healthy adult humans, which cannot be explained through effects in osteoblastic activity.	[Guadalupe-Grau, Amelia; Gustavo Ponce-Gonzalez, Jesus; Dorado, Cecilia; Olmedillas, Hugo; Fuentes, Teresa; Perez-Gomez, Jorge; Sanchis-Moysi, Joaquin; Calbet, Jose A. L.] Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Canary Islands, Spain; [German Rodriguez-Gonzalez, Francisco; Nicolas Diaz-Chico, Bonifacio] Univ Las Palmas Gran Canaria, Fac Hlth Sci, Dept Biochem & Physiol, Mol Endocrinol Grp, Las Palmas Gran Canaria, Canary Islands, Spain; [German Rodriguez-Gonzalez, Francisco; Nicolas Diaz-Chico, Bonifacio] Canary Isl Canc Res Inst ICIC, Las Palmas Gran Canaria, Canary Islands, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Guadalupe-Grau, A (corresponding author), Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Canary Islands, Spain.	lopezcalbet@gmail.com	González, Jesús Gustavo Ponce/H-9500-2015; Dorado García, Cecilia/ABC-2792-2021; PONCE GONZALEZ, JESUS G/R-1836-2019; Gómez, Jorge Pérez/R-1334-2019; Sanchis-Moysi, Joaquin/B-5561-2012; Olmedillas, Hugo/F-4809-2015; Fuentes, Teresa/K-7227-2014; SANCHIS-MOYSI, JOAQUIN/H-7017-2015; Pérez-Gómez, Jorge/AAS-9254-2020; Cecilia, Dorado-Garcia/B-4586-2010; , Jorge/ABC-8629-2020; Calbet, Jose A L/H-6693-2015; Guadalupe-Grau, Amelia/H-4961-2016	González, Jesús Gustavo Ponce/0000-0002-5982-7761; PONCE GONZALEZ, JESUS G/0000-0002-5982-7761; Olmedillas, Hugo/0000-0003-4625-2759; Fuentes, Teresa/0000-0003-1286-8731; SANCHIS-MOYSI, JOAQUIN/0000-0001-6602-7087; Cecilia, Dorado-Garcia/0000-0001-6616-6810; , Jorge/0000-0002-4054-9132; Calbet, Jose A L/0000-0002-9215-6234; Guadalupe-Grau, Amelia/0000-0003-2573-4572; antunez, Ariel/0000-0002-2548-7885; Rodriguez Gonzalez, Francisco G/0000-0002-8509-0804; Diaz Chico, Bonifacio Nicolas/0000-0001-5633-6185	Ministerio de Educacion y Ciencia [DEP2006-56076-C06-04/ACTI]; FEDER; Consejeria de Educacion, Cultura y Deportes del Gobierno de Canarias [2006/179 0001]; Proyecto Interreg IIIB BIOPOLIS; Fundacion del Instituto Canario de Investigacion del Cancer (FICIC); Cabildo de Gran Canaria; Cabildo de Tenerife; La Caja de Canarias; Proyecto estructurante de la ULPGC [ULPAPD-08/01-4]	Ministerio de Educacion y Ciencia(Spanish Government); FEDER(European Commission); Consejeria de Educacion, Cultura y Deportes del Gobierno de Canarias; Proyecto Interreg IIIB BIOPOLIS; Fundacion del Instituto Canario de Investigacion del Cancer (FICIC); Cabildo de Gran Canaria; Cabildo de Tenerife; La Caja de Canarias; Proyecto estructurante de la ULPGC	The study was supported by Ministerio de Educacion y Ciencia (DEP2006-56076-C06-04/ACTI) and FEDER; Consejeria de Educacion, Cultura y Deportes del Gobierno de Canarias (2006/179 0001 and FEDER); Proyecto Interreg IIIB BIOPOLIS, Fundacion del Instituto Canario de Investigacion del Cancer (FICIC), Cabildo de Gran Canaria, Cabildo de Tenerife and La Caja de Canarias, and Proyecto estructurante de la ULPGC: ULPAPD-08/01-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu EO, 1997, J CLIN ENDOCR METAB, V82, P3493, DOI 10.1210/jc.82.10.3493; Ding DC, 2005, PROSTATE, V62, P133, DOI 10.1002/pros.20128; FINKELSTEIN JS, 1987, ANN INTERN MED, V106, P354, DOI 10.7326/0003-4819-106-3; FINKELSTEIN JS, 1989, J CLIN ENDOCR METAB, V69, P776, DOI 10.1210/jcem-69-4-776; Greendale GA, 1997, J BONE MINER RES, V12, P1833, DOI 10.1359/jbmr.1997.12.11.1833; Guadalupe-Grau A, 2009, J APPL PHYSIOL, V106, P1100, DOI 10.1152/japplphysiol.91469.2008; Guadalupe-Grau A, 2011, BRIT J SPORT MED, V45, P95, DOI 10.1136/bjsm.2009.060285; Guerra B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003466; Krithivas K, 1999, J ENDOCRINOL, V162, P137, DOI 10.1677/joe.0.1620137; Langdahl BL, 2003, CALCIFIED TISSUE INT, V73, P237, DOI 10.1007/s00223-002-0019-8; Lee DK, 2003, J CLIN ENDOCR METAB, V88, P4043, DOI 10.1210/jc.2003-030261; Pederson L, 1999, P NATL ACAD SCI USA, V96, P505, DOI 10.1073/pnas.96.2.505; POCOCK NA, 1987, J CLIN INVEST, V80, P706, DOI 10.1172/JCI113125; Remes T, 2003, BONE, V32, P412, DOI 10.1016/S8756-3282(03)00032-2; Rodriguez G, 2006, INT J CANCER, V118, P1420, DOI 10.1002/ijc.21516; Salmen T, 2003, J BONE MINER RES, V18, P319, DOI 10.1359/jbmr.2003.18.2.319; Sanchis-Moysi J, 2010, SCAND J MED SCI SPOR, V20, P524, DOI 10.1111/j.1600-0838.2009.00969.x; Slemenda CW, 1997, J CLIN INVEST, V100, P1755, DOI 10.1172/JCI119701; SLEMENDA CW, 1991, J BONE MINER RES, V6, P561; SOROKO SB, 1994, J BONE MINER RES, V9, P761; STIGER F, 2008, CALCIF TISSUE INT; Valimaki VV, 2005, OSTEOPOROSIS INT, V16, P1633, DOI 10.1007/s00198-005-1889-1; Van Pottelbergh I, 2001, CLIN ENDOCRINOL, V55, P659, DOI 10.1046/j.1365-2265.2001.01403.x; Vicente-Rodriguez G, 2007, INT J SPORTS MED, V28, P386, DOI 10.1055/s-2006-924397; Zitzmann M, 2001, CLIN ENDOCRINOL, V55, P649, DOI 10.1046/j.1365-2265.2001.01391.x	25	17	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11529	10.1371/journal.pone.0011529	http://dx.doi.org/10.1371/journal.pone.0011529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634949	Green Published, Green Submitted, gold			2022-12-25	WOS:000279781600013
J	Valbuena, N; Moreno, S				Valbuena, Noelia; Moreno, Sergio			TOR and PKA Pathways Synergize at the Level of the Ste11 Transcription Factor to Prevent Mating and Meiosis in Fission Yeast	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; SCHIZOSACCHAROMYCES-POMBE; SEXUAL DEVELOPMENT; SACCHAROMYCES-CEREVISIAE; NITROGEN STARVATION; CELL-GROWTH; RAPAMYCIN; GENE; CAMP; MTOR	Background: In the fission yeast Schizosaccharomyces pombe, the TOR (target of rapamycin) and PKA (protein kinase A) signaling transduction pathways regulate the expression of genes required for cell growth and sexual differentiation in response to the nutritional environment. Inhibition of Tor2 signaling results in the induction of genes involved in sexual differentiation, and the cells undergo mating and meiosis, even under good nutritional conditions. The same phenotype is observed in mutants in which the PKA pathway is inactive. By contrast, Tor2 overexpression or mutations that hyperactivate PKA signaling impair sexual differentiation, even under poor nutritional conditions. Accordingly, a very important question is to understand the molecular mechanism by which these two pathways coordinately regulate gene expression in response to nutrients. Methodology/Principal Findings: Here we demonstrate that TOR and PKA pathways operate coordinately to negatively regulate sexual differentiation by inhibiting the nuclear accumulation of the Ste11 transcription factor. However, the Tor2 pathway is unable to block the nuclear localization of Ste11 under good nutritional conditions when the PKA pathway is inactive. Using microarray analyses, we found that both pathways inhibit sexual differentiation by blocking ste11-dependent gene expression. Conclusions/Significance: We conclude that both the PKA and the TOR pathways inhibit Ste11 nuclear accumulation to repress Ste11-dependent gene expression. However, the PKA pathway plays a quantitatively more important role than the TOR pathway in this process.	[Valbuena, Noelia; Moreno, Sergio] Univ Salamanca, Inst Biol Mol & Celular Canc, CSIC, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Valbuena, N (corresponding author), Univ Salamanca, Inst Biol Mol & Celular Canc, CSIC, E-37008 Salamanca, Spain.	smo@usal.es	Moreno, Sergio/K-3671-2014; IBSAL, Secretaría/H-3719-2011	Moreno, Sergio/0000-0002-8039-1413; 	Carlos III Institute, Ministerio de Sanidad; la Junta de Castilla y Leon [GR265]; Spanish Ministry of Science and Innovation [BFU2008-01808, CSD2007-00015]; Consolider [CSD2007-00015]; Junta de Castilla y Leon Grupo de Excelencia [GR 265]	Carlos III Institute, Ministerio de Sanidad(Instituto de Salud Carlos IIISpanish Government); la Junta de Castilla y Leon(Junta de Castilla y Leon); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon Grupo de Excelencia(Junta de Castilla y Leon)	N.V. is supported by a postdoctoral grant from the Carlos III Institute, Ministerio de Sanidad. Our group is supported by grants from la Junta de Castilla y Leon (Grupo de Excelencia grant GR265) and the Spanish Ministry of Science and Innovation (BFU2008-01808 and Consolider Ingenio CSD2007-00015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs Keith Gull and Olaf Nielsen for the anti-tubulin and anti-ste11 antibodies, Alberto de Luis for the microarray analysis, and Nicholas Skinner for corrections to the manuscript. N.V. is supported by a postdoctoral grant from the Carlos III Institute, Ministerio de Sanidad. Our group is supported by grants BFU2008-01808, Consolider CSD2007-00015 and Junta de Castilla y Leon Grupo de Excelencia GR 265.	Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Daga RR, 2003, CURR BIOL, V13, P2015, DOI 10.1016/j.cub.2003.10.061; DEVOTI J, 1991, EMBO J, V10, P3759, DOI 10.1002/j.1460-2075.1991.tb04945.x; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Higuchi T, 2002, MOL CELL BIOL, V22, P1, DOI 10.1128/MCB.22.1.1-11.2002; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; KAWAMUKAI M, 1991, CELL REGUL, V2, P155, DOI 10.1091/mbc.2.2.155; Kunitomo H, 2000, MOL BIOL CELL, V11, P3205, DOI 10.1091/mbc.11.9.3205; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; MAEDA T, 1994, J BIOL CHEM, V269, P9632; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Qin J, 2003, MOL CELL BIOL, V23, P3253, DOI 10.1128/MCB.23.9.3253-3264.2003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Smith FL, 1999, BRIT J PHARMACOL, V128, P220, DOI 10.1038/sj.bjp.0702771; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Uritani M, 2006, GENES CELLS, V11, P1367, DOI 10.1111/j.1365-2443.2006.01025.x; Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170; Yamamoto M, 1996, CELL STRUCT FUNCT, V21, P431, DOI 10.1247/csf.21.431; YAMAWAKIKATAOKA Y, 1989, P NATL ACAD SCI USA, V86, P5693, DOI 10.1073/pnas.86.15.5693	29	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11514	10.1371/journal.pone.0011514	http://dx.doi.org/10.1371/journal.pone.0011514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634885	Green Published, gold, Green Submitted			2022-12-25	WOS:000279715300024
J	Planas, J; Serrat, JM				Planas, Jordi; Serrat, Josep M.			Gene Promoter Evolution Targets the Center of the Human Protein Interaction Network	PLOS ONE			English	Article							EXPRESSION LEVEL; STRUCTURAL DETERMINANTS; SUBSTITUTION RATES; POSITIVE SELECTION; TRANSCRIPTION; BINDING; CONSTRAINTS; INTENSITY; ALIGNMENT; REVEAL	Assessing the contribution of promoters and coding sequences to gene evolution is an important step toward discovering the major genetic determinants of human evolution. Many specific examples have revealed the evolutionary importance of cis-regulatory regions. However, the relative contribution of regulatory and coding regions to the evolutionary process and whether systemic factors differentially influence their evolution remains unclear. To address these questions, we carried out an analysis at the genome scale to identify signatures of positive selection in human proximal promoters. Next, we examined whether genes with positively selected promoters (Prom(+) genes) show systemic differences with respect to a set of genes with positively selected protein-coding regions (Cod(+) genes). We found that the number of genes in each set was not significantly different (8.1% and 8.5%, respectively). Furthermore, a functional analysis showed that, in both cases, positive selection affects almost all biological processes and only a few genes of each group are located in enriched categories, indicating that promoters and coding regions are not evolutionarily specialized with respect to gene function. On the other hand, we show that the topology of the human protein network has a different influence on the molecular evolution of proximal promoters and coding regions. Notably, Prom+ genes have an unexpectedly high centrality when compared with a reference distribution (P = 0.008, for Eigenvalue centrality). Moreover, the frequency of Prom+ genes increases from the periphery to the center of the protein network (P = 0.02, for the logistic regression coefficient). This means that gene centrality does not constrain the evolution of proximal promoters, unlike the case with coding regions, and further indicates that the evolution of proximal promoters is more efficient in the center of the protein network than in the periphery. These results show that proximal promoters have had a systemic contribution to human evolution by increasing the participation of central genes in the evolutionary process.	[Planas, Jordi; Serrat, Josep M.] Univ Vic, Dept Syst Biol, Bioinformat & Med Stat Grp, Vic, Spain	Universitat de Vic - Universitat Central de Catalunya (UVic-UCC)	Planas, J (corresponding author), Univ Vic, Dept Syst Biol, Bioinformat & Med Stat Grp, Vic, Spain.	josepmaria.serrat@uvic.cat			Universitat de Vic; Generalitat de Catalunya [2009SGR-581]	Universitat de Vic; Generalitat de Catalunya(Generalitat de Catalunya)	This work has been supported with research funds of the Universitat de Vic, and with a research contract with the Generalitat de Catalunya (2009SGR-581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berglund J, 2009, PLOS BIOL, V7, P45, DOI 10.1371/journal.pbio.1000026; Bloom JD, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-14; Bloom JD, 2006, MOL BIOL EVOL, V23, P1751, DOI 10.1093/molbev/msl040; BRANDES U, NETWORK ANAL; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Davidson EH, 2006, REG GEN GEN REG; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Franzosa EA, 2009, MOL BIOL EVOL, V26, P2387, DOI 10.1093/molbev/msp146; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Haygood R, 2010, P NATL ACAD SCI USA, V107, P7853, DOI 10.1073/pnas.0911249107; Hoffman MM, 2010, GENOME RES, V20, P685, DOI 10.1101/gr.096719.109; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; Kim PM, 2007, P NATL ACAD SCI USA, V104, P20274, DOI 10.1073/pnas.0710183104; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Koudritsky M, 2008, NUCLEIC ACIDS RES, V36, P6795, DOI 10.1093/nar/gkn752; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Lemos B, 2004, NAT GENET, V36, P1059, DOI 10.1038/ng1427; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; PAGEL A, 2008, EVOLUTIONARY GENOMIC; Plotkin JB, 2007, MOL BIOL EVOL, V24, P1113, DOI 10.1093/molbev/msm044; R Development Core Team, 2009, R FDN STAT COMP; Rada-Iglesias A, 2008, GENOME RES, V18, P380, DOI 10.1101/gr.6880908; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Subramanian S, 2004, GENETICS, V168, P373, DOI 10.1534/genetics.104.028944; Tabach Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000807; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Torgerson DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000592; *UNIPROT CONS, 2010, NUCL ACIDS RES, V0038; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wolf JBW, 2009, GENOME BIOL EVOL, V1, P308, DOI 10.1093/gbe/evp030; Wolf MY, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-40; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042	48	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11476	10.1371/journal.pone.0011476	http://dx.doi.org/10.1371/journal.pone.0011476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628608	Green Published, gold, Green Submitted			2022-12-25	WOS:000279637100007
J	Holmes, K; Chapman, E; See, V; Cross, MJ				Holmes, Katherine; Chapman, Elinor; See, Violaine; Cross, Michael J.			VEGF Stimulates RCAN1.4 Expression in Endothelial Cells via a Pathway Requiring Ca2+/Calcineurin and Protein Kinase C-delta	PLOS ONE			English	Article							SYNDROME CRITICAL REGION; DOWN-SYNDROME; SELECTIVE INHIBITOR; GROWTH; CALCINEURIN; ANGIOGENESIS; PHOSPHORYLATION; ACTIVATION; DSCR1; GENE	Background: Vascular endothelial growth factor (VEGF) has previously been shown to upregulate the expression of the endogenous calcineurin inhibitor, regulator of calcineurin 1, variant 4 (RCAN1.4). The aim of this study was to determine the role and regulation of VEGF-mediated RCAN1.4 expression, using human dermal microvascular endothelial cells (HDMECs) as a model system. Methodology/Principal Findings: We show that VEGF is able to induce RCAN1.4 expression during cellular proliferation and differentiation, and that VEGF-mediated expression of RCAN1.4 was inhibited by the use of inhibitors to protein kinase C (PKC) and calcineurin. Further analysis revealed that siRNA silencing of PKC-delta expression partially inhibited VEGF-stimulated RCAN1.4 expression. Knockdown of RCAN1.4 with siRNA resulted in a decrease in cellular migration and disrupted tubular morphogenesis when HDMECs were either stimulated with VEGF in a collagen gel or in an endothelial/fibroblast co-culture model of angiogenesis. Analysis of intracellular signalling revealed that siRNA mediated silencing of RCAN1.4 resulted in increased expression of specific nuclear factor of activated T-cells (NFAT) regulated genes. Conclusions/Significance: Our data suggests that RCAN1.4 expression is induced by VEGFR-2 activation in a Ca2+ and PKC-delta dependent manner and that RCAN1.4 acts to regulate calcineurin activity and gene expression facilitating endothelial cell migration and tubular morphogenesis.	[Holmes, Katherine; Chapman, Elinor; Cross, Michael J.] Univ Liverpool, Dept Pharmacol & Therapeut, Sch Biomed Sci, Liverpool L69 3BX, Merseyside, England; [Chapman, Elinor] Bangor Univ, Sch Biol Sci, N W Canc Res Inst, Bangor, Gwynedd, Wales; [See, Violaine] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Bangor University; University of Liverpool	Holmes, K (corresponding author), Univ Liverpool, Dept Pharmacol & Therapeut, Sch Biomed Sci, Liverpool L69 3BX, Merseyside, England.	m.j.cross@liv.ac.uk	Chapman, Elinor A/F-6112-2010	Chapman, Elinor/0000-0002-4398-1705	North West Cancer Research Fund (NWCRF); BBSRC [BB/C520471/1]; Cancer Research Wales; Biotechnology and Biological Sciences Research Council [BB/C520471/1] Funding Source: researchfish	North West Cancer Research Fund (NWCRF); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research Wales; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	K.H. and M.J.C. are supported by North West Cancer Research Fund (NWCRF). V.S. is a recipient of a BBSRC David Phillips Fellowship (BB/C520471/1). E.C. is funded by Cancer Research Wales. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; CHAN B, 2005, P NATL ACAD SCI US; Crawford DR, 1997, ARCH BIOCHEM BIOPHYS, V342, P6, DOI 10.1006/abbi.1997.0109; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FOLKMAN J, 1986, CANCER RES, V46, P467; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Gliki G, 2002, CELL BIOL INT, V26, P751, DOI 10.1016/S1065-6995(02)90926-1; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Holmes Katherine, 2010, BMC Res Notes, V3, P53, DOI 10.1186/1756-0500-3-53; Iizuka M, 2004, J VASC RES, V41, P334, DOI 10.1159/000079832; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lee HJ, 2009, FEBS LETT, V583, P2557, DOI 10.1016/j.febslet.2009.07.023; Lindsey KQ, 2000, J INVEST DERM SYMP P, V5, P74, DOI 10.1046/j.1087-0024.2000.00013.x; Lorenzi O, 2008, J THROMB HAEMOST, V6, P1962, DOI 10.1111/j.1538-7836.2008.03138.x; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; OKANO Y, 1993, BIOCHEM BIOPH RES CO, V190, P842, DOI 10.1006/bbrc.1993.1125; PLEVIN R, 1990, BIOCHEM J, V268, P605, DOI 10.1042/bj2680605; QATSHA KA, 1993, P NATL ACAD SCI USA, V90, P4674, DOI 10.1073/pnas.90.10.4674; Qin LL, 2006, MOL CANCER RES, V4, P811, DOI 10.1158/1541-7786.MCR-06-0126; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Rahman I, 1998, THORAX, V53, P601, DOI 10.1136/thx.53.7.601; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Sorrell JM, 2007, CELLS TISSUES ORGANS, V186, P157, DOI 10.1159/000106670; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Vega RB, 2002, J BIOL CHEM, V277, P30401, DOI 10.1074/jbc.M200123200; Whittles CE, 2002, MICROCIRCULATION, V9, P513, DOI 10.1038/sj.mn.7800164; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yao YG, 2004, BIOCHEM BIOPH RES CO, V321, P648, DOI 10.1016/j.bbrc.2004.06.176; Zhao P, 2008, EXP BIOL MED, V233, P1289, DOI 10.3181/0803-RM-84	47	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11435	10.1371/journal.pone.0011435	http://dx.doi.org/10.1371/journal.pone.0011435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625401	Green Submitted, Green Published, gold			2022-12-25	WOS:000279522500006
J	Wanchanthuek, P; Bellgard, MI; La, T; Ryan, K; Moolhuijzen, P; Chapman, B; Black, M; Schibeci, D; Hunter, A; Barrero, R; Phillips, ND; Hampson, DJ				Wanchanthuek, Phatthanaphong; Bellgard, Matthew I.; La, Tom; Ryan, Karon; Moolhuijzen, Paula; Chapman, Brett; Black, Michael; Schibeci, David; Hunter, Adam; Barrero, Roberto; Phillips, Nyree D.; Hampson, David J.			The Complete Genome Sequence of the Pathogenic Intestinal Spirochete Brachyspira pilosicoli and Comparison with Other Brachyspira Genomes	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; SERPULINA-PILOSICOLI; HELICOBACTER-PYLORI; MOLECULAR EPIDEMIOLOGY; EASTERN HIGHLANDS; RISK-FACTORS; HYODYSENTERIAE; EXPRESSION; HUMANS; LIPOPOLYSACCHARIDE	Background: The anaerobic spirochete Brachyspira pilosicoli colonizes the large intestine of various species of birds and mammals, including humans. It causes "intestinal spirochetosis'', a condition characterized by mild colitis, diarrhea and reduced growth. This study aimed to sequence and analyse the bacterial genome to investigate the genetic basis of its specialized ecology and virulence. Methodology/Principal Findings: The genome of B. pilosicoli 95/1000 was sequenced, assembled and compared with that of the pathogenic Brachyspira hyodysenteriae and a near-complete sequence of Brachyspira murdochii. The B. pilosicoli genome was circular, composed of 2,586,443 bp with a 27.9 mol% G+C content, and encoded 2,338 genes. The three Brachyspira species shared 1,087 genes and showed evidence of extensive genome rearrangements. Despite minor differences in predicted protein functional groups, the species had many similar features including core metabolic pathways. Genes distinguishing B. pilosicoli from B. hyodysenteriae included those for a previously undescribed bacteriophage that may be useful for genetic manipulation, for a glycine reductase complex allowing use of glycine whilst protecting from oxidative stress, and for aconitase and related enzymes in the incomplete TCA cycle, allowing glutamate synthesis and function of the cycle during oxidative stress. B. pilosicoli had substantially fewer methyl-accepting chemotaxis genes than B. hyodysenteriae and hence these species are likely to have different chemotactic responses that may help to explain their different host range and colonization sites. B. pilosicoli lacked the gene for a new putative hemolysin identified in B. hyodysenteriae WA1. Both B. pilosicoli and B. murdochii lacked the rfbBADC gene cluster found on the B. hyodysenteriae plasmid, and hence were predicted to have different lipooligosaccharide structures. Overall, B. pilosicoli 95/1000 had a variety of genes potentially contributing to virulence. Conclusions/Significance: The availability of the complete genome sequence of B. pilosicoli 95/1000 will facilitate functional genomics studies aimed at elucidating host-pathogen interactions and virulence.	[Wanchanthuek, Phatthanaphong; Bellgard, Matthew I.; Ryan, Karon; Moolhuijzen, Paula; Chapman, Brett; Black, Michael; Schibeci, David; Hunter, Adam; Barrero, Roberto] Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia; [Wanchanthuek, Phatthanaphong] Mahasarakham Univ, Fac Informat, Maha Sarakham, Thailand; [La, Tom; Phillips, Nyree D.; Hampson, David J.] Murdoch Univ, Sch Vet & Biomed Sci, Anim Res Inst, Perth, WA, Australia	Murdoch University; Mahasarakham University; Murdoch University	Wanchanthuek, P (corresponding author), Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia.	d.hampson@murdoch.edu.au	Hampson, David/AAE-3666-2019; Black, Michael/H-7645-2016; Black, Michael/G-2684-2010; Hampson, David J/A-9464-2008	Black, Michael/0000-0002-7182-0714; Hampson, David J/0000-0002-7729-0427; Barrero, Roberto/0000-0002-7735-665X; Bellgard, Matthew/0000-0002-6303-9469	Australian Research Council; Novartis [LP0348441]; Western Australian Government; Mahasarakham University	Australian Research Council(Australian Research Council); Novartis(Novartis); Western Australian Government; Mahasarakham University	This study was supported by the Australian Research Council and Novartis Animal Vaccines through Linkage grant number LP0348441 for genomic sequencing and comparative genomic analysis for animal bacterial vaccine discovery, the Western Australian Government in establishment of the WA Centre of Excellence for Comparative Genomics and for support for this project, and the Mahasarakham University Research Affairs Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREESEN JR, 1994, ANTON LEEUW INT J G, V66, P223, DOI 10.1007/BF00871641; Bellgard MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004641; Boye M, 2001, VET MICROBIOL, V81, P33, DOI 10.1016/S0378-1135(01)00328-5; DALE MP, 1986, BIOCHEMISTRY-US, V25, P2522, DOI 10.1021/bi00357a036; Eckardt NA, 2001, PLANT CELL, V13, P723; FELLSTROM C, 1995, RES VET SCI, V59, P1, DOI 10.1016/0034-5288(95)90021-7; FUKUNAGA M, 1990, MICROBIOL IMMUNOL, V34, P565, DOI 10.1111/j.1348-0421.1990.tb01033.x; FUKUNAGA M, 1992, MICROBIOL IMMUNOL, V36, P161, DOI 10.1111/j.1348-0421.1992.tb01653.x; Graentzdoerffer A, 2001, ARCH MICROBIOL, V175, P8, DOI 10.1007/s002030000232; GREER JM, 1989, INFECT IMMUN, V57, P717, DOI 10.1128/IAI.57.3.717-723.1989; HALTER MR, 1988, INFECT IMMUN, V56, P3152, DOI 10.1128/IAI.56.12.3152-3156.1988; Hampson DJ, 2006, INT J SYST EVOL MICR, V56, P1009, DOI 10.1099/ijs.0.64004-0; Hampson DJ, 2006, EMERG INFECT DIS, V12, P869, DOI 10.3201/eid1205.051180; Hampson DJ, 1999, AUST VET J, V77, P48, DOI 10.1111/j.1751-0813.1999.tb12430.x; Hampson DJ, 2000, VET MICROBIOL, V73, P75, DOI 10.1016/S0378-1135(99)00200-X; Hellman J, 2002, J BIOL CHEM, V277, P14274, DOI 10.1074/jbc.M109696200; Hsu T, 2001, INFECT IMMUN, V69, P706, DOI 10.1128/IAI.69.2.706-711.2001; Humphrey SB, 1997, J BACTERIOL, V179, P323, DOI 10.1128/jb.179.2.323-329.1997; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; Jensen TK, 2010, VET PATHOL, V47, P334, DOI 10.1177/0300985809359054; JOENS LA, 1985, AM J VET RES, V46, P2369; Juliao PC, 2007, J BACTERIOL, V189, P4994, DOI 10.1128/JB.00146-07; KEENLEYSIDE WJ, 1994, MOL MICROBIOL, V11, P437, DOI 10.1111/j.1365-2958.1994.tb00325.x; Kilic AO, 2004, J BACTERIOL, V186, P4246, DOI 10.1128/JB.186.13.4246-4253.2004; KUNKLE RA, 1986, J CLIN MICROBIOL, V24, P669, DOI 10.1128/JCM.24.4.669-671.1986; Lee BJ, 1999, J MED MICROBIOL, V48, P411, DOI 10.1099/00222615-48-4-411; LEE JI, 1992, EPIDEMIOL INFECT, V109, P133; LEE JI, 1993, J CLIN MICROBIOL, V31, P16, DOI 10.1128/JCM.31.1.16-21.1993; Li CH, 2010, J BACTERIOL, V192, P2596, DOI 10.1128/JB.01502-09; Lichtensteiger CA, 1997, FEMS MICROBIOL LETT, V152, P269, DOI 10.1111/j.1574-6968.1997.tb10438.x; Little JW, 2005, PHAGES THEIR ROLES B, V1st, P37; Margawani KR, 2004, J MED MICROBIOL, V53, P325, DOI 10.1099/jmm.0.05415-0; Matson EG, 2007, ANAEROBE, V13, P89, DOI 10.1016/j.anaerobe.2007.04.004; McCaman MT, 2003, MICROBES INFECT, V5, P1, DOI 10.1016/S1286-4579(02)00048-5; Moeder W, 2007, PLANT MOL BIOL, V63, P273, DOI 10.1007/s11103-006-9087-x; Motro Y, 2008, MICROBIOL INSIGHTS, V1, P1; Motro Y, 2009, VET MICROBIOL, V134, P340, DOI 10.1016/j.vetmic.2008.09.051; Movahedi A, 2008, VET MICROBIOL, V131, P1, DOI 10.1016/j.vetmic.2008.02.011; Muniappa N, 1997, FEMS MICROBIOL LETT, V154, P159, DOI 10.1111/j.1574-6968.1997.tb12638.x; Munshi MA, 2004, EPIDEMIOL INFECT, V132, P137, DOI 10.1017/S095026880300116X; Naresh R, 2010, MICROBIOL-SGM, V156, P191, DOI 10.1099/mic.0.030262-0; Naresh R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008352; Nelson EJ, 2009, EMERG INFECT DIS, V15, P571, DOI 10.3201/eid1504.081214; NUESSEN ME, 1983, J IMMUNOL, V131, P997; Ochiai S, 1997, MICROBIOL IMMUNOL, V41, P445, DOI 10.1111/j.1348-0421.1997.tb01877.x; Onishi S, 2008, INFECT IMMUN, V76, P198, DOI 10.1128/IAI.01139-07; Oxberry SL, 1998, EPIDEMIOL INFECT, V121, P219, DOI 10.1017/S0950268898008863; PALMER RE, 1972, J BIOL CHEM, V247, P3420; Paster BJ, 2000, J MOL MICROB BIOTECH, V2, P341; Picardeau M, 1999, MOL MICROBIOL, V32, P437, DOI 10.1046/j.1365-2958.1999.01368.x; PIOTROWSKI J, 1991, BIOCHEM INT, V24, P749; Podkopaeva D. A., 2003, Mikrobiologiya, V72, P600; RodriguezHerva JJ, 1996, J BACTERIOL, V178, P1699, DOI 10.1128/jb.178.6.1699-1706.1996; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SCHWARTZ JJ, 1992, J BACTERIOL, V174, P3757, DOI 10.1128/JB.174.11.3757-3765.1992; Sharma A, 1998, INFECT IMMUN, V66, P5703, DOI 10.1128/IAI.66.12.5703-5710.1998; Somerville G, 1999, J BACTERIOL, V181, P1072, DOI 10.1128/JB.181.4.1072-1078.1999; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; SONNHAMMER ELL, 1995, GENE-COMBIS, V167, P1; Soong G, 2006, J CLIN INVEST, V116, P2297, DOI 10.1172/JCI27920; Stanton TB, 1997, INT J SYST BACTERIOL, V47, P1007, DOI 10.1099/00207713-47-4-1007; Stanton TB, 2006, PROKARYOTES, V7, P330; Tamames J, 2001, GENOME BIOL, V2; TERHUURNE AAHM, 1995, VET MICROBIOL, V46, P347, DOI 10.1016/0378-1135(95)00049-G; Trivett-Moore NL, 1998, J CLIN MICROBIOL, V36, P261, DOI 10.1128/JCM.36.1.261-265.1998; Trott Darren J., 2001, Animal Health Research Reviews, V2, P19; Trott DJ, 1997, J CLIN MICROBIOL, V35, P482, DOI 10.1128/JCM.35.2.482-485.1997; Trott DJ, 1997, EPIDEMIOL INFECT, V119, P369, DOI 10.1017/S0950268897008194; Trott DJ, 1996, INFECT IMMUN, V64, P4648, DOI 10.1128/IAI.64.11.4648-4654.1996; Trott DJ, 1998, INT J SYST BACTERIOL, V48, P659, DOI 10.1099/00207713-48-3-659; Trott DJ, 1996, INT J SYST BACTERIOL, V46, P206, DOI 10.1099/00207713-46-1-206; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Wang G, 1999, MICROBIOL-SGM, V145, P3245, DOI 10.1099/00221287-145-11-3245; Wang G, 1999, MOL MICROBIOL, V31, P1265, DOI 10.1046/j.1365-2958.1999.01268.x; Wang Y, 2008, GENETICS, V180, P391, DOI 10.1534/genetics.108.087981; Weissenbock H, 2005, VET MICROBIOL, V111, P67, DOI 10.1016/j.vetmic.2005.09.002; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; Wildschutte H, 2004, P NATL ACAD SCI USA, V101, P10644, DOI 10.1073/pnas.0404028101; Wilson K, 1990, CURRENT PROTOCOLS MO, P241; Zuerner RL, 2004, ANAEROBE, V10, P229, DOI 10.1016/j.anaerobe.2004.05.002; ZUERNER RL, 1993, J BACTERIOL, V175, P5445, DOI 10.1128/JB.175.17.5445-5451.1993; ZUERNER RL, 1994, J BACTERIOL, V176, P1087, DOI 10.1128/JB.176.4.1087-1092.1994	82	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11455	10.1371/journal.pone.0011455	http://dx.doi.org/10.1371/journal.pone.0011455			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625514	Green Published, gold, Green Submitted			2022-12-25	WOS:000279522500020
J	Gambino, F; Khelfaoui, M; Poulain, B; Bienvenu, T; Chelly, J; Humeau, Y				Gambino, Frederic; Khelfaoui, Malik; Poulain, Bernard; Bienvenu, Thierry; Chelly, Jamel; Humeau, Yann			Synaptic Maturation at Cortical Projections to the Lateral Amygdala in a Mouse Model of Rett Syndrome	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PYRAMIDAL NEURONS; CONDITIONED FEAR; PRESYNAPTIC LTP; MUTANT MICE; CYCLIC-AMP; MECP2; EXPRESSION; PLASTICITY; BRAIN	Rett syndrome (RTT) is a neuro-developmental disorder caused by loss of function of Mecp2 - methyl-CpG-binding protein 2 - an epigenetic factor controlling DNA transcription. In mice, removal of Mecp2 in the forebrain recapitulates most of behavioral deficits found in global Mecp2 deficient mice, including amygdala-related hyper-anxiety and lack of social interaction, pointing a role of Mecp2 in emotional learning. Yet very little is known about the establishment and maintenance of synaptic function in the adult amygdala and the role of Mecp2 in these processes. Here, we performed a longitudinal examination of synaptic properties at excitatory projections to principal cells of the lateral nucleus of the amygdala (LA) in Mecp2 mutant mice and their wild-type littermates. We first show that during animal life, Cortico-LA projections switch from a tonic to a phasic mode, whereas Thalamo-LA synapses are phasic at all ages. In parallel, we observed a specific elimination of Cortico-LA synapses and a decrease in their ability of generating presynaptic long term potentiation. In absence of Mecp2, both synaptic maturation and synaptic elimination were exaggerated albeit still specific to cortical projections. Surprisingly, associative LTP was unaffected at Mecp2 deficient synapses suggesting that synaptic maintenance rather than activity-dependent synaptic learning may be causal in RTT physiopathology. Finally, because the timing of synaptic evolution was preserved, we propose that some of the developmental effects of Mecp2 may be exerted within an endogenous program and restricted to synapses which maturate during animal life.	[Gambino, Frederic; Khelfaoui, Malik; Poulain, Bernard; Humeau, Yann] CNRS UPR 3212, Inst Neurosci Cellulaires & Integrat, Strasbourg, France; [Gambino, Frederic; Khelfaoui, Malik; Poulain, Bernard; Humeau, Yann] Univ Strasbourg, Strasbourg, France; [Khelfaoui, Malik; Bienvenu, Thierry; Chelly, Jamel] CHU Cochin, CNRS, UMR 8104, Inst Cochin,INSERM,U567, Paris, France; [Khelfaoui, Malik; Humeau, Yann] CNRS, UMR 5091, Bordeaux, France; [Khelfaoui, Malik; Humeau, Yann] Univ Bordeaux 2, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Gambino, F (corresponding author), CMU, Dept Neurosci Fondamentales, Geneva, Switzerland.	bodabour@gmail.com	Chelly, Jamel/J-7528-2015	Chelly, Jamel/0000-0002-0939-8719; gambino, frederic/0000-0002-2981-5030	Agence Nationale pour la Recherche; European Neuroscience Institutes Network; ATIP program	Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Neuroscience Institutes Network(European Commission); ATIP program	This study was supported by grants from the Agence Nationale pour la Recherche (YH, JC), the European Neuroscience Institutes Network (YH) and the ATIP program (YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2009, J NEUROSCI, V29, P4218, DOI 10.1523/JNEUROSCI.4225-08.2009; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Bauer EP, 2004, J NEUROSCI, V24, P9507, DOI 10.1523/JNEUROSCI.3567-04.2004; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Castro-Alamancos MA, 1999, J NEUROSCI, V19, P9090, DOI 10.1523/JNEUROSCI.19-20-09090.1999; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chapleau CA, 2009, NEUROBIOL DIS, V35, P219, DOI 10.1016/j.nbd.2009.05.001; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Dani VS, 2009, J NEUROSCI, V29, P11263, DOI 10.1523/JNEUROSCI.1019-09.2009; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Fourcaudot E, 2009, NAT NEUROSCI, V12, P1093, DOI 10.1038/nn.2378; Fourcaudot E, 2008, P NATL ACAD SCI USA, V105, P15130, DOI 10.1073/pnas.0806938105; Frick A, 2007, J PHYSIOL-LONDON, V585, P103, DOI 10.1113/jphysiol.2007.141788; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Humeau Y, 2007, J NEUROSCI, V27, P10947, DOI 10.1523/JNEUROSCI.2603-07.2007; Ito W, 2009, LEARN MEMORY, V16, P187, DOI 10.1101/lm.1190809; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lopez de Armentia M, 2007, J PHYSIOL-LONDON, V581, P961, DOI 10.1113/jphysiol.2007.101822; Mahanty NK, 1999, EUR J NEUROSCI, V11, P1217, DOI 10.1046/j.1460-9568.1999.00528.x; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Monteggia LM, 2009, BIOL PSYCHIAT, V65, P204, DOI 10.1016/j.biopsych.2008.10.036; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Pan BX, 2009, BIOL PSYCHIAT, V66, P964, DOI 10.1016/j.biopsych.2009.07.006; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Sun YE, 2006, NEURON, V49, P321, DOI 10.1016/j.neuron.2006.01.014; Szinyei C, 2000, J NEUROSCI, V20, P8909; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Wang H, 2006, J NEUROSCI, V26, P10911, DOI 10.1523/JNEUROSCI.1810-06.2006; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Weisskopf MG, 1999, J NEUROPHYSIOL, V81, P930, DOI 10.1152/jn.1999.81.2.930; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zoghbi HY, 2005, J CHILD NEUROL, V20, P736, DOI 10.1177/08830738050200090701	50	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11399	10.1371/journal.pone.0011399	http://dx.doi.org/10.1371/journal.pone.0011399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625482	Green Published, gold, Green Submitted			2022-12-25	WOS:000279465700003
J	Kantelhardt, SR; Caarls, W; de Vries, AHB; Hagen, GM; Jovin, TM; Schulz-Schaeffer, W; Rohde, V; Giese, A; Arndt-Jovin, DJ				Kantelhardt, Sven R.; Caarls, Wouter; de Vries, Anthony H. B.; Hagen, Guy M.; Jovin, Thomas M.; Schulz-Schaeffer, Walter; Rohde, Veit; Giese, Alf; Arndt-Jovin, Donna J.			Specific Visualization of Glioma Cells in Living Low-Grade Tumor Tissue	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MEDIATED SIGNAL-TRANSDUCTION; QUANTUM DOTS; GLIOBLASTOMA-MULTIFORME; 5-AMINOLEVULINIC ACID; MALIGNANT GLIOMA; BRAIN-TUMORS; FLUORESCENCE; SURVIVAL; EXPRESSION	Background: The current therapy of malignant gliomas is based on surgical resection, radio-chemotherapy and chemotherapy. Recent retrospective case-series have highlighted the significance of the extent of resection as a prognostic factor predicting the course of the disease. Complete resection in low-grade gliomas that show no MRI-enhanced images are especially difficult. The aim in this study was to develop a robust, specific, new fluorescent probe for glioma cells that is easy to apply to live tumor biopsies and could identify tumor cells from normal brain cells at all levels of magnification. Methodology/Principal Findings: In this investigation we employed brightly fluorescent, photostable quantum dots (QDs) to specifically target epidermal growth factor receptor (EGFR) that is upregulated in many gliomas. Living glioma and normal cells or tissue biopsies were incubated with QDs coupled to EGF and/or monoclonal antibodies against EGFR for 30 minutes, washed and imaged. The data include results from cell-culture, animal model and ex vivo human tumor biopsies of both low-grade and high-grade gliomas and show high probe specificity. Tumor cells could be visualized from the macroscopic to single cell level with contrast ratios as high as 1000: 1 compared to normal brain tissue. Conclusions/Significance: The ability of the targeted probes to clearly distinguish tumor cells in low-grade tumor biopsies, where no enhanced MRI image was obtained, demonstrates the great potential of the method. We propose that future application of specifically targeted fluorescent particles during surgery could allow intraoperative guidance for the removal of residual tumor cells from the resection cavity and thus increase patient survival.	[Kantelhardt, Sven R.; Rohde, Veit; Giese, Alf] Univ Gottingen, Dept Neurosurg, Gottingen, Germany; [Caarls, Wouter; de Vries, Anthony H. B.; Hagen, Guy M.; Jovin, Thomas M.; Arndt-Jovin, Donna J.] Max Planck Inst Biophys Chem, Lab Cellular Dynam, D-37077 Gottingen, Germany; [Schulz-Schaeffer, Walter] Univ Gottingen, Dept Neuropathol, Gottingen, Germany	University of Gottingen; Max Planck Society; University of Gottingen	Kantelhardt, SR (corresponding author), Univ Gottingen, Dept Neurosurg, Gottingen, Germany.	djovin@gwdg.de	Caarls, Wouter/N-9746-2018	Caarls, Wouter/0000-0001-9069-2378; Hagen, Guy/0000-0002-4802-9481	Head and Neck Cancer Research Foundation, Wiesbaden, Germany; EU [037465]; Novartis foundation for therapeutical research, Erlangen, Germany	Head and Neck Cancer Research Foundation, Wiesbaden, Germany; EU(European Commission); Novartis foundation for therapeutical research, Erlangen, Germany	This study was supported by the Head and Neck Cancer Research Foundation, Wiesbaden, Germany and the EU FP6 STREP FLUOROMAG project #037465. S.R.K. was the recipient of a stipend from the Novartis foundation for therapeutical research, Erlangen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt-Jovin DJ, 2009, IEEE T NANOBIOSCI, V8, P65, DOI 10.1109/TNB.2009.2016548; ARNDTJOVIN DJ, 2006, P SPIE, V6096; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Cambi A, 2007, NANO LETT, V7, P970, DOI 10.1021/nl0700503; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Delamarre E, 2009, AM J PATHOL, V175, P844, DOI 10.2353/ajpath.2009.080920; Echarte MM, 2007, FEBS LETT, V581, P2905, DOI 10.1016/j.febslet.2007.05.041; Franco-Hernandez C, 2007, INT J ONCOL, V30, P209; HAGEN GM, 2007, P SPIE, V6441; Halatsch ME, 2006, CANCER TREAT REV, V32, P74, DOI 10.1016/j.ctrv.2006.01.003; Heintzmann R, 2001, J MICROSC-OXFORD, V204, P119, DOI 10.1046/j.1365-2818.2001.00945.x; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Kantelhardt SR, 2008, LASER SURG MED, V40, P273, DOI 10.1002/lsm.20623; Lang FF, 2006, J CLIN ONCOL, V24, P1236, DOI 10.1200/JCO.2005.05.2399; Lidke DS, 2004, PHYSIOLOGY, V19, P322, DOI 10.1152/physiol.00030.2004; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mariani L, 2001, J NEURO-ONCOL, V53, P161, DOI 10.1023/A:1012253317934; Mauro A, 1990, J Neurosurg Sci, V34, P171; McGirt MJ, 2008, NEUROSURGERY, V63, P700, DOI 10.1227/01.NEU.0000325729.41085.73; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; MIYANAGA T, 2007, NEUROPATHOLOGY, V6, P6; Nakamura JL, 2007, EXPERT OPIN THER TAR, V11, P463, DOI 10.1517/14728222.11.4.463; Necesalova E, 2007, NEOPLASMA, V54, P212; Nguyen QT, 2010, P NATL ACAD SCI USA, V107, P4317, DOI 10.1073/pnas.0910261107; Nicholas MK, 2006, CLIN CANCER RES, V12, P7261, DOI 10.1158/1078-0432.CCR-06-0874; Parsons DW, 2008, SCIENCE; Puputti M, 2006, MOL CANCER RES, V4, P927, DOI 10.1158/1541-7786.MCR-06-0085; Rebetz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001936; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Smith AM, 2006, ANN BIOMED ENG, V34, P3, DOI 10.1007/s10439-005-9000-9; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stupp R, 2006, ONCOLOGIST, V11, P165, DOI 10.1634/theoncologist.11-2-165; Tang P, 1997, J NEURO-ONCOL, V35, P303, DOI 10.1023/A:1005824802617; Thorarinsdottir HK, 2008, CLIN CANCER RES, V14, P3386, DOI 10.1158/1078-0432.CCR-07-1616; WESTPHAL M, 1988, CANCER RES, V48, P731; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhang XM, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/9/095601	39	31	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11323	10.1371/journal.pone.0011323	http://dx.doi.org/10.1371/journal.pone.0011323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614029	gold, Green Published, Green Submitted			2022-12-25	WOS:000279370000006
J	Swant, J; Chirwa, S; Stanwood, G; Khoshbouei, H				Swant, Jarod; Chirwa, Sanika; Stanwood, Gregg; Khoshbouei, Habibeh			Methamphetamine Reduces LTP and Increases Baseline Synaptic Transmission in the CA1 Region of Mouse Hippocampus	PLOS ONE			English	Article							LONG-TERM POTENTIATION; D-5 DOPAMINE-RECEPTORS; RAT HIPPOCAMPUS; IN-VITRO; INTRAVENOUS METHAMPHETAMINE; METABOLITE AMPHETAMINE; AREA CA1; SLICE PREPARATION; 5-HT1A RECEPTORS; SEEKING BEHAVIOR	Methamphetamine (METH) is an addictive psychostimulant whose societal impact is on the rise. Emerging evidence suggests that psychostimulants alter synaptic plasticity in the brain-which may partly account for their adverse effects. While it is known that METH increases the extracellular concentration of monoamines dopamine, serotonin, and norepinephrine, it is not clear how METH alters glutamatergic transmission. Within this context, the aim of the present study was to investigate the effects of acute and systemic METH on basal synaptic transmission and long-term potentiation (LTP; an activity-induced increase in synaptic efficacy) in CA1 sub-field in the hippocampus. Both the acute ex vivo application of METH to hippocampal slices and systemic administration of METH decreased LTP. Interestingly, the acute ex vivo application of METH at a concentration of 30 or 60 mu M increased baseline synaptic transmission as well as decreased LTP. Pretreatment with eticlopride (D2-like receptor antagonist) did not alter the effects of METH on synaptic transmission or LTP. In contrast, pretreatment with D1/D5 dopamine receptor antagonist SCH23390 or 5-HT1A receptor antagonist NAN-190 abrogated the effect of METH on synaptic transmission. Furthermore, METH did not increase baseline synaptic transmission in D1 dopamine receptor haploinsufficient mice. Our findings suggest that METH affects excitatory synaptic transmission via activation of dopamine and serotonin receptor systems in the hippocampus. This modulation may contribute to synaptic maladaption induced by METH addiction and/or METH-mediated cognitive dysfunction.	[Swant, Jarod; Chirwa, Sanika; Khoshbouei, Habibeh] Meharry Med Coll, Nashville, TN 37208 USA; [Swant, Jarod; Chirwa, Sanika; Stanwood, Gregg; Khoshbouei, Habibeh] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Stanwood, Gregg] Vanderbilt Univ, Vanderbilt Kennedy Ctr, Nashville, TN USA	Meharry Medical College; Vanderbilt University; Vanderbilt University	Swant, J (corresponding author), Meharry Med Coll, Nashville, TN 37208 USA.	hkhoshbouei@mmc.edu		Stanwood, Gregg/0000-0001-6005-1203; Khoshbouei, Habibeh/0000-0002-1533-8771	National Science Foundation [IOS-0642188]; National Institutes of Health [DA026947, DA021471, T32 HL076133]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R24DA021471, R01DA026947] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Science Foundation (IOS-0642188), and the National Institutes of Health (DA026947, DA021471). Jarod Swant was supported by NIH training grant T32 HL076133. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 1977, Ciba Found Symp, P87; Barr AM, 2006, J PSYCHIATR NEUROSCI, V31, P301; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Brady AM, 2008, PSYCHOPHARMACOLOGY, V200, P205, DOI 10.1007/s00213-008-1195-7; BRIEN JF, 1978, RES COMMUN CHEM PATH, V22, P313; Brown PL, 2003, J NEUROSCI, V23, P3924; BURN JH, 1958, J PHYSIOL-LONDON, V144, P314, DOI 10.1113/jphysiol.1958.sp006104; Cadet JL, 2005, NEUROTOX RES, V8, P199, DOI 10.1007/BF03033973; Chambers RA, 2002, NEUROPSYCHOPHARMACOL, V27, P889, DOI 10.1016/S0893-133X(02)00365-2; Chirwa S, 2005, BRAIN RES BULL, V64, P433, DOI 10.1016/j.brainresbull.2004.09.012; Cho AK, 2001, SYNAPSE, V39, P161, DOI 10.1002/1098-2396(200102)39:2<161::AID-SYN7>3.0.CO;2-E; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; COOK CE, 1993, DRUG METAB DISPOS, V21, P717; COOK CE, 1992, DRUG METAB DISPOS, V20, P856; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Cooper D., 2005, Morbidity and Mortality Weekly Report, V54, P356; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; CREAGER R, 1980, J PHYSIOL-LONDON, V299, P409, DOI 10.1113/jphysiol.1980.sp013133; Cruickshank CC, 2009, ADDICTION, V104, P1085, DOI 10.1111/j.1360-0443.2009.02564.x; Del Olmo N, 2006, ANN NY ACAD SCI, V1074, P427, DOI 10.1196/annals.1369.043; del Olmo N, 2006, BRAIN RES, V1116, P120, DOI 10.1016/j.brainres.2006.07.001; DRAGO J, 1994, P NATL ACAD SCI USA, V91, P12564, DOI 10.1073/pnas.91.26.12564; ECKERT R, 1977, P NATL ACAD SCI USA, V74, P1748, DOI 10.1073/pnas.74.4.1748; El-Ghundi M, 1998, EUR J PHARMACOL, V353, P149, DOI 10.1016/S0014-2999(98)00414-2; Foster T C, 1991, Hippocampus, V1, P79, DOI 10.1002/hipo.450010108; Fowler JS, 2008, NEUROIMAGE, V43, P756, DOI 10.1016/j.neuroimage.2008.07.020; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; Goodwin JS, 2009, J BIOL CHEM, V284, P2978, DOI 10.1074/jbc.M805298200; Granado N, 2008, CEREB CORTEX, V18, P1, DOI 10.1093/cercor/bhm026; Guan X, 2009, NEUROSCIENCE, V161, P665, DOI 10.1016/j.neuroscience.2009.04.035; HERRON CE, 1985, NEUROSCI LETT, V60, P19, DOI 10.1016/0304-3940(85)90375-1; Hollon TR, 2002, J NEUROSCI, V22, P10801, DOI 10.1523/jneurosci.22-24-10801.2002; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; JAHNSEN H, 1980, BRAIN RES, V197, P83, DOI 10.1016/0006-8993(80)90436-9; KAIYA H, 1983, FOLIA PSYCHIAT NEU J, V37, P107; Kalueff AV, 2007, TRENDS PHARMACOL SCI, V28, P122, DOI 10.1016/j.tips.2007.01.002; KATZ B, 1967, J PHYSIOL-LONDON, V189, P535, DOI 10.1113/jphysiol.1967.sp008183; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kim SJ, 2007, NEURON, V56, P582, DOI 10.1016/j.neuron.2007.10.030; Kimura T, 2004, ANN NY ACAD SCI, V1025, P242, DOI 10.1196/annals.1316.030; Kojima T, 2003, BRAIN RES, V959, P165, DOI 10.1016/S0006-8993(02)03756-3; Lan KC, 1998, J FORMOS MED ASSOC, V97, P528; LOY R, 1980, J COMP NEUROL, V189, P699, DOI 10.1002/cne.901890406; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MELEGA WP, 1995, J PHARMACOL EXP THER, V274, P90; Mockett BG, 2004, BRAIN RES, V1021, P92, DOI 10.1016/j.brainres.2004.06.039; Montague DM, 2001, SYNAPSE, V39, P319, DOI 10.1002/1098-2396(20010315)39:4<319::AID-SYN1015>3.0.CO;2-1; Moriguchi S, 2002, EXP BRAIN RES, V144, P238, DOI 10.1007/s00221-002-1039-3; NASH JF, 1992, BRAIN RES, V581, P237, DOI 10.1016/0006-8993(92)90713-J; Navakkode S, 2007, NEUROPHARMACOLOGY, V52, P1547, DOI 10.1016/j.neuropharm.2007.02.010; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Newton TF, 2005, PHARMACOL BIOCHEM BE, V82, P704, DOI 10.1016/j.pbb.2005.11.012; Nicola SM, 1996, J NEUROSCI, V16, P1591; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Nishioku T, 1999, NEUROSCI LETT, V268, P81, DOI 10.1016/S0304-3940(99)00386-9; O'Neil ML, 2006, SYNAPSE, V60, P465, DOI 10.1002/syn.20320; Onaivi ES, 2002, ANN NY ACAD SCI, V965, P28; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Pugliese AM, 1998, BRIT J PHARMACOL, V124, P93; Ricoy UM, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.047.2009; Riviere GJ, 1999, J PHARMACOL EXP THER, V291, P1220; Riviere GJ, 2000, J PHARMACOL EXP THER, V292, P1042; Rogers JL, 2007, NEUROBIOL LEARN MEM, V87, P688, DOI 10.1016/j.nlm.2007.01.003; SAMHSA, 2007, OAS SER S, V40; SCATTON B, 1980, NEUROSCI LETT, V18, P125, DOI 10.1016/0304-3940(80)90314-6; SCHMITZ D, 1995, J NEUROSCI, V15, P7217; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SCHOBER W, 1991, J HIRNFORSCH, V32, P409; SCHWARTZKROIN PA, 1975, BRAIN RES, V85, P423, DOI 10.1016/0006-8993(75)90817-3; SCHWARTZKROIN PA, 1977, BRAIN RES, V128, P53, DOI 10.1016/0006-8993(77)90235-9; SCHWARTZKROIN PA, 1975, BRAIN RES, V89, P107, DOI 10.1016/0006-8993(75)90138-9; Segal DS, 2005, PSYCHOPHARMACOLOGY, V180, P501, DOI 10.1007/s00213-005-2188-4; SEGAL M, 1980, J PHYSIOL-LONDON, V303, P423, DOI 10.1113/jphysiol.1980.sp013297; SHTARK MB, 1976, J NEUROBIOL, V7, P551, DOI 10.1002/neu.480070608; SMITH DA, 1993, BRAIN RES, V608, P259, DOI 10.1016/0006-8993(93)91466-6; Stanwood GD, 2005, J COMP NEUROL, V487, P270, DOI 10.1002/cne.20548; STEPHANS SE, 1994, SYNAPSE, V17, P203, DOI 10.1002/syn.890170310; Stramiello M, 2008, NEUROPHARMACOLOGY, V55, P871, DOI 10.1016/j.neuropharm.2008.06.053; STRINGER JL, 1983, BRAIN RES, V280, P127, DOI 10.1016/0006-8993(83)91180-0; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Sun WL, 2003, J NEUROSCI, V23, P10258; Swant J, 2006, LEARN MEMORY, V13, P161, DOI 10.1101/lm.63806; SWANT J, 2009, SOC NEUR M; Thompson AM, 2005, NEUROPHARMACOLOGY, V49, P185, DOI 10.1016/j.neuropharm.2005.03.005; Thompson AM, 2004, NEUROSCIENCE, V127, P177, DOI 10.1016/j.neuroscience.2004.05.001; Thompson AM, 2002, NEUROPHARMACOLOGY, V42, P1039, DOI 10.1016/S0028-3908(02)00059-X; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Vorel SR, 2001, SCIENCE, V292, P1175, DOI 10.1126/science.1058043; Williams S, 2006, NEUROSCI LETT, V402, P46, DOI 10.1016/j.neulet.2006.03.075; Zombeck JA, 2009, PSYCHOPHARMACOLOGY, V201, P589, DOI 10.1007/s00213-008-1327-0; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	92	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11382	10.1371/journal.pone.0011382	http://dx.doi.org/10.1371/journal.pone.0011382			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614033	Green Published, Green Submitted, gold			2022-12-25	WOS:000279370000012
J	Gregson, AL; Hoji, A; Palchevskiy, V; Hu, S; Weigt, SS; Liao, E; Derhovanessian, A; Saggar, R; Song, S; Elashoff, R; Yang, OO; Belperio, JA				Gregson, Aric L.; Hoji, Aki; Palchevskiy, Vyacheslav; Hu, Scott; Weigt, S. Samuel; Liao, Eileen; Derhovanessian, Ariss; Saggar, Rajeev; Song, Sophie; Elashoff, Robert; Yang, Otto O.; Belperio, John A.			Protection against Bronchiolitis Obliterans Syndrome Is Associated with Allograft CCR7(+)CD45RA(-) T Regulatory Cells	PLOS ONE			English	Article							MINIMAL ACUTE REJECTION; LUNG-TRANSPLANTATION; HEART-LUNG; RECEPTOR EXPRESSION; NAIVE-LIKE; MIGRATION; SURVIVAL; CCR4; DYSFUNCTION; RECIPIENTS	Bronchiolitis obliterans syndrome (BOS) is the major obstacle to long-term survival after lung transplantation, yet markers for early detection and intervention are currently lacking. Given the role of regulatory T cells (Treg) in modulation of immunity, we hypothesized that frequencies of Treg in bronchoalveolar lavage fluid (BALF) after lung transplantation would predict subsequent development of BOS. Seventy BALF specimens obtained from 47 lung transplant recipients were analyzed for Treg lymphocyte subsets by flow cytometry, in parallel with ELISA measurements of chemokines. Allograft biopsy tissue was stained for chemokines of interest. Treg were essentially all CD45RA(-), and total Treg frequency did not correlate to BOS outcome. The majority of Treg were CCR4(+) and CD103(-) and neither of these subsets correlated to risk for BOS. In contrast, higher percentages of CCR7(+) Treg correlated to reduced risk of BOS. Additionally, the CCR7 ligand CCL21 correlated with CCR7(+) Treg frequency and inversely with BOS. Higher frequencies of CCR7(+) CD3(+)CD4(+)CD25(hi)Foxp3(+)CD45RA(-) 2 lymphocytes in lung allografts is associated with protection against subsequent development of BOS, suggesting that this subset of putative Treg may down-modulate alloimmunity. CCL21 may be pivotal for the recruitment of this distinct subset to the lung allograft and thereby decrease the risk for chronic rejection.	[Gregson, Aric L.; Yang, Otto O.] Univ Calif Los Angeles, Dept Med, Div Infect Dis, Los Angeles, CA 90024 USA; [Hoji, Aki; Yang, Otto O.] Univ Calif Los Angeles, UCLA AIDS Inst, Los Angeles, CA USA; [Palchevskiy, Vyacheslav; Hu, Scott; Weigt, S. Samuel; Derhovanessian, Ariss; Saggar, Rajeev; Belperio, John A.] Univ Calif Los Angeles, Dept Med, Div Pulm & Crit Care, Los Angeles, CA 90024 USA; [Liao, Eileen; Elashoff, Robert] Univ Calif Los Angeles, Dept Med, Dept Biomath Biostat, Los Angeles, CA 90024 USA; [Song, Sophie] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Yang, Otto O.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gregson, AL (corresponding author), Univ Calif Los Angeles, Dept Med, Div Infect Dis, Los Angeles, CA 90024 USA.	a.gregson@ucla.edu		Gregson, Aric/0000-0001-6806-0868	National Institutes of Health [HL080206, HL086491]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080206, K23HL102220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by National Institutes of Health grants HL080206 and HL086491 to JAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Githmi I, 2006, EUR J CARDIO-THORAC, V30, P846, DOI 10.1016/j.ejcts.2006.09.027; Allakhverdi Z, 2006, J ALLERGY CLIN IMMUN, V118, P1342, DOI 10.1016/j.jaci.2006.07.034; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Belperio JA, 2005, J CLIN INVEST, V115, P1150, DOI 10.1172/JCI200524233; Benghiat FS, 2005, TRANSPLANTATION, V79, P648, DOI 10.1097/01.TP.0000155179.61445.78; Bharat A, 2006, AM J TRANSPLANT, V6, P1799, DOI 10.1111/j.1600-6143.2006.01383.x; Bharat A, 2007, TRANSPLANTATION, V83, P150, DOI 10.1097/01.tp.0000250579.08042.b6; Burton CM, 2007, J HEART LUNG TRANSPL, V26, P681, DOI 10.1016/j.healun.2007.04.004; CERFBENSUSSAN N, 1987, EUR J IMMUNOL, V17, P1279, DOI 10.1002/eji.1830170910; Chalermskulrat W, 2003, CHEST, V123, P1825, DOI 10.1378/chest.123.6.1825; Christie JD, 2005, AM J RESP CRIT CARE, V171, P1312, DOI 10.1164/rccm.200409-1243OC; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Colovai AI, 2003, HUM IMMUNOL, V64, P31, DOI 10.1016/S0198-8859(02)00742-5; Daud SA, 2007, AM J RESP CRIT CARE, V175, P507, DOI 10.1164/rccm.200608-1079OC; ELLIS B, 2010, FLOWVIZ VISUALIZATIO; ELLIS B, 2010, FLOWCORE BASIC STRUC; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graca L, 2002, J EXP MED, V195, P1641, DOI 10.1084/jem.20012097; Gregson AL, 2008, TRANSPLANTATION, V85, P1056, DOI 10.1097/TP.0b013e318169bd85; Hachem RR, 2005, TRANSPLANTATION, V80, P1406, DOI 10.1097/01.tp.0000181161.60638.fa; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Iellem A, 2003, EUR J IMMUNOL, V33, P1488, DOI 10.1002/eji.200323658; Jaramillo A, 2005, PEDIATR TRANSPLANT, V9, P84, DOI 10.1111/j.1399-3046.2004.00270.x; Kao J, 2003, CIRCULATION, V107, P1958, DOI 10.1161/01.CIR.0000069270.16498.75; Karim M, 2005, BLOOD, V105, P4871, DOI 10.1182/blood-2004-10-3888; Khalifah AP, 2005, AM J TRANSPLANT, V5, P2022, DOI 10.1111/j.1600-6143.2005.00953.x; Kilshaw PJ, 1999, J CLIN PATHOL-MOL PA, V52, P203, DOI 10.1136/mp.52.4.203; Kunkel EJ, 2002, AM J PATHOL, V160, P347, DOI 10.1016/S0002-9440(10)64378-7; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Lim HW, 2006, J IMMUNOL, V177, P840, DOI 10.4049/jimmunol.177.2.840; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Menning A, 2007, EUR J IMMUNOL, V37, P1575, DOI 10.1002/eji.200737201; Mizobucbi T, 2003, J IMMUNOL, V171, P1140, DOI 10.4049/jimmunol.171.3.1140; R Development Core Team, 2009, R FDN STAT COMP; RAMSEY SD, 1995, CHEST, V108, P1594, DOI 10.1378/chest.108.6.1594; Rieger K, 2006, BLOOD, V107, P1717, DOI 10.1182/blood-2005-06-2529; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sarkar D., 2009, LATTICE LATTICE GRAP; Sharples LD, 1996, TRANSPLANTATION, V61, P560, DOI 10.1097/00007890-199602270-00008; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; SUNDARESAN S, 1995, ANN THORAC SURG, V60, P1341, DOI 10.1016/0003-4975(95)00751-6; Trulock EP, 2007, J HEART LUNG TRANSPL, V26, P782, DOI 10.1016/j.healun.2007.06.003; Tung JW, 2004, CLIN IMMUNOL, V110, P277, DOI 10.1016/j.clim.2003.11.016; Valentine VG, 1996, J HEART LUNG TRANSPL, V15, P371; Venken K, 2008, IMMUNOLOGY, V123, P79, DOI 10.1111/j.1365-2567.2007.02690.x; Vlad G, 2007, TRANSPL IMMUNOL, V18, P13, DOI 10.1016/j.trim.2007.03.001; Weigt SS, 2008, AM J TRANSPLANT, V8, P1512, DOI 10.1111/j.1600-6143.2008.02280.x; Wilkes DS, 2005, AM J RESP CRIT CARE, V172, P944, DOI 10.1164/rccm.200501-098WS; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022; 2009, HMISC HARRELL MISCEL	52	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11354	10.1371/journal.pone.0011354	http://dx.doi.org/10.1371/journal.pone.0011354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613873	Green Published, gold, Green Submitted			2022-12-25	WOS:000279369900006
J	Monsellier, E; Ramazzotti, M; Taddei, N; Chiti, F				Monsellier, Elodie; Ramazzotti, Matteo; Taddei, Niccolo; Chiti, Fabrizio			A Computational Approach for Identifying the Chemical Factors Involved in the Glycosaminoglycans-Mediated Acceleration of Amyloid Fibril Formation	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; IN-VITRO; EXTRACELLULAR-MATRIX; PROTEIN INTERACTIONS; ALZHEIMERS-DISEASE; PRION PROTEIN; CONGO RED; BINDING; POLYPEPTIDE; AMYLOIDOGENESIS	Background: Amyloid fibril formation is the hallmark of many human diseases, including Alzheimer's disease, type II diabetes and amyloidosis. Amyloid fibrils deposit in the extracellular space and generally co-localize with the glycosaminoglycans ( GAGs) of the basement membrane. GAGs have been shown to accelerate the formation of amyloid fibrils in vitro for a number of protein systems. The high number of data accumulated so far has created the grounds for the construction of a database on the effects of a number of GAGs on different proteins. Methodology/Principal Findings: In this study, we have constructed such a database and have used a computational approach that uses a combination of single parameter and multivariate analyses to identify the main chemical factors that determine the GAG-induced acceleration of amyloid formation. We show that the GAG accelerating effect is mainly governed by three parameters that account for three-fourths of the observed experimental variability: the GAG sulfation state, the solute molarity, and the ratio of protein and GAG molar concentrations. We then combined these three parameters into a single equation that predicts, with reasonable accuracy, the acceleration provided by a given GAG in a given condition. Conclusions/Significance: In addition to shedding light on the chemical determinants of the protein: GAG interaction and to providing a novel mathematical predictive tool, our findings highlight the possibility that GAGs may not have such an accelerating effect on protein aggregation under the conditions existing in the basement membrane, given the values of salt molarity and protein: GAG molar ratio existing under such conditions.	[Monsellier, Elodie; Ramazzotti, Matteo; Taddei, Niccolo; Chiti, Fabrizio] Univ Florence, Dipartimento Sci Biochim, Florence, Italy; [Chiti, Fabrizio] Consorzio Interuniv Ist Nazl Biostrutture & Biosi, Rome, Italy	University of Florence	Monsellier, E (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France.	fabrizio.chiti@unifi.it	Monsellier, Elodie/GRF-5106-2022; Ramazzotti, Matteo/J-4866-2012	Ramazzotti, Matteo/0000-0002-6862-9409; Taddei, Niccolo/0000-0003-2513-1018; Monsellier, Elodie/0000-0001-7944-7531	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca [PRIN 2007B57EAB, PRIN 20083ERXWS, FIRB RBNE03PX83]; European Union	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission)	This work was partially supported by grants from the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (projects PRIN 2007B57EAB, PRIN 20083ERXWS and FIRB RBNE03PX83) and the European Union (Project EURAMY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; ARUGA E, 1993, LAB INVEST, V69, P223; Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Bravo R, 2008, J BIOL CHEM, V283, P32471, DOI 10.1074/jbc.M709870200; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Fraser PE, 2001, J BIOL CHEM, V276, P6412, DOI 10.1074/jbc.M008128200; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hull RL, 2007, AM J PHYSIOL-CELL PH, V293, pC1586, DOI 10.1152/ajpcell.00208.2007; Kisilevsky R, 2007, AMYLOID, V14, P21, DOI 10.1080/13506120601116419; Levine D. M., 2006, BUSINESS STAT 1 COUR; Lindahl B, 1999, J BIOL CHEM, V274, P30631, DOI 10.1074/jbc.274.43.30631; MAGNUS JH, 1989, ANN RHEUM DIS, V48, P215, DOI 10.1136/ard.48.3.215; MAGNUS JH, 1991, SCAND J IMMUNOL, V34, P63, DOI 10.1111/j.1365-3083.1991.tb01521.x; MCCUBBIN WD, 1988, BIOCHEM J, V256, P775, DOI 10.1042/bj2560775; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; Meng F, 2007, BIOCHEMISTRY-US, V46, P12091, DOI 10.1021/bi7004834; Monsellier E, 2007, BIOPHYS J, V93, P4382, DOI 10.1529/biophysj.107.111336; Motamedi-Shad N, 2009, J BIOCHEM, V146, P805, DOI 10.1093/jb/mvp128; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; Park K, 2001, J BIOL CHEM, V276, P16611, DOI 10.1074/jbc.M008423200; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; SNOW AD, 1987, LAB INVEST, V57, P687; SNOW AD, 1988, AM J PATHOL, V133, P456; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; Takase K, 1998, FEBS LETT, V441, P271, DOI 10.1016/S0014-5793(98)01563-4; Uversky VN, 2005, MOL BRAIN RES, V134, P84, DOI 10.1016/j.molbrainres.2004.11.014; VANDUINEN SG, 1995, LAB INVEST, V73, P183; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Yamaguchi I, 2003, KIDNEY INT, V64, P1080, DOI 10.1046/j.1523-1755.2003.00167.x; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951; YOUNG ID, 1989, ACTA NEUROPATHOL, V78, P202, DOI 10.1007/BF00688210	44	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11363	10.1371/journal.pone.0011363	http://dx.doi.org/10.1371/journal.pone.0011363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613870	gold, Green Published			2022-12-25	WOS:000279369900012
J	Xiao, SQ; Jia, JY; Mo, DL; Wang, QW; Qin, LM; He, ZY; Zhao, XA; Huang, YK; Li, AN; Yu, JW; Niu, YN; Liu, XH; Chen, YS				Xiao, Shuqi; Jia, Jianyu; Mo, Delin; Wang, Qiwei; Qin, Limei; He, Zuyong; Zhao, Xiao; Huang, Yuankai; Li, Anning; Yu, Jingwei; Niu, Yuna; Liu, Xiaohong; Chen, Yaosheng			Understanding PRRSV Infection in Porcine Lung Based on Genome-Wide Transcriptome Response Identified by Deep Sequencing	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; GENE-EXPRESSION ANALYSIS; INNATE IMMUNE-RESPONSES; INFLUENZA-A VIRUS; ALVEOLAR MACROPHAGES; UP-REGULATION; PROINFLAMMATORY CYTOKINES; SIGNALING PATHWAYS; DENDRITIC CELLS; IN-VIVO	Porcine reproductive and respiratory syndrome ( PRRS) has been one of the most economically important diseases affecting swine industry worldwide and causes great economic losses each year. PRRS virus ( PRRSV) replicates mainly in porcine alveolar macrophages (PAMs) and dendritic cells (DCs) and develops persistent infections, antibody-dependent enhancement (ADE), interstitial pneumonia and immunosuppression. But the molecular mechanisms of PRRSV infection still are poorly understood. Here we report on the first genome-wide host transcriptional responses to classical North American type PRRSV (N-PRRSV) strain CH 1a infection using Solexa/Illumina's digital gene expression (DGE) system, a tag-based high-throughput transcriptome sequencing method, and analyse systematically the relationship between pulmonary gene expression profiles after N-PRRSV infection and infection pathology. Our results suggest that N-PRRSV appeared to utilize multiple strategies for its replication and spread in infected pigs, including subverting host innate immune response, inducing an anti-apoptotic and anti-inflammatory state as well as developing ADE. Upregulation expression of virus-induced pro-inflammatory cytokines, chemokines, adhesion molecules and inflammatory enzymes and inflammatory cells, antibodies, complement activation were likely to result in the development of inflammatory responses during N-PRRSV infection processes. N-PRRSV-induced immunosuppression might be mediated by apoptosis of infected cells, which caused depletion of immune cells and induced an anti-inflammatory cytokine response in which they were unable to eradicate the primary infection. Our systems analysis will benefit for better understanding the molecular pathogenesis of N-PRRSV infection, developing novel antiviral therapies and identifying genetic components for swine resistance/susceptibility to PRRS.	[Xiao, Shuqi; Jia, Jianyu; Mo, Delin; Wang, Qiwei; Qin, Limei; He, Zuyong; Zhao, Xiao; Huang, Yuankai; Li, Anning; Yu, Jingwei; Niu, Yuna; Liu, Xiaohong; Chen, Yaosheng] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Xiao, SQ (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	chyaosh@mail.sysu.edu.cn	He, Zuyong/AAU-9430-2021	Wang, Qiwei/0000-0003-3897-2529; Chen, Yaosheng/0000-0002-3871-7651; Li, Anning/0000-0001-7695-161X; Mo, Delin/0000-0002-8738-4486	National Natural Science Foundation of China [U0731003]; National Key Basic Research Plan (973 Project) [2006CB102101]; Ministry of National Agricultural Special Public Sector Research [nyhyzx07-034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Plan (973 Project)(National Basic Research Program of China); Ministry of National Agricultural Special Public Sector Research	This research was supported by National Natural Science Foundation of China (Grant No. U0731003) and National Key Basic Research Plan (973 Project) (Grant No. 2006CB102101) and the Ministry of National Agricultural Special Public Sector Research (Grant No. nyhyzx07-034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Ali T, 2007, VIRAL IMMUNOL, V20, P105, DOI 10.1089/vim.2006.0078; Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448; Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Albina E, 1998, J INTERF CYTOK RES, V18, P485, DOI 10.1089/jir.1998.18.485; Albina E, 1997, VET MICROBIOL, V55, P309, DOI 10.1016/S0378-1135(96)01322-3; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barman S, 2007, J VIROL, V81, P12169, DOI 10.1128/JVI.00835-07; Bennett ST, 2005, PHARMACOGENOMICS, V6, P373, DOI 10.1517/14622416.6.4.373; BEURA LK, 2009, J VIROL; Bowie AG, 2004, J CELL BIOCHEM, V91, P1099, DOI 10.1002/jcb.20026; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Buddaert W, 1998, ADV EXP MED BIOL, V440, P461; Calvert JG, 2007, J VIROL, V81, P7371, DOI 10.1128/JVI.00513-07; CARLSSON U, 2009, TRANSBOUND EMERG DIS; Cavanagh D, 1997, ARCH VIROL, V142, P629; Ceballos-Olvera I, 2010, VIROLOGY, V396, P30, DOI 10.1016/j.virol.2009.10.019; Chen NH, 2009, J VIROL METHODS, V161, P192, DOI 10.1016/j.jviromet.2009.06.007; Costers S, 2008, ARCH VIROL, V153, P1453, DOI 10.1007/s00705-008-0135-5; Costers S, 2006, J GEN VIROL, V87, P2341, DOI 10.1099/vir.0.81808-0; Dean GA, 2003, VET MICROBIOL, V97, P1, DOI 10.1016/j.vetmic.2003.08.010; Delputte PL, 2007, J INTERF CYTOK RES, V27, P757, DOI 10.1089/jir.2007.0001; Dinarello CA, 2004, J ENDOTOXIN RES, V10, P201, DOI 10.1179/096805104225006129; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Drew TW, 2000, VET RES, V31, P27, DOI 10.1051/vetres:2000055; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; Flores-Mendoza L, 2008, CLIN VACCINE IMMUNOL, V15, P720, DOI 10.1128/CVI.00224-07; Frieman M, 2008, VIRUS RES, V133, P101, DOI 10.1016/j.virusres.2007.03.015; Genini S, 2008, J GEN VIROL, V89, P2550, DOI 10.1099/vir.0.2008/003244-0; Girard M, 2001, J GEN VIROL, V82, P1253, DOI 10.1099/0022-1317-82-6-1253; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guo B., 1996, CHINESE J PREVENTIVE, V2, P1; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hossain H, 2006, CURR OPIN IMMUNOL, V18, P422, DOI 10.1016/j.coi.2006.05.018; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hu ZL, 2005, MAMM GENOME, V16, P792, DOI 10.1007/s00335-005-0060-9; Kash JC, 2006, J VIROL, V80, P3009, DOI 10.1128/JVI.80.6.3009-3020.2006; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; Katze MG, 2008, NAT REV IMMUNOL, V8, P644, DOI 10.1038/nri2377; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Lau DTY, 2008, HEPATOLOGY, V47, P799, DOI 10.1002/hep.22076; Lee CH, 2004, J IMMUNOL, V172, P7841, DOI 10.4049/jimmunol.172.12.7841; Lee SM, 2007, VIROLOGY, V365, P419, DOI 10.1016/j.virol.2007.04.001; Li GM, 2007, MICROBES INFECT, V9, P96, DOI 10.1016/j.micinf.2006.10.015; Li YF, 2007, VET J, V174, P577, DOI 10.1016/j.tvjl.2007.07.032; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Liu MT, 2000, J IMMUNOL, V165, P2327, DOI 10.4049/jimmunol.165.5.2327; Loving CL, 2007, IMMUNOLOGY, V120, P217, DOI 10.1111/j.1365-2567.2006.02493.x; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Masson F, 2010, CELL RES, V20, P1, DOI 10.1038/cr.2010.1; Mateu E, 2008, VET J, V177, P345, DOI 10.1016/j.tvjl.2007.05.022; McFadden G, 2009, NAT REV IMMUNOL, V9, P645, DOI 10.1038/nri2623; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mi J, 2001, HUM GENE THER, V12, P1343, DOI 10.1089/104303401750270995; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Miller LC, 2008, DEV BIOLOGICALS, V132, P169, DOI 10.1159/000317157; Miller LD, 2002, CANCER CELL, V2, P353, DOI 10.1016/S1535-6108(02)00181-2; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Ockenhouse CF, 2006, INFECT IMMUN, V74, P5561, DOI 10.1128/IAI.00408-06; Patton JB, 2009, VIRUS RES, V140, P161, DOI 10.1016/j.virusres.2008.12.002; Perlman S, 2005, NAT REV IMMUNOL, V5, P917, DOI 10.1038/nri1732; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Qiu HJ, 2005, VET IMMUNOL IMMUNOP, V106, P309, DOI 10.1016/j.vetimm.2005.03.008; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Suradhat S, 2003, J GEN VIROL, V84, P2755, DOI 10.1099/vir.0.19230-0; Suradhat S, 2003, J GEN VIROL, V84, P453, DOI 10.1099/vir.0.18698-0; SYED GH, 2009, TRENDS ENDOCRINOL ME; Thanawongnuwech R, 2004, CLIN DIAGN LAB IMMUN, V11, P901, DOI 10.1128/CDLI.11.5.901-908.2004; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Tsui PT, 2003, EMERG INFECT DIS, V9, P1064; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; Van Gorp H, 2008, J GEN VIROL, V89, P2943, DOI 10.1099/vir.0.2008/005009-0; Van Reeth K, 1999, RES VET SCI, V67, P47, DOI 10.1053/rvsc.1998.0277; Velculescu VE, 2007, NAT BIOTECHNOL, V25, P878, DOI 10.1038/nbt0807-878; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Wang X, 2007, ARCH VIROL, V152, P289, DOI 10.1007/s00705-006-0857-1; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007; Yuan SS, 2008, SCI CHINA SER C, V51, P271, DOI 10.1007/s11427-008-0023-y; Zhang XX, 1999, VIROLOGY, V262, P152, DOI 10.1006/viro.1999.9914; Zhou YJ, 2008, TRANSBOUND EMERG DIS, V55, P152, DOI 10.1111/j.1865-1682.2008.01020.x	89	106	117	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11377	10.1371/journal.pone.0011377	http://dx.doi.org/10.1371/journal.pone.0011377			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20614006	gold, Green Published, Green Submitted			2022-12-25	WOS:000279369900024
J	Laponogov, I; Pan, XS; Veselkov, DA; McAuley, KE; Fisher, LM; Sanderson, MR				Laponogov, Ivan; Pan, Xiao-Su; Veselkov, Dennis A.; McAuley, Katherine E.; Fisher, L. Mark; Sanderson, Mark R.			Structural Basis of Gate-DNA Breakage and Resealing by Type II Topoisomerases	PLOS ONE			English	Article							NUCLEIC-ACID STRUCTURES; STREPTOCOCCUS-PNEUMONIAE; GYRASE; IV; SOFTWARE; CLEAVAGE; 3-AMINOQUINAZOLINEDIONES; VISUALIZATION; QUINOLONES; INHIBITORS	Type II DNA topoisomerases are ubiquitous enzymes with essential functions in DNA replication, recombination and transcription. They change DNA topology by forming a transient covalent cleavage complex with a gate-DNA duplex that allows transport of a second duplex though the gate. Despite its biological importance and targeting by anticancer and antibacterial drugs, cleavage complex formation and reversal is not understood for any type II enzyme. To address the mechanism, we have used X-ray crystallography to study sequential states in the formation and reversal of a DNA cleavage complex by topoisomerase IV from Streptococcus pneumoniae, the bacterial type II enzyme involved in chromosome segregation. A high resolution structure of the complex captured by a novel antibacterial dione reveals two drug molecules intercalated at a cleaved B-form DNA gate and anchored by drug-specific protein contacts. Dione release generated drug-free cleaved and resealed DNA complexes in which the DNA gate instead adopts an unusual A/B-form helical conformation with a Mg(2+) ion repositioned to coordinate each scissile phosphodiester group and promote reversible cleavage by active-site tyrosines. These structures, the first for putative reaction intermediates of a type II topoisomerase, suggest how a type II enzyme reseals DNA during its normal reaction cycle and illuminate aspects of drug arrest important for the development of new topoisomerase-targeting therapeutics.	[Laponogov, Ivan; Veselkov, Dennis A.; Sanderson, Mark R.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Laponogov, Ivan; Pan, Xiao-Su; Fisher, L. Mark] St Georges Univ London, Div Basic Med Sci, London, England; [McAuley, Katherine E.] Diamond Light Source, Didcot, Oxon, England	University of London; King's College London; St Georges University London; Diamond Light Source	Laponogov, I (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	lfisher@sgul.ac.uk; mark.sanderson@kcl.ac.uk		Fisher, Larry Mark/0000-0002-2172-3369; McAuley, Katherine/0000-0002-9545-072X	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BBH00405X1, BBD01882X1]; Biotechnology and Biological Sciences Research Council [BB/H00405X/1] Funding Source: researchfish; BBSRC [BB/H00405X/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC). I. L. was supported by St George's and by BBSRC project grant BBH00405X1 (to L. M. F. and M. R. S). X. S. P. was funded by project grants BBH00405X1 and BBD01882X1 (to L. M. F.) from the BBSRC, and D. A. V. by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Deweese JE, 2008, NUCLEIC ACIDS RES, V36, P4883, DOI 10.1093/nar/gkn466; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Ellsworth EL, 2006, J MED CHEM, V49, P6435, DOI 10.1021/jm060505l; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Huband MD, 2007, ANTIMICROB AGENTS CH, V51, P1191, DOI 10.1128/AAC.01321-06; Laponogov I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000301; Laponogov I, 2009, NAT STRUCT MOL BIOL, V16, P667, DOI 10.1038/nsmb.1604; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leo E, 2005, J BIOL CHEM, V280, P14252, DOI 10.1074/jbc.M500156200; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPherson A, 2006, J STRUCT BIOL, V156, P387, DOI 10.1016/j.jsb.2006.09.006; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Noble CG, 2002, J MOL BIOL, V318, P361, DOI 10.1016/S0022-2836(02)00049-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan XS, 2009, ANTIMICROB AGENTS CH, V53, P3822, DOI 10.1128/AAC.00113-09; Pan XS, 1997, ANTIMICROB AGENTS CH, V41, P471, DOI 10.1128/AAC.41.2.471; Pan XS, 1996, ANTIMICROB AGENTS CH, V40, P2321, DOI 10.1128/AAC.40.10.2321; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Sissi C, 2009, NUCLEIC ACIDS RES, V37, P702, DOI 10.1093/nar/gkp024; Tran TP, 2007, BIOORG MED CHEM LETT, V17, P1312, DOI 10.1016/j.bmcl.2006.12.005; West KL, 2000, BIOCHEMISTRY-US, V39, P1223, DOI 10.1021/bi991328b	27	139	139	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11338	10.1371/journal.pone.0011338	http://dx.doi.org/10.1371/journal.pone.0011338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596531	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000279259900011
J	Kithcart, AP; Cox, GM; Sielecki, T; Short, A; Pruitt, J; Papenfuss, T; Shawler, T; Gienapp, I; Satoskar, AR; Whitacre, CC				Kithcart, Aaron P.; Cox, Gina M.; Sielecki, Thais; Short, Abigail; Pruitt, James; Papenfuss, Tracey; Shawler, Todd; Gienapp, Ingrid; Satoskar, Abhay R.; Whitacre, Caroline C.			A small-molecule inhibitor of macrophage migration inhibitory factor for the treatment of inflammatory disease	FASEB JOURNAL			English	Article						experimental autoimmune encephalomyelitis; multiple sclerosis; blood-brain barrier	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; FACTOR MIF; T-CELLS; INTERLEUKIN-7 RECEPTOR; CEREBROSPINAL-FLUID; NATALIZUMAB; THERAPIES; REVEALS	Multiple sclerosis (MS) is a chronic, debilitating disease of the central nervous system (CNS) characterized by demyelination and axon loss. The proinflammatory cytokine macrophage migration inhibitory factor (MIF) has been shown to be elevated in the cerebrospinal fluid of patients during relapses. The purpose of this study was to evaluate a new small-molecule inhibitor of MIF and its ability to reduce the severity of an animal model of MS, experimental autoimmune encephalomyelitis (EAE). We utilized 2 structurally related isoxazolines, which show in vitro inhibition of MIF tautomerase activity. We found that administration of an inhibitor of MIF to mice with established EAE immediately reduced the severity of clinical signs and expanded a population of regulatory T lymphocytes. We also noted that the inhibitor reduced relapses of disease in a relapsing/remitting model of EAE. An analysis of leukocyte migration into the brain revealed that administration of inhibitor reduced entry of these cells. No effects on inflammatory cytokine production or T-cell activation in the periphery were noted. From these studies, we conclude that a small-molecule inhibitor of MIF reduces the severity of EAE and prevents access of immune cells into the CNS, which could be of therapeutic relevance to MS.-Kithcart, A. P., Cox, G. M., Sielecki, T., Short, A., Pruitt, J., Papenfuss, T., Shawler, T., Gienapp, I., Satoskar, A. R., Whitacre, C. C. A small-molecule inhibitor of macrophage migration inhibitory factor for the treatment of inflammatory disease. FASEB J. 24, 4459-4466 (2010). www.fasebj.org	[Kithcart, Aaron P.; Cox, Gina M.; Short, Abigail; Shawler, Todd; Gienapp, Ingrid; Whitacre, Caroline C.] Ohio State Univ, Dept Mol Virol Immunol & Mol Genet, Columbus, OH 43210 USA; [Papenfuss, Tracey] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Satoskar, Abhay R.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Sielecki, Thais; Pruitt, James] Cytokine PharmaSci, King Of Prussia, PA USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Whitacre, CC (corresponding author), 208 Bricker Hall,190 N Oval Mall, Columbus, OH 43210 USA.	whitacre.3@osu.edu	Papenfuss, Tracey/E-3814-2011; Satoskar, Abhay/AAB-7748-2019		U.S. National Institutes of Health [AI 064320]; National MS Society [RG3272]; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR022198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064320] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National MS Society(National Multiple Sclerosis Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank additional members of the C.C.W. laboratory for their support and scientific discussion, including Kristen Smith, Jessica Williams, Amy Lovett-Racke, and Michael Racke. This project was supported by U.S. National Institutes of Health grant AI 064320 and National MS Society grant RG3272.	AROCA P, 1991, BIOCHEM J, V277, P393, DOI 10.1042/bj2770393; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bo L, 1996, J NEUROPATH EXP NEUR, V55, P1060, DOI 10.1097/00005072-199655100-00006; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; CHOU YK, 1992, J NEUROIMMUNOL, V38, P105, DOI 10.1016/0165-5728(92)90095-3; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Denkinger CM, 2003, J IMMUNOL, V170, P1274, DOI 10.4049/jimmunol.170.3.1274; Engelhardt Britta, 2006, V43, P259, DOI 10.1007/020; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Flores M, 2008, FASEB J, V22, P3661, DOI 10.1096/fj.08-111666; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Kleemann R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/610479; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Matsunaga J, 1999, J BIOL CHEM, V274, P3268, DOI 10.1074/jbc.274.6.3268; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Meyer-Siegler KL, 2007, GENES IMMUN, V8, P646, DOI 10.1038/sj.gene.6364427; Miller A, 1997, SOUTH MED J, V90, P367, DOI 10.1097/00007611-199704000-00001; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Niino M, 2000, J NEUROL SCI, V179, P127, DOI 10.1016/S0022-510X(00)00397-X; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Peterson JW, 2005, NEUROL CLIN, V23, P107, DOI 10.1016/j.ncl.2004.09.008; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Popa C, 2006, CYTOKINE, V36, P51, DOI 10.1016/j.cyto.2006.10.011; Powell ND, 2005, J IMMUNOL, V175, P5611, DOI 10.4049/jimmunol.175.9.5611; Racke MK, 2008, CURR OPIN NEUROL, V21, pS9, DOI 10.1097/01.wco.0000313359.61176.15; Rodriguez-Sosa M, 2003, INFECT IMMUN, V71, P1247, DOI 10.1128/IAI.71.3.1247-1254.2003; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Sanchez-Zamora Y, 2010, FASEB J, V24, P2583, DOI 10.1096/fj.09-147066; Satoskar AR, 2001, INFECT IMMUN, V69, P906, DOI 10.1128/IAI.69.2.906-911.2001; Schober A, 2008, J MOL MED, V86, P761, DOI 10.1007/s00109-008-0334-2; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; WEISER WY, 1989, P NATL ACAD SCI USA, V86, P7522, DOI 10.1073/pnas.86.19.7522; Wingerchuk DM, 2001, LAB INVEST, V81, P263, DOI 10.1038/labinvest.3780235; Yousry TA, 2006, NEW ENGL J MED, V354, P924, DOI 10.1056/NEJMoa054693; Zernecke A, 2008, CIRCULATION, V117, P1594, DOI 10.1161/CIRCULATIONAHA.107.729125	39	39	40	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4459	4466		10.1096/fj.10-162347	http://dx.doi.org/10.1096/fj.10-162347			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20624927	Green Published			2022-12-25	WOS:000283861100031
J	Wen, Y; Li, J; Yao, WM; Xiong, MQ; Hong, J; Peng, Y; Xiao, GF; Lin, DH				Wen, Yi; Li, Jun; Yao, Wenming; Xiong, Minqian; Hong, Jing; Peng, Yu; Xiao, Gengfu; Lin, Donghai			Unique Structural Characteristics of the Rabbit Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODEL-FREE APPROACH; MAGNETIC-RESONANCE RELAXATION; LINEAR EXTRAPOLATION METHOD; NMR SOLUTION STRUCTURE; MOLECULAR-DYNAMICS; BACKBONE DYNAMICS; SPIN-RELAXATION; BINDING SITES; HEAT-CAPACITY; CELLULAR PRP	Rabbits are one of the few mammalian species that appear to be resistant to transmissible spongiform encephalopathies due to the structural characteristics of the rabbit prion protein (RaPrPC) itself. Here, we determined the solution structures of the recombinant protein RaPrPC-(91-228) and its S173N variant and detected the backbone dynamics of their structured C-terminal domains-(121-228). In contrast to many other mammalian PrP(C)s, loop 165-172, which connects beta-sheet-2 and alpha-helix-2, is well-defined in RaPrPC. For the first time, order parameters S-2 are obtained for residues in this loop region, indicating that loop 165-172 of RaPrPC is highly ordered. Compared with the wild-type RaPrPC, less hydrogen bonds form in the S173N variant. The NMR dynamics analysis reveals a distinct increase in the structural flexibility of loop 165-172 and helix-3 after the S173N substitution, implying that the S173N substitution disturbs the long range interaction of loop 165-172 with helix-3, which further leads to a marked decrease in the global conformational stability. Significantly, RaPrPC possesses a unique charge distribution, carrying a continuous area of positive charges on the surface, which is distinguished from other PrP(C)s. The S173N substitution causes visible changes of the charge distribution around the recognition sites for the hypothetical protein X. Our results suggest that the ordered loop 165-172 and its interaction with helix-3, together with the unique distribution of surface electrostatic potential, significantly contribute to the unique structural characteristics of RaPrPC.	[Wen, Yi; Li, Jun; Yao, Wenming; Xiong, Minqian; Hong, Jing; Peng, Yu; Lin, Donghai] Chinese Acad Sci, Shanghai Inst Mat Med, NMR Lab, Shanghai 201203, Peoples R China; [Xiao, Gengfu] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Lin, Donghai] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen 361005, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Wuhan University; Xiamen University	Lin, DH (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, NMR Lab, 555 Zu Chongzhi Rd, Shanghai 201203, Peoples R China.	dhlin@mail.shcnc.ac.cn	li, jun/A-1197-2011; Lin, Donghai/A-1482-2011	Wuthrich, Kurt/0000-0001-8739-6965; Peng, Yu/0000-0003-2039-9015	National Natural Science Foundation of China [30730026, 30570352]; National Science & Technology Major Project Key New Drug Creation and Manufacturing Program, China [2009ZX09301-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project Key New Drug Creation and Manufacturing Program, China	This work was supported by grants from the National Natural Science Foundation of China (30730026 and 30570352) and the National Science & Technology Major Project Key New Drug Creation and Manufacturing Program, China (2009ZX09301-001).	ALONSO DOV, 1991, BIOCHEMISTRY-US, V30, P5974, DOI 10.1021/bi00238a023; Bae SH, 2009, BIOCHEMISTRY-US, V48, P8120, DOI 10.1021/bi900923b; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Billeter M, 1997, P NATL ACAD SCI USA, V94, P7281, DOI 10.1073/pnas.94.14.7281; BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calzolai L, 2000, P NATL ACAD SCI USA, V97, P8340, DOI 10.1073/pnas.97.15.8340; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Christen B, 2008, J MOL BIOL, V383, P306, DOI 10.1016/j.jmb.2008.08.045; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; Colombo MC, 2008, PROTEINS, V70, P1084, DOI 10.1002/prot.21604; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Dayie KT, 1996, ANNU REV PHYS CHEM, V47, P243, DOI 10.1146/annurev.physchem.47.1.243; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; Dima RI, 2004, P NATL ACAD SCI USA, V101, P15335, DOI 10.1073/pnas.0404235101; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Dyson HJ, 2002, ADV PROTEIN CHEM, V62, P311; Dyson HJ, 2001, METHOD ENZYMOL, V339, P258; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; GIBBS CJ, 1973, SCIENCE, V182, P67, DOI 10.1126/science.182.4107.67; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Hornemann S, 2004, EMBO REP, V5, P1159, DOI 10.1038/sj.embor.7400297; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Kaneko K, 1997, J MOL BIOL, V270, P574, DOI 10.1006/jmbi.1997.1135; KANEKO K, 1995, P NATL ACAD SCI USA, V92, P11160, DOI 10.1073/pnas.92.24.11160; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lefevre JF, 1996, BIOCHEMISTRY-US, V35, P2674, DOI 10.1021/bi9526802; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li J, 2007, J BIOMOL NMR, V38, P181, DOI 10.1007/s10858-006-9115-9; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Nisbet RM, 2010, J VIROL, V84, P6678, DOI 10.1128/JVI.02709-09; O'Sullivan DBD, 2009, PROTEIN SCI, V18, P410, DOI 10.1002/pro.44; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; PENG JW, 1992, BIOCHEMISTRY-US, V31, P8571, DOI 10.1021/bi00151a027; PENG JW, 1992, J MAGN RESON, V98, P308, DOI 10.1016/0022-2364(92)90135-T; Perez DR, 2010, J MOL BIOL, V400, P121, DOI 10.1016/j.jmb.2010.04.066; PRIVALOV PL, 1992, J MOL BIOL, V224, P715, DOI 10.1016/0022-2836(92)90555-X; PRIVALOV PL, 1990, J MOL BIOL, V213, P385, DOI 10.1016/S0022-2836(05)80198-6; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Santini S, 2004, CELL MOL LIFE SCI, V61, P951, DOI 10.1007/s00018-003-3455-3; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sigurdson CJ, 2007, BBA-MOL BASIS DIS, V1772, P610, DOI 10.1016/j.bbadis.2006.10.010; Spyracopoulos L, 2006, J BIOMOL NMR, V36, P215, DOI 10.1007/s10858-006-9083-0; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Surewicz WK, 2006, ACCOUNTS CHEM RES, V39, P654, DOI 10.1021/ar050226c; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Tjong H, 2007, NUCLEIC ACIDS RES, V35, P1465, DOI 10.1093/nar/gkm008; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Vassallo N, 2003, J NEUROCHEM, V86, P538, DOI 10.1046/j.1471-4159.2003.01882.x; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Xu HM, 2006, J BACTERIOL, V188, P1509, DOI 10.1128/JB.188.4.1509-1517.2006; Yin SM, 2003, PROTEIN EXPRES PURIF, V32, P104, DOI 10.1016/S1046-5928(03)00195-5; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang JP, 2010, J THEOR BIOL, V264, P119, DOI 10.1016/j.jtbi.2010.01.024; Zhang JP, 2009, J BIOMOL STRUCT DYN, V27, P159, DOI 10.1080/07391102.2009.10507305; Zhang M, 1998, J BIOL CHEM, V273, P21714, DOI 10.1074/jbc.273.34.21714; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200; Zidar J, 2008, J CHEM INF MODEL, V48, P283, DOI 10.1021/ci700226c; Ziegler J, 2003, J BIOL CHEM, V278, P50175, DOI 10.1074/jbc.M305234200	85	66	72	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31682	31693		10.1074/jbc.M110.118844	http://dx.doi.org/10.1074/jbc.M110.118844			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20639199	Green Published, hybrid			2022-12-25	WOS:000282764600060
J	Galello, F; Portela, P; Moreno, S; Rossi, S				Galello, Fiorella; Portela, Paula; Moreno, Silvia; Rossi, Silvia			Characterization of Substrates That Have a Differential Effect on Saccharomyces cerevisiae Protein Kinase A Holoenzyme Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PYRUVATE-KINASE; CATALYTIC SUBUNIT; SPECIFICITY DETERMINANTS; PHOSPHORYLATION SITES; DEPENDENT ACTIVATION; GLOBAL ANALYSIS; IN-VIVO; CAMP; PKA; IDENTIFICATION	The specificity in phosphorylation by kinases is determined by the molecular recognition of the peptide target sequence. In Saccharomyces cerevisiae, the protein kinase A(PKA) specificity determinants are less studied than in mammalian PKA. The catalytic turnover numbers of the catalytic subunits isoforms Tpk1 and Tpk2 were determined, and both enzymes are shown to have the same value of 3 s(-1). We analyze the substrate behavior and sequence determinants around the phosphorylation site of three protein substrates, Pyk1, Pyk2, and Nth1. Nth1 protein is a better substrate than Pyk1 protein, and both are phosphorylated by either Tpk1 or Tpk2. Both enzymes also have the same selectivity toward the protein substrates and the peptides derived from them. The three substrates contain one or more Arg-Arg-X-Ser consensus motif, but not all of them are phosphorylated. The determinants for specificity were studied using the peptide arrays. Acidic residues in the position P + 1 or in the N-terminal flank are deleterious, and positive residues present beyond P-2 and P-3 favor the catalytic reaction. A bulky hydrophobic residue position P + 4 an acidic residue, equivalent to the one in the inhibitory sequence of Bcy1, the yeast regulatory subunit of PKA. The substrate effect in the holoenzyme activation was analyzed, and we demonstrate that peptides and protein substrates sensitized the holoenzyme to activation by cAMP in different degrees, depending on their sequences. The results also suggest that protein substrates are better co-activators than peptide substrates.	[Rossi, Silvia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab QB1, RA-1428 Buenos Aires, DF, Argentina	University of Buenos Aires	Rossi, S (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab QB1, Ciudad Univ Pab 2 Piso 4, RA-1428 Buenos Aires, DF, Argentina.	srossi@qb.fcen.uba.ar		Rossi, Silvia/0000-0001-6996-0622	Agencia Nacional de Promocion Cientfica y Tecnologica [PICT 38212]; University of Buenos Aires [UBA X-197]; Consejo Nacional de Investigaciones Cientficas y Tecnicas [PIP5239]	Agencia Nacional de Promocion Cientfica y Tecnologica(ANPCyT); University of Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientficas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from the Agencia Nacional de Promocion Cientfica y Tecnologica (PICT 38212), from the University of Buenos Aires (UBA X-197), and from the Consejo Nacional de Investigaciones Cientficas y Tecnicas (PIP5239).	Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Chevtzoff C, 2005, BBA-BIOENERGETICS, V1706, P117, DOI 10.1016/j.bbabio.2004.10.001; Choi MG, 2005, J BIOL CHEM, V280, P26105, DOI 10.1074/jbc.M503551200; Deminoff SJ, 2009, GENETICS, V182, P529, DOI 10.1534/genetics.109.102178; DENIS CL, 1991, J BIOL CHEM, V266, P17932; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; Herman PK, 2002, CURR OPIN MICROBIOL, V5, P602, DOI 10.1016/S1369-5274(02)00377-6; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; KEMP BE, 1977, J BIOL CHEM, V252, P4888; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Kreegipuu A, 1999, NUCLEIC ACIDS RES, V27, P237, DOI 10.1093/nar/27.1.237; Kreegipuu A, 1998, FEBS LETT, V430, P45, DOI 10.1016/S0014-5793(98)00503-1; Lieser SA, 2005, BBA-PROTEINS PROTEOM, V1754, P191, DOI 10.1016/j.bbapap.2005.07.024; Loog M, 2005, BBA-PROTEINS PROTEOM, V1747, P261, DOI 10.1016/j.bbapap.2004.11.016; MAZON MJ, 1993, EUR J BIOCHEM, V213, P501, DOI 10.1111/j.1432-1033.1993.tb17787.x; Mesecar AD, 1997, BIOCHEMISTRY-US, V36, P6803, DOI 10.1021/bi962870s; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Moore MJ, 2003, J BIOL CHEM, V278, P10613, DOI 10.1074/jbc.M210807200; Neuberger G, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-1; Palomino A, 2006, NUCLEIC ACIDS RES, V34, P1427, DOI 10.1093/nar/gkl028; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Portela P, 2006, CELL SIGNAL, V18, P1072, DOI 10.1016/j.cellsig.2005.09.001; Portela P, 2002, J BIOL CHEM, V277, P30477, DOI 10.1074/jbc.M201094200; Portela P, 2006, BIOCHEM J, V396, P117, DOI 10.1042/BJ20051642; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rinaldi J, 2008, ARCH BIOCHEM BIOPHYS, V480, P95, DOI 10.1016/j.abb.2008.09.014; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Sherman F., 1981, METHODS YEAST GENETI; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; TAYLOR SS, 1992, ANNU REV CELL BIOL, V8, P429, DOI 10.1146/annurev.cb.08.110192.002241; TEGGE W, 1995, BIOCHEMISTRY-US, V34, P10569, DOI 10.1021/bi00033a032; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Tudisca V, 2010, EUR J CELL BIOL, V89, P339, DOI 10.1016/j.ejcb.2009.08.005; UNO I, 1983, J BIOL CHEM, V258, P867; Vigil D, 2004, BIOCHEMISTRY-US, V43, P5629, DOI 10.1021/bi0499157; Viste K, 2005, J BIOL CHEM, V280, P13279, DOI 10.1074/jbc.M413065200; WALSH D A, 1992, Current Opinion in Cell Biology, V4, P241, DOI 10.1016/0955-0674(92)90039-F; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; Wera S, 1999, BIOCHEM J, V343, P621, DOI 10.1042/0264-6021:3430621; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; YANG SM, 1995, BIOCHEMISTRY-US, V34, P6267, DOI 10.1021/bi00019a002; Zaremberg V, 2000, ARCH BIOCHEM BIOPHYS, V381, P74, DOI 10.1006/abbi.2000.1948; Zetterqvist O.Z., 1990, PEPTIDES PROTEIN PHO, P171; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	50	21	21	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29770	29779		10.1074/jbc.M110.120378	http://dx.doi.org/10.1074/jbc.M110.120378			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20639203	Green Published, hybrid			2022-12-25	WOS:000281984300012
J	Li, YQ; Gou, MY; Sun, Q; Hua, JA				Li, Yongqing; Gou, Mingyue; Sun, Qi; Hua, Jian			Requirement of Calcium Binding, Myristoylation, and Protein-Protein Interaction for the Copine BON1 Function in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C2 DOMAIN; PLASMA-MEMBRANE; CELL-DEATH; GROWTH; EXPRESSION; FAMILY; IDENTIFICATION; GENES	Copines are highly conserved proteins with lipid-binding activities found in animals, plants, and protists. They contain two calcium-dependent phospholipid binding C2 domains at the amino terminus and a VWA domain at the carboxyl terminus. The biological roles of most copines are not understood and the biochemical properties required for their functions are largely unknown. The Arabidopsis copine gene BON1/CPN1 is a negative regulator of cell death and defense responses. Here we probed the potential biochemical activities of BON1 through mutagenic studies. We found that mutations of aspartates in the C2 domains did not alter plasma membrane localization but compromised BON1 activity. Mutation at putative myristoylation residue glycine 2 altered plasma membrane localization of BON1 and rendered BON1 inactive. Mass spectrometry analysis of BON1 further suggests that the N-peptide of BON1 is modified. Furthermore, mutations that affect the interaction between BON1 and its functional partner BAP1 abolished BON1 function. This analysis reveals an unanticipated regulation of copine protein localization and function by calcium and lipid modification and suggests an important role in protein-protein interaction for the VWA domain of copines.	[Li, Yongqing; Gou, Mingyue; Hua, Jian] Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA; [Sun, Qi] Cornell Univ, Biocomp Serv Unit, Ithaca, NY 14853 USA	Cornell University; Cornell University	Hua, JA (corresponding author), Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA.	yongqing@berkeley.edu; jh299@cornell.edu	Gou, Mingyue/AAE-2018-2021		National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This work was supported, in whole or in part, by a grant from the National Science Foundation (to J. H.).	Banci L, 2002, J BIOL CHEM, V277, P12988, DOI 10.1074/jbc.M106875200; Batistic O, 2008, PLANT CELL, V20, P1346, DOI 10.1105/tpc.108.058123; Bayer M, 2009, SCIENCE, V323, P1485, DOI 10.1126/science.1167784; Caudell EG, 2000, BIOCHEMISTRY-US, V39, P13034, DOI 10.1021/bi001250v; Church DL, 2003, GENETICS, V165, P563; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Creutz CE, 1998, J BIOL CHEM, V273, P1393, DOI 10.1074/jbc.273.3.1393; Damer CK, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-46; Damer CK, 2007, EUKARYOT CELL, V6, P430, DOI 10.1128/EC.00322-06; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; DE VRIES JS, 2006, PLANT J, V45, P31; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Hua J, 2001, GENE DEV, V15, P2263, DOI 10.1101/gad.918101; Jambunathan N, 2001, PLANT CELL, V13, P2225, DOI 10.1105/tpc.13.10.2225; James P, 1996, GENETICS, V144, P1425; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Kierszniowska S, 2009, MOL CELL PROTEOMICS, V8, P612, DOI 10.1074/mcp.M800346-MCP200; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Liu JX, 2005, PLANTA, V221, P85, DOI 10.1007/s00425-004-1413-4; Mosher RA, 2006, PLANT CELL, V18, P1750, DOI 10.1105/tpc.105.039677; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagasaki N, 2008, FEBS J, V275, P2267, DOI 10.1111/j.1742-4658.2008.06379.x; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Thompson GA, 2000, PROG LIPID RES, V39, P19, DOI 10.1016/S0163-7827(99)00014-4; Tomsig JL, 2004, BIOCHEM J, V378, P1089, DOI 10.1042/BJ20031654; Tomsig JL, 2003, J BIOL CHEM, V278, P10048, DOI 10.1074/jbc.M212632200; Tomsig JL, 2000, BIOCHEMISTRY-US, V39, P16163, DOI 10.1021/bi0019949; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Yang HJ, 2006, PLANT J, V48, P238, DOI 10.1111/j.1365-313X.2006.02869.x; Yang SH, 2006, PLANT J, V45, P166, DOI 10.1111/j.1365-313X.2005.02585.x; Yang SH, 2004, PLANT CELL, V16, P1060, DOI 10.1105/tpc.020479; Zhai ZY, 2009, PLANT PHYSIOL, V149, P642, DOI 10.1104/pp.108.130260	34	17	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29884	29891		10.1074/jbc.M109.066100	http://dx.doi.org/10.1074/jbc.M109.066100			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20634289	Green Published, hybrid			2022-12-25	WOS:000281984300025
J	Luo, JY; Tang, M; Huang, JY; He, BC; Gao, JL; Chen, LA; Zuo, GW; Zhang, WL; Luo, Q; Shi, QO; Zhang, BQ; Bi, Y; Luo, XJ; Jiang, W; Su, YX; Shen, JK; Kim, SH; Huang, EY; Gao, YH; Zhou, JZ; Yang, K; Luu, HH; Pan, XC; Haydon, RC; Deng, ZL; He, TC				Luo, Jinyong; Tang, Min; Huang, Jiayi; He, Bai-Cheng; Gao, Jian-Li; Chen, Liang; Zuo, Guo-Wei; Zhang, Wenli; Luo, Qing; Shi, Qiong; Zhang, Bing-Qiang; Bi, Yang; Luo, Xiaoji; Jiang, Wei; Su, Yuxi; Shen, Jikun; Kim, Stephanie H.; Huang, Enyi; Gao, Yanhong; Zhou, Jian-Zhong; Yang, Ke; Luu, Hue H.; Pan, Xiaochuan; Haydon, Rex C.; Deng, Zhong-Liang; He, Tong-Chuan			TGF beta/BMP Type I Receptors ALK1 and ALK2 Are Essential for BMP9-induced Osteogenic Signaling in Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEINS; OSTEOBLAST DIFFERENTIATION; GROWTH-FACTOR; KINASE RECEPTOR; BMP; GENE; EXPRESSION; SMAD6; GENERATION; INDUCTION	Mesenchymal stem cells (MSCs) are bone marrow stromal cells that can differentiate into multiple lineages. We previously demonstrated that BMP9 is one of the most potent BMPs to induce osteogenic differentiation of MSCs. BMP9 is one of the least studied BMPs. Whereas ALK1, ALK5, and/or endoglin have recently been reported as potential BMP9 type I receptors in endothelial cells, little is known about type I receptor involvement in BMP9-induced osteogenic differentiation in MSCs. Here, we conduct a comprehensive analysis of the functional role of seven type I receptors in BMP9-induced osteogenic signaling in MSCs. We have found that most of the seven type I receptors are expressed in MSCs. However, using dominant-negative mutants for the seven type I receptors, we demonstrate that only ALK1 and ALK2 mutants effectively inhibit BMP9-induced osteogenic differentiation in vitro and ectopic ossification in MSC implantation assays. Protein fragment complementation assays demonstrate that ALK1 and ALK2 directly interact with BMP9. Likewise, RNAi silencing of ALK1 and ALK2 expression inhibits BMP9-induced BMPR-Smad activity and osteogenic differentiation in MSCs both in vitro and in vivo. Therefore, our results strongly suggest that ALK1 and ALK2 may play an important role in mediating BMP9-induced osteogenic differentiation. These findings should further aid us in understanding the molecular mechanism through which BMP9 regulates osteogenic differentiation of MSCs.	[Luo, Jinyong; Huang, Jiayi; He, Bai-Cheng; Gao, Jian-Li; Chen, Liang; Zuo, Guo-Wei; Zhang, Wenli; Luo, Qing; Shi, Qiong; Zhang, Bing-Qiang; Bi, Yang; Luo, Xiaoji; Jiang, Wei; Su, Yuxi; Shen, Jikun; Kim, Stephanie H.; Huang, Enyi; Gao, Yanhong; Zhou, Jian-Zhong; Yang, Ke; Luu, Hue H.; Haydon, Rex C.; Deng, Zhong-Liang; He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA; [Pan, Xiaochuan] Univ Chicago, Med Ctr, Dept Radiol, Chicago, IL 60637 USA; [Luo, Jinyong; Tang, Min; Huang, Jiayi; He, Bai-Cheng; Chen, Liang; Zuo, Guo-Wei; Luo, Qing; Shi, Qiong; Zhang, Bing-Qiang; Bi, Yang; Luo, Xiaoji; Su, Yuxi; Zhou, Jian-Zhong; Deng, Zhong-Liang; He, Tong-Chuan] Chongqing Med Univ, Affiliated Hosp, Chinese Minist Educ, Key Lab Diagnost Med Designated, Chongqing 400016, Peoples R China; [Zhang, Wenli] Sichuan Univ, W China Hosp, Dept Orthopaed Surg, Chengdu 610065, Sichuan, Peoples R China; [Huang, Enyi] Chongqing Univ, Sch Bioengn, Chongqing 400044, Peoples R China; [Gao, Yanhong] Jiatong Univ, Xinhua Hosp Shanghai, Dept Geriatr, Shanghai 200092, Peoples R China; [Yang, Ke] Third Mil Med Univ, Dept Cell Biol, Chongqing 400030, Peoples R China	University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Sichuan University; Chongqing University; Army Medical University	He, TC (corresponding author), Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, 5841 S Maryland Ave,MC3079, Chicago, IL 60637 USA.	tche@surgery.bsd.uchicago.edu	GAO, JianLi/J-4997-2017	GAO, JianLi/0000-0002-5977-0021; tang, min/0000-0001-5633-0816; Zhang, Wenli/0000-0002-4989-7950	National Institutes of Health [CA106569, AT004418, AR50142, AR054381]; Brinson Foundation; Orthopaedic Research and Education Foundation; Ministry of Science and Technology of China [2007AA2z400]; Natural Science Foundation of China [30901530, 30800658, 30772211]; Chongqing Science and Technology Commission [2008BB5396, 2009BB5060]; NATIONAL CANCER INSTITUTE [R01CA106569] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR054381, K08AR050142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brinson Foundation; Orthopaedic Research and Education Foundation; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Commission(Natural Science Foundation Project of CQ CSTC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by Research Grants CA106569, AT004418, AR50142, and AR054381 (to T.-C. H., R. C. H., and H. H. L.) from the National Institutes of Health. This work was also supported by The Brinson Foundation (to T.-C. H.), the Orthopaedic Research and Education Foundation (to R. C. H. and H. H. L.), the 863 Program of Ministry of Science and Technology of China (2007AA2z400, to T.-C. H. and Z.-L. D.), the Natural Science Foundation of China (30901530, to X. L., 30800658, to J.L., and 30772211, to Z.-L. D.), and the Natural Science Foundation Project of Chongqing Science and Technology Commission 2008BB5396 (to L. C. and M. T.) and 2009BB5060 (to J.L.).	Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Chen C, 2003, NAT BIOTECHNOL, V21, P294, DOI 10.1038/nbt795; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Gu ZY, 1999, DEVELOPMENT, V126, P2551; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Jane JA, 2002, MOL THER, V6, P464, DOI 10.1006/mthe.2002.0691; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo Q, 2007, GENE, V395, P160, DOI 10.1016/j.gene.2007.02.030; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Massague J, 1996, CANCER SURV, V27, P41; Miller AF, 2000, J BIOL CHEM, V275, P17937, DOI 10.1074/jbc.275.24.17937; Mishina Y, 1999, DEV BIOL, V213, P314, DOI 10.1006/dbio.1999.9378; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ploemacher RE, 1999, LEUKEMIA, V13, P428, DOI 10.1038/sj.leu.2401363; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Roelen BAJ, 1997, DEV DYNAM, V209, P418, DOI 10.1002/(SICI)1097-0177(199708)209:4<418::AID-AJA9>3.0.CO;2-L; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Shao ES, 2009, BLOOD, V114, P2197, DOI 10.1182/blood-2009-01-199166; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; VAN DINTHER M, 2010, J BONE MINER RES, V25, P1208; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167; Zhao M, 2002, J CELL BIOL, V157, P1049, DOI 10.1083/jcb.200109012; Zhou L, 2002, BIOTECHNIQUES, V33, P1126, DOI 10.2144/02335dd07	50	147	170	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29588	29598		10.1074/jbc.M110.130518	http://dx.doi.org/10.1074/jbc.M110.130518			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20628059	hybrid, Green Published			2022-12-25	WOS:000281740100060
J	Park, N; Skern, T; Gustin, KE				Park, Nogi; Skern, Tim; Gustin, Kurt E.			Specific Cleavage of the Nuclear Pore Complex Protein Nup62 by a Viral Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLIOVIRUS-INFECTED CELLS; 2A PROTEINASE; NUCLEOCYTOPLASMIC TRANSPORT; SUBSTRATE RECOGNITION; REPEAT REGIONS; IN-VITRO; IMPORT; RHINOVIRUS; NUCLEOPORINS; SITE	Previous work has shown that several nucleoporins, including Nup62 are degraded in cells infected with human rhinovirus (HRV) and poliovirus (PV) and that this contributes to the disruption of certain nuclear transport pathways. In this study, the mechanisms underlying proteolysis of Nup62 have been investigated. Analysis of Nup62 in lysates from HRV-infected cells revealed that Nup62 was cleaved at multiple sites during viral infection. The addition of purified HRV2 2A protease (2A(pro)) to uninfected HeLa whole cell lysates resulted in the cleavage of Nup62, suggesting that 2A(pro) is a major contributor to Nup62 processing. The ability of purified 2A(pro) to cleave bacterially expressed and purified Nup62 demonstrated that 2A(pro) directly cleaves Nup62 in vitro. Site-directed mutagenesis of putative cleavage sites in Nup62 identified six different positions that are cleaved by 2A(pro) in vitro. This analysis revealed that 2A(pro) cleavage sites were located between amino acids 103 and 298 in Nup62 and suggested that the N-terminal FG-rich region of Nup62 was released from the nuclear pore complex in infected cells. Analysis of HRV- and PV-infected cells using domain-specific antibodies confirmed that this was indeed the case. These results are consistent with a model whereby PV and HRV disrupt nucleo-cytoplasmic trafficking by selectively removing FG repeat domains from a subset of nuclear pore complex proteins.	[Park, Nogi; Gustin, Kurt E.] Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, Phoenix, AZ 85004 USA; [Skern, Tim] Med Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria	University of Arizona; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Gustin, KE (corresponding author), Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, 425 N 5th St, Phoenix, AZ 85004 USA.	kgustin@arizoan.edu	Skern, Tim/AAC-1732-2022; Gustin, Kurt/A-5003-2016	Skern, Tim/0000-0001-8865-5500; Gustin, Kurt/0000-0002-1824-9002	National Institutes of Health [AI059467, AI064432]; National Institutes of Health/NCRR COBRE [P20 RR15587]; INBRE [P20 RR016454]; Austrian Science Fund [P20889]; American Cancer Society [RSG 109705]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015587, P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI064432, R56AI059467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/NCRR COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); INBRE; Austrian Science Fund(Austrian Science Fund (FWF)); American Cancer Society(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI059467 and AI064432 and by National Institutes of Health/NCRR COBRE Grant P20 RR15587 and INBRE Grant P20 RR016454 (to K. E. G.). This work was also supported by Austrian Science Fund Grant P20889 (to T. S.) and by American Cancer Society Grant RSG 109705 (to K. E. G.).	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; ALDABE R, 1995, BIOCHEM BIOPH RES CO, V215, P928, DOI 10.1006/bbrc.1995.2553; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Belov GA, 2004, J VIROL, V78, P10166, DOI 10.1128/JVI.78.18.10166-10177.2004; Blom N, 1996, PROTEIN SCI, V5, P2203, DOI 10.1002/pro.5560051107; BUSS F, 1995, J CELL BIOL, V128, P251, DOI 10.1083/jcb.128.3.251; Castello A, 2009, J CELL SCI, V122, P3799, DOI 10.1242/jcs.055988; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; Ghildyal R, 2009, J VIROL, V83, P7349, DOI 10.1128/JVI.01748-08; Gradi A, 2004, J VIROL, V78, P3271, DOI 10.1128/JVI.78.7.3271-3278.2004; Gradi A, 2003, J VIROL, V77, P5026, DOI 10.1128/JVI.77.8.5026-5029.2003; Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; HELLEN CUT, 1992, J VIROL, V66, P3330, DOI 10.1128/JVI.66.6.3330-3338.1992; LAMPHEAR BJ, 1993, J BIOL CHEM, V268, P19200; LIEBIG HD, 1993, BIOCHEMISTRY-US, V32, P7581, DOI 10.1021/bi00080a033; LUBAS WA, 1995, BIOCHEMISTRY-US, V34, P1686, DOI 10.1021/bi00005a025; McBride AE, 1996, P NATL ACAD SCI USA, V93, P2296, DOI 10.1073/pnas.93.6.2296; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; MOLLA A, 1993, J VIROL, V67, P4688, DOI 10.1128/JVI.67.8.4688-4695.1993; Neznanov N, 2005, J BIOL CHEM, V280, P24153, DOI 10.1074/jbc.M502303200; OLSON MOJ, 1981, EXP CELL RES, V135, P259, DOI 10.1016/0014-4827(81)90161-0; PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603; Park N, 2008, J VIROL, V82, P1647, DOI 10.1128/JVI.01670-07; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Percipalle P, 1997, J MOL BIOL, V266, P722, DOI 10.1006/jmbi.1996.0801; Petersen JFW, 1999, EMBO J, V18, P5463, DOI 10.1093/emboj/18.20.5463; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SKERN T, 1994, METHOD ENZYMOL, V244, P583; Skern Tim, 2002, P199; SOMMERGRUBER W, 1992, J BIOL CHEM, V267, P22639; Sousa C, 2006, FEBS LETT, V580, P5713, DOI 10.1016/j.febslet.2006.09.023; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Waggoner S, 1998, J VIROL, V72, P6699, DOI 10.1128/JVI.72.8.6699-6709.1998; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; Zeitler B, 2004, J CELL BIOL, V167, P583, DOI 10.1083/jcb.200407156	48	78	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28796	28805		10.1074/jbc.M110.143404	http://dx.doi.org/10.1074/jbc.M110.143404			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20622012	hybrid, Green Published			2022-12-25	WOS:000281594000045
J	Haflidadottir, BS; Bergsteinsdottir, K; Praetorius, C; Steingrimsson, E				Haflidadottir, Benedikta S.; Bergsteinsdottir, Kristin; Praetorius, Christian; Steingrimsson, Eirikur			miR-148 Regulates Mitf in Melanoma Cells	PLOS ONE			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; MICRORNA EXPRESSION PROFILE; MALIGNANT-MELANOMA; LINEAGE SURVIVAL; MIRNA EXPRESSION; MESSENGER-RNA; GENE; MELANOCYTES; TARGET; CANCER	The Microphthalmia associated transcription factor (Mitf) is an important regulator in melanocyte development and has been shown to be involved in melanoma progression. The current model for the role of Mitf in melanoma assumes that the total activity of the protein is tightly regulated in order to secure cell proliferation. Previous research has shown that regulation of Mitf is complex and involves regulation of expression, splicing, protein stability and post-translational modifications. Here we show that microRNAs (miRNAs) are also involved in regulating Mitf in melanoma cells. Sequence analysis revealed conserved binding sites for several miRNAs in the Mitf 3'UTR sequence. Furthermore, miR-148 was shown to affect Mitf mRNA expression in melanoma cells through a conserved binding site in the 3'UTR sequence of mouse and human Mitf. In addition we confirm the previously reported effects of miR-137 on Mitf. Other miRNAs, miR-27a, miR-32 and miR-124 which all have conserved binding sites in the Mitf 3'UTR sequence did not have effects on Mitf. Our data show that miR-148 and miR-137 present an additional level of regulating Mitf expression in melanocytes and melanoma cells. Loss of this regulation, either by mutations or by shortening of the 3'UTR sequence, is therefore a likely factor in melanoma formation and/or progression.	[Haflidadottir, Benedikta S.; Bergsteinsdottir, Kristin; Praetorius, Christian; Steingrimsson, Eirikur] Univ Iceland, Dept Biochem & Mol Biol, Biomed Ctr, Fac Med, Reykjavik, Iceland	University of Iceland	Haflidadottir, BS (corresponding author), Univ Iceland, Dept Biochem & Mol Biol, Biomed Ctr, Fac Med, Reykjavik, Iceland.	eirikurs@hi.is		Praetorius, Christian/0000-0001-7514-5333; Steingrimsson, Eirikur/0000-0001-5826-7486	Icelandic Research Fund; University of Iceland Research Fund	Icelandic Research Fund; University of Iceland Research Fund	This work was supported by grants from the Icelandic Research Fund (www.rannis.is) and the University of Iceland Research Fund (www.hi.is/en/research_degrees). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2007, INVEST OPHTH VIS SCI, V48, P3962, DOI 10.1167/iovs.06-1221; BANDRES E, 2009, INT J CANC; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; Bora N, 1998, DEV DYNAM, V213, P283, DOI 10.1002/(SICI)1097-0177(199811)213:3<283::AID-AJA5>3.0.CO;2-H; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; GOSWAMI S, 2010, J BIOL CHEM; Hallsson JH, 2007, PIGM CELL RES, V20, P185, DOI 10.1111/j.1600-0749.2007.00373.x; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Huang ZM, 2009, J DIGEST DIS, V10, P188, DOI 10.1111/j.1751-2980.2009.00384.x; HUGHES MJ, 1993, J BIOL CHEM, V268, P20687; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Katada T, 2009, INT J ONCOL, V34, P537, DOI 10.3892/ijo_00000179; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McGill GG, 2006, J BIOL CHEM, V281, P10365, DOI 10.1074/jbc.M513094200; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Miller AJ, 2005, J BIOL CHEM, V280, P146, DOI 10.1074/jbc.M411757200; Mueller DW, 2009, BRIT J CANCER, V101, P551, DOI 10.1038/sj.bjc.6605204; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Murakami H, 2005, PIGM CELL RES, V18, P265, DOI 10.1111/j.1600-0749.2005.00234.x; Nakayama A, 1998, MECH DEVELOP, V70, P155, DOI 10.1016/S0925-4773(97)00188-3; Nguyen MTT, 2000, DEVELOPMENT, V127, P3581; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Selzer E, 2002, CANCER RES, V62, P2098; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Takeda K, 2000, HUM MOL GENET, V9, P125, DOI 10.1093/hmg/9.1.125; Vachtenheim J, 1999, CELL MOL BIOL, V45, P1075; Vachtenheim J, 2001, J INVEST DERMATOL, V117, P1505, DOI 10.1046/j.0022-202x.2001.01563.x; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wellbrock C, 2005, J CELL BIOL, V170, P703, DOI 10.1083/jcb.200505059; Wren JD, 2000, AM J HUM GENET, V67, P345, DOI 10.1086/303013; Wu M, 2000, GENE DEV, V14, P301; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Xu WD, 2000, EXP CELL RES, V255, P135, DOI 10.1006/excr.2000.4803; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	62	84	90	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11574	10.1371/journal.pone.0011574	http://dx.doi.org/10.1371/journal.pone.0011574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644734	Green Submitted, Green Published, gold			2022-12-25	WOS:000279884900014
J	Bjork, JM; Smith, AR; Chen, G; Hommer, DW				Bjork, James M.; Smith, Ashley R.; Chen, Gang; Hommer, Daniel W.			Adolescents, Adults and Rewards: Comparing Motivational Neurocircuitry Recruitment Using fMRI	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; EVENT-RELATED FMRI; ORBITOFRONTAL CORTEX; BRAIN ACTIVITY; RISK-TAKING; CHILDHOOD; CHILDREN; REGIONS; ANTICIPATION; NEUROSCIENCE	Background: Adolescent risk-taking, including behaviors resulting in injury or death, has been attributed in part to maturational differences in mesolimbic incentive-motivational neurocircuitry, including ostensible oversensitivity of the nucleus accumbens (NAcc) to rewards. Methodology/Principal Findings: To test whether adolescents showed increased NAcc activation by cues for rewards, or by delivery of rewards, we scanned 24 adolescents (age 12-17) and 24 adults age (22-42) with functional magnetic resonance imaging while they performed a monetary incentive delay (MID) task. The MID task was configured to temporally disentangle potential reward or potential loss anticipation-related brain signal from reward or loss notification-related signal. Subjects saw cues signaling opportunities to win or avoid losing $0, $.50, or $5 for responding quickly to a subsequent target. Subjects then viewed feedback of their trial success after a variable interval from cue presentation of between 6 to 17 s. Adolescents showed reduced NAcc recruitment by reward-predictive cues compared to adult controls in a linear contrast with non-incentive cues, and in a volume-of-interest analysis of signal change in the NAcc. In contrast, adolescents showed little difference in striatal and frontocortical responsiveness to reward deliveries compared to adults. Conclusions/Significance: In light of divergent developmental difference findings between neuroimaging incentive paradigms (as well as at different stages within the same task), these data suggest that maturational differences in incentive-motivational neurocircuitry: 1) may be sensitive to nuances of incentive tasks or stimuli, such as behavioral or learning contingencies, and 2) may be specific to the component of the instrumental behavior (such as anticipation versus notification).	[Bjork, James M.] NIDA, Div Clin Neurosci & Behav Res, NIH, Bethesda, MD 20892 USA; [Smith, Ashley R.; Hommer, Daniel W.] NIAAA, Lab Clin & Translat Studies, NIH, Bethesda, MD USA; [Chen, Gang] NIMH, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Bjork, JM (corresponding author), NIDA, Div Clin Neurosci & Behav Res, NIH, Bethesda, MD 20892 USA.	jbjork@mail.nih.gov	Smith, Ashley/GZB-0298-2022; Bjork, James/Q-5108-2019	Bjork, James/0000-0003-0593-3291; Lauwereyns, Jan/0000-0003-0551-2550	National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000081] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was sponsored by intramural research funds of the National Institute on Alcohol Abuse and Alcoholism (http://www.niaaa.nih.gov/ResearchInformation/IntramuralResearch/AboutDICBR/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjork JM, 2008, NEUROIMAGE, V42, P1609, DOI 10.1016/j.neuroimage.2008.06.035; Bjork JM, 2008, ADDICTION, V103, P1308, DOI 10.1111/j.1360-0443.2008.02250.x; Bjork JM, 2007, J NEUROSCI, V27, P4839, DOI 10.1523/JNEUROSCI.5469-06.2007; Bjork JM, 2007, BEHAV BRAIN RES, V177, P165, DOI 10.1016/j.bbr.2006.10.034; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; BJORK JM, 2009, J CHILD PSYCHOL PSYC; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dahl R E, 1996, Semin Pediatr Neurol, V3, P44, DOI 10.1016/S1071-9091(96)80028-3; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dillon DG, 2008, PSYCHOPHYSIOLOGY, V45, P36, DOI 10.1111/j.1469-8986.2007.00594.x; Durston S, 2001, J AM ACAD CHILD PSY, V40, P1012, DOI 10.1097/00004583-200109000-00009; Elliott R, 2004, NEUROIMAGE, V21, P984, DOI 10.1016/j.neuroimage.2003.10.010; Elliott R, 2003, J NEUROSCI, V23, P303; EPSTEIN R, 2007, MYTH TEEN BRAIN, P57; Ernst M, 2005, NEUROIMAGE, V25, P1279, DOI 10.1016/j.neuroimage.2004.12.038; Eshel N, 2007, NEUROPSYCHOLOGIA, V45, P1270, DOI 10.1016/j.neuropsychologia.2006.10.004; Fergusson DM, 2007, DRUG ALCOHOL DEPEN, V88, pS14, DOI 10.1016/j.drugalcdep.2006.12.011; FERGUSSON DM, 1995, J ABNORM CHILD PSYCH, V23, P183, DOI 10.1007/BF01447088; Figner B, 2009, J EXP PSYCHOL LEARN, V35, P709, DOI 10.1037/a0014983; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; GARDNER W, 1991, ADOLESCENT RISK TAKI, P41; GEIER CF, 2009, CEREB CORTEX; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Guyer AE, 2006, J NEUROSCI, V26, P6399, DOI 10.1523/JNEUROSCI.0666-06.2006; Hariri AR, 2006, J NEUROSCI, V26, P13213, DOI 10.1523/JNEUROSCI.3446-06.2006; Holm SM, 2009, J ADOLESCENT HEALTH, V45, P326, DOI 10.1016/j.jadohealth.2009.04.001; Johnson SB, 2009, J ADOLESCENT HEALTH, V45, P216, DOI 10.1016/j.jadohealth.2009.05.016; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Pardini D, 2007, DRUG ALCOHOL DEPEN, V88, pS38, DOI 10.1016/j.drugalcdep.2006.12.014; Reich W, 2000, J AM ACAD CHILD PSY, V39, P59, DOI 10.1097/00004583-200001000-00017; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Scheres A, 2007, BIOL PSYCHIAT, V61, P720, DOI 10.1016/j.biopsych.2006.04.042; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; SOMERVILLE LH, 2009, BRAIN COGN; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; STEINBERG L, 2009, BRAIN COGN; Strohle A, 2008, NEUROIMAGE, V39, P966, DOI 10.1016/j.neuroimage.2007.09.044; van Hell HH, 2010, EUR NEUROPSYCHOPHARM, V20, P153, DOI 10.1016/j.euroneuro.2009.11.010; Van Leijenhorst L, 2010, NEUROIMAGE, V51, P345, DOI 10.1016/j.neuroimage.2010.02.038; Van Leijenhorst L, 2010, CEREB CORTEX, V20, P61, DOI 10.1093/cercor/bhp078; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x	48	180	182	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11440	10.1371/journal.pone.0011440	http://dx.doi.org/10.1371/journal.pone.0011440			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625430	Green Published, Green Submitted, gold			2022-12-25	WOS:000279522500008
J	Galichet, C; Lovell-Badge, R; Rizzoti, K				Galichet, Christophe; Lovell-Badge, Robin; Rizzoti, Karine			Nestin-Cre Mice Are Affected by Hypopituitarism, Which Is Not Due to Significant Activity of the Transgene in the Pituitary Gland	PLOS ONE			English	Article							STEM-CELLS; MOUSE; GROWTH; GENE; RECOMBINATION; NEUROGENESIS; DEFICIENCY; ACTIVATION; EXPRESSION; HORMONE	Nestin-Cre mice express Cre recombinase under control of the rat nestin promoter and central nervous system (CNS) enhancer. While endogenous Nestin is expressed in some other tissues including the pituitary gland, Nestin-Cre mice induce recombination predominantly in the CNS. For this reason, they have been widely used to explore gene function or cell fate in the latter. Pituitary hormonal deficiencies, or hypopituitarism, are associated with a wide range of symptoms and with a significant morbidity. These can have a neural and/or a pituitary origin as the gland's secretions are controlled by the hypothalamus. We report here that Nestin-Cre mice themselves are affected by mild hypopituitarism. Hence, physiological consequences are expected, especially in combination with defects resulting from Cre mediated deletion of any gene under investigation. To further investigate the origin of this phenotype, we re-examined the activity of the transgene. We compared it with expression of Nestin itself in the context of the hypothalamo-pituitary axis, especially in the light of a recent report showing pituitary Nestin-Cre activity, which contrasts with previous data. Our results disagree with those of this recent study and do not support the claim that Nestin positive cells are present in the pituitary anlagen, the Rathke's pouch (RP). Moreover we did not observe any significant activity in the post-natal pituitary, in agreement with the initial report.	[Galichet, Christophe; Lovell-Badge, Robin; Rizzoti, Karine] MRC Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, London, England	MRC National Institute for Medical Research	Galichet, C (corresponding author), MRC Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, London, England.	krizzot@nimr.mrc.ac.uk	Galichet, Christophe/AAJ-5678-2021; Rizzoti, Karine/AAW-1090-2021	Galichet, Christophe/0000-0003-0244-9381; Rizzoti, Karine/0000-0003-0711-5452; Lovell-Badge, Robin/0000-0001-9364-4179	Medical Research Council [U117512772]; MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council (U117512772). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatzoglou KS, 2009, EARLY HUM DEV, V85, P705, DOI 10.1016/j.earlhumdev.2009.08.057; Chen JH, 2005, ENDOCRINOLOGY, V146, P3985, DOI 10.1210/en.2005-0185; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Gleiberman AS, 2008, P NATL ACAD SCI USA, V105, P6332, DOI 10.1073/pnas.0801644105; Higashi AY, 2009, J IMMUNOL, V182, P5633, DOI 10.4049/jimmunol.0802413; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Kelberman D, 2009, ENDOCR REV, V30, P790, DOI 10.1210/er.2009-0008; Krylyshkina O, 2005, ENDOCRINOLOGY, V146, P2376, DOI 10.1210/en.2004-1209; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li H, 1996, EMBO J, V15, P714, DOI 10.1002/j.1460-2075.1996.tb00407.x; Lichtenwalner RJ, 2006, J NEUROSCI RES, V83, P199, DOI 10.1002/jnr.20719; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; McGuinness L, 2003, ENDOCRINOLOGY, V144, P720, DOI 10.1210/en.2002-220847; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vankelecom H, 2007, SEMIN CELL DEV BIOL, V18, P559, DOI 10.1016/j.semcdb.2007.04.006; Wettschureck N, 2005, MOL CELL BIOL, V25, P1942, DOI 10.1128/MCB.25.5.1942-1948.2005; Young KM, 2010, GLIA, V58, P943, DOI 10.1002/glia.20976	25	55	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11443	10.1371/journal.pone.0011443	http://dx.doi.org/10.1371/journal.pone.0011443			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625432	gold, Green Published, Green Submitted			2022-12-25	WOS:000279522500010
J	Zhang, JX; Yan, XD; Shi, JF; Gong, QY; Weng, XC; Liu, YJ				Zhang, Jiaxing; Yan, Xiaodan; Shi, Jinfu; Gong, Qiyong; Weng, Xuchu; Liu, Yijun			Structural Modifications of the Brain in Acclimatization to High-Altitude	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; VOXEL-BASED MORPHOMETRY; HYPOXIC VENTILATORY RESPONSIVENESS; MILD COGNITIVE IMPAIRMENT; ANTERIOR CINGULATE CORTEX; CHRONIC MOUNTAIN-SICKNESS; SUBJECT DIFFUSION DATA; FRACTIONAL ANISOTROPY; SPATIAL STATISTICS; PREFRONTAL CORTEX	Adaptive changes in respiratory and cardiovascular responses at high altitude (HA) have been well clarified. However, the central mechanisms underlying HA acclimatization remain unclear. Using voxel-based morphometry (VBM) and diffusion tensor imaging (DTI) with fractional anisotropy (FA) calculation, we investigated 28 Han immigrant residents (17-22 yr) born and raised at HA of 2616-4200 m in Qinghai-Tibetan Plateau for at least 17 years and who currently attended college at sea-level (SL). Their family migrated from SL to HA 2-3 generations ago and has resided at HA ever since. Control subjects were matched SL residents. HA residents (vs. SL) showed decreased grey matter volume in the bilateral anterior insula, right anterior cingulate cortex, bilateral prefrontal cortex, left precentral cortex, and right lingual cortex. HA residents (vs. SL) had significantly higher FA mainly in the bilateral anterior limb of internal capsule, bilateral superior and inferior longitudinal fasciculus, corpus callosum, bilateral superior corona radiata, bilateral anterior external capsule, right posterior cingulum, and right corticospinal tract. Higher FA values in those regions were associated with decreased or unchanged radial diffusivity coinciding with no change of longitudinal diffusivity in HA vs. SL group. Conversely, HA residents had lower FA in the left optic radiation and left superior longitudinal fasciculus. Our data demonstrates that HA acclimatization is associated with brain structural modifications, including the loss of regional cortical grey matter accompanied by changes in the white matter, which may underlie the physiological adaptation of residents at HA.	[Zhang, Jiaxing; Shi, Jinfu; Weng, Xuchu] Chinese Acad Sci, Inst Psychol, Lab Higher Brain Funct, Beijing 100101, Peoples R China; [Zhang, Jiaxing] Xiamen Univ, Coll Med, Dept Physiol & Neurobiol, Xiamen, Peoples R China; [Yan, Xiaodan] NYU, Langone Med Ctr, New York, NY USA; [Gong, Qiyong] Sichuan Univ, W China Hosp, Huaxi Magnet Resonance Res Ctr, Chengdu 610064, Peoples R China; [Liu, Yijun] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA; [Liu, Yijun] Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA	Chinese Academy of Sciences; Institute of Psychology, CAS; Xiamen University; New York University; NYU Langone Medical Center; Sichuan University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Zhang, JX (corresponding author), Chinese Acad Sci, Inst Psychol, Lab Higher Brain Funct, Beijing 100101, Peoples R China.	xzhangj@163.com	Gong, Qiyong/W-3052-2019	Gong, Qiyong/0000-0002-5912-4871	National Science Foundation of China [30425008, 60628101]; Ministry of Science and Technology [2007CB512300]; China Postdoctoral Science Foundation [20060390129]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was funded by National Science Foundation of China (Project No. 30425008, No. 60628101), Ministry of Science and Technology (Project No. 2007CB512300) and China Postdoctoral Science Foundation (Project No. 20060390129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Bava S, 2010, BRAIN RES, V1327, P38, DOI 10.1016/j.brainres.2010.02.066; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beppu T, 2005, SURG NEUROL, V63, P56, DOI 10.1016/j.surneu.2004.02.034; Bernardi L, 1998, CLIN SCI, V95, P565, DOI 10.1042/cs0950565; Binks AP, 2008, J APPL PHYSIOL, V104, P212, DOI 10.1152/japplphysiol.00069.2007; Boero JA, 1999, J APPL PHYSIOL, V86, P1211, DOI 10.1152/jappl.1999.86.4.1211; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Brutsaert TD, 1999, AM J HUM BIOL, V11, P383, DOI 10.1002/(SICI)1520-6300(1999)11:3<383::AID-AJHB9>3.0.CO;2-X; BURNS SM, 1985, BRAIN RES, V340, P71, DOI 10.1016/0006-8993(85)90774-7; Chang LD, 2008, J NEUROIMMUNE PHARM, V3, P265, DOI 10.1007/s11481-008-9120-8; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Claydon VE, 2008, STROKE, V39, P336, DOI 10.1161/STROKEAHA.107.491498; Concha L, 2005, ANN NEUROL, V57, P188, DOI 10.1002/ana.20334; Constantinidis Christos, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P444, DOI 10.3758/CABN.4.4.444; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Curran LS, 1997, J APPL PHYSIOL, V83, P2098, DOI 10.1152/jappl.1997.83.6.2098; Dani JA, 2007, NAT NEUROSCI, V10, P403, DOI 10.1038/nn0407-403; Davatzikos C, 2004, NEUROIMAGE, V23, P17, DOI 10.1016/j.neuroimage.2004.05.010; Davenport PW, 2009, RESP PHYSIOL NEUROBI, V167, P72, DOI 10.1016/j.resp.2008.10.001; FRISANCHO AR, 1975, SCIENCE, V187, P313, DOI 10.1126/science.1089311; FRISANCHO AR, 1977, INT J BIOMETEOROL, V21, P135, DOI 10.1007/BF01553707; FRISANCHO AR, 1973, J APPL PHYSIOL, V34, P176, DOI 10.1152/jappl.1973.34.2.176; Frisancho AR, 1999, AM J PHYS ANTHROPOL, V109, P295, DOI 10.1002/(SICI)1096-8644(199907)109:3<295::AID-AJPA2>3.0.CO;2-U; FRISANCHO AR, 1995, AM J PHYS ANTHROPOL, V96, P431, DOI 10.1002/ajpa.1330960408; Gao W, 2009, AM J NEURORADIOL, V30, P290, DOI 10.3174/ajnr.A1363; Giuliani NR, 2005, SCHIZOPHR RES, V74, P135, DOI 10.1016/j.schres.2004.08.019; Green AL, 2008, EXP PHYSIOL, V93, P1022, DOI 10.1113/expphysiol.2007.039461; Gulani V, 2006, J NEURO-OPHTHALMOL, V26, P51, DOI 10.1097/01.wno.0000205978.86281.3e; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; HOCHACHKA PW, 1994, J CEREBR BLOOD F MET, V14, P671, DOI 10.1038/jcbfm.1994.84; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; Hogan AM, 2010, DEVELOPMENTAL SCI, V13, P533, DOI 10.1111/j.1467-7687.2009.00909.x; Huang BY, 2008, RADIOGRAPHICS, V28, P417, DOI 10.1148/rg.282075066; Hyafil A, 2009, J NEUROSCI, V29, P5135, DOI 10.1523/JNEUROSCI.2828-08.2009; Jansen GFA, 2007, J APPL PHYSIOL, V103, P518, DOI 10.1152/japplphysiol.01429.2006; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kanaan A, 2006, AM J PHYSIOL-REG I, V290, pR1105, DOI 10.1152/ajpregu.00535.2005; Kimmerly DS, 2007, AM J PHYSIOL-HEART C, V293, pH299, DOI 10.1152/ajpheart.00044.2007; LAMANNA JC, 1992, J APPL PHYSIOL, V72, P2238, DOI 10.1152/jappl.1992.72.6.2238; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Marconi C, 2004, J PHYSIOL-LONDON, V556, P661, DOI 10.1113/jphysiol.2003.059188; Moore LG, 2007, RESP PHYSIOL NEUROBI, V158, P180, DOI 10.1016/j.resp.2007.06.016; Morrell MJ, 2006, ADV EXP MED BIOL, V588, P75; Morrell MJ, 2003, SLEEP MED, V4, P451, DOI 10.1016/S1389-9457(03)00159-X; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; Paulus MP, 2009, NEUROSCI BIOBEHAV R, V33, P1080, DOI 10.1016/j.neubiorev.2009.05.003; Penaloza D, 2007, CIRCULATION, V115, P1132, DOI 10.1161/CIRCULATIONAHA.106.624544; PETERS J, 2009, NEUROSCIENC IN PRESS; Rivera-Ch M, 2003, J APPL PHYSIOL, V94, P1263, DOI 10.1152/japplphysiol.00857.2002; Schwartz ED, 2003, EXP NEUROL, V184, P570, DOI 10.1016/S0014-4886(03)00295-4; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Silton RL, 2010, NEUROIMAGE, V50, P1292, DOI 10.1016/j.neuroimage.2009.12.061; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Talairach I., 1988, COPLANAR STEREOTACTI; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; TRIPATHY V, 2006, HUM ECOL, V14, P77; Verberne AJM, 1998, PROG NEUROBIOL, V54, P149, DOI 10.1016/S0301-0082(97)00056-7; Versace A, 2008, ARCH GEN PSYCHIAT, V65, P1041, DOI 10.1001/archpsyc.65.9.1041; von Leupoldt A, 2005, CHEST, V128, P345, DOI 10.1378/chest.128.1.345; Wager TD, 2009, NEUROIMAGE, V47, P821, DOI 10.1016/j.neuroimage.2009.05.043; Westerterp-Plantenga MS, 1999, J APPL PHYSIOL, V87, P391, DOI 10.1152/jappl.1999.87.1.391; Wideroe M, 2009, NEUROIMAGE, V45, P880, DOI 10.1016/j.neuroimage.2008.12.007; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Wobrock T, 2008, BIOL PSYCHIAT, V63, P65, DOI 10.1016/j.biopsych.2007.02.026; Wu TY, 2006, HIGH ALT MED BIOL, V7, P193, DOI 10.1089/ham.2006.7.193; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; ZHUANG J, 1993, J APPL PHYSIOL, V74, P303, DOI 10.1152/jappl.1993.74.1.303	74	35	40	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11449	10.1371/journal.pone.0011449	http://dx.doi.org/10.1371/journal.pone.0011449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625426	Green Published, Green Submitted, gold			2022-12-25	WOS:000279522500016
J	Kalhan, R; Tran, BT; Colangelo, LA; Rosenberg, SR; Liu, KA; Thyagarajan, B; Jacobs, DR; Smith, LJ				Kalhan, Ravi; Tran, Betty T.; Colangelo, Laura A.; Rosenberg, Sharon R.; Liu, Kiang; Thyagarajan, Bharat; Jacobs, David R., Jr.; Smith, Lewis J.			Systemic Inflammation in Young Adults Is Associated with Abnormal Lung Function in Middle Age	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PULMONARY-FUNCTION; PLASMA-FIBRINOGEN; RISK DEVELOPMENT; DISEASE; COPD; POPULATION; MARKERS; HYPERTENSION; RECRUITMENT	Background: Systemic inflammation is associated with reduced lung function in both healthy individuals and those with chronic obstructive pulmonary disease (COPD). Whether systemic inflammation in healthy young adults is associated with future impairment in lung health is uncertain. Methodology/Principal Findings: We evaluated the association between plasma fibrinogen and C-reactive protein (CRP) in young adults and lung function in the Coronary Artery Risk Development in Young Adults cohort study. Higher year 7 fibrinogen was associated with greater loss of forced vital capacity (FVC) between years 5 and 20 (439 mL in quartile 4 vs. 398 mL in quartile 1, P<0.001) and forced expiratory volume in 1 second (FEV1) (487 mL in quartile 4 vs. 446 mL in quartile 1, P<0.001) independent of cigarette smoking, body habitus, baseline lung function and demographic factors. Higher year 7 CRP was also associated with both greater loss of FVC (455 mL in quartile 4 vs. 390 mL in quartile 1, P<0.001) and FEV1 (491 mL in quartile 4 vs. 442 mL in quartile 1, P = 0.001). Higher year 7 fibrinogen and CRP were associated with abnormal FVC at year 20 (odds ratio (OR) per standard deviation 1.51 (95% confidence interval (CI): 1.30-1.75) for fibrinogen and 1.35 (95% CI: 1.14-1.59) for CRP). Higher year 5 fibrinogen was additionally associated with abnormal FEV1. A positive interaction was observed between pack-years cigarette smoking and year 7 CRP for the COPD endpoint, and among participants with greater than 10 pack-years of cigarette exposure, year 7 CRP was associated with greater odds of COPD at year 20 (OR per standard deviation 1.53 (95% CI: 1.08-2.16). Conclusion/Significance: Systemic inflammation in young adults is associated with abnormal lung function in middle age. In particular, elevated CRP may identify vulnerability to COPD among individuals who smoke.	[Kalhan, Ravi; Rosenberg, Sharon R.; Smith, Lewis J.] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Asthma Chron Obstruct Pulm Dis COPD, Chicago, IL 60611 USA; [Tran, Betty T.] Univ Washington, Div Pulm & Crit Care, Seattle, WA 98195 USA; [Colangelo, Laura A.; Liu, Kiang] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Thyagarajan, Bharat] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Jacobs, David R., Jr.] Univ Oslo, Dept Nutr, Oslo, Norway	Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle; Northwestern University; Feinberg School of Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Oslo	Kalhan, R (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Asthma Chron Obstruct Pulm Dis COPD, Chicago, IL 60611 USA.	r-kalhan@northwestern.edu	Fazli, Ghazal/AAE-8320-2022	Jacobs, David/0000-0002-7232-0543; Smith, Lewis J/0000-0002-4728-1562; Kalhan, Ravi/0000-0003-2443-0876	National Heart, Lung, and Blood Institute (NHLBI) [N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-95095, N01-HC045134]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048050, N01HC095095, N01HC048047, N01HC045134, N01HC048048, N01HC048049] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053560, R01HL048049, R29HL048048, R01HL048048, R01HL048050] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The CARDIA study is funded by National Heart, Lung, and Blood Institute (NHLBI, www.nhlbi.nih.gov) contracts N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050 (CARDIA field centers), N01-HC-95095 (CARDIA Coordinating Center), and N01-HC045134 Reading Center (CARDIA Pulmonary Reading Center). NHLBI had no role in the data analysis, interpretation, or writing of this report. This manuscript was reviewed and approved by CARDIA's independent Publications and Presentations and Steering Committees.	[Anonymous], 1979, AM REV RESPIR DIS, V119, P831; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1987, Am Rev Respir Dis, V136, P1285; Aronson D, 2006, AM J RESP CRIT CARE, V174, P626, DOI 10.1164/rccm.200602-243OC; Engstrom G, 2009, THORAX, V64, P211, DOI 10.1136/thx.2008.102079; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Fogarty AW, 2007, THORAX, V62, P515, DOI 10.1136/thx.2006.066969; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Haffner SM, 2007, AM J MED, V120, P10, DOI 10.1016/j.amjmed.2007.06.006; Hancox RJ, 2007, THORAX, V62, P1064, DOI 10.1136/thx.2006.076877; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HUGHES GH, 1987, CONTROL CLIN TRIALS, V8, pS68; Lakoski SG, 2006, ARCH INTERN MED, V166, P345, DOI 10.1001/archinte.166.3.345; MacNee William, 2005, Proc Am Thorac Soc, V2, P50, DOI 10.1513/pats.200411-056SF; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Mannino DM, 2003, AM J MED, V114, P758, DOI 10.1016/S0002-9343(03)00185-2; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Pankow JS, 2001, ATHEROSCLEROSIS, V154, P681, DOI 10.1016/S0021-9150(00)00586-4; Pinto-Plata VM, 2006, THORAX, V61, P23, DOI 10.1136/thx.2005.042200; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rasmussen F, 2009, EUR RESPIR J, V33, P382, DOI 10.1183/09031936.00040708; Reiner AP, 2006, J THROMB HAEMOST, V4, P1279, DOI 10.1111/j.1538-7836.2006.01907.x; Rossi A, 2008, INT J OBESITY, V32, P1423, DOI 10.1038/ijo.2008.103; Shaaban R, 2006, RESP MED, V100, P2112, DOI 10.1016/j.rmed.2006.03.027; Sunyer J, 2008, EUR RESPIR J, V32, P92, DOI 10.1183/09031936.00052507; Thyagarajan B, 2006, INT J EPIDEMIOL, V35, P1001, DOI 10.1093/ije/dyl049; van Durme YMTA, 2009, AM J RESP CRIT CARE, V179, P375, DOI 10.1164/rccm.200810-1540OC; van Eeden SF, 2001, AM J RESP CRIT CARE, V164, P826, DOI 10.1164/ajrccm.164.5.2010160; Walter RE, 2008, CHEST, V133, P19, DOI 10.1378/chest.07-0058	29	70	70	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11431	10.1371/journal.pone.0011431	http://dx.doi.org/10.1371/journal.pone.0011431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625390	Green Submitted, Green Published, gold			2022-12-25	WOS:000279465700013
J	Brandley, MC; Wang, YZ; Guo, XG; de Oca, ANM; Ortiz, MF; Hikida, T; Ota, H				Brandley, Matthew C.; Wang, Yuezhao; Guo, Xianguang; Nieto Montes de Oca, Adrian; Feria Ortiz, Manuel; Hikida, Tsutomu; Ota, Hidetoshi			Bermuda as an Evolutionary Life Raft for an Ancient Lineage of Endangered Lizards	PLOS ONE			English	Article							LATE PLEISTOCENE; AVES; DIVERSIFICATION; STRATIGRAPHY; SPECIATION; TERRAPINS; RALLIDAE; POSITION; CHOICE	Oceanic islands are well known for harboring diverse species assemblages and are frequently the basis of research on adaptive radiation and neoendemism. However, a commonly overlooked role of some islands is their function in preserving ancient lineages that have become extinct everywhere else (paleoendemism). The island archipelago of Bermuda is home to a single species of extant terrestrial vertebrate, the endemic skink Plestiodon (formerly Eumeces) longirostris. The presence of this species is surprising because Bermuda is an isolated, relatively young oceanic island approximately 1000 km from the eastern United States. Here, we apply Bayesian phylogenetic analyses using a relaxed molecular clock to demonstrate that the island of Bermuda, although no older than two million years, is home to the only extant representative of one of the earliest mainland North American Plestiodon lineages, which diverged from its closest living relatives 11.5 to 19.8 million years ago. This implies that, within a short geological time frame, mainland North American ancestors of P. longirostris colonized the recently emergent Bermuda and the entire lineage subsequently vanished from the mainland. Thus, our analyses reveal that Bermuda is an example of a "life raft'' preserving millions of years of unique evolutionary history, now at the brink of extinction. Threats such as habitat destruction, littering, and non-native species have severely reduced the population size of this highly endangered lizard.	[Brandley, Matthew C.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Brandley, Matthew C.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Wang, Yuezhao; Guo, Xianguang] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Nieto Montes de Oca, Adrian; Feria Ortiz, Manuel] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Biol Evolut, Mexico City 04510, DF, Mexico; [Hikida, Tsutomu] Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto, Japan	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Universidad Nacional Autonoma de Mexico; Kyoto University	Brandley, MC (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	matthew.brandley@yale.edu	Guo, Xianguang/C-3282-2013; NIETO-MONTES DE OCA, ADRIAN/GQP-4296-2022	Guo, Xianguang/0000-0001-7721-7388; 	National Natural Science Foundation of China [30700062]; National Science Foundation [OISE 0513295, OISE 0611646]; National Science Foundation Doctoral Dissertation Improvement [DEB 0709885]; Linnean Society Systematics Fund; Museum of Vertebrate Zoology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); National Science Foundation Doctoral Dissertation Improvement(National Science Foundation (NSF)); Linnean Society Systematics Fund; Museum of Vertebrate Zoology	This project was funded the National Natural Science Foundation of China (30700062) awarded to X. G.; and the the National Science Foundation East Asia and Pacific Program grants (OISE 0513295 and OISE 0611646, in conjunction with the National Natural Science Foundation of China and the Japan Society for the Promotion of Science), National Science Foundation Doctoral Dissertation Improvement grant (DEB 0709885), the Linnean Society Systematics Fund, and multiple grants from the Museum of Vertebrate Zoology awarded to M. C. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; BRANDLEY MC, 2010, SYST BIOL IN PRESS; Calsbeek R, 2003, NATURE, V426, P552, DOI 10.1038/nature02143; Censky EJ, 1998, NATURE, V395, P556, DOI 10.1038/26886; Conrad JL, 2008, B AM MUS NAT HIST, P1, DOI 10.1206/310.1; Coughlan JP, 2004, MOL ECOL NOTES, V4, P678, DOI 10.1111/j.1471-8286.2004.00782.x; Davenport J, 2005, CHELONIAN CONSERV BI, V4, P956; Davenport J, 2001, ORYX, V35, P332, DOI 10.1046/j.1365-3008.2001.00200.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Evans SE, 1999, GEOBIOS-LYON, V32, P889, DOI 10.1016/S0016-6995(99)80871-7; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; GARMAN S, 1884, B US NAT HIST MUS, V25, P287; Gillespie RG, 2002, ANNU REV ENTOMOL, V47, P595, DOI 10.1146/annurev.ento.47.091201.145244; HEARTY PJ, 1992, GEOL SOC AM BULL, V104, P471, DOI 10.1130/0016-7606(1992)104<0471:AAAOPL>2.3.CO;2; Hearty PJ, 1999, GEOLOGY, V27, P375, DOI 10.1130/0091-7613(1999)027<0375:AMMPSL>2.3.CO;2; Hearty PJ, 2004, QUATERNARY SCI REV, V23, P1151, DOI 10.1016/j.quascirev.2003.09.008; Hearty PJ, 2002, SEDIMENT GEOL, V153, P1, DOI 10.1016/S0037-0738(02)00261-0; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; IUCN, 2008, 2008 IUCN RED LIST T; Jamieson IG, 2007, ANIM CONSERV, V10, P139, DOI 10.1111/j.1469-1795.2006.00095.x; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Meylan PA, 2000, ZOOL J LINN SOC-LOND, V128, P51, DOI 10.1006/zjls.1999.0199; Nydam RL, 2002, J VERTEBR PALEONTOL, V22, P276, DOI 10.1671/0272-4634(2002)022[0276:ANTLFT]2.0.CO;2; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Olson SL, 2000, P BIOL SOC WASH, V113, P356; Olson SL, 2003, P NATL ACAD SCI USA, V100, P12825, DOI 10.1073/pnas.1934576100; Olson SL, 2001, P BIOL SOC WASH, V114, P509; Olson SL, 2008, P BIOL SOC WASH, V121, P130, DOI 10.2988/07-27.1; Olson SL, 2006, J HERPETOL, V40, P394, DOI 10.1670/0022-1511(2006)40[394:GCOEAS]2.0.CO;2; Olson Storrs L., 2005, Monografies de la Societat d'Historia Natural de les Balears, V12, P219; Parham JF, 2008, BIOL LETTERS, V4, P216, DOI 10.1098/rsbl.2007.0599; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith Hobart M., 2005, Journal of Kansas Herpetology, V14, P15; STEBBINS GL, 1965, ECOL MONOGR, V35, P1, DOI 10.2307/1942216; Sterrer W, 1998, B MAR SCI, V62, P809; TAYLOR EH, 1935, KANSAS U SCI B, V23, P1; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; VACHER HL, 1995, GEOLOGICAL SOC AM SP, V300, P269; Wiens JJ, 2006, EVOLUTION, V60, P123, DOI 10.1111/j.0014-3820.2006.tb01088.x; WINGATE DAVID B., 1965, HERPETOLOGICA, V21, P202	45	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11375	10.1371/journal.pone.0011375	http://dx.doi.org/10.1371/journal.pone.0011375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614024	gold, Green Published			2022-12-25	WOS:000279370000008
J	Huijbers, EJM; Ringvall, M; Femel, J; Kalamajski, S; Lukinius, A; Abrink, M; Hellman, L; Olsson, AK				Huijbers, Elisabeth J. M.; Ringvall, Maria; Femel, Julia; Kalamajski, Sebastian; Lukinius, Agneta; Abrink, Magnus; Hellman, Lars; Olsson, Anna-Karin			Vaccination against the extra domain-B of fibronectin as a novel tumor therapy	FASEB JOURNAL			English	Article						therapeutic; immunization; neovascularization; extracellular matrix; angiogenesis	HUMAN-ANTIBODY; ISOFORM; ANGIOGENESIS; MARKER; EXPRESSION; MICE; NEOVASCULATURE; RESPONSES; CELLS; IGE	Monoclonal antibody-based therapies have made an important contribution to current treatment strategies for cancer and autoimmune disease. However, the cost for these new drugs puts a significant strain on the health-care economy, resulting in limited availability for patients. Therapeutic vaccination, defined as induction of immunity against a disease-related self-molecule, is therefore an attractive alternative. To analyze the potential of such an approach, we have developed a vaccine against the extra domain-B (ED-B) of fibronectin. This 91-aa domain, inserted by alternative splicing, is expressed during vasculogenesis in the embryo, but essentially undetectable under normal conditions in the adult. However, ED-B is highly expressed around angiogenic vasculature, such as in tumorigenesis. Here, we demonstrate that it is possible to break self-tolerance and induce a strong antibody response against ED-B by vaccination. Nineteen of 20 vaccinated mice responded with production of anti-ED-B antibodies and displayed a 70% reduction in tumor size compared to those lacking anti-ED-B antibodies. Analysis of the tumor tissue revealed that immunization against ED-B induced several changes, consistent with an attack by the immune system. These data show that tumor vascular antigens are highly interesting candidates for development of therapeutic vaccines targeting solid tumors.-Huijbers, E. J. M., Ringvall, M., Femel, J., Kalamajski, S., Lukinius, A., Abrink, M., Hellman, L., Olsson, A.-K. Vaccination against the extra domain-B of fibronectin as a novel tumor therapy. FASEB J. 24, 4535-4544 (2010). www.fasebj.org	[Olsson, Anna-Karin] Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, SE-75123 Uppsala, Sweden; [Hellman, Lars] Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, SE-75123 Uppsala, Sweden; [Lukinius, Agneta] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75123 Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Olsson, AK (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, Husargatan 3,Box 582, SE-75123 Uppsala, Sweden.	anna-karin.olsson@imbim.uu.se	Åbrink, Magnus/AAK-8346-2020; Huijbers, Elisabeth J.M./K-7764-2013	Huijbers, Elisabeth J.M./0000-0002-7742-9839; Kalamajski, Sebastian/0000-0002-6600-9302; Abrink, Magnus/0000-0002-1335-3927	Swedish Research Council; Swedish Cancer Society; Swedish Society of Medicine; Jeansson's Foundation; Ake Wiberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Society of Medicine; Jeansson's Foundation; Ake Wiberg Foundation	The authors thank Dr. Lene Uhrbom (Department of Genetics and Pathology, Uppsala University) for providing tissue sections of normal mouse brain and glioma and Prof. Dario Neri (Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland) for providing SIP anti-ED-B antibodies. The authors also thank Prof. Wilhelm Jahnen-Dechent and Dr. Daniela Dreymuller (Institute for Biomedical Engineering, RWTH Aachen, Aachen, Germany) for generously teaching us the wound-healing model. Financial support was provided by The Swedish Research Council, The Swedish Cancer Society, The Swedish Society of Medicine, Jeansson's Foundation, and the Ake Wiberg Foundation.	[Anonymous], 1988, LAB ANIM-UK, V22, P195; Astrof S, 2009, ANGIOGENESIS, V12, P165, DOI 10.1007/s10456-009-9136-6; Birchler MT, 2003, LARYNGOSCOPE, V113, P1231, DOI 10.1097/00005537-200307000-00023; BurtonWurster N, 1997, MATRIX BIOL, V15, P441, DOI 10.1016/S0945-053X(97)90018-4; CARNEMOLLA B, 1989, J CELL BIOL, V108, P1139, DOI 10.1083/jcb.108.3.1139; Carnemolla B, 1996, INT J CANCER, V68, P397, DOI 10.1002/(SICI)1097-0215(19961104)68:3<397::AID-IJC20>3.3.CO;2-D; Castellani P, 2002, AM J PATHOL, V161, P1695, DOI 10.1016/S0002-9440(10)64446-X; CASTELLANI P, 1994, INT J CANCER, V59, P612, DOI 10.1002/ijc.2910590507; Demartis S, 2001, EUR J NUCL MED, V28, P534, DOI 10.1007/s002590100480; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Halin C, 2002, NAT BIOTECHNOL, V20, P264, DOI 10.1038/nbt0302-264; Haller BK, 2010, ONCOGENE, V29, P4276, DOI 10.1038/onc.2010.176; HAUPTMANN S, 1995, LAB INVEST, V73, P172; HELLMAN L, 1994, EUR J IMMUNOL, V24, P415, DOI 10.1002/eji.1830240222; Hellman L, 2008, EXPERT REV VACCINES, V7, P193, DOI 10.1586/14760584.7.2.193; KACZMAREK J, 1994, INT J CANCER, V59, P11, DOI 10.1002/ijc.2910590104; Le Buanec H, 2007, VACCINE, V25, P7206, DOI 10.1016/j.vaccine.2007.07.029; Ma YB, 2007, AM J RESP CRIT CARE, V176, P439, DOI 10.1164/rccm.200610-1405OC; Magnusson SE, 2009, FASEB J, V23, P875, DOI 10.1096/fj.08-120394; Midulla M, 2000, CANCER RES, V60, P164; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Peters JH, 1996, CELL ADHES COMMUN, V4, P127, DOI 10.3109/15419069609010767; Ridolfi L, 2009, IMMUNOBIOLOGY, V214, P61, DOI 10.1016/j.imbio.2008.03.003; Ringvall M, 2009, VACCINE, V28, P48, DOI 10.1016/j.vaccine.2009.09.122; Santimaria M, 2003, CLIN CANCER RES, V9, P571; Sauer S, 2009, BLOOD, V113, P2265, DOI 10.1182/blood-2008-06-160416; Schliemann C, 2009, BLOOD, V113, P2275, DOI 10.1182/blood-2008-05-160747; Tarli L, 1999, BLOOD, V94, P192, DOI 10.1182/blood.V94.1.192.413k22_192_198; Tchougounova E, 2009, ONCOGENE, V28, P1537, DOI 10.1038/onc.2009.9; Vernersson M, 2002, FASEB J, V16, P875, DOI 10.1096/fj.01-0879fje; ZARDI L, 1987, EMBO J, V6, P2337, DOI 10.1002/j.1460-2075.1987.tb02509.x	31	36	38	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4535	4544		10.1096/fj.10-163022	http://dx.doi.org/10.1096/fj.10-163022			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20634349				2022-12-25	WOS:000283861100038
J	Wexler-Cohen, Y; Ashkenazi, A; Viard, M; Blumenthal, R; Shai, Y				Wexler-Cohen, Yael; Ashkenazi, Avraham; Viard, Mathias; Blumenthal, Robert; Shai, Yechiel			Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain	FASEB JOURNAL			English	Article						membrane fusion; HIV-1 entry inhibitor; peptide-membrane interaction; viral envelope protein	TRIMERIC COILED-COIL; IMMUNODEFICIENCY-VIRUS; POTENT INHIBITORS; CORE STRUCTURE; ENTRY; TYPE-1; SURFACE; DESIGN; REGION; STABILIZATION	The interactions between the N- and C-terminal heptad repeat (NHR and CHR) regions of the human immunodeficiency virus (HIV-1) glycoprotein gp41 create a structure comprising a 6-helix bundle (SHB). A sequence in the SHB named the "pocket" is crucial for the SHB's stability and for the fusion inhibitory activity of 36-residue NHR peptide N36. We report that a short 27-residue peptide, N27, which lacks the pocket sequence, exhibits potent inhibitory activity in both cell-cell and virus-cell fusion assays when fatty acids were conjugated to its N but not C terminus. Furthermore, mutations in the positions that prevent interaction with the CHR but not with the NHR resulted in a dramatic reduction in N27 activity. These data support a mechanism in which N27 mainly targets the CHR rather than the internal NHR coiled-coil, reveal the N-terminal edge of the endogenous core structure in situ and hence complement our recent findings of the C-terminal edge of the core, and provide a new approach for designing short inhibitors from the NHR region of other lentiviruses due to similarities in their envelope proteins.-Wexler-Cohen, Y., Ashkenazi, A., Viard, M., Blumenthal, R., Shai, Y. Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain. FASEB J. 24, 4196-4202 (2010). www.fasebj.org	[Wexler-Cohen, Yael; Ashkenazi, Avraham; Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Viard, Mathias; Blumenthal, Robert] NCI, Nanobiol Program, Ctr Canc Res, Frederick, MD 21701 USA; [Viard, Mathias] SAIC Frederick Inc, Basic Res Program, NCI Frederick, Frederick, MD USA	Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Shai, Y (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	yechiel.shai@weizmann.ac.il		Ashkenazi, Avraham/0000-0002-1253-497X	Israel Science Foundation; National Cancer Institute, NIH [HHSN26120080001E]; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC008303] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Batya Zarmi for her valuable help with peptide purification, and Dr. Ayala Sharp and Eitan Ariel and the staff of the flow cytometry unit at the Weizmann Institute of Science for their valuable technical assistance and advice. This study was supported by the Israel Science Foundation and has been funded in part with federal funds from the National Cancer Institute, NIH, under contract HHSN26120080001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government. This research was supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	Alfsen A, 2005, MOL BIOL CELL, V16, P4267, DOI 10.1091/mbc.E05-03-0192; Bewley CA, 2002, J BIOL CHEM, V277, P14238, DOI 10.1074/jbc.M201453200; Bianchi E, 2005, P NATL ACAD SCI USA, V102, P12903, DOI 10.1073/pnas.0502449102; Brugger B, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-70; Burton A, 2003, LANCET INFECT DIS, V3, P260, DOI 10.1016/S1473-3099(03)00620-0; Cao J, 1996, J VIROL, V70, P1340, DOI 10.1128/JVI.70.3.1340-1354.1996; Center RJ, 2002, J VIROL, V76, P7863, DOI 10.1128/JVI.76.15.7863-7867.2002; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Clapham PR, 2002, J GEN VIROL, V83, P1809, DOI 10.1099/0022-1317-83-8-1809; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Dimitrov AS, 2003, BIOCHEMISTRY-US, V42, P14150, DOI 10.1021/bi035154g; Dimitrov DS, 2004, NAT REV MICROBIOL, V2, P109, DOI 10.1038/nrmicro817; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; Kilgore NR, 2003, J VIROL, V77, P7669, DOI 10.1128/JVI.77.13.7669-7672.2003; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Louis JM, 2003, J BIOL CHEM, V278, P20278, DOI 10.1074/jbc.M301627200; Melikyan GB, 2006, J VIROL, V80, P3249, DOI 10.1128/JVI.80.7.3249-3258.2006; MERRIFIELD RB, 1982, BIOCHEMISTRY-US, V21, P5020, DOI 10.1021/bi00263a028; NIEVA JL, 1994, BIOCHEMISTRY-US, V33, P3201, DOI 10.1021/bi00177a009; Noah E, 2008, BIOCHEMISTRY-US, V47, P6782, DOI 10.1021/bi7023139; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Sia SK, 2002, P NATL ACAD SCI USA, V99, P14664, DOI 10.1073/pnas.232566599; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; Sollner TH, 2004, CURR OPIN CELL BIOL, V16, P429, DOI 10.1016/j.ceb.2004.06.015; Suntoke TR, 2005, J BIOL CHEM, V280, P19852, DOI 10.1074/jbc.M502196200; WEISS A, 1984, J IMMUNOL, V133, P123; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wexler-Cohen Y, 2007, FASEB J, V21, P3677, DOI 10.1096/fj.07-8582com; Wexler-Cohen Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000509; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; Yang XZ, 2006, J VIROL, V80, P4388, DOI 10.1128/JVI.80.9.4388-4395.2006; Yu H, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-93; Zhang CWH, 2001, J BIOL CHEM, V276, P39577, DOI 10.1074/jbc.M107147200	37	27	28	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4196	4202		10.1096/fj.09-151704	http://dx.doi.org/10.1096/fj.09-151704			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20605950	Green Published			2022-12-25	WOS:000283861100008
J	Sarparanta, J; Blandin, G; Charton, K; Vihola, A; Marchand, S; Milic, A; Hackman, P; Ehler, E; Richard, I; Udd, B				Sarparanta, Jaakko; Blandin, Gaelle; Charton, Karine; Vihola, Anna; Marchand, Sylvie; Milic, Astrid; Hackman, Peter; Ehler, Elisabeth; Richard, Isabelle; Udd, Bjarne			Interactions with M-band Titin and Calpain 3 Link Myospryn (CMYA5) to Tibial and Limb-girdle Muscular Dystrophies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-SPECIFIC CALPAIN; SARCOMERIC M-BAND; SKELETAL-MUSCLE; IMMUNOELECTRON MICROSCOPY; PROTEIN MYOSPRYN; BINDING PARTNER; TERMINAL REGION; GENE-EXPRESSION; DISTAL MYOPATHY; KINASE DOMAIN	Mutations in the Cterminus of titin, situated at the M-band of the striated muscle sarcomere, cause tibial muscular dystrophy (TMD) and limb-girdle muscular dystrophy (LGMD) type 2J. Mutations in the protease calpain 3 (CAPN3), in turn, lead to LGMD2A, and secondary CAPN3 deficiency in LGMD2J suggests that the pathomechanisms of the diseases are linked. Yeast two-hybrid screens carried out to elucidate the molecular pathways of TMD/LGMD2J and LGMD2A resulted in the identification of myospryn (CMYA5, cardiomyopathy-associated 5) as a binding partner for both M-band titin and CAPN3. Additional yeast two-hybrid and coimmunoprecipitation studies confirmed both interactions. The interaction of myospryn and M-band titin was supported by localization of endogenous and transfected myospryn at the M-band level. Coexpression studies showed that myospryn is a proteolytic substrate for CAPN3 and suggested that myospryn may protect CAPN3 from autolysis. Myospryn is a muscle-specific protein of the tripartite motif superfamily, reported to function in vesicular trafficking and protein kinaseAsignaling and implicated in the pathogenesis of Duchenne muscular dystrophy. The novel interactions indicate a role for myospryn in the sarcomeric M-band and may be relevant for the molecular pathomechanisms of TMD/LGMD2J and LGMD2A.	[Sarparanta, Jaakko] Univ Helsinki, Folkhalsan Inst Genet, Biomedicum Helsinki C307B, FI-00014 Helsinki, Finland; [Hackman, Peter; Udd, Bjarne] Univ Helsinki, Dept Med Genet, Haartman Inst, FI-00014 Helsinki, Finland; [Blandin, Gaelle; Charton, Karine; Marchand, Sylvie; Milic, Astrid; Richard, Isabelle] Genethon CNRS UMR8587, F-91000 Evry, France; [Ehler, Elisabeth] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Ehler, Elisabeth] Kings Coll London, Div Cardiovasc, London SE1 1UL, England; [Udd, Bjarne] Tampere Univ Hosp & Med Sch, Dept Neurol, Tampere 33520, Finland; [Udd, Bjarne] Vaasa Cent Hosp, Dept Neurol, Vaasa 65130, Finland	University of Helsinki; University of Helsinki; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; University of London; King's College London; University of London; King's College London; Tampere University; Tampere University Hospital; Vaasa Central Hospital	Sarparanta, J (corresponding author), Univ Helsinki, Folkhalsan Inst Genet, Biomedicum Helsinki C307B, POB 63, FI-00014 Helsinki, Finland.	jaakko.sarparanta@helsinki.fi	Charton, Karine/J-5705-2013; Sarparanta, Jaakko/AAQ-1713-2020; charton, karine/AAU-4926-2021; Richard, isabelle/J-8298-2013; Blandin, Gaelle/N-9745-2013	Charton, Karine/0000-0001-7419-140X; Sarparanta, Jaakko/0000-0002-5497-5255; charton, karine/0000-0001-7419-140X; Blandin, Gaelle/0000-0003-2790-9524; Ehler, Elisabeth/0000-0001-5646-5964	Association Francaise Contre les Myopathies; Folkhalsan Research Foundation; Academy of Finland; The Sigrid Juselius Foundation; University of Helsinki Research Foundation; EMBO [ASTF 13-08]; MRC [G0400153] Funding Source: UKRI; Medical Research Council [G0400153] Funding Source: researchfish	Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); Folkhalsan Research Foundation; Academy of Finland(Academy of Finland); The Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Helsinki Research Foundation; EMBO(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Association Francaise Contre les Myopathies (to B.U. and I.R.), the Folkhalsan Research Foundation, the Academy of Finland, The Sigrid Juselius Foundation (to B. U.), and University of Helsinki Research Foundation and EMBO Short Term Fellowship ASTF 13-08 (to J.S.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bagnato P, 2003, J CELL BIOL, V160, P245, DOI 10.1083/jcb.200208109; Benson MA, 2004, J BIOL CHEM, V279, P10450, DOI 10.1074/jbc.M312664200; Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448; Duguez S, 2006, FEBS J, V273, P3427, DOI 10.1111/j.1742-4658.2006.05351.x; Durham JT, 2006, J BIOL CHEM, V281, P6841, DOI 10.1074/jbc.M510499200; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fukuzawa A, 2008, J CELL SCI, V121, P1841, DOI 10.1242/jcs.028019; FURST DO, 1988, J CELL BIOL, V106, P1563, DOI 10.1083/jcb.106.5.1563; Granzier H, 2007, MUSCLE NERVE, V36, P740, DOI 10.1002/mus.20886; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; Hackman P, 2008, NEUROMUSCULAR DISORD, V18, P922, DOI 10.1016/j.nmd.2008.07.010; Haravuori H, 2001, NEUROLOGY, V56, P869, DOI 10.1212/WNL.56.7.869; Huang YC, 2008, HUM MOL GENET, V17, P1855, DOI 10.1093/hmg/ddn081; Kinbara K, 1997, ARCH BIOCHEM BIOPHYS, V342, P99, DOI 10.1006/abbi.1997.0108; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; Kouloumenta A, 2007, J BIOL CHEM, V282, P35211, DOI 10.1074/jbc.M704733200; Kramerova I, 2005, HUM MOL GENET, V14, P2125, DOI 10.1093/hmg/ddi217; Kramerova I, 2008, HUM MOL GENET, V17, P3271, DOI 10.1093/hmg/ddn223; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Lange S, 2005, J MOL BIOL, V345, P289, DOI 10.1016/j.jmb.2004.10.040; Lange S, 2002, J CELL SCI, V115, P4925, DOI 10.1242/jcs.00181; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; McElhinny AS, 2002, J CELL BIOL, V157, P125, DOI 10.1083/jcb.200108089; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Obermann WMJ, 1997, EMBO J, V16, P211, DOI 10.1093/emboj/16.2.211; Obermann WMJ, 1996, J CELL BIOL, V134, P1441, DOI 10.1083/jcb.134.6.1441; Ojima K, 2005, J MUSCLE RES CELL M, V26, P409, DOI 10.1007/s10974-005-9023-8; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Ono Y, 2006, J BIOL CHEM, V281, P18519, DOI 10.1074/jbc.M601029200; PORTER GA, 1992, J CELL BIOL, V117, P997, DOI 10.1083/jcb.117.5.997; Reynolds JG, 2008, J BIOL CHEM, V283, P8070, DOI 10.1074/jbc.C700221200; Reynolds JG, 2007, BBA-MOL CELL RES, V1773, P891, DOI 10.1016/j.bbamcr.2007.04.004; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Sarparanta J, 2008, J MUSCLE RES CELL M, V29, P177, DOI 10.1007/s10974-008-9165-6; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; SUZUKI A, 1994, EUR J BIOCHEM, V220, P283, DOI 10.1111/j.1432-1033.1994.tb18624.x; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Tinsley CL, 2005, NEUROMUSCULAR DISORD, V15, P717; Tkatchenko AV, 2001, NEUROMUSCULAR DISORD, V11, P269, DOI 10.1016/S0960-8966(00)00198-X; Udd B, 2005, NEUROLOGY, V64, P636, DOI 10.1212/01.WNL.0000151853.50144.82; UDD B, 1991, MUSCLE NERVE, V14, P1050, DOI 10.1002/mus.880141103; UDD B, 1993, ARCH NEUROL-CHICAGO, V50, P604, DOI 10.1001/archneur.1993.00540060044015; VAN DEN BERGH PYK, 2003, ANN NEUROL, V54, P248; VAN DER VEN PFM, 2000, CELL MOTIL CYTOSKEL, V45, P149	48	43	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30304	30315		10.1074/jbc.M110.108720	http://dx.doi.org/10.1074/jbc.M110.108720			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20634290	Green Published, hybrid			2022-12-25	WOS:000281984300066
J	Spinale, FG; Mukherjee, R; Zavadzkas, JA; Koval, CN; Bouges, S; Stroud, RE; Dobrucki, LW; Sinusas, AJ				Spinale, Francis G.; Mukherjee, Rupak; Zavadzkas, Juozas A.; Koval, Christine N.; Bouges, Shenikqua; Stroud, Robert E.; Dobrucki, Lawrence W.; Sinusas, Albert J.			Cardiac Restricted Overexpression of Membrane Type-1 Matrix Metalloproteinase Causes Adverse Myocardial Remodeling following Myocardial Infarction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEFT-VENTRICULAR FUNCTION; TGF-BETA; HEART-FAILURE; 1-MATRIX METALLOPROTEINASE; ACTIVATION; MICE; INHIBITION; MATRIX-METALLOPROTEINASE-9; TRANSCRIPTION; FIBROBLASTS	The membrane type-1 matrix metalloproteinase (MT1MMP) is a unique member of the MMP family, but induction patterns and consequences of MT1-MMP overexpression (MT1-MMPexp), in a left ventricular (LV) remodeling process such as myocardial infarction (MI), have not been explored. MT1-MMP promoter activity (murine luciferase reporter) increased 20-fold at 3 days and 50-fold at 14 days post-MI. MI was then induced in mice with cardiac restricted MT1-MMPexp (n = 58) and wild type (WT, n = 60). Post-MI survival was reduced (67% versus 46%, p < 0.05), and LV ejection fraction was lower in the post-MI MT1-MMPexp mice compared with WT (41 +/- 2 versus 32 +/- 2%, p < 0.05). In the post-MI MT1-MMPexp mice, LV myocardial MMP activity, as assessed by radiotracer uptake, and MT1-MMP-specific proteolytic activity using a specific fluorogenic assay were both increased by 2-fold. LV collagen content was increased by nearly 2-fold in the post-MI MT1-MMPexp compared with WT. Using a validated fluorogenic construct, it was discovered that MT1-MMP proteolytically processed the pro-fibrotic molecule, latency-associated transforming growth factor-1 binding protein (LTBP-1), and MT1-MMP-specific LTBP-1 proteolytic activity was increased by 4-fold in the post-MIMT1-MMPexp group. Early and persistent MT1-MMP promoter activity occurred post-MI, and increased myocardial MT1-MMP levels resulted in poor survival, worsening of LV function, and significant fibrosis. A molecular mechanism for the adverse LV matrix remodeling with MT1-MMP induction is increased processing of pro-fibrotic signaling molecules. Thus, a proteolytically diverse portfolio exists for MT1-MMP within the myocardium and likely plays a mechanistic role in adverse LV remodeling.	[Spinale, Francis G.; Mukherjee, Rupak; Zavadzkas, Juozas A.; Koval, Christine N.; Bouges, Shenikqua; Stroud, Robert E.] Med Univ S Carolina, Charleston, SC 29425 USA; [Spinale, Francis G.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29425 USA; [Dobrucki, Lawrence W.; Sinusas, Albert J.] Yale Univ, Sch Med New Haven, New Haven, CT 06510 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Yale University	Sinusas, AJ (corresponding author), Room 625,770 MUSC Complex,114 Doughty St, Charleston, SC 29425 USA.	wilburnm@musc.edu	Sinusas, Albert J/A-7235-2009; Dobrucki, Wawrzyniec L/D-3987-2009	Dobrucki, Wawrzyniec L/0000-0002-6807-217X	National Institutes of Health [HL057952, HL059165, HL078825]; Veterans Affairs Health Administration; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078650, P01HL078825, R01HL057952, R01HL059165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Health Administration(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL057952, HL059165, and HL078825. This work was also supported by a Merit Award from the Veterans Affairs Health Administration.	Baciu PC, 2003, EXP CELL RES, V291, P167, DOI 10.1016/S0014-4827(03)00387-2; Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Deschamps AM, 2005, CIRCULATION, V111, P1166, DOI 10.1161/01.CIR.0000157149.71297.3A; GULICK J, 1991, J BIOL CHEM, V266, P9180; Guo C, 2003, J BIOL CHEM, V278, P46699, DOI 10.1074/jbc.M307238200; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Ikonomidis JS, 2005, AM J PHYSIOL-HEART C, V288, pH149, DOI 10.1152/ajpheart.00370.2004; King MK, 2003, CIRC RES, V92, P177, DOI 10.1161/01.RES.0000052312.41419.55; Koli K, 2001, MICROSC RES TECHNIQ, V52, P354, DOI 10.1002/1097-0029(20010215)52:4<354::AID-JEMT1020>3.0.CO;2-G; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; Matsusaka H, 2006, HYPERTENSION, V47, P711, DOI 10.1161/01.HYP.0000208840.30778.00; Mukherjee R, 2006, AM J PHYSIOL-HEART C, V291, pH2216, DOI 10.1152/ajpheart.01343.2005; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Okada A, 1997, J CELL BIOL, V137, P67, DOI 10.1083/jcb.137.1.67; Peterson JT, 2006, CARDIOVASC RES, V69, P677, DOI 10.1016/j.cardiores.2005.11.032; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Sodek KL, 2007, BRIT J CANCER, V97, P358, DOI 10.1038/sj.bjc.6603863; Spinale FG, 2000, CIRCULATION, V102, P1944, DOI 10.1161/01.CIR.102.16.1944; Spinale FG, 1998, CIRC RES, V82, P482, DOI 10.1161/01.RES.82.4.482; Spinale FG, 2009, CIRC-HEART FAIL, V2, P351, DOI 10.1161/CIRCHEARTFAILURE.108.844845; Spruill LS, 2007, AM J PHYSIOL-CELL PH, V293, pC1362, DOI 10.1152/ajpcell.00545.2006; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Su HL, 2005, CIRCULATION, V112, P3157, DOI 10.1161/CIRCULATIONAHA.105.583021; Sundstrom J, 2004, CIRCULATION, V109, P2850, DOI 10.1161/01.CIR.0000129318.79570.84; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; Tatti O, 2008, EXP CELL RES, V314, P2501, DOI 10.1016/j.yexcr.2008.05.018; Vanhoutte D, 2006, CARDIOVASC RES, V69, P604, DOI 10.1016/j.cardiores.2005.10.002; Wilson EM, 2003, CIRCULATION, V107, P2857, DOI 10.1161/01.CIR.0000068375.40887.FA	30	47	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30316	30327		10.1074/jbc.M110.158196	http://dx.doi.org/10.1074/jbc.M110.158196			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20643648	hybrid, Green Published			2022-12-25	WOS:000281984300067
J	Schmitt, P; Wilmes, M; Pugniere, M; Aumelas, A; Bachere, E; Sahl, HG; Schneider, T; Destoumieux-Garzon, D				Schmitt, Paulina; Wilmes, Miriam; Pugniere, Martine; Aumelas, Andre; Bachere, Evelyne; Sahl, Hans-Georg; Schneider, Tanja; Destoumieux-Garzon, Delphine			Insight into Invertebrate Defensin Mechanism of Action OYSTER DEFENSINS INHIBIT PEPTIDOGLYCAN BIOSYNTHESIS BY BINDING TO LIPID II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL BIOSYNTHESIS; ANTIMICROBIAL PEPTIDES; CRASSOSTREA-GIGAS; MAMMALIAN DEFENSINS; ANTIBIOTIC-ACTIVITY; ESCHERICHIA-COLI; INSECT DEFENSIN; GENE-REGULATION; BACTERIA; BETA-DEFENSIN-3	Three oyster defensin variants (Cg-Defh1, Cg-Defh2, and Cg-Defm) were produced as recombinant peptides and characterized in terms of activities and mechanism of action. In agreement with their spectrum of activity almost specifically directed against Gram-positive bacteria, oyster defensins were shown here to be specific inhibitors of a bacterial biosynthesis pathway rather than mere membrane-active agents. Indeed, at lethal concentrations, the three defensins did not compromise Staphylococcus aureus membrane integrity but inhibited the cell wall biosynthesis as indicated by the accumulation of the UDP-N-acetylmuramyl-pentapeptide cell wall precursor. In addition, a combination of antagonization assays, thin layer chromatography, and surface plasmon resonance measurements showed that oyster defensins bind almost irreversibly to the lipid II peptidoglycan precursor, thereby inhibiting the cell wall biosynthesis. To our knowledge, this is the first detailed analysis of the mechanism of action of antibacterial defensins produced by invertebrates. Interestingly, the three defensins, which were chosen as representative of the oyster defensin molecular diversity, bound differentially to lipid II. This correlated with their differential antibacterial activities. From our experimental data and the analysis of oyster defensin sequence diversity, we propose that oyster defensin activity results from selective forces that have conserved residues involved in lipid II binding and diversified residues at the surface of oyster defensins that could improve electrostatic interactions with the bacterial membranes.	[Schmitt, Paulina; Bachere, Evelyne; Destoumieux-Garzon, Delphine] Univ Montpellier 2, CNRS, UMR 5119, Lab Ecosyst Lagunaires, F-34095 Montpellier, France; [Schmitt, Paulina; Bachere, Evelyne; Destoumieux-Garzon, Delphine] Univ Montpellier 2, IFREMER, UMR 5119, Lab Ecosyst Lagunaires,IRD, F-34095 Montpellier, France; [Wilmes, Miriam; Sahl, Hans-Georg; Schneider, Tanja] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Sect, D-53105 Bonn, Germany; [Aumelas, Andre] CNRS, UMR 5048, INSERM, U554, F-34090 Montpellier, France; [Aumelas, Andre] Univ Montpellier I, Ctr Biochim Struct, F-34090 Montpellier, France; [Aumelas, Andre] Univ Montpellier 2, Ctr Biochim Struct, F-34090 Montpellier, France; [Pugniere, Martine] Ctr Etud Agents Pathogenes & Biotechnol Sante, CNRS, UMR 5236, Inst Biol, F-34965 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Bonn; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS)	Destoumieux-Garzon, D (corresponding author), Univ Montpellier 2, CNRS, UMR 5119, Lab Ecosyst Lagunaires, Pl Eugene Bataillon,CC80, F-34095 Montpellier, France.	Delphine.Destoumieux.Garzon@ifremer.fr	Bachere, Evelyne/O-6117-2014; PUGNIERE, Martine/AAD-4315-2020; Destoumieux-Garzón, Delphine/O-3328-2014; Pugniere, Martine/T-1355-2017; Schneider, Tanja/L-8049-2013	PUGNIERE, Martine/0000-0002-2049-2909; Destoumieux-Garzón, Delphine/0000-0002-8793-9138; Pugniere, Martine/0000-0002-2049-2909; Schneider, Tanja/0000-0001-7269-4716; Schmitt, Paulina/0000-0001-6598-837X	Ifremer; CNRS; Languedoc-Roussillon region; Federal Ministry of Education and Research; Program Becas Chile-Comision Nacional de Investigacion Cientifica y Tecnologica; University of Montpellier 2 (Systemes Integres en Biologie, Agronomie, Geosciences, Hydrosciences, Environnement)	Ifremer; CNRS(Centre National de la Recherche Scientifique (CNRS)); Languedoc-Roussillon region(Region Occitanie); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Program Becas Chile-Comision Nacional de Investigacion Cientifica y Tecnologica; University of Montpellier 2 (Systemes Integres en Biologie, Agronomie, Geosciences, Hydrosciences, Environnement)	This work was supported in part by Ifremer, CNRS, the Languedoc-Roussillon region ("Chercheur(se) d'Avenir" program, REVAResp project), and the German Federal Ministry of Education and Research (Skinstaph project and the BONFOR program of the Medical Faculty, University of Bonn).; Supported by a graduate scholarship from Program Becas Chile-Comision Nacional de Investigacion Cientifica y Tecnologica and a traveling grant from University of Montpellier 2 (Systemes Integres en Biologie, Agronomie, Geosciences, Hydrosciences, Environnement).	Boulanger N, 2004, INFECT IMMUN, V72, P7140, DOI 10.1128/IAI.72.12.7140-7146.2004; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; COCIANCICH S, 1993, J BIOL CHEM, V268, P19239; DAI D, 1988, J BACTERIOL, V170, P2197, DOI 10.1128/jb.170.5.2197-2201.1988; Destoumieux-Garzon D, 2003, MOL MICROBIOL, V49, P1031, DOI 10.1046/j.1365-2958.2003.03610.x; Timothy DA, 2006, BBA-BIOMEMBRANES, V1758, P1285, DOI 10.1016/j.bbamem.2006.03.016; Duperthuy M, 2010, ENVIRON MICROBIOL, V12, P951, DOI 10.1111/j.1462-2920.2009.02138.x; Fay JC, 2003, ANNU REV GENOM HUM G, V4, P213, DOI 10.1146/annurev.genom.4.020303.162528; Froy O, 2003, TRENDS GENET, V19, P684, DOI 10.1016/j.tig.2003.10.010; Garcia JRC, 2001, CELL TISSUE RES, V306, P257, DOI 10.1007/s004410100433; Gonzalez M, 2007, DEV COMP IMMUNOL, V31, P332, DOI 10.1016/j.dci.2006.07.006; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Hadjicharalambous C, 2008, BIOCHEMISTRY-US, V47, P12626, DOI 10.1021/bi800335e; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hetru C, 1997, Methods Mol Biol, V78, P35; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; KOHLRAUSCH U, 1991, FEMS MICROBIOL LETT, V78, P253; Lamberty M, 1999, J BIOL CHEM, V274, P9320, DOI 10.1074/jbc.274.14.9320; LEEUW ED, 2010, FEBS LETT, V584, P1543; MARTIN E, 1995, J LEUKOCYTE BIOL, V58, P128, DOI 10.1002/jlb.58.2.128; Morgera F, 2008, J PEPT SCI, V14, P518, DOI 10.1002/psc.981; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Nakajima Y, 2003, BBA-GEN SUBJECTS, V1624, P125, DOI 10.1016/j.bbagen.2003.10.004; Otvos L, 2000, J PEPT SCI, V6, P497; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Sahl HG, 2005, J LEUKOCYTE BIOL, V77, P466, DOI 10.1189/jlb.0804452; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Saulnier D, 2000, DIS AQUAT ORGAN, V40, P109, DOI 10.3354/dao040109; Schmitt P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-23; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Schneider T, 2009, ANTIMICROB AGENTS CH, V53, P1610, DOI 10.1128/AAC.01040-08; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schneider T, 2010, CURR OPIN INVEST DR, V11, P157; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Sugiarto H, 2007, FEMS MICROBIOL LETT, V270, P195, DOI 10.1111/j.1574-6968.2007.00642.x; Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200; van Heijenoort J, 2001, GLYCOBIOLOGY, V11, p25R; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Yang Y, 2009, BIOPOLYMERS, V91, P207, DOI 10.1002/bip.21119; Yang YS, 2000, BIOCHEMISTRY-US, V39, P14436, DOI 10.1021/bi0011835; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2	45	103	107	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29208	29216		10.1074/jbc.M110.143388	http://dx.doi.org/10.1074/jbc.M110.143388			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20605792	hybrid, Green Published			2022-12-25	WOS:000281740100021
J	Frentz, D; Boucher, CAB; Assel, M; De Luca, A; Fabbiani, M; Incardona, F; Libin, P; Manca, N; Muller, V; Nuallain, BO; Paredes, R; Prosperi, M; Quiros-Roldan, E; Ruiz, L; Sloot, PMA; Torti, C; Vandamme, AM; Van Laethem, K; Zazzi, M; van de Vijver, DAMC				Frentz, Dineke; Boucher, Charles A. B.; Assel, Matthias; De Luca, Andrea; Fabbiani, Massimiliano; Incardona, Francesca; Libin, Pieter; Manca, Nino; Mueller, Viktor; Nuallain, Breanndan O.; Paredes, Roger; Prosperi, Mattia; Quiros-Roldan, Eugenia; Ruiz, Lidia; Sloot, Peter M. A.; Torti, Carlo; Vandamme, Anne-Mieke; Van Laethem, Kristel; Zazzi, Maurizio; van de Vijver, David A. M. C.			Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over Time	PLOS ONE			English	Article							DRUG-RESISTANCE; ANTIRETROVIRAL THERAPY; PROTEASE	Background: Several decision support systems have been developed to interpret HIV-1 drug resistance genotyping results. This study compares the ability of the most commonly used systems (ANRS, Rega, and Stanford's HIVdb) to predict virological outcome at 12, 24, and 48 weeks. Methodology/Principal Findings: Included were 3763 treatment-change episodes (TCEs) for which a HIV-1 genotype was available at the time of changing treatment with at least one follow-up viral load measurement. Genotypic susceptibility scores for the active regimens were calculated using scores defined by each interpretation system. Using logistic regression, we determined the association between the genotypic susceptibility score and proportion of TCEs having an undetectable viral load (<50 copies/ml) at 12 (8-16) weeks (2152 TCEs), 24 (16-32) weeks (2570 TCEs), and 48 (44-52) weeks (1083 TCEs). The Area under the ROC curve was calculated using a 10-fold cross-validation to compare the different interpretation systems regarding the sensitivity and specificity for predicting undetectable viral load. The mean genotypic susceptibility score of the systems was slightly smaller for HIVdb, with 1.92 +/- 1.17, compared to Rega and ANRS, with 2.22 +/- 1.09 and 2.23 +/- 1.05, respectively. However, similar odds ratio's were found for the association between each-unit increase in genotypic susceptibility score and undetectable viral load at week 12; 1.6 [95% confidence interval 1.5-1.7] for HIVdb, 1.7 [1.5-1.8] for ANRS, and 1.7 [1.9-1.6] for Rega. Odds ratio's increased over time, but remained comparable (odds ratio's ranging between 1.9-2.1 at 24 weeks and 1.9-2.2 at 48 weeks). The Area under the curve of the ROC did not differ between the systems at all time points; p = 0.60 at week 12, p = 0.71 at week 24, and p = 0.97 at week 48. Conclusions/Significance: Three commonly used HIV drug resistance interpretation systems ANRS, Rega and HIVdb predict virological response at 12, 24, and 48 weeks, after change of treatment to the same extent.	[Frentz, Dineke; Boucher, Charles A. B.; van de Vijver, David A. M. C.] Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam, Netherlands; [Boucher, Charles A. B.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Assel, Matthias] Univ Stuttgart, High Performance Comp Ctr Stuttgart, Stuttgart, Germany; [De Luca, Andrea; Fabbiani, Massimiliano] Univ Cattolica Sacro Cuore, Inst Clin Infect Dis, I-00168 Rome, Italy; [De Luca, Andrea] Univ Hosp Siena, Infect Dis Unit 2, Siena, Italy; [Incardona, Francesca] Informa SrL, Rome, Italy; [Libin, Pieter] MyBioData, Rotselaar, Belgium; [Manca, Nino] Univ Brescia, Sch Med, Inst Microbiol, Brescia, Italy; [Mueller, Viktor] Eotvos Lorand Univ, Inst Biol, Budapest, Hungary; [Nuallain, Breanndan O.; Sloot, Peter M. A.] Univ Amsterdam, Amsterdam, Netherlands; [Paredes, Roger; Ruiz, Lidia] SIDA irsiCaixa, Inst Recerca, Badalona, Spain; [Prosperi, Mattia] Catholic Univ, Clin Infect Dis, Rome, Italy; [Quiros-Roldan, Eugenia; Torti, Carlo] Univ Brescia, Sch Med, Inst Infect & Trop Dis, Brescia, Italy; [Zazzi, Maurizio] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy; [Van Laethem, Kristel] Katholieke Univ Leuven, Rega Inst, Leuven, Belgium	Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; University of Stuttgart; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Siena; University Hospital of Siena; University of Brescia; Eotvos Lorand University; University of Amsterdam; Institut de Recerca de la Sida - IrsiCaixa; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Brescia; University of Siena; KU Leuven	Frentz, D (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam, Netherlands.	d.vandevijver@erasmusmc.nl	Fabbiani, Massimiliano/K-8842-2016; Van Laethem, Kristel/R-6282-2016; ROLDAN, Maria Eugenia QUIROS/K-7586-2015; Ruiz, Lidia/ABF-9720-2021; De Luca, Andrea/G-8810-2011; Zazzi, Maurizio/K-3422-2018; Müller, Viktor/B-3493-2009; Vandamme, Anne-Mieke/I-4127-2012; Sloot, Peter/B-3078-2014	Fabbiani, Massimiliano/0000-0002-1343-812X; Van Laethem, Kristel/0000-0001-6036-2271; ROLDAN, Maria Eugenia QUIROS/0000-0003-1452-9100; De Luca, Andrea/0000-0002-9561-9193; Zazzi, Maurizio/0000-0002-0344-6281; Müller, Viktor/0000-0001-8212-4880; Vandamme, Anne-Mieke/0000-0002-6594-2766; van de Vijver, David/0000-0001-5877-8526; Sloot, Peter/0000-0002-3848-5395	EU [IST-027446]; EuResist project [IST-2004-027173]; IUAP [P6/41]; CHAIN 7FP [223131]; FWO [G.0611.09N]; Belgian Ministry of Social Affairs; Health Insurance System	EU(European Commission); EuResist project; IUAP; CHAIN 7FP; FWO(FWO); Belgian Ministry of Social Affairs; Health Insurance System	This work was supported by the EU-funded Virolab project (IST-027446), EuResist project (IST-2004-027173), IUAP P6/41, CHAIN 7FP (223131), FWO grant (G.0611.09N) and the AIDS Reference Laboratory of Leuven which receives support from the Belgian Ministry of Social Affairs through a fund within the Health Insurance System. Informa co-funded the project that gave origine to the EuResist DB, used in the paper, and it contributed to the project with coordination and implementation roles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brun-Vezinet F, 2004, ANTIVIR THER, V9, P465; Cingolani A, 2002, AIDS, V16, P369, DOI 10.1097/00002030-200202150-00008; De Luca A, 2003, J INFECT DIS, V187, P1934, DOI 10.1086/375355; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; Fox ZV, 2007, AIDS, V21, P2033, DOI 10.1097/QAD.0b013e32825a69e4; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Larder B, 2007, ANTIVIR THER, V12, P15; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lorenzi P, 1999, AIDS, V13, pF17, DOI 10.1097/00002030-199902040-00001; Meynard JL, 2002, AIDS, V16, P727, DOI 10.1097/00002030-200203290-00008; Prosperi MCF, 2009, ANTIVIR THER, V14, P433; Ravela J, 2003, JAIDS-J ACQ IMM DEF, V33, P8, DOI 10.1097/00126334-200305010-00002; RHEE SY, 2009, J INFECT DIS; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Sloot PMA, 2009, PHILOS T R SOC A, V367, P2691, DOI 10.1098/rsta.2009.0043; Sloot P, 2008, STUD HEALTH TECHNOL, V138, P188; Tural C, 2002, AIDS, V16, P209, DOI 10.1097/00002030-200201250-00010; Van Laethem K, 2002, ANTIVIR THER, V7, P123; Zazzi M, 2009, J ANTIMICROB CHEMOTH, V64, P616, DOI 10.1093/jac/dkp252	20	50	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11505	10.1371/journal.pone.0011505	http://dx.doi.org/10.1371/journal.pone.0011505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634893	Green Published, gold			2022-12-25	WOS:000279715300016
J	Vigil, A; Ortega, R; Jain, A; Nakajima-Sasaki, R; Tan, XL; Chomel, BB; Kasten, RW; Koehler, JE; Felgner, PL				Vigil, Adam; Ortega, Rocio; Jain, Aarti; Nakajima-Sasaki, Rie; Tan, Xiaolin; Chomel, Bruno B.; Kasten, Rickie W.; Koehler, Jane E.; Felgner, Philip L.			Identification of the Feline Humoral Immune Response to Bartonella henselae Infection by Protein Microarray	PLOS ONE			English	Article							GEL-ELECTROPHORESIS; ANTIBODY-RESPONSES; DOMESTIC CATS; EXPRESSION; PREDICTION; REVEALS; PREVALENCE; CHALLENGE; FRAMEWORK; PATHOGEN	Background: Bartonella henselae is the zoonotic agent of cat scratch disease and causes potentially fatal infections in immunocompromised patients. Understanding the complex interactions between the host's immune system and bacterial pathogens is central to the field of infectious diseases and to the development of effective diagnostics and vaccines. Methodology: We report the development of a microarray comprised of proteins expressed from 96% (1433/1493) of the predicted ORFs encoded by the genome of the zoonotic pathogen Bartonella henselae. The array was probed with a collection of 62 uninfected, 62 infected, and 8 "specific-pathogen free'' naive cat sera, to profile the antibody repertoire elicited during natural Bartonella henselae infection. Conclusions: We found that 7.3% of the B. henselae proteins on the microarray were seroreactive and that seroreactivity was not evenly distributed between predicted protein function or subcellular localization. Membrane proteins were significantly most likely to be seroreactive, although only 23% of the membrane proteins were reactive. Conversely, we found that proteins involved in amino acid transport and metabolism were significantly underrepresented and did not contain any seroreactive antigens. Of all seroreactive antigens, 52 were differentially reactive with sera from infected cats, and 53 were equally reactive with sera from infected and uninfected cats. Thirteen of the seroreactive antigens were found to be differentially seroreactive between B. henselae type I and type II. Based on these results, we developed a classifier algorithm that was capable of accurately discerning 93% of the infected animals using the microarray platform. The seroreactivity and diagnostic potential of these antigens was then validated on an immunostrip platform, which correctly identified 98% of the infected cats. Our protein microarray platform provides a high-throughput, comprehensive analysis of the feline humoral immune response to natural infection with the alpha-proteobacterium B. henselae at an antigen-specific, sera-specific, and genome-wide level. Furthermore, these results provide novel insight and utility in diagnostics, vaccine development, and understanding of host-pathogen interaction.	[Vigil, Adam; Ortega, Rocio; Jain, Aarti; Nakajima-Sasaki, Rie; Tan, Xiaolin; Felgner, Philip L.] Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA; [Chomel, Bruno B.; Kasten, Rickie W.] Univ Calif Irvine, Sch Vet Med, Dept Populat Hlth & Reprod, Irvine, CA 92717 USA; [Koehler, Jane E.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California San Francisco	Vigil, A (corresponding author), Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA.	vigila@uci.edu			National Institutes of Health/National Institute of Allergy and Infectious Diseases [U01A1061363, U54065359, R01 AI52813]; California HIV/AIDS Research Program; Burroughs Wellcome Fund; Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052813, U54AI065359] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); California HIV/AIDS Research Program; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health/National Institute of Allergy and Infectious Diseases grants U01A1061363 (to P.L.F.), U54065359 (to P.L.F. and J.E.K.) and R01 AI52813 (to J.E.K.). J.E.K. received funding from a California HIV/AIDS Research Program Award and a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research. The cat study was supported by a grant from the Center for Companion Animal Health (George and Phyllis Miller Feline Research Fund), School of Veterinary Medicine, University of California, Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BALDI P, 2001, BIOINFORMATICS MACHI, pR21; Barbour AG, 2008, INFECT IMMUN, V76, P3374, DOI 10.1128/IAI.00048-08; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benhnia MREI, 2008, J VIROL, V82, P3751, DOI 10.1128/JVI.02244-07; Chang CC, 2002, J INFECT DIS, V186, P1733, DOI 10.1086/345764; Chomel BB, 2006, EMERG INFECT DIS, V12, P389, DOI 10.3201/eid1203.050931; CHOMEL BB, 1995, J CLIN MICROBIOL, V33, P2445, DOI 10.1128/JCM.33.9.2445-2450.1995; Davies DH, 2008, J VIROL, V82, P652, DOI 10.1128/JVI.01706-07; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194; Eyles JE, 2007, PROTEOMICS, V7, P2172, DOI 10.1002/pmic.200600985; Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106; FELGNER PL, 2009, P NATL ACAD SCI US; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Greene CE, 1996, J CLIN MICROBIOL, V34, P1682, DOI 10.1128/JCM.34.7.1682-1685.1996; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Davies DH, 2007, PROTEOMICS, V7, P1678, DOI 10.1002/pmic.200600926; JAMESON P, 1995, J INFECT DIS, V172, P1145, DOI 10.1093/infdis/172.4.1145; Kreil DP, 2004, BIOINFORMATICS, V20, P2026, DOI 10.1093/bioinformatics/bth193; Lindroos HL, 2005, J BACTERIOL, V187, P6155, DOI 10.1128/JB.187.17.6155-6165.2005; Long AD, 2001, J BIOL CHEM, V276, P19937, DOI 10.1074/jbc.M010192200; Marano N, 2007, REV SCI TECH OIE, V26, P203, DOI 10.20506/rst.26.1.1736; Molina DM, 2010, VACCINE, V28, P3014, DOI 10.1016/j.vaccine.2009.12.020; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Pamelard F, 2009, METHODS MOL BIOL, V570, P413, DOI 10.1007/978-1-60327-394-7_24; Regnery RL, 1996, AM J VET RES, V57, P1714; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Sundaresh S, 2007, BIOINFORMATICS, V23, pI508, DOI 10.1093/bioinformatics/btm207; Sundaresh S, 2006, BIOINFORMATICS, V22, P1760, DOI 10.1093/bioinformatics/btl162; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Vigil A, 2010, FUTURE MICROBIOL, V5, P241, DOI 10.2217/FMB.09.127; Yamamoto K, 2003, VET MICROBIOL, V92, P73, DOI 10.1016/S0378-1135(02)00347-4	37	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11447	10.1371/journal.pone.0011447	http://dx.doi.org/10.1371/journal.pone.0011447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625509	Green Published, gold			2022-12-25	WOS:000279522500014
J	Zuniga, JE; Hammill, JT; Drory, O; Nuss, JE; Burnett, JC; Gussio, R; Wipf, P; Bavari, S; Brunger, AT				Zuniga, Jorge E.; Hammill, Jared T.; Drory, Omri; Nuss, Jonathan E.; Burnett, James C.; Gussio, Rick; Wipf, Peter; Bavari, Sina; Brunger, Axel T.			Iterative Structure-Based Peptide-Like Inhibitor Design against the Botulinum Neurotoxin Serotype A	PLOS ONE			English	Article							TOXIN TYPE-A; SMALL-MOLECULE INHIBITORS; ALPHA-AMINO-ACIDS; CLOSTRIDIUM-BOTULINUM; SECONDARY STRUCTURE; LIGHT-CHAIN; NEUROTRANSMITTER RELEASE; CONFORMATIONAL-ANALYSIS; SUBSTRATE RECOGNITION; REMARKABLE RESISTANCE	The botulinum neurotoxin serotype A light chain (BoNT/A LC) protease is the catalytic component responsible for the neuroparalysis that is characteristic of the disease state botulism. Three related peptide-like molecules (PLMs) were designed using previous information from co-crystal structures, synthesized, and assayed for in vitro inhibition against BoNT/A LC. Our results indicate these PLMS are competitive inhibitors of the BoNT/A LC protease and their K(i) values are in the nM-range. A co-crystal structure for one of these inhibitors was determined and reveals that the PLM, in accord with the goals of our design strategy, simultaneously involves both ionic interactions via its P1 residue and hydrophobic contacts by means of an aromatic group in the P2' position. The PLM adopts a helical conformation similar to previously determined co-crystal structures of PLMs, although there are also major differences to these other structures such as contacts with specific BoNT/A LC residues. Our structure further demonstrates the remarkable plasticity of the substrate binding cleft of the BoNT/A LC protease and provides a paradigm for iterative structure-based design and development of BoNT/A LC inhibitors.	[Zuniga, Jorge E.; Drory, Omri; Brunger, Axel T.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Zuniga, Jorge E.; Drory, Omri; Brunger, Axel T.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Zuniga, Jorge E.; Drory, Omri; Brunger, Axel T.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Zuniga, Jorge E.; Drory, Omri; Brunger, Axel T.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Zuniga, Jorge E.; Drory, Omri; Brunger, Axel T.] Stanford Univ, Dept Photon Sci, Stanford, CA 94305 USA; [Hammill, Jared T.; Wipf, Peter] Univ Pittsburgh, Ctr Chem Methodol & Lib Dev, Pittsburgh, PA USA; [Nuss, Jonathan E.; Bavari, Sina] USA, Med Res Inst Infect Dis, Div Bacteriol, Dept Immunol Target Identificat & Translat Res, Frederick, MD USA; [Burnett, James C.] NCI, Target Struct Based Drug Discovery Grp, Frederick, MD 21701 USA; [Gussio, Rick] NCI, Informat Technol Branch, Dev Therapeut Program, Frederick, MD 21701 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zuniga, JE (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	pwipf@pitt.edu; brunger@stanford.edu	Hammill, Jared/AAW-7751-2020; Wipf, Peter/AAG-1771-2021; Bavari, Sina/L-3642-2019	Hammill, Jared/0000-0002-9463-0526; Wipf, Peter/0000-0001-7693-5863; Bavari, Sina/0000-0001-8424-5635; Brunger, Axel/0000-0001-5121-2036	Howard Hughes Medical Institute; Department of Defense	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Department of Defense(United States Department of Defense)	This work was supported by the Howard Hughes Medical Institute and the Department of Defense (proposal number 3.10024_06_RD_B to A.T.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Albanese A, 1995, ALIMENT PHARM THERAP, V9, P599; Bachrach SM, 2008, J ORG CHEM, V73, P2466, DOI 10.1021/jo702665r; Bhidayasiri R, 2005, J NEUROL SCI, V235, P1, DOI 10.1016/j.jns.2005.04.017; Binz T, 2002, BIOCHEMISTRY-US, V41, P1717, DOI 10.1021/bi0157969; BINZ T, 1994, J BIOL CHEM, V269, P1617; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; Breidenbach MA, 2005, TRENDS MOL MED, V11, P377, DOI 10.1016/j.molmed.2005.06.012; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Burnett JC, 2007, J MED CHEM, V50, P2127, DOI 10.1021/jm061446e; Burnett JC, 2007, J BIOL CHEM, V282, P5004, DOI 10.1074/jbc.M608166200; Burnett JC, 2003, BIOCHEM BIOPH RES CO, V310, P84, DOI 10.1016/j.bbrc.2003.08.112; Carter P, 2003, NUCLEIC ACIDS RES, V31, P3293, DOI 10.1093/nar/gkg626; Caya JG, 2004, ARCH PATHOL LAB MED, V128, P653; Chen S, 2007, J BIOL CHEM, V282, P9621, DOI 10.1074/jbc.M611211200; Cheng CA, 2006, AM J HEALTH-SYST PH, V63, P225, DOI 10.2146/sp/06001; Cheng CA, 2006, AM J HEALTH-SYST PH, V63, P145, DOI 10.2146/ajhp050137; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster KA, 2005, DRUG DISCOV TODAY, V10, P563, DOI 10.1016/S1359-6446(05)03389-1; Foster KA, 2004, EXPERT OPIN INV DRUG, V13, P1437, DOI 10.1517/13543784.13.11.1437; Glogau RG, 1998, DERMATOL SURG, V24, P817, DOI 10.1111/j.1524-4725.1998.tb04257.x; Glogau RG, 2002, CLIN J PAIN, V18, pS191, DOI 10.1097/00002508-200211001-00012; Gui D, 2003, ALIMENT PHARM THER, V18, P1, DOI 10.1046/j.1365-2036.2003.01598.x; GUI D, 1994, LANCET, V344, P1127, DOI 10.1016/S0140-6736(94)90633-5; Hermone AR, 2008, CHEMMEDCHEM, V3, P1905, DOI 10.1002/cmdc.200800241; Keller JE, 2006, NEUROSCIENCE, V139, P629, DOI 10.1016/j.neuroscience.2005.12.029; KUMARAN D, 2008, J BIOL CHEM; Kumaran D, 2008, J BIOL CHEM, V283, P18883, DOI 10.1074/jbc.M801240200; Kumaran D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000165; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Li HT, 1999, ORG LETT, V1, P91, DOI 10.1021/ol990573k; Lipozencic Jasna, 2006, Acta Dermatovenerol Croat, V14, P60; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paddle BM, 2003, J APPL TOXICOL, V23, P139, DOI 10.1002/jat.903; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; SCHIAVO G, 1993, J BIOL CHEM, V268, P11516; SCHIAVO G, 1994, J BIOL CHEM, V269, P20213; Schmidt JJ, 1995, J PROTEIN CHEM, V14, P703, DOI 10.1007/BF01886909; Schmidt JJ, 2003, APPL ENVIRON MICROB, V69, P297, DOI 10.1128/AEM.69.1.297-303.2003; Schmidt JJ, 2002, FEBS LETT, V532, P423, DOI 10.1016/S0014-5793(02)03738-9; Schmidt JJ, 1998, FEBS LETT, V435, P61, DOI 10.1016/S0014-5793(98)01041-2; Schmidt JJ, 2001, ANAL BIOCHEM, V296, P130, DOI 10.1006/abio.2001.5236; Schmidt JJ, 1997, J PROTEIN CHEM, V16, P19, DOI 10.1023/A:1026386710428; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; Silvaggi NR, 2008, BIOCHEMISTRY-US, V47, P5736, DOI 10.1021/bi8001067; Silvaggi NR, 2007, CHEM BIOL, V14, P533, DOI 10.1016/j.chembiol.2007.03.014; Singh BR, 2000, NAT STRUCT BIOL, V7, P617, DOI 10.1038/77900; Sposito MMM, 2002, PLAST RECONSTR SURG, V110, P601, DOI 10.1097/00006534-200208000-00037; Sposito MMM, 2002, AESTHET PLAST SURG, V26, P89, DOI 10.1007/s00266-002-1491-2; Turton K, 2002, TRENDS BIOCHEM SCI, V27, P552, DOI 10.1016/S0968-0004(02)02177-1; Wang CB, 2009, HETEROCYCLES, V79, P487, DOI 10.3987/COM-08-S(D)8; Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102; Willis B, 2008, ANGEW CHEM INT EDIT, V47, P8360, DOI 10.1002/anie.200705531; WIPF P, 1988, HELV CHIM ACTA, V71, P258, DOI 10.1002/hlca.19880710129; WIPF P, 1988, HELV CHIM ACTA, V71, P268, DOI 10.1002/hlca.19880710130; Wipf P, 2009, CHIMIA, V63, P764, DOI 10.2533/chimia.2009.764; Ye YH, 2005, BIOPOLYMERS, V80, P172, DOI 10.1002/bip.20201; Zuniga JE, 2008, STRUCTURE, V16, P1588, DOI 10.1016/j.str.2008.07.011	61	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11378	10.1371/journal.pone.0011378	http://dx.doi.org/10.1371/journal.pone.0011378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614028	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000279370000009
J	Kim, MJ; Chae, SS; Koh, YH; Lee, SK; Jo, SA				Kim, Min-Ju; Chae, San Sook; Koh, Young Ho; Lee, Suk Kyung; Jo, Sangmee Ahn			Glutamate carboxypeptidase II: an amyloid peptide-degrading enzyme with physiological function in the brain	FASEB JOURNAL			English	Article						Alzheimer's disease; peptidase; amyloid-beta; oligomer	LINKED ACIDIC DIPEPTIDASE; ALZHEIMERS-DISEASE; BETA-PROTEIN; N-ACETYLASPARTYLGLUTAMATE; MEMBRANE ANTIGEN; CEREBROSPINAL-FLUID; MASS-SPECTROMETRY; PROSTATE-CANCER; HYPOTHESIS; INHIBITION	Proteolytic processing of amyloid peptides (A beta s) is one important mechanism that controls the brain A beta level. Although several A beta-degrading enzymes were identified, evidence has suggested the presence of other peptidases. Here, we report a novel function of glutamate carboxypeptidase II (GCPII) in A beta degradation in brain, which is a peptidase involved in N-acetylaspartylglutamate cleavage, folate metabolism, and prostate tumorigenesis. Maldi-Tof/MS analysis showed that recombinant human GCPII cleaved the A beta 1-40 and A beta 1-42 monomers at their C-termini, producing smaller fragments, and A beta 1-14 that lacked aggregation property and cellular toxicity. GCPII also degrades soluble oligomers and fibrils and can reduce the endogenous plaque size in brain sections obtained from amyloid precursor protein (APP) Swedish/presinilin (PS)-1 Delta E9 transgenic mice. Overexpression of GCPII in either HEK293-APP Swedish cells or primary neurons and glial cells reduced the levels of secreted or exogenously supplemented A beta s and reduced A beta-induced neurotoxicity, suggesting the biological significance of GCPII-mediated A beta cleavage. Moreover, treatment of 8-mo-old transgenic mice for 1 mo with 2-(phosphonomethyl)-pentanedioic acid (10 mg/kg, intraperitoneally), a specific GCPII inhibitor, increased cerebral A beta content. These results suggest an important physiological role for GCPII in A beta clearance in brain and provide the evidence that dysregulation of GCPII is involved in Alzheimer's disease pathology.-Kim, M.-J., Chae, S. S., Koh, Y. H., Lee, S. K., Jo, S. A. Glutamate carboxypeptidase II: an amyloid peptide-degrading enzyme with physiological function in the brain. FASEB J. 24, 4491-4502 (2010). www.fasebj.org	[Kim, Min-Ju; Chae, San Sook; Koh, Young Ho; Lee, Suk Kyung; Jo, Sangmee Ahn] Korea Ctr Dis Control & Prevent, Div Brain Dis, Ctr Biomed Sci, Natl Inst Hlth, Seoul 122701, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science	Jo, SA (corresponding author), Korea Ctr Dis Control & Prevent, Div Brain Dis, Ctr Biomed Sci, Natl Inst Hlth, Seoul 122701, South Korea.	sangmeeaj@nih.go.kr			National Institute of Health, Korea [4845-300-210]	National Institute of Health, Korea	The authors thank Dr. Jeewoo Lee (Seoul National University, Seoul, Korea) for providing the PMPA for the study. The authors also thank Drs. J. T. Coyle, I. Jo, and K. Ahn for their critical reading and valuable comments of the manuscript, and Dr. S.Y. Suh for her preliminary work. This study was supported by an intramural research fund from the National Institute of Health (4845-300-210), Korea.	Anderson MO, 2007, BIOORGAN MED CHEM, V15, P6678, DOI 10.1016/j.bmc.2007.08.006; Bacich DJ, 2002, J NEUROCHEM, V83, P20, DOI 10.1046/j.1471-4159.2002.01117.x; Barinka C, 2008, J MOL BIOL, V376, P1438, DOI 10.1016/j.jmb.2007.12.066; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; Berger UV, 1999, J COMP NEUROL, V415, P52, DOI 10.1002/(SICI)1096-9861(19991206)415:1<52::AID-CNE4>3.0.CO;2-K; Borreguero JM, 2005, P NATL ACAD SCI USA, V102, P6015, DOI 10.1073/pnas.0502006102; Carson JA, 2002, J NEUROCHEM, V81, P1, DOI 10.1046/j.1471-4159.2002.00855.x; Chang SS, 1999, MOL UROL, V3, P313; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Chopra M, 2009, J PHARMACOL EXP THER, V330, P212, DOI 10.1124/jpet.109.152553; Devlin AM, 2000, HUM MOL GENET, V9, P2837, DOI 10.1093/hmg/9.19.2837; Fricker AC, 2009, NEUROPHARMACOLOGY, V56, P1060, DOI 10.1016/j.neuropharm.2009.03.002; Ghadge GD, 2003, P NATL ACAD SCI USA, V100, P9554, DOI 10.1073/pnas.1530168100; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Hlouchova K, 2007, J NEUROCHEM, V101, P682, DOI 10.1111/j.1471-4159.2006.04341.x; Jo C, 2005, BBA-MOL CELL RES, V1743, P187, DOI 10.1016/j.bbamcr.2004.11.002; Kim J, 2007, J NUTR, V137, P2093, DOI 10.1093/jn/137.9.2093; Kim MJ, 2007, EXP MOL MED, V39, P14, DOI 10.1038/emm.2007.3; Larner AJ, 1999, NEUROBIOL AGING, V20, P65; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Leissring Malcolm A., 2006, Current Alzheimer Research, V3, P431, DOI 10.2174/156720506779025206; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Liao MQ, 2007, FEBS LETT, V581, P1161, DOI 10.1016/j.febslet.2007.02.026; Mesters JR, 2006, EMBO J, V25, P1375, DOI 10.1038/sj.emboj.7600969; Michaud A, 1997, MOL PHARMACOL, V51, P1070, DOI 10.1124/mol.51.6.1070; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Nourhashemi F, 2000, AM J CLIN NUTR, V71, p643S; Ogawa T, 2005, J NEUROCHEM, V95, P1156, DOI 10.1111/j.1471-4159.2005.03436.x; Orning L, 1999, ARCH BIOCHEM BIOPHYS, V368, P131, DOI 10.1006/abbi.1999.1289; Passani LA, 1997, MOL CHEM NEUROPATHOL, V31, P97, DOI 10.1007/BF02815236; Peng XQ, 2010, EUR J PHARMACOL, V627, P156, DOI 10.1016/j.ejphar.2009.10.062; Portelius E, 2006, J PROTEOME RES, V5, P1010, DOI 10.1021/pr050475v; Portelius E, 2007, J PROTEOME RES, V6, P4433, DOI 10.1021/pr0703627; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Rajasekaran AK, 2005, AM J PHYSIOL-CELL PH, V288, pC975, DOI 10.1152/ajpcell.00506.2004; ROBINSON MB, 1987, J BIOL CHEM, V262, P14498; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shea TB, 2002, J ALZHEIMERS DIS, V4, P261, DOI 10.3233/JAD-2002-4401; Skidgel RA, 2004, PEPTIDES, V25, P521, DOI 10.1016/j.peptides.2003.12.010; Slusher BS, 1999, NAT MED, V5, P1396, DOI 10.1038/70971; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tsai G, 2003, SYNAPSE, V50, P285, DOI 10.1002/syn.10263; Tsukamoto T, 2007, DRUG DISCOV TODAY, V12, P767, DOI 10.1016/j.drudis.2007.07.010; Xi ZX, 2010, NEUROPHARMACOLOGY, V58, P304, DOI 10.1016/j.neuropharm.2009.06.016; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Zhou J, 2005, NAT REV DRUG DISCOV, V4, P1015, DOI 10.1038/nrd1903	47	24	24	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4491	4502		10.1096/fj.09-148825	http://dx.doi.org/10.1096/fj.09-148825			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20624932				2022-12-25	WOS:000283861100034
J	Patterson, ST; Reithmeier, RAF				Patterson, Sian T.; Reithmeier, Reinhart A. F.			Cell Surface Rescue of Kidney Anion Exchanger 1 Mutants by Disruption of Chaperone Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL TUBULAR-ACIDOSIS; N-LINKED OLIGOSACCHARIDES; ENDOPLASMIC-RETICULUM; MEMBRANE GLYCOPROTEIN; ERYTHROCYTE-MEMBRANE; ASIAN OVALOCYTOSIS; TRANSPORT PROTEIN; CYSTIC-FIBROSIS; IMPAIRED TRAFFICKING; MOLECULAR CHAPERONES	Mutations in the human kidney anion exchanger 1 (kAE1) membrane glycoprotein cause impaired urine acidification resulting in distal renal tubular acidosis (dRTA). Dominant and recessive dRTA kAE1 mutants exhibit distinct trafficking defects with retention in the endoplasmic reticulum (ER), Golgi, or mislocalization to the apical membrane in polarized epithelial cells. We examined the interaction of kAE1 with the quality control system responsible for the folding of membrane glycoproteins and the retention and degradation of misfolded mutants. Using small molecule inhibitors to disrupt chaperone interactions, two functional, dominant kAE1 mutants (R589H and R901stop), retained in the ER and targeted to the proteasome for degradation by ubiquitination, were rescued to the basolateral membrane of Madin-Darby canine kidney cells. In contrast, the Golgi-localized, recessive G701D and the severely misfolded, ER-retained dominant Southeast Asian ovalocytosis (SAO) mutants were not rescued. These results show that functional dRTA mutants are retained in the ER due to their interaction with molecular chaperones, particularly calnexin, and that disruption of these interactions can promote their escape from the ER and cell surface rescue.	[Patterson, Sian T.; Reithmeier, Reinhart A. F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto	Reithmeier, RAF (corresponding author), Univ Toronto, Dept Biochem, MSB5216,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	r.reithmeier@utoronto.ca			Canadian Institutes of Health Research [MOP102493]; Faculty of Medicine, University of Toronto; NIH [P540-GM67082, P30-DK79307]; CIHR; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM067082] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Faculty of Medicine, University of Toronto(University of Toronto); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant (MOP102493) from the Canadian Institutes of Health Research and funding from the Faculty of Medicine, University of Toronto. Development of reagents supplied by Jeff Brodsky (University of Pittsburgh) was supported by NIH Center Grants (P540-GM67082 and P30-DK79307).; Recipient of a studentship award from the CIHR Strategic Training Program in Membrane Proteins in Health and Disease.	Batlle D, 2001, ANNU REV MED, V52, P471, DOI 10.1146/annurev.med.52.1.471; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; BROSIUS FC, 1989, J BIOL CHEM, V264, P7784; Bruce LJ, 2000, BIOCHEM J, V350, P41, DOI 10.1042/0264-6021:3500041; CASEY JR, 1992, J BIOL CHEM, V267, P11940; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; Cheung JC, 2005, BIOCHEM J, V392, P425, DOI 10.1042/BJ20051076; Cordat E, 2006, TRAFFIC, V7, P117, DOI 10.1111/j.1600-0854.2005.00366.x; Cordat E, 2003, TRAFFIC, V4, P642, DOI 10.1034/j.1600-0854.2003.00123.x; Cordat E, 2006, BIOCHEM CELL BIOL, V84, P949, DOI 10.1139/O06-200; Demaurex N., 2003, CALRETICULIN, P134; Devonald MAJ, 2003, NAT GENET, V33, P125, DOI 10.1038/ng1082; Farmen SL, 2005, AM J PHYSIOL-LUNG C, V289, pL1123, DOI 10.1152/ajplung.00049.2005; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fewell SW, 2004, J BIOL CHEM, V279, P51131, DOI 10.1074/jbc.M404857200; GROVES JD, 1994, MOL MEMBR BIOL, V11, P31, DOI 10.3109/09687689409161027; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Jarolim P, 1998, J BIOL CHEM, V273, P6380, DOI 10.1074/jbc.273.11.6380; JOHNSON LG, 1992, NAT GENET, V2, P21, DOI 10.1038/ng0992-21; Kameh H, 1998, BIOCHEM CELL BIOL, V76, P823, DOI 10.1139/bcb-76-5-823; Karet FE, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000023433.08833.88; Kittanakom S, 2008, BIOCHEM J, V410, P271, DOI 10.1042/BJ20070615; KOLLERTJONS A, 1993, AM J PHYSIOL, V265, pF813, DOI 10.1152/ajprenal.1993.265.6.F813; Li J, 2000, BIOCHEM J, V349, P51, DOI 10.1042/0264-6021:3490051; Loo TW, 2008, BIOCHEM J, V413, P29, DOI 10.1042/BJ20071690; Loo TW, 2005, MOL PHARMACEUT, V2, P407, DOI 10.1021/mp0500521; Okiyoneda T, 2008, BBA-MOL CELL RES, V1783, P1585, DOI 10.1016/j.bbamcr.2008.04.002; OVERTON WR, 1988, CYTOMETRY, V9, P619, DOI 10.1002/cyto.990090617; Patterson ST, 2009, J BIOL CHEM, V284, P14547, DOI 10.1074/jbc.M809076200; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; PIMPLIKAR SW, 1986, J BIOL CHEM, V261, P9770; Popov M, 1999, J BIOL CHEM, V274, P17635, DOI 10.1074/jbc.274.25.17635; Quilty JA, 2002, BIOCHEM J, V368, P895, DOI 10.1042/BJ20020574; Quilty JA, 2002, AM J PHYSIOL-RENAL, V282, pF810, DOI 10.1152/ajprenal.00216.2001; Rodriguez-Soriano J, 2000, PEDIATR NEPHROL, V14, P1121, DOI 10.1007/s004670000407; Rungroj N, 2004, J BIOL CHEM, V279, P13833, DOI 10.1074/jbc.M400188200; SAMPSON HM, 2008, WILEY ENCY CHEM BIOL, P1; Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348; SCHOFIELD AE, 1992, NATURE, V355, P836, DOI 10.1038/355836a0; TAM LY, 1994, J BIOL CHEM, V269, P32542; Tanner MJA, 2002, CURR OPIN HEMATOL, V9, P133, DOI 10.1097/00062752-200203000-00009; TANNER MJA, 1988, BIOCHEM J, V256, P703, DOI 10.1042/bj2560703; Tanphaichitr VS, 1998, J CLIN INVEST, V102, P2173, DOI 10.1172/JCI4836; Toye AM, 2004, J CELL SCI, V117, P1399, DOI 10.1242/jcs.00974; Toye AM, 2002, BLOOD, V99, P342, DOI 10.1182/blood.V99.1.342; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; Wang Y, 2007, MOL MEMBR BIOL, V24, P65, DOI 10.1080/09687860600945263; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009	53	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33423	33434		10.1074/jbc.M110.144261	http://dx.doi.org/10.1074/jbc.M110.144261			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20628050	hybrid, Green Published			2022-12-25	WOS:000283048200077
J	Khorosjutina, O; Wanrooij, PH; Walfridsson, J; Szilagyi, Z; Zhu, XF; Baraznenok, V; Ekwall, K; Gustafsson, CM				Khorosjutina, Olga; Wanrooij, Paulina H.; Walfridsson, Julian; Szilagyi, Zsolt; Zhu, Xuefeng; Baraznenok, Vera; Ekwall, Karl; Gustafsson, Claes M.			A Chromatin-remodeling Protein Is a Component of Fission Yeast Mediator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHD1; SUBUNITS; CHROMODOMAINS; EXPRESSION; ACTIVATOR; COMPLEX; DOMAIN; GENES; SAGA	The multiprotein Mediator complex is an important regulator of RNA polymerase II-dependent genes in eukaryotic cells. In contrast to the situation in many other eukaryotes, the conserved Med15 protein is not a stable component of Mediator isolated from fission yeast. We here demonstrate that Med15 exists in a protein complex together with Hrp1, a CHD1 ATP-dependent chromatin-remodeling protein. The Med15-Hrp1 subcomplex is not a component of the core Mediator complex but can interact with the L-Mediator conformation. Deletion of med15(+) and hrp1(+) causes very similar effects on global steady-state levels of mRNA, and genome-wide analyses demonstrate that Med15 associates with a distinct subset of Hrp1-bound gene promoters. Our findings therefore indicate that Mediator may directly influence histone density at regulated promoters.	[Wanrooij, Paulina H.; Szilagyi, Zsolt; Zhu, Xuefeng; Gustafsson, Claes M.] Univ Gothenburg, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden; Karolinska Inst, Div Metab Dis, SE-14186 Stockholm, Sweden; [Walfridsson, Julian; Ekwall, Karl] Karolinska Inst, Dept Biosci & Med Nutr, SE-14186 Stockholm, Sweden; [Walfridsson, Julian; Ekwall, Karl] Univ Coll Sodertorn, Dept Life Sci, SE-14157 Huddinge, Sweden; [Gustafsson, Claes M.] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany	University of Gothenburg; Karolinska Institutet; Karolinska Institutet; Sodertorn University; Max Planck Society	Gustafsson, CM (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.	claes.gustafsson@medkem.gu.se	Wanrooij, Paulina/R-1509-2019; Wanrooij, Paulina/C-6002-2012	Wanrooij, Paulina/0000-0002-8607-7564; Wanrooij, Paulina/0000-0002-8607-7564; Gustafsson, Claes/0000-0003-3531-8468; Ekwall, Karl/0000-0002-3029-4041	Swedish Cancer Society; Swedish Research Council; European Union (EU); "The Epigenome" Network of Excellence (NoE) network; EU Marie Curie Early Stage Training Center; Goran Gustafsson Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union (EU)(CGIAREuropean Commission); "The Epigenome" Network of Excellence (NoE) network; EU Marie Curie Early Stage Training Center; Goran Gustafsson Foundation	This work was supported by grants from Swedish Cancer Society (to K.E. and C.M.G.), Swedish Research Council (to K.E. and C.M.G.), the European Union (EU) "The Epigenome" Network of Excellence (NoE) network (to K.E.), the EU Marie Curie Early Stage Training Center "Mitomed-Train" (to P.H.W.), and the Goran Gustafsson Foundation (to C.M.G.).	Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Beve J, 2005, J BIOL CHEM, V280, P41366, DOI 10.1074/jbc.M511181200; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Borggrefe T, 2002, J BIOL CHEM, V277, P44202, DOI 10.1074/jbc.M207195200; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Buck MJ, 2004, GENOMICS, V83, P349, DOI 10.1016/j.ygeno.2003.11.004; Elmlund H, 2006, P NATL ACAD SCI USA, V103, P15788, DOI 10.1073/pnas.0607483103; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Iacovoni JS, 1999, GENE, V232, P53, DOI 10.1016/S0378-1119(99)00116-X; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lemieux K, 2008, BIOCHEM BIOPH RES CO, V369, P1103, DOI 10.1016/j.bbrc.2008.02.144; Linder T, 2008, NUCLEIC ACIDS RES, V36, P2489, DOI 10.1093/nar/gkn070; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Meyer KD, 2008, EMBO J, V27, P1447, DOI 10.1038/emboj.2008.78; Myers LC, 1999, P NATL ACAD SCI USA, V96, P67, DOI 10.1073/pnas.96.1.67; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Okuda M, 2007, J MOL BIOL, V365, P1047, DOI 10.1016/j.jmb.2006.10.039; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Samuelsen CO, 2003, P NATL ACAD SCI USA, V100, P6422, DOI 10.1073/pnas.1030497100; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Spahr H, 2000, J BIOL CHEM, V275, P1351, DOI 10.1074/jbc.275.2.1351; Spahr H, 2001, P NATL ACAD SCI USA, V98, P11985, DOI 10.1073/pnas.211253898; Stokes DG, 1996, P NATL ACAD SCI USA, V93, P7137, DOI 10.1073/pnas.93.14.7137; SUZUKI Y, 1988, MOL CELL BIOL, V8, P4991, DOI 10.1128/MCB.8.11.4991; Tanaka N, 1998, BIOCHEM BIOPH RES CO, V245, P246, DOI 10.1006/bbrc.1998.8406; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; Walfridsson J, 2007, EMBO J, V26, P2868, DOI 10.1038/sj.emboj.7601728; Wiren M, 2005, EMBO J, V24, P2906, DOI 10.1038/sj.emboj.7600758; Xue YT, 2004, YEAST, V21, P25, DOI 10.1002/yea.1053; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004	36	17	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29729	29737		10.1074/jbc.M110.153858	http://dx.doi.org/10.1074/jbc.M110.153858			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20622008	Green Published, hybrid			2022-12-25	WOS:000281984300008
J	Aalto, AP; Poranen, MM; Grimes, JM; Stuart, DI; Bamford, DH				Aalto, Antti P.; Poranen, Minna M.; Grimes, Jonathan M.; Stuart, David I.; Bamford, Dennis H.			In Vitro Activities of the Multifunctional RNA Silencing Polymerase QDE-1 of Neurospora crassa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; INTERFERENCE; EXPRESSION; PROTEIN; REPLICATION; INTERACTS; PATHWAY; SIRNAS; GENES; DICER	QDE-1 is an RNA-and DNA-dependent RNA polymerase that has functions in the RNA silencing and DNA repair pathways of the filamentous fungus Neurospora crassa. The crystal structure of the dimeric enzyme has been solved, and the fold of its catalytic core is related closely to that of eukaryotic DNA-dependent RNA polymerases. However, the specific activities of this multifunctional enzyme are still largely unknown. In this study, we characterized the in vitro activities of the N-terminally truncated QDE-1 Delta N utilizing structure-based mutagenesis. Our results indicate that QDE-1 displays five distinct catalytic activities, which can be dissected by mutating critical amino acids or by altering reaction conditions. Our data also suggest that the RNA-and DNA-dependent activities have different modes for the initiation of RNA synthesis, which may reflect the mechanism that enables the polymerase to discriminate between template nucleic acids. Moreover, we show that QDE-1 is a highly potent terminal nucleotidyltransferase. Our results suggest that QDE-1 is able to regulate its activity mode depending on the template nucleic acid. This work extends our understanding of the biochemical properties of the QDE-1 enzyme and related RNA polymerases.	[Bamford, Dennis H.] Univ Helsinki, Bioctr 2, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Bamford, Dennis H.] Univ Helsinki, Bioctr 2, Dept Biosci, FIN-00014 Helsinki, Finland; [Grimes, Jonathan M.; Stuart, David I.] Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England	University of Helsinki; University of Helsinki; University of Oxford	Bamford, DH (corresponding author), Univ Helsinki, Bioctr 2, Inst Biotechnol, POB 56, FIN-00014 Helsinki, Finland.	dennis.bamford@helsinki.fi		Bamford, Dennis/0000-0002-6438-8118; Stuart, David/0000-0002-3426-4210; Grimes, Jonathan Mark/0000-0001-9698-0389; Poranen, Minna/0000-0002-4775-3670	Academy of Finland Finnish Centre of Excellence [1129684]; United Kingdom Medical Research Council and SPINE2COMPLEXES [LSHGCT-2006-031220]; MRC [G0500365, G1000099] Funding Source: UKRI; Medical Research Council [G1000099, G0500365] Funding Source: researchfish	Academy of Finland Finnish Centre of Excellence(Academy of Finland); United Kingdom Medical Research Council and SPINE2COMPLEXES(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Academy of Finland Finnish Centre of Excellence Programme 2006-2011 (1129684, to D. H. B.) and by the United Kingdom Medical Research Council and SPINE2COMPLEXES (LSHGCT-2006-031220).	Catalanotto C, 2006, FEMS MICROBIOL LETT, V254, P182, DOI 10.1111/j.1574-6968.2005.00037.x; Catalanotto C, 2004, MOL CELL BIOL, V24, P2536, DOI 10.1128/MCB.24.6.2536-2545.2004; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; Choudhary S, 2007, MOL CELL BIOL, V27, P3995, DOI 10.1128/MCB.00186-07; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1997, P NATL ACAD SCI USA, V94, P10233, DOI 10.1073/pnas.94.19.10233; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; Forrest EC, 2004, NUCLEIC ACIDS RES, V32, P2123, DOI 10.1093/nar/gkh530; Fulci V, 2007, CURR OPIN MICROBIOL, V10, P199, DOI 10.1016/j.mib.2007.03.016; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Goldoni M, 2004, FUNGAL GENET BIOL, V41, P1016, DOI 10.1016/j.fgb.2004.08.002; GOTTLIEB P, 1992, J VIROL, V66, P2611, DOI 10.1128/JVI.66.5.2611-2616.1992; Laurila MRL, 2005, J STRUCT BIOL, V149, P111, DOI 10.1016/j.jsb.2004.10.001; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Lee SR, 2007, NAT STRUCT MOL BIOL, V14, P604, DOI 10.1038/nsmb1262; Lipardi C, 2009, P NATL ACAD SCI USA, V106, P15645, DOI 10.1073/pnas.0904984106; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Nolan T, 2008, NUCLEIC ACIDS RES, V36, P532, DOI 10.1093/nar/gkm1071; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pickford A, 2003, CURR GENET, V42, P220, DOI 10.1007/s00294-002-0351-6; Poranen MM, 2008, J VIROL, V82, P9254, DOI 10.1128/JVI.01044-08; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; Sambrook J, 2001, MOL CLONING LAB MANU; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Yang HY, 2001, J VIROL, V75, P11088, DOI 10.1128/JVI.75.22.11088-11095.2001	36	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29367	29374		10.1074/jbc.M110.139121	http://dx.doi.org/10.1074/jbc.M110.139121			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20647305	hybrid, Green Published			2022-12-25	WOS:000281740100039
J	Mizutani, T; Yazawa, T; Ju, YF; Imamichi, Y; Uesaka, M; Inaoka, Y; Matsuura, K; Kamiki, Y; Oki, M; Umezawa, A; Miyamoto, K				Mizutani, Tetsuya; Yazawa, Takashi; Ju, Yunfeng; Imamichi, Yoshitaka; Uesaka, Miki; Inaoka, Yoshihiko; Matsuura, Kaoru; Kamiki, Yasue; Oki, Masaya; Umezawa, Akihiro; Miyamoto, Kaoru			Identification of a Novel Distal Control Region Upstream of the Human Steroidogenic Acute Regulatory Protein (StAR) Gene That Participates in SF-1-dependent Chromatin Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; ELEMENT-BINDING-PROTEIN; LIPOID ADRENAL-HYPERPLASIA; OVARIAN GRANULOSA-CELLS; MESENCHYMAL STEM-CELLS; FACTOR-I; NUCLEAR RECEPTOR; TRANSCRIPTIONAL REGULATION; PROMOTER ACTIVITY; HISTONE MODIFICATIONS	StAR (steroidogenic acute regulatory protein) mediates the transport of cholesterol from the outer to the inner mitochondrial membrane, the process of which is the rate-limiting step for steroidogenesis. Transcriptional regulation of the proximal promoter of the human StAR gene has been well characterized, where as analysis of its distal control region has not. Recently, we found that SF-1 (steroidogenic factor 1) induced the differentiation of mesenchymal stem cells (MSCs) into steroidogenic cells with the concomitant strong induction of StAR expression. Here, we show, using differentiated MSCs, that StAR expression is regulated by a novel distal control region. Using electrophoretic mobility shift (EMSA) and chromatin immunoprecipitation (ChIP) assays, we identified novel SF-1 binding sites between 3,000 and 3,400 bp upstream of StAR. A luciferase reporter assay revealed that the region worked as a strong regulator to exert maximal transcription of StAR. ChIP analysis of histone H3 revealed that upon SF-1 expression, nucleosome eviction took place at the SF-1 binding sites, not only in the promoter but also in the distal SF-1 binding sites. Chromosome conformation capture analysis revealed that the region upstream of StAR formed a chromatin loop both in the differentiated MSCs and in KGN cells, a human granulosa cell tumor cell line, where SF-1 is endogenously expressed. Finally, SF-1 knockdown resulted in disrupted formation of this chromatin loop in KGN cells. These results indicate that the novel distal control region participate in StAR activation through SF-1 dependent alterations of chromatin structure, including histone eviction and chromatin loop formation.	[Mizutani, Tetsuya; Yazawa, Takashi; Ju, Yunfeng; Imamichi, Yoshitaka; Uesaka, Miki; Inaoka, Yoshihiko; Matsuura, Kaoru; Kamiki, Yasue; Miyamoto, Kaoru] Univ Fukui, Fac Med Sci, Dept Biochem, Eiheiji, Fukui 9101193, Japan; [Mizutani, Tetsuya; Yazawa, Takashi; Oki, Masaya; Miyamoto, Kaoru] Univ Fukui, Org Life Sci Adv Programs, Translat Res Ctr, Eiheiji, Fukui 9101193, Japan; [Oki, Masaya] Univ Fukui, Fac Engn, Dept Appl Chem & Biotechnol, Eiheiji, Fukui 9101193, Japan; [Oki, Masaya] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Tokyo 1578535, Japan	University of Fukui; University of Fukui; University of Fukui; Japan Science & Technology Agency (JST); National Center for Child Health & Development - Japan	Miyamoto, K (corresponding author), Univ Fukui, Fac Med Sci, Dept Biochem, Eiheiji, Fukui 9101193, Japan.	kmiyamot@u-fukui.ac.jp	Yazawa, Takashi/AEZ-6785-2022	Yazawa, Takashi/0000-0003-4526-6585	Health and Labor Sciences Research; Ministry of Education, Culture, Sports, Science and Culture; Yamaguchi Endocrine Research Foundation; Japan Science and Technology Agency	Health and Labor Sciences Research(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamaguchi Endocrine Research Foundation; Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a grant from Health and Labor Sciences Research; a grant from the Ministry of Education, Culture, Sports, Science and Culture; the Yamaguchi Endocrine Research Foundation; and the Precursory Research for Embryonic Science and Technology program from the Japan Science and Technology Agency.	ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; AEsoy R, 2002, ENDOCRINOLOGY, V143, P295, DOI 10.1210/en.143.1.295; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; Bose HS, 1996, NEW ENGL J MED, V335, P1870, DOI 10.1056/NEJM199612193352503; Caron KM, 1997, MOL ENDOCRINOL, V11, P138, DOI 10.1210/me.11.2.138; Caron KM, 1997, P NATL ACAD SCI USA, V94, P11540, DOI 10.1073/pnas.94.21.11540; Chen WY, 2005, MOL CELL BIOL, V25, P10442, DOI 10.1128/MCB.25.23.10442-10453.2005; Chen XX, 2005, MOL CELL BIOL, V25, P3209, DOI 10.1128/MCB.25.8.3209-3219.2005; Christenson LK, 1999, J BIOL CHEM, V274, P26591, DOI 10.1074/jbc.274.37.26591; Christenson LK, 2001, J BIOL CHEM, V276, P27392, DOI 10.1074/jbc.M101650200; Clark BJ, 1999, ENDOCRINOLOGY, V140, P4390, DOI 10.1210/en.140.10.4390; CLARK BJ, 1995, MOL ENDOCRINOL, V9, P1346, DOI 10.1210/me.9.10.1346; Duggavathi R, 2008, GENE DEV, V22, P1871, DOI 10.1101/gad.472008; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Hammer GD, 1999, MOL CELL, V3, P521, DOI 10.1016/S1097-2765(00)80480-3; Hasegawa T, 2000, MOL ENDOCRINOL, V14, P1462, DOI 10.1210/me.14.9.1462; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hinshelwood MM, 2003, MOL CELL ENDOCRINOL, V207, P39, DOI 10.1016/S0303-7207(03)00257-0; Hiroi H, 2004, MOL ENDOCRINOL, V18, P791, DOI 10.1210/me.2003-0305; IKEDA Y, 1994, MOL ENDOCRINOL, V8, P654, DOI 10.1210/me.8.5.654; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; LaVoie HA, 1999, ENDOCRINOLOGY, V140, P146, DOI 10.1210/en.140.1.146; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; LUO XR, 1995, ENDOCR RES, V21, P517, DOI 10.3109/07435809509030469; Manna PR, 2003, STEROIDS, V68, P1125, DOI 10.1016/j.steroids.2003.07.009; Manna PR, 2003, J MOL ENDOCRINOL, V30, P381, DOI 10.1677/jme.0.0300381; Manna PR, 2002, MOL ENDOCRINOL, V16, P184, DOI 10.1210/me.16.1.184; Mizutani T, 2000, J BIOL CHEM, V275, P22512, DOI 10.1074/jbc.M001631200; Mizutani T, 2001, MOL ENDOCRINOL, V15, P1693, DOI 10.1210/me.15.10.1693; Mori T, 2005, MOL CELL BIOL, V25, P5183, DOI 10.1128/MCB.25.12.5183-5195.2005; MOROHASHI K, 1992, J BIOL CHEM, V267, P17913; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7; OwenHughes T, 1996, EMBO J, V15, P4702, DOI 10.1002/j.1460-2075.1996.tb00847.x; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Reinhart AJ, 1999, MOL ENDOCRINOL, V13, P729, DOI 10.1210/me.13.5.729; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Rusovici R, 2005, BIOL REPROD, V72, P862, DOI 10.1095/biolreprod.104.034298; Rust W, 1998, J MOL ENDOCRINOL, V21, P189, DOI 10.1677/jme.0.0210189; SADOVSKY Y, 1995, P NATL ACAD SCI USA, V92, P10939, DOI 10.1073/pnas.92.24.10939; Sandhoff TW, 1998, ENDOCRINOLOGY, V139, P4820, DOI 10.1210/en.139.12.4820; Shea-Eaton WK, 2001, ENDOCRINOLOGY, V142, P1525, DOI 10.1210/en.142.4.1525; Shimizu T, 2009, MOL CELL BIOCHEM, V328, P41, DOI 10.1007/s11010-009-0072-y; Silverman E, 1999, J BIOL CHEM, V274, P17987, DOI 10.1074/jbc.274.25.17987; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; SUGAWARA T, 1995, BIOCHEMISTRY-US, V34, P12506, DOI 10.1021/bi00039a004; Sugawara T, 1997, BIOCHEMISTRY-US, V36, P7249, DOI 10.1021/bi9628984; Sugawara T, 1996, BIOCHEMISTRY-US, V35, P9052, DOI 10.1021/bi960057r; Vicent GP, 2004, MOL CELL, V16, P439, DOI 10.1016/j.molcel.2004.10.025; Wooton-Kee CR, 2000, ENDOCRINOLOGY, V141, P1345, DOI 10.1210/en.141.4.1345; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613; Yazawa T, 2003, ENDOCRINOLOGY, V144, P1920, DOI 10.1210/en.2002-221070; Yazawa T, 2006, ENDOCRINOLOGY, V147, P4104, DOI 10.1210/en.2006-0162; Yazawa T, 2010, MOL ENDOCRINOL, V24, P485, DOI 10.1210/me.2009-0352; Yazawa T, 2009, ENDOCRINOLOGY, V150, P3885, DOI 10.1210/en.2008-1310; Yoshino M, 2002, BIOL REPROD, V66, P1813, DOI 10.1095/biolreprod66.6.1813; Zhao H, 2006, J BIOL CHEM, V281, P30573, DOI 10.1074/jbc.M606803200	64	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28240	28251		10.1074/jbc.M110.129510	http://dx.doi.org/10.1074/jbc.M110.129510			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20601698	Green Published, hybrid			2022-12-25	WOS:000281404100067
J	Rooijakkers, SHM; Rasmussen, SL; McGillivray, SM; Bartnikas, TB; Mason, AB; Friedlander, AM; Nizet, V				Rooijakkers, Suzan H. M.; Rasmussen, Suzanne L.; McGillivray, Shauna M.; Bartnikas, Thomas B.; Mason, Anne B.; Friedlander, Arthur M.; Nizet, Victor			Human Transferrin Confers Serum Resistance against Bacillus anthracis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; INNATE IMMUNITY; LETHAL TOXIN; IRON; BACTERIAL; LACTOFERRIN; MICE; ACQUISITION; COMPLEMENT; VIRULENCE	The innate immune system in humans consists of both cellular and humoral components that collaborate to eradicate invading bacteria from the body. Here, we discover that the Gram-positive bacterium Bacillus anthracis, the causative agent of anthrax, does not grow in human serum. Fractionation of serum by gel filtration chromatography led to the identification of human transferrin as the inhibiting factor. Purified transferrin blocks growth of both the fully virulent encapsulated B. anthracis Ames and the non-encapsulated Sterne strain. Growth inhibition was also observed in serum of wild-type mice but not of hypotransferrinemic mice that only have similar to 1% circulating transferrin levels. We were able to definitely assign the bacteriostatic activity of transferrin to its iron-binding function: neither iron-saturated transferrin nor a recombinant transferrin mutant unable to bind iron could inhibit growth of B. anthracis. Additional iron could restore bacterial growth in human serum. The observation that other important Gram-positive pathogens are not inhibited by transferrin suggests they have evolved effective mechanisms to circumvent serum iron deprivation. These findings provide a better understanding of human host defense mechanisms against anthrax and provide a mechanistic basis for the antimicrobial activity of human transferrin.	[Rooijakkers, Suzan H. M.] Univ Med Ctr Utrecht, NL-3584 CX Utrecht, Netherlands; [Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Rasmussen, Suzanne L.; Friedlander, Arthur M.] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Bartnikas, Thomas B.] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Mason, Anne B.] Univ Vermont, Dept Biochem, Coll Med, Burlington, VT 05405 USA; [Nizet, Victor] Rady Childrens Hosp, San Diego, CA 92123 USA	Utrecht University; Utrecht University Medical Center; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Boston Children's Hospital; University of Vermont; Rady Childrens Hospital San Diego	Rooijakkers, SHM (corresponding author), Univ Med Ctr Utrecht, G04-614, NL-3584 CX Utrecht, Netherlands.	s.h.m.rooijakkers@umcutrecht.nl	Nizet, Victor/AAF-3190-2019; Mason, Anne B/A-6754-2008; McGillivray, Shauna/AAN-3074-2021	McGillivray, Shauna/0000-0002-8863-1522; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health [AI077780, DK084122-01, DK21739]; European Organization of Molecular Biology (EMBO); NIGMS [GM068524]; Hartwell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK084122, R01DK021739, R56DK021739, K99DK084122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Organization of Molecular Biology (EMBO)(European Molecular Biology Organization (EMBO)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Hartwell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health Grants AI077780 (to V. N.), DK084122-01 (to T. B. B.), and DK21739 (to A. B. M.). This work was also supported by the European Organization of Molecular Biology (EMBO) (to S. H. M. R.).; Supported by an IRACDA postdoctoral fellowship from NIGMS (GM068524) and a Biomedical Research Fellowship from The Hartwell Foundation.	Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Aguilera O, 2003, FEBS LETT, V548, P5, DOI 10.1016/S0014-5793(03)00719-1; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; BELLAMY W, 1992, BIOCHIM BIOPHYS ACTA, V1121, P130, DOI 10.1016/0167-4838(92)90346-F; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; BEZKOROVAINY A, 1982, ADV EXP MED BIOL, V135, P139; Bischof TS, 2007, J INFECT DIS, V195, P888, DOI 10.1086/511824; BULLEN JJ, 1974, INFECT IMMUN, V10, P443, DOI 10.1128/IAI.10.3.443-450.1974; CATALDI A, 1990, MOL MICROBIOL, V4, P1111, DOI 10.1111/j.1365-2958.1990.tb00685.x; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; Cornelissen CN, 2003, FRONT BIOSCI-LANDMRK, V8, pD836, DOI 10.2741/1076; CORNELISSEN CN, 1994, MOL MICROBIOL, V14, P843, DOI 10.1111/j.1365-2958.1994.tb01320.x; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; ELLISON RT, 1988, INFECT IMMUN, V56, P2774, DOI 10.1128/IAI.56.11.2774-2781.1988; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Friedlander AM, 2000, CURR CLIN TOPICS INF, V20, P335; Fukao T, 2004, LANCET INFECT DIS, V4, P166, DOI 10.1016/S1473-3099(04)00940-5; Gonzalez-Chavez SA, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.07.020; Harvill ET, 2005, INFECT IMMUN, V73, P4420, DOI 10.1128/IAI.73.7.4420-4422.2005; Jeffrey PD, 1998, BIOCHEMISTRY-US, V37, P13978, DOI 10.1021/bi9812064; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Legrand D, 2008, ADV EXP MED BIOL, V606, P163, DOI 10.1007/978-0-387-74087-4_6; Lisanby MW, 2008, J IMMUNOL, V181, P4989, DOI 10.4049/jimmunol.181.7.4989; Mason AB, 2004, PROTEIN EXPRES PURIF, V36, P318, DOI 10.1016/j.pep.2004.04.013; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; McGillivray SM, 2009, J INNATE IMMUN, V1, P494, DOI 10.1159/000225955; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; ORAM JD, 1968, BIOCHIM BIOPHYS ACTA, V170, P351, DOI 10.1016/0304-4165(68)90015-9; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Ribot WJ, 2006, INFECT IMMUN, V74, P5029, DOI 10.1128/IAI.00275-06; Roos A, 2003, MOL IMMUNOL, V39, P655, DOI 10.1016/S0161-5890(02)00254-7; ROSSING N, 1981, CLIN PHYSIOL, V1, P275, DOI 10.1111/j.1475-097X.1981.tb00896.x; Taylor JM, 2002, MOL MICROBIOL, V43, P1603, DOI 10.1046/j.1365-2958.2002.02850.x; Trenor CC, 2000, BLOOD, V96, P1113, DOI 10.1182/blood.V96.3.1113.015k03_1113_1118; VALENTI P, 1982, ANTIMICROB AGENTS CH, V21, P840, DOI 10.1128/AAC.21.5.840; Valenti P, 2005, CELL MOL LIFE SCI, V62, P2576, DOI 10.1007/s00018-005-5372-0; Wally J, 2007, BIOMETALS, V20, P249, DOI 10.1007/s10534-006-9062-7; Wally J, 2006, J BIOL CHEM, V281, P24934, DOI 10.1074/jbc.M604592200; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; WILLIAMS J, 1980, BIOCHEM J, V185, P483, DOI 10.1042/bj1850483	42	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27609	27613		10.1074/jbc.M110.154930	http://dx.doi.org/10.1074/jbc.M110.154930			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20615872	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000281404100016
J	Craik, AC; Veldhoen, RA; Czernick, M; Buckland, TW; Kyselytzia, K; Ghosh, S; Lai, R; Damaraju, S; Underhill, DA; Mackey, JR; Goping, IS				Craik, A. C.; Veldhoen, R. A.; Czernick, M.; Buckland, T. W.; Kyselytzia, K.; Ghosh, S.; Lai, R.; Damaraju, S.; Underhill, D. A.; Mackey, J. R.; Goping, I. S.			The BH3-only protein Bad confers breast cancer taxane sensitivity through a nonapoptotic mechanism	ONCOGENE			English	Article						Bad; taxane; paclitaxel; docetaxel; apoptosis; breast cancer	CELL-SURVIVAL; BH3 DOMAIN; EXPRESSION PATTERNS; MAMMARY-GLAND; MITOTIC BLOCK; APOPTOSIS; PHOSPHORYLATION; BCL-2; DEATH; PACLITAXEL	Antimitotic agents such as taxanes (paclitaxel and docetaxel) have greatly advanced the treatment of breast cancer, although variable patient response and drug toxicity are major limitations. Lack of validated predictive markers for taxane responsiveness precludes a priori identification of patients who are most likely to respond to treatment; thus, a subset of patients endure toxic side effects with marginal benefit. Mechanistic insights into taxane therapeutic activity may lead to rational therapeutic improvements. In this paper we report that the proapoptotic BH3-only protein Bad has a major role in taxane-induced cell death in vitro, and clinically is a prognostic indicator for overall survival of breast cancer patients after adjuvant taxane chemotherapy. Unexpectedly, Bad did not induce the mitochondrial apoptotic machinery in response to taxane treatment. Instead, Bad indirectly facilitated cell death by stimulating cellular proliferation. As dividing cells are the targets of taxane therapy, Bad-stimulated proliferation may be a marker of taxane sensitivity. Our studies indicate that quantification of Bad protein levels may have value as a diagnostic tool. They also suggest that cells expressing Bad are more sensitive to taxanes because of their altered cell cycle dynamics and reveal a clinically relevant proliferative role of Bad in breast cancer. Oncogene (2010) 29, 5381-5391; doi: 10.1038/onc.2010.272; published online 5 July 2010	[Craik, A. C.; Veldhoen, R. A.; Czernick, M.; Buckland, T. W.; Kyselytzia, K.; Goping, I. S.] Univ Alberta, Dept Biochem, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada; [Ghosh, S.; Underhill, D. A.; Mackey, J. R.; Goping, I. S.] Univ Alberta, Dept Oncol, Sch Canc Engn & Imaging Sci Med, Edmonton, AB T6G 2H7, Canada; [Lai, R.; Damaraju, S.] Univ Alberta, Dept Lab Med & Pathol, Sch Clin & Lab Sci, Edmonton, AB T6G 2H7, Canada; [Damaraju, S.; Mackey, J. R.] Cross Canc Inst, Alberta Hlth Serv, PolyomX Program, Edmonton, AB T6G 1Z2, Canada; [Underhill, D. A.] Univ Alberta, Dept Med Genet, Sch Human Dev, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta; University of Alberta; Alberta Health Services (AHS); University of Alberta; University of Alberta	Goping, IS (corresponding author), Univ Alberta, Dept Biochem, Sch Mol & Syst Med, 5-73 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	igoping@ualberta.ca	Veldhoen, Richard/M-8168-2019	Veldhoen, Richard/0000-0003-4643-2960; Underhill, Darrell/0000-0003-0957-7407	QEII; Mary Johnston Melanoma Research Chair; Alberta Cancer Research Institute; Canadian Breast Cancer Foundation	QEII; Mary Johnston Melanoma Research Chair; Alberta Cancer Research Institute; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	We thank Drs Thomas Simmen, Roseline Godbout and Simonetta Sipione for helpful discussions, Ms Yisu Li for assistance with gene expression microarray analysis and Ms Cheryl Santos for excellent technical input. We also thank the anonymous reviewers for insightful suggestions that improved this study. ACC is a recipient of a QEII Graduate Scholarship. DAU is supported by the Mary Johnston Melanoma Research Chair. ISG is a recipient of a Recruitment Award from the Alberta Cancer Research Institute. This work was supported by operating grants from the Alberta Cancer Research Institute and the Canadian Breast Cancer Foundation awarded to ISG.	Aapro MS, 2001, ONCOLOGIST, V6, P36, DOI 10.1634/theoncologist.6-4-376; Al-Bazz YO, 2009, EUR J CANCER, V45, P694, DOI 10.1016/j.ejca.2008.11.044; Andreeff M, 1999, LEUKEMIA, V13, P1881, DOI 10.1038/sj.leu.2401573; Blagosklonny MV, 1999, INT J CANCER, V83, P151, DOI 10.1002/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO;2-5; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Cannings E, 2007, BREAST CANCER RES TR, V102, P173, DOI 10.1007/s10549-006-9323-8; Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8; Chang JC, 2008, BREAST CANCER RES TR, V108, P233, DOI 10.1007/s10549-007-9590-z; Chattopadhyay A, 2001, ONCOGENE, V20, P4507, DOI 10.1038/sj.onc.1204584; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Czernick M, 2009, BIOCHEM BIOPH RES CO, V379, P145, DOI 10.1016/j.bbrc.2008.12.025; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Derry WB, 1998, CANCER RES, V58, P1177; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fernando RI, 2004, MOL BIOL CELL, V15, P3266, DOI 10.1091/mbc.E03-11-0823; Fernando R, 2007, J BIOL CHEM, V282, P28864, DOI 10.1074/jbc.M700785200; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; Gilmore AP, 2002, J BIOL CHEM, V277, P27643, DOI 10.1074/jbc.M108863200; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; GRAHAM KA, 1986, BREAST CANCER RES TR, V8, P29, DOI 10.1007/BF01805922; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Janumyan Y, 2008, J BIOL CHEM, V283, P34108, DOI 10.1074/jbc.M806294200; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Jordan MA, 1996, CANCER RES, V56, P816; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Kelekar A, 1997, MOL CELL BIOL, V17, P7040, DOI 10.1128/MCB.17.12.7040; Kitada S, 1998, AM J PATHOL, V152, P51; Klumpp S, 2003, NEUROCHEM INT, V42, P555, DOI 10.1016/S0197-0186(02)00174-2; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li R, 2005, CELL DEATH DIFFER, V12, P292, DOI 10.1038/sj.cdd.4401554; Liu QY, 1997, CLIN CANCER RES, V3, P2039; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; MATSCHIN.FM, 1968, J BIOL CHEM, V243, P2730; McGrogan BT, 2008, BBA-REV CANCER, V1785, P96, DOI 10.1016/j.bbcan.2007.10.004; Metcalfe AD, 1999, J CELL SCI, V112, P1771; Noguchi S, 2006, CANCER SCI, V97, P813, DOI 10.1111/j.1349-7006.2006.00265.x; OSBORNE CK, 1987, BREAST CANCER RES TR, V9, P111, DOI 10.1007/BF01807363; Pellegrini F, 2005, CANCER INVEST, V23, P264, DOI 10.1081/CNV-200055970; Perez EA, 1999, SEMIN ONCOL, V26, P1; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Roy SS, 2009, MOL CELL, V33, P377, DOI 10.1016/j.molcel.2009.01.018; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schorr K, 1999, J MAMMARY GLAND BIOL, V4, P153, DOI 10.1023/A:1018773123899; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Smith AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006224; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tan TT, 2005, CANCER CELL, V7, P227, DOI 10.1016/j.ccr.2005.02.008; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Upreti M, 2008, J BIOL CHEM, V283, P35517, DOI 10.1074/jbc.M805019200; Virdee K, 2000, CURR BIOL, V10, P1151, DOI 10.1016/S0960-9822(00)00702-8; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101; Zhou XM, 2000, J BIOL CHEM, V275, P25046, DOI 10.1074/jbc.M002526200; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	66	18	19	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	39					5381	5391		10.1038/onc.2010.272	http://dx.doi.org/10.1038/onc.2010.272			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664EZ	20603619				2022-12-25	WOS:000282944500005
J	De Rosa, MC; Giardina, B; Bianchi, C; Carelli Alinovi, C; Pirolli, D; Ferraccioli, G; De Santis, M; Di Sante, G; Ria, F				De Rosa, Maria Cristina; Giardina, Bruno; Bianchi, Caterina; Carelli Alinovi, Cristiana; Pirolli, Davide; Ferraccioli, Gianfranco; De Santis, Maria; Di Sante, Gabriele; Ria, Francesco			Modeling the Ternary Complex TCR-V beta/CollagenII(261-273)/HLA-DR4 Associated with Rheumatoid Arthritis	PLOS ONE			English	Article							T-CELL RECOGNITION; PEPTIDE-MHC COMPLEXES; CLASS-II MOLECULE; HLA-DR4 DRA-ASTERISK-0101; RECEPTOR RECOGNITION; STRUCTURAL BASIS; SELF-PEPTIDE; COLLAGEN; BINDING; TCR	Background: It is known that genetic predisposition to rheumatoid arthritis (RA) is associated with the MHC class II allele HLA-DR4 and that residues 261-273 of type II collagen (huCollp261) represent an immunodominant T cell epitope restricted by the DR4 molecule. Despite recent advances in characterization of MHC and T cell receptor (TCR) contacts to this epitope, the atomic details of TCR/huCollp261/HLA-DR4 ternary complex are not known. Methodology/Principal Findings: Here we have used computational modeling to get insight into this interaction. A three-dimensional model of the TCR V beta domain from a DR4(+) patient affected by RA has been derived by homology modeling techniques. Subsequently, the structure of the TCR V beta domain in complex with huCollp261/HLA-DR4 was obtained from a docking approach in conjunction with a filtering procedure based on biochemical information. The best complex from the docking experiments was then refined by 20 ns of molecular dynamics simulation in explicit water. The predicted model is consistent with available experimental data. Our results indicate that residues 97-101 of CDR3 beta are critical for recognition of huCollp261/HLA-DR4 by TCR. We also show that TCR contacts on p/MHC surface affect the conformation of the shared epitope expressed by DR alleles associated with RA susceptibility. Conclusions/Significance: This work presents a three-dimensional model for the ternary complex TCR-V beta/collagenII(261-273)/HLA-DR4 associated with rheumatoid arthritis that can provide insights into the molecular mechanisms of self reactivity.	[De Rosa, Maria Cristina] CNR, Ist Chim Riconoscimento Mol, Rome, Italy; [Giardina, Bruno; Bianchi, Caterina; Carelli Alinovi, Cristiana; Pirolli, Davide] Univ Cattolica Sacro Cuore, Ist Biochim & Biochim Clin, Rome, Italy; [Ferraccioli, Gianfranco; De Santis, Maria] Univ Cattolica Sacro Cuore, Dipartimento Reumatol, Rome, Italy; [Di Sante, Gabriele; Ria, Francesco] Univ Cattolica Sacro Cuore, Ist Patol Gen, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	De Rosa, MC (corresponding author), CNR, Ist Chim Riconoscimento Mol, Rome, Italy.	mariacristina.derosa@icrm.cnr.it	Ria, Francesco/AAD-1174-2022; De Santis, Maria/K-2644-2018; Di Sante, Gabriele/K-8629-2016; De Rosa, Maria Cristina/K-3814-2014; carelli alinovi, cristiana/L-2212-2018; Di Sante, Gabriele/N-5280-2018; Di Sante, Gabriele/AHD-9850-2022; Di Sante, Gabriele/N-5294-2018	Ria, Francesco/0000-0001-7455-4290; De Santis, Maria/0000-0002-3196-1336; Di Sante, Gabriele/0000-0001-6608-3388; De Rosa, Maria Cristina/0000-0002-9611-2490; Di Sante, Gabriele/0000-0001-6608-3388; Di Sante, Gabriele/0000-0001-6608-3388; Di Sante, Gabriele/0000-0001-6608-3388; Pirolli, Davide/0000-0003-2303-2577; Ferraccioli, Gianfranco/0000-0002-6884-4301	Consiglio Nazionale delle Ricerche (CNR)	Consiglio Nazionale delle Ricerche (CNR)(Consiglio Nazionale delle Ricerche (CNR))	This work was supported by Consiglio Nazionale delle Ricerche (CNR). Computer simulations were performed at the Caspur Interuniversities Consortium for Supercomputing Applications (grant DPM@CASPUR 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Badou A, 2001, EUR J IMMUNOL, V31, P2487, DOI 10.1002/1521-4141(200108)31:8<2487::AID-IMMU2487>3.0.CO;2-L; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Collins EJ, 2008, IMMUNOL RES, V41, P267, DOI 10.1007/s12026-008-8040-2; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Deng L, 2007, TRENDS BIOCHEM SCI, V32, P500, DOI 10.1016/j.tibs.2007.08.007; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; Fridkis-Hareli M, 2000, HUM IMMUNOL, V61, P640, DOI 10.1016/S0198-8859(00)00126-9; FU XT, 1995, J EXP MED, V181, P915, DOI 10.1084/jem.181.3.915; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; HAMMER J, 1995, J EXP MED, V181, P1847, DOI 10.1084/jem.181.5.1847; Hausmann S, 1999, J IMMUNOL, V162, P338; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; HIRAIWA A, 1990, P NATL ACAD SCI USA, V87, P8051, DOI 10.1073/pnas.87.20.8051; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kjellen P, 1998, EUR J IMMUNOL, V28, P755, DOI 10.1002/(SICI)1521-4141(199802)28:02<755::AID-IMMU755>3.0.CO;2-2; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T, 2004, SCI STKE, V2004, P1; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; LONDEI M, 1989, P NATL ACAD SCI USA, V86, P636, DOI 10.1073/pnas.86.2.636; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; NEPOM GT, 1989, ARTHRITIS RHEUM, V32, P15, DOI 10.1002/anr.1780320104; Ria F., 2001, Current Molecular Medicine (Hilversum), V1, P297, DOI 10.2174/1566524013363690; Ria F, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2553; Rosloniec EF, 2002, J IMMUNOL, V168, P253, DOI 10.4049/jimmunol.168.1.253; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Russell AS, 2008, PHARMACOECONOMICS, V26, P831, DOI 10.2165/00019053-200826100-00004; Sakurai Y, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2043; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SIGNORELLI KL, 1995, CELL IMMUNOL, V162, P217, DOI 10.1006/cimm.1995.1072; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stocker U, 2000, PROTEINS, V40, P145, DOI 10.1002/(SICI)1097-0134(20000701)40:1<145::AID-PROT160>3.0.CO;2-Y; WATSON WC, 1994, CLIN IMMUNOL IMMUNOP, V73, P27, DOI 10.1006/clin.1994.1166; Wilson DB, 1999, J IMMUNOL, V163, P6424; WORDSWORTH BP, 1989, P NATL ACAD SCI USA, V86, P10049, DOI 10.1073/pnas.86.24.10049; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920	42	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11550	10.1371/journal.pone.0011550	http://dx.doi.org/10.1371/journal.pone.0011550			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644721	Green Published, gold			2022-12-25	WOS:000279884900008
J	Marg, S; Winkler, U; Sestu, M; Himmel, M; Schonherr, M; Bar, J; Mann, A; Moser, M; Mierke, CT; Rottner, K; Blessing, M; Hirrlinger, J; Ziegler, WH				Marg, Susanna; Winkler, Ulrike; Sestu, Marcello; Himmel, Mirko; Schoenherr, Madeleine; Baer, Janina; Mann, Amrit; Moser, Markus; Mierke, Claudia T.; Rottner, Klemens; Blessing, Manfred; Hirrlinger, Johannes; Ziegler, Wolfgang H.			The Vinculin-Delta In20/21 Mouse: Characteristics of a Constitutive, Actin-Binding Deficient Splice Variant of Vinculin	PLOS ONE			English	Article							FOCAL ADHESIONS; PROTEIN; TALIN; DYNAMICS; ACTIVATION; COOPERATE; SUGGESTS; SEQUENCE; SITES; CELLS	Background: The cytoskeletal adaptor protein vinculin plays a fundamental role in cell contact regulation and affects central aspects of cell motility, which are essential to both embryonal development and tissue homeostasis. Functional regulation of this evolutionarily conserved and ubiquitously expressed protein is dominated by a high-affinity, autoinhibitory head-to-tail interaction that spatially restricts ligand interactions to cell adhesion sites and, furthermore, limits the residency time of vinculin at these sites. To date, no mutants of the vinculin protein have been characterized in animal models. Methodology/Principal Findings: Here, we investigate vinculin-Delta Ex20, a splice variant of the protein lacking the 68 amino acids encoded by exon 20 of the vinculin gene VCL. Vinculin-Delta Ex20 was found to be expressed alongside with wild type protein in a knock-in mouse model with a deletion of introns 20 and 21 (VCL-Delta In20/21 allele) and shows defective head-to-tail interaction. Homozygous VCL-Delta In20/21 embryos die around embryonal day E12.5 showing cranial neural tube defects and exencephaly. In mouse embryonic fibroblasts and upon ectopic expression, vinculin-Delta Ex20 reveals characteristics of constitutive head binding activity. Interestingly, the impact of vinculin-Delta Ex20 on cell contact induction and stabilization, a hallmark of the vinculin head domain, is only moderate, thus allowing invasion and motility of cells in three-dimensional collagen matrices. Lacking both F-actin interaction sites of the tail, the vinculin-Delta Ex20 variant unveils vinculin's dynamic binding to cell adhesions independent of a cytoskeletal association, and thus differs from head-to-tail binding deficient mutants such as vinculin-T12, in which activated F-actin binding locks the protein variant to cell contact sites. Conclusions/Significance: Vinculin-Delta Ex20 is an active variant supporting adhesion site stabilization without an enhanced mechanical coupling. Its presence in a transgenic animal reveals the potential of splice variants in the vinculin gene to alter vinculin function in vivo. Correct control of vinculin is necessary for embryonic development.	[Marg, Susanna; Winkler, Ulrike; Sestu, Marcello; Himmel, Mirko; Schoenherr, Madeleine; Baer, Janina; Hirrlinger, Johannes; Ziegler, Wolfgang H.] Univ Leipzig, Fac Med, Interdisciplinary Ctr Clin Res IZKF, Leipzig, Germany; [Winkler, Ulrike; Hirrlinger, Johannes] Univ Leipzig, Fac Med, Carl Ludwig Inst Physiol, Leipzig, Germany; [Mann, Amrit; Blessing, Manfred] Univ Leipzig, Fac Vet Med, Ctr Biotechnol & Biomed, Leipzig, Germany; [Moser, Markus] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Mierke, Claudia T.] Univ Erlangen Nurnberg, Ctr Med Phys & Technol, Erlangen, Germany; [Rottner, Klemens] Helmholtz Ctr Infect Res, Cytoskeleton Dynam Grp, Braunschweig, Germany; [Ziegler, Wolfgang H.] Hannover Med Sch, Dept Nephrol, D-3000 Hannover, Germany	Leipzig University; Leipzig University; Leipzig University; Max Planck Society; University of Erlangen Nuremberg; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School	Marg, S (corresponding author), Univ Leipzig, Fac Med, Interdisciplinary Ctr Clin Res IZKF, Leipzig, Germany.	wolfgang.ziegler@medizin.uni-leipzig.de	Rottner, Klemens/AAE-5030-2020; Mierke, Claudia Tanja/L-5293-2018; Hirrlinger, Johannes/F-5984-2010	Mierke, Claudia Tanja/0000-0002-6622-335X; Ziegler, Wolfgang H./0000-0003-4529-1916; Rottner, Klemens/0000-0003-4244-4198; Himmel, Mirko/0000-0001-7872-8016	Deutsche Forschungsgemeinschaft [Zi545/4-1, Ro 2414/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft [Zi545/4-1 to WHZ and MB; Ro 2414/1-2 to KR] and the Interdisciplinary Centre for Clinical Research (IZKF) Leipzig at the Faculty of Medicine of the University of Leipzig [projects N04 to WHZ; N05 to JH; C34 to WHZ and JH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; BARSTEAD RJ, 1991, J CELL BIOL, V114, P715, DOI 10.1083/jcb.114.4.715; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Diez G, 2008, BIOCHEM BIOPH RES CO, V373, P69, DOI 10.1016/j.bbrc.2008.05.182; Diez G, 2009, BIOPHYS J, V97, P3105, DOI 10.1016/j.bpj.2009.09.039; FERNANDEZ JLR, 1992, J CELL BIOL, V119, P427, DOI 10.1083/jcb.119.2.427; FERNANDEZ JLR, 1993, J CELL BIOL, V122, P1285, DOI 10.1083/jcb.122.6.1285; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Himmel M, 2009, J BIOL CHEM, V284, P13832, DOI 10.1074/jbc.M900266200; Hirrlinger J, 2001, J NEUROCHEM, V76, P627, DOI 10.1046/j.1471-4159.2001.00101.x; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; Jousse C, 1998, BIOCHEM J, V334, P147, DOI 10.1042/bj3340147; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Maeda M, 1997, CIRCULATION, V95, P17, DOI 10.1161/01.CIR.95.1.17; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Mierke CT, 2010, J BIOL CHEM, V285, P13121, DOI 10.1074/jbc.M109.087171; Mierke CT, 2008, BIOPHYS J, V94, P661, DOI 10.1529/biophysj.107.108472; Mohl CC, 2009, CELL MOTIL CYTOSKEL, V66, P350, DOI 10.1002/cm.20375; MOISEYEVA EP, 1993, J BIOL CHEM, V268, P4318; Olson TM, 2002, CIRCULATION, V105, P431, DOI 10.1161/hc0402.102930; Rabut G., 2005, LIVE CELL IMAGING LA, P101; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Steimle PA, 1999, J BIOL CHEM, V274, P18414, DOI 10.1074/jbc.274.26.18414; Vasile VC, 2006, BIOCHEM BIOPH RES CO, V345, P998, DOI 10.1016/j.bbrc.2006.04.151; Witt S, 2004, J BIOL CHEM, V279, P31533, DOI 10.1074/jbc.M314245200; Xu WM, 1998, DEVELOPMENT, V125, P327; Xu WM, 1998, J CELL SCI, V111, P1535; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zaidel-Bar R, 2009, J CELL BIOL, V186, P317, DOI 10.1083/jcb.200811067; Zemljic-Harpf AE, 2004, AM J PATHOL, V165, P1033, DOI 10.1016/S0002-9440(10)63364-0; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Ziegler WH, 2010, TRANSL RES BIOMED, V2, P136; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	39	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11530	10.1371/journal.pone.0011530	http://dx.doi.org/10.1371/journal.pone.0011530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644727	Green Published, gold			2022-12-25	WOS:000279884900006
J	Bajenoff, M; Narni-Mancinelli, E; Brau, F; Lauvau, G				Bajenoff, Marc; Narni-Mancinelli, Emilie; Brau, Frederic; Lauvau, Gregoire			Visualizing Early Splenic Memory CD8(+) T Cells Reactivation against Intracellular Bacteria in the Mouse	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELL; LISTERIA-MONOCYTOGENES; LYMPH-NODE; DENDRITIC CELLS; PROTECTIVE IMMUNITY; PRECURSOR FREQUENCY; GAMMA-INTERFERON; WHITE PULP; IFN-GAMMA; IN-VIVO	Memory CD8(+) T cells represent an important effector arm of the immune response in maintaining long-lived protective immunity against viruses and some intracellular bacteria such as Listeria monocytogenes (L.m). Memory CD8(+) T cells are endowed with enhanced antimicrobial effector functions that perfectly tail them to rapidly eradicate invading pathogens. It is largely accepted that these functions are sufficient to explain how memory CD8(+) T cells can mediate rapid protection. However, it is important to point out that such improved functional features would be useless if memory cells were unable to rapidly find the pathogen loaded/infected cells within the infected organ. Growing evidences suggest that the anatomy of secondary lymphoid organs (SLOs) fosters the cellular interactions required to initiate naive adaptive immune responses. However, very little is known on how the SLOs structures regulate memory immune responses. Using Listeria monocytogenes (L.m) as a murine infection model and imaging techniques, we have investigated if and how the architecture of the spleen plays a role in the reactivation of memory CD8(+) T cells and the subsequent control of L. m growth. We observed that in the mouse, memory CD8(+) T cells start to control L. m burden 6 hours after the challenge infection. At this very early time point, L.m-specific and non-specific memory CD8(+) T cells localize in the splenic red pulp and form clusters around L. m infected cells while naive CD8(+) T cells remain in the white pulp. Within these clusters that only last few hours, memory CD8(+) T produce inflammatory cytokines such as IFN-gamma and CCL3 nearby infected myeloid cells known to be crucial for L.m killing. Altogether, we describe how memory CD8(+) T cells trafficking properties and the splenic microanatomy conjugate to create a spatio-temporal window during which memory CD8(+) T cells provide a local response by secreting effector molecules around infected cells.	[Bajenoff, Marc; Narni-Mancinelli, Emilie; Lauvau, Gregoire] INSERM, U924, Grp Avenir, Valbonne, France; [Bajenoff, Marc; Narni-Mancinelli, Emilie; Brau, Frederic; Lauvau, Gregoire] Univ Nice Sophia Antipolis, Nice, France; [Bajenoff, Marc] Ctr Immunol Marseille Luminy, INSERM, UMR S 631, Marseille, France; [Bajenoff, Marc; Brau, Frederic] CNRS, UMR 6102, Marseille, France; [Bajenoff, Marc] Univ Aix Marseille 2, UM 631, Marseille, France; [Bajenoff, Marc] CNRS, UMR6097, IPMC, F-06560 Valbonne, France; [Lauvau, Gregoire] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Yeshiva University	Bajenoff, M (corresponding author), INSERM, U924, Grp Avenir, Valbonne, France.	bajenoff@ciml.univ-mrs.fr; gregoire.lauvau@einstein.yu.edu	Narni-Mancinelli, Emilie/X-1888-2018	Narni-Mancinelli, Emilie/0000-0002-7001-1026	Institut National de la Sante et de la Recherche Medicale (INSERM-Avenir); Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche (ANR)-Maladies Infectieuses et leur Environnement (MIE) [ANR-08-JCJC-0134-01)]; Fondation pour la Recherche Medicale (FRM)	Institut National de la Sante et de la Recherche Medicale (INSERM-Avenir)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)-Maladies Infectieuses et leur Environnement (MIE)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This research was supported by grants from Institut National de la Sante et de la Recherche Medicale (INSERM-Avenir), Centre National de la Recherche Scientifique (CNRS), Agence Nationale de la Recherche (ANR)-Maladies Infectieuses et leur Environnement (MIE) EMICIF-2008, ANR-08-JCJC-0134-01). E.N.M. was a recipient of a Fondation pour la Recherche Medicale (FRM) fellowship and an ANR-MIE Contrat Duree Determinee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichele P, 2003, J IMMUNOL, V171, P1148, DOI 10.4049/jimmunol.171.3.1148; Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Bajenoff M, 2008, J IMMUNOL, V181, P3947, DOI 10.4049/jimmunol.181.6.3947; Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Bousso P, 1998, IMMUNITY, V9, P169, DOI 10.1016/S1074-7613(00)80599-3; Busch DH, 1999, IMMUNOL REV, V172, P163, DOI 10.1111/j.1600-065X.1999.tb01364.x; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chen Q, 2006, NAT IMMUNOL, V7, P1299, DOI 10.1038/ni1406; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; FAHEY TJ, 1992, J IMMUNOL, V148, P2764; Faust N, 2000, BLOOD, V96, P719; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Huster KM, 2006, EUR J IMMUNOL, V36, P1453, DOI 10.1002/eji.200635874; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Messingham KAN, 2007, J IMMUNOL, V179, P2457, DOI 10.4049/jimmunol.179.4.2457; Muraille E, 2007, CELL MICROBIOL, V9, P1445, DOI 10.1111/j.1462-5822.2007.00883.x; Narni-Mancinelli E, 2007, J EXP MED, V204, P2075, DOI 10.1084/jem.20070204; Pewe LL, 2004, J IMMUNOL, V172, P3151, DOI 10.4049/jimmunol.172.5.3151; PORTNOY DA, 1989, J EXP MED, V170, P2141, DOI 10.1084/jem.170.6.2141; Raue HP, 2004, J IMMUNOL, V173, P6873, DOI 10.4049/jimmunol.173.11.6873; Rocha B, 2006, IMMUNOL REV, V211, P182, DOI 10.1111/j.0105-2896.2006.00378.x; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Smeltz RB, 2007, J IMMUNOL, V178, P4786, DOI 10.4049/jimmunol.178.8.4786; Soderberg KA, 2005, P NATL ACAD SCI USA, V102, P16315, DOI 10.1073/pnas.0506190102; Tvinnereim AR, 2000, INFECT IMMUN, V68, P2196, DOI 10.1128/IAI.68.4.2196-2204.2000; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Unsoeld H, 2004, J IMMUNOL, V173, P3013, DOI 10.4049/jimmunol.173.5.3013; Willard-Mack CL, 2006, TOXICOL PATHOL, V34, P409, DOI 10.1080/01926230600867727; Wong P, 2003, ANNU REV IMMUNOL, V21, P29, DOI 10.1146/annurev.immunol.21.120601.141114; Young AJ, 1999, SEMIN IMMUNOL, V11, P73, DOI 10.1006/smim.1999.0163; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005	49	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11524	10.1371/journal.pone.0011524	http://dx.doi.org/10.1371/journal.pone.0011524			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634957	Green Published, gold			2022-12-25	WOS:000279781600009
J	Lorenzen, J; David, S; Bahlmann, FH; de Groot, K; Bahlmann, E; Kielstein, JT; Haller, H; Fliser, D				Lorenzen, Johan; David, Sascha; Bahlmann, Ferdinand H.; de Groot, Kirsten; Bahlmann, Elisabeth; Kielstein, Jan T.; Haller, Hermann; Fliser, Danilo			Endothelial Progenitor Cells and Cardiovascular Events in Patients with Chronic Kidney Disease - a Prospective Follow-Up Study	PLOS ONE			English	Article							ERYTHROPOIETIN; NUMBER	Background: Endothelial progenitor cells (EPCs) mediate vascular repair and regeneration. Their number in peripheral blood is related to cardiovascular events in individuals with normal renal function. Methods: We evaluated the association between functionally active EPCs (cell culture) and traditional cardiovascular risk factors in 265 patients with chronic kidney disease stage V receiving hemodialysis therapy. Thereafter, we prospectively assessed cardiovascular events, e. g. myocardial infarction, percutaneous transluminal coronary angioplasty (including stenting), aortocoronary bypass, stroke and angiographically verified stenosis of peripheral arteries, and cardiovascular death in this cohort. Results: In our patients EPCs were related only to age (r = 0.154; p = 0.01). During a median follow-up period of 36 months 109 (41%) patients experienced a cardiovascular event. In a multiple Cox regression analysis, we identified EPCs (p = 0.03) and patient age (p = 0.01) as the only independent variables associated with incident cardiovascular events. Moreover, a total of 70 patients died during follow-up, 45 of those due to cardiovascular causes. Log rank test confirmed statistical significance for EPCs concerning incident cardiovascular events (p = 0.02). Conclusions: We found a significant association between the number of functionally active EPCs and cardiovascular events in patients with chronic kidney disease. Thus, defective vascular repair and regeneration may be responsible, at least in part, for the enormous cardiovascular morbidity in this population.	[Lorenzen, Johan; David, Sascha; de Groot, Kirsten; Bahlmann, Elisabeth; Kielstein, Jan T.; Haller, Hermann] Hannover Med Sch, Dept Internal Med, Div Nephrol, D-3000 Hannover, Germany; [Bahlmann, Ferdinand H.; Fliser, Danilo] Univ Saarland, Med Ctr, Dept Internal Med 4, D-6650 Homburg, Germany	Hannover Medical School; Saarland University	Lorenzen, J (corresponding author), Hannover Med Sch, Dept Internal Med, Div Nephrol, D-3000 Hannover, Germany.	indfli@uks.eu	Kielstein, Jan T./I-2956-2019; David, Sascha/AAL-6909-2021	Kielstein, Jan T./0000-0001-8110-9064; Lorenzen, Johan/0000-0002-9132-948X	Else-Kroner-Fresenius Foundation, Germany	Else-Kroner-Fresenius Foundation, Germany	The study was supported by an unrestricted grant from Else-Kroner-Fresenius Foundation, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahlmann FH, 2005, HYPERTENSION, V45, P526, DOI 10.1161/01.HYP.0000159191.98140.89; Bahlmann FH, 2004, BLOOD, V103, P921, DOI 10.1182/blood-2003-04-1284; Bahlmann FH, 2003, KIDNEY INT, V64, P1648, DOI 10.1046/j.1523-1755.2003.00279.x; Chan CT, 2005, AM J PHYSIOL-RENAL, V289, pF679, DOI 10.1152/ajprenal.00127.2005; Choi JH, 2004, ARTERIOSCL THROM VAS, V24, P1246, DOI 10.1161/01.ATV.0000133488.56221.4a; de Groot K, 2005, TRANSPLANTATION, V79, P941, DOI 10.1097/00007890-200504270-00012; de Groot K, 2004, KIDNEY INT, V66, P641, DOI 10.1111/j.1523-1755.2004.00784.x; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI200113152; Dzau VJ, 2005, HYPERTENSION, V46, P7, DOI 10.1161/01.HYP.0000168923.92885.f7; FADINI GP, 2009, ATHEROSCLEROSIS 0405; Fliser D, 2004, NEPHROL DIAL TRANSPL, V19, P2952, DOI 10.1093/ndt/gfh577; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Gueler F, 2005, BLOOD PURIFICAT, V23, P196, DOI 10.1159/000083941; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Leri A, 2005, CIRC RES, V97, P299, DOI 10.1161/01.RES.0000179774.56498.d2; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Ritz E, 2004, BLOOD PURIFICAT, V22, P28, DOI 10.1159/000074921; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Steiner S, 2006, TRANSPLANTATION, V81, P599, DOI 10.1097/01.tp.0000198418.06383.e8; Steiner S, 2005, AM J KIDNEY DIS, V46, P520, DOI 10.1053/j.ajkd.2005.05.015; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814	26	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11477	10.1371/journal.pone.0011477	http://dx.doi.org/10.1371/journal.pone.0011477			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628606	Green Submitted, gold, Green Published			2022-12-25	WOS:000279637100008
J	Schmid, CD; Bucher, P				Schmid, Christoph D.; Bucher, Philipp			MER41 Repeat Sequences Contain Inducible STAT1 Binding Sites	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; CHIP-SEQ EXPERIMENTS; DNA-BINDING; ELEMENTS; DATABASE; NETWORK; METHYLATION; ACTIVATION; VERTEBRATE; DISCOVERY	Chromatin immunoprecipitation combined with massively parallel sequencing methods (ChIP-seq) is becoming the standard approach to study interactions of transcription factors (TF) with genomic sequences. At the example of public STAT1 ChIP-seq data sets, we present novel approaches for the interpretation of ChIP-seq data. We compare recently developed approaches to determine STAT1 binding sites from ChIP-seq data. Assessing the content of the established consensus sequence for STAT1 binding sites, we find that the usage of "negative control'' ChIP-seq data fails to provide substantial advantages. We derive a single refined probabilistic model of STAT1 binding sequences from these ChIP-seq data. Contrary to previous claims, we find no evidence that STAT1 binds to multiple distinct motifs upon interferon-gamma stimulation in vivo. While a large majority of genomic sites with high ChIP-seq signal is associated with a nucleotide sequence ressembling a STAT1 binding site, only a very small subset of the over 5 million potential STAT1 binding sites in the human genome is covered by ChIP-seq data. Furthermore a surprisingly large fraction of the ChIP-seq signal (5%) is absorbed by a small family of repetitive sequences (MER41). The observation of the binding of activated STAT1 protein to a specific repetitive element bolsters similar reports concerning p53 and other TFs, and strengthens the notion of an involvement of repeats in gene regulation. Incidentally MER41 are specific to primates, consequently, regulatory mechanisms in the IFN-STAT pathway might fundamentally differ between primates and rodents. On a methodological aspect, the presence of large numbers of nearly identical binding sites in repetitive sequences may lead to wrong conclusions about intrinsic binding preferences of TF as illustrated by the spacing analysis STAT1 tandem motifs. Therefore, ChIP-seq data should be analyzed independently within repetitive and non-repetitive sequences.	[Schmid, Christoph D.; Bucher, Philipp] Swiss Inst Expt Canc Res GR BUCHER, SV ISREC, Ecole Polytech Fed Lausanne, Swiss Inst Bioinformat, Lausanne, Switzerland; [Schmid, Christoph D.] Swiss Trop & Publ Hlth Inst Swiss TPH, Basel, Switzerland; [Schmid, Christoph D.] Univ Basel, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Swiss Institute of Bioinformatics; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Schmid, CD (corresponding author), Swiss Inst Expt Canc Res GR BUCHER, SV ISREC, Ecole Polytech Fed Lausanne, Swiss Inst Bioinformat, Lausanne, Switzerland.	Christoph.Schmid@unibas.ch			Swiss Government	Swiss Government	This work was done with support from the Swiss Government (direct funding to the Swiss Institute of Bioinformatics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann-Liebrich U, 2005, SOZ PRAVENTIV MED, V50, P245, DOI 10.1007/s00038-005-4075-5; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Hu JJ, 2005, NUCLEIC ACIDS RES, V33, P4899, DOI 10.1093/nar/gki791; Iseli C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000579; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johnson R, 2009, MOL BIOL EVOL, V26, P1491, DOI 10.1093/molbev/msp058; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Laperriere D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-23; Lecine P, 1996, MOL CELL BIOL, V16, P6829; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; Li XX, 1998, BIOCHIMIE, V80, P703, DOI 10.1016/S0300-9084(99)80023-6; Montgomery SB, 2006, BIOINFORMATICS, V22, P637, DOI 10.1093/bioinformatics/btk027; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Polak P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-133; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Schmid CD, 2007, CELL, V131, P831, DOI 10.1016/j.cell.2007.11.017; Schutz F, 2008, BIOINFORMATICS, V24, P1399, DOI 10.1093/bioinformatics/btn201; Sepp T, 1997, J VIROL, V71, P771, DOI 10.1128/JVI.71.1.771-777.1997; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; van Nimwegen E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S4; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Ward LD, 2008, BIOINFORMATICS, V24, pI165, DOI 10.1093/bioinformatics/btn154; Whitington T, 2009, NUCLEIC ACIDS RES, V37, P14, DOI 10.1093/nar/gkn866; Wormald S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-254; Xu H, 2008, BIOINFORMATICS, V24, P2344, DOI 10.1093/bioinformatics/btn402; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zhang ZD, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000158	49	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11425	10.1371/journal.pone.0011425	http://dx.doi.org/10.1371/journal.pone.0011425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625510	Green Published, gold, Green Submitted			2022-12-25	WOS:000279522500005
J	Tarosso, LF; Sauer, MM; Sanabani, S; Giret, MT; Tomiyama, HI; Sidney, J; Piaskowski, SM; Diaz, RS; Sabino, EC; Sette, A; Kalil, J; Watkins, DI; Kallas, EG				Tarosso, Leandro F.; Sauer, Mariana M.; Sanabani, Sabri; Giret, Maria Teresa; Tomiyama, Helena I.; Sidney, John; Piaskowski, Shari M.; Diaz, Ricardo S.; Sabino, Ester C.; Sette, Alessandro; Kalil-Filho, Jorge; Watkins, David I.; Kallas, Esper G.			Unexpected Diversity of Cellular Immune Responses against Nef and Vif in HIV-1-Infected Patients Who Spontaneously Control Viral Replication	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV CONTROLLERS; INFECTION; PEPTIDE; GENE; CD8; REACTIVITY; ABSENCE; VIREMIA; CD4(+)	Background: HIV-1-infected individuals who spontaneously control viral replication represent an example of successful containment of the AIDS virus. Understanding the anti-viral immune responses in these individuals may help in vaccine design. However, immune responses against HIV-1 are normally analyzed using HIV-1 consensus B 15-mers that overlap by 11 amino acids. Unfortunately, this method may underestimate the real breadth of the cellular immune responses against the autologous sequence of the infecting virus. Methodology and Principal Findings: Here we compared cellular immune responses against nef and vif-encoded consensus B 15-mer peptides to responses against HLA class I-predicted minimal optimal epitopes from consensus B and autologous sequences in six patients who have controlled HIV-1 replication. Interestingly, our analysis revealed that three of our patients had broader cellular immune responses against HLA class I-predicted minimal optimal epitopes from either autologous viruses or from the HIV-1 consensus B sequence, when compared to responses against the 15-mer HIV-1 type B consensus peptides. Conclusion and Significance: This suggests that the cellular immune responses against HIV-1 in controller patients may be broader than we had previously anticipated.	[Tarosso, Leandro F.; Kalil-Filho, Jorge; Kallas, Esper G.] Univ Sao Paulo, Clin Immunol & Allergy Div, Sao Paulo, Brazil; [Sauer, Mariana M.; Giret, Maria Teresa; Tomiyama, Helena I.; Diaz, Ricardo S.; Kallas, Esper G.] Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil; [Sanabani, Sabri; Sabino, Ester C.] Sao Paulo Blood Bank, Sao Paulo, Brazil; [Sidney, John; Sette, Alessandro] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Piaskowski, Shari M.; Watkins, David I.] Univ Wisconsin, Sch Med, Dept Pathol, Madison, WI 53706 USA	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); La Jolla Institute for Immunology; University of Wisconsin System; University of Wisconsin Madison	Tarosso, LF (corresponding author), Univ Sao Paulo, Clin Immunol & Allergy Div, Sao Paulo, Brazil.	esper.kallas@gmail.com	Diaz, Ricardo/K-3978-2012; Sette, Alessandro/AFO-8916-2022; Kallas, Esper G/C-9539-2012; Tarosso, Leandro F./H-6267-2012; Sanabani, Sabri Saeed/F-5600-2012; Sabino, Ester C/F-7750-2010; KALIL, JORGE/C-8029-2012	Sanabani, Sabri Saeed/0000-0002-8876-8262; Sabino, Ester C/0000-0003-2623-5126; KALIL, JORGE/0000-0001-8415-4274; Kallas, Esper/0000-0003-2026-6925	National Institutes of Health [R24 RR015371]; Ministry of Health [914/BRA/3014-UNESCO]; Sao Paulo City Health Department [2004-0.168.922-7]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [04/15856-9]; Coordenacao de Aperfeicoamento de Pessoal de Ni-vel Superior (CAPES), Brazilian Ministry of Education; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR015371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073230] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health; Sao Paulo City Health Department; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Ni-vel Superior (CAPES), Brazilian Ministry of Education(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health Grant R24 RR015371 (to D. I. W.), Brazilian Program for STD and AIDS - Ministry of Health Grant 914/BRA/3014-UNESCO and the Sao Paulo City Health Department Grant 2004-0.168.922-7 (to E. G. K.), and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 04/15856-9 (to E. G. K., E. C. S., and R. S. D.). L. F. T., M. T. M. G., and M. M. S. were supported by the Coordenacao de Aperfeicoamento de Pessoal de Ni-vel Superior (CAPES), Brazilian Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The following reagents were obtained through the NIH AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: complete HIV-1 Consensus subtype B peptide sets (15-mers overlapping by 11 acids) of Nef (Cat# 5189, Lot# 8) and Vif (Cat# 6446, Lot# 7).	Alexander L, 2000, J VIROL, V74, P4361, DOI 10.1128/JVI.74.9.4361-4376.2000; Altfeld M, 2003, J VIROL, V77, P7330, DOI 10.1128/JVI.77.13.7330-7340.2003; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Chowdhury IH, 1996, J VIROL, V70, P5336, DOI 10.1128/JVI.70.8.5336-5345.1996; Coplan PM, 2005, J INFECT DIS, V191, P1427, DOI 10.1086/428450; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Draenert R, 2003, J IMMUNOL METHODS, V275, P19, DOI 10.1016/S0022-1759(02)00541-0; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Harrer T, 1996, J IMMUNOL, V156, P2616; Hassaine G, 2000, VIROLOGY, V276, P169, DOI 10.1006/viro.2000.0543; Kallas Esper Georges, 2004, Braz J Infect Dis, V8, P399, DOI 10.1590/S1413-86702004000600003; Kern F, 2000, EUR J IMMUNOL, V30, P1676, DOI 10.1002/1521-4141(200006)30:6<1676::AID-IMMU1676>3.0.CO;2-V; Kiecker F, 2004, HUM IMMUNOL, V65, P523, DOI 10.1016/j.humimm.2004.02.017; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; KORBER BTM, 2005, HIV MOL IMMUNOLOGY 2; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Liu BD, 2004, J VIROL, V78, P2072, DOI 10.1128/JVI.78.4.2072-2081.2004; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Rhodes DI, 2000, J VIROL, V74, P10581, DOI 10.1128/JVI.74.22.10581-10588.2000; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Saez-Cirion A, 2007, TRENDS IMMUNOL, V28, P532, DOI 10.1016/j.it.2007.09.002; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Salvi R, 1998, J VIROL, V72, P3646, DOI 10.1128/JVI.72.5.3646-3657.1998; Sanabani S, 2006, AIDS RES HUM RETROV, V22, P171, DOI 10.1089/aid.2006.22.171; Simon JHM, 1999, J VIROL, V73, P2675, DOI 10.1128/JVI.73.4.2675-2681.1999; SOVA P, 1995, J VIROL, V69, P2557, DOI 10.1128/JVI.69.4.2557-2564.1995; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Walker Bruce D, 2007, Top HIV Med, V15, P134; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; You LW, 2007, LECT NOTES COMPUT SC, V4774, P337; Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254; Zimmerman C, 2002, NATURE, V415, P88, DOI 10.1038/415088a	48	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11436	10.1371/journal.pone.0011436	http://dx.doi.org/10.1371/journal.pone.0011436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625436	Green Published, gold			2022-12-25	WOS:000279465700017
J	Rokah, OH; Shpilberg, O; Granot, G				Rokah, Oshrat Hershkovitz; Shpilberg, Ofer; Granot, Galit			NAD(P)H Quinone Oxidoreductase Protects TAp63 gamma from Proteasomal Degradation and Regulates TAp63 gamma-Dependent Growth Arrest	PLOS ONE			English	Article							P53 GENE FAMILY; P63 EXPRESSION; NAD(P)H-QUINONE-OXIDOREDUCTASE-1 NQO1; NAD(P)H-QUINONE OXIDOREDUCTASE-1; P53-DEPENDENT APOPTOSIS; GENOTOXIC STRESS; DNA-DAMAGE; BLADDER; CANCER; MECHANISM	Background: p63 is a member of the p53 transcription factor family. p63 is expressed from two promoters resulting in proteins with opposite functions: the transcriptionally active TAp63 and the dominant-negative Delta Np63. Similar to p53, the TAp63 isoforms induce cell cycle arrest and apoptosis. The Delta Np63 isoforms are dominant-negative variants opposing the activities of p53, TAp63 and TAp73. To avoid unnecessary cell death accompanied by proper response to stress, the expression of the p53 family members must be tightly regulated. NAD(P)H quinone oxidoreductase (NQO1) has recently been shown to interact with and inhibit the degradation of p53. Due to the structural similarities between p53 and p63, we were interested in studying the ability of wild-type and polymorphic, inactive NQO1 to interact with and stabilize p63. We focused on TAp63 gamma, as it is the most potent transcription activator and it is expected to have a role in tumor suppression. Principal Findings: We show that TAp63 gamma can be degraded by the 20S proteasomes. Wild-type but not polymorphic, inactive NQO1 physically interacts with TAp63 gamma, stabilizes it and protects it from this degradation. NQO1-mediated TAp63 gamma stabilization was especially prominent under stress. Accordingly, we found that downregulation of NQO1 inhibits TAp63 gamma-dependant p21 upregulation and TAp63 gamma-induced growth arrest stimulated by doxorubicin. Conclusions/Significance: Our report is the first to identify this new mechanism demonstrating a physical and functional relationship between NQO1 and the most potent p63 isoform, TAp63 gamma. These findings appoint a direct role for NQO1 in the regulation of TAp63 gamma expression, especially following stress and may therefore have clinical implications for tumor development and therapy.	[Rokah, Oshrat Hershkovitz; Shpilberg, Ofer; Granot, Galit] Tel Aviv Univ, Sackler Sch Med, Beilinson Hosp, Felsenstein Med Res Ctr, Petah Tiqwa, Israel; [Shpilberg, Ofer] Tel Aviv Univ, Sackler Sch Med, Beilinson Hosp, Rabin Med Ctr,Inst Hematol, Petah Tiqwa, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Rokah, OH (corresponding author), Tel Aviv Univ, Sackler Sch Med, Beilinson Hosp, Felsenstein Med Res Ctr, Petah Tiqwa, Israel.	galitg@clalit.org.il	Hershkovitz-Rokah, Oshrat/GLR-2539-2022; Hershkovitz-Rokah, Oshrat/GVT-8614-2022	Hershkovitz-Rokah, Oshrat/0000-0003-4685-0679				Asher G, 2002, P NATL ACAD SCI USA, V99, P3099, DOI 10.1073/pnas.052706799; Asher G, 2005, MOL CELL, V17, P645, DOI 10.1016/j.molcel.2005.01.020; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Bernassola F, 2005, ONCOGENE, V24, P6982, DOI 10.1038/sj.onc.1208843; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Chao C, 2006, CANCER EPIDEM BIOMAR, V15, P979, DOI 10.1158/1055-9965.EPI-05-0899; Crook T, 2000, ONCOGENE, V19, P3439, DOI 10.1038/sj.onc.1203656; Cross JV, 1999, J BIOL CHEM, V274, P31150, DOI 10.1074/jbc.274.44.31150; Fagerholm R, 2008, NAT GENET, V40, P844, DOI 10.1038/ng.155; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Garate M, 2008, EMBO REP, V9, P576, DOI 10.1038/embor.2008.48; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Kaelin WG, 1999, ONCOGENE, V18, P7701, DOI 10.1038/sj.onc.1202955; Katoh I, 2000, ONCOGENE, V19, P3126, DOI 10.1038/sj.onc.1203644; Koga F, 2003, CLIN CANCER RES, V9, P5501; Koutsodontis G, 2005, BIOCHEM J, V389, P443, DOI 10.1042/BJ20041980; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; MacPartlin M, 2005, J BIOL CHEM, V280, P30604, DOI 10.1074/jbc.M503352200; Marchini S, 2008, ANN ONCOL, V19, P501, DOI 10.1093/annonc/mdm519; Massion PP, 2003, CANCER RES, V63, P7113; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moll UM, 2004, MOL CANCER RES, V2, P371; Okada Y, 2002, EXP CELL RES, V276, P194, DOI 10.1006/excr.2002.5535; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Papoutsaki M, 2005, ONCOGENE, V24, P6970, DOI 10.1038/sj.onc.1208835; Park BJ, 2000, CANCER RES, V60, P3370; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Reigan P, 2007, BIOCHEMISTRY-US, V46, P5941, DOI 10.1021/bi700008y; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Sanyal S, 2007, SCAND J UROL NEPHROL, V41, P182, DOI 10.1080/00365590600991946; Siegel D, 2001, MOL PHARMACOL, V59, P263, DOI 10.1124/mol.59.2.263; Traver RD, 1997, BRIT J CANCER, V75, P69, DOI 10.1038/bjc.1997.11; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540	41	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11401	10.1371/journal.pone.0011401	http://dx.doi.org/10.1371/journal.pone.0011401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613985	Green Submitted, gold, Green Published			2022-12-25	WOS:000279370000026
J	Jefferson, A; Colella, S; Moralli, D; Wilson, N; Yusuf, M; Gimelli, G; Ragoussis, J; Volpi, EV				Jefferson, Andrew; Colella, Stefano; Moralli, Daniela; Wilson, Natalie; Yusuf, Mohammed; Gimelli, Giorgio; Ragoussis, Jiannis; Volpi, Emanuela V.			Altered Intra-Nuclear Organisation of Heterochromatin and Genes in ICF Syndrome	PLOS ONE			English	Article							DE-NOVO METHYLATION; CHROMOSOME INSTABILITY; DNA HYPOMETHYLATION; SATELLITE DNA; CHROMATIN-STRUCTURE; FACIAL ANOMALIES; DNMT3B MUTATIONS; CELL-NUCLEI; IMMUNODEFICIENCY; LOCALIZATION	The ICF syndrome is a rare autosomal recessive disorder, the most common symptoms of which are immunodeficiency, facial anomalies and cytogenetic defects involving decondensation and instability of chromosome 1, 9 and 16 centromeric regions. ICF is also characterised by significant hypomethylation of the classical satellite DNA, the major constituent of the juxtacentromeric heterochromatin. Here we report the first attempt at analysing some of the defining genetic and epigenetic changes of this syndrome from a nuclear architecture perspective. In particular, we have compared in ICF ( Type 1 and Type 2) and controls the large-scale organisation of chromosome 1 and 16 juxtacentromeric heterochromatic regions, their intra-nuclear positioning, and co-localisation with five specific genes (BTG2, CNN3, ID3, RGS1, F13A1), on which we have concurrently conducted expression and methylation analysis. Our investigations, carried out by a combination of molecular and cytological techniques, demonstrate the existence of specific and quantifiable differences in the genomic and nuclear organisation of the juxtacentromeric heterochromatin in ICF. DNA hypomethylation, previously reported to correlate with the decondensation of centromeric regions in metaphase described in these patients, appears also to correlate with the heterochromatin spatial configuration in interphase. Finally, our findings on the relative positioning of hypomethylated satellite sequences and abnormally expressed genes suggest a connection between disruption of long-range geneheterochromatin associations and some of the changes in gene expression in ICF. Beyond its relevance to the ICF syndrome, by addressing fundamental principles of chromosome functional organisation within the cell nucleus, this work aims to contribute to the current debate on the epigenetic impact of nuclear architecture in development and disease.	[Jefferson, Andrew; Colella, Stefano; Moralli, Daniela; Wilson, Natalie; Yusuf, Mohammed; Ragoussis, Jiannis; Volpi, Emanuela V.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Gimelli, Giorgio] Ist Giannina Gaslini, Lab Citogenet, Genoa, Italy	University of Oxford; Wellcome Centre for Human Genetics; University of Genoa; IRCCS Istituto Giannina Gaslini	Jefferson, A (corresponding author), John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England.	emanuela.volpi@well.ox.ac.uk	Ragoussis, Ioannis/AAD-9790-2022; Colella, Stefano/A-7040-2008	Colella, Stefano/0000-0003-3139-6055; Ragoussis, Ioannis/0000-0002-8515-0934; Volpi, Emanuela/0000-0002-2422-9104	Wellcome Trust [075491/Z/04]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust {075491/Z/04}. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barki-Celli L, 2005, GENE CHROMOSOME CANC, V43, P339, DOI 10.1002/gcc.20179; Bartova E, 2002, J STRUCT BIOL, V139, P76, DOI 10.1016/S1047-8477(02)00560-9; Bickmore WA, 2003, HUM MOL GENET, V12, pR207, DOI 10.1093/hmg/ddg260; Blanco-Betancourt CE, 2004, BLOOD, V103, P2683, DOI 10.1182/blood-2003-08-2632; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Dietzel S, 2004, J CELL SCI, V117, P4603, DOI 10.1242/jcs.01330; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ehrlich M, 2003, CLIN IMMUNOL, V109, P17, DOI 10.1016/S1521-6616(03)00201-8; Ehrlich M, 2001, HUM MOL GENET, V10, P2917, DOI 10.1093/hmg/10.25.2917; Enukashvily NI, 2007, CYTOGENET GENOME RES, V118, P42, DOI 10.1159/000106440; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Francastel C, 2001, P NATL ACAD SCI USA, V98, P12120, DOI 10.1073/pnas.211444898; Gilbert N, 2007, J CELL BIOL, V177, P401, DOI 10.1083/jcb.200607133; Gisselsson D, 2005, CHROMOSOMA, V114, P118, DOI 10.1007/s00412-005-0343-7; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hansen RS, 2000, HUM MOL GENET, V9, P2575, DOI 10.1093/hmg/9.18.2575; Hassan KMA, 2001, HUM GENET, V109, P452; Heidari M, 2006, LEUKEMIA, V20, P304, DOI 10.1038/sj.leu.2404071; Hepperger C, 2007, CHROMOSOMA, V116, P117, DOI 10.1007/s00412-006-0084-2; Hernandez R, 1997, CYTOGENET CELL GENET, V76, P196, DOI 10.1159/000134548; Hewitt SL, 2004, EUR J IMMUNOL, V34, P3604, DOI 10.1002/eji.200425469; Jaco I, 2008, J CELL BIOL, V181, P885, DOI 10.1083/jcb.200803042; JEANPIERRE M, 1993, HUM MOL GENET, V2, P731, DOI 10.1093/hmg/2.6.731; Ji WZ, 1997, MUTAT RES-FUND MOL M, V379, P33, DOI 10.1016/S0027-5107(97)00088-2; Jiang YL, 2005, HUM MUTAT, V25, P56, DOI 10.1002/humu.20113; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; KOKALJVOKAC N, 1993, CYTOGENET CELL GENET, V63, P11, DOI 10.1159/000133492; Kondo T, 2000, HUM MOL GENET, V9, P597, DOI 10.1093/hmg/9.4.597; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kubota T, 2004, AM J MED GENET A, V129A, P290, DOI 10.1002/ajmg.a.30135; Luciani JJ, 2005, EUR J HUM GENET, V13, P41, DOI 10.1038/sj.ejhg.5201293; Luciani JJ, 2006, J CELL SCI, V119, P2518, DOI 10.1242/jcs.02965; MARASCHIO P, 1988, J MED GENET, V25, P173, DOI 10.1136/jmg.25.3.173; MARASCHIO P, 1992, ANN HUM GENET, V56, P273, DOI 10.1111/j.1469-1809.1992.tb01152.x; Matarazzo MR, 2007, P NATL ACAD SCI USA, V104, P16546, DOI 10.1073/pnas.0702924104; MINIOU P, 1994, HUM MOL GENET, V3, P2093, DOI 10.1093/hmg/3.12.2093; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Pezzolo A, 2002, HAEMATOLOGICA, V87, P329; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; SAWYER JR, 1995, AM J MED GENET, V56, P203, DOI 10.1002/ajmg.1320560218; Scheuermann MO, 2004, EXP CELL RES, V301, P266, DOI 10.1016/j.yexcr.2004.08.031; Schubeler D, 2000, GENE DEV, V14, P940; SCHUFFENHAUER S, 1995, HUM GENET, V96, P562, DOI 10.1007/BF00197412; Shopland LS, 2006, J CELL BIOL, V174, P27, DOI 10.1083/jcb.200603083; STACEY M, 1995, J MED GENET, V32, P502, DOI 10.1136/jmg.32.7.502; Sumner AT, 1998, J MED GENET, V35, P833, DOI 10.1136/jmg.35.10.833; Tanabe H, 2002, P NATL ACAD SCI USA, V99, P4424, DOI 10.1073/pnas.072618599; Tao Q, 2002, HUM MOL GENET, V11, P2091, DOI 10.1093/hmg/11.18.2091; TIEPOLO L, 1979, HUM GENET, V51, P127, DOI 10.1007/BF00287166; Tuck-Muller CM, 2000, CYTOGENET CELL GENET, V89, P121, DOI 10.1159/000015590; Ueda Y, 2006, DEVELOPMENT, V133, P1183, DOI 10.1242/dev.02293; Wijmenga C, 2000, HUM MUTAT, V16, P509, DOI 10.1002/1098-1004(200012)16:6<509::AID-HUMU8>3.3.CO;2-M; Wijmenga C, 1998, AM J HUM GENET, V63, P803, DOI 10.1086/302021; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052	65	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11364	10.1371/journal.pone.0011364	http://dx.doi.org/10.1371/journal.pone.0011364			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613881	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000279369900013
J	Ge, XH; Gebe, JA; Bollyky, PL; James, EA; Yang, JB; Stern, LJ; Kwok, WW				Ge, Xinhui; Gebe, John A.; Bollyky, Paul L.; James, Eddie A.; Yang, Junbao; Stern, Lawrence J.; Kwok, William W.			Peptide-MHC Cellular Microarray with Innovative Data Analysis System for Simultaneously Detecting Multiple CD4 T-Cell Responses	PLOS ONE			English	Article							CLASS-II TETRAMERS; INFLUENZA; AUTOANTIGEN; EPITOPES; ANTIGEN; IDENTIFICATION; PHENOTYPE; VIRUS	Background: Peptide: MHC cellular microarrays have been proposed to simultaneously characterize multiple Ag-specific populations of T cells. The practice of studying immune responses to complicated pathogens with this tool demands extensive knowledge of T cell epitopes and the availability of peptide: MHC complexes for array fabrication as well as a specialized data analysis approach for result interpretation. Methodology/Principal Findings: We co-immobilized peptide: DR0401 complexes, anti-CD28, anti-CD11a and cytokine capture antibodies on the surface of chamber slides to generate a functional array that was able to detect rare Ag-specific T cell populations from previously primed in vitro T cell cultures. A novel statistical methodology was also developed to facilitate batch processing of raw array-like data into standardized endpoint scores, which linearly correlated with total Ag-specific T cell inputs. Applying these methods to analyze Influenza A viral antigen-specific T cell responses, we not only revealed the most prominent viral epitopes, but also demonstrated the heterogeneity of anti-viral cellular responses in healthy individuals. Applying these methods to examine the insulin producing beta-cell autoantigen specific T cell responses, we observed little difference between autoimmune diabetic patients and healthy individuals, suggesting a more subtle association between diabetes status and peripheral autoreactive T cells. Conclusions/Significance: The data analysis system is reliable for T cell specificity and functional testing. Peptide: MHC cellular microarrays can be used to obtain multi-parametric results using limited blood samples in a variety of translational settings.	[Ge, Xinhui; Gebe, John A.; Bollyky, Paul L.; James, Eddie A.; Yang, Junbao; Kwok, William W.] Benaroya Res Inst Virginia Mason, Seattle, WA USA; [Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Pathol, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	Benaroya Research Institute; Virginia Mason Medical Center; University of Massachusetts System; University of Massachusetts Worcester	Ge, XH (corresponding author), Benaroya Res Inst Virginia Mason, Seattle, WA USA.	bkwok@benaroyaresearch.org	James, Eddie/V-4929-2019	James, Eddie/0000-0002-7217-5729	W.K from American Diabetes Association [ADA 7-06-RA-75]; National Institutes of Health [R21 DK077525-02, HHSN272200900043C, U19 AI57319]; Juvenile Diabetes Research Foundation [3-2008-548]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077525] Funding Source: NIH RePORTER	W.K from American Diabetes Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants to W.K from American Diabetes Association (ADA 7-06-RA-75, www.diabetes.org) and National Institutes of Health (R21 DK077525-02; HHSN272200900043C, www.nih.gov), and a grant to LJ.S from National Institutes of Health (U19 AI57319, www.nih.gov). X. G is currently supported by Juvenile Diabetes Research Foundation International Postdoctoral Fellowship Award (3-2008-548, www.jdrf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, Nature, V419, P323; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Chen DS, 2006, CURR OPIN CHEM BIOL, V10, P28, DOI 10.1016/j.cbpa.2006.01.001; Chen DS, 2005, PLOS MED, V2, P1018, DOI 10.1371/journal.pmed.0020265; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Durinovic-Bello I, 2006, P NATL ACAD SCI USA, V103, P11683, DOI 10.1073/pnas.0603682103; Ge XH, 2010, J VIROL, V84, P3312, DOI 10.1128/JVI.02226-09; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kwong GA, 2009, J AM CHEM SOC, V131, P9695, DOI 10.1021/ja9006707; Nepom GT, 2001, P NATL ACAD SCI USA, V98, P1763, DOI 10.1073/pnas.98.4.1763; Newell EW, 2009, NAT METHODS, V6, P497, DOI 10.1038/nmeth.1344; Novak EJ, 1999, J CLIN INVEST, V104, pR63, DOI 10.1172/JCI8476; Peakman M, 1999, J CLIN INVEST, V104, P1449, DOI 10.1172/JCI7936; Soen Y, 2003, PLOS BIOL, V1, P429, DOI 10.1371/journal.pbio.0000065; Song Q, 2010, ANAL CHEM, V82, P473, DOI 10.1021/ac9024363; Stone JD, 2005, P NATL ACAD SCI USA, V102, P3744, DOI 10.1073/pnas.0407019102; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Wicker LS, 1996, J CLIN INVEST, V98, P2597, DOI 10.1172/JCI119079; Yang JB, 2006, J IMMUNOL, V176, P2781, DOI 10.4049/jimmunol.176.5.2781; Yang JB, 2006, CLIN IMMUNOL, V120, P21, DOI 10.1016/j.clim.2006.03.008; 2005, NATURE METHOD, V2, P321	21	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11355	10.1371/journal.pone.0011355	http://dx.doi.org/10.1371/journal.pone.0011355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20634998	Green Published, Green Submitted, gold			2022-12-25	WOS:000279259900023
J	Budding, AE; Grasman, ME; Lin, F; Bogaards, JA; Soeltan-Kaersenhout, DJ; Vandenbroucke-Grauls, CMJE; van Bodegraven, AA; Savelkoul, PHM				Budding, A. E.; Grasman, M. E.; Lin, F.; Bogaards, J. A.; Soeltan-Kaersenhout, D. J.; Vandenbroucke-Grauls, C. M. J. E.; van Bodegraven, A. A.; Savelkoul, P. H. M.			IS-pro: high-throughput molecular fingerprinting of the intestinal microbiota	FASEB JOURNAL			English	Article						profiling; 16S-23S IS region; complex microbial communities; gut bacteria; phylum sorting	16S RIBOSOMAL-RNA; FRAGMENT-LENGTH-POLYMORPHISM; INTERGENIC SPACER ANALYSIS; BACTERIAL COMMUNITIES; DIVERSITY; DISEASE; REPRODUCIBILITY; IDENTIFICATION; INDEXES; CLONING	The human intestinal microbiota is known to play an important role in human health and disease, and with the advent of novel molecular techniques, disease-specific variations in its composition have been found. However, analysis of the intestinal microbiota has not yet been applicable in large-scale clinical research or routine diagnostics because of the complex and expensive nature of the techniques needed. Here, we describe a new PCR-based profiling technique for high-throughput analysis of the human intestinal microbiota, which we have termed IS-pro. This technique combines bacterial species differentiation by the length of the 16S-23S rDNA interspace region with instant taxonomic classification by phylum-specific fluorescent labeling of PCR primers. We validated IS-pro in silico, in vitro, and in vivo, on human colonic biopsies and feces, and introduced a standardized protocol for data analysis. IS-pro is easy to implement in general clinical microbiological laboratories with access to capillary gel electrophoresis, and the high-throughput nature of the test makes analysis of large numbers of samples feasible. This combination renders IS-pro ideally suited for use in clinical research and routine diagnostics.-Budding, A. E., Grasman, M. E., Lin, F., Bogaards, J. A., Soeltan-Kaersenhout, D. J., Vandenbroucke-Grauls, C. M. J. E., van Bodegraven, A. A., Savelkoul, P. H. M. IS-pro: high-throughput molecular fingerprinting of the intestinal microbiota. FASEB J. 24, 4556-4564 (2010). www.fasebj.org	[Budding, A. E.; Lin, F.; Soeltan-Kaersenhout, D. J.; Vandenbroucke-Grauls, C. M. J. E.; Savelkoul, P. H. M.] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, NL-1007 MB Amsterdam, Netherlands; [Grasman, M. E.; van Bodegraven, A. A.] Vrije Univ Amsterdam Med Ctr, Dept Gastroenterol & Hepatol, NL-1007 MB Amsterdam, Netherlands; [Bogaards, J. A.] Vrije Univ Amsterdam Med Ctr, Dept Clin Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Budding, AE (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, POB 7057, NL-1007 MB Amsterdam, Netherlands.	d.budding@vumc.nl	van Bodegraven, Ad/ABG-4367-2020; Vandenbroucke-Grauls, Christina/AAO-7953-2020; van Bodegraven, Ad A/L-3180-2013	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Budding, Andries/0000-0001-5128-5411; Bogaards, Johannes/0000-0002-3389-5141				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blackwood CB, 2007, APPL ENVIRON MICROB, V73, P5276, DOI 10.1128/AEM.00514-07; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dunbar J, 2001, APPL ENVIRON MICROB, V67, P190, DOI 10.1128/AEM.67.1.190-197.2001; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Engebretson JJ, 2003, APPL ENVIRON MICROB, V69, P4823, DOI 10.1128/AEM.69.8.4823-4829.2003; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Fisher MM, 2000, MICROBIAL ECOL, V40, P125, DOI 10.1007/s002480000049; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Guasp C, 2000, INT J SYST EVOL MICR, V50, P1629, DOI 10.1099/00207713-50-4-1629; Gurtler V, 1996, MICROBIOL-SGM, V142, P3, DOI 10.1099/13500872-142-1-3; Hoffmann M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-90; Hold GL, 2002, FEMS MICROBIOL ECOL, V39, P33, DOI 10.1111/j.1574-6941.2002.tb00904.x; HUNTER PR, 1990, J CLIN MICROBIOL, V28, P1903, DOI 10.1128/JCM.28.9.1903-1905.1990; JENSEN MA, 1993, APPL ENVIRON MICROB, V59, P945, DOI 10.1128/AEM.59.4.945-952.1993; Leuko S, 2007, EXTREMOPHILES, V11, P203, DOI 10.1007/s00792-006-0028-z; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Nesme X, 2004, MOL MICROBIAL ECOLOG, P671; Niers L, 2009, ALLERGY, V64, P1349, DOI 10.1111/j.1398-9995.2009.02021.x; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; PETERSON C, 2007, J VIS EXP, V2, P164; Ranjard L, 2001, APPL ENVIRON MICROB, V67, P4479, DOI 10.1128/AEM.67.10.4479-4487.2001; Ren DW, 2011, INT J SYST EVOL MICR, V61, P580, DOI 10.1099/ijs.0.023143-0; Schneider T, 2008, LANCET INFECT DIS, V8, P179, DOI 10.1016/S1473-3099(08)70042-2; Stewart FJ, 2007, J MOL EVOL, V65, P44, DOI 10.1007/s00239-006-0235-3; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Wilton SD, 1997, BIOTECHNIQUES, V22, P642, DOI 10.2144/97224bm14; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	31	69	72	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2010	24	11					4556	4564		10.1096/fj.10-156190	http://dx.doi.org/10.1096/fj.10-156190			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20643909				2022-12-25	WOS:000283861100040
J	Menezes, K; de Menezes, JRL; Nascimento, MA; Santos, RD; Coelho-Sampaio, T				Menezes, Karla; Lacerda de Menezes, Joao Ricardo; Nascimento, Marcos Assis; Santos, Raphael de Siqueira; Coelho-Sampaio, Tatiana			Polylaminin, a polymeric form of laminin, promotes regeneration after spinal cord injury	FASEB JOURNAL			English	Article						CNS regeneration; neuroprotection; protein polymerization	NECROSIS-FACTOR-ALPHA; BASEMENT-MEMBRANE; FUNCTIONAL RECOVERY; AXON REGENERATION; CNS; ADULT; INFLAMMATION; TRANSECTION; STRATEGIES; MATRICES	Regeneration of spinal cord injury (SCI) is a major topic of biomedical research. Laminin is an extracellular matrix protein implicated in neural development and regeneration, but despite that, there are no reports of exogenous laminin contributing to improve the outcome of experimental SCI. Here we investigated whether a biomimetic polymer of laminin assembled on pH acidification, henceforth called polylaminin, could be used to treat SCI in rats. Acute local injection of polylaminin, but not of nonpolymerized laminin, improved motor function after thoracic compression, partial or complete transection. In the latter case, the BBB score for open field locomotion 8 wk after lesion increased from 4.2 +/- 0.48 to 8.8 +/- 1.14 in animals treated with polylaminin of human origin. Accordingly, neurons retrogradely labeled from the sublesion stump were detected in the spinal cord and brain stem, indicating regrowth of short and long fibers across a complete transection. Polylaminin also played an unsuspected anti-inflammatory role, which underlies the early onset of its positive effects on locomotion from the first week after treatment. The beneficial effects of polylaminin were not observed in animals treated with the nonpolymerized protein or vehicle only. We propose that polylaminin is a promising therapeutic agent to treat human SCI.-Menezes, K., Menezes, J. R. L., Nascimento, M. A., Siqueira Santos, R., Coelho-Sampaio, T. Polylaminin, a polymeric form of laminin, promotes regeneration after spinal cord injury. FASEB J. 24, 4513-4522 (2010). www.fasebj.org	[Coelho-Sampaio, Tatiana] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Ctr Ciencias Saude, BR-21941590 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Coelho-Sampaio, T (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Ctr Ciencias Saude, Sala B1-011, BR-21941590 Rio De Janeiro, Brazil.	tcsampaio@histo.ufrj.br	Menezes, João R. L./D-5668-2012	Assis Nascimento, Marcos/0000-0002-9830-9801	Brazilian National Research Council (CNPq); State of Rio de Janeiro Research Agency (FAPERJ)	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Rio de Janeiro Research Agency (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The authors thank the excellent technical assistance of Ian Machado de Freitas. This work was supported by grants from the Brazilian National Research Council (CNPq) and from the State of Rio de Janeiro Research Agency (FAPERJ).	Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BERNSTEIN JJ, 1985, BRAIN RES, V327, P135, DOI 10.1016/0006-8993(85)91507-0; Brechtel K, 2006, SPINAL CORD, V44, P605, DOI 10.1038/sj.sc.3101894; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Bunge MB, 2008, J SPINAL CORD MED, V31, P262, DOI 10.1080/10790268.2008.11760720; Cai ZW, 2003, BRAIN RES, V975, P37, DOI 10.1016/S0006-8993(03)02545-9; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Coutts M, 2008, EXP NEUROL, V209, P368, DOI 10.1016/j.expneurol.2007.09.002; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Freire E, 2004, J CELL SCI, V117, P4067, DOI 10.1242/jcs.01276; Freire E, 2002, J CELL SCI, V115, P4867, DOI 10.1242/jcs.00173; Freire E, 2000, J BIOL CHEM, V275, P817, DOI 10.1074/jbc.275.2.817; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Grimpe B, 2002, J NEUROSCI, V22, P3144, DOI 10.1523/JNEUROSCI.22-08-03144.2002; Hermann GE, 2001, NEUROBIOL DIS, V8, P590, DOI 10.1006/nbdi.2001.0414; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; LIESI P, 1985, EMBO J, V4, P2505, DOI 10.1002/j.1460-2075.1985.tb03963.x; LuckenbillEdds L, 1997, BRAIN RES REV, V23, P1, DOI 10.1016/S0165-0173(96)00013-6; Meiners S, 2003, MOL NEUROBIOL, V27, P177, DOI 10.1385/MN:27:2:177; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Barroso MMS, 2008, J BIOL CHEM, V283, P11714, DOI 10.1074/jbc.M709301200; Scheele S, 2007, J MOL MED, V85, P825, DOI 10.1007/s00109-007-0182-5; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tsiper MV, 2002, J CELL SCI, V115, P1005; Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008; Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687; Verma P, 2008, NEUROREHAB NEURAL RE, V22, P429, DOI 10.1177/1545968307313500; Wiksten M, 2004, J NEUROSCI RES, V78, P403, DOI 10.1002/jnr.20159; Wondimu Z, 2006, MATRIX BIOL, V25, P89, DOI 10.1016/j.matbio.2005.10.001; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; YURCHENCO PD, 1985, J BIOL CHEM, V260, P7636	43	28	31	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4513	4522		10.1096/fj.10-157628	http://dx.doi.org/10.1096/fj.10-157628			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20643907				2022-12-25	WOS:000283861100036
J	Murphy, KT; Koopman, R; Naim, T; Leger, B; Trieu, J; Ibebunjo, C; Lynch, GS				Murphy, Kate T.; Koopman, Rene; Naim, Timur; Leger, Bertrand; Trieu, Jennifer; Ibebunjo, Chikwendu; Lynch, Gordon S.			Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function	FASEB JOURNAL			English	Article						aging; muscle hypertrophy; muscle atrophy; TGF-beta	CONTRACTION-INDUCED INJURY; DYSTROPHIC MDX MICE; MUSCULAR-DYSTROPHY; RESISTANCE EXERCISE; GENE-EXPRESSION; MESSENGER-RNA; SARCOPENIA; AGE; GROWTH; PROTEIN	Sarcopenia is the progressive loss of skeletal muscle mass and function with advancing age, leading to reduced mobility and quality of life. We tested the hypothesis that antibody-directed myostatin inhibition would attenuate the decline in mass and function of muscles of aged mice and that apoptosis would be reduced. Eighteen-month-old C57BL/6 mice were treated for 14 wk with a once-weekly injection of saline (control, n=9) or a mouse chimera of anti-human myostatin antibody (PF-354, 10 mg/kg; n=12). PF-354 prevented the age-related reduction in body mass and increased soleus, gastrocnemius, and quadriceps muscle mass (P<0.05). PF-354 increased fiber cross-sectional area by 12% and enhanced maximum in situ force of tibialis anterior (TA) muscles by 35% (P<0.05). PF-354 increased the proportion of type IIa fibers by 114% (P<0.01) and enhanced activity of oxidative enzymes (SDH) by 39% (P<0.01). PF-354 reduced markers of apoptosis in TA muscle cross-sections by 56% (P<0.03) and reduced caspase3 mRNA by 65% (P<0.04). Antibody-directed myostatin inhibition attenuated the decline in mass and function of muscles of aging mice, in part, by reducing apoptosis. These observations identify novel roles for myostatin in regulation of muscle mass and highlight the therapeutic potential of antibody-directed myostatin inhibition for sarcopenia.-Murphy, K. T., Koopman, R., Naim, T., Leger, B., Trieu, J., Ibebunjo, C. Lynch, G. S. Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function. FASEB J. 24, 4433-4442 (2010). www.fasebj.org	[Murphy, Kate T.; Koopman, Rene; Naim, Timur; Leger, Bertrand; Trieu, Jennifer; Lynch, Gordon S.] Univ Melbourne, Dept Physiol, Basic & Clin Myol Lab, Melbourne, Vic 3010, Australia; [Ibebunjo, Chikwendu] Pfizer Global Res & Dev, Groton, CT USA	University of Melbourne; Pfizer	Lynch, GS (corresponding author), Univ Melbourne, Dept Physiol, Basic & Clin Myol Lab, Melbourne, Vic 3010, Australia.	gsl@unimelb.edu.au	Léger, Bertrand/AAK-4356-2020; Lynch, Gordon/G-9553-2015; Ibebunjo, Chikwendu/AAP-8881-2021	Lynch, Gordon/0000-0001-9220-9810; Murphy, Kate/0000-0003-1993-4367; Leger, Bertrand/0000-0003-2782-1442	Pfizer Global Research and Development (USA); Australian Association of Gerontology; National Health and Medical Research Council (NHMRC); Netherlands Organization for Scientific Research (NWO); Swiss National Fund	Pfizer Global Research and Development (USA)(Pfizer); Australian Association of Gerontology; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Swiss National Fund(Swiss National Science Foundation (SNSF))	This study was supported by research grants from Pfizer Global Research and Development (USA) and the Australian Association of Gerontology. K.T.M. is supported by a Biomedical Australian Fellowship from the National Health and Medical Research Council (NHMRC). R.K. was supported by a Rubicon Research Fellowship from the Netherlands Organization for Scientific Research (NWO). B.L. is supported by a Fellowship from the Swiss National Fund. C.I. helped design the experiments, assisted in data analysis, and contributed to the writing and editing of the manuscript. The authors declare no conflicts of interest.	Amirouche A, 2009, ENDOCRINOLOGY, V150, P286, DOI 10.1210/en.2008-0959; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; BLANCO CE, 1988, HISTOCHEM J, V20, P230, DOI 10.1007/BF01747468; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2005, FASEB J, V19, P543, DOI 10.1096/fj.04-2796com; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Carlson CJ, 1999, AM J PHYSIOL-REG I, V277, pR601, DOI 10.1152/ajpregu.1999.277.2.R601; Chelh I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-196; Cohn RD, 2007, NEUROMUSCULAR DISORD, V17, P290, DOI 10.1016/j.nmd.2007.01.011; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dellorusso C, 2001, J MUSCLE RES CELL M, V22, P467, DOI 10.1023/A:1014587918367; Dirks A, 2002, AM J PHYSIOL-REG I, V282, pR519, DOI 10.1152/ajpregu.00458.2001; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; FAULKNER JA, 1995, J GERONTOL A-BIOL, V50, P124; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; Garcia-Roves PM, 2006, AM J PHYSIOL-ENDOC M, V290, pE1172, DOI 10.1152/ajpendo.00633.2005; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Harcourt LJ, 2005, AM J PATHOL, V166, P1131, DOI 10.1016/S0002-9440(10)62333-4; Joulia D, 2003, EXP CELL RES, V286, P263, DOI 10.1016/S0014-4827(03)00074-0; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; KARPATI G, 1986, AM J MED GENET, V25, P653, DOI 10.1002/ajmg.1320250407; Koopman R, 2006, EUR J APPL PHYSIOL, V96, P525, DOI 10.1007/s00421-005-0118-0; Koopman R, 2006, AM J PHYSIOL-ENDOC M, V290, pE1245, DOI 10.1152/ajpendo.00530.2005; Kovacheva EL, 2010, ENDOCRINOLOGY, V151, P628, DOI 10.1210/en.2009-1177; LeBrasseur NK, 2009, J GERONTOL A-BIOL, V64, P940, DOI 10.1093/gerona/glp068; Leeuwenburgh C, 2005, AM J PHYSIOL-REG I, V288, pR1288, DOI 10.1152/ajpregu.00576.2004; Liu CM, 2008, GENE THER, V15, P155, DOI 10.1038/sj.gt.3303016; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Lynch GS, 2008, EXPERT OPIN EMERG DR, V13, P655, DOI [10.1517/14728210802544476, 10.1517/14728210802544476 ]; Lynch GS, 2004, CLIN EXP PHARMACOL P, V31, P557, DOI 10.1111/j.1440-1681.2004.04026.x; Lynch GS, 2004, INTERN MED J, V34, P294, DOI 10.1111/j.1444-0903.2004.00568.x; Lynch GS, 2001, J PHYSIOL-LONDON, V535, P591, DOI 10.1111/j.1469-7793.2001.00591.x; Marzetti E, 2008, MECH AGEING DEV, V129, P542, DOI 10.1016/j.mad.2008.05.005; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Morissette MR, 2009, AGING CELL, V8, P573, DOI 10.1111/j.1474-9726.2009.00508.x; Murphy KT, 2010, AM J PATHOL, V176, P2425, DOI 10.2353/ajpath.2010.090932; Rios R, 2001, BIOCHEM BIOPH RES CO, V280, P561, DOI 10.1006/bbrc.2000.4159; Roubenoff R, 1998, J CLIN ENDOCR METAB, V83, P1502, DOI 10.1210/jc.83.5.1502; Ryall JG, 2008, AM J PHYSIOL-HEART C, V294, pH2587, DOI 10.1152/ajpheart.00985.2007; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schertzer JD, 2007, AM J PATHOL, V171, P1180, DOI 10.2353/ajpath.2007.070292; Schertzer JD, 2006, AM J PHYSIOL-ENDOC M, V291, pE499, DOI 10.1152/ajpendo.00101.2006; Short KR, 2005, J APPL PHYSIOL, V99, P95, DOI 10.1152/japplphysiol.00129.2005; Siriett V, 2007, MOL THER, V15, P1463, DOI 10.1038/sj.mt.6300182; Siriett V, 2006, J CELL PHYSIOL, V209, P866, DOI 10.1002/jcp.20778; Siu PM, 2009, MED SCI SPORT EXER, V41, P1876, DOI 10.1249/MSS.0b013e3181a6470b; Steelman CA, 2006, FASEB J, V20, P580, DOI 10.1096/fj.05-5125fje; Wagner KR, 2002, ANN NEUROL, V52, P832, DOI 10.1002/ana.10385; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Welle S, 2009, AM J PHYSIOL-ENDOC M, V296, pE567, DOI 10.1152/ajpendo.90862.2008; Yarasheski K E, 2002, J Nutr Health Aging, V6, P343; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	54	91	99	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2010	24	11					4433	4442		10.1096/fj.10-159608	http://dx.doi.org/10.1096/fj.10-159608			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20624929				2022-12-25	WOS:000283861100029
J	Nakagawa, M; Ueyama, M; Tsuruta, H; Uno, T; Kanamaru, K; Mikami, B; Yamagata, H				Nakagawa, Masataka; Ueyama, Megumi; Tsuruta, Hiroki; Uno, Tomohide; Kanamaru, Kengo; Mikami, Bunzo; Yamagata, Hiroshi			Functional Analysis of the Cucumisin Propeptide as a Potent Inhibitor of Its Mature Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBTILISIN-LIKE PROTEASE; INTRAMOLECULAR CHAPERONE; CLEAVAGE SPECIFICITY; SERINE PROTEASES; STRUCTURAL BASIS; MELON FRUITS; AQUALYSIN-I; GENE; PATHWAY; BPN'	Cucumisin is a subtilisin-like serine protease (subtilase) that is found in the juice of melon fruits (Cucumis melo L.). It is synthesized as a preproprotein consisting of a signal peptide, NH2-terminal propeptide, and 67-kDa protease domain. We investigated the role of this propeptide (88 residues) in the cucumisin precursor. Complementary DNAs encoding the propeptides of cucumisin, two other plant subtilases (Arabidopsis ARA12 and rice RSP1), and bacterial subtilisin E were expressed in Escherichia coli independently of their mature enzymes. The cucumisin propeptide strongly inhibited cucumisin in a competitive manner with a K-i value of 6.2 +/- 0.55 nM. Interestingly, cucumisin was also strongly inhibited by ARA12 and RSP1 propeptides but not by the subtilisin E propeptide. In contrast, the propeptides of cucumisin, ARA12, and RSP1 did not inhibit subtilisin. Deletion analysis clearly showed that two hydrophobic regions, Asn(32)-Met(38) and Gly(97)-Leu(103), in the cucumisin propeptide were important for its inhibitory activity. Site-directed mutagenesis also confirmed the role of a Val(36)-centerd hydrophobic cluster within the Asn(32)-Met(38) region in cucumisin inhibition. Circular dichroism spectroscopy revealed that the cucumisin propeptide had a secondary structure without a cognate protease domain and that the thermal unfolding of the propeptide at 90 degrees C was only partial and reversible. A tripeptide, Ile(35)-Val(36)-Tyr(37), in the Asn(32)-Met(38) region was thought to contribute toward the formation of a proper secondary structure necessary for cucumisin inhibition. This is the first report on the function and structural information of the propeptide of a plant serine protease.	[Yamagata, Hiroshi] Kobe Univ, Grad Sch Agr Sci, Biochem Lab, Nada Ku, Kobe, Hyogo 6578501, Japan; [Tsuruta, Hiroki] Kobe Univ, Off Collaborat Res & Technol Dev, Nada Ku, Kobe, Hyogo 6578501, Japan; [Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Appl Struct Biol, Kyoto 6110011, Japan	Kobe University; Kobe University; Kyoto University	Yamagata, H (corresponding author), Kobe Univ, Grad Sch Agr Sci, Biochem Lab, Nada Ku, Rokkodaicho 1-1, Kobe, Hyogo 6578501, Japan.	yamagata@kobe-u.ac.jp	Tsuruta, Hiroki/M-7668-2016; Kanamaru, Kengo/GNP-8187-2022	Tsuruta, Hiroki/0000-0003-2739-8488; Kanamaru, Kengo/0000-0002-6844-0841	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe), Ministry of Education, Culture, Sports, Science and Technology, Japan (to H. Y.).	Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; Antao CM, 2005, PLANT PHYSIOL BIOCH, V43, P637, DOI 10.1016/j.plaphy.2005.05.001; BAKER D, 1992, PROTEINS, V12, P339, DOI 10.1002/prot.340120406; Beers EP, 2004, PHYTOCHEMISTRY, V65, P43, DOI 10.1016/j.phytochem.2003.09.005; Boyd PM, 2002, BBA-PROTEIN STRUCT M, V1596, P269, DOI 10.1016/S0167-4838(02)00228-5; Cedzich A, 2009, J BIOL CHEM, V284, P14068, DOI 10.1074/jbc.M900370200; Copeland R. A., 2000, ENZYMES PRACTICAL IN, P76; EDER J, 1993, J MOL BIOL, V233, P293, DOI 10.1006/jmbi.1993.1507; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Feliciangeli SF, 2006, J BIOL CHEM, V281, P16108, DOI 10.1074/jbc.M600760200; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Groves MR, 1998, PROTEINS, V32, P504, DOI 10.1002/(SICI)1097-0134(19980901)32:4<504::AID-PROT8>3.0.CO;2-F; Hamilton JMU, 2003, BIOCHEM J, V370, P57, DOI 10.1042/BJ20021125; Huang HW, 1997, PROTEIN ENG, V10, P1227, DOI 10.1093/protein/10.10.1227; IKEMURA H, 1987, J BIOL CHEM, V262, P7859; Jain SC, 1998, J MOL BIOL, V284, P137, DOI 10.1006/jmbi.1998.2161; Jean L, 2003, J BIOL CHEM, V278, P28572, DOI 10.1074/jbc.M303827200; Kojima S, 2005, FEBS LETT, V579, P4430, DOI 10.1016/j.febslet.2005.06.083; Kojima S, 1998, J MOL BIOL, V277, P1007, DOI 10.1006/jmbi.1998.1671; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LI YY, 1995, J BIOL CHEM, V270, P25127, DOI 10.1074/jbc.270.42.25127; Liu JX, 2007, PLANT J, V51, P897, DOI 10.1111/j.1365-313X.2007.03195.x; Liu XW, 2001, SEED SCI RES, V11, P55, DOI 10.1079/SSR200060; Marie-Claire C, 2001, J MOL BIOL, V305, P151, DOI 10.1006/jmbi.2000.4233; Meichtry J, 1999, PLANT MOL BIOL, V39, P749, DOI 10.1023/A:1006193414434; Neuteboom LW, 1999, PLANT MOL BIOL, V39, P273, DOI 10.1023/A:1006104205959; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P17223, DOI 10.1073/pnas.0907587106; Rautengarten C, 2005, PLOS COMPUT BIOL, V1, P297, DOI 10.1371/journal.pcbi.0010040; Rautengarten C, 2008, PLANT J, V54, P466, DOI 10.1111/j.1365-313X.2008.03437.x; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; RIBEIRO A, 1995, PLANT CELL, V7, P785, DOI 10.1105/tpc.7.6.785; Sabala I, 1997, PHYSIOL PLANTARUM, V99, P316, DOI 10.1034/j.1399-3054.1997.990215.x; Sambrook J, 2001, MOL CLONING LAB MANU; Sasakawa H, 2002, J MOL BIOL, V317, P159, DOI 10.1006/jmbi.2002.5412; Schaller A, 2004, PLANTA, V220, P183, DOI 10.1007/s00425-004-1407-2; Shinde U, 1999, J BIOL CHEM, V274, P15615, DOI 10.1074/jbc.274.22.15615; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STAHL ML, 1984, J BACTERIOL, V158, P411, DOI 10.1128/JB.158.2.411-418.1984; Takagi H, 2001, FEBS LETT, V508, P210, DOI 10.1016/S0014-5793(01)03053-8; TAYLOR MAJ, 1995, PROTEIN ENG, V8, P59, DOI 10.1093/protein/8.1.59; Tornero P, 1996, P NATL ACAD SCI USA, V93, P6332, DOI 10.1073/pnas.93.13.6332; UCHIKOBA T, 1995, J BIOCHEM-TOKYO, V117, P1126, DOI 10.1093/oxfordjournals.jbchem.a124817; YAMAGATA H, 1989, AGR BIOL CHEM TOKYO, V53, P1009, DOI 10.1080/00021369.1989.10869404; Yamagata H, 2000, BIOSCI BIOTECH BIOCH, V64, P1947, DOI 10.1271/bbb.64.1947; Yamagata H, 2002, J BIOL CHEM, V277, P11582, DOI 10.1074/jbc.M109946200; YAMAGATA H, 1994, J BIOL CHEM, V269, P32725	48	21	22	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29797	29807		10.1074/jbc.M109.083162	http://dx.doi.org/10.1074/jbc.M109.083162			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20639575	Green Published, hybrid			2022-12-25	WOS:000281984300015
J	Dautant, A; Velours, J; Giraud, MF				Dautant, Alain; Velours, Jean; Giraud, Marie-France			Crystal Structure of the Mg center dot ADP-inhibited State of the Yeast F(1)c(10)-ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-SYNTHASE; ROTOR RING; MOLECULAR ARCHITECTURE; BOVINE F-1-ATPASE; CATALYTIC SITES; NA+-ATPASE; SUBUNIT-C; RESOLUTION; MECHANISM; F1-ATPASE	The F(1)c(10) subcomplex of the yeast F1F0-ATP synthase includes the membrane rotor part c(10)-ring linked to a catalytic head, (alpha beta)(3), by a central stalk, gamma delta epsilon. The Saccharomyces cerevisiae yF(1)c(10).ADP subcomplex was crystallized in the presence of Mg center dot ADP, dicyclohexylcarbodiimide (DCCD), and azide. The structure was solved by molecular replacement using a high resolution model of the yeast F-1 and a bacterial c-ring model with 10 copies of the c-subunit. The structure refined to 3.43-angstrom resolution displays new features compared with the original yF(1)c(10) and with the yF1 inhibited by adenylyl imidodiphosphate (AMP-PNP) (yF(1)(I-III)). An ADP molecule was bound in both beta(DP) and beta(TP) catalytic sites. The alpha(DP)-beta(DP) pair is slightly open and resembles the novel conformation identified in yF(1), whereas the alpha(TP)-beta(TP) pair is very closed and resembles more a DP pair. yF(1)c(10) ADP provides a model of a new Mg center dot ADP-inhibited state of the yeast F-1. As for the original yF(1) and yF(1)c(10) structures, the foot of the central stalk is rotated by similar to 40 degrees with respect to bovine structures. The assembly of the F-1 central stalk with the F(0)c-ring rotor is mainly provided by electrostatic interactions. On the rotor ring, the essential cGlu(59) carboxylate group is surrounded by hydrophobic residues and is not involved in hydrogen bonding.	[Dautant, Alain; Velours, Jean; Giraud, Marie-France] Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Dautant, A (corresponding author), Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	A.Dautant@ibgc.cnrs.fr; Marie-France.Giraud@ibgc.cnrs.fr			Region Aquitaine; Agence Nationale de la Recherche [ANR-06-PCVI-0016]; European Synchrotron Radiation Facility; Synchrotron SOLEIL	Region Aquitaine(Region Nouvelle-Aquitaine); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Synchrotron Radiation Facility; Synchrotron SOLEIL	This work was supported by the Region Aquitaine, the Agence Nationale de la Recherche (ANR-06-PCVI-0016), the European Synchrotron Radiation Facility, and the synchrotron SOLEIL.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Andrews SH, 2001, BIOCHEMISTRY-US, V40, P10664, DOI 10.1021/bi0155697; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; BOYER PD, 1988, TRENDS BIOCHEM SCI, V13, P5, DOI 10.1016/0968-0004(88)90005-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; DIPIETRO A, 1986, BIOCHIM BIOPHYS ACTA, V851, P283, DOI 10.1016/0005-2728(86)90136-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Girvin ME, 1998, BIOCHEMISTRY-US, V37, P8817, DOI 10.1021/bi980511m; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; HERMOLIN J, 1989, J BIOL CHEM, V264, P3896; HYNDMAN DJ, 1994, J BIOL CHEM, V269, P28871; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kabaleeswaran V, 2009, J BIOL CHEM, V284, P10546, DOI 10.1074/jbc.M900544200; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; Karmali AM, 2009, ACTA CRYSTALLOGR D, V65, P121, DOI 10.1107/S0907444908040006; Kiselyova OI, 2005, J CRYST GROWTH, V275, pE1447, DOI 10.1016/j.jcrysgro.2004.11.234; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lau WCY, 2008, J MOL BIOL, V382, P1256, DOI 10.1016/j.jmb.2008.08.014; Leslie AGW, 2000, PHILOS T ROY SOC B, V355, P465, DOI 10.1098/rstb.2000.0588; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2009, J MOL BIOL, V391, P498, DOI 10.1016/j.jmb.2009.05.082; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; MILGROM YM, 1990, BIOCHIM BIOPHYS ACTA, V1020, P43, DOI 10.1016/0005-2728(90)90091-H; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Oberfeld B, 2006, BIOCHEMISTRY-US, V45, P1841, DOI 10.1021/bi052304+; Pogoryelov D, 2008, FEBS J, V275, P4850, DOI 10.1111/j.1742-4658.2008.06623.x; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Schouppe C, 1999, J BIOENERG BIOMEMBR, V31, P105, DOI 10.1023/A:1005495626823; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Talbot JC, 2009, J BIOENERG BIOMEMBR, V41, P349, DOI 10.1007/s10863-009-9235-5; Uhlin U, 1997, STRUCTURE, V5, P1219, DOI 10.1016/S0969-2126(97)00272-4; Vollmar M, 2009, J BIOL CHEM, V284, P18228, DOI 10.1074/jbc.M109.006916; VON BALLMOOS C, 2007, BIOCHEMISTRY-US, V46, P11800; VON BALLMOOS C, 2007, J BIOENERG BIOMEMBR, V39, P441; Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1	49	66	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29502	29510		10.1074/jbc.M110.124529	http://dx.doi.org/10.1074/jbc.M110.124529			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20610387	hybrid, Green Published			2022-12-25	WOS:000281740100052
J	Pradhan, S; Alrehani, N; Patel, V; Khatlani, T; Vijayan, KV				Pradhan, Subhashree; Alrehani, Nawaf; Patel, Vimal; Khatlani, Tanvir; Vijayan, K. Vinod			Cross-talk between Serine/Threonine Protein Phosphatase 2A and Protein Tyrosine Phosphatase 1B Regulates Src Activation and Adhesion of Integrin alpha(IIb)beta(3) to Fibrinogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-ANTIGENS; MIDDLE-T; PHOSPHORYLATION; KINASE; POLYMORPHISM; REVEALS; FAMILY; CELLS; PTP1B	Integrin alpha(IIb)beta(3) signaling mediated by kinases and phosphatases participate in hemostasis and thrombosis, in part, by supporting stable platelet adhesion. Our previous studies indicate that the genetic manipulation of PP2Ac alpha (alpha isoform of the catalytic subunit of protein phosphatase 2A) negatively regulate the adhesion of human embryonal kidney 293 cells expressing alpha(IIb)beta(3) to fibrinogen. Here, we demonstrated that small interference RNA (siRNA) mediated knockdown of PP2Ac alpha in 293 alpha(IIb)beta(3) cells led to the dephosphorylation of Src Tyr-529, phosphorylation of Src Tyr-418 and an increased Src kinase activity. Conversely, overexpression of PP2Ac alpha decreased the basal Src activity. Pharmacological inhibition of PP2Ac in human platelets or PP2Ac alpha knockdown in primary murine megakaryocytes resulted in Src activation. PP2Ac alpha-depleted 293 alpha(IIb)beta(3) cells did not alter the serine (Ser) phosphorylation of Src but enhanced the Ser-50 phosphorylation of protein tyrosine phosphatase 1B (PTP-1B) with a concomitant increase in the PTP-1B activity. Src activation in the PP2Ac alpha-depleted 293 alpha(IIb)beta(3) cells was abolished by siRNA mediated knockdown of PTP-1B. Pharmacological inhibition of Src or knockdown of Src, PTP-1B blocked the enhanced activation of extracellular signal-regulated kinase (ERK1/2) and the increased adhesiveness of PP2Ac alpha-depleted 293 alpha(IIb)beta(3) cells to fibrinogen, respectively. Thus, inactivation of PP2Ac alpha promotes hyperphosphorylation of PTP-1B Ser-50, elevates PTP-1B activity, which dephosphorylates Src Tyr-529 to activate Src and its downstream ERK1/2 signaling pathways that regulate alpha(IIb)beta(3) adhesion. Moreover, these studies extend the notion that a cross-talk between Ser/Thr and Tyr phosphatases can fine-tune alpha(IIb)beta(3) outside-in signaling.	[Vijayan, K. Vinod] Baylor Coll Med, Thrombosis Res Sect, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Vijayan, KV (corresponding author), Baylor Coll Med, Thrombosis Res Sect, Dept Med, 1 Baylor Plaza,BCM 286,N1319, Houston, TX 77030 USA.	vvijayan@bcm.tmc.edu			National Institutes of Health [HL081613, T32HL072754]; American Heart Association [GRNT2260224]; Fondren Foundation; Mary R. Gibson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081613, T32HL072754] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fondren Foundation; Mary R. Gibson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by Grant HL081613 from the National Institutes of Health. This work was also supported by the American Heart Association (GRNT2260224) and the Fondren Foundation.; <SUP>1</SUP>Supported by Grant T32HL072754 from the National Institutes of Health.; <SUP>2</SUP>Supported by the Mary R. Gibson Foundation.	Ablooglu AJ, 2009, BLOOD, V113, P3585, DOI 10.1182/blood-2008-09-180687; Arias-Salgado EG, 2005, J CELL BIOL, V170, P837, DOI 10.1083/jcb.200503125; Artcanuthurry Valerie, 1996, Seminars in Thrombosis and Hemostasis, V22, P317, DOI 10.1055/s-2007-999026; BRAUTIGAN DL, 1993, MOL CELL BIOCHEM, V128, P121; CAMPBELL KS, 1995, J VIROL, V69, P3721, DOI 10.1128/JVI.69.6.3721-3728.1995; CHACKALAPARAMPIL I, 1994, ONCOGENE, V9, P1947; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Gushiken FC, 2008, J BIOL CHEM, V283, P12862, DOI 10.1074/jbc.M708804200; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; McCluskey A, 2002, J MED CHEM, V45, P1151, DOI 10.1021/jm010066k; Moeslein FM, 1999, J BIOL CHEM, V274, P26697, DOI 10.1074/jbc.274.38.26697; MOYERS JS, 1993, MOL CELL BIOL, V13, P2391, DOI 10.1128/MCB.13.4.2391; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Ravichandran LV, 2001, MOL ENDOCRINOL, V15, P1768, DOI 10.1210/me.15.10.1768; Rita M, 2003, INT J CANCER, V103, P38, DOI 10.1002/ijc.10772; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Su XY, 2008, BLOOD, V112, P592, DOI 10.1182/blood-2007-09-110437; Vijayan KV, 2000, J CLIN INVEST, V105, P793, DOI 10.1172/JCI6982; Vijayan KV, 2003, J BIOL CHEM, V278, P3860, DOI 10.1074/jbc.M208680200; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Weiser D. C., 2003, CURR PROTOC PROTEIN; Yokoyama N, 2001, FEBS LETT, V505, P460, DOI 10.1016/S0014-5793(01)02874-5; Young MRI, 2002, INT J CANCER, V100, P276, DOI 10.1002/ijc.10491; Zhang YJ, 2009, J CELL BIOL, V184, P785, DOI 10.1083/jcb.200810155; Zou ZY, 2007, BLOOD, V109, P3284, DOI 10.1182/blood-2006-10-051664	30	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29059	29068		10.1074/jbc.M109.085167	http://dx.doi.org/10.1074/jbc.M109.085167			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20615878	hybrid, Green Published			2022-12-25	WOS:000281740100007
J	Shen, XC; Xi, G; Radhakrishnan, Y; Clemmons, DR				Shen, Xinchun; Xi, Gang; Radhakrishnan, Yashwanth; Clemmons, David R.			PDK1 Recruitment to the SHPS-1 Signaling Complex Enhances Insulin-like Growth Factor-I-stimulated AKT Activation and Vascular Smooth Muscle Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; DEPENDENT TYROSINE PHOSPHORYLATION; PHOSPHATIDYLINOSITOL 3-KINASE; PDK1-INTERACTING PROTEIN; P85 SUBUNIT; SRC KINASE; RECEPTOR; BINDING; IDENTIFICATION; LOCALIZATION	In vascular smooth muscle cells, exposed to hyperglycemia and insulin-like growth factor-I (IGF-I), SHPS-1 functions as a scaffold protein, and a signaling complex is assembled that leads to AKT activation. However, the underlying mechanism by which formation of this complex activates the kinase that phosphorylates AKT (Thr(308)) is unknown. Therefore, we investigated the mechanism of PDK1 recruitment to the SHPS-1 signaling complex and the consequences of disrupting PDK1 recruitment for downstream signaling. Our results show that following IGF-I stimulation, PDK1 is recruited to SHPS-1, and its recruitment is mediated by Grb2, which associates with SHPS-1 via its interaction with Pyk2, a component of the SHPS-1-associated complex. A proline-rich sequence in PDK1 bound to an Src homology 3 domain in Grb2 in response to IGF-I. Disruption of Grb2-PDK1 by expression of either a Grb2 Src homology 3 domain or a PDK1 proline to alanine mutant inhibited PDK1 recruitment to SHPS-1, leading to impaired IGF-I-stimulated AKT Thr(308) phosphorylation. Following its recruitment to SHPS-1, PDK1 was further activated via Tyr(373/376) phosphorylation, and this was required for a maximal increase in PDK1 kinase activity and AKT-mediated FOXO3a Thr(32) phosphorylation. PDK1 recruitment was also required for IGF-I to prevent apoptosis that occurred in response to hyperglycemia. Assembly of the Grb2-PDK1 complex on SHPS-1 was specific for IGF-I signaling because inhibiting PDK1 recruitment to SHPS-1 had no effect on EGF-stimulated AKT Thr(308) phosphorylation. These findings reveal a novel mechanism for recruitment of PDK1 to the SHPS-1 signaling complex, which is required for IGF-I-stimulated AKT Thr(308) phosphorylation and inhibition of apoptosis.	[Shen, Xinchun; Xi, Gang; Radhakrishnan, Yashwanth; Clemmons, David R.] Univ N Carolina, Sch Med, Dept Med, Div Endocrinol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Clemmons, DR (corresponding author), Univ N Carolina, Sch Med, Dept Med, Div Endocrinol, CB 7170,8024 Burnett Womack, Chapel Hill, NC 27599 USA.	endo@med.unc.edu	Xi, Gang/C-1498-2011		National Institutes of Health [HL56850, AG022331]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL56850 and AG022331.	Alberobello AT, 2010, J BIOL CHEM, V285, P6563, DOI 10.1074/jbc.M109.097410; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Allen RT, 2005, APOPTOSIS, V10, P525, DOI 10.1007/s10495-005-1882-3; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Belham C, 1999, CURR BIOL, V9, pR93, DOI 10.1016/S0960-9822(99)80058-X; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Block K, 2008, J BIOL CHEM, V283, P24061, DOI 10.1074/jbc.M803964200; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Chun J, 2005, BIOCHEM BIOPH RES CO, V326, P136, DOI 10.1016/j.bbrc.2004.10.208; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Felsch JS, 1998, P NATL ACAD SCI USA, V95, P5051, DOI 10.1073/pnas.95.9.5051; Fiory F, 2005, MOL CELL BIOL, V25, P10803, DOI 10.1128/MCB.25.24.10803-10814.2005; Flynn P, 2000, CURR BIOL, V10, P1439, DOI 10.1016/S0960-9822(00)00801-0; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Grillo S, 2000, EUR J BIOCHEM, V267, P6642, DOI 10.1046/j.1432-1327.2000.01759.x; Guo JF, 2006, CIRC RES, V99, P1367, DOI 10.1161/01.RES.0000252830.01581.fd; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Ito K, 2009, P NATL ACAD SCI USA, V106, P8689, DOI 10.1073/pnas.0900064106; Jones JI, 1996, P NATL ACAD SCI USA, V93, P2482, DOI 10.1073/pnas.93.6.2482; King CC, 2004, J BIOL CHEM, V279, P37518, DOI 10.1074/jbc.M405340200; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Kurata A, 2008, CANCER SCI, V99, P1827, DOI 10.1111/j.1349-7006.2008.00874.x; Kwon M, 2006, ENDOCRINOLOGY, V147, P1458, DOI 10.1210/en.2005-1115; Lawlor MA, 2001, J CELL SCI, V114, P2903; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lieskovska J, 2006, J BIOL CHEM, V281, P25041, DOI 10.1074/jbc.M602866200; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; Maile LA, 2007, ENDOCRINOLOGY, V148, P2435, DOI 10.1210/en.2006-1440; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Michel JJC, 2005, MOL CELL, V20, P661, DOI 10.1016/j.molcel.2005.10.013; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; Nakamura A, 2008, MOL CELL BIOL, V28, P5996, DOI 10.1128/MCB.00114-08; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Park J, 2001, J BIOL CHEM, V276, P37459, DOI 10.1074/jbc.M105916200; PARKER A, 1995, ENDOCRINOLOGY, V136, P2470, DOI 10.1210/en.136.6.2470; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Radhakrishnan Y, 2008, J BIOL CHEM, V283, P16320, DOI 10.1074/jbc.M801687200; Radhakrishnan Y, 2010, J BIOL CHEM, V285, P15682, DOI 10.1074/jbc.M109.092270; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SHEN X, 2010, CELL MOL LI IN PRESS; Shen XC, 2009, MOL CELL PROTEOMICS, V8, P1539, DOI 10.1074/mcp.M800543-MCP200; Steiler TL, 2003, ENDOCRINOLOGY, V144, P5259, DOI 10.1210/en.2003-0447; Taniyama Y, 2003, MOL CELL BIOL, V23, P8019, DOI 10.1128/MCB.23.22.8019-8029.2003; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Xi G, 2008, MOL ENDOCRINOL, V22, P2162, DOI 10.1210/me.2008-0079; Yang KJ, 2008, J BIOL CHEM, V283, P1480, DOI 10.1074/jbc.M706361200; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467	55	15	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29416	29424		10.1074/jbc.M110.155325	http://dx.doi.org/10.1074/jbc.M110.155325			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20643654	Green Published, hybrid			2022-12-25	WOS:000281740100044
J	Blacklock, BJ; Scheffler, BE; Shepard, MR; Jayasuriya, N; Minto, RE				Blacklock, Brenda J.; Scheffler, Brian E.; Shepard, Michael R.; Jayasuriya, Naomi; Minto, Robert E.			Functional Diversity in Fungal Fatty Acid Synthesis THE FIRST ACETYLENASE FROM THE PACIFIC GOLDEN CHANTERELLE, CANTHARELLUS FORMOSUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE PROTEINS; ENDOPLASMIC-RETICULUM; CREPENYNATE PATHWAY; NATURAL ACETYLENES; HISTIDINE-RESIDUES; ARABIDOPSIS FAD2; DESATURASE GENE; POLYACETYLENES; IDENTIFICATION; BASIDIOMYCETE	Acetylenic specialized metabolites containing one or more carbon-carbon triple bonds are widespread, being found in fungi, vascular and lower plants, marine sponges and algae, and insects. Plants, moss, and most recently, insects, have been shown to employ an energetically difficult, sequential dehydrogenation mechanism for acetylenic bond formation. Here, we describe the cloning and heterologous expression in yeast of a linoleoyl 12-desaturase (acetylenase) and a bifunctional desaturase with Delta(12)-/Delta(14)-regiospecificity from the Pacific golden chanterelle. The acetylenase gene, which is the first identified from a fungus, is phylogenetically distinct from known plant and fungal desaturases. Together, the bifunctional desaturase and the acetylenase provide the enzymatic activities required to drive oleate through linoleate to crepenynate and the conjugated enyne (14Z)-dehydrocrepenynate, the branchpoint precursors to a major class of acetylenic natural products.	Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA; [Scheffler, Brian E.] Jamie Whitten Delta States Res Ctr, Genom & Bioinformat Res Unit, Stoneville, MS 38776 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Minto, RE (corresponding author), 402 N Blackford St,LD 326, Indianapolis, IN 46202 USA.	rminto@iupui.edu	Jayasuriya, Niranjali/H-2351-2014	Scheffler, Brian/0000-0003-1968-8952; Minto, Robert/0000-0001-7070-6832	National Institutes of Health [R15 GM06493-02]; American Cancer Society, Ohio Division; Miami University (Ohio); School of Science, Indiana University-Purdue University Indianapolis; National Science Foundation [CHE 0619254, DBI 0821661]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society, Ohio Division(American Cancer Society); Miami University (Ohio); School of Science, Indiana University-Purdue University Indianapolis; National Science Foundation(National Science Foundation (NSF))	This work was supported, in whole or in part, by National Institutes of Health Grant R15 GM06493-02. This work was also supported by a grant from the American Cancer Society, Ohio Division and startup support from Miami University (Ohio) and the School of Science, Indiana University-Purdue University Indianapolis.; NMR and MS data were collected using instruments acquired through the support of National Science Foundation Grants CHE 0619254 and DBI 0821661. We acknowledge John Dyer and Ed Cahoon for helpful discussions. Plasmids for Delta 12 and Myc-tagged Delta 15 desaturases were appreciated gifts from Ed Cahoon, Ralph Dewey, and John Dyer. C. alpina seed oil was provided by Richard Adlof (United States Department of Agriculture, Peoria, IL). We greatly appreciate the efforts of many undergraduate researchers and Errol Huffman, who earlier tested necessary but unfruitful approaches to the isolation of a fungal acetylenase.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; AVELANGEMACHEREL MH, 1995, FEBS LETT, V361, P111, DOI 10.1016/0014-5793(95)00163-4; Badami RC, 1980, PROG LIPID RES, V19, P119; BARLEY GC, 1987, J CHEM RES-S, P232; Beckmann C, 2002, ANGEW CHEM INT EDIT, V41, P2298, DOI 10.1002/1521-3773(20020703)41:13&lt;2298::AID-ANIE2298&gt;3.0.CO;2-G; Bohlmann F., 1973, NATURALLY OCCURRING; Broadwater JA, 2002, J BIOL CHEM, V277, P15613, DOI 10.1074/jbc.M200231200; Buist PH, 2004, NAT PROD REP, V21, P249, DOI 10.1039/b302094k; BULOCK JD, 1955, J CHEM SOC, P4270, DOI 10.1039/jr9550004270; Cahoon EB, 2004, J BIOL CHEM, V279, P12495, DOI 10.1074/jbc.M314329200; Cahoon EB, 2003, PLANT J, V34, P671, DOI 10.1046/j.1365-313X.2003.01757.x; Carlsson AS, 2004, EUR J BIOCHEM, V271, P2991, DOI 10.1111/j.1432-1033.2004.04231.x; CELMER WD, 1952, J AM CHEM SOC, V74, P1870, DOI 10.1021/ja01127a529; Christie WW, 1998, CHEM PHYS LIPIDS, V94, P35, DOI 10.1016/S0009-3084(98)00016-4; Covello PS, 1996, PLANT PHYSIOL, V111, P223, DOI 10.1104/pp.111.1.223; Dyer JM, 2004, J AM OIL CHEM SOC, V81, P647, DOI 10.1007/s11746-004-956-x; FARRELL IW, 1987, J CHEM RES-S, P234; FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Fernandez-Lopez R, 2005, MICROBIOL-SGM, V151, P3517, DOI 10.1099/mic.0.28216-0; FORD GL, 1985, J CHROMATOGR, V346, P431, DOI 10.1016/S0021-9673(00)90536-3; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hashimoto K, 2008, J LIPID RES, V49, P183, DOI 10.1194/jlr.M700377-JLR200; Hiroi Masaru, 1992, Transactions of the Mycological Society of Japan, V33, P517; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jaworski J, 2003, CURR OPIN PLANT BIOL, V6, P178, DOI 10.1016/S1369-5266(03)00013-X; Lee M, 1998, SCIENCE, V280, P915, DOI 10.1126/science.280.5365.915; Millar AA, 2000, TRENDS PLANT SCI, V5, P95, DOI 10.1016/S1360-1385(00)01566-1; Minto RE, 2008, PROG LIPID RES, V47, P233, DOI 10.1016/j.plipres.2008.02.002; Minto RE, 2009, APPL ENVIRON MICROB, V75, P1156, DOI 10.1128/AEM.02049-08; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; PANG Z, 1991, J ORG CHEM, V56, P1233, DOI 10.1021/jo00003a054; Parish CA, 2004, J NAT PROD, V67, P1900, DOI 10.1021/np0497853; Redhead SA, 1997, MYCOTAXON, V65, P285; Reed DW, 2003, J AM CHEM SOC, V125, P10635, DOI 10.1021/ja036489o; Rosa LH, 2006, WORLD J MICROB BIOT, V22, P539, DOI 10.1007/s11274-005-9002-7; ROST B, 1995, PROTEIN SCI, V4, P521; Sakai H, 2005, MOL GENET GENOMICS, V273, P336, DOI 10.1007/s00438-005-1138-5; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Serra M, 2007, P NATL ACAD SCI USA, V104, P16444, DOI 10.1073/pnas.0705385104; Shanklin J, 2003, FEBS LETT, V545, P188, DOI 10.1016/S0014-5793(03)00529-5; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; Singh SP, 2005, CURR OPIN PLANT BIOL, V8, P197, DOI 10.1016/j.pbi.2005.01.012; Sperling P, 2000, EUR J BIOCHEM, V267, P3801, DOI 10.1046/j.1432-1327.2000.01418.x; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; Tang GQ, 2005, PLANT J, V44, P433, DOI 10.1111/j.1365-313X.2005.02535.x; Vance DE, 2008, N COMP BIOC, P1; Watanabe K, 2004, BIOSCI BIOTECH BIOCH, V68, P721, DOI 10.1271/bbb.68.721; Zhang S, 2007, FEBS LETT, V581, P315, DOI 10.1016/j.febslet.2006.12.031	51	19	20	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28442	28449		10.1074/jbc.M110.151498	http://dx.doi.org/10.1074/jbc.M110.151498			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20606235	hybrid, Green Published			2022-12-25	WOS:000281594000007
J	Christian, BE; Spremulli, LL				Christian, Brooke E.; Spremulli, Linda L.			Preferential Selection of the 5 '-Terminal Start Codon on Leaderless mRNAs by Mammalian Mitochondrial Ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATION INITIATION; PUNCTUATION MODEL; PURIFICATION; TRANSCRIPTS	Mammalian mitochondrial mRNAs are basically leaderless, having few or no untranslated nucleotides prior to the 5'-start codon. We demonstrate here that mammalian mitochondrial 55 S ribosomes preferentially form initiation complexes at a 5'-terminal AUG codon over an internal AUG. The preferential use of the 5'-start codon is also seen on mitochondrial 28 S small subunits, which suggests that mitochondrial translation initiation on leaderless mRNAs does not require the large ribosomal subunit. The selection of the 5'-AUG is dependent on the presence of fMet-tRNA and is enhanced by the presence of the mitochondrial initiation factor IF2(mt). In prokaryotes, IF3 is believed to antagonize initiation on leaderless mRNAs. However, IF3(mt) stimulates initiation complex formation on leaderless mRNAs when tested with 55 S ribosomes. The addition of even a few nucleotides 5' to the AUG codon significantly reduces the efficiency of initiation, highlighting the importance of the leaderless or nearly leaderless nature of mitochondrial mRNAs. In addition, very few initiation complexes could form on a hybrid mRNA construct consisting of tRNA(Met) attached at the 5'-end of a mitochondrial protein-coding sequence. This observation demonstrates that post-transcriptional processing	[Christian, Brooke E.; Spremulli, Linda L.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Spremulli, LL (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	linda_spremulli@unc.edu	Christian, Brooke Elizabeth/ABA-8019-2021	Christian, Brooke/0000-0002-1495-5639	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032734] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM032734] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhargava K, 2005, NUCLEIC ACIDS RES, V33, P7011, DOI 10.1093/nar/gki1007; Brock JE, 2008, RNA, V14, P2159, DOI 10.1261/rna.1089208; Christian BE, 2009, BIOCHEMISTRY-US, V48, P3269, DOI 10.1021/bi8023493; CLAYTON DA, 1984, ANNU REV BIOCHEM, V53, P573; Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5; Gaur R, 2008, MOL CELL, V29, P180, DOI 10.1016/j.molcel.2007.11.021; Grasso DG, 2007, METHOD ENZYMOL, V430, P59, DOI 10.1016/S0076-6879(07)30004-9; GRAVES MC, 1983, ARCH BIOCHEM BIOPHYS, V222, P192, DOI 10.1016/0003-9861(83)90516-7; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; Jones CN, 2008, RNA, V14, P862, DOI 10.1261/rna.909208; Kaberdina AC, 2009, MOL CELL, V33, P227, DOI 10.1016/j.molcel.2008.12.014; Koc EC, 2002, J BIOL CHEM, V277, P35541, DOI 10.1074/jbc.M202498200; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; LIAO HX, 1989, J BIOL CHEM, V264, P7518; Ma JH, 1996, J BIOL CHEM, V271, P5805, DOI 10.1074/jbc.271.10.5805; MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Ringquist S, 1998, METH MOL B, V77, P283; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Stewart JB, 2009, GENE, V445, P49, DOI 10.1016/j.gene.2009.06.006; Tedin K, 1999, MOL MICROBIOL, V31, P67, DOI 10.1046/j.1365-2958.1999.01147.x; Temperley RJ, 2010, BBA-BIOENERGETICS, V1797, P1081, DOI 10.1016/j.bbabio.2010.02.036; Udagawa T, 2004, J BIOL CHEM, V279, P8539, DOI 10.1074/jbc.M308784200	27	35	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28379	28386		10.1074/jbc.M110.149054	http://dx.doi.org/10.1074/jbc.M110.149054			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20610392	hybrid, Green Published			2022-12-25	WOS:000281404100080
J	Imam, JS; Buddavarapu, K; Lee-Chang, JS; Ganapathy, S; Camosy, C; Chen, Y; Rao, MK				Imam, J. S.; Buddavarapu, K.; Lee-Chang, J. S.; Ganapathy, S.; Camosy, C.; Chen, Y.; Rao, M. K.			MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers	ONCOGENE			English	Article						Cancer; Six1; microRNA; miR-185; tumor suppressor	HOMEOPROTEIN SIX1; GENE-EXPRESSION; OVEREXPRESSION; APOPTOSIS; RESISTANCE; MECHANISM; CARCINOMA; TRAIL; EZRIN	Homeobox genes encode transcription factors that are essential for normal development and are often dysregulated in cancers. The molecular mechanisms that cause their misregulation in cancers are largely unknown. In this study, we investigate the mechanism by which the Six1 homeobox protein, which has a crucial role during development, is frequently deregulated in several poor outcome, aggressive, metastatic adult human cancers, including breast cancer, ovarian cancer, hepatocellular carcinoma and pediatric malignancies such as rhabdomyosarcoma and Wilms' tumor. Our results reveal that miRNA-185 translationally represses Six1 by binding to its 3'-untranslated region. Analyses of ovarian cancers, pediatric renal tumors and multiple breast cancer cell lines showed decreased miR-185 expression, paralleling an increase in Six1 levels. Further investigation revealed that miR-185 impedes anchorage-independent growth and cell migration, in addition to suppressing tumor growth in vivo, implicating it to be a potent tumor suppressor. Our results indicate that miR-185 mediates its tumor suppressor function by regulating cell-cycle proteins and Six1 transcriptional targets c-myc and cyclin A1. Furthermore, we show that miR-185 sensitizes Six1-overexpressing resistant cancer cells to apoptosis in general and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in particular. Together, our findings suggest that the altered expression of the novel tumor suppressor miR-185 may be one of the central events that leads to dysregulation of oncogenic protein Six1 in human cancers. Oncogene (2010) 29, 4971-4979; doi: 10.1038/onc.2010.233; published online 5 July 2010	[Rao, M. K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Ganapathy, S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiat Oncol, San Antonio, TX 78229 USA; [Chen, Y.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Rao, MK (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, Greehey Childrens Canc Res Inst, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	RaoM@uthscsa.edu	Ganapathy, Suthakar/C-1266-2013	Ganapathy, Suthakar/0000-0003-3828-5382; Imam, J Saadi/0000-0003-3463-838X	San Antonio Area Foundation; GCCRI	San Antonio Area Foundation; GCCRI	We thank Jennifer Rebeles and Tiffany Jones for their assistance in flow cytometry and data analysis; Dr Yao-Fu-Chang for his suggestions in the preparation of this paper; Drs James Garbe and Martha Stampfer of Lawrence Berkeley National Laboratory for kindly providing us normal HMEC RNA samples; the Children's Oncology Group for providing Wilms' tumor and matched control kidney tissues; Dr Russell Broaddus and Ovarian Cancer Translational Research Tumor Bank, MD Anderson Cancer Center for normal and ovarian cancer tissues; and Dr Padmanabhan Swami, UT Health Science Center, San Antonio for recombinant human TRAIL. Financial support: This work was supported by San Antonio Area Foundation Grant (JSI and MKR) and GCCRI startup fund (MKR).	Behbakht K, 2007, CANCER RES, V67, P3036, DOI 10.1158/0008-5472.CAN-06-3755; Coletta RD, 2004, P NATL ACAD SCI USA, V101, P6478, DOI 10.1073/pnas.0401139101; Coletta RD, 2008, CANCER RES, V68, P2204, DOI 10.1158/0008-5472.CAN-07-3141; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Ford HL, 1998, P NATL ACAD SCI USA, V95, P12608, DOI 10.1073/pnas.95.21.12608; Grifone R, 2005, DEVELOPMENT, V132, P2235, DOI 10.1242/dev.01773; Li CM, 2002, AM J PATHOL, V160, P2181, DOI 10.1016/S0002-9440(10)61166-2; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; McCoy EL, 2009, J CLIN INVEST, V119, P2663, DOI 10.1172/JCI37691; Ng KT, 2006, BRIT J CANCER, V95, P1050, DOI 10.1038/sj.bjc.6603399; Ozaki H, 2004, DEVELOPMENT, V131, P551, DOI 10.1242/dev.00943; Radisky DC, 2009, J CLIN INVEST, V119, P2528, DOI 10.1172/JCI40555; Reichenberger KJ, 2005, CANCER RES, V65, P2668, DOI 10.1158/0008-5472.CAN-04-4286; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Shen C, 2008, BIOLOGICALS, V36, P263, DOI 10.1016/j.biologicals.2008.02.002; Shin MS, 2001, CANCER RES, V61, P4942; Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x; Wan F, 2008, INT J CANCER, V123, P32, DOI 10.1002/ijc.23463; Wang SL, 2003, P NATL ACAD SCI USA, V100, P15095, DOI 10.1073/pnas.2435285100; Wang SL, 2004, CANCER RES, V64, P6666, DOI 10.1158/0008-5472.CAN-04-1734; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Xu PX, 2003, DEVELOPMENT, V130, P3085, DOI 10.1242/dev.00536; Yu YL, 2006, CANCER RES, V66, P1982, DOI 10.1158/0008-5472.CAN-05-2360; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zheng WM, 2003, DEVELOPMENT, V130, P3989, DOI 10.1242/dev.00628	25	144	158	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	35					4971	4979		10.1038/onc.2010.233	http://dx.doi.org/10.1038/onc.2010.233			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	646XP	20603620				2022-12-25	WOS:000281578700011
J	Meng, L; Gabai, VL; Sherman, MY				Meng, L.; Gabai, V. L.; Sherman, M. Y.			Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis	ONCOGENE			English	Article						HSF1; HER2; growth arrest; senescence; p21; survivin	CANCER-CELLS; MOLECULAR CHAPERONES; SENESCENCE PATHWAYS; PROTEIN HSP72; GENE; ONCOGENESIS; EXPRESSION; APOPTOSIS; SURVIVIN; DEATH	The heat-shock transcription factor HSF1 was recently shown to have a key role in the development of tumors associated with activation of Ras or inactivation of p53. Here, we show that HSF1 is required for the cell transformation and tumorigenesis induced by the human epidermal growth factor receptor-2 (HER2) oncogene responsible for aggressive breast tumors. Upon expression of HER2, untransformed human mammary epithelial MCF-10A cells underwent neoplastic transformation, formed foci in culture and tumors in nude mouse xenografts. However, expression of HER2 in MCF-10A cells with knockdown of HSF1 did not cause either foci formation or tumor growth in xenografts. The antitumorigenic effect of downregulation of HSF1 was associated with HER2-induced accumulation of the cyclin-dependent kinase inhibitor p21 and decrease in the mitotic regulator survivin, which resulted in growth inhibition and cell senescence. In fact, either knockout of p21 or overexpression of survivin alleviated these effects of HSF1 knockdown. The proliferation of certain human HER2-positive breast cancer lines also requires HSF1, as its knockdown led to upregulation of p21 and/or decrease in survivin, precipitating growth arrest. Similar effects were observed with a small-molecular-weight inhibitor of the heat-shock response NZ28. The effects of HSF1 knockdown on the growth arrest and senescence of HER2-expressing cells were associated with downregulation of heat-shock protein (Hsp) 72 and Hsp27. Therefore, HSF1 is critical for proliferation of HER2-expressing cells, most likely because it maintains the levels of HSPs, which in turn control regulators of senescence p21 and survivin. Oncogene (2010) 29, 5204-5213; doi:10.1038/onc.2010.277; published online 12 July 2010	[Meng, L.; Gabai, V. L.; Sherman, M. Y.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Sherman, MY (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,K-323, Boston, MA 02118 USA.	gabai@bu.edu; sherma1@bu.edu	Gabai, Vladimir L/I-1650-2013	Gabai, Vladimir L/0000-0003-4505-4718; Sherman, Michael/0000-0003-3345-073X	National Institute of Health [CA081244]; NATIONAL CANCER INSTITUTE [R01CA081244] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institute of Health CA081244. We thank Dr B Park and Dr C Spangenberg for their kind supply of MCF-10A cells and HER2-overexpressing retroviral vector.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Bachman KE, 2004, CANCER BIOL THER, V3, P221, DOI 10.4161/cbt.3.2.666; Cahill CM, 1996, J BIOL CHEM, V271, P24874; Cahill CM, 1997, ADV EXP MED BIOL, V400, P625; Cai L, 2003, CELL RES, V13, P93, DOI 10.1038/sj.cr.7290154; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Gabai VL, 2009, MOL CELL BIOL, V29, P559, DOI 10.1128/MCB.01041-08; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Khaleque M, 2008, ONCOGENE, V27, P1886, DOI 10.1038/sj.onc.1210834; Khaleque MA, 2005, ONCOGENE, V24, P6564, DOI 10.1038/sj.onc.1208798; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; MORIMOTO RI, 1992, J BIOL CHEM, V267, P21987; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Roninson IB, 2003, CANCER RES, V63, P2705; Singh IS, 2002, J BIOL CHEM, V277, P4981, DOI 10.1074/jbc.M108154200; Singh IS, 2000, J BIOL CHEM, V275, P9841, DOI 10.1074/jbc.275.13.9841; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; Trost TM, 2005, CANCER RES, V65, P840; Wu GJ, 2005, CANCER RES, V65, P758; Xie Y, 2002, J BIOL CHEM, V277, P11802, DOI 10.1074/jbc.M109296200; Xie Y, 2002, BIOCHEM BIOPH RES CO, V291, P1071, DOI 10.1006/bbrc.2002.6562; Yaglom JA, 2007, CANCER RES, V67, P2373, DOI 10.1158/0008-5472.CAN-06-3796; Zaarur N, 2006, CANCER RES, V66, P1783, DOI 10.1158/0008-5472.CAN-05-3692	31	106	107	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2010	29	37					5204	5213		10.1038/onc.2010.277	http://dx.doi.org/10.1038/onc.2010.277			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	650QZ	20622894	Green Accepted			2022-12-25	WOS:000281867200009
J	Qian, SB; Zhang, XQ; Sun, J; Bennink, JR; Yewdell, JW; Patterson, C				Qian, Shu-Bing; Zhang, Xingqian; Sun, Jun; Bennink, Jack R.; Yewdell, Jonathan W.; Patterson, Cam			mTORC1 Links Protein Quality and Quantity Control by Sensing Chaperone Availability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK; LIFE-SPAN; TRANSLATIONAL CONTROL; HYDROGEN-PEROXIDE; BINDING PARTNER; TOR; RAPAMYCIN; STRESS; RAPTOR; CHIP	Balanced protein synthesis and degradation are crucial for proper cellular function. Protein synthesis is tightly coupled to energy status and nutrient levels by the mammalian target of rapamycin complex 1 (mTORC1). Quality of newly synthesized polypeptides is maintained by the molecular chaperone and ubiquitin-proteasome systems. Little is known about how cells integrate information about the quantity and quality of translational products simultaneously. We demonstrate that cells distinguish moderate reductions in protein quality from severe protein misfolding using molecular chaperones to differentially regulate mTORC1 signaling. Moderate reduction of chaperone availability enhances mTORC1 signaling, whereas stress-induced complete depletion of chaperoning capacity suppresses mTORC1 signaling. Molecular chaperones regulate mTORC1 assembly in coordination with nutrient availability. This mechanism enables mTORC1 to rapidly detect and respond to environmental cues while also sensing intracellular protein misfolding. The tight linkage between protein quality and quantity control provides a plausible mechanism coupling protein misfolding with metabolic dyshomeostasis.	[Qian, Shu-Bing; Zhang, Xingqian; Sun, Jun] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Bennink, Jack R.; Yewdell, Jonathan W.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; [Patterson, Cam] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27599 USA	Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of North Carolina; University of North Carolina Chapel Hill	Qian, SB (corresponding author), Cornell Univ, Div Nutr Sci, 301 Biotech, Ithaca, NY 14853 USA.	sq38@cornell.edu; cpatters@med.unc.edu	yewdell, jyewdell@nih.gov jonathan/A-1702-2012		National Institutes of Health through NIAID; National Institutes of Health [GM61728, AG024282, DK056350]; Cornell Startup Research Funds; Ellison Medical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG024282] Funding Source: NIH RePORTER	National Institutes of Health through NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell Startup Research Funds; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health through NIAID (to J. R. B. and J. W. Y.) and National Institutes of Health Grants GM61728, AG024282, and DK056350 (to C. P.). This work was also supported by Cornell Startup Research Funds and the Ellison Medical Foundation (to S. B. Q.).	Adami A, 2007, MOL CELL, V27, P509, DOI 10.1016/j.molcel.2007.05.040; Bae GU, 1999, J BIOL CHEM, V274, P32596, DOI 10.1074/jbc.274.46.32596; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Ding M, 2002, MOL CELL BIOCHEM, V234, P81, DOI 10.1023/A:1015901232124; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; GOLDBERG AL, 1974, ANNU REV BIOCHEM, V43, P835, DOI 10.1146/annurev.bi.43.070174.004155; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Huang CS, 2002, CANCER RES, V62, P5689; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; JURIVICH DA, 1991, J CELL PHYSIOL, V148, P252, DOI 10.1002/jcp.1041480210; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kraiss LW, 2001, J SURG RES, V97, P20, DOI 10.1006/jsre.2001.6091; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Lin RZ, 1997, J BIOL CHEM, V272, P31196, DOI 10.1074/jbc.272.49.31196; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Neel JV, 1999, NUTR REV, V57, pS2, DOI 10.1111/j.1753-4887.1999.tb01782.x; Ohji G, 2006, J BIOCHEM, V139, P129, DOI 10.1093/jb/mvj008; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Qian SB, 2006, J IMMUNOL, V177, P227, DOI 10.4049/jimmunol.177.1.227; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Trotter EW, 2002, J BIOL CHEM, V277, P44817, DOI 10.1074/jbc.M204686200; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	49	37	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27385	27395		10.1074/jbc.M110.120295	http://dx.doi.org/10.1074/jbc.M110.120295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20605781	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000281172700067
J	Slocombe, KE; Kaller, T; Call, J; Zuberbuhler, K				Slocombe, Katie E.; Kaller, Tanja; Call, Josep; Zuberbuehler, Klaus			Chimpanzees Extract Social Information from Agonistic Screams	PLOS ONE			English	Article							WILD CHIMPANZEES; COMMUNICATION; RECRUITMENT; RESPONSES; SIZE	Chimpanzee (Pan troglodytes) agonistic screams are graded vocal signals that are produced in a context-specific manner. Screams given by aggressors and victims can be discriminated based on their acoustic structure but the mechanisms of listener comprehension of these calls are currently unknown. In this study, we show that chimpanzees extract social information from these vocal signals that, combined with their more general social knowledge, enables them to understand the nature of out-of-sight social interactions. In playback experiments, we broadcast congruent and incongruent sequences of agonistic calls and monitored the response of bystanders. Congruent sequences were in accordance with existing social dominance relations; incongruent ones violated them. Subjects looked significantly longer at incongruent sequences, despite them being acoustically less salient (fewer call types from fewer individuals) than congruent ones. We concluded that chimpanzees categorised an apparently simple acoustic signal into victim and aggressor screams and used pragmatics to form inferences about third-party interactions they could not see.	[Slocombe, Katie E.; Kaller, Tanja] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Call, Josep] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany; [Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland	University of York - UK; Max Planck Society; University of St Andrews	Slocombe, KE (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	ks553@york.ac.uk	Slocombe, Katie E/B-8788-2016; Zuberbühler, Klaus/A-9053-2011	Slocombe, Katie E/0000-0002-7310-1887; Zuberbühler, Klaus/0000-0001-8378-088X	Biotechnology and Biological Sciences Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from the Biotechnology and Biological Sciences Research Council to KZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MCP, 2008, BEHAVIOUR, V145, P1065, DOI 10.1163/156853908784474498; Barlow KE, 1997, ANIM BEHAV, V53, P991, DOI 10.1006/anbe.1996.0398; Brown WD, 2006, ANIM BEHAV, V72, P225, DOI 10.1016/j.anbehav.2006.01.012; CHENEY DL, 1995, J COMP PSYCHOL, V109, P134, DOI 10.1037/0735-7036.109.2.134; Corballis MC, 2002, HAND MOUTH ORIGINS L; Farago T, 2010, ANIM BEHAV, V79, P917, DOI 10.1016/j.anbehav.2010.01.005; Goodall J., 1986, CHIMPANZEES GOMBE PA; GOUZOULES S, 1984, ANIM BEHAV, V32, P182, DOI 10.1016/S0003-3472(84)80336-X; HANEY M, 1993, J COMP PSYCHOL, V107, P373, DOI 10.1037/0735-7036.107.4.373; Herbinger I, 2009, ANIM BEHAV, V78, P1389, DOI 10.1016/j.anbehav.2009.09.010; Kojima S, 2003, PRIMATES, V44, P225, DOI 10.1007/s10329-002-0014-8; MCGREGOR PK, 1992, PLAYBACK STUDIES ANI, V228, P1; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Newton-Fisher NE, 2004, PRIMATES, V45, P81, DOI 10.1007/s10329-003-0064-6; Onishi KH, 2007, ACTA PSYCHOL, V124, P106, DOI 10.1016/j.actpsy.2006.09.009; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Seyfarth RM, 2005, TRENDS COGN SCI, V9, P264, DOI 10.1016/j.tics.2005.04.001; Slocombe KE, 2007, P NATL ACAD SCI USA, V104, P17228, DOI 10.1073/pnas.0706741104; Slocombe KE, 2009, ANIM COGN, V12, P441, DOI 10.1007/s10071-008-0204-x; Slocombe KE, 2005, CURR BIOL, V15, P1779, DOI 10.1016/j.cub.2005.08.068; Slocombe KE, 2005, J COMP PSYCHOL, V119, P67, DOI 10.1037/0735-7036.119.1.67; SLOCOMBE KE, ANIMAL BEHA IN PRESS; Taylor AM, 2010, ANIM BEHAV, V79, P205, DOI 10.1016/j.anbehav.2009.10.030; Tomasello M, 2008, JEAN NICOD LECT, P1; Vasconcelos RO, 2010, ETHOLOGY, V116, P155, DOI 10.1111/j.1439-0310.2009.01722.x; Zuberbuhler K, 1999, J COMP PSYCHOL, V113, P33, DOI 10.1037/0735-7036.113.1.33	26	47	47	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11473	10.1371/journal.pone.0011473	http://dx.doi.org/10.1371/journal.pone.0011473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644722	gold, Green Published, Green Submitted			2022-12-25	WOS:000279884900004
J	Wang, CG; Wang, Z; Luo, JT; Li, Q; Li, Y; Ahn, K; Prows, DR; Wu, RL				Wang, Chenguang; Wang, Zhong; Luo, Jiangtao; Li, Qin; Li, Yao; Ahn, Kwangmi; Prows, Daniel R.; Wu, Rongling			A Model for Transgenerational Imprinting Variation in Complex Traits	PLOS ONE			English	Article							EPIGENETIC INHERITANCE; DNA METHYLATION; PLANTS; GENE; GENOME; GROWTH; ALLELE; LOCI	Despite the fact that genetic imprinting, i.e., differential expression of the same allele due to its different parental origins, plays a pivotal role in controlling complex traits or diseases, the origin, action and transmission mode of imprinted genes have still remained largely unexplored. We present a new strategy for studying these properties of genetic imprinting with a two-stage reciprocal F-2 mating design, initiated with two contrasting inbred lines. This strategy maps quantitative trait loci that are imprinted (i.e., iQTLs) based on their segregation and transmission across different generations. By incorporating the allelic configuration of an iQTL genotype into a mixture model framework, this strategy provides a path to trace the parental origin of alleles from previous generations. The imprinting effects of iQTLs and their interactions with other traditionally defined genetic effects, expressed in different generations, are estimated and tested by implementing the EM algorithm. The strategy was used to map iQTLs responsible for survival time with four reciprocal F-2 populations and test whether and how the detected iQTLs inherit their imprinting effects into the next generation. The new strategy will provide a tool for quantifying the role of imprinting effects in the creation and maintenance of phenotypic diversity and elucidating a comprehensive picture of the genetic architecture of complex traits and diseases.	[Wang, Chenguang; Li, Qin] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [Wang, Zhong; Luo, Jiangtao; Ahn, Kwangmi; Wu, Rongling] Penn State Univ, Ctr Stat Genet, Hershey, PA USA; [Li, Yao] W Virginia Univ, Dept Stat, Morgantown, WV 26506 USA; [Prows, Daniel R.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; West Virginia University; University System of Ohio; University of Cincinnati	Wang, CG (corresponding author), Univ Florida, Dept Stat, Gainesville, FL 32611 USA.	rwu@hes.hmc.psu.edu	Ahn, Kwangmi/GLV-4077-2022; Wang, Zhong/C-3737-2014		National Science Foundation (NSF) [DMS/NIGMS-0540745]; Changjiang Scholarship Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075562] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Changjiang Scholarship Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Science Foundation (NSF) grant DMS/NIGMS-0540745 and Changjiang Scholarship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; Cheng Y, 2009, METHODS MOL BIOL, V573, P189, DOI 10.1007/978-1-60761-247-6_11; Cheverud JM, 2008, P NATL ACAD SCI USA, V105, P4253, DOI 10.1073/pnas.0706562105; CHURCHILL GA, 1994, GENETICS, V138, P963; Constancia M, 2004, NATURE, V432, P53, DOI 10.1038/432053a; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; Cui YH, 2007, J THEOR BIOL, V244, P115, DOI 10.1016/j.jtbi.2006.07.009; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Isles AR, 2000, TRENDS COGN SCI, V4, P309, DOI 10.1016/S1364-6613(00)01504-7; Itier JM, 1998, NATURE, V393, P125, DOI 10.1038/30120; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Kahn A, 2009, J GERONTOL A-BIOL, V64, P195, DOI 10.1093/gerona/gln064; Kakutani T, 2002, PLANT CELL PHYSIOL, V43, P1106, DOI 10.1093/pcp/pcf131; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; LANDER ES, 1989, GENETICS, V121, P185; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Li YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003131; Liu T, 2007, GENOMICS, V90, P276, DOI 10.1016/j.ygeno.2007.04.004; Ma CX, 2002, GENETICS, V161, P1751; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Paterson AH, 2006, NAT REV GENET, V7, P174, DOI 10.1038/nrg1806; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Prows DR, 2007, PHYSIOL GENOMICS, V30, P271, DOI 10.1152/physiolgenomics.00038.2007; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Richards EJ, 2008, CURR OPIN GENET DEV, V18, P221, DOI 10.1016/j.gde.2008.01.014; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; SCHALKWYK L, 2010, J HUM GENET, V86, P196; Sha K, 2008, ANNU REV GENOM HUM G, V9, P197, DOI 10.1146/annurev.genom.122007.110031; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wen S, 2009, ALGORITHM MOL BIOL, V4, DOI 10.1186/1748-7188-4-11; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Wolf JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000091; Wu R., 2007, STAT GENETICS QUANTI; Xu SZ, 2003, GENETICS, V163, P789; Yang RQ, 2010, BIOINFORMATICS, V26, P235, DOI 10.1093/bioinformatics/btp620; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; ZENG ZB, 1994, GENETICS, V136, P1457	51	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11396	10.1371/journal.pone.0011396	http://dx.doi.org/10.1371/journal.pone.0011396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644725	gold, Green Submitted, Green Published			2022-12-25	WOS:000279884900001
J	Benakanakere, MR; Zhao, JW; Galicia, JC; Martin, M; Kinane, DF				Benakanakere, Manjunatha R.; Zhao, Jiawei; Galicia, Johnah C.; Martin, Michael; Kinane, Denis F.			Sphingosine Kinase-1 Is Required for Toll Mediated beta-Defensin 2 Induction in Human Oral Keratinocytes	PLOS ONE			English	Article							GINGIVAL EPITHELIAL-CELLS; GLYCOGEN-SYNTHASE KINASE-3; ANTIMICROBIAL PEPTIDES; PORPHYROMONAS-GINGIVALIS; HUMAN BETA-DEFENSIN-2; IN-VITRO; CYTOKINE PRODUCTION; GENE-EXPRESSION; UP-REGULATION; HOST-DEFENSE	Background: Host defense against invading pathogens is triggered by various receptors including toll-like receptors (TLRs). Activation of TLRs is a pivotal step in the initiation of innate, inflammatory, and antimicrobial defense mechanisms. Human beta-defensin 2 (HBD-2) is a cationic antimicrobial peptide secreted upon Gram-negative bacterial perturbation in many cells. Stimulation of various TLRs has been shown to induce HBD-2 in oral keratinocytes, yet the underlying cellular mechanisms of this induction are poorly understood. Principal Findings: Here we demonstrate that HBD-2 induction is mediated by the Sphingosine kinase-1 (Sphk-1) and augmented by the inhibition of Glycogen Synthase Kinase-3 beta (GSK-3 beta) via the Phosphoinositide 3-kinase (PI3K) dependent pathway. HBD-2 secretion was dose dependently inhibited by a pharmacological inhibitor of Sphk-1. Interestingly, inhibition of GSK-3 beta by SB 216763 or by RNA interference, augmented HBD-2 induction. Overexpression of Sphk-1 with concomitant inhibition of GSK-3 beta enhanced the induction of beta-defensin-2 in oral keratinocytes. Ectopic expression of constitutively active GSK-3 beta (S9A) abrogated HBD-2 whereas kinase inactive GSK-3 beta (R85A) induced higher amounts of HBD-2. Conclusions/Significance: These data implicate Sphk-1 in HBD-2 regulation in oral keratinocytes which also involves the activation of PI3K, AKT, GSK-3 beta and ERK 1/2. Thus we reveal the intricate relationship and pathways of toll-signaling molecules regulating HBD-2 which may have therapeutic potential.	[Benakanakere, Manjunatha R.; Zhao, Jiawei; Galicia, Johnah C.; Kinane, Denis F.] Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA; [Martin, Michael] Univ Louisville, Sch Dent, Oral Hlth & Syst Dis Ctr, Louisville, KY 40292 USA	University of Pennsylvania; University of Louisville	Benakanakere, MR (corresponding author), Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA.	dfkinane@dental.upenn.edu		Galicia, Johnah/0000-0003-1908-5801	United States Public Health Service; National Institutes of Health; NIDCR [DE017384]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017384] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by United States Public Health Service, National Institutes of Health, NIDCR grant DE017384 to DFK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arimura Y, 2004, ANTICANCER RES, V24, P4051; Benakanakere MR, 2009, J BIOL CHEM, V284, P23107, DOI 10.1074/jbc.M109.013862; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Burns E, 2010, J IMMUNOL, V184, P1455, DOI 10.4049/jimmunol.0900378; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Chong KT, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-75; Danai Pajman, 2005, Curr Infect Dis Rep, V7, P329, DOI 10.1007/s11908-005-0005-1; Danai PA, 2007, CRIT CARE MED, V35, P410, DOI 10.1097/01.CCM.0000253405.17038.43; Diamond G, 2000, INFECT IMMUN, V68, P113, DOI 10.1128/IAI.68.1.113-119.2000; Donnarumma G, 2007, PEPTIDES, V28, P2286, DOI 10.1016/j.peptides.2007.09.009; EldarFinkelman H, 1996, P NATL ACAD SCI USA, V93, P10228, DOI 10.1073/pnas.93.19.10228; Eskan MA, 2008, EUR J IMMUNOL, V38, P1138, DOI 10.1002/eji.200737898; Eskan MA, 2007, INFECT IMMUN, V75, P892, DOI 10.1128/IAI.01604-06; Falco A, 2008, MOL IMMUNOL, V45, P757, DOI 10.1016/j.molimm.2007.06.358; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Ganz T, 2002, J CLIN INVEST, V109, P693, DOI 10.1172/JCI200215218; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ganz T, 2004, CR BIOL, V327, P539, DOI 10.1016/j.crvi.2003.12.007; Garcia CA, 2009, J IMMUNOL, V183, P4475, DOI 10.4049/jimmunol.0901283; Garcia CA, 2008, J IMMUNOL, V181, P8363, DOI 10.4049/jimmunol.181.12.8363; Garg SK, 2006, CLIN IMMUNOL, V121, P23, DOI 10.1016/j.clim.2006.06.003; Garg SK, 2006, CLIN IMMUNOL, V121, P260, DOI 10.1016/j.clim.2006.09.002; Garg SK, 2004, J INFECT DIS, V189, P2129, DOI 10.1086/386286; Gould I M, 2009, Int J Antimicrob Agents, V34 Suppl 3, pS2, DOI 10.1016/S0924-8579(09)70549-7; Haider AS, 2006, J INVEST DERMATOL, V126, P869, DOI 10.1038/sj.jid.5700157; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hajishengallis G, 2009, J IMMUNOL, V182, P6690, DOI 10.4049/jimmunol.0900524; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Harder J, 2004, J INVEST DERMATOL, V123, P522, DOI 10.1111/j.0022-202X.2004.23234.x; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Huttner KM, 1999, PEDIATR RES, V45, P785, DOI 10.1203/00006450-199906000-00001; Jang BC, 2004, BIOCHEM BIOPH RES CO, V320, P1026, DOI 10.1016/j.bbrc.2004.06.049; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Kaiser V, 2000, J LEUKOCYTE BIOL, V68, P779; Karliner JS, 2009, J CARDIOVASC PHARM, V53, P189, DOI 10.1097/FJC.0b013e3181926706; Kennedy S, 2009, CURR OPIN PHARMACOL, V9, P194, DOI 10.1016/j.coph.2008.11.002; Kinane DF, 2006, GENES IMMUN, V7, P190, DOI 10.1038/sj.gene.6364282; Kota S, 2008, J BIOL CHEM, V283, P22417, DOI 10.1074/jbc.M710415200; Krisanaprakornkit S, 2002, J IMMUNOL, V168, P316, DOI 10.4049/jimmunol.168.1.316; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Liu LD, 2003, J IMMUNOL, V170, P575, DOI 10.4049/jimmunol.170.1.575; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Markeeva N, 2005, EXP ONCOL, V27, P308; Markeeva N, 2005, EXP ONCOL, V27, P130; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Means CK, 2009, CARDIOVASC RES, V82, P193, DOI 10.1093/cvr/cvp086; Mizukawa N, 2000, ANTICANCER RES, V20, P2005; Nakayama K, 2001, J IMMUNOL, V167, P1145, DOI 10.4049/jimmunol.167.3.1145; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Rehani K, 2008, BBA-MOL CELL RES, V1783, P375, DOI 10.1016/j.bbamcr.2007.12.003; Ruse M, 2006, IMMUNOL RES, V34, P33, DOI 10.1385/IR:34:1:33; Scott MG, 2000, CRIT REV IMMUNOL, V20, P407; Shiba H, 2005, J PERIODONTAL RES, V40, P153, DOI 10.1111/j.1600-0765.2005.00781.x; Shida D, 2008, CANCER RES, V68, P6569, DOI 10.1158/0008-5472.CAN-08-0411; Shida D, 2008, CURR DRUG TARGETS, V9, P662, DOI 10.2174/138945008785132402; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Travis SM, 2001, CURR OPIN IMMUNOL, V13, P89, DOI 10.1016/S0952-7915(00)00187-4; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Wang YM, 2006, J INFRARED MILLIM W, V25, P50; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; Yamaguchi Y, 2002, J IMMUNOL, V169, P2516, DOI 10.4049/jimmunol.169.5.2516; Yamane D, 2009, J BIOL CHEM, V284, P13648, DOI 10.1074/jbc.M807498200; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yoshida A, 2009, ANTICANCER RES, V29, P907; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhi L, 2006, J CELL PHYSIOL, V208, P109, DOI 10.1002/jcp.20646	79	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11512	10.1371/journal.pone.0011512	http://dx.doi.org/10.1371/journal.pone.0011512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634980	Green Published, gold, Green Submitted			2022-12-25	WOS:000279715300023
J	Zhang, XW; Bearer, EL; Boulat, B; Hall, FS; Uhl, GR; Jacobs, RE				Zhang, Xiaowei; Bearer, Elaine L.; Boulat, Benoit; Hall, F. Scott; Uhl, George R.; Jacobs, Russell E.			Altered Neurocircuitry in the Dopamine Transporter Knockout Mouse Brain	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; PREPULSE INHIBITION DEFICITS; VIVO H-1-NMR SPECTROSCOPY; MEDIAL PREFRONTAL CORTEX; VENTRAL TEGMENTAL AREA; IN-VIVO; MICE LACKING; ALZHEIMERS-DISEASE; NEURAL CIRCUITS; COCAINE REWARD	The plasma membrane transporters for the monoamine neurotransmitters dopamine, serotonin, and norepinephrine modulate the dynamics of these monoamine neurotransmitters. Thus, activity of these transporters has significant consequences for monoamine activity throughout the brain and for a number of neurological and psychiatric disorders. Gene knockout (KO) mice that reduce or eliminate expression of each of these monoamine transporters have provided a wealth of new information about the function of these proteins at molecular, physiological and behavioral levels. In the present work we use the unique properties of magnetic resonance imaging (MRI) to probe the effects of altered dopaminergic dynamics on meso-scale neuronal circuitry and overall brain morphology, since changes at these levels of organization might help to account for some of the extensive pharmacological and behavioral differences observed in dopamine transporter (DAT) KO mice. Despite the smaller size of these animals, voxel-wise statistical comparison of high resolution structural MR images indicated little morphological change as a consequence of DAT KO. Likewise, proton magnetic resonance spectra recorded in the striatum indicated no significant changes in detectable metabolite concentrations between DAT KO and wild-type (WT) mice. In contrast, alterations in the circuitry from the prefrontal cortex to the mesocortical limbic system, an important brain component intimately tied to function of mesolimbic/mesocortical dopamine reward pathways, were revealed by manganese-enhanced MRI (MEMRI). Analysis of co-registered MEMRI images taken over the 26 hours after introduction of Mn2+ into the prefrontal cortex indicated that DAT KO mice have a truncated Mn2+ distribution within this circuitry with little accumulation beyond the thalamus or contralateral to the injection site. By contrast, WT littermates exhibit Mn2+ transport into more posterior midbrain nuclei and contralateral mesolimbic structures at 26 hr post-injection. Thus, DAT KO mice appear, at this level of anatomic resolution, to have preserved cortico-striatal-thalamic connectivity but diminished robustness of reward-modulating circuitry distal to the thalamus. This is in contradistinction to the state of this circuitry in serotonin transporter KO mice where we observed more robust connectivity in more posterior brain regions using methods identical to those employed here.	[Zhang, Xiaowei; Bearer, Elaine L.; Boulat, Benoit; Jacobs, Russell E.] CALTECH, Beckman Inst, Biol Imaging Ctr, Pasadena, CA 91125 USA; [Bearer, Elaine L.] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Hall, F. Scott; Uhl, George R.] Natl Inst Drug Abuse, Intramural Res Program, Mol Neurobiol Branch, Baltimore, MD USA	California Institute of Technology; University of New Mexico; University of New Mexico's Health Sciences Center; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Zhang, XW (corresponding author), CALTECH, Beckman Inst, Biol Imaging Ctr, Pasadena, CA 91125 USA.	rjacobs@caltech.edu	Hall, F. Scott/C-3036-2013; Jacobs, Russell/H-1087-2011	Hall, F. Scott/0000-0002-0822-4063; Jacobs, Russell/0000-0002-1382-8486	Beckman Institute; NINDS [RO1 NS062184, RO1 NS046810]; NIDA [R01DA18184]; NCRR [U24 RR021760]; National Institute on Drug Abuse, Intramural Research Program; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062184, R01NS046810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000165, R01DA018184] Funding Source: NIH RePORTER	Beckman Institute; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Drug Abuse, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The project was funded in part by the Beckman Institute, NINDS RO1 NS062184 and RO1 NS046810 (E.L.B.), NIDA R01DA18184, and NCRR U24 RR021760 Mouse BIRN (R.E.J.) and, in part, by the National Institute on Drug Abuse, Intramural Research Program (G.R.U. and F.S.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2001, IEEE T MED IMAGING, V20, P1131, DOI 10.1109/42.963816; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Aoki I, 2002, MAGNET RESON MED, V48, P927, DOI 10.1002/mrm.10320; Ariano MA, 1998, DEV NEUROSCI-BASEL, V20, P237, DOI 10.1159/000017317; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Bearer EL, 2007, NEUROIMAGE, V37, P230, DOI 10.1016/j.neuroimage.2007.05.010; Bearer EL, 2009, NEUROIMAGE, V46, P1091, DOI 10.1016/j.neuroimage.2009.03.026; Bonci A, 2003, TRENDS PHARMACOL SCI, V24, P172, DOI 10.1016/S0165-6147(03)00068-3; Bosse R, 1997, NEURON, V19, P127, DOI 10.1016/S0896-6273(00)80353-0; BOTTOMLEY PA, 1987, ANN NY ACAD SCI, V508, P333, DOI 10.1111/j.1749-6632.1987.tb32915.x; Brenhouse HC, 2008, J NEUROSCI, V28, P2375, DOI 10.1523/JNEUROSCI.5064-07.2008; BROMAN J, 2004, RAT NERVOUS SYSTEM, P1269; Brun CC, 2009, NEUROIMAGE, V48, P37, DOI 10.1016/j.neuroimage.2009.05.022; Canals S, 2008, NEUROIMAGE, V40, P458, DOI 10.1016/j.neuroimage.2007.12.007; Caron MG, 1996, AM J PSYCHIAT, V153, P1515; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Carson RP, 2002, J PHARMACOL EXP THER, V301, P410, DOI 10.1124/jpet.301.2.410; Chan KC, 2008, NEUROIMAGE, V40, P1166, DOI 10.1016/j.neuroimage.2008.01.002; Chen JS, 2006, BIOL PSYCHIAT, V59, P1180, DOI 10.1016/j.biopsych.2006.02.024; Chen L, 2003, ANN NEUROL, V54, pS91, DOI 10.1002/ana.10655; Comings DE, 2000, PROG BRAIN RES, V126, P325; Cyr M, 2005, NEUROIMAGE, V26, P83, DOI 10.1016/j.neuroimage.2005.01.039; Dedeoglu A, 2004, BRAIN RES, V1012, P60, DOI 10.1016/j.brainres.2004.02.079; Dong H.W., 2008, ALLEN REFERENCE ATLA; Drago J, 1998, DEV NEUROSCI-BASEL, V20, P188, DOI 10.1159/000017313; DRAPEAU P, 1984, J PHYSIOL-LONDON, V348, P493, DOI 10.1113/jphysiol.1984.sp015121; Drevets WC, 2007, ANN NY ACAD SCI, V1121, P499, DOI 10.1196/annals.1401.029; Drobyshevsky A, 2005, J NEUROSCI, V25, P5988, DOI 10.1523/JNEUROSCI.4983-04.2005; ELLURU RG, 1995, MOL BIOL CELL, V6, P21, DOI 10.1091/mbc.6.1.21; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Floresco SB, 2007, J NEUROSCI, V27, P2045, DOI 10.1523/JNEUROSCI.5474-06.2007; Franken IHA, 2005, EUR J PHARMACOL, V526, P199, DOI 10.1016/j.ejphar.2005.09.025; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Gainetdinov RR, 2008, N-S ARCH PHARMACOL, V377, P301, DOI 10.1007/s00210-007-0216-0; Gainetdinov RR, 2002, TRENDS PHARMACOL SCI, V23, P367, DOI 10.1016/S0165-6147(02)02044-8; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Gainetdinov RR, 2001, J AM ACAD CHILD PSY, V40, P380, DOI 10.1097/00004583-200103000-00020; Gerfen C.R., 2004, RAT NERVOUS SYSTEM, P455, DOI DOI 10.1016/B978-012547638-6/50019-5; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goncalves L, 2009, BRAIN RES BULL, V78, P240, DOI 10.1016/j.brainresbull.2008.11.012; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Groenewegen HJ, 2000, PROG BRAIN RES, V126, P3; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Hasan KM, 2001, J MAGN RESON, V152, P41, DOI 10.1006/jmre.2001.2400; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hetherington HP, 1997, NMR BIOMED, V10, P360, DOI 10.1002/(SICI)1099-1492(199712)10:8<360::AID-NBM477>3.0.CO;2-8; Hof PR., 2000, COMP CYTOARCHITECTON; HURLEY KM, 1991, J COMP NEUROL, V308, P249, DOI 10.1002/cne.903080210; John CE, 2006, NEUROCHEM INT, V49, P737, DOI 10.1016/j.neuint.2006.06.004; Jones S, 2005, CURR OPIN PHARMACOL, V5, P20, DOI 10.1016/j.coph.2004.08.011; Kalisch R, 2004, NEUROIMAGE, V23, P382, DOI 10.1016/j.neuroimage.2004.06.012; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; Kassubek J, 2004, J NEUROL NEUROSUR PS, V75, P213; KIDA S, 1993, NEUROPATH APPL NEURO, V19, P480, DOI 10.1111/j.1365-2990.1993.tb00476.x; Kochunov P, 2001, J COMPUT ASSIST TOMO, V25, P805, DOI 10.1097/00004728-200109000-00023; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; Lau JC, 2008, NEUROIMAGE, V42, P19, DOI 10.1016/j.neuroimage.2008.04.252; LeBihan D, 1995, NMR BIOMED, V8, P375, DOI 10.1002/nbm.1940080711; Lee EF, 2005, ANAT EMBRYOL, V210, P245, DOI 10.1007/s00429-005-0048-y; Lepore N, 2008, IEEE T MED IMAGING, V27, P129, DOI 10.1109/TMI.2007.906091; Lyoo IK, 2002, BIOL PSYCHIAT, V51, P195, DOI 10.1016/S0006-3223(01)01313-0; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Madabhushi A, 2005, IEEE T MED IMAGING, V24, P561, DOI 10.1109/TMI.2004.843256; Marjanska M, 2005, P NATL ACAD SCI USA, V102, P11906, DOI 10.1073/pnas.0505513102; Mattiello J, 1997, MAGNET RESON MED, V37, P292, DOI 10.1002/mrm.1910370226; MCDONALD AJ, 1991, NEUROSCIENCE, V44, P1, DOI 10.1016/0306-4522(91)90247-L; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; Mori S, 2001, MAGN RESON MED, V46, P18, DOI 10.1002/mrm.1155; Morris PG, 1999, J PSYCHOPHARMACOL, V13, P330, DOI 10.1177/026988119901300403; Mundorf ML, 2001, J NEUROCHEM, V79, P130, DOI 10.1046/j.1471-4159.2001.00554.x; Murayama Y, 2006, MAGN RESON IMAGING, V24, P349, DOI 10.1016/j.mri.2005.12.031; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; NARITA K, 1990, BRAIN RES, V510, P289, DOI 10.1016/0006-8993(90)91379-U; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Papadakis NG, 1999, MAGN RESON IMAGING, V17, P881, DOI 10.1016/S0730-725X(99)00029-6; Pautler RG, 2003, MAGNET RESON MED, V50, P33, DOI 10.1002/mrm.10498; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Paxinos G., 2004, RAT NERVOUS SYSTEM, V3rd; Pfefferbaum A, 2000, ALCOHOL CLIN EXP RES, V24, P1214, DOI 10.1097/00000374-200008000-00012; Pouwels PJW, 1998, MAGN RESON MED, V39, P53, DOI 10.1002/mrm.1910390110; Ralph RJ, 2001, J NEUROSCI, V21, P305, DOI 10.1523/JNEUROSCI.21-01-00305.2001; Ratiney H, 2005, NMR BIOMED, V18, P1, DOI 10.1002/nbm.895; Robbins TW, 2002, NEUROBIOL LEARN MEM, V78, P625, DOI 10.1006/nlme.2002.4103; Rodriguiz RM, 2004, BEHAV BRAIN RES, V148, P185, DOI 10.1016/S0166-4328(03)00187-6; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Ross B, 2001, ANAT RECORD, V265, P54, DOI 10.1002/ar.1058; Rothman DL, 2003, ANNU REV PHYSIOL, V65, P401, DOI 10.1146/annurev.physiol.65.092101.142131; RUDIN M, 1995, EUR J PHARM SCI, V3, P255, DOI 10.1016/0928-0987(95)00012-3; Sanacora G, 1999, NEUROSCIENTIST, V5, P192, DOI 10.1177/107385849900500316; Satpute-Krishnan P, 2006, P NATL ACAD SCI USA, V103, P16532, DOI 10.1073/pnas.0607527103; Shattuck DW, 2001, IEEE T MED IMAGING, V20, P1167, DOI 10.1109/42.963819; Shen HW, 2004, NEUROPSYCHOPHARMACOL, V29, P1790, DOI 10.1038/sj.npp.1300476; SHINONAGA Y, 1994, NEUROSCIENCE, V58, P389, DOI 10.1016/0306-4522(94)90045-0; SIDHU A, 2003, DOPAMINE RECEPTORS T; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Snyder SH, 2006, NEURON, V49, P484, DOI 10.1016/j.neuron.2006.02.002; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sora I, 2001, P NATL ACAD SCI USA, V98, P5300, DOI 10.1073/pnas.091039298; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; Spanagel R, 2003, CLIN NEUROSCI RES, V3, P325, DOI 10.1016/S1566-2772(03)00094-X; Spring S, 2007, NEUROIMAGE, V35, P1424, DOI 10.1016/j.neuroimage.2007.02.023; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; Thanos PK, 2008, SYNAPSE, V62, P319, DOI 10.1002/syn.20503; Tkac I, 2004, MAGN RESON MED, V52, P478, DOI 10.1002/mrm.20184; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Toga A.W., 2002, BRAIN MAPPING METHOD; Trinh JV, 2003, NEUROSCIENCE, V118, P297, DOI 10.1016/S0306-4522(03)00165-9; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; Uhl GR, 2003, MOVEMENT DISORD, V18, pS71, DOI 10.1002/mds.10578; Van der Linden A, 2007, NMR BIOMED, V20, P522, DOI 10.1002/nbm.1131; van Eden CG, 2000, PROG BRAIN RES, V126, P49; vanDoorn A, 1996, EUR J MORPHOL, V34, P325, DOI 10.1076/ejom.34.4.325.13041; VanDoorn A, 1996, EUR J MORPHOL, V34, P5, DOI 10.1076/ejom.34.1.5.13156; Verma R, 2005, P NATL ACAD SCI USA, V102, P6978, DOI 10.1073/pnas.0407828102; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Watanabe T, 2001, MAGNET RESON MED, V46, P424, DOI 10.1002/mrm.1209; Wieshmann UC, 1999, MAGN RESON IMAGING, V17, P1269, DOI 10.1016/S0730-725X(99)00082-X; Wong JYF, 2003, EUR J PHARMACOL, V472, P39, DOI 10.1016/S0014-2999(03)01862-4; Yamashita M, 2006, NEUROPSYCHOPHARMACOL, V31, P2132, DOI 10.1038/sj.npp.1301009; Yavich L, 2007, J NEUROSCI, V27, P10196, DOI 10.1523/JNEUROSCI.0665-07.2007; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	129	49	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11506	10.1371/journal.pone.0011506	http://dx.doi.org/10.1371/journal.pone.0011506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634895	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000279715300017
J	Re, M; Pampillo, M; Savard, M; Dubuc, C; McArdle, CA; Millar, RP; Conn, PM; Gobeil, F; Bhattacharya, M; Babwah, AV				Re, Michelle; Pampillo, Macarena; Savard, Martin; Dubuc, Celena; McArdle, Craig A.; Millar, Robert P.; Conn, P. Michael; Gobeil, Fernand, Jr.; Bhattacharya, Moshmi; Babwah, Andy V.			The Human Gonadotropin Releasing Hormone Type I Receptor Is a Functional Intracellular GPCR Expressed on the Nuclear Membrane	PLOS ONE			English	Article							C-TERMINAL TAIL; PROSTAGLANDIN E-2 RECEPTORS; CELL-SURFACE EXPRESSION; HYPOGONADOTROPIC HYPOGONADISM; PHARMACOLOGICAL CHAPERONES; BETA-2-ADRENERGIC RECEPTOR; PROTEIN-KINASE; BREAST-CANCER; GNRH RECEPTOR; LOCALIZATION	The mammalian type I gonadotropin releasing hormone receptor (GnRH-R) is a structurally unique G protein-coupled receptor (GPCR) that lacks cytoplasmic tail sequences and displays inefficient plasma membrane expression (PME). Compared to its murine counterparts, the primate type I receptor is inefficiently folded and retained in the endoplasmic reticulum (ER) leading to a further reduction in PME. The decrease in PME and concomitant increase in intracellular localization of the mammalian GnRH-RI led us to characterize the spatial distribution of the human and mouse GnRH receptors in two human cell lines, HEK 293 and HTR-8/SVneo. In both human cell lines we found the receptors were expressed in the cytoplasm and were associated with the ER and nuclear membrane. A molecular analysis of the receptor protein sequence led us to identify a putative monopartite nuclear localization sequence (NLS) in the first intracellular loop of GnRH-RI. Surprisingly, however, neither the deletion of the NLS nor the addition of the Xenopus GnRH-R cytoplasmic tail sequences to the human receptor altered its spatial distribution. Finally, we demonstrate that GnRH treatment of nuclei isolated from HEK 293 cells expressing exogenous GnRH-RI triggers a significant increase in the acetylation and phosphorylation of histone H3, thereby revealing that the nuclear-localized receptor is functional. Based on our findings, we conclude that the mammalian GnRH-RI is an intracellular GPCR that is expressed on the nuclear membrane. This major and novel discovery causes us to reassess the signaling potential of this physiologically and clinically important receptor.	[Re, Michelle; Pampillo, Macarena; Babwah, Andy V.] Childrens Hlth Res Inst, London, ON, Canada; [Re, Michelle; Pampillo, Macarena; Babwah, Andy V.] Lawson Hlth Res Inst, London, ON, Canada; [Re, Michelle; Pampillo, Macarena; Babwah, Andy V.] Univ Western Ontario, Dept Obstet & Gynaecol, London, ON, Canada; [Re, Michelle; Bhattacharya, Moshmi; Babwah, Andy V.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Savard, Martin; Dubuc, Celena; Gobeil, Fernand, Jr.] Univ Sherbrooke, Dept Pharmacol, Sherbrooke, PQ J1K 2R1, Canada; [McArdle, Craig A.] Univ Bristol, Dept Clin Sci S Bristol, Labs Integrated Neurosci & Endocrinol, Bristol, Avon, England; [Millar, Robert P.] Queens Med Res Inst, MRC Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland; [Conn, P. Michael] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Sherbrooke; University of Bristol; University of Edinburgh; Oregon Health & Science University; Oregon National Primate Research Center	Re, M (corresponding author), Childrens Hlth Res Inst, London, ON, Canada.	Fernand.Gobeil@usherbrooke.ca; ababwah@uwo.ca	Millar, Robert P/A-4853-2012; McArdle, Craig/AAQ-5660-2021	McArdle, Craig/0000-0003-4836-5351; Millar, Robert P/0000-0003-3606-2708	Natural Sciences and Engineering Research Council of Canada (NSERC) [327334-2006]; Canadian Institute of Health Research (CIHR) [89832]; National Institutes of Health [HD-19899, RR-00163, HD-18185]; CIHR/CIHR's Institute of Gender and Health/Ontario Women's Health Council; NSERC University Faculty; Department of Obstetrics and Gynaecology, University of Western Ontario; Fonds de la recherche en sante du Quebec (FRSQ); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD018185, R37HD019899, R01HD019899, P30HD018185] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163, K01RR000163] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR/CIHR's Institute of Gender and Health/Ontario Women's Health Council(Canadian Institutes of Health Research (CIHR)); NSERC University Faculty(Natural Sciences and Engineering Research Council of Canada (NSERC)); Department of Obstetrics and Gynaecology, University of Western Ontario; Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Research reported in this study was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC, http://www.nserc-crsng.gc.ca) 327334-2006 (AVB), the Canadian Institute of Health Research (CIHR, http://www.cihr-irsc.gc.ca) MOP# 89832 (FG) and the National Institutes of Health (http://www.nih.gov) Grants HD-19899, RR-00163, and HD-18185 (PMC). The following are recipients of a salary award and studentships: Andy Babwah: CIHR/CIHR's Institute of Gender and Health/Ontario Women's Health Council New Investigator Award, Moshmi Bhattacharya: NSERC University Faculty Award and Michelle Re: Department of Obstetrics and Gynaecology, University of Western Ontario, Studentships. Martin Savard was supported by a fellowship award from the Fonds de la recherche en sante du Quebec (FRSQ, http://www.frsq.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARORA KK, 1995, J BIOL CHEM, V270, P22820, DOI 10.1074/jbc.270.39.22820; Babwah AV, 2003, J BIOL CHEM, V278, P5419, DOI 10.1074/jbc.M211053200; Bhattacharya M, 1998, P NATL ACAD SCI USA, V95, P15792, DOI 10.1073/pnas.95.26.15792; Bhattacharya M, 1999, J BIOL CHEM, V274, P15719, DOI 10.1074/jbc.274.22.15719; Bhattacharya M, 2004, J NEUROSCI, V24, P8752, DOI 10.1523/JNEUROSCI.3155-04.2004; Boivin B, 2003, J BIOL CHEM, V278, P29153, DOI 10.1074/jbc.M301738200; Brothers SP, 2006, J MOL ENDOCRINOL, V37, P479, DOI 10.1677/jme.1.02142; Brothers SP, 2003, J CLIN ENDOCR METAB, V88, P6107, DOI 10.1210/jc.2003-031047; Cao TT, 2005, MOL PHARMACOL, V67, P288, DOI 10.1124/mol.104.003608; Cavanagh PC, 2009, AM J PHYSIOL-CELL PH, V297, pC17, DOI 10.1152/ajpcell.00013.2009; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Chen R, 2000, AM J PHYSIOL-RENAL, V279, pF440, DOI 10.1152/ajprenal.2000.279.3.F440; Cheng KW, 2000, ENDOCRINOLOGY, V141, P2340, DOI 10.1210/en.141.7.2340; Chou CS, 2004, J CLIN ENDOCR METAB, V89, P1459, DOI 10.1210/jc.2003-031636; Cornea A, 2001, J BIOL CHEM, V276, P2153, DOI 10.1074/jbc.M007850200; EGGENA P, 1993, HYPERTENSION, V22, P496, DOI 10.1161/01.HYP.22.4.496; Finch AR, 2008, J ENDOCRINOL, V196, P353, DOI 10.1677/JOE-07-0471; Gardner LA, 2006, J BIOL CHEM, V281, P33537, DOI 10.1074/jbc.M601809200; Gobeil F, 2002, CIRC RES, V90, P682, DOI 10.1161/01.RES.0000013303.17964.7A; Gobeil F, 2006, CAN J PHYSIOL PHARM, V84, P287, DOI 10.1139/Y05-127; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Grosse R, 2000, J BIOL CHEM, V275, P9193, DOI 10.1074/jbc.275.13.9193; Hislop JN, 2005, J MOL ENDOCRINOL, V35, P177, DOI 10.1677/jme.1.01809; Janovick JA, 2006, J BIOL CHEM, V281, P8417, DOI 10.1074/jbc.M510601200; Janovick JA, 2003, ENDOCRINE, V22, P317, DOI 10.1385/ENDO:22:3:317; Janovick JA, 2003, J PHARMACOL EXP THER, V305, P608, DOI 10.1124/jpet.102.048454; Janovick JA, 2007, MOL CELL ENDOCRINOL, V272, P77, DOI 10.1016/j.mce.2007.04.012; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Jong YJI, 2007, J NEUROCHEM, V101, P458, DOI 10.1111/j.1471-4159.2006.04382.x; KAISER UB, 1994, GENOMICS, V20, P506, DOI 10.1006/geno.1994.1211; KAKAR SS, 1992, BIOCHEM BIOPH RES CO, V189, P289, DOI 10.1016/0006-291X(92)91556-6; Knollman PE, 2008, ARCH BIOCHEM BIOPHYS, V477, P92, DOI 10.1016/j.abb.2008.05.011; Leanos-Miranda A, 2005, J CLIN ENDOCR METAB, V90, P3001, DOI 10.1210/jc.2004-2071; Leanos-Miranda A, 2002, J CLIN ENDOCR METAB, V87, P4825, DOI 10.1210/jc.2002-020961; Lee DK, 2004, J BIOL CHEM, V279, P7901, DOI 10.1074/jbc.M306377200; Lu D, 1998, ENDOCRINOLOGY, V139, P365, DOI 10.1210/en.139.1.365; Mangia A, 2002, ONCOL REP, V9, P1127; Maudsley S, 2004, CANCER RES, V64, P7533, DOI 10.1158/0008-5472.CAN-04-1360; Maya-Nunez G, 2000, ENDOCRINE, V13, P401, DOI 10.1385/ENDO:13:3:401; Meethal SV, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-103; MILLAR RP, 1983, FEBS LETT, V153, P382, DOI 10.1016/0014-5793(83)80648-6; MOREL G, 1987, CELL TISSUE RES, V248, P541, DOI 10.1007/BF00216482; O'Malley KL, 2003, J BIOL CHEM, V278, P28210, DOI 10.1074/jbc.M300792200; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Petrovska R, 2005, BRIT J PHARMACOL, V144, P651, DOI 10.1038/sj.bjp.0706087; Pietila EM, 2005, J BIOL CHEM, V280, P26622, DOI 10.1074/jbc.M413815200; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Savard M, 2008, J CELL PHYSIOL, V216, P234, DOI 10.1002/jcp.21398; Sedgley KR, 2006, J ENDOCRINOL, V191, P625, DOI 10.1677/joe.1.07067; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; SZENDE B, 1994, RECEPTOR, V4, P201; Tetsuka M, 2004, ENDOCRINOLOGY, V145, P3712, DOI 10.1210/en.2003-1638; Uberti MA, 2005, J PHARMACOL EXP THER, V313, P16, DOI 10.1124/jpet.104.079541; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Venkatesan S, 2001, J BIOL CHEM, V276, P40133, DOI 10.1074/jbc.M105722200; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Watson PH, 2000, J BONE MINER RES, V15, P1033, DOI 10.1359/jbmr.2000.15.6.1033; Watson PH, 2000, BONE, V26, P221, DOI 10.1016/S8756-3282(99)00264-1	59	45	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11489	10.1371/journal.pone.0011489	http://dx.doi.org/10.1371/journal.pone.0011489			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628612	gold, Green Submitted, Green Published			2022-12-25	WOS:000279637100014
J	Nair, AK; Sugunan, D; Kumar, H; Anilkumar, G				Nair, Anup Kumar; Sugunan, Divya; Kumar, Harish; Anilkumar, Gopalakrishnapillai			Case-Control Analysis of SNPs in GLUT4, RBP4 and STRA6: Association of SNPs in STRA6 with Type 2 Diabetes in a South Indian Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION-FACTOR-7-LIKE-2 TCF7L2 GENE; INSULIN-RESISTANCE; SERUM RETINOL; RISK LOCI; SUSCEPTIBILITY; POLYMORPHISMS; VARIANTS; RETINOL-BINDING-PROTEIN-4; REPLICATION	Background: The inverse relationship between GLUT4 and RBP4 expression is known to play a role in the pathogenesis of type 2 diabetes. Elevated levels of RBP4 were shown to cause insulin resistance in muscles and liver. Identification of STRA6 as a cell surface receptor for RBP4 provides further link in this axis and hence we analyzed SNPs in these three genes for association with type 2 diabetes in a South Indian population. Methodology/Principal Findings: Selected SNPs in the three genes were analyzed in a total of 2002 individuals belonging to Dravidian ethnicity, South India, by Tetra Primer ARMS PCR or RFLP PCR. Allele frequencies and genotype distribution were calculated in cases and controls and were analyzed for association by Chi-squared test and Logistic regression. Haplotype analysis was carried out for each gene by including all the markers in a single block. We observed a significant association of three SNPs, rs974456, rs736118, and rs4886578 in STRA6 with type 2 diabetes (P = 0.001, OR 0.79[0.69-0.91], P = 0.003, OR 0.81[0.71-0.93], and P = 0.001, OR 0.74[0.62-0.89] respectively). None of the SNPs in RBP4 and GLUT4 showed any association with type 2 diabetes. Haplotype analysis revealed that two common haplotypes H1 (111, P = 0.001, OR 1.23[1.08-1.40]) and H2 (222, P = 0.002 OR 0.73[0.59-0.89]) in STRA6, H6 (2121, P = 0.006, OR 1.69[1.51-2.48]) in RBP4 and H4 (2121, P = 0.01 OR 1.41[1.07-1.85]) in GLUT4 were associated with type 2 diabetes. Conclusion: SNPs in STRA6, gene coding the cell surface receptor for RBP4, were significantly associated with type 2 diabetes and further genetic and functional studies are required to understand and ascertain its role in the manifestation of type 2 diabetes.	[Nair, Anup Kumar; Sugunan, Divya; Anilkumar, Gopalakrishnapillai] Amrita Vishwa Vidyapeetham, Amrita Sch Biotechnol, Kollam, Kerala, India; [Kumar, Harish] Amrita Vishwa Vidyapeetham, Amrita Inst Med Sci, Kochi, Kerala, India	Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Amritapuri; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi	Nair, AK (corresponding author), Amrita Vishwa Vidyapeetham, Amrita Sch Biotechnol, Kollam, Kerala, India.	ammasanil@am.amrita.edu	Nair, Anup K/AAE-5957-2021; gopala, Anilkumar/AAG-2713-2021	Nair, Anup/0000-0002-0424-1616; Gopalakrishnapillai, Anilkumar/0000-0002-0465-578X	Department of Science and Technology, Govt. of India [SR/SO/HS-0008/2008]; CSIR	Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Department of Science and Technology, Govt. of India, with a funding number SR/SO/HS-0008/2008. CSIR fellowship to AKN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Aeberli I, 2007, J CLIN ENDOCR METAB, V92, P4359, DOI 10.1210/jc.2007-0468; BARONI MG, 1992, HUM GENET, V88, P557, DOI 10.1007/BF00219344; Bendahhou S, 2003, J BIOL CHEM, V278, P51779, DOI 10.1074/jbc.M310278200; CHOI WH, 1991, DIABETES, V40, P1712, DOI 10.2337/diabetes.40.12.1712; CONSOLI A, 1992, DIABETES CARE, V15, P430, DOI 10.2337/diacare.15.3.430; Damcott CM, 2006, DIABETES, V55, P2654, DOI 10.2337/db06-0338; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Hu C, 2008, DIABETIC MED, V25, P11, DOI 10.1111/j.1464-5491.2007.02314.x; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kovacs P, 2007, DIABETES, V56, P3095, DOI 10.2337/db06-1647; Li ZZ, 2010, J INT MED RES, V38, P95, DOI 10.1177/147323001003800111; Ma DH, 2007, J BIOL CHEM, V282, P5781, DOI 10.1074/jbc.M608776200; MATSUTANI A, 1990, DIABETES, V39, P1534, DOI 10.2337/diabetes.39.12.1534; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mohan V, 2007, INDIAN J MED RES, V125, P217; Munkhtulga L, 2007, HUM GENET, V120, P879, DOI 10.1007/s00439-006-0264-4; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; ORAHILLY S, 1992, DIABETOLOGIA, V35, P486, DOI 10.1007/BF02342449; Pontiroli AE, 1996, ACTA DIABETOL, V33, P193; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scott LJ, 2006, DIABETES, V55, P2649, DOI 10.2337/db06-0341; SHEA JL, 2009, OBESITY SIL IN PRESS; Szeto W, 2001, CANCER RES, V61, P4197; Takebayashi K, 2007, J CLIN ENDOCR METAB, V92, P2712, DOI 10.1210/jc.2006-1249; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Wang GJ, 2006, PHARMACOGENOMICS, V7, P203, DOI 10.2217/14622416.7.2.203; White T, 2008, MOL VIS, V14, P2458; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang CL, 2006, DIABETES, V55, P2645, DOI 10.2337/db06-0643	41	39	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11444	10.1371/journal.pone.0011444	http://dx.doi.org/10.1371/journal.pone.0011444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625434	Green Published, Green Submitted, gold			2022-12-25	WOS:000279522500011
J	Schreiber, HA; Hulseberg, PD; Lee, J; Prechl, J; Barta, P; Szlavik, N; Harding, JS; Fabry, Z; Sandor, M				Schreiber, Heidi A.; Hulseberg, Paul D.; Lee, JangEun; Prechl, Jozsef; Barta, Peter; Szlavik, Nora; Harding, Jeffrey S.; Fabry, Zsuzsanna; Sandor, Matyas			Dendritic Cells in Chronic Mycobacterial Granulomas Restrict Local Anti-Bacterial T Cell Response in a Murine Model	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; TUBERCULOSIS SECRETORY ANTIGEN; PROGRAMMED DEATH-1 LIGANDS; INDUCED LIVER GRANULOMAS; CYTOKINE PRODUCTION; INTERFERON-GAMMA; IMMUNE-RESPONSE; IN-VITRO; INTRACELLULAR SURVIVAL; PULMONARY GRANULOMA	Background: Mycobacterium-induced granulomas are the interface between bacteria and host immune response. During acute infection dendritic cells (DCs) are critical for mycobacterial dissemination and activation of protective T cells. However, their role during chronic infection in the granuloma is poorly understood. Methodology/Principal Findings: We report that an inflammatory subset of murine DCs are present in granulomas induced by Mycobacteria bovis strain Bacillus Calmette-guerin (BCG), and both their location in granulomas and costimulatory molecule expression changes throughout infection. By flow cytometric analysis, we found that CD11c(+) cells in chronic granulomas had lower expression of MHCII and co-stimulatory molecules CD40, CD80 and CD86, and higher expression of inhibitory molecules PD-L1 and PD-L2 compared to CD11c(+) cells from acute granulomas. As a consequence of their phenotype, CD11c(+) cells from chronic lesions were unable to support the reactivation of newly-recruited, antigen 85B-specific CD4(+)IFN gamma T+ cells or induce an IFN gamma response from naive T cells in vivo and ex vivo. The mechanism of this inhibition involves the PD-1:PD-L signaling pathway, as ex vivo blockade of PD-L1 and PD-L2 restored the ability of isolated CD11c(+) cells from chronic lesions to stimulate a protective IFN gamma T cell response. Conclusions/Significance: Our data suggest that DCs in chronic lesions may facilitate latent infection by down-regulating protective T cell responses, ultimately acting as a shield that promotes mycobacterium survival. This DC shield may explain why mycobacteria are adapted for long-term survival in granulomatous lesions.	[Schreiber, Heidi A.; Hulseberg, Paul D.; Lee, JangEun; Prechl, Jozsef; Harding, Jeffrey S.; Fabry, Zsuzsanna; Sandor, Matyas] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Schreiber, Heidi A.; Hulseberg, Paul D.; Harding, Jeffrey S.; Fabry, Zsuzsanna; Sandor, Matyas] Univ Wisconsin, Cellular & Mol Pathol Training Program, Madison, WI USA; [Barta, Peter] Semmelweis Univ, Dept Pulmonol, H-1085 Budapest, Hungary; [Szlavik, Nora] Hosp Bajcsy Zsilinszky, Budapest, Hungary	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Semmelweis University	Schreiber, HA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53706 USA.	msandor@wisc.edu	Prechl, József/B-2094-2009	Prechl, József/0000-0003-3859-4353	National Institutes of Health [R01-A1048087, R21-A1072638]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS037570, R01NS037570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health funding R01-A1048087 and R21-A1072638 (M. Sandor). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson KL, 2008, J IMMUNOL, V180, P2981, DOI 10.4049/jimmunol.180.5.2981; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bodnar KA, 2001, INFECT IMMUN, V69, P800, DOI 10.1128/IAI.69.2.800-809.2001; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Buettner M, 2005, J IMMUNOL, V174, P4203, DOI 10.4049/jimmunol.174.7.4203; Cai GF, 2004, CELL IMMUNOL, V230, P89, DOI 10.1016/j.cellimm.2004.09.004; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Cheadle EJ, 2003, IMMUNOLOGY, V108, P79, DOI 10.1046/j.1365-2567.2003.01543.x; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chiu BC, 2004, AM J PATHOL, V164, P1021, DOI 10.1016/S0002-9440(10)63189-6; Co DO, 2004, CLIN IMMUNOL, V113, P130, DOI 10.1016/j.clim.2004.08.012; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Emile JF, 1997, J PATHOL, V181, P25, DOI 10.1002/(SICI)1096-9896(199701)181:1<25::AID-PATH747>3.0.CO;2-Z; Ernst JD, 2007, J CLIN INVEST, V117, P1738, DOI 10.1172/JCI31810; ETCHECHOURY I, 2009, ZOONOSES PUBLIC HLTH; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Fortsch D, 2000, J IMMUNOL, V165, P978, DOI 10.4049/jimmunol.165.2.978; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Gonzalez-Juarrero M, 2001, INFECT IMMUN, V69, P1127, DOI 10.1128/IAI.69.2.1127-1133.2001; GRANGE JM, 1994, EUR RESPIR J, V7, P1564, DOI 10.1183/09031936.94.07091564; Gu T, 2008, CELL MOL IMMUNOL, V5, P33, DOI 10.1038/cmi.2008.4; Hanekom WA, 2003, J INFECT DIS, V188, P257, DOI 10.1086/376451; Havlir DV, 1999, NEW ENGL J MED, V340, P367, DOI 10.1056/NEJM199902043400507; Heninger E, 2006, J IMMUNOL, V177, P3303, DOI 10.4049/jimmunol.177.5.3303; Hickman SP, 2002, J IMMUNOL, V168, P4636, DOI 10.4049/jimmunol.168.9.4636; Hingley-Wilson SM, 2003, NAT IMMUNOL, V4, P949, DOI 10.1038/ni981; Hlavsa MC, 2008, CLIN INFECT DIS, V47, P168, DOI 10.1086/589240; Hogan LH, 2001, J IMMUNOL, V166, P6367, DOI 10.4049/jimmunol.166.10.6367; Humphreys IR, 2006, MICROBES INFECT, V8, P1339, DOI 10.1016/j.micinf.2005.12.023; Inman BA, 2007, CANCER-AM CANCER SOC, V109, P1499, DOI 10.1002/cncr.22588; Jiao XN, 2002, J IMMUNOL, V168, P1294, DOI 10.4049/jimmunol.168.3.1294; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Lagranderie M, 2003, IMMUNOLOGY, V108, P352, DOI 10.1046/j.1365-2567.2003.01609.x; Larsen JM, 2007, IMMUNOLOGY, V121, P276, DOI 10.1111/j.1365-2567.2007.02575.x; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Leon B, 2005, SEMIN IMMUNOL, V17, P313, DOI 10.1016/j.smim.2005.05.013; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Ling CY, 2006, J NEUROSCI, V26, P731, DOI 10.1523/JNEUROSCI.3502-05.2006; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Loke P, 2003, P NATL ACAD SCI USA, V100, P5336, DOI 10.1073/pnas.0931259100; Mariotti S, 2002, EUR J IMMUNOL, V32, P3050, DOI 10.1002/1521-4141(200211)32:11<3050::AID-IMMU3050>3.0.CO;2-K; Martino A, 2004, J LEUKOCYTE BIOL, V76, P827, DOI 10.1189/jlb.0703313; McLean GR, 2000, MOL IMMUNOL, V37, P837, DOI 10.1016/S0161-5890(00)00101-2; Meier A, 2008, AIDS, V22, P655, DOI 10.1097/QAD.0b013e3282f4de23; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Mohagheghpour N, 2000, INFECT IMMUN, V68, P5824, DOI 10.1128/IAI.68.10.5824-5829.2000; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Motta A, 2007, IMMUNOLOGY, V121, P462, DOI 10.1111/j.1365-2567.2007.02564.x; Natarajan K, 2003, J INFECT DIS, V187, P914, DOI 10.1086/368173; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Ojo O, 2008, EMERG INFECT DIS, V14, P1931, DOI 10.3201/eid1412.071135; ORME IM, 1987, J IMMUNOL, V138, P293; Popov A, 2008, J MOL MED, V86, P145, DOI 10.1007/s00109-007-0262-6; Rejic R, 2005, TUBERCULOSIS, V85, P81, DOI 10.1016/j.tube.2004.09.006; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; ROCHE PW, 1995, TRENDS MICROBIOL, V3, P397, DOI 10.1016/S0966-842X(00)88986-6; Rodwell TC, 2008, EMERG INFECT DIS, V14, P909, DOI 10.3201/eid1406.071485; Sacco Randy E., 1996, Methods (Orlando), V9, P215, DOI 10.1006/meth.1996.0028; Salam N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002869; SANDOR M, 1995, J IMMUNOL, V155, P275; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Saunders PA, 2005, EUR J IMMUNOL, V35, P3561, DOI 10.1002/eji.200526347; Scanga CA, 2000, J EXP MED, V192, P347, DOI 10.1084/jem.192.3.347; SCHREIBER HA, 2009, IMMUNOL LETT; Sinha A, 2006, J IMMUNOL, V177, P468, DOI 10.4049/jimmunol.177.1.468; Sunder S, 2009, J CLIN MICROBIOL, V47, P1249, DOI 10.1128/JCM.02042-08; Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939; Toussirot E, 2004, EXPERT OPIN PHARMACO, V5, P581, DOI 10.1517/14656566.5.3.581; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Tsuchiya T, 2002, AM J RESP CRIT CARE, V165, P1640, DOI 10.1164/rccm.2110086; Uehira K, 2002, CLIN IMMUNOL, V105, P296, DOI 10.1006/clim.2002.5287; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538	84	38	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11453	10.1371/journal.pone.0011453	http://dx.doi.org/10.1371/journal.pone.0011453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625513	Green Published, gold, Green Submitted			2022-12-25	WOS:000279522500019
J	Sindhava, V; Woodman, ME; Stevenson, B; Bondada, S				Sindhava, Vishal; Woodman, Michael E.; Stevenson, Brian; Bondada, Subbarao			Interleukin-10 Mediated Autoregulation of Murine B-1 B-Cells and Its Role in Borrelia hermsii Infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; FACTOR-KAPPA-B; IMMUNE-RESPONSES; MARGINAL ZONE; T-CELLS; IL-10; PROLIFERATION; EXPRESSION; ANTIGEN; IGM	B cells are typically characterized as positive regulators of the immune response, primarily by producing antibodies. However, recent studies indicate that various subsets of B cells can perform regulatory functions mainly through IL-10 secretion. Here we discovered that peritoneal B-1 (B-1P) cells produce high levels of IL-10 upon stimulation with several Toll-like receptor (TLR) ligands. High levels of IL-10 suppressed B-1P cell proliferation and differentiation response to all TLR ligands studied in an autocrine manner in vitro and in vivo. IL-10 that accumulated in cultures inhibited B-1P cells at second and subsequent cell divisions mainly at the G1/S interphase. IL-10 inhibits TLR induced B-1P cell activation by blocking the classical NF-kappa B pathway. Co-stimulation with CD40 or BAFF abrogated the IL-10 inhibitory effect on B-1P cells during TLR stimulation. Finally, B-1P cells adoptively transferred from the peritoneal cavity of IL-10(-/-) mice showed better clearance of Borrelia hermsii than wild-type B-1P cells. This study described a novel autoregulatory property of B-1P cells mediated by B-1P cell derived IL-10, which may affect the function of B-1P cells in infection and autoimmunity.	[Sindhava, Vishal; Woodman, Michael E.; Stevenson, Brian; Bondada, Subbarao] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA; [Sindhava, Vishal; Bondada, Subbarao] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY USA	University of Kentucky; University of Kentucky	Sindhava, V (corresponding author), Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA.	bondada@uky.edu			National Institutes of Health (NIH) [CA09357, AI076956]; University of Kentucky College of Medicine; University of Kentucky; NATIONAL CANCER INSTITUTE [T32CA009357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076956] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kentucky College of Medicine; University of Kentucky; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were funded by National Institutes of Health (NIH) grants CA09357, AI076956 and funds from the vice president for research at the University of Kentucky to S. Bondada and exploratory funds from the University of Kentucky College of Medicine to Brian Stevenson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alugupalli KR, 2007, J IMMUNOL, V178, P3740, DOI 10.4049/jimmunol.178.6.3740; Alugupalli KR, 2003, J IMMUNOL, V170, P3819, DOI 10.4049/jimmunol.170.7.3819; Amano M, 1998, J IMMUNOL, V161, P1710; ARNOLD LW, 1994, J EXP MED, V179, P1585, DOI 10.1084/jem.179.5.1585; Baumann M, 2000, MACROMOL MATER ENG, V280, P1, DOI 10.1002/1439-2054(20000801)280:1<1::AID-MAME1>3.0.CO;2-U; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; Blenman KRM, 2006, LAB INVEST, V86, P1136, DOI 10.1038/labinvest.3700468; Bolz DD, 2006, INFECT IMMUN, V74, P6750, DOI 10.1128/IAI.01160-06; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Chumley MJ, 2002, J IMMUNOL, V169, P1735, DOI 10.4049/jimmunol.169.4.1735; Cole LE, 2009, P NATL ACAD SCI USA, V106, P4343, DOI 10.1073/pnas.0813411106; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Dasu T, 2009, MOL IMMUNOL, V46, P2655, DOI 10.1016/j.molimm.2009.04.015; Driessler F, 2004, CLIN EXP IMMUNOL, V135, P64, DOI 10.1111/j.1365-2249.2004.02342.x; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Fischer Helene, 2001, BMC Physiology, V1, P1, DOI 10.1186/1472-6793-1-1; GarciaMonco JC, 1997, J INFECT DIS, V175, P1243, DOI 10.1086/593681; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Goetz M, 2007, INFLAMM BOWEL DIS, V13, P1365, DOI 10.1002/ibd.20215; Goodnow CC, 2007, CELL, V130, P25, DOI 10.1016/j.cell.2007.06.033; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Gururajan M, 2008, J IMMUNOL, V181, P4590, DOI 10.4049/jimmunol.181.7.4590; Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; HARDY RR, 1987, SCIENCE, V236, P81, DOI 10.1126/science.3105057; Lazarus JJ, 2006, J IMMUNOL, V177, P7076, DOI 10.4049/jimmunol.177.10.7076; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; LIN TZ, 1992, CLIN IMMUNOL IMMUNOP, V65, P10, DOI 10.1016/0090-1229(92)90242-G; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Marcelletti JF, 1996, J IMMUNOL, V157, P3323; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Montecino-Rodriguez E, 2006, TRENDS IMMUNOL, V27, P428, DOI 10.1016/j.it.2006.07.005; Moon BG, 2004, J IMMUNOL, V172, P6020, DOI 10.4049/jimmunol.172.10.6020; MORRIS DL, 1993, J EXP MED, V177, P857, DOI 10.1084/jem.177.3.857; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Neumann M, 1996, J IMMUNOL, V157, P4862; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; PALM NW, 2009, P NATL ACAD SCI US; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Perrin GQ, 1999, BLOOD, V93, P208, DOI 10.1182/blood.V93.1.208.401k06_208_216; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Rosado MM, 2009, MUCOSAL IMMUNOL, V2, P351, DOI 10.1038/mi.2009.15; ROTHSTEIN TL, 1988, J IMMUNOL, V140, P2880; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schottelius AJG, 1999, J BIOL CHEM, V274, P31868, DOI 10.1074/jbc.274.45.31868; Sen G, 2002, MOL IMMUNOL, V39, P57, DOI 10.1016/S0161-5890(02)00047-0; Shames BD, 1998, SHOCK, V10, P389, DOI 10.1097/00024382-199812000-00002; Shimomura Y, 2008, INT IMMUNOL, V20, P729, DOI 10.1093/intimm/dxn031; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Stoermann B, 2007, EUR J IMMUNOL, V37, P1613, DOI 10.1002/eji.200636640; Tangye SG, 1998, LEUKEMIA LYMPHOMA, V31, P121, DOI 10.3109/10428199809057592; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Wong SC, 2002, J BIOL CHEM, V277, P30707, DOI 10.1074/jbc.M202460200; Woodman ME, 2009, J LEUKOCYTE BIOL, V86, P727, DOI 10.1189/jlb.0309169; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	58	39	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11445	10.1371/journal.pone.0011445	http://dx.doi.org/10.1371/journal.pone.0011445			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625435	Green Published, gold, Green Submitted			2022-12-25	WOS:000279522500012
J	Guendel, I; Carpio, L; Pedati, C; Schwartz, A; Teal, C; Kashanchi, F; Kehn-Hall, K				Guendel, Irene; Carpio, Lawrence; Pedati, Caitlin; Schwartz, Arnold; Teal, Christine; Kashanchi, Fatah; Kehn-Hall, Kylene			Methylation of the Tumor Suppressor Protein, BRCA1, Influences Its Transcriptional Cofactor Function	PLOS ONE			English	Article							RNA-POLYMERASE-II; DNA-DAMAGE RESPONSE; BREAST-CANCER CELLS; ARGININE METHYLATION; IN-VIVO; SACCHAROMYCES-CEREVISIAE; SIGNAL TRANSDUCER; GENE-EXPRESSION; NUCLEAR EXPORT; PRMT1	Background: Approximately half of hereditary breast cancers have mutations in either BRCA1 or BRCA2. BRCA1 is a multifaceted tumor suppressor protein that has implications in processes such as cell cycle, transcription, DNA damage response and chromatin remodeling. This multifunctional nature of BRCA1 is achieved by exerting its many effects through modulation of transcription. Many cellular events are dictated by covalent modification of proteins, an important mechanism in regulating protein and genome function; of which protein methylation is an important posttranslational modification with activating or repressive effects. Methods/Principal Findings: Here we demonstrate for the first time that BRCA1 is methylated both in breast cancer cell lines and breast cancer tumor samples at arginine and lysine residues through immunoprecipitation and western blot analysis. Arginine methylation by PRMT1 was observed in vitro and the region of BRCA1 504-802 shown to be highly methylated. PRMT1 was detected in complex with BRCA1 504-802 through in vitro binding assays and co-immunoprecipitated with BRCA1. Inhibition of methylation resulted in decreased BRCA1 methylation and alteration of BRCA1 binding to promoters in vivo as shown through chromatin immunoprecipitation assays. Knockdown of PRMT1 also resulted in increased BRCA1 binding to particular promoters in vivo. Finally, following methylation inhibition, Sp1 was found to preferentially associate with hypo-methylated BRCA1 and STAT1 was found to preferentially associate with hyper-methylated BRCA1. Conclusions/Significance: These results suggest that methylation may influence either the ability of BRCA1 to bind to specific promoters or protein-protein interactions which alters the recruitment of BRCA1 to these promoters. Thus, given the importance of BRCA1 to genomic stability, methylation of BRCA1 may ultimately affect the tumor suppressor ability of BRCA1.	[Guendel, Irene; Carpio, Lawrence; Pedati, Caitlin; Kashanchi, Fatah] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Schwartz, Arnold] George Washington Univ, Med Ctr, Dept Pathol, Washington, DC 20037 USA; [Teal, Christine] George Washington Univ, Med Ctr, Breast Care Ctr, Washington, DC 20037 USA; [Guendel, Irene; Carpio, Lawrence; Kashanchi, Fatah; Kehn-Hall, Kylene] George Mason Univ, Dept Mol & Microbiol, Natl Ctr Biodef & Infect Dis, Manassas, VA USA	George Washington University; George Washington University; George Washington University; George Mason University	Guendel, I (corresponding author), George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA.	kkehnhal@gmu.edu	Kehn-Hall, Kylene/I-5752-2013	Kehn-Hall, Kylene/0000-0001-8036-7213	George Washington University's Cancer Institute	George Washington University's Cancer Institute	This work was supported by an American Cancer Society Seed Grant from The George Washington University's Cancer Institute to KKH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch S, 2003, FEBS LETT, V541, P149, DOI 10.1016/S0014-5793(03)00315-6; AKIYAMA K, 1994, BBA-GENE STRUCT EXPR, V1219, P15, DOI 10.1016/0167-4781(94)90241-0; Altiok S, 1999, J BIOL CHEM, V274, P32274, DOI 10.1074/jbc.274.45.32274; Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; ARTEAGA CL, 1993, J CELL BIOCHEM, P187; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Boisvert FM, 2005, GENE DEV, V19, P671, DOI 10.1101/gad.1279805; Boisvert FM, 2005, CELL CYCLE, V4, P1834, DOI 10.4161/cc.4.12.2250; Cable PL, 2003, MOL CARCINOGEN, V38, P85, DOI 10.1002/mc.10148; Chen CF, 1996, J BIOL CHEM, V271, P32863, DOI 10.1074/jbc.271.51.32863; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen DH, 2004, J BIOCHEM, V136, P371, DOI 10.1093/jb/mvh131; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Feng ZH, 2004, J BIOL CHEM, V279, P28574, DOI 10.1074/jbc.M404137200; Fung H, 2001, J BIOL CHEM, V276, P42011, DOI 10.1074/jbc.M106423200; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; Gatei M, 2000, CANCER RES, V60, P3299; Gatei M, 2001, J BIOL CHEM, V276, P17276, DOI 10.1074/jbc.M011681200; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Herrmann F, 2005, J BIOL CHEM, V280, P38005, DOI 10.1074/jbc.M502458200; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Herrmann F, 2009, GENES CELLS, V14, P309, DOI 10.1111/j.1365-2443.2008.01266.x; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Ikeda S, 2002, BIOCHEM BIOPH RES CO, V296, P785, DOI 10.1016/S0006-291X(02)00939-7; Jin SQ, 2000, ONCOGENE, V19, P4050, DOI 10.1038/sj.onc.1203759; KAKIMOTO Y, 1970, J BIOL CHEM, V245, P5751; KAKIMOTO Y, 1971, BIOCHIM BIOPHYS ACTA, V243, P31, DOI 10.1016/0005-2795(71)90033-X; Kehn K, 2007, ONCOGENE, V26, P5060, DOI 10.1038/sj.onc.1210319; Krum SA, 2003, J BIOL CHEM, V278, P52012, DOI 10.1074/jbc.M308418200; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Lee HM, 2000, EUR J BIOCHEM, V267, P591, DOI 10.1046/j.1432-1327.2000.01043.x; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Man S, 2007, CANCER METAST REV, V26, P737, DOI 10.1007/s10555-007-9087-6; Maor S, 2007, HORM METAB RES, V39, P179, DOI 10.1055/s-2007-970415; Maor SB, 2000, MOL GENET METAB, V69, P130, DOI 10.1006/mgme.1999.2958; Maor S, 2007, CANCER LETT, V257, P236, DOI 10.1016/j.canlet.2007.07.019; Mark WY, 2005, J MOL BIOL, V345, P275, DOI 10.1016/j.jmb.2004.10.045; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Ouchi T, 2000, P NATL ACAD SCI USA, V97, P5208, DOI 10.1073/pnas.080469697; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Pahlich S, 2005, PROTEINS, V61, P164, DOI 10.1002/prot.20579; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; PAIK WK, 1967, BIOCHEM BIOPH RES CO, V29, P14, DOI 10.1016/0006-291X(67)90533-5; Pao GM, 2000, P NATL ACAD SCI USA, V97, P1020, DOI 10.1073/pnas.97.3.1020; Parvin JD, 2009, ENVIRON MOL MUTAGEN, V50, P649, DOI 10.1002/em.20475; Paull TT, 2001, P NATL ACAD SCI USA, V98, P6086, DOI 10.1073/pnas.111125998; Rezai-Zadeh N, 2003, GENE DEV, V17, P1019, DOI 10.1101/gad.1068003; Rodriguez JA, 2000, J BIOL CHEM, V275, P38589, DOI 10.1074/jbc.M003851200; Rosen EM, 2003, J CELL PHYSIOL, V196, P19, DOI 10.1002/jcp.10257; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Smith JJ, 1999, J BIOL CHEM, V274, P13229, DOI 10.1074/jbc.274.19.13229; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Williamson EA, 2002, ONCOGENE, V21, P3199, DOI 10.1038/sj.onc.1205461; Wilson CA, 1997, ONCOGENE, V14, P1, DOI 10.1038/sj.onc.1200924; Wilson DM, 1997, P NATL ACAD SCI USA, V94, P12754, DOI 10.1073/pnas.94.24.12754; Wooderchak WL, 2008, BIOCHEMISTRY-US, V47, P9456, DOI 10.1021/bi800984s; Yu MC, 2004, GENE DEV, V18, P2024, DOI 10.1101/gad.1223204; Yun CY, 2000, J CELL BIOL, V150, P707, DOI 10.1083/jcb.150.4.707; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	76	58	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11379	10.1371/journal.pone.0011379	http://dx.doi.org/10.1371/journal.pone.0011379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20614009	Green Submitted, Green Published, gold			2022-12-25	WOS:000279369900025
J	Schmitt, MW; Venkatesan, RN; Pillaire, MJ; Hoffmann, JS; Sidorova, JM; Loeb, LA				Schmitt, Michael W.; Venkatesan, Ranga N.; Pillaire, Marie-Jeanne; Hoffmann, Jean-Sebastien; Sidorova, Julia M.; Loeb, Lawrence A.			Active Site Mutations in Mammalian DNA Polymerase delta Alter Accuracy and Replication Fork Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; ESCHERICHIA-COLI; AMINO-ACID; MISMATCH REPAIR; CANCER GENOME; FIDELITY; MUTATOR; MICE; EXONUCLEASE; PROCESSIVITY	DNA polymerase delta (pol delta) is one of the two main replicative polymerases in eukaryotes; it synthesizes the lagging DNA strand and also functions in DNA repair. In previous work, we demonstrated that heterozygous expression of the pol delta L604G variant in mice results in normal life span and no apparent phenotype, whereas a different substitution at the same position, L604K, is associated with shortened life span and accelerated carcinogenesis. Here, we report in vitro analysis of the homologous mutations at position Leu-606 in human pol delta. Four-subunit human pol delta variants that harbor or lack 3' -> 5'-exonucleolytic proofreading activity were purified from Escherichia coli. The pol delta L606G and L606K holoenzymes retain catalytic activity and processivity similar to that of wild type pol delta. pol delta L606G is highly error prone, incorporating single noncomplementary nucleotides at a high frequency during DNA synthesis, whereas pol delta L606K is extremely accurate, with a higher fidelity of single nucleotide incorporation by the active site than that of wild type pol delta. However, pol delta L606K is impaired in the bypass of DNA adducts, and the homologous variant in mouse embryonic fibroblasts results in a decreased rate of replication fork progression in vivo. These results indicate that different substitutions at a single active site residue in a eukaryotic polymerase can either increase or decrease the accuracy of synthesis relative to wild type and suggest that enhanced fidelity of base selection by a polymerase active site can result in impaired lesion bypass and delayed replication fork progression.	[Loeb, Lawrence A.] Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA; [Venkatesan, Ranga N.; Sidorova, Julia M.; Loeb, Lawrence A.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Pillaire, Marie-Jeanne; Hoffmann, Jean-Sebastien] CNRS, Inst Pharmacol & Struct Biol, Genet Instabil & Canc Grp, F-31077 Toulouse, France; [Pillaire, Marie-Jeanne; Hoffmann, Jean-Sebastien] Univ Toulouse, F-31077 Toulouse, France	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse	Loeb, LA (corresponding author), Univ Washington, Sch Med, Dept Biochem, Box 357705, Seattle, WA 98195 USA.	laloeb@u.washington.edu	Hoffmann, Jean-Sebastien/O-9183-2014; Pillaire, Marie-Jeanne/P-1579-2014	Hoffmann, Jean-Sebastien/0000-0003-2222-354X; Pillaire, Marie-Jeanne/0000-0001-6866-7416; Sidorova, Julia/0000-0001-5502-4323	National Institutes of Health [R01 CA102029, R01 CA115802, P01 CA077852, F30 AG030314, T32 GM007266]; NATIONAL CANCER INSTITUTE [R01CA102029, P01CA077852, R01CA115802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG030314] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA102029, R01 CA115802, and P01 CA077852 (to L. A. L.) and F30 AG030314 and T32 GM007266 (to M. W. S.).	Albertson TM, 2009, P NATL ACAD SCI USA, V106, P17101, DOI 10.1073/pnas.0907147106; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Beard WA, 2003, STRUCTURE, V11, P489, DOI 10.1016/S0969-2126(03)00051-0; Bebenek K, 1995, METHOD ENZYMOL, V262, P217; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Beckman RA, 2006, P NATL ACAD SCI USA, V103, P14140, DOI 10.1073/pnas.0606271103; Bielas JH, 2007, TRENDS GENET, V23, P154, DOI 10.1016/j.tig.2007.02.009; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Conti C, 2007, MOL BIOL CELL, V18, P3059, DOI 10.1091/mbc.E06-08-0689; Creighton S, 1995, METHOD ENZYMOL, V262, P232; ECKERT KA, 1993, J BIOL CHEM, V268, P13462; Fazlieva R, 2009, NUCLEIC ACIDS RES, V37, P2854, DOI 10.1093/nar/gkp155; Floyd RA, 1995, THE OXYGEN PARADOX, P89; Fox EJ, 2009, CANCER RES, V69, P4948, DOI 10.1158/0008-5472.CAN-09-1231; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Goldsby RE, 2002, P NATL ACAD SCI USA, V99, P15560, DOI 10.1073/pnas.232340999; Greaves LC, 2009, BBA-GEN SUBJECTS, V1790, P1015, DOI 10.1016/j.bbagen.2009.04.018; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jin YH, 2005, MOL CELL BIOL, V25, P461, DOI 10.1128/MCB.25.1.461-471.2005; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; LOEB LA, 1974, CANCER RES, V34, P2311; Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345; Loh E, 2007, J BIOL CHEM, V282, P12201, DOI 10.1074/jbc.M611294200; Loh E, 2010, P NATL ACAD SCI USA, V107, P1154, DOI 10.1073/pnas.0912451107; Lu XQ, 2002, J BIOL CHEM, V277, P24340, DOI 10.1074/jbc.M200065200; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; MAKI H, 1985, J BIOL CHEM, V260, P2987; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; McElhinny SAN, 2007, J BIOL CHEM, V282, P2324, DOI 10.1074/jbc.M609591200; Meira LB, 2009, P NATL ACAD SCI USA, V106, P888, DOI 10.1073/pnas.0807030106; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Patel PH, 2001, J BIOL CHEM, V276, P5044, DOI 10.1074/jbc.M008701200; Pillaire MJ, 2007, CELL CYCLE, V6, P471, DOI 10.4161/cc.6.4.3857; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Schmitt MW, 2009, BIOCHIMIE, V91, P1163, DOI 10.1016/j.biochi.2009.06.007; Shah SN, 2010, NUCLEIC ACIDS RES, V38, P1149, DOI 10.1093/nar/gkp1131; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; Shinkai A, 2001, J BIOL CHEM, V276, P46759, DOI 10.1074/jbc.M104780200; STOCKI SA, 1995, J MOL BIOL, V254, P15, DOI 10.1006/jmbi.1995.0595; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1; Venkatesan RN, 2007, MOL CELL BIOL, V27, P7669, DOI 10.1128/MCB.00002-07; Venkatesan RN, 2006, J BIOL CHEM, V281, P4486, DOI 10.1074/jbc.M510245200; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; WEAVER DT, 1984, J MOL BIOL, V180, P961, DOI 10.1016/0022-2836(84)90266-3	54	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32264	32272		10.1074/jbc.M110.147017	http://dx.doi.org/10.1074/jbc.M110.147017			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20628184	Green Published, hybrid			2022-12-25	WOS:000282683000039
J	Lakshminarasimhan, M; Madzelan, P; Nan, R; Milkovic, NM; Wilson, MA				Lakshminarasimhan, Mahadevan; Madzelan, Peter; Nan, Ruth; Milkovic, Nicole M.; Wilson, Mark A.			Evolution of New Enzymatic Function by Structural Modulation of Cysteine Reactivity in Pseudomonas fluorescens Isocyanide Hydratase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTAL-STRUCTURE; ESCHERICHIA-COLI HSP31; SACCHAROMYCES-CEREVISIAE; INTRACELLULAR PROTEASE; ISONITRILE HYDRATASE; SULFINIC ACID; HUMAN DJ-1; DEGRADATION; MEMBER; SUPERFAMILY	Isocyanide (formerly isonitrile) hydratase (EC 4.2.1.103) is an enzyme of the DJ-1 superfamily that hydrates isocyanides to yield the corresponding N-formamide. In order to understand the structural basis for isocyanide hydratase (ICH) catalysis, we determined the crystal structures of wild-type and several site-directed mutants of Pseudomonas fluorescens ICH at resolutions ranging from 1.0 to 1.9 angstrom. We also developed a simple UV-visible spectrophotometric assay for ICH activity using 2-naphthyl isocyanide as a substrate. ICH contains a highly conserved cysteine residue (Cys(101)) that is required for catalysis and interacts with Asp(17), Thr(102), and an ordered water molecule in the active site. Asp(17) has carboxylic acid bond lengths that are consistent with protonation, and we propose that it activates the ordered water molecule to hydrate organic isocyanides. In contrast to Cys(101) and Asp(17), Thr(102) is tolerant of mutagenesis, and the T102V mutation results in a substrate-inhibited enzyme. Although ICH is similar to human DJ-1 (1.6 angstrom C-alpha root mean square deviation), structural differences in the vicinity of Cys(101) disfavor the facile oxidation of this residue that is functionally important in human DJ-1 but would be detrimental to ICH activity. The ICH active site region also exhibits surprising conformational plasticity and samples two distinct conformations in the crystal. ICH represents a previously uncharacterized clade of the DJ-1 superfamily that possesses a novel enzymatic activity, demonstrating that the DJ-1 core fold can evolve diverse functions by subtle modulation of the environment of a conserved, reactive cysteine residue.	[Wilson, Mark A.] Univ Nebraska, Beadle Ctr N164, Dept Biochem, Lincoln, NE 68588 USA; Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Wilson, MA (corresponding author), Univ Nebraska, Beadle Ctr N164, Dept Biochem, Lincoln, NE 68588 USA.	mwilson13@unl.edu		Lakshminarasimhan, Mahadevan/0000-0001-9475-4927	National Institutes of Health [P20 RR017675-08, R01 GM092999-01]; United States Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Institutes of Health, National Center for Research Resources [RR007707]; National Science Foundation [DBI-0619764]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707, P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR017675-08 and R01 GM092999-01 (to M. A. W.). Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under Contract DE-AC02-06CH11357. Use of the BioCARS Sector 14 was supported by the National Institutes of Health, National Center for Research Resources, under Grant RR007707. The Beckman-Coulter XL-I analytical ultracentrifuge was acquired with National Science Foundation Grant DBI-0619764.	Aleyasin H, 2007, P NATL ACAD SCI USA, V104, P18748, DOI 10.1073/pnas.0709379104; Bandyopadhyay S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-6; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brockway LO, 1936, J AM CHEM SOC, V58, P2516, DOI 10.1021/ja01303a044; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Du XL, 2000, P NATL ACAD SCI USA, V97, P14079, DOI 10.1073/pnas.260503597; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esteve-Nunez A, 2001, MICROBIOL MOL BIOL R, V65, P335, DOI 10.1128/MMBR.65.3.335-352.2001; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Fioravanti E, 2008, BIOCHEMISTRY-US, V47, P11581, DOI 10.1021/bi800882v; FURUKAWA K, 1986, J BACTERIOL, V166, P392, DOI 10.1128/jb.166.2.392-398.1986; Goda M, 2002, J BIOL CHEM, V277, P45860, DOI 10.1074/jbc.M208571200; Goda M, 2001, J BIOL CHEM, V276, P23480, DOI 10.1074/jbc.M007856200; Gordy W, 1942, J AM CHEM SOC, V64, P2952, DOI 10.1021/ja01264a063; Graille M, 2004, STRUCTURE, V12, P839, DOI 10.1016/S0969-2126(04)00113-3; Halio SB, 1996, J BACTERIOL, V178, P2605, DOI 10.1128/jb.178.9.2605-2612.1996; Honbou K, 2003, J BIOL CHEM, V278, P31380, DOI 10.1074/jbc.M305878200; Huai Q, 2003, FEBS LETT, V549, P171, DOI 10.1016/S0014-5793(03)00764-6; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee SJ, 2003, J BIOL CHEM, V278, P44552, DOI 10.1074/jbc.M304517200; Lucas JI, 2007, MOL BIOL EVOL, V24, P551, DOI 10.1093/molbev/msl186; Malki A, 2005, J BIOL CHEM, V280, P14420, DOI 10.1074/jbc.M408296200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Ohnishi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P431, DOI 10.1271/bbb.69.431; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedras MSC, 2009, PHYTOCHEMISTRY, V70, P394, DOI 10.1016/j.phytochem.2009.01.005; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; PRIJAMBADA ID, 1995, APPL ENVIRON MICROB, V61, P2020, DOI 10.1128/AEM.61.5.2020-2022.1995; Quigley PM, 2003, P NATL ACAD SCI USA, V100, P3137, DOI 10.1073/pnas.0530312100; Rakus JF, 2008, BIOCHEMISTRY-US, V47, P9944, DOI 10.1021/bi800914r; SCHEUER PJ, 1992, ACCOUNTS CHEM RES, V25, P433, DOI 10.1021/ar00022a001; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SMITH CD, 1995, MOL PHARMACOL, V47, P241; Sung KS, 2001, TETRAHEDRON LETT, V42, P4845, DOI 10.1016/S0040-4039(01)00863-2; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Tao X, 2003, J BIOL CHEM, V278, P31372, DOI 10.1074/jbc.M304221200; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Wei Y, 2007, PLOS COMPUT BIOL, V3, P120, DOI 10.1371/journal.pcbi.0030010; Wilson MA, 2005, J MOL BIOL, V353, P678, DOI 10.1016/j.jmb.2005.08.033; Wilson MA, 2004, P NATL ACAD SCI USA, V101, P1531, DOI 10.1073/pnas.0308089100; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Yanagisawa D, 2008, J CEREBR BLOOD F MET, V28, P563, DOI 10.1038/sj.jcbfm.9600553; Yeh JI, 1998, ACTA CRYSTALLOGR D, V54, P479, DOI 10.1107/S0907444998004697; ZAPF S, 1995, J ANTIBIOT, V48, P36, DOI 10.7164/antibiotics.48.36	57	26	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29651	29661		10.1074/jbc.M110.147934	http://dx.doi.org/10.1074/jbc.M110.147934			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20630867	Green Published, hybrid			2022-12-25	WOS:000281740100066
J	Finsterwald, C; Fiumelli, H; Cardinaux, JR; Martin, JL				Finsterwald, Charles; Fiumelli, Hubert; Cardinaux, Jean-Rene; Martin, Jean-Luc			Regulation of Dendritic Development by BDNF Requires Activation of CRTC1 by Glutamate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE COINCIDENCE DETECTOR; NEUROTROPHIC FACTOR; CORTICAL-NEURONS; SYNAPTIC PLASTICITY; SIGNALING PATHWAYS; NUCLEAR TRANSPORT; GENE-EXPRESSION; C-FOS; CREB; GROWTH	Dendritic growth is essential for the establishment of a functional nervous system. Among extrinsic signals that control dendritic development, substantial evidence indicates that BDNF regulates dendritic morphology. However, little is known about the underlying mechanisms by which BDNF controls dendritic growth. In this study, we show that the MAPK signaling pathway and the transcription factor cAMP response element-binding protein (CREB) mediate the effects of BDNF on dendritic length and complexity. However, phosphorylation of CREB alone is not sufficient for the stimulation of dendritic growth by BDNF. Thus, using a mutant form of CREB unable to bind CREB-regulated transcription coactivator (CRTC1), we demonstrate that this effect also requires a functional interaction between CREB and CRTC1. Moreover, inhibition of CRTC1 expression by shRNA-mediated knockdown abolished BDNF-induced dendritic growth of cortical neurons. Interestingly, we found that nuclear translocation of CRTC1 results from activation of NMDA receptors by glutamate, a process that is essential for the effects of BDNF on dendritic development. Together, these data identify a previously unrecognized mechanism by which CREB and the coactivator CRTC1 mediate the effects of BDNF on dendritic growth.	[Martin, Jean-Luc] Univ Lausanne, Dept Physiol, CH-1005 Lausanne, Switzerland; [Cardinaux, Jean-Rene; Martin, Jean-Luc] Univ Lausanne, Ctr Psychiat Neurosci, CH-1008 Prilly, Switzerland; [Cardinaux, Jean-Rene] Univ Lausanne, Univ Med Ctr, Dept Psychiat, Serv Child & Adolescent Psychiat, CH-1008 Prilly, Switzerland	University of Lausanne; University of Lausanne; University of Lausanne	Martin, JL (corresponding author), Univ Lausanne, Dept Physiol, CH-1005 Lausanne, Switzerland.	jean-luc.martin@unil.ch	Cardinaux, Jean-René/G-5391-2012	Cardinaux, Jean-René/0000-0001-6423-0014; Martin, Jean-Luc/0000-0002-5082-4687	Swiss National Science Foundation [31003A-124783, 3100A0-120699]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants 31003A-124783 (to J.-L.M.) and 3100A0-120699 (to J.-R.C.).	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Benavides-Piccione R, 2004, PROG NEUROBIOL, V74, P111, DOI 10.1016/j.pneurobio.2004.08.001; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Burkhalter J, 2007, J BIOL CHEM, V282, P5152, DOI 10.1074/jbc.M608548200; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Deng J, 2009, NEUROSCIENCE, V159, P1023, DOI 10.1016/j.neuroscience.2009.01.073; Dijkhuizen PA, 2005, J NEUROBIOL, V62, P278, DOI 10.1002/neu.20100; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Horch HW, 1999, NEURON, V23, P353; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Jan YN, 2001, GENE DEV, V15, P2627, DOI 10.1101/gad.916501; Konur S, 2005, NEURON, V46, P401, DOI 10.1016/j.neuron.2005.04.022; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; LORIAUX MM, 1993, P NATL ACAD SCI USA, V90, P9046, DOI 10.1073/pnas.90.19.9046; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Redmond L, 2005, CELL CALCIUM, V37, P411, DOI 10.1016/j.ceca.2005.01.009; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Takei N, 1998, J BIOL CHEM, V273, P27620, DOI 10.1074/jbc.273.42.27620; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; Yang F, 2001, NAT NEUROSCI, V4, P19, DOI 10.1038/82858; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; Zhou Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000016	39	55	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28587	28595		10.1074/jbc.M110.125740	http://dx.doi.org/10.1074/jbc.M110.125740			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20639200	Green Published, hybrid			2022-12-25	WOS:000281594000022
J	Kleene, R; Cassens, C; Bahring, R; Theis, T; Xiao, MF; Dityatev, A; Schafer-Nielsen, C; Doring, F; Wischmeyer, E; Schachner, M				Kleene, Ralf; Cassens, Claas; Baehring, Robert; Theis, Thomas; Xiao, Mei-Fang; Dityatev, Alexander; Schafer-Nielsen, Claus; Doering, Frank; Wischmeyer, Erhard; Schachner, Melitta			Functional Consequences of the Interactions among the Neural Cell Adhesion Molecule NCAM, the Receptor Tyrosine Kinase TrkB, and the Inwardly Rectifying K+ Channel KIR3.3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNELS; NEUROTROPHIC FACTOR; SYNAPTIC PLASTICITY; NEURITE OUTGROWTH; PROTEIN-KINASE; BRAIN; ASSOCIATION; HIPPOCAMPUS; EXPRESSION; DEPENDENCE	Cell adhesion molecules and neurotrophin receptors are crucial for the development and the function of the nervous system. Among downstream effectors of neurotrophin receptors and recognition molecules are ion channels. Here, we provide evidence that G protein-coupled inwardly rectifying K+ channel Kir3.3 directly binds to the neural cell adhesion molecule (NCAM) and neurotrophin receptor TrkB. We identified the binding sites for NCAM and TrkB at the C-terminal intracellular domain of Kir3.3. The interaction between NCAM, TrkB, and Kir3.3 was supported by immunocytochemical co-localization of Kir3.3, NCAM, and/or TrkB at the surface of hippocampal neurons. Co-expression of TrkB and Kir3.1/3.3 in Xenopus oocytes increased the K+ currents evoked by Kir3.1/3.3 channels. This current enhancement was reduced by the concomitant co-expression with NCAM. Both surface fluorescence measurements of microinjected oocytes and cell surface biotinylation of transfected CHO cells indicated that the cell membrane localization of Kir3.3 is regulated by TrkB and NCAM. Furthermore, the level of Kir3.3, but not of Kir3.2, at the plasma membranes was reduced in TrkB-deficient mice, supporting the notion that TrkB regulates the cell surface expression of Kir3.3. The premature expression of developmentally late appearing Kir3.1/3.3 in hippocampal neurons led to a reduction of NCAM-induced neurite outgrowth. Our observations indicate a decisive role for the neuronal K+ channel in regulating NCAM-dependent neurite outgrowth and attribute a physiologically meaningful role to the functional interplay of Kir3.3, NCAM, and TrkB in ontogeny.	[Kleene, Ralf; Cassens, Claas; Theis, Thomas; Xiao, Mei-Fang; Dityatev, Alexander; Schachner, Melitta] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Baehring, Robert] Univ Klinikum Hamburg Eppendorf, Zentrum Expt Med, D-20246 Hamburg, Germany; [Schafer-Nielsen, Claus] Schafer N ApS, DK-2100 Copenhagen, Denmark; [Doering, Frank; Wischmeyer, Erhard] Univ Wurzburg, Inst Physiol, D-97070 Wurzburg, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; Rutgers State University New Brunswick	Schachner, M (corresponding author), Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Martinistr 85, D-20246 Hamburg, Germany.	melitta.schachner@zmnh.uni-hamburg.de	Dityatev, Alexander/A-4034-2008; Bähring, Robert/F-7146-2010; Theis, Thomas/I-4247-2019	Dityatev, Alexander/0000-0002-0472-0553; Theis, Thomas/0000-0001-5555-8501; Bahring, Robert/0000-0002-0406-5958; Doring, Frank/0000-0003-1017-1498	Deutsche Forschungsgemeinschaft [SCHA185/17-4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHA185/17-4.	BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Bergami Matteo, 2009, Commun Integr Biol, V2, P14; Beuten J, 2007, BIOL PSYCHIAT, V61, P48, DOI 10.1016/j.biopsych.2006.02.023; Brennaman LH, 2010, ADV EXP MED BIOL, V663, P299, DOI 10.1007/978-1-4419-1170-4_19; Cassens C, 2010, J BIOL CHEM, V285, P28959, DOI 10.1074/jbc.M110.114835; Delling M, 2002, J NEUROSCI, V22, P7154; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; EDELMAN GM, 1983, P NATL ACAD SCI-BIOL, V80, P4384, DOI 10.1073/pnas.80.14.4384; Grosse G, 2003, MOL CELL NEUROSCI, V24, P709, DOI 10.1016/S1044-7431(03)00234-3; Ippolito DL, 2002, J BIOL CHEM, V277, P32692, DOI 10.1074/jbc.M204407200; Isomoto S, 1997, JPN J PHYSIOL, V47, P11, DOI 10.2170/jjphysiol.47.11; Iwasaki Y, 1997, BIOCHEMISTRY-US, V36, P2694, DOI 10.1021/bi962057x; Jelacic TM, 2000, J BIOL CHEM, V275, P36211, DOI 10.1074/jbc.M007087200; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Karschin C, 1996, J NEUROSCI, V16, P3559; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; Kozell LB, 2009, J NEUROSCI, V29, P11662, DOI 10.1523/JNEUROSCI.1413-09.2009; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Mackowiak M, 2005, BRAIN RES, V1055, P149, DOI 10.1016/j.brainres.2005.07.001; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; Rogalski SL, 2000, J BIOL CHEM, V275, P25082, DOI 10.1074/jbc.M000183200; Schachner M, 1997, CURR OPIN CELL BIOL, V9, P627, DOI 10.1016/S0955-0674(97)80115-9; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Stork O, 1999, J NEUROBIOL, V40, P343, DOI 10.1002/(SICI)1097-4695(19990905)40:3<343::AID-NEU6>3.0.CO;2-S; Stork O, 1997, EUR J NEUROSCI, V9, P1117, DOI 10.1111/j.1460-9568.1997.tb01464.x; TANNAHILL L, 1995, EUR J NEUROSCI, V7, P1424, DOI 10.1111/j.1460-9568.1995.tb01136.x; Torrecilla M, 2002, J NEUROSCI, V22, P4328, DOI 10.1523/JNEUROSCI.22-11-04328.2002; Wischmeyer E, 1997, MOL CELL NEUROSCI, V9, P194, DOI 10.1006/mcne.1997.0614; Xu K, 2007, PHARMACOGENOMICS J, V7, P368, DOI 10.1038/sj.tpj.6500430	37	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28968	28979		10.1074/jbc.M110.114876	http://dx.doi.org/10.1074/jbc.M110.114876			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20610389	hybrid, Green Published			2022-12-25	WOS:000281594000062
J	Wheeler, SE; Suzuki, S; Thomas, SM; Sen, M; Leeman-Neill, RJ; Chiosea, SI; Kuan, CT; Bigner, DD; Gooding, WE; Lai, SY; Grandis, JR				Wheeler, S. E.; Suzuki, S.; Thomas, S. M.; Sen, M.; Leeman-Neill, R. J.; Chiosea, S. I.; Kuan, C-T; Bigner, D. D.; Gooding, W. E.; Lai, S. Y.; Grandis, J. R.			Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation	ONCOGENE			English	Article						head and neck cancer; epidermal growth factor receptor; EGFRvIII; STAT3; cancer cell invasion	CONSTITUTIVE ACTIVATION; SIGNAL TRANSDUCERS; MOUSE FIBROBLASTS; EXPRESSION; EGFR; CARCINOMA; TRANSCRIPTION-3; RESISTANCE; PROMOTES; KINASE	Epidermal growth factor receptor (EGFR) is frequently overexpressed in head and neck squamous cell carcinoma (HNSCC) where aberrant signaling downstream of this receptor contributes to tumor growth. EGFR variant III (EGFRvIII) is the most commonly altered form of EGFR and contains a truncated ligand-binding domain. We previously reported that EGFRvIII is expressed in up to 40% of HNSCC tumors where it is associated with increased proliferation, tumor growth and chemoresistance to antitumor drugs including the EGFR-targeting monoclonal antibody cetuximab. Cetuximab was FDA-approved in 2006 for HNSCC but has not been shown to prevent invasion or metastasis. This study was undertaken to evaluate the mechanisms of EGFRvIII-mediated cell motility and invasion in HNSCC. We found that EGFRvIII induced HNSCC cell migration and invasion in conjunction with increased signal transducer and activator of transcription 3 (STAT3) activation, which was not abrogated by cetuximab treatment. Further investigation showed that EGF-induced expression of the STAT3 target gene HIF1-alpha, was abolished by cetuximab in HNSCC cells expressing wild-type EGFR under hypoxic conditions, but not in EGFRvIII-expressing HNSCC cells. These results suggest that EGFRvIII mediates HNSCC cell migration and invasion by increased STAT3 activation and induction of HIF1-alpha, which contribute to cetuximab resistance in EGFRvIII-expressing HNSCC tumors. Oncogene (2010) 29, 5135-5145; doi:10.1038/onc.2009.279; published online 12 July 2010	[Wheeler, S. E.; Suzuki, S.; Thomas, S. M.; Sen, M.; Lai, S. Y.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15213 USA; [Wheeler, S. E.; Suzuki, S.; Thomas, S. M.; Sen, M.; Leeman-Neill, R. J.; Chiosea, S. I.; Gooding, W. E.; Lai, S. Y.; Grandis, J. R.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA; [Leeman-Neill, R. J.; Chiosea, S. I.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Kuan, C-T; Bigner, D. D.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Gooding, W. E.] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15213 USA; [Grandis, J. R.] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Grandis, JR (corresponding author), Univ Pittsburgh, Dept Otolaryngol, 200 Lothrop St,Suite 500, Pittsburgh, PA 15213 USA.	jgrandis@pitt.edu	Thomas, Sufi/O-1487-2018; Thomas, Sufi Mary/AFR-1642-2022	Thomas, Sufi/0000-0001-5370-0842; Thomas, Sufi Mary/0000-0001-5370-0842; Chiosea, Simion/0000-0002-5766-8779; Lai, Stephen/0000-0001-8301-7286; Wheeler, Sarah/0000-0002-7851-9836	American Cancer Society [CRP-08-229-01]; NIH [EY08098];  [RO1 CA77308];  [RO1 CA101840];  [P50 CA097190]; NATIONAL CANCER INSTITUTE [R01CA077308, R37CA011898, P50CA097190, R01CA101840] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008098] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Grants RO1 CA77308, RO1 CA101840 and P50 CA097190, and an American Cancer Society Clinical Research professorship CRP-08-229-01 (to JRG) and the NIH core Grant EY08098.	Andersen P, 2008, INT J CANCER, V122, P342, DOI 10.1002/ijc.23109; Antonyak MA, 1998, J BIOL CHEM, V273, P2817, DOI 10.1074/jbc.273.5.2817; Besser D, 1999, MOL CELL BIOL, V19, P1401; BIGNER SH, 1990, CANCER RES, V50, P8017; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Cai XM, 2005, INT J CANCER, V117, P905, DOI 10.1002/ijc.21251; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; DIEDRICH U, 1995, J NEUROL, V242, P683, DOI 10.1007/BF00866920; GARCIA DP, 1993, CANCER RES, V53, P3217; Germain D, 2007, CLIN CANCER RES, V13, P5665, DOI 10.1158/1078-0432.CCR-06-2491; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; GRANDIS JR, 1993, J CELL BIOCHEM, P188; Huang M, 2002, ONCOGENE, V21, P8804, DOI 10.1038/sj.onc.1206028; Ji HB, 2006, P NATL ACAD SCI USA, V103, P7817, DOI 10.1073/pnas.0510284103; Kijima T, 2002, CELL GROWTH DIFFER, V13, P355; Kira M, 2002, J BIOL CHEM, V277, P12931, DOI 10.1074/jbc.M110795200; Lal A, 2002, CANCER RES, V62, P3335; Leeman RJ, 2006, EXPERT OPIN BIOL TH, V6, P231, DOI 10.1517/14712598.6.3.231; Leong PL, 2003, P NATL ACAD SCI USA, V100, P4138, DOI 10.1073/pnas.0534764100; Li B, 2004, ONCOGENE, V23, P4594, DOI 10.1038/sj.onc.1207602; Li DN, 2007, J CLIN INVEST, V117, P346, DOI 10.1172/JCI30446; Masuda M, 2002, CANCER RES, V62, P3351; Mizoguchi M, 2006, J NEUROPATH EXP NEUR, V65, P1181, DOI 10.1097/01.jnen.0000248549.14962.b2; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Moscatello DK, 1998, J BIOL CHEM, V273, P200, DOI 10.1074/jbc.273.1.200; Nagane M, 1998, P NATL ACAD SCI USA, V95, P5724, DOI 10.1073/pnas.95.10.5724; Narita Y, 2002, CANCER RES, V62, P6764; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Niu GL, 2008, MOL CANCER RES, V6, P1099, DOI 10.1158/1541-7786.MCR-07-2177; Olapade-Olaopa EO, 2000, BRIT J CANCER, V82, P186; Oritani K, 1999, BLOOD, V93, P1346, DOI 10.1182/blood.V93.4.1346.404k15_1346_1354; Pedersen MW, 2004, INT J CANCER, V108, P643, DOI 10.1002/ijc.11566; Pedersen MW, 2001, ANN ONCOL, V12, P745, DOI 10.1023/A:1011177318162; Qiu ZJ, 2007, CANCER SCI, V98, P1099, DOI 10.1111/j.1349-7006.2007.00485.x; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Sen M, 2009, CANCER CHEMOTH PHARM, V63, P983, DOI 10.1007/s00280-008-0823-6; Silver DL, 2004, CANCER RES, V64, P3550, DOI 10.1158/0008-5472.CAN-03-3959; Sinibaldi D, 2000, ONCOGENE, V19, P5419, DOI 10.1038/sj.onc.1203947; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Sriuranpong V, 2003, CANCER RES, V63, P2948; SUGAWA N, 1990, P NATL ACAD SCI USA, V87, P8602, DOI 10.1073/pnas.87.21.8602; Tang CY, 2000, J PHARMACOL EXP THER, V293, P453; Thomas SM, 2003, CANCER RES, V63, P5629; Vermorken JB, 2007, J CLIN ONCOL, V25, P2171, DOI 10.1200/JCO.2006.06.7447; Weppler SA, 2007, RADIOTHER ONCOL, V83, P333, DOI 10.1016/j.radonc.2007.04.025; Xi SC, 2005, ONCOGENE, V24, P970, DOI 10.1038/sj.onc.1208316; Xi SC, 2003, J BIOL CHEM, V278, P31574, DOI 10.1074/jbc.M303499200; Zhang Q, 2004, CANCER RES, V64, P6166, DOI 10.1158/0008-5472.CAN-04-0504	49	80	89	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	37					5135	5145		10.1038/onc.2009.279	http://dx.doi.org/10.1038/onc.2009.279			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	650QZ	20622897	Green Accepted, Green Submitted			2022-12-25	WOS:000281867200003
J	Okumu, FO; Govella, NJ; Moore, SJ; Chitnis, N; Killeen, GF				Okumu, Fredros O.; Govella, Nicodem J.; Moore, Sarah J.; Chitnis, Nakul; Killeen, Gerry F.			Potential Benefits, Limitations and Target Product-Profiles of Odor-Baited Mosquito Traps for Malaria Control in Africa	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; ENTOMOLOGIC INOCULATION RATES; GLOSSINA-MORSITANS-CENTRALIS; EXPERIMENTAL HUT TRIALS; HUMAN SKIN EMANATIONS; ANOPHELES-GAMBIAE; PLASMODIUM-FALCIPARUM; VECTOR-CONTROL; BED NETS; FIELD-EVALUATION	Background: Traps baited with synthetic human odors have been proposed as suitable technologies for controlling malaria and other mosquito-borne diseases. We investigated the potential benefits of such traps for preventing malaria transmission in Africa and the essential characteristics that they should possess so as to be effective. Methods and Principal Findings: An existing mathematical model was reformulated to distinguish availability of hosts for attack by mosquitoes from availability of blood per se. This adaptation allowed the effects of pseudo-hosts such as odor-baited mosquito traps, which do not yield blood but which can nonetheless be attacked by the mosquitoes, to be simulated considering communities consisting of users and non-users of insecticide-treated nets (ITNs), currently the primary malaria prevention method. We determined that malaria transmission declines as trap coverage (proportion of total availability of all hosts and pseudo hosts that traps constitute) increases. If the traps are more attractive than humans and are located in areas where mosquitoes are most abundant, 20-130 traps per 1000 people would be sufficient to match the impact of 50% community-wide ITN coverage. If such traps are used to complement ITNs, malaria transmission can be reduced by 99% or more in most scenarios representative of Africa. However, to match cost-effectiveness of ITNs, the traps delivery, operation and maintenance would have to cost a maximum of US$4.25 to 27.61 per unit per year. Conclusions and Significance: Odor-baited mosquito traps might potentially be effective and affordable tools for malaria control in Africa, particularly if they are used to complement, rather than replace, existing methods. We recommend that developers should focus on super-attractive baits and cheaper traps to enhance cost-effectiveness, and that the most appropriate way to deploy such technologies is through vertical delivery mechanisms.	[Okumu, Fredros O.; Govella, Nicodem J.; Moore, Sarah J.; Killeen, Gerry F.] Ifakara Hlth Inst, Biomed & Environm Sci Themat Grp, Ifakara, Tanzania; [Okumu, Fredros O.; Moore, Sarah J.] London Sch Hyg & Trop Med, Publ Hlth Entomol Grp, Dept Infect Dis, London WC1, England; [Govella, Nicodem J.; Killeen, Gerry F.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Chitnis, Nakul] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland	Ifakara Health Institute; University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Liverpool; University of Basel; Swiss Tropical & Public Health Institute	Okumu, FO (corresponding author), Ifakara Hlth Inst, Biomed & Environm Sci Themat Grp, Ifakara, Tanzania.	fredros@ihi.or.tz	Chitnis, Nakul/B-3105-2013; Moore, Sarah J/HGE-7143-2022	Moore, Sarah J/0000-0002-0938-6654; Chitnis, Nakul/0000-0002-1103-9141	Bill & Melinda Gates Foundation [51431, 45114]; President's Malaria Initiative (USAID) [621-A-00-08-0007-00]; London School of Hygiene and Tropical Medicine [RCA-3125]; Wellcome Trust [076806]; PATH-MACEPA; Malaria Transmission Consortium (MTC)	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); President's Malaria Initiative (USAID)(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); London School of Hygiene and Tropical Medicine; Wellcome Trust(Wellcome TrustEuropean Commission); PATH-MACEPA; Malaria Transmission Consortium (MTC)	This work was supported with funds from the Bill & Melinda Gates Foundation provided through research grants from the Global Health Discovery Program (Grand Challenges Explorations Grant No. 53214) and direct award numbers 51431 and 45114) as well as the President's Malaria Initiative (USAID award No. 621-A-00-08-0007-00). Personal support was provided to FOO through a PhD studentship at the London School of Hygiene and Tropical Medicine (Grant No. RCA-3125) and to GFK through a Wellcome Trust Research Career Development Fellowship (Award No. 076806). NC was supported by a postdoctoral fellowship from PATH-MACEPA and a grant from the Malaria Transmission Consortium (MTC), a project funded by the Bill & Melinda Gates Foundation (BMGF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, Trans R Soc Trop Med Hyg, V86, P499; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 2005, ROLL BACK MAL GLOB S; [Anonymous], 2008, WORLD MAL REP 2008; [Anonymous], 2007, INS TREAT NETS POS S; Ansell J, 2002, T ROY SOC TROP MED H, V96, P113, DOI 10.1016/S0035-9203(02)90271-3; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; Bernier UR, 2002, J AM MOSQUITO CONTR, V18, P186; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Bernier UR, 2007, INSECT REPELLENTS PR, P77; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; BRAIMAH N, 2005, INT J TROP INSECT SC, P1; Cairncross S, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P771; Charlwood JD, 1997, B ENTOMOL RES, V87, P445, DOI 10.1017/S0007485300041304; Chitnis Nakul, 2008, Journal of Biological Dynamics, V2, P259, DOI 10.1080/17513750701769857; Clements A. N., 1992, BIOL MOSQUITOES, V1; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Costantini C., 1993, Parassitologia (Rome), V35, P5; DAY JF, 1994, AM J TROP MED HYG, V50, P126, DOI 10.4269/ajtmh.1994.50.126; Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106; FEACHEM RG, 1980, PROC R SOC SER B-BIO, V209, P15, DOI 10.1098/rspb.1980.0068; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699; Garrett-Jones C, 1975, WHOMAL75851; Gillies M, 1987, ANOPHELINAE AFRICA S; GILLIES MT, 1972, B ENTOMOL RES, V61, P389, DOI 10.1017/S0007485300047295; Govella NJ, 2010, AM J TROP MED HYG, V82, P415, DOI 10.4269/ajtmh.2010.09-0579; Grieco JP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000716; Gu WD, 2003, T ROY SOC TROP MED H, V97, P43, DOI 10.1016/S0035-9203(03)90018-6; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; HADI A, 2000, PARTICIPATORY APPROA, P332; Hanson K, 2003, B WORLD HEALTH ORGAN, V81, P269; Hawley WA, 2003, AM J TROP MED HYG, V68, P168, DOI 10.4269/ajtmh.2003.68.168; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hutchinson RA, 2007, B ENTOMOL RES, V97, P591, DOI 10.1017/S0007485307005263; Ito T, 2006, DEV OLYSET NET TOOL; Kauman PE, 2008, J AM MOSQUITO CONTR, V24, P528; Kawada H, 2005, J VECTOR ECOL, V30, P181; Kelly DW, 2000, PARASITOLOGY, V120, P319, DOI 10.1017/S0031182099005442; Khan ZR, 2000, PEST MANAG SCI, V56, P957, DOI 10.1002/1526-4998(200011)56:11<957::AID-PS236>3.0.CO;2-T; Killeen GF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-121; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Killeen GF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-161; Killeen GF, 2007, T ROY SOC TROP MED H, V101, P867, DOI 10.1016/j.trstmh.2007.04.022; Killeen GF, 2004, AM J TROP MED HYG, V71, P87, DOI 10.4269/ajtmh.2004.71.2_suppl.0700087; Killeen GF, 2003, LANCET INFECT DIS, V3, P297, DOI 10.1016/S1473-3099(03)00611-X; Killeen GF, 2001, T ROY SOC TROP MED H, V95, P469, DOI 10.1016/S0035-9203(01)90005-7; Killeen GF, 2000, AM J TROP MED HYG, V62, P545, DOI 10.4269/ajtmh.2000.62.545; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kline DL, 2006, J AM MOSQUITO CONTR, V22, P490, DOI 10.2987/8756-971X(2006)22[490:TATTFA]2.0.CO;2; Kline DL, 1999, J AM MOSQUITO CONTR, V15, P276; Kline DL, 2002, J VECTOR ECOL, V27, P1; KNOLS BGJ, 1993, MED VET ENTOMOL, V7, P161, DOI 10.1111/j.1365-2915.1993.tb00670.x; KOELLA JC, 1991, ACTA TROP, V49, P1, DOI 10.1016/0001-706X(91)90026-G; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; KUSNETSOV RL, 1977, TROPICAL DOCTOR, V7, P81; Lacroix R, 2005, PLOS BIOL, V3, P1590, DOI 10.1371/journal.pbio.0030298; Le Menach A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-23; Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10; Lindblade KA, 2005, TROP MED INT HEALTH, V10, P1141, DOI 10.1111/j.1365-3156.2005.01501.x; LINDSAY SW, 1995, MED VET ENTOMOL, V9, P50, DOI 10.1111/j.1365-2915.1995.tb00116.x; LINDSAY SW, 1993, J MED ENTOMOL, V30, P368, DOI 10.1093/jmedent/30.2.368; LINDSAY SW, 1991, MED VET ENTOMOL, V5, P477, DOI 10.1111/j.1365-2915.1991.tb00576.x; LINES JD, 1987, MED VET ENTOMOL, V1, P37, DOI 10.1111/j.1365-2915.1987.tb00321.x; Logan JG, 2007, PEST MANAG SCI, V63, P647, DOI 10.1002/ps.1408; Lwetoijera DW, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-18; MacDONALD G., 1956, BULL WORLD HEALTH ORGAN, V15, P613; Magesa SM, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-34; Mathenge EM, 2002, MED VET ENTOMOL, V16, P67, DOI 10.1046/j.0269-283x.2002.00350.x; Mathenge EM, 2004, AM J TROP MED HYG, V70, P33, DOI 10.4269/ajtmh.2004.70.33; Maxwell C. A., 2006, Journal of Vector Borne Diseases, V43, P1; Miller JR, 2010, P NATL ACAD SCI USA, V107, P22, DOI 10.1073/pnas.0908453107; MILLER JE, 1991, MED VET ENTOMOL, V5, P465, DOI 10.1111/j.1365-2915.1991.tb00575.x; Mukabana W. R., 2002, DIFFERENTIAL ATTRACT; N'Guessan R, 2001, MED VET ENTOMOL, V15, P97, DOI 10.1046/j.1365-2915.2001.00284.x; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; Okumu FO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-12; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; OKUMU OF, 2008, OPEN TROPICAL MED J, V1, P68; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Pickett JA, 1997, AGR ECOSYST ENVIRON, V64, P149, DOI 10.1016/S0167-8809(97)00033-9; Qiu YT, 2006, MED VET ENTOMOL, V20, P280, DOI 10.1111/j.1365-2915.2006.00627.x; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Ribeiro JMC, 1996, B WORLD HEALTH ORGAN, V74, P299; Roitberg BD, 2003, BEHAV ECOL, V14, P736, DOI 10.1093/beheco/arg055; Ross A, 2006, AM J TROP MED HYG, V75, P32, DOI 10.4269/ajtmh.2006.75.32; SAUL AJ, 1990, J APPL ECOL, V27, P123, DOI 10.2307/2403572; Sauli V, 2003, J HIGH ENERGY PHYS; Schmied WH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-230; Service MW, 1997, J MED ENTOMOL, V34, P579, DOI 10.1093/jmedent/34.6.579; SERVICE MW, 1980, INT J BIOMETEOROL, V24, P347, DOI 10.1007/BF02250577; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Shililu J, 2003, AM J TROP MED HYG, V69, P295, DOI 10.4269/ajtmh.2003.69.295; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; SMITH T, 1995, ACTA TROP, V59, P1, DOI 10.1016/0001-706X(94)00082-C; Soremekun S, 2004, TROP MED INT HEALTH, V9, P664, DOI 10.1111/j.1365-3156.2004.01250.x; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Takken W, 2009, TRENDS PARASITOL, V25, P101, DOI 10.1016/j.pt.2008.12.002; Tami A, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-19; Thompson R, 1997, AM J TROP MED HYG, V57, P550, DOI 10.4269/ajtmh.1997.57.550; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; Tumwine JK, 2003, INT J ENVIRON HEAL R, V13, P107, DOI 10.1080/0960312031000098035; VALE GA, 1988, B ENTOMOL RES, V78, P31, DOI 10.1017/S0007485300016059; *WHO, 2009, WHO PEST EV SCHEM SP; WHO, 2009, GLOB MAL ACT PLAN; WILLEMSE L, 1991, B ENTOMOL RES, V81, P351, DOI 10.1017/S0007485300033630; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	116	53	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11573	10.1371/journal.pone.0011573	http://dx.doi.org/10.1371/journal.pone.0011573			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644731	gold, Green Published, Green Submitted			2022-12-25	WOS:000279884900013
J	Ueyama, M; Akimoto, Y; Ichimiya, T; Ueda, R; Kawakami, H; Aigaki, T; Nishihara, S				Ueyama, Morio; Akimoto, Yoshihiro; Ichimiya, Tomomi; Ueda, Ryu; Kawakami, Hayato; Aigaki, Toshiro; Nishihara, Shoko			Increased Apoptosis of Myoblasts in Drosophila Model for the Walker-Warburg Syndrome	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; O-MANNOSYLTRANSFERASE ACTIVITY; EYE-BRAIN DISEASE; ALPHA-DYSTROGLYCAN; POMT1 GENE; MUTATIONS; MUSCLE; LAMININ; DISRUPTION; IDENTIFICATION	Walker-Warburg syndrome, a progressive muscular dystrophy, is a severe disease with various kinds of symptoms such as muscle weakness and occasional seizures. The genes of protein O-mannosyltransferases 1 and 2 (POMT1 and POMT2), fukutin, and fukutin-related protein are responsible for this syndrome. In our previous study, we cloned Drosophila orthologs of human POMT1 and POMT2 and identified their activity. However, the mechanism of onset of this syndrome is not well understood. Furthermore, little is known about the behavioral properties of the Drosophila POMT1 and POMT2 mutants, which are called rotated abdomen (rt) and twisted (tw), respectively. First, we performed various kinds of behavioral tests and described in detail the muscle structures by using these mutants. The mutant flies exhibited abnormalities in heavy exercises such as climbing or flight but not in light movements such as locomotion. Defective motor function in mutants appeared immediately after eclosion and was exaggerated with aging. Along with motor function, muscle ultrastructure in the tw mutant was altered, as seen in human patients. We demonstrated that expression of RNA interference (RNAi) for the rt gene and the tw mutant was almost completely lethal and semi-lethal, respectively. Flies expressing RNAi had reduced lifespans. These findings clearly demonstrate that Drosophila POMT mutants are models for human muscular dystrophy. We then observed a high density of myoblasts with an enhanced degree of apoptosis in the tw mutant, which completely lost enzymatic activity. In this paper, we propose a novel mechanism for the development of muscular dystrophy: POMT mutation causes high myoblast density and position derangement, which result in apoptosis, muscle disorganization, and muscle cell defects.	[Ueyama, Morio; Ichimiya, Tomomi; Nishihara, Shoko] Soka Univ, Dept Bioinformat, Tokyo, Japan; [Akimoto, Yoshihiro; Kawakami, Hayato] Kyorin Univ, Sch Med, Dept Anat, Tokyo, Japan; [Ueda, Ryu] Natl Inst Genet, Invertebrate Genet Lab, Shizuoka, Japan; [Aigaki, Toshiro] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 158, Japan	Soka University; Kyorin University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tokyo Metropolitan University	Ueyama, M (corresponding author), Soka Univ, Dept Bioinformat, Tokyo, Japan.	shoko@t.soka.ac.jp		Ueyama, Morio/0000-0002-2950-7361; Nishihara, Shoko/0000-0002-1668-2603	Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Matching Fund for Private Universities [S0901015]; NICHD	Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Matching Fund for Private Universities; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by funds from the Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST), and from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Matching Fund for Private Universities, S0901015, 2009-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. T. Maqbool, Dr. D. Yamamoto, Bloomington stock center, and Szeged stock center for providing fly stocks, Dr. M. Umeda for providing anti- Dg antibody, Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa for providing other 1st antibodies, C. Ohkura for data handling of locomotion assay, M. Fukuda, and S. Matubara for technical assistance of electron microscopy, Dr. T. J. Fuwa for suggesting the experimental methods, Dr. S. Yamamura for discussion about muscular dystrophies, Dr. T. Matsuo, Dr. D. Yamamoto, and Dr. Y. Fuyama for comments on the manuscript, and anonymous reviewers for constructive comments.	Akasaka-Manya K, 2004, BIOCHEM BIOPH RES CO, V325, P75, DOI 10.1016/j.bbrc.2004.10.001; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bouchet C, 2007, MOL GENET METAB, V90, P93, DOI 10.1016/j.ymgme.2006.09.005; BROWN NH, 1994, DEVELOPMENT, V120, P1221; Burton EA, 2002, CELL, V108, P5, DOI 10.1016/S0092-8674(01)00626-2; Chiba A, 1997, J BIOL CHEM, V272, P2156; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Cormand B, 2001, NEUROLOGY, V56, P1059, DOI 10.1212/WNL.56.8.1059; CULLEN MJ, 1975, J NEUROL SCI, V24, P179, DOI 10.1016/0022-510X(75)90232-4; Currier SC, 2005, AM J MED GENET A, V133A, P53, DOI 10.1002/ajmg.a.30487; DAVIS BK, 1980, DROSOPH INF SERV, V55, P31; de Bernabe DBV, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013870; de Bernabe DBV, 2003, J MED GENET, V40, P845; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; DOBYNS WB, 1989, AM J MED GENET, V32, P195, DOI 10.1002/ajmg.1320320213; DWAYNE GS, 2004, NATURE CELL BIO, V6, P388; Emery AEH, 2002, NEUROMUSCULAR DISORD, V12, P343, DOI 10.1016/S0960-8966(01)00303-0; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Greener MJ, 2000, FEBS LETT, V482, P13, DOI 10.1016/S0014-5793(00)02018-4; Haines N, 2007, MOL BIOL CELL, V18, P4721, DOI 10.1091/mbc.E07-01-0047; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; Kaneuchi T, 2003, BIOGERONTOLOGY, V4, P157, DOI 10.1023/A:1024145822785; Lyalin D, 2006, GENETICS, V172, P343, DOI 10.1534/genetics.105.049650; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2002, J BIOL CHEM, V277, P35503, DOI 10.1074/jbc.M206033200; Martin D, 1999, J CELL BIOL, V145, P191, DOI 10.1083/jcb.145.1.191; MartinBlanco E, 1996, P NATL ACAD SCI USA, V93, P6048, DOI 10.1073/pnas.93.12.6048; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Mostacciuolo ML, 1996, HUM GENET, V97, P277, DOI 10.1007/BF02185752; Muntoni F, 2004, NAT MED, V10, P676, DOI 10.1038/nm0704-676; Neuman S, 2001, GENE, V263, P17, DOI 10.1016/S0378-1119(00)00584-9; Poulton JS, 2006, P NATL ACAD SCI USA, V103, P12775, DOI 10.1073/pnas.0603817103; Prokop A, 1998, DEV BIOL, V196, P58, DOI 10.1006/dbio.1997.8830; Roy S, 1999, BIOESSAYS, V21, P486, DOI 10.1002/(SICI)1521-1878(199906)21:6&lt;486::AID-BIES5&gt;3.0.CO;2-M; Schneider M, 2006, DEVELOPMENT, V133, P3805, DOI 10.1242/dev.02549; Shcherbata HR, 2007, EMBO J, V26, P481, DOI 10.1038/sj.emboj.7601503; Soler C, 2004, DEVELOPMENT, V131, P6041, DOI 10.1242/dev.01527; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Takemae H, 2003, J BIOL CHEM, V278, P15571, DOI 10.1074/jbc.M301123200; Takeuchi K, 2009, SCIENCE, V323, P1740, DOI 10.1126/science.1165712; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; VOIT T, 2004, MYOLOGY, P1203; Wairkar YP, 2008, J NEUROSCI, V28, P3781, DOI 10.1523/JNEUROSCI.0478-08.2008; Walker AE, 1942, ARCH NEUROL PSYCHIAT, V48, P13; WARBURG M, 1976, HUM HERED, V26, P137, DOI 10.1159/000152795; WARBURG M, 1978, AM J OPHTHALMOL, V85, P88, DOI 10.1016/S0002-9394(14)76671-1; Willer T, 2004, P NATL ACAD SCI USA, V101, P14126, DOI 10.1073/pnas.0405899101; Williams ST, 2003, APOPTOSIS, V8, P353, DOI 10.1023/A:1024168901003; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Yanagisawa A, 2007, NEUROLOGY, V69, P1254, DOI 10.1212/01.wnl.0000268489.60809.c4; YARNITZKY T, 1995, DEV BIOL, V169, P609, DOI 10.1006/dbio.1995.1173	55	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11557	10.1371/journal.pone.0011557	http://dx.doi.org/10.1371/journal.pone.0011557			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644630	Green Published, gold, Green Submitted			2022-12-25	WOS:000279822300011
J	Plager, DA; Kahl, JC; Asmann, YW; Nilson, AE; Pallanch, JF; Friedman, O; Kita, H				Plager, Douglas A.; Kahl, Jane C.; Asmann, Yan W.; Nilson, Allan E.; Pallanch, John F.; Friedman, Oren; Kita, Hirohito			Gene Transcription Changes in Asthmatic Chronic Rhinosinusitis with Nasal Polyps and Comparison to Those in Atopic Dermatitis	PLOS ONE			English	Article							INCREASED EXPRESSION; ALLERGIC RHINITIS; CYTOKINE; CELLS; DIFFERENTIATION; INFLAMMATION; EOSINOPHILS; RECRUITMENT; HEALTH; IL-33	Background: Asthmatic chronic rhinosinusitis with nasal polyps (aCRSwNP) is a common disruptive eosinophilic disease without effective medical treatment. Therefore, we sought to identify gene expression changes, particularly those occurring early, in aCRSwNP. To highlight expression changes associated with eosinophilic epithelial inflammation, we further compared the changes in aCRSwNP with those in a second eosinophilic epithelial disease, atopic dermatitis (AD), which is also closely related to asthma. Methods/Principal Findings: Genome-wide mRNA levels measured by exon array in both nasosinus inflamed mucosa and adjacent polyp from 11 aCRSwNP patients were compared to those in nasosinus tissue from 17 normal or rhinitis subjects without polyps. Differential expression of selected genes was confirmed by qRT-PCR or immunoassay, and transcription changes common to AD were identified. Comparison of aCRSwNP inflamed mucosa and polyp to normal/rhinitis tissue identified 447 differentially transcribed genes at $2 fold-change and adjusted p-value, 0.05. These included increased transcription of chemokines localized to chromosome 17q11.2 (CCL13, CCL2, CCL8, and CCL11) that favor eosinophil and monocyte chemotaxis and chemokines (CCL18, CCL22, and CXCL13) that alternatively-activated monocyte-derived cells have been shown to produce. Additional transcription changes likely associated with Th2-like eosinophilic inflammation were prominent and included increased IL1RL1 (IL33 receptor) and EMR1&3 and decreased CRISP2&3. A down-regulated PDGFB-centric network involving several smooth muscle-associated genes was also implicated. Genes at 17q11.2, genes associated with alternative activation or smooth muscle, and the IL1RL1 gene were also differentially transcribed in AD. Conclusions/Significance: Our data implicate several genes or gene sets in aCRSwNP and eosinophilic epithelial inflammation, some that likely act in the earlier stages of inflammation. The identified gene expression changes provide additional diagnostic and therapeutic targets for aCRSwNP and other eosinophilic epithelial diseases.	[Plager, Douglas A.; Nilson, Allan E.; Kita, Hirohito] Mayo Clin, Allerg Dis Res Lab, Rochester, MN 55905 USA; [Kahl, Jane C.; Asmann, Yan W.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Pallanch, John F.; Friedman, Oren] Mayo Clin, Dept Otorhinolaryngol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Plager, DA (corresponding author), Mayo Clin, Allerg Dis Res Lab, Rochester, MN 55905 USA.	plager.douglas@mayo.edu			National Institutes of Health [AI 58208, AI 49235]; Mayo Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI058208, R01AI049235, R56AI049235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI 58208 and AI 49235 and by the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson LM, 2009, J SEP SCI, V32, P44, DOI 10.1002/jssc.200800474; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard C, 2008, MUCOSAL IMMUNOL, V1, P289, DOI 10.1038/mi.2008.15; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Collins J G, 1997, Vital Health Stat 10, P1; Fritz SB, 2003, J ALLERGY CLIN IMMUN, V112, P1057, DOI 10.1016/j.jaci.2003.09.042; Goetzel RZ, 2003, J OCCUP ENVIRON MED, V45, P5, DOI 10.1097/00043764-200301000-00007; Gros E, 2009, J ALLERGY CLIN IMMUN, V124, P753, DOI 10.1016/j.jaci.2009.07.004; Hamann J, 2007, EUR J IMMUNOL, V37, P2797, DOI 10.1002/eji.200737553; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36; Huvenne W, 2009, CURR ALLERGY ASTHM R, V9, P213, DOI 10.1007/s11882-009-0031-4; Jacobsen EA, 2008, J EXP MED, V205, P699, DOI 10.1084/jem.20071840; Johnson-Huang LM, 2009, J CLIN IMMUNOL, V29, P247, DOI 10.1007/s10875-009-9278-8; Kin HB, 2009, CHEST, V135, P295, DOI 10.1378/chest.08-0962; KITA H, 2003, BIOL EOSINOPHILS ALL, P305; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Laprise C, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-21; Liu Z, 2004, J ALLERGY CLIN IMMUN, V114, P783, DOI 10.1016/j.jaci.2004.04.052; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McDougall CM, 2008, AM J RESP CELL MOL, V39, P560, DOI 10.1165/rcmb.2007-0325OC; Olsson M, 2006, ALLERGY, V61, P1132, DOI 10.1111/j.1398-9995.2006.01151.x; Plager DA, 2007, EXP DERMATOL, V16, P28, DOI 10.1111/j.1600-0625.2006.00504.x; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; Richer SL, 2008, AM J RHINOL, V22, P228, DOI 10.2500/ajr.2008.22.3162; Rostkowska-Nadolska Beata, 2008, Otolaryngol Pol, V62, P261, DOI 10.1016/S0030-6657(08)70251-8; Saaf AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004017; Smith DE, 2010, CLIN EXP ALLERGY, V40, P200, DOI 10.1111/j.1365-2222.2009.03384.x; Stankovic KM, 2008, LARYNGOSCOPE, V118, P881, DOI 10.1097/MLG.0b013e31816b4b6f; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Taha RA, 2000, J ALLERGY CLIN IMMUN, V105, P1002, DOI 10.1067/mai.2000.106483; Tieu DD, 2009, J ALLERGY CLIN IMMUN, V124, P37, DOI 10.1016/j.jaci.2009.04.045; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Walsh ER, 2008, J EXP MED, V205, P1285, DOI 10.1084/jem.20071836; Werfel T, 2009, J INVEST DERMATOL, V129, P1878, DOI 10.1038/jid.2009.71; Zou J, 2002, GENOME BIOL, V3	37	58	60	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11450	10.1371/journal.pone.0011450	http://dx.doi.org/10.1371/journal.pone.0011450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625511	Green Submitted, Green Published, gold			2022-12-25	WOS:000279522500017
J	Khatib, AM; Lahlil, R; Scamuffa, N; Akimenko, MA; Ernest, S; Lomri, A; Lalou, C; Seidah, NG; Villoutreix, BO; Calvo, F; Siegfried, G				Khatib, Abdel-Majid; Lahlil, Rachid; Scamuffa, Nathalie; Akimenko, Marie-Andree; Ernest, Sylvain; Lomri, Abdderahim; Lalou, Claude; Seidah, Nabil G.; Villoutreix, Bruno O.; Calvo, Fabien; Siegfried, Geraldine			Zebrafish ProVEGF-C Expression, Proteolytic Processing and Inhibitory Effect of Unprocessed ProVEGF-C during Fin Regeneration	PLOS ONE			English	Article							PROPROTEIN CONVERTASES FURIN; GROWTH-FACTOR; VEGF-C; VASCULAR DEVELOPMENT; CELLS; RECEPTORS; PACE4; PC5	Background: In zebrafish, vascular endothelial growth factor-C precursor (proVEGF-C) processing occurs within the dibasic motif HSIIRR214 suggesting the involvement of one or more basic amino acid-specific proprotein convertases (PCs) in this process. In the present study, we examined zebrafish proVEGF-C expression and processing and the effect of unprocessed proVEGF-C on caudal fin regeneration. Methodology/Principal Findings: Cell transfection assays revealed that the cleavage of proVEGF-C, mainly mediated by the proprotein convertases Furin and PC5 and to a less degree by PACE4 and PC7, is abolished by PCs inhibitors or by mutation of its cleavage site (HSIIRR214 into HSIISS214). In vitro, unprocessed proVEGF-C failed to activate its signaling proteins Akt and ERK and to induce cell proliferation. In vivo, following caudal fin amputation, the induction of VEGF-C, Furin and PC5 expression occurs as early as 2 days post-amputation (dpa) with a maximum levels at 4-7 dpa. Using immunofluorescence staining we localized high expression of VEGF-C and the convertases Furin and PC5 surrounding the apical growth zone of the regenerating fin. While expression of wild-type proVEGF-C in this area had no effect, unprocessed proVEGF-C inhibited fin regeneration. Conclusions/Significances: Taken together, these data indicate that zebrafish fin regeneration is associated with upregulation of VEGF-C and the convertases Furin and PC5 and highlight the inhibitory effect of unprocessed proVEGF-C on fin regeneration.	[Khatib, Abdel-Majid; Lahlil, Rachid; Scamuffa, Nathalie; Lalou, Claude; Calvo, Fabien] Univ Paris 07, Hop St Louis, Inst Genet Mol, INSERM,UMRS940,Equipe Avenir, Paris, France; [Lahlil, Rachid; Siegfried, Geraldine] INSERM, U770, Le Kremlin Bicetre, France; [Akimenko, Marie-Andree] Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Ernest, Sylvain] Ecole Normale Super, INSERM, U784, F-75231 Paris, France; [Lomri, Abdderahim] Univ Paris 07, Lariboisiere Hosp, INSERM, U606, Paris, France; [Seidah, Nabil G.] IRCM, Clin Res Inst Montreal, Montreal, PQ, Canada; [Villoutreix, Bruno O.] Univ Paris 05, INSERM, U648, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Ottawa; Ottawa Hospital Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Khatib, AM (corresponding author), Univ Paris 07, Hop St Louis, Inst Genet Mol, INSERM,UMRS940,Equipe Avenir, Paris, France.	geraldine.siegfried@inserm.fr	Villoutreix, Bruno/I-4565-2015; Lahlil, Rachid/AAK-1654-2020; Seidah, Nabil/I-3596-2013; Siegfried, Géraldine/N-6017-2018; KHATIB, Abdel-Majid/A-9948-2015; Ernest, Sylvain/C-5513-2011	Villoutreix, Bruno/0000-0002-6456-7730; Seidah, Nabil/0000-0001-6503-9342; KHATIB, Abdel-Majid/0000-0001-6957-0384; Ernest, Sylvain/0000-0001-5382-5338; siegfried, geraldine/0000-0002-6346-5206; calvo, fabien/0000-0002-0298-7633; LALOU, Claude/0000-0002-5271-7439; Lahlil, Rachid/0000-0003-2966-6386; Lomri, Abderrahim/0000-0001-9847-026X	Institut national du cancer (INCA)	Institut national du cancer (INCA)(Institut National du Cancer (INCA) France)	This work was supported by Institut national du cancer (INCA) to AMK, BV and GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; BASAK A, NOVEL ENEDIYNYL PEPT; Bergeron E, 2003, BIOCHEM J, V373, P475, DOI 10.1042/BJ20021630; Bontemps Y, 2007, MED RES REV, V27, P631, DOI 10.1002/med.20072; Cao J, 2005, J BIOL CHEM, V280, P10974, DOI 10.1074/jbc.M412370200; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Creemers JWM, 2008, FRONT BIOSCI-LANDMRK, V13, P4960, DOI 10.2741/3055; DRIEVER W, 1993, IN VITRO CELL DEV-AN, V29, P749; Eggert A, 2000, CLIN CANCER RES, V6, P1900; Eyries M, 2008, CIRC RES, V103, P432, DOI 10.1161/CIRCRESAHA.108.179333; Fukumoto S, 2005, THER APHER DIAL, V9, P319, DOI 10.1111/j.1744-9987.2005.00289.x; Huang HY, 2001, LAB INVEST, V81, P1729, DOI 10.1038/labinvest.3780386; Iovine MK, 2007, NAT CHEM BIOL, V3, P613, DOI 10.1038/nchembio.2007.36; Jin WJ, 2005, J BIOL CHEM, V280, P36551, DOI 10.1074/jbc.M502264200; Johnson SL, 1999, METHOD CELL BIOL, V59, P301; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Joukov V, 1996, EMBO J, V15, P290; Karkkainen MJ, 2002, NAT CELL BIOL, V4, pE2, DOI 10.1038/ncb0102-e2; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; Lalou C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009992; Lapierre M, 2007, CANCER RES, V67, P9030, DOI 10.1158/0008-5472.CAN-07-0807; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Lymboussaki A, 1999, CIRC RES, V85, P992; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; Ober EA, 2004, EMBO REP, V5, P78, DOI 10.1038/sj.embor.7400047; Pepper MS, 1998, J CELL PHYSIOL, V177, P439, DOI 10.1002/(SICI)1097-4652(199812)177:3<439::AID-JCP7>3.0.CO;2-2; Petrova TV, 1999, EXP CELL RES, V253, P117, DOI 10.1006/excr.1999.4707; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Raya A, 2004, CLONING STEM CELLS, V6, P345, DOI 10.1089/clo.2004.6.345; Scamuffa N, 2008, GUT, V57, P1573, DOI 10.1136/gut.2007.141812; Scamuffa N, 2008, J CLIN INVEST, V118, P352, DOI 10.1172/JCI32040; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; ZHENG M, 1994, J NEUROSCI, V14, P4656	39	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11438	10.1371/journal.pone.0011438	http://dx.doi.org/10.1371/journal.pone.0011438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625388	Green Published, Green Submitted, gold			2022-12-25	WOS:000279465700018
J	Wu, B; Zhou, D; Fu, F; Luo, QJ; Wang, L; Traulsen, A				Wu, Bin; Zhou, Da; Fu, Feng; Luo, Qingjun; Wang, Long; Traulsen, Arne			Evolution of Cooperation on Stochastic Dynamical Networks	PLOS ONE			English	Article							DIRECT RECIPROCITY; PRISONERS-DILEMMA; GAMES; INDIVIDUALS; BEHAVIOR	Cooperative behavior that increases the fitness of others at a cost to oneself can be promoted by natural selection only in the presence of an additional mechanism. One such mechanism is based on population structure, which can lead to clustering of cooperating agents. Recently, the focus has turned to complex dynamical population structures such as social networks, where the nodes represent individuals and links represent social relationships. We investigate how the dynamics of a social network can change the level of cooperation in the network. Individuals either update their strategies by imitating their partners or adjust their social ties. For the dynamics of the network structure, a random link is selected and breaks with a probability determined by the adjacent individuals. Once it is broken, a new one is established. This linking dynamics can be conveniently characterized by a Markov chain in the configuration space of an ever-changing network of interacting agents. Our model can be analytically solved provided the dynamics of links proceeds much faster than the dynamics of strategies. This leads to a simple rule for the evolution of cooperation: The more fragile links between cooperating players and non-cooperating players are (or the more robust links between cooperators are), the more likely cooperation prevails. Our approach may pave the way for analytically investigating coevolution of strategy and structure.	[Wu, Bin; Wang, Long] Peking Univ, Ctr Syst & Control, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China; [Wu, Bin; Traulsen, Arne] Max Planck Inst Evolutionary Biol, Emmy Noether Grp Evolutionary Dynam, Plon, Germany; [Zhou, Da] Peking Univ, Sch Math Sci, Beijing 100871, Peoples R China; [Fu, Feng] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Luo, Qingjun] Peking Univ, Sch Elect Engn & Comp Sci, Beijing 100871, Peoples R China	Peking University; Max Planck Society; Peking University; Harvard University; Peking University	Wu, B (corresponding author), Peking Univ, Ctr Syst & Control, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China.	bin.wu@evolbio.mpg.de	Wang, Long/A-7798-2010; Traulsen, Arne/A-4955-2009; Gao, Y./GWZ-3665-2022; Fu, Feng/R-3686-2017; Fu, Feng/A-3376-2009	Wang, Long/0000-0001-5600-8157; Traulsen, Arne/0000-0002-0669-5267; Fu, Feng/0000-0001-8252-1990; Fu, Feng/0000-0001-8252-1990; Zhou, Da/0000-0002-0272-6644	China Scholarship Council [2009601286]; Natural Science Foundation of China [10625101]; 973 Fund [2006CB805900]; National Natural Science Foundation of China [10972002, 60736022]; Deutsche Forschungsgemeinschaft	China Scholarship Council(China Scholarship Council); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Fund(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	B.W. gratefully acknowledges the financial support from China Scholarship Council (2009601286). D.Z. acknowledges support by the Natural Science Foundation of China (10625101) and 973 Fund (2006CB805900). L.W. acknowledges support by the National Natural Science Foundation of China (10972002 and 60736022). A.T. acknowledges support by the Emmy-Noether program of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Biely C, 2007, PHYSICA D, V228, P40, DOI 10.1016/j.physd.2007.02.004; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; Bshary R, 2005, BIOL LETTERS, V1, P396, DOI 10.1098/rsbl.2005.0344; Chen XJ, 2008, PHYSICA A, V387, P5609, DOI 10.1016/j.physa.2008.05.043; DO AL, 2009, NEW J PHYS IN PRESS; EBEL H, 2002, CONDMAT0211666; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hanaki N, 2007, MANAGE SCI, V53, P1036, DOI 10.1287/mnsc.1060.0625; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Levin SA, 2009, SPRINGER SER GAME TH, P1, DOI 10.1007/978-3-540-85436-4; LINDGREN K, 1994, PHYSICA D, V75, P292, DOI 10.1016/0167-2789(94)90289-5; Maynard Smith J., 1982, pi; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2010, PHILOS T R SOC B, V365, P19, DOI 10.1098/rstb.2009.0215; Ohtsuki H, 2007, J THEOR BIOL, V247, P462, DOI 10.1016/j.jtbi.2007.03.018; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pacheco JM, 2008, J THEOR BIOL, V250, P723, DOI 10.1016/j.jtbi.2007.10.040; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Pacheco JM, 2006, J THEOR BIOL, V243, P437, DOI 10.1016/j.jtbi.2006.06.027; Perc M, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.022101; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Poncela J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083031; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; SEGBROECK SV, 2009, PHYS REV LETT, V102; Sigmund K., 2010, CALCULUS SELFISHNESS; Skyrms B, 2000, P NATL ACAD SCI USA, V97, P9340, DOI 10.1073/pnas.97.16.9340; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Taylor C, 2007, EVOLUTION, V61, P2281, DOI 10.1111/j.1558-5646.2007.00196.x; Tomassini M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016132; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011909; Traulsen A, 2010, EVOLUTION, V64, P316, DOI 10.1111/j.1558-5646.2009.00899.x; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Segbroeck S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-287; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118; ZSCHALER G, 2009, ARXIV09100940	52	135	140	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11187	10.1371/journal.pone.0011187	http://dx.doi.org/10.1371/journal.pone.0011187			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614025	gold, Green Published, Green Submitted			2022-12-25	WOS:000279370000003
J	Iadevaia, V; Caldarola, S; Biondini, L; Gismondi, A; Karlsson, S; Dianzani, I; Loreni, F				Iadevaia, V.; Caldarola, S.; Biondini, L.; Gismondi, A.; Karlsson, S.; Dianzani, I.; Loreni, F.			PIM1 kinase is destabilized by ribosomal stress causing inhibition of cell cycle progression	ONCOGENE			English	Article						ribosome synthesis; cell cycle arrest; erythroleukemia cells; PIM1; RPS19; p27(Kip1)	DIAMOND-BLACKFAN ANEMIA; ACTIVATION; P53; PROTEINS; PROLIFERATION; BIOGENESIS; DISRUPTION; REGULATORS; P27(KIP1); STABILITY	PIM1 is a constitutively active serine/threonine kinase regulated by cytokines, growth factors and hormones. It has been implicated in the control of cell cycle progression and apoptosis and its overexpression has been associated with various kinds of lymphoid and hematopoietic malignancies. The activity of PIM1 is dependent on the phosphorylation of several targets involved in transcription, cell cycle and apoptosis. We have recently observed that PIM1 interacts with ribosomal protein (RP) S19 and cosediments with ribosomes. Defects in ribosome synthesis (ribosomal stress) have been shown to activate a p53-dependent growth arrest response. To investigate if PIM1 could have a role in the response to ribosomal stress, we induced ribosome synthesis alterations in TF-1 and K562 erythroid cell lines. We found that RP deficiency, induced by RNA interference or treatment with inhibitor of nucleolar functions, causes a drastic destabilization of PIM1. The lower level of PIM1 induces an increase in the cell cycle inhibitor p27(Kip1) and blocks cell proliferation even in the absence of p53. Notably, restoring PIM1 level by transfection causes a recovery of cell growth. Our data indicate that PIM1 may act as a sensor for ribosomal stress independently of or in concert with the known p53-dependent mechanisms. Oncogene (2010) 29, 5490-5499; doi:10.1038/onc.2010.279; published online 19 July 2010	[Iadevaia, V.; Caldarola, S.; Biondini, L.; Gismondi, A.; Loreni, F.] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Karlsson, S.] Univ Lund Hosp, Lund Stem Cell Ctr, Dept Mol Med & Gene Therapy, S-22185 Lund, Sweden; [Dianzani, I.] Univ Piemonte Orientale, Dept Med Sci, Novara, Italy	University of Rome Tor Vergata; Lund University; Skane University Hospital; University of Eastern Piedmont Amedeo Avogadro	Loreni, F (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci, I-00133 Rome, Italy.	loreni@uniroma2.it	Iadevaia, Valentina/J-8613-2017; Gismondi, Angelo/N-4264-2015; Iadevaia, Valentina/H-2950-2019	Iadevaia, Valentina/0000-0002-8393-8541; Gismondi, Angelo/0000-0002-9257-9667; Iadevaia, Valentina/0000-0002-8393-8541	Telethon, Italy [GGP07242]; Diamond Blackfan Anemia Foundation Inc.; Italian Ministry for University and Research (MIUR)	Telethon, Italy(Fondazione Telethon); Diamond Blackfan Anemia Foundation Inc.; Italian Ministry for University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	We thank Marcello Giorgi for expert technical assistance. The financial support of Telethon, Italy (Grant No. GGP07242) is gratefully acknowledged. This work was also supported by grants from Diamond Blackfan Anemia Foundation Inc. and the Italian Ministry for University and Research (MIUR) FIRB and PRIN.	Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Badhai J, 2009, FEBS LETT, V583, P2049, DOI 10.1016/j.febslet.2009.05.023; Caldarola S, 2009, FEBS J, V276, P3199, DOI 10.1111/j.1742-4658.2009.07036.x; Chiocchetti A, 2005, HAEMATOLOGICA, V90, P1453; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Hammerman PS, 2005, BLOOD, V105, P4477, DOI 10.1182/blood-2004-09-3706; Idol RA, 2007, BLOOD CELL MOL DIS, V39, P35, DOI 10.1016/j.bcmd.2007.02.001; LAIRD PW, 1993, NUCLEIC ACIDS RES, V21, P4750, DOI 10.1093/nar/21.20.4750; Larrea MD, 2009, CELL CYCLE, V8, P3455, DOI 10.4161/cc.8.21.9789; Liu JM, 2006, BLOOD, V107, P4583, DOI 10.1182/blood-2005-12-4831; Losman JA, 2003, J BIOL CHEM, V278, P4800, DOI 10.1074/jbc.M208246200; Mayer C, 2005, CELL CYCLE, V4, P1036, DOI 10.4161/cc.4.8.1925; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Miyake K, 2005, MOL THER, V11, P627, DOI 10.1016/j.ymthe.2004.12.001; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Orru S, 2007, MOL CELL PROTEOMICS, V6, P382, DOI 10.1074/mcp.M600156-MCP200; Panic L, 2007, CELL CYCLE, V6, P20, DOI 10.4161/cc.6.1.3666; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; SELTEN G, 1985, EMBO J, V4, P1793, DOI 10.1002/j.1460-2075.1985.tb03852.x; Shah N, 2008, EUR J CANCER, V44, P2144, DOI 10.1016/j.ejca.2008.06.044; Shay KP, 2005, MOL CANCER RES, V3, P170; Soeiro I, 2006, MOL CELL BIOL, V26, P6170, DOI 10.1128/MCB.02182-05; Steinman RA, 2002, ONCOGENE, V21, P3403, DOI 10.1038/sj.onc.1205325; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; Urashima M, 1998, BLOOD, V92, P959, DOI 10.1182/blood.V92.3.959.414k21_959_967; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; Wang Z, 2001, J Vet Sci, V2, P167; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	34	41	41	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	40					5490	5499		10.1038/onc.2010.279	http://dx.doi.org/10.1038/onc.2010.279			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664FM	20639905				2022-12-25	WOS:000282945800006
J	Prevost, M; Vertongen, P; Raussens, V; Roberts, DJ; Cnudde, J; Perret, J; Waelbroeck, M				Prevost, Martine; Vertongen, Pascale; Raussens, Vincent; Roberts, David Jonathan; Cnudde, Johnny; Perret, Jason; Waelbroeck, Magali			Mutational and Cysteine Scanning Analysis of the Glucagon Receptor N-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICOTROPIN-RELEASING-FACTOR; PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; 1ST-EXTRACELLULAR DOMAIN; MOLECULAR RECOGNITION; EXTRACELLULAR DOMAIN; BINDING-SITE; RESIDUES; SECRETIN; HORMONE	The glucagon receptor belongs to the B family of G-protein coupled receptors. Little structural information is available about this receptor and its association with glucagon. We used the substituted cysteine accessibility method and three-dimensional molecular modeling based on the gastrointestinal insulinotropic peptide and glucagon-like peptide 1 receptor structures to study the N-terminal domain of this receptor, a central element for ligand binding and specificity. Our results showed that Asp(63), Arg(116), and Lys(98) are essential for the receptor structure and/or ligand binding because mutations of these three residues completely disrupted or markedly impaired the receptor function. In agreement with these data, our models revealed that Asp(63) and Arg(116) form a salt bridge, whereas Lys(98) is engaged in cation-pi interactions with the conserved tryptophans 68 and 106. The native receptor could not be labeled by hydrophilic cysteine biotinylation reagents, but treatment of intact cells with [2-(trimethylammonium)ethyl]methanethiosulfonate increased the glucagon binding site density. This result suggested that an unidentified protein with at least one free cysteine associated with the receptor prevented glucagon recognition and that [2-(trimethylammonium)ethyl]methanethiosulfonate treatment relieved this inhibition. The substituted cysteine accessibility method was also performed on 15 residues selected using the three-dimensional models. Several receptor mutants, despite a relatively high predicted cysteine accessibility, could not be labeled by specific reagents. The three-dimensional models show that these mutated residues are located on one face of the protein. This could be part of the interface between the receptor and the unidentified inhibitory protein, making these residues inaccessible to biotinylation compounds.	[Waelbroeck, Magali] Univ Libre Bruxelles, Lab Chim Biol & Nutr, Fac Med, B-1070 Brussels, Belgium; Univ Libre Bruxelles, Lab Struct & Fonct Membranes Biol, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Waelbroeck, M (corresponding author), Univ Libre Bruxelles, Lab Chim Biol & Nutr, Fac Med, 808 Route Lennik CP611, B-1070 Brussels, Belgium.	mawaelbr@ulb.ac.be			Fonds de la Recherche Scientifique Medicale [3.4541.03]; Communaute Francaise de Belgique	Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Communaute Francaise de Belgique(Australian Research Council)	This work was supported by Fonds de la Recherche Scientifique Medicale Grant 3.4541.03 and by an "Action de Recherche Concertee" from the Communaute Francaise de Belgique.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Authier F, 2008, CELL MOL LIFE SCI, V65, P1880, DOI 10.1007/s00018-008-7479-6; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5; Gourlet P, 1996, PEPTIDES, V17, P825, DOI 10.1016/0196-9781(96)00107-6; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Javitch JA, 2002, METHOD ENZYMOL, V343, P137; Javitch JA, 1998, METHOD ENZYMOL, V296, P331; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kusano S, 2008, PROTEIN SCI, V17, P1907, DOI 10.1110/ps.036012.108; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Morfis M, 2003, TRENDS PHARMACOL SCI, V24, P596, DOI 10.1016/j.tips.2003.09.001; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Perret J, 2002, BIOCHEM J, V362, P389, DOI 10.1042/0264-6021:3620389; Perrin MH, 2007, J BIOL CHEM, V282, P37529, DOI 10.1074/jbc.M703748200; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SAVAGE MD, 1992, AVIDIN BOTIN CHEM HD, P273; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STEPHENSON RP, 1956, BRIT J PHARM CHEMOTH, V11, P379, DOI 10.1111/j.1476-5381.1956.tb00006.x; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vilardaga JP, 1997, EUR J BIOCHEM, V246, P173, DOI 10.1111/j.1432-1033.1997.00173.x; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565	35	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30951	30958		10.1074/jbc.M110.102814	http://dx.doi.org/10.1074/jbc.M110.102814			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20647307	Green Published, hybrid			2022-12-25	WOS:000282135500060
J	Horita, S; Ishibashi, J; Nagata, K; Miyakawa, T; Yamakawa, M; Tanokura, M				Horita, Shoichiro; Ishibashi, Jun; Nagata, Koji; Miyakawa, Takuya; Yamakawa, Minoru; Tanokura, Masaru			Isolation, cDNA Cloning, and Structure-based Functional Characterization of Oryctin, a Hemolymph Protein from the Coconut Rhinoceros Beetle, Oryctes rhinoceros, as a Novel Serine Protease Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVOMUCOID 3RD DOMAIN; KAZAL-TYPE INHIBITOR; CHEMICAL-SHIFT; ELASTASE; SEQUENCE; CRYSTAL; COMPLEX	We isolated oryctin, a 66-residue peptide, from the hemolymph of the coconut rhinoceros beetle Oryctes rhinoceros and cloned its cDNA. Oryctin is dissimilar to any other known peptides in amino acid sequence, and its function has been unknown. To reveal that function, we determined the solution structure of recombinant C-13, N-15-labeled oryctin by heteronuclear NMR spectroscopy. Oryctin exhibits a fold similar to that of Kazal-type serine protease inhibitors but has a unique additional C-terminal alpha-helix. We performed protease inhibition assays of oryctin against several bacterial and eukaryotic proteases. Oryctin does inhibit the following serine proteases: alpha-chymotrypsin, endopeptidase K, subtilisin Carlsberg, and leukocyte elastase, with K-i values of 3.9 x 10(-10) (M), 6.2 x 10(-10) (M), 1.4 x 10(-9) (M), and 1.2 x 10(-8) (M), respectively. Although the target molecule of oryctin in the beetle hemolymph remains obscure, our results showed that oryctin is a novel single domain Kazal-type inhibitor and could play a key role in protecting against bacterial infections.	[Horita, Shoichiro; Nagata, Koji; Miyakawa, Takuya; Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Ishibashi, Jun; Yamakawa, Minoru] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Yamakawa, Minoru] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tokyo; National Institute of Agrobiological Sciences - Japan; University of Tsukuba	Tanokura, M (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp		Nagata, Koji/0000-0002-4704-0603; Tanokura, Masaru/0000-0001-5072-2480	Enhancement of Center of Excellence, Special Coordination Funds for Promoting Science and Technology, Science and Technology Agency, Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Enhancement of Center of Excellence, Special Coordination Funds for Promoting Science and Technology, Science and Technology Agency, Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Enhancement of Center of Excellence, Special Coordination Funds for Promoting Science and Technology, Science and Technology Agency, Japan; and by the National Project on Protein Structural and Functional Analyses, the Targeted Proteins Research Program, and grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Baker BM, 1997, J MOL BIOL, V268, P557, DOI 10.1006/jmbi.1997.0977; BODE W, 1986, EMBO J, V5, P2453, DOI 10.1002/j.1460-2075.1986.tb04521.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; EGUCHI M, 1994, J BIOCHEM-TOKYO, V115, P881, DOI 10.1093/oxfordjournals.jbchem.a124434; FRIEDRICH T, 1993, J BIOL CHEM, V268, P16216; FUJINAGA M, 1987, J MOL BIOL, V195, P397, DOI 10.1016/0022-2836(87)90659-0; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ishibashi J, 1999, EUR J BIOCHEM, V266, P616, DOI 10.1046/j.1432-1327.1999.00906.x; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Lauber T, 2003, J MOL BIOL, V328, P205, DOI 10.1016/S0022-2836(03)00245-6; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; Tomie T, 2003, BIOCHEM BIOPH RES CO, V307, P261, DOI 10.1016/S0006-291X(03)01162-8; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yang J, 1998, EUR J BIOCHEM, V255, P734, DOI 10.1046/j.1432-1327.1998.2550734.x	17	14	14	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30150	30158		10.1074/jbc.M110.124735	http://dx.doi.org/10.1074/jbc.M110.124735			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20630859	Green Published, hybrid			2022-12-25	WOS:000281984300052
J	Jiang, M; Chen, MJ; Guo, ZF; Guo, ZH				Jiang, Ming; Chen, Minjiao; Guo, Zu-Feng; Guo, Zhihong			A Bicarbonate Cofactor Modulates 1,4-Dihydroxy-2-naphthoyl-Coenzyme A Synthase in Menaquinone Biosynthesis of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIMETHYLAMINE N-OXIDE; ENOYL-COA HYDRATASE; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; NAPHTHOATE SYNTHASE; ANGSTROM RESOLUTION; ADENYLYL-CYCLASE; PHOTOSYSTEM-II; QUINONE POOL; VITAMIN-K	1,4-Dihydroxy-2-naphthoyl coenzyme A (DHNA-CoA) synthase is a typical crotonase-fold protein catalyzing an intramolecular Claisen condensation in the menaquinone biosynthetic pathway. We have characterized this enzyme from Escherichia coli and found that it is activated by bicarbonate in a concentration-dependent manner. The bicarbonate binding site has been identified in the crystal structure of a virtually identical ortholog (96.8% sequence identity) from Salmonella typhimurium through comparison with a bicarbonate-insensitive orthologue. Kinetic properties of the enzyme and its site-directed mutants of the bicarbonate binding site indicate that the exogenous bicarbonate anion is essential to the enzyme activity. With this essential catalytic role, the simple bicarbonate anion is an enzyme cofactor, which is usually a small organic molecule derived from vitamins, a metal ion, or a metal-containing polyatomic anionic complex. This finding leads to classification of the DHNA-CoA synthases into two evolutionarily conserved subfamilies: type I enzymes that are bicarbonate-dependent and contain a conserved glycine at the bicarbonate binding site; and type II enzymes that are bicarbonate-independent and contain a conserved aspartate at the position similar to the enzyme-bound bicarbonate. In addition, the unique location of the enzyme-bound bicarbonate allows it to be proposed as a catalytic base responsible for abstraction of the alpha-proton of the thioester substrate in the enzymatic reaction, suggesting a unified catalytic mechanism for all DHNA-CoA synthases.	[Jiang, Ming; Chen, Minjiao; Guo, Zu-Feng; Guo, Zhihong] Hong Kong Univ Sci & Technol, Dept Chem, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Guo, ZH (corresponding author), Hong Kong Univ Sci & Technol, Dept Chem, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.	chguo@ust.hk	guo, zufeng/C-8035-2011; Chen, Minjiao/A-8117-2012	guo, zufeng/0000-0002-4370-9445; Guo, Zhihong/0000-0003-0374-8412	Research Grants Council of the Hong Kong Special Administrative Region of the People's Republic of China [GRF601209]	Research Grants Council of the Hong Kong Special Administrative Region of the People's Republic of China(Hong Kong Research Grants Council)	This work was supported by the Research Grants Council of the Hong Kong Special Administrative Region of the People's Republic of China (Grant GRF601209).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bekker M, 2007, MICROBIOL-SGM, V153, P1974, DOI 10.1099/mic.0.2007/006098-0; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Berkner KL, 2005, ANNU REV NUTR, V25, P127, DOI 10.1146/annurev.nutr.25.050304.092713; Bugel S, 2008, VITAM HORM, V78, P393, DOI 10.1016/S0083-6729(07)00016-7; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Cronk JD, 2006, BIOCHEMISTRY-US, V45, P4351, DOI 10.1021/bi052272q; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DORDINE RL, 1994, BIOCHEMISTRY-US, V33, P14733, DOI 10.1021/bi00253a011; Dosselaere F, 2001, CRIT REV MICROBIOL, V27, P75, DOI 10.1080/20014091096710; DOWD P, 1995, ANNU REV NUTR, V15, P419, DOI 10.1146/annurev.nu.15.070195.002223; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel CK, 1998, J MOL BIOL, V275, P847, DOI 10.1006/jmbi.1997.1491; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; FERNANDEZ F, 1985, BIOCHEM SOC T, V13, P223, DOI 10.1042/bst0130223; Garcion C, 2008, PLANT PHYSIOL, V147, P1279, DOI 10.1104/pp.108.119420; Glasner ME, 2006, J MOL BIOL, V360, P228, DOI 10.1016/j.jmb.2006.04.055; Gross J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-117; Hernandez-Guillamon M, 2007, J BIOCHEM, V142, P571, DOI 10.1093/jb/mvm165; Hiratsuka T, 2008, SCIENCE, V321, P1670, DOI 10.1126/science.1160446; Holden HM, 2001, ACCOUNTS CHEM RES, V34, P145, DOI 10.1021/ar000053l; IGBAVBOA U, 1990, EUR J BIOCHEM, V192, P441, DOI 10.1111/j.1432-1033.1990.tb19246.x; Jiang M, 2008, BIOCHEMISTRY-US, V47, P3426, DOI 10.1021/bi7023755; Jiang M, 2007, ORG LETT, V9, P4765, DOI 10.1021/ol702126m; Jiang M, 2007, BIOCHEMISTRY-US, V46, P10979, DOI 10.1021/bi700810x; Jiang M, 2009, BIOCHEMISTRY-US, V48, P6921, DOI 10.1021/bi900897h; Johnston JM, 2005, ACTA CRYSTALLOGR D, V61, P1199, DOI [10.1107/s0907444905017531, 10.1107/S0904777905017531]; Jones R. W., 1982, FUNCTION QUINONES EN, P465; Kiema TR, 1999, BIOCHEMISTRY-US, V38, P2991, DOI 10.1021/bi981646v; Kurosu M, 2007, J MED CHEM, V50, P3973, DOI 10.1021/jm070638m; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefebvre-Legendre L, 2007, J BIOL CHEM, V282, P13250, DOI 10.1074/jbc.M610249200; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Lu XQ, 2008, BIOORG MED CHEM LETT, V18, P5963, DOI 10.1016/j.bmcl.2008.07.130; Meganathan R, 2001, VITAM HORM, V61, P173; Meganathan R., 1996, ESCHERICHIA COLI SAL, P642; Modis Y, 1998, STRUCTURE, V6, P957, DOI 10.1016/S0969-2126(98)00098-7; MULLERNEWEN G, 1995, EUR J BIOCHEM, V228, P68, DOI 10.1111/j.1432-1033.1995.tb20230.x; Mursula AM, 2001, J MOL BIOL, V309, P845, DOI 10.1006/jmbi.2001.4671; POLGLASE WJ, 1966, BIOCHIM BIOPHYS ACTA, V118, P425, DOI 10.1016/S0926-6593(66)80053-X; REPASKE R, 1978, J BACTERIOL, V135, P1162, DOI 10.1128/JB.135.3.1162-1164.1978; Seto H, 2008, J AM CHEM SOC, V130, P5614, DOI 10.1021/ja710207s; Shanahan CM, 1998, CRIT REV EUKAR GENE, V8, P357, DOI 10.1615/CritRevEukarGeneExpr.v8.i3-4.60; Shestopalov AI, 1997, FEBS LETT, V404, P272, DOI 10.1016/S0014-5793(97)00143-9; Shevela D, 2008, BBA-BIOENERGETICS, V1777, P532, DOI 10.1016/j.bbabio.2008.03.031; Shevela D, 2007, PHOTOSYNTH RES, V94, P247, DOI 10.1007/s11120-007-9200-2; Steegborn C, 2005, NAT STRUCT MOL BIOL, V12, P32, DOI 10.1038/nsmb880; Strater N, 1999, P NATL ACAD SCI USA, V96, P11151, DOI 10.1073/pnas.96.20.11151; Sun LM, 2009, P NATL ACAD SCI USA, V106, P2041, DOI 10.1073/pnas.0812220106; SUTTIE JW, 1995, ANNU REV NUTR, V15, P399, DOI 10.1146/annurev.nu.15.070195.002151; Truglio JJ, 2003, J BIOL CHEM, V278, P42352, DOI 10.1074/jbc.M307399200; Ulaganathan V, 2007, ACTA CRYSTALLOGR F, V63, P908, DOI 10.1107/S1744309107047720; Ulas G, 2008, BIOCHEMISTRY-US, V47, P3073, DOI 10.1021/bi8000424; UNDEN G, 1988, ARCH MICROBIOL, V150, P499, DOI 10.1007/BF00422294; Watsuji TO, 2006, BIOSCI BIOTECH BIOCH, V70, P753, DOI 10.1271/bbb.70.753; Widhalm JR, 2009, P NATL ACAD SCI USA, V106, P5599, DOI 10.1073/pnas.0900738106; WISSENBACH U, 1990, ARCH MICROBIOL, V154, P60; WISSENBACH U, 1992, ARCH MICROBIOL, V158, P68, DOI 10.1007/BF00249068	58	18	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30159	30169		10.1074/jbc.M110.147702	http://dx.doi.org/10.1074/jbc.M110.147702			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20643650	hybrid, Green Published			2022-12-25	WOS:000281984300053
J	Joo, HJ; Kim, KY; Yim, YH; Jin, YX; Kim, H; Kim, MY; Paik, YK				Joo, Hyoe-Jin; Kim, Kwang-Youl; Yim, Yong-Hyeon; Jin, You-Xun; Kim, Heekyeong; Kim, Mun-Young; Paik, Young-Ki			Contribution of the Peroxisomal acox Gene to the Dynamic Balance of Daumone Production in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAUER PHEROMONE COMPONENT; BIOGENESIS DISORDERS; BETA-OXIDATION; TEMPERATURE; BIOSYNTHESIS; OXIDASE	Dauer pheromones or daumones, which are signaling molecules that interrupt development and reproduction (dauer larvae) during unfavorable growth conditions, are essential for cellular homeostasis in Caenorhabditis elegans. According to earlier studies, dauer larva formation in strain N2 is enhanced by a temperature increase, suggesting the involvement of a temperature-dependent component in dauer pheromone biosynthesis or sensing. Several naturally occurring daumone analogs (e. g. daumones 1-3) have been identified, and these molecules are predicted to be synthesized in different physiological settings in this nematode. To elucidate the molecular regulatory system that may influence the dynamic balance of specific daumone production in response to sudden temperature changes, we characterized the peroxisomal acox gene encoding acyl-CoA oxidase, which is predicted to catalyze the first reaction during biosynthesis of the fatty acid component of daumones. Using acox-1(ok2257) mutants and a new, robust analytical method, we quantified the three most abundant daumones in worm bodies and showed that acox likely contributes to the dynamic production of various quantities of three different daumones in response to temperature increase, changes that are critical in C. elegans for coping with the natural environmental changes it faces.	[Paik, Young-Ki] Yonsei Univ, World Class Univ Program, Dept Biomed Sci,Dept Biochem, Yonsei Proteome Res Ctr,Coll Life Sci & Biotechno, Seoul 120749, South Korea; [Yim, Yong-Hyeon; Jin, You-Xun] Korea Res Inst Stand & Sci, Taejon 305340, South Korea	Yonsei University; Korea Research Institute of Standards & Science (KRISS)	Paik, YK (corresponding author), Yonsei Univ, World Class Univ Program, Dept Biomed Sci,Dept Biochem, Yonsei Proteome Res Ctr,Coll Life Sci & Biotechno, Seoul 120749, South Korea.	paikyk@yonsei.ac.kr		kim, kwangyoul/0000-0001-8667-3369	Ministry of Health and Welfare of Republic of Korea [A030003]; World Class University through National Research Foundation of Korea [R31-2008-000-10086-0]	Ministry of Health and Welfare of Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); World Class University through National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported in part by Korea Health 21 R & DProject Ministry of Health and Welfare of Republic of Korea Grant A030003 (to Y.-K. P.) and by World Class University Program Grant R31-2008-000-10086-0 through the National Research Foundation of Korea.	Butcher RA, 2008, P NATL ACAD SCI USA, V105, P14288, DOI 10.1073/pnas.0806676105; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Butcher RA, 2009, ORG LETT, V11, P3100, DOI 10.1021/ol901011c; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; DMOCHOWSKA A, 1990, GENE, V88, P247, DOI 10.1016/0378-1119(90)90038-S; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gurvitz A, 2000, YEAST, V17, P188, DOI 10.1002/1097-0061(20000930)17:3<188::AID-YEA27>3.0.CO;2-E; Imamura A, 2001, J MED GENET, V38, P871, DOI 10.1136/jmg.38.12.871; Jeong PY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004162; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Joo HJ, 2009, BIOCHEM J, V422, P61, DOI 10.1042/BJ20090513; Lee J, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.022665; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Pungaliya C, 2009, P NATL ACAD SCI USA, V106, P7708, DOI 10.1073/pnas.0811918106; Sambrook J., 1989, MOL CLONING, pA1; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Thieringer H, 2003, J CELL SCI, V116, P1797, DOI 10.1242/jcs.00380; Wanders RJA, 2004, MOL GENET METAB, V83, P16, DOI 10.1016/j.ymgme.2004.08.016	22	50	56	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29319	29325		10.1074/jbc.M110.122663	http://dx.doi.org/10.1074/jbc.M110.122663			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20610393	hybrid, Green Published			2022-12-25	WOS:000281740100034
J	Lee, SY; Lau, ATY; Jeong, CH; Shim, JH; Kim, HG; Kim, J; Bode, AM; Dong, ZG				Lee, Sung-Young; Lau, Andy T. Y.; Jeong, Chul-Ho; Shim, Jung-Hyun; Kim, Hong-Gyum; Kim, Jaebong; Bode, Ann M.; Dong, Zigang			Histone XH2AX Is Required for Xenopus Anterior Neural Development CRITICAL ROLE OF THREONINE 16 PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSAL MARGINAL ZONE; DNA-DAMAGE; CHROMATIN MODIFICATIONS; CHK1; METHYLATION; H2AX; SPECIFICATION; TRANSCRIPTION; REPLICATION; KINASES	A role for histone H2AX, one of the variants of the nucleosome core histone H2A, has been demonstrated in DNA repair, tumor suppression, apoptosis, and cell cycle checkpoint function. However, the physiological function and post-translational modification of histone H2AX during vertebrate development have not been elucidated. Here, we provide evidence showing that Xenopus histone H2AX (XH2AX) has a role in the anterior neural plate for eye field formation during Xenopus embryogenesis. A loss-of-function study clearly demonstrated a critical role of XH2AX in anterior neural specification. Through a differentiation assay with Xenopus animal cap embryonic stem cells, we confirmed that XH2AX is required for the activin-induced anterior neural specification of the ectoderm. Furthermore, we found that Chk1 is an essential kinase to phosphorylate histone XH2AX at Thr(16), which is involved in the biological function of this histone. Taken together, our findings reveal that XH2AX has a specific role in anterior neural formation of Xenopus, which is mediated through phosphorylation of XH2AX at Thr(16) by Chk1.	[Lee, Sung-Young; Lau, Andy T. Y.; Jeong, Chul-Ho; Shim, Jung-Hyun; Kim, Hong-Gyum; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Kim, Jaebong] Hallym Univ, Coll Med, Dept Biochem, Chunchon 200702, Kangwon Do, South Korea	University of Minnesota System; Hallym University	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	Lau, Andy Tao Yin/AAX-9980-2021; Kim, Jaebong/AAV-1986-2021	Lau, Andy Tao Yin/0000-0002-7146-7789; Kim, Jaebong/0000-0003-1609-338X; Shim, Jung-Hyun/0000-0002-4062-4016	National Institutes of Health [CA077646, CA111536, CA120388, R37 CA081064, ES016548]; Hormel Foundation; NATIONAL CANCER INSTITUTE [R01CA111536, R01CA120388, R37CA081064, R01CA077646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA077646, CA111536, CA120388, R37 CA081064, and ES016548.; This work was also supported by The Hormel Foundation.	ARIIZUMI T, 2009, CURR PROTOC STEM CEL, pCH1; Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Cosgrove MS, 2005, BIOCHEM CELL BIOL, V83, P468, DOI 10.1139/O05-137; Ehrenhofer-Murray AE, 2004, EUR J BIOCHEM, V271, P2335, DOI 10.1111/j.1432-1033.2004.04162.x; Enders GH, 2008, J BIOL CHEM, V283, P17749, DOI 10.1074/jbc.R800021200; EYAL-GILADI H., 1954, ARCH BIOL [PARIS], V65, P179; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Grant PA, 2001, GENOME BIOL, V2; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; Green JBA, 1997, P NATL ACAD SCI USA, V94, P8596, DOI 10.1073/pnas.94.16.8596; Hadnagy A, 2008, MOL CANCER THER, V7, P740, DOI 10.1158/1535-7163.MCT-07-2284; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Iouzalen N, 1996, NUCLEIC ACIDS RES, V24, P3947, DOI 10.1093/nar/24.20.3947; ISENBERG I, 1979, ANNU REV BIOCHEM, V48, P159, DOI 10.1146/annurev.bi.48.070179.001111; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Lupo G, 2000, INT J DEV BIOL, V44, P627; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Okabayashi K, 2003, CURR OPIN GENET DEV, V13, P502, DOI 10.1016/S0959-437X(03)00111-4; Papan C, 2007, DEV BIOL, V305, P161, DOI 10.1016/j.ydbio.2007.02.005; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Ridgway P, 2004, J BIOL CHEM, V279, P43815, DOI 10.1074/jbc.M408409200; Ruiz i Altaba A, 1989, Nature, V341, P33; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; SHIH J, 1992, DEVELOPMENT, V116, P887; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Steinbach OC, 1997, NATURE, V389, P395, DOI 10.1038/38755; Takai H, 2000, GENE DEV, V14, P1439; THOMSEN G, 1990, CELL, V63, P485, DOI 10.1016/0092-8674(90)90445-K; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Vermaak D, 1998, CURR BIOL, V8, P533, DOI 10.1016/S0960-9822(98)70206-4; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wuebbles RD, 2004, CELL MOL LIFE SCI, V61, P2148, DOI 10.1007/s00018-004-4175-z; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Xu RH, 1996, P NATL ACAD SCI USA, V93, P834, DOI 10.1073/pnas.93.2.834; Zaid O, 2005, CELL MOL LIFE SCI, V62, P1653, DOI 10.1007/s00018-005-5091-6; Zaugg K, 2007, P NATL ACAD SCI USA, V104, P3805, DOI 10.1073/pnas.0611584104; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	47	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29525	29534		10.1074/jbc.M110.127233	http://dx.doi.org/10.1074/jbc.M110.127233			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20639511	Green Published, hybrid			2022-12-25	WOS:000281740100054
J	Skipwith, CG; Cao, WJ; Zheng, XL				Skipwith, Christopher G.; Cao, Wenjing; Zheng, X. Long			Factor VIII and Platelets Synergistically Accelerate Cleavage of von Willebrand Factor by ADAMTS13 under Fluid Shear Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-CLEAVING PROTEASE; GLYCOPROTEIN IB; ENDOTHELIAL-CELLS; BINDING; ULTRALARGE; SURFACE; CONFORMATION; DEFICIENCY; MUTATIONS; THROMBIN	Previous studies have demonstrated that factor VIII (FVIII) or platelets alone increase cleavage of von Willebrand factor (VWF) by ADAMTS13 under mechanically induced shear stresses. We show in this study that the combination of FVIII and platelets at the physiological concentrations is more effective than either one alone. In the absence of FVIII, lyophilized platelets increase the formation of cleavage product by 2-3-fold. However, in the presence of physiological concentration of FVIII (1 nM), the formation of VWF cleavage product increases dramatically as a function of increasing platelets with the maximal rate enhancement of similar to 8-fold. Conversely, in the presence of a physiological concentration of lyophilized platelets (150 x 10(3)/mu l), the half-maximal concentration of FVIII required to accelerate VWF proteolysis by ADAMTS13 reduces by similar to 10-fold (to similar to 0.3 nM) compared with that in the absence of platelets (similar to 3.0 nM). Further studies using the FVIII derivative that lacks an acidic region (a3), an antiplatelet glycoprotein 1b alpha IgG, and a purified recombinant VWF-A1 domain or glycoprotein 1b alpha-stripped platelets demonstrate that the synergistic rate-enhancing effect of FVIII and platelets depends on their specific binding interactions with VWF. Our findings suggest that FVIII and platelets are cofactors that regulate proteolysis of multimeric VWF by ADAMTS13 under physiological conditions.	[Skipwith, Christopher G.; Zheng, X. Long] Childrens Hosp Philadelphia, Biochem & Mol Biophys Grad Program, Philadelphia, PA 19104 USA; [Skipwith, Christopher G.; Cao, Wenjing; Zheng, X. Long] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Skipwith, Christopher G.; Cao, Wenjing; Zheng, X. Long] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Zheng, XL (corresponding author), 816G Abramson Res Ctr, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	zheng@email.chop.edu	Zheng, X. Long/ABD-7362-2021	Zheng, X. Long/0000-0003-1680-5295	National Institutes of Health [R01HL079027, P01 HL074124]; National Aeronautics and Space Administration (NASA); American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081588, P01HL074124, R01HL079027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL079027 and P01 HL074124-Project 3 (to X. L. Z.). This work was also supported by a National Aeronautics and Space Administration (NASA)-Harriett G. Jenkins Predoctoral fellowship project (to C. G. S.), an American Heart Association postdoctoral fellowship (to W. C.).	Ai JH, 2005, J BIOL CHEM, V280, P29428, DOI 10.1074/jbc.M505513200; Anderson PJ, 2006, J BIOL CHEM, V281, P850, DOI 10.1074/jbc.M504540200; BUDDE U, 1993, BLOOD, V82, P1749; Cao WJ, 2008, P NATL ACAD SCI USA, V105, P7416, DOI 10.1073/pnas.0801735105; Castaman G, 2003, HAEMATOLOGICA, V88, P94; COLLER BS, 1983, BLOOD, V61, P99; Dong JF, 2005, J THROMB HAEMOST, V3, P1710, DOI 10.1111/j.1538-7836.2005.01360.x; Dong JF, 2003, J BIOL CHEM, V278, P29633, DOI 10.1074/jbc.M301385200; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Feys HB, 2009, J THROMB HAEMOST, V7, P2088, DOI 10.1111/j.1538-7836.2009.03620.x; Furlan M, 1997, BLOOD, V89, P3097, DOI 10.1182/blood.V89.9.3097; Furlan M, 1998, BLOOD, V91, P2839, DOI 10.1182/blood.V91.8.2839.2839_2839_2846; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; GOTO S, 1995, J BIOL CHEM, V270, P23352, DOI 10.1074/jbc.270.40.23352; Jin SY, 2009, J THROMB HAEMOST, V7, P1749, DOI 10.1111/j.1538-7836.2009.03570.x; Kinlough-Rathbone RL, 2000, THROMB RES, V99, P165, DOI 10.1016/S0049-3848(00)00240-1; Kokame K, 2002, P NATL ACAD SCI USA, V99, P11902, DOI 10.1073/pnas.172277399; Laje P, 2009, BLOOD, V113, P2172, DOI 10.1182/blood-2008-08-173021; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Liu LB, 1997, J BIOL CHEM, V272, P1997, DOI 10.1074/jbc.272.3.1997; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Nishio K, 2004, P NATL ACAD SCI USA, V101, P10578, DOI 10.1073/pnas.0402041101; OZEKI M, 2009, THROMB RES, V125, P17; Rayes J, 2010, BLOOD, V115, P4870, DOI 10.1182/blood-2009-11-254193; Sadler JE, 2005, J THROMB HAEMOST, V3, P1702, DOI 10.1111/j.1538-7836.2005.01369.x; SADLER JE, 1991, J BIOL CHEM, V266, P22777; Shankaran H, 2004, BIOPHYS J, V86, P576, DOI 10.1016/S0006-3495(04)74136-3; Shim K, 2008, BLOOD, V111, P651, DOI 10.1182/blood-2007-05-093021; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Tsai HM, 2003, SEMIN THROMB HEMOST, V29, P479; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Turner N, 2009, J THROMB HAEMOST, V7, P229, DOI 10.1111/j.1538-7836.2008.03209.x; Vincentelli A, 2003, NEW ENGL J MED, V349, P343, DOI 10.1056/NEJMoa022831; VLOT AJ, 1995, BLOOD, V85, P3150, DOI 10.1182/blood.V85.11.3150.bloodjournal85113150; Weeterings C, 2008, BLOOD, V112, P3227, DOI 10.1182/blood-2008-02-139113; Wu T, 2010, BLOOD, V115, P370, DOI 10.1182/blood-2009-03-210369; YEO E, 1993, BLOOD, V82, pA612; Zanardelli S, 2009, BLOOD, V114, P2819, DOI 10.1182/blood-2009-05-224915; Zhang P, 2007, BLOOD, V110, P1887, DOI 10.1182/blood-2007-04-083329; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905; Zheng XL, 2008, ANNU REV PATHOL-MECH, V3, P249, DOI 10.1146/annurev.pathmechdis.3.121806.154311; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200; Zheng XL, 2004, BLOOD, V103, P4043, DOI 10.1182/blood-2003-11-4035; Zheng XL, 2002, CURR OPIN HEMATOL, V9, P389, DOI 10.1097/00062752-200209000-00001	48	45	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28596	28603		10.1074/jbc.M110.131227	http://dx.doi.org/10.1074/jbc.M110.131227			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20605782	Green Published, hybrid			2022-12-25	WOS:000281594000023
J	Santos, J; Gonzalez-Sanchez, L; Villa-Morales, M; Ors, I; Lopez-Nieva, P; Vaquero, C; Gonzalez-Gugel, E; Fernandez-Navarro, P; Roncero, AM; Guenet, JL; Montagutelli, X; Fernandez-Piqueras, J				Santos, J.; Gonzalez-Sanchez, L.; Villa-Morales, M.; Ors, I.; Lopez-Nieva, P.; Vaquero, C.; Gonzalez-Gugel, E.; Fernandez-Navarro, P.; Roncero, A. M.; Guenet, J-L; Montagutelli, X.; Fernandez-Piqueras, J.			The stromal gene encoding the CD274 antigen as a genetic modifier controlling survival of mice with gamma-radiation-induced T-cell lymphoblastic lymphomas	ONCOGENE			English	Article						T-cell lymphoblastic lymphoma; gamma-irradiation; survival; thymus stroma; Cd274 gene	RECOMBINANT CONGENIC STRAINS; INDUCED THYMIC LYMPHOMAS; NON-HODGKINS-LYMPHOMA; TUMOR-SUSCEPTIBILITY; POSITIVE SELECTION; POTENTIAL MECHANISM; BREAST-CANCER; MOUSE MODELS; BONE-MARROW; B7-H1	Using an inter-specific subcongenic strain, Nested Recombinant Haplotype 3 (NRH3), generated between two mouse strains showing extreme differences in gamma-radiation-induced thymic lymphoma susceptibility (SEG/Pas and C57BL/6J), we have identified a critical region on chromosome 19 that regulates survival of mice suffering from T-cell lymphoblastic lymphomas. Mapped on this region, the gene encoding the Cd274 ligand is able to trigger an inhibitory effect that modulates T-cell receptor (TCR) signalling and affects thymocyte maturation. Interestingly, this gene shows differential expression between thymic stromal cells from both strains in early response to a single sublethal c-ray dose, but is inhibited in T-cell lymphoblastic lymphomas. Furthermore, we have identified several polymorphisms in the complementary DNA sequence of this gene that affect the affinity for its Cd279 receptor and are able to induce a differential rate of thymocyte apoptosis. Taken together, our data are consistent with Cd274 acting as a genetic modifier that influences the survival of c-radiation-induced T-cell lymphoma-bearing mice. The data similarly support the idea of a co-evolution of tumour cells and associated stromal cells to generate a favourable microenvironment for T-cell lymphoma growth. Oncogene (2010) 29, 5265-5273; doi:10.1038/onc.2010.280; published online 19 July 2010	[Santos, J.; Gonzalez-Sanchez, L.; Villa-Morales, M.; Ors, I.; Vaquero, C.; Gonzalez-Gugel, E.; Roncero, A. M.; Fernandez-Piqueras, J.] Univ Autonoma Madrid, CSIC, Dept Biol Celular & Inmunol, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Santos, J.; Gonzalez-Sanchez, L.; Villa-Morales, M.; Ors, I.; Vaquero, C.; Gonzalez-Gugel, E.; Fernandez-Piqueras, J.] MICINN, ISCIII, Madrid, Spain; [Lopez-Nieva, P.] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona, Catalonia, Spain; [Fernandez-Navarro, P.] Inst Salud Carlos III, Area Epidemiol Ambiental & Canc, Ctr Nacl Epidemiol, Madrid, Spain; [Fernandez-Navarro, P.] Minist Sanidad & Consumo, Madrid, Spain; [Guenet, J-L; Montagutelli, X.] Inst Pasteur, Unite Genet Mammiferes, F-75724 Paris, France	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Instituto de Salud Carlos III; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Fernandez-Piqueras, J (corresponding author), Univ Autonoma Madrid, CSIC, Dept Biol Celular & Inmunol, Ctr Biol Mol Severo Ochoa, Nicolas Cabrera 1, E-28049 Madrid, Spain.	jfpiqueras@cbm.uam.es	Santos, Javier/ABF-5755-2021; Navarro, Pablo Fernandez/E-8893-2018; VILLA-MORALES, MARIA C./H-8797-2015; Nieva, Pilar López/R-9516-2019	Santos, Javier/0000-0002-4168-6251; Navarro, Pablo Fernandez/0000-0001-9427-2581; VILLA-MORALES, MARIA C./0000-0001-7906-0169; Nieva, Pilar López/0000-0001-6369-2444; Gonzalez-Sanchez, Laura/0000-0002-4749-2423; RONCERO SANCHEZ, ANA MARIA/0000-0002-2542-9028	European Commission [FI6R-CT2003-508842]; Spanish Ministry of Education and Science [SAF-2006-09437, SAF2009-11426]	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Education and Science(Spanish Government)	This work was supported by the European Commission contract number FI6R-CT2003-508842 to JS and by the Spanish Ministry of Education and Science contract number SAF-2006-09437 and SAF2009-11426 to JFP. We thank Arturo Morales for the critical reading of the paper.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Balmain A, 2002, CELL, V108, P145, DOI 10.1016/S0092-8674(02)00622-0; Bian YS, 2007, HUM MOL GENET, V16, P3128, DOI 10.1093/hmg/ddm274; Blank C, 2007, CANCER IMMUNOL IMMUN, V56, P739, DOI 10.1007/s00262-006-0272-1; BRATHWAITE O, 1992, CANCER RES, V52, P3791; Burgio G, 2007, GENETICS, V177, P2321, DOI 10.1534/genetics.107.078006; Cormier RT, 2000, ONCOGENE, V19, P3182, DOI 10.1038/sj.onc.1203646; DEVEREUX TR, 1994, MAMM GENOME, V5, P749, DOI 10.1007/BF00292007; DIAMOND LE, 1988, IMMUNOGENETICS, V28, P71, DOI 10.1007/BF00346154; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Elahi E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004388; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hare KJ, 1999, J IMMUNOL, V162, P3978; Inman BA, 2007, CANCER-AM CANCER SOC, V109, P1499, DOI 10.1002/cncr.22588; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Jawad M, 2007, BLOOD CELL MOL DIS, V38, P69, DOI 10.1016/j.bcmd.2006.10.009; Keir ME, 2005, J IMMUNOL, V175, P7372, DOI 10.4049/jimmunol.175.11.7372; Kodama Y, 2004, CARCINOGENESIS, V25, P143, DOI 10.1093/carcin/bgg177; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228; Lwin T, 2007, LEUKEMIA, V21, P1521, DOI 10.1038/sj.leu.2404723; Mao JH, 2003, CURR OPIN GENET DEV, V13, P14, DOI 10.1016/S0959-437X(03)00005-4; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Matin A, 1999, NAT GENET, V23, P237, DOI 10.1038/13874; Mori N, 2000, J RADIAT RES, V41, P367, DOI 10.1269/jrr.41.367; Muhlbauer M, 2006, J HEPATOL, V45, P520, DOI 10.1016/j.jhep.2006.05.007; Nishimura H, 2000, J EXP MED, V191, P891, DOI 10.1084/jem.191.5.891; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Ochiai Y, 2003, ONCOGENE, V22, P1098, DOI 10.1038/sj.onc.1206202; Ogawa K, 2007, CANCER RES, V67, P4016, DOI 10.1158/0008-5472.CAN-06-4498; Oka S, 1999, J VET MED SCI, V61, P709, DOI 10.1292/jvms.61.709; Patocs A, 2007, NEW ENGL J MED, V357, P2543, DOI 10.1056/NEJMoa071825; Pelham RJ, 2006, P NATL ACAD SCI USA, V103, P19848, DOI 10.1073/pnas.0609635104; Saito Y, 2001, ONCOGENE, V20, P5243, DOI 10.1038/sj.onc.1204675; Sandlund JT, 1996, NEW ENGL J MED, V334, P1238, DOI 10.1056/NEJM199605093341906; Santos J, 2002, ONCOGENE, V21, P6680, DOI 10.1038/sj.onc.1205846; Santos J, 2001, ONCOGENE, V20, P2186, DOI 10.1038/sj.onc.1204297; Santos J, 2009, CANCER RES, V69, P2577, DOI 10.1158/0008-5472.CAN-08-1821; Villa-Morales M, 2006, ONCOGENE, V25, P2022, DOI 10.1038/sj.onc.1209234; Villa-Morales M, 2007, CANCER RES, V67, P5107, DOI 10.1158/0008-5472.CAN-06-4006; Wang M, 2003, CANCER RES, V63, P3317; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Wintterle S, 2003, CANCER RES, V63, P7462	48	5	7	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2010	29	38					5265	5273		10.1038/onc.2010.280	http://dx.doi.org/10.1038/onc.2010.280			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	653KE	20639904				2022-12-25	WOS:000282089100005
J	Aldecoa, R; Marin, I				Aldecoa, Rodrigo; Marin, Ignacio			Jerarca: Efficient Analysis of Complex Networks Using Hierarchical Clustering	PLOS ONE			English	Article							FUNCTIONAL MODULES; PROTEIN COMPLEXES; PREDICTION; INTERACTOME	Background: How to extract useful information from complex biological networks is a major goal in many fields, especially in genomics and proteomics. We have shown in several works that iterative hierarchical clustering, as implemented in the UVCluster program, is a powerful tool to analyze many of those networks. However, the amount of computation time required to perform UVCluster analyses imposed significant limitations to its use. Methodology/Principal Findings: We describe the suite Jerarca, designed to efficiently convert networks of interacting units into dendrograms by means of iterative hierarchical clustering. Jerarca is divided into three main sections. First, weighted distances among units are computed using up to three different approaches: a more efficient version of UVCluster and two new, related algorithms called RCluster and SCluster. Second, Jerarca builds dendrograms based on those distances, using well-known phylogenetic algorithms, such as UPGMA or Neighbor-Joining. Finally, Jerarca provides optimal partitions of the trees using statistical criteria based on the distribution of intra- and intercluster connections. Outputs compatible with the phylogenetic software MEGA and the Cytoscape package are generated, allowing the results to be easily visualized. Conclusions/Significance: The four main advantages of Jerarca in respect to UVCluster are: 1) Improved speed of a novel UVCluster algorithm; 2) Additional, alternative strategies to perform iterative hierarchical clustering; 3) Automatic evaluation of the hierarchical trees to obtain optimal partitions; and, 4) Outputs compatible with popular software such as MEGA and Cytoscape.	[Aldecoa, Rodrigo; Marin, Ignacio] CSIC, IBV, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Aldecoa, R (corresponding author), CSIC, IBV, Valencia, Spain.	imarin@ibv.csic.es	Marin, Ignacio/A-9524-2009; Aldecoa, Rodrigo/I-3569-2012	Marin, Ignacio/0000-0002-1315-8961; Aldecoa, Rodrigo/0000-0002-8041-3416	Programa Nacional de Biotecnologia; Ministerio de Ciencia e Innovacion, Spain [BIO2008-05067]	Programa Nacional de Biotecnologia; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by grant BIO2008-05067 (Programa Nacional de Biotecnologia; Ministerio de Ciencia e Innovacion, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittokallio T, 2006, BRIEF BIOINFORM, V7, P243, DOI 10.1093/bib/bbl022; Altaf-Ul-Amin M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-207; Arnau V, 2005, BIOINFORMATICS, V21, P364, DOI 10.1093/bioinformatics/bti021; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Brun C, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-95; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; FARRIS JS, 1972, AM NAT, V106, P645, DOI 10.1086/282802; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Lu HC, 2004, NUCLEIC ACIDS RES, V32, P4804, DOI 10.1093/nar/gkh814; Lucas JI, 2006, J MOL BIOL, V357, P9, DOI 10.1016/j.jmb.2005.12.068; Marco A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-69; Marco A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-442; Nei M, 2000, MOL EVOLUTION PHYLOG; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Pereira-Leal JB, 2004, PROTEINS, V54, P49, DOI 10.1002/prot.10505; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Sokal R., 1958, U KANSAS SCI B, V38, P1409; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Watts D. J, 1999, SMALL WORLDS DYNAMIC; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22	28	32	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11585	10.1371/journal.pone.0011585	http://dx.doi.org/10.1371/journal.pone.0011585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644733	Green Published, Green Submitted, gold			2022-12-25	WOS:000279884900021
J	Caesar, R; Manieri, M; Kelder, T; Boekschoten, M; Evelo, C; Muller, M; Kooistra, T; Cinti, S; Kleemann, R; Drevon, CA				Caesar, Robert; Manieri, Monia; Kelder, Thomas; Boekschoten, Mark; Evelo, Chris; Mueller, Michael; Kooistra, Teake; Cinti, Saverio; Kleemann, Robert; Drevon, Christian A.			A Combined Transcriptomics and Lipidomics Analysis of Subcutaneous, Epididymal and Mesenteric Adipose Tissue Reveals Marked Functional Differences	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; MESSENGER-RNA EXPRESSION; FATTY-ACID-COMPOSITION; GENE-EXPRESSION; LYMPHOID-CELLS; INSULIN SENSITIVITY; HUMAN PREADIPOCYTES; GLUCOSE-METABOLISM; OBESE SUBJECTS; IN-VITRO	Depot-dependent differences in adipose tissue physiology may reflect specialized functions and local interactions between adipocytes and surrounding tissues. We combined time-resolved microarray analyses of mesenteric- (MWAT), subcutaneous- (SWAT) and epididymal adipose tissue (EWAT) during high-fat feeding of male transgenic ApoE3Leiden mice with histology, targeted lipidomics and biochemical analyses of metabolic pathways to identify differentially regulated processes and site-specific functions. EWAT was found to exhibit physiological zonation. De novo lipogenesis in fat proximal to epididymis was stably low, whereas de novo lipogenesis distal to epididymis and at other locations was down-regulated in response to high-fat diet. The contents of linoleic acid and alpha-linolenic acid in EWAT were increased compared to other depots. Expression of the androgen receptor (Ar) was higher in EWAT than in MWAT and SWAT. We suggest that Ar may mediate depot-dependent differences in de novo lipogenesis rate and propose that accumulation of linoleic acid and alpha-linolenic acid in EWAT is favored by testosterone-mediated inhibition of de novo lipogenesis and may promote further elongation and desaturation of these polyunsaturated fatty acids during spermatogenesis.	[Caesar, Robert; Drevon, Christian A.] Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Nutr, Oslo, Norway; [Caesar, Robert] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, Gothenburg, Sweden; [Manieri, Monia; Cinti, Saverio] Univ Ancona, Sch Med, Dept Mol Pathol & Innovat Therapies, Ancona, Italy; [Kelder, Thomas; Evelo, Chris] Maastricht Univ, Dept Bioinformat, BiGCaT, Maastricht, Netherlands; [Boekschoten, Mark; Mueller, Michael] TI Food & Nutr, Nutrigenom Consortium, Wageningen, Netherlands; [Boekschoten, Mark; Mueller, Michael] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands; [Kooistra, Teake; Kleemann, Robert] TNO Qual Life, BioSci, Leiden, Netherlands	University of Oslo; University of Gothenburg; Marche Polytechnic University; Maastricht University; Top Institute Food & Nutrition; Wageningen University & Research; Netherlands Organization Applied Science Research	Caesar, R (corresponding author), Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Nutr, Oslo, Norway.	Robert.Caesar@wlab.gu.se	Boekschoten, Mark V/A-2458-2011; Muller, Michael/B-5795-2008; Boekschoten, Mark/AAS-4597-2021; Evelo, Chris TA/D-2914-2009; Caesar, Robert/AAX-3205-2020; Muller, Michael/M-5724-2019	Boekschoten, Mark V/0000-0002-2139-0795; Muller, Michael/0000-0002-5930-9905; Boekschoten, Mark/0000-0002-2139-0795; Evelo, Chris TA/0000-0002-5301-3142; Muller, Michael/0000-0002-5930-9905; CINTI, Saverio/0000-0003-0362-5017	Nutrigenomics Organisation; EC-funded Network of Excellence [FOOD-2004-506360]; Johan Throne Holst Foundation for Nutrition Research; Freia Medical Research Fund	Nutrigenomics Organisation; EC-funded Network of Excellence; Johan Throne Holst Foundation for Nutrition Research; Freia Medical Research Fund	This project was funded by the Nutrigenomics Organisation (www.nugo.org/), EC-funded Network of Excellence, grant number FOOD-2004-506360. Financial support was also obtained from the Johan Throne Holst Foundation for Nutrition Research and the Freia Medical Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER P, 1990, J CLIN INVEST, V86, P1595, DOI 10.1172/JCI114880; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baccini M, 2008, GENES NUTR, V3, P147, DOI 10.1007/s12263-008-0102-5; Bastelica D, 2002, ARTERIOSCL THROM VAS, V22, P173, DOI 10.1161/hq0102.101552; Caserta F, 2001, AM J PHYSIOL-ENDOC M, V280, pE238, DOI 10.1152/ajpendo.2001.280.2.E238; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; DREVON CA, 1993, OMEGA 3 FATTY ACIDS, P1; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; EINERJENSEN N, 1974, J REPROD FERTIL, V37, P145; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FAUST IM, 1976, AM J PHYSIOL, V231, P538, DOI 10.1152/ajplegacy.1976.231.2.538; Ferre P, 1999, P NUTR SOC, V58, P621, DOI 10.1017/S0029665199000816; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Gao YJ, 2006, CARDIOVASC RES, V71, P363, DOI 10.1016/j.cardiores.2006.03.013; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; He ZB, 2004, AM J PHYSIOL-ENDOC M, V287, pE424, DOI 10.1152/ajpendo.00568.2003; HELLMER J, 1992, J CLIN ENDOCR METAB, V75, P15, DOI 10.1210/jc.75.1.15; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; Joyner J, 2002, HORM METAB RES, V34, P223, DOI 10.1055/s-2002-32144; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; LEMONNIER D, 1972, J CLIN INVEST, V51, P2907, DOI 10.1172/JCI107115; Letexier D, 2005, DIABETES METAB, V31, P558, DOI 10.1016/S1262-3636(07)70231-8; LIN DS, 1993, J LIPID RES, V34, P491; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohn M, 2002, FASEB J, V16, P1057, DOI 10.1096/fj.02-0024com; Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054; Mattacks CA, 1997, BRIT J NUTR, V77, P621, DOI 10.1079/BJN19970061; Mattacks Christine A, 2004, Lymphat Res Biol, V2, P107, DOI 10.1089/lrb.2004.2.107; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Montague CT, 1997, DIABETES, V46, P342, DOI 10.2337/diabetes.46.3.342; Motoshima H, 2002, J CLIN ENDOCR METAB, V87, P5662, DOI 10.1210/JC.2002-020635; NISSEN HP, 1981, ANDROLOGIA, V13, P444; NISSEN HP, 1983, ANDROLOGIA, V15, P264; POND CM, 1995, J LIPID RES, V36, P2219; Pond CM, 1998, IMMUNOL LETT, V63, P159, DOI 10.1016/S0165-2478(98)00074-1; Pond CM, 2005, PROSTAG LEUKOTR ESS, V73, P17, DOI 10.1016/j.plefa.2005.04.005; Pond CM, 2003, BRIT J NUTR, V89, P375, DOI 10.1079/BJN2002784; POULOS A, 1973, COMP BIOCHEM PHYSIOL, V46, P541, DOI 10.1016/0305-0491(73)90094-1; REBUFFESCRIVE M, 1990, J CLIN ENDOCR METAB, V71, P1215, DOI 10.1210/jcem-71-5-1215; Reynisdottir S, 1997, J CLIN ENDOCR METAB, V82, P4162, DOI 10.1210/jc.82.12.4162; Roberts R, 2009, DIABETOLOGIA, V52, P882, DOI 10.1007/s00125-009-1300-4; Saether T, 2003, BIOL REPROD, V69, P117, DOI 10.1095/biolreprod.102.014035; Saether T, 2007, REPRODUCTION, V133, P467, DOI 10.1530/REP-06-00294; Scott T W, 1973, J Reprod Fertil Suppl, V18, P65; SRINIVASAN V, 1986, INDIAN J EXP BIOL, V24, P487; Stewart TM, 2009, HUM REPROD, V24, P1561, DOI 10.1093/humrep/dep075; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4; Towle HC, 2001, P NATL ACAD SCI USA, V98, P13476, DOI 10.1073/pnas.251530798; Uyeda K, 2002, BIOCHEM PHARMACOL, V63, P2075, DOI 10.1016/S0006-2952(02)01012-2; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570; Zalata AA, 1998, MOL HUM REPROD, V4, P111, DOI 10.1093/molehr/4.2.111	60	74	77	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11525	10.1371/journal.pone.0011525	http://dx.doi.org/10.1371/journal.pone.0011525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634946	gold, Green Published, Green Submitted			2022-12-25	WOS:000279781600010
J	Salvi, N; Guellich, A; Michelet, P; Demoule, A; Le Guen, M; Renou, L; Bonne, G; Riou, B; Langeron, O; Coirault, C				Salvi, Nadege; Guellich, Aziz; Michelet, Pierre; Demoule, Alexandre; Le Guen, Morgan; Renou, Laure; Bonne, Gisele; Riou, Bruno; Langeron, Olivier; Coirault, Catherine			Upregulation of PPAR beta/delta Is Associated with Structural and Functional Changes in the Type I Diabetes Rat Diaphragm	PLOS ONE			English	Article							CONTRACTILE CHARACTERISTICS; MYOSIN PHENOTYPE; GENE-EXPRESSION; MUSCLE; CARDIOMYOPATHY; RELAXATION; SKELETAL; STIMULATION; METFORMIN; KINETICS	Background: Diabetes mellitus is associated with alterations in peripheral striated muscles and cardiomyopathy. We examined diaphragmatic function and fiber composition and identified the role of peroxisome proliferator-activated receptors (PPAR alpha and beta/delta) as a factor involved in diaphragm muscle plasticity in response to type I diabetes. Methodology/Principal Findings: Streptozotocin-treated rats were studied after 8 weeks and compared with their controls. Diaphragmatic strips were stimulated in vitro and mechanical and energetic variables were measured, cross bridge kinetics assessed, and the effects of fatigue and hypoxia evaluated. Morphometry, myosin heavy chain isoforms, PPAR alpha and beta/delta gene and protein expression were also assessed. Diabetes induced a decrease in maximum velocity of shortening (-14%, P<0.05) associated with a decrease in myosin ATPase activity (-49%, P<0.05), and an increase in force (+20%, P<0.05) associated with an increase in the number of cross bridges (+14%, P<0.05). These modifications were in agreement with a shift towards slow myosin heavy chain fibers and were associated with an upregulation of PPAR beta/delta (+314% increase in gene and +190% increase in protein expression, P<0.05). In addition, greater resistances to fatigue and hypoxia were observed in diabetic rats. Conclusions/Significance: Type I diabetes induced complex mechanical and energetic changes in the rat diaphragm and was associated with an up-regulation of PPAR beta/delta that could improve resistance to fatigue and hypoxia and favour the shift towards slow myosin heavy chain isoforms.	[Salvi, Nadege; Michelet, Pierre; Le Guen, Morgan; Riou, Bruno; Langeron, Olivier] Univ Paris 06, INSERM, UMRS 956, Inst Myol,IFR14, Paris, France; [Guellich, Aziz; Demoule, Alexandre; Bonne, Gisele; Coirault, Catherine] Univ Paris 06, INSERM, UMRS 974, Inst Myol,IFR14, Paris, France; [Renou, Laure; Bonne, Gisele; Coirault, Catherine] Univ Paris 06, CNRS, UMR 7215, Inst Myol,IFR14, Paris, France; [Riou, Bruno] Grp Hosp Pitie Salpetriere, AP HP, Dept Emergency Med & Surg, F-75634 Paris, France; [Le Guen, Morgan; Langeron, Olivier] Grp Hosp Pitie Salpetriere, AP HP, Dept Anesthesiol & Crit Care, F-75634 Paris, France; [Demoule, Alexandre] Grp Hosp Pitie Salpetriere, AP HP, Dept Pneumol, F-75634 Paris, France; [Bonne, Gisele] Grp Hosp Pitie Salpetriere, AP HP, Dept Metab Biochem, F-75634 Paris, France; [Coirault, Catherine] Hop Bicetre, AP HP, Dept Physiol, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Salvi, N (corresponding author), Univ Paris 06, INSERM, UMRS 956, Inst Myol,IFR14, Paris, France.	bruno.riou@psl.aphp.fr	Coirault, Catherine/I-2979-2016; Coirault, Catherine/S-2454-2019; Bonne, Gisèle/G-3121-2013; Demoule, Alexandre/ABG-4915-2021	Coirault, Catherine/0000-0002-5594-1057; Bonne, Gisèle/0000-0002-2516-3258; Demoule, Alexandre/0000-0002-0432-7217				Amour J, 2008, ANESTH ANALG, V107, P1130, DOI 10.1213/ane.0b013e3181806903; Amour J, 2007, ANESTHESIOLOGY, V107, P452, DOI 10.1097/01.anes.0000278909.40408.24; BEATTY CH, 1959, J BIOL CHEM, V234, P11; BELOFFCH.A, 1968, BIOCHEM J, V110, P529, DOI 10.1042/bj1100529; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Burkart EM, 2007, J CLIN INVEST, V117, P3930, DOI 10.1172/JCI32578; Clanton TL, 2001, J APPL PHYSIOL, V90, P2508, DOI 10.1152/jappl.2001.90.6.2508; Coirault C, 1999, AM J PHYSIOL-CELL PH, V277, pC1170, DOI 10.1152/ajpcell.1999.277.6.C1170; COIRAULT C, 1995, AM J RESP CRIT CARE, V152, P1275, DOI 10.1164/ajrccm.152.4.7551382; COIRAULT C, 1993, J APPL PHYSIOL, V75, P2265, DOI 10.1152/jappl.1993.75.5.2265; COIRAULT C, 1994, J APPL PHYSIOL, V76, P1468, DOI 10.1152/jappl.1994.76.4.1468; Escher P, 2001, ENDOCRINOLOGY, V142, P4195, DOI 10.1210/en.142.10.4195; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Hida W, 1996, AM J RESP CRIT CARE, V153, P1875, DOI 10.1164/ajrccm.153.6.8665049; HILL AV, 1964, PROC R SOC SER B-BIO, V159, P319, DOI 10.1098/rspb.1964.0005; Howlett RA, 2007, EXP PHYSIOL, V92, P887, DOI 10.1113/expphysiol.2007.037291; Huang CJ, 2007, PULM PHARMACOL THER, V20, P69, DOI 10.1016/j.pupt.2005.11.012; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Lecarpentier Y, 2008, J THEOR BIOL, V250, P92, DOI 10.1016/j.jtbi.2007.09.022; Lecarpentier Y, 1998, FASEB J, V12, P981, DOI 10.1096/fasebj.12.11.981; LECARPENTIER YC, 1979, AM J PHYSIOL, V237, pH455, DOI 10.1152/ajpheart.1979.237.4.H455; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mancini M, 1999, CHEST, V115, P1553, DOI 10.1378/chest.115.6.1553; McGuire M, 1998, EXP PHYSIOL, V83, P481, DOI 10.1113/expphysiol.1998.sp004131; McGuire M, 1999, EXP PHYSIOL, V84, P1051, DOI 10.1111/j.1469-445X.1999.01916.x; METZGER JM, 1985, J APPL PHYSIOL, V58, P1085, DOI 10.1152/jappl.1985.58.4.1085; Muoio DM, 2010, BBA-MOL CELL BIOL L, V1801, P281, DOI 10.1016/j.bbalip.2009.11.007; PARADISE NF, 1981, AM J PHYSIOL, V241, pH348, DOI 10.1152/ajpheart.1981.241.3.H348; Scano G, 2000, CHEST, V117, P960, DOI 10.1378/chest.117.4.960; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Sieck GC, 1998, COMP BIOCHEM PHYS B, V119, P435, DOI 10.1016/S0305-0491(98)00005-4; Sieck GC, 1996, J APPL PHYSIOL, V80, P2179, DOI 10.1152/jappl.1996.80.6.2179; STEARNS SB, 1979, J LIPID RES, V20, P654; van Lunteren E, 2003, RESP PHYSIOL NEUROBI, V135, P9, DOI 10.1016/S1569-9048(03)00038-7; van Lunteren E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007832; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; WANKE T, 1992, RESPIRATION, V59, P233; WANKE T, 1991, AM REV RESPIR DIS, V143, P97, DOI 10.1164/ajrccm/143.1.97; WATCHKO JF, 1993, J APPL PHYSIOL, V75, P1341, DOI 10.1152/jappl.1993.75.3.1341; WHITE JES, 1992, DIABETIC MED, V9, P954, DOI 10.1111/j.1464-5491.1992.tb01739.x; Yu BC, 2008, CARDIOVASC RES, V80, P78, DOI 10.1093/cvr/cvn172	42	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11494	10.1371/journal.pone.0011494	http://dx.doi.org/10.1371/journal.pone.0011494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628611	Green Published, Green Submitted, gold			2022-12-25	WOS:000279637100016
J	Hiona, A; Sanz, A; Kujoth, GC; Pamplona, R; Seo, AY; Hofer, T; Someya, S; Miyakawa, T; Nakayama, C; Samhan-Arias, AK; Servais, S; Barger, JL; Portero-Otin, M; Tanokura, M; Prolla, TA; Leeuwenburgh, C				Hiona, Asimina; Sanz, Alberto; Kujoth, Gregory C.; Pamplona, Reinald; Seo, Arnold Y.; Hofer, Tim; Someya, Shinichi; Miyakawa, Takuya; Nakayama, Chie; Samhan-Arias, Alejandro K.; Servais, Stephane; Barger, Jamie L.; Portero-Otin, Manuel; Tanokura, Masaru; Prolla, Tomas A.; Leeuwenburgh, Christiaan			Mitochondrial DNA Mutations Induce Mitochondrial Dysfunction, Apoptosis and Sarcopenia in Skeletal Muscle of Mitochondrial DNA Mutator Mice	PLOS ONE			English	Article							OXIDATIVE STRESS; DELETION MUTATIONS; POINT MUTATIONS; CALORIC RESTRICTION; ELECTRON-TRANSPORT; HYDROGEN-PEROXIDE; CELL-DEATH; CAUSAL ROLE; LIFE-SPAN; AGE	Background: Aging results in a progressive loss of skeletal muscle, a condition known as sarcopenia. Mitochondrial DNA (mtDNA) mutations accumulate with aging in skeletal muscle and correlate with muscle loss, although no causal relationship has been established. Methodology/Principal Findings: We investigated the relationship between mtDNA mutations and sarcopenia at the gene expression and biochemical levels using a mouse model that expresses a proofreading-deficient version (D257A) of the mitochondrial DNA Polymerase c, resulting in increased spontaneous mtDNA mutation rates. Gene expression profiling of D257A mice followed by Parametric Analysis of Gene Set Enrichment (PAGE) indicates that the D257A mutation is associated with a profound downregulation of gene sets associated with mitochondrial function. At the biochemical level, sarcopenia in D257A mice is associated with a marked reduction (35-50%) in the content of electron transport chain (ETC) complexes I, III and IV, all of which are partly encoded by mtDNA. D257A mice display impaired mitochondrial bioenergetics associated with compromised state-3 respiration, lower ATP content and a resulting decrease in mitochondrial membrane potential (Delta psi(m)). Surprisingly, mitochondrial dysfunction was not accompanied by an increase in mitochondrial reactive oxygen species (ROS) production or oxidative damage. Conclusions/Significance: These findings demonstrate that mutations in mtDNA can be causal in sarcopenia by affecting the assembly of functional ETC complexes, the lack of which provokes a decrease in oxidative phosphorylation, without an increase in oxidative stress, and ultimately, skeletal muscle apoptosis and sarcopenia.	[Hiona, Asimina; Seo, Arnold Y.; Hofer, Tim; Servais, Stephane; Leeuwenburgh, Christiaan] Univ Florida, Coll Med, Inst Aging, Dept Aging & Geriatr Res,Div Biol Aging, Gainesville, FL USA; [Sanz, Alberto] Univ Tampere, Inst Med Technol, Mitochondrial Gene Express & Dis Grp, FIN-33101 Tampere, Finland; [Sanz, Alberto] Univ Tampere, Tampere Univ Hosp, FIN-33101 Tampere, Finland; [Kujoth, Gregory C.; Someya, Shinichi; Prolla, Tomas A.] Univ Wisconsin, Dept Genet & Med Genet, Madison, WI USA; [Pamplona, Reinald; Portero-Otin, Manuel] Univ Lleida, Inst Recerca Biomed Lleida, Dept Expt Med, Lleida, Spain; [Someya, Shinichi; Miyakawa, Takuya; Nakayama, Chie; Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan; [Samhan-Arias, Alejandro K.] Univ Extremadura, Fac Sci, Dept Biochem & Mol Biol, Badajoz, Spain; [Barger, Jamie L.] LifeGen Technol LLC, Madison, WI USA	State University System of Florida; University of Florida; Tampere University; Tampere University; Tampere University Hospital; University of Wisconsin System; University of Wisconsin Madison; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; University of Tokyo; Universidad de Extremadura	Hiona, A (corresponding author), Natl Hellen Res Fdn, Inst Biol Res & Biotechnol, Athens, Greece.	taprolla@wisc.edu; cleeuwen@aging.ufl.edu	Portero-Otin, Manuel/B-7122-2009; Pamplona, Reinald/A-7359-2010; Sanz, Alberto/O-2329-2015; Servais, Stephane/Q-6057-2017; Samhan-Arias, Alejandro/J-3593-2014; SANZ, ALBERTO/F-8432-2011	Portero-Otin, Manuel/0000-0002-1823-0299; Pamplona, Reinald/0000-0003-4337-6107; Sanz, Alberto/0000-0003-2149-1753; Servais, Stephane/0000-0002-3127-9679; Samhan-Arias, Alejandro/0000-0001-9602-4848; Barger, Jamie/0000-0001-8694-0068; Tanokura, Masaru/0000-0001-5072-2480; Kujoth, Gregory/0000-0002-6636-2800; Leeuwenburgh, Christiaan/0000-0003-0826-4257	National Institute on Aging [AG17994, AG21042]; National Institutes of Health [AG021905]; American Heart Predoctoral Fellowship [0415166B, 0525346B, 0615256B]; Academy of Finland; University of Florida Institute on Aging; Spanish Ministry of Education and Science [BFU2006-14495/BFI]; Spanish Ministry of Health (ISCIII, Red de Envejecimiento y Fragilidad) [RD06/0013/0012, PI081843]; Autonomous Government of Catalonia [2005SGR00101]; Ministry of Education, Culture, Sports, Science, and Technologies of Japan; Claude D. Pepper Older Americans Independence Center Genomics and Biomarker Core [1 P30 AG028740]; NATIONAL INSTITUTE ON AGING [R01AG017994, P30AG028740, R01AG021042, R01AG021905] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Predoctoral Fellowship; Academy of Finland(Academy of Finland); University of Florida Institute on Aging; Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of Health (ISCIII, Red de Envejecimiento y Fragilidad)(Spanish Government); Autonomous Government of Catalonia(Generalitat de Catalunya); Ministry of Education, Culture, Sports, Science, and Technologies of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Claude D. Pepper Older Americans Independence Center Genomics and Biomarker Core; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants from the National Institute on Aging (AG17994 and AG21042) to CL, National Institutes of Health (AG021905) to TAP, an American Heart Predoctoral Fellowship to AH (0415166B), an American Heart Postdoctoral Fellowship to TH (0525346B), a grant from the Academy of Finland to AS, and an American Heart Predoctoral Fellowship to AYS (0615256B). Oxidative stress analysis was supported by the University of Florida Institute on Aging and Claude D. Pepper Older Americans Independence Center (1 P30 AG028740) Genomics and Biomarker Core. This research was also supported in part by I+D grants from the Spanish Ministry of Education and Science (BFU2006-14495/BFI), the Spanish Ministry of Health (ISCIII, Red de Envejecimiento y Fragilidad, RD06/0013/0012, and PI081843), and the Autonomous Government of Catalonia (2005SGR00101) to RP and MPO. Additional support was provided to MT by the National Projects on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science, and Technologies of Japan. Dr. Barger of LifeGen Technologies was involved with analysis of gene expression data from microarray experiments. No other funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014; Alexeyev MF, 2004, CLIN SCI, V107, P355, DOI 10.1042/CS20040148; BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9; Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312; Barja G, 2002, J BIOENERG BIOMEMBR, V34, P227, DOI 10.1023/A:1016039604958; BEYER RE, 1984, MECH AGEING DEV, V24, P309, DOI 10.1016/0047-6374(84)90116-7; Bohr VA, 1999, BIOCHIMIE, V81, P155, DOI 10.1016/S0300-9084(99)80048-0; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212; Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502; Chabi B, 2005, BIOCHEM BIOPH RES CO, V332, P542, DOI 10.1016/j.bbrc.2005.04.153; Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x; Cheadle Chris, 2003, Appl Bioinformatics, V2, P209; CHUNG SS, 1994, AGING-CLIN EXP RES, V6, P193, DOI 10.1007/BF03324239; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567; Desai VG, 1996, ARCH BIOCHEM BIOPHYS, V333, P145, DOI 10.1006/abbi.1996.0375; Dirks A, 2002, AM J PHYSIOL-REG I, V282, pR519, DOI 10.1152/ajpregu.00458.2001; Dirks AJ, 2004, FREE RADICAL BIO MED, V36, P27, DOI 10.1016/j.freeradbiomed.2003.10.003; Drew B, 2003, AM J PHYSIOL-REG I, V285, pR1259, DOI 10.1152/ajpregu.00264.2003; Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002; DUBESSAY P, 2007, BIOCHIMIE; Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510; Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; Hagen TM, 2002, P NATL ACAD SCI USA, V99, P7184; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARMAN D, 1972, AM J CLIN NUTR, V25, P839; Harper ME, 1998, AM J PHYSIOL-ENDOC M, V275, pE197, DOI 10.1152/ajpendo.1998.275.2.E197; Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235; Herrero A, 1999, AGING-CLIN EXP RES, V11, P294, DOI 10.1007/BF03339803; Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001; Izyumov DS, 2004, BBA-BIOENERGETICS, V1658, P141, DOI 10.1016/j.bbabio.2004.05.007; Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058; KATAYAMA M, 1991, BIOCHEM INT, V25, P47; Kerner J, 2001, AM J PHYSIOL-ENDOC M, V281, pE1054; Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002; LATORRE A, 1986, P NATL ACAD SCI USA, V83, P8649, DOI 10.1073/pnas.83.22.8649; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; LEE CM, 1993, J GERONTOL, V48, pB201, DOI 10.1093/geronj/48.6.B201; LINNANE AW, 1990, BIOCHEM INT, V22, P1067; Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004; Marcell TJ, 2003, J GERONTOL A-BIOL, V58, P911, DOI 10.1093/gerona/58.10.M911; Marcinek DJ, 2005, J PHYSIOL-LONDON, V569, P467, DOI 10.1113/jphysiol.2005.097782; McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x; McKiernan S, 2004, FASEB J, V18, P580, DOI 10.1096/fj.03-0667fje; MELOV S, 1994, NUCLEIC ACIDS RES, V22, P1075, DOI 10.1093/nar/22.6.1075; Miyoshi N, 2006, P NATL ACAD SCI USA, V103, P1727, DOI 10.1073/pnas.0510346103; Mott JL, 2001, MUTAT RES-FUND MOL M, V474, P35, DOI 10.1016/S0027-5107(00)00159-7; MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; PIERI C, 1993, MECH AGEING DEV, V70, P201, DOI 10.1016/0047-6374(93)90048-V; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; PROCTOR DN, 1995, J APPL PHYSIOL, V78, P2033, DOI 10.1152/jappl.1995.78.6.2033; Roubenoff R, 2000, EUR J CLIN NUTR, V54, pS40, DOI 10.1038/sj.ejcn.1601024; Sanz A, 2005, BIOGERONTOLOGY, V6, P15, DOI 10.1007/s10522-004-7380-0; Sanz A, 2007, EXP GERONTOL, V42, P173, DOI 10.1016/j.exger.2006.10.003; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Someya S, 2007, BRAIN RES, V1182, P26, DOI 10.1016/j.brainres.2007.08.090; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; TROYER DL, 1990, ANAT HISTOL EMBRYOL, V19, P154, DOI 10.1111/j.1439-0264.1990.tb00899.x; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com; Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017	87	186	193	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11468	10.1371/journal.pone.0011468	http://dx.doi.org/10.1371/journal.pone.0011468			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628647	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000279589300013
J	van Boven, M; Donker, T; van der Lubben, M; van Gageldonk-Lafeber, RB; Beest, DET; Koopmans, M; Meijer, A; Timen, A; Swaan, C; Dalhuijsen, A; Hahne, S; van den Hoek, A; Teunis, P; van der Sande, MAB; Wallinga, J				van Boven, Michiel; Donker, Tjibbe; van der Lubben, Mariken; van Gageldonk-Lafeber, Rianne B.; Beest, Dennis E. Te; Koopmans, Marion; Meijer, Adam; Timen, Aura; Swaan, Corien; Dalhuijsen, Anton; Hahne, Susan; van den Hoek, Anneke; Teunis, Peter; van der Sande, Marianne A. B.; Wallinga, Jacco			Transmission of Novel Influenza A(H1N1) in Households with Post-Exposure Antiviral Prophylaxis	PLOS ONE			English	Article							PANDEMIC INFLUENZA; DISEASE; OSELTAMIVIR; VIRUS; PATHOGENESIS; PARAMETERS; INFECTION; CONTACTS	Background: Despite impressive advances in our understanding of the biology of novel influenza A(H1N1) virus, little is as yet known about its transmission efficiency in close contact places such as households, schools, and workplaces. These are widely believed to be key in supporting propagating spread, and it is therefore of importance to assess the transmission levels of the virus in such settings. Methodology/Principal Findings: We estimate the transmissibility of novel influenza A(H1N1) in 47 households in the Netherlands using stochastic epidemic models. All households contained a laboratory confirmed index case, and antiviral drugs (oseltamivir) were given to both the index case and other households members within 24 hours after detection of the index case. Among the 109 household contacts there were 9 secondary infections in 7 households. The overall estimated secondary attack rate is low (0.075, 95% CI: 0.037-0.13). There is statistical evidence indicating that older persons are less susceptible to infection than younger persons (relative susceptibility of older persons: 0.11, 95% CI: 0.024-0.43. Notably, the secondary attack rate from an older to a younger person is 0.35 (95% CI: 0.14-0.61) when using an age classification of <= 12 versus.12 years, and 0.28 (95% CI: 0.12-0.50) when using an age classification of <= 18 versus >18 years. Conclusions/Significance: Our results indicate that the overall household transmission levels of novel influenza A(H1N1) in antiviral-treated households were low in the early stage of the epidemic. The relatively high rate of adult-to-child transmission indicates that control measures focused on this transmission route will be most effective in minimizing the total number of infections.	[van Boven, Michiel; Donker, Tjibbe; van der Lubben, Mariken; van Gageldonk-Lafeber, Rianne B.; Beest, Dennis E. Te; Koopmans, Marion; Meijer, Adam; Timen, Aura; Swaan, Corien; Hahne, Susan; Teunis, Peter; van der Sande, Marianne A. B.; Wallinga, Jacco] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Beest, Dennis E. Te] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Dalhuijsen, Anton] Publ Hlth Serv Hollands Midden, Unit Infect Dis Control, Leiden, Netherlands; [van den Hoek, Anneke] Publ Hlth Serv, Dept Infect Dis, Amsterdam, Netherlands; [van der Sande, Marianne A. B.; Wallinga, Jacco] Univ Med Ctr Utrecht, Julius Ctr Hlth Res & Primary Care, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Public Health Service Amsterdam; Utrecht University; Utrecht University Medical Center	van Boven, M (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	michiel.van.boven@rivm.nl	Wallinga, Jacco/C-4382-2018; Timen, Aura/GLV-4130-2022	Wallinga, Jacco/0000-0003-1725-5627; van der Sande, Marianne AB/0000-0002-4778-6739; Donker, Tjibbe/0000-0001-9022-4240; Koopmans, Marion/0000-0002-5204-2312; te Beest, Dennis E./0000-0001-5265-9008	Dutch Ministry of Health, Welfare and Sport	Dutch Ministry of Health, Welfare and Sport	This study was funded by the Dutch Ministry of Health, Welfare and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDY CL, 1991, BIOMETRICS, V47, P961, DOI 10.2307/2532652; Ball F, 1999, J APPL PROBAB, V36, P473, DOI 10.1017/S0021900200017265; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Ghani AC, 2009, PLOS CURR INFLUENZA, V1, DOI [10.1371/currents.RRN1130, DOI 10.1371/CURRENTS.RRN1130]; Glass K, 2009, J R SOC INTERFACE, V6, P695, DOI 10.1098/rsif.2008.0404; HAHNE S, 2009, EURO SURVEILLANCE, V14; Halloran ME, 2007, AM J EPIDEMIOL, V165, P212, DOI 10.1093/aje/kwj362; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; LONGINI IM, 1988, AM J EPIDEMIOL, V128, P845, DOI 10.1093/oxfordjournals.aje.a115038; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Meijer A, 2009, J CLIN VIROL, V45, P179, DOI 10.1016/j.jcv.2009.06.003; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; O'Neill PD, 2009, BIOSTATISTICS, V10, P779, DOI 10.1093/biostatistics/kxp031; Odaira F, 2009, EUROSURVEILLANCE, V14, P2; Pawitan Y, 2001, ALL LIKELIHOOD STAT; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Shun-Shin M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3172; van Boven M, 2007, PLOS COMPUT BIOL, V3, P1394, DOI 10.1371/journal.pcbi.0030145; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Yang Y, 2006, J ROY STAT SOC C-APP, V55, P317, DOI 10.1111/j.1467-9876.2006.00539.x; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	36	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11442	10.1371/journal.pone.0011442	http://dx.doi.org/10.1371/journal.pone.0011442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628642	Green Published, Green Submitted, gold			2022-12-25	WOS:000279589300003
J	Guo, L; Lu, ZH				Guo, Li; Lu, Zuhong			The Fate of miRNA* Strand through Evolutionary Analysis: Implication for Degradation As Merely Carrier Strand or Potential Regulatory Molecule?	PLOS ONE			English	Article							SMALL RNAS; MICRORNA; EXPRESSION; IDENTIFICATION; GENES; CELL; BIOGENESIS; MECHANISMS; ASYMMETRY; SIRNAS	Background: During typical microRNA (miRNA) biogenesis, one strand of a similar to 22 nt RNA duplex is preferentially selected for entry into a silencing complex, whereas the other strand, known as the passenger strand or miRNA* strand, is degraded. Recently, some miRNA* sequences were reported as guide miRNAs with abundant expression. Here, we intended to discover evolutionary implication of the fate of miRNA* strand by analyzing miRNA/miRNA* sequences across vertebrates. Principal Findings: Mature miRNAs based on gene families were well conserved especially for their seed sequences across vertebrates, while their passenger strands always showed various divergence patterns. The divergence mainly resulted from divergence of different animal species, homologous miRNA genes and multicopy miRNA hairpin precursors. Some miRNA* sequences were phylogenetically conserved in seed and anchor sequences similar to mature miRNAs, while others revealed high levels of nucleotide divergence despite some of their partners were highly conserved. Most of those miRNA precursors that could generate abundant miRNAs from both strands always were well conserved in sequences of miR-#-5p and miR-#-3p, especially for their seed sequences. Conclusions: The final fate of miRNA* strand, either degraded as merely carrier strand or expressed abundantly as potential functional guide miRNA, may be destined across evolution. Well-conserved miRNA* strands, particularly conservation in seed sequences, maybe afford potential opportunities for contributing to regulation network. The study will broaden our understanding of potential functional miRNA* species.	[Guo, Li; Lu, Zuhong] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China; [Lu, Zuhong] Southeast Univ, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing, Peoples R China	Southeast University - China; Southeast University - China	Guo, L (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China.	zhlu@seu.edu.cn	Lu, Zuhong/A-5448-2013	Lu, Zuhong/0000-0003-3332-2615	National Natural Science Foundation of China [30871393]; Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-discipline Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-discipline Foundation	The work is supported by the project 30871393 from National Natural Science Foundation of China and funded by Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-discipline Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bompfunewerer AF, 2005, THEOR BIOSCI, V123, P301, DOI 10.1016/j.thbio.2005.01.002; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; GUO L, 2010, ANAL ISOMIR IN PRESS; Guo L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007944; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu N, 2008, CELL RES, V18, P985, DOI 10.1038/cr.2008.278; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nelson PT, 2006, RNA, V12, P187, DOI 10.1261/rna.2258506; Niwa R, 2007, CURR OPIN GENET DEV, V17, P145, DOI 10.1016/j.gde.2007.02.004; O'Toole AS, 2006, NUCLEIC ACIDS RES, V34, P3338, DOI 10.1093/nar/gkl428; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schwarz DS, 2007, CELL, V131, P30, DOI 10.1016/S0092-8674(03)00759-1; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x	48	173	179	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11387	10.1371/journal.pone.0011387	http://dx.doi.org/10.1371/journal.pone.0011387			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613982	Green Published, gold, Green Submitted			2022-12-25	WOS:000279370000016
J	Hostager, BS; Fox, DK; Whitten, D; Wilkerson, CG; Eipper, BA; Francone, VP; Rothman, PB; Colgan, JD				Hostager, Bruce S.; Fox, Daniel K.; Whitten, Douglas; Wilkerson, Curtis G.; Eipper, Betty A.; Francone, Victor P.; Rothman, Paul B.; Colgan, John D.			HOIL-1L Interacting Protein (HOIP) as an NF-kappa B Regulating Component of the CD40 Signaling Complex	PLOS ONE			English	Article							SERINE-PROTEASE; APOPTOSIS; IDENTIFICATION; TRAF2; CELLS; LYMPHOCYTES; RECRUITMENT; ACTIVATION; MECHANISM; ROLES	The tumor necrosis factor receptor (TNFR) superfamily mediates signals critical for regulation of the immune system. One family member, CD40, is important for the efficient activation of antibody-producing B cells and other antigen-presenting cells. The molecules and mechanisms that mediate CD40 signaling are only partially characterized. Proteins known to interact with the cytoplasmic domain of CD40 include members of the TNF receptor-associated factor (TRAF) family, which regulate signaling and serve as links to other signaling molecules. To identify additional proteins important for CD40 signaling, we used a combined stimulation/immunoprecipitation procedure to isolate CD40 signaling complexes from B cells and characterized the associated proteins by mass spectrometry. In addition to known CD40-interacting proteins, we detected SMAC/DIABLO, HTRA2/Omi, and HOIP/RNF31/PAUL/ZIBRA. We found that these previously unknown CD40-interacting partners were recruited in a TRAF2-dependent manner. HOIP is a ubiquitin ligase capable of mediating NF-kappa B activation through the ubiquitin-dependent activation of IKK gamma. We found that a mutant HOIP molecule engineered to lack ubiquitin ligase activity inhibited the CD40-mediated activation of NF-kappa B. Together, our results demonstrate a powerful approach for the identification of signaling molecules associated with cell surface receptors and indicate an important role for the ubiquitin ligase activity of HOIP in proximal CD40 signaling.	[Hostager, Bruce S.; Rothman, Paul B.; Colgan, John D.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Fox, Daniel K.] Univ Iowa, Med Scientist Training Program, Iowa City, IA USA; [Whitten, Douglas; Wilkerson, Curtis G.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Whitten, Douglas; Wilkerson, Curtis G.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT USA; [Francone, Victor P.] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA	University of Iowa; University of Iowa; Michigan State University; Michigan State University; University of Connecticut; Geisinger Commonwealth School of Medicine	Hostager, BS (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	bruce-hostager@uiowa.edu		Colgan, John/0000-0001-9273-2644	Carver Trust; American Cancer Society/Holden Comprehensive Cancer Center; National Institutes of Health (NIH) [DK32948, R01AI054821, R01AI077516]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077516, R01AI067489, R01AI054821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK032948, R01DK032948, R37DK032948] Funding Source: NIH RePORTER	Carver Trust; American Cancer Society/Holden Comprehensive Cancer Center(American Cancer Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a Carver Trust Medical Research Initiative Grant (BSH), an American Cancer Society/Holden Comprehensive Cancer Center grant (BSH), and National Institutes of Health (NIH) (www.nih.gov) grants DK32948 (BAE), R01AI054821 (PBR) and R01AI077516 ( PBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson RJ, 2006, EUR J IMMUNOL, V36, P2535, DOI 10.1002/eji.200535483; Bishop GA, 2007, ADV EXP MED BIOL, V597, P131; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Ehrlund A, 2009, MOL CELL BIOL, V29, P2230, DOI 10.1128/MCB.00743-08; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Hollmann CA, 2002, EXP CELL RES, V280, P201, DOI 10.1006/excr.2002.5640; Hostager BS, 2003, J BIOL CHEM, V278, P45382, DOI 10.1074/jbc.M306708200; Hostager BS, 1996, J IMMUNOL, V157, P1047; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; Jin SK, 2003, GENE DEV, V17, P359, DOI 10.1101/gad.1047003; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kuai J, 2003, J BIOL CHEM, V278, P14363, DOI 10.1074/jbc.M208672200; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; MCKEAN DJ, 1983, J IMMUNOL, V131, P2726; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pineda G, 2007, ADV EXP MED BIOL, V597, P80; Rowland SL, 2007, J IMMUNOL, V179, P4645, DOI 10.4049/jimmunol.179.7.4645; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Thompson HGR, 2004, EXP CELL RES, V295, P448, DOI 10.1016/j.yexcr.2004.01.019; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vidalain PO, 2000, EMBO J, V19, P3304, DOI 10.1093/emboj/19.13.3304; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; Xie P, 2008, CYTOKINE GROWTH F R, V19, P199, DOI 10.1016/j.cytogfr.2008.04.002	28	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11380	10.1371/journal.pone.0011380	http://dx.doi.org/10.1371/journal.pone.0011380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614026	Green Published, gold, Green Submitted			2022-12-25	WOS:000279370000010
J	Lee, SH; Cho, SY; Shannon, MF; Fan, J; Rangasamy, D				Lee, Sung-Hun; Cho, Soo-Young; Shannon, M. Frances; Fan, Jun; Rangasamy, Danny			The Impact of CpG Island on Defining Transcriptional Activation of the Mouse L1 Retrotransposable Elements	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; LINE-1 RETROTRANSPOSONS; EPIGENETIC REGULATION; MAMMALIAN GENOMES; BINDING-SITES; SUBFAMILY; GENES; DNA; AMPLIFICATION; INTERFERENCE	Background: L1 retrotransposable elements are potent insertional mutagens responsible for the generation of genomic variation and diversification of mammalian genomes, but reliable estimates of the numbers of actively transposing L1 elements are mostly nonexistent. While the human and mouse genomes contain comparable numbers of L1 elements, several phylogenetic and L1Xplore analyses in the mouse genome suggest that 1,500-3,000 active L1 elements currently exist and that they are still expanding in the genome. Conversely, the human genome contains only 150 active L1 elements. In addition, there is a discrepancy among the nature and number of mouse L1 elements in L1Xplore and the mouse genome browser at the UCSC and in the literature. To date, the reason why a high copy number of active L1 elements exist in the mouse genome but not in the human genome is unknown, as are the potential mechanisms that are responsible for transcriptional activation of mouse L1 elements. Methodology/Principal Findings: We analyzed the promoter sequences of the 1,501 potentially active mouse L1 elements retrieved from the GenBank and L1Xplore databases and evaluated their transcription factors binding sites and CpG content. To this end, we found that a substantial number of mouse L1 elements contain altered transcription factor YY1 binding sites on their promoter sequences that are required for transcriptional initiation, suggesting that only a half of L1 elements are capable of being transcriptionally active. Furthermore, we present experimental evidence that previously unreported CpG islands exist in the promoters of the most active T(F) family of mouse L1 elements. The presence of sequence variations and polymorphisms in CpG islands of L1 promoters that arise from transition mutations indicates that CpG methylation could play a significant role in determining the activity of L1 elements in the mouse genome. Conclusions: A comprehensive analysis of mouse L1 promoters suggests that the number of transcriptionally active elements is significantly lower than the total number of full-length copies from the three active mouse L1 families. Like human L1 elements, the CpG islands and potentially the transcription factor YY1 binding sites are likely to be required for transcriptional initiation of mouse L1 elements.	[Lee, Sung-Hun; Shannon, M. Frances; Fan, Jun; Rangasamy, Danny] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Cho, Soo-Young] Hanyang Univ, Div Mol & Life Sci, Ansan, South Korea	Australian National University; John Curtin School of Medical Research; Hanyang University	Lee, SH (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	Danny.Rangasamy@anu.edu.au						Allen E, 2003, P NATL ACAD SCI USA, V100, P9940, DOI 10.1073/pnas.1737401100; Athanikar JN, 2004, NUCLEIC ACIDS RES, V32, P3846, DOI 10.1093/nar/gkh698; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Beraldi R, 2006, MOL REPROD DEV, V73, P279, DOI 10.1002/mrd.20423; Boissinot S, 2004, GENOME RES, V14, P1221, DOI 10.1101/gr.2326704; Chen JM, 2005, HUM GENET, V117, P411, DOI 10.1007/s00439-005-1321-0; DeBerardinis RJ, 1999, GENOMICS, V56, P317, DOI 10.1006/geno.1998.5729; DeBerardinis RJ, 1998, NAT GENET, V20, P288, DOI 10.1038/3104; Dmitriev SE, 2007, MOL CELL BIOL, V27, P4685, DOI 10.1128/MCB.02138-06; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Fontanillas P, 2007, PLOS GENET, V3, P2256, DOI 10.1371/journal.pgen.0030210; FURANO AV, 1988, NUCLEIC ACIDS RES, V16, P9215, DOI 10.1093/nar/16.19.9215; Furano AV, 2000, PROG NUCLEIC ACID RE, V64, P255, DOI 10.1016/S0079-6603(00)64007-2; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Graham T, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/75327; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hata K, 1997, GENE, V189, P227, DOI 10.1016/S0378-1119(96)00856-6; Huda A, 2009, ANN NY ACAD SCI, V1178, P276, DOI 10.1111/j.1749-6632.2009.05007.x; Huda A, 2009, GENE, V436, P12, DOI 10.1016/j.gene.2009.01.013; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Khatib H, 2007, MAMM GENOME, V18, P538, DOI 10.1007/s00335-007-9039-z; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Ko CY, 2008, J BIOL CHEM, V283, P30919, DOI 10.1074/jbc.M804029200; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee SH, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-53; Lu KP, 2003, J BIOL CHEM, V278, P28201, DOI 10.1074/jbc.M303888200; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; Montoya-Durango DE, 2009, MUTAT RES-FUND MOL M, V665, P20, DOI 10.1016/j.mrfmmm.2009.02.011; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Naas TP, 1998, EMBO J, V17, P590, DOI 10.1093/emboj/17.2.590; Nigumann P, 2002, GENOMICS, V79, P628, DOI 10.1006/geno.2002.6758; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Schones DE, 2005, BIOINFORMATICS, V21, P307, DOI 10.1093/bioinformatics/bth480; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Walser JC, 2008, GENOME RES, V18, P1403, DOI 10.1101/gr.076455.108; Wang Z, 2006, PLOS COMPUT BIOL, V2, P979, DOI 10.1371/journal.pcbi.0020113; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheelan SJ, 2005, GENOME RES, V15, P1073, DOI 10.1101/gr.3688905; Yang N, 2003, NUCLEIC ACIDS RES, V31, P4929, DOI 10.1093/nar/gkg663	46	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11353	10.1371/journal.pone.0011353	http://dx.doi.org/10.1371/journal.pone.0011353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613872	Green Published, Green Submitted, gold			2022-12-25	WOS:000279369900005
J	Hu, F; Gartenhaus, RB; Eichberg, D; Liu, Z; Fang, HB; Rapoport, AP				Hu, F.; Gartenhaus, R. B.; Eichberg, D.; Liu, Z.; Fang, H-B; Rapoport, A. P.			PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21	ONCOGENE			English	Article						PDZ-binding kinase; tumor suppressor p53; cyclin-dependent kinase inhibitor p21WAF1; PBK/TOPK	ORIGINATED PROTEIN-KINASE; PDZ-BINDING KINASE; DNA-DAMAGE; MITOTIC KINASE; MUTANT P53; HUMAN HOMOLOG; GLIOMA-CELLS; WILD-TYPE; APOPTOSIS; TOPK	PBK/TOPK (PDZ-binding kinase, T-LAK-cell-originated protein kinase) is a serine-threonine kinase that is overexpressed in a variety of tumor cells but its role in oncogenesis remains unclear. Here we show, by co-immunoprecipitation experiments and yeast two-hybrid analysis, that PBK/TOPK physically interacts with the tumor suppressor p53 through its DNA-binding (DBD) domain in HCT116 colorectal carcinoma cells that express wild-type p53. PBK also binds to p53 mutants carrying five common point mutations in the DBD domain. The PBK-p53 interaction appears to down-modulate p53 transactivation function as indicated by PBK/TOPK knockdown experiments, which show upregulated expression of the key p53 target gene and cyclin-dependent kinase inhibitor p21 in HCT116 cells, particularly after genotoxic damage from doxorubicin. Furthermore, stable PBK/TOPK knockdown cell lines (derived from HCT116 and MCF-7 cells) showed increased apoptosis, G(2)/M arrest and slower growth as compared to stable empty vector-transfected control cell lines. Gene microarray studies identified additional p53 target genes involved in apoptosis or cell cycling, which were differentially regulated by PBK knockdown. Together, these data suggest that increased levels of PBK/TOPK may contribute to tumor cell development and progression through suppression of p53 function and consequent reductions in the cell-cycle regulatory proteins such as p21. PBK/TOPK may therefore be a valid target for antineoplastic kinase inhibitors to sensitize tumor cells to chemotherapy-induced apoptosis and growth suppression. Oncogene (2010) 29, 5464-5474; doi:10.1038/onc.2010.275; published online 12 July 2010	[Hu, F.; Gartenhaus, R. B.; Eichberg, D.; Liu, Z.; Fang, H-B; Rapoport, A. P.] Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Rapoport, AP (corresponding author), Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, 22 S Greene St, Baltimore, MD 21201 USA.	arapoport@umm.edu			Marlene and Stewart Greenebaum Cancer Center	Marlene and Stewart Greenebaum Cancer Center	This work was supported in part by philanthropic gifts from Mr Willard Hackerman, Mr and Mrs Robert Becker, and Mr and Mrs Gaylord Christle. Additional funds were provided by the Marlene and Stewart Greenebaum Cancer Center.	Abe Y, 2000, J BIOL CHEM, V275, P21525, DOI 10.1074/jbc.M909629199; Abe Y, 2007, J MOL BIOL, V370, P231, DOI 10.1016/j.jmb.2007.04.067; Ayllon V, 2007, ONCOGENE, V26, P3451, DOI 10.1038/sj.onc.1210142; Bartke T, 2001, ONCOGENE, V20, P571, DOI 10.1038/sj.onc.1204124; Brooks WS, 2008, J BIOL CHEM, V283, P22304, DOI 10.1074/jbc.M803238200; Brooks WS, 2007, EXP CELL RES, V313, P665, DOI 10.1016/j.yexcr.2006.11.020; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cote S, 2002, CYTOKINE, V20, P113, DOI 10.1006/cyto.2002.1988; Dougherty JD, 2005, J NEUROSCI, V25, P10773, DOI 10.1523/JNEUROSCI.3207-05.2005; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gaudet S, 2000, P NATL ACAD SCI USA, V97, P5167, DOI 10.1073/pnas.090102397; Guo NH, 1997, CANCER RES, V57, P1735; Hagn F, 2010, J BIOL CHEM, V285, P3439, DOI 10.1074/jbc.M109.065391; Harada H, 2003, CANCER LETT, V191, P109, DOI 10.1016/S0304-3835(02)00592-X; Herrero-Martin D, 2009, BRIT J CANCER, V101, P80, DOI 10.1038/sj.bjc.6605104; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Komarova EA, 1997, EMBO J, V16, P1391, DOI 10.1093/emboj/16.6.1391; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Li MX, 2003, J BIOL CHEM, V278, P41059, DOI 10.1074/jbc.M307149200; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; Matsumoto S, 2004, BIOCHEM BIOPH RES CO, V325, P997, DOI 10.1016/j.bbrc.2004.10.133; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Nandi A, 2004, BLOOD CELL MOL DIS, V32, P240, DOI 10.1016/j.bcmd.2003.10.004; Nandi AK, 2006, LEUKEMIA RES, V30, P437, DOI 10.1016/j.leukres.2005.08.011; Nandi AK, 2007, BIOCHEM BIOPH RES CO, V358, P181, DOI 10.1016/j.bbrc.2007.04.125; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oh SM, 2007, CANCER RES, V67, P5186, DOI 10.1158/0008-5472.CAN-06-4506; Park JH, 2006, CANCER RES, V66, P9186, DOI 10.1158/0008-5472.CAN-06-1601; Patel S, 2008, NUCLEIC ACIDS RES, V36, P5139, DOI 10.1093/nar/gkn490; Pohl U, 1999, CELL PHYSIOL BIOCHEM, V9, P29, DOI 10.1159/000016300; Rikhof B, 2003, CANCER BIOL THER, V2, P707; Simons-Evelyn M, 2001, BLOOD CELL MOL DIS, V27, P825, DOI 10.1006/bcmd.2001.0452; Sot B, 2007, J BIOL CHEM, V282, P29193, DOI 10.1074/jbc.M705544200; Soussi T, 2007, ONCOGENE, V26, P2145, DOI 10.1038/sj.onc.1210280; Soussi T, 2006, CLIN CANCER RES, V12, P62, DOI 10.1158/1078-0432.CCR-05-0413; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Wendt J, 2006, ONCOGENE, V25, P972, DOI 10.1038/sj.onc.1209031; Zhu F, 2007, GASTROENTEROLOGY, V133, P219, DOI 10.1053/j.gastro.2007.04.048; Zykova TA, 2006, CLIN CANCER RES, V12, P6884, DOI 10.1158/1078-0432.CCR-06-0410	42	88	92	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	40					5464	5474		10.1038/onc.2010.275	http://dx.doi.org/10.1038/onc.2010.275			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664FM	20622899				2022-12-25	WOS:000282945800004
J	Gabilly, ST; Dreyfuss, BW; Karamoko, M; Corvest, V; Kropat, J; Page, MD; Merchant, SS; Hamel, PP				Gabilly, Stephane T.; Dreyfuss, Beth Welty; Karamoko, Mohamed; Corvest, Vincent; Kropat, Janette; Page, M. Dudley; Merchant, Sabeeha S.; Hamel, Patrice P.			CCS5, a Thioredoxin-like Protein Involved in the Assembly of Plastid c-Type Cytochromes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOL-DISULFIDE OXIDOREDUCTASES; BACILLUS-SUBTILIS RESA; CHLAMYDOMONAS-REINHARDTII; SYSTEM-II; NUCLEAR TRANSFORMATION; XANTHOPHYLL CYCLE; ESCHERICHIA-COLI; B(6)F COMPLEX; BIOGENESIS; HEME	The c-type cytochromes are metalloproteins with a heme molecule covalently linked to the sulfhydryls of a CXXCH hemebinding site. In plastids, at least six assembly factors are required for heme attachment to the apo-forms of cytochrome f and cytochrome c(6) in the thylakoid lumen. CCS5, controlling plastid cytochrome c assembly, was identified through insertional mutagenesis in the unicellular green alga Chlamydomonas reinhardtii. The complementing gene encodes a protein with similarity to Arabidopsis thaliana HCF164, which is a thylakoid membrane-anchored protein with a lumen-facing thioredoxin-like domain. HCF164 is required for cytochrome b(6)f biogenesis, but its activity and site of action in the assembly process has so far remained undeciphered. We show that CCS5 is a component of a trans-thylakoid redox pathway and operates by reducing the CXXCH heme-binding site of apocytochrome c prior to the heme ligation reaction. The proposal is based on the following findings: 1) the ccs5 mutant is rescued by exogenous thiols; 2) CCS5 interacts with apocytochrome f and c6 in a yeast two-hybrid assay; and 3) recombinant CCS5 is able to reduce a disulfide in the CXXCH heme-binding site of apocytochrome f.	[Hamel, Patrice P.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Hamel, Patrice P.] Ohio State Univ, Dept Mol Cellular Biochem, Columbus, OH 43210 USA; [Gabilly, Stephane T.; Hamel, Patrice P.] Ohio State Univ, Mol Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA; [Dreyfuss, Beth Welty; Kropat, Janette; Page, M. Dudley; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Dreyfuss, Beth Welty; Kropat, Janette; Page, M. Dudley; Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Merchant, SS (corresponding author), POB 951569, Los Angeles, CA 90095 USA.	merchant@chem.ucla.edu; hamel.16@osu.edu			National Institutes of Health [GM48350]; Muscular Dystrophy Association [4727]; National Science Foundation [MCB-0920062]; National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2004-35318-14953]; Div Of Molecular and Cellular Bioscience [0920062] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); National Science Foundation(National Science Foundation (NSF)); National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM48350. This work was also supported by Muscular Dystrophy Association Grant 4727, National Science Foundation Grant MCB-0920062 (to P.P.H.), and National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service Grant 2004-35318-14953 (to S.S.M.).	Bardischewsky F, 2001, J BACTERIOL, V183, P257, DOI 10.1128/JB.183.1.257-263.2001; Beckett CS, 2000, MOL MICROBIOL, V38, P465, DOI 10.1046/j.1365-2958.2000.02174.x; BENNOUN P, 1980, GENETICS, V95, P39; Bialek W, 2008, BIOCHEMISTRY-US, V47, P5515, DOI 10.1021/bi701973g; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; BONNARD G, 2010, ANTIOXID RE IN PRESS; Carrell CJ, 1997, STRUCTURE, V5, P1613, DOI 10.1016/S0969-2126(97)00309-2; Colbert CL, 2006, P NATL ACAD SCI USA, V103, P4410, DOI 10.1073/PNAS.0600552103; COLLIER JL, 1995, J BACTERIOL, V177, P3269, DOI 10.1128/jb.177.11.3269-3276.1995; Crow A, 2004, J BIOL CHEM, V279, P23654, DOI 10.1074/jbc.M402823200; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Deshmukh M, 2000, MOL MICROBIOL, V35, P123, DOI 10.1046/j.1365-2958.2000.01683.x; Dreyfuss BW, 2003, J BIOL CHEM, V278, P2604, DOI 10.1074/jbc.M208652200; DREYFUSS BW, 1999, P 1 INT C PHOT, V4, P3139; Erlendsson LS, 2003, J BIOL CHEM, V278, P17852, DOI 10.1074/jbc.M300103200; Erlendsson LS, 2002, J BACTERIOL, V184, P1423, DOI 10.1128/JB.184.5.1423-1429.2002; Feissner RE, 2006, MOL MICROBIOL, V60, P563, DOI 10.1111/j.1365-2958.2006.05132.x; Feissner RE, 2005, J BACTERIOL, V187, P3941, DOI 10.1128/JB.187.12.3941-3949.2005; FENTON JM, 1990, PHOTOSYNTH RES, V26, P59, DOI 10.1007/BF00048977; Ferguson SJ, 2008, BBA-BIOENERGETICS, V1777, P980, DOI 10.1016/j.bbabio.2008.03.020; Frawley ER, 2009, P NATL ACAD SCI USA, V106, P10201, DOI 10.1073/pnas.0903132106; Giege P, 2008, MITOCHONDRION, V8, P61, DOI 10.1016/j.mito.2007.10.001; Goldman BS, 1998, P NATL ACAD SCI USA, V95, P5003, DOI 10.1073/pnas.95.9.5003; GOLDSCHMIDTCLERMONT M, 1990, MOL GEN GENET, V223, P417, DOI 10.1007/BF00264448; GUMPEL NJ, 1994, CURR GENET, V26, P438, DOI 10.1007/BF00309931; Hamel P, 2009, BBA-MOL CELL RES, V1793, P125, DOI 10.1016/j.bbamcr.2008.06.017; Hamel PP, 2003, J BIOL CHEM, V278, P2593, DOI 10.1074/jbc.M208651200; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOWE G, 1995, MOL GEN GENET, V246, P156, DOI 10.1007/BF00294678; HOWE G, 1993, P NATL ACAD SCI USA, V90, P1862, DOI 10.1073/pnas.90.5.1862; HOWE G, 1992, EMBO J, V11, P2789, DOI 10.1002/j.1460-2075.1992.tb05346.x; James P, 1996, GENETICS, V144, P1425; Kerfeld CA, 1998, ANNU REV PLANT PHYS, V49, P397, DOI 10.1146/annurev.arplant.49.1.397; Kimball RA, 2003, J MOL MICROB BIOTECH, V5, P133, DOI 10.1159/000070263; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; Kuras R, 1997, J BIOL CHEM, V272, P32427, DOI 10.1074/jbc.272.51.32427; Kuras R, 2007, P NATL ACAD SCI USA, V104, P9906, DOI 10.1073/pnas.0702340104; Lemeille S, 2009, PLOS BIOL, V7, P664, DOI 10.1371/journal.pbio.1000045; Lennartz K, 2001, PLANT CELL, V13, P2539, DOI 10.1105/tpc.13.11.2539; Leon R, 2007, ADV EXP MED BIOL, V616, P1; Lyska D, 2007, PLANT CELL PHYSIOL, V48, P1737, DOI 10.1093/pcp/pcm146; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Meyer EH, 2005, P NATL ACAD SCI USA, V102, P16113, DOI 10.1073/pnas.0503473102; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Moller M, 2006, ANTIOXID REDOX SIGN, V8, P823, DOI 10.1089/ars.2006.8.823; MOTOHASHI K, 2010, ANTIOXID RE IN PRESS; Motohashi K, 2006, J BIOL CHEM, V281, P35039, DOI 10.1074/jbc.M605938200; Nakamoto SS, 2000, BIOCHIMIE, V82, P603, DOI 10.1016/S0300-9084(00)00605-2; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Ortenberg R, 2003, ANTIOXID REDOX SIGN, V5, P403, DOI 10.1089/152308603768295140; Page MLD, 2004, J BIOL CHEM, V279, P32474, DOI 10.1074/jbc.M404285200; Petsalaki Evangelia I., 2006, Genomics Proteomics & Bioinformatics, V4, P48, DOI 10.1016/S1672-0229(06)60016-8; Porat A, 2004, RES MICROBIOL, V155, P617, DOI 10.1016/j.resmic.2004.05.005; Quinlan GJ, 1998, NATO ADV SCI I A-LIF, V297, P263; ROCHAIX JD, 2009, ORGANELLAR METABOLIC, V2, P819; Sanders C, 2010, TRENDS MICROBIOL, V18, P266, DOI 10.1016/j.tim.2010.03.006; Shimogawara K, 1998, GENETICS, V148, P1821; Stirnimann CU, 2006, CELL MOL LIFE SCI, V63, P1642, DOI 10.1007/s00018-006-6055-1; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; Turkarslan S, 2008, MOL MICROBIOL, V70, P652, DOI 10.1111/j.1365-2958.2008.06441.x; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Xie ZY, 1998, GENETICS, V148, P681; [No title captured]	65	24	24	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29738	29749		10.1074/jbc.M109.099069	http://dx.doi.org/10.1074/jbc.M109.099069			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20628047	hybrid, Green Published			2022-12-25	WOS:000281984300009
J	Nagao, R; Moriguchi, A; Tomo, T; Niikura, A; Nakajima, S; Suzuki, T; Okumura, A; Iwai, M; Shen, JR; Ikeuchi, M; Enami, I				Nagao, Ryo; Moriguchi, Akira; Tomo, Tatsuya; Niikura, Ayako; Nakajima, Saori; Suzuki, Takehiro; Okumura, Akinori; Iwai, Masako; Shen, Jian-Ren; Ikeuchi, Masahiko; Enami, Isao			Binding and Functional Properties of Five Extrinsic Proteins in Oxygen-evolving Photosystem II from a Marine Centric Diatom, Chaetoceros gracilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; 12 KDA PROTEIN; CYTOCHROME C-550; CHLAMYDOMONAS-REINHARDTII; CROSS-RECONSTITUTION; THYLAKOID MEMBRANES; CYANIDIUM-CALDARIUM; EVOLUTION SYSTEM; RED ALGA; COMPLEXES	Oxygen-evolving photosystem II (PSII) isolated from a marine centric diatom, Chaetoceros gracilis, contains a novel extrinsic protein (Psb31) in addition to four red algal type extrinsic proteins of PsbO, PsbQ', PsbV, and PsbU. In this study, the five extrinsic proteins were purified from alkaline Tris extracts of the diatom PSII by anion and cation exchange chromatographic columns at different pH values. Reconstitution experiments in various combinations with the purified extrinsic proteins showed that PsbO, PsbQ', and Psb31 rebound directly to PSII in the absence of other extrinsic proteins, indicating that these extrinsic proteins have their own binding sites in PSII intrinsic proteins. On the other hand, PsbV and PsbU scarcely rebound to PSII alone, and their effective bindings required the presence of all of the other extrinsic proteins. Interestingly, PSII reconstituted with Psb31 alone considerably restored the oxygen evolving activity in the absence of PsbO, indicating that Psb31 serves as a substitute in part for PsbO in supporting oxygen evolution. A significant difference found between PSIIs reconstituted with Psb31 and with PsbO is that the oxygen evolving activity of the former is scarcely stimulated by Cl- and Ca2+ ions but that of the latter is largely stimulated by these ions, although rebinding of PsbV and PsbU activated oxygen evolution in the absence of Cl- and Ca2+ ions in both the former and latter PSIIs. Based on these results, we proposed a model for the association of the five extrinsic proteins with intrinsic proteins in diatom PSII and compared it with those in PSIIs from the other organisms.	[Nagao, Ryo; Iwai, Masako; Ikeuchi, Masahiko] Univ Tokyo, Dept Life Sci Biol, Grad Sch Art & Sci, Meguro Ku, Tokyo 1538902, Japan; [Moriguchi, Akira; Tomo, Tatsuya; Nakajima, Saori; Enami, Isao] Tokyo Univ Sci, Dept Biol, Fac Sci, Shinjuku Ku, Tokyo 1628601, Japan; [Niikura, Ayako; Shen, Jian-Ren] Okayama Univ, Div Biosci, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Suzuki, Takehiro] RIKEN, Biomol Characterizat Team, Discovery Res Inst, Wako, Saitama 3510198, Japan; [Okumura, Akinori] Nihon Univ, Dept Integrated Sci Phys & Biol, Coll Humanities & Sci, Setagaya Ku, Tokyo 1568550, Japan	University of Tokyo; Tokyo University of Science; Okayama University; RIKEN; Nihon University	Enami, I (corresponding author), Univ Tokyo, Dept Life Sci Biol, Grad Sch Art & Sci, Meguro Ku, Tokyo 1538902, Japan.	enami@rs.noda.tus.ac.jp	Okumura, Akinori/AAT-4389-2021; Shen, Jian-Ren/B-2558-2011; Okumura, Akinori/B-6456-2017; Suzuki, Takehiro/B-3210-2013; Tomo, Tatsuya/K-7680-2012; NAGAO, Ryo/D-4117-2012	Okumura, Akinori/0000-0002-3977-6207; Okumura, Akinori/0000-0002-3977-6207; Tomo, Tatsuya/0000-0002-9369-1941; NAGAO, Ryo/0000-0001-8212-3001; Iwai, Masako/0000-0001-6121-7543	Ministry of Education of Japan [18570049, 21570038, 22370017]	Ministry of Education of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research from the Ministry of Education of Japan 18570049 (to I. E.) and 21570038 and 22370017 (to T. T.), and Research Fellow (to R. N.) from the Japan Society for the Promotion of Science.	BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; BRICKER TM, 2007, PHOTOSYSTEM, V2, P95; Enami I, 2005, FEBS J, V272, P5020, DOI 10.1111/j.1742-4658.2005.04912.x; Enami I, 1998, BIOCHEMISTRY-US, V37, P2787, DOI 10.1021/bi9724624; Enami I, 2003, PLANT CELL PHYSIOL, V44, P820, DOI 10.1093/pcp/pcg106; ENAMI I, 1989, BIOCHIM BIOPHYS ACTA, V977, P33, DOI 10.1016/S0005-2728(89)80006-4; Enami I, 2000, PLANT CELL PHYSIOL, V41, P1354, DOI 10.1093/pcp/pcd069; ENAMI I, 1994, BBA-BIOENERGETICS, V1185, P75, DOI 10.1016/0005-2728(94)90195-3; Enami I, 1995, BBA-BIOENERGETICS, V1232, P208, DOI 10.1016/0005-2728(95)00122-0; Enami I, 2008, PHOTOSYNTH RES, V98, P349, DOI 10.1007/s11120-008-9343-9; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; GHANOTAKIS DF, 1985, FEBS LETT, V192, P1, DOI 10.1016/0014-5793(85)80030-2; GHANOTAKIS DF, 1984, FEBS LETT, V167, P127, DOI 10.1016/0014-5793(84)80846-7; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; IKEUCHI M, 1988, FEBS LETT, V241, P99, DOI 10.1016/0014-5793(88)81039-1; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kashino Y, 2006, J BIOL CHEM, V281, P20834, DOI 10.1074/jbc.M603188200; KUWABARA T, 1982, PLANT CELL PHYSIOL, V23, P533, DOI 10.1093/oxfordjournals.pcp.a076378; MIYAO M, 1984, FEBS LETT, V168, P118, DOI 10.1016/0014-5793(84)80218-5; MIYAO M, 1983, BIOCHIM BIOPHYS ACTA, V725, P87, DOI 10.1016/0005-2728(83)90227-X; MIYAO M, 1984, FEBS LETT, V170, P350, DOI 10.1016/0014-5793(84)81342-3; MIYAO M, 1989, BIOCHIM BIOPHYS ACTA, V977, P315, DOI 10.1016/S0005-2728(89)80086-6; Nagao R, 2007, BBA-BIOENERGETICS, V1767, P1353, DOI 10.1016/j.bbabio.2007.10.007; Nagao R, 2010, BBA-BIOENERGETICS, V1797, P160, DOI 10.1016/j.bbabio.2009.09.008; Ohta H, 2003, EUR J BIOCHEM, V270, P4156, DOI 10.1046/j.1432-1033.2003.03810.x; Okumura A, 2008, BBA-BIOENERGETICS, V1777, P1545, DOI 10.1016/j.bbabio.2008.09.004; Ono T, 1999, BIOCHEMISTRY-US, V38, P8778, DOI 10.1021/bi982949s; ONO T, 1984, FEBS LETT, V168, P281, DOI 10.1016/0014-5793(84)80263-X; ONO TA, 1983, FEBS LETT, V164, P255, DOI 10.1016/0014-5793(83)80297-X; Roose JL, 2007, PHOTOSYNTH RES, V92, P369, DOI 10.1007/s11120-006-9117-1; Roose JL, 2007, P NATL ACAD SCI USA, V104, P2548, DOI 10.1073/pnas.0609337104; Seidler A, 1996, BBA-BIOENERGETICS, V1277, P35, DOI 10.1016/S0005-2728(96)00102-8; SHEN JR, 1995, BIOCHEMISTRY-US, V34, P12661, DOI 10.1021/bi00039a023; Shen JR, 1998, BIOCHEMISTRY-US, V37, P1551, DOI 10.1021/bi971676i; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Summerfield TC, 2005, BIOCHEMISTRY-US, V44, P805, DOI 10.1021/bi048394k; Suzuki T, 2005, PHOTOSYNTH RES, V84, P239, DOI 10.1007/s11120-004-7760-y; Suzuki T, 2004, PLANT CELL PHYSIOL, V45, P1168, DOI 10.1093/pcp/pch131; Suzuki T, 2003, PLANT CELL PHYSIOL, V44, P76, DOI 10.1093/pcp/pcg010; Thornton LE, 2004, PLANT CELL, V16, P2164, DOI 10.1105/tpc.104.023515; YAMAMOTO Y, 1981, FEBS LETT, V133, P265, DOI 10.1016/0014-5793(81)80520-0	43	40	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29191	29199		10.1074/jbc.M110.146092	http://dx.doi.org/10.1074/jbc.M110.146092			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20630872	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000281740100019
J	Wang, CR; Yoo, Y; Fan, HP; Kim, E; Guan, KL; Guan, JL				Wang, Chenran; Yoo, Youngdong; Fan, Huaping; Kim, Eunjung; Guan, Kun-Liang; Guan, Jun-Lin			Regulation of Integrin beta 1 Recycling to Lipid Rafts by Rab1a to Promote Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO GTPASES; PLASMA-MEMBRANE; N-WASP; PROTEIN; TRAFFICKING; ADHESION; VESICLES; MOTILITY; COMPLEX; BINDING	Rab1a is a member of the Rab family of small GTPases with a well characterized function in the regulation of vesicle trafficking from the endoplasmic reticulum to the Golgi apparatus and within Golgi compartments. The integrin family heterodimeric transmembrane proteins serve as major receptors for extracellular matrix proteins, which play essential roles in cell adhesion and migration. Although effects on intracellular trafficking of integrins or other key cargos by Rab1a could influence cell migration, the regulatory mechanisms linking Rab1a to cell migration are not well understood. Here, we report identification of Rab1a as a novel regulator of cell migration using an unbiased RNAi screen targeting GTPases. Inhibition of Rab1a reduced integrin-mediated cell adhesion and spreading on fibronectins, reduced integrin beta 1 localization to lipid rafts, and decreased recycling of integrin beta 1 to the plasma membrane. Analysis of Rab1a effector molecules showed that p115 mediated Rab1a regulation of integrin recycling and lipid raft localization in cell migration. Taken together, these results suggest a novel function for Rab1a in the regulation of cell migration through controlling integrin beta 1 recycling and localization to lipid rafts via a specific downstream effector pathway.	[Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Kim, Eunjung; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Kim, Eunjung; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego; University of California System; University of California San Diego	Guan, JL (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA.	jlguan@umich.edu	wang, chenran/N-6629-2013; Guan, Kun-Liang/ADK-7088-2022; Fan, Huaping/B-8762-2012		National Institutes of Health [HL073394]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grant HL073394 (to J.-L. G.).	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Collins RN, 2003, MOL MEMBR BIOL, V20, P105, DOI 10.1080/0968768031000085892; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; DEL POZO MA, 2004, CELL CYCLE, V3, P725; DEL POZO MA, 2004, SCIENCE, V303, P839; Fabbri M, 2005, MOL BIOL CELL, V16, P5793, DOI 10.1091/mbc.E05-05-0413; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hauck CR, 2002, EMBO J, V21, P6289, DOI 10.1093/emboj/cdf631; Holleran BJ, 2003, J LEUKOCYTE BIOL, V73, P243, DOI 10.1189/jlb.0902439; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; Huttenlocher A, 2005, NAT CELL BIOL, V7, P336, DOI 10.1038/ncb0405-336; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Krauss K, 1999, J BIOL CHEM, V274, P36921, DOI 10.1074/jbc.274.52.36921; Leitinger B, 2002, J CELL SCI, V115, P963; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Manes S, 2006, MOL MEMBR BIOL, V23, P59, DOI 10.1080/09687860500430069; Manes S, 2000, IUBMB LIFE, V49, P89; MARCANTONIO EE, 1988, J CELL BIOL, V106, P1765, DOI 10.1083/jcb.106.5.1765; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nielsen E, 2008, PLANT PHYSIOL, V147, P1516, DOI 10.1104/pp.108.121798; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Satoh A, 2003, TRAFFIC, V4, P153, DOI 10.1034/j.1600-0854.2003.00103.x; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SZTUL E, 1993, J BIOL CHEM, V268, P1876; Vassilieva EV, 2008, AM J PHYSIOL-GASTR L, V295, pG965, DOI 10.1152/ajpgi.00082.2008; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; WU CY, 1995, J CELL SCI, V108, P2511; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006; Yoo YD, 2006, J BIOL CHEM, V281, P15352, DOI 10.1074/jbc.M511825200	49	72	77	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29398	29405		10.1074/jbc.M110.141440	http://dx.doi.org/10.1074/jbc.M110.141440			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20639577	Green Published, hybrid			2022-12-25	WOS:000281740100042
J	Akin, BL; Chen, ZH; Jones, LR				Akin, Brandy L.; Chen, Zhenhui; Jones, Larry R.			Superinhibitory Phospholamban Mutants Compete with Ca2+ for Binding to SERCA2a by Stabilizing a Unique Nucleotide-dependent Conformational State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; CALCIUM-PUMP; CROSS-LINKING; ATP-BINDING; FUNCTIONAL INTERACTIONS; ENERGY-TRANSFER; SF21 CELLS; CA2+-ATPASE; INHIBITION; THAPSIGARGIN	Three cross-linkable phospholamban (PLB) mutants of increasing inhibitory strength (N30C-PLB < N27A,N30C,L37A-PLB (PLB3) < N27A,N30C,L37A,V49G-PLB (PLB4)) were used to determine whether PLB decreases the Ca2+ affinity of SERCA2a by competing for Ca2+ binding. The functional effects of N30C-PLB, PLB3, and PLB4 on Ca2+-ATPase activity and E1 similar to P formation were correlated with their binding interactions with SERCA2a measured by chemical cross-linking. Successively higher Ca2+ concentrations were required to both activate the enzyme co-expressed with N30C-PLB, PLB3, and PLB4 and to dissociate N30C-PLB, PLB3, and PLB4 from SERCA2a, suggesting competition between PLB and Ca2+ for binding to SERCA2a. This was confirmed with the Ca2+ pump mutant, D351A, which is catalytically inactive but retains strong Ca2+ binding. Increasingly higher Ca2+ concentrations were also required to dissociate N30C-PLB, PLB3, and PLB4 from D351A, demonstrating directly that PLB antagonizes Ca2+ binding. Finally, the specific conformation of E2 (Ca2+-free state of SERCA2a) that binds PLB was investigated using the Ca2+-pump inhibitors thapsigargin and vanadate. Crosslinking assays conducted in the absence of Ca2+ showed that PLB bound preferentially to E2 with bound nucleotide, forming a remarkably stable complex that is highly resistant to both thapsigargin and vanadate. In the presence of ATP, N30C-PLB had an affinity for SERCA2a approaching that of vanadate (micromolar), whereas PLB3 and PLB4 had much higher affinities, severalfold greater than even thapsigargin (nanomolar or higher). We conclude that PLB decreases Ca2+ binding to SERCA2a by stabilizing a unique E2.ATP state that is unable to bind thapsigargin or vanadate.	Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Jones, LR (corresponding author), 1800 N Capitol Ave, Indianapolis, IN 46202 USA.	lrjones@iupui.edu			National Institutes of Health [HL49428]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049428, R01HL049428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL49428.	ANDERSEN JP, 1985, BIOCHIM BIOPHYS ACTA, V815, P9, DOI 10.1016/0005-2736(85)90467-5; Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Chen ZH, 2003, J BIOL CHEM, V278, P48348, DOI 10.1074/jbc.M309545200; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Chen ZH, 2010, J BIOL CHEM, V285, P3253, DOI 10.1074/jbc.M109.080820; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Cornea RL, 2000, J BIOL CHEM, V275, P41487, DOI 10.1074/jbc.M008195200; DEJESUS F, 1993, FEBS LETT, V332, P229, DOI 10.1016/0014-5793(93)80638-B; Fortea MI, 2001, J BIOL CHEM, V276, P37266, DOI 10.1074/jbc.M103949200; Haghighi K, 2001, J BIOL CHEM, V276, P24145, DOI 10.1074/jbc.M102403200; INESI G, 1984, J BIOL CHEM, V259, P996; INESI G, 1980, J BIOL CHEM, V255, P3025; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; JONES LR, 1978, J BIOL CHEM, V253, P1643; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; JONES LR, 1979, BIOCHIM BIOPHYS ACTA, V557, P230, DOI 10.1016/0005-2736(79)90105-6; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; LACAPERE JJ, 1990, J BIOL CHEM, V265, P348; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mahaney JE, 2000, BIOPHYS J, V78, P1306, DOI 10.1016/S0006-3495(00)76686-0; Marchand A, 2008, J BIOL CHEM, V283, P14867, DOI 10.1074/jbc.M710165200; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; McIntosh DB, 1999, J BIOL CHEM, V274, P25227, DOI 10.1074/jbc.274.36.25227; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Montigny C, 2008, BIOCHEMISTRY-US, V47, P12159, DOI 10.1021/bi8006498; Montigny C, 2007, BIOCHEMISTRY-US, V46, P15162, DOI 10.1021/bi701855r; PICK U, 1982, J BIOL CHEM, V257, P6111; Reddy LG, 1999, BIOCHEMISTRY-US, V38, P3954, DOI 10.1021/bi981795d; Reddy LG, 2003, BIOCHEMISTRY-US, V42, P4585, DOI 10.1021/bi026995a; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; SAGARA Y, 1992, J BIOL CHEM, V267, P12606; SHAM JSK, 1991, AM J PHYSIOL, V261, pH1344, DOI 10.1152/ajpheart.1991.261.4.H1344; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Trieber CA, 2005, BIOCHEMISTRY-US, V44, P3289, DOI 10.1021/bi047878d; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; Waggoner JR, 2007, BIOCHEMISTRY-US, V46, P1999, DOI 10.1021/bi061365k; WATANABE T, 1981, BIOCHEMISTRY-US, V20, P6617, DOI 10.1021/bi00526a015; WICTOME M, 1992, BIOCHEM J, V283, P525, DOI 10.1042/bj2830525; Zhang ZS, 2000, BIOCHEMISTRY-US, V39, P8758, DOI 10.1021/bi000185m	49	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28540	28552		10.1074/jbc.M110.151779	http://dx.doi.org/10.1074/jbc.M110.151779			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20622261	Green Published, hybrid			2022-12-25	WOS:000281594000018
J	Vallur, AC; Maizels, N				Vallur, Aarthy C.; Maizels, Nancy			Complementary Roles for Exonuclease 1 and Flap Endonuclease 1 in Maintenance of Triplet Repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SECONDARY STRUCTURES; DEPENDENT MANNER; DNA METABOLISM; G4 DNA; EXPANSION; YEAST; FRAGILITY; REPAIR; INSTABILITY	Trinucleotide repeats can form stable secondary structures that promote genomic instability. To determine how such structures are resolved, we have defined biochemical activities of the related RAD2 family nucleases, FEN1 (Flap endonuclease 1) and EXO1 (exonuclease 1), on substrates that recapitulate intermediates in DNA replication. Here, we show that, consistent with its function in lagging strand replication, human (h) FEN1 could cleave 5'-flaps bearing structures formed by CTG or CGG repeats, although less efficiently than unstructured flaps. hEXO1 did not exhibit endonuclease activity on 5'-flaps bearing structures formed by CTG or CGG repeats, although it could excise these substrates. Neither hFEN1 nor hEXO1 was affected by the stem-loops formed by CTG repeats interrupting duplex regions adjacent to 5'-flaps, but both enzymes were inhibited by G4 structures formed by CGG repeats in analogous positions. Hydroxyl radical footprinting showed that hFEN1 binding caused hypersensitivity near the flap/duplex junction, whereas hEXO1 binding caused hypersensitivity very close to the 5'-end, correlating with the predominance of hFEN1 endonucleolytic activity versus hEXO1 exonucleolytic activity on 5'-flap substrates. These results show that FEN1 and EXO1 can eliminate structures formed by trinucleotide repeats in the course of replication, relying on endonucleolytic and exonucleolytic activities, respectively. These results also suggest that unresolved G4 DNA may prevent key steps in normal post-replicative DNA processing.	[Vallur, Aarthy C.; Maizels, Nancy] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; [Maizels, Nancy] Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Maizels, N (corresponding author), Univ Washington, Sch Med, Dept Immunol, HSB H474A,1959 NE Pacific St, Seattle, WA 98195 USA.	maizels@u.washington.edu			National Institutes of Health [PO1 CA77852]; NATIONAL CANCER INSTITUTE [P01CA077852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 CA77852 (to N. M.).	Balakumaran BS, 2000, HUM MOL GENET, V9, P93, DOI 10.1093/hmg/9.1.93; Barnes CJ, 1996, J BIOL CHEM, V271, P29624, DOI 10.1074/jbc.271.47.29624; Callahan JL, 2003, MOL CELL BIOL, V23, P7849, DOI 10.1128/MCB.23.21.7849-7860.2003; Daee DL, 2007, MOL CELL BIOL, V27, P102, DOI 10.1128/MCB.01167-06; Frank G, 2001, J BIOL CHEM, V276, P36295, DOI 10.1074/jbc.M103397200; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; Henricksen LA, 2000, J BIOL CHEM, V275, P16420, DOI 10.1074/jbc.M909635199; Hou CX, 2009, NAT STRUCT MOL BIOL, V16, P869, DOI 10.1038/nsmb.1638; Kovtun IV, 2001, BIOCHEM CELL BIOL, V79, P325, DOI 10.1139/bcb-79-3-325; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Lee B, 2002, NUCLEIC ACIDS RES, V30, P942, DOI 10.1093/nar/30.4.942; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Lee S, 2002, EXP MOL MED, V34, P313, DOI 10.1038/emm.2002.44; Lin YF, 2006, NAT STRUCT MOL BIOL, V13, P179, DOI 10.1038/nsmb1042; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; Lin YF, 2009, MOL CARCINOGEN, V48, P350, DOI 10.1002/mc.20488; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Liu Y, 2003, J BIOL CHEM, V278, P13728, DOI 10.1074/jbc.M212061200; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; McMurray CT, 1999, P NATL ACAD SCI USA, V96, P1823, DOI 10.1073/pnas.96.5.1823; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Singh P, 2007, J BIOL CHEM, V282, P3465, DOI 10.1074/jbc.M606582200; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Sun H, 1999, NUCLEIC ACIDS RES, V27, P1978, DOI 10.1093/nar/27.9.1978; Sun XM, 2003, DNA REPAIR, V2, P925, DOI 10.1016/S1568-7864(03)00093-4; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Vallur AC, 2008, P NATL ACAD SCI USA, V105, P16508, DOI 10.1073/pnas.0805327105; Vallur AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008908; Voineagu I, 2009, NAT STRUCT MOL BIOL, V16, P226, DOI 10.1038/nsmb.1527; White PJ, 1999, MOL CELL BIOL, V19, P5675; Wilson DM, 1998, NUCLEIC ACIDS RES, V26, P3762, DOI 10.1093/nar/26.16.3762; Yang JH, 2007, GENE, V393, P110, DOI 10.1016/j.gene.2007.01.025	39	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28514	28519		10.1074/jbc.M110.132738	http://dx.doi.org/10.1074/jbc.M110.132738			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20643645	Green Published, hybrid			2022-12-25	WOS:000281594000015
J	Golubkov, VS; Cieplak, P; Chekanov, AV; Ratnikov, BI; Aleshin, AE; Golubkova, NV; Postnova, TI; Radichev, IA; Rozanov, DV; Zhu, WH; Motamedchaboki, K; Strongin, AY				Golubkov, Vladislav S.; Cieplak, Piotr; Chekanov, Alexei V.; Ratnikov, Boris I.; Aleshin, Alexander E.; Golubkova, Natalya V.; Postnova, Tatiana I.; Radichev, Ilian A.; Rozanov, Dmitri V.; Zhu, Wenhong; Motamedchaboki, Khatereh; Strongin, Alex Y.			Internal Cleavages of the Autoinhibitory Prodomain Are Required for Membrane Type 1 Matrix Metalloproteinase Activation, although Furin Cleavage Alone Generates Inactive Proteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC DOMAIN; CELL-MIGRATION; 1-MATRIX METALLOPROTEINASE; INTRACELLULAR ACTIVATION; PROPROTEIN CONVERTASES; TISSUE INHIBITOR; CYSTEINE SWITCH; IV COLLAGENASE; MT1-MMP; SURFACE	The functional activity of invasion-promoting membrane type 1 matrix metalloproteinase (MT1-MMP) is elevated in cancer. This elevated activity promotes cancer cell migration, invasion, and metastasis. MT1-MMP is synthesized as a zymogen, the latency of which is maintained by its prodomain. Excision by furin was considered sufficient for the prodomain release and MT1-MMP activation. We determined, however, that the full-length intact prodomain released by furin alone is a potent autoinhibitor of MT1-MMP. Additional MMP cleavages within the prodomain sequence are required to release the MT1-MMP enzyme activity. Using mutagenesis of the prodomain sequence and mass spectrometry analysis of the prodomain fragments, we demonstrated that the intradomain cleavage of the PGD down arrow L-50 site initiates the MT1-MMP activation, whereas the (RRKR111)-R-108 down arrow Y-112 cleavage by furin completes the removal and the degradation of the autoinhibitory prodomain and the liberation of the functional activity of the emerging enzyme of MT1-MMP.	[Golubkov, Vladislav S.; Cieplak, Piotr; Chekanov, Alexei V.; Ratnikov, Boris I.; Aleshin, Alexander E.; Golubkova, Natalya V.; Postnova, Tatiana I.; Radichev, Ilian A.; Rozanov, Dmitri V.; Zhu, Wenhong; Motamedchaboki, Khatereh; Strongin, Alex Y.] La Jolla Canc Res Fdn, Canc Res Ctr, Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), La Jolla Canc Res Fdn, Canc Res Ctr, Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	strongin@burnham.org	Golubkov, Vladislav/L-6828-2017; Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	National Institutes of Health [CA83017, CA77470]; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA83017 and CA77470 (to A.Y.S.).	BECKER JW, 1995, PROTEIN SCI, V4, P1966, DOI 10.1002/pro.5560041002; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Chernov AV, 2009, J BIOL CHEM, V284, P12727, DOI 10.1074/jbc.M900273200; Deryugina EI, 2004, TRAFFIC, V5, P627, DOI 10.1111/j.1600-0854.2004.00206.x; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; FOTOUHI N, 1994, J BIOL CHEM, V269, P30227; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Golubkov VS, 2007, J BIOL CHEM, V282, P36283, DOI 10.1074/jbc.M706290200; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; HANGLOW AC, 1993, AGENTS ACTIONS, V39, P148; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; Li W, 2004, CANCER RES, V64, P8657, DOI 10.1158/0008-5472.CAN-04-3019; Lichte A, 1996, FEBS LETT, V397, P277, DOI 10.1016/S0014-5793(96)01206-9; Maskos K, 2005, BIOCHIMIE, V87, P249, DOI 10.1016/j.biochi.2004.11.019; MAST AE, 1991, J BIOL CHEM, V266, P15810; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Remacle AG, 2006, ONCOGENE, V25, P5648, DOI 10.1038/sj.onc.1209572; Rosenblum G, 2007, J AM CHEM SOC, V129, P13566, DOI 10.1021/ja073941l; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Shiryaev SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004952; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; VALLEE BL, 1990, P NATL ACAD SCI USA, V87, P220, DOI 10.1073/pnas.87.1.220; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Zdobnov EM, 2002, BIOINFORMATICS, V18, P368, DOI 10.1093/bioinformatics/18.2.368	41	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27726	27736		10.1074/jbc.M110.135442	http://dx.doi.org/10.1074/jbc.M110.135442			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20605791	hybrid, Green Published			2022-12-25	WOS:000281404100028
J	Betancur-R, R; Arturo, AP; Duque-Caro, H; Santos, SR				Betancur-R, Ricardo; Arturo, Acero P.; Duque-Caro, Hermann; Santos, Scott R.			Phylogenetic and Morphologic Analyses of a Coastal Fish Reveals a Marine Biogeographic Break of Terrestrial Origin in the Southern Caribbean	PLOS ONE			English	Article							REEF FISHES; COMPARATIVE PHYLOGEOGRAPHY; GENETIC-DIVERGENCE; SEA CATFISHES; EVOLUTIONARY HISTORY; POPULATION-STRUCTURE; NICHE CONSERVATISM; BAJA-CALIFORNIA; MIXED MODELS; SPECIATION	Background: Marine allopatric speciation involves interplay between intrinsic organismal properties and extrinsic factors. However, the relative contribution of each depends on the taxon under study and its geographic context. Utilizing sea catfishes in the Cathorops mapale species group, this study tests the hypothesis that both reproductive strategies conferring limited dispersal opportunities and an apparent geomorphologic barrier in the Southern Caribbean have promoted speciation in this group from a little studied area of the world. Methodology/Principal Findings: Mitochondrial gene sequences were obtained from representatives of the Cathorops mapale species group across its distributional range from Colombia to Venezuela. Morphometric and meristic analyses were also done to assess morphologic variation. Along a similar to 2000 km transect, two major lineages, Cathorops sp. and C. mapale, were identified by levels of genetic differentiation, phylogenetic reconstructions, and morphological analyses. The lineages are separated by similar to 150 km at the Santa Marta Massif (SMM) in Colombia. The northward displacement of the SMM into the Caribbean in the early Pleistocene altered the geomorphology of the continental margin, ultimately disrupting the natural habitat of C. mapale. The estimated similar to 0.86 my divergence of the lineages from a common ancestor coincides with the timing of the SMM displacement at similar to 0.78 my. Main Conclusions/Significance: Results presented here support the hypothesis that organismal properties as well as extrinsic factors lead to diversification of the Cathorops mapale group along the northern coast of South America. While a lack of pelagic larval stages and ecological specialization are forces impacting this process, the identification of the SMM as contributing to allopatric speciation in marine organisms adds to the list of recognized barriers in the Caribbean. Comparative examination of additional Southern Caribbean taxa, particularly those with varying life history traits and dispersal capabilities, will determine the extent by which the SMM has influenced marine phylogeography in the region.	[Betancur-R, Ricardo; Santos, Scott R.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Betancur-R, Ricardo; Arturo, Acero P.] Univ Nacl Colombia, CECIMAR INVEMAR, Santa Marta, Colombia; [Duque-Caro, Hermann] Duque Caro & Cia Ltda, Bogota, Colombia	Auburn University System; Auburn University; Universidad Nacional de Colombia	Betancur-R, R (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	betanri@gmail.com	Santos, Scott R/A-7472-2009	Acero P., Arturo/0000-0002-6637-9901	National Science Foundation [DEB-0315963]; COLCIENCIAS, Colombia [1101-09-138-98, 117-09-12459]; Duque Caro y Cia. Ltda, Bogota D.C., Colombia	National Science Foundation(National Science Foundation (NSF)); COLCIENCIAS, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Duque Caro y Cia. Ltda, Bogota D.C., Colombia	The study was funded by: 1) The All Catfish Species Inventory project supported by the National Science Foundation DEB-0315963 (http://www.nsf.gov/). 2) COLCIENCIAS 1101-09-138-98, 117-09-12459, Colombia (http://www.colciencias.gov.co). 3) Duque Caro y Cia. Ltda, Bogota D.C., Colombia. The only role of this agency in the study was to support the salary of the third author (H. Duque-Caro). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acero P.A., 2005, MEMORIA FUNDACION SA, V163, P37; ACERO PA, 1985, ZOOLOGICAL IMPLICATI, P433; AVISE JC, 1987, EVOLUTION, V41, P991, DOI 10.1111/j.1558-5646.1987.tb05872.x; Barandica Juan Carlos Narvaez, 2008, Boletin de Investigaciones Marinas y Costeras, V37, P163; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; BERGGREN WA, 1995, SEPM SPEC PUBL, V54, P212; Bermingham Eldredge, 1997, P113, DOI 10.1016/B978-012417540-2/50009-9; Bernardi G, 2005, MOL ECOL, V14, P4085, DOI 10.1111/j.1365-294X.2005.02729.x; Bernardi G, 2003, EVOLUTION, V57, P1599; Bernardi G, 2004, MAR BIOL, V145, P803, DOI 10.1007/s00227-004-1355-1; Betancur-R R, 2005, ZOOTAXA, P45; Betancur-R R, 2007, MOL PHYLOGENET EVOL, V45, P339, DOI 10.1016/j.ympev.2007.02.022; Betancur-R R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-175; Betancur R, 2009, EVOLUTION, V63, P1232, DOI 10.1111/j.1558-5646.2009.00640.x; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; Briggs JC, 2007, DIVERS DISTRIB, V13, P544, DOI 10.1111/j.1472-4642.2007.00362.x; BULA G, 1977, AN I INV MAR PUNTA B, V9, P45; CAMPBELL CJ, 1968, PORT SPAIN TRINIDAD, P247; Carlin JL, 2003, MAR BIOL, V143, P1057, DOI 10.1007/s00227-003-1151-3; Cervigon F., 1991, PECES MARINOS VENEZU; Coates Anthony G., 1996, P21; COLIN PL, 1995, B MAR SCI, V56, P48; COSEL RV, 1976, MITTEILUNGEN I COLOM, V8, P83; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Dawson MN, 2001, EVOLUTION, V55, P1167; Diaz Juan M., 1995, Caribbean Journal of Science, V31, P104; Drummond AJ, 2007, ROUGH GUIDE BEAST 1; Duque-Caro H, 1979, GEOLOGICAL GEOPHYS I, V29, P329, DOI DOI 10.1016/j.ympev.2017.04.003; DUQUECARO H, 1990, PALAEOGEOGR PALAEOCL, V77, P203, DOI 10.1016/0031-0182(90)90178-A; FitzSimmons NN, 1997, GENETICS, V147, P1843; Hellberg ME, 2002, B MAR SCI, V70, P273; Hickerson MJ, 2001, MAR BIOL, V138, P407, DOI 10.1007/s002270000465; *INVEMAR, 2003, INF EST AMB MAR COST; IRVING EM, 1975, US GEOLOGICAL SURVEY, V846, P1; Jennings RM, 2009, J HERED, V100, P86, DOI 10.1093/jhered/esn067; Jolliffe, 2002, PRINCIPAL COMPONENT; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Landau B, 2008, PALAEOGEOGR PALAEOCL, V257, P445, DOI 10.1016/j.palaeo.2007.10.019; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marceniuk AP, 2008, NEOTROP ICHTHYOL, V6, P25, DOI 10.1590/S1679-62252008000100004; McCune AR, 1998, ENDLESS FORMS, P172; Mendoza-Carranza Manuel, 2005, Hidrobiológica, V15, P275; MENDOZACARRANZA M, 2003, HIDROBIOLOGICA, V12, P119; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Pelc RA, 2009, J BIOGEOGR, V36, P1881, DOI 10.1111/j.1365-2699.2009.02138.x; Planes S, 2001, EVOLUTION, V55, P2263; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Richards VP, 2007, MOL ECOL, V16, P139, DOI 10.1111/j.1365-294X.2006.03145.x; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Roberts MA, 2004, GENETICS, V166, P1857, DOI 10.1534/genetics.166.4.1857; Rocha LA, 2003, J BIOGEOGR, V30, P1161, DOI 10.1046/j.1365-2699.2003.00900.x; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson M.J., 2004, R8S VERSION 1 70 USE; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Taylor MS, 2006, MOL ECOL, V15, P695, DOI 10.1111/j.1365-294X.2006.02820.x; TSCHANZ CM, 1974, GEOL SOC AM BULL, V85, P273, DOI 10.1130/0016-7606(1974)85<273:GEOTSN>2.0.CO;2; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; WOODRING WP, 1974, GESELLSCHAFT BASEL, V84, P209; YANEZARANCIBIA A, 1988, MAR ECOL PROG SER, V49, P215, DOI 10.3354/meps049215; Zwickl D., 2006, GARLI GENETIC ALGORI	71	18	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11566	10.1371/journal.pone.0011566	http://dx.doi.org/10.1371/journal.pone.0011566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644638	Green Submitted, gold, Green Published			2022-12-25	WOS:000279822300017
J	Nielsen, UN; Osler, GHR; Campbell, CD; Neilson, R; Burslem, DFRP; van der Wal, R				Nielsen, Uffe N.; Osler, Graham H. R.; Campbell, Colin D.; Neilson, Roy; Burslem, David F. R. P.; van der Wal, Rene			The Enigma of Soil Animal Species Diversity Revisited: The Role of Small-Scale Heterogeneity	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; ORIBATID MITES ACARI; MICROBIAL DIVERSITY; HEATHER MOORLAND; HABITAT; BIODIVERSITY; COMPLEXITY; COMMUNITY; BIRCH; CRYPTOSTIGMATA	Background: "The enigma of soil animal species diversity'' was the title of a popular article by J. M. Anderson published in 1975. In that paper, Anderson provided insights on the great richness of species found in soils, but emphasized that the mechanisms contributing to the high species richness belowground were largely unknown. Yet, exploration of the mechanisms driving species richness has focused, almost exclusively, on above-ground plant and animal communities, and nearly 35 years later we have several new hypotheses but are not much closer to revealing why soils are so rich in species. One persistent but untested hypothesis is that species richness is promoted by small-scale environmental heterogeneity. Methodology/Principal Findings: To test this hypothesis we manipulated small-scale heterogeneity in soil properties in a one-year field experiment and investigated the impacts on the richness of soil fauna and evenness of the microbial communities. We found that heterogeneity substantially increased the species richness of oribatid mites, collembolans and nematodes, whereas heterogeneity had no direct influence on the evenness of either the fungal, bacterial or archaeal communities or on species richness of the large and mobile mesostigmatid mites. These results suggest that the heterogeneity-species richness relationship is scale dependent. Conclusions: Our results provide direct evidence for the hypothesis that small-scale heterogeneity in soils increase species richness of intermediate-sized soil fauna. The concordance of mechanisms between above and belowground communities suggests that the relationship between environmental heterogeneity and species richness may be a general property of ecological communities.	[Nielsen, Uffe N.; Osler, Graham H. R.; Campbell, Colin D.] Macaulay Land Use Res Inst, Aberdeen AB9 2QJ, Scotland; [Nielsen, Uffe N.; Burslem, David F. R. P.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Nielsen, Uffe N.; van der Wal, Rene] Univ Aberdeen, Aberdeen Ctr Environm Sustainabil, Aberdeen, Scotland; [Campbell, Colin D.] Swedish Univ Agr Sci, Dept Soil & Environm, Uppsala, Sweden; [Neilson, Roy] Scottish Crop Res Inst, Dundee DD2 5DA, Scotland	James Hutton Institute; University of Aberdeen; University of Aberdeen; Swedish University of Agricultural Sciences; James Hutton Institute	Nielsen, UN (corresponding author), Macaulay Land Use Res Inst, Aberdeen AB9 2QJ, Scotland.	uffe@nrel.colostate.edu	van der Wal, Rene/F-3177-2010; Campbell, Colin D/B-3944-2010; Neilson, Roy/Q-1206-2019; Burslem, David FRP/F-1204-2019	Campbell, Colin D/0000-0002-5163-7656; Burslem, David FRP/0000-0001-6033-0990; Neilson, Roy/0000-0003-4544-2227; Nielsen, Uffe N/0000-0003-2400-7453	Aberdeen Centre for Environmental Sustainability; Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	Aberdeen Centre for Environmental Sustainability; Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	UNN acknowledges funding from the Aberdeen Centre for Environmental Sustainability; GO, CDC and RN acknowledge funding from the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.M., 1975, P51; ANDERSON JM, 1978, SOIL BIOL BIOCHEM, V10, P77, DOI 10.1016/0038-0717(78)90014-7; ANDERSON JM, 1978, OECOLOGIA, V32, P341, DOI 10.1007/BF00345112; Bardgett RD, 2002, ZOOLOGY, V105, P367, DOI 10.1078/0944-2006-00072; Blackwood CB, 2007, APPL ENVIRON MICROB, V73, P5276, DOI 10.1128/AEM.00514-07; Borken W, 2003, SOIL SCI SOC AM J, V67, P1888, DOI 10.2136/sssaj2003.1888; Brussaard L, 2007, AGR ECOSYST ENVIRON, V121, P233, DOI 10.1016/j.agee.2006.12.013; Burnett MR, 1998, CONSERV BIOL, V12, P363, DOI 10.1046/j.1523-1739.1998.96238.x; Chust G, 2003, CONSERV BIOL, V17, P1712, DOI 10.1111/j.1523-1739.2003.00564.x; Downes BJ, 1998, ECOL MONOGR, V68, P237, DOI 10.1890/0012-9615(1998)068[0237:HSAROL]2.0.CO;2; Ducarme X, 2004, PEDOBIOLOGIA, V48, P139, DOI 10.1016/j.pedobi.2003.10.002; Dykhuizen DE, 1998, ANTON LEEUW INT J G, V73, P25, DOI 10.1023/A:1000665216662; Farley RA, 1999, J ECOL, V87, P688, DOI 10.1046/j.1365-2745.1999.00390.x; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; GILL R W, 1969, Ecology (Washington D C), V50, P805, DOI 10.2307/1933694; Hansen RA, 1998, APPL SOIL ECOL, V9, P17, DOI 10.1016/S0929-1393(98)00048-1; Hansen RA, 2000, ECOLOGY, V81, P1120, DOI 10.1890/0012-9658(2000)081[1120:EOHCAC]2.0.CO;2; Hopkin S.P., 2007, KEY COLLEMBOLA SPRIN; Huston M.A., 1994, BIOL DIVERSITY; JEFFRIES M, 1993, OIKOS, V67, P142, DOI 10.2307/3545104; Keith AM, 2006, SOIL BIOL BIOCHEM, V38, P3421, DOI 10.1016/j.soilbio.2006.05.013; MACFADYEN A., 1962, ADVANCES ECOL RES, V1, P1, DOI 10.1016/S0065-2504(08)60299-8; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MITCHELL MJ, 1978, ECOLOGY, V59, P516, DOI 10.2307/1936582; Mitchell RJ, 2007, J ECOL, V95, P540, DOI 10.1111/j.1365-2745.2007.01227.x; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Nichols WF, 1998, CONSERV BIOL, V12, P371, DOI 10.1046/j.1523-1739.1998.96237.x; Osler GHR, 2006, PEDOBIOLOGIA, V50, P323, DOI 10.1016/j.pedobi.2006.05.001; Robson BJ, 1999, AUST J ECOL, V24, P599, DOI 10.1046/j.1442-9993.1999.01007.x; Ruf A, 2005, ECOTOX ENVIRON SAFE, V62, P290, DOI 10.1016/j.ecoenv.2005.03.029; Singh BK, 2006, APPL ENVIRON MICROB, V72, P7278, DOI 10.1128/AEM.00510-06; SMILES DE, 1988, BIOL FERT SOILS, V6, P204, DOI 10.1007/BF00260817; STANTON NL, 1979, ECOLOGY, V60, P295, DOI 10.2307/1937658; Svenning JC, 1999, J ECOL, V87, P55, DOI 10.1046/j.1365-2745.1999.00329.x; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Treves DS, 2003, MICROB ECOL, V45, P20, DOI 10.1007/s00248-002-1044-x; Wardle D.A, 2002, MG POP BIOL, V34, P1, DOI 10.1515/9781400847297; Wardle DA, 1996, SOIL BIOL BIOCHEM, V28, P1549, DOI 10.1016/S0038-0717(96)00293-3; WAUTHY G, 1982, ACTA OECOL-OEC GEN, V3, P469; Xia BC, 2001, PROG NAT SCI, V11, P818; Young IM, 1998, GLOBAL CHANGE BIOL, V4, P703, DOI 10.1046/j.1365-2486.1998.00194.x; Zhou JZ, 2002, APPL ENVIRON MICROB, V68, P326, DOI 10.1128/AEM.68.1.326-334.2002	43	79	83	6	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11567	10.1371/journal.pone.0011567	http://dx.doi.org/10.1371/journal.pone.0011567			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644639	Green Published, Green Submitted, gold			2022-12-25	WOS:000279822300018
J	Zouk, H; Marchand, L; Polychronakos, C				Zouk, Hana; Marchand, Luc; Polychronakos, Constantin			Study of Transcriptional Effects in Cis at the IFIH1 Locus	PLOS ONE			English	Article							ACTING REGULATORY VARIATION; GENOME-WIDE ASSOCIATION; HUMAN GENE-EXPRESSION; SINGLE NUCLEOTIDE; PRIMER EXTENSION; DNA POOLS; RIG-I; HELICASE; PROTEIN; CELL	Background: The Thr allele at the non-synonymous single-nucleotide polymorphism (nsSNP) Thr946Ala in the IFIH1 gene confers risk for Type 1 diabetes (T1D). The SNP is embedded in a 236 kb linkage disequilibrium (LD) block that includes four genes: IFIH1, GCA, FAP and KCNH7. The absence of common nsSNPs in the other genes makes the IFIH1 SNP the strongest functional candidate, but it could be merely a marker of association, due to LD with a variant regulating expression levels of IFIH1 or neighboring genes. Methodology/Principal Findings: We investigated the effect of the T1D-associated variation on mRNA transcript expression of these genes. Heterozygous mRNA from lymphoblastoid cell lines (LCLs), pancreas and thymus was examined by allelic expression imbalance, to detect effects in cis on mRNA expression. Using single-nucleotide primer extension, we found no difference between mRNA transcripts in 9 LCLs, 6 pancreas and 13 thymus samples, suggesting that GCA and FAP are not involved. On the other hand, KCNH7 was not expressed at a detectable level in all tissues examined. Moreover, the association of the Thr946Ala SNP with T1D is not due to modulation of IFIH1 expression in organs involved in the disease, pointing to the IFIH1 nsSNP as the causal variant. Conclusions/Significance: The mechanism of the association of the nsSNP with T1D remains to be determined, but does not involve mRNA modulation. It becomes necessary to study differential function of the IFIH1 protein alleles at Thr946Ala to confirm that it is responsible for the disease association.	[Zouk, Hana; Marchand, Luc; Polychronakos, Constantin] McGill Univ, Montreal Childrens Hosp, Res Inst, Endocrine Genet Lab,Hlth Ctr, Montreal, PQ H3H 1P3, Canada; [Zouk, Hana; Polychronakos, Constantin] McGill Univ, Dept Human Genet, Montreal, PQ H3H 1P3, Canada; [Polychronakos, Constantin] McGill Univ, Ctr Hlth, Dept Paediat, Montreal, PQ H3H 1P3, Canada	McGill University; McGill University; McGill University	Zouk, H (corresponding author), McGill Univ, Montreal Childrens Hosp, Res Inst, Endocrine Genet Lab,Hlth Ctr, Montreal, PQ H3H 1P3, Canada.	constantin.polychronakos@mcgill.ca		Zouk, Hana/0000-0001-6492-6118; Polychronakos, Constantin/0000-0002-7624-6635	Juvenile Diabetes Research Foundation International; Fonds de Recherche en Sante du Quebec	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was funded by the Juvenile Diabetes Research Foundation International. HZ is supported by a doctoral scholarship from the Fonds de Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjos SM, 2005, GENES IMMUN, V6, P305, DOI 10.1038/sj.gene.6364211; BOYHAN A, 1992, J BIOL CHEM, V267, P2928; Bray NJ, 2006, PSYCHIAT GENET, V16, P173, DOI 10.1097/01.ypg.0000218612.35139.84; Bray NJ, 2003, HUM GENET, V113, P149, DOI 10.1007/s00439-003-0956-y; Buckland PR, 2004, HUM MOL GENET, V13, pR255, DOI 10.1093/hmg/ddh227; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Fassnacht M, 2005, CLIN CANCER RES, V11, P5566, DOI 10.1158/1078-0432.CCR-05-0699; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hoogendoorn B, 2000, HUM GENET, V107, P488, DOI 10.1007/s004390000397; Hyoty H, 2002, DIABETOLOGIA, V45, P1353, DOI 10.1007/s00125-002-0852-3; Kang DC, 2004, ONCOGENE, V23, P1789, DOI 10.1038/sj.onc.1207300; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Marchand L, 2007, DIABETES, V56, P709, DOI 10.2337/db06-0402; Marinou I, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2179; McCann JA, 2001, BIOCHEM BIOPH RES CO, V286, P943, DOI 10.1006/bbrc.2001.5500; Muhlbauer E, 2007, CELL MOL LIFE SCI, V64, P768, DOI 10.1007/s00018-007-6478-3; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Norton N, 2002, HUM GENET, V110, P471, DOI 10.1007/s00439-002-0706-6; Pastinen T, 2005, HUM MOL GENET, V14, P3963, DOI 10.1093/hmg/ddi420; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Qu HQ, 2008, DIABETOLOGIA, V51, P473, DOI 10.1007/s00125-007-0895-6; Roivainen M, 2006, INT J BIOCHEM CELL B, V38, P721, DOI 10.1016/j.biocel.2005.08.019; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Singer-Sam J, 1992, PCR Methods Appl, V1, P160; SINGERSAM J, 1992, P NATL ACAD SCI USA, V89, P10469, DOI 10.1073/pnas.89.21.10469; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; van der Werf N, 2007, DIABETES-METAB RES, V23, P169, DOI 10.1002/dmrr.695; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851	36	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11564	10.1371/journal.pone.0011564	http://dx.doi.org/10.1371/journal.pone.0011564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644636	Green Published, Green Submitted, gold			2022-12-25	WOS:000279822300015
J	Meadows, SK; Dressman, HK; Daher, P; Himburg, H; Russell, JL; Doan, P; Chao, NJ; Lucas, J; Nevins, JR; Chute, JP				Meadows, Sarah K.; Dressman, Holly K.; Daher, Pamela; Himburg, Heather; Russell, J. Lauren; Doan, Phuong; Chao, Nelson J.; Lucas, Joseph; Nevins, Joseph R.; Chute, John P.			Diagnosis of Partial Body Radiation Exposure in Mice Using Peripheral Blood Gene Expression Profiles	PLOS ONE			English	Article							SIGNATURES; BIOMARKERS; LEUKEMIA; PREDICT; CANCER; RISK; PROGENITOR; MANAGEMENT; WORKERS; HEALTH	In the event of a terrorist-mediated attack in the United States using radiological or improvised nuclear weapons, it is expected that hundreds of thousands of people could be exposed to life-threatening levels of ionizing radiation. We have recently shown that genome-wide expression analysis of the peripheral blood (PB) can generate gene expression profiles that can predict radiation exposure and distinguish the dose level of exposure following total body irradiation (TBI). However, in the event a radiation-mass casualty scenario, many victims will have heterogeneous exposure due to partial shielding and it is unknown whether PB gene expression profiles would be useful in predicting the status of partially irradiated individuals. Here, we identified gene expression profiles in the PB that were characteristic of anterior hemibody-, posterior hemibody- and single limb-irradiation at 0.5 Gy, 2 Gy and 10 Gy in C57Bl6 mice. These PB signatures predicted the radiation status of partially irradiated mice with a high level of accuracy (range 79-100%) compared to non-irradiated mice. Interestingly, PB signatures of partial body irradiation were poorly predictive of radiation status by site of injury (range 16-43%), suggesting that the PB molecular response to partial body irradiation was anatomic site specific. Importantly, PB gene signatures generated from TBI-treated mice failed completely to predict the radiation status of partially irradiated animals or non-irradiated controls. These data demonstrate that partial body irradiation, even to a single limb, generates a characteristic PB signature of radiation injury and thus may necessitate the use of multiple signatures, both partial body and total body, to accurately assess the status of an individual exposed to radiation.	[Meadows, Sarah K.; Daher, Pamela; Himburg, Heather; Russell, J. Lauren; Doan, Phuong; Chao, Nelson J.; Chute, John P.] Duke Univ, Dept Med, Div Cellular Therapy, Durham, NC 27706 USA; [Dressman, Holly K.; Lucas, Joseph; Nevins, Joseph R.; Chute, John P.] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Chute, John P.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA	Duke University; Duke University; Duke University	Meadows, SK (corresponding author), Duke Univ, Dept Med, Div Cellular Therapy, Durham, NC 27706 USA.	john.chute@duke.edu	Doan, Phuong L./Q-2093-2019	Doan, Phuong L./0000-0003-1361-2068	National Institute for Allergy and Infectious Diseases (JPC) [AI-067798-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Diseases (JPC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grant AI-067798-01 from the National Institute for Allergy and Infectious Diseases (JPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2004, CANCER RES, V64, P6368, DOI 10.1158/0008-5472.CAN-04-1883; Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; Bader JL, 2008, PREHOSP EMERG CARE, V12, P1, DOI 10.1080/10903120701710595; Baird AE, 2007, STROKE, V38, P694, DOI 10.1161/01.STR.0000250431.99687.7b; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Blakely WF, 2005, HEALTH PHYS, V89, P494, DOI 10.1097/01.HP.0000175913.36594.a4; Brengues M, 2010, HEALTH PHYS, V98, P179, DOI 10.1097/01.HP.0000346706.44253.5c; BUDDEMEIER B, 2009, RAD EVENT MED MA AUG; Carvalho CM, 2008, J AM STAT ASSOC, V103, P1438, DOI 10.1198/016214508000000869; Coleman CN, 2009, ANN EMERG MED, V53, P213, DOI 10.1016/j.annemergmed.2007.12.021; Dainiak N, 2007, EXP HEMATOL, V35, P17, DOI 10.1016/j.exphem.2007.01.007; *DEP EN, MANH PROJ OFF HIST H; DiCarlo AL, 2008, RADIAT RES, V169, P712, DOI 10.1667/RR1295.1; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Fliedner TM, 2009, STEM CELLS, V27, P1205, DOI 10.1002/stem.16; Grace MB, 2002, INT J RADIAT BIOL, V78, P1011, DOI 10.1080/09553000210158056; Grande T, 2006, INT J RADIAT ONCOL, V64, P612, DOI 10.1016/j.ijrobp.2005.09.036; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; LUCAS JE, 2009, SPARSE STAT MODELING, P155; Lucas J, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1436; Lucas JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004523; Mandel M, 2006, LUPUS, V15, P451, DOI 10.1191/0961203306lu2332oa; Meadows SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001912; Mettler FA, 2002, NEW ENGL J MED, V346, P1554, DOI 10.1056/NEJMra000365; MILLER SW, 1985, AM J CARDIOL, V55, P171, DOI 10.1016/0002-9149(85)90322-4; Ossetrova NI, 2009, INT J RADIAT BIOL, V85, P837, DOI 10.3109/09553000903154799; Paul S, 2008, INT J RADIAT ONCOL, V71, P1236, DOI 10.1016/j.ijrobp.2008.03.043; Prasanna Pataje G S, 2010, Radiat Res, V173, P245, DOI 10.1667/RR1993.1; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; Schubauer-Berigan MK, 2007, RADIAT RES, V167, P222, DOI 10.1667/RR0724.1; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Thompson LJ, 2009, P NATL ACAD SCI USA, V106, P22433, DOI 10.1073/pnas.0912386106; Tyburski JB, 2008, RADIAT RES, V170, P1, DOI 10.1667/RR1265.1; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; WANG Q, 2007, B INT SOC BAYESIAN A, V14, P4; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Weinstock DM, 2008, BLOOD, V111, P5440, DOI 10.1182/blood-2008-01-134817; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; WONG O, 1995, OCCUP ENVIRON MED, V52, P380, DOI 10.1136/oem.52.6.380; Yoshinaga S, 2004, RADIOLOGY, V233, P313, DOI 10.1148/radiol.2332031119; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	43	41	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11535	10.1371/journal.pone.0011535	http://dx.doi.org/10.1371/journal.pone.0011535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634956	Green Published, Green Submitted, gold			2022-12-25	WOS:000279781600015
J	Lesur, I; Textoris, J; Loriod, B; Courbon, C; Garcia, S; Leone, M; Nguyen, C				Lesur, Isabelle; Textoris, Julien; Loriod, Beatrice; Courbon, Cecile; Garcia, Stephane; Leone, Marc; Nguyen, Catherine			Gene Expression Profiles Characterize Inflammation Stages in the Acute Lung Injury in Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ANGIOTENSIN-CONVERTING ENZYME; LIPID-METABOLISM; OLEIC-ACID; DNA MICROARRAYS; MOUSE MODEL; SEPSIS; INTERLEUKIN-6; STIMULATION; ACTIVATION	Acute Lung Injury (ALI) carries about 50 percent mortality and is frequently associated with an infection (sepsis). Life-support treatment with mechanical ventilation rescues many patients, although superimposed infection or multiple organ failure can result in death. The outcome of a patient developing sepsis depends on two factors: the infection and the preexisting inflammation. In this study, we described each stage of the inflammation process using a transcriptional approach and an animal model. Female C57BL6/J mice received an intravenous oleic acid injection to induce an acute lung injury (ALI). Lung expression patterns were analyzed using a 9900 cDNA mouse microarray (MUSV29K). Our gene-expression analysis revealed marked changes in the immune and inflammatory response metabolic pathways, notably lipid metabolism and transcription. The early stage (1 hour-1.5 hours) is characterized by a pro-inflammatory immune response. Later (3 hours-4 hours), the immune cells migrate into inflamed tissues through interaction with vascular endothelial cells. Finally, at late stages of lung inflammation (18 hours-24 hours), metabolism is deeply disturbed. Highly expressed proinflammatory cytokines activate transcription of many genes and lipid metabolism. In this study, we described a global overview of critical events occurring during lung inflammation which is essential to understand infectious pathologies such as sepsis where inflammation and infection are intertwined. Based on these data, it becomes possible to isolate the impact of a pathogen at the transcriptional level from the global gene expression modifications resulting from the infection associated with the inflammation.	[Lesur, Isabelle; Textoris, Julien; Loriod, Beatrice; Nguyen, Catherine] Univ Mediterranee, TAGC, INSERM, U928, Marseille, France; [Textoris, Julien; Leone, Marc] Univ Mediterranee, Hop Nord, AP HM, Serv Anesthesie & Reanimat, Marseille, France; [Courbon, Cecile] Univ Mediterranee, Hop LaTimone, AP HM, Serv Anesthesie & Reanimat, Marseille, France; [Garcia, Stephane] Univ Mediterranee, Fac Med, Secteur Nord, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Lesur, I (corresponding author), Univ Mediterranee, TAGC, INSERM, U928, Parc Sci Luminy, Marseille, France.	nguyen@tagc.univ-mrs.fr	Nguyen, Catherine/M-4119-2016; Leone, Marc/P-4835-2016; Textoris, Julien/H-3317-2019; loriod, beatrice bl/L-2948-2016	Nguyen, Catherine/0000-0001-9376-6360; Leone, Marc/0000-0002-3097-758X; Textoris, Julien/0000-0002-3821-9337; loriod, beatrice bl/0000-0001-5801-2264	Conseil Regional Provence Alpes Cote d'Azur; Societe Francaise d'Anesthesie et de Reanimation; Ministere de la sante	Conseil Regional Provence Alpes Cote d'Azur(Region Provence-Alpes-Cote d'AzurRegion Auvergne-Rhone-Alpes); Societe Francaise d'Anesthesie et de Reanimation; Ministere de la sante	This work was supported by grants from Conseil Regional Provence Alpes Cote d'Azur, Societe Francaise d'Anesthesie et de Reanimation, and le Ministere de la sante (Programme Hospitalier de Recherche Clinique, PHRC 2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DH, 1996, BRIT J ANAESTH, V77, P17, DOI 10.1093/bja/77.1.17; AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; ARGILES JM, 1989, BIOCHEM J, V259, P673, DOI 10.1042/bj2590673; Armstrong L, 1997, THORAX, V52, P442, DOI 10.1136/thx.52.5.442; BAUMANN H, 1989, ANN NY ACAD SCI, V557, P280; Bein K, 2009, AM J RESP CELL MOL, V41, P226, DOI 10.1165/rcmb.2008-0317OC; Bem RA, 2009, AM J PHYSIOL-LUNG C, V296, pL46, DOI 10.1152/ajplung.00467.2007; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; BIRCH HE, 1986, J BIOL CHEM, V261, P8077; Bone RC, 1997, CHEST, V112, P235, DOI 10.1378/chest.112.1.235; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bulfone-Paus S, 1999, FASEB J, V13, P1575, DOI 10.1096/fasebj.13.12.1575; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; CASEY L, 1981, CRIT CARE MED, V9, P651, DOI 10.1097/00003246-198109000-00008; CAVAILLON J, 1998, PATHOPHYSIOLOGICAL R, P127; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; CHINNAIYAN AM, 2001, MOL SIGNATURES SEPSI; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; CROWL RM, 1991, J BIOL CHEM, V266, P2647; DERKS CM, 1977, AM J PATHOL, V87, P143; Diehl F, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf078; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FEINGOLD KR, 1992, J LIPID RES, V33, P1765; Giannoudis PV, 1998, BRIT J SURG, V85, P986; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; GRANJEAUD S, MIQC; GRUNFELD C, 1991, CANCER RES, V51, P2803; Hardardottir I, 1995, BIOCHEM SOC T, V23, P1013, DOI 10.1042/bst0231013; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; HOWARD M, 1992, IMMUNOL TODAY, V13, P198, DOI 10.1016/0167-5699(92)90153-X; Huang HW, 2007, J BIOMED SCI, V14, P169, DOI 10.1007/s11373-006-9135-1; Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208; Johnson SB, 2007, ANN SURG, V245, P611, DOI 10.1097/01.sla.0000251619.10648.32; KASAMA T, 1994, J IMMUNOL, V152, P3559; Kopterides P, 2009, CLIN MICROBIOL INFEC, V15, P325, DOI 10.1111/j.1469-0691.2009.02750.x; Leone M, 2003, ANN FR ANESTH, V22, P721, DOI 10.1016/S0750-7658(03)00327-7; Lopez F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-38; Loureiro RMB, 2008, BRIT J HAEMATOL, V141, P739, DOI 10.1111/j.1365-2141.2008.07105.x; Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; NIJSTEN MWN, 1991, SURGERY, V109, P761; Olman MA, 2004, J IMMUNOL, V172, P2668, DOI 10.4049/jimmunol.172.4.2668; Opdenakker G, 2001, Verh K Acad Geneeskd Belg, V63, P531; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puthier D, 2004, J IMMUNOL, V173, P6109, DOI 10.4049/jimmunol.173.10.6109; PUTHIER D, NYLONARRAY; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Saban MR, 2001, PHYSIOL GENOMICS, V5, P147, DOI 10.1152/physiolgenomics.2001.5.3.147; SCHUSTER DP, 1994, AM J RESP CRIT CARE, V149, P245, DOI 10.1164/ajrccm.149.1.8111590; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; Tanaka TS, 2000, P NATL ACAD SCI USA, V97, P9127, DOI 10.1073/pnas.97.16.9127; TEVELDE AA, 1990, BLOOD, V76, P1392; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulrich K, 2005, AM J PHYSIOL-LUNG C, V288, pL1179, DOI 10.1152/ajplung.00450.2004; Villar J, 2008, INTENS CARE MED, V34, P488, DOI 10.1007/s00134-007-0937-z; Wang ZX, 2008, AM J RESP CELL MOL, V38, P724, DOI 10.1165/rcmb.2007-0354OC; Woerndle RH, 2008, J AM OSTEOPATH ASSOC, V108, P486; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Worgall TS, 2009, CURR OPIN CLIN NUTR, V12, P105, DOI 10.1097/MCO.0b013e32832595b7; Wurfel Mark M, 2007, Proc Am Thorac Soc, V4, P77, DOI 10.1513/pats.200608-149JG; Zhou ZH, 2005, AM J RESP CRIT CARE, V172, P344, DOI 10.1164/rccm.200503-343OC	65	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11485	10.1371/journal.pone.0011485	http://dx.doi.org/10.1371/journal.pone.0011485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628605	Green Published, gold, Green Submitted			2022-12-25	WOS:000279637100012
J	Kurz, A; Double, KL; Lastres-Becker, I; Tozzi, A; Tantucci, M; Bockhart, V; Bonin, M; Garcia-Arencibia, M; Nuber, S; Schlaudraff, F; Liss, B; Fernandez-Ruiz, J; Gerlach, M; Wullner, U; Luddens, H; Calabresi, P; Auburger, G; Gispert, S				Kurz, Alexander; Double, Kay L.; Lastres-Becker, Isabel; Tozzi, Alessandro; Tantucci, Michela; Bockhart, Vanessa; Bonin, Michael; Garcia-Arencibia, Moises; Nuber, Silke; Schlaudraff, Falk; Liss, Birgit; Fernandez-Ruiz, Javier; Gerlach, Manfred; Wuellner, Ullrich; Lueddens, Hartmut; Calabresi, Paolo; Auburger, Georg; Gispert, Suzana			A53T-Alpha-Synuclein Overexpression Impairs Dopamine Signaling and Striatal Synaptic Plasticity in Old Mice	PLOS ONE			English	Article							HUMAN ALPHA-SYNUCLEIN; RECEPTOR MESSENGER-RNA; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; NEURONAL DYSFUNCTION; GLOBUS-PALLIDUS; GENE-EXPRESSION; RAT-BRAIN; STIMULATION; ACTIVATION	Background: Parkinson's disease (PD), the second most frequent neurodegenerative disorder at old age, can be caused by elevated expression or the A53T missense mutation of the presynaptic protein alpha-synuclein (SNCA). PD is characterized pathologically by the preferential vulnerability of the dopaminergic nigrostriatal projection neurons. Methodology/Principal Findings: Here, we used two mouse lines overexpressing human A53T-SNCA and studied striatal dysfunction in the absence of neurodegeneration to understand early disease mechanisms. To characterize the progression, we employed young adult as well as old mice. Analysis of striatal neurotransmitter content demonstrated that dopamine (DA) levels correlated directly with the level of expression of SNCA, an observation also made in SNCA-deficient (knockout, KO) mice. However, the elevated DA levels in the striatum of old A53T-SNCA overexpressing mice may not be transmitted appropriately, in view of three observations. First, a transcriptional downregulation of the extraneural DA degradation enzyme catechol-ortho-methytransferase (COMT) was found. Second, an upregulation of DA receptors was detected by immunoblots and autoradiography. Third, extensive transcriptome studies via microarrays and quantitative real-time RTPCR (qPCR) of altered transcript levels of the DA-inducible genes Atf2, Cb1, Freq, Homer1 and Pde7b indicated a progressive and genotype-dependent reduction in the postsynaptic DA response. As a functional consequence, long term depression (LTD) was absent in corticostriatal slices from old transgenic mice. Conclusions/Significance: Taken together, the dysfunctional neurotransmission and impaired synaptic plasticity seen in the A53T-SNCA overexpressing mice reflect early changes within the basal ganglia prior to frank neurodegeneration. As a model of preclinical stages of PD, such insights may help to develop neuroprotective therapeutic approaches.	[Kurz, Alexander; Lastres-Becker, Isabel; Auburger, Georg; Gispert, Suzana] Goethe Univ Frankfurt, Sch Med, Dept Neurol, Frankfurt, Germany; [Double, Kay L.] Neurosci Res Australia, Sydney, NSW, Australia; [Double, Kay L.] Univ New S Wales, Sydney, NSW, Australia; [Tozzi, Alessandro; Tantucci, Michela; Calabresi, Paolo] Univ Perugia, Osped S Maria Misericordia, Neurol Clin, I-06100 Perugia, Italy; [Bockhart, Vanessa; Lueddens, Hartmut] Johannes Gutenberg Univ Mainz, Dept Psychiat, D-6500 Mainz, Germany; [Bonin, Michael] Univ Tubingen, Dept Med Genet, Tubingen, Germany; [Garcia-Arencibia, Moises; Fernandez-Ruiz, Javier] Univ Complutense, Dept Biochem & Mol Biol, E-28040 Madrid, Spain; [Garcia-Arencibia, Moises; Fernandez-Ruiz, Javier] Univ Complutense, Fac Med, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-28040 Madrid, Spain; [Nuber, Silke] Univ Tubingen, Dept Med Genet, Tubingen, Germany; [Schlaudraff, Falk; Liss, Birgit] Univ Ulm, Inst Gen Physiol, Ulm, Germany; [Gerlach, Manfred] Univ Wurzburg, Dept Child & Adolescent Psychiat Psychosomat & Ps, Lab Clin Neurochem, Wurzburg, Germany; [Wuellner, Ullrich] Univ Bonn, Dept Neurol, D-5300 Bonn, Germany; [Tozzi, Alessandro; Calabresi, Paolo] European Brain Res Inst, Fdn Santa Lucia IRCCS CERC, Rome, Italy	Goethe University Frankfurt; Neuroscience Research Australia; University of New South Wales Sydney; Hospital Santa Maria della Misericordia; University of Perugia; Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen; Complutense University of Madrid; CIBERNED; Complutense University of Madrid; Eberhard Karls University of Tubingen; Ulm University; University of Wurzburg; University of Bonn; IRCCS Santa Lucia	Kurz, A (corresponding author), Goethe Univ Frankfurt, Sch Med, Dept Neurol, Frankfurt, Germany.	gispert-sanchez@em.uni-frankfurt.de	Wüllner, Ullrich/R-6790-2019; Double, Kay/AAX-7902-2021; Cao, Pengxiu/I-5378-2012; Tozzi, Alessandro/AAB-8707-2022; Becker, Isabel Lastres/AAB-6788-2019; Garcia-Arencibia, Moises/B-5538-2012; Garcia-Arencibia, Moises/K-9920-2013; Tozzi, Alessandro/G-7254-2011; Lastres-Becker, Isabel/R-3403-2018; Calabresi, Paolo/G-8496-2011; FERNANDEZ RUIZ, JOSE JAVIER/S-3875-2018	Double, Kay/0000-0001-8712-7781; Becker, Isabel Lastres/0000-0002-4968-2175; Garcia-Arencibia, Moises/0000-0002-1618-4487; Lastres-Becker, Isabel/0000-0002-4968-2175; Calabresi, Paolo/0000-0003-0326-5509; FERNANDEZ RUIZ, JOSE JAVIER/0000-0002-4490-0604; Tozzi, Alessandro/0000-0003-3153-2424; liss, Birgit/0000-0002-6733-9207	Deutsche Forschungsgemeinschaft [GI 342/3-1]; Bundesministerium fuer Forschung und Technologie [8.2.7]; National Health and Medical Research Council of Australia; Comunidad de Madrid [S-SAL-0261/2006]; CIBERNED [CB06/05/0089]; European Community [HEALTH-2007-22918]; Ministero della Salute; BMBF (NGFN-Net); Gemeinnuetzige Hertiestiftung; Alfried Krupp Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fuer Forschung und Technologie; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Comunidad de Madrid(Comunidad de Madrid); CIBERNED(Instituto de Salud Carlos III); European Community(European Commission); Ministero della Salute(Ministry of Health, Italy); BMBF (NGFN-Net)(Federal Ministry of Education & Research (BMBF)); Gemeinnuetzige Hertiestiftung; Alfried Krupp Foundation	This work was supported by the Deutsche Forschungsgemeinschaft [GI 342/3-1], the Bundesministerium fuer Forschung und Technologie [NGFN2 and NGFNplus Parkinson Net, Project 8.2.7], the National Health and Medical Research Council of Australia; Comunidad de Madrid [S-SAL-0261/2006], the CIBERNED [CB06/05/0089]; the European Community [HEALTH-2007-22918, REPLACES to P.C.], the Ministero della Salute [Progetto Strategico 2007 to P.C.]. I.L.-B. was a fellow of the Alexander von Humboldt Foundation. K.L.D. was a Fellow of the National Health and Medical Research Council of Australia, S.N. had a Stipendium of the Deutschen Parkinson Gesellschaft. This work was supported by the BMBF (NGFN-Net), the Gemeinnuetzige Hertiestiftung (B.L.), and the Alfried Krupp Foundation (B.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; ALWANDI A, 2008, NEUROBIOL AGING; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cabin DE, 2002, J NEUROSCI, V22, P8797; Calabresi P, 2001, J NEUROSCI, V21, P5110, DOI 10.1523/JNEUROSCI.21-14-05110.2001; Calabresi P, 1997, J NEUROSCI, V17, P1940; CALABRESI P, 1990, J NEUROPHYSIOL, V63, P663, DOI 10.1152/jn.1990.63.4.663; Calabresi P, 2000, TRENDS NEUROSCI, V23, pS57, DOI 10.1016/S1471-1931(00)00017-3; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Calabresi P, 2009, BRAIN, V132, P285, DOI 10.1093/brain/awn340; CAO P, PLOS ONE, V5, pE9312; Cenci MA, 2006, J NEUROCHEM, V99, P381, DOI 10.1111/j.1471-4159.2006.04124.x; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Costa C, 2008, J NEUROSCI, V28, P8040, DOI 10.1523/JNEUROSCI.1947-08.2008; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Gerfen CR, 2000, TRENDS NEUROSCI, V23, pS64, DOI 10.1016/S1471-1931(00)00019-7; Gispert S, 2003, MOL CELL NEUROSCI, V24, P419, DOI 10.1016/S1044-7431(03)00198-2; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Grundemann J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn084; Henning J, 2007, EUR J NEUROSCI, V25, P239, DOI 10.1111/j.1460-9568.2006.05264.x; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; JIANG ZG, 1991, J PHYSIOL-LONDON, V443, P533, DOI 10.1113/jphysiol.1991.sp018850; KITA H, 1994, BRAIN RES, V636, P308, DOI 10.1016/0006-8993(94)91030-8; Kitada T, 2009, J NEUROCHEM, V111, P696, DOI 10.1111/j.1471-4159.2009.06350.x; Krasnova IN, 2007, NEUROTOX RES, V11, P107, DOI 10.1007/BF03033390; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kuwajima M, 2007, J NEUROSCI, V27, P6249, DOI 10.1523/JNEUROSCI.3819-06.2007; Lastres-Becker I, 2002, BRAIN RES, V929, P236, DOI 10.1016/S0006-8993(01)03403-5; LEHMANN A, 1974, ATLAS STEREOTAXIQUE; Liu SM, 2004, EMBO J, V23, P4506, DOI 10.1038/sj.emboj.7600451; Lotharius J, 2002, HUM MOL GENET, V11, P2395, DOI 10.1093/hmg/11.20.2395; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Mosharov EV, 2006, J NEUROSCI, V26, P9304, DOI 10.1523/JNEUROSCI.0519-06.2006; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Pearson AG, 2005, NEUROSCIENCE, V133, P437, DOI 10.1016/j.neuroscience.2005.02.029; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Richfield EK, 2002, EXP NEUROL, V175, P35, DOI 10.1006/exnr.2002.7882; ROMERO J, 1995, BRAIN RES, V694, P223, DOI 10.1016/0006-8993(95)00835-E; RUBINO T, 1994, NEUROREPORT, V5, P2493, DOI 10.1097/00001756-199412000-00022; Sasaki T, 2004, J NEUROCHEM, V89, P474, DOI 10.1111/j.1471-4159.2004.02354.x; SEEMAN P, 1990, FASEB J, V4, P2737, DOI 10.1096/fasebj.4.10.2197154; Seidel K, 2010, ANN NEUROL, V67, P684, DOI 10.1002/ana.21966; Senior SL, 2008, EUR J NEUROSCI, V27, P947, DOI 10.1111/j.1460-9568.2008.06055.x; Sidhu A, 2004, FEBS LETT, V565, P1, DOI 10.1016/j.febslet.2004.03.063; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tappe A, 2006, P NATL ACAD SCI USA, V103, P774, DOI 10.1073/pnas.0505900103; Thomas U, 2002, J NEUROCHEM, V81, P407, DOI 10.1046/j.1471-4159.2002.00869.x; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; Wersinger C, 2005, BIOCHEMISTRY-US, V44, P13612, DOI 10.1021/bi050402p; Winter C, 2000, NEUROSCIENCE, V95, P753; Yamada H, 2007, BRAIN RES, V1131, P88, DOI 10.1016/j.brainres.2006.11.011; Zeng BY, 1999, NEUROSCI LETT, V276, P71, DOI 10.1016/S0304-3940(99)00762-4	57	88	89	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11464	10.1371/journal.pone.0011464	http://dx.doi.org/10.1371/journal.pone.0011464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628651	Green Published, gold			2022-12-25	WOS:000279589300011
J	Adam, V; Petrlova, J; Wang, J; Eckschlager, T; Trnkova, L; Kizek, R				Adam, Vojtech; Petrlova, Jitka; Wang, Joseph; Eckschlager, Tomas; Trnkova, Libuse; Kizek, Rene			Zeptomole Electrochemical Detection of Metallothioneins	PLOS ONE			English	Article							SPECIATION; PROTEINS; LEVEL	Background: Thiol-rich peptides and proteins possess a large number of biological activities and may serve as markers for numerous health problems including cancer. Metallothionein (MT), a small molecular mass protein rich in cysteine, may be considered as one of the promising tumour markers. The aim of this paper was to employ chronopotentiometric stripping analysis (CPSA) for highly sensitive detection of MT. Methodology/Principal Findings: In this study, we used adsorptive transfer stripping technique coupled with CPSA for detection of cysteine, glutathione oxidized and reduced, phytochelatin, bovine serum albumin, and metallothionein. Under the optimal conditions, we were able to estimate detection limits down to tens of fg per ml. Further, this method was applied to detect metallothioneins in blood serum obtained from patients with breast cancer and in neuroblastoma cells resistant and sensitive to cisplatin in order to show the possible role of metallothioneins in carcinogenesis. It was found that MT level in blood serum was almost twice higher as compared to the level determined in healthy individuals. Conclusions/Significance: This paper brings unique results on the application of ultra-sensitive electroanalytical method for metallothionein detection. The detection limit and other analytical parameters are the best among the parameters of other techniques. In spite of the fact that the paper is mainly focused on metallothionein, it is worth mentioning that successful detection of other biologically important molecules is possible by this method. Coupling of this method with simple isolation methods such as antibody-modified paramagnetic particles may be implemented to lab-on-chip instrument.	[Adam, Vojtech; Petrlova, Jitka; Kizek, Rene] Mendel Univ Brno, Fac Agron, Dept Chem & Biochem, Brno, Czech Republic; [Wang, Joseph] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA; [Eckschlager, Tomas] Charles Univ Prague, Fac Med 2, Dept Paediat Haematol & Oncol, Prague, Czech Republic; [Trnkova, Libuse] Masaryk Univ, Fac Sci, Dept Chem, CS-61137 Brno, Czech Republic	Mendel University in Brno; University of California System; University of California San Diego; Charles University Prague; Masaryk University Brno	Adam, V (corresponding author), Mendel Univ Brno, Fac Agron, Dept Chem & Biochem, Brno, Czech Republic.	kizek@sci.muni.cz	Adam, Vojtech/D-7686-2012; Kizek, Rene/D-7748-2012; Wang, Joseph/C-6175-2011	Adam, Vojtech/0000-0002-8527-286X; Kizek, Rene/0000-0002-0467-6169	GAAV [IAA40199071]	GAAV(Grant Agency of the Czech Republic)	Financial support from GAAV IAA40199071 is highly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM V, 2010, TRAC TRENDS IN PRESS, P158; Adam V, 2008, SENSORS-BASEL, V8, P2293, DOI 10.3390/s8042293; DIEZEL W, 1972, ANAL BIOCHEM, V48, P617, DOI 10.1016/0003-2697(72)90117-0; Eckschlager T, 2009, CURR PROTEIN PEPT SC, V10, P360, DOI 10.2174/138920309788922243; Fabrik I, 2008, ELECTROANAL, V20, P1521, DOI 10.1002/elan.200704215; Fagerholm R, 2008, NAT GENET, V40, P844, DOI 10.1038/ng.155; Ferrarello CN, 2000, ANAL CHEM, V72, P5874, DOI 10.1021/ac0004411; Harrington CF, 2005, ANAL CHEM, V77, P4034, DOI 10.1021/ac050256t; Kizek R, 2001, ANAL CHEM, V73, P4801, DOI 10.1021/ac010126u; Knipp M, 2007, J MED CHEM, V50, P4075, DOI 10.1021/jm070271l; Kondo T, 2006, NAT PROTOC, V1, P2940, DOI 10.1038/nprot.2006.421; Kulasingam V, 2008, NAT CLIN PRACT ONCOL, V5, P588, DOI 10.1038/ncponc1187; LONG GL, 1983, ANAL CHEM, V55, pA712, DOI 10.1021/ac00258a001; Luo DB, 2003, ANAL CHEM, V75, P6346, DOI 10.1021/ac0300643; MARGOSHES M, 1957, J AM CHEM SOC, V79, P4813, DOI 10.1021/ja01574a064; Murphy BJ, 2008, MOL CANCER RES, V6, P483, DOI 10.1158/1541-7786.MCR-07-0341; Petrlova J, 2006, ELECTROCHIM ACTA, V51, P5112, DOI 10.1016/j.electacta.2006.03.078; Poulsen CB, 2006, BLOOD, V108, P3514, DOI 10.1182/blood-2006-04-015305; Strouhal M, 2003, BIOELECTROCHEMISTRY, V60, P29, DOI 10.1016/S1567-5394(03)00043-4; Szpunar J, 2005, ANALYST, V130, P442, DOI 10.1039/b418265k; Trnkova L, 2002, BIOELECTROCHEMISTRY, V56, P57, DOI 10.1016/S1567-5394(02)00048-8; Wang ZX, 2002, ANAL CHEM, V74, P626, DOI 10.1021/ac010862y; Wei H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-7; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	24	63	64	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11441	10.1371/journal.pone.0011441	http://dx.doi.org/10.1371/journal.pone.0011441			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625429	gold, Green Published			2022-12-25	WOS:000279522500009
J	Roepke, TK; Purtell, K; King, EC; La Perle, KMD; Lerner, DJ; Abbott, GW				Roepke, Torsten K.; Purtell, Kerry; King, Elizabeth C.; La Perle, Krista M. D.; Lerner, Daniel J.; Abbott, Geoffrey W.			Targeted Deletion of Kcne2 Causes Gastritis Cystica Profunda and Gastric Neoplasia	PLOS ONE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; POTASSIUM CHANNELS; CANCER-CELLS; HELICOBACTER-PYLORI; MONGOLIAN GERBILS; OXYNTIC ATROPHY; PARIETAL-CELLS; ACID-SECRETION; MUTANT MICE; K+ CHANNEL	Gastric cancer is the second leading cause of cancer death worldwide. Predisposing factors include achlorhydria, Helicobacter pylori infection, oxyntic atrophy and TFF2-expressing metaplasia. In parietal cells, apical potassium channels comprising the KCNQ1 alpha subunit and the KCNE2 beta subunit provide a K+ efflux current to facilitate gastric acid secretion by the apical H(+)K(+)ATPase. Accordingly, genetic deletion of murine Kcnq1 or Kcne2 impairs gastric acid secretion. Other evidence has suggested a role for KCNE2 in human gastric cancer cell proliferation, independent of its role in gastric acidification. Here, we demonstrate that 1-year-old Kcne2(-/-) mice in a pathogen-free environment all exhibit a severe gastric preneoplastic phenotype comprising gastritis cystica profunda, 6-fold increased stomach mass, increased Ki67 and nuclear Cyclin D1 expression, and TFF2- and cytokeratin 7-expressing metaplasia. Some Kcne2(-/-) mice also exhibited pyloric polypoid adenomas extending into the duodenum, and neoplastic invasion of thin walled vessels in the sub-mucosa. Finally, analysis of human gastric cancer tissue indicated reduced parietal cell KCNE2 expression. Together with previous findings, the results suggest KCNE2 disruption as a possible risk factor for gastric neoplasia.	[Roepke, Torsten K.; Purtell, Kerry; King, Elizabeth C.; Abbott, Geoffrey W.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Roepke, Torsten K.; Lerner, Daniel J.; Abbott, Geoffrey W.] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA; [La Perle, Krista M. D.] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA	Cornell University; Cornell University; University System of Ohio; Ohio State University	Roepke, TK (corresponding author), Charite, Clin Cardiol & Angiol, D-13353 Berlin, Germany.	gwa2001@med.cornell.edu	La Perle, Krista Marie DuBray/B-3099-2015	Abbott, Geoffrey/0000-0003-4552-496X	National Heart, Lung and Blood Institute, National Institutes of Health [R01 HL079275]; American Heart Association [0855756D]; Irma T. Hirschl Career Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Irma T. Hirschl Career Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	G.W.A. is supported by the National Heart, Lung and Blood Institute, National Institutes of Health (R01 HL079275), the American Heart Association (Grant-In-Aid 0855756D), and an Irma T. Hirschl Career Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Arcangeli A, 1999, J NEUROBIOL, V40, P214; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BEAUCHAMP RD, 1989, J CLIN INVEST, V84, P1017, DOI 10.1172/JCI114223; BECHADE D, 2007, ENDOSCOPY; Bianchi L, 1998, CANCER RES, V58, P815; Boivin GP, 1996, LAB INVEST, V74, P513; Chen SZ, 2005, CANCER CHEMOTH PHARM, V56, P212, DOI 10.1007/s00280-004-0960-5; Cherubini A, 2000, BRIT J CANCER, V83, P1722, DOI 10.1054/bjoc.2000.1497; Conti DJ, 2004, AM J TRANSPLANT, V4, P166; De Falco M, 2004, J ANAT, V205, P405, DOI 10.1111/j.0021-8782.2004.00347.x; Diaz-Meyer N, 2003, J MED GENET, V40, P797, DOI 10.1136/jmg.40.11.797; Elso CM, 2004, HUM MOL GENET, V13, P2813, DOI 10.1093/hmg/ddh307; FITZPATRICK GV, 2002, NAT GENET; FONDE EC, 1986, AM J GASTROENTEROL, V81, P459; Fujita A, 2002, J PHYSIOL-LONDON, V540, P85, DOI 10.1113/jphysiol.2001.013439; Gao P, 2004, WORLD J GASTROENTERO, V10, P2936; Geibel JP, 2005, WORLD J GASTROENTERO, V11, P5259, DOI 10.3748/wjg.v11.i34.5259; Giraud AS, 2007, GASTROENTEROLOGY, V132, P2053, DOI 10.1053/j.gastro.2007.03.074; Goldenring JR, 2006, AM J PHYSIOL-GASTR L, V291, pG999, DOI 10.1152/ajpgi.00187.2006; Itoi T, 2000, J GASTROENTEROL, V35, P142, DOI 10.1007/s005350050027; JIANG W, 1992, CANCER RES, V52, P2980; Kurland J, 2006, GASTROINTEST ENDOSC, V63, P716, DOI 10.1016/j.gie.2005.11.027; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Malinowska DH, 2004, AM J PHYSIOL-CELL PH, V286, pC495, DOI 10.1152/ajpcell.00386.2003; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Mitomi H, 1998, SCAND J GASTROENTERO, V33, P1226; Mohammed IA, 2002, MODERN PATHOL, V15, P611, DOI 10.1038/modpathol.3880574; Nozaki K, 2008, GASTROENTEROLOGY, V134, P511, DOI 10.1053/j.gastro.2007.11.058; Ogawa M, 2006, AM J PHYSIOL-GASTR L, V290, pG793, DOI 10.1152/ajpgi.00309.2005; OZENC AM, 1988, ARCH SURG-CHICAGO, V123, P372; Pan YL, 2007, CANCER LETT, V246, P129, DOI 10.1016/j.canlet.2006.02.010; Park KH, 2001, NEUROSCI LETT, V298, P29, DOI 10.1016/S0304-3940(00)01710-9; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schmidt PH, 1999, LAB INVEST, V79, P639; SHAO X, 2005, CANC BIOL THER, V4; Stepan V, 2005, J BIOL CHEM, V280, P15700, DOI 10.1074/jbc.M413037200; Suzuki T, 2004, INT J ONCOL, V25, P153; Vallon V, 2005, P NATL ACAD SCI USA, V102, P17864, DOI 10.1073/pnas.0505860102; Wang TC, 2000, GASTROENTEROLOGY, V118, P36, DOI 10.1016/S0016-5085(00)70412-4; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989; Yamashita M, 2002, APMIS, V110, P717, DOI 10.1034/j.1600-0463.2002.1101005.x; Yoshizawa N, 2007, LAB INVEST, V87, P1265, DOI 10.1038/labinvest.3700682; Zavros Y, 2005, ONCOGENE, V24, P2354, DOI 10.1038/sj.onc.1208407; Zhai Y, 2002, AM J PATHOL, V160, P1229, DOI 10.1016/S0002-9440(10)62550-3; Zheng Q, 2004, J GASTROEN HEPATOL, V19, P1192, DOI 10.1111/j.1440-1746.2004.03469.x	48	56	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11451	10.1371/journal.pone.0011451	http://dx.doi.org/10.1371/journal.pone.0011451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625512	Green Published, gold, Green Accepted			2022-12-25	WOS:000279522500018
J	Bae, JS; Cheong, HS; Park, BL; Kim, LH; Han, CS; Park, TJ; Kim, JY; Pasaje, CFA; Lee, JS; Shin, HD				Bae, Joon Seol; Cheong, Hyun Sub; Park, Byung Lae; Kim, Lyoung Hyo; Han, Chang Soo; Park, Tae Joon; Kim, Jason Yongha; Pasaje, Charisse Flerida A.; Lee, Jin Sol; Shin, Hyoung Doo			Genome-Wide Profiling of Structural Genomic Variations in Korean HapMap Individuals	PLOS ONE			English	Article							COPY NUMBER VARIATION; IDENTIFICATION; ABERRATIONS; FREQUENCY; VARIANTS; SEQUENCE; DISEASE; RISK	Background: Structural genomic variation study, along with microarray technology development has provided many genomic resources related with architecture of human genome, and led to the fact that human genome structure is a lot more complicated than previously thought. Methodology/Principal Findings: In the case of International HapMap Project, Epstein-Barr various immortalized cell lines were preferably used over blood in order to get a larger number of genomic DNA. However, genomic aberration stemming from immortalization process, biased representation of the donor tissue, and culture process may influence the accuracy of SNP genotypes. In order to identify chromosome aberrations including loss of heterozygosity (LOH), large-scale and small-scale copy number variations, we used Illumina HumanHap500 BeadChip (555,352 markers) on Korean HapMap individuals (n = 90) to obtain Log R ratio and B allele frequency information, and then utilized the data with various programs including Illumina ChromoZone, cnvParition and PennCNV. As a result, we identified 28 LOHs (>3 mb) and 35 large-scale CNVs (>1 mb), with 4 samples having completely duplicated chromosome. In addition, after checking the sample quality (standard deviation of log R ratio <0.30), we selected 79 samples and used both signal intensity and B allele frequency simultaneously for identification of small-scale CNVs (<1 mb) to discover 4,989 small-scale CNVs. Identified CNVs in this study were successfully validated using visual examination of the genoplot images, overlapping analysis with previously reported CNVs in DGV, and quantitative PCR. Conclusion/Significance: In this study, we describe the result of the identified chromosome aberrations in Korean HapMap individuals, and expect that these findings will provide more meaningful information on the human genome.	[Bae, Joon Seol; Park, Tae Joon; Kim, Jason Yongha; Pasaje, Charisse Flerida A.; Lee, Jin Sol; Shin, Hyoung Doo] Sogang Univ, Dept Life Sci, Lab Genom Divers, Seoul, South Korea; [Cheong, Hyun Sub; Park, Byung Lae; Kim, Lyoung Hyo; Han, Chang Soo; Shin, Hyoung Doo] SNP Genet Inc, Dept Genet Epidemiol, Seoul, South Korea	Sogang University; SNP Genetics	Bae, JS (corresponding author), Sogang Univ, Dept Life Sci, Lab Genom Divers, Seoul, South Korea.	hdshin@sogang.ac.kr	Pasaje, Charisse Flerida A./J-7990-2014; Pasaje, Charisse Flerida A./AAY-8793-2020	Pasaje, Charisse Flerida A./0000-0002-9780-3680; Pasaje, Charisse Flerida A./0000-0002-9780-3680	Korean government (MEST) [2009-0080157, 2010-0011206]	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a grant from the Korea Science and Engineering Foundation (KOSEF) funded by the Korean government (MEST) (No. 2009-0080157 and 2010-0011206). SNP Genetics, Inc. provided the Beadstation500 scanner instrument and BeadStudio 3.2 software used in the research; they also were involved in the design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Bae JS, 2008, BIOCHEM BIOPH RES CO, V373, P593, DOI 10.1016/j.bbrc.2008.06.083; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Beissbarth T, 2006, METHOD ENZYMOL, V411, P340, DOI 10.1016/S0076-6879(06)11018-6; Bonassi S, 2008, CARCINOGENESIS, V29, P1178, DOI 10.1093/carcin/bgn075; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Conrad S, 2009, NATURE, V460, DOI 10.1038/nature08353; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Cusco I, 2009, HUM MOL GENET, V18, P1795, DOI 10.1093/hmg/ddp092; Erdogan F, 2008, EUR J MED GENET, V51, P81, DOI 10.1016/j.ejmg.2007.09.007; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; He M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004684; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jeon JP, 2007, CANCER GENET CYTOGEN, V173, P122, DOI 10.1016/j.cancergencyto.2006.10.010; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kim KJ, 2006, GENOMICS, V88, P535, DOI 10.1016/j.ygeno.2006.03.003; Koolen DA, 2009, HUM MUTAT, V30, P283, DOI 10.1002/humu.20883; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Middeldorp A, 2008, J PATHOL, V216, P25, DOI 10.1002/path.2375; Patterson D, 2009, HUM GENET, V126, P195, DOI 10.1007/s00439-009-0696-8; Pedersen RK, 1999, CANCER GENET CYTOGEN, V110, P128, DOI 10.1016/S0165-4608(98)00204-0; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; VANHEMEL JO, 1992, HUM GENET, V88, P661, DOI 10.1007/BF02265294; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wang K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn641; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	31	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11417	10.1371/journal.pone.0011417	http://dx.doi.org/10.1371/journal.pone.0011417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625389	Green Published, gold, Green Submitted			2022-12-25	WOS:000279465700005
J	Schweizer, ML; Furuno, JP; Harris, AD; Johnson, JK; Shardell, MD; McGregor, JC; Thom, KA; Sakoulas, G; Perencevich, EN				Schweizer, Marin L.; Furuno, Jon P.; Harris, Anthony D.; Johnson, J. Kristie; Shardell, Michelle D.; McGregor, Jessina C.; Thom, Kerri A.; Sakoulas, George; Perencevich, Eli N.			Empiric Antibiotic Therapy for Staphylococcus aureus Bacteremia May Not Reduce In-Hospital Mortality: A Retrospective Cohort Study	PLOS ONE			English	Article							METHICILLIN-RESISTANT; ANTIMICROBIAL TREATMENT; PATIENT OUTCOMES; IMPACT; COMORBIDITY; INFECTIONS; RISK; PREDICTORS; VANCOMYCIN; USA300	Background: Appropriate empiric therapy, antibiotic therapy with in vitro activity to the infecting organism given prior to confirmed culture results, may improve Staphylococcus aureus outcomes. We aimed to measure the clinical impact of appropriate empiric antibiotic therapy on mortality, while statistically adjusting for comorbidities, severity of illness and presence of virulence factors in the infecting strain. Methodology: We conducted a retrospective cohort study of adult patients admitted to a tertiary-care facility from January 1, 2003 to June 30, 2007, who had S. aureus bacteremia. Time to appropriate therapy was measured from blood culture collection to the receipt of antibiotics with in vitro activity to the infecting organism. Cox proportional hazard models were used to measure the association between receipt of appropriate empiric therapy and in-hospital mortality, statistically adjusting for patient and pathogen characteristics. Principal Findings: Among 814 admissions, 537 (66%) received appropriate empiric therapy. Those who received appropriate empiric therapy had a higher hazard of 30-day in-hospital mortality (Hazard Ratio (HR): 1.52; 95% confidence interval (CI): 0.99, 2.34). A longer time to appropriate therapy was protective against mortality (HR: 0.79; 95% CI: 0.60, 1.03) except among the healthiest quartile of patients (HR: 1.44; 95% CI: 0.66, 3.15). Conclusions/Significance: Appropriate empiric therapy was not associated with decreased mortality in patients with S. aureus bacteremia except in the least ill patients. Initial broad antibiotic selection may not be widely beneficial.	[Schweizer, Marin L.; Furuno, Jon P.; Harris, Anthony D.; Shardell, Michelle D.; Thom, Kerri A.] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; [Schweizer, Marin L.; Perencevich, Eli N.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Johnson, J. Kristie] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [McGregor, Jessina C.] Oregon Hlth & Sci Univ, Coll Pharm, Dept Pharm, Portland, OR 97201 USA; [Sakoulas, George] Sharp Mem Hosp & Rehabil Ctr, San Diego, CA USA; [Perencevich, Eli N.] Iowa City VA Med Ctr, Iowa City, IA USA	University System of Maryland; University of Maryland Baltimore; University of Iowa; University System of Maryland; University of Maryland Baltimore; Oregon Health & Science University; Sharp Memorial Hospital Rehabilitation & Physical Therapy; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Schweizer, ML (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA.	marin-schweizer@uiowa.edu	McGregor, Jessina C/A-7625-2008	Schweizer, Marin/0000-0002-3604-0093; McGregor, Jessina/0000-0002-6093-5444; Perencevich, Eli/0000-0002-3721-3355	Pfizer, Inc [IIR GA5951BG]; National Institutes of Health [1R01A160859-01A1, 1K24AI079040 - 01A1, 1K01AI071015-02, 1K12RR02350-03, KL2RR024141, K12HD043489]; US Department of Veterans Affairs Health Services Research and Develop [RCD-02-026-2, IIR-05-123-1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043489] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002350, KL2RR024141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI079040, K01AI071015] Funding Source: NIH RePORTER	Pfizer, Inc(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs Health Services Research and Develop(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by an investigator-initiated research grant from Pfizer, Inc (IIR GA5951BG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AD Harris is supported by the National Institutes of Health grants 1R01A160859-01A1 and 1K24AI079040 - 01A1. JP Furuno is supported by National Institutes of Health grant 1K01AI071015-02. JK Johnson is supported by National Institutes of Health grant 1K12RR02350-03. JC McGregor is supported by National Institutes of Health grant KL2RR024141. EN Perencevich was supported by US Department of Veterans Affairs Health Services Research and Develop grants RCD-02-026-2 and IIR-05-123-1. MD Shardell is supported by National Institutes of Health grant K12HD043489.	Ammerlaan H, 2009, CLIN INFECT DIS, V49, P997, DOI 10.1086/605555; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Chang FY, 2003, MEDICINE, V82, P333, DOI 10.1097/01.md.0000091184.93122.09; Clinical and Laboratory Standards Institute, 2008, M100S19 CLSI; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Forrest GN, 2006, J ANTIMICROB CHEMOTH, V58, P154, DOI 10.1093/jac/dkl146; Furuno JP, 2007, INFECT CONT HOSP EP, V28, P666, DOI 10.1086/518348; Furuno JP, 2005, EMERG INFECT DIS, V11, P1539, DOI 10.3201/eid1110.050508; Gomez J, 2007, EUR J CLIN MICROBIOL, V26, P239, DOI 10.1007/s10096-007-0272-x; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Johnson JK, 2007, EMERG INFECT DIS, V13, P1195, DOI 10.3201/eid1308.061575; Khatib R, 2006, EUR J CLIN MICROBIOL, V25, P181, DOI 10.1007/s10096-006-0096-0; Kim PW, 2005, AM J RESP CRIT CARE, V171, P616, DOI 10.1164/rccm.200407-916OC; Kim SH, 2006, CLIN MICROBIOL INFEC, V12, P13, DOI 10.1111/j.1469-0691.2005.01294.x; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Leibovici L, 1998, J INTERN MED, V244, P379; Lesens O, 2003, INFECT CONT HOSP EP, V24, P890, DOI 10.1086/502156; Lin MY, 2008, ANTIMICROB AGENTS CH, V52, P3188, DOI 10.1128/AAC.01553-07; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lodise Thomas P., 2003, Clinical Infectious Diseases, V36, P1418, DOI 10.1086/375057; McGregor JC, 2005, AM J EPIDEMIOL, V161, P483, DOI 10.1093/aje/kwi068; McGregor JC, 2007, CLIN INFECT DIS, V45, P329, DOI 10.1086/519283; McGregor JC, 2006, J CLIN EPIDEMIOL, V59, P1266, DOI 10.1016/j.jclinepi.2006.01.016; Mylotte JM, 2000, CLIN INFECT DIS, V31, P1170, DOI 10.1086/317421; Osih RB, 2007, ANTIMICROB AGENTS CH, V51, P839, DOI 10.1128/AAC.00901-06; Robinson JO, 2009, EUR J CLIN MICROBIOL, V28, P353, DOI 10.1007/s10096-008-0632-1; Roghmann MC, 2000, ARCH INTERN MED, V160, P1001, DOI 10.1001/archinte.160.7.1001; RomeroVivas J, 1995, CLIN INFECT DIS, V21, P1417, DOI 10.1093/clinids/21.6.1417; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Schramm GE, 2006, CRIT CARE MED, V34, P2069, DOI 10.1097/01.CCM.0000227655.41566.3E; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Shorr AF, 2008, CRIT CARE MED, V36, P2335, DOI 10.1097/CCM.0b013e31818103ea; Soriano A, 2000, CLIN INFECT DIS, V30, P368, DOI 10.1086/313650; Stryjewski ME, 2007, CLIN INFECT DIS, V44, P190, DOI 10.1086/510386; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.060716; Tam VH, 2007, J INFECT DIS, V195, P1818, DOI 10.1086/518003	39	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11432	10.1371/journal.pone.0011432	http://dx.doi.org/10.1371/journal.pone.0011432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625395	Green Submitted, Green Published, gold			2022-12-25	WOS:000279465700014
J	Dash, PK; Orsi, SA; Zhang, M; Grill, RJ; Pati, S; Zhao, J; Moore, AN				Dash, Pramod K.; Orsi, Sara A.; Zhang, Min; Grill, Raymond J.; Pati, Shibani; Zhao, Jing; Moore, Anthony N.			Valproate Administered after Traumatic Brain Injury Provides Neuroprotection and Improves Cognitive Function in Rats	PLOS ONE			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; HISTONE DEACETYLASE INHIBITION; CONTROLLED CORTICAL IMPACT; SPATIAL MEMORY DEFICITS; CLOSED-HEAD INJURY; CELLS IN-VITRO; MOOD STABILIZER; MEDIATED NEUROPROTECTION; GENE-EXPRESSION; H3 ACETYLATION	Background: Traumatic brain injury (TBI) initiates a complex series of neurochemical and signaling changes that lead to pathological events including neuronal hyperactivity, excessive glutamate release, inflammation, increased blood-brain barrier (BBB) permeability and cerebral edema, altered gene expression, and neuronal dysfunction. It is believed that a drug combination, or a single drug acting on multiple targets, may be an effective strategy to treat TBI. Valproate, a widely used antiepileptic drug, has a number of targets including GABA transaminase, voltage-gated sodium channels, glycogen synthase kinase (GSK)-3, and histone deacetylases (HDACs), and therefore may attenuate a number of TBI-associated pathologies. Methodology/Principal Findings: Using a rodent model of TBI, we tested if post-injury administration of valproate can decrease BBB permeability, reduce neural damage and improve cognitive outcome. Dose-response studies revealed that systemic administration of 400 mg/kg (i.p.), but not 15, 30, 60 or 100 mg/kg, increases histone H3 and H4 acetylation, and reduces GSK-3 activity, in the hippocampus. Thirty min post-injury administration of 400 mg/kg valproate improved BBB integrity as indicated by a reduction in Evans Blue dye extravasation. Consistent with its dose response to inhibit GSK-3 and HDACs, valproate at 400 mg/kg, but not 100 mg/kg, reduced TBI-associated hippocampal dendritic damage, lessened cortical contusion volume, and improved motor function and spatial memory. These behavioral improvements were not observed when SAHA (suberoylanilide hydroxamic acid), a selective HDAC inhibitor, was administered. Conclusion/Significance: Our findings indicate that valproate given soon after TBI can be neuroprotective. As clinically proven interventions that can be used to minimize the damage following TBI are not currently available, the findings from this report support the further testing of valproate as an acute therapeutic strategy.	[Dash, Pramod K.; Orsi, Sara A.; Zhang, Min; Zhao, Jing; Moore, Anthony N.] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX USA; [Dash, Pramod K.; Orsi, Sara A.; Zhang, Min; Zhao, Jing; Moore, Anthony N.] Univ Texas Hlth Sci Ctr Houston, Dept Neurosurg, Houston, TX USA; [Grill, Raymond J.] Univ Texas Hlth Sci Ctr Houston, Dept Integrated Biol & Pharmacol, Houston, TX USA; [Pati, Shibani] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Dash, PK (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX USA.	P.Dash@uth.tmc.edu		Dash, Pramod/0000-0001-6746-1002	Department of Defense [W81XWH-08-2-0134]; National Institutes of Health (NIH) [5T32HD049350]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD049350] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was made possible by funding support from the Department of Defense (W81XWH-08-2-0134) and a training grant from National Institutes of Health (NIH) (5T32HD049350). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Brandt C, 2006, NEUROPHARMACOLOGY, V51, P789, DOI 10.1016/j.neuropharm.2006.05.021; Butler LM, 2000, CANCER RES, V60, P5165; Chen G, 1999, J NEUROCHEM, V72, P1327, DOI 10.1046/j.1471-4159.2000.0721327.x; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dash RR, 2009, J HAZARD MATER, V163, P1, DOI 10.1016/j.jhazmat.2008.06.051; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eleuteri S, 2009, NEUROTOX RES, V15, P127, DOI 10.1007/s12640-009-9013-5; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faraco G, 2006, MOL PHARMACOL, V70, P1876, DOI 10.1124/mol.106.027912; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Gobbel GT, 2007, CHILD NERV SYST, V23, P1171, DOI 10.1007/s00381-007-0345-2; Gonzales E, 2006, SHOCK, V25, P395, DOI 10.1097/01.shk.0000209522.28120.c8; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hao YL, 2004, J NEUROSCI, V24, P6590, DOI 10.1523/JNEUROSCI.5747-03.2004; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Jallon P, 2001, DRUG SAFETY, V24, P969, DOI 10.2165/00002018-200124130-00004; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kanai H, 2004, PHARMACOGENOMICS J, V4, P336, DOI 10.1038/sj.tpj.6500269; Li YQ, 2008, SURGERY, V144, P217, DOI 10.1016/j.surg.2008.03.037; Li YQ, 2010, J SURG RES, V159, P474, DOI 10.1016/j.jss.2009.04.011; Long DA, 1996, BRAIN RES, V717, P109, DOI 10.1016/0006-8993(95)01500-0; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI 10.1089/neu.2008-0794; Mattson MP, 2002, PHYSIOL REV, V82, P637, DOI 10.1152/physrev.00004.2002; McDonald HY, 2005, NEUROSCI LETT, V385, P70, DOI 10.1016/j.neulet.2005.05.022; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Miller JS, 2009, NEUROPHARMACOLOGY, V56, P1116, DOI 10.1016/j.neuropharm.2009.03.006; Miller Laura C, 2008, Expert Rev Neurother, V8, P1817, DOI 10.1586/14737175.8.12.1817; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; Ooba S, 2008, NEUROSCI RES, V62, P195, DOI 10.1016/j.neures.2008.08.005; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; Richon VM, 1998, P NATL ACAD SCI USA, V95, P3003, DOI 10.1073/pnas.95.6.3003; Roberge MC, 2008, NEUROSCIENCE, V156, P11, DOI 10.1016/j.neuroscience.2008.05.062; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Royo NC, 2007, NEUROSCIENCE, V148, P359, DOI 10.1016/j.neuroscience.2007.06.014; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Sharma S, 2005, BRAIN RES BULL, V67, P482, DOI 10.1016/j.brainresbull.2005.07.015; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; Sinn DI, 2007, NEUROBIOL DIS, V26, P464, DOI 10.1016/j.nbd.2007.02.006; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Wada A, 2009, J PHARMACOL SCI, V110, P14, DOI 10.1254/jphs.09R02CR; Wada A, 2009, FRONT BIOSCI-LANDMRK, V14, P1558, DOI 10.2741/3324; Watterson JM, 2002, BRAIN RES, V934, P69, DOI 10.1016/S0006-8993(02)02362-4; Xing GQ, 2009, NEUROSCI LETT, V454, P38, DOI 10.1016/j.neulet.2009.01.047; Yin D, 2007, CLIN CANCER RES, V13, P1045, DOI 10.1158/1078-0432.CCR-06-1261; Yuan PX, 2001, J BIOL CHEM, V276, P31674, DOI 10.1074/jbc.M104309200; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhang Z, 2008, CELL MOL LIFE SCI, V65, P4055, DOI 10.1007/s00018-008-8521-4; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007	72	148	156	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11383	10.1371/journal.pone.0011383	http://dx.doi.org/10.1371/journal.pone.0011383			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614021	Green Published, Green Submitted, gold			2022-12-25	WOS:000279370000013
J	Sahu, N; Morales, JL; Fowell, D; August, A				Sahu, Nisebita; Morales, J. Luis; Fowell, Deborah; August, Avery			Modeling Susceptibility versus Resistance in Allergic Airway Disease Reveals Regulation by Tec Kinase Itk	PLOS ONE			English	Article							CD4(+) T-CELLS; MICE LACKING; HOUSE-DUST; MURINE MODEL; TYROSINE KINASE; ASTHMA; ANTIGEN; EXPOSURE; RESPONSES; INFLAMMATION	Murine models of allergic asthma have been used to understand the mechanisms of development and pathology in this disease. In addition, knockout mice have contributed significantly to our understanding of the roles of specific molecules and cytokines in these models. However, results can vary significantly depending on the mouse strain used in the model, and in particularly in understanding the effect of specific knockouts. For example, it can be equivocal as to whether specific gene knockouts affect the susceptibility of the mice to developing the disease, or lead to resistance. Here we used a house dust mite model of allergic airway inflammation to examine the response of two strains of mice (C57BL/6 and BALB/c) which differ in their responses in allergic airway inflammation. We demonstrate an algorithm that can facilitate the understanding of the behavior of these models with regards to susceptibility (to allergic airway inflammation) (Saai) or resistance (Raai) in this model. We verify that both C57BL/6 and BALB/c develop disease, but BALB/c mice have higher Saai for development. We then use this approach to show that the absence of the Tec family kinase Itk, which regulates the production of Th2 cytokines, leads to Raai in the C57BL/6 background, but decreases Saai on the BALB/c background. We suggest that the use of such approaches could clarify the behavior of various knockout mice in modeling allergic asthma.	[Sahu, Nisebita; Morales, J. Luis; August, Avery] Penn State Univ, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Sahu, Nisebita; Morales, J. Luis; August, Avery] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Sahu, Nisebita] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Fowell, Deborah] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Rochester	Sahu, N (corresponding author), Harvard Univ, Sch Med, Ctr Canc, Massachusetts Gen Hosp,Dept Med, Charlestown, MA USA.	averyaugust@cornell.edu			National Institutes of Health [AI051626, AI065566, AI073955]; American Academy of Allergy Asthma and Immunology Strategic Training in Allergy Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI065566, R01AI073955, R01AI050201, R01AI065566, R01AI051626, R56AI073955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Academy of Allergy Asthma and Immunology Strategic Training in Allergy Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI051626, AI065566 and AI073955 to AA. NS was the recipient of an American Academy of Allergy Asthma and Immunology Strategic Training in Allergy Research (ST*AR) Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au-Yeung BB, 2006, J IMMUNOL, V176, P3895, DOI 10.4049/jimmunol.176.7.3895; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; CORRY D, 1997, J EXP MED, V1185, P1715; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; EWART S, 1995, J APPL PHYSIOL, V79, P560, DOI 10.1152/jappl.1995.79.2.560; Ferrara TJ, 2006, J ALLERGY CLIN IMMUN, V117, P780, DOI 10.1016/j.jaci.2005.12.1330; Finkelman FD, 2008, J ALLERGY CLIN IMMUN, V121, P603, DOI 10.1016/j.jaci.2008.01.008; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Fujiwara M, 2007, J ALLERGY CLIN IMMUN, V119, P662, DOI 10.1016/j.jaci.2006.12.643; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Gueders MM, 2009, INFLAMM RES, V58, P845, DOI 10.1007/s00011-009-0054-2; HOLT PG, 1981, IMMUNOLOGY, V42, P409; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; KUNG TT, 1994, INT ARCH ALLERGY IMM, V105, P83, DOI 10.1159/000236807; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Miller AT, 2004, IMMUNITY, V21, P67, DOI 10.1016/j.immuni.2004.06.009; MIYAMOTO T, 1968, J ALLERGY, V42, P14, DOI 10.1016/0021-8707(68)90128-7; Mueller C, 2003, J IMMUNOL, V170, P5056, DOI 10.4049/jimmunol.170.10.5056; Neeno T, 1996, J IMMUNOL, V156, P3191; OBRIEN RM, 1992, J ALLERGY CLIN IMMUN, V89, P1021, DOI 10.1016/0091-6749(92)90225-Q; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; SAHU N, 2008, J IMMUNOL, V3180; Sahu N, 2008, J IMMUNOL, V181, P6125, DOI 10.4049/jimmunol.181.9.6125; Sahu N, 2008, J IMMUNOL, V180, P3833, DOI 10.4049/jimmunol.180.6.3833; Sakai K, 1999, CLIN EXP IMMUNOL, V118, P9; Schaeffer EM, 2001, NAT IMMUNOL, V2, P1183, DOI 10.1038/ni734; Schramm CM, 2004, AM J PATHOL, V164, P295, DOI 10.1016/S0002-9440(10)63119-7; Swirski FK, 2002, CLIN EXP ALLERGY, V32, P411, DOI 10.1046/j.1365-2222.2002.01291.x; Swirski FK, 2002, J IMMUNOL, V169, P3499, DOI 10.4049/jimmunol.169.7.3499; Walsh ER, 2008, J EXP MED, V205, P1285, DOI 10.1084/jem.20071836; Whitehead GS, 2003, AM J PHYSIOL-LUNG C, V285, pL32, DOI 10.1152/ajplung.00390.2002; Zhu WY, 2009, IMMUNOGENETICS, V61, P199, DOI 10.1007/s00251-008-0353-8	34	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11348	10.1371/journal.pone.0011348	http://dx.doi.org/10.1371/journal.pone.0011348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596543	Green Published, Green Submitted, gold			2022-12-25	WOS:000279259900019
J	Wang, ZH; Yeats, T; Han, H; Jetter, R				Wang, Zhonghua; Yeats, Trevor; Han, Hong; Jetter, Reinhard			Cloning and Characterization of Oxidosqualene Cyclases from Kalanchoe daigremontiana ENZYMES CATALYZING UP TO 10 REARRANGEMENT STEPS YIELDING FRIEDELIN AND OTHER TRITERPENOIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-AMYRIN SYNTHASE; CYCLOARTENOL SYNTHASE; LANOSTEROL SYNTHASE; LUPEOL SYNTHASE; ACTIVE-SITE; BIOSYNTHESIS; TRITERPENE; CYCLIZATION; 2,3-OXIDOSQUALENE; MECHANISM	The first committed step in triterpenoid biosynthesis is the cyclization of oxidosqualene to polycyclic alcohols or ketones C30H50O. It is catalyzed by single oxidosqualene cyclase (OSC) enzymes that can carry out varying numbers of carbocation rearrangements and, thus, generate triterpenoids with diverse carbon skeletons. OSCs from diverse plant species have been cloned and characterized, the large majority of them catalyzing relatively few rearrangement steps. It was recently predicted that special OSCs must exist that can form friedelin, the pentacyclic triterpenoid whose formation involves the maximum possible number of rearrangement steps. The goal of the present study, therefore, was to clone a friedelin synthase from Kalanchoe daigremontiana, a plant species known to accumulate this triterpenoid in its leaf surface waxes. Five OSC cDNAs were isolated, encoding proteins with 761-779 amino acids and sharing between 57.4 and 94.3% nucleotide sequence identity. Heterologous expression in yeast and GC-MS analyses showed that one of the OSCs generated the steroid cycloartenol together with minor side products, whereas the other four enzymes produced mixtures of pentacyclic triterpenoids dominated by lupeol (93%), taraxerol (60%), glutinol (66%), and friedelin (71%), respectively. The cycloartenol synthase was found expressed in all leaf tissues, whereas the lupeol, taraxerol, glutinol, and friedelin synthases were expressed only in the epidermis layers lining the upper and lower surfaces of the leaf blade. It is concluded that the function of these enzymes is to form respective triterpenoid aglycones destined to coat the leaf exterior, probably as defense compounds against pathogens or herbivores.	[Jetter, Reinhard] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Jetter, R (corresponding author), Univ British Columbia, Dept Bot, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	jetter@interchange.ubc.ca		Han, Hong/0000-0001-8977-9679	Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Canada Research Chairs	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs(Canada Research ChairsCGIAR)	This work was supported by a Natural Sciences and Engineering Research Council of Canada Special Research Opportunity Grant, by the Canada Foundation for Innovation, and by the Canada Research Chairs Program.	Abe I, 1996, J AM CHEM SOC, V118, P9180, DOI 10.1021/ja961643a; ABE I, 1995, LIPIDS, V30, P231, DOI 10.1007/BF02537826; ABE I, 1993, CHEM REV, V93, P2189, DOI 10.1021/cr00022a009; Cattel L, 1998, CRIT REV BIOCHEM MOL, V33, P353, DOI 10.1080/10409239891204378; Corey EJ, 1997, J AM CHEM SOC, V119, P1277, DOI 10.1021/ja963227w; Corey EJ, 1997, J AM CHEM SOC, V119, P1289, DOI 10.1021/ja963228o; Fazio GC, 2004, J AM CHEM SOC, V126, P5678, DOI 10.1021/ja0318784; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Guhling O, 2006, ARCH BIOCHEM BIOPHYS, V448, P60, DOI 10.1016/j.abb.2005.12.013; Hart EA, 1999, J AM CHEM SOC, V121, P9887, DOI 10.1021/ja992589b; Hayashi H, 2001, EUR J BIOCHEM, V268, P6311, DOI 10.1046/j.0014-2956.2001.02588.x; Herrera JBR, 2000, J AM CHEM SOC, V122, P6765, DOI 10.1021/ja0013226; Kurti L, 2008, J AM CHEM SOC, V130, P9031, DOI 10.1021/ja800980h; Kushiro T, 1998, EUR J BIOCHEM, V256, P238, DOI 10.1046/j.1432-1327.1998.2560238.x; Kushiro T, 2000, J AM CHEM SOC, V122, P6816, DOI 10.1021/ja0010709; Lodeiro S, 2005, J AM CHEM SOC, V127, P14132, DOI 10.1021/ja053791j; Lodeiro S, 2007, J AM CHEM SOC, V129, P11213, DOI 10.1021/ja073133u; Markstadter C, 2000, CHEMOECOLOGY, V10, P33, DOI 10.1007/s000490050005; Morikubo N, 2006, J AM CHEM SOC, V128, P13184, DOI 10.1021/ja063358p; Phillips DR, 2006, CURR OPIN PLANT BIOL, V9, P305, DOI 10.1016/j.pbi.2006.03.004; PORALLA K, 1994, TRENDS BIOCHEM SCI, V19, P157, DOI 10.1016/0968-0004(94)90276-3; Segura MJR, 2003, NAT PROD REP, V20, P304, DOI 10.1039/b008338k; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VAN MAARSEVEEN C, 2009, PHYTOCHEMISTRY, V70, P899; VAN MAARSEVEEN C, 2009, PLANT CELL ENVIRON, V32, P73; Xu R, 2004, PHYTOCHEMISTRY, V65, P261, DOI 10.1016/j.phytochem.2003.11.014	27	53	63	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29703	29712		10.1074/jbc.M109.098871	http://dx.doi.org/10.1074/jbc.M109.098871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20610397	hybrid, Green Published			2022-12-25	WOS:000281984300005
J	Gaekwad, J; Zhang, YH; Zhang, W; Reeves, J; Wolfert, MA; Boons, GJ				Gaekwad, Jidnyasa; Zhang, Yanghui; Zhang, Wei; Reeves, Jaxk; Wolfert, Margreet A.; Boons, Geert-Jan			Differential Induction of Innate Immune Responses by Synthetic Lipid A Derivatives	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; NEISSERIA-MENINGITIDIS; BACTERIAL LIPOPOLYSACCHARIDES; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; NEGATIVE REGULATION; SIGNALING PATHWAYS; ACQUIRED-IMMUNITY; MOUSE MACROPHAGES	Recent studies have indicated that lipopolysaccharides (LPS) isolated from particular bacterial strains can bias innate immune responses toward different signal transduction pathways thereby eliciting unique patterns of cytokines. Heterogeneity in the structure of lipid A (the active component of LPS) and possible contaminations with other inflammatory components have made it difficult to confirm these observations and dissect molecular motifs that may be responsible for modulatory properties. To address these issues, we have examined, for the first time, the ability of a range of well defined synthetic lipid As and isolated LPS and lipid A preparations to induce the production of a wide range of cytokines in three different mouse cell types. It was found that, for a given compound, the potencies of production of the various cytokines differed significantly. An additive model, in which a chemical change in the structure of a compound effects the potencies of all cytokines in the same manner, could describe the potencies of the cytokines for all compounds. Thus, no evidence was found that the structure of lipid A can modulate the pattern of cytokine production. In addition, the statistical analysis showed that the relative ordering of the potencies of the compounds was identical in the different cell types and that structural features such as the presence of a 3-deoxy-D-manno-octulosonic acid moiety, anomeric phosphate, lipid length, and acylation pattern were important for pro-inflammatory activity. Finally, it was found that transcriptional and post-transcription control mechanisms determine potencies and efficacies of cytokine production in cell-specific manners.	[Boons, Geert-Jan] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Zhang, Wei; Reeves, Jaxk] Univ Georgia, Dept Stat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Boons, GJ (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	gjboons@ccrc.uga.edu	Zhang, Yanghui/O-4931-2017; Wolfert, Margreet A/J-1726-2016; Boons, Geert-Jan P H/J-3211-2016	Zhang, Yanghui/0000-0003-2189-3496; Wolfert, Margreet A/0000-0003-4864-0026; Boons, Geert-Jan P H/0000-0003-3111-5954	NIGMS [R01GM061761]; NCI [R01CA088986]; NATIONAL CANCER INSTITUTE [R01CA088986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061761] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM061761 from NIGMS and Grant R01CA088986 from NCI.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexander C, 2002, TRENDS GLYCOSCI GLYC, V14, P69, DOI 10.4052/tigg.14.69; ALLEY EW, 1995, GENE, V158, P247, DOI 10.1016/0378-1119(94)00892-V; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Caroff M, 2002, MICROBES INFECT, V4, P915, DOI 10.1016/S1286-4579(02)01612-X; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Cekic C, 2009, J BIOL CHEM, V284, P31982, DOI 10.1074/jbc.M109.046383; Dabbagh K, 2003, CURR OPIN INFECT DIS, V16, P199, DOI 10.1097/00001432-200306000-00003; Darveau RP, 1998, CURR OPIN MICROBIOL, V1, P36, DOI 10.1016/S1369-5274(98)80140-9; Demchenko AV, 2003, J AM CHEM SOC, V125, P6103, DOI 10.1021/ja029316s; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0; Finlay BB, 2004, NAT REV MICROBIOL, V2, P497, DOI 10.1038/nrmicro908; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; GALANOS C, 1985, EUR J BIOCHEM, V148, P1, DOI 10.1111/j.1432-1033.1985.tb08798.x; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; IMOTO M, 1985, TETRAHEDRON LETT, V26, P1545, DOI 10.1016/S0040-4039(00)98548-4; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Janusch H, 2002, J ENDOTOXIN RES, V8, P343, DOI 10.1179/096805102125000678; John CM, 2009, J LIPID RES, V50, P424, DOI 10.1194/jlr.M800184-JLR200; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kawasaki K, 2004, J BIOL CHEM, V279, P20044, DOI 10.1074/jbc.M401275200; KULSHIN VA, 1992, J BACTERIOL, V174, P1793, DOI 10.1128/jb.174.6.1793-1800.1992; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; Maiti KK, 2010, EUR J ORG CHEM, V2010, P80, DOI 10.1002/ejoc.200900973; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Mathiak G, 2003, INT J MOL MED, V11, P41; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; Mukherjee P, 2003, J IMMUNOTHER, V26, P47, DOI 10.1097/00002371-200301000-00006; Munford RS, 2008, INFECT IMMUN, V76, P454, DOI 10.1128/IAI.00939-07; Muroi M, 2002, INFECT IMMUN, V70, P6043, DOI 10.1128/IAI.70.11.6043-6047.2002; Netea MG, 2001, EUR J IMMUNOL, V31, P2529, DOI 10.1002/1521-4141(200109)31:9<2529::AID-IMMU2529>3.0.CO;2-B; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Okemoto K, 2006, J IMMUNOL, V176, P1203, DOI 10.4049/jimmunol.176.2.1203; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park DSW, 2008, BIOMED MICRODEVICES, V10, P21, DOI 10.1007/s10544-007-9106-y; Pasare C, 2004, SEMIN IMMUNOL, V16, P23, DOI 10.1016/j.smim.2003.10.006; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RALPH P, 1977, J IMMUNOL, V119, P950; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Rice TW, 2005, ANNU REV MED, V56, P225, DOI 10.1146/annurev.med.56.082103.104356; Salkowski CA, 1997, INFECT IMMUN, V65, P3239, DOI 10.1128/IAI.65.8.3239-3247.1997; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; VAN AMERSFOORT ES, 2003, CLIN MICROBIOL REV, V16, P379; VAN DER LEY P, 2001, INFECT IMMUN, V69, P5981; Vasan M, 2007, ORG BIOMOL CHEM, V5, P2087, DOI 10.1039/b704427e; Wan YZ, 2009, J BIOL CHEM, V284, P10367, DOI 10.1074/jbc.M807822200; Ye JP, 1997, FASEB J, V11, P825, DOI 10.1096/fasebj.11.11.9285480; Yoshizaki H, 2001, ANGEW CHEM INT EDIT, V40, P1475, DOI 10.1002/1521-3773(20010417)40:8<1475::AID-ANIE1475>3.0.CO;2-V; Zhang Y, 2008, CHEM-EUR J, V14, P558, DOI 10.1002/chem.200701165; Zhang YH, 2007, BIOORGAN MED CHEM, V15, P4800, DOI 10.1016/j.bmc.2007.05.012; Zhang YH, 2007, J AM CHEM SOC, V129, P5200, DOI 10.1021/ja068922a; Zughaier S, 2006, VACCINE, V24, P1291, DOI 10.1016/j.vaccine.2005.09.039; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	69	38	41	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29375	29386		10.1074/jbc.M110.115204	http://dx.doi.org/10.1074/jbc.M110.115204			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20634284	hybrid, Green Published			2022-12-25	WOS:000281740100040
J	Tanno, B; Sesti, F; Cesi, V; Bossi, G; Ferrari-Amorotti, G; Bussolari, R; Tirindelli, D; Calabretta, B; Raschella, G				Tanno, Barbara; Sesti, Fabiola; Cesi, Vincenzo; Bossi, Gianluca; Ferrari-Amorotti, Giovanna; Bussolari, Rita; Tirindelli, Donatella; Calabretta, Bruno; Raschella, Giuseppe			Expression of Slug Is Regulated by c-Myb and Is Required for Invasion and Bone Marrow Homing of Cancer Cells of Different Origin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-METASTASIS; BREAST-CANCER; ANTISENSE OLIGODEOXYNUCLEOTIDES; DOWN-REGULATION; NEURAL CREST; SNAIL GENES; B-MYB; NEUROBLASTOMA; CARCINOMA	In metastatic cancer cells, the process of invasion is regulated by several transcription factors that induce changes required for migration and resistance to apoptosis. Slug (SNAI2, Snail2) is involved in epithelial mesenchymal transition in physiological and in pathological contexts. We show here that in embryonic kidney, colon carcinoma, chronic myeloid leukemia-blast crisis, and in neuroblastoma cells, expression of Slug is transcriptionally regulated by c-Myb via Myb binding sites in the 5'-flanking region and in the first intron of the slug gene. In embryonic kidney and neuroblastoma cells, c-Myb induced vimentin, fibronectin, and N-cadherin expression and membrane ruffling via actin polymerization consistent with the acquisition of a mesenchymal-like phenotype. Furthermore, down-regulation of endogenous c-Myb levels in colon carcinoma cells led to increased expression of E-cadherin and reduced levels of vimentin. Some of these changes are predominantly Slug-dependent as Slug silencing via RNA interference (RNAi) reverts the cells to a quasi-parental condition. Changes in gene expression and morphology induced by c-Myb-activated Slug correlated with increased ability to migrate (embryonic kidney) and to invade through a Matrigel membrane (embryonic kidney, colon carcinoma, neuroblastoma). c-Myb-dependent Slug expression was also essential for the homing of chronic myeloid leukemia K562 cells to the bone marrow. In summary, we show here that the proto-oncogene c-Myb controls Slug transcription in tumor cells of different origin. Such a regulatory pathway contributes to the acquisition of invasive properties that are important for the metastatic process.	[Tanno, Barbara; Sesti, Fabiola; Cesi, Vincenzo; Tirindelli, Donatella; Raschella, Giuseppe] Italian Natl Agcy New Technol Energy & Sustainabl, Lab Radiat Biol & Biomed, Res Ctr Casaccia, I-00123 Rome, Italy; [Bossi, Gianluca] Regina Elena Inst Canc Res, Dept Expt Oncol, I-00158 Rome, Italy; [Ferrari-Amorotti, Giovanna; Calabretta, Bruno] Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy; [Bussolari, Rita] Univ Modena, Dept Hematol Oncol, I-41100 Modena, Italy; [Calabretta, Bruno] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Italian National Agency New Technical Energy & Sustainable Economics Development; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Jefferson University	Raschella, G (corresponding author), ENEA Res Ctr Casaccia, Lab Radiat Biol & Biomed, Via Anguillarese 301, I-00123 Rome, Italy.	giuseppe.raschella@enea.it	Bossi, Gianluca/B-9394-2017; Bossi, Gianluca/ABH-6846-2020	Bossi, Gianluca/0000-0002-2947-1063; Bossi, Gianluca/0000-0002-2947-1063; Sesti, Fabiola/0000-0003-4142-1760	Fondazione Italiana per la Lotta al Neuroblastoma; National Institutes of Health [RO1 CA95111]; Associazione Italiana per la Ricerca sul Cancro [8804]; NATIONAL CANCER INSTITUTE [R01CA095111] Funding Source: NIH RePORTER	Fondazione Italiana per la Lotta al Neuroblastoma; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Fondazione Italiana per la Lotta al Neuroblastoma (to G. R.). This work was also supported by National Institutes of Health Grant RO1 CA95111 (NCI; to B. C.) and Associazione Italiana per la Ricerca sul Cancro IG Grant 8804 (to G. B.).	Nieto MA, 2009, INT J DEV BIOL, V53, P1541, DOI 10.1387/ijdb.072410mn; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Berge T, 2007, BLOOD CELL MOL DIS, V39, P278, DOI 10.1016/j.bcmd.2007.05.007; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Boutet A, 2007, CELL CYCLE, V6, P638, DOI 10.4161/cc.6.6.4022; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Catalano A, 2004, J BIOL CHEM, V279, P46706, DOI 10.1074/jbc.M406696200; Civenni G, 2009, SEMIN CANCER BIOL, V19, P68, DOI 10.1016/j.semcancer.2008.11.003; Drabsch Y, 2007, P NATL ACAD SCI USA, V104, P13762, DOI 10.1073/pnas.0700104104; DRESSLER GR, 2002, MOUSE DEV PATTERNING, P395; DREWINKO B, 1978, J NATL CANCER I, V61, P75, DOI 10.1093/jnci/61.1.75; ESS KC, 1995, MOL CELL BIOL, V15, P5707; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GUERIN M, 1990, ONCOGENE, V5, P131; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Gurtner A, 2010, J BIOL CHEM, V285, P14160, DOI 10.1074/jbc.M109.094813; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Inukai T, 1999, MOL CELL, V4, P343, DOI 10.1016/S1097-2765(00)80336-6; Karafiat V, 2005, CELL MOL LIFE SCI, V62, P2516, DOI 10.1007/s00018-005-5297-7; Kauraniemi P, 2000, CANCER RES, V60, P5323; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Liotta LA, 2001, NATURE, V410, P24, DOI 10.1038/35065180; MELANI C, 1991, CANCER RES, V51, P2897; Olmeda D, 2008, ONCOGENE, V27, P4690, DOI 10.1038/onc.2008.118; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Ramsay RG, 2003, EXPERT OPIN THER TAR, V7, P235; RAMSAY RG, 1992, CELL GROWTH DIFFER, V3, P723; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Raschella G, 1999, CANCER RES, V59, P3365; RASCHELLA G, 1992, CANCER RES, V52, P4221; RATAJCZAK MZ, 1992, P NATL ACAD SCI USA, V89, P11823, DOI 10.1073/pnas.89.24.11823; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Syed M, 2008, CLIN EXP METASTAS, V25, P787, DOI 10.1007/s10585-008-9192-0; Tanno B, 2002, J BIOL CHEM, V277, P23172, DOI 10.1074/jbc.M200141200; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thompson MA, 1998, CANCER RES, V58, P5168; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Vitali R, 2008, CLIN CANCER RES, V14, P4622, DOI 10.1158/1078-0432.CCR-07-5210; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0	43	48	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29434	29445		10.1074/jbc.M109.089045	http://dx.doi.org/10.1074/jbc.M109.089045			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20622260	Green Published, hybrid			2022-12-25	WOS:000281740100046
J	Veale, EL; Rees, KA; Mathie, A; Trapp, S				Veale, Emma L.; Rees, Kathryn A.; Mathie, Alistair; Trapp, Stefan			Dominant Negative Effects of a Non-conducting TREK1 Splice Variant Expressed in Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACKGROUND POTASSIUM CHANNEL; DOMAIN K+ CHANNEL; FUNCTIONAL EXPRESSION; ENDOPLASMIC-RETICULUM; K-2P CHANNELS; TASK-1; SUBUNIT; LOCALIZATION; TRANSPORT; CLONING	Two-pore domain potassium (K-2P) channels modulate neuronal excitability throughout the entire CNS. The stretch-activated channel TREK1 (K(2P)2.1) is expressed widely in brain and has been linked to depression, neuroprotection, pain perception, and epilepsy. Little, however, is known about the regulation of TREK1 expression on the transcriptional and translational level or about its trafficking to the plasma membrane. Here we have used PCR techniques to identify a splice variant of TREK1 expressed in the brain, which encodes a heavily truncated TREK1 protein retaining a single transmembrane domain. Functional expression of this splice variant TREK1 Delta Ex4 in tsA201 cells in the presence or absence of wild type TREK1 revealed that TREK1 Delta Ex4 has no channel activity itself but reduced TREK1 whole cell current amplitude. Confocal analysis of the expression of fluorescently tagged TREK1 variants revealed that TREK1 Delta Ex4 is translated, but it is retained in the intracellular compartment. Additionally, TREK1 Delta Ex4 reduced the level of TREK1 expression in the plasma membrane. Long and short forms of TREK1 derived from alternative translation initiation are differentially affected by TREK1 Delta Ex4, with the short form (lacking the first 41 amino acids at its N terminus) unaffected. This differential regulatory role of TREK1 Delta Ex4 will alter the functional profile of TREK1 current in neurons where they are expressed. These results indicate that the N-terminal domain and first transmembrane domain of TREK1 are likely to be important for channel dimerization and trafficking to the plasma membrane.	[Trapp, Stefan] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Sect, London SW7 2AZ, England; [Trapp, Stefan] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London SW7 2AZ, England; Univ Kent, Medway Sch Pharm, Chatham ME4 4TB, Kent, England; Univ Greenwich Medway, Medway Sch Pharm, Chatham ME4 4TB, Kent, England	Imperial College London; Imperial College London; University of Greenwich; University of Kent; University of Greenwich	Trapp, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Sect, S Kensington Campus, London SW7 2AZ, England.	s.trapp@imperial.ac.uk	Veale, Emma/AAA-5022-2022; Mathie, Alistair/K-7198-2019; Trapp, Stefan/D-9240-2011	Veale, Emma/0000-0002-6778-9929; Mathie, Alistair/0000-0001-6094-2890; Trapp, Stefan/0000-0003-0665-4948	Medical Research Council [G0600928, G0200370]; MRC [G0200370, G0600928] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Medical Research Council (Ref. G0600928 (to S. T.) and Ref. G0200370 (to E. L. V. and A. M.)).	Aller MI, 2008, NEUROSCIENCE, V151, P1154, DOI 10.1016/j.neuroscience.2007.12.011; Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Brenner T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1480, DOI 10.1152/ajpendo.90652.2008; Chapman CG, 2000, MOL BRAIN RES, V82, P74; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; DOWNING JEG, 1987, P NATL ACAD SCI USA, V84, P7739, DOI 10.1073/pnas.84.21.7739; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Franks NP, 2004, TRENDS PHARMACOL SCI, V25, P601, DOI 10.1016/j.tips.2004.09.003; Franks NP, 1999, NAT NEUROSCI, V2, P395, DOI 10.1038/8054; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; Gu WL, 2002, J PHYSIOL-LONDON, V539, P657, DOI 10.1113/jphysiol.2001.013432; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Honore E, 2002, EMBO J, V21, P2968, DOI 10.1093/emboj/cdf288; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Hsu K, 2004, MOL CELL, V14, P259, DOI 10.1016/S1097-2765(04)00183-2; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Kang D, 2005, J PHYSIOL-LONDON, V564, P103, DOI 10.1113/jphysiol.2004.081059; Kang DW, 2004, J PHYSIOL-LONDON, V554, P64, DOI 10.1113/jphysiol.2003.054387; Karschin C, 2001, MOL CELL NEUROSCI, V18, P632, DOI 10.1006/mcne.2001.1045; Kim D, 2003, TRENDS PHARMACOL SCI, V24, P648, DOI 10.1016/j.tips.2003.10.008; Lauritzen I, 2003, J BIOL CHEM, V278, P32068, DOI 10.1074/jbc.M302631200; Lesage F, 2003, NEUROPHARMACOLOGY, V44, P1, DOI 10.1016/S0028-3908(02)00339-8; Li XT, 2006, CARDIOVASC RES, V69, P86, DOI 10.1016/j.cardiores.2005.08.018; Linden AM, 2006, J PHARMACOL EXP THER, V317, P615, DOI 10.1124/jpet.105.098525; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Mathie A, 2007, CURR OPIN INVEST DR, V8, P555; Mathie A, 2007, J PHYSIOL-LONDON, V578, P377, DOI 10.1113/jphysiol.2006.121582; Meadows HJ, 2000, PFLUG ARCH EUR J PHY, V439, P714, DOI 10.1007/s004240050997; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; O'Kelly I, 2008, TRAFFIC, V9, P72, DOI 10.1111/j.1600-0854.2007.00663.x; Pei L, 2003, P NATL ACAD SCI USA, V100, P7803, DOI 10.1073/pnas.1232448100; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Sakura H, 1995, FEBS LETT, V377, P338, DOI 10.1016/0014-5793(95)01369-5; Sandoz G, 2008, J NEUROSCI, V28, P8545, DOI 10.1523/JNEUROSCI.1962-08.2008; Sandoz G, 2006, EMBO J, V25, P5864, DOI 10.1038/sj.emboj.7601437; Sandoz G, 2009, P NATL ACAD SCI USA, V106, P14628, DOI 10.1073/pnas.0906267106; Shikano S, 2005, NAT CELL BIOL, V7, P985, DOI 10.1038/ncb1297; Simkin D, 2008, J PHYSIOL-LONDON, V586, P5651, DOI 10.1113/jphysiol.2008.161927; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Talley EM, 2003, NEUROSCIENTIST, V9, P46, DOI 10.1177/1073858402239590; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; Thomas D, 2008, NEURON, V58, P859, DOI 10.1016/j.neuron.2008.04.016; Trapp S, 2008, J NEUROSCI, V28, P8844, DOI 10.1523/JNEUROSCI.1810-08.2008; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Zanzouri M, 2006, BIOCHEM BIOPH RES CO, V348, P1350, DOI 10.1016/j.bbrc.2006.07.194; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zuzarte M, 2007, TRAFFIC, V8, P1093, DOI 10.1111/j.1600-0854.2007.00593.x; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	55	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29295	29304		10.1074/jbc.M110.108423	http://dx.doi.org/10.1074/jbc.M110.108423			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20605797	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000281740100032
J	Meyer, NH; Tripsianes, K; Vincendeau, M; Madl, T; Kateb, F; Brack-Werner, R; Sattler, M				Meyer, N. Helge; Tripsianes, Konstantinos; Vincendeau, Michelle; Madl, Tobias; Kateb, Fatiha; Brack-Werner, Ruth; Sattler, Michael			Structural Basis for Homodimerization of the Src-associated during Mitosis, 68-kDa Protein (Sam68) Qua1 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING; KH-DOMAIN; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; BACKBONE DYNAMICS; DIPOLAR COUPLINGS; NMR-SPECTROSCOPY; SPLICE VARIANT; CD44; RELAXATION	Sam68 (Src-associated during mitosis, 68 kDa) is a prototypical member of the STAR (signal transducer and activator of RNA) family of RNA-binding proteins. STAR proteins bind mRNA targets and modulate cellular processes such as cell cycle regulation and tissue development in response to extracellular signals. Sam68 has been shown to modulate alternative splicing of the pre-mRNAs of CD44 and Bcl-xL, which are linked to tumor progression and apoptosis. Sam68 and other STAR proteins recognize bipartite RNA sequences and are thought to function as homodimers. However, the structural and functional roles of the self-association are not known. Here, we present the solution structure of the Sam68 Qua1 homodimerization domain. Each monomer consists of two antiparallel alpha-helices connected by a short loop. The two subunits are arranged perpendicular to each other in an unusual four-helix topology. Mutational analysis of Sam68 in vitro and in a cell-based assay revealed that the Qua1 domain and residues within the dimerization interface are essential for alternative splicing of a CD44 minigene. Together, our results indicate that the Qua1 homodimerization domain is required for regulation of alternative splicing by Sam68.	[Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany; [Meyer, N. Helge; Tripsianes, Konstantinos; Madl, Tobias; Kateb, Fatiha; Sattler, Michael] Tech Univ Munich, Dept Chem, Munich Ctr Integrated Prot Sci CiPSM, D-85747 Garching, Germany; [Vincendeau, Michelle; Brack-Werner, Ruth] Helmholtz Zentrum Munchen, Inst Virol, D-85764 Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Sattler, M (corresponding author), Helmholtz Zentrum Munchen, Inst Biol Struct, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	sattler@helmholtz-muenchen.de	Sattler, Michael/A-2407-2012; Brack-Werner, Ruth/M-4615-2014; Madl, Tobias/B-1682-2012; Tripsianes, Konstantinos/I-8382-2014; Vincendeau, Michelle/AAD-4320-2022	Sattler, Michael/0000-0002-1594-0527; Brack-Werner, Ruth/0000-0002-8651-9318; Madl, Tobias/0000-0002-9725-5231; Tripsianes, Konstantinos/0000-0003-0948-813X; 	Deutsche Forschungsgemeinschaft; Alexander von Humboldt foundation; EMBO fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humboldt foundation(Alexander von Humboldt Foundation); EMBO fellowship(European Molecular Biology Organization (EMBO))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft and grants from the Alexander von Humboldt foundation (to K. T. and F. K.) and an EMBO fellowship (to T. M.).	ARCH R, 1992, SCIENCE, V257, P682, DOI 10.1126/science.1496383; Babic I, 2004, ONCOGENE, V23, P3781, DOI 10.1038/sj.onc.1207484; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; Beuck C, 2010, STRUCTURE, V18, P377, DOI 10.1016/j.str.2009.12.016; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Busa R, 2007, ONCOGENE, V26, P4372, DOI 10.1038/sj.onc.1210224; Chen TP, 1997, MOL CELL BIOL, V17, P5707, DOI 10.1128/MCB.17.10.5707; COOPER DL, 1995, NAT MED, V1, P635, DOI 10.1038/nm0795-635; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Di Fruscio M, 1999, P NATL ACAD SCI USA, V96, P2710, DOI 10.1073/pnas.96.6.2710; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Goddard T. D, 2007, SPARKY 3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Guitard E, 1998, BIOCHEM BIOPH RES CO, V245, P562, DOI 10.1006/bbrc.1998.8374; Hadian K, 2009, J BIOL CHEM, V284, P33384, DOI 10.1074/jbc.M109.021659; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Itoh M, 2002, NUCLEIC ACIDS RES, V30, P5452, DOI 10.1093/nar/gkf673; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li JL, 2002, J VIROL, V76, P4526, DOI 10.1128/JVI.76.9.4526-4535.2002; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lipsitz RS, 2004, ANNU REV BIOPH BIOM, V33, P387, DOI 10.1146/annurev.biophys.33.110502.140306; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Madl T, 2009, ANGEW CHEM INT EDIT, V48, P8259, DOI 10.1002/anie.200902561; Maguire ML, 2005, J MOL BIOL, V348, P265, DOI 10.1016/j.jmb.2005.02.058; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Najib S, 2005, CELL MOL LIFE SCI, V62, P36, DOI 10.1007/s00018-004-4309-3; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; OTTING G, 1990, Q REV BIOPHYS, V23, P39, DOI 10.1017/S0033583500005412; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Pillay I, 1996, CELL GROWTH DIFFER, V7, P1487; RICHARD S, 1995, MOL CELL BIOL, V15, P186, DOI 10.1128/MCB.15.1.186; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sherman L, 1998, GENE DEV, V12, P1058, DOI 10.1101/gad.12.7.1058; Sherman L, 1996, CURR TOP MICROBIOL, V213, P249; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; Thompson J.D., 2002, CURRENT PROTOCOLS BI; Tisserant A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001418; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; WANG LL, 1995, J BIOL CHEM, V270, P2010, DOI 10.1074/jbc.270.5.2010; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Yang DW, 1999, J BIOMOL NMR, V14, P333, DOI 10.1023/A:1008314803561; Zorn AM, 1997, GENE DEV, V11, P2176, DOI 10.1101/gad.11.17.2176	53	30	32	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28893	28901		10.1074/jbc.M110.126185	http://dx.doi.org/10.1074/jbc.M110.126185			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20610388	Green Published, hybrid			2022-12-25	WOS:000281594000054
J	Yang, ZT; Philips, JD; Doty, RT; Giraudi, P; Ostrow, JD; Tiribelli, C; Smith, A; Abkowitz, JL				Yang, Zhantao; Philips, John D.; Doty, Raymond T.; Giraudi, Pablo; Ostrow, J. Donald; Tiribelli, Claudio; Smith, Ann; Abkowitz, Janis L.			Kinetics and Specificity of Feline Leukemia Virus Subgroup C Receptor (FLVCR) Export Function and Its Dependence on Hemopexin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTOSE PERMEASE; HEME-HEMOPEXIN; ESCHERICHIA-COLI; IRON HOMEOSTASIS; TRANSPORTER; EXPRESSION; BILIRUBIN; BINDING; MECHANISM; PROTEIN	The feline leukemia virus subgroup C receptor (FLVCR) is a heme export protein that is required for proerythroblast survival and facilitates macrophage heme iron recycling. However, its mechanism of heme export and substrate specificity are uncharacterized. Using [Fe-55]heme and the fluorescent heme analog zinc mesoporphyrin, we investigated whether export by FLVCR depends on the availability and avidity of extracellular heme-binding proteins. Export was 100-fold more efficient when the medium contained hemopexin (K-d < 1 pM) compared with albumin (K-d = 5 nM) at the same concentration and was not detectable when the medium lacked heme-binding proteins. Besides heme, FLVCR could export other cyclic planar porphyrins, such as protoporphyrin IX and coproporphyrin. However, FLVCR has a narrow substrate range because unconjugated bilirubin, the primary breakdown product of heme, was not transported. As neither protoporphyrin IX nor coproporphyrin export improved with extracellular hemopexin (versus albumin), our observations further suggest that hemopexin, an abundant protein with a serum concentration (6.7-25 mu M) equivalent to that of the iron transport protein transferrin (22-31 mu M), by accepting heme from FLVCR and targeting it to the liver, might regulate macrophage heme export and heme iron recycling in vivo. Final studies show that hemopexin directly interacts with FLVCR, which also helps explain why FLVCR, in contrast to some major facilitator superfamily members, does not function as a bidirectional gradient-dependent transporter. Together, these data argue that hemopexin has a role in assuring systemic iron balance during homeostasis in addition to its established role as a scavenger during internal bleeding or hemolysis.	[Yang, Zhantao; Doty, Raymond T.; Abkowitz, Janis L.] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Ostrow, J. Donald] Univ Washington, Dept Med, Div Gastroenterol Hepatol, Seattle, WA 98195 USA; [Philips, John D.] Univ Utah, Sch Med, Div Hematol, Salt Lake City, UT 84132 USA; [Giraudi, Pablo; Tiribelli, Claudio] Univ Trieste, Ctr Studi Fegato, I-34127 Trieste, Italy; [Giraudi, Pablo; Tiribelli, Claudio] Univ Trieste, Dept Clin Anesthesiol Surg Anat Pathol Dermatol H, I-34127 Trieste, Italy; [Smith, Ann] Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; University of Trieste; University of Trieste; University of Missouri System; University of Missouri Kansas City	Abkowitz, JL (corresponding author), Univ Washington, Dept Med, Div Hematol, POB 357710,1959 NE Pacific St, Seattle, WA 98195 USA.	janabk@u.washington.edu	Tiribelli, Claudio/A-4716-2014	Tiribelli, Claudio/0000-0001-6596-7595; Doty, Raymond/0000-0002-9312-8622	National Institutes of Health [R01 HL31823, R01 DK020503, P30 DK072437, DK085146]; Telethon [GGP05062]; University of Missouri-Kansas City; Ministry of Foreign Affairs, Rome, Italy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020503, P30DK072437, R01DK085146, R56DK085146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telethon(Fondazione Telethon); University of Missouri-Kansas City; Ministry of Foreign Affairs, Rome, Italy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL31823, R01 DK020503, P30 DK072437, and DK085146. This work was also supported by Telethon Grant GGP05062 and the University of Missouri-Kansas City Research Incentive Funds.; Ph.D. student sponsored by a fellowship from the Ministry of Foreign Affairs, Rome, Italy.	Abkowitz JL, 1998, STEM CELLS, V16, P288, DOI 10.1002/stem.160288; Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Abramson J, 2004, MOL MEMBR BIOL, V21, P227, DOI 10.1080/09687680410001716862; Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Bayon JE, 2001, J LAB CLIN MED, V138, P313, DOI 10.1067/mlc.2001.118746; Benvenisti-Zarom L, 2006, NEUROSCI LETT, V398, P230, DOI 10.1016/j.neulet.2006.01.003; Brown JK, 2006, J VIROL, V80, P1742, DOI 10.1128/JVI.80.4.1742-1751.2006; Calligaris S, 2006, FEBS LETT, V580, P1355, DOI 10.1016/j.febslet.2006.01.056; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; De Domenico I, 2007, MOL BIOL CELL, V18, P2569, DOI 10.1091/mbc.E07-01-0060; Delanghe JR, 2001, CLIN CHIM ACTA, V312, P13, DOI 10.1016/S0009-8981(01)00586-1; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Duvigneau JC, 2008, LAB INVEST, V88, P70, DOI 10.1038/labinvest.3700691; Eskew JD, 1999, J BIOL CHEM, V274, P638, DOI 10.1074/jbc.274.2.638; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; FLETCHER J, 1968, NATURE, V218, P1211, DOI 10.1038/2181211a0; Frawley ER, 2009, P NATL ACAD SCI USA, V106, P10201, DOI 10.1073/pnas.0903132106; Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821; HRKAL Z, 1974, EUR J BIOCHEM, V43, P73, DOI 10.1111/j.1432-1033.1974.tb03386.x; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Li RC, 2009, J CEREBR BLOOD F MET, V29, P953, DOI 10.1038/jcbfm.2009.19; Liang XY, 2009, J LEUKOCYTE BIOL, V86, P229, DOI 10.1189/jlb.1208742; LUBBEN M, 1994, J BIOL CHEM, V269, P21473; Morello N, 2009, J CELL MOL MED, V13, P4192, DOI 10.1111/j.1582-4934.2008.00611.x; MORGAN WT, 1980, BIOCHIM BIOPHYS ACTA, V624, P271, DOI 10.1016/0005-2795(80)90246-9; MORRIS CM, 1993, NEUROSCI LETT, V149, P141, DOI 10.1016/0304-3940(93)90756-B; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Ostrow JD, 2007, TRANSL RES, V149, P37, DOI 10.1016/j.trsl.2006.07.006; Ponka P, 1997, BLOOD, V89, P1; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Quigley JG, 2000, BLOOD, V95, P1093, DOI 10.1182/blood.V95.3.1093.003k01_1093_1099; Rigato L, 2004, BIOCHEM J, V383, P335, DOI 10.1042/BJ20040599; Roca L, 2006, PEDIATR RES, V60, P724, DOI 10.1203/01.pdr.0000245992.89965.94; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Sassa S, 2006, J CLIN BIOCHEM NUTR, V38, P138, DOI 10.3164/jcbn.38.138; SEERY VL, 1973, J BIOL CHEM, V248, P3796; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104; SMITH A, 1979, BIOCHEM J, V182, P47, DOI 10.1042/bj1820047; SMITH A, 1984, J BIOL CHEM, V259, P2049; Smith K.M., 1975, PORPHYRINS METALLOPO; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Tailor CS, 1999, J VIROL, V73, P6500, DOI 10.1128/JVI.73.8.6500-6505.1999; Tolosano E, 1999, BLOOD, V94, P3906, DOI 10.1182/blood.V94.11.3906; Tolosano E, 1996, BIOCHEM BIOPH RES CO, V218, P694, DOI 10.1006/bbrc.1996.0124; Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017; Vardy E, 2004, PROTEIN SCI, V13, P1832, DOI 10.1110/ps.04657704; Vitek L, 2009, CURR PHARM DESIGN, V15, P2869, DOI 10.2174/138161209789058237; Worthington MT, 2001, AM J PHYSIOL-GASTR L, V280, pG1172, DOI 10.1152/ajpgi.2001.280.6.G1172; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zukor H, 2009, J NEUROCHEM, V109, P776, DOI 10.1111/j.1471-4159.2009.06007.x	63	66	70	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28874	28882		10.1074/jbc.M110.119131	http://dx.doi.org/10.1074/jbc.M110.119131			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20610401	Green Published, hybrid			2022-12-25	WOS:000281594000052
J	Haque, ME; Elmore, KB; Tripathy, A; Koc, H; Koc, EC; Spremulli, LL				Haque, Md. Emdadul; Elmore, Kevin B.; Tripathy, Ashutosh; Koc, Hasan; Koc, Emine C.; Spremulli, Linda L.			Properties of the C-terminal Tail of Human Mitochondrial Inner Membrane Protein Oxa1L and Its Interactions with Mammalian Mitochondrial Ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREDICTING COILED COILS; TRANSLATIONAL INITIATION-FACTOR-3; CIRCULAR-DICHROISM; COMPLEX; INSERTION; EXPORT; YEAST; IDENTIFICATION; EXTENSIONS; MACHINERY	In humans the mitochondrial inner membrane protein Oxa1L is involved in the biogenesis of membrane proteins and facilitates the insertion of both mitochondrial- and nuclear-encoded proteins from the mitochondrial matrix into the inner membrane. The C-terminal similar to 100-amino acid tail of Oxa1L (Oxa1L-CTT) binds to mitochondrial ribosomes and plays a role in the co-translational insertion of mitochondria-synthesized proteins into the inner membrane. Contrary to suggestions made for yeast Oxa1p, our results indicate that the C-terminal tail of human Oxa1L does not form a coiled-coil helical structure in solution. The Oxa1L-CTT exists primarily as a monomer in solution but forms dimers and tetramers at high salt concentrations. The binding of Oxa1L-CTT to mitochondrial ribosomes is an enthalpy-driven process with a K-d of 0.3-0.8 mu M and a stoichiometry of 2. Oxa1L-CTT cross-links to mammalian mitochondrial homologs of the bacterial ribosomal proteins L13, L20, and L28 and to mammalian mitochondrial specific ribosomal proteins MRPL48, MRPL49, and MRPL51. Oxa1L-CTT does not cross-link to proteins decorating the conventional exit tunnel of the bacterial large ribosomal subunit (L22, L23, L24, and L29).	[Haque, Md. Emdadul; Elmore, Kevin B.; Spremulli, Linda L.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Tripathy, Ashutosh] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Koc, Hasan; Koc, Emine C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Spremulli, LL (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	Linda_spremulli@unc.edu		Elmore, Kevin/0000-0001-6740-9159	National Institutes of Health [GM 32734, GM071034]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032734, R01GM071034] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 32734 (to L.L.S.) and GM071034 (to E.C.K.).	BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Bhargava K, 2005, NUCLEIC ACIDS RES, V33, P7011, DOI 10.1093/nar/gki1007; Bonnefoy N, 2009, BBA-MOL CELL RES, V1793, P60, DOI 10.1016/j.bbamcr.2008.05.004; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Canaves JM, 1998, J BIOL CHEM, V273, P34214, DOI 10.1074/jbc.273.51.34214; Choy N, 2003, J MOL BIOL, V334, P527, DOI 10.1016/j.jmb.2003.09.059; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; EMDADUL HM, 2008, MITOCHONDRION, V8, P254; FRERE V, 1995, J BIOL CHEM, V270, P17502, DOI 10.1074/jbc.270.29.17502; Graack HR, 1998, BIOCHEM J, V329, P433, DOI 10.1042/bj3290433; Grasso DG, 2007, METHOD ENZYMOL, V430, P59, DOI 10.1016/S0076-6879(07)30004-9; Gruschke S, 2010, J BIOL CHEM, V285, P19022, DOI 10.1074/jbc.M110.113837; Haque ME, 2008, NUCLEIC ACIDS RES, V36, P589, DOI 10.1093/nar/gkm1072; Haque ME, 2008, J MOL BIOL, V384, P929, DOI 10.1016/j.jmb.2008.09.077; He SC, 1997, MOL BIOL CELL, V8, P1449, DOI 10.1091/mbc.8.8.1449; Hell K, 1998, P NATL ACAD SCI USA, V95, P2250, DOI 10.1073/pnas.95.5.2250; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Jia LX, 2009, EUKARYOT CELL, V8, P1792, DOI 10.1128/EC.00219-09; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; KITAKAWA M, 1991, BIOCHIMIE, V73, P813, DOI 10.1016/0300-9084(91)90061-5; Koc EC, 2002, J BIOL CHEM, V277, P35541, DOI 10.1074/jbc.M202498200; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; LAU SYM, 1984, J BIOL CHEM, V259, P3253; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Miller JL, 2008, PROTEIN SCI, V17, P251, DOI 10.1110/ps.073185608; Miller JL, 2009, J PROTEOME RES, V8, P4789, DOI 10.1021/pr9004844; Nakajima H, 2001, J BIOL CHEM, V276, P42915, DOI 10.1074/jbc.M106015200; Nargang FE, 2002, J BIOL CHEM, V277, P12846, DOI 10.1074/jbc.M112099200; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; PEL HJ, 1994, MOL BIOL REP, V19, P183, DOI 10.1007/BF00986960; PIETROMONACO SF, 1991, BIOCHIMIE, V73, P827, DOI 10.1016/0300-9084(91)90062-6; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Saaf A, 1998, J BIOL CHEM, V273, P30415, DOI 10.1074/jbc.273.46.30415; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Smits P, 2007, NUCLEIC ACIDS RES, V35, P4686, DOI 10.1093/nar/gkm441; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stiburek L, 2007, J MOL BIOL, V374, P506, DOI 10.1016/j.jmb.2007.09.044; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; ZHOU NE, 1992, J BIOL CHEM, V267, P2664	45	35	42	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28353	28362		10.1074/jbc.M110.148262	http://dx.doi.org/10.1074/jbc.M110.148262			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20601428	Green Published, hybrid			2022-12-25	WOS:000281404100077
J	Yu, J; Cao, Q; Yu, J; Wu, L; Dallol, A; Li, J; Chen, G; Grasso, C; Cao, X; Lonigro, RJ; Varambally, S; Mehra, R; Palanisamy, N; Wu, JY; Latif, F; Chinnaiyan, AM				Yu, J.; Cao, Q.; Yu, J.; Wu, L.; Dallol, A.; Li, J.; Chen, G.; Grasso, C.; Cao, X.; Lonigro, R. J.; Varambally, S.; Mehra, R.; Palanisamy, N.; Wu, J. Y.; Latif, F.; Chinnaiyan, A. M.			The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer	ONCOGENE			English	Article						polycomb group proteins; EZH2; SLIT2; prostate cancer; epigenetic silencing; DNA hypermethylation	FREQUENT EPIGENETIC INACTIVATION; GROUP PROTEIN EZH2; CONTROL CELL FATE; EXPRESSION SIGNATURE; SQUAMOUS-CELL; BETA-CATENIN; E-CADHERIN; GENE; POLYCOMB; TUMOR	The neuronal repellent SLIT2 is repressed in a number of cancer types primarily through promoter hypermethylation. SLIT2, however, has not been studied in prostate cancer. Through genome-wide location analysis we identified SLIT2 as a target of polycomb group (PcG) protein EZH2. The EZH2-containing polycomb repressive complexes bound to the SLIT2 promoter inhibiting its expression. SLIT2 was downregulated in a majority of metastatic prostate tumors, showing a negative correlation with EZH2. This repressed expression could be restored by methylation inhibitors or EZH2-suppressing compounds. In addition, a low level of SLIT2 expression was associated with aggressive prostate, breast and lung cancers. Functional assays showed that SLIT2 inhibited prostate cancer cell proliferation and invasion. Thus, this study showed for the first time the epigenetic silencing of SLIT2 in prostate tumors, and supported SLIT2 as a potential biomarker for aggressive solid tumors. Importantly, PcG-mediated repression may serve as a precursor for the silencing of SLIT2 by DNA methylation in cancer. Oncogene (2010) 29, 5370-5380; doi: 10.1038/onc.2010.269; published online 12 July 2010	[Chinnaiyan, A. M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Dept Pathol & Urol, Ann Arbor, MI 48109 USA; [Yu, J.; Wu, L.; Wu, J. Y.] Northwestern Univ, Div Hematol Oncol, Dept Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Yu, J.; Cao, Q.; Yu, J.; Li, J.; Chen, G.; Grasso, C.; Cao, X.; Lonigro, R. J.; Varambally, S.; Mehra, R.; Palanisamy, N.; Chinnaiyan, A. M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Yu, J.; Cao, Q.; Grasso, C.; Cao, X.; Varambally, S.; Mehra, R.; Palanisamy, N.; Chinnaiyan, A. M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Yu, J.; Lonigro, R. J.; Chinnaiyan, A. M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Dallol, A.; Latif, F.] Univ Birmingham, Inst Biomed Res, Dept Med & Mol Genet, Edgbaston, England; [Chinnaiyan, A. M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Wu, J. Y.] Northwestern Univ, Dept Neurol, Lurie Comprehens Canc Ctr, Ctr Genet Med, Chicago, IL 60611 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Birmingham; University of Michigan System; University of Michigan; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Howard Hughes Med Inst, Dept Pathol & Urol, 1500 E Med Ctr Dr,5410 CCGC, Ann Arbor, MI 48109 USA.	jindan-yu@northwestern.edu; arul@umich.edu	Palanisamy, Nallasivam/ABC-8844-2020; Dallol, Ashraf/H-8661-2012; WU, Longtao/G-6477-2014; Cao, Qi/A-5517-2010; Chen, Guoan/J-9140-2018	Palanisamy, Nallasivam/0000-0002-0633-9772; Dallol, Ashraf/0000-0002-8803-228X; WU, Longtao/0000-0003-3463-4127; Cao, Qi/0000-0002-5140-3681; Chen, Guoan/0000-0001-5608-6761; Varambally, Sooryanarayana/0000-0002-2277-1127	NIH [P50CA69568, P50CA090386, 1R01CA132874-01A1, CA114197, CA107193, K99CA129565-01A1]; Early Detection Research Network [UO1 111275]; US Department of Defense [PC051081, PC080665]; James S McDonnell Foundation; Searle Foundation; Doris Duke Charitable Foundation; Prostate Cancer Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA107193, R01CA132874, K99CA129565, R01CA114197, P50CA090386, R00CA129565, P50CA069568, U01CA111275] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Detection Research Network; US Department of Defense(United States Department of Defense); James S McDonnell Foundation; Searle Foundation; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Prostate Cancer Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the NIH Prostate Specialized Program of Research Excellence Grants P50CA69568 and P50CA090386, Early Detection Research Network Grant UO1 111275 (to AMC), the NIH 1R01CA132874-01A1 (to AMC), CA114197 and CA107193 (to JYW) and K99CA129565-01A1 (to JY), the US Department of Defense PC051081 (to AMC) and PC080665 (to JY), and the James S McDonnell Foundation Grant JSMF (to JYW) and Searle Foundation (to JYW). AMC is supported by a Burroughs Welcome Foundation Award in Clinical Translational Research, a Doris Duke Charitable Foundation Distinguished Clinical Investigator Award, the Prostate Cancer Foundation and the Howard Hughes Medical Institute. AMC is an American Cancer Society Research Professor.	Astuti D, 2004, BRIT J CANCER, V90, P515, DOI 10.1038/sj.bjc.6601447; Beke L, 2007, ONCOGENE, V26, P4590, DOI 10.1038/sj.onc.1210248; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Dallol A, 2003, ONCOGENE, V22, P4611, DOI 10.1038/sj.onc.1206687; Dallol A, 2003, CANCER RES, V63, P1054; Dallol A, 2002, CANCER RES, V62, P5874; Dammann R, 2005, EUR J CANCER, V41, P1223, DOI 10.1016/j.ejca.2005.02.020; Dammann R, 2005, HISTOL HISTOPATHOL, V20, P645, DOI 10.14670/HH-20.645; Dunwell TL, 2009, EPIGENETICS-US, V4, P265, DOI 10.4161/epi.9137; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Jin J, 2009, BIOCHEM BIOPH RES CO, V379, P86, DOI 10.1016/j.bbrc.2008.12.022; Kanno R, 2008, CANCER SCI, V99, P1077, DOI 10.1111/j.1349-7006.2008.00797.x; Kim HK, 2008, NEOPLASIA, V10, P1411, DOI 10.1593/neo.08804; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liu SJ, 2005, CANCER RES, V65, P1277, DOI 10.1158/0008-5472.CAN-04-4532; Mathews LA, 2009, DIFFERENTIATION, V78, P1, DOI 10.1016/j.diff.2009.04.002; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Prasad A, 2004, J BIOL CHEM, V279, P9115, DOI 10.1074/jbc.M308083200; Prasad A, 2008, J BIOL CHEM, V283, P26624, DOI 10.1074/jbc.M800679200; Prasad A, 2007, J LEUKOCYTE BIOL, V82, P465, DOI 10.1189/jlb.1106678; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; Sharma G, 2007, LIFE SCI, V80, P1873, DOI 10.1016/j.lfs.2007.02.026; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tseng RC, 2010, CANCER RES, V70, P543, DOI 10.1158/0008-5472.CAN-09-2084; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Werbowetski-Ogilvie TE, 2006, ONCOGENE, V25, P5103, DOI 10.1038/sj.onc.1209524; Wong K, 2002, CURR OPIN GENET DEV, V12, P583, DOI 10.1016/S0959-437X(02)00343-X; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	46	63	68	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	39					5370	5380		10.1038/onc.2010.269	http://dx.doi.org/10.1038/onc.2010.269			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664EZ	20622896	Green Accepted			2022-12-25	WOS:000282944500004
J	Nogueira, C; Buckup, PA; Menezes, NA; Oyakawa, OT; Kasecker, TP; Neto, MBR; da Silva, JMC				Nogueira, Cristiano; Buckup, Paulo A.; Menezes, Naercio A.; Oyakawa, Osvaldo T.; Kasecker, Thais P.; Ramos Neto, Mario B.; da Silva, Jose Maria C.			Restricted-Range Fishes and the Conservation of Brazilian Freshwaters	PLOS ONE			English	Article							BIODIVERSITY HOTSPOTS; PROTECTED AREAS; STRATEGIES; PRIORITIES; PATTERNS; THREATS; AMAZON; RIVER; UNITS; DAMS	Background: Freshwaters are the most threatened ecosystems on earth. Although recent assessments provide data on global priority regions for freshwater conservation, local scale priorities remain unknown. Refining the scale of global biodiversity assessments (both at terrestrial and freshwater realms) and translating these into conservation priorities on the ground remains a major challenge to biodiversity science, and depends directly on species occurrence data of high taxonomic and geographic resolution. Brazil harbors the richest freshwater ichthyofauna in the world, but knowledge on endemic areas and conservation in Brazilian rivers is still scarce. Methodology/Principal Findings: Using data on environmental threats and revised species distribution data we detect and delineate 540 small watershed areas harboring 819 restricted-range fishes in Brazil. Many of these areas are already highly threatened, as 159 (29%) watersheds have lost more than 70% of their original vegetation cover, and only 141 (26%) show significant overlap with formally protected areas or indigenous lands. We detected 220 (40%) critical watersheds overlapping hydroelectric dams or showing both poor formal protection and widespread habitat loss; these sites harbor 344 endemic fish species that may face extinction if no conservation action is in place in the near future. Conclusions/Significance: We provide the first analysis of site-scale conservation priorities in the richest freshwater ecosystems of the globe. Our results corroborate the hypothesis that freshwater biodiversity has been neglected in former conservation assessments. The study provides a simple and straightforward method for detecting freshwater priority areas based on endemism and threat, and represents a starting point for integrating freshwater and terrestrial conservation in representative and biogeographically consistent site-scale conservation strategies, that may be scaled-up following naturally linked drainage systems. Proper management (e. g. forestry code enforcement, landscape planning) and conservation (e. g. formal protection) of the 540 watersheds detected herein will be decisive in avoiding species extinction in the richest aquatic ecosystems on the planet.	[Nogueira, Cristiano; Ramos Neto, Mario B.] Conservacao Int Brasil, Programa Cerrado Pantanal, Brasilia, DF, Brazil; [Buckup, Paulo A.] Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, Rio De Janeiro, Brazil; [Menezes, Naercio A.; Oyakawa, Osvaldo T.] Univ Sao Paulo, Museu Zool, Secao Ictiol, Sao Paulo, Brazil; [Kasecker, Thais P.; da Silva, Jose Maria C.] Conservacao Int Brasil, Programa Amazonia, Belem, Para, Brazil	Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo	Nogueira, C (corresponding author), Univ Brasilia, Dept Zool, Brasilia, DF, Brazil.	cnogueira@unb.br	Buckup, Paulo Andreas/H-6729-2013; da Silva, José Maria Cardoso/K-3479-2016; Menezes, Naercio A./K-8763-2013; Nogueira, Cristiano de C. de Campos/I-5100-2012	Buckup, Paulo Andreas/0000-0002-1156-3226; da Silva, José Maria Cardoso/0000-0002-7229-6694; Menezes, Naercio A./0000-0002-9634-6051; Nogueira, Cristiano de C. de Campos/0000-0003-1835-6761	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Gordon and Betty Moore Foundation	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) provided research grants and fellowships. The Gordon and Betty Moore Foundation provided research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2002, CONSERV BIOL, V16, P1435, DOI 10.1046/j.1523-1739.2002.01532.x; Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Abell R, 2007, BIOL CONSERV, V134, P48, DOI 10.1016/j.biocon.2006.08.017; Agostinho AA, 2004, REV FISH BIOL FISHER, V14, P11, DOI 10.1007/s11160-004-3551-y; Amis MA, 2009, BIOL CONSERV, V142, P2217, DOI 10.1016/j.biocon.2009.04.021; *ANA, 2006, OTT NIV 6 VERS 07 12; ANA, 2006, TOP HIDR MET CONSTR; *ANA, 2007, GEO BRAS REC HIDR RE; *ANA, 2007, MAN CONSTR BAS HIDR; *ANA, 2006, REG HIDR SUP GEST IN; Anderson EP, 2006, AQUAT CONSERV, V16, P679, DOI 10.1002/aqc.806; Araujo MB, 2001, ECOGRAPHY, V24, P103, DOI 10.1034/j.1600-0587.2001.240112.x; BARTHEM RB, 1991, BIOL CONSERV, V55, P339, DOI 10.1016/0006-3207(91)90037-A; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Brooks T, 2004, CONSERV BIOL, V18, P1682, DOI 10.1111/j.1523-1739.2004.00457.x; Buckup PA, 2007, CATALOGO ESPECIES PE; Chapman AD, 2006, GLOBAL BIODIVERSITY; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Duellman W. E., 1986, BIOL AMPHIBIANS; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; FabrU N.N., 2005, MANEJO PESCA GRANDES; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6; Hausdorf B, 2002, SYST BIOL, V51, P648, DOI 10.1080/10635150290102320; HIJMANS RJ, 2004, 5 0 GEOGRAPHIC INFOR; *IBGE, 2004, MAP BIOM BRAS RIO JA; *ISA, 2009, ARE IND BRAS MAP; IUCN, 2007, IUCN RED LIST THREAT; IUCN, 2012, IUCN RED LIST CATEGO, VSecond; *IUCN, 2009, WILDL CHANG WORLD AN; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Langeani F., 2009, ESTADO ARTE PERSPECT, V1, P211; Lawler JJ, 2003, CONSERV BIOL, V17, P875, DOI 10.1046/j.1523-1739.2003.01638.x; Loyola RD, 2007, DIVERS DISTRIB, V13, P389, DOI 10.1111/j.1472-4642.2007.00345.x; Magurran AE, 2009, SCIENCE, V325, P1215, DOI 10.1126/science.1177215; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; MINISTERIO DO MEIO AMBIENTE - MMA, 2003, LIST ESP FAUN BRAS A; Mittermeier RA, 1997, MEGADIVERSITY EARTHS; *MMA, 2006, MAP AR PRIOR CONS US; MMA, 2007, MAP COB VEG BIOM BRA; *MMA, 2009, UNID CONSERV PROT IN; *MME, 2009, SIPOT SIST INF POT H; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 2003, BIOSCIENCE, V53, P916; Paynter Jr R. A., 1991, ORNITHOLOGICAL GAZET; PETRERE M, 1996, FISHERIES LARGE TROP, V2, P111; Quinn CH, 2005, BIODIVERS CONSERV, V14, P297, DOI 10.1007/s10531-004-5048-3; Regnier C, 2009, CONSERV BIOL, V23, P1214, DOI 10.1111/j.1523-1739.2009.01245.x; REINTHAL PN, 1991, CONSERV BIOL, V5, P231, DOI 10.1111/j.1523-1739.1991.tb00128.x; ROSEN DE, 1978, SYST ZOOL, V27, P159, DOI 10.2307/2412970; Rosenfield JA, 2002, GLOBAL ECOL BIOGEOGR, V11, P323, DOI 10.1046/j.1466-822X.2002.00287.x; Saunders DL, 2002, CONSERV BIOL, V16, P30, DOI 10.1046/j.1523-1739.2002.99562.x; Stattersfield Alison J., 1998, Birdlife Conservation Series, V7, P1; Vanzolini PE., 1992, SUPPLEMENT ORNITHOLO; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x	55	97	103	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11390	10.1371/journal.pone.0011390	http://dx.doi.org/10.1371/journal.pone.0011390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613986	Green Published, Green Submitted, gold			2022-12-25	WOS:000279370000019
J	Nishikawa, M; Shibata, T				Nishikawa, Masatoshi; Shibata, Tatsuo			Nonadaptive Fluctuation in an Adaptive Sensory System: Bacterial Chemoreceptor	PLOS ONE			English	Article							STATE-DEPENDENT INACTIVATION; ESCHERICHIA-COLI; BEHAVIORAL VARIABILITY; STOCHASTIC SIMULATION; COVALENT MODIFICATION; CHEMOTACTIC RESPONSE; SIGNAL-TRANSDUCTION; FLAGELLAR MOTORS; ADAPTATION; AMPLIFICATION	Background: Sensory systems often exhibit an adaptation or desensitization after a transient response, making the system ready to receive a new signal over a wide range of backgrounds. Because of the strong influence of thermal stochastic fluctuations on the biomolecules responsible for the adaptation, such as many membrane receptors and channels, their response is inherently noisy, and the adaptive property is achieved as a statistical average. Methodology/Principal Findings: Here, we study a simple kinetic model characterizing the essential aspects of these adaptive molecular systems and show theoretically that, while such an adaptive sensory system exhibits a perfect adaptation property on average, its temporal stochastic fluctuations are able to be sensitive to the environmental conditions. Among the adaptive sensory systems, an extensively studied model system is the bacterial receptor responsible for chemotaxis. The model exhibits a nonadaptive fluctuation sensitive to the environmental ligand concentration, while perfect adaptation is achieved on average. Furthermore, we found that such nonadaptive fluctuation makes the bacterial behavior dependent on the environmental chemoattractant concentrations, which enhances the chemotactic performance. Conclusions/Significance: This result indicates that adaptive sensory systems can make use of such stochastic fluctuation to carry environmental information, which is not possible by means of the average, while keeping responsive to the changing stimulus.	[Nishikawa, Masatoshi; Shibata, Tatsuo] Hiroshima Univ, Dept Math & Life Sci, Hiroshima, Japan; [Nishikawa, Masatoshi; Shibata, Tatsuo] Japan Sci & Technol Agcy, CREST, Osaka, Japan; [Shibata, Tatsuo] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Hiroshima University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Nishikawa, M (corresponding author), Hiroshima Univ, Dept Math & Life Sci, Hiroshima, Japan.	shibata@hiroshima-u.ac.jp	Shibata, Tatsuo/A-8119-2012	Shibata, Tatsuo/0000-0002-9294-9998	Japan Science and Technology Agency (JST); Core Research of Evolutional Science and Technology (CREST); JST Precursory Research for Embryonic Science and Technology (PRESTO)	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Core Research of Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); JST Precursory Research for Embryonic Science and Technology (PRESTO)	This work was supported by funding from the Japan Science and Technology Agency (JST), Core Research of Evolutional Science and Technology (CREST) (www.sysbio.jst.go.jp) and JST Precursory Research for Embryonic Science and Technology (PRESTO) (www.model.jst.go.jp). There are no numbers for these grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAKURA S, 1984, J MOL BIOL, V176, P349, DOI 10.1016/0022-2836(84)90494-7; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Barkai N, 2001, CR ACAD SCI IV-PHYS, V2, P871, DOI 10.1016/S1296-2147(01)01230-6; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; BLOCK SM, 1982, CELL, V31, P215, DOI 10.1016/0092-8674(82)90421-4; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; Clark DA, 2005, P NATL ACAD SCI USA, V102, P9150, DOI 10.1073/pnas.0407659102; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; de Gennes PG, 2004, EUR BIOPHYS J BIOPHY, V33, P691, DOI 10.1007/s00249-004-0426-z; Emonet T, 2008, P NATL ACAD SCI USA, V105, P3304, DOI 10.1073/pnas.0705463105; Ferguson SSG, 1998, SEMIN CELL DEV BIOL, V9, P119, DOI 10.1006/scdb.1997.0216; Friedlander T, 2009, P NATL ACAD SCI USA, V106, P22558, DOI 10.1073/pnas.0902146106; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Hansen CH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040001; KHAN S, 1980, J MOL BIOL, V138, P563, DOI 10.1016/S0022-2836(80)80018-0; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; MAROM S, 1994, BIOPHYS J, V67, P579, DOI 10.1016/S0006-3495(94)80517-X; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Rao CV, 2004, PLOS BIOL, V2, P239, DOI 10.1371/journal.pbio.0020049; Shibata T, 2005, P NATL ACAD SCI USA, V102, P331, DOI 10.1073/pnas.0403350102; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Tostevin F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.218101; Tu YH, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.208101; Tu YH, 2008, P NATL ACAD SCI USA, V105, P14855, DOI 10.1073/pnas.0807569105	31	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11224	10.1371/journal.pone.0011224	http://dx.doi.org/10.1371/journal.pone.0011224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613875	Green Published, gold, Green Submitted			2022-12-25	WOS:000279369900001
J	Henri, J; Rispal, D; Bayart, E; van Tilbeurgh, H; Seraphin, B; Graille, M				Henri, Julien; Rispal, Delphine; Bayart, Emilie; van Tilbeurgh, Herman; Seraphin, Bertrand; Graille, Marc			Structural and Functional Insights into Saccharomyces cerevisiae Tpa1, a Putative Prolylhydroxylase Influencing Translation Termination and Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; FISSION YEAST SREBP; MESSENGER-RNA; CRYSTAL-STRUCTURE; RELEASE-FACTORS; ACTIVATOR BINDS; GENE-EXPRESSION; LOW-OXYGEN; PROTEIN; UPSTREAM	Efficiency of translation termination relies on the specific recognition of the three stop codons by the eukaryotic translation termination factor cRF1. To date only a few proteins are known to be involved in translation termination in eukaryotes. Saccharomyces cerevisiae Tpa1, a largely conserved but uncharacterized protein, has been described to associate with a messenger ribonucleoprotein complex located at the 3' end of mRNAs that contains at least eRF1, eRF3, and Pab1. Deletion of the TPA1 gene results in a decrease of translation termination efficacy and an increase in mRNAs half-lives and longer mRNA poly(A) tails. In parallel, Schizosaccharomyces pombe Ofd1, a Tpa1 ortholog, and its partner Nro1 have been implicated in the regulation of the stability of a transcription factor that regulates genes essential for the cell response to hypoxia. To gain insight into Tpa1/Ofd1 function, we have solved the crystal structure of S. cerevisiae Tpa1 protein. This protein is composed of two equivalent domains with the double-stranded beta-helix fold. The N-terminal domain displays a highly conserved active site with strong similarities with prolyl-4-hydroxylases. Further functional studies show that the integrity of Tpa1 active site as well as the presence of Yor051c/Ett1 (the S. cerevisiae Nro1 ortholog) are essential for correct translation termination. In parallel, we show that Tpa1 represses the expression of genes regulated by Hap1, a transcription factor involved in the response to levels of heme and oxygen. Altogether, our results support that Tpa1 is a putative enzyme acting as an oxygen sensor and influencing several distinct regulatory pathways.	[Rispal, Delphine; Seraphin, Bertrand] IGBMC, F-67404 Illkirch Graffenstaden, France; [Henri, Julien; van Tilbeurgh, Herman; Graille, Marc] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire, UMR8619, F-91405 Orsay, France; [Rispal, Delphine; Bayart, Emilie; Seraphin, Bertrand] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Seraphin, B (corresponding author), IGBMC, 1 Rue Laurent Fries,BP 10142, F-67404 Illkirch Graffenstaden, France.	seraphin@igbmc.fr; marc.graille@u-psud.fr	Bayart, Emilie/AAV-6534-2020; Henri, Julien/AAB-3427-2020; GRAILLE, Marc/D-3242-2014; Henri, Julien B/E-3340-2017	Henri, Julien/0000-0003-0772-8881; GRAILLE, Marc/0000-0002-7853-5852; Henri, Julien B/0000-0003-0772-8881; BAYART, Emilie/0000-0001-5865-5542; Seraphin, Bertrand/0000-0002-5168-1921	La Ligue contre le Cancer; CNRS; Agence Nationale pour la Recherche [ANR-06-BLAN-0075-02]; European Union [LSHG-CT-2005-512028]	La Ligue contre le Cancer(Ligue nationale contre le cancer); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Union(European Commission)	This work was supported by La Ligue contre le Cancer "Equipe Labelisee 2008"and the CNRS. This work was also supported by the CNRS and Agence Nationale pour la Recherche Grant ANR-06-BLAN-0075-02 (to M. G.).; Supported by the European Union 6th Framework programs "3D-Repertoire" (LSHG-CT-2005-512028).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Alkalaeva EZ, 2006, CELL, V125, P1125, DOI 10.1016/j.cell.2006.04.035; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; ARAVIND L, 2001, GENOME BIOL, V2; BONETTI B, 1995, J MOL BIOL, V251, P334, DOI 10.1006/jmbi.1995.0438; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cassab GI, 1998, ANNU REV PLANT PHYS, V49, P281, DOI 10.1146/annurev.arplant.49.1.281; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cleasby A, 1996, NAT STRUCT BIOL, V3, P470, DOI 10.1038/nsb0596-470; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Cosson B, 2002, MOL CELL BIOL, V22, P3301, DOI 10.1128/MCB.22.10.3301-3315.2002; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davies BSJ, 2006, GENETICS, V174, P191, DOI 10.1534/genetics.106.059964; Diez J, 2000, P NATL ACAD SCI USA, V97, P3913, DOI 10.1073/pnas.080072997; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Frolova L, 1996, RNA, V2, P334; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Graille M, 2005, MOL CELL, V20, P917, DOI 10.1016/j.molcel.2005.10.025; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Heurgue-Hamard V, 2002, EMBO J, V21, P769, DOI 10.1093/emboj/21.4.769; Heurgue-Hamard V, 2006, J BIOL CHEM, V281, P36140, DOI 10.1074/jbc.M608571200; Hon T, 2003, J BIOL CHEM, V278, P50771, DOI 10.1074/jbc.M303677200; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hughes AL, 2007, J BIOL CHEM, V282, P24388, DOI 10.1074/jbc.M701326200; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Jiang YD, 2002, EUKARYOT CELL, V1, P481, DOI 10.1128/EC.1.3.481-490.2002; Jiang YD, 2001, MOL CELL BIOL, V21, P6161, DOI 10.1128/MCB.21.18.6161-6169.2001; Just VJ, 2004, J BIOL CHEM, V279, P19867, DOI 10.1074/jbc.M313820200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Keeling KM, 2006, MOL CELL BIOL, V26, P5237, DOI 10.1128/MCB.02448-05; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; Koski MK, 2009, J BIOL CHEM, V284, P25290, DOI 10.1074/jbc.M109.014050; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kushner DB, 2003, P NATL ACAD SCI USA, V100, P15764, DOI 10.1073/pnas.2536857100; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lee CYS, 2009, EMBO J, V28, P135, DOI 10.1038/emboj.2008.271; LODI T, 1991, MOL CELL BIOL, V11, P3762, DOI 10.1128/MCB.11.7.3762; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Mora L, 2007, J BIOL CHEM, V282, P35638, DOI 10.1074/jbc.M706076200; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Noueiry AO, 2003, MOL CELL BIOL, V23, P4094, DOI 10.1128/MCB.23.12.4094-4106.2003; Pang H, 2004, J BIOL CHEM, V279, P1491, DOI 10.1074/jbc.M310022200; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; PFEIFER K, 1987, CELL, V49, P9, DOI 10.1016/0092-8674(87)90750-1; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; PFEIFER K, 1987, CELL, V49, P19, DOI 10.1016/0092-8674(87)90751-3; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Ramil E, 2000, MOL MICROBIOL, V37, P1116, DOI 10.1046/j.1365-2958.2000.02065.x; Scheller N, 2009, P NATL ACAD SCI USA, V106, P13517, DOI 10.1073/pnas.0906413106; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Steiner RA, 2002, P NATL ACAD SCI USA, V99, P16625, DOI 10.1073/pnas.262506299; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valachovic M, 2006, GENETICS, V173, P1893, DOI 10.1534/genetics.105.053025; von der Haar T, 2007, TRENDS MICROBIOL, V15, P78, DOI 10.1016/j.tim.2006.12.002; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	72	28	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30767	30778		10.1074/jbc.M110.106864	http://dx.doi.org/10.1074/jbc.M110.106864			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20630870	Green Published, hybrid			2022-12-25	WOS:000282135500045
J	Dodd, D; Moon, YH; Swaminathan, K; Mackie, RI; Cann, IKO				Dodd, Dylan; Moon, Young-Hwan; Swaminathan, Kankshita; Mackie, Roderick I.; Cann, Isaac K. O.			Transcriptomic Analyses of Xylan Degradation by Prevotella bryantii and Insights into Energy Acquisition by Xylanolytic Bacteroidetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GUT SYMBIONT; BETA-D-XYLOSIDASE; ALKALINE CELLULASE; GENE-CLUSTER; SP NOV.; BACTERIA; PROTEIN; FERMENTATION; SEQUENCE; CATABOLISM	Enzymatic depolymerization of lignocellulose by microbes in the bovine rumen and the human colon is critical to gut health and function within the host. Prevotella bryantii B(1)4 is a rumen bacterium that efficiently degrades soluble xylan. To identify the genes harnessed by this bacterium to degrade xylan, the transcriptomes of P. bryantii cultured on either wheat arabinoxylan or a mixture of its monosaccharide components were compared by DNA microarray and RNA sequencing approaches. The most highly induced genes formed a cluster that contained putative outer membrane proteins analogous to the starch utilization system identified in the prominent human gut symbiont Bacteroides thetaiotaomicron. The arrangement of genes in the cluster was highly conserved in other xylanolytic Bacteroidetes, suggesting that the mechanism employed by xylan utilizers in this phylum is conserved. A number of genes encoding proteins with unassigned function were also induced on wheat arabinoxylan. Among these proteins, a hypothetical protein with low similarity to glycoside hydrolases was shown to possess endoxylanase activity and subsequently assigned to glycoside hydrolase family 5. The enzyme was designated PbXyn5A. Two of the most similar proteins to PbXyn5A were hypothetical proteins from human colonic Bacteroides spp., and when expressed each protein exhibited endoxylanase activity. By using site-directed mutagenesis, we identified two amino acid residues that likely serve as the catalytic acid/base and nucleophile as in other GH5 proteins. This study therefore provides insights into capture of energy by xylanolytic Bacteroidetes and the application of their enzymes as a resource in the biofuel industry.	[Dodd, Dylan; Cann, Isaac K. O.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Dodd, Dylan; Moon, Young-Hwan; Swaminathan, Kankshita; Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA; [Dodd, Dylan; Moon, Young-Hwan; Swaminathan, Kankshita; Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Swaminathan, Kankshita] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cann, IKO (corresponding author), Univ Illinois, Inst Genom Biol 1105, 1206 W Gregory Dr, Urbana, IL 61801 USA.	icann@illinois.edu		Dodd, Dylan/0000-0001-6210-6239	Energy Biosciences Institute; NIDDK, National Institutes of Health [1F30DK084726]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK084726] Funding Source: NIH RePORTER	Energy Biosciences Institute; NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Energy Biosciences Institute. D.D. was partially supported by National Institutes of Health Fellowship 1F30DK084726 from NIDDK.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Bakir MA, 2006, INT J SYST EVOL MICR, V56, P151, DOI 10.1099/ijs.0.63914-0; BRYANT MP, 1958, J BACTERIOL, V76, P15, DOI 10.1128/JB.76.1.15-23.1958; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chassard C, 2006, FEMS MICROBIOL LETT, V254, P116, DOI 10.1111/j.1574-6968.2005.00016.x; Chassard C, 2008, INT J SYST EVOL MICR, V58, P1008, DOI 10.1099/ijs.0.65504-0; Chassard C, 2007, FEMS MICROBIOL ECOL, V61, P121, DOI 10.1111/j.1574-6941.2007.00314.x; DEHORITY BA, 1967, APPL MICROBIOL, V15, P987, DOI 10.1128/AEM.15.5.987-993.1967; DEHORITY BA, 1966, J BACTERIOL, V91, P1724, DOI 10.1128/JB.91.5.1724-1729.1966; Della JN, 1996, J BACTERIOL, V178, P7180; Dodd D, 2010, J BACTERIOL, V192, P2335, DOI 10.1128/JB.01654-09; Dodd D, 2009, GCB BIOENERGY, V1, P2, DOI 10.1111/j.1757-1707.2009.01004.x; Dodd D, 2009, J BACTERIOL, V191, P3328, DOI 10.1128/JB.01628-08; Edwards JE, 2004, ANTON LEEUW INT J G, V86, P263, DOI 10.1023/B:ANTO.0000047942.69033.24; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Flint HJ, 1997, BBA-PROTEIN STRUCT M, V1337, P161, DOI 10.1016/S0167-4838(96)00213-0; GASPARIC A, 1995, APPL ENVIRON MICROB, V61, P2958, DOI 10.1128/AEM.61.8.2958-2964.1995; GASPARIC A, 1995, FEMS MICROBIOL LETT, V125, P135; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HESPELL RB, 1987, APPL ENVIRON MICROB, V53, P2849, DOI 10.1128/AEM.53.12.2849-2853.1987; Kelly G, 1999, NAT STRUCT BIOL, V6, P313; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mirande C, 2010, J APPL MICROBIOL, V109, P451, DOI 10.1111/j.1365-2672.2010.04671.x; Miyazaki K, 2005, MICROBIOL-SGM, V151, P4121, DOI 10.1099/mic.0.28270-0; Miyazaki K, 2003, J BACTERIOL, V185, P2219, DOI 10.1128/JB.185.7.2219-2226.2003; Miyazaki K, 1997, ANAEROBE, V3, P373, DOI 10.1006/anae.1997.0125; Morrison M, 2010, MICROB ECOL, V59, P212, DOI 10.1007/s00248-009-9562-4; OZAKI K, 1990, J GEN MICROBIOL, V136, P1327, DOI 10.1099/00221287-136-7-1327; SALYERS AA, 1982, J FOOD BIOCHEM, V6, P39, DOI 10.1111/j.1745-4514.1982.tb00295.x; SALYERS AA, 1981, APPL ENVIRON MICROB, V41, P1065, DOI 10.1128/AEM.41.4.1065-1068.1981; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Shirai T, 2001, J MOL BIOL, V310, P1079, DOI 10.1006/jmbi.2001.4835; Sonnenburg ED, 2006, P NATL ACAD SCI USA, V103, P8834, DOI 10.1073/pnas.0603249103; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WEAVER J, 1992, APPL ENVIRON MICROB, V58, P2764, DOI 10.1128/AEM.58.9.2764-2770.1992	43	81	90	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30261	30273		10.1074/jbc.M110.141788	http://dx.doi.org/10.1074/jbc.M110.141788			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20622018	hybrid, Green Published			2022-12-25	WOS:000281984300062
J	Sugiura, M; Iwai, E; Hayashi, H; Boussac, A				Sugiura, Miwa; Iwai, Eri; Hayashi, Hidenori; Boussac, Alain			Differences in the Interactions between the Subunits of Photosystem II Dependent on D1 Protein Variants in the Thermophilic Cyanobacterium Thermosynechococcus elongatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ELECTRON-ACCEPTOR; CYTOCHROME B(559); GENE-EXPRESSION; COMPLEX; REDOX; LIGHT; PSBA; D1-PROTEIN; RESOLUTION	The main cofactors involved in the oxygen evolution activity of Photosystem II (PSII) are located in two proteins, D1 (PsbA) and D2 (PsbD). In Thermosynechococcus elongatus, a thermophilic cyanobacterium, the D1 protein is encoded by either the psbA(1) or the psbA(3) gene, the expression of which is dependent on environmental conditions. It has been shown that the energetic properties of the PsbA1-PSII and those of the PsbA3-PSII differ significantly (Sugiura, M., Kato, Y., Takahashi, R., Suzuki, H., Watanabe, T., Noguchi, T., Rappaport, F., and Boussac, A. (2010) Biochim. Biophys. Acta 1797, 1491-1499). In this work the structural stability of PSII upon a PsbA1/PsbA3 exchange was investigated. Two deletion mutants lacking another PSII subunit, PsbJ, were constructed in strains expressing either PsbA1 or PsbA3. The PsbJ subunit is a 4-kDa transmembrane polypeptide that is surrounded by D1 (i.e. PsbA1), PsbK, and cytochrome b(559) (Cyt b(559)) in existing three-dimensional models. It is shown that the structural properties of the PsbA3/Delta PsbJ-PSII are not significantly affected. The polypeptide contents, the Cyt b(559) properties, and the proportion of PSII dimer were similar to those found for PsbA3-PSII. In contrast, in PsbA1/Delta PsbJ-PSII the stability of the dimer is greatly diminished, the EPR properties of the Cyt b(559) likely indicates a decrease in its redox potential, and many other PSII subunits are lacking. These results shows that the 21-amino acid substitutions between PsbA1 and PsbA3, which appear to be mainly conservative, must include side chains that are involved in a network of interactions between PsbA and the other PSII subunits.	[Sugiura, Miwa; Hayashi, Hidenori] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 7908577, Japan; [Sugiura, Miwa; Hayashi, Hidenori] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan; [Sugiura, Miwa; Iwai, Eri; Hayashi, Hidenori] Ehime Univ, Dept Chem, Matsuyama, Ehime 7908577, Japan; [Boussac, Alain] CEA Saclay, CNRS, URA 2096, IBiTec S, F-91191 Gif Sur Yvette, France	Ehime University; Ehime University; Ehime University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Sugiura, M (corresponding author), Ehime Univ, Cell Free Sci & Technol Res Ctr, Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	miwa.sugiura@ehime-u.ac.jp			Ministry of Education, Science, Sports, Culture, and Technology [21612007]; Japan Society for the Promotion of Science; CNRS; European Union [212508]	Ministry of Education, Science, Sports, Culture, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CNRS(Centre National de la Recherche Scientifique (CNRS)); European Union(European Commission)	This study was supported by Grant-in-aid for scientific research 21612007 from the Ministry of Education, Science, Sports, Culture, and Technology (to M. S.) and the Japan Society for the Promotion of Science and CNRS under the Japan-France Research Cooperative Program. This work was also supported in part by the European Union/Energy Network project SOLAR-H2 (FP7 contract 212508).	Ala PJ, 1997, BIOCHEMISTRY-US, V36, P1573, DOI 10.1021/bi962234u; Baena-Gonzalez E, 2002, PHILOS T R SOC B, V357, P1451, DOI 10.1098/rstb.2002.1141; Bentley FK, 2008, BIOCHEMISTRY-US, V47, P11637, DOI 10.1021/bi800804h; BERTHOMIEU C, 1992, BIOCHEMISTRY-US, V31, P11460, DOI 10.1021/bi00161a026; Edelman M, 2008, PHOTOSYNTH RES, V98, P609, DOI 10.1007/s11120-008-9342-x; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; GOLDEN JW, 1988, SCIENCE, V242, P1421, DOI 10.1126/science.3144039; GOLDEN SS, 1995, J BACTERIOL, V177, P1651, DOI 10.1128/jb.177.7.1651-1654.1995; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Horton P, 2008, FEBS J, V275, P1069, DOI 10.1111/j.1742-4658.2008.06263.x; Huesgen PF, 2009, RES MICROBIOL, V160, P726, DOI 10.1016/j.resmic.2009.08.005; Hughes JL, 2010, BBA-BIOENERGETICS, V1797, P11, DOI 10.1016/j.bbabio.2009.07.007; Hung CH, 2007, BBA-BIOENERGETICS, V1767, P686, DOI 10.1016/j.bbabio.2007.02.016; IKEUCHI M, 1988, PLANT CELL PHYSIOL, V29, P1233; Iwai M, 2010, PLANT CELL PHYSIOL, V51, P554, DOI 10.1093/pcp/pcq020; Johnson Victoria A, 2009, Top HIV Med, V17, P138; Kaminskaya O, 1999, BIOCHEMISTRY-US, V38, P16223, DOI 10.1021/bi991257g; Kaminskaya O, 2007, BIOCHEMISTRY-US, V46, P1091, DOI 10.1021/bi0613022; Kato Y, 2009, P NATL ACAD SCI USA, V106, P17365, DOI 10.1073/pnas.0905388106; Kato Y, 2009, J BIOCHEM, V146, P463, DOI 10.1093/jb/mvp073; Kawakami K, 2009, P NATL ACAD SCI USA, V106, P8567, DOI 10.1073/pnas.0812797106; Kerfeld CA, 1998, ANNU REV PLANT PHYS, V49, P397, DOI 10.1146/annurev.arplant.49.1.397; Kos PB, 2008, BBA-BIOENERGETICS, V1777, P74, DOI 10.1016/j.bbabio.2007.10.015; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Loll B, 2008, BIOL CHEM, V389, P609, DOI 10.1515/BC.2008.058; Mohanty P, 2007, PHOTOSYNTH RES, V94, P217, DOI 10.1007/s11120-007-9184-y; Mulo P, 2008, PHOTOSYNTH RES, V98, P489, DOI 10.1007/s11120-008-9320-3; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Murray JW, 2008, ENERG ENVIRON SCI, V1, P161, DOI 10.1039/b810067p; Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123; Regel RE, 2001, J BIOL CHEM, V276, P41473, DOI 10.1074/jbc.M102007200; Roncel M, 2003, J BIOL INORG CHEM, V8, P206, DOI 10.1007/s00775-002-0406-7; SHEN JR, 1993, J BIOL CHEM, V268, P20408; Shen JR, 2000, BIOCHEMISTRY-US, V39, P14739, DOI 10.1021/bi001402m; Shibuya Y, 2010, BIOCHEMISTRY-US, V49, P493, DOI 10.1021/bi9018829; Sicora CI, 2006, BBA-BIOENERGETICS, V1757, P47, DOI 10.1016/j.bbabio.2005.11.002; Sicora CI, 2008, BBA-BIOENERGETICS, V1777, P130, DOI 10.1016/j.bbabio.2007.09.001; Sicora CI, 2009, BBA-BIOENERGETICS, V1787, P105, DOI 10.1016/j.bbabio.2008.12.002; Stewart DH, 1998, BBA-BIOENERGETICS, V1367, P63, DOI 10.1016/S0005-2728(98)00139-X; Sugiura M, 1999, PLANT CELL PHYSIOL, V40, P1219, DOI 10.1093/oxfordjournals.pcp.a029510; Sugiura M, 2004, BIOCHEMISTRY-US, V43, P13549, DOI 10.1021/bi048732h; Sugiura M, 2008, BBA-BIOENERGETICS, V1777, P331, DOI 10.1016/j.bbabio.2008.01.007; Sugiura M, 2010, BBA-BIOENERGETICS, V1797, P1546, DOI 10.1016/j.bbabio.2010.03.020; Sugiura M, 2010, BBA-BIOENERGETICS, V1797, P1491, DOI 10.1016/j.bbabio.2010.03.022; Sugiura M, 2009, BIOCHEMISTRY-US, V48, P7856, DOI 10.1021/bi901067b; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Takahashi T, 2009, J BIOL CHEM, V284, P15598, DOI 10.1074/jbc.M109.000372; Tichy M, 2003, BBA-BIOENERGETICS, V1605, P55, DOI 10.1016/S0005-2728(03)00064-1; Un S, 2007, BIOCHEMISTRY-US, V46, P3138, DOI 10.1021/bi062084f; Vass I, 2007, ANN NY ACAD SCI, V1113, P114, DOI 10.1196/annals.1391.017	54	19	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30008	30018		10.1074/jbc.M110.136945	http://dx.doi.org/10.1074/jbc.M110.136945			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20630865	Green Published, hybrid			2022-12-25	WOS:000281984300038
J	Gingras, AR; Bate, N; Goult, BT; Patel, B; Kopp, PM; Emsley, J; Barsukov, IL; Roberts, GCK; Critchley, DR				Gingras, Alexandre R.; Bate, Neil; Goult, Benjamin T.; Patel, Bipin; Kopp, Petra M.; Emsley, Jonas; Barsukov, Igor L.; Roberts, Gordon C. K.; Critchley, David R.			Central Region of Talin Has a Unique Fold That Binds Vinculin and Actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSKELETAL PROTEIN TALIN; INTEGRIN ACTIVATION; STRUCTURAL BASIS; MOLECULAR-GRAPHICS; ALPHA-SYNEMIN; I/LWEQ MODULE; F-ACTIN; DOMAIN; ADHESION; ROD	Talin is an adaptor protein that couples integrins to F-actin. Structural studies show that the N-terminal talin head contains an atypical FERM domain, whereas the N- and C-terminal parts of the talin rod include a series of alpha-helical bundles. However, determining the structure of the central part of the rod has proved problematic. Residues 1359-1659 are homologous to the MESDc1 gene product, and we therefore expressed this region of talin in Escherichia coli. The crystal structure shows a unique fold comprised of a 5- and 4-helix bundle. The 5-helix bundle is composed of nonsequential helices due to insertion of the 4-helix bundle into the loop at the C terminus of helix alpha 3. The linker connecting the bundles forms a two-stranded anti-parallel beta-sheet likely limiting the relative movement of the two bundles. Because the 5-helix bundle contains the N and C termini of this module, we propose that it is linked by short loops to adjacent bundles, whereas the 4-helix bundle protrudes from the rod. This suggests the 4-helix bundle has a unique role, and its pI (7.8) is higher than other rod domains. Both helical bundles contain vinculin-binding sites but that in the isolated 5-helix bundle is cryptic, whereas that in the isolated 4-helix bundle is constitutively active. In contrast, both bundles are required for actin binding. Finally, we show that the MESDc1 protein, which is predicted to have a similar fold, is a novel actin-binding protein.	[Roberts, Gordon C. K.; Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Emsley, Jonas] Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Nottingham NG7 2RD, England; [Barsukov, Igor L.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England	University of Leicester; University of Nottingham; University of Liverpool	Critchley, DR (corresponding author), Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 9HN, Leics, England.	drc@le.ac.uk	Goult, Benjamin T/B-3127-2009; Gingras, Alexandre R/E-1867-2011; emsley, jonas/A-8509-2016	Goult, Benjamin T/0000-0002-3438-2807; Gingras, Alexandre R/0000-0002-5373-0176; emsley, jonas/0000-0002-8949-8030; Roberts, Gordon/0000-0001-6200-1373	National Institutes of Health, NIGMS Cell Migration Consortium [U54GM64346]; Wellcome Trust; Cancer Research United Kingdom; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/G003637/1] Funding Source: researchfish; BBSRC [BB/G003637/1] Funding Source: UKRI	National Institutes of Health, NIGMS Cell Migration Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research United Kingdom(Cancer Research UK); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant U54GM64346 from NIGMS Cell Migration Consortium. This work was also supported by the Wellcome Trust, Cancer Research United Kingdom.	ALBIGESRIZO C, 1995, J CELL SCI, V108, P3317; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Brett TJ, 2006, NAT STRUCT MOL BIOL, V13, P121, DOI 10.1038/nsmb1043; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Conti FJ, 2008, DEVELOPMENT, V135, P2043, DOI 10.1242/dev.015818; Conti FJ, 2009, DEVELOPMENT, V136, P3597, DOI 10.1242/dev.035857; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; DEL RIO A, 2009, SCIENCE, V323, P638; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar N, 2006, CURRENT PROTOCOLS S, P561; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2009, J BIOL CHEM, V284, P8857, DOI 10.1074/jbc.M805937200; Gingras AR, 2006, BIOCHEMISTRY-US, V45, P1805, DOI 10.1021/bi052136l; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Goult BT, 2010, FEBS LETT, V584, P2237, DOI 10.1016/j.febslet.2010.04.028; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Goult BT, 2009, J MOL BIOL, V394, P944, DOI 10.1016/j.jmb.2009.09.061; Goult BT, 2009, J BIOL CHEM, V284, P15097, DOI 10.1074/jbc.M900078200; HAGMANN J, 1992, J BIOL CHEM, V267, P14424; Hemmings L, 1996, J CELL SCI, V109, P2715; Himmel M, 2009, J BIOL CHEM, V284, P13832, DOI 10.1074/jbc.M900266200; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kopp PM, 2010, EUR J CELL BIOL, V89, P661, DOI 10.1016/j.ejcb.2010.05.003; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Lee HS, 2004, J MOL BIOL, V343, P771, DOI 10.1016/j.jmb.2004.08.069; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Moes M, 2007, J BIOL CHEM, V282, P17280, DOI 10.1074/jbc.M611846200; MOLONY L, 1987, J BIOL CHEM, V262, P7790; Monkley SJ, 2000, DEV DYNAM, V219, P560, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2-Y; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Patel B, 2006, J BIOL CHEM, V281, P7458, DOI 10.1074/jbc.M508058200; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; Ratnikov B, 2005, J CELL SCI, V118, P4921, DOI 10.1242/jcs.02682; Roberts Gordon C. K., 2009, Biophysical Reviews, V1, P61, DOI 10.1007/s12551-009-0009-4; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Schmidt JM, 1999, ARCH BIOCHEM BIOPHYS, V366, P139, DOI 10.1006/abbi.1999.1204; Senetar MA, 2004, BIOCHEMISTRY-US, V43, P15418, DOI 10.1021/bi0487239; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smith SJ, 2007, BIOCHEMISTRY-US, V46, P10886, DOI 10.1021/bi700637a; Sun N, 2008, EXP CELL RES, V314, P1839, DOI 10.1016/j.yexcr.2008.01.034; Sun N, 2008, BIOCHEM J, V409, P657, DOI 10.1042/BJ20071188; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; VALE RD, 1985, J NEUROSCI, V5, P2762; Wang YF, 2008, J CLIN INVEST, V118, P812, DOI 10.1172/JCI34239; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wines ME, 2001, GENOMICS, V72, P88, DOI 10.1006/geno.2000.6466; Winkler J, 1997, EUR J BIOCHEM, V243, P430, DOI 10.1111/j.1432-1033.1997.0430a.x; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	65	46	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29577	29587		10.1074/jbc.M109.095455	http://dx.doi.org/10.1074/jbc.M109.095455			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20610383	hybrid, Green Published			2022-12-25	WOS:000281740100059
J	Golczak, M; Palczewski, K				Golczak, Marcin; Palczewski, Krzysztof			An Acyl-covalent Enzyme Intermediate of Lecithin: Retinol Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; PURIFICATION; ACCUMULATION; MECHANISM; ESTERS; CELLS; LIVER; CYCLE	Synthesis of fatty acid retinyl esters determines systemic vitamin A levels and provides substrate for production of visual chromophore (11-cis-retinal) in vertebrates. Lecithin: retinol acyltransferase (LRAT), the main enzyme responsible for retinyl ester formation, catalyzes the transfer of an acyl group from the sn-1 position of phosphatidylcholine to retinol. To delineate the catalytic mechanism of this reaction, we expressed and purified a fully active, soluble form of this enzyme and used it to examine the possible formation of a transient acyl-enzyme intermediate. Detailed mass spectrometry analyses revealed that LRAT undergoes spontaneous, covalent modification upon incubation with a variety of phosphatidylcholine substrates. The addition of an acyl chain occurs at the Cys(161) residue, indicating formation of a thioester intermediate. This observation provides the first direct experimental evidence of thioester intermediate formation that constitutes the initial step in the proposed LRAT catalytic reaction. Additionally, we examined the effect of increasing fatty acyl side chain length in phosphatidylcholine on substrate accessibility in this reaction, which provided insights into the function of the single membrane-spanning domain of LRAT. These observations are critical to understanding the catalytic mechanism of LRAT protein family members as well as other lecithin: acyltransferases wherein Cys residues are required for catalysis.	[Golczak, Marcin; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Case Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University	Golczak, M (corresponding author), Aldelbert Rd, Cleveland, OH 44106 USA.	mxg149@case.edu			National Institutes of Health [EY009339, P30 EY11373]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R01EY009339, P30EY011373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY009339 and Core Grant P30 EY11373. This work was also supported by the Foundation Fighting Blindness.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Batten ML, 2005, PLOS MED, V2, P1177, DOI 10.1371/journal.pmed.0020333; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Bok D, 2003, BIOCHEMISTRY-US, V42, P6090, DOI 10.1021/bi0342416; BURGER A, 1993, FEBS LETT, V329, P25, DOI 10.1016/0014-5793(93)80185-W; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Han BG, 2010, PROTEIN EXPRES PURIF, V71, P103, DOI 10.1016/j.pep.2010.01.018; Hoffman MD, 2006, J MASS SPECTROM, V41, P229, DOI 10.1002/jms.981; Isken A, 2007, J BIOL CHEM, V282, P1144, DOI 10.1074/jbc.M609109200; Jahng WJ, 2003, BIOCHEMISTRY-US, V42, P12805, DOI 10.1021/bi035370p; MACDONALD PN, 1988, BIOCHEM BIOPH RES CO, V156, P157, DOI 10.1016/S0006-291X(88)80818-0; MACDONALD PN, 1988, J BIOL CHEM, V263, P12478; Moise AR, 2007, J BIOL CHEM, V282, P2081, DOI 10.1074/jbc.M608315200; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PEREZGIL J, 1990, BIOCHEM J, V270, P761, DOI 10.1042/bj2700761; SAARI JC, 1989, J BIOL CHEM, V264, P8636; SHI YQ, 1993, BIOCHEMISTRY-US, V32, P1257, DOI 10.1021/bi00056a009; SHINGLETON JL, 1989, BIOCHEMISTRY-US, V28, P9641, DOI 10.1021/bi00451a015; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Uyama T, 2009, J LIPID RES, V50, P685, DOI 10.1194/jlr.M800453-JLR200; VON LINTIG J, 2010, TRENDS BIOCHEM SCI, V35, P400	24	23	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29217	29222		10.1074/jbc.M110.152314	http://dx.doi.org/10.1074/jbc.M110.152314			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20628054	Green Published, hybrid			2022-12-25	WOS:000281740100022
J	Ragan, EJ; An, CJ; Yang, CT; Kanost, MR				Ragan, Emily J.; An, Chunju; Yang, Celeste T.; Kanost, Michael R.			Analysis of Mutually Exclusive Alternatively Spliced Serpin-1 Isoforms and Identification of Serpin-1 Proteinase Complexes in Manduca sexta Hemolymph	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPHENOLOXIDASE-ACTIVATING PROTEINASE-3; COMPARATIVE GENOMIC ANALYSIS; INNATE IMMUNE-RESPONSE; REACTIVE CENTER LOOP; ALPHA(1)-PROTEINASE INHIBITOR; FUNCTIONAL DIVERSIFICATION; TOLL ACTIVATION; DROSOPHILA; EXPRESSION; EVOLUTION	Mutually exclusive alternative splicing produces transcripts for 12 serpin-1 isoforms in Manduca sexta that differ only in the region encoding the carboxyl-terminal 36-40-amino acid residues. This variable region includes the reactive center loop, which determines the inhibitory selectivity of the serpin. We investigated mRNA levels of individual serpin-1 isoforms by quantitative PCR. The 12 isoforms were expressed at similar levels in hemocytes, but in fat body isoform B mRNA was present at significantly higher levels than isoforms C, D, E, F, G, J, K, and Z. To investigate the presence of individual serpin-1 isoforms in plasma we used immunoaffinity purification of serpin-1 isoforms from M. sexta plasma, followed by two-dimensional PAGE and identification of protein spots by digestion with a series of proteinases and analysis of the resulting peptides by MALDI-TOF/TOF. We identified nine of the 12 serpin-1 isoforms and, through analysis of putative serpin-1-proteinase complexes, identified three endogenous M. sexta proteinase targets of serpin-1. Our results suggest that M. sexta serpin-1 isoforms A, E, and J can inhibit hemolymph proteinase 8, which activates the cytokine spatzle. At least one isoform of serpin-1 can inhibit hemocyte proteinase 1, another M. sexta blood proteinase. In addition, a complex of serpin-1K in a complex with M. sexta midgut chymotrypsin was identified, suggesting serpin-1 isoforms may also function to protect insect tissues from digestive proteinases that may leak into the hemocoel.	[Ragan, Emily J.; An, Chunju; Yang, Celeste T.; Kanost, Michael R.] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	Kansas State University	Kanost, MR (corresponding author), 141Chalmers Hall, Manhattan, KS 66506 USA.	kanost@ksu.edu		Kanost, Michael/0000-0002-6827-0061	National Institutes of Health [GM41247]; National Institutes of Health, National Center for Research Resources [P20 RR-016464]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL079888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041247, R29GM041247, R01GM041247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM41247. This is contribution 10-259-J from the Kansas Agricultural Experiment Station.; We thank Rebekah Woolsey from the Nevada Proteomics Center for sample digestion and mass spectrometry. The Nevada Proteomics Center is supported by National Institutes of Health Grant P20 RR-016464 from the INBRE Program of the National Center for Research Resources. We also thank Dr. Maureen Gorman for providing serpin-1I used for antiserum production, Dr. Haobo Jiang for antiserum to HP6, HP8, and prophenoloxidase-activating proteinase-3, Yang Wang for help characterizing isoform-specific antisera, and Dr. Rollie Clem for the use of the BioRad IEF unit.	An CJ, 2010, FEBS J, V277, P148, DOI 10.1111/j.1742-4658.2009.07465.x; An CJ, 2009, J BIOL CHEM, V284, P19716, DOI 10.1074/jbc.M109.007112; Barbour KW, 2002, MOL BIOL EVOL, V19, P718, DOI 10.1093/oxfordjournals.molbev.a004130; Borner S, 2008, GENE, V415, P23, DOI 10.1016/j.gene.2008.02.004; Brandt KS, 2004, ARCH INSECT BIOCHEM, V55, P200, DOI 10.1002/arch.10139; Danielli A, 2003, J BIOL CHEM, V278, P4184, DOI 10.1074/jbc.M208187200; DE GREGORIO E, 2002, DEV CELL, V3, P581; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; DUNN PE, 1983, J INVERTEBR PATHOL, V41, P77, DOI 10.1016/0022-2011(83)90238-0; Forsyth S, 2003, GENOMICS, V81, P336, DOI 10.1016/S0888-7543(02)00041-1; Furusawa T, 2008, J PROTEOME RES, V7, P938, DOI 10.1021/pr070405j; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Harlow E., 1988, ANTIBODIES LAB MANUA; Hashimoto C, 2003, DEV CELL, V5, P945, DOI 10.1016/S1534-5807(03)00338-1; Hegedus DD, 2008, GENE, V418, P15, DOI 10.1016/j.gene.2008.03.015; HILL RE, 1987, NATURE, V326, P96, DOI 10.1038/326096a0; Hodges D, 1999, GENETICS, V151, P263; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jiang H, 1995, INSECT BIOCHEM MOLEC, V25, P1093, DOI 10.1016/0965-1748(95)00042-9; Jiang HB, 2008, INSECT SCI, V15, P53, DOI 10.1111/j.1744-7917.2008.00187.x; JIANG HB, 1994, J BIOL CHEM, V269, P55; Jiang HB, 2005, INSECT BIOCHEM MOLEC, V35, P931, DOI 10.1016/j.ibmb.2005.03.009; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Jiang HB, 1996, J BIOL CHEM, V271, P28017, DOI 10.1074/jbc.271.45.28017; Jiang HB, 1997, J BIOL CHEM, V272, P1082, DOI 10.1074/jbc.272.2.1082; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; John JPP, 2007, J PROTEOME RES, V6, P2695, DOI 10.1021/pr070157r; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost M.R., 1990, P139; KANOST MR, 1995, INSECT BIOCHEM MOLEC, V25, P285, DOI 10.1016/0965-1748(94)00067-R; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Kruger O, 2002, GENE, V293, P97, DOI 10.1016/S0378-1119(02)00697-2; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Li JP, 1999, STRUCTURE, V7, P103, DOI 10.1016/S0969-2126(99)80013-6; Ligoxygakis P, 2003, CURR BIOL, V13, P2097, DOI 10.1016/j.cub.2003.10.062; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Michel K, 2006, P NATL ACAD SCI USA, V103, P16858, DOI 10.1073/pnas.0608033103; Myung JK, 2008, AMINO ACIDS, V35, P485, DOI 10.1007/s00726-007-0551-y; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Odronitz F, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-21; PETERSON AM, 1995, INSECT BIOCHEM MOLEC, V25, P765, DOI 10.1016/0965-1748(94)00092-V; Ragan EJ, 2008, THESIS KANSAS STATE; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; SASAKI T, 1991, EUR J BIOCHEM, V202, P255, DOI 10.1111/j.1432-1033.1991.tb16370.x; Scherfer C, 2008, DEV BIOL, V323, P189, DOI 10.1016/j.ydbio.2008.08.030; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Tang H, 2008, DEV CELL, V15, P617, DOI 10.1016/j.devcel.2008.08.017; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; Wang Y, 2006, J BIOL CHEM, V281, P9271, DOI 10.1074/jbc.M513797200; Wang Y, 2006, GENOMICS, V87, P399, DOI 10.1016/j.ygeno.2005.10.003; Wang Y, 2004, INSECT BIOCHEM MOLEC, V34, P387, DOI 10.1016/j.ibmb.2003.12.005; Wang Y, 2007, INSECT BIOCHEM MOLEC, V37, P1015, DOI 10.1016/j.ibmb.2007.05.013; Whisstock JC, 2006, CURR OPIN STRUC BIOL, V16, P761, DOI 10.1016/j.sbi.2006.10.005; Zheng YP, 2009, COMP BIOCHEM PHYS B, V154, P165, DOI 10.1016/j.cbpb.2009.05.016; Zhu YF, 2003, J BIOL CHEM, V278, P46556, DOI 10.1074/jbc.M309682200; Zou Z, 2005, J BIOL CHEM, V280, P14341, DOI 10.1074/jbc.M500570200; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	60	21	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29642	29650		10.1074/jbc.M110.125419	http://dx.doi.org/10.1074/jbc.M110.125419			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20624920	Green Published, hybrid			2022-12-25	WOS:000281740100065
J	Bogani, F; Corredeira, I; Fernandez, V; Sattler, U; Rutvisuttinunt, W; Defais, M; Boehmer, PE				Bogani, Federica; Corredeira, Ilsa; Fernandez, Virneliz; Sattler, Ulrike; Rutvisuttinunt, Wiriya; Defais, Martine; Boehmer, Paul E.			Association between the Herpes Simplex Virus-1 DNA Polymerase and Uracil DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN-BINDING-PROTEIN; BASE EXCISION-REPAIR; TYPE-1 ORIGIN; PROCESSIVITY FACTOR; REPLICATION COMPARTMENTS; VIRAL REPLICATION; HELICASE-PRIMASE; STRAND EXCHANGE; NERVOUS-SYSTEM; CATALYTIC-SITE	Herpes simplex virus-1 (HSV-1) is a large dsDNA virus that encodes its own DNA replication machinery and other enzymes involved in DNA transactions. We recently reported that the HSV-1 DNA polymerase catalytic subunit (UL30) exhibits apurinic/apyrimidinic and 5'-deoxyribose phosphate lyase activities. Moreover, UL30, in conjunction with the viral uracil DNA glycosylase (UL2), cellular apurinic/apyrimidinic endonuclease, and DNA ligase III alpha-XRCC1, performs uracil-initiated base excision repair. Base excision repair is required to maintain genome stability as a means to counter the accumulation of unusual bases and to protect from the loss of DNA bases. Here we show that the HSV-1 UL2 associates with the viral replisome. We identified UL2 as a protein that co-purifies with the DNA polymerase through numerous chromatographic steps, an interaction that was verified by co-immunoprecipitation and direct binding studies. The interaction between UL2 and the DNA polymerase is mediated through the UL30 subunit. Moreover, UL2 co-localizes with UL30 to nuclear viral prereplicative sites. The functional consequence of this interaction is that replication of uracil-containing templates stalls at positions -1 and -2 relative to the template uracil because of the fact that these are converted into non-instructional abasic sites. These findings support the existence of a viral repair complex that may be capable of replication-coupled base excision repair and further highlight the role of DNA repair in the maintenance of the HSV-1 genome.	[Boehmer, Paul E.] Univ Arizona, Dept Basic Med Sci, Coll Med, Phoenix, AZ 85004 USA; [Sattler, Ulrike; Defais, Martine] CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse 4, France	University of Arizona; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Boehmer, PE (corresponding author), 425 N 5th St, Phoenix, AZ 85004 USA.	boehmer@email.arizona.edu		Boehmer, Paul/0000-0003-4479-0529	National Institutes of Health [GM62643]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62643 (to P. E. B.)	Arana ME, 2004, DNA REPAIR, V3, P659, DOI 10.1016/j.dnarep.2004.02.006; Aslani A, 2002, J BIOL CHEM, V277, P41204, DOI 10.1074/jbc.M208270200; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Boehmer PE, 2003, PROG NUCLEIC ACID RE, V75, P139, DOI 10.1016/S0079-6603(03)75005-3; Boehmer PE, 2003, IUBMB LIFE, V55, P13, DOI 10.1080/1521654031000070645; Boehmer PE, 1996, METHOD ENZYMOL, V275, P16; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Bogani F, 2008, P NATL ACAD SCI USA, V105, P11709, DOI 10.1073/pnas.0806375105; Bogani F, 2009, J BIOL CHEM, V284, P16784, DOI 10.1074/jbc.M109.010413; BRUCKNER RC, 1991, J BIOL CHEM, V266, P2669; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Burkham J, 1998, J VIROL, V72, P10100, DOI 10.1128/JVI.72.12.10100-10107.1998; Courcelle CT, 2001, J VIROL, V75, P7592, DOI 10.1128/JVI.75.16.7592-7601.2001; CRUTE JJ, 1989, J BIOL CHEM, V264, P19266; CRUTE JJ, 1989, P NATL ACAD SCI USA, V86, P2186, DOI 10.1073/pnas.86.7.2186; De Silva FS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-145; De Silva FS, 2003, J VIROL, V77, P159, DOI 10.1128/JVI.77.1.159-166.2003; FIERER DS, 1992, J VIROL, V66, P3986, DOI 10.1128/JVI.66.7.3986-3995.1992; FOCHER F, 1992, CHROMOSOMA, V102, pS67, DOI 10.1007/BF02451788; GALLO ML, 1988, J VIROL, V62, P2874, DOI 10.1128/JVI.62.8.2874-2883.1988; GALLO ML, 1989, J VIROL, V63, P5023, DOI 10.1128/JVI.63.12.5023-5029.1989; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOODRICH LD, 1990, J VIROL, V64, P5738, DOI 10.1128/JVI.64.12.5738-5749.1990; GOTTLIEB J, 1990, J VIROL, V64, P5976, DOI 10.1128/JVI.64.12.5976-5987.1990; Greagg MA, 1999, P NATL ACAD SCI USA, V96, P9045, DOI 10.1073/pnas.96.16.9045; He XD, 2000, J VIROL, V74, P5726, DOI 10.1128/JVI.74.12.5726-5728.2000; HEILBRONN R, 1989, J VIROL, V63, P3683, DOI 10.1128/JVI.63.9.3683-3692.1989; HERNANDEZ TR, 1990, J BIOL CHEM, V265, P11227; Ishii K, 2002, VIROLOGY, V303, P232, DOI 10.1006/viro.2002.1721; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; KNOPF KW, 1979, EUR J BIOCHEM, V98, P231, DOI 10.1111/j.1432-1033.1979.tb13181.x; Komazin-Meredith G, 2008, P NATL ACAD SCI USA, V105, P10721, DOI 10.1073/pnas.0802676105; Lehman IR, 1999, J BIOL CHEM, V274, P28059, DOI 10.1074/jbc.274.40.28059; Liptak LM, 1996, J VIROL, V70, P1759, DOI 10.1128/JVI.70.3.1759-1767.1996; Lukonis CJ, 1996, J VIROL, V70, P1751, DOI 10.1128/JVI.70.3.1751-1758.1996; Makhov AM, 2003, P NATL ACAD SCI USA, V100, P898, DOI 10.1073/pnas.0237171100; Makhov AM, 1996, EMBO J, V15, P1742, DOI 10.1002/j.1460-2075.1996.tb00520.x; MCGEOCH DJ, 1988, J VIROL, V62, P444, DOI 10.1128/JVI.62.2.444-453.1988; MULLANEY J, 1989, J GEN VIROL, V70, P449, DOI 10.1099/0022-1317-70-2-449; Muylaert I, 2010, J BIOL CHEM, V285, P13761, DOI 10.1074/jbc.M110.107920; Nimonkar AV, 2003, NUCLEIC ACIDS RES, V31, P5275, DOI 10.1093/nar/gkg740; Nimonkar AV, 2003, P NATL ACAD SCI USA, V100, P10201, DOI 10.1073/pnas.1534569100; Nimonkar AV, 2003, J BIOL CHEM, V278, P9678, DOI 10.1074/jbc.M212555200; Nimonkar AV, 2002, J BIOL CHEM, V277, P15182, DOI 10.1074/jbc.M109988200; Parlanti E, 2007, NUCLEIC ACIDS RES, V35, P1569, DOI 10.1093/nar/gkl1159; Prichard MN, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-55; Prichard MN, 1996, J VIROL, V70, P3018, DOI 10.1128/JVI.70.5.3018-3025.1996; PURIFOY DJM, 1977, NATURE, V269, P621, DOI 10.1038/269621a0; PYLES RB, 1994, J VIROL, V68, P4963, DOI 10.1128/JVI.68.8.4963-4972.1994; QUINLAN MP, 1984, CELL, V36, P857, DOI 10.1016/0092-8674(84)90035-7; QUINN JP, 1985, NUCLEIC ACIDS RES, V13, P8143, DOI 10.1093/nar/13.22.8143; Ranneberg-Nilsen T, 2008, J MOL BIOL, V381, P276, DOI 10.1016/j.jmb.2008.05.028; Reuven NB, 2004, J MOL BIOL, V342, P57, DOI 10.1016/j.jmb.2004.07.012; Sampson DA, 2000, J BIOL CHEM, V275, P2931, DOI 10.1074/jbc.275.4.2931; Severini A, 1996, J VIROL, V70, P3169, DOI 10.1128/JVI.70.5.3169-3175.1996; Stanitsa ES, 2006, J BIOL CHEM, V281, P3439, DOI 10.1074/jbc.M511239200; STRANG BL, 2010, J GEN VIROL IN PRESS; Taylor TJ, 2003, VIROLOGY, V309, P232, DOI 10.1016/S0042-6822(03)00107-7; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; VAUGHAN PJ, 1985, J VIROL, V53, P501, DOI 10.1128/JVI.53.2.501-508.1985; Villani G, 2002, NUCLEIC ACIDS RES, V30, P3323, DOI 10.1093/nar/gkf463; WILLIAMS MV, 1984, J BIOL CHEM, V259, P80; Wilson DM, 2007, NEUROSCIENCE, V145, P1187, DOI 10.1016/j.neuroscience.2006.07.011; WU CA, 1988, J VIROL, V62, P435, DOI 10.1128/JVI.62.2.435-443.1988; Zhu Y, 2008, DNA REPAIR, V7, P95, DOI 10.1016/j.dnarep.2007.08.001	65	28	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27664	27672		10.1074/jbc.M110.131235	http://dx.doi.org/10.1074/jbc.M110.131235			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20601642	Green Published, hybrid			2022-12-25	WOS:000281404100022
J	Thielen, BK; McNevin, JP; McElrath, MJ; Hunt, BVS; Klein, KC; Lingappa, JR				Thielen, Beth K.; McNevin, John P.; McElrath, M. Juliana; Hunt, Brook Vander Stoep; Klein, Kevin C.; Lingappa, Jaisri R.			Innate Immune Signaling Induces High Levels of TC-specific Deaminase Activity in Primary Monocyte-derived Cells through Expression of APOBEC3A Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BLOOD MONONUCLEAR-CELLS; VIF PROTEIN; ANTIVIRAL ACTIVITY; HIV-1 VIF; IN-VIVO; REVERSE TRANSCRIPTION; LINE-1 RETROTRANSPOSITION; INDEPENDENT INHIBITION; ANTIRETROVIRAL FACTOR	In HIV-1-infected individuals, G-to-A hypermutation is found in HIV-1 DNA isolated from peripheral blood mononuclear cells (PBMCs). These mutations are thought to result from editing by one or more host enzymes in the APOBEC3 (A3) family of cytidine deaminases, which act on CC (APOBEC3G) and TC (other A3 proteins) dinucleotide motifs in DNA (edited cytidine underlined). Although many A3 proteins display high levels of deaminase activity in model systems, only low levels of A3 deaminase activity have been found in primary cells examined to date. In contrast, here we report high levels of deaminase activity at TC motifs when whole PBMCs or isolated primary monocyte- derived cells were treated with interferon-alpha (IFN alpha) or IFN alpha-inducing toll-like receptor ligands. Induction of TC-specific deaminase activity required new transcription and translation and correlated with the appearance of two APOBEC3A (A3A) isoforms. Knockdown of A3A in monocytes with siRNA abolished TC-specific deaminase activity, confirming that A3A isoforms are responsible for all TC-specific deaminase activity observed. Both A3A isoforms appear to be enzymatically active; moreover, our mutational studies raise the possibility that the smaller isoform results from internal translational initiation. In contrast to the high levels of TC-specific activity observed in IFN alpha-treated monocytes, CC-specific activity remained low in PBMCs, suggesting that A3G deaminase activity is relatively inhibited, unlike that of A3A. Together, these findings suggest that deaminase activity of A3A isoforms in monocytes and macrophages may play an important role in host defense against viruses.	[Thielen, Beth K.; Hunt, Brook Vander Stoep; Klein, Kevin C.; Lingappa, Jaisri R.] Univ Washington, Dept Global Hlth, Seattle, WA 98102 USA; [McNevin, John P.; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [McElrath, M. Juliana; Lingappa, Jaisri R.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Lingappa, JR (corresponding author), Univ Washington, Dept Global Hlth, Box 358116,1616 Eastlake Ave E,Suite 305, Seattle, WA 98102 USA.	jais@u.washington.edu	Thielen, Beth Kristine/I-7811-2019	Thielen, Beth Kristine/0000-0001-5922-0241; mcnevin, john paul/0000-0002-9893-9256	National Institutes of Health [R01AI078781, T32 AI007140]; Poncin Scholarship Fund; University of Washington; NIGMS, National Institutes of Health [5 T32 GM07266]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078781, T32AI007140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Poncin Scholarship Fund; University of Washington(University of Washington); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI078781 (to J. R. L.).; The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1-3.; Supported by the University of Washington Medical Scientist Training Program (NIGMS, National Institutes of Health, Grant 5 T32 GM07266), an STD AIDS Research Training Fellowship (National Institutes of Health Grant T32 AI007140), the Poncin Scholarship Fund, and a University of Washington Achievement Rewards for College Scientists (ARCS) scholarship.	Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200; Anderson JL, 2008, VIROLOGY, V375, P1, DOI 10.1016/j.virol.2008.01.042; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Broliden K, 2006, J INTERN MED, V260, P285, DOI 10.1111/j.1365-2796.2006.01697.x; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; FITZGIBBON JE, 1993, AIDS RES HUM RETROV, V9, P833, DOI 10.1089/aid.1993.9.833; Goila-Gaur R, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-61; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Janini M, 2001, J VIROL, V75, P7973, DOI 10.1128/JVI.75.17.7973-7986.2001; Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005; Kijak GH, 2008, VIROLOGY, V376, P101, DOI 10.1016/j.virol.2008.03.017; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Kotani A, 2007, P NATL ACAD SCI USA, V104, P1616, DOI 10.1073/pnas.0610732104; Land AM, 2008, J VIROL, V82, P8172, DOI 10.1128/JVI.01115-08; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Loo YM, 2007, CURR TOP MICROBIOL, V316, P295; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Madsen P, 1999, J INVEST DERMATOL, V113, P162, DOI 10.1046/j.1523-1747.1999.00682.x; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nguyen DH, 2007, J VIROL, V81, P4465, DOI 10.1128/JVI.02510-06; OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Pace C, 2006, J VIROL, V80, P9259, DOI 10.1128/JVI.00888-06; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Petit V, 2009, PHILOS T R SOC B, V364, P705, DOI 10.1098/rstb.2008.0272; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Ribeiro AC, 2005, J VIROL, V79, P823, DOI 10.1128/JVI.79.2.823-833.2005; Sarkis PTN, 2006, J IMMUNOL, V177, P4530, DOI 10.4049/jimmunol.177.7.4530; Schumacher AJ, 2005, P NATL ACAD SCI USA, V102, P9854, DOI 10.1073/pnas.0501694102; Sen GC, 2007, CURR TOP MICROBIOL, V316, P233; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Takahashi Y, 1998, Int Rev Immunol, V17, P309, DOI 10.3109/08830189809054408; Takai A, 2009, ONCOGENE, V28, P469, DOI 10.1038/onc.2008.415; Thielen BK, 2007, PLOS PATHOG, V3, P1320, DOI 10.1371/journal.ppat.0030135; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; Trapp S, 2009, J VIROL, V83, P884, DOI 10.1128/JVI.00023-08; Trivedi NR, 2006, J INVEST DERMATOL, V126, P1071, DOI 10.1038/sj.jid.5700213; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Turelli P, 2008, J VIROL, V82, P6585, DOI 10.1128/JVI.00216-08; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; VARTANIAN JP, 1994, P NATL ACAD SCI USA, V91, P3092, DOI 10.1073/pnas.91.8.3092; Wiegand HL, 2007, J VIROL, V81, P13694, DOI 10.1128/JVI.01646-07; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang W, 2008, CELL MICROBIOL, V10, P112, DOI 10.1111/j.1462-5822.2007.01020.x; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	80	76	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27753	27766		10.1074/jbc.M110.102822	http://dx.doi.org/10.1074/jbc.M110.102822			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20615867	Green Published, hybrid			2022-12-25	WOS:000281404100031
J	Rohwer, S; Wang, LK				Rohwer, Sievert; Wang, Luan-Keng			A Quantitative Analysis of Flight Feather Replacement in the Moustached Tree Swift Hemiprocne mystacea, a Tropical Aerial Forager	PLOS ONE			English	Article							LIFE-HISTORY IMPLICATIONS; PRIMARY MOLT; PATTERNS; PTILOCHRONOLOGY; PERFORMANCE; BIRDS	The functional life span of feathers is always much less than the potential life span of birds, so feathers must be renewed regularly. But feather renewal entails important energetic, time and performance costs that must be integrated into the annual cycle. Across species the time required to replace flight feather increases disproportionately with body size, resulting in complex, multiple waves of feather replacement in the primaries of many large birds. We describe the rules of flight feather replacement for Hemiprocne mystacea, a small, 60g tree swift from the New Guinea region. This species breeds and molts in all months of the year, and flight feather molt occurs during breeding in some individuals. H. mystacea is one to be the smallest species for which stepwise replacement of the primaries and secondaries has been documented; yet, primary replacement is extremely slow in this aerial forager, requiring more than 300 days if molt is not interrupted. We used growth bands to show that primaries grow at an average rate of 2.86 mm/d. The 10 primaries are a single molt series, while the 11 secondaries and five rectrices are each broken into two molt series. In large birds stepwise replacement of the primaries serves to increase the rate of primary replacement while minimizing gaps in the wing. But stepwise replacement of the wing quills in H. mystacea proceeds so slowly that it may be a consequence of the ontogeny of stepwise molting, rather than an adaptation, because the average number of growing primaries is probably lower than 1.14 feathers per wing.	[Rohwer, Sievert] Univ Washington, Burke Museum, Seattle, WA 98195 USA; Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rohwer, S (corresponding author), Univ Washington, Burke Museum, Seattle, WA 98195 USA.	rohwer@u.washington.edu			Hugh Ferguson; Burke Endowment; AMNH; Lady McNeice; Loke Cheng Kim Foundation; Burke Museum	Hugh Ferguson; Burke Endowment; AMNH; Lady McNeice; Loke Cheng Kim Foundation; Burke Museum	Burke expeditions to the Solomon Islands were supported by Hugh Ferguson and the Burke Endowment for Ornithology. LKW was awarded a study grant from the AMNH, and was supported by Lady McNeice, the Loke Cheng Kim Foundation, and by Eddy Fellowships from the Burke Museum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMOLE NP, 1968, CONDOR, V70, P35, DOI 10.2307/1366507; Bridge Eli S., 2006, Marine Ornithology, V34, P7; BRODIN A, 1993, ORNIS SCAND, V24, P167, DOI 10.2307/3676732; Chai P, 1997, J EXP BIOL, V200, P1527; EDELSTAM C, 1984, ANN ZOOL FENN, V21, P271; Edwards AE, 2005, CONDOR, V107, P835, DOI 10.1650/7533.1; Filardi CE, 2001, CONDOR, V103, P555, DOI 10.1650/0010-5422(2001)103[0555:LHIOCA]2.0.CO;2; Forshaw J. M., 1977, PARROTS WORLD, Vsecond; Ginn H. B., 1983, MOULT BIRDS BTO GUID; Jenni L., 1994, BIOL MOULT BIRDS; LANGSTON NE, 1995, CONDOR, V97, P1, DOI 10.2307/1368978; Langston NE, 1996, OIKOS, V76, P498, DOI 10.2307/3546343; Lind J, 2001, FUNCT ECOL, V15, P29; LINDSTROM A, 1993, PHYSIOL ZOOL, V66, P490, DOI 10.1086/physzool.66.4.30163805; MICHENER HAROLD, 1938, CONDOR, V40, P149, DOI 10.2307/1363421; MILLER ALDEN H., 1941, CONDOR, V43, P113, DOI 10.2307/1364415; MURPHY ME, 1991, AUK, V108, P695, DOI 10.2307/4088109; MURPHY ME, 1995, COMP BIOCHEM PHYS A, V111, P385, DOI 10.1016/0300-9629(95)00039-A; POTTS GR, 1971, IBIS, V113, P298, DOI 10.1111/j.1474-919X.1971.tb05159.x; Pyle P, 2005, CONDOR, V107, P823, DOI 10.1650/7598.1; RASMUSSEN PC, 1988, CONDOR, V90, P220, DOI 10.2307/1368451; Rohwer S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000132; Rohwer S, 2008, CONDOR, V110, P799, DOI 10.1525/cond.2008.8320; Rohwer VG, 2009, ORNITOL NEOTROP, V20, P565; Shugart GW, 1996, CONDOR, V98, P222, DOI 10.2307/1369140; Slagsvold T, 1996, ECOLOGY, V77, P461, DOI 10.2307/2265622; STRESEMANN ERWIN, 1966, J ORNITHOL, V107, P1; Stresemann V., 1960, Journal fuer Ornithologie, V101, P373, DOI 10.1007/BF01671228; Swaddle JP, 1996, J AVIAN BIOL, V27, P103, DOI 10.2307/3677139; TUCKER VA, 1991, AUK, V108, P108; WOOD HAROLD B., 1950, AUK, V67, P486; Yuri T, 1997, AUK, V114, P249, DOI 10.2307/4089166; [No title captured]	33	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11586	10.1371/journal.pone.0011586	http://dx.doi.org/10.1371/journal.pone.0011586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644642	gold, Green Published, Green Submitted			2022-12-25	WOS:000279884900022
J	Balasubramanian, S; Mani, SK; Kasiganesan, H; Baicu, CC; Kuppuswamy, D				Balasubramanian, Sundaravadivel; Mani, Santhosh K.; Kasiganesan, Harinath; Baicu, Catalin C.; Kuppuswamy, Dhandapani			Hypertrophic Stimulation Increases beta-actin Dynamics in Adult Feline Cardiomyocytes	PLOS ONE			English	Article							OVERLOAD CARDIAC-HYPERTROPHY; CYTOPLASMIC GAMMA-ACTIN; FOCAL COMPLEX-FORMATION; PRESSURE-OVERLOAD; C-SRC; INTEGRIN; EXPRESSION; MUSCLE; ACTIVATION; ADHESION	The myocardium responds to hemodynamic stress through cellular growth and organ hypertrophy. The impact of cytoskeletal elements on this process, however, is not fully understood. While alpha-actin in cardiomyocytes governs muscle contraction in combination with the myosin motor, the exact role of beta-actin has not been established. We hypothesized that in adult cardiomyocytes, as in non-myocytes, beta-actin can facilitate cytoskeletal rearrangement within cytoskeletal structures such as Z-discs. Using a feline right ventricular pressure overload (RVPO) model, we measured the level and distribution of beta-actin in normal and pressure overloaded myocardium. Resulting data demonstrated enriched levels of beta-actin and enhanced translocation to the Triton-insoluble cytoskeletal and membrane skeletal complexes. In addition, RVPO in vivo and in vitro hypertrophic stimulation with endothelin (ET) or insulin in isolated adult cardiomyocytes enhanced the content of polymerized fraction (F-actin) of beta-actin. To determine the localization and dynamics of beta-actin, we adenovirally expressed GFP-tagged beta-actin in isolated adult cardiomyocytes. The ectopically expressed beta-actin-GFP localized to the Z-discs, costameres, and cell termini. Fluorescence recovery after photobleaching (FRAP) measurements of beta-actin dynamics revealed that beta-actin at the Z-discs is constantly being exchanged with beta-actin from cytoplasmic pools and that this exchange is faster upon hypertrophic stimulation with ET or insulin. In addition, in electrically stimulated isolated adult cardiomyocytes, while beta-actin overexpression improved cardiomyocyte contractility, immunoneutralization of beta-actin resulted in a reduced contractility suggesting that beta-actin could be important for the contractile function of adult cardiomyocytes. These studies demonstrate the presence and dynamics of beta-actin in the adult cardiomyocyte and reinforce its usefulness in measuring cardiac cytoskeletal rearrangement during hypertrophic stimulation.	[Balasubramanian, Sundaravadivel; Mani, Santhosh K.; Kasiganesan, Harinath; Baicu, Catalin C.; Kuppuswamy, Dhandapani] Med Univ S Carolina, Gazes Cardiac Res Inst, Dept Med, Div Cardiol, Charleston, SC 29425 USA; [Kuppuswamy, Dhandapani] Vet Affairs Med Ctr, Ralph H Johnson Dept, Charleston, SC 29403 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Balasubramanian, S (corresponding author), Med Univ S Carolina, Gazes Cardiac Res Inst, Dept Med, Div Cardiol, Charleston, SC 29425 USA.	balasubr@musc.edu			National Institutes of Health (NIH) [RHL092124A]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092124] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health (NIH) grant RHL092124A (to D.K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2003, J BIOL CHEM, V278, P42214, DOI 10.1074/jbc.M303428200; Balasubramanian S, 2006, J MOL CELL CARDIOL, V41, P669, DOI 10.1016/j.yjmcc.2006.04.022; Balasubramanian Sundaravadivel, 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P52; Berni R, 2009, AM J PHYSIOL-HEART C, V296, pH1625, DOI 10.1152/ajpheart.01057.2008; Brancaccio M, 2006, CARDIOVASC RES, V70, P422, DOI 10.1016/j.cardiores.2005.12.015; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Carson JA, 2000, J APPL PHYSIOL, V88, P337, DOI 10.1152/jappl.2000.88.1.337; CHERNIN MI, 1990, CLIN EXP HYPERTENS A, V12, P617, DOI 10.3109/10641969009073488; COOPER G, 1974, J APPL PHYSIOL, V37, P762, DOI 10.1152/jappl.1974.37.5.762; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Hanft LM, 2007, NEUROMUSCULAR DISORD, V17, P569, DOI 10.1016/j.nmd.2007.03.004; Harborth J, 2001, J CELL SCI, V114, P4557; HILENSKI LL, 1991, CELL TISSUE RES, V264, P577, DOI 10.1007/BF00319047; Hsueh WA, 1998, HYPERTENSION, V31, P176, DOI 10.1161/01.HYP.31.1.176; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kaneda Y, 2002, MOL THER, V6, P219, DOI 10.1006/mthe.2002.0647; Kee AJ, 2009, J MUSCLE RES CELL M, V30, P187, DOI 10.1007/s10974-009-9193-x; Khaitlina SY, 2001, INT REV CYTOL, V202, P35, DOI 10.1016/S0074-7696(01)02003-4; Kuppuswamy D, 2002, CIRC RES, V90, P1240, DOI 10.1161/01.RES.0000025080.78636.23; Kuppuswamy D, 1997, J BIOL CHEM, V272, P4500, DOI 10.1074/jbc.272.7.4500; Laser M, 2000, J BIOL CHEM, V275, P35624, DOI 10.1074/jbc.M006124200; Liew CC, 2004, NAT REV GENET, V5, P811, DOI 10.1038/nrg1470; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; MANN DL, 1989, CIRC RES, V64, P1079, DOI 10.1161/01.RES.64.6.1079; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Nagai T, 1999, AM J CARDIOL, V83, p38H; Rao JY, 2004, CURR CANCER DRUG TAR, V4, P345, DOI 10.2174/1568009043332998; Ren J, 2007, J MOL CELL CARDIOL, V42, P367, DOI 10.1016/j.yjmcc.2006.11.002; Renley BA, 1998, CELL MOTIL CYTOSKEL, V41, P264, DOI 10.1002/(SICI)1097-0169(1998)41:3<264::AID-CM7>3.3.CO;2-Q; RHEE D, 1994, CELL MOTIL CYTOSKEL, V28, P1, DOI 10.1002/cm.970280102; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Satoh M, 2006, P NATL ACAD SCI USA, V103, P7432, DOI 10.1073/pnas.0510444103; Shimada Y, 1997, CELL STRUCT FUNCT, V22, P59, DOI 10.1247/csf.22.59; SIMPSON DG, 1993, J CELL BIOL, V123, P323, DOI 10.1083/jcb.123.2.323; Skwarek-Maruszewska A, 2009, J CELL SCI, V122, P2119, DOI 10.1242/jcs.046805; Sonnemann KJ, 2006, DEV CELL, V11, P387, DOI 10.1016/j.devcel.2006.07.001; Stilli D, 2006, EXP PHYSIOL, V91, P571, DOI 10.1113/expphysiol.2005.032607; Sussman MA, 2000, J CLIN INVEST, V105, P875, DOI 10.1172/JCI8497; Takeda K, 2000, CELL MOTIL CYTOSKEL, V46, P59, DOI 10.1002/(SICI)1097-0169(200005)46:1<59::AID-CM6>3.0.CO;2-Q; TERRACIO L, 1991, CIRC RES, V68, P734, DOI 10.1161/01.RES.68.3.734; Tuxworth WJ, 2008, BASIC RES CARDIOL, V103, P41, DOI 10.1007/s00395-007-0682-z; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; vonArx P, 1995, J CELL BIOL, V131, P1759, DOI 10.1083/jcb.131.6.1759; Wang J, 2005, CELL MOTIL CYTOSKEL, V61, P34, DOI 10.1002/cm.20063; Willey CD, 2003, J MOL CELL CARDIOL, V35, P671, DOI 10.1016/S0022-2828(03)00112-3; Wu X, 2010, AM J PHYSIOL-HEART C, V298, pH2071, DOI 10.1152/ajpheart.01156.2009; Xu L, 2006, J BIOL CHEM, V281, P34430, DOI 10.1074/jbc.M607446200; Yu JG, 2005, J HISTOCHEM CYTOCHEM, V53, P839, DOI 10.1369/jhc.4A6608.2005	50	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11470	10.1371/journal.pone.0011470	http://dx.doi.org/10.1371/journal.pone.0011470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20635003	Green Submitted, Green Published, gold			2022-12-25	WOS:000279781600003
J	Cala, O; Pinaud, N; Simon, C; Fouquet, E; Laguerre, M; Dufourc, EJ; Pianet, I				Cala, Olivier; Pinaud, Noel; Simon, Cecile; Fouquet, Eric; Laguerre, Michel; Dufourc, Erick J.; Pianet, Isabelle			NMR and molecular modeling of wine tannins binding to saliva proteins: revisiting astringency from molecular and colloidal prospects	FASEB JOURNAL			English	Article						procyanidins; proline-rich-proteins; DOSY NMR; STD NMR; molecular dynamics; hydrophilic interactions; hydrophobic interactions	PROLINE-RICH PROTEIN; PROCYANIDIN DIMERS; CONDENSED TANNINS; DIFFUSION NMR; SPECTROSCOPY; PRECIPITATION; BITTERNESS; WATER; ACETYLCHOLINE; POLYPHENOLS	In organoleptic science, the association of tannins to saliva proteins leads to the poorly understood phenomenon of astringency. To decipher this interaction at molecular and colloidal levels, the binding of 4 procyanidin dimers (B1-4) and 1 trimer (C2) to a human saliva proline-rich peptide, IB7(14), was studied. Interactions have been characterized by measuring dissociation constants, sizes of complexes, number, and nature of binding sites using NMR (chemical shift variations, diffusion-ordered spectroscopy, and saturation transfer diffusion). The binding sites were identified using molecular mechanics, and the hydrophilic/hydrophobic nature of the interactions was resolved by calculating the molecular lipophilicity potential within the complexes. The following comprehensive scheme can be proposed: 1) below the tannin critical micelle concentration (CMC), interaction is specific, and the procyanidin anchorage always occurs on the same three IB7(14) sites. The tannin 3-dimensional structure plays a key role in the binding force and in the tannin's ability to act as a bidentate ligand: tannins adopting an extended conformation exhibit higher affinity toward protein and initiate the formation of a network. 2) Above the CMC, after the first specific hydrophilic interaction has taken place, a random hydrophobic stacking occurs between tannins and proteins. The whole process is discussed in the general frame of wine tannins eliciting astringency.-Cala, O., Pinaud, N., Simon, C., Fouquet, E., Laguerre, M., Dufourc, E. J., Pianet, I. NMR and molecular modeling of wine tannins binding to saliva proteins: revisiting astringency from molecular and colloidal prospects. FASEB J. 24, 4281-4290 (2010). www.fasebj.org	[Pinaud, Noel; Fouquet, Eric; Pianet, Isabelle] Univ Bordeaux, Inst Mol Sci, CESAMO, Talence, France; [Cala, Olivier; Simon, Cecile; Laguerre, Michel; Dufourc, Erick J.] Univ Bordeaux, Pessac, France	UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Pianet, I (corresponding author), Univ Bordeaux 1, Inst Mol Sci, UMR 5255, CNRS,CESAMO, 351 Cours Liberat, F-33405 Talence, France.	i.pianet@ism.u-bordeaux1.fr	Cala, Olivier/AAE-8065-2019; DUFOURC, Erick Joel/AAA-4992-2020	Cala, Olivier/0000-0003-3579-0973; DUFOURC, Erick Joel/0000-0002-8221-9326; Pinaud, Noel/0000-0001-7646-5312; FOUQUET, ERIC/0000-0002-2081-8155	Conseil Interprofessionnel de Bordeaux (CIVB, Bordeaux, France); Region Aquitaine; Centre National de la Recherche Scientifique (CNRS); Universite de Bordeaux; European Union	Conseil Interprofessionnel de Bordeaux (CIVB, Bordeaux, France); Region Aquitaine(Region Nouvelle-Aquitaine); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite de Bordeaux; European Union(European Commission)	This work was supported by the Conseil Interprofessionnel de Bordeaux (CIVB, Bordeaux, France), the Region Aquitaine, the Centre National de la Recherche Scientifique (CNRS), the Universite de Bordeaux, and the European Union, which helps the Conseil Regional d'Aquitaine.	ARNOLD RA, 1980, J AGR FOOD CHEM, V28, P675, DOI 10.1021/jf60229a026; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; Baxter NJ, 1996, J CHEM SOC FARADAY T, V92, P231, DOI 10.1039/ft9969200231; Baxter NJ, 1997, BIOCHEMISTRY-US, V36, P5566, DOI 10.1021/bi9700328; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boisselier E, 2008, CHEM-EUR J, V14, P5577, DOI 10.1002/chem.200701607; CARTEAU D, 2007, CR CHIM, V11, P493; Carteau D, 2007, LANGMUIR, V23, P3561, DOI 10.1021/la062339q; Carvalho E, 2006, J AGR FOOD CHEM, V54, P8936, DOI 10.1021/jf061835h; Charlton AJ, 2002, J AGR FOOD CHEM, V50, P1593, DOI 10.1021/jf010897z; Charlton AJ, 1996, FEBS LETT, V382, P289, DOI 10.1016/0014-5793(96)00186-X; Chung KT, 1998, TRENDS FOOD SCI TECH, V9, P168, DOI 10.1016/S0924-2244(98)00028-4; Cohen Y, 2005, ANGEW CHEM INT EDIT, V44, P520, DOI 10.1002/anie.200300637; Corder R, 2006, NATURE, V444, P566, DOI 10.1038/444566a; DARDEN TA, 1993, ENVIRON HEALTH PERSP, V101, P410, DOI 10.2307/3431897; Duluard S, 2008, J RAMAN SPECTROSC, V39, P627, DOI 10.1002/jrs.1896; Fabre S, 2010, CR CHIM, V13, P561, DOI 10.1016/j.crci.2009.11.007; Gawel R., 1998, AUST J GRAPE WINE R, V4, P74, DOI DOI 10.1111/J.1755-0238.1998.TB00137.X; HAGERMAN AE, 1981, J BIOL CHEM, V256, P4494; Hagerman AE, 1998, J AGR FOOD CHEM, V46, P2590, DOI 10.1021/jf971097k; JOSLYN M. A., 1964, ADVANCE FOOD RES, V13, P179; Kallithraka S, 2001, J SCI FOOD AGR, V81, P261, DOI 10.1002/1097-0010(20010115)81:2<261::AID-JSFA804>3.0.CO;2-T; Kawamoto H, 1996, PHYTOCHEMISTRY, V41, P1427, DOI 10.1016/0031-9422(95)00728-8; LEA AGH, 1978, J SCI FOOD AGR, V29, P478, DOI 10.1002/jsfa.2740290512; LeSolleu H, 1997, J LIPID MEDIAT CELL, V16, P75; LUCK G, 1994, PHYTOCHEMISTRY, V37, P357, DOI 10.1016/0031-9422(94)85061-5; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; MURRAY NJ, 1994, EUR J BIOCHEM, V219, P923, DOI 10.1111/j.1432-1033.1994.tb18574.x; Ornelas C, 2007, CHEM COMMUN, P5093, DOI 10.1039/b710391c; Pascal C, 2008, J AGR FOOD CHEM, V56, P6724, DOI 10.1021/jf800790d; Pascal C, 2007, J AGR FOOD CHEM, V55, P4895, DOI 10.1021/jf0704108; Peleg H, 1999, J SCI FOOD AGR, V79, P1123, DOI 10.1002/(SICI)1097-0010(199906)79:8<1123::AID-JSFA336>3.3.CO;2-4; Pianet I, 2008, LANGMUIR, V24, P11027, DOI 10.1021/la8015904; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Schwarz B, 2008, EUR FOOD RES TECHNOL, V227, P1693, DOI 10.1007/s00217-008-0895-x; Simon C, 2003, BIOCHEMISTRY-US, V42, P10385, DOI 10.1021/bi034354p; Simon C, 2003, J PEPT SCI, V9, P125, DOI 10.1002/psc.438; Singleton V. L., 1976, In 'Phenolic, sulfur, and nitrogen compounds in food flavors' [see FSTA (1977) 9 5T271]., P47; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; SWAIN T, 1962, COMP BIOCH, V3, P755; Tarascou I, 2006, EUR J ORG CHEM, V2006, P5367, DOI 10.1002/ejoc.200600668; Tarascou I, 2007, MAGN RESON CHEM, V45, P157, DOI 10.1002/mrc.1938; Tarascou I, 2006, MAGN RESON CHEM, V44, P868, DOI 10.1002/mrc.1867; VANGUNSTEREN WF, 1987, GROMOS 97 MANUAL; Vidal S, 2003, J SCI FOOD AGR, V83, P564, DOI 10.1002/jsfa.1394	46	87	89	1	96	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4281	4290		10.1096/fj.10-158741	http://dx.doi.org/10.1096/fj.10-158741			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20605948				2022-12-25	WOS:000283861100016
J	Fernandes, MS; Reddy, MM; Croteau, NJ; Walz, C; Weisbach, H; Podar, K; Band, H; Carroll, M; Reiter, A; Larson, RA; Salgia, R; Griffin, JD; Sattler, M				Fernandes, Margret S.; Reddy, Mamatha M.; Croteau, Nicole J.; Walz, Christoph; Weisbach, Henry; Podar, Klaus; Band, Hamid; Carroll, Martin; Reiter, Andreas; Larson, Richard A.; Salgia, Ravi; Griffin, James D.; Sattler, Martin			Novel Oncogenic Mutations of CBL in Human Acute Myeloid Leukemia That Activate Growth and Survival Pathways Depend on Increased Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACQUIRED UNIPARENTAL DISOMY; BCR/ABL-TRANSFORMED-CELLS; C-CBL; TYROSINE KINASES; DOWN-REGULATION; NEGATIVE REGULATION; V-CBL; FLT3; EXPRESSION; ABL	Acute myeloid leukemia (AML) is characterized by multiple mutagenic events that affect proliferation, survival, as well as differentiation. Recently, gain-of-function mutations in the alpha helical structure within the linker sequence of the E3 ubiquitin ligase CBL have been associated with AML. We identified four novel CBL mutations, including a point mutation (Y371H) and a putative splice site mutation in AML specimens. Characterization of these two CBL mutants revealed that coexpression with the receptor tyrosine kinases FLT3 (Fms-like tyrosine kinase 3) or KIT-induced ligand independent growth or ligand hyperresponsiveness, respectively. Growth of cells expressing mutant CBL required expression and kinase activity of FLT3. In addition to the CBL-dependent phosphorylation of FLT3 and CBL itself, transformation was associated with activation of Akt and STAT5 and required functional expression of the small GTPases Rho, Rac, and Cdc42. Furthermore, the mutations led to constitutively elevated intracellular reactive oxygen species levels, which is commonly linked to increased glucose metabolism in cancer cells. Inhibition of hexokinase with 2-deoxyglucose blocked the transforming activity of CBL mutants and reduced activation of signaling mechanisms. Overall, our data demonstrate that mutations of CBL alter cellular biology at multiple levels and require not only the activation of receptor proximal signaling events but also an increase in cellular glucose metabolism. Pathways that are activated by CBL gain-of-function mutations can be efficiently targeted by small molecule drugs.	[Fernandes, Margret S.; Reddy, Mamatha M.; Croteau, Nicole J.; Weisbach, Henry; Podar, Klaus; Griffin, James D.; Sattler, Martin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Fernandes, Margret S.; Reddy, Mamatha M.; Podar, Klaus; Griffin, James D.; Sattler, Martin] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; [Walz, Christoph] Heidelberg Univ, Univ Med Mannheim, Inst Pathol, D-69120 Heidelberg, Germany; [Walz, Christoph; Reiter, Andreas] Heidelberg Univ, Univ Med Mannheim, Med Klin 3, D-69120 Heidelberg, Germany; [Podar, Klaus] Heidelberg Univ, Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany; [Band, Hamid] Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska Med Ctr, Dept Genet, Coll Med, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska Med Ctr, Dept Cell Biol & Anat, Coll Med, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Coll Med, Omaha, NE 68198 USA; [Carroll, Martin] Univ Penn, Div Hematol & Oncol, Philadelphia, PA 19104 USA; [Larson, Richard A.; Salgia, Ravi] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Pennsylvania; University of Chicago	Sattler, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	martin_sattler@dfci.harvard.edu	Larson, Richard A./AAE-7223-2019; Podar, Klaus/ABD-1112-2020; Band, Hamid/AAF-4701-2020	Larson, Richard A./0000-0001-9168-3203; Podar, Klaus/0000-0002-7414-3632; 	National Institutes of Health [5R01CA134660-02, 5R01CA116552-04, 5R01CA99163-09, 5R01CA87986-12, 5R01CA105489-06, 5R01CA10075006, 5R01CA125541-04, 5R01CA129501]; Leukemia and Lymphoma Society SCOR; German Jose Carreras Leukemia Foundation [DJCLS R06/02]; United States Department of Defense; Adams Barr Program in Innovative Cancer Research; NATIONAL CANCER INSTITUTE [R01CA100750, R01CA087986, R01CA099163, R01CA125541, R01CA116552, R01CA134660, R01CA061593, R01CA105489, R01CA129501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society SCOR(Leukemia and Lymphoma Society); German Jose Carreras Leukemia Foundation; United States Department of Defense(United States Department of Defense); Adams Barr Program in Innovative Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01CA134660-02 (to M.S.), 5R01CA116552-04, 5R01CA99163-09, 5R01CA87986-12, and 5R01CA105489-06 (to H.B.), and 5R01CA10075006, 5R01CA125541-04, and 5R01CA129501-02 (to R.S.), a Leukemia and Lymphoma Society SCOR grant (to J.D.G.), German Jose Carreras Leukemia Foundation Grant DJCLS R06/02 (to C.W.), the United States Department of Defense, and the Adams Barr Program in Innovative Cancer Research (to M.S.).	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; ANDO K, 1993, P NATL ACAD SCI USA, V90, P9571, DOI 10.1073/pnas.90.20.9571; Andoniou CE, 1996, ONCOGENE, V12, P1981; ANDONIOU CE, 1994, EMBO J, V13, P4515, DOI 10.1002/j.1460-2075.1994.tb06773.x; Banerji L, 2004, EXPERT OPIN THER TAR, V8, P221, DOI 10.1517/14728222.8.3.221; BLAKE TJ, 1991, ONCOGENE, V6, P653; Caligiuri MA, 2007, BLOOD, V110, P1022, DOI 10.1182/blood-2006-12-061176; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; FREDRICKSON TN, 1984, J NATL CANCER I, V72, P447; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; KEANE MM, 1995, ONCOGENE, V10, P2367; Kim JH, 2005, BLOOD, V105, P1717, DOI 10.1182/blood-2004-03-0849; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; Makishima H, 2009, J CLIN ONCOL, V27, P6109, DOI 10.1200/JCO.2009.23.7503; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Marengere LEM, 1997, J IMMUNOL, V159, P70; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Pelish HE, 2006, NAT CHEM BIOL, V2, P221, DOI 10.1038/nchembio0406-221b; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Reddi AL, 2007, J BIOL CHEM, V282, P29336, DOI 10.1074/jbc.M701797200; Reindl C, 2009, CLIN CANCER RES, V15, P2238, DOI 10.1158/1078-0432.CCR-08-1325; Rodrigues MS, 2008, ANTIOXID REDOX SIGN, V10, P1813, DOI 10.1089/ars.2008.2071; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Sargin B, 2007, BLOOD, V110, P1004, DOI 10.1182/blood-2007-01-066076; Sattler M, 1999, BLOOD, V93, P2928; Sattler M, 1998, LEUKEMIA, V12, P637, DOI 10.1038/sj.leu.2401010; Sattler M, 2002, ONCOGENE, V21, P1423, DOI 10.1038/sj.onc.1205202; Sattler M, 1996, ONCOGENE, V12, P839; Sitnicka E, 2003, BLOOD, V102, P881, DOI 10.1182/blood-2002-06-1694; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Szymkiewicz I, 2002, J BIOL CHEM, V277, P39666, DOI 10.1074/jbc.M205535200; Thien CBF, 2005, GROWTH FACTORS, V23, P161, DOI 10.1080/08977190500153763; Walz C, 2006, J BIOL CHEM, V281, P18177, DOI 10.1074/jbc.M600064200; Weisberg E, 2002, CANCER CELL, V1, P433, DOI 10.1016/S1535-6108(02)00069-7; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186	42	32	33	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32596	32605		10.1074/jbc.M110.106161	http://dx.doi.org/10.1074/jbc.M110.106161			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20622007	Green Published, hybrid			2022-12-25	WOS:000282683000074
J	Studach, L; Wang, WH; Weber, G; Tang, JB; Hullinger, RL; Malbrue, R; Liu, XQ; Andrisani, O				Studach, Leo; Wang, Wen-Horng; Weber, Gregory; Tang, Jiabin; Hullinger, Ronald L.; Malbrue, Raphael; Liu, Xiaoqi; Andrisani, Ourania			Polo-like Kinase 1 Activated by the Hepatitis B Virus X Protein Attenuates Both the DNA Damage Checkpoint and DNA Repair Resulting in Partial Polyploidy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLK1 PHOSPHORYLATION; CHK1 ACTIVATION; GENE-EXPRESSION; P53; REPLICATION; CLASPIN; ADAPTATION; POLO-LIKE-KINASE-1; INHIBITOR; RECOVERY	Hepatitis B virus X protein (pX), implicated in hepatocarcinogenesis, induces DNA damage because of re-replication and allows propagation of damaged DNA, resulting in partial polyploidy and oncogenic transformation. The mechanism by which pX allows cells with DNA damage to continue proliferating is unknown. Herein, we show pX activates Polo-like kinase 1 (Plk1) in the G(2) phase, thereby attenuating the DNA damage checkpoint. Specifically, in the G(2) phase of pX-expressing cells, the checkpoint kinase Chk1 was inactive despite DNA damage, and protein levels of claspin, an adaptor of ataxia telangiectasia- mutated and Rad3-related protein-mediated Chk1 phosphorylation, were reduced. Pharmacologic inhibition or knockdown of Plk1 restored claspin protein levels, Chk1 activation, and p53 stabilization. Also, protein levels of DNA repair protein Mre11 were decreased in the G2 phase of pX-expressing cells but not with Plk1 knockdown. Interestingly, in pX-expressing cells, Mre11 co-immunoprecipitated with transfected Plk1 Polo-box domain, and inhibition of Plk1 increased Mre11 stability in cycloheximide-treated cells. These results suggest that pX-activated Plk1 by down-regulating Mre11 attenuates DNA repair. Importantly, concurrent inhibition of Plk1, p53, and Mre11 increased the number of pX-expressing cells with DNA damage entering mitosis, relative to Plk1 inhibition alone. By contrast, inhibition or knockdown of Plk1 reduced pX-induced polyploidy while increasing apoptosis. We conclude Plk1, activated by pX, allows propagation of DNA damage by concurrently attenuating the DNA damage checkpoint and DNA repair, resulting in polyploidy. We propose this novel Plk1 mechanism initiates pX-mediated hepatocyte transformation.	[Studach, Leo; Wang, Wen-Horng; Hullinger, Ronald L.; Malbrue, Raphael; Andrisani, Ourania] Purdue Univ, Ctr Canc Res, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Weber, Gregory; Tang, Jiabin; Liu, Xiaoqi] Purdue Univ, Ctr Canc Res, Dept Biochem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Andrisani, O (corresponding author), 625 Harrison St, W Lafayette, IN 47907 USA.	andrisao@purdue.edu		Andrisani, Ourania/0000-0002-6230-0303	National Institutes of Health [DK044533, CA135192]; Purdue University Cytometry Laboratory; NATIONAL CANCER INSTITUTE [R21CA135192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044533, R29DK044533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Purdue University Cytometry Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK044533 and CA135192 (to O.A.).; We acknowledge support of the Purdue University Cytometry Laboratory.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Andrisani OM, 1999, INT J ONCOL, V15, P373; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Cha HJ, 2007, J BIOL CHEM, V282, P22984, DOI 10.1074/jbc.M700735200; Chen J, 2006, FEBS LETT, V580, P3624, DOI 10.1016/j.febslet.2006.05.047; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; Incassati A, 2006, ONCOGENE, V25, P2444, DOI 10.1038/sj.onc.1209276; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Lee S, 2002, J BIOL CHEM, V277, P8730, DOI 10.1074/jbc.M108025200; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li H, 2008, J BIOL CHEM, V283, P6209, DOI 10.1074/jbc.M709007200; Lin L, 2005, ONCOGENE, V24, P3385, DOI 10.1038/sj.onc.1208554; Liu XS, 2010, EMBO REP, V11, P626, DOI 10.1038/embor.2010.90; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Madden CR, 2001, J VIROL, V75, P3851, DOI 10.1128/JVI.75.8.3851-3858.2001; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Murphy PJM, 2004, J BIOL CHEM, V279, P30195, DOI 10.1074/jbc.M403539200; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; Paulovich AG, 1998, GENETICS, V150, P75; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Peters U, 2006, NAT CHEM BIOL, V2, P618, DOI 10.1038/nchembio826; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; Rakotomalala L, 2008, J BIOL CHEM, V283, P28729, DOI 10.1074/jbc.M802751200; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Spardy N, 2009, CANCER RES, V69, P7022, DOI 10.1158/0008-5472.CAN-09-0925; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Studach LL, 2009, HEPATOLOGY, V50, P414, DOI 10.1002/hep.22996; Su Q, 1998, HEPATOLOGY, V27, P1109, DOI 10.1002/hep.510270428; Syljuasen RG, 2007, ONCOGENE, V26, P5833, DOI 10.1038/sj.onc.1210402; Syljuasen RG, 2006, CANCER RES, V66, P10253, DOI 10.1158/0008-5472.CAN-06-2144; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; Tang J, 2008, ONCOGENE, V27, P6635, DOI 10.1038/onc.2008.262; Tarn C, 1999, J BIOL CHEM, V274, P2327, DOI 10.1074/jbc.274.4.2327; Tarn C, 2002, J VIROL, V76, P9763, DOI 10.1128/JVI.76.19.9763-9772.2002; Tarn C, 2001, J BIOL CHEM, V276, P34671, DOI 10.1074/jbc.M104105200; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Terradillos O, 1997, ONCOGENE, V14, P395, DOI 10.1038/sj.onc.1200850; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; VAN VUGT MATM, 2004, MOL CELL, V15, P799; VAN VUGT MATM, 2005, ONCOGENE, V24, P2844; VAN VUGT MATM, 2001, J BIOL CHEM, V276, P41656; Wang WH, 2008, J BIOL CHEM, V283, P25455, DOI 10.1074/jbc.M801934200; Wang WH, 2004, MOL CELL BIOL, V24, P10352, DOI 10.1128/MCB.24.23.10352-10365.2004; Wang X, 2006, MOL CELL, V23, P331, DOI 10.1016/j.molcel.2006.06.022; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wu ZQ, 2008, J BIOL CHEM, V283, P25503, DOI 10.1074/jbc.M803304200; Wu ZQ, 2008, P NATL ACAD SCI USA, V105, P1919, DOI 10.1073/pnas.0712063105; Yamada S, 2004, ONCOGENE, V23, P5901, DOI 10.1038/sj.onc.1207782; Yang XM, 2009, J BIOL CHEM, V284, P28775, DOI 10.1074/jbc.M109.017681; Yang XM, 2009, J BIOL CHEM, V284, P18588, DOI 10.1074/jbc.C109.001560; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9; Zhang H, 2007, CANCER LETT, V245, P184, DOI 10.1016/j.canlet.2006.01.005; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994	71	36	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30282	30293		10.1074/jbc.M109.093963	http://dx.doi.org/10.1074/jbc.M109.093963			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20624918	Green Published, hybrid			2022-12-25	WOS:000281984300064
J	Eot-Houllier, G; Venoux, M; Vidal-Eychenie, S; Hoang, MT; Giorgi, D; Rouquier, S				Eot-Houllier, Gregory; Venoux, Magali; Vidal-Eychenie, Sophie; Hoang, Minh-Thao; Giorgi, Dominique; Rouquier, Sylvie			Plk1 Regulates Both ASAP Localization and Its Role in Spindle Pole Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-A; CENTROSOME ABERRATIONS; MITOTIC CENTROSOMES; KINASE AURORA; PHOSPHORYLATION; RECRUITMENT; TARGET; SUBSTRATE; COMPLEX; BINDING	Bipolar spindle formation is essential for faithful chromosome segregation at mitosis. Because centrosomes define spindle poles, abnormal number and structural organization of centrosomes can lead to loss of spindle bipolarity and genetic integrity. ASAP (aster-associated protein or MAP9) is a centrosome- and spindle-associated protein, the deregulation of which induces severe mitotic defects. Its phosphorylation by Aurora A is required for spindle assembly and mitosis progression. Here, we show that ASAP is localized to the spindle poles by Polo-like kinase 1 (Plk1) (a mitotic kinase that plays an essential role in centrosome regulation and mitotic spindle assembly) through the gamma-TuRC-dependent pathway. We also demonstrate that ASAP is a novel substrate of Plk1 phosphorylation and have identified serine 289 as the major phosphorylation site by Plk1 in vivo. ASAP phosphorylated on serine 289 is localized to centrosomes during mitosis, but this phosphorylation is not required for its Plk1-dependent localization at the spindle poles. We show that phosphorylated ASAP on serine 289 contributes to spindle pole stability in a microtubule-dependent manner. These data reveal a novel function of ASAP in centrosome integrity. Our results highlight dual ASAP regulation by Plk1 and further confirm the importance of ASAP for spindle pole organization, bipolar spindle assembly, and mitosis.	[Eot-Houllier, Gregory; Venoux, Magali; Vidal-Eychenie, Sophie; Hoang, Minh-Thao; Giorgi, Dominique; Rouquier, Sylvie] CNRS, Inst Genet Humaine, Grp Microtubules & Cycle Cellularie, UPR 1142, F-34396 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Rouquier, S (corresponding author), CNRS, Inst Genet Humaine, Grp Microtubules & Cycle Cellularie, UPR 1142, Rue Cardonille, F-34396 Montpellier 5, France.	rouquier@igh.cnrs.fr	giorgi, dominique/M-1529-2019	Rouquier, Sylvie/0000-0003-2448-6837	CNRS; Association pour la Recherche contre le Cancer [4027]; Ligue Nationale contre le Cancer; Fondation Jerome Lejeune; Institut National du Cancer (France); Ministere de l'Enseignement de la Recherche et de la Technologie; Association pour la Recherche contre le Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Fondation Jerome Lejeune; Institut National du Cancer (France)(Institut National du Cancer (INCA) France); Ministere de l'Enseignement de la Recherche et de la Technologie; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by the CNRS and Association pour la Recherche contre le Cancer Grant 4027 (to S. R.), Ligue Nationale contre le Cancer Grants Comite de l'Herault-2007 and Comite de l'Aude-2009 (to S. R.), and by the Fondation Jerome Lejeune (S. R.).; Supported by postdoctoral fellowships from the Institut National du Cancer (France) (2008) and the Ligue Nationale contre le Cancer (2009).; Supported by fellowships from Ministere de l'Enseignement de la Recherche et de la Technologie and the Association pour la Recherche contre le Cancer.	Archambault V, 2008, GENE DEV, V22, P2707, DOI 10.1101/gad.486808; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Budde PP, 2001, J CELL BIOL, V153, P149, DOI 10.1083/jcb.153.1.149; Chan EHY, 2008, CHROMOSOMA, V117, P457, DOI 10.1007/s00412-008-0165-5; Eckerdt F, 2009, CELL CYCLE, V8, P2413, DOI 10.4161/cc.8.15.9086; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Jang CY, 2009, J CELL SCI, V122, P1334, DOI 10.1242/jcs.044321; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Macurek L, 2009, CANCER RES, V69, P4555, DOI 10.1158/0008-5472.CAN-09-0142; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Moudjou M, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P111; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Oshimori N, 2009, EMBO J, V28, P2066, DOI 10.1038/emboj.2009.161; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Saffin JM, 2005, P NATL ACAD SCI USA, V102, P11302, DOI 10.1073/pnas.0500964102; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Tamura Y, 2009, ONCOGENE, V28, P107, DOI 10.1038/onc.2008.368; Tillement V, 2009, BIOL CELL, V101, P1, DOI 10.1042/BC20070162; VAN DE WEERDT BCM, 2006, CELL CYCLE, V5, P853; VAN VUGT MATM, 2004, J BIOL CHEM, V279, P36841; Venoux M, 2008, HUM MOL GENET, V17, P215, DOI 10.1093/hmg/ddm298; Vigneron S, 2009, EMBO J, V28, P2786, DOI 10.1038/emboj.2009.228; Wang X, 2008, DEV CELL, V14, P331, DOI 10.1016/j.devcel.2007.12.007; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Zhang XY, 2009, J CELL SCI, V122, P2240, DOI 10.1242/jcs.042747; Zhu H, 2009, J CELL SCI, V122, P2750, DOI 10.1242/jcs.048223; Zhu H, 2008, J CELL BIOL, V183, P835, DOI 10.1083/jcb.200807046; Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001	47	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29556	29568		10.1074/jbc.M110.144220	http://dx.doi.org/10.1074/jbc.M110.144220			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20615875	Green Published, hybrid			2022-12-25	WOS:000281740100057
J	Fiuza, M; Letek, M; Leiba, J; Villadangos, AF; Vaquera, J; Zanella-Cleon, I; Mateos, LM; Molle, V; Gil, JA				Fiuza, Maria; Letek, Michal; Leiba, Jade; Villadangos, Almudena F.; Vaquera, Jose; Zanella-Cleon, Isabelle; Mateos, Luis M.; Molle, Virginie; Gil, Jose A.			Phosphorylation of a Novel Cytoskeletal Protein (RsmP) Regulates Rod-shaped Morphology in Corynebacterium glutamicum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; INTERMEDIATE-FILAMENT STRUCTURE; PREDICTING COILED COILS; CELL-WALL SYNTHESIS; ESCHERICHIA-COLI; CROSS-LINKING; POLAR GROWTH; DIVISION; DIVIVA; MREB	Corynebacteria grow by wall extension at the cell poles, with DivIVA being an essential protein orchestrating cell elongation and morphogenesis. DivIVA is considered a scaffolding protein able to recruit other proteins and enzymes involved in polar peptidoglycan biosynthesis. Partial depletion of DivIVA induced overexpression of cg3264, a previously uncharacterized gene that encodes a novel coiled coil-rich protein specific for corynebacteria and a few other actinomycetes. By partial depletion and overexpression of Cg3264, we demonstrated that this protein is an essential cytoskeletal element needed for maintenance of the rod-shaped morphology of Corynebacterium glutamicum, and it was therefore renamed RsmP (rod-shaped morphology protein). RsmP forms long polymers in vitro in the absence of any cofactors, thus resembling eukaryotic intermediate filaments. We also investigated whether RsmP could be regulated post-translationally by phosphorylation, like eukaryotic intermediate filaments. RsmP was phosphorylated in vitro by the PknA protein kinase and to a lesser extent by PknL. A mass spectrometric analysis indicated that phosphorylation exclusively occurred on a serine (Ser-6) and two threonine (Thr-168 and Thr-211) residues. We confirmed that mutagenesis to alanine (phosphoablative protein) totally abolished PknA-dependent phosphorylation of RsmP. Interestingly, when the three residues were converted to aspartic acid, the phosphomimetic protein accumulated at the cell poles instead of making filaments along the cell, as observed for the native or phosphoablative RsmP proteins, indicating that phosphorylation of RsmP is necessary for directing cell growth at the cell poles.	[Leiba, Jade; Zanella-Cleon, Isabelle; Molle, Virginie] Univ Lyon 1, CNRS, Inst Biol & Chim Prot, BioSci IFR128,UMR 5086, F-69367 Lyon 07, France; [Fiuza, Maria; Letek, Michal; Villadangos, Almudena F.; Vaquera, Jose; Mateos, Luis M.; Gil, Jose A.] Univ Leon, Fac Biol, Dept Biol Mol, Area Microbiol, E-24071 Leon, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universidad de Leon	Molle, V (corresponding author), Univ Lyon 1, CNRS, Inst Biol & Chim Prot, BioSci IFR128,UMR 5086, 7 Passage Vercors, F-69367 Lyon 07, France.	vmolle@ibcp.fr; jagils@unileon.es	Letek, Michal/AAH-4292-2019; Gil, José A./L-1800-2019; Letek, Michal/K-3903-2019; Gil, Jose A./C-3902-2009; Letek, Michal/C-6345-2008; MATEOS DELGADO, LUIS MARIANO/ABB-8848-2021; MOLLE, Virginie/D-4050-2019; Gil, Jose/A-3795-2010	Gil, José A./0000-0002-5069-2637; Letek, Michal/0000-0002-9509-5174; Gil, Jose A./0000-0002-5069-2637; Letek, Michal/0000-0002-9509-5174; MATEOS DELGADO, LUIS MARIANO/0000-0001-7763-582X; MOLLE, Virginie/0000-0002-6573-3411; Leiba, Jade/0000-0003-0584-9524	National Research Agency [ANR-06-MIME-027-01, ANR-09-MIEN-004]; Junta de Castilla y Leon [LE040A07, LE28A10-2]; Ministerio de Ciencia y Tecnologia (Spain) [BIO2008-00519]; Ministerio de Educacion y Ciencia	National Research Agency(French National Research Agency (ANR)); Junta de Castilla y Leon(Junta de Castilla y Leon); Ministerio de Ciencia y Tecnologia (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported in part by National Research Agency Grants ANR-06-MIME-027-01 and ANR-09-MIEN-004 (to V. M.), Junta de Castilla y Leon Grants LE040A07 and LE28A10-2 (to J. A. G. and L. M. M.), and Ministerio de Ciencia y Tecnologia (Spain) Grant BIO2008-00519 (to J. A. G.).; Recipient of a fellowship from the Ministerio de Educacion y Ciencia.	Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Ausmees N, 2006, J MOL MICROB BIOTECH, V11, P152, DOI 10.1159/000094051; Bagchi S, 2008, MOL MICROBIOL, V70, P1037, DOI 10.1111/j.1365-2958.2008.06473.x; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205; Canova MJ, 2008, PLASMID, V60, P149, DOI 10.1016/j.plasmid.2008.05.002; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Charulatha V, 2001, J BIOMED MATER RES, V54, P122, DOI 10.1002/1097-4636(200101)54:1<122::AID-JBM15>3.0.CO;2-N; Chou SM, 1997, J NEUROL SCI, V152, P198, DOI 10.1016/S0022-510X(97)00161-5; Cohen-Gonsaud M, 2009, J BIOL CHEM, V284, P19290, DOI 10.1074/jbc.M109.019653; Daniel RA, 2000, MOL MICROBIOL, V35, P299, DOI 10.1046/j.1365-2958.2000.01724.x; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; DePedro MA, 1997, J BACTERIOL, V179, P2823, DOI 10.1128/jb.179.9.2823-2834.1997; Divakaruni AV, 2007, MOL MICROBIOL, V66, P174, DOI 10.1111/j.1365-2958.2007.05910.x; DOI M, 1988, J BACTERIOL, V170, P4619, DOI 10.1128/jb.170.10.4619-4624.1988; DOMINGO A, 1992, P223; Downing DT, 1996, PROTEINS, V25, P215, DOI 10.1002/(SICI)1097-0134(199606)25:2<215::AID-PROT7>3.0.CO;2-G; Elderkin S, 2002, J MOL BIOL, V320, P23, DOI 10.1016/S0022-2836(02)00404-7; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Fiuza M, 2008, J BIOL CHEM, V283, P36553, DOI 10.1074/jbc.M807175200; Flardh K, 2003, MOL MICROBIOL, V49, P1523, DOI 10.1046/j.1365-2958.2003.03660.x; Freire P, 2009, J MOL BIOL, V385, P1345, DOI 10.1016/j.jmb.2008.12.026; Fuhrmann C, 1997, J VET MED B, V44, P287, DOI 10.1111/j.1439-0450.1997.tb00975.x; GEISLER N, 1988, EMBO J, V7, P15, DOI 10.1002/j.1460-2075.1988.tb02778.x; Graumann PL, 2009, CELL MOTIL CYTOSKEL, V66, P909, DOI 10.1002/cm.20381; Hamasha K, 2010, BIOCHEM BIOPH RES CO, V391, P664, DOI 10.1016/j.bbrc.2009.11.117; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; JAMES GA, 1995, J BACTERIOL, V177, P907, DOI 10.1128/jb.177.4.907-915.1995; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; Leaver M, 2005, MOL MICROBIOL, V57, P1196, DOI 10.1111/j.1365-2958.2005.04736.x; Letek M, 2006, J BACTERIOL, V188, P409, DOI 10.1128/JB.188.2.409-423.2006; Letek M, 2008, J BACTERIOL, V190, P3283, DOI 10.1128/JB.01934-07; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Mateos LM, 1996, J BACTERIOL, V178, P5768, DOI 10.1128/jb.178.19.5768-5775.1996; Mengin-Lecreulx D, 1998, J BACTERIOL, V180, P4406, DOI 10.1128/JB.180.17.4406-4412.1998; Muchova K, 2002, MICROBIOL-SGM, V148, P807, DOI 10.1099/00221287-148-3-807; Nguyen L, 2007, J BACTERIOL, V189, P7896, DOI 10.1128/JB.00726-07; Nishio Y, 2003, GENOME RES, V13, P1572, DOI 10.1101/gr.1285603; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; Ramos A, 2003, MICROBIOL-SGM, V149, P3531, DOI 10.1099/mic.0.26653-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANTAMARIA RI, 1985, J BACTERIOL, V162, P463, DOI 10.1128/JB.162.1.463-467.1985; Santos JM, 1999, MOL MICROBIOL, V32, P789, DOI 10.1046/j.1365-2958.1999.01397.x; SCHAFER A, 1990, J BACTERIOL, V172, P1663, DOI 10.1128/jb.172.3.1663-1666.1990; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Schultz C, 2009, MOL MICROBIOL, V74, P724, DOI 10.1111/j.1365-2958.2009.06897.x; Shih YL, 2006, MICROBIOL MOL BIOL R, V70, P729, DOI 10.1128/MMBR.00017-06; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Soufo HJD, 2004, EMBO REP, V5, P789, DOI 10.1038/sj.embor.7400209; Stahlberg H, 2004, MOL MICROBIOL, V52, P1281, DOI 10.1111/j.1365-2958.2004.04074.x; STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2; STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tauch A, 2005, J BACTERIOL, V187, P4671, DOI 10.1128/JB.187.13.4671-4682.2005; UMEDA A, 1983, MICROBIOL IMMUNOL, V27, P663, DOI 10.1111/j.1348-0421.1983.tb00629.x; Vats P, 2009, MOL MICROBIOL, V72, P170, DOI 10.1111/j.1365-2958.2009.06632.x; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Wang SB, 2009, FEMS MICROBIOL LETT, V297, P101, DOI 10.1111/j.1574-6968.2009.01678.x; Zuckerkandl E., 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	72	24	24	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29387	29397		10.1074/jbc.M110.154427	http://dx.doi.org/10.1074/jbc.M110.154427			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20622015	Green Published, hybrid			2022-12-25	WOS:000281740100041
J	VanDuijn, MM; Dekker, LJM; Zeneyedpour, L; Smitt, PAES; Luider, TM				VanDuijn, Martijn M.; Dekker, Lennard J. M.; Zeneyedpour, L.; Smitt, Peter A. E. Sillevis; Luider, Theo M.			Immune Responses Are Characterized by Specific Shared Immunoglobulin Peptides That Can Be Detected by Proteomic Techniques	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-H; ANTIBODY; CELL; REPERTOIRE; DIVERSITY; REACTIVITY; ANTIGENS; CANCER	In the adaptive immune response, immunoglobulins develop that bind specifically to the antigens to which the organism was exposed. Immunoglobulins may bind to known or unknown antigens in a variety of diseases and have been used in the past to identify novel antigens for use as a biomarker. We propose that the immunoglobulins themselves could also be used as biomarkers in antibody-mediated disease. In this proteomic study, rats were immunized with one of two purified antigens, and immunoglobulins from pre- and postimmune sera were analyzed with nano-LC coupled mass spectrometry. It was found that the two treatment groups could be distinguished based on cluster analysis of the immunoglobulin peptides from the immune sera. In addition, we identified 684 specific peptides that were differentially present in one of the two treated groups. We could find an amino acid sequence for 44% of the features in the mass spectra by combining database-driven and de novo sequencing techniques. The latter were essential for sequence identification, as the more common database-driven approach suffers from a poor representation of immunoglobulins in the available data-bases. Our data show that the development of immunoglobulins during an immune response is not a fully random process, but that instead selection pressures exist that favor the best binding amino acid sequences, and that this selection is shared between different animals. This finding implies that immunoglobulin peptides could indeed be a powerful and easily accessible class of biomarkers.	[VanDuijn, Martijn M.; Dekker, Lennard J. M.; Zeneyedpour, L.; Smitt, Peter A. E. Sillevis; Luider, Theo M.] Erasmus MC, Dept Neurol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Luider, TM (corresponding author), Erasmus MC, Dept Neurol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	t.luider@erasmusmc.nl		van Duijn, Martijn/0000-0002-6654-994X	TI Pharma; NWO (Nederlandse Organisatie voor Wetenschappelijke Onderzoek) Horizon Breakthrough [9351808]	TI Pharma; NWO (Nederlandse Organisatie voor Wetenschappelijke Onderzoek) Horizon Breakthrough(Netherlands Organization for Scientific Research (NWO))	This work was supported by TI Pharma (to M. M. V. D.) and the NWO (Nederlandse Organisatie voor Wetenschappelijke Onderzoek) Horizon Breakthrough Grant 9351808 (to L. D. and L.Z.).	Andersen PS, 2007, MOL IMMUNOL, V44, P412, DOI 10.1016/j.molimm.2006.02.021; Baranzini SE, 1999, J IMMUNOL, V163, P5133; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; Hay F.C., 2008, PRACTICAL IMMUNOLOGY, P115; Janeway C., 2001, IMMUNOBIOLOGY, V5th; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Leidinger P, 2008, INT J CANCER, V123, P1631, DOI 10.1002/ijc.23680; LOH DY, 1983, CELL, V33, P85, DOI 10.1016/0092-8674(83)90337-9; MANLEY GT, 1995, ANN NEUROL, V38, P102, DOI 10.1002/ana.410380117; Poulsen TR, 2007, J IMMUNOL, V179, P3841, DOI 10.4049/jimmunol.179.6.3841; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Saada R, 2007, IMMUNOL CELL BIOL, V85, P323, DOI 10.1038/sj.icb.7100055; Sahin U, 1997, CURR OPIN IMMUNOL, V9, P709, DOI 10.1016/S0952-7915(97)80053-2; Sehgal D, 1998, J IMMUNOL, V161, P5347; Sodeyama N, 1999, J NEUROL NEUROSUR PS, V66, P97, DOI 10.1136/jnnp.66.1.97; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6	19	20	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29247	29253		10.1074/jbc.M110.139071	http://dx.doi.org/10.1074/jbc.M110.139071			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20615873	Green Published, hybrid			2022-12-25	WOS:000281740100026
J	Clark, EB; Jovov, B; Rooj, AK; Fuller, CM; Benos, DJ				Clark, Edlira B.; Jovov, Biljana; Rooj, Arun K.; Fuller, Catherine M.; Benos, Dale J.			Proteolytic Cleavage of Human Acid-sensing Ion Channel 1 by the Serine Protease Matriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNELS; SURFACE EXPRESSION; XENOPUS-OOCYTES; ACTIVATION; CELLS; ENAC; MIGRATION; SUBUNITS; DOMAINS; GLIOMAS	Acid-sensing ion channel 1 (ASIC1) is a H+-gated channel of the amiloride-sensitive epithelial Na+ channel (ENaC)/degenerin family. ASIC1 is expressed mostly in the central and peripheral nervous system neurons. ENaC and ASIC function is regulated by several serine proteases. The type II transmembrane serine protease matriptase activates the prototypical alpha beta gamma ENaC channel, but we found that matriptase is expressed in glioma cells and its expression is higher in glioma compared with normal astrocytes. Therefore, the goal of this study was to test the hypothesis that matriptase regulates ASIC1 function. Matriptase decreased the acid-activated ASIC1 current as measured by two-electrode voltage clamp in Xenopus oocytes and cleaved ASIC1 expressed in oocytes or CHO K1 cells. Inactive S805A matriptase had no effect on either the current or the cleavage of ASIC1. The effect of matriptase on ASIC1 was specific, because it did not affect the function of ASIC2 and no matriptase-specific ASIC2 fragments were detected in oocytes or in CHO cells. Three matriptase recognition sites were identified in ASIC1 (Arg-145, Lys-185, and Lys-384). Site-directed mutagenesis of these sites prevented matriptase cleavage of ASIC1. Our results show that matriptase is expressed in glioma cells and that matriptase specifically cleaves ASIC1 in heterologous expression systems.	[Clark, Edlira B.; Rooj, Arun K.; Fuller, Catherine M.; Benos, Dale J.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Jovov, Biljana] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA	University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill	Benos, DJ (corresponding author), 1918 Univ Blvd,MCLM 702, Birmingham, AL 35294 USA.	benos@uab.edu	Fuller, Cathy/B-4046-2011		National Institutes of Health [DK 37206]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK037206, R01DK037206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 37206.	Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Bashari E, 2009, AM J PHYSIOL-CELL PH, V296, pC372, DOI 10.1152/ajpcell.00200.2008; Berdiev BK, 2003, J BIOL CHEM, V278, P15023, DOI 10.1074/jbc.M300991200; Bubien JK, 1999, AM J PHYSIOL-CELL PH, V276, pC1405, DOI 10.1152/ajpcell.1999.276.6.C1405; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Hu JC, 2009, J BIOL CHEM, V284, P36334, DOI 10.1074/jbc.M109.032870; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kadurin I, 2008, BIOCHEM J, V412, P469, DOI 10.1042/BJ20071614; Kapoor N, 2009, J BIOL CHEM, V284, P24526, DOI 10.1074/jbc.M109.037390; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Lin CY, 2008, FRONT BIOSCI-LANDMRK, V13, P621, DOI 10.2741/2707; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; List K, 2009, FUTURE ONCOL, V5, P97, DOI 10.2217/14796694.5.1.97; Meltzer RH, 2007, J BIOL CHEM, V282, P25548, DOI 10.1074/jbc.M703825200; Miyata S, 2007, HUM CELL, V20, P100, DOI 10.1111/j.1749-0774.2007.00035.x; Poirot O, 2004, J BIOL CHEM, V279, P38448, DOI 10.1074/jbc.M407381200; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Saugstad JA, 2004, J BIOL CHEM, V279, P55514, DOI 10.1074/jbc.M411849200; Shipway A, 2004, BIOCHEM BIOPH RES CO, V324, P953, DOI 10.1016/j.bbrc.2004.09.123; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Vila-Carriles WH, 2006, J BIOL CHEM, V281, P19220, DOI 10.1074/jbc.M603100200; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Vukicevic M, 2006, J BIOL CHEM, V281, P714, DOI 10.1074/jbc.M510472200; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014	29	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27130	27143		10.1074/jbc.M110.153213	http://dx.doi.org/10.1074/jbc.M110.153213			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20601429	Green Published, hybrid			2022-12-25	WOS:000281172700044
J	Kotchoni, SO; Jimenez-Lopez, JC; Gao, DY; Edwards, V; Gachomo, EW; Margam, VM; Seufferheld, MJ				Kotchoni, Simeon O.; Jimenez-Lopez, Jose C.; Gao, Dongying; Edwards, Vincent; Gachomo, Emma W.; Margam, Venu M.; Seufferheld, Manfredo J.			Modeling-Dependent Protein Characterization of the Rice Aldehyde Dehydrogenase (ALDH) Superfamily Reveals Distinct Functional and Structural Features	PLOS ONE			English	Article							GENE SUPERFAMILY; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; VIBRIO-HARVEYI; SALT TOLERANCE; EXPRESSION; PLANTS; STRESS; SPECIFICITY; EVOLUTION	The completion of the rice genome sequence has made it possible to identify and characterize new genes and to perform comparative genomics studies across taxa. The aldehyde dehydrogenase (ALDH) gene superfamily encoding for NAD(P)(+)-dependent enzymes is found in all major plant and animal taxa. However, the characterization of plant ALDHs has lagged behind their animal-and prokaryotic-ALDH homologs. In plants, ALDHs are involved in abiotic stress tolerance, male sterility restoration, embryo development and seed viability and maturation. However, there is still no structural property-dependent functional characterization of ALDH protein superfamily in plants. In this paper, we identify members of the rice ALDH gene superfamily and use the evolutionary nesting events of retrotransposons and protein-modeling-based structural reconstitution to report the genetic and molecular and structural features of each member of the rice ALDH superfamily in abiotic/biotic stress responses and developmental processes. Our results indicate that rice-ALDHs are the most expanded plant ALDHs ever characterized. This work represents the first report of specific structural features mediating functionality of the whole families of ALDHs in an organism ever characterized.	[Kotchoni, Simeon O.; Gao, Dongying; Edwards, Vincent] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Jimenez-Lopez, Jose C.] CSIC, Estn Expt Zaidin, Dept Biochem Cell & Mol Biol Plants, Granada, Spain; [Gachomo, Emma W.] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Margam, Venu M.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Seufferheld, Manfredo J.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); South Dakota State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Illinois System; University of Illinois Urbana-Champaign	Kotchoni, SO (corresponding author), Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA.	skotchon@purdue.edu	Jimenez-Lopez, Jose C./H-5896-2011; Margam, Venu M/E-5876-2010	Jimenez-Lopez, Jose C./0000-0002-1470-360X; Margam, Venu/0000-0001-6510-4618				Ahvazi B, 2000, BIOCHEM J, V349, P853, DOI 10.1042/bj3490853; ALTSHUL SF, 1997, NUCLEIC ACIDS RES, V25, P402; Bains J, 2008, J MOL BIOL, V379, P597, DOI 10.1016/j.jmb.2008.04.031; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bartels D, 2001, TRENDS PLANT SCI, V6, P284, DOI 10.1016/S1360-1385(01)01983-5; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bornberg-Bauer E, 2005, CELL MOL LIFE SCI, V62, P435, DOI 10.1007/s00018-004-4416-1; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Deuschle K, 2001, PLANT J, V27, P345, DOI 10.1046/j.1365-313X.2001.01101.x; Di Costanzo L, 2007, J MOL BIOL, V366, P481, DOI 10.1016/j.jmb.2006.11.023; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Estey T, 2007, EXP EYE RES, V84, P3, DOI 10.1016/j.exer.2006.04.010; FARRES J, 1995, BIOCHEMISTRY-US, V34, P2592, DOI 10.1021/bi00008a025; Gao CX, 2009, GENE, V431, P86, DOI 10.1016/j.gene.2008.11.010; Gonzalez-Segura L, 2009, J MOL BIOL, V385, P542, DOI 10.1016/j.jmb.2008.10.082; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hempel J, 2001, CHEM-BIOL INTERACT, V130, P39, DOI 10.1016/S0009-2797(00)00220-9; Igarashi Y, 1997, PLANT MOL BIOL, V33, P857, DOI 10.1023/A:1005702408601; Jiang N, 2004, CURR OPIN PLANT BIOL, V7, P115, DOI 10.1016/j.pbi.2004.01.004; Kahraman A, 2007, J MOL BIOL, V368, P283, DOI 10.1016/j.jmb.2007.01.086; Khoury GA, 2009, PROTEIN SCI, V18, P2125, DOI 10.1002/pro.227; Kim S, 2005, INDOOR AIR, V15, P317, DOI 10.1111/j.1600-0668.2005.00368.x; Kirch HH, 2005, PLANT MOL BIOL, V57, P315, DOI 10.1007/s11103-004-7796-6; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Kirch HH, 2001, PLANT J, V28, P555, DOI 10.1046/j.1365-313X.2001.01176.x; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kotchoni S, 2003, BULG J PLANT PHYSL S, V2003, P37; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; KOTCHONI SO, 2004, THESIS U BONN GERMAN; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LINDAHL R, 1992, CRIT REV BIOCHEM MOL, V27, P283, DOI 10.3109/10409239209082565; Liu F, 2002, PLANT PHYSIOL, V130, P1657, DOI 10.1104/pp.012336; Liu F, 2001, PLANT CELL, V13, P1063, DOI 10.1105/tpc.13.5.1063; Livesay DR, 2005, PROTEIN SCI, V14, P1158, DOI 10.1110/ps.041221105; Livesay DR, 2003, BIOCHEMISTRY-US, V42, P3464, DOI 10.1021/bi026918f; Marchitti SA, 2007, BIOCHEM BIOPH RES CO, V356, P792, DOI 10.1016/j.bbrc.2007.03.046; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; MARINO M, 1995, PROTEIN ENG, V8, P551, DOI 10.1093/protein/8.6.551; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Munoz-Clares RA, 2010, ARCH BIOCHEM BIOPHYS, V493, P71, DOI 10.1016/j.abb.2009.09.006; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Perozich J, 2001, CHEM-BIOL INTERACT, V130, P115, DOI 10.1016/S0009-2797(00)00227-1; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; Rodrigues SM, 2006, J EXP BOT, V57, P1909, DOI 10.1093/jxb/erj132; Rodriguez-Zavala J, 2001, CHEM-BIOL INTERACT, V130, P151, DOI 10.1016/S0009-2797(00)00230-1; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; Shin JH, 2009, PLANT PHYSIOL, V149, P905, DOI 10.1104/pp.108.130716; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; STROEHER VL, 1995, PLANT MOL BIOL, V27, P541, DOI 10.1007/BF00019320; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Tsuji H, 2003, FEBS LETT, V546, P369, DOI 10.1016/S0014-5793(03)00631-8; VANGUNSTEREN WF, 1996, BIOMOLECULAR SIMULAT, P96; Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004; Vasiliou Vasilis, 2005, Human Genomics, V2, P138; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WESSLER SR, 1995, CURR OPIN GENET DEV, V5, P814, DOI 10.1016/0959-437X(95)80016-X; Wood AJ, 2009, BRYOLOGIST, V112, P1, DOI 10.1639/0007-2745-112.1.1; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; Zhang L, 1999, BIOCHEMISTRY-US, V38, P11440, DOI 10.1021/bi991101g; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	69	38	40	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11516	10.1371/journal.pone.0011516	http://dx.doi.org/10.1371/journal.pone.0011516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634950	Green Published, Green Submitted, gold			2022-12-25	WOS:000279781600005
J	Park, B; Ying, HY; Shen, XA; Park, JS; Qiu, Y; Shyam, R; Yue, BYJT				Park, BumChan; Ying, Hongyu; Shen, Xiang; Park, Jeong-Seok; Qiu, Ye; Shyam, Rajalekshmy; Yue, Beatrice Y. J. T.			Impairment of Protein Trafficking upon Overexpression and Mutation of Optineurin	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; NF-KAPPA-B; CELL-DEATH; MOLECULAR-CLONING; PLASMA-MEMBRANE; GOLGI-APPARATUS; MYOSIN-VI; WILD-TYPE; MUTANT; RECEPTOR	Background: Glaucoma is a major blinding disease characterized by progressive loss of retinal ganglion cells (RGCs) and axons. Optineurin is one of the candidate genes identified so far. A mutation of Glu(50) to Lys (E50K) has been reported to be associated with a more progressive and severe disease. Optineurin, known to interact with Rab8, myosin VI and transferrin receptor (TfR), was speculated to have a role in protein trafficking. Here we determined whether, and how optineurin overexpression and E50K mutation affect the internalization of transferrin (Tf), widely used as a marker for receptor-mediated endocytosis. Methodology/Principal Findings: Human retinal pigment epithelial (RPE) and rat RGC5 cells transfected to overexpress wild type optineurin were incubated with Texas Red-Tf to evaluate Tf uptake. Granular structures or dots referred to as foci formed in perinuclear regions after transfection. An impairment of the Tf uptake was in addition observed in transfected cells. Compared to overexpression of the wild type, E50K mutation yielded an increased foci formation and a more pronounced defect in Tf uptake. Co-transfection with TfR, but not Rab8 or myosin VI, construct rescued the optineurin inhibitory effect, suggesting that TfR was the factor involved in the trafficking phenotype. Forced expression of both wild type and E50K optineurin rendered TfR to colocalize with the foci. Surface biotinylation experiments showed that the surface level of TfR was also reduced, leading presumably to an impeded Tf uptake. A non-consequential Leu(157) to Ala (L157A) mutation that displayed much reduced foci formation and TfR binding had normal TfR distribution, normal surface TfR level and normal Tf internalization. Conclusions/Significance: The present study demonstrates that overexpression of wild type optineurin results in impairment of the Tf uptake in RPE and RGC5 cells. The phenotype is related to the optineurin interaction with TfR. Our results further indicate that E50K induces more dramatic effects than the wild type optineurin, and is thus a gain-of-function mutation. The defective protein trafficking may be one of the underlying bases why glaucoma pathology develops in patients with E50K mutation.	[Park, BumChan; Ying, Hongyu; Shen, Xiang; Park, Jeong-Seok; Qiu, Ye; Shyam, Rajalekshmy; Yue, Beatrice Y. J. T.] Univ Illinois, Chicago Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Park, B (corresponding author), Univ Illinois, Chicago Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60680 USA.	beatyue@uic.edu		Shyam, Rajalekshmy/0000-0003-2154-4173	National Eye Institute, National Institutes of Health, Bethesda, Maryland [EY01792]; American Health Assistance Foundation, Clarksburg, Maryland;  [EY018828];  [EY005628];  [EY003890]; NATIONAL EYE INSTITUTE [R01EY003890, R01EY005628, R01EY018828, P30EY001792] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); American Health Assistance Foundation, Clarksburg, Maryland; ; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Grants EY018828, EY005628, and EY003890 (to B.Y.J.T.Y.) and Core Grant EY01792 from the National Eye Institute, National Institutes of Health, Bethesda, Maryland; and by a grant from the American Health Assistance Foundation, Clarksburg, Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; Aung T, 2005, INVEST OPHTH VIS SCI, V46, P2816, DOI 10.1167/iovs.04-1133; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; Chalasani ML, 2008, EXP EYE RES, V87, P1, DOI 10.1016/j.exer.2007.10.021; Chalasani ML, 2007, INVEST OPHTH VIS SCI, V48, P1607, DOI 10.1167/iovs.06-0834; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Chibalina MV, 2008, METHOD ENZYMOL, V438, P11, DOI 10.1016/S0076-6879(07)38002-6; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; De Marco N, 2006, J BIOL CHEM, V281, P16147, DOI 10.1074/jbc.M601467200; del Toro D, 2009, MOL BIOL CELL, V20, P1478, DOI 10.1091/mbc.E08-07-0726; Fan BJ, 2006, CLIN BIOCHEM, V39, P231, DOI 10.1016/j.clinbiochem.2005.11.010; Fernandez-Sanchez E, 2008, BIOCHEM J, V409, P669, DOI 10.1042/BJ20070533; Gonatas NK, 2006, J NEUROL SCI, V246, P21, DOI 10.1016/j.jns.2006.01.019; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; Hauser MA, 2006, J GLAUCOMA, V15, P358, DOI 10.1097/01.ijg.0000212255.17950.42; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Koga T, 2010, AM J PATHOL, V176, P343, DOI 10.2353/ajpath.2010.090194; Kroeber M, 2006, EXP EYE RES, V82, P1075, DOI 10.1016/j.exer.2005.11.004; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Laifenfeld D, 2007, J NEUROSCI, V27, P7141, DOI 10.1523/JNEUROSCI.4599-06.2007; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; Magadan JG, 2006, MOL CELL BIOL, V26, P2595, DOI 10.1128/MCB.26.7.2595-2614.2006; Moreland RJ, 2000, NUCLEIC ACIDS RES, V28, P1986, DOI 10.1093/nar/28.9.1986; Morino C, 2004, EXP CELL RES, V297, P380, DOI 10.1016/j.yexcr.2004.03.038; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Nagabhushana A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-4; Park BC, 2006, AM J PATHOL, V169, P1976, DOI 10.2353/ajpath.2006.060400; Park SY, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-43; Perret E, 2005, CURR OPIN CELL BIOL, V17, P423, DOI 10.1016/j.ceb.2005.06.008; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Ramjeesingh M, 2003, BIOCHEM J, V374, P793, DOI 10.1042/BJ20030683; Rezaie T, 2005, INVEST OPHTH VIS SCI, V46, P2404, DOI 10.1167/iovs.04-1243; Rezaie T, 2005, GENOMICS, V85, P131, DOI 10.1016/j.ygeno.2004.10.011; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Schwamborn K, 2000, J BIOL CHEM, V275, P22780, DOI 10.1074/jbc.M001500200; Shen X, 2008, J BIOL CHEM, V283, P603, DOI 10.1074/jbc.M708250200; Strick DJ, 2005, MOL BIOL CELL, V16, P5699, DOI 10.1091/mbc.E05-03-0204; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Tezel G, 2008, PROG BRAIN RES, V173, P409, DOI 10.1016/S0079-6123(08)01128-X; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Vittitow JL, 2002, BIOCHEM BIOPH RES CO, V298, P67, DOI 10.1016/S0006-291X(02)02395-1; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30; Ying HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009168; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	54	47	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11547	10.1371/journal.pone.0011547	http://dx.doi.org/10.1371/journal.pone.0011547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634958	Green Published, Green Submitted, gold			2022-12-25	WOS:000279781600024
J	Kahsai, L; Kapan, N; Dircksen, H; Winther, AME; Nassel, DR				Kahsai, Lily; Kapan, Neval; Dircksen, Heinrich; Winther, Asa M. E.; Nassel, Dick R.			Metabolic Stress Responses in Drosophila Are Modulated by Brain Neurosecretory Cells That Produce Multiple Neuropeptides	PLOS ONE			English	Article							TACHYKININ-RELATED PEPTIDES; ION-TRANSPORT PEPTIDE; CENTRAL-NERVOUS-SYSTEM; INSULIN-LIKE PEPTIDES; RETROCEREBRAL COMPLEX; FUNCTIONAL-CHARACTERIZATION; ADIPOKINETIC HORMONE; LOCUSTATACHYKININ-I; MALPIGHIAN TUBULES; FLUID SECRETION	In Drosophila, neurosecretory cells that release peptide hormones play a prominent role in the regulation of development, growth, metabolism, and reproduction. Several types of peptidergic neurosecretory cells have been identified in the brain of Drosophila with release sites in the corpora cardiaca and anterior aorta. We show here that in adult flies the products of three neuropeptide precursors are colocalized in five pairs of large protocerebral neurosecretory cells in two clusters (designated ipc-1 and ipc-2a): Drosophila tachykinin (DTK), short neuropeptide F (sNPF) and ion transport peptide (ITP). These peptides were detected by immunocytochemistry in combination with GFP expression driven by the enhancer trap Gal4 lines c929 and Kurs-6, both of which are expressed in ipc-1 and 2a cells. This mix of colocalized peptides with seemingly unrelated functions is intriguing and prompted us to initiate analysis of the function of the ten neurosecretory cells. We investigated the role of peptide signaling from large ipc-1 and 2a cells in stress responses by monitoring the effect of starvation and desiccation in flies with levels of DTK or sNPF diminished by RNA interference. Using the Gal4-UAS system we targeted the peptide knockdown specifically to ipc-1 and 2a cells with the c929 and Kurs-6 drivers. Flies with reduced DTK or sNPF levels in these cells displayed decreased survival time at desiccation and starvation, as well as increased water loss at desiccation. Our data suggest that homeostasis during metabolic stress requires intact peptide signaling by ipc-1 and 2a neurosecretory cells.	[Kahsai, Lily; Kapan, Neval; Dircksen, Heinrich; Winther, Asa M. E.; Nassel, Dick R.] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Stockholm University	Kahsai, L (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	dnassel@zoologi.su.se	Dircksen, Heinrich/C-7704-2013; Winther, Åsa/E-8842-2010	Dircksen, Heinrich/0000-0001-7815-4868; 	Swedish Research Council [621- 2007-6500]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by the Swedish Research Council (VR, Grant 621- 2007-6500; http://www.vr.se/) to D. R. Nassel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUDSLEY N, 1992, J EXP BIOL, V173, P261; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Birse RT, 2006, J NEUROBIOL, V66, P33, DOI 10.1002/neu.20189; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; BROWN MR, 1994, J INSECT PHYSIOL, V40, P399, DOI 10.1016/0022-1910(94)90158-9; Cabrero P, 2002, J EXP BIOL, V205, P3799; CANTERA R, 1992, CELL TISSUE RES, V269, P459, DOI 10.1007/BF00353901; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Choi MY, 2001, CELL TISSUE RES, V306, P459, DOI 10.1007/s00441-001-0467-x; Choi YJ, 2005, J COMP NEUROL, V482, P372, DOI 10.1002/cne.20419; Coast GM, 2002, ADV INSECT PHYSIOL, V29, P279, DOI 10.1016/S0065-2806(02)29004-9; Dircksen H, 2008, J COMP NEUROL, V509, P23, DOI 10.1002/cne.21715; Dircksen H, 2009, J EXP BIOL, V212, P401, DOI 10.1242/jeb.026112; Ewer J, 2005, HORM BEHAV, V48, P418, DOI 10.1016/j.yhbeh.2005.05.018; Feng GP, 2003, EUR J NEUROSCI, V18, P227, DOI 10.1046/j.1460-9568.2003.02719.x; Gade G, 1997, PHYSIOL REV, V77, P963, DOI 10.1152/physrev.1997.77.4.963; Geminard C, 2006, DIABETES, V55, pS5, DOI 10.2337/db06-S001; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Glantz RM, 2000, J NEUROSCI, V20, P1780; Hamanaka Y, 2004, CELL TISSUE RES, V318, P403, DOI 10.1007/s00441-004-0935-1; Hamanaka Y, 2007, CELL TISSUE RES, V329, P581, DOI 10.1007/s00441-007-0433-3; Hartenstein V, 2006, J ENDOCRINOL, V190, P555, DOI 10.1677/joe.1.06964; Hewes RS, 2003, DEVELOPMENT, V130, P1771, DOI 10.1242/dev.00404; HOMBERG U, 1991, J COMP NEUROL, V303, P35, DOI 10.1002/cne.903030105; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; Johard HAD, 2003, PEPTIDES, V24, P1571, DOI 10.1016/j.peptides.2003.08.012; Johard HAD, 2008, J COMP NEUROL, V507, P1479, DOI 10.1002/cne.21636; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; JOHNSON EC, 2006, INVERTEBRATE NEUROPE, P1; Kean L, 2002, AM J PHYSIOL-REG I, V282, pR1297, DOI 10.1152/ajpregu.00584.2001; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Lange AB, 2001, PEPTIDES, V22, P229, DOI 10.1016/S0196-9781(00)00386-7; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; LEE KS, 2008, NAT CELL BIOL; Lee KS, 2009, FEBS LETT, V583, P2573, DOI 10.1016/j.febslet.2009.07.024; MATSUMOTO S, 1989, INSECT BIOCHEM, V19, P277, DOI 10.1016/0020-1790(89)90073-5; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Mertens I, 2002, BIOCHEM BIOPH RES CO, V297, P1140, DOI 10.1016/S0006-291X(02)02351-3; Nassel DR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-90; NASSEL DR, 1995, REGUL PEPTIDES, V57, P297, DOI 10.1016/0167-0115(95)00043-B; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; Nassel DR, 1999, PEPTIDES, V20, P141, DOI 10.1016/S0196-9781(98)00142-9; Nichols R, 2003, ANNU REV ENTOMOL, V48, P485, DOI 10.1146/annurev.ento.48.091801.112525; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; POELS J, 2008, PEPTIDES; Predel R, 2004, J COMP NEUROL, V474, P379, DOI 10.1002/cne.20145; Raabe M, 1989, RECENT DEV INSECT NE; Radford JC, 2002, J BIOL CHEM, V277, P38810, DOI 10.1074/jbc.M203694200; Reale V, 2004, EUR J NEUROSCI, V19, P570, DOI 10.1111/j.0953-816X.2003.03141.x; Ring M, 1998, INSECT BIOCHEM MOLEC, V28, P51, DOI 10.1016/S0965-1748(97)00096-9; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Siviter RJ, 2000, J BIOL CHEM, V275, P23273, DOI 10.1074/jbc.M002875200; Skaer NJV, 2002, J EXP BIOL, V205, P1869; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Veenstra JA, 2009, INSECT BIOCHEM MOLEC, V39, P755, DOI 10.1016/j.ibmb.2009.09.008; Veenstra JA, 2008, CELL TISSUE RES, V334, P499, DOI 10.1007/s00441-008-0708-3; Wegener C, 2006, J NEUROCHEM, V96, P1362, DOI 10.1111/j.1471-4159.2005.03634.x; Winther AME, 2006, MOL CELL NEUROSCI, V31, P399, DOI 10.1016/j.mcn.2005.10.010; Winther AME, 2003, J COMP NEUROL, V464, P180, DOI 10.1002/cne.10790; Winther AME, 2001, J EXP BIOL, V204, P1269; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102	68	67	67	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11480	10.1371/journal.pone.0011480	http://dx.doi.org/10.1371/journal.pone.0011480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628603	Green Published, Green Submitted, gold			2022-12-25	WOS:000279637100010
J	Noben-Trauth, K; Latoche, JR; Neely, HR; Bennett, B				Noben-Trauth, Konrad; Latoche, Joseph R.; Neely, Harold R.; Bennett, Beth			Phenotype and Genetics of Progressive Sensorineural Hearing Loss (Snhl1) in the LXS Set of Recombinant Inbred Strains of Mice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MOUSE; IMPAIRMENT; INHERITANCE	Progressive sensorineural hearing loss is the most common form of acquired hearing impairment in the human population. It is also highly prevalent in inbred strains of mice, providing an experimental avenue to systematically map genetic risk factors and to dissect the molecular pathways that orchestrate hearing in peripheral sensory hair cells. Therefore, we ascertained hearing function in the inbred long sleep (ILS) and inbred short sleep (ISS) strains. Using auditory-evoked brain stem response (ABR) and distortion product otoacoustic emission (DPOAE) measurements, we found that ISS mice developed a high-frequency hearing loss at twelve weeks of age that progressed to lower frequencies by 26 weeks of age in the presence of normal endocochlear potentials and unremarkable inner ear histology. ILS mice exhibited milder hearing loss, showing elevated thresholds and reduced DPOAEs at the higher frequencies by 26 weeks of age. To map the genetic variants that underlie this hearing loss we computed ABR thresholds of 63 recombinant inbred stains derived from the ISS and ILS founder strains. A single locus was linked to markers associated with ISS alleles on chromosome 10 with a highly significant logarithm of odds (LOD) score of 15.8. The 2-LOD confidence interval spans,4 Megabases located at position 54-60 Mb. This locus, termed sensorineural hearing loss 1 (Snhl1), accounts for approximately 82% of the phenotypic variation. In summary, this study identifies a novel hearing loss locus on chromosome 10 and attests to the prevalence and genetic heterogeneity of progressive hearing loss in common mouse strains.	[Noben-Trauth, Konrad; Latoche, Joseph R.; Neely, Harold R.] Natl Inst Deafness & Other Commun Disorders, Neurogenet Sect, Mol Biol Lab, NIH, Rockville, MD USA; [Bennett, Beth] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Colorado System; University of Colorado Boulder	Noben-Trauth, K (corresponding author), Natl Inst Deafness & Other Commun Disorders, Neurogenet Sect, Mol Biol Lab, NIH, Rockville, MD USA.	nobentk@nidcd.nih.gov			National Institutes of Health (NIH) [RO1AA08940]; University of Colorado; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA008940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000056] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Intramural Research Program at the National Institutes of Health (NIH) (KNT), by funds from the University of Colorado and grants from the NIH (RO1AA08940, BB) www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown SDM, 2008, NAT REV GENET, V9, P277, DOI 10.1038/nrg2309; Drayton M, 2006, HEARING RES, V212, P128, DOI 10.1016/j.heares.2005.11.006; Friedman RA, 2009, HUM MOL GENET, V18, P785, DOI 10.1093/hmg/ddn402; Hendrickx JJ, 2007, B-ENT, P51; Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831; Konings A, 2009, EAR HEARING, V30, P151, DOI 10.1097/AUD.0b013e3181987080; Leibovici M, 2008, CURR TOP DEV BIOL, V84, P385, DOI 10.1016/S0070-2153(08)00608-X; Liu XZ, 2007, J PATHOL, V211, P188, DOI 10.1002/path.2102; Martin GK, 2007, HEARING RES, V234, P59, DOI 10.1016/j.heares.2007.09.002; Mashimo T, 2006, MAMM GENOME, V17, P841, DOI 10.1007/s00335-004-2438-5; MCCLEARN GE, 1970, ANNU REV GENET, V4, P437, DOI 10.1146/annurev.ge.04.120170.002253; Nemoto M, 2004, BIOCHEM BIOPH RES CO, V324, P1283, DOI 10.1016/j.bbrc.2004.09.186; *NIDCD, 2010, STAT EP; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Noben-Trauth K, 2009, BRAIN RES, V1277, P42, DOI 10.1016/j.brainres.2009.02.012; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Van Eyken E, 2007, AUDIOL NEURO-OTOL, V12, P345, DOI 10.1159/000106478; Williams RW, 2004, MAMM GENOME, V15, P637, DOI 10.1007/s00335-004-2380-6; Witmer PD, 2003, GENOME RES, V13, P485, DOI 10.1101/gr.717903; Zheng QY, 2009, NEUROBIOL AGING, V30, P1693, DOI 10.1016/j.neurobiolaging.2007.12.011; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	21	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11459	10.1371/journal.pone.0011459	http://dx.doi.org/10.1371/journal.pone.0011459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628639	Green Published, gold, Green Submitted			2022-12-25	WOS:000279589300007
J	Epeldegui, M; Thapa, DR; De La Cruz, J; Kitchen, S; Zack, JA; Martinez-Maza, O				Epeldegui, Marta; Thapa, Dharma R.; De La Cruz, Justin; Kitchen, Scott; Zack, Jerome A.; Martinez-Maza, Otoniel			CD40 Ligand (CD154) Incorporated into HIV Virions Induces Activation-Induced Cytidine Deaminase (AID) Expression in Human B Lymphocytes	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; ACTIVE ANTIRETROVIRAL THERAPY; CLASS SWITCH RECOMBINATION; BLOOD MONONUCLEAR-CELLS; NON-HODGKINS-LYMPHOMA; CD4(+) T-CELLS; VIRUS INFECTION; HOMOSEXUAL MEN; SERUM-LEVELS; IMMUNOGLOBULIN	Most AIDS-associated non-Hodgkin's lymphoma (AIDS-NHL) arises fromerrors in immunoglobulin heavy-chain gene (IgH) class switch recombination (CSR) or somatic hypermutation (SHM), events that occur in germinal center (GC) B cells and require the activity of activation induced cytidine deaminase (AID). Several oncogenic viruses (EBV, HCV, HPV) can induce AID gene (AID) expression, and elevated AID expression is seen in circulating lymphocytes prior to AIDS-NHL diagnosis. Here, we report that HIV produced in peripheral blood mononuclear cells (PBMC) induced AID expression in normal human B cells. Since HIV produced in PBMC contains host cell CD40 ligand (CD40L) incorporated into the viral membrane, and CD40L is known to induce AID expression in human B cells, the role of virion-associated CD40L in HIV-induced AID expression was examined. Only viruses expressing functional CD40L were seen to induce AID expression; CD40L-negative HIV did not induce AID expression. The induction of AID expression by CD40L+ HIV was abrogated by addition of blocking anti-CD40L antibody. AID protein was detected in B cells exposed to CD40L+ HIV using intracellular multicolor flow cytometry, with most AID producing B cells expressing the CD71 activation marker on their surface. Therefore, HIV virions that express CD40L induce AID expression in B cells, and this induction appears to be due to a direct interaction between CD40L on these viruses and CD40 on B cells. These findings are consistent with a role for HIV in the direct stimulation of B cells, potentially leading to the accumulation of molecular lesions that have the potential to contribute to the development of NHL.	[Epeldegui, Marta; Thapa, Dharma R.; De La Cruz, Justin; Zack, Jerome A.; Martinez-Maza, Otoniel] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol, Los Angeles, CA 90095 USA; [Epeldegui, Marta; Thapa, Dharma R.; De La Cruz, Justin; Zack, Jerome A.; Martinez-Maza, Otoniel] Univ Calif Los Angeles, David Geffen Sch Med, Dept Immunol, Los Angeles, CA 90095 USA; [Epeldegui, Marta; Thapa, Dharma R.; De La Cruz, Justin; Zack, Jerome A.; Martinez-Maza, Otoniel] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol Genet, Los Angeles, CA 90095 USA; [Kitchen, Scott; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Kitchen, Scott; Zack, Jerome A.; Martinez-Maza, Otoniel] Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA 90095 USA; [Martinez-Maza, Otoniel] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Zack, Jerome A.; Martinez-Maza, Otoniel] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA; [Martinez-Maza, Otoniel] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Epeldegui, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol, Los Angeles, CA 90095 USA.	omartinez@mednet.ucla.edu	Martinez-Maza, Otoniel/B-2667-2009; Thapa, Dharma/C-2854-2012	Martinez-Maza, Otoniel/0000-0003-1364-0675; 	NIH [R01-CA57152, P50-CA96888, U01-AI35040, T32-CA009120]; University of California [D04-LA-403, ID05-LA-047]; UCLA Center for AIDS Research (CFAR) NIH/NIAID [AI028697]; NATIONAL CANCER INSTITUTE [R01CA057152, P50CA096888, T32CA009120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035040, P30AI028697] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); UCLA Center for AIDS Research (CFAR) NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by NIH grants R01-CA57152, P50-CA96888, U01-AI35040 and T32-CA009120, as well as by grants from the University-wide AIDS Research Program of the University of California (D04-LA-403 and ID05-LA-047). UCLA AIDS Institute core facilities used in this study were supported by an NIH grant: UCLA Center for AIDS Research (CFAR) NIH/NIAID AI028697. This work was carried out in the facilities of the UCLA AIDS Institute, which were supported, in part, by funds from the James B. Pendleton Charitable Trust and the McCarthy Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADORI A, 1991, AIDS, V5, P821, DOI 10.1097/00002030-199107000-00005; AMADORI A, 1990, IMMUNOL TODAY, V11, P374, DOI 10.1016/0167-5699(90)90144-X; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; BERBERIAN L, 1993, SCIENCE, V261, P1588, DOI 10.1126/science.7690497; BIRX DL, 1990, BLOOD, V76, P2303; Bonnet F, 2006, CLIN INFECT DIS, V42, P411, DOI 10.1086/499054; Bonnet F, 2004, CANCER-AM CANCER SOC, V101, P317, DOI 10.1002/cncr.20354; Boshoff C, 2002, NAT REV CANCER, V2, P373, DOI 10.1038/nrc797; Breen EC, 2006, TUMOR BIOL, V27, P187, DOI 10.1159/000093022; Breen EC, 2005, AIDS, V19, P1711, DOI 10.1097/01.aids.0000184924.04983.7c; Breen EC, 2003, CLIN IMMUNOL, V109, P119, DOI 10.1016/S1521-6616(03)00214-6; BREEN EC, 1990, J IMMUNOL, V144, P480; Dorsett Y, 2007, J EXP MED, V204, P2225, DOI 10.1084/jem.20070884; Epeldegui M, 2007, AIDS, V21, P2265, DOI 10.1097/QAD.0b013e3282ef9f59; Epeldegui M, 2007, MOL IMMUNOL, V44, P934, DOI 10.1016/j.molimm.2006.03.018; Epeldegui M, 2006, CURR OPIN ONCOL, V18, P444, DOI 10.1097/01.cco.0000239882.23839.e5; He B, 2003, J IMMUNOL, V171, P5215, DOI 10.4049/jimmunol.171.10.5215; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Malaspina A, 2006, P NATL ACAD SCI USA, V103, P2262, DOI 10.1073/pnas.0511094103; Martin G, 2004, CLIN IMMUNOL, V111, P275, DOI 10.1016/j.clim.2004.02.004; Martin G, 2007, J VIROL, V81, P5872, DOI 10.1128/JVI.02542-06; Martinez-Maza O, 2002, CURR OPIN ONCOL, V14, P528, DOI 10.1097/00001622-200209000-00009; MARTINEZMAZA O, 1987, J IMMUNOL, V138, P3720; MARTINEZMAZA O, 1992, RES IMMUNOL, V143, P764, DOI 10.1016/0923-2494(92)80020-L; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; MIZUMA H, 1988, CLIN EXP IMMUNOL, V71, P410; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; PAHWA SG, 1984, ANN INTERN MED, V101, P757, DOI 10.7326/0003-4819-101-6-757; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; PLUDA JM, 1993, J CLIN ONCOL, V11, P1099, DOI 10.1200/JCO.1993.11.6.1099; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Reiser J, 1996, P NATL ACAD SCI USA, V93, P15266, DOI 10.1073/pnas.93.26.15266; Rosina J, 2007, PHYSIOL RES, V56, pS93, DOI 10.33549/physiolres.931306; SCHNITTMAN SM, 1986, SCIENCE, V233, P1084, DOI 10.1126/science.3016902; SCHROFF RW, 1983, CLIN IMMUNOL IMMUNOP, V27, P300, DOI 10.1016/0090-1229(83)90083-1; Swingler S, 2008, CELL HOST MICROBE, V4, P63, DOI 10.1016/j.chom.2008.05.015; Vatakis DN, 2007, J VIROL, V81, P3574, DOI 10.1128/JVI.02569-06; YAWETZ S, 1995, BLOOD, V85, P1843, DOI 10.1182/blood.V85.7.1843.bloodjournal8571843	39	39	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11448	10.1371/journal.pone.0011448	http://dx.doi.org/10.1371/journal.pone.0011448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625427	Green Submitted, Green Published, gold			2022-12-25	WOS:000279522500015
J	McKinnon, LR; Kimani, M; Wachihi, C; Nagelkerke, NJ; Muriuki, FK; Kariri, A; Lester, RT; Gelmon, L; Ball, TB; Plummer, FA; Kaul, R; Kimani, J				McKinnon, Lyle R.; Kimani, Makobu; Wachihi, Charles; Nagelkerke, Nico J.; Muriuki, Festus K.; Kariri, Anthony; Lester, Richard T.; Gelmon, Lawrence; Ball, T. Blake; Plummer, Francis A.; Kaul, Rupert; Kimani, Joshua			Effect of Baseline HIV Disease Parameters on CD4+T Cell Recovery After Antiretroviral Therapy Initiation in Kenyan Women	PLOS ONE			English	Article							HIV-1-INFECTED PATIENTS; INFECTED PATIENTS; IMMUNODEFICIENCY; ACTIVATION; RECONSTITUTION; COHORT; RISK	Background: Antiretroviral therapy (ART) for HIV infection reconstitutes the immune system and improves survival. However, the rate and extent of CD4+ T cell recovery varies widely. We assessed the impact of several factors on immune reconstitution in a large Kenyan cohort. Methodology/Principal Findings: HIV-infected female sex workers from a longitudinal cohort, with at least 1 year of pre-ART and 6 months of post-ART follow-up (n = 79), were enrolled in the current study. The median pre-ART follow-up was 4,040 days. CD4 counts were measured biannually and viral loads where available. The median CD4 count at ART initiation was 180 cells/ul, which increased to 339 cells/ul at the most recent study visit. The rate of CD4+ T cell increase on ART was 7.91 cells/month (mean = 13, range -25.92 to 169.4). LTNP status prior to ART initiation did not associate with the rate of CD4 recovery on ART. In univariate analyses, associations were observed for CD4 recovery rate and duration of pre-ART immunosuppression (r = -0.326, p = 0.004) and CD4 nadir (r = 0.284, p = 0.012). In multivariate analysis including age, CD4 nadir, duration of HIV infection, duration of pre-ART immunosuppression, and baseline viral load, only CD4 nadir (p = 0.007) and not duration of immunosupression (p = 0.87) remained significantly associated with the rate of CD4 recovery. Conclusions/Significance: These data suggest that prior duration of immune suppression does not predict subsequent recovery once ART is initiated and confirm the previous observation that the degree of CD4 depletion prior to ART initiation is the most important determinant of subsequent immune reconstitution.	[McKinnon, Lyle R.; Kaul, Rupert] Univ Toronto, Dept Med, Toronto, ON, Canada; [McKinnon, Lyle R.; Kimani, Makobu; Wachihi, Charles; Muriuki, Festus K.; Kariri, Anthony; Lester, Richard T.; Gelmon, Lawrence; Plummer, Francis A.; Kaul, Rupert; Kimani, Joshua] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Nagelkerke, Nico J.] United Arab Emirates Univ, Dept Community Med, Al Ain, U Arab Emirates; [Lester, Richard T.; Gelmon, Lawrence; Ball, T. Blake; Plummer, Francis A.; Kimani, Joshua] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Ball, T. Blake] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Ball, T. Blake] Publ Hlth Agcy Canada, Lab HIV Immunol, Winnipeg, MB, Canada; [Plummer, Francis A.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	University of Toronto; University of Nairobi; United Arab Emirates University; University of Manitoba; University of Manitoba; Public Health Agency of Canada; Public Health Agency of Canada	McKinnon, LR (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	sijuisijali@gmail.com	Kimani, Makobu/V-6369-2019	Kimani, Makobu/0000-0001-9275-4018; McKinnon, Lyle/0000-0002-7157-0700; Kaul, Rupert/0000-0002-1586-4093	United States President's Plan for AIDS Relief (PEPFAR) [U62/CCU024510-05]; National Institutes of Health [R01 AI56980 A1]; Canadian Institutes of Health Research (CIHR) through the Grand Challenges in Global Health Initiative [HOP-43135, MOP-89983]; Bill and Melinda Gates FoundationCanada Research Chair; International Infectious Diseases and Global Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056980] Funding Source: NIH RePORTER	United States President's Plan for AIDS Relief (PEPFAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR) through the Grand Challenges in Global Health Initiative(Canadian Institutes of Health Research (CIHR)); Bill and Melinda Gates FoundationCanada Research Chair; International Infectious Diseases and Global Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for these studies was provided by the United States President's Plan for AIDS Relief (PEPFAR) Grant no. U62/CCU024510-05, as well as grants from the National Institutes of Health (R01 AI56980 A1), the Canadian Institutes of Health Research (HOP-43135), the Bill and Melinda Gates Foundation, and the Canadian Institutes of Health Research (CIHR) through the Grand Challenges in Global Health Initiative to FP, and Canadian Institutes of Health Research (CIHR) (MOP-89983) to RK. Salary support for FP and RK is provided by the Canada Research Chair program, and for LM by a CIHR Biomedical/Clinical HIV/AIDS Research Fellowship and the International Infectious Diseases and Global Health Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KB, 2003, JAIDS-J ACQ IMM DEF, V33, P125, DOI 10.1097/00126334-200306010-00002; Benito DM, 2005, JAIDS-J ACQ IMM DEF, V38, P373, DOI 10.1097/01.qai.0000153105.42455.c2; Benveniste O, 2005, J INFECT DIS, V191, P1670, DOI 10.1086/429670; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Delobel P, 2006, J VIROL, V80, P10229, DOI 10.1128/JVI.00965-06; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Goicoechea M, 2006, J INFECT DIS, V194, P29, DOI 10.1086/504718; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Micheloud D, 2008, J INFECTION, V56, P130, DOI 10.1016/j.jinf.2007.12.001; Miro JM, 2006, CLIN INFECT DIS, V43, P79, DOI 10.1086/504872; Okulicz JF, 2010, CLIN INFECT DIS, V50, P1187, DOI 10.1086/651421; Robbins GK, 2009, CLIN INFECT DIS, V48, P350, DOI 10.1086/595888; Siddique MA, 2006, J INFECT DIS, V194, P661, DOI 10.1086/505913; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7	18	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11434	10.1371/journal.pone.0011434	http://dx.doi.org/10.1371/journal.pone.0011434			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625393	Green Published, Green Submitted, gold			2022-12-25	WOS:000279465700016
J	Christensen, A; Svensson, K; Thelin, L; Zhang, WJ; Tintor, N; Prins, D; Funke, N; Michalak, M; Schulze-Lefert, P; Saijo, Y; Sommarin, M; Widell, S; Persson, S				Christensen, Anna; Svensson, Karin; Thelin, Lisa; Zhang, Wenjing; Tintor, Nico; Prins, Daniel; Funke, Norma; Michalak, Marek; Schulze-Lefert, Paul; Saijo, Yusuke; Sommarin, Marianne; Widell, Susanne; Persson, Staffan			Higher Plant Calreticulins Have Acquired Specialized Functions in Arabidopsis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; EXPRESSION; PROTEIN; IDENTIFICATION; CALCIUM; GENE; CHAPERONE; RECEPTOR; CALNEXIN	Background: Calreticulin (CRT) is a ubiquitous ER protein involved in multiple cellular processes in animals, such as protein folding and calcium homeostasis. Like in animals, plants have evolved divergent CRTs, but their physiological functions are less understood. Arabidopsis contains three CRT proteins, where the two CRTs AtCRT1a and CRT1b represent one subgroup, and AtCRT3 a divergent member. Methodology/Principal Findings: Through expression of single Arabidopsis family members in CRT-deficient mouse fibroblasts we show that both subgroups have retained basic CRT functions, including ER Ca2+-holding potential and putative chaperone capabilities. However, other more general cellular defects due to the absence of CRT in the fibroblasts, such as cell adhesion deficiencies, were not fully restored. Furthermore, in planta expression, protein localization and mutant analyses revealed that the three Arabidopsis CRTs have acquired specialized functions. The AtCRT1a and CRT1b family members appear to be components of a general ER chaperone network. In contrast, and as recently shown, AtCRT3 is associated with immune responses, and is essential for responsiveness to the bacterial Pathogen-Associated Molecular Pattern (PAMP) elf18, derived from elongation factor (EF)-Tu. Whereas constitutively expressed AtCRT1a fully complemented Atcrt1b mutants, AtCRT3 did not. Conclusions/Significance: We conclude that the physiological functions of the two CRT subgroups in Arabidopsis have diverged, resulting in a role for AtCRT3 in PAMP associated responses, and possibly more general chaperone functions for AtCRT1a and CRT1b.	[Christensen, Anna; Thelin, Lisa; Sommarin, Marianne] Lund Univ, Dept Biochem, Ctr Chem & Chem Engn, Lund, Sweden; [Christensen, Anna; Sommarin, Marianne] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Svensson, Karin; Zhang, Wenjing; Widell, Susanne] Lund Univ, Dept Cell & Organism Biol, Lund, Sweden; [Tintor, Nico; Schulze-Lefert, Paul; Saijo, Yusuke] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany; [Prins, Daniel; Michalak, Marek] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Persson, Staffan] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	Lund University; Umea University; Lund University; Max Planck Society; University of Alberta; Max Planck Society	Christensen, A (corresponding author), Lund Univ, Dept Biochem, Ctr Chem & Chem Engn, Lund, Sweden.	persson@mpimp-golm.mpg.de	Persson, Staffan/S-8399-2016; Schulze-Lefert, Paul/B-6707-2011	Persson, Staffan/0000-0002-6377-5132; 	Max-Planck Gesellschaft; Canadian Institute of Health Research [MOP-15291]; Alberta Heritage for Medical; Swedish Research Council; Swedish Foundation for Strategic Research; Swedish Research Council Formas; Carl Tryggers Foundation	Max-Planck Gesellschaft(Max Planck Society); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage for Medical; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Carl Tryggers Foundation	NF and SP were funded through the Max-Planck Gesellschaft. MM is supported by the Canadian Institute of Health Research (MOP-15291), and DP was supported by an Alberta Heritage for Medical Research Summer Student Award. MS was supported by the Swedish Research Council, Swedish Foundation for Strategic Research, and The Swedish Research Council Formas. SW was supported by the Carl Tryggers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson A, 2005, PHYSIOL PLANTARUM, V123, P92, DOI 10.1111/j.1399-3054.2004.00434.x; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BAKSH S, 1991, J BIOL CHEM, V266, P21458; Baluska F, 1999, PLANT J, V19, P481, DOI 10.1046/j.1365-313X.1999.00530.x; BECHTOLD N, 1994, GENE TRANSFER PLANTS, P19; Bedard K, 2005, INT REV CYTOL, V245, P91, DOI 10.1016/S0074-7696(05)45004-4; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Borisjuk N, 1998, PLANTA, V206, P504, DOI 10.1007/s004250050427; CHEN FQ, 1994, PLANT CELL, V6, P835, DOI 10.1105/tpc.6.6.835; Christensen A, 2008, PLANT CELL PHYSIOL, V49, P912, DOI 10.1093/pcp/pcn065; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Coughlan SJ, 1997, PLANT MOL BIOL, V34, P897, DOI 10.1023/A:1005822327479; Crofts AJ, 1998, TRENDS PLANT SCI, V3, P396, DOI 10.1016/S1360-1385(98)01312-0; Day B, 2006, PLANT CELL, V18, P2782, DOI 10.1105/tpc.106.044693; DENECKE J, 1995, PLANT CELL, V7, P391, DOI 10.1105/tpc.7.4.391; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Fadel MP, 2001, J BIOL CHEM, V276, P27083, DOI 10.1074/jbc.M101676200; Jia XY, 2008, J EXP BOT, V59, P739, DOI 10.1093/jxb/erm369; Jia XY, 2009, PHYSIOL PLANTARUM, V136, P127, DOI [10.1111/j.1399-3054.2009.1223.x, 10.1111/j.1399-3054.2009.01223.x]; Jin H, 2009, P NATL ACAD SCI USA, V106, P13612, DOI 10.1073/pnas.0906144106; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LeClere S, 2001, PLANT MOL BIOL, V46, P695, DOI 10.1023/A:1011699722052; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Li ZG, 2008, PROG NAT SCI, V18, P1219, DOI 10.1016/j.pnsc.2008.02.013; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Meyers BC, 2002, PLANT J, V32, P77, DOI 10.1046/j.1365-313X.2002.01404.x; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Mutwil M, 2008, NUCLEIC ACIDS RES, V36, pW320, DOI 10.1093/nar/gkn292; Mutwil M, 2010, PLANT PHYSIOL, V152, P29, DOI 10.1104/pp.109.145318; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; NAPIER RM, 1995, J EXP BOT, V46, P1603, DOI 10.1093/jxb/46.10.1603; Navazio L, 2002, BIOCHEMISTRY-US, V41, P14141, DOI 10.1021/bi0204701; Nelson DE, 1997, PLANT PHYSIOL, V114, P29, DOI 10.1104/pp.114.1.29; Opas M, 1996, J CELL BIOL, V135, P1913, DOI 10.1083/jcb.135.6.1913; Opas M, 1996, PROTOPLASMA, V191, P164, DOI 10.1007/BF01281814; Papp S, 2007, J BIOL CHEM, V282, P16585, DOI 10.1074/jbc.M701011200; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Persson S, 2003, PLANT PHYSIOL, V133, P1385, DOI 10.1104/pp.103.024943; Persson S, 2002, GENE, V297, P151, DOI 10.1016/S0378-1119(02)00880-6; Persson S, 2001, PLANT PHYSIOL, V126, P1092, DOI 10.1104/pp.126.3.1092; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; ROBERTSON D, 1992, J MICROSC-OXFORD, V168, P85, DOI 10.1111/j.1365-2818.1992.tb03253.x; Saijo Y, 2009, EMBO J, V28, P3439, DOI 10.1038/emboj.2009.263; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Williams CM, 1997, SEX PLANT REPROD, V10, P83, DOI 10.1007/s004970050071; Wyatt SE, 2002, TRANSGENIC RES, V11, P1, DOI 10.1023/A:1013917701701	51	57	59	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11342	10.1371/journal.pone.0011342	http://dx.doi.org/10.1371/journal.pone.0011342			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596537	Green Published, gold			2022-12-25	WOS:000279259900015
J	Deng, B; Parthasarathy, S; Wang, WF; Gibney, BR; Battaile, KP; Lovell, S; Benson, DR; Zhu, H				Deng, Bin; Parthasarathy, Sudharsan; Wang, WenFang; Gibney, Brian R.; Battaile, Kevin P.; Lovell, Scott; Benson, David R.; Zhu, Hao			Study of the Individual Cytochrome b(5) and Cytochrome b(5) Reductase Domains of Ncb5or Reveals a Unique Heme Pocket and a Possible Role of the CS Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RES; NITRATE REDUCTASE; SULFITE OXIDASE; MOLECULAR-REPLACEMENT; ANGSTROM RESOLUTION; APOCYTOCHROME B(5); FUSION PROTEIN; BIS-HISTIDINE; EXPRESSION; COMPLEXES	NADH cytochrome b(5) oxidoreductase (Ncb5or) is found in animals and contains three domains similar to cytochrome b5 (b(5)), CHORD-SGT1 (CS), and cytochrome b5 reductase (b(5)R). Ncb5or has an important function, as suggested by the diabetes and lipoatrophy phenotypes in Ncb5or null mice. To elucidate the structural and functional properties of human Ncb5or, we generated its individual b5 and b5R domains (Ncb5or-b(5) and Ncb5or-b(5)R, respectively) and compared them with human microsomal b5 (Cyb5A) and b(5)R(Cyb5R3). A1.25 angstrom x-ray crystal structure of Ncb5or-b(5) reveals nearly orthogonal planes of the imidazolyl rings of heme-ligating residues His(89) and His(112), consistent with a highly anisotropic low spin EPR spectrum. Ncb5or is the first member of the cytochrome b(5) family shown to have such a heme environment. Like other b(5) family members, Ncb5or-b(5) has two helix-loop-helix motifs surrounding heme. However, Ncb5or-b5 differs from Cyb5A with respect to location of the second heme ligand (His(112)) and of polypeptide conformation in its vicinity. Electron transfer from Ncb5or-b5R to Ncb5or-b(5) is much less efficient than from Cyb5R3 to Cyb5A, possibly as a consequence of weaker electrostatic interactions. The CS linkage probably obviates the need for strong interactions between b(5) and b5R domains in Ncb5or. Studies with a construct combining the Ncb5or CS and b(5)R domains suggest that the CS domain facilitates docking of the b(5) and b(5)R domains. Trp(114) is an invariant surface residue in all known Ncb5or orthologs but appears not to contribute to electron transfer from the b(5)R domain to the b(5) domain.	[Parthasarathy, Sudharsan; Benson, David R.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Zhu, Hao] Univ Kansas, Med Ctr, Dept Clin Lab Sci, Kansas City, KS 66160 USA; [Deng, Bin; Wang, WenFang; Zhu, Hao] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66160 USA; [Zhu, Hao] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Benson, David R.] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA; [Lovell, Scott] Univ Kansas, Prot Struct Lab, Struct Biol Ctr, Lawrence, KS 66047 USA; [Battaile, Kevin P.] Argonne Natl Lab, Ind Macromol Crystallog Assoc Collaborat Access T, Adv Photon Source, Argonne, IL 60439 USA; [Gibney, Brian R.] CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA	University of Kansas; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas; United States Department of Energy (DOE); Argonne National Laboratory; City University of New York (CUNY) System; Brooklyn College (CUNY)	Benson, DR (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	drb@ku.edu; hzhu@kumc.edu		Battaile, Kevin/0000-0003-0833-3259; Gibney, Brian/0000-0002-8966-7463	National Institutes of Health [RO1 DK067355, 5P20 RR17708]; American Heart Association [0755879T]; United States Department of Energy [W-31-109-Eng-38]; Industrial Macromolecular Crystallography Association through Center for Advanced Radiation Sources at the University of Chicago; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); United States Department of Energy(United States Department of Energy (DOE)); Industrial Macromolecular Crystallography Association through Center for Advanced Radiation Sources at the University of Chicago; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK067355 (to H. Franklin Bunn and H.Z.) and by National Institutes of Health Centers of Biomedical Research Excellence-Protein Structure and Function award 5P20 RR17708 (to the University of Kansas, R. P. Hanzlik, P.I.). This work was also supported by American Heart Association Grant-in-Aid 0755879T (to B.R.G.). Use of the Advanced Photon Source was supported by the United States Department of Energy under Contract W-31-109-Eng-38, and use of the Industrial Macromolecular Crystallography Association Collaborative Access Team beamline 17-ID was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with the Center for Advanced Radiation Sources at the University of Chicago.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barber MJ, 2002, ARCH BIOCHEM BIOPHYS, V402, P38, DOI 10.1016/S0003-9861(02)00035-8; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Berry EA, 2008, J BIOL INORG CHEM, V13, P481, DOI 10.1007/s00775-008-0372-9; BORGESE N, 1990, BIOCHEM J, V266, P341, DOI 10.1042/bj2660341; CANNONS AC, 1993, J BIOL CHEM, V268, P3268; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Cowley AB, 2004, PROTEIN SCI, V13, P2316, DOI 10.1110/ps.04817704; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis CA, 2002, ARCH BIOCHEM BIOPHYS, V400, P63, DOI 10.1006/abbi.2002.2783; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Durley RCE, 1996, ACTA CRYSTALLOGR D, V52, P65, DOI 10.1107/S0907444995007827; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falzone CJ, 1996, BIOCHEMISTRY-US, V35, P6519, DOI 10.1021/bi960501q; Finn RD, 2008, J BIOL CHEM, V283, P31385, DOI 10.1074/jbc.M803496200; Garcia-Ranea JA, 2002, FEBS LETT, V529, P162, DOI 10.1016/S0014-5793(02)03321-5; HYDE GE, 1991, J BIOL CHEM, V266, P23542; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; Kawano M, 1998, BIOCHEM BIOPH RES CO, V245, P666, DOI 10.1006/bbrc.1998.8502; KESSLER DL, 1972, J BIOL CHEM, V247, P6566; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; LEDERER F, 1983, EUR J BIOCHEM, V132, P95, DOI 10.1111/j.1432-1033.1983.tb07330.x; LEDERER F, 1994, BIOCHIMIE, V76, P674, DOI 10.1016/0300-9084(94)90144-9; LLOYD E, 1994, BIOCHEMISTRY-US, V33, P11432, DOI 10.1021/bi00204a005; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Madej MG, 2006, EMBO J, V25, P4963, DOI 10.1038/sj.emboj.7601361; MATHEWS FS, 1972, J MOL BIOL, V64, P449, DOI 10.1016/0022-2836(72)90510-4; MATHEWS FS, 1971, NATURE-NEW BIOL, V233, P15, DOI 10.1038/newbio233015a0; MATHEWS FS, 1979, PORPHYRINS, V7, P107; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McLaughlin LA, 2010, MOL PHARMACOL, V78, P269, DOI 10.1124/mol.110.064246; MEYER TE, 1995, ARCH BIOCHEM BIOPHYS, V318, P457, DOI 10.1006/abbi.1995.1254; MIGITA CT, 1981, J AM CHEM SOC, V103, P4378, DOI 10.1021/ja00405a015; MITCHELL AG, 1995, J BIOL CHEM, V270, P29766; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida H, 1996, PROTEINS, V26, P32, DOI 10.1002/(SICI)1097-0134(199609)26:1<32::AID-PROT3>3.0.CO;2-I; PIETRINI G, 1988, P NATL ACAD SCI USA, V85, P7246, DOI 10.1073/pnas.85.19.7246; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; RodriguezMaranon MJ, 1996, BIOCHEMISTRY-US, V35, P16378, DOI 10.1021/bi961895o; Roma GW, 2006, ARCH BIOCHEM BIOPHYS, V452, P69, DOI 10.1016/j.abb.2006.04.021; Rudolph MJ, 2003, ACTA CRYSTALLOGR D, V59, P1183, DOI 10.1107/S0907444903009934; SALERNO JC, 1984, J BIOL CHEM, V259, P2331; SALERNO JC, 1984, J AM CHEM SOC, V106, P2156, DOI 10.1021/ja00319a041; Shirabe K, 1998, BBA-PROTEIN STRUCT M, V1384, P16, DOI 10.1016/S0167-4838(97)00146-5; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; STRITTMATTER P, 1990, J BIOL CHEM, V265, P21709; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WALKER FA, 1986, J AM CHEM SOC, V108, P5288, DOI 10.1021/ja00277a038; Wirtz M, 2000, FARADAY DISCUSS, V116, P221, DOI 10.1039/b001520m; XIA ZX, 1987, P NATL ACAD SCI USA, V84, P2629, DOI 10.1073/pnas.84.9.2629; Xie JX, 2004, P NATL ACAD SCI USA, V101, P10750, DOI 10.1073/pnas.0404044101; Yantsevich AV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1096, DOI 10.1134/S0006297908100052; Yatsunyk LA, 2006, INORG CHEM, V45, P5417, DOI 10.1021/ic060283h; YUBISUI T, 1987, P NATL ACAD SCI USA, V84, P3609, DOI 10.1073/pnas.84.11.3609; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang YZ, 2010, J LIPID RES, V51, P53, DOI 10.1194/jlr.M900146-JLR200; Zhu H, 2004, J BIOL CHEM, V279, P30316, DOI 10.1074/jbc.M402664200; Zhu H, 1999, P NATL ACAD SCI USA, V96, P14742, DOI 10.1073/pnas.96.26.14742; Zoppellaro G, 2009, BIOPOLYMERS, V91, P1064, DOI 10.1002/bip.21267	67	23	26	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30181	30191		10.1074/jbc.M110.120329	http://dx.doi.org/10.1074/jbc.M110.120329			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20630863	Green Published, hybrid			2022-12-25	WOS:000281984300055
J	West, MB; Segu, ZM; Feasley, CL; Kang, P; Klouckova, I; Li, CL; Novotny, MV; West, CM; Mechref, Y; Hanigan, MH				West, Matthew B.; Segu, Zaneer M.; Feasley, Christa L.; Kang, Pilsoo; Klouckova, Iveta; Li, Chenglong; Novotny, Milos V.; West, Christopher M.; Mechref, Yehia; Hanigan, Marie H.			Analysis of Site-specific Glycosylation of Renal and Hepatic gamma-Glutamyl Transpeptidase from Normal Human Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRIC ANALYSIS; SOLID-PHASE PERMETHYLATION; ESCHERICHIA-COLI; N-GLYCOSYLATION; SUGAR CHAINS; HUMAN-KIDNEY; HUMAN-LIVER; TRANSFERASE; GLYCANS; GLUTATHIONE	The cell surface glycoprotein gamma-glutamyl transpeptidase (GGT) was isolated from healthy human kidney and liver to characterize its glycosylation in normal human tissue in vivo. GGT is expressed by a single cell type in the kidney. The spectrum of N-glycans released from kidney GGT constituted a subset of the N-glycans identified from renal membrane glycoproteins. Recent advances in mass spectrometry enabled us to identify the microheterogeneity and relative abundance of glycans on specific glycopeptides and revealed a broader spectrum of glycans than was observed among glycans enzymatically released from isolated GGT. A total of 36 glycan compositions, with 40 unique structures, were identified by site-specific glycan analysis. Up to 15 different glycans were observed at a single site, with site-specific variation in glycan composition. N-Glycans released from liver membrane glycoproteins included many glycans also identified in the kidney. However, analysis of hepatic GGT glycopeptides revealed 11 glycan compositions, with 12 unique structures, none of which were observed on kidney GGT. No variation in glycosylation was observed among multiple kidney and liver donors. Two glycosylation sites on renal GGT were modified exclusively by neutral glycans. In silico modeling of GGT predicts that these two glycans are located in clefts on the surface of the protein facing the cell membrane, and their synthesis may be subject to steric constraints. This is the first analysis at the level of individual glycopeptides of a human glycoprotein produced by two different tissues in vivo and provides novel insights into tissue-specific and site-specific glycosylation in normal human tissues.	[Hanigan, Marie H.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Biomed Res Ctr, Oklahoma City, OK 73104 USA; [Segu, Zaneer M.; Mechref, Yehia] Indiana Univ, Dept Chem, METACyt Biochem Anal Ctr, Bloomington, IN 47405 USA; [Feasley, Christa L.; West, Christopher M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA; [Kang, Pilsoo; Klouckova, Iveta; Novotny, Milos V.; Mechref, Yehia] Indiana Univ, Natl Ctr Glycom & Glycoproteom, Dept Chem, Bloomington, IN 47405 USA; [Li, Chenglong] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Indiana University System; Indiana University Bloomington; University of Oklahoma System; University of Oklahoma Health Sciences Center; Indiana University System; Indiana University Bloomington; University System of Ohio; Ohio State University	Hanigan, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Biomed Res Ctr, Rm 264,975 NE 10th St, Oklahoma City, OK 73104 USA.	marie-hanigan@ouhsc.edu	Li, Chenglong/E-7182-2010; Mechref, Yehia/I-5126-2013	Li, Chenglong/0000-0003-3174-8719; Mechref, Yehia/0000-0002-6661-6073	National Institutes of Health [F32CA128338, RO1CA57530, R56CA057530]; NCRR for the National Center for Glycomics and Glycoproteomics at Indiana University [RR018942]; Eli Lilly Endowment; Office of the Vice President for Research; Department of Biochemistry and Molecular Biology at University of Oklahoma Health Sciences Center; NATIONAL CANCER INSTITUTE [F32CA128338, R56CA057530, R01CA057530] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR for the National Center for Glycomics and Glycoproteomics at Indiana University; Eli Lilly Endowment(Eli Lilly); Office of the Vice President for Research; Department of Biochemistry and Molecular Biology at University of Oklahoma Health Sciences Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant F32CA128338 (to M. B. W.), Grants RO1CA57530 and R56CA057530 (to M. H. H.), and Grant RR018942 from the NCRR for the National Center for Glycomics and Glycoproteomics at Indiana University (to M.V.N. and Y.M.). This work was also supported by the Indiana Metabolomics and Cytomics Initiative (METACyt) funded by a grant from Eli Lilly Endowment (to Y.M.). The Oklahoma Center for Medical Glycobiology is supported by the Office of the Vice President for Research and the Department of Biochemistry and Molecular Biology at University of Oklahoma Health Sciences Center.	Alley WR, 2009, RAPID COMMUN MASS SP, V23, P495, DOI 10.1002/rcm.3899; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; ARAI K, 1989, CLIN CHIM ACTA, V184, P75, DOI 10.1016/0009-8981(89)90258-1; ARAI K, 1992, CLIN CHIM ACTA, V210, P35, DOI 10.1016/0009-8981(92)90043-P; Babu P, 2009, GLYCOCONJUGATE J, V26, P975, DOI 10.1007/s10719-008-9146-4; Boanca G, 2007, J BIOL CHEM, V282, P534, DOI 10.1074/jbc.M607694200; Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048; Czlapinski JL, 2006, CURR OPIN CHEM BIOL, V10, P645, DOI 10.1016/j.cbpa.2006.10.009; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; ESWAR N, 2006, COMP PROTEIN STRUC S, V15, P200; EVJEN G, 1992, CLIN CHIM ACTA, V209, P27, DOI 10.1016/0009-8981(92)90330-S; Fenaille F, 2007, GLYCOBIOLOGY, V17, P932, DOI 10.1093/glycob/cwm060; GARDELL SJ, 1981, J BIOL CHEM, V256, P4799; Gil GC, 2009, PROTEOMICS, V9, P2555, DOI 10.1002/pmic.200800775; Goldberg D, 2009, BIOINFORMATICS, V25, P365, DOI 10.1093/bioinformatics/btn636; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hanigan MH, 1996, J HISTOCHEM CYTOCHEM, V44, P1101, DOI 10.1177/44.10.8813074; HANIGAN MH, 1993, BIOCHEMISTRY-US, V32, P6302, DOI 10.1021/bi00075a026; Haslam SM, 2006, CURR OPIN STRUC BIOL, V16, P584, DOI 10.1016/j.sbi.2006.08.006; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HUGHEY RP, 1978, ARCH BIOCHEM BIOPHYS, V186, P211, DOI 10.1016/0003-9861(78)90430-7; HUSEBY NE, 1981, CLIN CHIM ACTA, V111, P39, DOI 10.1016/0009-8981(81)90418-6; Ikeda Y, 2005, METHOD ENZYMOL, V401, P408, DOI 10.1016/S0076-6879(05)01025-6; Inoue M, 2000, BIOCHEMISTRY-US, V39, P7764, DOI 10.1021/bi000220p; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Kang P, 2005, RAPID COMMUN MASS SP, V19, P3421, DOI 10.1002/rcm.2210; Kang P, 2008, RAPID COMMUN MASS SP, V22, P721, DOI 10.1002/rcm.3395; King JB, 2009, J BIOL CHEM, V284, P9059, DOI 10.1074/jbc.M809608200; Kinlough CL, 2005, METHOD ENZYMOL, V401, P426, DOI 10.1016/S0076-6879(05)01026-8; Kirschner KN, 2001, P NATL ACAD SCI USA, V98, P10541, DOI 10.1073/pnas.191362798; Knezevic A, 2009, J PROTEOME RES, V8, P694, DOI 10.1021/pr800737u; Kristiansen TZ, 2004, MOL CELL PROTEOMICS, V3, P715, DOI 10.1074/mcp.M400015-MCP200; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Miki K, 2001, J NUCL MED, V42, P733; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Okada T, 2006, P NATL ACAD SCI USA, V103, P6471, DOI 10.1073/pnas.0511020103; Peracaula R, 2008, DIS MARKERS, V25, P207, DOI 10.1155/2008/797629; RUTENBERG HL, 1969, LANCET, V2, P559; Schachter H, 2000, GLYCOCONJUGATE J, V17, P465; SHAW LM, 1979, CLIN BIOCHEM, V12, P256, DOI 10.1016/S0009-9120(79)80120-4; SHAW LM, 1978, CLIN CHEM, V24, P905; Suzuki H, 2002, J BIOL CHEM, V277, P43536, DOI 10.1074/jbc.M207680200; TATE SS, 1988, ARCH BIOCHEM BIOPHYS, V262, P397, DOI 10.1016/0003-9861(88)90390-6; THIOUDELLET C, 1994, EUR J BIOCHEM, V222, P1009, DOI 10.1111/j.1432-1033.1994.tb18952.x; TSUCHIDA S, 1985, CLIN CHIM ACTA, V152, P17, DOI 10.1016/0009-8981(85)90171-8; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; YAMASHITA K, 1989, J BIOCHEM-TOKYO, V105, P728, DOI 10.1093/oxfordjournals.jbchem.a122736; YAMASHITA K, 1986, J BIOCHEM-TOKYO, V99, P55, DOI 10.1093/oxfordjournals.jbchem.a135479	52	36	40	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29511	29524		10.1074/jbc.M110.145938	http://dx.doi.org/10.1074/jbc.M110.145938			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20622017	Green Published, hybrid			2022-12-25	WOS:000281740100053
J	Bartoccioni, P; del Rio, C; Ratera, M; Kowalczyk, L; Baldwin, JM; Zorzano, A; Quick, M; Baldwin, SA; Vazquez-Ibar, JL; Palacin, M				Bartoccioni, Paola; del Rio, Cesar; Ratera, Merce; Kowalczyk, Lukasz; Baldwin, Jocelyn M.; Zorzano, Antonio; Quick, Matthias; Baldwin, Stephen A.; Luis Vazquez-Ibar, Jose; Palacin, Manuel			Role of Transmembrane Domain 8 in Substrate Selectivity and Translocation of SteT, a Member of the L-Amino Acid Transporter (LAT) Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINURIC PROTEIN INTOLERANCE; FLAVIN-CONTAINING MONOOXYGENASE; ESCHERICHIA-COLI K-12; 4F2 HEAVY-CHAIN; LIGHT SUBUNIT; NEUROTRANSMITTER TRANSPORTERS; ALTERNATING ACCESS; CRYSTAL-STRUCTURE; MEMBRANE-PROTEIN; OXIDATIVE STRESS	System L-amino acid transporters (LAT) belong to the amino acid, polyamine, and organic cation superfamily of transporters and include the light subunits of heteromeric amino acid transporters and prokaryotic homologues. Cysteine reactivity of SteT (serine/threonine antiporter) has been used here to study the substrate-binding site of LAT transporters. Residue Cys-291, in transmembrane domain 8 (TM8), is inactivated by thiol reagents in a substrate protectable manner. Surprisingly, DTT activated the transporter by reducing residue Cys-291. Cysteine-scanning mutagenesis of TM8 showed DTT activation in the single-cysteine mutants S287C, G294C, and S298C, lining the same alpha-helical face. S-Thiolation in Escherichia coli cells resulted in complete inactivation of the single-cysteine mutant G294C. L-Serine blocked DTT activation with an EC50 similar to the apparent K-M of this mutant. Thus, S-thiolation abolished substrate translocation but not substrate binding. Mutation of Lys-295, to Cys (K295C) broadened the profile of inhibitors and the spectrum of substrates with the exception of imino acids. A structural model of SteT based on the structural homologue AdiC (arginine/agmatine antiporter) positions residues Cys-291 and Lys-295 in the putative substrate binding pocket. All this suggests that Lys-295 is a main determinant in the recognition of the side chain of SteT substrates. In contrast, Gly-294 is not facing the surface, suggesting conformational changes involving TM8 during the transport cycle. Our results suggest that TM8 sculpts the substrate-binding site and undergoes conformational changes during the transport cycle of SteT.	[Bartoccioni, Paola; del Rio, Cesar; Ratera, Merce; Kowalczyk, Lukasz; Zorzano, Antonio; Luis Vazquez-Ibar, Jose; Palacin, Manuel] Inst Biomed Res, Barcelona 08028, Spain; [Bartoccioni, Paola; Palacin, Manuel] Ctr Biomed Res Rare Dis, U731, Barcelona 08028, Spain; [Baldwin, Jocelyn M.; Baldwin, Stephen A.] Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [Zorzano, Antonio; Palacin, Manuel] Univ Barcelona, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Quick, Matthias] Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, Dept Psychiat, New York, NY 10032 USA; [Quick, Matthias] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Luis Vazquez-Ibar, Jose] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Leeds; University of Barcelona; Columbia University; New York State Psychiatry Institute; ICREA	Vazquez-Ibar, JL (corresponding author), Inst Biomed Res, Barcelona 08028, Spain.	jose.luis.vazquez-ibar@irbbarcelona.org; manuel.palacin@irbbarcelona.org	Kowalczyk, Lukasz/E-7905-2013; Palacín, Manuel/G-9786-2015; Zorzano, Antonio/R-5479-2018; Bartoccioni, Paola/AAS-8831-2020; Vazquez-Ibar, Jose-Luis/AAD-8827-2021	Kowalczyk, Lukasz/0000-0002-5771-2506; Vazquez-Ibar, Jose-Luis/0000-0002-8314-3378; Ratera, Merce/0000-0001-5224-9172; Palacin, Manuel/0000-0002-8670-293X; Bartoccioni, Paola Chiara/0000-0001-8835-8450	Spanish Ministry of Science and Innovation [BFU2006-14600-C02-01, SAF2009-12606-C02-01, BFU2008-04637]; EC [201924]; United Kingdom Biotechnology and Biological Sciences Research Council [BBS/B/14418]; Generalitat de Catalunya [SGR 1355]; University of Leeds; Biotechnology and Biological Sciences Research Council [BBS/B/14418] Funding Source: researchfish; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EC(European CommissionEuropean Commission Joint Research Centre); United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Generalitat de Catalunya(Generalitat de Catalunya); University of Leeds; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ICREA(ICREA)	This work was supported in part by Spanish Ministry of Science and Innovation Grants BFU2006-14600-C02-01 and SAF2009-12606-C02-01 (to M. P.), Grant BFU2008-04637 (to J. L. V.), EC FP7 Grant 201924 (EDICT) (to M. P. and S. A. B.), United Kingdom Biotechnology and Biological Sciences Research Council Grant BBS/B/14418 (Membrane Protein Structure Initiative) (to S. A. B.), Generalitat de Catalunya 2009 SGR 1355, and the University of Leeds.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Bartoccioni P, 2008, HUM MOL GENET, V17, P1845, DOI 10.1093/hmg/ddn080; Bassi MT, 2001, PFLUG ARCH EUR J PHY, V442, P286, DOI 10.1007/s004240100537; BENITEZ LV, 1974, J BIOL CHEM, V249, P6234; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; Casagrande F, 2008, J BIOL CHEM, V283, P33240, DOI 10.1074/jbc.M806917200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; delCardayre SB, 1998, J BIOL CHEM, V273, P5744, DOI 10.1074/jbc.273.10.5744; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Feliubadalo L, 1999, NAT GENET, V23, P52, DOI 10.1038/12652; Fernandez E, 2005, J BIOL CHEM, V280, P19364, DOI 10.1074/jbc.M412516200; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gasol E, 2004, J BIOL CHEM, V279, P31228, DOI 10.1074/jbc.M402428200; GUO WXA, 1991, ANAL BIOCHEM, V198, P143; Hochgrafe F, 2007, J BIOL CHEM, V282, P25981, DOI 10.1074/jbc.C700105200; Holmes AJ, 2000, J CHEM SOC PERK T 2, P1639, DOI 10.1039/b004028m; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Jimenez-Vidal M, 2004, J BIOL CHEM, V279, P11214, DOI 10.1074/jbc.M309866200; Kaleeba JAR, 2006, SCIENCE, V311, P1921, DOI 10.1126/science.1120878; Koyanagi T, 2004, J BACTERIOL, V186, P343, DOI 10.1128/JB.186.2.343-350.2004; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; LIN WS, 1975, CAN J BIOCHEM CELL B, V53, P298, DOI 10.1139/o75-042; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Palacin M, 2005, PHYSIOLOGY, V20, P112, DOI 10.1152/physiol.00051.2004; Palacin M, 2004, PFLUG ARCH EUR J PHY, V447, P490, DOI 10.1007/s00424-003-1062-7; Pineda M, 1999, J BIOL CHEM, V274, P19738, DOI 10.1074/jbc.274.28.19738; Pother DC, 2009, J BACTERIOL, V191, P7520, DOI 10.1128/JB.00937-09; Reig N, 2002, EMBO J, V21, P4906, DOI 10.1093/emboj/cdf500; Reig N, 2007, J BIOL CHEM, V282, P13270, DOI 10.1074/jbc.M610695200; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Rhee KY, 2005, P NATL ACAD SCI USA, V102, P467, DOI 10.1073/pnas.0406133102; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; STARK MJR, 1987, GENE, V51, P255, DOI 10.1016/0378-1119(87)90314-3; Suh JK, 2000, ARCH BIOCHEM BIOPHYS, V381, P317, DOI 10.1006/abbi.2000.1965; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; Vangelatos I, 2009, MOL MEMBR BIOL, V26, P356, DOI 10.1080/09687680903170546; Veettil MV, 2008, J VIROL, V82, P12126, DOI 10.1128/JVI.01146-08; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	61	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28764	28776		10.1074/jbc.M110.116632	http://dx.doi.org/10.1074/jbc.M110.116632			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20610400	Green Published, hybrid			2022-12-25	WOS:000281594000042
J	Ingalla, EQ; Miller, JK; Wald, JH; Workman, HC; Kaur, RP; Yen, L; Fry, WHD; Borowsky, AD; Young, LJT; Sweeney, C; Carraway, KL				Ingalla, Ellen Q.; Miller, Jamie K.; Wald, Jessica H.; Workman, Heather C.; Kaur, Rouminder P.; Yen, Lily; Fry, William H. D.; Borowsky, Alexander D.; Young, Lawrence J. T.; Sweeney, Colleen; Carraway, Kermit L., III			Post-transcriptional Mechanisms Contribute to the Suppression of the ErbB3 Negative Regulator Protein Nrdp1 in Mammary Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST; NEU PROTOONCOGENE; TRANSGENIC MICE; EXPRESSION; CANCER; FAMILY; GROWTH; INDUCTION; BIOLOGY; HER3	The ErbB2 and ErbB3 receptor tyrosine kinases act synergistically to promote cellular properties associated with tumor development. Previous studies indicate that endogenous ErbB3 protein is markedly elevated in mouse mammary tumors induced by transgenic ErbB2 overexpression. However, this occurs in the absence of elevated ErbB3 transcript, indicating that post-transcriptional regulatory mechanisms play crucial roles in suppressing ErbB3 protein in normal tissue. Our previous studies also demonstrate that protein levels of Nrdp1, an E3 ubiquitin ligase that targets ErbB3 for degradation, are markedly suppressed in tumors from ErbB2 transgenic animals relative to normal tissue. Here we demonstrate that transgenic expression of Nrdp1 cDNA in the mouse mammary gland is not sufficient to suppress elevated ErbB3 levels or tumor initiation and growth in ErbB2 transgenic mice. Unexpectedly, Nrdp1 protein is absent in tumors from Nrdp1/ErbB2 bigenic mice, and real time PCR analysis indicates that Nrdp1 protein levels are suppressed post-transcriptionally. Nrdp1 protein is more resistant to proteasome-dependent degradation when exogenously expressed in cultured MCF10A nontransformed human breast epithelial cells than in breast tumor cells. These observations indicate that mammary tumors use potent post-transcriptional mechanisms to suppress Nrdp1 protein levels and that protein destabilization may play a central role in Nrdp1 loss in tumors.	[Ingalla, Ellen Q.; Miller, Jamie K.; Wald, Jessica H.; Workman, Heather C.; Kaur, Rouminder P.; Yen, Lily; Fry, William H. D.; Sweeney, Colleen; Carraway, Kermit L., III] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA; [Borowsky, Alexander D.] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Borowsky, Alexander D.; Young, Lawrence J. T.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Carraway, KL (corresponding author), Univ Calif Davis, Ctr Canc, Res Bldg 3,Rm 1100B,4645 2nd Ave, Sacramento, CA 95817 USA.	klcarraway@ucdavis.edu	Borowsky, Alexander D/S-5404-2017		National Institutes of Health [CA123541, GM068994, CA118384, T32 RR07038]; United States Army Medical Research and Materiel Command [W81XWH-06-1-0402]; Eugene Cota-Robles; NATIONAL CANCER INSTITUTE [P30CA093373, R01CA118384, R01CA123541] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR024037, T32RR007038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Eugene Cota-Robles; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA123541 and GM068994 (to K. L. C.), CA118384 (to C. S.), and T32 RR07038 (to H. C. W.).; Supported by United States Army Medical Research and Materiel Command Fellowship W81XWH-06-1-0402.; Recipient of a Eugene Cota-Robles graduate fellowship.	Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Campbell MR, 2010, CLIN CANCER RES, V16, P1373, DOI 10.1158/1078-0432.CCR-09-1218; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Carraway Kermit L. III, 2008, P169, DOI 10.1007/978-1-59745-356-1_12; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Di Cosimo S, 2008, EUR J CANCER, V44, P2781, DOI 10.1016/j.ejca.2008.09.026; Diamonti AJ, 2002, P NATL ACAD SCI USA, V99, P2866, DOI 10.1073/pnas.052709799; Fry WHD, 2009, EXP CELL RES, V315, P697, DOI 10.1016/j.yexcr.2008.07.022; Funes M, 2006, J BIOL CHEM, V281, P19310, DOI 10.1074/jbc.M603225200; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hamburger AW, 2008, J MAMMARY GLAND BIOL, V13, P225, DOI 10.1007/s10911-008-9077-5; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Jackson-Fisher AJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2198; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; LEMOINE NR, 1992, BRIT J CANCER, V66, P1116, DOI 10.1038/bjc.1992.420; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; Naidu R, 1998, BRIT J CANCER, V78, P1385, DOI 10.1038/bjc.1998.689; Pal SK, 2007, REV ENDOCR METAB DIS, V8, P269, DOI 10.1007/s11154-007-9040-6; Pedersen K, 2009, MOL CELL BIOL, V29, P3319, DOI 10.1128/MCB.01803-08; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Rasmussen S. B., 2000, METHODS MAMMARY GLAN, P75; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; SASSEN A, 2008, BREAST CANCER RES, V10, P8; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; SIEGEL PM, 1994, MOL CELL BIOL, V14, P7068, DOI 10.1128/MCB.14.11.7068; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stern DF, 2008, J MAMMARY GLAND BIOL, V13, P215, DOI 10.1007/s10911-008-9083-7; Sweeney C, 2006, J MAMMARY GLAND BIOL, V11, P89, DOI 10.1007/s10911-006-9015-3; Travis A, 1996, BRIT J CANCER, V74, P229, DOI 10.1038/bjc.1996.342; Wakefield LM, 2003, COMPARATIVE MED, V53, P424; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yen L, 2006, CANCER RES, V66, P11279, DOI 10.1158/0008-5472.CAN-06-2319; Zaczek A, 2008, J CANCER RES CLIN, V134, P271, DOI 10.1007/s00432-007-0284-z	38	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28691	28697		10.1074/jbc.M110.127977	http://dx.doi.org/10.1074/jbc.M110.127977			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20628057	Green Published, hybrid			2022-12-25	WOS:000281594000034
J	Li, JD; Kline, CF; Hund, TJ; Anderson, ME; Mohler, PJ				Li, Jingdong; Kline, Crystal F.; Hund, Thomas J.; Anderson, Mark E.; Mohler, Peter J.			Ankyrin-B Regulates Kir6.2 Membrane Expression and Function in Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; SINUS NODE DISEASE; ISOFORM SPECIFICITY; CARDIAC-ARRHYTHMIA; ACTIN CYTOSKELETON; HUMAN-ERYTHROCYTES; MOLECULAR-BASIS; CARDIOMYOCYTES; INHIBITION; MUTATIONS	Ankyrin polypeptides are critical for normal membrane protein expression in diverse cell types, including neurons, myocytes, epithelia, and erythrocytes. Ankyrin dysfunction results in defects in membrane expression of ankyrin-binding partners (including ion channels, transporters, and cell adhesion molecules), resulting in aberrant cellular function and disease. Here, we identify a new role for ankyrin-B in cardiac cell biology. We demonstrate that cardiac sarcolemmal K-ATP channels directly associate with ankyrin-B in heart via the K-ATP channel alpha-subunit Kir6.2. We demonstrate that primary myocytes lacking ankyrin-B display defects in Kir6.2 protein expression, membrane expression, and function. Moreover, we demonstrate a secondary role for ankyrin-B in regulating K-ATP channel gating. Finally, we demonstrate that ankyrin-B forms a membrane complex with K-ATP channels and the cardiac Na/K-ATPase, a second key membrane transporter involved in the cardiac ischemia response. Collectively, our new findings define a new role for cardiac ankyrin polypeptides in regulation of ion channel membrane expression in heart.	[Li, Jingdong; Kline, Crystal F.; Hund, Thomas J.; Anderson, Mark E.; Mohler, Peter J.] Univ Iowa, Carver Coll Med, Div Cardiovasc Med, Dept Internal Med, Iowa City, IA 52242 USA; [Anderson, Mark E.; Mohler, Peter J.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Mohler, PJ (corresponding author), Univ Iowa, Carver Coll Med, Div Cardiovasc Med, Dept Internal Med, CBRB 2283,285 Newton Rd, Iowa City, IA 52242 USA.	peter-mohler@uiowa.edu	Hund, Thomas/C-9222-2012	Li, Jingdong/0000-0003-3914-5074	National Institutes of Health [HL084583, HL083422, HL079031, HL62494, HL70250, HL096805]; Pew Scholars Trust; Fondation Leducq Award (Alliance for Calmodulin Kinase Signaling in Heart Disease); NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096652, R00HL096805, K99HL096805, R01HL062494, R01HL070250, R01HL084583, R01HL083422, R01HL079031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Trust; Fondation Leducq Award (Alliance for Calmodulin Kinase Signaling in Heart Disease); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL084583 and HL083422 (to P. J. M.), HL079031, HL62494, and HL70250 (to M. E. A.), and HL096805 (to T. J. H.). This work was also supported by the Pew Scholars Trust (to P. J. M.) and the Fondation Leducq Award (Alliance for Calmodulin Kinase Signaling in Heart Disease) (to P. J. M. and M. E. A.).	Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1992, J BIOL CHEM, V267, P8703; BENNETT V, 1985, ANNU REV BIOCHEM, V54, P273, DOI 10.1146/annurev.biochem.54.1.273; BENNETT V, 1982, J CELL BIOCHEM, V18, P49, DOI 10.1002/jcb.1982.240180106; Bhasin N, 2007, AM J PHYSIOL-HEART C, V293, pH109, DOI 10.1152/ajpheart.00059.2007; Brady PA, 1996, AM J PHYSIOL-HEART C, V271, pH2710, DOI 10.1152/ajpheart.1996.271.6.H2710; Cunha SR, 2007, J BIOL CHEM, V282, P4875, DOI 10.1074/jbc.M607096200; Cunha SR, 2006, CARDIOVASC RES, V71, P22, DOI 10.1016/j.cardiores.2006.03.018; Furukawa T, 1996, PFLUG ARCH EUR J PHY, V431, P504, DOI 10.1007/s004240050028; Glavind-Kristensen M, 2004, BRIT J PHARMACOL, V143, P872, DOI 10.1038/sj.bjp.0706016; Gross GJ, 2003, AM J PHYSIOL-HEART C, V285, pH921, DOI 10.1152/ajpheart.00421.2003; Gudmundsson H, 2010, CIRC RES, V107, P84, DOI 10.1161/CIRCRESAHA.110.216713; Gumina RJ, 2003, AM J PHYSIOL-HEART C, V284, pH2106, DOI 10.1152/ajpheart.00057.2003; Haruna T, 1998, CIRCULATION, V98, P2905, DOI 10.1161/01.CIR.98.25.2905; Hibino H, 1999, CURR TOP MEMBR, V46, P243; Hund TJ, 2009, CARDIOVASC RES, V81, P742, DOI 10.1093/cvr/cvn348; Kane GC, 2005, J MOL CELL CARDIOL, V38, P937, DOI 10.1016/j.yjmcc.2005.02.026; Kline CF, 2009, P NATL ACAD SCI USA, V106, P16669, DOI 10.1073/pnas.0907138106; Le Scouarnec S, 2008, P NATL ACAD SCI USA, V105, P15617, DOI 10.1073/pnas.0805500105; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; Li JD, 2007, CHANNELS, V1, P387, DOI 10.4161/chan.5449; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Michaely P, 1995, J BIOL CHEM, V270, P31298, DOI 10.1074/jbc.270.52.31298; Minami K, 2004, DIABETES, V53, pS176, DOI 10.2337/diabetes.53.suppl_3.S176; Mohler PJ, 2008, J CARDIOVASC ELECTR, V19, P516, DOI 10.1111/j.1540-8167.2007.01097.x; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2004, J BIOL CHEM, V279, P25798, DOI 10.1074/jbc.M401296200; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Morrissey Alison, 2005, BMC Physiol, V5, P1, DOI 10.1186/1472-6793-5-1; MORROW JS, 1989, J CELL BIOL, V108, P455, DOI 10.1083/jcb.108.2.455; Nawada R, 1997, CIRCULATION, V96, P599; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Nilsson KR, 2009, J CARDIOVASC PHARM, V54, P106, DOI 10.1097/FJC.0b013e3181b2b6ed; Proks P, 2006, DIABETES, V55, P1731, DOI 10.2337/db05-1420; Sedlacek K, 2008, CIRC-CARDIOVASC GENE, V1, P93, DOI 10.1161/CIRCGENETICS.108.792192; Suzuki M, 2002, J CLIN INVEST, V109, P509, DOI 10.1172/JC1200214270; Suzuki M, 2001, CIRC RES, V88, P570, DOI 10.1161/01.RES.88.6.570; Tammaro P, 2006, J PHYSIOL-LONDON, V571, P3, DOI 10.1113/jphysiol.2005.099168; Tammaro P, 2005, EMBO J, V24, P2318, DOI 10.1038/sj.emboj.7600715; Terzic A, 1996, J PHYSIOL-LONDON, V492, P395, DOI 10.1113/jphysiol.1996.sp021316; Wheeler A, 2008, MOL PHARMACOL, V74, P1333, DOI 10.1124/mol.108.048355; Yellon DM, 2003, PHYSIOL REV, V83, P1113, DOI 10.1152/physrev.00009.2003; Yokoshiki H, 1997, PFLUG ARCH EUR J PHY, V434, P203, DOI 10.1007/s004240050384	47	44	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28723	28730		10.1074/jbc.M110.147868	http://dx.doi.org/10.1074/jbc.M110.147868			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20610380	Green Published, hybrid			2022-12-25	WOS:000281594000038
J	Petutschnig, EK; Jones, AME; Serazetdinova, L; Lipka, U; Lipka, V				Petutschnig, Elena K.; Jones, Alexandra M. E.; Serazetdinova, Liliya; Lipka, Ulrike; Lipka, Volker			The Lysin Motif Receptor-like Kinase (LysM-RLK) CERK1 Is a Major Chitin-binding Protein in Arabidopsis thaliana and Subject to Chitin-induced Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTORS; PLASMA-MEMBRANE RECEPTOR; MASS-SPECTROMETRY; INNATE IMMUNITY; PTERIS-RYUKYUENSIS; MOLECULAR-PATTERNS; CELL-SEPARATION; PLANT; PERCEPTION; DOMAIN	Plants detect potential pathogens by sensing microbe-associated molecular patterns via pattern recognition receptors. In the dicot model plant Arabidopsis, the lysin motif (LysM)-containing chitin elicitor receptor kinase 1 (CERK1) has been shown to be essential for perception of the fungal cell wall component chitin and for resistance to fungal pathogens. Recent in vitro studies with CERK1 protein expressed heterologously in yeast suggested direct chitin binding activity. Here we show in an affinity purification approach that CERK1 is a major chitin-binding protein of Arabidopsis cells, along with several known and putative chitinases. The ectodomain of CERK1 harbors three distinct LysM domains with potential ligand binding capacity. We demonstrate that the CERK1 ectodomain binds chitin and partially deacetylated chitosan directly without any requirement for interacting proteins and that all three LysM domains are necessary for chitin binding. Ligand-induced phosphorylation events are a general feature of animal and plant signal transduction pathways. Our studies show that chitin, chitin oligomers, and chitosan rapidly induce in vivo phosphorylation of CERK1 at multiple residues in the juxtamembrane and kinase domain. Functional analyses with a kinase dead variant provide evidence that kinase activity of CERK1 is required for its chitin-dependent in vivo phosphorylation, as well as for early defense responses and downstream signaling. Collectively, our data suggest that in Arabidopsis, CERK1 is a major chitin, chitosan, and chito-oligomer binding component and that chitin signaling depends on CERK1 post-translational modification and kinase activity.	[Petutschnig, Elena K.; Lipka, Volker] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Cell Biol, D-37073 Gottingen, Germany; [Petutschnig, Elena K.; Jones, Alexandra M. E.; Serazetdinova, Liliya; Lipka, Ulrike; Lipka, Volker] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	University of Gottingen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Lipka, V (corresponding author), Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Cell Biol, Untere Karspuele 2, D-37073 Gottingen, Germany.	volker.lipka@biologie.uni-goettingen.de	poinssot, benoit/B-2569-2009; Jones, Alexandra/B-5227-2009	poinssot, benoit/0000-0001-5890-4318; Jones, Alexandra/0000-0003-2571-8708; Petutschnig, Elena/0000-0002-0846-1878	Gatsby Charitable Foundation; Deutsche Forschungsgemeinschaft [SPP1212/LI 1317/3-1]	Gatsby Charitable Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Gatsby Charitable Foundation and the Deutsche Forschungsgemeinschaft (Grant SPP1212/LI 1317/3-1).	Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Cardinale F, 2000, J BIOL CHEM, V275, P36734, DOI 10.1074/jbc.M007418200; Chen LT, 2010, CELL HOST MICROBE, V7, P185, DOI 10.1016/j.chom.2010.02.008; Choi MY, 2008, MOL CELLS, V26, P200; Erbs G, 2008, CHEM BIOL, V15, P438, DOI 10.1016/j.chembiol.2008.03.017; Gimenez-Ibanez S, 2009, PLANT SIGNAL BEHAV, V4, P539, DOI 10.4161/psb.4.6.8697; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Gonzalez-Carranza ZH, 2007, J EXP BOT, V58, P3719, DOI 10.1093/jxb/erm222; Guo L, 2003, J AM SOC MASS SPECTR, V14, P1022, DOI 10.1016/S1044-0305(03)00206-X; Gust AA, 2007, J BIOL CHEM, V282, P32338, DOI 10.1074/jbc.M704886200; Iizasa E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.027540; Iriti M, 2009, PLANT SIGNAL BEHAV, V4, P66, DOI 10.4161/psb.4.1.7408; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Lindbo JA, 2007, PLANT PHYSIOL, V145, P1232, DOI 10.1104/pp.107.106377; MacLean Daniel, 2008, BMC Res Notes, V1, P30, DOI 10.1186/1756-0500-1-30; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; MARGISPINHEIRO M, 1991, PLANT MOL BIOL, V17, P243, DOI 10.1007/BF00039499; McInnes C, 1997, BIOPOLYMERS, V43, P339, DOI 10.1002/(SICI)1097-0282(1997)43:5<339::AID-BIP2>3.0.CO;2-W; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Neuhaus JM, 1999, PATHOGENESIS-RELATED PROTEINS IN PLANTS, P77; Nurnberger T, 2006, TRENDS PLANT SCI, V11, P519, DOI 10.1016/j.tplants.2006.09.005; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; Ohnuma T, 2008, J BIOL CHEM, V283, P5178, DOI 10.1074/jbc.M707156200; Onaga S, 2008, GLYCOBIOLOGY, V18, P414, DOI 10.1093/glycob/cwn018; Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Roy I, 2003, ENZYME MICROB TECH, V32, P582, DOI 10.1016/S0141-0229(03)00027-9; Ruse CI, 2002, ANAL CHEM, V74, P1658, DOI 10.1021/ac0157122; Shin-ya Y, 2001, BIOCHEM ENG J, V7, P85, DOI 10.1016/S1369-703X(00)00129-7; Staehelin C, 2000, MOL PLANT MICROBE IN, V13, P72, DOI 10.1094/MPMI.2000.13.1.72; Steen H, 2005, P NATL ACAD SCI USA, V102, P3948, DOI 10.1073/pnas.0409536102; Tsay YG, 2000, ANAL BIOCHEM, V287, P55, DOI 10.1006/abio.2000.4837; Vander P, 1998, PLANT PHYSIOL, V118, P1353, DOI 10.1104/pp.118.4.1353; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wan JR, 2008, PLANT SIGNAL BEHAV, V3, P831, DOI 10.4161/psb.3.10.5916; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Zhang B, 2002, MOL PLANT MICROBE IN, V15, P963, DOI 10.1094/MPMI.2002.15.9.963; Zhang XC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-183; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	47	291	307	6	82	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28902	28911		10.1074/jbc.M110.116657	http://dx.doi.org/10.1074/jbc.M110.116657			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20610395	Green Published, hybrid			2022-12-25	WOS:000281594000055
J	Abe, N; Borson, SH; Gambello, MJ; Wang, F; Cavalli, V				Abe, Namiko; Borson, Steven H.; Gambello, Michael J.; Wang, Fan; Cavalli, Valeria			Mammalian Target of Rapamycin (mTOR) Activation Increases Axonal Growth Capacity of Injured Peripheral Nerves	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGENERATION IN-VIVO; SENSORY NEURONS; PROTEIN-SYNTHESIS; MESSENGER-RNA; C-JUN; NERVOUS-SYSTEM; LESION SITE; TRANSPORT; TRANSLATION; PATHWAY	Unlike neurons in the central nervous system (CNS), injured neurons in the peripheral nervous system (PNS) can regenerate their axons and reinnervate their targets. However, functional recovery in the PNS often remains suboptimal, especially in cases of severe damage. The lack of regenerative ability of CNS neurons has been linked to down-regulation of the mTOR (mammalian target of rapamycin) pathway. We report here that PNS dorsal root ganglial neurons (DRGs) activate mTOR following damage and that this activity enhances axonal growth capacity. Furthermore, genetic up-regulation of mTOR activity by deletion of tuberous sclerosis complex 2 (TSC2) in DRGs is sufficient to enhance axonal growth capacity in vitro and in vivo. We further show that mTOR activity is linked to the expression of GAP-43, a crucial component of axonal outgrowth. However, although TSC2 deletion in DRGs facilitates axonal regrowth, it leads to defects in target innervation. Thus, whereas manipulation of mTOR activity could provide new strategies to stimulate nerve regeneration in the PNS, fine control of mTOR activity is required for proper target innervation.	[Cavalli, Valeria] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Gambello, Michael J.] Univ Texas Hlth Sci Ctr, Dept Pediat, Div Med Genet, Houston, TX 77030 USA; [Wang, Fan] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Washington University (WUSTL); University of Texas System; University of Texas Health Science Center Houston; Duke University	Cavalli, V (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Campus Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.	cavalli@pcg.wustl.edu			NINDS, National Institutes of Health [RO1NS060709]; Wings for Life Foundation; Washington University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060709] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wings for Life Foundation; Washington University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NINDS, National Institutes of Health Grant RO1NS060709 (to V. C.). This work was also supported by the Wings for Life Foundation (to F. W.).; Supported by a Washington University Summer Undergraduate Research Fellowship.	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Ackermann PW, 2002, J ORTHOP RES, V20, P849, DOI 10.1016/S0736-0266(01)00159-0; AIGNER L, 1995, J CELL BIOL, V128, P647, DOI 10.1083/jcb.128.4.647; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Broude E, 1997, EXP NEUROL, V148, P367, DOI 10.1006/exnr.1997.6665; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Caroni P, 1997, BIOESSAYS, V19, P767, DOI 10.1002/bies.950190906; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hernandez O, 2007, GENESIS, V45, P101, DOI 10.1002/dvg.20271; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; JENKINS R, 1991, NEUROSCI LETT, V129, P107, DOI 10.1016/0304-3940(91)90731-8; Kusik BW, 2010, DEV DYNAM, V239, P482, DOI 10.1002/dvdy.22190; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lindwall C, 2005, MOL CELL NEUROSCI, V29, P269, DOI 10.1016/j.mcn.2005.03.002; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Michaelevski I, 2010, MOL CELL PROTEOMICS, V9, P976, DOI 10.1074/mcp.M900369-MCP200; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Nie D, 2010, NAT NEUROSCI, V13, P163, DOI 10.1038/nn.2477; O'Brien JJ, 2007, J NEUROCHEM, V103, P288, DOI 10.1111/j.1471-4159.2007.04736.x; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schwaiger FW, 2000, EUR J NEUROSCI, V12, P1165, DOI 10.1046/j.1460-9568.2000.00005.x; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Smith DS, 1997, J NEUROSCI, V17, P646; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Sung YJ, 2006, NEUROSCIENCE, V141, P697, DOI 10.1016/j.neuroscience.2006.04.033; Tanabe K, 2000, J NEUROSCI, V20, P4138; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Vogelaar CF, 2009, MOL CELL NEUROSCI, V42, P102, DOI 10.1016/j.mcn.2009.06.002; Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511; White DM, 2000, BRAIN RES, V868, P31, DOI 10.1016/S0006-8993(00)02259-9; Wildonger J, 2008, GENE DEV, V22, P2447, DOI 10.1101/gad.1724108; Willis DE, 2006, CURR OPIN NEUROBIOL, V16, P111, DOI 10.1016/j.conb.2006.01.002; Woolf CJ, 2003, NEURON, V38, P153, DOI 10.1016/S0896-6273(03)00233-2; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107	58	164	172	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28034	28043		10.1074/jbc.M110.125336	http://dx.doi.org/10.1074/jbc.M110.125336			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20615870	Green Published, hybrid			2022-12-25	WOS:000288742300002
J	Oinuma, I; Ito, Y; Katoh, H; Negishi, M				Oinuma, Izumi; Ito, Yuri; Katoh, Hironori; Negishi, Manabu			Semaphorin 4D/Plexin-B1 Stimulates PTEN Activity through R-Ras GTPase-activating Protein Activity, Inducing Growth Cone Collapse in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; TUMOR-SUPPRESSOR PTEN; PHOSPHOINOSITIDE 3-KINASE; RECEPTOR PLEXIN-B1; AXON GUIDANCE; KINASE CK2; PDZ-RHOGEF; PHOSPHORYLATION; FAMILY; TRANSMEMBRANE	Plexins are receptors for axonal guidance molecules semaphorins. We recently reported that the semaphorin 4D (Sema4D) receptor, Plexin-B1, suppresses PI3K signaling through the R-Ras GTPase-activating protein (GAP) activity, inducing growth cone collapse. Phosphatidylinositol 3-phosphate level is critically regulated by PI3K and PTEN (phosphatase and tensin homologue deleted chromosome ten). Here we examined the involvement of PTEN in the Plexin-B1-induced repulsive response. Phosphorylation of PTEN at Ser-380 is known to suppress its phosphatase activity. Sema4D induced the dephosphorylation of PTEN at Ser-380 and stimulated PTEN phosphatase activity in hippocampal neurons. Knockdown of endogenous PTEN suppressed the Sema4D-induced growth cone collapse. Phosphorylation mimic PTEN mutant suppressed the Sema4D-induced growth cone collapse, whereas phosphorylation-resistant PTEN mutant by itself induced growth cone collapse. Plexin-B1-induced PTEN dephosphorylation through R-Ras GAP activity and R-Ras GAP activity was by itself sufficient for PTEN dephosphorylation and activation. We also suggested that the Sema4D-induced PTEN dephosphorylation and growth cone collapse were mediated by the inhibition of casein kinase 2 alpha activity. Thus, we propose that Sema4D/Plexin-B1 promotes the dephosphorylation and activation of PTEN through the R-Ras GAP activity, inducing growth cone collapse.	[Oinuma, Izumi; Ito, Yuri; Katoh, Hironori; Negishi, Manabu] Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Negishi, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068501, Japan.	mnegishi@pharm.kyoto-u.ac.jp		Katoh, Hironori/0000-0002-8191-8117	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan.	Arevalo MA, 2006, MOL BIOL CELL, V17, P3369, DOI 10.1091/mbc.E05-12-1144; Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Barberis D, 2004, FASEB J, V18, P592, DOI 10.1096/fj.03-0957fje; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Chadborn NH, 2006, J CELL SCI, V119, P951, DOI 10.1242/jcs.02801; Christensen CRL, 1998, CANCER RES, V58, P1238; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gericke A, 2006, GENE, V374, P1, DOI 10.1016/j.gene.2006.02.024; Ito Y, 2006, EMBO REP, V7, P704, DOI 10.1038/sj.embor.7400737; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kumanogoh A, 2003, J CELL SCI, V116, P3463, DOI 10.1242/jcs.00674; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Leslie NR, 2000, BIOCHEM J, V346, P827, DOI 10.1042/0264-6021:3460827; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marte BM, 1997, CURR BIOL, V7, P63, DOI 10.1016/S0960-9822(06)00028-5; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Negishi M, 2002, J BIOCHEM, V132, P157, DOI 10.1093/oxfordjournals.jbchem.a003205; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Oinuma I, 2007, J BIOL CHEM, V282, P303, DOI 10.1074/jbc.M607979200; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Saito Y, 2009, EMBO REP, V10, P614, DOI 10.1038/embor.2009.63; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Suire S, 2002, CURR BIOL, V12, P1068, DOI 10.1016/S0960-9822(02)00933-8; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Uesugi K, 2009, J BIOL CHEM, V284, P6743, DOI 10.1074/jbc.M805213200; van Diepen MT, 2009, NAT CELL BIOL, V11, P1191, DOI 10.1038/ncb1961; Waimey KE, 2006, NEUROSCIENTIST, V12, P398, DOI 10.1177/1073858406292631; Yamamoto T, 1995, J BIOL CHEM, V270, P30557, DOI 10.1074/jbc.270.51.30557; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	48	38	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28200	28209		10.1074/jbc.M110.147546	http://dx.doi.org/10.1074/jbc.M110.147546			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20610402	hybrid, Green Published			2022-12-25	WOS:000281404100063
J	Ikonomov, OC; Sbrissa, D; Fligger, J; Delvecchio, K; Shisheva, A				Ikonomov, Ognian C.; Sbrissa, Diego; Fligger, Jason; Delvecchio, Khortnal; Shisheva, Assia			ArPIKfyve Regulates Sac3 Protein Abundance and Turnover DISRUPTION OF THE MECHANISM BY Sac3(I41T) MUTATION CAUSING CHARCOT-MARIE-TOOTH 4J DISORDER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; PIKFYVE; VAC14; TRAFFICKING; COMPLEX; YEAST	The mammalian phosphatidylinositol (3,5)-bisphosphate (PtdIns(3,5)P-2) phosphatase Sac3 and ArPIKfyve, the associated regulator of the PtdIns3P-5 kinase PIKfyve, form a stable binary complex that associates with PIKfyve in a ternary complex to increase PtdIns(3,5)P-2 production. Whether the ArPIKfyve-Sac3 subcomplex functions outside the PIKfyve context is unknown. Here we show that stable or transient expression of ArPIKfyve(WT) in mammalian cells elevates steady-state protein levels and the PtdIns(3,5)P-2-hydrolyzing activity of Sac3, whereas knockdown of ArPIKfyve has the opposite effect. These manipulations do not alter the Sac3 mRNA levels, suggesting that ArPIKfyve might control Sac3 protein degradation. Inhibition of protein synthesis in COS cells by cycloheximide reveals remarkably rapid turnover of expressed Sac3(WT) (t(1/2) = 18.8 min), resulting from a proteasome-dependent clearance as evidenced by the extended Sac3(WT) half-life upon inhibiting proteasome activity. Coexpression of ArPIKfyve(WT), but not the N-or C-terminal halves, prolongs the Sac3WT half-life consistent with enhanced Sac3 protein stability through association with full-length ArPIKfyve. We further demonstrate that mutant Sac3, harboring the pathogenic Ile-to-Thr substitution at position 41 found in patients with CMT4J disorder, is similar to Sac3(WT) with regard to PtdIns(3,5)P2-hydrolyzing activity, association with ArPIKfyve, or rapid proteasome-dependent clearance. Remarkably, however, neither is the steady-state Sac3(I41T) elevated nor is the Sac3(I41T) half-life extended by coexpressed ArPIKfyve(WT), indicating that unlike with Sac3(WT), ArPIKfyve fails to prevent Sac3(I41T) rapid loss. Together, our data indentify a novel regulatory mechanism whereby ArPIKfyve enhances Sac3 abundance by attenuating Sac3 proteasome-dependent degradation and suggest that a failure of this mechanism could be the primary molecular defect in the pathogenesis of CMT4J.	[Ikonomov, Ognian C.; Sbrissa, Diego; Fligger, Jason; Delvecchio, Khortnal; Shisheva, Assia] Wayne State Univ, Dept Physiol, Sch Med, Detroit, MI 48201 USA	Wayne State University	Shisheva, A (corresponding author), Wayne State Univ, Dept Physiol, Sch Med, 540 E Canfield, Detroit, MI 48201 USA.	ashishev@med.wayne.edu		Delvecchio, Khortnal/0000-0002-5441-5709	National Institutes of Health [DK58058]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK58058 (to A. S.). This work was also supported by a grant from the American Diabetes Association (to A. S.).	Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Botelho RJ, 2009, BIOESSAYS, V31, P1127, DOI 10.1002/bies.200900060; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gong L, 2008, ENDOCRINOLOGY, V149, P3346, DOI 10.1210/en.2007-0945; Ikonomov NC, 2007, EXP CELL RES, V313, P2404, DOI 10.1016/j.yexcr.2007.03.024; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Ikonomov OC, 2009, J BIOL CHEM, V284, P35794, DOI 10.1074/jbc.M109.037515; Ikonomov OC, 2009, J BIOL CHEM, V284, P23961, DOI 10.1074/jbc.M109.025361; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lundgren J, 2005, MOL CELL BIOL, V25, P4662, DOI 10.1128/MCB.25.11.4662-4675.2005; Manford A, 2010, EMBO J, V29, P1489, DOI 10.1038/emboj.2010.57; Nicot AS, 2006, MOL BIOL CELL, V17, P3062, DOI 10.1091/mbc.e05-12-1120; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Sbrissa D, 2004, MOL CELL BIOL, V24, P10437, DOI 10.1128/MCB.24.23.10437-10447.2004; Sbrissa D, 2001, MOL CELL ENDOCRINOL, V181, P35, DOI 10.1016/S0303-7207(01)00539-1; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Sbrissa D, 2008, J MOL BIOL, V384, P766, DOI 10.1016/j.jmb.2008.10.009; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Zhang XB, 2008, BRAIN, V131, P1990, DOI 10.1093/brain/awn114; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104	24	34	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26760	26764		10.1074/jbc.C110.154658	http://dx.doi.org/10.1074/jbc.C110.154658			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20630877	hybrid, Green Published			2022-12-25	WOS:000281172700006
J	Hunter, MJ; Treharne, KJ; Winter, AK; Cassidy, DM; Land, S; Mehta, A				Hunter, Mairi J.; Treharne, Kate J.; Winter, Alexandra K.; Cassidy, Diane M.; Land, Stephen; Mehta, Anil			Expression of Wild-Type CFTR Suppresses NF-kappa B-Driven Inflammatory Signalling	PLOS ONE			English	Article							CYSTIC-FIBROSIS GENE; PROTEIN-KINASE CK2; TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY EPITHELIAL-CELLS; PSEUDOMONAS-AERUGINOSA; UP-REGULATION; CL-CHANNEL; IDENTIFICATION; ACTIVATION; INHIBITION	Background: Mutation of the cystic fibrosis transmembrane-conductance regulator (CFTR) causes cystic fibrosis (CF) but not all CF aspects can easily be explained by deficient ion transport. CF-inflammation provides one example but its pathogenesis remains controversial. Here, we tested the simple but fundamental hypothesis that wild-type CFTR is needed to suppress NF-kappa B activity. Methodology/Principal Findings: In lung epithelial (H441) and engineered (H57) cell lines; we report that inflammatory markers are significantly suppressed by wild-type CFTR. Transient-transfection of wild-type CFTR into CFTR-naive H441 cells, dose-dependently down-regulates both basal and Tumour Necrosis Factor-alpha evoked NF-kappa B activity when compared to transfection with empty vector alone (p < 0.01, n > 5). This effect was also observed in CFTR-naive H57-HeLa cells which stably express a reporter of NF-kappa B activity, confirming that the CFTR-mediated repression of inflammation was not due to variable reporter gene transfection efficiency. In contrast, H57 cells transfected with a control cyano-fluorescent protein show a significantly elevated basal level of NF-kappa B activity above control. Initial cell seeding density may be a critical factor in mediating the suppressive effects of CFTR on inflammation as only at a certain density (1 x 10(5) cells/well) did we observe the reduction in NF-kappa B activity. CFTR channel activity may be necessary for this suppression because the CFTR specific inhibitor CFTRinh172 significantly stimulates NF-kappa B activity by similar to 30% in CFTR expressing 16HBE14o- cells whereas pharmacological elevation of cyclic-AMP depresses activity by similar to 25% below baseline. Conclusions/Significance: These data indicate that CFTR has inherent anti-inflammatory properties. We propose that the hyper-inflammation found in CF may arise as a consequence of disrupted repression of NF-kappa B signalling which is normally mediated by CFTR. Our data therefore concur with in vivo and in vitro data from Vij and colleagues which highlights CFTR as a suppressor of basal inflammation acting through NF-kappa B, a central hub in inflammatory signalling.	[Hunter, Mairi J.; Treharne, Kate J.; Winter, Alexandra K.; Cassidy, Diane M.; Land, Stephen; Mehta, Anil] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Dundee DD1 9SY, Scotland	University of Dundee	Hunter, MJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Dundee DD1 9SY, Scotland.	a.mehta@dundee.ac.uk		Land, Stephen/0000-0001-9216-5969	CF [Trust-PJ538]; Wellcome Trust [075237]; Chest Research-Education Fund	CF; Wellcome Trust(Wellcome TrustEuropean Commission); Chest Research-Education Fund	CF Trust-PJ538 (MJH) www.cftrust.org.uk, Wellcome Trust (075237) (KJT/DC) www.wellcome.ac.uk and the Chest Research-Education Fund (AW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachhuber T, 2008, J BIOL CHEM, V283, P13225, DOI 10.1074/jbc.M704532200; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Caci E, 2008, BIOCHEM J, V413, P135, DOI 10.1042/BJ20080029; Carrabino S, 2006, J CYST FIBROS, V5, P113, DOI 10.1016/j.jcf.2005.12.003; Comer DM, 2009, QJM-INT J MED, V102, P793, DOI 10.1093/qjmed/hcp120; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Dechecchi MC, 2007, AM J RESP CELL MOL, V36, P615, DOI 10.1165/rcmb.2006-0200OC; DECHECCHI MC, 2008, J CYST FIBROS; DiMango E, 1998, J CLIN INVEST, V101, P2598, DOI 10.1172/JCI2865; Dudez T, 2008, BBA-MOL CELL RES, V1783, P779, DOI 10.1016/j.bbamcr.2008.01.007; Eidelman O, 2001, MOL MED, V7, P523, DOI 10.1007/BF03401858; Hallows KR, 2006, J BIOL CHEM, V281, P4231, DOI 10.1074/jbc.M511029200; Kalin N, 1999, J CLIN INVEST, V103, P1379, DOI 10.1172/JCI5731; Kelly M, 2010, J PHARMACOL EXP THER, V333, P60, DOI 10.1124/jpet.109.162032; Kerbiriou M, 2007, BBA-MOL BASIS DIS, V1772, P1236, DOI 10.1016/j.bbadis.2007.10.004; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kongsuphol P, 2009, J BIOL CHEM, V284, P5645, DOI 10.1074/jbc.M806780200; Kramer BW, 2009, SEMIN FETAL NEONAT M, V14, P2, DOI 10.1016/j.siny.2008.08.011; Land SC, 2004, AM J PHYSIOL-LUNG C, V286, pL473, DOI 10.1152/ajplung.00401.2002; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Marcorelles P, 2007, PEDIATR PULM, V42, P1032, DOI 10.1002/ppul.20690; Muhlebach MS, 1999, AM J RESP CRIT CARE, V160, P186, DOI 10.1164/ajrccm.160.1.9808096; Muselet-Charlier C, 2007, BIOCHEM BIOPH RES CO, V357, P402, DOI 10.1016/j.bbrc.2007.03.141; Nagayama S, 1999, FEBS LETT, V455, P215, DOI 10.1016/S0014-5793(99)00880-7; Noah TL, 1997, J INFECT DIS, V175, P638, DOI 10.1093/infdis/175.3.638; Pagano MA, 2008, BIOCHEMISTRY-US, V47, P7925, DOI 10.1021/bi800316z; Pagano MA, 2010, BIOCHEM J, V426, P19, DOI 10.1042/BJ20090813; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; Perez Aura, 2004, Journal of Structural and Functional Genomics, V5, P179, DOI 10.1023/B:JSFG.0000028982.59273.bd; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rae C, 2006, BIOCHEM BIOPH RES CO, V349, P416, DOI 10.1016/j.bbrc.2006.08.067; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Schwiebert LM, 1999, AM J PHYSIOL-CELL PH, V276, pC700, DOI 10.1152/ajpcell.1999.276.3.C700; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Singh NN, 2008, J MOL MED, V86, P887, DOI 10.1007/s00109-008-0352-0; Srivastava M, 1999, MOL MED, V5, P753, DOI 10.1007/BF03402099; Stanke F, 2006, HUM GENET, V119, P331, DOI 10.1007/s00439-006-0140-2; Tabary O, 1998, AM J PATHOL, V153, P921, DOI 10.1016/S0002-9440(10)65633-7; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; Treharne KJ, 2009, CELL PHYSIOL BIOCHEM, V24, P347, DOI 10.1159/000257427; Treharne KJ, 2009, MOL CELL BIOCHEM, V329, P107, DOI 10.1007/s11010-009-0118-1; TREZISE AEO, 1993, HUM MOL GENET, V2, P213, DOI 10.1093/hmg/2.3.213; Venkatakrishnan A, 2000, AM J RESP CELL MOL, V23, P396, DOI 10.1165/ajrcmb.23.3.3949; Verhaeghe C, 2007, J CYST FIBROS, V6, P304, DOI 10.1016/j.jcf.2006.12.001; Verhaeghe C, 2007, BIOCHEM PHARMACOL, V73, P1982, DOI 10.1016/j.bcp.2007.03.019; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Weber AJ, 2001, AM J PHYSIOL-LUNG C, V281, pL71, DOI 10.1152/ajplung.2001.281.1.L71; Welsh M., 2001, SCRIVER, P5121	51	52	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11598	10.1371/journal.pone.0011598	http://dx.doi.org/10.1371/journal.pone.0011598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644644	Green Published, Green Submitted, gold			2022-12-25	WOS:000279884900028
J	Hesling, I; Dilharreguy, B; Peppe, S; Amirault, M; Bouvard, M; Allard, M				Hesling, Isabelle; Dilharreguy, Bixente; Peppe, Sue; Amirault, Marion; Bouvard, Manuel; Allard, Michele			The Integration of Prosodic Speech in High Functioning Autism: A Preliminary fMRI Study	PLOS ONE			English	Article							LISTENING PREFERENCES; EMOTIONAL PROSODY; RIGHT-HEMISPHERE; DEFAULT MODE; CHILDREN; BRAIN; COMPREHENSION; PERCEPTION; NETWORKS; PITCH	Background: Autism is a neurodevelopmental disorder characterized by a specific triad of symptoms such as abnormalities in social interaction, abnormalities in communication and restricted activities and interests. While verbal autistic subjects may present a correct mastery of the formal aspects of speech, they have difficulties in prosody (music of speech), leading to communication disorders. Few behavioural studies have revealed a prosodic impairment in children with autism, and among the few fMRI studies aiming at assessing the neural network involved in language, none has specifically studied prosodic speech. The aim of the present study was to characterize specific prosodic components such as linguistic prosody (intonation, rhythm and emphasis) and emotional prosody and to correlate them with the neural network underlying them. Methodology/Principal Findings: We used a behavioural test (Profiling Elements of the Prosodic System, PEPS) and fMRI to characterize prosodic deficits and investigate the neural network underlying prosodic processing. Results revealed the existence of a link between perceptive and productive prosodic deficits for some prosodic components (rhythm, emphasis and affect) in HFA and also revealed that the neural network involved in prosodic speech perception exhibits abnormal activation in the left SMG as compared to controls (activation positively correlated with intonation and emphasis) and an absence of deactivation patterns in regions involved in the default mode. Conclusions/Significance: These prosodic impairments could not only result from activation patterns abnormalities but also from an inability to adequately use the strategy of the default network inhibition, both mechanisms that have to be considered for decreasing task performance in High Functioning Autism.	[Hesling, Isabelle; Dilharreguy, Bixente; Amirault, Marion; Bouvard, Manuel; Allard, Michele] Univ Victor Segalen, Lab Imagerie Mol & Fonctionnelle, CNRS, UMR 5231, Bordeaux, France; [Peppe, Sue] Queen Margaret Univ Coll, Edinburgh, Midlothian, Scotland; [Bouvard, Manuel] CHRS, Bordeaux, France; [Allard, Michele] EPHE, F-75006 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Queen Margaret University; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Hesling, I (corresponding author), Univ Victor Segalen, Lab Imagerie Mol & Fonctionnelle, CNRS, UMR 5231, Bordeaux, France.	isabelle.hesling@wanadoo.fr	ALLARD, Michèle/D-8538-2014	dilharreguy, bixente/0000-0002-7771-1383; Hesling, Isabelle/0000-0002-3719-983X	Fondation de France Recherche Autisme [2006 012484]	Fondation de France Recherche Autisme	This study was supported by the Fondation de France Recherche Autisme 2006 012484. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*APA, 1994, DSM 4 DIAGN STAT MAN; Baddeley AD, 1992, SPEED CAPACITY LANGU; BALTAXE CSJ, 1985, PROSODIC DEV NORMAL, P95; BARONCOHEN S, 1994, BRIT J PSYCHIAT, V165, P640, DOI 10.1192/bjp.165.5.640; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Bonnel A, 2003, J COGNITIVE NEUROSCI, V15, P226, DOI 10.1162/089892903321208169; Breitenstein C, 1998, BRAIN LANG, V65, P243; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Buchanan L, 2000, BRAIN COGNITION, V43, P65; Burack J., 2001, DEV AUTISM PERSPECTI; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Dehaene S, 1997, NEUROREPORT, V8, P3809, DOI 10.1097/00001756-199712010-00030; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Fay W.H., 1980, EMERGING LANGUAGE AU; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; George MS, 1996, ARCH NEUROL-CHICAGO, V53, P665, DOI 10.1001/archneur.1996.00550070103017; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Grady CL, 2010, CEREB CORTEX, V20, P1432, DOI 10.1093/cercor/bhp207; Groen WB, 2009, J AUTISM DEV DISORD, V39, P742, DOI 10.1007/s10803-008-0682-3; Guberina P, 1981, VERBOTONAL METHOD RE; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Heaton P, 2008, AUTISM, V12, P203, DOI 10.1177/1362361307085270; Hesling I, 2005, NEUROIMAGE, V24, P937, DOI 10.1016/j.neuroimage.2004.11.003; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Imaizumi S, 1997, NEUROREPORT, V8, P2809, DOI 10.1097/00001756-199708180-00031; Jarvinen-Pasley A, 2008, DEVELOPMENTAL SCI, V11, P109, DOI 10.1111/j.1467-7687.2007.00644.x; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; KLIN A, 1991, J AUTISM DEV DISORD, V21, P29, DOI 10.1007/BF02206995; KLIN A, 1992, J CHILD PSYCHOL PSYC, V33, P763, DOI 10.1111/j.1469-7610.1992.tb00911.x; Korpilahti P, 2007, J AUTISM DEV DISORD, V37, P1539, DOI 10.1007/s10803-006-0271-2; Kuhl PK, 2005, DEVELOPMENTAL SCI, V8, pF1, DOI 10.1111/j.1467-7687.2004.00384.x; Kujala T, 2005, NEUROSCI LETT, V383, P260, DOI 10.1016/j.neulet.2005.04.048; Kuperberg GR, 2000, J COGNITIVE NEUROSCI, V12, P321, DOI 10.1162/089892900562138; Lepisto T, 2008, BIOL PSYCHOL, V77, P25, DOI 10.1016/j.biopsycho.2007.08.010; Luna B, 2002, NEUROLOGY, V59, P834, DOI 10.1212/WNL.59.6.834; Mason RA, 2008, NEUROPSYCHOLOGIA, V46, P269, DOI 10.1016/j.neuropsychologia.2007.07.018; Meyer M, 2002, HUM BRAIN MAPP, V17, P73, DOI 10.1002/hbm.10042; Muller RA, 1997, NEUROREPORT, V8, P3767; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Paul R, 2005, J AUTISM DEV DISORD, V35, P861, DOI 10.1007/s10803-005-0031-8; Paul R, 2005, J AUTISM DEV DISORD, V35, P205, DOI 10.1007/s10803-004-1999-1; Peppe S, 2003, CLIN LINGUIST PHONET, V17, P345, DOI 10.1080/0269920031000079994; Peppe S, 2006, J PRAGMATICS, V38, P1776, DOI 10.1016/j.pragma.2005.07.004; Peppe S, 2007, J SPEECH LANG HEAR R, V50, P1015, DOI 10.1044/1092-4388(2007/071); Perani D, 1998, BRAIN, V121, P1841, DOI 10.1093/brain/121.10.1841; Pierce K, 2004, BRAIN, V127, P2703, DOI 10.1093/brain/awh289; Plante E, 2006, BRAIN LANG, V97, P332, DOI 10.1016/j.bandl.2005.12.004; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ring HA, 1999, BRAIN, V122, P1305, DOI 10.1093/brain/122.7.1305; Ross ED, 1997, BRAIN LANG, V56, P27, DOI 10.1006/brln.1997.1731; Russo NM, 2008, CLIN NEUROPHYSIOL, V119, P1720, DOI 10.1016/j.clinph.2008.01.108; Samson F, 2006, J AUTISM DEV DISORD, V36, P65, DOI 10.1007/s10803-005-0043-4; SAUSSURE FD, 1976, COURS LINGUISTIQUE G; Schlosser MJ, 1998, HUM BRAIN MAPP, V6, P1, DOI 10.1002/(SICI)1097-0193(1998)6:1<1::AID-HBM1>3.0.CO;2-7; Shriberg LD, 2001, J SPEECH LANG HEAR R, V44, P1097, DOI 10.1044/1092-4388(2001/087); Shriberg LD., 1990, PROSODY VOICE SCREEN; TAGERFLUSBERG H, 1981, J AUTISM DEV DISORD, V11, P45, DOI 10.1007/BF01531340; Tesink CMJY, 2009, BRAIN, V132, P1941, DOI 10.1093/brain/awp103; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wang AT, 2006, BRAIN, V129, P932, DOI 10.1093/brain/awl032; Young EC, 2005, LANG SPEECH HEAR SER, V36, P62, DOI 10.1044/0161-1461(2005/006); ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; Zatorre RJ, 1996, J COGNITIVE NEUROSCI, V8, P29, DOI 10.1162/jocn.1996.8.1.29	66	37	38	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11571	10.1371/journal.pone.0011571	http://dx.doi.org/10.1371/journal.pone.0011571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644633	Green Published, Green Submitted, gold			2022-12-25	WOS:000279822300021
J	Kalushkova, A; Fryknas, M; Lemaire, M; Fristedt, C; Agarwal, P; Eriksson, M; Deleu, S; Atadja, P; Osterborg, A; Nilsson, K; Vanderkerken, K; Oberg, F; Jernberg-Wiklund, H				Kalushkova, Antonia; Fryknas, Marten; Lemaire, Miguel; Fristedt, Charlotte; Agarwal, Prasoon; Eriksson, Maria; Deleu, Sarah; Atadja, Peter; Osterborg, Anders; Nilsson, Kenneth; Vanderkerken, Karin; Oberg, Fredrik; Jernberg-Wiklund, Helena			Polycomb Target Genes Are Silenced in Multiple Myeloma	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; MONOCLONAL GAMMOPATHY; DNA METHYLATION; UNDETERMINED SIGNIFICANCE; EXPRESSION SIGNATURE; CANCER-CELLS; LONG-TERM; EZH2; MECHANISMS; MUTATIONS	Multiple myeloma (MM) is a genetically heterogeneous disease, which to date remains fatal. Finding a common mechanism for initiation and progression of MM continues to be challenging. By means of integrative genomics, we identified an underexpressed gene signature in MM patient cells compared to normal counterpart plasma cells. This profile was enriched for previously defined H3K27-tri-methylated genes, targets of the Polycomb group (PcG) proteins in human embryonic fibroblasts. Additionally, the silenced gene signature was more pronounced in ISS stage III MM compared to stage I and II. Using chromatin immunoprecipitation (ChIP) assay on purified CD138+ cells from four MM patients and on two MM cell lines, we found enrichment of H3K27me3 at genes selected from the profile. As the data implied that the Polycomb-targeted gene profile would be highly relevant for pharmacological treatment of MM, we used two compounds to chemically revert the H3K27-tri-methylation mediated gene silencing. The S-adenosylhomocysteine hydrolase inhibitor 3-Deazaneplanocin (DZNep) and the histone deacetylase inhibitor LBH589 (Panobinostat), reactivated the expression of genes repressed by H3K27me3, depleted cells from the PRC2 component EZH2 and induced apoptosis in human MM cell lines. In the immunocompetent 5T33MM in vivo model for MM, treatment with LBH589 resulted in gene upregulation, reduced tumor load and increased overall survival. Taken together, our results reveal a common gene signature in MM, mediated by gene silencing via the Polycomb repressor complex. The importance of the underexpressed gene profile in MM tumor initiation and progression should be subjected to further studies.	[Kalushkova, Antonia; Fryknas, Marten; Fristedt, Charlotte; Agarwal, Prasoon; Eriksson, Maria; Nilsson, Kenneth; Oberg, Fredrik; Jernberg-Wiklund, Helena] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden; [Lemaire, Miguel; Deleu, Sarah; Vanderkerken, Karin] Vrije Univ Brussel, Dept Hematol & Immunol, Brussels, Belgium; [Atadja, Peter] Novartis Inst Biomed Res, Cambridge, MA USA; [Osterborg, Anders] Karolinska Univ Hosp Solna, Dept Hematol, Stockholm, Sweden	Uppsala University; Vrije Universiteit Brussel; Novartis; Karolinska Institutet; Karolinska University Hospital	Kalushkova, A (corresponding author), Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden.	Helena.Jernberg_Wiklund@genpat.uu.se	Agarwal, Prasoon/H-8101-2019; Vanderkerken, Karin/I-3513-2013; Agarwal, Prasoon/D-7303-2016	Agarwal, Prasoon/0000-0003-1813-7606; Agarwal, Prasoon/0000-0003-1813-7606; Kalushkova, Antonia/0000-0003-4535-506X; Vanderkerken, Karin/0000-0002-2137-7179; Jernberg Wiklund, Helena/0000-0002-9319-7986	Swedish Cancer Society; Swedish Research Council; Multiple Myeloma Research Foundation; VonKantzows stiftelse; Stichting tegen Kanker; FWO-Vlaanderen; GOA-Vrije Universiteit Brussel	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Multiple Myeloma Research Foundation; VonKantzows stiftelse; Stichting tegen Kanker; FWO-Vlaanderen(FWO); GOA-Vrije Universiteit Brussel	This work was supported by grants from The Swedish Cancer Society, The Swedish Research Council, The Multiple Myeloma Research Foundation, VonKantzows stiftelse, Stichting tegen Kanker, FWO-Vlaanderen and GOA-Vrije Universiteit Brussel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli L, 2007, BRIT J HAEMATOL, V136, P565, DOI 10.1111/j.1365-2141.2006.06467.x; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chng WJ, 2007, CANCER RES, V67, P2982, DOI 10.1158/0008-5472.CAN-06-4046; Croonquist PA, 2005, ONCOGENE, V24, P6269, DOI 10.1038/sj.onc.1208771; Fiskus W, 2006, MOL CANCER THER, V5, P3096, DOI 10.1158/1535-7163.MCT-06-0418; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Ghosh N, 2001, J BIOL CHEM, V276, P15264, DOI 10.1074/jbc.M100862200; Hallek M, 1998, BLOOD, V91, P3, DOI 10.1182/blood.V91.1.3.3_3_21; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Holling TM, 2007, J IMMUNOL, V179, P5317, DOI 10.4049/jimmunol.179.8.5317; JERNBERGWIKLUND H, 1992, LEUKEMIA, V6, P310; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Landgren O, 2009, BLOOD, V113, P5412, DOI 10.1182/blood-2008-12-194241; Maiso P, 2006, CANCER RES, V66, P5781, DOI 10.1158/0008-5472.CAN-05-4186; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; MATSUOKA Y, 1967, P SOC EXP BIOL MED, V125, P1246; Mattioli M, 2005, ONCOGENE, V24, P2461, DOI 10.1038/sj.onc.1208447; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; RADL J, 1979, J IMMUNOL, V122, P609; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; SIEGEL DD, 2008, ASH ANN M, P2781; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Trudel S, 2005, BLOOD, V105, P2941, DOI 10.1182/blood-2004-10-3913; Tshuikina M, 2008, EXP HEMATOL, V36, P1673, DOI 10.1016/j.exphem.2008.08.001; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Vanderkerken K, 2003, IMMUNOL REV, V194, P196, DOI 10.1034/j.1600-065X.2003.00035.x; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weiss BM, 2009, BLOOD, V113, P5418, DOI 10.1182/blood-2008-12-195008; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077; Zhan FH, 2002, BLOOD, V99, P1745, DOI 10.1182/blood.V99.5.1745; Zhou Q, 2008, MOL CANCER RES, V6, P873, DOI 10.1158/1541-7786.MCR-07-0330	52	75	80	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11483	10.1371/journal.pone.0011483	http://dx.doi.org/10.1371/journal.pone.0011483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634887	Green Published, gold, Green Submitted			2022-12-25	WOS:000279715300003
J	Palacios, G; Lovoll, M; Tengs, T; Hornig, M; Hutchison, S; Hui, J; Kongtorp, RT; Savji, N; Bussetti, AV; Solovyov, A; Kristoffersen, AB; Celone, C; Street, C; Trifonov, V; Hirschberg, DL; Rabadan, R; Egholm, M; Rimstad, E; Lipkin, WI				Palacios, Gustavo; Lovoll, Marie; Tengs, Torstein; Hornig, Mady; Hutchison, Stephen; Hui, Jeffrey; Kongtorp, Ruth-Torill; Savji, Nazir; Bussetti, Ana V.; Solovyov, Alexander; Kristoffersen, Anja B.; Celone, Christopher; Street, Craig; Trifonov, Vladimir; Hirschberg, David L.; Rabadan, Raul; Egholm, Michael; Rimstad, Espen; Lipkin, W. Ian			Heart and Skeletal Muscle Inflammation of Farmed Salmon Is Associated with Infection with a Novel Reovirus	PLOS ONE			English	Article							ATLANTIC SALMON; OUTBREAK	Atlantic salmon (Salmo salar L.) mariculture has been associated with epidemics of infectious diseases that threaten not only local production, but also wild fish coming into close proximity to marine pens and fish escaping from them. Heart and skeletal muscle inflammation (HSMI) is a frequently fatal disease of farmed Atlantic salmon. First recognized in one farm in Norway in 1999[1], HSMI was subsequently implicated in outbreaks in other farms in Norway and the United Kingdom[2]. Although pathology and disease transmission studies indicated an infectious basis, efforts to identify an agent were unsuccessful. Here we provide evidence that HSMI is associated with infection with piscine reovirus (PRV). PRV is a novel reovirus identified by unbiased high throughput DNA sequencing and a bioinformatics program focused on nucleotide frequency as well as sequence alignment and motif analyses. Formal implication of PRV in HSMI will require isolation in cell culture and fulfillment of Koch's postulates, or prevention or modification of disease through use of specific drugs or vaccines. Nonetheless, as our data indicate that a causal relationship is plausible, measures must be taken to control PRV not only because it threatens domestic salmon production but also due to the potential for transmission to wild salmon populations.	[Palacios, Gustavo; Hornig, Mady; Hui, Jeffrey; Savji, Nazir; Bussetti, Ana V.; Solovyov, Alexander; Street, Craig; Hirschberg, David L.; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, New York, NY 10027 USA; [Lovoll, Marie; Tengs, Torstein; Kristoffersen, Anja B.] Natl Vet Inst, Oslo, Norway; [Kongtorp, Ruth-Torill] Minist Fisheries & Coastal Affairs, Oslo, Norway; [Trifonov, Vladimir; Rabadan, Raul] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Trifonov, Vladimir; Rabadan, Raul] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA; [Rimstad, Espen] Norwegian Sch Vet Sci, Oslo, Norway	Columbia University; Norwegian Veterinary Institute; Columbia University; Columbia University; Norwegian University of Life Sciences	Palacios, G (corresponding author), Columbia Univ, Ctr Infect & Immun, New York, NY 10027 USA.	espen.rimstad@nvh.no; wil2001@columbia.edu	Hornig, Mady/AAE-8431-2020; Rabadan, Raul/AAZ-7367-2020; Palacios, Gustavo/I-7773-2015; Lipkin, W. Ian/ABE-6216-2020	Hornig, Mady/0000-0001-7572-3092; Palacios, Gustavo/0000-0001-5062-1938; Lipkin, W. Ian/0000-0002-8768-9386; Rabadan, Raul/0000-0001-7946-9255	National Institutes of Health [AI57158]; Google.org; Norwegian Research Council [186907, 178950]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Google.org(Google Incorporated); Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (AI57158), Google.org and the Norwegian Research Council (Grant 186907 and 178950). The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Ferguson HW, 2005, J FISH DIS, V28, P119, DOI 10.1111/j.1365-2761.2004.00602.x; Jones RC, 2000, REV SCI TECH OIE, V19, P614, DOI 10.20506/rst.19.2.1237; Kongtorp RT, 2009, J FISH DIS, V32, P253, DOI 10.1111/j.1365-2761.2008.00983.x; Kongtorp RT, 2006, J FISH DIS, V29, P233, DOI 10.1111/j.1365-2761.2006.00710.x; Kongtorp RT, 2004, DIS AQUAT ORGAN, V59, P217, DOI 10.3354/dao059217; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MERTENS P, 2005, FAMILY REOVIRIDAE FA; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas O, 1902, P ZOOL SOC LOND, V1902, P2; TRIFONOV V, MBIO UNPUB; Watanabe K, 2006, DIS AQUAT ORGAN, V70, P183, DOI 10.3354/dao070183	22	175	187	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11487	10.1371/journal.pone.0011487	http://dx.doi.org/10.1371/journal.pone.0011487			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634888	Green Published, gold			2022-12-25	WOS:000279715300004
J	Bernard, E; Solignat, M; Gay, B; Chazal, N; Higgs, S; Devaux, C; Briant, L				Bernard, Eric; Solignat, Maxime; Gay, Bernard; Chazal, Nathalie; Higgs, Stephen; Devaux, Christian; Briant, Laurence			Endocytosis of Chikungunya Virus into Mammalian Cells: Role of Clathrin and Early Endosomal Compartments	PLOS ONE			English	Article							MOSQUITO CELLS; LOW PH; ENTRY; INFECTION; EPIDEMIC; CHOLESTEROL; OUTBREAK; RAB5; ALPHAVIRUSES; CYTOSKELETON	Background: The replicative cycle of chikungunya virus (CHIKV), an alphavirus that recently re-emerged in India and in Indian Ocean area, remains mostly unknown. The aim of the present study was to investigate the intracellular trafficking pathway(s) hijacked by CHIKV to enter mammalian cells. Methodology/Principal Findings: Entry pathways were investigated using a variety of pharmacological inhibitors or overexpression of dominant negative forms of proteins perturbating cellular endocytosis. We found that CHIKV infection of HEK293T mammalian cells is independent of clathrin heavy chain and-dependent of functional Eps15, and requires integrity of Rab5-, but not Rab7-positive endosomal compartment. Cytoskeleton integrity is crucial as cytochalasin D and nocodazole significantly reduced infection of the cells. Finally, both methyl beta-cyclodextrin and lysomotropic agents impaired CHIKV infection, supporting that a cholesterol-, pH-dependent step is required to achieve productive infection. Interestingly, differential sensitivity to lysomotropic agents was observed between the prototypal 37997 African strain of CHIKV and the LR-OPY1 virus isolated from the recent outbreak in Reunion Island. Conclusions: Together our data indicate that CHIKV entry in its target cells is essentially mediated by clathrin-independent, Eps15-dependent endocytosis. Despite that this property is shared by the prototypal 37997 African strain of CHIKV and the LR-OPY1 virus isolated from the recent outbreak in La Reunion Island, differential sensitivity to lysomotropic agents may support that the LR-OPY1 strain has acquired specific entry mechanisms.	[Bernard, Eric; Solignat, Maxime; Gay, Bernard; Chazal, Nathalie; Devaux, Christian; Briant, Laurence] Univ Montpellier I, CNRS, UMR5236, Ctr Etud Agents Pathogenes & Biotechnol Sante CPB, Montpellier, France; [Higgs, Stephen] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Higgs, Stephen] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX USA	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Bernard, E (corresponding author), Univ Montpellier I, CNRS, UMR5236, Ctr Etud Agents Pathogenes & Biotechnol Sante CPB, Montpellier, France.	Laurence.briant@univ-montp1.fr	Chazal, Nathalie/AAH-2937-2021; Briant, Laurence/AAB-9281-2021	Chazal, Nathalie/0000-0002-1528-9607; Briant, Laurence/0000-0002-1995-3501	Centre National de la Recherche Scientifique (CNRS) and University of Montpellier; French ANR; National Institutes of Health (NIH) [AI R21 AI073389]; Centre National de la Recherche Scientifique-Delegation Generale pour l'Armement (CNRS-DGA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073389] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique (CNRS) and University of Montpellier(Centre National de la Recherche Scientifique (CNRS)); French ANR(French National Research Agency (ANR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre National de la Recherche Scientifique-Delegation Generale pour l'Armement (CNRS-DGA)(Centre National de la Recherche Scientifique (CNRS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by institutional funds from the Centre National de la Recherche Scientifique (CNRS) and University of Montpellier and a grant from the French ANR. SH was supported in part by funding from the National Institutes of Health (NIH) AI R21 AI073389. MS is supported by a Centre National de la Recherche Scientifique-Delegation Generale pour l'Armement (CNRS-DGA) PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0; Ahn A, 2002, J VIROL, V76, P3267, DOI 10.1128/JVI.76.7.3267-3275.2002; Ashok A, 2003, J VIROL, V77, P1347, DOI 10.1128/JVI.77.2.1347-1356.2003; Beltrame A, 2007, EMERG INFECT DIS, V13, P1264, DOI 10.3201/eid1308.070161; Benmerah A, 1999, J CELL SCI, V112, P1303; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; *CAREC, 2006, CHIK MART FRENCH GUY, V26, P17; Chastel Claude, 2005, Bull Acad Natl Med, V189, P1827; Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003; DEPOORTERE E, 2006, EUROSURVEILLANCE, V11, P2; Durrbach A, 1996, J CELL SCI, V109, P457; FAN DP, 1978, CELL, V15, P985, DOI 10.1016/0092-8674(78)90282-9; Galperin E, 2003, J CELL SCI, V116, P4799, DOI 10.1242/jcs.00801; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GREISERWILKE I, 1989, J GEN VIROL, V70, P743, DOI 10.1099/0022-1317-70-3-743; HAMMON WM, 1960, T ASSOC AM PHYSICIAN, V73, P140; Hernandez R, 2001, J VIROL, V75, P2010, DOI 10.1128/JVI.75.4.2010-2013.2001; HIGASHI N, 1967, VIROLOGY, V33, P55, DOI 10.1016/0042-6822(67)90093-1; Hollinshead M, 2001, J CELL BIOL, V154, P389, DOI 10.1083/jcb.200104124; Hunter AW, 2000, J CELL SCI, V113, P4379; *INVS, 2006, EP CHIK REUN POINT S; Karabatsos N., 1985, INT CATALOGUE ARBOVI; KIELIAN M, 1990, MOL BIOL MED, V7, P17; KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P553, DOI 10.1016/0035-9203(65)90158-6; Kolokoltsov AA, 2006, VIROLOGY, V347, P333, DOI 10.1016/j.virol.2005.11.051; Kumar NP, 2008, J GEN VIROL, V89, P1945, DOI 10.1099/vir.0.83628-0; Lamaze C, 1997, J BIOL CHEM, V272, P20332, DOI 10.1074/jbc.272.33.20332; Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MARSH M, 1984, BIOCHEM SOC T, V12, P981, DOI 10.1042/bst0120981; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; MCCRAE AWR, 1971, T ROY SOC TROP MED H, V65, P152, DOI 10.1016/0035-9203(71)90212-4; MIRANDA AF, 1974, J CELL BIOL, V62, P406, DOI 10.1083/jcb.62.2.406; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; PADBIDRI VS, 1979, J HYG EPID MICROB IM, V23, P445; Paredes AM, 2004, VIROLOGY, V324, P373, DOI 10.1016/j.virol.2004.03.046; Pastorino B, 2004, J MED VIROL, V74, P277, DOI 10.1002/jmv.20168; PHALEN T, 1991, J CELL BIOL, V112, P615, DOI 10.1083/jcb.112.4.615; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Rao T R, 1966, J Indian Med Assoc, V46, P248; Ravi V, 2006, Indian J Med Microbiol, V24, P83; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; ROSS R. W., 1956, JOUR HYG, V54, P177; Roussel A, 2006, STRUCTURE, V14, P75, DOI 10.1016/j.str.2005.09.014; Rulli NE, 2007, ANN NY ACAD SCI, V1102, P96, DOI 10.1196/annals.1408.007; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; SHAH KV, 1964, INDIAN J MED RES, V52, P676; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; SIMIZU B, 1984, J VIROL, V51, P254, DOI 10.1128/JVI.51.1.254-258.1984; Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024; SOURISSEAU M, 2007, P NATL ACAD SCI USA, V102, P2760; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Vainio S, 2002, EMBO REP, V3, P95, DOI 10.1093/embo-reports/kvf010; Vashishtha M, 1998, J CELL BIOL, V140, P91, DOI 10.1083/jcb.140.1.91; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Warner E., 2006, Morbidity and Mortality Weekly Report, V55, P1040	64	116	119	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11479	10.1371/journal.pone.0011479	http://dx.doi.org/10.1371/journal.pone.0011479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628602	Green Published, Green Submitted, gold			2022-12-25	WOS:000279637100009
J	Balakumaran, A; Pawelczyk, E; Ren, JQ; Sworder, B; Chaudhry, A; Sabatino, M; Stroncek, D; Frank, JA; Robey, PG				Balakumaran, Arun; Pawelczyk, Edyta; Ren, Jiaqiang; Sworder, Brian; Chaudhry, Aneeka; Sabatino, Marianna; Stroncek, David; Frank, Joseph A.; Robey, Pamela G.			Superparamagnetic Iron Oxide Nanoparticles Labeling of Bone Marrow Stromal (Mesenchymal) Cells Does Not Affect Their "Stemness''	PLOS ONE			English	Article							IN-VIVO; FERUMOXIDES; TRACKING; OSTEOGENESIS; TRAFFICKING; FIBROBLASTS; EXPRESSION; MOUSE; MRI	Superparamagnetic iron oxide nanoparticles (SPION) are increasingly used to label human bone marrow stromal cells (BMSCs, also called "mesenchymal stem cells'') to monitor their fate by in vivo MRI, and by histology after Prussian blue (PB) staining. SPION-labeling appears to be safe as assessed by in vitro differentiation of BMSCs, however, we chose to resolve the question of the effect of labeling on maintaining the "stemness'' of cells within the BMSC population in vivo. Assays performed include colony forming efficiency, CD146 expression, gene expression profiling, and the "gold standard'' of evaluating bone and myelosupportive stroma formation in vivo in immuncompromised recipients. SPION-labeling did not alter these assays. Comparable abundant bone with adjoining host hematopoietic cells were seen in cohorts of mice that were implanted with SPION-labeled or unlabeled BMSCs. PB+ adipocytes were noted, demonstrating their donor origin, as well as PB+ pericytes, indicative of self-renewal of the stem cell in the BMSC population. This study confirms that SPION labeling does not alter the differentiation potential of the subset of stem cells within BMSCs.	[Balakumaran, Arun; Sworder, Brian; Robey, Pamela G.] Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA; [Pawelczyk, Edyta; Chaudhry, Aneeka; Frank, Joseph A.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Ren, Jiaqiang; Sabatino, Marianna; Stroncek, David] NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Frank, Joseph A.] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Balakumaran, A (corresponding author), Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA.	balakumarana@nidcr.nih.gov	Robey, Pamela Gehron/H-1429-2011; Frank, Joseph/W-2021-2019	Robey, Pamela Gehron/0000-0002-5316-5576; Sworder, Brian/0000-0002-5902-5507	National Institute of Dental and Craniofacial Research; Clinical Center, IRP, NIH, Department of Health and Human Services; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000380] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL002120, ZIACL090007] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Clinical Center, IRP, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); CLINICAL CENTER	This study was supported by the Intramural Research Program of the National Institute of Dental and Craniofacial Research and the Clinical Center, IRP, NIH, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SA, 2005, BLOOD, V105, P420, DOI 10.1182/blood-2004-06-2222; Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017; Arbab AS, 2005, NMR BIOMED, V18, P553, DOI 10.1002/nbm.991; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Arbab AS, 2004, HUM GENE THER, V15, P351, DOI 10.1089/104303404322959506; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bianco P, 2006, METHOD ENZYMOL, V419, P117, DOI 10.1016/S0076-6879(06)19006-0; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Frank JA, 2004, CYTOTHERAPY, V6, P621, DOI 10.1080/14653240410005267-1; Kostura L, 2004, NMR BIOMED, V17, P513, DOI 10.1002/nbm.925; Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Lee ESM, 2009, STEM CELLS, V27, P1921, DOI 10.1002/stem.112; Mankani MH, 2004, RADIOLOGY, V230, P369, DOI 10.1148/radiol.2302011529; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pawelczyk E, 2006, NMR BIOMED, V19, P581, DOI 10.1002/nbm.1038; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stroncek DF, 2009, MOL DIAGN THER, V13, P181, DOI 10.2165/01250444-200913030-00003; Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; WESTEN H, 1979, J EXP MED, V150, P919, DOI 10.1084/jem.150.4.919; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	25	85	87	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11462	10.1371/journal.pone.0011462	http://dx.doi.org/10.1371/journal.pone.0011462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628641	Green Submitted, Green Published, gold			2022-12-25	WOS:000279589300010
J	Rocha, GM; Teixeira, DE; Miranda, K; Weissmuller, G; Bisch, PM; de Souza, W				Rocha, Gustavo Miranda; Teixeira, Dirceu Esdras; Miranda, Kildare; Weissmueller, Gilberto; Bisch, Paulo Mascarello; de Souza, Wanderley			Structural Changes of the Paraflagellar Rod during Flagellar Beating in Trypanosoma cruzi	PLOS ONE			English	Article							KINETOPLASTID PARASITES; CELL-SURFACE; ORGANIZATION; COMPONENTS; BRUCEI; MOTILITY; CHARGE; GENE	Background: Trypanosoma cruzi, the agent of Chagas disease, is a protozoan member of the Kinetoplastidae family characterized for the presence of specific and unique structures that are involved in different cell activities. One of them is the paraflagellar rod (PFR), a complex array of filaments connected to the flagellar axoneme. Although the function played by the PFR is not well established, it has been shown that silencing of the synthesis of its major proteins by either knockout of RNAi impairs and/or modifies the flagellar motility. Methodology/Principal Findings: Here, we present results obtained by atomic force microscopy (AFM) and transmission electron microscopy (TEM) of replicas of quick-frozen, freeze-fractured, deep-etched and rotary-replicated cells to obtain detailed information of the PFR structures in regions of the flagellum in straight and in bent state. The images obtained show that the PFR is not a fixed and static structure. The pattern of organization of the PFR filament network differs between regions of the flagellum in a straight state and those in a bent state. Measurements of the distances between the PFR filaments and the filaments that connect the PFR to the axoneme as well as of the angles between the intercrossed filaments supported this idea. Conclusions/Significance: Graphic computation based on the information obtained allowed the proposal of an animated model for the PFR structure during flagellar beating and provided a new way of observing PFR filaments during flagellar beating.	[Rocha, Gustavo Miranda; Teixeira, Dirceu Esdras; Miranda, Kildare; de Souza, Wanderley] Univ Fed Rio de Janeiro, Lab Ultraestrutura Celular Hertha Meyer, Rio De Janeiro, Brazil; [Rocha, Gustavo Miranda; Miranda, Kildare; Weissmueller, Gilberto; Bisch, Paulo Mascarello; de Souza, Wanderley] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estruct & Bioimag, Rio De Janeiro, Brazil; [Rocha, Gustavo Miranda; Miranda, Kildare; de Souza, Wanderley] Inst Nacl Metrol Normalizacao & Qualidade Ind, Rio De Janeiro, Brazil; [Weissmueller, Gilberto; Bisch, Paulo Mascarello] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Fis Biol, BR-21941 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal do Rio de Janeiro	Rocha, GM (corresponding author), Univ Fed Rio de Janeiro, Lab Ultraestrutura Celular Hertha Meyer, Cidade Univ, Rio De Janeiro, Brazil.	wsouza@biof.ufrj.br	Teixeira, Dirceu Esdras/ABB-3196-2020; Mascarello Bisch, Paulo/GRF-5572-2022	Teixeira, Dirceu Esdras/0000-0002-8305-8261; Weissmuller, Gilberto/0000-0002-0345-7335	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao Universitaria Jose Bonifacio (FUJB)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Universitaria Jose Bonifacio (FUJB)	This work was supported by grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Fundacao Universitaria Jose Bonifacio (FUJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdille MH, 2008, EXP PARASITOL, V118, P614, DOI 10.1016/j.exppara.2007.11.011; Akaki M, 2001, PARASITOL RES, V87, P193, DOI 10.1007/PL00008574; Bastin P, 1999, MOL CELL BIOL, V19, P8191; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; BOVEE EC, 1972, J THEOR BIOL, V35, P259, DOI 10.1016/0022-5193(72)90038-0; de Souza W, 2008, CURR PHARM DESIGN, V14, P822, DOI 10.2174/138161208784041123; de Souza W, 2009, MEM I OSWALDO CRUZ, V104, P89, DOI 10.1590/S0074-02762009000900014; DESOUZA W, 1978, J CELL SCI, V33, P285; Dvorak JA, 2000, J ELECTRON MICROSC, V49, P429, DOI 10.1093/oxfordjournals.jmicro.a023825; FARINA M, 1986, J PROTOZOOL, V33, P552, DOI 10.1111/j.1550-7408.1986.tb05661.x; Gadelha C, 2004, MOL BIOCHEM PARASIT, V136, P113, DOI 10.1016/j.molbiopara.2004.03.006; GOODENOUGH UW, 1982, J CELL BIOL, V95, P798, DOI 10.1083/jcb.95.3.798; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; Hunger-Glaser I, 1997, MOL BIOCHEM PARASIT, V90, P347, DOI 10.1016/S0166-6851(97)00139-4; Katta SS, 2009, MOL BIOCHEM PARASIT, V164, P105, DOI 10.1016/j.molbiopara.2008.12.002; Moreira-Leite FF, 1999, MOL BIOCHEM PARASIT, V104, P131, DOI 10.1016/S0166-6851(99)00143-7; Portman N, 2010, INT J PARASITOL, V40, P135, DOI 10.1016/j.ijpara.2009.10.005; Ralston KS, 2008, INT J PARASITOL, V38, P869, DOI 10.1016/j.ijpara.2008.03.003; Rocha GM, 2008, MICROSC RES TECHNIQ, V71, P133, DOI 10.1002/jemt.20535; Rusconi F, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-6; Santrich C, 1997, MOL BIOCHEM PARASIT, V90, P95, DOI 10.1016/S0166-6851(97)00149-7; SCHLIWA M, 1981, J CELL BIOL, V90, P222, DOI 10.1083/jcb.90.1.222; SOUTOPADRON T, 1984, ACTA TROP, V41, P215; TETLEY L, 1985, J CELL SCI, V74, P1; Tuxhorn J, 1998, CELL MOTIL CYTOSKEL, V40, P133, DOI 10.1016/j.semcdb.2008.07.005; VICKERMAN K, 1973, J PROTOZOOL, V20, P394, DOI 10.1111/j.1550-7408.1973.tb00909.x; WALTERS LL, 1987, AM J TROP MED HYG, V36, P294, DOI 10.4269/ajtmh.1987.36.294	27	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11407	10.1371/journal.pone.0011407	http://dx.doi.org/10.1371/journal.pone.0011407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613980	Green Published, gold, Green Submitted			2022-12-25	WOS:000279370000031
J	Yuede, CM; Wozniak, DF; Creeley, CE; Taylor, GT; Olney, JW; Farber, NB				Yuede, Carla M.; Wozniak, David F.; Creeley, Catherine E.; Taylor, George T.; Olney, John W.; Farber, Nuri B.			Behavioral Consequences of NMDA Antagonist-Induced Neuroapoptosis in the Infant Mouse Brain	PLOS ONE			English	Article							METHYL-D-ASPARTATE; APOPTOTIC NEURODEGENERATION; WORKING-MEMORY; EARLY EXPOSURE; DEFICITS; MICE; ETHANOL; COMBINATION; KETAMINE	Background: Exposure to NMDA glutamate antagonists during the brain growth spurt period causes widespread neuroapoptosis in the rodent brain. This period in rodents occurs during the first two weeks after birth, and corresponds to the third trimester of pregnancy and several years after birth in humans. The developing human brain may be exposed to NMDA antagonists through drug-abusing mothers or through anesthesia. Methodology/Principal Findings: We evaluated the long-term neurobehavioral effects of mice exposed to a single dose of the NMDA antagonist, phencyclidine (PCP), or saline, on postnatal day 2 (P2) or P7, or on both P2 and P7. PCP treatment on P2 + P7 caused more severe cognitive impairments than either single treatment. Histological examination of acute neuroapoptosis resulting from exposure to PCP indicated that the regional pattern of degeneration induced by PCP in P2 pups was different from that in P7 pups. The extent of damage when evaluated quantitatively on P7 was greater for pups previously treated on P2 compared to pups treated only on P7. Conclusions: These findings signify that PCP induces different patterns of neuroapoptosis depending on the developmental age at the time of exposure, and that exposure at two separate developmental ages causes more severe neuropathological and neurobehavioral consequences than a single treatment.	[Yuede, Carla M.; Wozniak, David F.; Creeley, Catherine E.; Olney, John W.; Farber, Nuri B.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Yuede, Carla M.; Taylor, George T.] Univ Missouri, Dept Psychol, St Louis, MO 63121 USA	Washington University (WUSTL); University of Missouri System; University of Missouri Saint Louis	Yuede, CM (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	yuedec@psychiatry.wustl.edu		FARBER, NURI/0000-0003-3178-1877	National Institute on Drug Abuse [T32DA002761, DA05072]; MERIT [HD37100]; NBF [ES01244304]; Bantly Foundation (NBF); NIH [P30 NS057105]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD037100, R01HD037100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); MERIT; NBF; Bantly Foundation (NBF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by T32DA002761 and DA05072 (JWO) from the National Institute on Drug Abuse, MERIT award HD37100 (JWO), Research grant ES01244304 (NBF), The Bantly Foundation (NBF), and NIH Neuroscience Blueprint Interdisciplinary Center Core Grant P30 NS057105 to Washington University (DFW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Boctor SY, 2010, NEUROTOXICOLOGY, V31, P42, DOI 10.1016/j.neuro.2009.10.007; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Cheng ZW, 2005, J NEUROSCI RES, V81, P284, DOI 10.1002/jnr.20559; DiMaggio C, 2009, J NEUROSURG ANESTH, V21, P286, DOI 10.1097/ANA.0b013e3181a71f11; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Fredriksson A, 2004, NEUROTOX RES, V6, P435, DOI 10.1007/BF03033280; Fredriksson A, 2004, BEHAV BRAIN RES, V153, P367, DOI 10.1016/j.bbr.2003.12.026; Fredriksson A, 2007, ANESTHESIOLOGY, V107, P427, DOI 10.1097/01.anes.0000278892.62305.9c; Gallitano-Mendel A, 2007, NEUROSCIENCE, V148, P633, DOI 10.1016/j.neuroscience.2007.05.050; Hartman RE, 2001, EXP NEUROL, V170, P326, DOI 10.1006/exnr.2001.7715; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2001, BIOCHEM PHARMACOL, V62, P401, DOI 10.1016/S0006-2952(01)00696-7; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Johnson SA, 2008, J NEUROSURG ANESTH, V20, P21, DOI 10.1097/ANA.0b013e3181271850; Kalkman CJ, 2009, ANESTHESIOLOGY, V110, P805, DOI 10.1097/ALN.0b013e31819c7124; Khuchua Z, 2003, NEUROSCIENCE, V119, P101, DOI 10.1016/S0306-4522(03)00094-0; Mitchell AS, 2002, J NEUROSCI, V22, P1922, DOI 10.1523/JNEUROSCI.22-05-01922.2002; Nakatani-Pawlak A, 2009, BIOL PHARM BULL, V32, P1576, DOI 10.1248/bpb.32.1576; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Paxinos G., 2007, ATLAS DEV MOUSE BRAI; Slikker W, 2007, TOXICOL SCI, V98, P145, DOI 10.1093/toxsci/kfm084; Wang C, 2001, NEUROSCIENCE, V107, P535, DOI 10.1016/S0306-4522(01)00384-0; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; Wiley JL, 2003, PSYCHOPHARMACOLOGY, V165, P378, DOI 10.1007/s00213-002-1297-6; Wozniak DF, 2007, NEUROBIOL DIS, V26, P14, DOI 10.1016/j.nbd.2006.11.014; Wozniak DF, 2004, NEUROBIOL DIS, V17, P403, DOI 10.1016/j.nbd.2004.08.006; Young C, 2005, NEUROBIOL DIS, V20, P608, DOI 10.1016/j.nbd.2005.04.014; Young C, 2005, BRIT J PHARMACOL, V146, P189, DOI 10.1038/sj.bjp.0706301; Zou XJ, 2009, INT J DEV NEUROSCI, V27, P727, DOI 10.1016/j.ijdevneu.2009.06.010	31	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11374	10.1371/journal.pone.0011374	http://dx.doi.org/10.1371/journal.pone.0011374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613880	Green Published, Green Submitted, gold			2022-12-25	WOS:000279369900022
J	Acharjee, S; Noorbakhsh, F; Stemkowski, PL; Olechowski, C; Cohen, EA; Ballanyi, K; Kerr, B; Pardo, C; Smith, PA; Power, C				Acharjee, Shaona; Noorbakhsh, Farshid; Stemkowski, Patrick L.; Olechowski, Camille; Cohen, Eric A.; Ballanyi, Klaus; Kerr, Bradley; Pardo, Carlos; Smith, Peter A.; Power, Christopher			HIV-1 viral protein R causes peripheral nervous system injury associated with in vivo neuropathic pain	FASEB JOURNAL			English	Article						dorsal root ganglion; electrophysiology; calcium imaging; interferon-alpha	DORSAL ROOT-GANGLIA; SENSORY NEURONS; VPR PROTEIN; AXONAL POLYNEUROPATHY; CHANNEL CURRENTS; INTERFERON-ALPHA; RAT; REGENERATION; EXPRESSION; K+	Painful peripheral neuropathy has become the principal neurological disorder in HIV/AIDS patients. Herein, we investigated the effects of a cytotoxic HIV-1 accessory protein, viral protein R (Vpr), on the peripheral nervous system (PNS). Host and viral gene expression was investigated in peripheral nerves from HIV-infected individuals and in HIV-infected human dorsal root ganglion (DRG) cultures by RT-PCR and immunocytochemistry. Cytosolic calcium ([Ca2+]) fluxes and neuronal membrane responses were analyzed in cultured DRGs. Neurobehavioral responses and cytokine levels were assessed in a transgenic mouse model in which the vpr transgene was expressed in an immunodeficient background (vpr/RAG1(-/-)). Vpr transcripts and proteins were detected in peripheral nerves and DRGs from HIV-infected patients. Exposure of rat or human cultured DRG neurons to Vpr rapidly increased [Ca2+] and action potential frequency while increasing input resistance. HIV infection of human DRG cultures caused neurite retraction (P<0.05), accompanied by induction of interferon-alpha (IFN-alpha) transcripts (P<0.05). vpr/RAG1(-/-) mice expressed Vpr together with increased IFN-alpha (P<0.05) in the PNS and also exhibited mechanical allodynia, unlike their vpr/RAG1(-/-) littermates (P<0.05). Herein, Vpr caused DRG neuronal damage, likely through cytosolic calcium activation and cytokine perturbation, highlighting Vpr's contribution to HIV-associated peripheral neuropathy and ensuing neuropathic pain.-Acharjee, S., Noorbakhsh, S., Stemkowski, P. L., Olechowski, C., Cohen, E. A., Ballanyi, K., Kerr, B., Pardo, C., Smith, P. A., Power, C. HIV-1 viral protein R causes peripheral nervous system injury associated with in vivo neuropathic pain. FASEB J. 24, 4343-4353 (2010). www.fasebj.org	[Power, Christopher] Univ Alberta, Dept Med, Heritage Med Res Ctr 6, Edmonton, AB T6G 2S2, Canada; [Power, Christopher] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada; [Ballanyi, Klaus] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2S2, Canada; [Stemkowski, Patrick L.; Olechowski, Camille; Ballanyi, Klaus; Kerr, Bradley; Smith, Peter A.] Univ Alberta, Ctr Neurosci, Edmonton, AB T6G 2S2, Canada; [Smith, Peter A.] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2S2, Canada; [Kerr, Bradley] Univ Alberta, Dept Anesthesiol & Pain Med, Edmonton, AB T6G 2S2, Canada; [Cohen, Eric A.] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ, Canada; [Cohen, Eric A.] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Pardo, Carlos] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Johns Hopkins University	Power, C (corresponding author), Univ Alberta, Dept Med, Heritage Med Res Ctr 6, Edmonton, AB T6G 2S2, Canada.	chris.power@ualberta.ca	Power, Christopher/C-7181-2013; Pardo, Carlos A./A-5192-2008	Pardo, Carlos A./0000-0002-4128-5335; Power, Christopher/0000-0002-5131-9711	Alberta Heritage Foundation for Medical Research (AHFMR); Canadian Institutes for Health Research (CIHR); Canada Research Chairs (Tier 1) in Retrovirology and Neurological Infection and Immunity; Multiple Sclerosis Society of Canada	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs (Tier 1) in Retrovirology and Neurological Infection and Immunity(Canada Research Chairs); Multiple Sclerosis Society of Canada	The authors thank Araya Ruangkittisakul for technical assistance and Dr. Yu Zhu for helpful discussions. F.N. holds fellowships from the Alberta Heritage Foundation for Medical Research (AHFMR) and the Canadian Institutes for Health Research (CIHR). E.C. and C.P. hold Canada Research Chairs (Tier 1) in Retrovirology and Neurological Infection and Immunity, respectively. B.K. holds a Don Paty Career Award from the Multiple Sclerosis Society of Canada. K.B. is an AHFMR Scientist, and C.P. is an AHFMR Senior Scholar. These studies were supported by the CIHR.	Abdulla FA, 2002, J NEUROPHYSIOL, V88, P2518, DOI 10.1152/jn.00913.2001; Abdulla FA, 2001, J NEUROPHYSIOL, V85, P644, DOI 10.1152/jn.2001.85.2.644; ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Alier KA, 2008, J PHARMACOL EXP THER, V324, P224, DOI 10.1124/jpet.107.129171; BERNSEN PLJA, 1985, LANCET, V1, P50; Bruce-Keller AJ, 2003, J NEUROSCI, V23, P8417; Cherry CL, 2009, NEUROLOGY, V73, P315, DOI 10.1212/WNL.0b013e3181af7a22; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; CHRISTOPHER P, 2003, ANN NEUROL, V53, P731; Dickie P, 2004, VIROLOGY, V322, P69, DOI 10.1016/j.virol.2004.01.026; Emir S, 1999, PEDIATR HEMAT ONCOL, V16, P557, DOI 10.1080/088800199276868; Gold MS, 1996, J NEUROPHYSIOL, V75, P2629, DOI 10.1152/jn.1996.75.6.2629; Gonzalez-Duarte Alejandra, 2007, Curr HIV/AIDS Rep, V4, P114, DOI 10.1007/s11904-007-0017-6; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Hirota H, 1996, J EXP MED, V183, P2627, DOI 10.1084/jem.183.6.2627; Huang MB, 2000, J NEUROVIROL, V6, P202, DOI 10.3109/13550280009015823; JACOBS JM, 1976, J NEUROL SCI, V29, P95, DOI 10.1016/0022-510X(76)90083-6; Jolivalt CG, 2008, EUR J PAIN, V12, P76, DOI 10.1016/j.ejpain.2007.03.008; Jones G, 2005, VIROLOGY, V334, P178, DOI 10.1016/j.virol.2005.01.027; Jones GJ, 2007, J NEUROSCI, V27, P3703, DOI 10.1523/JNEUROSCI.5522-06.2007; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Keswani SC, 2006, J NEUROSCI, V26, P10299, DOI 10.1523/JNEUROSCI.3135-06.2006; Keswani SC, 2002, AIDS, V16, P2105, DOI 10.1097/00002030-200211080-00002; Le Rouzic E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-11; LEVY DN, 1994, P NATL ACAD SCI USA, V91, P10873, DOI 10.1073/pnas.91.23.10873; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Linley JE, 2008, J NEUROSCI, V28, P11240, DOI 10.1523/JNEUROSCI.2297-08.2008; Lu VB, 2009, J PHYSIOL-LONDON, V587, P1013, DOI 10.1113/jphysiol.2008.166306; MARRION NV, 1991, NEURON, V6, P533, DOI 10.1016/0896-6273(91)90056-6; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; NEGORO K, 1994, MUSCLE NERVE, V17, P1351; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Noorbakhsh F, 2005, J IMMUNOL, V174, P7320, DOI 10.4049/jimmunol.174.11.7320; Okamoto K, 2001, EXP NEUROL, V169, P386, DOI 10.1006/exnr.2001.7677; Olechowski CJ, 2009, PAIN, V141, P156, DOI 10.1016/j.pain.2008.11.002; Pandya R, 2005, CAN J NEUROL SCI, V32, P201, DOI 10.1017/S0317167100003978; Pardo CA, 2001, J PERIPHER NERV SYST, V6, P21, DOI 10.1046/j.1529-8027.2001.006001021.x; Passmore GM, 2003, J NEUROSCI, V23, P7227, DOI 10.1523/JNEUROSCI.23-18-07227.2003; Piller SC, 1999, J VIROL, V73, P4230, DOI 10.1128/JVI.73.5.4230-4238.1999; Piller SC, 1996, P NATL ACAD SCI USA, V93, P111, DOI 10.1073/pnas.93.1.111; Piller SC, 1998, P NATL ACAD SCI USA, V95, P4595, DOI 10.1073/pnas.95.8.4595; RANCE NE, 1988, NEUROLOGY, V38, P265, DOI 10.1212/WNL.38.2.265; Rho MB, 1995, BRAIN BEHAV IMMUN, V9, P366, DOI 10.1006/brbi.1995.1034; Ruangkittisakul A, 2006, J NEUROSCI, V26, P11870, DOI 10.1523/JNEUROSCI.3357-06.2006; Rutkove SB, 1997, ARCH NEUROL-CHICAGO, V54, P907, DOI 10.1001/archneur.1997.00550190093020; Sas AR, 2009, J NEUROSCI, V29, P3948, DOI 10.1523/JNEUROSCI.5595-08.2009; Smyth K, 2007, HIV MED, V8, P367, DOI 10.1111/j.1468-1293.2007.00478.x; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Vallejo R, 2010, PAIN PRACT, V10, P167, DOI 10.1111/j.1533-2500.2010.00367.x; WALL PD, 1983, PAIN, V17, P321, DOI 10.1016/0304-3959(83)90164-1; WALTER GB, 1998, MUSCLE NERVE, V21, P1188; White FA, 2009, MOL INTERV, V9, P188, DOI 10.1124/mi.9.4.7; Zhong J, 1999, J NEUROSCI, V19, P4305; Zhu Y, 2009, FASEB J, V23, P2928, DOI 10.1096/fj.08-128819	54	41	42	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4343	4353		10.1096/fj.10-162313	http://dx.doi.org/10.1096/fj.10-162313			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20628092				2022-12-25	WOS:000283861100022
J	Prathapam, T; Aleshin, A; Guan, YH; Gray, JW; Martin, GS				Prathapam, Tulsiram; Aleshin, Alexey; Guan, Yinghui; Gray, Joe W.; Martin, G. Steven			p27(Kip1) Mediates Addiction of Ovarian Cancer Cells to MYCC (c-MYC) and Their Dependence on MYC Paralogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE ADDICTION; CELLULAR SENESCENCE; CYCLE PROGRESSION; GENE; EXPRESSION; OVEREXPRESSION; PROLIFERATION; TARGET; PHOSPHORYLATION; TUMORIGENESIS	The MYCC (c-MYC) gene is amplified in 30-60% of human ovarian cancers. We assessed the functional significance of MYCC amplification by siRNA inhibition of MYCC or MYC paralogs in a panel of ovarian cancer cell lines expressing varying levels of MYCC. Inactivation of MYCC inhibited cell proliferation and induced replicative senescence only in lines with amplified MYCC, indicating that these cells are addicted to continued MYCC overexpression. In contrast, siRNA knockdown of all three MYC isoforms inhibited proliferation of MYCC non-amplified ovarian cancer cells without inducing replicative senescence, and did not inhibit the proliferation of telomerase-immortalized ovarian surface epithelial cells. The arrest induced by MYCC knockdown was accompanied by an increase in the level of the Cdk inhibitor p27(Kip1) and a decrease in cyclin A expression and Cdk2 activity, and could be reversed by RNAi knockdown of p27(Kip1) or Rb, or by overexpression of cyclin A/Cdk2. The arrest induced by knockdown of all three MYC isoforms could similarly be reversed by p27(Kip1) knockdown. Our findings indicate that the addiction of MYCC-amplified ovarian cancer cells to MYCC differs from the dependence of MYCC non-amplified cancer cells on MYC paralogs, but both are mediated, at least in part, by p27(Kip1). They also suggest that growth of ovarian cancers may be blocked by inhibition of MYCC or MYC paralogs.	[Martin, G. Steven] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Guan, Yinghui; Gray, Joe W.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Guan, Yinghui; Gray, Joe W.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Martin, GS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 16 Barker Hall 3204, Berkeley, CA 94720 USA.	gsm@berkeley.edu	Gray, Joe/AAX-9549-2020		National Institutes of Health [CA 17542, P50 CA 83639]; Office of Science, Office of Biological and Environmental Research, United States Department of Energy [DE-AC0205CH11231]; Philip Morris External Research Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Biological and Environmental Research, United States Department of Energy(United States Department of Energy (DOE)); Philip Morris External Research Program	This work was supported, in whole or in part, by National Institutes of Health Grants CA 17542 (to G.S.M.) and P50 CA 83639 (to J.W.G.). This work was also supported by the Office of Science, Office of Biological and Environmental Research, United States Department of Energy Contract DE-AC0205CH11231 (to J.W.G.) and the Philip Morris External Research Program (to G.S.M.).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Baena E, 2005, P NATL ACAD SCI USA, V102, P7286, DOI 10.1073/pnas.0409260102; Chen CH, 2005, INT J GYNECOL CANCER, V15, P878, DOI 10.1111/j.1525-1438.2005.00150.x; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dimova I, 2006, EUR J CANCER, V42, P674, DOI 10.1016/j.ejca.2005.11.022; Felsher DW, 2008, CANCER RES, V68, P3081, DOI 10.1158/0008-5472.CAN-07-5832; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Harper JW, 1998, GENE DEV, V12, P285, DOI 10.1101/gad.12.3.285; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; Hydbring P, 2010, P NATL ACAD SCI USA, V107, P58, DOI 10.1073/pnas.0900121106; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; Lancaster JM, 2004, J SOC GYNECOL INVEST, V11, P51, DOI 10.1016/j.jsgi.2003.07.004; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Muller D, 1997, ONCOGENE, V15, P2561, DOI 10.1038/sj.onc.1201440; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; Pelengaris S, 2003, ARCH BIOCHEM BIOPHYS, V416, P129, DOI 10.1016/S0003-9861(03)00294-7; Popescu NC, 2002, J CELL MOL MED, V6, P151, DOI 10.1111/j.1582-4934.2002.tb00183.x; Prathapam T, 2006, P NATL ACAD SCI USA, V103, P2695, DOI 10.1073/pnas.0511186103; Prochownik Edward V, 2004, Expert Rev Anticancer Ther, V4, P289, DOI 10.1586/14737140.4.2.289; Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192; Sherr CJ, 2000, CANCER RES, V60, P3689; Oskarsson T, 2006, GENE DEV, V20, P2024, DOI 10.1101/gad.381206; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Vlach J, 1996, EMBO J, V15, P6595, DOI 10.1002/j.1460-2075.1996.tb01050.x; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Wu R, 2003, AM J PATHOL, V162, P1603, DOI 10.1016/S0002-9440(10)64294-0; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258; Zorn KK, 2003, CLIN CANCER RES, V9, P4811	44	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32529	32538		10.1074/jbc.M110.151902	http://dx.doi.org/10.1074/jbc.M110.151902			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20647308	Green Published, hybrid			2022-12-25	WOS:000282683000067
J	Vergara, A; Vitagliano, L; Merlino, A; Sica, F; Marino, K; Verde, C; di Prisco, G; Mazzarella, L				Vergara, Alessandro; Vitagliano, Luigi; Merlino, Antonello; Sica, Filomena; Marino, Katia; Verde, Cinzia; di Prisco, Guido; Mazzarella, Lelio			An Order-Disorder Transition Plays a Role in Switching Off the Root Effect in Fish Hemoglobins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TREMATOMUS-BERNACCHII; STRUCTURAL BASIS; PAGOTHENIA-BERNACCHII; TETRAMERIC HEMOGLOBIN; DEOXY; NEWNESI; BINDING; EQUILIBRIA; STABILITY	The Root effect is a widespread property among fish hemoglobins whose structural basis remains largely obscure. Here we report a crystallographic and spectroscopic characterization of the non-Root-effect hemoglobin isolated from the Antarctic fish Trematomus newnesi in the deoxygenated form. The crystal structure unveils that the T state of this hemoglobin is stabilized by a strong H-bond between the side chains of Asp95 alpha and Asp101 beta at the alpha(1)beta(2) and alpha(2)beta(1) interfaces. This unexpected finding undermines the accepted paradigm that correlates the presence of this unusual H-bond with the occurrence of the Root effect. Surprisingly, the T state is characterized by an atypical flexibility of two alpha chains within the tetramer. Indeed, regions such as the CD alpha corner and the EF alpha pocket, which are normally well ordered in the T state of tetrameric hemoglobins, display high B-factors and non-continuous electron densities. This flexibility also leads to unusual distances between the heme iron and the proximal and distal His residues. These observations are in line with Raman micro-spectroscopy studies carried out both in solution and in the crystal state. The findings here presented suggest that in fish hemoglobins the Root effect may be switched off through a significant destabilization of the T state regardless of the presence of the inter-aspartic H-bond. Similar mechanisms may also operate for other non-Root effect hemoglobins. The implications of the flexibility of the CD alpha corner for the mechanism of the T-R transition in tetrameric hemoglobins are also discussed.	[Mazzarella, Lelio] Univ Naples Federico II, Dept Chem, I-80126 Naples, Italy; [Vergara, Alessandro; Vitagliano, Luigi; Merlino, Antonello; Sica, Filomena; Mazzarella, Lelio] CNR, Ist Biostrutture & Bioimmagini, I-80134 Naples, Italy; [Marino, Katia; Verde, Cinzia; di Prisco, Guido] CNR, Inst Prot Biochem, I-80131 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Mazzarella, L (corresponding author), Complesso Univ Monte S Angelo, Via Cinthia, I-80126 Naples, Italy.	lelio.mazzarella@unina.it	Vergara, Alessandro/C-4435-2013; Merlino, Antonello/AAI-2114-2020	Vergara, Alessandro/0000-0003-4135-0245; Merlino, Antonello/0000-0002-1045-7720; VERDE, Cinzia/0000-0001-6185-282X	PNRA (Italian National Programme for Antarctic Research); Evolution and Biodiversity in the Antarctic (EBA); Scientific Committee for Antarctic Research (SCAR); Ministero Italiano dell'Universita e della Ricerca Scientifica	PNRA (Italian National Programme for Antarctic Research); Evolution and Biodiversity in the Antarctic (EBA); Scientific Committee for Antarctic Research (SCAR); Ministero Italiano dell'Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR))	This work was financially supported by PNRA (Italian National Programme for Antarctic Research) and is in the framework of the programme Evolution and Biodiversity in the Antarctic (EBA), sponsored by the Scientific Committee for Antarctic Research (SCAR). This study was also supported in part by the Ministero Italiano dell'Universita e della Ricerca Scientifica (PRIN 2007 "Struttura, funzione ed evoluzione di emoproteine da organismi marini artici ed antartici: meccanismi di adattamento al freddo e acquisizione di nuove funzioni").	BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; Berenbrink M, 2005, SCIENCE, V307, P1752, DOI 10.1126/science.1107793; Bonaventura C, 2004, ACTA PHYSIOL SCAND, V182, P245, DOI 10.1111/j.1365-201X.2004.01359.x; Brittain T, 2005, J INORG BIOCHEM, V99, P120, DOI 10.1016/j.jinorgbio.2004.09.025; BRITTAIN T, 1987, COMP BIOCHEM PHYS B, V86, P473, DOI 10.1016/0305-0491(87)90434-2; CAMARDELLA L, 1992, J MOL BIOL, V224, P449, DOI 10.1016/0022-2836(92)91007-C; CHOI S, 1982, J AM CHEM SOC, V104, P4345, DOI 10.1021/ja00380a006; DAVINO R, 1994, J BIOL CHEM, V269, P9675; Giangiacomo L, 2001, BIOCHEMISTRY-US, V40, P3062, DOI 10.1021/bi002297j; Giordano D, 2009, FEBS J, V276, P2266, DOI 10.1111/j.1742-4658.2009.06954.x; ITO N, 1995, J MOL BIOL, V250, P648, DOI 10.1006/jmbi.1995.0405; JONES TA, 1991, ACTA CRYSTALLOGR D, V56, P714; Mazzarella L, 2006, PROTEINS, V62, P316, DOI 10.1002/prot.20709; Mazzarella L, 1999, J MOL BIOL, V287, P897, DOI 10.1006/jmbi.1999.2632; Mazzarella L, 2006, PROTEINS, V65, P490, DOI 10.1002/prot.21114; Merlino A, 2008, SPECTROSC-INT J, V22, P143, DOI 10.1155/2008/328463; Merlino A, 2010, J PHYS CHEM B, V114, P7002, DOI 10.1021/jp908525s; Merlino A, 2009, MAR GENOM, V2, P51, DOI 10.1016/j.margen.2009.04.003; Merlino A, 2009, BIOPOLYMERS, V91, P1117, DOI 10.1002/bip.21206; Mylvaganam SE, 1996, NAT STRUCT BIOL, V3, P275, DOI 10.1038/nsb0396-275; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; Perutz MF, 1996, NAT STRUCT BIOL, V3, P211, DOI 10.1038/nsb0396-211; PERUTZ MF, 1980, PROC R SOC SER B-BIO, V208, P135, DOI 10.1098/rspb.1980.0047; Riccio A, 2002, P NATL ACAD SCI USA, V99, P9801, DOI 10.1073/pnas.132182099; Riccio A, 2001, ACTA CRYSTALLOGR D, V57, P1144, DOI 10.1107/S0907444901007739; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Smulevich G, 1998, J RAMAN SPECTROSC, V29, P57, DOI 10.1002/(SICI)1097-4555(199801)29:1<57::AID-JRS209>3.0.CO;2-P; Tame JRH, 1996, J MOL BIOL, V259, P749, DOI 10.1006/jmbi.1996.0355; UNZAI S, 2008, MUTAGENIC STUDIES OR; Verde C, 2004, PROTEIN SCI, V13, P2766, DOI 10.1110/ps.04861504; Verde C, 2008, CURR PROTEIN PEPT SC, V9, P578, DOI 10.2174/138920308786733895; Vergara A, 2008, METHOD ENZYMOL, V436, P425, DOI 10.1016/S0076-6879(08)36024-8; Vergara A, 2009, BIOPHYS J, V97, P866, DOI 10.1016/j.bpj.2009.04.056; Vitagliano L, 2008, J AM CHEM SOC, V130, P10527, DOI 10.1021/ja803363p; Yokoyama T, 2004, J BIOL CHEM, V279, P28632, DOI 10.1074/jbc.M401740200	38	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32568	32575		10.1074/jbc.M110.143537	http://dx.doi.org/10.1074/jbc.M110.143537			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20610398	hybrid, Green Published			2022-12-25	WOS:000282683000071
J	Lanaspa, MA; Andres-Hernando, A; Li, NX; Rivard, CJ; Cicerchi, C; Roncal-Jimenez, C; Schrier, RW; Berl, T				Lanaspa, Miguel A.; Andres-Hernando, Ana; Li, Nanxing; Rivard, Christopher J.; Cicerchi, Christina; Roncal-Jimenez, Carlos; Schrier, Robert W.; Berl, Tomas			The Expression of Aquaporin-1 in the Medulla of the Kidney Is Dependent on the Transcription Factor Associated with Hypertonicity, TonEBP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING PROTEIN; URINARY CONCENTRATING ABILITY; WATER-CHANNEL; RAT-KIDNEY; OSMOTIC-STRESS; STIMULATES TRANSCRIPTION; RESPONSIVE ELEMENT; EPITHELIAL-CELLS; GENE-EXPRESSION; PKC-DELTA	Expression of aquaporin-1 (AQP1) and -2 (AQP2) channels in the kidney are critical for the maintenance of water homeostasis and the operation of the urinary concentrating mechanism. Hypertonic stress induced in inner medullary (IMCD3) cells by addition of NaCl to the medium substantially up-regulated the mRNA and protein expression of AQP1, suggesting that its activation occurs at a transcriptional and a translational levels. In contrast, no up-regulation of AQP1 was observed when these cells were exposed to the same tonicity by addition of urea. To explore the transcriptional activation of aqp1 under hypertonic stress, we examined the role of the transcription factor associated with hypertonicity, TonEBP. Treatment of IMCD3 cells with the TonEBP inhibitor rottlerin or silencing its expression with specific shRNA technology led to a substantial reduction in AQP1 expression under hypertonic conditions. Moreover, we defined a conserved TonEBP binding site located 811 bp upstream of the aqp1 exon that is essential for its expression. Single site-directed mutation of this TonE site led to a 54 +/- 5% (p < 0.01) decrease in AQP1 luciferase-driven activity under hypertonic stress. TonEBP mutant mice display marked decrement in the expression of AQP1 in the inner medulla. In conclusion, these data demonstrate that TonEBP is necessary for the regulation of AQP1 expression in the inner medulla of the kidney under hypertonic conditions.	[Lanaspa, Miguel A.; Andres-Hernando, Ana; Li, Nanxing; Rivard, Christopher J.; Cicerchi, Christina; Roncal-Jimenez, Carlos; Schrier, Robert W.; Berl, Tomas] Univ Colorado, Dept Med, Div Renal Dis & Hypertens, Denver, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Berl, T (corresponding author), Univ Colorado Denver, Div Renal Dis & Hypertens, Sch Med, 12700 E 19th Ave, Aurora, CO 80015 USA.	tomas.berl@ucdenver.edu	Lanaspa, Miguel/AAO-4971-2020	Andres-Hernando, Ana/0000-0002-0676-0188				Andres-Hernando A, 2008, J BIOL CHEM, V283, P25082, DOI 10.1074/jbc.M802381200; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Capasso JM, 2003, ANN NY ACAD SCI, V986, P410, DOI 10.1111/j.1749-6632.2003.tb07222.x; Cha JH, 2001, J AM SOC NEPHROL, V12, P2221, DOI 10.1681/ASN.V12112221; Ferraris JD, 2006, CONTRIB NEPHROL, V152, P125, DOI 10.1159/000096320; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Gajghate S, 2009, J BONE MINER RES, V24, P992, DOI [10.1359/JBMR.090103, 10.1359/jbmr.090103]; Gallazzini M, 2006, P NATL ACAD SCI USA, V103, P15260, DOI 10.1073/pnas.0607133103; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Han KH, 2004, AM J PHYSIOL-RENAL, V287, pF878, DOI 10.1152/ajprenal.00047.2004; Handler JS, 2001, KIDNEY INT, V60, P408, DOI 10.1046/j.1523-1755.2001.060002408.x; Handler JS, 2001, NEPHRON, V87, P106, DOI 10.1159/000045897; Handler JS, 1996, KIDNEY INT, V49, P1682, DOI 10.1038/ki.1996.246; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Jenq W, 1998, BIOCHEM BIOPH RES CO, V245, P804, DOI 10.1006/bbrc.1998.8518; Kasono K, 2005, NEPHROL DIAL TRANSPL, V20, P509, DOI 10.1093/ndt/gfh677; Kim JA, 2007, METHOD ENZYMOL, V428, P253, DOI 10.1016/S0076-6879(07)28014-0; King LS, 2001, NEW ENGL J MED, V345, P175, DOI 10.1056/NEJM200107193450304; Lanaspa MA, 2007, P NATL ACAD SCI USA, V104, P13672, DOI 10.1073/pnas.0702752104; Lanaspa MA, 2007, AM J PHYSIOL-RENAL, V292, pF230, DOI 10.1152/ajprenal.00075.2006; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Maunsbach AB, 1997, J AM SOC NEPHROL, V8, P1; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Miyakawa H, 1998, AM J PHYSIOL-RENAL, V274, pF753, DOI 10.1152/ajprenal.1998.274.4.F753; Nakayama Y, 2000, J BIOL CHEM, V275, P38275, DOI 10.1074/jbc.M004678200; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P11663, DOI 10.1073/pnas.90.24.11663; NIELSEN S, 1995, AM J PHYSIOL-RENAL, V268, pF1023, DOI 10.1152/ajprenal.1995.268.6.F1023; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Rim JS, 1998, J BIOL CHEM, V273, P20615, DOI 10.1074/jbc.273.32.20615; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Storm R, 2003, AM J PHYSIOL-RENAL, V284, pF189, DOI 10.1152/ajprenal.00245.2002; Stroud JC, 2002, NAT STRUCT BIOL, V9, P90, DOI 10.1038/nsb749; Umenishi F, 2003, J BIOL CHEM, V278, P15765, DOI 10.1074/jbc.M209980200; Umenishi F, 2005, BIOCHEM BIOPH RES CO, V338, P1593, DOI 10.1016/j.bbrc.2005.10.127; Umenishi F, 2005, J AM SOC NEPHROL, V16, P600, DOI 10.1681/ASN.2004030241; Umenishi F, 2002, BIOCHEM BIOPH RES CO, V292, P771, DOI 10.1006/bbrc.2002.6709; Van Putten V, 2001, J BIOL CHEM, V276, P1226, DOI 10.1074/jbc.M003581200; VANLIEBURG AF, 1994, AM J HUM GENET, V55, P648; Wang XQ, 2009, MOL BIOL CELL, V20, P791, DOI 10.1091/mbc.E08-07-0732; Woo SK, 2000, AM J PHYSIOL-RENAL, V278, pF1006; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; Zhao HY, 2002, AM J PHYSIOL-RENAL, V282, pF710, DOI 10.1152/ajprenal.00303.2001	46	41	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31694	31703		10.1074/jbc.M109.093690	http://dx.doi.org/10.1074/jbc.M109.093690			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20639513	Green Published, hybrid			2022-12-25	WOS:000282764600061
J	Ueno, T; Tanaka, K; Kaneko, K; Taga, Y; Sata, T; Irie, S; Hattori, S; Ogawa-Goto, K				Ueno, Tomonori; Tanaka, Keisuke; Kaneko, Keiko; Taga, Yuki; Sata, Tetsutaro; Irie, Shinkichi; Hattori, Shunji; Ogawa-Goto, Kiyoko			Enhancement of Procollagen Biosynthesis by p180 through Augmented Ribosome Association on the Endoplasmic Reticulum in Response to Stimulated Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCALE IDENTIFICATION; GENE-EXPRESSION; ASCORBIC-ACID; COLLAGEN; PROTEINS; RECEPTOR; GOLGI; PROLIFERATION; CELLS; ACCUMULATION	A coiled-coil microtubule-bundling protein, p180, was originally reported as a ribosome-binding protein on the rough endoplasmic reticulum (ER) and is highly expressed in secretory tissues. Recently, we reported a novel role for p180 in the trans-Golgi network (TGN) expansion following stimulated collagen secretion. Here, we show that p180 plays a key role in procollagen biosynthesis and secretion in diploid fibroblasts. Depletion of p180 caused marked reductions of secreted collagens without significant loss of the ER membrane or mRNA. Metabolic labeling experiments revealed that the procollagen biosynthetic activity was markedly affected following p180 depletion. Moreover, loss of p180 perturbs ascorbate-stimulated de novo biosynthesis mainly in the membrane fraction with a preferential secretion defect of large proteins. At the EM level, one of the most prominent morphological features of p180-depleted cells was insufficient ribosome association on the ER membranes. In contrast, the ER of control cells was studded with numerous ribosomes, which were further enhanced by ascorbate. Similarly biochemical analysis confirmed that levels of membrane-bound ribosomes were altered in a p180-dependent manner. Taken together, our data suggest that p180 plays crucial roles in enhancing collagen biosynthesis at the entry site of the secretory compartments by a novel mechanism that mainly involves facilitating ribosome association on the ER.	[Ueno, Tomonori; Tanaka, Keisuke; Taga, Yuki; Irie, Shinkichi; Hattori, Shunji; Ogawa-Goto, Kiyoko] Nippi Res Inst Biomatrix, Toride, Ibaraki 3020017, Japan; [Kaneko, Keiko; Sata, Tetsutaro; Ogawa-Goto, Kiyoko] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan; [Irie, Shinkichi; Hattori, Shunji; Ogawa-Goto, Kiyoko] Japan Inst Leather Res, Adachi Ku, Tokyo 1208601, Japan	National Institute of Infectious Diseases (NIID)	Ogawa-Goto, K (corresponding author), Nippi Res Inst Biomatrix, Toride, Ibaraki 3020017, Japan.	kgoto@nippi-inc.co.jp	Taga, Yuki/I-2781-2019	Taga, Yuki/0000-0001-9100-758X				Bai JZ, 2008, CELL BIOL INT, V32, P473, DOI 10.1016/j.cellbi.2007.10.002; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Becker F, 1999, J CELL BIOL, V146, P273, DOI 10.1083/jcb.146.2.273; Benyamini P, 2009, MOL BIOL CELL, V20, P732, DOI 10.1091/mbc.E08-07-0682; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; BREUL SD, 1980, J BIOL CHEM, V255, P5250; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; CARDINALE GJ, 1974, ADV ENZYMOL RAMB, V41, P245; CHAN D, 1990, BIOCHEM J, V269, P175, DOI 10.1042/bj2690175; Dejgaard K, 2010, J PROTEOME RES, V9, P1763, DOI 10.1021/pr900900x; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Diehn M, 2006, PLOS GENET, V2, P39, DOI 10.1371/journal.pgen.0020011; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Fromme JC, 2005, CURR OPIN CELL BIOL, V17, P345, DOI 10.1016/j.ceb.2005.06.004; Ghosh AK, 2002, EXP BIOL MED, V227, P301, DOI 10.1177/153537020222700502; HATA RI, 1989, J CELL PHYSIOL, V138, P8, DOI 10.1002/jcp.1041380103; Hattori S, 2002, ANAL BIOCHEM, V301, P27, DOI 10.1006/abio.2001.5479; Hyde M, 2002, J CELL BIOL, V156, P993, DOI 10.1083/jcb.200112008; KUROSAKA D, 1994, J BIOCHEM-TOKYO, V115, P853, DOI 10.1093/oxfordjournals.jbchem.a124429; Lerner RS, 2003, RNA, V9, P1123, DOI 10.1261/rna.5610403; LEVENE CI, 1975, ANN NY ACAD SCI, V258, P288, DOI 10.1111/j.1749-6632.1975.tb29289.x; Lindquist JN, 2004, J BIOL CHEM, V279, P23822, DOI 10.1074/jbc.M314060200; MARCHI F, 1984, J CELL BIOL, V98, P1705, DOI 10.1083/jcb.98.5.1705; Mironov AA, 2001, J CELL BIOL, V155, P1225, DOI 10.1083/jcb.200108073; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Ogawa-Goto K, 2002, J VIROL, V76, P2350, DOI 10.1128/JVI.76.5.2350-2362.2002; Ogawa-Goto K, 2007, MOL BIOL CELL, V18, P3741, DOI 10.1091/mbc.E06-12-1125; PETERKOFSKY B, 1971, BIOCHEMISTRY-US, V10, P988, DOI 10.1021/bi00782a009; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; Ramirez F, 2006, MATRIX BIOL, V25, P365, DOI 10.1016/j.matbio.2006.05.002; SAVITZ AJ, 1990, NATURE, V346, P540, DOI 10.1038/346540a0; SCHWARZ RI, 1993, NUTRITION GENE EXPRE, P483; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Stephens SB, 2008, MOL BIOL CELL, V19, P623, DOI 10.1091/mbc.E07-07-0677; SULLIVAN TA, 1994, J BIOL CHEM, V269, P22500; Thiele BJ, 2004, CIRC RES, V95, P1058, DOI 10.1161/01.RES.0000149166.33833.08; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; TRELSTAD RL, 1979, DEV BIOL, V71, P228, DOI 10.1016/0012-1606(79)90166-0; Ueno T, 2010, EXP CELL RES, V316, P329, DOI 10.1016/j.yexcr.2009.11.009; WANKER EE, 1995, J CELL BIOL, V130, P29, DOI 10.1083/jcb.130.1.29	40	32	34	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29941	29950		10.1074/jbc.M109.094607	http://dx.doi.org/10.1074/jbc.M109.094607			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20647306	Green Published, hybrid			2022-12-25	WOS:000281984300031
J	Denoncin, K; Vertommen, D; Paek, E; Collet, JF				Denoncin, Katleen; Vertommen, Didier; Paek, Eunok; Collet, Jean-Francois			The Protein-disulfide Isomerase DsbC Cooperates with SurA and DsbA in the Assembly of the Essential beta-Barrel Protein LptD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE BIOGENESIS; ESCHERICHIA-COLI; NONCONSECUTIVE DISULFIDE; CHAPERONE ACTIVITY; CELL-ENVELOPE; OXIDASE DSBA; COMPLEX; BOND; LIPOPOLYSACCHARIDE; IDENTIFICATION	The assembly of the beta-barrel proteins present in the outermembrane (OM) of Gram-negative bacteria is poorly characterized. After translocation across the inner membrane, unfolded beta-barrel proteins are escorted across the periplasm by chaperones that reside within this compartment. Two partially redundant chaperones, SurA and Skp, are considered to transport the bulk mass of beta-barrel proteins. We found that the periplasmic disulfide isomerase DsbC cooperates with SurA and the thiol oxidase DsbA in the folding of the essential beta-barrel protein LptD. LptD inserts lipopolysaccharides in the OM. It is also the only beta-barrel protein with more than two cysteine residues. We found that surAdsbC mutants, but not skpdsbC mutants, exhibit a synthetic phenotype. They have a decreased OM integrity, which is due to the lack of the isomerase activity of DsbC. We also isolated DsbC in a mixed disulfide complex with LptD. As such, LptD is identified as the first substrate of DsbC that is localized in the OM. Thus, electrons flowing from the cytoplasmic thioredoxin system maintain the integrity of the OM by assisting the folding of one of the most important beta-barrel proteins.	Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Denoncin, Katleen; Collet, Jean-Francois] Brussels Ctr Redox Biol, B-1200 Brussels, Belgium; [Paek, Eunok] Univ Seoul, Dept Mech & Informat Engn, Seoul 130743, South Korea	Universite Catholique Louvain; University of Seoul	Collet, JF (corresponding author), 75-39 Ave Hippocrate, B-1200 Brussels, Belgium.	jfcollet@uclouvain.be	Collet, Jean Francois/F-2105-2010	Collet, Jean-Francois/0000-0001-8069-7036; Vertommen, Didier/0000-0001-7648-8282	Interuniversity Attraction Pole Programme-Belgian Science Policy Network [P6/05, P6/28]; Korean Ministry of Education, Science and Technology [FPR-08-A1-020]; Center for Cell Signaling Research and Drug Discovery Research [R15-2006-020]; Fonds de la Recherche Scientifique-FNRS	Interuniversity Attraction Pole Programme-Belgian Science Policy Network; Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Center for Cell Signaling Research and Drug Discovery Research; Fonds de la Recherche Scientifique-FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was supported by funds from Interuniversity Attraction Pole Programme-Belgian Science Policy Network P6/05 (to J.-F. C. and K. D.), and P6/28 (to D. V.) 21C Frontier Functional Proteomics Project Grant FPR-08-A1-020 from the Korean Ministry of Education, Science and Technology, National Core Research Center Program Grant R15-2006-020 through the Center for Cell Signaling Research and Drug Discovery Research (to E. P.), and grants from the Fonds de la Recherche Scientifique-FNRS (to J.-F. C.).	Abe S, 2003, MICROBIOL-SGM, V149, P1265, DOI 10.1099/mic.0.25927-0; Berkmen M, 2005, J BIOL CHEM, V280, P11387, DOI 10.1074/jbc.M411774200; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chen J, 1999, J BIOL CHEM, V274, P19601, DOI 10.1074/jbc.274.28.19601; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Choi S, 2010, J PROTEOME RES, V9, P626, DOI 10.1021/pr900771r; COLLET JF, 2010, ANTIOXID RE IN PRESS; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Gleiter S, 2008, BBA-MOL CELL RES, V1783, P530, DOI 10.1016/j.bbamcr.2008.02.009; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Leverrier P, 2010, PROTEOMICS, V10, P771, DOI 10.1002/pmic.200900461; Liu XQ, 2001, J BIOL CHEM, V276, P1146, DOI 10.1074/jbc.M004929200; Messens J, 2007, J BIOL CHEM, V282, P31302, DOI 10.1074/jbc.M705236200; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Misra RV, 2005, NUCLEIC ACIDS RES, V33, pD329, DOI 10.1093/nar/gki028; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Shouldice SR, 2010, MOL MICROBIOL, V75, P13, DOI 10.1111/j.1365-2958.2009.06952.x; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Vertommen D, 2008, MOL MICROBIOL, V67, P336, DOI 10.1111/j.1365-2958.2007.06030.x; Vertommen D, 2009, PROTEOMICS, V9, P2432, DOI 10.1002/pmic.200800794; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Yamanaka Kunitoshi, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P193	35	40	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29425	29433		10.1074/jbc.M110.119321	http://dx.doi.org/10.1074/jbc.M110.119321			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20615876	Green Published, hybrid			2022-12-25	WOS:000281740100045
J	Li, DH; Harper, SL; Tang, HY; Maksimova, Y; Gallagher, PG; Speicher, DW				Li, Donghai; Harper, Sandra L.; Tang, Hsin-Yao; Maksimova, Yelena; Gallagher, Patrick G.; Speicher, David W.			A Comprehensive Model of the Spectrin Divalent Tetramer Binding Region Deduced Using Homology Modeling and Chemical Cross-linking of a Mini-spectrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; ERYTHROCYTE SPECTRIN; ALPHA-SPECTRIN; CRYSTAL-STRUCTURE; HEMOLYTIC-ANEMIA; INITIATION SITE; MEMBRANE; DOCKING; COMPLEX; ACTIN	Spectrin dimer-tetramer interconversion is a critical contributor to red cell membrane stability, but some properties of spectrin tetramer formation cannot be studied effectively using monomeric recombinant domains. To address these limitations, a fused alpha beta mini-spectrin was produced that forms wildtype divalent tetramer complexes. Using this mini-spectrin, a medium-resolution structure of a seven-repeat bivalent tetramer was produced using homology modeling coupled with chemical cross-linking. Inter-and intramolecular cross-links provided critical distance constraints for evaluating and optimizing the best conformational model and appropriate docking interfaces. The two strands twist around each other to form a super-coiled, rope-like structure with the AB helix face of one strand associating with the opposing AC helix face. Interestingly, two tetramer site hereditary anemia mutations that exhibit wild-type binding in univalent head-to-head assays are located in the interstrand region. This suggests that perturbations of the interstrand region can destabilize spectrin tetramers and the membrane skeleton. The alpha subunit N-terminal cross-links to multiple sites on both strands, demonstrating that this non-homologous tail remains flexible and forms heterogeneous structures in the tetramer complex. Although no cross-links were observed involving the beta subunit non-homologous C-terminal tail, several cross-links were observed only when this domain was present, suggesting it induces subtle conformational changes to the tetramer site region. This medium-resolution model provides a basis for further studies of the bivalent spectrin tetramer site, including analysis of functional consequences of interstrand interactions and mutations located at substantial molecular distances from the tetramer site.	[Li, Donghai; Harper, Sandra L.; Tang, Hsin-Yao; Speicher, David W.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA; [Li, Donghai] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Ctr, Nanjing 210093, Jiangsu, Peoples R China; [Maksimova, Yelena; Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA	The Wistar Institute; Nanjing University; Yale University	Speicher, DW (corresponding author), Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	speicher@wistar.org		Tang, Hsin-Yao/0000-0003-1838-018X	National Institutes of Health [HL38794, HL64558]; NCI [CA10815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038794, R01HL064558, R01HL065448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL38794 (to D. W. S.) and HL64558 (to P. G. G.) and CA10815 (NCI core grant to the Wistar Institute).	AGRE P, 1985, NATURE, V314, P380, DOI 10.1038/314380a0; An XL, 2002, J BIOL CHEM, V277, P31796, DOI 10.1074/jbc.M204567200; BRENNER SL, 1980, J BIOL CHEM, V255, P1670; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2003, PROTEINS, V52, P68, DOI 10.1002/prot.10388; COHEN CM, 1980, CELL, V21, P875, DOI 10.1016/0092-8674(80)90451-1; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; El-Shafey A, 2006, PROTEIN SCI, V15, P429, DOI 10.1110/ps.051685706; FOWLER V, 1980, J CELL BIOL, V85, P361, DOI 10.1083/jcb.85.2.361; Gaetani M, 2008, BLOOD, V111, P5712, DOI 10.1182/blood-2007-11-122457; Gallagher PG, 2004, SEMIN HEMATOL, V41, P142, DOI 10.1053/j.seminhematol.2004.01.003; Harper SL, 2010, J BIOL CHEM, V285, P11003, DOI 10.1074/jbc.M109.083048; Ipsaro JJ, 2010, BLOOD, V115, P4843, DOI 10.1182/blood-2010-01-261396; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Li DH, 2008, J BIOL CHEM, V283, P1553, DOI 10.1074/jbc.M706981200; Li DH, 2007, BIOCHEMISTRY-US, V46, P10585, DOI 10.1021/bi7007905; LIU SC, 1984, CELL, V37, P587, DOI 10.1016/0092-8674(84)90389-1; LIU SC, 1987, J CELL BIOL, V104, P527, DOI 10.1083/jcb.104.3.527; Mandell JG, 2001, PROTEIN ENG, V14, P105, DOI 10.1093/protein/14.2.105; MANNO S, 1995, J BIOL CHEM, V270, P5659, DOI 10.1074/jbc.270.10.5659; MARCHESI V. T., 1968, SCIENCE, V159, P203, DOI 10.1126/science.159.3811.203; MORROW JS, 1981, J CELL BIOL, V88, P463, DOI 10.1083/jcb.88.2.463; Park S, 2000, FEBS LETT, V485, P81, DOI 10.1016/S0014-5793(00)02186-4; Park S, 2003, J BIOL CHEM, V278, P21837, DOI 10.1074/jbc.M300617200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SPEICHER DW, 1992, J BIOL CHEM, V267, P14775; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; Speicher K D, 2000, J Biomol Tech, V11, P74; Tang HY, 2004, BIOCHEMISTRY-US, V43, P4251, DOI 10.1021/bi036092x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UNGEWICKELL E, 1979, NATURE, V280, P811, DOI 10.1038/280811a0; Ursitti JA, 1996, J BIOL CHEM, V271, P6636, DOI 10.1074/jbc.271.12.6636; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0; ZARKOWSKY HS, 1975, BRIT J HAEMATOL, V29, P537, DOI 10.1111/j.1365-2141.1975.tb02740.x	36	19	20	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29535	29545		10.1074/jbc.M110.145573	http://dx.doi.org/10.1074/jbc.M110.145573			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20610390	Green Published, hybrid			2022-12-25	WOS:000281740100055
J	Yamamoto, K; Miyazaki, K; Higashi, S				Yamamoto, Kazuhiro; Miyazaki, Kaoru; Higashi, Shouichi			Cholesterol Sulfate Alters Substrate Preference of Matrix Metalloproteinase-7 and Promotes Degradations of Pericellular Laminin-332 and Fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; CELLULAR ADHESION; TUMOR INVASION; MEMBRANE RAFTS; LIPID RAFTS; MATRILYSIN; CELLS; BETA; INTEGRIN; SURFACE	Localization of secreted matrix metalloproteinases (MMPs) on the cell surface is required not only for processing of cell surface proteins, but also for controlled degradation of the extracellular matrix (ECM). Our previous study demonstrated that binding of MMP-7 (matrilysin) to cell surface cholesterol sulfate (CS) is essential for the cell membrane-associated proteolytic action of this MMP. In this study, we investigated the role of CS in the MMP-7-catalyzed degradation of protein components of ECM. We found that the degradation of laminin-332 (laminin-5) catalyzed by MMP-7 was accelerated dramatically in the presence of CS, whereas the sulfated lipid inhibited the degradation of casein catalyzed by the protease. The MMP-7 catalyzed degradation of fibronectin was partially inhibited in the presence of low concentrations of CS, whereas it was accelerated significantly at high concentrations of the lipid. Therefore, it is likely that CS alters the substrate preference of MMP-7. We also found that the proteins of which MMP-7-catalyzed degradation were accelerated by CS also had affinities for CS, suggesting that CS facilitates the proteolyses by cross-linking MMP-7 to its substrates. Moreover, MMP-7 tethered to cancer cell surface via CS degraded fibronectin and laminin-332 coated on a culture plate. The degradations of the adhesive proteins led to significant detachment of the cells from the plate. Taken together, our findings provide a novel mechanism in which cell surface CS promotes the proteolytic activities of MMP-7 toward selective substrates in the pericellular ECM, thereby contributing to cancer cell migration and metastasis.	[Higashi, Shouichi] Yokohama City Univ, Int Grad Sch Arts & Sci, Div Cell Biol, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan	Yokohama City University	Higashi, S (corresponding author), Yokohama City Univ, Int Grad Sch Arts & Sci, Div Cell Biol, Totsuka Ku, 641-12 Maioka Cho, Yokohama, Kanagawa 2440813, Japan.	shigashi@yokohama-cu.ac.jp	Yamamoto, Kazuhiro/AAD-9650-2019		JST; Ministry of Education, Culture, Sports, Science and Technology of Japan [17014077, 21570118]	JST(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by JST (Research for Promoting Technological Seeds to S.H.) and Grants-in-Aid for Scientific Research on Priority Areas 17014077 (to K.M.) and Research (C) 21570118 (to S.H.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Haro H, 2000, J CLIN INVEST, V105, P143, DOI 10.1172/JCI7091; Higashi S, 2003, J BIOL CHEM, V278, P14020, DOI 10.1074/jbc.M212264200; Higashi S, 1998, INT J HEMATOL, V67, P229; Higashi S, 1999, J BIOL CHEM, V274, P10497, DOI 10.1074/jbc.274.15.10497; Higashi S, 2008, J BIOL CHEM, V283, P10068, DOI 10.1074/jbc.M709509200; Higashi S, 2008, J BIOL CHEM, V283, P35735, DOI 10.1074/jbc.M806285200; Hueber AO, 2002, EMBO REP, V3, P190, DOI 10.1093/embo-reports/kvf022; Ishikawa T, 1996, CANCER LETT, V107, P5, DOI 10.1016/0304-3835(96)04336-4; Kariya Y, 2002, J BIOCHEM, V132, P607, DOI 10.1093/oxfordjournals.jbchem.a003263; Kariya Y, 2004, J BIOL CHEM, V279, P24774, DOI 10.1074/jbc.M400670200; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; Kioi M, 2003, ONCOGENE, V22, P8662, DOI 10.1038/sj.onc.1207181; KITSON N, 1992, BIOCHIM BIOPHYS ACTA, V1111, P127, DOI 10.1016/0005-2736(92)90282-Q; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Mitsiades N, 2001, CANCER RES, V61, P577; MIYAZAKI K, 1990, CANCER RES, V50, P7758; Mizushima H, 1998, HORM RES, V50, P7, DOI 10.1159/000053118; MONTGOMERY AMP, 1994, P NATL ACAD SCI USA, V91, P8856, DOI 10.1073/pnas.91.19.8856; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagashima Y, 1997, INT J CANCER, V72, P441, DOI 10.1002/(SICI)1097-0215(19970729)72:3<441::AID-IJC11>3.0.CO;2-F; Noe V, 2001, J CELL SCI, V114, P111; Ogawa T, 2007, MOL BIOL CELL, V18, P1621, DOI 10.1091/mbc.E06-09-0806; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Remy L, 2006, CANCER RES, V66, P11228, DOI 10.1158/0008-5472.CAN-06-1187; Ristorcelli E, 2009, INT J CANCER, V125, P1016, DOI 10.1002/ijc.24375; RUOSLAHTI E, 1992, BRIT J CANCER, V66, P239, DOI 10.1038/bjc.1992.250; Sawey ET, 2007, P NATL ACAD SCI USA, V104, P19327, DOI 10.1073/pnas.0705953104; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Tsunezumi J, 2008, FEBS J, V275, P4810, DOI 10.1111/j.1742-4658.2008.06620.x; vonBredow DC, 1997, EXP CELL RES, V236, P341, DOI 10.1006/excr.1997.3711; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yamamoto K, 2006, J BIOL CHEM, V281, P9170, DOI 10.1074/jbc.M510377200; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Yu Q, 2000, GENE DEV, V14, P163	43	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28862	28873		10.1074/jbc.M110.136994	http://dx.doi.org/10.1074/jbc.M110.136994			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20605794	Green Published, hybrid			2022-12-25	WOS:000281594000051
J	Bengoechea-Alonso, MT; Ericsson, J				Bengoechea-Alonso, M. T.; Ericsson, J.			Tumor suppressor Fbxw7 regulates TGF beta signaling by targeting TGIF1 for degradation	ONCOGENE			English	Article						TGF beta; TGIF; Fbxw7; ubiquitin; tumor suppressor; protein degradation	SMAD TRANSCRIPTIONAL COREPRESSOR; F-BOX PROTEIN; PHOSPHORYLATION-DEPENDENT DEGRADATION; FBW7 UBIQUITIN LIGASE; CYCLIN-E; C-MYC; GROWTH; TRANSDUCTION; SCFFBW7; CANCER	Transforming growth factor-beta (TGF beta) signaling regulates multiple cellular processes, including extracellular matrix production, cell growth, apoptosis and differentiation. Dysfunction of TGF beta signaling has been implicated in various human disorders ranging from vascular diseases to cancer. TGF beta signaling is negatively regulated by the transcriptional repressor TGF beta-induced factor 1 (TGIF1). The tumor suppressor Fbxw7 is the substrate-recognition factor of a ubiquitin ligase that targets multiple proteins for degradation, including c-Myc, cyclin E, c-Jun and Notch. Here, we describe that TGIF1 is targeted for degradation by Fbxw7 in a phosphorylation-dependent manner. Inactivation of Fbxw7 results in the accumulation of phosphorylated TGIF1 molecules and repression of TGF beta-dependent transcription. Cancer cell lines with inactivating mutations in Fbxw7 show enhanced levels of TGIF1 and attenuated TGF beta-dependent signaling. Importantly, inactivation of Fbxw7 attenuates TGF beta-dependent regulation of cell growth and migration. Taken together, our results suggest that Fbxw7 is a novel regulator of TGF beta signaling. Oncogene (2010) 29, 5322-5328; doi: 10.1038/onc.2010.278; published online 12 July 2010	[Bengoechea-Alonso, M. T.; Ericsson, J.] Univ Coll Dublin, UCD Conway Inst, Sch Med & Med Sci, Dublin D4, Ireland	University College Dublin	Ericsson, J (corresponding author), Univ Coll Dublin, UCD Conway Inst, Sch Med & Med Sci, Dublin D4, Ireland.	johan.ericsson@ucd.ie	Ericsson, Johan/AAA-6664-2020	Ericsson, Johan/0000-0003-1186-6574	Ludwig Institute for Cancer Research Ltd.; Science Foundation Ireland [07/SK/B1242b]	Ludwig Institute for Cancer Research Ltd.; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	We thank Ulla Engstrom for peptide synthesis and antibody purification, and Aris Moustakas, Lars van der Heide and Peter Lonn for plasmids, antibodies and advice. This work was supported by a grant from the Ludwig Institute for Cancer Research Ltd. JE is the recipient of a Science Foundation Ireland Stokes Professorship Award (07/SK/B1242b).	Bartholin L, 2006, MOL CELL BIOL, V26, P990, DOI 10.1128/MCB.26.3.990-1001.2006; Bengoechea-Alonso MT, 2009, J BIOL CHEM, V284, P5885, DOI 10.1074/jbc.M807906200; Faresse N, 2008, EMBO J, V27, P1804, DOI 10.1038/emboj.2008.109; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lo RS, 2001, EMBO J, V20, P128, DOI 10.1093/emboj/20.1.128; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Miyazono K, 2003, CANCER SCI, V94, P230, DOI 10.1111/j.1349-7006.2003.tb01425.x; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Onoyama I, 2008, CELL CYCLE, V7, P3307, DOI 10.4161/cc.7.21.6931; Pessah M, 2001, P NATL ACAD SCI USA, V98, P6198, DOI 10.1073/pnas.101579798; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wotton D, 1999, J BIOL CHEM, V274, P37105, DOI 10.1074/jbc.274.52.37105; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Wotton D, 2001, CELL GROWTH DIFFER, V12, P457; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217	26	38	39	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2010	29	38					5322	5328		10.1038/onc.2010.278	http://dx.doi.org/10.1038/onc.2010.278			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	653KE	20622901				2022-12-25	WOS:000282089100010
J	Loukin, S; Zhou, XL; Su, ZW; Saimi, Y; Kung, C				Loukin, Stephen; Zhou, Xinliang; Su, Zhenwei; Saimi, Yoshiro; Kung, Ching			Wild-type and Brachyolmia-causing Mutant TRPV4 Channels Respond Directly to Stretch Force	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION CHANNEL; VR-OAC; MECHANISMS; CELL; MUTATIONS; REVEALS; CALCIUM; PATCH	Whether animal ion channels functioning as mechanosensors are directly activated by stretch force or indirectly by ligands produced by the stretch is a crucial question. TRPV4, a key molecular model, can be activated by hypotonicity, but the mechanism of activation is unclear. One model has this channel being activated by a downstream product of phospholipase A(2), relegating mechanosensitivity to the enzymes or their regulators. We expressed rat TRPV4 in Xenopus oocytes and repeatedly examined >200 excised patches bathed in a simple buffer. We found that TRPV4 can be activated by tens of mm Hg pipette suctions with open probability rising with suction even in the presence of relevant enzyme inhibitors. Mechanosensitivity of TRPV4 provides the simplest explanation of its various force-related physiological roles, one of which is in the sensing of weight load during bone development. Gain-of-function mutants cause heritable skeletal dysplasias in human. We therefore examined the brachyolmia-causing R616Q gain-of-function channel and found increased whole-cell current densities compared with wild-type channels. Single-channel analysis revealed that R616Q channels maintain mechanosensitivity but have greater constitutive activity and no change in unitary conductance or rectification.	[Loukin, Stephen; Zhou, Xinliang; Su, Zhenwei; Saimi, Yoshiro; Kung, Ching] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Kung, Ching] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Loukin, S (corresponding author), Univ Wisconsin, Mol Biol Lab, 1525 Linden Dr, Madison, WI 53706 USA.	shloukin@wisc.edu	Su, Zhenwei/C-3185-2018	Su, Zhenwei/0000-0002-5591-418X	National Institutes of Health [GM054867, NS067360, GM047856]; Vilas Trust of the University of Wisconsin, Madison, WI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054867, R01GM047856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS067360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vilas Trust of the University of Wisconsin, Madison, WI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM054867 (to Y. S.) and NS067360 and GM047856 (to C. K.). This work was also supported by the Vilas Trust of the University of Wisconsin, Madison, WI.	Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Camacho N, 2010, AM J MED GENET A, V152A, P1169, DOI 10.1002/ajmg.a.33392; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; EVERAERTS W, 2009, PROG BIOPHY IN PRESS; GOLDIN AL, 1992, METHOD ENZYMOL, V207, P266; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Liedtke W, 2008, ANN NY ACAD SCI, V1144, P42, DOI 10.1196/annals.1418.012; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Loukin SH, 1997, EMBO J, V16, P4817, DOI 10.1093/emboj/16.16.4817; Loukin S, 2010, J BIOL CHEM, V285, P19884, DOI 10.1074/jbc.M110.113936; Loukin SH, 2009, FEBS LETT, V583, P754, DOI 10.1016/j.febslet.2009.01.027; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Mizoguchi F, 2008, J CELL PHYSIOL, V216, P47, DOI 10.1002/jcp.21374; Nilius B, 2003, PFLUG ARCH EUR J PHY, V446, P298, DOI 10.1007/s00424-003-1028-9; Nilius B, 2010, NAT GENET, V42, P98, DOI 10.1038/ng0210-98; Patel AJ, 2001, CURR OPIN CELL BIOL, V13, P422, DOI 10.1016/S0955-0674(00)00231-3; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Su ZW, 2009, PFLUG ARCH EUR J PHY, V458, P861, DOI 10.1007/s00424-009-0680-0; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Zhang Y, 2000, J PHYSIOL-LONDON, V523, P117, DOI 10.1111/j.1469-7793.2000.t01-1-00117.x; Zhang Y, 2000, J PHYSIOL-LONDON, V523, P101, DOI 10.1111/j.1469-7793.2000.00101.x; Zhang Y, 2000, J PHYSIOL-LONDON, V523, P83, DOI 10.1111/j.1469-7793.2000.t01-2-00083.x; Zhou XL, 2003, P NATL ACAD SCI USA, V100, P7105, DOI 10.1073/pnas.1230540100	36	101	101	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27176	27181		10.1074/jbc.M110.143370	http://dx.doi.org/10.1074/jbc.M110.143370			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20605796	hybrid, Green Published			2022-12-25	WOS:000281172700048
J	Isgren, CM; Upjohn, MM; Fernandez-Fuente, M; Massey, C; Pollott, G; Verheyen, KLP; Piercy, RJ				Isgren, Cajsa M.; Upjohn, Melissa M.; Fernandez-Fuente, Marta; Massey, Claire; Pollott, Geoff; Verheyen, Kristien L. P.; Piercy, Richard J.			Epidemiology of Exertional Rhabdomyolysis Susceptibility in Standardbred Horses Reveals Associated Risk Factors and Underlying Enhanced Performance	PLOS ONE			English	Article							POLYSACCHARIDE STORAGE MYOPATHY; CREATINE-KINASE ACTIVITY; SKELETAL-MUSCLE; THOROUGHBRED RACEHORSES; UNITED-KINGDOM; QUARTER HORSES; GYS1 MUTATION; EXERCISE; RESPONSES; HERITABILITY	Background: Exertional rhabdomyolysis syndrome is recognised in many athletic horse breeds and in recent years specific forms of the syndrome have been identified. However, although Standardbred horses are used worldwide for racing, there is a paucity of information about the epidemiological and performance-related aspects of the syndrome in this breed. The objectives of this study therefore were to determine the incidence, risk factors and performance effects of exertional rhabdomyolysis syndrome in Standardbred trotters and to compare the epidemiology and genetics of the syndrome with that in other breeds. Methodology/Principal Findings: A questionnaire-based case-control study (with analysis of online race records) was conducted following identification of horses that were determined susceptible to exertional rhabdomyolysis (based on serum biochemistry) from a total of 683 horses in 22 yards. Thirty six exertional rhabdomyolysis-susceptible horses were subsequently genotyped for the skeletal muscle glycogen synthase (GYS1) mutation responsible for type 1 polysaccharide storage myopathy. A total of 44 susceptible horses was reported, resulting in an annual incidence of 6.4 (95% CI 4.6-8.2%) per 100 horses. Female horses were at significantly greater risk than males (odds ratio 7.1; 95% CI 2.1-23.4; p = 0.001) and nervous horses were at a greater risk than horses with calm or average temperaments (odds ratio 7.9; 95% CI 2.3-27.0; p = 0.001). Rhabdomyolysis-susceptible cases performed better from standstill starts (p = 0.04) than controls and had a higher percentage of wins (p = 0.006). All exertional rhabdomyolysis-susceptible horses tested were negative for the R309H GYS1 mutation. Conclusions/Significance: Exertional rhabdomyolysis syndrome in Standardbred horses has a similar incidence and risk factors to the syndrome in Thoroughbred horses. If the disorder has a genetic basis in Standardbreds, improved performance in susceptible animals may be responsible for maintenance of the disorder in the population.	[Isgren, Cajsa M.; Upjohn, Melissa M.; Fernandez-Fuente, Marta; Massey, Claire; Pollott, Geoff; Verheyen, Kristien L. P.; Piercy, Richard J.] Univ London Royal Vet Coll, Dept Vet Clin Sci, London, England; [Pollott, Geoff] Univ London Royal Vet Coll, Dept Vet Basic Sci, London, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College	Isgren, CM (corresponding author), Univ London Royal Vet Coll, Dept Vet Clin Sci, London, England.	rpiercy@rvc.ac.uk	Verheyen, Kristien/I-3300-2014; Fernandez-Fuente, Marta/A-1761-2014	Verheyen, Kristien/0000-0002-5077-224X; 				BEECH J, 1993, RES VET SCI, V54, P110, DOI 10.1016/0034-5288(93)90019-C; Collinder E, 1997, EQUINE VET J, V29, P117, DOI 10.1111/j.2042-3306.1997.tb01652.x; Dranchak PK, 2005, JAVMA-J AM VET MED A, V227, P762, DOI 10.2460/javma.2005.227.762; DRANCHAK PK, 2004, ANAL RECURRENT EXERT; Firshman AM, 2003, AM J VET RES, V64, P1319, DOI 10.2460/ajvr.2003.64.1319; FRAUENFELDER HC, 1986, EQUINE VET J, V18, P371, DOI 10.1111/j.2042-3306.1986.tb03657.x; HARRIS PA, 1991, BRIT VET J, V147, P373, DOI 10.1016/0007-1935(91)90011-B; Hunt LM, 2008, EQUINE VET J, V40, P171, DOI 10.2746/042516408X244262; JEFFCOTT LB, 1982, EQUINE VET J, V14, P185, DOI 10.1111/j.2042-3306.1982.tb02389.x; Lentz LR, 1999, AM J VET RES, V60, P992; Lentz LR, 1999, AM J VET RES, V60, P684; LINDHOLM A, 1974, ACTA VET SCAND, V15, P325; MacLeay JM, 1999, AM J VET RES, V60, P250; MacLeay JM, 1999, AM J VET RES, V60, P1562; MacLeay JM, 2000, AM J VET RES, V61, P1390, DOI 10.2460/ajvr.2000.61.1390; Martin BB, 2000, J AM VET MED ASSOC, V216, P554, DOI 10.2460/javma.2000.216.554; McCue ME, 2008, J VET INTERN MED, V22, P1228, DOI 10.1111/j.1939-1676.2008.0167.x; McCue M E, 2006, Equine Vet J Suppl, P340; McCue ME, 2009, VET PATHOL, V46, P1281, DOI 10.1354/vp.08-VP-0177-M-FL; Mccue ME, 2008, GENOMICS, V91, P458, DOI 10.1016/j.ygeno.2008.01.011; McGowan CM, 2002, VET REC, V151, P623, DOI 10.1136/vr.151.21.623; McGowan CM, 2002, VET REC, V150, P535, DOI 10.1136/vr.150.17.535; McKenzie EC, 2004, AM J VET RES, V65, P74, DOI 10.2460/ajvr.2004.65.74; McKenzie EC, 2003, J VET INTERN MED, V17, P693, DOI 10.1892/0891-6640(2003)017&lt;0693:EODSFA&gt;2.3.CO;2; Oki H, 2007, J ANIM BREED GENET, V124, P185, DOI 10.1111/j.1439-0388.2007.00659.x; ROSSDALE PD, 1985, VET REC, V116, P66, DOI 10.1136/vr.116.3.66; RUDOLPH JA, 1992, NAT GENET, V2, P144, DOI 10.1038/ng1092-144; Singer ER, 2008, VET J, V175, P76, DOI 10.1016/j.tvjl.2006.11.009; Stanley RL, 2009, EQUINE VET J, V41, P597, DOI 10.2746/042516409X407611; Upjohn MM, 2005, VET REC, V156, P763, DOI 10.1136/vr.156.24.763; VALBERG S, 1993, EQUINE VET J, V25, P11, DOI 10.1111/j.2042-3306.1993.tb02893.x; Valberg S J, 1999, Equine Vet J Suppl, P533; Valentine BA, 2000, VET PATHOL, V37, P193, DOI 10.1354/vp.37-2-193; Wilsher S, 2006, EQUINE VET J, V38, P113, DOI 10.2746/042516406776563305	34	27	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11594	10.1371/journal.pone.0011594	http://dx.doi.org/10.1371/journal.pone.0011594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644724	Green Published, gold, Green Submitted			2022-12-25	WOS:000279884900025
J	Romaguera, D; Angquist, L; Du, HD; Jakobsen, MU; Forouhi, NG; Halkjaer, J; Feskens, EJM; van der A, DL; Masala, G; Steffen, A; Palli, D; Wareham, NJ; Overvad, K; Tjonneland, A; Boeing, H; Riboli, E; Sorensen, TIA				Romaguera, Dora; Aengquist, Lars; Du, Huaidong; Jakobsen, Marianne Uhre; Forouhi, Nita G.; Halkjaer, Jytte; Feskens, Edith J. M.; van der A, Daphne L.; Masala, Giovanna; Steffen, Annika; Palli, Domenico; Wareham, Nicholas J.; Overvad, Kim; Tjonneland, Anne; Boeing, Heiner; Riboli, Elio; Sorensen, Thorkild I. A.			Dietary Determinants of Changes in Waist Circumference Adjusted for Body Mass Index - a Proxy Measure of Visceral Adiposity	PLOS ONE			English	Article							EPIC-OXFORD PARTICIPANTS; MIDDLE-AGED MEN; GLYCEMIC INDEX; ABDOMINAL ADIPOSITY; SUBSEQUENT CHANGES; EUROPEAN MEN; PHYSICAL-ACTIVITY; ALCOHOL-CONSUMPTION; INSULIN-RESISTANCE; ENERGY DENSITY	Background: Given the recognized health effects of visceral fat, the understanding of how diet can modulate changes in the phenotype "waist circumference for a given body mass index (WCBMI)'', a proxy measure of visceral adiposity, is deemed necessary. Hence, the objective of the present study was to assess the association between dietary factors and prospective changes in visceral adiposity as measured by changes in the phenotype WCBMI. Methods and Findings: We analyzed data from 48,631 men and women from 5 countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Anthropometric measurements were obtained at baseline and after a median follow-up time of 5.5 years. WCBMI was defined as the residuals of waist circumference regressed on body mass index, and annual change in WCBMI (Delta WCBMI, cm/y) was defined as the difference between residuals at follow-up and baseline, divided by follow-up time. The association between energy, energy density (ED), macronutrients, alcohol, glycemic index (GI), glycemic load (GL), fibre and Delta WCBMI was modelled using centre-specific adjusted linear regression, and random-effects meta-analyses to obtain pooled estimates. Men and women with higher ED and GI diets showed significant increases in their WCBMI, compared to those with lower ED and GI [1 kcal/g greater ED predicted a Delta WCBMI of 0.09 cm (95% CI 0.05 to 0.13) in men and 0.15 cm (95% CI 0.09 to 0.21) in women; 10 units greater GI predicted a Delta WCBMI of 0.07 cm (95% CI 0.03 to 0.12) in men and 0.06 cm (95% CI 0.03 to 0.10) in women]. Among women, lower fibre intake, higher GL, and higher alcohol consumption also predicted a higher Delta WCBMI. Conclusions: Results of this study suggest that a diet with low GI and ED may prevent visceral adiposity, defined as the prospective changes in WCBMI. Additional effects may be obtained among women of low alcohol, low GL, and high fibre intake.	[Romaguera, Dora; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; [Aengquist, Lars; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Du, Huaidong; van der A, Daphne L.] Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands; [Du, Huaidong] Nutr & Toxicol Res Inst Maastricht, Dept Human Biol, Maastricht, Netherlands; [Jakobsen, Marianne Uhre] Aarhus Univ Hosp, Dept Clin Epidemiol, Aalborg, Denmark; [Forouhi, Nita G.; Wareham, Nicholas J.] Addenbrookes Hosp, MRC Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Halkjaer, Jytte; Tjonneland, Anne] Inst Canc Epidemiol, Danish Canc Soc, Copenhagen, Denmark; [Feskens, Edith J. M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Masala, Giovanna; Palli, Domenico] ISPO Canc Res & Prevent Inst, Mol & Nutr Epidemiol Unit, Florence, Italy; [Steffen, Annika; Boeing, Heiner] German Inst Human Nutr, Dept Epidemiol, Potsdam, Nuthetal, Germany; [Overvad, Kim] Aarhus Univ, Dept Epidemiol, Sch Publ Hlth, Aarhus, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Dept Cardiol, Aalborg Hosp, Aalborg, Denmark	Imperial College London; University of Copenhagen; Netherlands National Institute for Public Health & the Environment; Maastricht University; Maastricht University Medical Centre (MUMC); Aarhus University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Danish Cancer Society; Wageningen University & Research; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University	Romaguera, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England.	d.romaguera-bosch@imperial.ac.uk	Jakobsen, Marianne Uhre/I-8550-2018; Feskens, Edith JM/A-3757-2012; Romaguera, Dora/ABE-7004-2020; Feskens, Edith/ABI-1446-2020; Steffen, Annika/H-7709-2018; Steffen, Annika/E-8540-2016; Romaguera, Dora/AAB-2852-2020; Masala, Giovanna/AAC-5474-2022	Jakobsen, Marianne Uhre/0000-0001-6518-4136; Romaguera, Dora/0000-0002-5762-8558; Feskens, Edith/0000-0001-5819-2488; Steffen, Annika/0000-0003-4072-9245; Steffen, Annika/0000-0003-4072-9245; Masala, Giovanna/0000-0002-5758-9069; PALLI, Domenico/0000-0002-5558-2437; Angquist, Lars/0000-0002-9516-4424; Riboli, Elio/0000-0001-6795-6080; Du, Huaidong/0000-0002-9814-0049; Forouhi, Nita/0000-0002-5041-248X; Overvad, Kim/0000-0001-6429-7921; Tjonneland, Anne/0000-0003-4385-2097; tumino, rosario/0000-0003-2666-414X	European Union [FOOD-CT-2005-513946]; Medical Research Council [MC_UP_A100_1003, MC_U106179471] Funding Source: researchfish; MRC [MC_UP_A100_1003] Funding Source: UKRI	European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DiOGenes is the acronym of the project "Diet, Obesity and Genes'' supported by the European Union (Contract no. FOOD-CT-2005-513946). The parties of the project are listed on the web-site of the project (http://www.diogenes-eu.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Chaston TB, 2008, INT J OBESITY, V32, P619, DOI 10.1038/sj.ijo.0803761; Dallongeville J, 1998, INT J OBESITY, V22, P1178, DOI 10.1038/sj/ijo/0800744; Deharveng G, 1999, EUR J CLIN NUTR, V53, P60, DOI 10.1038/sj.ejcn.1600677; Du H, 2009, INT J OBESITY, V33, P1280, DOI 10.1038/ijo.2009.163; Du HD, 2010, AM J CLIN NUTR, V91, P329, DOI 10.3945/ajcn.2009.28191; Du HD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005339; Feldeisen SE, 2007, APPL PHYSIOL NUTR ME, V32, P46, DOI [10.1139/H06-101, 10.1139/h06-101]; Forouhi NG, 2009, AM J CLIN NUTR, V90, P1632, DOI 10.3945/ajcn.2009.27828; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; Haftenberger M, 2002, PUBLIC HEALTH NUTR, V5, P1147, DOI 10.1079/PHN2002396; Halkjaer J, 2004, BRIT J NUTR, V92, P735, DOI 10.1079/BJN20041246; Halkjaer J, 2006, AM J CLIN NUTR, V84, P789, DOI 10.1093/ajcn/84.4.789; Han TS, 1998, INT J EPIDEMIOL, V27, P422, DOI 10.1093/ije/27.3.422; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P39, DOI 10.1001/jama.295.1.39; Janssen I, 2005, J AM GERIATR SOC, V53, P2112, DOI 10.1111/j.1532-5415.2005.00505.x; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Kaaks R, 1997, INT J EPIDEMIOL, V26, pS15, DOI 10.1093/ije/26.suppl_1.S15; Kahn HS, 1997, AM J PUBLIC HEALTH, V87, P747, DOI 10.2105/AJPH.87.5.747; Koh-Banerjee P, 2003, AM J CLIN NUTR, V78, P719, DOI 10.1093/ajcn/78.4.719; Koster A, 2008, AM J EPIDEMIOL, V167, P1465, DOI 10.1093/aje/kwn079; Lau C, 2005, DIABETES CARE, V28, P1397, DOI 10.2337/diacare.28.6.1397; Lee K, 2008, NUTRITION, V24, P625, DOI 10.1016/j.nut.2008.03.004; Liese AD, 2005, DIABETES CARE, V28, P2832, DOI 10.2337/diacare.28.12.2832; Mendez MA, 2009, AM J CLIN NUTR, V89, P316, DOI 10.3945/ajcn.2008.26444; Okosun IS, 2001, J HUM HYPERTENS, V15, P307, DOI 10.1038/sj.jhh.1001179; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Romaguera D, 2009, J NUTR, V139, P1728, DOI 10.3945/jn.109.108902; Schuetze M, 2009, EUR J CLIN NUTR, V63, P1143, DOI 10.1038/ejcn.2009.39; Spencer EA, 2004, PUBLIC HEALTH NUTR, V7, P723, DOI 10.1079/PHN2004600; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Summerbell CD, 2009, INT J OBESITY, V33, pS1, DOI 10.1038/ijo.2009.80; Tolstrup JS, 2008, AM J CLIN NUTR, V87, P957, DOI 10.1093/ajcn/87.4.957; Vadstrup ES, 2003, INT J OBESITY, V27, P238, DOI 10.1038/sj.ijo.802203; van Bakel MME, 2009, EUR J CLIN NUTR, V63, pS188, DOI 10.1038/ejcn.2009.81; van Bakel MME, 2009, J NUTR, V139, P568, DOI 10.3945/jn.108.097121; Vergnaud AC, 2009, BRIT J NUTR, V102, P302, DOI 10.1017/S0007114508162109; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366	44	76	76	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11588	10.1371/journal.pone.0011588	http://dx.doi.org/10.1371/journal.pone.0011588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644647	Green Published, gold, Green Submitted			2022-12-25	WOS:000279884900023
J	Sharma, P; Ignatchenko, V; Grace, K; Ursprung, C; Kislinger, T; Gramolini, AO				Sharma, Parveen; Ignatchenko, Vladimir; Grace, Kevin; Ursprung, Claudia; Kislinger, Thomas; Gramolini, Anthony O.			Endoplasmic Reticulum Protein Targeting of Phospholamban: A Common Role for an N-Terminal Di-Arginine Motif in ER Retention?	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; SARCOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; CARDIAC CONTRACTILITY; POTASSIUM CHANNELS; SKELETAL-MUSCLE; BINDING-SITES; BETA-SUBUNIT; GOLGI; SARCOLIPIN	Background: Phospholamban (PLN) is an effective inhibitor of the sarco(endo) plasmic reticulum Ca(2+)-ATPase, which transports Ca(2+) into the SR lumen, leading to muscle relaxation. A mutation of PLN in which one of the di-arginine residues at positions 13 and 14 was deleted led to a severe, early onset dilated cardiomyopathy. Here we were interested in determining the cellular mechanisms involved in this disease-causing mutation. Methodology/Principal Finding: Mutations deleting codons for either or both Arg13 or Arg14 resulted in the mislocalization of PLN from the ER. Our data show that PLN is recycled via the retrograde Golgi to ER membrane traffic pathway involving COP-I vesicles, since co-immunoprecipitation assays determined that COP I interactions are dependent on an intact di-arginine motif as PLN R Delta 14 did not co-precipitate with COP I containing vesicles. Bioinformatic analysis determined that the di-arginine motif is present in the first 25 residues in a large number of all ER/SR Gene Ontology (GO) annotated proteins. Mutations in the di-arginine motif of the Sigma 1-type opioid receptor, the beta-subunit of the signal recognition particle receptor, and Sterol-O-acyltransferase, three proteins identified in our bioinformatic screen also caused mislocalization of these known ER-resident proteins. Conclusion: We conclude that PLN is enriched in the ER due to COP I-mediated transport that is dependent on its intact diarginine motif and that the N-terminal di-arginine motif may act as a general ER retrieval sequence.	[Sharma, Parveen; Grace, Kevin; Ursprung, Claudia; Gramolini, Anthony O.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Ignatchenko, Vladimir; Kislinger, Thomas] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Kislinger, Thomas] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Gramolini, Anthony O.] Toronto Gen Res Inst, Div Cellular & Mol Biol, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Sharma, P (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	anthony.gramolini@utoronto.ca	Kislinger, Thomas/A-5934-2008	Kislinger, Thomas/0000-0003-3525-5540; Sharma, Parveen/0000-0002-5534-2417; Grace, Kevin/0000-0003-4746-6353	Heart and Stroke Foundation of Ontario [T-6281]; Canadian Institutes of Health Research [MOP-84267]; Canadian Foundation for Innovation; Connaught Foundation; Heart and Stroke/Richard Lewar Centre of Cardiovascular Excellence	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Connaught Foundation(University of Toronto); Heart and Stroke/Richard Lewar Centre of Cardiovascular Excellence	This study was supported by the Heart and Stroke Foundation of Ontario (#T-6281) http://www.heartandstroke.ca/, Canadian Institutes of Health Research (MOP-84267) http://www.cihr-irsc.gc.ca/, Canadian Foundation for Innovation, Connaught Foundation, and the Heart and Stroke/Richard Lewar Centre of Cardiovascular Excellence. AOG is a Canada Research Chair and a New Investigator of the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200; Bord S, 2001, J CLIN ENDOCR METAB, V86, P2309, DOI 10.1210/jc.86.5.2309; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Dolinski K, 2007, ANNU REV GENET, V41, P465, DOI 10.1146/annurev.genet.40.110405.090439; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Elschenbroich S, 2009, J PROTEOME RES, V8, P4860, DOI 10.1021/pr900318k; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Gramolini AO, 2004, P NATL ACAD SCI USA, V101, P16807, DOI 10.1073/pnas.0407815101; Gu S, 2007, J BIOL CHEM, V282, P33064, DOI 10.1074/jbc.M702685200; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Harter C, 1996, P NATL ACAD SCI USA, V93, P1902, DOI 10.1073/pnas.93.5.1902; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P726, DOI 10.1124/jpet.103.051292; Itzhaki Z, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r125; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Kain R, 1998, J BIOL CHEM, V273, P981, DOI 10.1074/jbc.273.2.981; Kim KH, 2008, J PHARMACOL EXP THER, V324, P160, DOI 10.1124/jpet.107.125773; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; Kraev A, 1996, GENOMICS, V37, P105, DOI 10.1006/geno.1996.0526; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Legate KR, 2003, J BIOL CHEM, V278, P27712, DOI 10.1074/jbc.M302158200; Liu W, 2005, J CELL BIOL, V168, P1053, DOI 10.1083/jcb.200410142; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; MacLennan DH, 2003, ANN NY ACAD SCI, V986, P472, DOI 10.1111/j.1749-6632.2003.tb07231.x; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; MARTIN FC, 1983, EUR J CLIN INVEST, V13, P49, DOI 10.1111/j.1365-2362.1983.tb00064.x; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Michelsen K, 2007, J CELL BIOL, V179, P209, DOI 10.1083/jcb.200704142; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; Ponting CP, 2002, ANNU REV BIOPH BIOM, V31, P45, DOI 10.1146/annurev.biophys.31.082901.134314; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Stenoien DL, 2007, AM J PHYSIOL-CELL PH, V292, pC2084, DOI 10.1152/ajpcell.00523.2006; Stephens DJ, 2000, J CELL SCI, V113, P2177; TADA M, 1982, ANNU REV PHYSIOL, V44, P401, DOI 10.1146/annurev.ph.44.030182.002153; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033; Wilke RA, 1999, J BIOL CHEM, V274, P18387, DOI 10.1074/jbc.274.26.18387; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198; Zhang JY, 2003, J BIOL CHEM, V278, P7459, DOI 10.1074/jbc.M207976200; Zvaritch E, 2000, J BIOL CHEM, V275, P14985, DOI 10.1074/jbc.275.20.14985	51	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11496	10.1371/journal.pone.0011496	http://dx.doi.org/10.1371/journal.pone.0011496			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634894	gold, Green Submitted, Green Published			2022-12-25	WOS:000279715300009
J	Barbosa, VC				Barbosa, Valmir C.			Network Conduciveness with Application to the Graph-Coloring and Independent-Set Optimization Transitions	PLOS ONE			English	Article							ACYCLIC ORIENTATIONS; PHASE-TRANSITIONS	Background: Given an undirected graph, we consider the two problems of combinatorial optimization, which ask that its chromatic and independence numbers be found. Although both problems are NP-hard, when either one is solved on the incrementally denser graphs of a random sequence, at certain critical values of the number of edges, it happens that the transition to the next value causes optimal solutions to be obtainable substantially more easily than right before it. Methodology/Principal Findings: We introduce the notion of a network's conduciveness, a probabilistically interpretable measure of how the network's structure allows it to be conducive to roaming agents, in certain conditions, from one portion of the network to another. We demonstrate that the performance jumps of graph coloring and independent sets at the critical-value transitions in the number of edges can be understood by resorting to the network that represents the solution space of the problems for each graph and examining its conduciveness between the non-optimal solutions and the optimal ones. Right past each transition, this network becomes strikingly more conducive in the direction of the optimal solutions than it was just before it, while at the same time becoming less conducive in the opposite direction. Conclusions/Significance: Network conduciveness provides a useful conceptual framework for explaining the performance jumps associated with graph coloring and independent sets. We believe it may also become instrumental in helping clarify further issues related to NP-hardness that remain poorly understood. Additionally, it may become useful also in other areas in which network theory has a role to play.	Univ Fed Rio de Janeiro, COPPE, Inst Alberto Luiz Coimbra Posgrad & Pesquisa Engn, Programa Engn Sistemas & Computacao, BR-21945 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Barbosa, VC (corresponding author), Univ Fed Rio de Janeiro, COPPE, Inst Alberto Luiz Coimbra Posgrad & Pesquisa Engn, Programa Engn Sistemas & Computacao, BR-21945 Rio De Janeiro, Brazil.	valmir@cos.ufrj.br		Carneiro Barbosa, Valmir/0000-0003-1010-7170	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was partially supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and a Cientista do Nosso Estado grant from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa V.C., 2000, ATLAS EDGE REVERSAL; Barbosa VC, 2004, J COMB OPTIM, V8, P419, DOI 10.1007/s10878-004-4835-9; Barbosa VC, 2004, PHYSICA A, V343, P401, DOI 10.1016/j.physa.2004.05.055; Barbosa VC, 1999, INFORM PROCESS LETT, V72, P71, DOI 10.1016/S0020-0190(99)00120-9; Barbosa VC, 2004, J COMB OPTIM, V8, P41, DOI 10.1023/B:JOCO.0000021937.26468.b2; BOLLOBA B, 2009, HDB LARGE SCALE RAND; Bondy J.A., 2008, GRAPH THEORY; Bornholdt S, 2003, HDB GRAPHS NETWORKS; BRELAZ D, 1979, COMMUN ACM, V22, P251, DOI 10.1145/359094.359101; CARRAGHAN R, 1990, OPER RES LETT, V9, P375, DOI 10.1016/0167-6377(90)90057-C; CHEESEMAN P, 1991, P 12 INT JOINT C ART, P331; Culberson J, 2001, THEOR COMPUT SCI, V265, P227, DOI 10.1016/S0304-3975(01)00164-5; DEMING RW, 1979, J COMB THEORY B, V26, P101, DOI 10.1016/0095-8956(79)90048-0; Garey M.R., 1979, COMPUTERS INTRACTABI; Giordana A, 2000, MACH LEARN, V41, P217, DOI 10.1023/A:1007620705405; Johnson David S., 1990, HDB THEORETICAL COMP, VA, P67; JOHNSON DS, 1993, DFMAX C SEMIEXHAUSTI; Latham PE, 2009, SCHOLARPEDIA, V4, P1658, DOI [10.4249/scholarpedia.1658, DOI 10.4249/SCHOLARPEDIA.1658]; MITCHELL D, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P459; Newman MEJ., 2006, STRUCTURE DYNAMICS N; SLANEY J, 2001, P 17 INT JOINT C ART, P254; Stanley R. P., 1973, Discrete Mathematics, V5, P171, DOI 10.1016/0012-365X(73)90108-8; TRICK MA, 1994, COLOR C EASY CODE GR	24	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11232	10.1371/journal.pone.0011232	http://dx.doi.org/10.1371/journal.pone.0011232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628597	Green Published, Green Submitted, gold			2022-12-25	WOS:000279637100001
J	Wilbanks, EG; Facciotti, MT				Wilbanks, Elizabeth G.; Facciotti, Marc T.			Evaluation of Algorithm Performance in ChIP-Seq Peak Detection	PLOS ONE			English	Article							FACTOR-BINDING SITES; GENOME-WIDE IDENTIFICATION; CHROMATIN-IMMUNOPRECIPITATION; MODEL; DECONVOLUTION; PROFILES; NETWORK; TOOL; MAP	Next-generation DNA sequencing coupled with chromatin immunoprecipitation (ChIP-seq) is revolutionizing our ability to interrogate whole genome protein-DNA interactions. Identification of protein binding sites from ChIP-seq data has required novel computational tools, distinct from those used for the analysis of ChIP-Chip experiments. The growing popularity of ChIP-seq spurred the development of many different analytical programs (at last count, we noted 31 open source methods), each with some purported advantage. Given that the literature is dense and empirical benchmarking challenging, selecting an appropriate method for ChIP-seq analysis has become a daunting task. Herein we compare the performance of eleven different peak calling programs on common empirical, transcription factor datasets and measure their sensitivity, accuracy and usability. Our analysis provides an unbiased critical assessment of available technologies, and should assist researchers in choosing a suitable tool for handling ChIP-seq data.	[Wilbanks, Elizabeth G.; Facciotti, Marc T.] Univ Calif Davis, Grad Grp Microbiol, Davis, CA 95616 USA; [Facciotti, Marc T.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Wilbanks, Elizabeth G.; Facciotti, Marc T.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Wilbanks, EG (corresponding author), Univ Calif Davis, Grad Grp Microbiol, Davis, CA 95616 USA.	mtfacciotti@ucdavis.edu	Facciotti, Marc/AAF-9227-2020	Facciotti, Marc/0000-0003-4453-3274	National Science Foundation; UC Davis	National Science Foundation(National Science Foundation (NSF)); UC Davis	This work was supported by a National Science Foundation Graduate Research Fellowship to EGW and MTF's start-up funds from UC Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BARSKI A, 2009, J CELL BIOCH; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BLAHNIK K, 2009, NUCL ACIDS RES; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Collins PJ, 2007, PLOS GENET, V3, P2247, DOI 10.1371/journal.pgen.0030208; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Feng WX, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S23; Hon G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000201; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johannes F, 2010, BIOINFORMATICS, V26, P1000, DOI 10.1093/bioinformatics/btq087; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kallin EM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000506; KHARCHENKO PV, 2008, NAT BIOTECHNOL; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Laajala TD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-618; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lun DS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r142; McPherson JD, 2009, NAT METHODS, V6, pS2, DOI [10.1038/NMETH.F.268, 10.1038/nmeth.f.268]; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Qi Y, 2006, NAT BIOTECHNOL, V24, P963, DOI 10.1038/nbt1233; QIN S, 2009, HMM BASED ALGORITHM; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reiss DJ, 2008, BIOINFORMATICS, V24, P396, DOI 10.1093/bioinformatics/btm592; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; ROSENBLOOM KR, 2009, NUCL ACIDS RES  1117; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Spyrou C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-299; Taslim C, 2009, BIOINFORMATICS, V25, P2334, DOI 10.1093/bioinformatics/btp384; Tuteja G, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp536; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Vega VB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005241; Wang CM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-81; Wilder S, 2010, SWEMBL GENERIC PEAK; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Xu H, 2008, BIOINFORMATICS, V24, P2344, DOI 10.1093/bioinformatics/btn402; Xu H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-436; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZD, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000158	50	196	203	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11471	10.1371/journal.pone.0011471	http://dx.doi.org/10.1371/journal.pone.0011471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628599	Green Published, Green Submitted, gold			2022-12-25	WOS:000279637100004
J	Das, D; Luo, X; Singh, A; Gu, YP; Ghosh, S; Mukhopadhyay, CK; Chen, SG; Sy, MS; Kong, QZ; Singh, N				Das, Dola; Luo, Xiu; Singh, Ajay; Gu, Yaping; Ghosh, Soumya; Mukhopadhyay, Chinmay K.; Chen, Shu G.; Sy, Man-Sun; Kong, Qingzhong; Singh, Neena			Paradoxical Role of Prion Protein Aggregates in Redox-Iron Induced Toxicity	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; DEPENDENT GENERATION; REPEAT REGION; COPPER; DISEASE; METALS; PATHOGENESIS; CONVERSION; REDUCTION; AUTOPHAGY	Background: Imbalance of iron homeostasis has been reported in sporadic Creutzfeldt-Jakob-disease (sCJD) affected human and scrapie infected animal brains, but the contribution of this phenotype to disease associated neurotoxicity is unclear. Methodology/Principal Findings: Using cell models of familial prion disorders, we demonstrate that exposure of cells expressing normal prion protein (PrPC) or mutant PrP forms to a source of redox-iron induces aggregation of PrPC and specific mutant PrP forms. Initially this response is cytoprotective, but becomes increasingly toxic with time due to accumulation of PrP-ferritin aggregates. Mutant PrP forms that do not aggregate are not cytoprotective, and cells show signs of acute toxicity. Intracellular PrP-ferritin aggregates induce the expression of LC3-II, indicating stimulation of autophagy in these cells. Similar observations are noted in sCJD and scrapie infected hamster brains, lending credence to these results. Furthermore, phagocytosis of PrP-ferritin aggregates by astrocytes is cytoprotective, while culture in astrocyte conditioned medium (CM) shows no measurable effect. Exposure to H2O2, on the other hand, does not cause aggregation of PrP, and cells show acute toxicity that is alleviated by CM. Conclusions/Significance: These observations suggest that aggregation of PrP in response to redox-iron is cytoprotective. However, subsequent co-aggregation of PrP with ferritin induces intracellular toxicity unless the aggregates are degraded by autophagosomes or phagocytosed by adjacent scavenger cells. H2O2, on the other hand, does not cause aggregation of PrP, and induces toxicity through extra-cellular free radicals. Together with previous observations demonstrating imbalance of iron homeostasis in prion disease affected brains, these observations provide insight into the mechanism of neurotoxicity by redox-iron, and the role of PrP in this process.	[Das, Dola; Luo, Xiu; Singh, Ajay; Gu, Yaping; Ghosh, Soumya; Chen, Shu G.; Sy, Man-Sun; Kong, Qingzhong; Singh, Neena] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Mukhopadhyay, Chinmay K.] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India	Case Western Reserve University; Jawaharlal Nehru University, New Delhi	Das, D (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	ajay.singh2@case.edu; neena.singh@case.edu	Chen, Shu G./O-4750-2014; Das, Dola/I-1802-2014; Chen, Shu G./AAK-7301-2021; Chen, Shu/Z-2943-2019	Chen, Shu G./0000-0001-7180-3001; Chen, Shu G./0000-0001-7180-3001; 	National Institutes of Health [R21AG033423, R01NS044209]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants R21AG033423 and R01NS044209 (to NS) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Allsop D, 2008, BIOCHEM SOC T, V36, P1293, DOI 10.1042/BST0361293; Aronoff-Spencer E, 2000, BIOCHEMISTRY-US, V39, P13760, DOI 10.1021/bi001472t; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Basu S, 2007, MOL BIOL CELL, V18, P3302, DOI 10.1091/mbc.E07-04-0317; Brown DR, 1999, J NEUROSCI RES, V58, P717; Brown LR, 2003, J NEUROCHEM, V87, P353, DOI 10.1046/j.1471-4159.2003.01996.x; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chinta SJ, 2008, BBA-GEN SUBJECTS, V1780, P1362, DOI 10.1016/j.bbagen.2008.02.005; Choi CJ, 2006, NEUROTOXICOLOGY, V27, P777, DOI 10.1016/j.neuro.2006.06.004; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Gimenez-Xavier P, 2009, NEUROTOXICOLOGY, V30, P658, DOI 10.1016/j.neuro.2009.04.007; Gregory A, 2005, FOLIA NEUROPATHOL, V43, P286, DOI 10.1016/B978-0-444-63233-3.00019-1; Gu YP, 2003, J NEUROCHEM, V84, P10, DOI 10.1046/j.1471-4159.2003.01255.x; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Heiseke A, 2010, CURR ISSUES MOL BIOL, V12, P87; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Kawano T, 2007, INT J BIOL SCI, V3, P57; Kim BH, 2007, NEUROSCI LETT, V422, P158, DOI 10.1016/j.neulet.2007.05.061; Kim NH, 2005, FASEB J, V19, P783, DOI 10.1096/fj.04-2117fje; Kim NH, 2000, BRAIN RES, V884, P98, DOI 10.1016/S0006-8993(00)02907-3; Koiri RK, 2008, BIOMETALS, V21, P117, DOI 10.1007/s10534-007-9098-3; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Lehmann S, 2002, CURR OPIN CHEM BIOL, V6, P187, DOI 10.1016/S1367-5931(02)00295-8; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mishra RS, 2002, J BIOL CHEM, V277, P24554, DOI 10.1074/jbc.M200213200; Miura T, 2005, BIOCHEMISTRY-US, V44, P8712, DOI 10.1021/bi0501784; Molina-Holgado F, 2007, BIOMETALS, V20, P639, DOI 10.1007/s10534-006-9033-z; Oh JM, 2008, MOL CELL NEUROSCI, V39, P238, DOI 10.1016/j.mcn.2008.07.003; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Petersen RB, 2005, ACTA NEUROPATHOL, V110, P232, DOI 10.1007/s00401-005-1034-4; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2004, PRION BIOL DIS; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; Ruiz FH, 2000, BIOCHEM BIOPH RES CO, V269, P491, DOI 10.1006/bbrc.2000.2270; Shearer J, 2007, INORG CHEM, V46, P710, DOI 10.1021/ic061236s; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006115; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000336; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004468; Singh N, 1997, J BIOL CHEM, V272, P28461, DOI 10.1074/jbc.272.45.28461; Tabner BJ, 2005, BIOCHEM SOC T, V33, P548, DOI 10.1042/BST0330548; Turnbull S, 2003, NEUROSCI LETT, V336, P159, DOI 10.1016/S0304-3940(02)01254-5; Turnbull S, 2003, BIOCHEMISTRY-US, V42, P7675, DOI 10.1021/bi030036e; Varela-Nallar L, 2006, BIOL RES, V39, P39, DOI 10.4067/S0716-97602006000100005; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	49	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11420	10.1371/journal.pone.0011420	http://dx.doi.org/10.1371/journal.pone.0011420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625431	Green Published, gold, Green Submitted			2022-12-25	WOS:000279522500004
J	Meeran, SM; Patel, SN; Tollefsbol, TO				Meeran, Syed M.; Patel, Shweta N.; Tollefsbol, Trygve O.			Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; TELOMERASE REVERSE-TRANSCRIPTASE; GENE-EXPRESSION; DNA METHYLATION; APOPTOSIS; PROMOTER; GROWTH; TRICHOSTATIN; ACETYLATION; MODULATION	Background: Sulforaphane (SFN), an isothiocyanate found in cruciferous vegetables, is a common dietary component that has histone deacetylase inhibition activity and exciting potential in cancer prevention. The mechanisms by which SFN imparts its chemopreventive properties are of considerable interest and little is known of its preventive potential for breast cancer. Principal Findings: We found that SFN significantly inhibits the viability and proliferation of breast cancer cells in vitro while it has negligible effects on normal breast cells. Inhibition of telomerase has received considerable attention because of its high expression in cancer cells and extremely low level of expression in normal cells. SFN treatment dose-and time-dependently inhibited human telomerase reverse transcriptase (hTERT), the catalytic regulatory subunit of telomerase, in both MCF-7 and MDA-MB-231 human breast cancer cells. DNA methyltransferases (DNMTs), especially DNMT1 and DNMT3a, were also decreased in SFN-treated breast cancer cells suggesting that SFN may repress hTERT by impacting epigenetic pathways. Down-regulation of DNMTs in response to SFN induced site-specific CpG demethylation occurring primarily in the first exon of the hTERT gene thereby facilitating CTCF binding associated with hTERT repression. Chromatin immunoprecipitation (ChIP) analysis of the hTERT promoter revealed that SFN increased the level of active chromatin markers acetyl-H3, acetyl-H3K9 and acetyl-H4, whereas the trimethyl-H3K9 and trimethyl-H3K27 inactive chromatin markers were decreased in a dose-dependent manner. SFN-induced hyperacetylation facilitated the binding of many hTERT repressor proteins such as MAD1 and CTCF to the hTERT regulatory region. Depletion of CTCF using siRNA reduced the SFN-induced down-regulation of hTERT mRNA transcription in these breast cancer cells. In addition, down-regulation of hTERT expression facilitated the induction of cellular apoptosis in human breast cancer cells. Significance: Collectively, our results provide novel insights into SFN-mediated epigenetic down-regulation of telomerase in breast cancer prevention and may open new avenues for approaches to SFN-mediated cancer prevention.	[Meeran, Syed M.; Patel, Shweta N.; Tollefsbol, Trygve O.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Ctr Aging, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Meeran, SM (corresponding author), Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA.	trygve@uab.edu	Meeran, Syed Musthapa/AAG-2157-2020	Meeran, Syed Musthapa/0000-0003-3859-146X; Tollefsbol, Trygve/0000-0002-0284-1511	National Cancer Institute [R01 CA129415]; NATIONAL CANCER INSTITUTE [R01CA129415] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R01 CA129415 National Cancer Institute (http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2003, J ANTI-AGING MED, V6, P315, DOI 10.1089/109454503323028911; Anderson CJ, 2006, ONCOGENE, V25, P61, DOI 10.1038/sj.onc.1209011; Berletch JB, 2008, J CELL BIOCHEM, V103, P509, DOI 10.1002/jcb.21417; Bhamre S, 2009, PROSTATE, V69, P181, DOI 10.1002/pros.20869; Choi JH, 2010, BIOCHEM BIOPH RES CO, V391, P449, DOI 10.1016/j.bbrc.2009.11.078; Choi KC, 2009, CANCER RES, V69, P583, DOI 10.1158/0008-5472.CAN-08-2442; Chu WF, 2009, ORAL ONCOL, V45, P998, DOI 10.1016/j.oraloncology.2009.05.641; Ciftci K, 2003, J PHARM PHARMACOL, V55, P1135, DOI 10.1211/002235703322277177; Cornblatt BS, 2007, CARCINOGENESIS, V28, P1485, DOI 10.1093/carcin/bgm049; Dashwood RH, 2008, NUTR REV, V66, pS36, DOI 10.1111/j.1753-4887.2008.00065.x; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P222, DOI 10.1002/mc.20380; Guilleret I, 2002, INT J CANCER, V101, P335, DOI 10.1002/ijc.10593; Ho E, 2009, J NUTR, V139, P2393, DOI 10.3945/jn.109.113332; Hou M, 2002, EXP CELL RES, V274, P25, DOI 10.1006/excr.2001.5462; Jacinto FV, 2007, CANCER RES, V67, P11481, DOI 10.1158/0008-5472.CAN-07-2687; Jew S, 2009, J MED FOOD, V12, P925, DOI 10.1089/jmf.2008.0268; Kyo S, 2008, CANCER SCI, V99, P1528, DOI 10.1111/j.1349-7006.2008.00878.x; Li YY, 2009, INT J CANCER, V125, P286, DOI 10.1002/ijc.24398; Liu L, 2004, GENE, V340, P1, DOI 10.1016/j.gene.2004.06.011; Liu L, 2004, MOL CANCER THER, V3, P1003; Meeran SM, 2007, EXP DERMATOL, V16, P405, DOI 10.1111/j.1600-0625.2007.00542.x; Munster P, 2009, CLIN CANCER RES, V15, P2488, DOI 10.1158/1078-0432.CCR-08-1930; Murakami J, 2005, CANCER CHEMOTH PHARM, V56, P22, DOI 10.1007/s00280-004-0976-x; Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Myzak MC, 2007, EXP BIOL MED, V232, P227; Naasani I, 2003, CANCER RES, V63, P824; Nian H, 2009, ENVIRON MOL MUTAGEN, V50, P213, DOI 10.1002/em.20454; Patil BS, 2009, J AGR FOOD CHEM, V57, P8142, DOI 10.1021/jf9000132; Pledgie-Tracy A, 2007, MOL CANCER THER, V6, P1013, DOI 10.1158/1535-7163.MCT-06-0494; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Renaud S, 2005, NUCLEIC ACIDS RES, V33, P6850, DOI 10.1093/nar/gki989; Schwab M, 2008, IMMUNOLOGY, V125, P241, DOI 10.1111/j.1365-2567.2008.02834.x; Shun MC, 2004, NUTR CANCER, V48, P95, DOI 10.1207/s15327914nc4801_13; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Suenaga M, 2002, INT J CANCER, V97, P621, DOI 10.1002/ijc.10082; Takakura M, 2001, NUCLEIC ACIDS RES, V29, P3006, DOI 10.1093/nar/29.14.3006; Telang U, 2009, EXP BIOL MED, V234, P287, DOI 10.3181/0808-RM-241; Wei N, 2009, FASEB J, V23; Woo HJ, 2007, EXP MOL PATHOL, V82, P77, DOI 10.1016/j.yexmp.2006.02.004; Xiao D, 2009, PHARM RES-DORDR, V26, P1729, DOI 10.1007/s11095-009-9883-5; Xu DW, 2001, P NATL ACAD SCI USA, V98, P3826, DOI 10.1073/pnas.071043198; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	44	253	260	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11457	10.1371/journal.pone.0011457	http://dx.doi.org/10.1371/journal.pone.0011457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625516	Green Submitted, Green Published, gold			2022-12-25	WOS:000279522500022
J	Hosking, MP; Tirotta, E; Ransohoff, RM; Lane, TE				Hosking, Martin P.; Tirotta, Emanuele; Ransohoff, Richard M.; Lane, Thomas E.			CXCR2 Signaling Protects Oligodendrocytes and Restricts Demyelination in a Mouse Model of Viral-Induced Demyelination	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HEPATITIS-VIRUS; CHEMOKINE RECEPTORS; MURINE CORONAVIRUS; IFN-GAMMA; MEDIATED DEMYELINATION; MICE LACKING; SPINAL-CORD; JHM STRAIN; T-CELLS	Background: The functional role of ELR-positive CXC chemokines during viral - induced demyelination was assessed. Inoculation of the neuroattenuated JHM strain of mouse hepatitis virus (JHMV) into the CNS of susceptible mice results in an acute encephalomyelitis that evolves into a chronic demyelinating disease, modeling white matter pathology observed in the human demyelinating disease Multiple Sclerosis. Methodology/Principal Findings: JHMV infection induced the rapid and sustained expression of transcripts specific for the ELR (+) chemokine ligands CXCL1 and CXCL2, as well as their binding receptor CXCR2, which was enriched within the spinal cord during chronic infection. Inhibiting CXCR2 signaling with neutralizing antiserum significantly (p < 0.03) delayed clinical recovery. Moreover, CXCR2 neutralization was associated with an increase in the severity of demyelination that was independent of viral recrudescence or modulation of neuroinflammation. Rather, blocking CXCR2 was associated with increased numbers of apoptotic cells primarily within white matter tracts, suggesting that oligodendrocytes were affected. JHMV infection of enriched oligodendrocyte progenitor cell (OPC) cultures revealed that apoptosis was associated with elevated expression of cleaved caspase 3 and muted Bcl-2 expression. Inclusion of CXCL1 within JHMV infected cultures restricted caspase 3 cleavage and increased Bcl-2 expression that was associated with a significant (p < 0.001) decrease in apoptosis. CXCR2 deficient oligodendrocytes were refractory to CXCL1 mediated protection from JHMV - induced apoptosis, readily activating caspase 3 and down regulating Bcl-2. Conclusion/Significance: These findings highlight a previously unappreciated role for CXCR2 signaling in protecting oligodendrocyte lineage cells from apoptosis during inflammatory demyelination initiated by viral infection of the CNS.	[Hosking, Martin P.; Tirotta, Emanuele; Lane, Thomas E.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Lane, Thomas E.] Univ Calif Irvine, Inst Immunol, Irvine, CA 92717 USA; [Lane, Thomas E.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Ctr, Irvine, CA 92717 USA; [Ransohoff, Richard M.] Cleveland Clin, Dept Neurosci, Lerner Res Inst, Neuroinflammat Res Ctr, Cleveland, OH 44106 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Cleveland Clinic Foundation	Hosking, MP (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	tlane@uci.edu			National Institutes of Health (NIH) [NS41249, T32 AI-060573]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041249] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health (NIH) grants NS41249 to T. E. L. supported this work. M. P. H. was supported by NIH T32 AI-060573. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajetto A, 2001, FRONT NEUROENDOCRIN, V22, P147, DOI 10.1006/frne.2001.0214; Balabanov R, 2006, J NEUROSCI, V26, P5143, DOI 10.1523/JNEUROSCI.0737-06.2006; Ben-Hur T, 1998, J NEUROSCI, V18, P5777, DOI 10.1523/jneurosci.18-15-05777.1998; Bergmann CC, 1996, J GEN VIROL, V77, P315, DOI 10.1099/0022-1317-77-2-315; Call DR, 2001, AM J PATHOL, V158, P715, DOI 10.1016/S0002-9440(10)64014-X; Carlson T, 2008, J EXP MED, V205, P811, DOI 10.1084/jem.20072404; Carollo M, 2001, BRIT J PHARMACOL, V134, P1166, DOI 10.1038/sj.bjp.0704371; CHEEVER FS, 1949, J EXP MED, V90, P181, DOI 10.1084/jem.90.3.181; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dorf ME, 2000, J NEUROIMMUNOL, V111, P109, DOI 10.1016/S0165-5728(00)00371-4; DSouza SD, 1996, J EXP MED, V184, P2361, DOI 10.1084/jem.184.6.2361; Glabinski AR, 1997, AM J PATHOL, V150, P617; Gonzalez JM, 2006, AM J PATHOL, V168, P796, DOI 10.2353/ajpath.2006.050496; Gonzalez JM, 2005, GLIA, V51, P22, DOI 10.1002/glia.20182; HIRANO N, 1978, JPN J EXP MED, V48, P71; Horuk R, 1997, J IMMUNOL, V158, P2882; Hosking MP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000648; Hovelmeyer N, 2005, J IMMUNOL, V175, P5875, DOI 10.4049/jimmunol.175.9.5875; KERSTETTER AE, 2009, EXP NEUROL; Kielian T, 2000, AM J PATHOL, V157, P647, DOI 10.1016/S0002-9440(10)64575-0; Kuhlmann T, 1999, GLIA, V28, P34, DOI 10.1002/(SICI)1098-1136(199910)28:1<34::AID-GLIA4>3.0.CO;2-8; Lane TE, 1998, J IMMUNOL, V160, P970; Lin MT, 1997, J VIROL, V71, P383, DOI 10.1128/JVI.71.1.383-391.1997; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Liu LP, 2010, NAT NEUROSCI, V13, P319, DOI 10.1038/nn.2491; Liu MT, 2001, J IMMUNOL, V167, P4091, DOI 10.4049/jimmunol.167.7.4091; Liu Y, 2006, J VIROL, V80, P395, DOI 10.1128/JVI.80.1.395-403.2006; Liu Y, 2005, J VIROL, V79, P47, DOI 10.1128/JVI.79.1.47-56.2005; Liu Y, 2003, J VIROL, V77, P11952, DOI 10.1128/JVI.77.22.11952-11963.2003; Liu Y, 2007, VIROLOGY, V360, P364, DOI 10.1016/j.virol.2006.10.044; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; Mehrad B, 1999, J IMMUNOL, V163, P6086; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; OKA A, 1993, J NEUROSCI, V13, P1441; Omari KM, 2009, AM J PATHOL, V174, P164, DOI 10.2353/ajpath.2009.080350; Omari KM, 2006, GLIA, V53, P24, DOI 10.1002/glia.20246; Omari KM, 2005, BRAIN, V128, P1003, DOI 10.1093/brain/awh479; Padovani-Claudio DA, 2006, GLIA, V54, P471, DOI 10.1002/glia.20383; Parra B, 1999, J IMMUNOL, V162, P1641; Parra B, 1997, VIROLOGY, V233, P260, DOI 10.1006/viro.1997.8613; Perlman S, 2000, EFFECTS OF MICROBES ON THE IMMUNE SYSTEM, P331; Pewe L, 2002, J IMMUNOL, V168, P1547, DOI 10.4049/jimmunol.168.4.1547; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popivanova BK, 2003, BRAIN RES, V970, P195, DOI 10.1016/S0006-8993(03)02343-6; Pouly S, 2000, J NEUROPATH EXP NEUR, V59, P280, DOI 10.1093/jnen/59.4.280; Robinson S, 1998, J NEUROSCI, V18, P10457; Rubio N, 2007, VIROLOGY, V358, P98, DOI 10.1016/j.virol.2006.08.003; Rubio N, 2006, CELL IMMUNOL, V239, P31, DOI 10.1016/j.cellimm.2006.03.003; Schwartz T, 2002, J NEUROVIROL, V8, P392, DOI 10.1080/13550280260422695; SELMAJ KW, 1988, ANN NEUROL, V23, P339, DOI 10.1002/ana.410230405; Stiles LN, 2006, EUR J IMMUNOL, V36, P613, DOI 10.1002/eji.200535509; STOHLMAN SA, 1981, NEUROLOGY, V31, P38, DOI 10.1212/WNL.31.1.38; Takahashi JL, 2003, ANN NEUROL, V53, P588, DOI 10.1002/ana.10519; Totoiu MO, 2004, EXP NEUROL, V187, P254, DOI 10.1016/j.expneurol.2004.01.028; Trifilo MJ, 2004, VIROLOGY, V327, P8, DOI 10.1016/j.virol.2004.06.027; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; Ubogu EE, 2006, TRENDS PHARMACOL SCI, V27, P48, DOI 10.1016/j.tips.2005.11.002; Valles A, 2006, NEUROBIOL DIS, V22, P312, DOI 10.1016/j.nbd.2005.11.015; Walsh KB, 2008, J VIROL, V82, P3031, DOI 10.1128/JVI.02033-07; WANG FI, 1992, LAB INVEST, V66, P744; Wang ZY, 2003, VIROLOGY, V312, P60, DOI 10.1016/S0042-6822(03)00181-8; Wu GF, 1999, J VIROL, V73, P8771, DOI 10.1128/JVI.73.10.8771-8780.1999; XUE SR, 1995, VIROLOGY, V208, P173, DOI 10.1006/viro.1995.1140; Yu N, 1998, P NATL ACAD SCI USA, V95, P2624, DOI 10.1073/pnas.95.5.2624	68	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11340	10.1371/journal.pone.0011340	http://dx.doi.org/10.1371/journal.pone.0011340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596532	gold, Green Published			2022-12-25	WOS:000279259900013
J	Yang, JQ; Huang, J; Chatterjee, TK; Twait, E; Fisher, RA				Yang, Jianqi; Huang, Jie; Chatterjee, Tapan K.; Twait, Erik; Fisher, Rory A.			A Novel Mechanism Involving Coordinated Regulation of Nuclear Levels and Acetylation of NF-YA and Bcl6 Activates RGS4 Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-BETA; SIGNAL-TRANSDUCTION; C/EBP-BETA; HISTONE DEACETYLASE; GENE-TRANSCRIPTION; NERVOUS-SYSTEM; CELL LYMPHOMA; SMOOTH-MUSCLE; CCAAT BOX; EXPRESSION	Neuronally enriched RGS4 plays a critical role attenuating G protein signaling in brain, although the mechanisms regulating RGS4 expression are unknown. Here we describe a novel mechanism for transcriptional activation of RGS4 in neuron-like PC6 cells, where RGS4 is markedly induced during confluence-induced growth arrest. Transcriptional activation of RGS4 in confluent PC6 cells was accompanied by impaired G(i/o)-dependent MAPK activation. In the human RGS4 gene promoter, we identified three phylogenetically conserved cis-elements: an inverted CCAAT box element (ICE), a cAMP response element, and a B-cell lymphoma 6 (Bcl6)-binding site. The ICE and the cAMP response element mediate activation, and the Bcl6 site mediates repression of RGS4 transcription. Activation of RGS4 transcription in confluent PC6 cells is accompanied by increases in NF-YA and C/EBP beta and decreases in Bcl6 levels in the nucleus. Increases in NF-YA and C/EBP beta lead to their increased binding to the RGS4 promoter in vivo, and dominant negative forms of these proteins repressed RGS4 promoter activity. Acetylation of NF-YA and Bcl6 were increased in postconfluent cells. Trichostatin A stimulation of RGS4 promoter activity, accompanied by increased binding of NF-YA and decreased binding of Bcl6 to the promoter, was abolished by mutation of the ICE and enhanced by mutation of the Bcl6 site. These findings demonstrate a dynamic and coordinated regulation of nuclear levels and acetylation status of trans-acting factors critical in determining the off/on state of the RGS4 promoter.	[Yang, Jianqi; Huang, Jie; Fisher, Rory A.] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA; [Twait, Erik] Univ Iowa, Dept Surg, Carver Coll Med, Iowa City, IA 52242 USA; [Chatterjee, Tapan K.] Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45221 USA	University of Iowa; University of Iowa; University of Cincinnati	Fisher, RA (corresponding author), Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA.	rory-fisher@uiowa.edu	Chatterjee, Rima/J-8066-2017	Fisher, Rory/0000-0003-3108-4836	National Institutes of Health [GM075033, GM075033-03s1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM075033 and GM075033-03s1 (to R.A.F.).	Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Albig AR, 2005, MOL BIOL CELL, V16, P609, DOI 10.1091/mbc.e04-06-0479; APARICIO O, 2005, CURRENT PROTOCOLS MO; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Buchwald M, 2009, CANCER LETT, V280, P160, DOI 10.1016/j.canlet.2009.02.028; Buckbinder L, 1997, P NATL ACAD SCI USA, V94, P7868, DOI 10.1073/pnas.94.15.7868; Buckholtz JW, 2007, J NEUROSCI, V27, P1584, DOI 10.1523/JNEUROSCI.5112-06.2007; Calao M, 2008, TRENDS BIOCHEM SCI, V33, P339, DOI 10.1016/j.tibs.2008.04.015; Cesena TI, 2008, MOL CELL ENDOCRINOL, V289, P94, DOI 10.1016/j.mce.2008.03.009; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Chakravarty K, 2004, J BIOL CHEM, V279, P15385, DOI 10.1074/jbc.M309905200; Chatterjee TK, 2003, J BIOL CHEM, V278, P30261, DOI 10.1074/jbc.M212687200; Chen GK, 2004, MOL PHARMACOL, V65, P906, DOI 10.1124/mol.65.4.906; Cheng YS, 2008, J CELL BIOCHEM, V105, P922, DOI 10.1002/jcb.21893; Ci WM, 2008, CURR OPIN HEMATOL, V15, P381, DOI 10.1097/MOH.0b013e328302c7df; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; Ding J, 2006, NAT NEUROSCI, V9, P832, DOI 10.1038/nn1700; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; Ellis L, 2009, CANCER LETT, V280, P145, DOI 10.1016/j.canlet.2008.11.012; Grillet N, 2003, J NEUROSCI, V23, P10613; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; HONG JX, 1993, J IMMUNOL, V150, P3895; Hopfner R, 2000, CANCER RES, V60, P121; Hu WH, 2009, AM J PHYSIOL-CELL PH, V296, pC1310, DOI 10.1152/ajpcell.00573.2008; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Huynh KD, 2000, GENE DEV, V14, P1810; Jump DB, 1997, J BIOL CHEM, V272, P27778, DOI 10.1074/jbc.272.44.27778; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Kranenburg O, 2001, ONCOGENE, V20, P1540, DOI 10.1038/sj.onc.1204187; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; Leontiadis LJ, 2009, CELL SIGNAL, V21, P1218, DOI 10.1016/j.cellsig.2009.03.013; Lin TC, 2009, EPILEPSY BEHAV, V14, P316, DOI 10.1016/j.yebeh.2008.12.005; Liu ZY, 2004, J BIOL CHEM, V279, P14120, DOI 10.1074/jbc.M309547200; Manni I, 2008, MOL BIOL CELL, V19, P5203, DOI 10.1091/mbc.E08-03-0295; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Polo JM, 2008, BLOOD, V112, P644, DOI 10.1182/blood-2008-01-131813; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Sikder H, 2009, J IMMUNOL, V183, P1657, DOI 10.4049/jimmunol.0900057; SINHA S, 1995, P NATL ACAD SCI USA, V92, P1624, DOI 10.1073/pnas.92.5.1624; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Wang Q, 2002, J BIOL CHEM, V277, P24949, DOI 10.1074/jbc.M203802200; Wong CW, 1998, MOL CELL BIOL, V18, P5500, DOI 10.1128/MCB.18.9.5500; Xie Y, 2009, CANCER RES, V69, P5743, DOI 10.1158/0008-5472.CAN-08-3564; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Yang JQ, 2001, J BIOL CHEM, V276, P25742, DOI 10.1074/jbc.M102821200; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; YU LJ, 1995, CELL GROWTH DIFFER, V6, P1505; Yun JH, 2003, J BIOL CHEM, V278, P36966, DOI 10.1074/jbc.M305178200; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101; Zhu QS, 2004, J BIOL CHEM, V279, P29902, DOI 10.1074/jbc.M400438200	55	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29760	29769		10.1074/jbc.M110.121459	http://dx.doi.org/10.1074/jbc.M110.121459			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20630860	Green Published, hybrid			2022-12-25	WOS:000281984300011
J	Chao, JD; Papavinasasundaram, KG; Zheng, XJ; Chavez-Steenbock, A; Wang, XT; Lee, GQ; Av-Gay, Y				Chao, Joseph D.; Papavinasasundaram, Kadamba G.; Zheng, Xingji; Chavez-Steenbock, Ana; Wang, Xuetao; Lee, Guinevere Q.; Av-Gay, Yossef			Convergence of Ser/Thr and Two-component Signaling to Coordinate Expression of the Dormancy Regulon in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIC RESPONSE; KINASE CASCADE; DNA-BINDING; SERINE/THREONINE KINASE; CARBON-MONOXIDE; PROTEIN; GENE; PHOSPHORYLATION; VIRULENCE; SYSTEM	Signal transduction in Mycobacterium tuberculosis is mediated primarily by the Ser/Thr protein kinases and the two-component systems. The Ser/Thr kinase PknH has been shown to regulate growth of M. tuberculosis in a mouse model and in response to NO stress in vitro. Comparison of a pknH deletion mutant (Delta pknH) with its parental M. tuberculosis H37Rv strain using iTRAQ enabled us to quantify >700 mycobacterial proteins. Among these, members of the hypoxia-and NO-inducible dormancy (DosR) regulon were disregulated in the Delta pknH mutant. Using kinase assays, protein-protein interactions, and mass spectrometry analysis, we demonstrated that the two-component response regulator DosR is a substrate of PknH. PknH phosphorylation of DosR mapped to Thr(198) and Thr(205) on the key regulatory helix alpha 10 involved in activation and dimerization of DosR. PknH Thr phosphorylation and DosS Asp phosphorylation of DosR cooperatively enhanced DosR binding to cognate DNA sequences. Transcriptional analysis comparing Delta pknH and parental M. tuberculosis revealed that induction of the DosR regulon was subdued in the Delta pknH mutant in response to NO. Together, these results indicate that PknH phosphorylation of DosR is required for full induction of the DosR regulon and demonstrate convergence of the two major signal transduction systems for the first time in M. tuberculosis.	[Papavinasasundaram, Kadamba G.; Zheng, Xingji; Chavez-Steenbock, Ana; Wang, Xuetao; Lee, Guinevere Q.; Av-Gay, Yossef] Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC V5Z 3J5, Canada; [Chao, Joseph D.; Av-Gay, Yossef] Univ British Columbia, Dept Med, Dept Microbiol & Immunol, Vancouver, BC V5Z 3J5, Canada	University of British Columbia; University of British Columbia	Av-Gay, Y (corresponding author), Univ British Columbia, Dept Med, Div Infect Dis, 2733 Heather St, Vancouver, BC V5Z 3J5, Canada.	yossi@interchange.ubc.ca	Av-Gay, Yossef/H-5128-2019; Av-Gay, Yossef/H-2311-2014; Lee, Guinevere Q./D-4436-2017	Av-Gay, Yossef/0000-0002-9547-0237; Lee, Guinevere Q./0000-0002-9412-886X; Chao, Joseph/0000-0003-1212-7570; PAPAVINASASUNDARAM, KADAMBA/0000-0001-7837-1344	Canadian Institutes of Health Research [MOP-68857]; TB Veterans Charitable Foundation; Canadian Institutes of Health Research Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); TB Veterans Charitable Foundation; Canadian Institutes of Health Research Canada(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant MOP-68857 (to Y. A.-G.) and the TB Veterans Charitable Foundation (to Y. A.-G.).; Recipient of the Canadian Institutes of Health Research Canada Graduate Scholarships Doctoral Award.	Av-Gay Y, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P359; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Bartek IL, 2009, TUBERCULOSIS, V89, P310, DOI 10.1016/j.tube.2009.06.001; Boon C, 2001, J BACTERIOL, V183, P2672, DOI 10.1128/JB.183.8.2672-2676.2001; Chauhan S, 2008, J BACTERIOL, V190, P5394, DOI 10.1128/JB.00488-08; Converse PJ, 2009, INFECT IMMUN, V77, P1230, DOI 10.1128/IAI.01117-08; Drumm JE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000460; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645; Honaker RW, 2009, INFECT IMMUN, V77, P3258, DOI 10.1128/IAI.01449-08; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Huth JR, 1997, PROTEIN SCI, V6, P2359; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Lin WJ, 2009, MOL MICROBIOL, V71, P1477, DOI 10.1111/j.1365-2958.2009.06616.x; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Malhotra V, 2004, FEMS MICROBIOL LETT, V231, P237, DOI 10.1016/S0378-1097(04)00002-3; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Nariya H, 2005, MOL MICROBIOL, V58, P367, DOI 10.1111/j.1365-2958.2005.04826.x; Nariya H, 2006, MOL MICROBIOL, V60, P1205, DOI 10.1111/j.1365-2958.2006.05178.x; Newton GL, 2003, J BACTERIOL, V185, P3476, DOI 10.1128/JB.185.11.3476-3479.2003; O'Hare H, 2008, J MICROBIOL METH, V73, P79, DOI 10.1016/j.mimet.2008.02.008; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Paget E, 1996, J BACTERIOL, V178, P6357, DOI 10.1128/jb.178.21.6357-6360.1996; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Phalip V, 2001, BIOCHEM J, V360, P639, DOI 10.1042/0264-6021:3600639; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Rajagopal L, 2003, J BIOL CHEM, V278, P14429, DOI 10.1074/jbc.M212747200; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Rosenkrands I, 2002, J BACTERIOL, V184, P3485, DOI 10.1128/JB.184.13.3485-3491.2002; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Saini DK, 2004, FEBS LETT, V565, P75, DOI 10.1016/j.febslet.2004.02.092; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Sickmann A, 2001, PROTEOMICS, V1, P200, DOI 10.1002/1615-9861(200102)1:2<200::AID-PROT200>3.0.CO;2-V; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; STEPANOVA AN, 2005, SCI STKE, pCM4; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wisedchaisri G, 2005, J MOL BIOL, V354, P630, DOI 10.1016/j.jmb.2005.09.048; Wisedchaisri G, 2008, J MOL BIOL, V378, P227, DOI 10.1016/j.jmb.2008.02.029; Zhang ZG, 2004, PLANT PHYSIOL, V136, P2971, DOI 10.1104/pp.103.034686; Zheng XJ, 2007, BIOCHEM BIOPH RES CO, V355, P162, DOI 10.1016/j.bbrc.2007.01.122	54	79	84	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29239	29246		10.1074/jbc.M110.132894	http://dx.doi.org/10.1074/jbc.M110.132894			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20630871	hybrid, Green Published			2022-12-25	WOS:000281740100025
J	Chu, PY; Li, TK; Ding, ST; Lai, IR; Shen, TL				Chu, Pei-Yu; Li, Tsai-Kun; Ding, Shih-Torng; Lai, I-Rue; Shen, Tang-Long			EGF-induced Grb7 Recruits and Promotes Ras Activity Essential for the Tumorigenicity of Sk-Br3 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BOUND PROTEIN-7; FOCAL ADHESION KINASE; SIGNAL-TRANSDUCTION PROTEIN; MIGRATION; FAMILY; PHOSPHORYLATION; PROLIFERATION; ASSOCIATION; PROGRESSION; CARCINOMA	Co-amplification and co-overexpression of ErbB2 and Grb7 are frequently found in various cancers, including breast cancer. Biochemical and functional correlations of the two molecules have identified Grb7 to be a pivotal mediator downstream of ErbB2-mediated oncogenesis. However, it remains largely unknown how Grb7 is involve in the ErbB2-mediated tumorigenesis. In this study, we show that Grb7-mediated cell proliferation and growth are essential for the tumorigenesis that occurs in ErbB2-Grb7-overexpressing breast cancer cells. Intrinsically, EGF-induced de novo Grb7 tyrosine phosphorylation/activation recruits and activates Ras-GTPases and subsequently promotes the phosphorylation of ERK1/2, thereby stimulating tumor growth. Furthermore, we also found the anti-tumor effect could be synergized by co-treatment with Herceptin plus Grb7 knockdown in Sk-Br3 breast cancer cells. Our findings illustrate an underlying mechanism by which Grb7 promotes tumorigenesis through the formation of a novel EGFR-Grb7-Ras signaling complex, thereby highlighting the potential strategy of targeting Grb7 as an anti-breast cancer therapy.	Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10617, Taiwan; [Li, Tsai-Kun] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10051, Taiwan; [Li, Tsai-Kun; Ding, Shih-Torng; Shen, Tang-Long] Natl Taiwan Univ, Ctr Biotechnol, Taipei 10617, Taiwan; [Ding, Shih-Torng] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10617, Taiwan; [Lai, I-Rue] Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, Taipei 10051, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University		shentl@ntu.edu.tw	Shen, Tang-Long/C-7460-2011	Lai, I-Rue/0000-0002-3444-8255; LI, TSAI-KUN/0000-0003-0393-2340; Ding, Shih-Torng/0000-0002-9866-1776; Shen, Tang-Long/0000-0001-6264-3608	National Science Council [NSC-96-2311-B-002-023-MY3]; National Taiwan University [98R0311]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This work was supported by National Science Council Grant NSC-96-2311-B-002-023-MY3 and Frontier Research Grant of National Taiwan University 98R0311 (to T.-L. S.).	Bai T, 2008, CARCINOGENESIS, V29, P473, DOI 10.1093/carcin/bgm221; Benusiglio PR, 2006, BRIT J CANCER, V95, P1689, DOI 10.1038/sj.bjc.6603473; Castro AF, 2005, METHODS, V37, P190, DOI 10.1016/j.ymeth.2005.05.015; Chu PY, 2009, J BIOL CHEM, V284, P20215, DOI 10.1074/jbc.M109.018259; Daly RJ, 1998, CELL SIGNAL, V10, P613, DOI 10.1016/S0898-6568(98)00022-9; Depetris RS, 2009, NAT STRUCT MOL BIOL, V16, P833, DOI 10.1038/nsmb.1642; Depetris RS, 2005, MOL CELL, V20, P325, DOI 10.1016/j.molcel.2005.09.001; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Han DC, 2000, J BIOL CHEM, V275, P28911, DOI 10.1074/jbc.M001997200; Han DC, 1999, J BIOL CHEM, V274, P24425, DOI 10.1074/jbc.274.34.24425; Han DC, 2002, J BIOL CHEM, V277, P45655, DOI 10.1074/jbc.M203165200; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; Itoh S, 2007, MOL CANCER RES, V5, P667, DOI 10.1158/1541-7786.MCR-06-0282; Kao J, 2006, GENE CHROMOSOME CANC, V45, P761, DOI 10.1002/gcc.20339; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Li HB, 2005, ONCOGENE, V24, P4206, DOI 10.1038/sj.onc.1208591; Lucas-Fernandez E, 2008, CURR GENOMICS, V9, P60, DOI 10.2174/138920208783884847; Lyons RJ, 2001, J BIOL CHEM, V276, P17172, DOI 10.1074/jbc.M009756200; Nadler Y, 2010, ANN ONCOL, V21, P466, DOI 10.1093/annonc/mdp346; Porter CJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-58; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Shen TL, 2001, FEBS LETT, V499, P176, DOI 10.1016/S0014-5793(01)02545-5; Shen TL, 2004, FRONT BIOSCI-LANDMRK, V9, P192, DOI 10.2741/1229; Shen TL, 2002, J BIOL CHEM, V277, P29069, DOI 10.1074/jbc.M203085200; Tanaka S, 2000, J CELL PHYSIOL, V183, P411, DOI 10.1002/(SICI)1097-4652(200006)183:3<411::AID-JCP14>3.0.CO;2-Z; Tanaka S, 2006, JNCI-J NATL CANCER I, V98, P491, DOI 10.1093/jnci/djj105; Wojcik J, 1999, BIOCHEM BIOPH RES CO, V259, P113, DOI 10.1006/bbrc.1999.0727	27	38	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29279	29285		10.1074/jbc.C110.114124	http://dx.doi.org/10.1074/jbc.C110.114124			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20622016	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000281740100030
J	Tay, SP; Yeo, CWS; Chai, C; Chua, PJ; Tan, HM; Ang, AXY; Yip, DLH; Sung, JX; Tan, PH; Bay, BH; Wong, SH; Tang, C; Tan, JMM; Lim, KL				Tay, Shiam-Peng; Yeo, Calvin W. S.; Chai, Chou; Chua, Pei-Jou; Tan, Hui-Mei; Ang, Alex X. Y.; Yip, Daniel L. H.; Sung, Jian-Xiong; Tan, Puay Hoon; Bay, Boon-Huat; Wong, Siew-Heng; Tang, Carol; Tan, Jeanne M. M.; Lim, Kah-Leong			Parkin Enhances the Expression of Cyclin-dependent Kinase 6 and Negatively Regulates the Proliferation of Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE JUVENILE PARKINSONISM; TUMOR-SUPPRESSOR GENE; COMMON FRAGILE SITES; HEPATOCELLULAR-CARCINOMA; TUMORIGENICITY; CHROMOSOME-6; SOLUBILITY; MUTATIONS; PROTEINS; DISEASE	Although mutations in the parkin gene are frequently associated with familial Parkinsonism, emerging evidence suggests that parkin also plays a role in cancers as a putative tumor suppressor. Supporting this, we show here that parkin expression is dramatically reduced in several breast cancer-derived cell lines as well as in primary breast cancer tissues. Importantly, we found that ectopic parkin expression in parkin-deficient breast cancer cells mitigates their proliferation rate both in vitro and in vivo, as well as reduces the capacity of these cells to migrate. Cell cycle analysis revealed the arrestment of a significant percentage of parkin-expressing breast cancer cells at the G1-phase. However, we did not observe significant changes in the levels of the G1-associated cyclin D1 and E. On the other hand, the level of cyclin-dependent kinase 6 (CDK6) is dramatically and selectively elevated in parkin-expressing breast cancer cells, the extent of which correlates well with the expression of parkin. Interestingly, a recent study demonstrated that CDK6 restrains the proliferation of breast cancer cells. Taken together, our results support a negative role for parkin in tumorigenesis and provide a potential mechanism by which parkin exerts its suppressing effects on breast cancer cell proliferation.	[Tay, Shiam-Peng; Yeo, Calvin W. S.; Tan, Hui-Mei; Tan, Jeanne M. M.; Lim, Kah-Leong] Natl Inst Neurosci, Neurodegenerat Res Lab, Singapore 308433, Singapore; [Tang, Carol] Natl Inst Neurosci, Neurooncol Res Lab, Singapore 308433, Singapore; [Chua, Pei-Jou; Bay, Boon-Huat] Natl Univ Singapore, Dept Anat, Singapore 117597, Singapore; [Yeo, Calvin W. S.; Lim, Kah-Leong] Natl Univ Singapore, Dept Physiol, Singapore 117597, Singapore; [Tay, Shiam-Peng; Wong, Siew-Heng] Natl Univ Singapore, Dept Microbiol, Singapore 117597, Singapore; [Ang, Alex X. Y.; Yip, Daniel L. H.] Raffles Inst, Singapore 575954, Singapore; [Sung, Jian-Xiong] Ngee Ann Polytech, Singapore 599489, Singapore; [Chai, Chou; Tan, Jeanne M. M.; Lim, Kah-Leong] Duke NUS Grad Med Sch, Singapore 169857, Singapore; [Tan, Puay Hoon] Singapore Gen Hosp, Singapore 169608, Singapore	National Neuroscience Institute (NNI); National Neuroscience Institute (NNI); National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Singapore General Hospital	Tan, JMM (corresponding author), Natl Inst Neurosci, Neurodegenerat Res Lab, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	tmm18sg@yahoo.com.sg; kahleong.lim@duke-nus.edu.sg	Tan, Jeanne/GQI-3612-2022; Lim, Kah/L-5426-2019; Lim, Kah-Leong/AAY-3308-2020	Lim, Kah-Leong/0000-0002-5440-2588	Khoo's Discovery Award; Singapore Millennium Foundation	Khoo's Discovery Award; Singapore Millennium Foundation	This work was supported by grants from Khoo's Discovery Award (to K.-L. L.) and Singapore Millennium Foundation (to C. Y. and J. T.).	Bednarek AK, 2001, CANCER RES, V61, P8068; Cesari R, 2003, P NATL ACAD SCI USA, V100, P5956, DOI 10.1073/pnas.0931262100; DE LA IGLESIA N, 2008, J NEUROSCI, V28, P5870; Denison SR, 2003, GENE CHROMOSOME CANC, V38, P40, DOI 10.1002/gcc.10236; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Druck T, 1998, ONCOL RES, V10, P341; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fujiwara M, 2008, ONCOGENE, V27, P6002, DOI 10.1038/onc.2008.199; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; IKEUCHI K, 2009, INT J CANC IN PRESS; Ishii H, 2001, CANCER RES, V61, P1578; KEYOMARSI K, 1995, ONCOGENE, V11, P941; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lucas JJ, 2004, MOL CANCER RES, V2, P105; Mengesdorf T, 2002, P NATL ACAD SCI USA, V99, P15042, DOI 10.1073/pnas.232588799; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Nagasawa M, 2001, ONCOGENE, V20, P2889, DOI 10.1038/sj.onc.1204396; NEGRINI M, 1994, CANCER RES, V54, P1331; Picchio MC, 2004, CLIN CANCER RES, V10, P2720, DOI 10.1158/1078-0432.CCR-03-0086; Smith DI, 2006, CANCER LETT, V232, P48, DOI 10.1016/j.canlet.2005.06.049; Smith DI, 1998, INT J ONCOL, V12, P187; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Suyama E, 2003, P NATL ACAD SCI USA, V100, P5616, DOI 10.1073/pnas.1035850100; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Wang C, 2005, HUM MOL GENET, V14, P3885, DOI 10.1093/hmg/ddi413; Wang C, 2005, J NEUROCHEM, V93, P422, DOI 10.1111/j.1471-4159.2005.03023.x; Wang F, 2004, GENE CHROMOSOME CANC, V40, P85, DOI 10.1002/gcc.20020	28	73	76	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29231	29238		10.1074/jbc.M110.108241	http://dx.doi.org/10.1074/jbc.M110.108241			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20630868	Green Published, hybrid			2022-12-25	WOS:000281740100024
J	Nagasaka, K; Pim, D; Massimi, P; Thomas, M; Tomaic, V; Subbaiah, VK; Kranjec, C; Nakagawa, S; Yano, T; Taketani, Y; Myers, M; Banks, L				Nagasaka, K.; Pim, D.; Massimi, P.; Thomas, M.; Tomaic, V.; Subbaiah, V. K.; Kranjec, C.; Nakagawa, S.; Yano, T.; Taketani, Y.; Myers, M.; Banks, L.			The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction	ONCOGENE			English	Article						hScrib; phosphorylation; ERK; protein kinase A	LARGE TUMOR-SUPPRESSOR; PAPILLOMAVIRUS E6 PROTEINS; MAP KINASE KINASE; DISCS LARGE; HUMAN SCRIBBLE; NUCLEAR TRANSLOCATION; MEDIATED DEGRADATION; CYCLE PROGRESSION; DOCKING SITES; HUMAN HOMOLOG	The cell polarity regulator, human Scribble (hScrib), is a potential tumour suppressor whose loss is a frequent event in late-stage cancer development. Little is yet known about the mode of action of hScrib, although recent reports suggest its role in the regulation of cell signalling. In this study we show that hScrib is a direct regulator of extracellular signal-regulated kinase (ERK). In human keratinocytes, loss of hScrib results in elevated phospho-ERK levels and concomitant increased nuclear translocation of phospho-ERK. We also show that hScrib interacts with ERK through two well-conserved kinase interaction motif (KIM) docking sites, both of which are also required for ERK-induced phosphorylation of hScrib on two distinct residues. Although wild-type hScrib can downregulate activation of ERK and oncogenic Ras co-transforming activity, an hScrib mutant that lacks the carboxy terminal KIM docking site has no such effects. These results provide a clear mechanistic explanation of how hScrib can regulate ERK signalling and begin to explain how loss of hScrib during cancer development can contribute to disease progression. Oncogene (2010) 29, 5311-5321; doi:10.1038/onc.2010.265; published online 12 July 2010	[Nagasaka, K.; Pim, D.; Massimi, P.; Thomas, M.; Tomaic, V.; Subbaiah, V. K.; Kranjec, C.; Myers, M.; Banks, L.] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [Nagasaka, K.; Nakagawa, S.; Yano, T.; Taketani, Y.] Univ Tokyo, Dept Obstet & Gynecol, Grad Sch Med, Tokyo, Japan	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Tokyo	Banks, L (corresponding author), Int Ctr Genet Engn & Biotechnol, Area Sci Pk,Padriciano 99, I-34012 Trieste, Italy.	nagasaka@icgeb.org; banks@icgeb.org	Kranjec, Christian/ABA-9194-2021; Nagasaka, Kazunori/AAM-4311-2020; , Subbaiah/AAB-9747-2021	Nagasaka, Kazunori/0000-0002-0696-5175; Krishna, Vanitha/0000-0002-0444-531X; Kranjec, Christian/0000-0001-9713-7406	Yoshida (YKK) Scholarship Foundation; Associazione Italiana per la Ricerca sul Cancro	Yoshida (YKK) Scholarship Foundation; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Yoshida (YKK) Scholarship Foundation (to KN) and by a research grant from the Associazione Italiana per la Ricerca sul Cancro (to LB). We are also very grateful to David Allen (Nextgen Sciences) for his kind support and advice on the phospho-mapping analyses.	Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Gardiol D, 1999, ONCOGENE, V18, P5487, DOI 10.1038/sj.onc.1202920; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Houslay MD, 2000, MOL PHARMACOL, V58, P659, DOI 10.1124/mol.58.4.659; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; MacKenzie SJ, 2000, J BIOL CHEM, V275, P16609, DOI 10.1074/jbc.275.22.16609; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Massimi P, 2006, ONCOGENE, V25, P4276, DOI 10.1038/sj.onc.1209457; Massimi P, 2008, EXP CELL RES, V314, P3306, DOI 10.1016/j.yexcr.2008.08.016; Nagasaka K, 2006, CANCER SCI, V97, P1217, DOI 10.1111/j.1349-7006.2006.00315.x; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Nakagawa S, 2004, BRIT J CANCER, V90, P194, DOI 10.1038/sj.bjc.6601465; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Nola S, 2008, HUM MOL GENET, V17, P3552, DOI 10.1093/hmg/ddn248; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Thomas M, 2005, ONCOGENE, V24, P6222, DOI 10.1038/sj.onc.1208757; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zeitler J, 2004, J CELL BIOL, V167, P1137, DOI 10.1083/jcb.200407158; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	41	64	65	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	38					5311	5321		10.1038/onc.2010.265	http://dx.doi.org/10.1038/onc.2010.265			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	653KE	20622900				2022-12-25	WOS:000282089100009
J	Cinar, HN; Kothary, M; Datta, AR; Tall, BD; Sprando, R; Bilecen, K; Yildiz, F; McCardell, B				Cinar, Hediye Nese; Kothary, Mahendra; Datta, Atin R.; Tall, Ben D.; Sprando, Robert; Bilecen, Kivanc; Yildiz, Fitnat; McCardell, Barbara			Vibrio cholerae Hemolysin Is Required for Lethality, Developmental Delay, and Intestinal Vacuolation in Caenorhabditis elegans	PLOS ONE			English	Article							PORE-FORMING TOXINS; HOST-PATHOGEN INTERACTIONS; LIVE ORAL VACCINE; EL-TOR HEMOLYSIN; CELL VACUOLATION; BACTERIAL PATHOGENESIS; VIRULENCE FACTORS; CYTOLYSIN; O1; PROTEASE	Background: Cholera toxin (CT) and toxin-co-regulated pili (TCP) are the major virulence factors of Vibrio cholerae O1 and O139 strains that contribute to the pathogenesis of disease during devastating cholera pandemics. However, CT and TCP negative V. cholerae strains are still able to cause severe diarrheal disease in humans through mechanisms that are not well understood. Methodology/Principal Findings: To determine the role of other virulence factors in V. cholerae pathogenesis, we used a CT and TCP independent infection model in the nematode Caenorhabditis elegans and identified the hemolysin A (hlyA) gene as a factor responsible for animal death and developmental delay. We demonstrated a correlation between the severity of infection in the nematode and the level of hemolytic activity in the V. cholerae biotypes. At the cellular level, V. cholerae infection induces formation of vacuoles in the intestinal cells in a hlyA dependent manner, consistent with the previous in vitro observations. Conclusions/Significance: Our data strongly suggest that HlyA is a virulence factor in C. elegans infection leading to lethality and developmental delay presumably through intestinal cytopathic changes.	[Cinar, Hediye Nese; Kothary, Mahendra; Datta, Atin R.; Tall, Ben D.; McCardell, Barbara] US FDA, Div Virulence Assessment, Laurel, MD USA; [Bilecen, Kivanc; Yildiz, Fitnat] Univ Calif Santa Cruz, Dept Environm Toxicol, Santa Cruz, CA 95064 USA; [Sprando, Robert] US FDA, Div Toxicol, Laurel, MD USA	US Food & Drug Administration (FDA); University of California System; University of California Santa Cruz; US Food & Drug Administration (FDA)	Cinar, HN (corresponding author), US FDA, Div Virulence Assessment, Laurel, MD USA.	hediye.cinar@fda.hhs.gov	Bilecen, Kivanc/E-3308-2019	Bilecen, Kivanc/0000-0002-6254-3516; Tall, Ben/0000-0003-0399-3629	Food and Drug Administration	Food and Drug Administration(United States Department of Health & Human Services)	This study was funded by Food and Drug Administration intramural funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2002, CURR OPIN MICROBIOL, V5, P97, DOI 10.1016/S1369-5274(02)00293-X; ALM RA, 1991, J CLIN MICROBIOL, V29, P2438, DOI 10.1128/JCM.29.11.2438-2445.1991; Alouf J., 2005, COMPREHENSIVE SOURCE; Aroian R, 2007, CURR OPIN MICROBIOL, V10, P57, DOI 10.1016/j.mib.2006.12.008; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; Beyhan S, 2006, INFECT IMMUN, V74, P3633, DOI 10.1128/IAI.01750-05; Christie R. N. E. Atkins, 1944, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V22, P197; Coelho A, 2000, INFECT IMMUN, V68, P1700, DOI 10.1128/IAI.68.3.1700-1705.2000; DATTA AR, 1984, J BACTERIOL, V160, P808, DOI 10.1128/JB.160.2.808-811.1984; Faruque SM, 2004, P NATL ACAD SCI USA, V101, P2123, DOI 10.1073/pnas.0308485100; Figueroa-Arredondo P, 2001, INFECT IMMUN, V69, P1613, DOI 10.1128/IAI.69.3.1613-1624.2001; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Gutierrez MG, 2007, P NATL ACAD SCI USA, V104, P1829, DOI 10.1073/pnas.0601437104; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; ICHINOSE Y, 1987, INFECT IMMUN, V55, P1090, DOI 10.1128/IAI.55.5.1090-1093.1987; Ikigai H, 1996, INFECT IMMUN, V64, P2968, DOI 10.1128/IAI.64.8.2968-2973.1996; Kurz CL, 2007, CURR OPIN MICROBIOL, V10, P10, DOI 10.1016/j.mib.2006.12.001; Kurz CL, 2003, NAT REV GENET, V4, P380, DOI 10.1038/nrg1067; Kurz CL, 2000, TRENDS MICROBIOL, V8, P142, DOI 10.1016/S0966-842X(99)01691-1; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; LEVINE M M, 1988, Lancet, V2, P467; LEVINE MM, 1988, INFECT IMMUN, V56, P161, DOI 10.1128/IAI.56.1.161-167.1988; Marroquin LD, 2000, GENETICS, V155, P1693; MICHALSKI J, 1993, INFECT IMMUN, V61, P4462, DOI 10.1128/IAI.61.10.4462-4468.1993; Mitra R, 2000, INFECT IMMUN, V68, P1928, DOI 10.1128/IAI.68.4.1928-1933.2000; Moschioni M, 2002, CELL MICROBIOL, V4, P397, DOI 10.1046/j.1462-5822.2002.00199.x; Nass R., 2007, CURR PROTOC TOXICOL, V31, P1, DOI [10.1002/0471140856.tx0109s31, DOI 10.1002/0471140856.TX0109S31]; Ogierman MA, 1997, J BACTERIOL, V179, P7072, DOI 10.1128/jb.179.22.7072-7080.1997; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Ottaviani D, 2009, INT J FOOD MICROBIOL, V132, P47, DOI 10.1016/j.ijfoodmicro.2009.03.014; Ou GW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007806; Pulak Rock, 2006, V351, P275; RADER AE, 1988, INFECT IMMUN, V56, P1414, DOI 10.1128/IAI.56.6.1414-1419.1988; RICHARDSON K, 1986, INFECT IMMUN, V54, P415, DOI 10.1128/IAI.54.2.415-420.1986; Saka HA, 2007, AUTOPHAGY, V3, P363, DOI 10.4161/auto.4159; SATCHELL KJF, 2003, MICROB PATHOGENESIS, P481; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Sprando RL, 2009, FOOD CHEM TOXICOL, V47, P722, DOI 10.1016/j.fct.2009.01.007; Sulston JHJ, 1988, NEMATODE CAENORHABDI; Tacket CO, 1997, AM J TROP MED HYG, V56, P533, DOI 10.4269/ajtmh.1997.56.533; TACKET CO, 1993, J INFECT DIS, V168, P1536, DOI 10.1093/infdis/168.6.1536; TACKET CO, 1995, J INFECT DIS, V172, P883, DOI 10.1093/infdis/172.3.883; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Wood WB, 1988, NEMATODE CAENORHABDI; Zitzer A, 1997, EUR J BIOCHEM, V247, P209, DOI 10.1111/j.1432-1033.1997.00209.x	49	37	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11558	10.1371/journal.pone.0011558	http://dx.doi.org/10.1371/journal.pone.0011558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644623	gold, Green Published, Green Submitted			2022-12-25	WOS:000279822300012
J	Razidlo, DF; Whitney, TJ; Casper, ME; McGee-Lawrence, ME; Stensgard, BA; Li, XD; Secreto, FJ; Knutson, SK; Hiebert, SW; Westendorf, JJ				Razidlo, David F.; Whitney, Tiffany J.; Casper, Michelle E.; McGee-Lawrence, Meghan E.; Stensgard, Bridget A.; Li, Xiaodong; Secreto, Frank J.; Knutson, Sarah K.; Hiebert, Scott W.; Westendorf, Jennifer J.			Histone Deacetylase 3 Depletion in Osteo/Chondroprogenitor Cells Decreases Bone Density and Increases Marrow Fat	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; PPAR-GAMMA; RUNX2; ROLES; INHIBITOR; COMPLEX; HDAC3; CBFA1; SMRT	Histone deacetylase (Hdac)3 is a nuclear enzyme that contributes to epigenetic programming and is required for embryonic development. To determine the role of Hdac3 in bone formation, we crossed mice harboring loxP sites around exon 7 of Hdac3 with mice expressing Cre recombinase under the control of the osterix promoter. The resulting Hdac3 conditional knockout (CKO) mice were runted and had severe deficits in intramembranous and endochondral bone formation. Calvarial bones were significantly thinner and trabecular bone volume in the distal femur was decreased 75% in the Hdac3 CKO mice due to a substantial reduction in trabecular number. Hdac3-CKO mice had fewer osteoblasts and more bone marrow adipocytes as a proportion of tissue area than their wildtype or heterozygous littermates. Bone formation rates were depressed in both the cortical and trabecular regions of Hdac3 CKO femurs. Microarray analyses revealed that numerous developmental signaling pathways were affected by Hdac3-deficiency. Thus, Hdac3 depletion in osterix-expressing progenitor cells interferes with bone formation and promotes bone marrow adipocyte differentiation. These results demonstrate that Hdac3 inhibition is detrimental to skeletal health.	[Razidlo, David F.; Whitney, Tiffany J.; Casper, Michelle E.; McGee-Lawrence, Meghan E.; Stensgard, Bridget A.; Li, Xiaodong; Secreto, Frank J.; Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Razidlo, David F.; Whitney, Tiffany J.; Casper, Michelle E.; McGee-Lawrence, Meghan E.; Stensgard, Bridget A.; Li, Xiaodong; Secreto, Frank J.; Westendorf, Jennifer J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Knutson, Sarah K.; Hiebert, Scott W.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA	Mayo Clinic; Mayo Clinic; Vanderbilt University	Razidlo, DF (corresponding author), Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA.	westendorf.jennifer@mayo.edu		McGee-Lawrence, Meghan/0000-0002-2728-5849; Casper Taylor, Michelle/0000-0003-1707-6645	National Institutes of Health [R01-AR048147, T32-AR056950]; Mayo Clinic Foundation; NATIONAL CANCER INSTITUTE [R01CA141071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR056950, R01AR048147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The National Institutes of Health (R01-AR048147 and T32-AR056950) and the Mayo Clinic Foundation supported this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Bellosta P, 2003, J BONE MINER RES, V18, P818, DOI 10.1359/jbmr.2003.18.5.818; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; BOER JD, 2006, TISSUE ENG; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; CHOO MK, 2009, BONE; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Enomoto H, 2004, J CELL SCI, V117, P417, DOI 10.1242/jcs.00866; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; GALLAY SH, 1994, J ORTHOPAED RES, V12, P515, DOI 10.1002/jor.1100120408; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2002, GENE DEV, V16, P3130, DOI 10.1101/gad.1037502; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Han JW, 2000, CANCER RES, V60, P6068; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; IWAMI K, 1993, INT J BIOCHEM, V25, P1631, DOI 10.1016/0020-711X(93)90522-G; Iwaniec Urszula T., 2008, V447, P325, DOI 10.1007/978-1-59745-242-7_21; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Kaback LA, 2008, J CELL PHYSIOL, V214, P173, DOI 10.1002/jcp.21176; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Kim KH, 2007, FEBS LETT, V581, P3303, DOI 10.1016/j.febslet.2007.06.012; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Kobayashi H, 2000, BIOCHEM BIOPH RES CO, V273, P630, DOI 10.1006/bbrc.2000.2981; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lamour V, 2007, J BIOL CHEM, V282, P36240, DOI 10.1074/jbc.M705833200; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Makita N, 2008, GENE, V413, P8, DOI 10.1016/j.gene.2007.12.025; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; McGee-Lawrence ME, 2009, J BIOMECH, V42, P1378, DOI 10.1016/j.jbiomech.2008.11.039; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Petit M. A., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P213; PRATAP J, 2008, J BONE MINERAL RE S1, V23; Qiu L, 2000, MOL BIOL CELL, V11, P2069, DOI 10.1091/mbc.11.6.2069; Reinholz GG, 2009, OSTEOARTHR CARTILAGE, V17, P723, DOI 10.1016/j.joca.2008.10.011; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rosen CJ, 2009, CRIT REV EUKAR GENE, V19, P109, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.20; Sambucetti LC, 1999, J BIOL CHEM, V274, P34940, DOI 10.1074/jbc.274.49.34940; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; WESTENDORF JJ, 2007, J CELL BIOCH; Wiech NL, 2009, CURR TOP MED CHEM, V9, P257, DOI 10.2174/156802609788085241; Wise LD, 2007, BIRTH DEFECTS RES B, V80, P57, DOI 10.1002/bdrb.20104; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	62	88	92	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11492	10.1371/journal.pone.0011492	http://dx.doi.org/10.1371/journal.pone.0011492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20628553	Green Published, Green Submitted, gold			2022-12-25	WOS:000279715300007
J	Aumeunier, A; Grela, F; Ramadan, A; Van, LP; Bardel, E; Alcala, AG; Jeannin, P; Akira, S; Bach, JF; Thieblemont, N				Aumeunier, Aude; Grela, Francoise; Ramadan, Abdulraouf; Linh Pham Van; Bardel, Emilie; Alcala, Alejandro Gomez; Jeannin, Pascale; Akira, Shizuo; Bach, Jean-Francois; Thieblemont, Nathalie			Systemic Toll-Like Receptor Stimulation Suppresses Experimental Allergic Asthma and Autoimmune Diabetes in NOD Mice	PLOS ONE			English	Article								Background: Infections may be associated with exacerbation of allergic and autoimmune diseases. Paradoxically, epidemiological and experimental data have shown that some microorganisms can also prevent these pathologies. This observation is at the origin of the hygiene hypothesis according to which the decline of infections in western countries is at the origin of the increased incidence of both Th1-mediated autoimmune diseases and Th2-mediated allergic diseases over the last decades. We have tested whether Toll-like receptor (TLR) stimulation can recapitulate the protective effect of infectious agents on allergy and autoimmunity. Methods and Findings: Here, we performed a systematic study of the disease-modifying effects of a set of natural or synthetic TLR agonists using two experimental models, ovalbumin (OVA)-induced asthma and spontaneous autoimmune diabetes, presenting the same genetic background of the non obese diabetic mouse (NOD) that is highly susceptible to both pathologies. In the same models, we also investigated the effect of probiotics. Additionally, we examined the effect of the genetic invalidation of MyD88 on the development of allergic asthma and spontaneous diabetes. We demonstrate that multiple TLR agonists prevent from both allergy and autoimmunity when administered parenterally. Probiotics which stimulate TLRs also protect from these two diseases. The physiological relevance of these findings is further suggested by the major acceleration of OVA-induced asthma in MyD88 invalidated mice. Our results strongly indicate that the TLR-mediated effects involve immunoregulatory cytokines such as interleukin (IL)-10 and transforming growth factor (TGF)-beta and different subsets of regulatory T cells, notably CD4(+)CD25(+)FoxP3(+) T cells for TLR4 agonists and NKT cells for TLR3 agonists. Conclusions/Significance: These observations demonstrate that systemic administration of TLR ligands can suppress both allergic and autoimmune responses. They provide a plausible explanation for the hygiene hypothesis. They also open new therapeutic perspectives for the prevention of these pathologies.	[Aumeunier, Aude; Grela, Francoise; Ramadan, Abdulraouf; Linh Pham Van; Bardel, Emilie; Alcala, Alejandro Gomez; Bach, Jean-Francois; Thieblemont, Nathalie] Univ Paris 05, Paris, France; [Aumeunier, Aude; Grela, Francoise; Ramadan, Abdulraouf; Linh Pham Van; Bardel, Emilie; Alcala, Alejandro Gomez; Thieblemont, Nathalie] CNRS, UMR8147, Paris, France; [Jeannin, Pascale] INSERM, U564, Angers, France; [Akira, Shizuo] Osaka Univ, Dept Host Def, Osaka, Japan; [Bach, Jean-Francois] INSERM, U1013, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Osaka University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Thieblemont, N (corresponding author), Univ Paris 05, Paris, France.	nathalie.thieblemont@parisdescartes.fr	JEANNIN, Pascale/K-8656-2015; Thieblemont, Nathalie/P-1329-2017	Thieblemont, Nathalie/0000-0002-8898-9217; JEANNIN, Pascale/0000-0002-3666-3856; Pham Van, Linh/0000-0001-7107-1496	Juvenile Diabetes Research Foundation (JDRF); Fondation pour la Recherche Medicale [DAL20041203162]; Chancellerie des Universites de Paris (Legs Poix); Association Francaise des Diabetiques (AFD); Fondation Day-Solvay	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Chancellerie des Universites de Paris (Legs Poix); Association Francaise des Diabetiques (AFD); Fondation Day-Solvay	This work was supported by grants from the Juvenile Diabetes Research Foundation (JDRF), Fondation pour la Recherche Medicale (#DAL20041203162), Chancellerie des Universites de Paris (Legs Poix); Association Francaise des Diabetiques (AFD); Fondation Day-Solvay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2003, EUR J IMMUNOL, V33, P2717, DOI 10.1002/eji.200323329; Alyanakian MA, 2006, DIABETES, V55, P179, DOI 10.2337/diabetes.55.1.179; Anders HJ, 2004, FASEB J, V18, P534, DOI 10.1096/fj.03-0646fje; Araujo LM, 2004, EUR J IMMUNOL, V34, P327, DOI 10.1002/eji.200324151; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Camateros P, 2007, AM J RESP CRIT CARE, V175, P1241, DOI 10.1164/rccm.200701-054OC; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Cohen SJ, 2010, J IMMUNOL, V184, P212, DOI 10.4049/jimmunol.0900296; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hollingsworth JW, 2006, J IMMUNOL, V176, P5856, DOI 10.4049/jimmunol.176.10.5856; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Jeon SG, 2007, J ALLERGY CLIN IMMUN, V120, P803, DOI 10.1016/j.jaci.2007.05.030; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kimzey SL, 2004, J IMMUNOL, V173, P632, DOI 10.4049/jimmunol.173.1.632; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; MAKINO S, 1980, Experimental Animals (Tokyo), V29, P1; Marty RR, 2006, CIRCULATION, V113, P258, DOI 10.1161/CIRCULATIONAHA.105.564294; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Moisan J, 2006, AM J PHYSIOL-LUNG C, V290, pL987, DOI 10.1152/ajplung.00440.2005; Murakami D, 2007, CLIN EXP ALLERGY, V37, P339, DOI 10.1111/j.1365-2222.2006.02633.x; Nanto-Salonen K, 2008, LANCET, V372, P1746, DOI 10.1016/S0140-6736(08)61309-4; Nyirenda Mukanthu H., 2009, Inflammation & Allergy Drug Targets, V8, P124; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Quintana FJ, 2000, J IMMUNOL, V165, P6148, DOI 10.4049/jimmunol.165.11.6148; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Rosenfeldt V, 2003, J ALLERGY CLIN IMMUN, V111, P389, DOI 10.1067/mai.2003.389; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Sel S, 2007, J IMMUNOL, V178, P7805, DOI 10.4049/jimmunol.178.12.7805; SERREZE DV, 1989, J AUTOIMMUN, V2, P759, DOI 10.1016/0896-8411(89)90003-6; Shah Uzma, 2002, Adv Pediatr, V49, P299; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Su SB, 2005, J IMMUNOL, V175, P6303, DOI 10.4049/jimmunol.175.10.6303; TAKEI I, 1992, J AUTOIMMUN, V5, P665, DOI 10.1016/0896-8411(92)90184-R; Tarkowski M, 2007, AM J PHYSIOL-LUNG C, V292, pL207, DOI 10.1152/ajplung.00157.2005; Tian J, 2001, J IMMUNOL, V167, P1081, DOI 10.4049/jimmunol.167.2.1081; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Tulic MK, 2007, J IMMUNOL, V179, P132, DOI 10.4049/jimmunol.179.1.132; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Zaccone P, 2004, EUR J IMMUNOL, V34, P3246, DOI 10.1002/eji.200425285	60	98	104	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11484	10.1371/journal.pone.0011484	http://dx.doi.org/10.1371/journal.pone.0011484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V28NK	20628601	Green Published, Green Submitted, gold			2022-12-25	WOS:000208687300001
J	Hervouet, E; Lalier, L; Debien, E; Cheray, M; Geairon, A; Rogniaux, H; Loussouarn, D; Martin, SA; Vallette, FM; Cartron, PF				Hervouet, Eric; Lalier, Lisenn; Debien, Emilie; Cheray, Mathilde; Geairon, Audrey; Rogniaux, Helene; Loussouarn, Delphine; Martin, Stephane A.; Vallette, Francois M.; Cartron, Pierre-Francois			Disruption of Dnmt1/PCNA/UHRF1 Interactions Promotes Tumorigenesis from Human and Mice Glial Cells	PLOS ONE			English	Article							HEMI-METHYLATED DNA; NEURAL PROGENITORS; SRA DOMAIN; DNMT1; HYPOMETHYLATION; TUMORS; HYPERMETHYLATION; 5-METHYLCYTOSINE; RECOGNITION; COMPLEX	Global DNA hypomethylation is a hallmark of cancer cells, but its molecular mechanisms have not been elucidated. Here, we show that the disruption of Dnmt1/PCNA/UHRF1 interactions promotes a global DNA hypomethylation in human gliomas. We then demonstrate that the Dnmt1 phosphorylations by Akt and/or PKC abrogate the interactions of Dnmt1 with PCNA and UHRF1 in cellular and acelluar studies including mass spectrometric analyses and the use of primary cultured patient-derived glioma. By using methylated DNA immunoprecipitation, methylation and CGH arrays, we show that global DNA hypomethylation is associated with genes hypomethylation, hypomethylation of DNA repeat element and chromosomal instability. Our results reveal that the disruption of Dnmt1/PCNA/UHRF1 interactions acts as an oncogenic event and that one of its signatures (i.e. the low level of mMTase activity) is a molecular biomarker associated with a poor prognosis in GBM patients. We identify the genetic and epigenetic alterations which collectively promote the acquisition of tumor/glioma traits by human astrocytes and glial progenitor cells as that promoting high proliferation and apoptosis evasion.	[Hervouet, Eric; Lalier, Lisenn; Debien, Emilie; Cheray, Mathilde; Loussouarn, Delphine; Martin, Stephane A.; Vallette, Francois M.; Cartron, Pierre-Francois] Equipe Labellisee Ligue Natl Canc, INSERM, Ctr Rech Cancerol Nantes Angers,U892, Equipe Aspect Mecanist & Physiopathol Act Prot Fa, Nantes, France; [Hervouet, Eric; Lalier, Lisenn; Debien, Emilie; Cheray, Mathilde; Vallette, Francois M.; Cartron, Pierre-Francois] Univ Nantes, Fac Med, Dept Rech Cancerol, IFR26, Nantes, France; [Geairon, Audrey; Rogniaux, Helene] INRA, Biopolymere Interact Assemblages UR1268, Plate Forme BIBS, F-44026 Nantes, France; [Loussouarn, Delphine] CHU Nantes, HGRL, Serv Anat Pathol, F-44035 Nantes 01, France; [Martin, Stephane A.] CHU Nantes, Hop G&R Laennec, Serv Neurochirurg, F-44035 Nantes 01, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; INRAE; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Hervouet, E (corresponding author), Equipe Labellisee Ligue Natl Canc, INSERM, Ctr Rech Cancerol Nantes Angers,U892, Equipe Aspect Mecanist & Physiopathol Act Prot Fa, Nantes, France.	pierre-francois.cartron@univ-nantes.fr	Hervouet, Eric/U-5784-2019; Cartron, Pierre Francois/K-9802-2015; Vallette, Francois M/K-9047-2015; Lalier, Lisenn/K-9230-2015; Vallette, Francois/N-2361-2018	Vallette, Francois M/0000-0002-3296-8572; Cartron, Pierre-Francois/0000-0002-3393-784X; Vallette, Francois/0000-0003-0802-0519; Cheray, Mathilde/0000-0002-7551-6357	Association pour la Recherche contre le Cancer (ARC) [1020, 3907]; INCa (Region Grand Ouest); En avant la vie	Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); INCa (Region Grand Ouest)(Institut National du Cancer (INCA) France); En avant la vie	This work was supported by grants from the Association pour la Recherche contre le Cancer (ARC#1020 and #3907). E. H. was supported by a fellowship from INCa (Region Grand Ouest). E. D. was supported by a fellowship from "En avant la vie''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; BOSTICK M, 2007, SCIENCE, V27, P2187; Cartron PF, 2003, MOL CELL BIOL, V23, P4701, DOI 10.1128/MCB.23.13.4701-4712.2003; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Easwaran HP, 2004, EMBO REP, V5, P1181, DOI 10.1038/sj.embor.7400295; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ehrlich M, 2006, ONCOGENE, V25, P2636, DOI 10.1038/sj.onc.1209145; Ehrlich M, 2002, ONCOGENE, V21, P6694, DOI 10.1038/sj.onc.1205890; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; ROBERTSON KD, 2000, DNMT1 FORMS COMPLEX, V25, P338; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Sehgal A, 1998, SEMIN SURG ONCOL, V14, P3; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Stauber RH, 2007, CANCER RES, V67, P5999, DOI 10.1158/0008-5472.CAN-07-0494; Tran Y, 1998, ONCOGENE, V17, P3499, DOI 10.1038/sj.onc.1202258; Vertino PM, 2002, CELL CYCLE, V1, P416, DOI 10.4161/cc.1.6.270; Yokochi Tomoki, 2004, Methods Mol Biol, V287, P285	33	99	107	31	223	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11333	10.1371/journal.pone.0011333	http://dx.doi.org/10.1371/journal.pone.0011333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613874	Green Published, Green Submitted, gold			2022-12-25	WOS:000279369900002
J	Kharraz, Y; Salmand, PA; Camus, A; Auriol, J; Gueydan, C; Kruys, V; Morello, D				Kharraz, Yacine; Salmand, Pierre-Adrien; Camus, Anne; Auriol, Jacques; Gueydan, Cyril; Kruys, Veronique; Morello, Dominique			Impaired Embryonic Development in Mice Overexpressing the RNA-Binding Protein TIAR	PLOS ONE			English	Article							AU-RICH ELEMENT; MESSENGER-RNA; STRESS GRANULES; POSTTRANSCRIPTIONAL REGULATION; EXPRESSION; CULTURE; TRANSLATION; DEPHOSPHORYLATION; IDENTIFICATION; GASTRULATION	Background: TIA-1-related (TIAR) protein is a shuttling RNA-binding protein involved in several steps of RNA metabolism. While in the nucleus TIAR participates to alternative splicing events, in the cytoplasm TIAR acts as a translational repressor on specific transcripts such as those containing AU-Rich Elements (AREs). Due to its ability to assemble abortive pre-initiation complexes coalescing into cytoplasmic granules called stress granules, TIAR is also involved in the general translational arrest observed in cells exposed to environmental stress. However, the in vivo role of this protein has not been studied so far mainly due to severe embryonic lethality upon tiar invalidation. Methodology/Principal Findings: To examine potential TIAR tissue-specificity in various cellular contexts, either embryonic or adult, we constructed a TIAR transgenic allele (loxPGFPloxPTIAR) allowing the conditional expression of TIAR protein upon Cre recombinase activity. Here, we report the role of TIAR during mouse embryogenesis. We observed that early TIAR overexpression led to low transgene transmission associated with embryonic lethality starting at early post-implantation stages. Interestingly, while pre-implantation steps evolved correctly in utero, in vitro cultured embryos were very sensitive to culture medium. Control and transgenic embryos developed equally well in the G2 medium, whereas culture in M16 medium led to the phosphorylation of eIF2 alpha that accumulated in cytoplasmic granules precluding transgenic blastocyst hatching. Our results thus reveal a differential TIAR-mediated embryonic response following artificial or natural growth environment. Conclusions/Significance: This study reports the importance of the tightly balanced expression of the RNA-binding protein TIAR for normal embryonic development, thereby emphasizing the role of post-transcriptional regulations in early embryonic programming.	[Kharraz, Yacine; Gueydan, Cyril; Kruys, Veronique] Univ Libre Bruxelles, Fac Sci, Lab Biol Mol Gene, Gosselies, Belgium; [Salmand, Pierre-Adrien; Auriol, Jacques; Morello, Dominique] Univ Toulouse, CBD, CNRS, UMR5547, Toulouse, France; [Camus, Anne] Univ Paris Diderot Paris 7, CNRS, Lab Specificat Destins Cellulaires Chez Souris, Inst Jacques Monod,UMR 7592, Paris, France; [Kruys, Veronique] Ctr Microscopy & Mol Imaging, Gosselies, Belgium	Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Kharraz, Y (corresponding author), Univ Libre Bruxelles, Fac Sci, Lab Biol Mol Gene, Gosselies, Belgium.	vkruys@ulb.ac.be	Camus, Anne/P-1515-2014; Kharraz, Yacine/I-1202-2015; Kruys, Veronique I/N-6613-2018	Kharraz, Yacine/0000-0001-9172-7624; Gueydan, Cyril/0000-0003-3097-7667; Kruys, Veronique/0000-0002-3144-5403; Camus, Anne/0000-0002-8820-0407	Direction Generale des Technologies, de la Recherche et de l'Energie; Medical Scientific Research [2.4.511.00.F]; Actions de Recherches Concertees [00-05/250, AV.06/11-345]; Association pour la Recherche sur le Cancer [3823]; Alliance des Recherches sur le Cancer network Pole proteomique et Cancer; Conseil Regional Cibles therapeutiques et recherche de nouveaux marqueurs diagnostics et pronostics dans les cancers and La Ligue Contre le Cancer; Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture/Fonds National de la Recherche Scientifique; Fonds Van Buren (Belgium)	Direction Generale des Technologies, de la Recherche et de l'Energie; Medical Scientific Research; Actions de Recherches Concertees; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Alliance des Recherches sur le Cancer network Pole proteomique et Cancer; Conseil Regional Cibles therapeutiques et recherche de nouveaux marqueurs diagnostics et pronostics dans les cancers and La Ligue Contre le Cancer; Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture/Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fonds Van Buren (Belgium)	This work was funded by the Direction Generale des Technologies, de la Recherche et de l'Energie (region Wallonne), the Fund for Medical Scientific Research (Belgium, grant 2.4.511.00.F), and the Actions de Recherches Concertees (grants 00-05/250 and AV.06/11-345), the Association pour la Recherche sur le Cancer #3823, Alliance des Recherches sur le Cancer network Pole proteomique et Cancer, Conseil Regional Cibles therapeutiques et recherche de nouveaux marqueurs diagnostics et pronostics dans les cancers and La Ligue Contre le Cancer. YK was supported by a Ph.D. fellowship from the Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture/Fonds National de la Recherche Scientifique and by a grant from the Fonds Van Buren (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2004, J LEUKOCYTE BIOL, V76, P42, DOI 10.1189/jlb.1103536; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Ang SL, 2004, SEMIN CELL DEV BIOL, V15, P555, DOI 10.1016/j.semcdb.2004.04.009; Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Beck ARP, 1998, P NATL ACAD SCI USA, V95, P2331, DOI 10.1073/pnas.95.5.2331; Bell CE, 2008, MOL HUM REPROD, V14, P691, DOI 10.1093/molehr/gan063; Boiani M, 2005, STEM CELLS, V23, P1089, DOI 10.1634/stemcells.2004-0352; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; DelGatto F, 1997, MOL CELL BIOL, V17, P5106, DOI 10.1128/MCB.17.9.5106; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Gardner DK, 1998, FERTIL STERIL, V69, P84, DOI 10.1016/S0015-0282(97)00438-X; Gouble A, 2002, CANCER RES, V62, P1489; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hamatani Toshio, 2006, Hum Cell, V19, P98; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Jones GM, 1998, HUM REPROD, V13, P169, DOI 10.1093/humrep/13.1.169; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kandasamy K, 2005, J BIOL CHEM, V280, P1931, DOI 10.1074/jbc.M405937200; KAUFMAN, 1992, ATLAS MOUSE DEV; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kim HS, 2007, MOL CELL BIOL, V27, P6806, DOI 10.1128/MCB.01036-07; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Liao BS, 2007, NAT STRUCT MOL BIOL, V14, P511, DOI 10.1038/nsmb1249; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; MCKEE AE, 2005, BMC DEV BIOL, V20, P5; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Perea-Gomez A, 2004, CURR BIOL, V14, P197, DOI 10.1016/j.cub.2004.01.030; Pfister S, 2007, GENE EXPR PATTERNS, V7, P558, DOI 10.1016/j.modgep.2007.01.005; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Rivera-Perez JA, 2003, DEV BIOL, V261, P470, DOI 10.1016/S0012-1606(03)00302-6; Ron D, 2007, TRANSLATIONAL CONTRO, P345; Vidal F, 1998, MOL REPROD DEV, V51, P274, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;274::AID-MRD6&gt;3.0.CO;2-M; Yu CD, 2007, MOL CELL, V25, P765, DOI 10.1016/j.molcel.2007.01.025; Yu Q, 2003, J BIOL CHEM, V278, P1579, DOI 10.1074/jbc.M203526200; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zhang T, 2005, J CELL SCI, V118, P5453, DOI 10.1242/jcs.02669; Zhu H, 2003, MOL CELL BIOL, V23, P5959, DOI 10.1128/MCB.23.17.5959-5971.2003	46	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11352	10.1371/journal.pone.0011352	http://dx.doi.org/10.1371/journal.pone.0011352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596534	gold, Green Published, Green Submitted			2022-12-25	WOS:000279259900022
J	Xin, YR; Chanrion, B; Liu, MM; Galfalvy, H; Costa, R; Ilievski, B; Rosoklija, G; Arango, V; Dwork, AJ; Mann, JJ; Tycko, B; Haghighi, F				Xin, Yurong; Chanrion, Benjamin; Liu, Meng-Min; Galfalvy, Hanga; Costa, Ramiro; Ilievski, Boro; Rosoklija, Gorazd; Arango, Victoria; Dwork, Andrew J.; Mann, J. John; Tycko, Benjamin; Haghighi, Fatemeh			Genome-Wide Divergence of DNA Methylation Marks in Cerebral and Cerebellar Cortices	PLOS ONE			English	Article							CHROMATIN REPEAT LENGTH; EXPRESSION; CORTEX; SIGNATURES; TISSUE	Background: Emerging evidence suggests that DNA methylation plays an expansive role in the central nervous system (CNS). Large-scale whole genome DNA methylation profiling of the normal human brain offers tremendous potential in understanding the role of DNA methylation in brain development and function. Methodology/Significant Findings: Using methylation-sensitive SNP chip analysis (MSNP), we performed whole genome DNA methylation profiling of the prefrontal, occipital, and temporal regions of cerebral cortex, as well as cerebellum. These data provide an unbiased representation of CpG sites comprising 377,509 CpG dinucleotides within both the genic and intergenic euchromatic region of the genome. Our large-scale genome DNA methylation profiling reveals that the prefrontal, occipital, and temporal regions of the cerebral cortex compared to cerebellum have markedly different DNA methylation signatures, with the cerebral cortex being hypermethylated and cerebellum being hypomethylated. Such differences were observed in distinct genomic regions, including genes involved in CNS function. The MSNP data were validated for a subset of these genes, by performing bisulfite cloning and sequencing and confirming that prefrontal, occipital, and temporal cortices are significantly more methylated as compared to the cerebellum. Conclusions: These findings are consistent with known developmental differences in nucleosome repeat lengths in cerebral and cerebellar cortices, with cerebrum exhibiting shorter repeat lengths than cerebellum. Our observed differences in DNA methylation profiles in these regions underscores the potential role of DNA methylation in chromatin structure and organization in CNS, reflecting functional specialization within cortical regions.	[Xin, Yurong; Chanrion, Benjamin; Galfalvy, Hanga; Costa, Ramiro; Ilievski, Boro; Rosoklija, Gorazd; Arango, Victoria; Dwork, Andrew J.; Mann, J. John; Haghighi, Fatemeh] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Xin, Yurong; Chanrion, Benjamin; Galfalvy, Hanga; Costa, Ramiro; Ilievski, Boro; Rosoklija, Gorazd; Arango, Victoria; Dwork, Andrew J.; Mann, J. John; Haghighi, Fatemeh] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Liu, Meng-Min; Dwork, Andrew J.; Tycko, Benjamin] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Liu, Meng-Min; Tycko, Benjamin] Columbia Univ Coll Phys & Surg, Taub Inst Res Aging Brain, New York, NY 10032 USA; [Ilievski, Boro; Rosoklija, Gorazd; Dwork, Andrew J.; Mann, J. John] Univ Ss Cyril & Methodius, Sch Med, Skopje, North Macedonia; [Rosoklija, Gorazd] Univ Ss Cyril & Methodius, Macedonian Acad Sci & Arts, Skopje, North Macedonia	Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University; Saints Cyril & Methodius University of Skopje; Saints Cyril & Methodius University of Skopje	Xin, YR (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.	fgh3@columbia.edu	Galfalvy, Hanga/AAI-5492-2020; Arango, Victoria/K-9377-2015	Galfalvy, Hanga/0000-0001-7156-6106; Arango, Victoria/0000-0001-8811-400X	National Institute of Mental Health [MH048514]; National Human Genome Research institute [HG002915]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K22HG002915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064168, R01MH060877, R01MH048514] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Human Genome Research institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institute of Mental Health (MH048514) and the National Human Genome Research institute (HG002915). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERKOWITZ EM, 1983, J NEUROCHEM, V41, P516, DOI 10.1111/j.1471-4159.1983.tb04769.x; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Clouaire T, 2008, CELL MOL LIFE SCI, V65, P1509, DOI 10.1007/s00018-008-7324-y; Cui W, 2009, J NEUROSCI RES, V87, P1123, DOI 10.1002/jnr.21936; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; ERMINI M, 1978, FEBS LETT, V90, P167, DOI 10.1016/0014-5793(78)80322-6; Geiman TM, 2010, MOL REPROD DEV, V77, P105, DOI 10.1002/mrd.21118; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; JAEGER AW, 1982, EMBO J, V1, P811, DOI 10.1002/j.1460-2075.1982.tb01252.x; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kelly TM, 1996, ACTA PSYCHIAT SCAND, V94, P337, DOI 10.1111/j.1600-0447.1996.tb09869.x; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li JZ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-336; Putignano E, 2007, NEURON, V53, P747, DOI 10.1016/j.neuron.2007.02.007; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Takizawa T, 2008, TRENDS NEUROSCI, V31, P343, DOI 10.1016/j.tins.2008.03.005; THOMAS JO, 1977, CELL, V10, P633, DOI 10.1016/0092-8674(77)90096-4; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Yuan E, 2006, CANCER RES, V66, P3443, DOI 10.1158/0008-5472.CAN-05-3739	25	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11357	10.1371/journal.pone.0011357	http://dx.doi.org/10.1371/journal.pone.0011357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596539	Green Published, gold, Green Submitted			2022-12-25	WOS:000279259900025
J	Brini, M; Di Leva, F; Ortega, CK; Domi, T; Ottolini, D; Leonardi, E; Tosatto, SCE; Carafoli, E				Brini, Marisa; Di Leva, Francesca; Ortega, Claudia K.; Domi, Teuta; Ottolini, Denis; Leonardi, Emanuela; Tosatto, Silvio C. E.; Carafoli, Ernesto			Deletions and Mutations in the Acidic Lipid-binding Region of the Plasma Membrane Ca2+ Pump A STUDY ON DIFFERENT SPLICING VARIANTS OF ISOFORM 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-PUMP; INHIBITORY INTERACTION; PROTEIN SEQUENCES; HIGH-AFFINITY; CA2+-ATPASE; DOMAIN; IDENTIFICATION; PURIFICATION; CALMODULIN; EXPRESSION	Acidic phospholipids increase the affinity of the plasma membrane Ca2+-ATPase pump for Ca2+. They interact with the C-terminal region of the pump and with a domain in the loop connecting transmembrane domains 2 and 3 (A(L) region) next to site A of alternative splicing. The contribution of the two phospholipid-binding sites and the possible interference of splicing inserts at site A with the regulation of the ATPase activity of isoform 2 of the pump by phospholipids have been analyzed. The activity of the full-length z/b variant (no insert at site A), the w/b (with insert at site A), and the w/a variant, containing both the 45-amino acid A-site insert and a C-site insert that truncates the pump in the calmodulin binding domain, has been analyzed in microsomal membranes of overexpressing CHO cells. The A-site insertion did not modify the phospholipid sensitivity of the pump, but the doubly inserted w/a variant became insensitive to acidic phospholipids, even if containing the intact AL phospholipid binding domain. Pump mutants in which 12 amino acids had been deleted, or single lysine mutations introduced, in the AL region were studied by monitoring agonist-induced Ca2+ transients in overexpressing CHO cells. The 12-residue deletion completely abolished the ATPase activity of the w/a variant but only reduced that of the z/b variant, which was also affected by the single lysine substitutions in the same domain. A structural interpretation of the interplay of the pump with phospholipids, and of the mechanism of their activation, is proposed on the basis of molecular modeling studies.	[Brini, Marisa; Di Leva, Francesca; Domi, Teuta; Ottolini, Denis] Univ Padua, Dept Biol Chem, I-35131 Padua, Italy; [Di Leva, Francesca; Domi, Teuta; Ottolini, Denis] Univ Padua, Dept Expt Vet Sci, I-35131 Padua, Italy; [Ortega, Claudia K.; Carafoli, Ernesto] Venetian Inst Mol Med, I-35129 Padua, Italy; [Leonardi, Emanuela; Tosatto, Silvio C. E.] Univ Padua, Dept Biol, I-35131 Padua, Italy	University of Padua; University of Padua; Veneto Institute Molecular Medicine; University of Padua	Brini, M (corresponding author), Univ Padua, Dept Biol Chem, Viale G Colombo 3, I-35131 Padua, Italy.	marisa.brini@unipd.it	Tosatto, Silvio/B-2840-2009; Carafoli, Ernesto/K-5192-2016; Brini, Marisa/K-5189-2016; leonardi, emanuela/AAN-2392-2020; domi, teuta/K-9646-2016	Tosatto, Silvio/0000-0003-4525-7793; Carafoli, Ernesto/0000-0002-7826-0094; leonardi, emanuela/0000-0001-8486-8461; domi, teuta/0000-0002-8377-5594; Brini, Marisa/0000-0001-5141-0243; DI LEVA, Francesca/0000-0002-6167-0679	Telethon Foundation [GGP04169]; Italian Ministry of University and Research; European Union [LSHG-CT-20054-512063]	Telethon Foundation(Fondazione Telethon); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission)	This work was supported by the Telethon Foundation Project GGP04169 (to M. B.), the Italian Ministry of University and Research PRIN 2003 and 2005 (to M. B.), and by the FP6 Program of the European Union, FP6 Integrated Project EUROHEAR, LSHG-CT-20054-512063 (to E. C.).	ADAMO HP, 1992, BIOCHEM J, V283, P355, DOI 10.1042/bj2830355; Albrecht M, 2003, PROTEIN ENG, V16, P459, DOI 10.1093/protein/gzg063; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Brini M, 2003, J BIOL CHEM, V278, P24500, DOI 10.1074/jbc.M300784200; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; BRODIN P, 1992, EUR J BIOCHEM, V204, P939, DOI 10.1111/j.1432-1033.1992.tb16715.x; Chicka MC, 2003, J BIOL CHEM, V278, P18464, DOI 10.1074/jbc.M301482200; Domi T, 2007, ANN NY ACAD SCI, V1099, P237, DOI 10.1196/annals.1387.043; Elwess NL, 1997, J BIOL CHEM, V272, P17981, DOI 10.1074/jbc.272.29.17981; ENYEDI A, 1987, J BIOL CHEM, V262, P6425; Ficarella R, 2007, P NATL ACAD SCI USA, V104, P1516, DOI 10.1073/pnas.0609775104; Grati M, 2006, J CELL SCI, V119, P2995, DOI 10.1242/jcs.03030; HEIM R, 1992, J BIOL CHEM, V267, P24476; HILFIKER H, 1994, J BIOL CHEM, V269, P26178; HOFMANN F, 1993, J BIOL CHEM, V268, P10252; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Juranic N, 2010, J BIOL CHEM, V285, P4015, DOI 10.1074/jbc.M109.060491; Linde CI, 2008, CELL CALCIUM, V43, P550, DOI 10.1016/j.ceca.2007.09.003; MISSIAEN L, 1989, BIOCHEM J, V261, P1055, DOI 10.1042/bj2611055; MISSIAEN L, 1989, BIOCHEM J, V263, P687, DOI 10.1042/bj2630687; PAPP B, 1989, J BIOL CHEM, V264, P4577; Perez-Gordones MC, 2009, ARCH BIOCHEM BIOPHYS, V489, P55, DOI 10.1016/j.abb.2009.07.010; Pinto FD, 2006, FEBS LETT, V580, P1576, DOI 10.1016/j.febslet.2006.01.088; Pinto FD, 2002, J BIOL CHEM, V277, P12784, DOI 10.1074/jbc.M111055200; Rimessi A, 2005, J BIOL CHEM, V280, P37195, DOI 10.1074/jbc.M504921200; Tosatto SCE, 2002, PROTEIN ENG, V15, P279, DOI 10.1093/protein/15.4.279; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Vullo A, 2006, NUCLEIC ACIDS RES, V34, pW164, DOI 10.1093/nar/gkl166; Xiong YN, 2009, BIOCHEM BIOPH RES CO, V384, P32, DOI 10.1016/j.bbrc.2009.04.044	32	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30779	30791		10.1074/jbc.M110.140475	http://dx.doi.org/10.1074/jbc.M110.140475			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20643655	Green Published, hybrid			2022-12-25	WOS:000282135500046
J	Mortier, A; Loos, T; Gouwy, M; Ronsse, I; Van Damme, J; Proost, P				Mortier, Anneleen; Loos, Tamara; Gouwy, Mieke; Ronsse, Isabelle; Van Damme, Jo; Proost, Paul			Posttranslational Modification of the NH2-terminal Region of CXCL5 by Proteases or Peptidylarginine Deiminases (PAD) Differently Affects Its Biological Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRANULOCYTE CHEMOTACTIC PROTEIN-2; NEUTROPHIL-ACTIVATING PEPTIDE-78; POSTTRANSCRIPTIONAL REGULATION; INTERLEUKIN-8 RECEPTOR; INFLAMMATORY RESPONSE; RHEUMATOID-ARTHRITIS; TISSUE INFLAMMATION; CHEMOKINE RECEPTORS; ENDOTHELIAL-CELLS; SERINE PROTEASES	Posttranslational modifications, e. g. proteolysis, glycosylation, and citrullination regulate chemokine function, affecting leukocyte migration during inflammatory responses. Here, modification of CXCL5/epithelial cell-derived neutrophil-activating protein-78 (ENA-78) by proteases or peptidylarginine deiminases (PAD) was evaluated. Slow CXCL5(1-78) processing by the myeloid cell marker aminopeptidase N/CD13 into CXCL5(2-78) hardly affected its in vitro activity, but slowed down the activation of CXCL5 by the neutrophil protease cathepsin G. PAD, an enzyme with a potentially important function in autoimmune diseases, site-specifically deiminated Arg(9) in CXCL5 to citrulline, generating [Cit(9)] CXCL5(1-78). Compared with CXCL5(1-78), [Cit9] CXCL5(1-78) less efficiently induced intracellular calcium signaling, phosphorylation of extracellular signal-regulated kinase, internalization of CXCR2, and in vitro neutrophil chemotaxis. In contrast, conversion of CXCL5 into the previously reported natural isoform CXCL5(8-78) provided at least 3-fold enhanced biological activity in these tests. Citrullination, but not NH2-terminal truncation, reduced the capacity of CXCL5 to up-regulate the expression of the integrin alpha-chain CD11b on neutrophils. Truncation nor citrullination significantly affected the ability of CXCL5 to up-regulate CD11a expression or shedding of CD62L. In line with the in vitro results, CXCL5(8-78) and CXCL5(978) induced a more pronounced neutrophil influx in vivo compared with CXCL5(1-78). Administration of 300 pmol of either CXCL5(1-78) or [Cit9] CXCL5(1-78) failed to attract neutrophils to the peritoneal cavity. Citrullination of the more potent CXCL5(9-78) lowers its chemotactic potency in vivo and confirms the tempering effect of citrullination in vitro. The highly divergent effects of modifications of CXCL5 on neutrophil influx underline the potential importance of tissue-specific interactions between chemokines and PAD or proteases.	[Mortier, Anneleen; Loos, Tamara; Gouwy, Mieke; Ronsse, Isabelle; Van Damme, Jo; Proost, Paul] Katholieke Univ Leuven, Rega Inst, Lab Mol Immunol, B-3000 Louvain, Belgium	KU Leuven	Proost, P (corresponding author), Katholieke Univ Leuven, Rega Inst, Lab Mol Immunol, B-3000 Louvain, Belgium.	paul.proost@rega.kuleuven.be	Gouwy, Mieke/I-4642-2018; Proost, Paul/V-3052-2017	Gouwy, Mieke/0000-0002-4035-4810; Proost, Paul/0000-0002-0133-5545; Mortier, Anneleen/0000-0002-9662-674X; Van Damme, Jo/0000-0002-6707-1167	Center of Excellence [EF/05/15]; K.U. Leuven, Concerted Research Actions [G.O.A./2007/15]; Regional Government of Flanders; Fund for Scientific Research of Flanders; Interuniversity Attraction Poles Program-Belgian; European Union [LSHB-CT-2005-518167]	Center of Excellence; K.U. Leuven, Concerted Research Actions(KU Leuven); Regional Government of Flanders; Fund for Scientific Research of Flanders(FWO); Interuniversity Attraction Poles Program-Belgian; European Union(European Commission)	This work was supported in part by the Center of Excellence Grant EF/05/15 from K.U. Leuven, Concerted Research Actions Grant G.O.A./2007/15 from the Regional Government of Flanders, the Fund for Scientific Research of Flanders (F.W.O. Vlaanderen), the Interuniversity Attraction Poles Program-Belgian Science Policy, and the European Union 6FP EC contract INNOCHEM Grant LSHB-CT-2005-518167.	Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; ASHMUN RA, 1990, BLOOD, V75, P462; BAINTON DF, 1987, J EXP MED, V166, P1641, DOI 10.1084/jem.166.6.1641; BENBARUCH A, 1995, J BIOL CHEM, V270, P9121, DOI 10.1074/jbc.270.16.9121; BRELJAK D, 2003, HAEMA, V6, P453; Chang X, 2005, RHEUMATOLOGY, V44, P40, DOI 10.1093/rheumatology/keh414; Colditz IG, 2007, THROMB HAEMOSTASIS, V97, P688, DOI 10.1160/TH07-02-0105; D'Amico G, 2000, NAT IMMUNOL, V1, P387, DOI 10.1038/80819; Dinauer Mary C., 2007, V412, P489, DOI 10.1007/978-1-59745-467-4_30; Eyles JL, 2006, NAT CLIN PRACT RHEUM, V2, P500, DOI 10.1038/ncprheum0291; Fan J, 2005, EUR RESPIR J, V26, P933, DOI 10.1183/09031936.05.00120204; Foulquier C, 2007, ARTHRITIS RHEUM-US, V56, P3541, DOI 10.1002/art.22983; Gomez-Gaviro M, 2007, J IMMUNOL, V178, P8053, DOI 10.4049/jimmunol.178.12.8053; Gouwy M, 2005, CYTOKINE GROWTH F R, V16, P561, DOI 10.1016/j.cytogfr.2005.03.005; Gouwy M, 2008, MOL PHARMACOL, V74, P485, DOI 10.1124/mol.108.045146; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Hamilton TA, 2007, J LEUKOCYTE BIOL, V82, P213, DOI 10.1189/jlb.1206754; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Imaizumi TA, 1997, AM J RESP CELL MOL, V17, P181, DOI 10.1165/ajrcmb.17.2.2818; JIANG YL, 1991, BIOCHEM BIOPH RES CO, V178, P1400, DOI 10.1016/0006-291X(91)91049-I; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; Kinloch A, 2008, ARTHRITIS RHEUM, V58, P2287, DOI 10.1002/art.23618; KOCH AE, 1994, J CLIN INVEST, V94, P1012, DOI 10.1172/JCI117414; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Locati M, 2001, IMMUNOBIOLOGY, V204, P536, DOI 10.1078/0171-2985-00090; LOOK AT, 1989, J CLIN INVEST, V83, P1299, DOI 10.1172/JCI114015; Loos T, 2008, BLOOD, V112, P2648, DOI 10.1182/blood-2008-04-149039; Loos T, 2006, LAB INVEST, V86, P902, DOI 10.1038/labinvest.3700453; Loos T, 2009, HAEMATOL-HEMATOL J, V94, P1346, DOI 10.3324/haematol.2009.006973; Loos T, 2009, METHOD ENZYMOL, V461, P3, DOI 10.1016/S0076-6879(09)05401-9; LUKACS NW, 1995, AM J PHYSIOL-LUNG C, V268, pL856, DOI 10.1152/ajplung.1995.268.5.L856; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Menten P, 1999, J CLIN INVEST, V104, pR1, DOI 10.1172/JCI7318; Mortier A, 2008, PHARMACOL THERAPEUT, V120, P197, DOI 10.1016/j.pharmthera.2008.08.006; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Newburger Peter E, 2006, Hematology Am Soc Hematol Educ Program, P104; Nufer O, 1999, BIOCHEMISTRY-US, V38, P636, DOI 10.1021/bi981294s; Pham CTN, 2008, INT J BIOCHEM CELL B, V40, P1317, DOI 10.1016/j.biocel.2007.11.008; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Proost P, 2008, J EXP MED, V205, P2085, DOI 10.1084/jem.20080305; Proost P, 2007, BLOOD, V110, P37, DOI 10.1182/blood-2006-10-049072; Riemann D, 1999, IMMUNOL TODAY, V20, P83, DOI 10.1016/S0167-5699(98)01398-X; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; ROT A, 1992, IMMUNOL TODAY, V13, P291, DOI 10.1016/0167-5699(92)90039-A; Salanga CL, 2009, CELL MOL LIFE SCI, V66, P1370, DOI 10.1007/s00018-008-8666-1; Savino B, 2009, J BIOL CHEM, V284, P26207, DOI 10.1074/jbc.M109.029249; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; SHIPP MA, 1993, BLOOD, V82, P1052, DOI 10.1182/blood.V82.4.1052.bloodjournal8241052; Strell C, 2007, CELL MOL LIFE SCI, V64, P3306, DOI 10.1007/s00018-007-7402-6; Struyf S, 2004, CIRC RES, V95, P855, DOI 10.1161/01.RES.0000146674.38319.07; Struyf S, 2009, J IMMUNOL, V182, P666, DOI 10.4049/jimmunol.182.1.666; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Turner AJ, 2004, HDB PROTEOLYTIC ENZY, V1, P289; VanDamme J, 1997, J LEUKOCYTE BIOL, V62, P563, DOI 10.1002/jlb.62.5.563; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; WALZ A, 1991, J EXP MED, V174, P1355, DOI 10.1084/jem.174.6.1355; Wuyts A, 1999, EUR J BIOCHEM, V260, P421, DOI 10.1046/j.1432-1327.1999.00166.x; Wuyts A, 1997, BIOCHEMISTRY-US, V36, P2716, DOI 10.1021/bi961999z; Zarbock A, 2009, MICROCIRCULATION, V16, P31, DOI 10.1080/10739680802350104	62	42	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29750	29759		10.1074/jbc.M110.119388	http://dx.doi.org/10.1074/jbc.M110.119388			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20630876	hybrid, Green Published			2022-12-25	WOS:000281984300010
J	Lassen, KG; Wissing, S; Lobritz, MA; Santiago, M; Greene, WC				Lassen, Kara G.; Wissing, Silke; Lobritz, Michael A.; Santiago, Mario; Greene, Warner C.			Identification of Two APOBEC3F Splice Variants Displaying HIV-1 Antiviral Activity and Contrasting Sensitivity to Vif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 VIF; CYTIDINE DEAMINATION; ENZYME APOBEC3G; DNA; HYPERMUTATION; EXPRESSION; RESTRICTION; DEGRADATION; EVOLUTION; INFECTION	Approximately half of all human genes undergo alternative mRNA splicing. This process often yields homologous gene products exhibiting diverse functions. Alternative splicing of APOBEC3G (A3G) and APOBEC3F (A3F), the major host resistance factors targeted by the HIV-1 protein Vif, has not been explored. We investigated the effects of alternative splicing on A3G/A3F gene expression and antiviral activity. Three alternatively spliced A3G mRNAs and two alternatively spliced A3F mRNAs were detected in peripheral blood mononuclear cells in each of 10 uninfected, healthy donors. Expression of these splice variants was altered in different cell subsets and in response to cellular stimulation. Alternatively spliced A3G variants were insensitive to degradation by Vif but displayed no antiviral activity against HIV-1. Conversely, alternative splicing of A3F produced a 37-kDa variant lacking exon 2 (A3F Delta 2) that was prominently expressed in macrophages and monocytes and was resistant to Vif-mediated degradation. Alternative splicing also produced a 24-kDa variant of A3F lacking exons 2-4 (A3F Delta 2-4) that was highly sensitive to Vif. Both A3F Delta 2 and A3F Delta 2-4 displayed reduced cytidine deaminase activity and moderate antiviral activity. These alternatively spliced A3F gene products, particularly A3F Delta 2, were incorporated into HIV virions, albeit at levels less than wild-type A3F. Thus, alternative splicing of A3F mRNA generates truncated antiviral proteins that differ sharply in their sensitivity to Vif.	Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Lobritz, Michael A.] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Case Western Reserve University	Greene, WC (corresponding author), 1650 Owens St, San Francisco, CA 94158 USA.	wgreene@gladstone.ucsf.edu		Santiago, Mario L./0000-0001-7792-2706	NIAID Division of Intramural Research [R01 AI065329]; amfAR; Foundation for AIDS Research [107395-43-RFRL]; California Institute of Regenerative Medicine; Case Western Reserve University [T32 GM07250]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	NIAID Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); amfAR; Foundation for AIDS Research; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Case Western Reserve University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI065329 (to W. C. G.) from the NIAID Division of Intramural Research.; Supported by the Mathilde Krim Fellowship from amfAR, the Foundation for AIDS Research (107395-43-RFRL).; Supported by a post-doctoral fellowship from California Institute of Regenerative Medicine.; Supported by the Case Western Reserve University Medical Scientist Training Program Grant T32 GM07250.	Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Browne EP, 2009, VIROLOGY, V387, P313, DOI 10.1016/j.virol.2009.02.026; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen L, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r3; Cho SJ, 2006, J VIROL, V80, P2069, DOI 10.1128/JVI.80.4.2069-2072.2006; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Croft L, 2000, NAT GENET, V24, P340, DOI 10.1038/74153; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Hache G, 2006, AIDS REV, V8, P148; Harari A, 2009, J VIROL, V83, P295, DOI 10.1128/JVI.01665-08; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Irimia M, 2009, BIOESSAYS, V31, P40, DOI 10.1002/bies.080092; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; MBISA JL, 2007, J VIROL; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Munk C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r48; Mulder LCF, 2008, P NATL ACAD SCI USA, V105, P5501, DOI 10.1073/pnas.0710190105; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Okeoma CM, 2009, J VIROL, V83, P3029, DOI 10.1128/JVI.02536-08; REFSLAND EW, NUCL ACIDS RES; Russell RA, 2009, J VIROL, V83, P1992, DOI 10.1128/JVI.01621-08; Santiago ML, 2008, SCIENCE, V321, P1343, DOI 10.1126/science.1161121; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; Ulenga NK, 2008, J INFECT DIS, V198, P486, DOI 10.1086/590212; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang L, 2008, VIROLOGY, V370, P113, DOI 10.1016/j.virol.2007.08.027; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	54	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29326	29335		10.1074/jbc.M110.154054	http://dx.doi.org/10.1074/jbc.M110.154054			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20624919	Green Published, hybrid			2022-12-25	WOS:000281740100035
J	Merdzhanova, G; Gout, S; Keramidas, M; Edmond, V; Coll, JL; Brambilla, C; Brambilla, E; Gazzeri, S; Eymin, B				Merdzhanova, G.; Gout, S.; Keramidas, M.; Edmond, V.; Coll, J-L; Brambilla, C.; Brambilla, E.; Gazzeri, S.; Eymin, B.			The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo	ONCOGENE			English	Article						alternative splicing; angiogenesis; cancer; E2F1; SC35; VEGF-A	METASTATIC COLORECTAL-CANCER; TUMOR ANGIOGENESIS; SPLICE VARIANTS; LUNG-TUMORS; VEGF; EXPRESSION; VEGF(165)B; CARCINOMA; RECEPTORS; DEATH	The transcription factor E2F1 has a crucial role in the control of cell growth and has been shown to regulate neoangiogenesis in a p53-dependent manner through inhibition of activity of the VEGF-A (vascular endothelial growth factor) promoter. Besides being regulated by transcription, VEGF-A is also highly regulated by pre-mRNA alternative splicing, resulting in the expression of several VEGF isoforms with either pro-(VEGF(xxx)) or anti-(VEGF(xxx)b) angiogenic properties. Recently, we identified the SR (Ser-Rich/Arg) protein SC35, a splicing factor, as a new transcriptional target of E2F1. Here, we show that E2F1 downregulates the activity of the VEGF-A promoter in tumour cells independently of p53, leading to a strong decrease in VEGFxxx mRNA levels. We further show that, strikingly, E2F1 alters the ratio of pro-VEGF(xxx) versus anti-VEGF(xxx)b angiogenic isoforms, favouring the anti-angiogenic isoforms, by a mechanism involving the induction of SC35 expression. Finally, using lung tumour xenografts in nude mice, we provide evidence that E2F1 and SC35 proteins increase the VEGF165b/VEGF ratio and decrease tumour neovascularization in vivo. Overall, these findings highlight E2F1 and SC35 as two regulators of the VEGF(xxx)/VEGF(xxx)b angiogenic switch in human cancer cells, a role that could be crucial during tumour progression, as well as in tumour response to antiangiogenic therapies. Oncogene (2010) 29, 5392-5403; doi: 10.1038/onc. 2010.281; published online 19 July 2010	[Merdzhanova, G.; Gout, S.; Keramidas, M.; Edmond, V.; Coll, J-L; Brambilla, C.; Brambilla, E.; Gazzeri, S.; Eymin, B.] Univ Grenoble 1, Inst Albert Bonniot, Grenoble, France; [Keramidas, M.; Coll, J-L] INSERM, U823, Equipe Cibles Therapeurt & Diagnost & Vectoris Dr, Grenoble, France; [Merdzhanova, G.; Gout, S.; Edmond, V.; Brambilla, C.; Brambilla, E.; Gazzeri, S.; Eymin, B.] INSERM, Equipe Bases Mol Progress Canc Poumon 2, Inst Albert Bonniot, U823, F-38042 Grenoble 09, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Eymin, B (corresponding author), INSERM, Equipe Bases Mol Progress Canc Poumon 2, Inst Albert Bonniot, U823, BP170, F-38042 Grenoble 09, France.	Beatrice.Eymin@ujf-grenoble.fr	Eymin, Beatrice/M-1962-2013; Coll, Jean-Luc/G-2520-2013; gazzeri, sylvie/M-1961-2013; eymin, beatrice/U-4670-2019; gazzeri, sylvie/U-4669-2019	Eymin, Beatrice/0000-0002-7311-3810; Coll, Jean-Luc/0000-0002-2453-3552; gazzeri, sylvie/0000-0001-5817-1839; eymin, beatrice/0000-0002-7311-3810; gazzeri, sylvie/0000-0001-5817-1839	Ligue Nationale contre le Cancer; Conseil Scientifique National d'AGIR a dom; Research French Ministry; Fondation pour la Recherche Medicale (FRM); Association pour la Recherche Contre le Cancer (ARC); Conseil Scientifique National d'AGIR	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Conseil Scientifique National d'AGIR a dom; Research French Ministry; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Association pour la Recherche Contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Conseil Scientifique National d'AGIR	We thank Patricia Betton, Pascal Perron and Celine Lampreia for technical assistance. This work was supported by the Ligue Nationale contre le Cancer (Equipe Labellisee Ligue 2007) and by the Conseil Scientifique National d'AGIR a dom. Galina Merdzhanova was supported by fellowships from the Research French Ministry and the Fondation pour la Recherche Medicale (FRM). Stephanie Gout was supported by a fellowship from Association pour la Recherche Contre le Cancer (ARC). Valerie Edmond was supported by a grant from the Conseil Scientifique National d'AGIR a dom.	Bachelder RE, 2001, CANCER RES, V61, P5736; Bachelder RE, 2002, CANCER RES, V62, P7203; Bates DO, 2006, CLIN SCI, V110, P575, DOI 10.1042/CS20050292; Bates DO, 2002, CANCER RES, V62, P4123; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Catena R, 2007, INT J CANCER, V120, P2096, DOI 10.1002/ijc.22461; Cheung N, 1998, HUM PATHOL, V29, P910, DOI 10.1016/S0046-8177(98)90195-2; Cohen CD, 2005, J AM SOC NEPHROL, V16, P1958, DOI 10.1681/ASN.2005020204; Davis JN, 2006, CANCER RES, V66, P11897, DOI 10.1158/0008-5472.CAN-06-2497; Elias AP, 2008, CANCER MICROENVIRON, V1, P131, DOI 10.1007/s12307-008-0013-4; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fontemaggi G, 2009, NAT STRUCT MOL BIOL, V16, P1086, DOI 10.1038/nsmb.1669; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hurwitz HI, 2005, J CLIN ONCOL, V23, P3502, DOI 10.1200/JCO.2005.10.017; Jiang SX, 2007, MOL CELL BIOL, V27, P1696, DOI 10.1128/MCB.01760-06; Kawamura H, 2008, CANCER RES, V68, P4683, DOI 10.1158/0008-5472.CAN-07-6577; Ladomery MR, 2007, CANCER LETT, V249, P133, DOI 10.1016/j.canlet.2006.08.015; Lantuejoul S, 2003, J PATHOL, V200, P336, DOI 10.1002/path.1367; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Nowak DG, 2008, J CELL SCI, V121, P3487, DOI 10.1242/jcs.016410; Nowak DG, 2010, J BIOL CHEM, V285, P5532, DOI 10.1074/jbc.M109.074930; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Pritchard-Jones RO, 2007, BRIT J CANCER, V97, P223, DOI 10.1038/sj.bjc.6603839; Qin GJ, 2006, P NATL ACAD SCI USA, V103, P11015, DOI 10.1073/pnas.0509533103; RAK J, 1995, CANCER RES, V55, P4575; Rennel ES, 2008, BRIT J CANCER, V98, P1250, DOI 10.1038/sj.bjc.6604309; Robinson CJ, 2001, J CELL SCI, V114, P853; Salon C, 2007, ONCOGENE, V26, P6927, DOI 10.1038/sj.onc.1210499; Salon C, 2006, CELL DEATH DIFFER, V13, P260, DOI 10.1038/sj.cdd.4401739; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Varey AHR, 2008, BRIT J CANCER, V98, P1366, DOI 10.1038/sj.bjc.6604308; Woolard J, 2004, CANCER RES, V64, P7822, DOI 10.1158/0008-5472.CAN-04-0934; Zhang LL, 2000, CANCER RES, V60, P3655	34	68	70	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	39					5392	5403		10.1038/onc.2010.281	http://dx.doi.org/10.1038/onc.2010.281			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664EZ	20639906	Green Submitted			2022-12-25	WOS:000282944500006
J	Sakamoto, K; Triplett, AA; Schuler, LA; Wagner, KU				Sakamoto, K.; Triplett, A. A.; Schuler, L. A.; Wagner, K-U			Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer	ONCOGENE			English	Article						prolactin; Janus kinase 2; Stat5; gene targeting; transgenic; breast cancer	GROWTH-FACTOR-ALPHA; BREAST-CANCER; EPITHELIAL-CELLS; SIGNAL TRANSDUCER; ER-ALPHA; EXPRESSION; ACTIVATION; RECEPTOR; STAT5A; GENE	The prolactin receptor (PRLR), its associated Janus kinase 2 (Jak2) and the signal transducer and activator of transcription 5 (Stat5) are essential for normal mammary gland development. Owing to the upregulation of the PRLR and the local synthesis of its ligand in neoplastic cells, it has been proposed that PRL can act as a local growth factor in human breast cancers. This notion is supported by experimental evidence in transgenic mice, which showed that the mammary-specific expression of PRL contributes to carcinogenesis in vivo. To assess the importance of Jak2/Stat5 signaling during mammary cancer initiation and progression, we generated a PRL-induced mammary cancer model that allows the functional ablation of the Jak2 gene in the mammary epithelium before and after neoplastic transformation. Collectively, the results of this study show that the functional ablation of Jak2 protects against the onset of PRL-induced mammary tumorigenesis, suggesting that targeting this kinase is a relevant strategy for mammary cancer prevention. Surprisingly, Jak2 deficiency did not affect the growth and survival of PRL-induced mammary cancer cells in culture and in vivo. Consequently, Jak2 cannot be a sole therapeutic target to treat the established disease. PRL-induced mammary cancers exhibited an upregulation of ErbB2 and other ErbB receptor tyrosine kinases that may supersede the functionality of PRLR signaling through Jak2. Oncogene (2010) 29, 5359-5369; doi: 10.1038/onc.2010.274; published online 19 July 2010	[Sakamoto, K.; Triplett, A. A.; Wagner, K-U] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Schuler, L. A.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA; [Wagner, K-U] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Wisconsin System; University of Wisconsin Madison; University of Nebraska System; University of Nebraska Medical Center	Wagner, KU (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, DRCII Room 5033, Omaha, NE 68198 USA.	kuwagner@unmc.edu	Wagner, Kay-Uwe/B-6044-2009	Wagner, Kay-Uwe/0000-0002-5081-0226	National Cancer Institute [CA117930, CA78312]; Nebraska Cancer and Smoking Disease Research Program [NE DHHS LB506 2009-45]; Susan G Komen Breast Cancer Foundation [PDF0600835]; NATIONAL CANCER INSTITUTE [R01CA117930, R01CA078312] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Nebraska Cancer and Smoking Disease Research Program; Susan G Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Public Health Service Grant CA117930 (to K-UW) as well as Grant CA78312 (to LAS) from the National Cancer Institute. Additional financial support provided to K-UW by the Nebraska Cancer and Smoking Disease Research Program (NE DHHS LB506 2009-45) was imperative to finance the maintenance of the Jak2 conditional knockout model. KS received a postdoctoral fellowship from the Susan G Komen Breast Cancer Foundation (PDF0600835).	AOUIJAMALI MA, 2003, CANCER RES, V63, P3764; Arendt LM, 2008, AM J PATHOL, V172, P194, DOI 10.2353/ajpath.2008.070597; Arendt LM, 2006, AM J PATHOL, V168, P1365, DOI 10.2353/ajpath.2006.050861; Boulanger CA, 2005, ONCOGENE, V24, P552, DOI 10.1038/sj.onc.1208185; Brockman JL, 2005, MOL CELL ENDOCRINOL, V239, P45, DOI 10.1016/j.mce.2005.04.006; Brockman JL, 2002, MOL ENDOCRINOL, V16, P774, DOI 10.1210/me.16.4.774; Cardiff RD, 1998, J MAMMARY GLAND BIOL, V3, P3, DOI 10.1023/A:1018714016205; CLEVENGER CV, 1995, AM J PATHOL, V146, P695; Cotarla I, 2004, INT J CANCER, V108, P665, DOI 10.1002/ijc.11619; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dominguez-Caceres MA, 2004, ONCOGENE, V23, P7378, DOI 10.1038/sj.onc.1208002; GINSBURG E, 1995, CANCER RES, V55, P2591; Hankinson SE, 1999, J NATL CANCER I, V91, P629, DOI 10.1093/jnci/91.7.629; Henry MD, 2004, ONCOGENE, V23, P6980, DOI 10.1038/sj.onc.1207827; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Humphreys RC, 1999, CELL GROWTH DIFFER, V10, P685; Iavnilovitch E, 2004, INT J CANCER, V112, P607, DOI 10.1002/ijc.20484; Iavnilovitch E, 2002, MOL CANCER RES, V1, P32; Kim A, 2005, BREAST CANCER RES, V7, pR708, DOI 10.1186/bcr1281; Krempler A, 2004, GENESIS, V40, P52, DOI 10.1002/gene.20063; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Garcia-Martinez JM, 2010, CELL SIGNAL, V22, P415, DOI 10.1016/j.cellsig.2009.10.013; Matulka LA, 2005, DRUG DISCOV TODAY, V2, P1, DOI DOI 10.1016/J.DDMOD.2005.05.008; Matulka LA, 2007, DEV BIOL, V303, P29, DOI 10.1016/j.ydbio.2006.12.017; MEDINA D, 2000, METHODS MAMMARY GLAN, P137; Miermont AM, 2010, CARCINOGENESIS, V31, P1124, DOI 10.1093/carcin/bgq048; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Oakes SR, 2007, ONCOGENE, V26, P543, DOI 10.1038/sj.onc.1209838; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Pardanani A, 2008, LEUKEMIA, V22, P23, DOI 10.1038/sj.leu.2404948; Ren SX, 2002, ONCOGENE, V21, P4335, DOI 10.1038/sj.onc.1205484; Rose-Hellekant TA, 2003, ONCOGENE, V22, P4664, DOI 10.1038/sj.onc.1206619; Sakamoto K, 2007, MOL ENDOCRINOL, V21, P1877, DOI 10.1210/me.2006-0316; Sakamoto K, 2009, CANCER RES, V69, P6642, DOI 10.1158/0008-5472.CAN-09-0746; Shillingford JM, 2002, MOL ENDOCRINOL, V16, P563, DOI 10.1210/me.16.3.563; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Tang JZ, 2010, ENDOCRINOLOGY, V151, P43, DOI 10.1210/en.2009-0651; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; TORNELL J, 1991, INT J CANCER, V49, P114, DOI 10.1002/ijc.2910490121; Tran TH, 2010, CANCER RES, V70, P1711, DOI 10.1158/0008-5472.CAN-09-2314; Triplett AA, 2008, NEOPLASIA, V10, P1325, DOI 10.1593/neo.08524; Tworoger SS, 2006, CANCER LETT, V243, P160, DOI 10.1016/j.canlet.2006.01.032; Wagner KU, 2008, J MAMMARY GLAND BIOL, V13, P93, DOI 10.1007/s10911-008-9062-z; Wagner Kay-Uwe, 1997, Genes and Function, V1, P233; Wagner KU, 2002, DEVELOPMENT, V129, P1377; Wagner KU, 2004, MOL CELL BIOL, V24, P5510, DOI 10.1128/MCB.24.12.5510-5520.2004; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; WELLINGS SR, 1975, J NATL CANCER I, V55, P231; Wennbo H, 1997, J CLIN INVEST, V100, P2744, DOI 10.1172/JCI119820	52	41	42	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	39					5359	5369		10.1038/onc.2010.274	http://dx.doi.org/10.1038/onc.2010.274			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664EZ	20639901	Green Accepted			2022-12-25	WOS:000282944500003
J	Massaeli, H; Sun, T; Li, XA; Shallow, H; Wu, J; Xu, JM; Li, WT; Hanson, C; Guo, J; Zhang, ST				Massaeli, Hamid; Sun, Tao; Li, Xian; Shallow, Heidi; Wu, Jimmy; Xu, Jianmin; Li, Wentao; Hanson, Christian; Guo, Jun; Zhang, Shetuan			Involvement of Caveolin in Low K+-induced Endocytic Degradation of Cell-surface Human Ether-a-go-go-related Gene (hERG) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-INDEPENDENT ENDOCYTOSIS; LONG-QT SYNDROME; I-KR; DEPENDENT ENDOCYTOSIS; CARDIAC-ARRHYTHMIA; POTASSIUM CHANNEL; EXTRACELLULAR K+; INTERNALIZATION; CARDIOMYOCYTES; IDENTIFICATION	Reduction in the rapidly activating delayed rectifier K+ channel current (I-Kr) due to either mutations in the human ether-a-go-go-related gene (hERG) or drug block causes inherited or drug-induced long QT syndrome. A reduction in extracellular K+ concentration ([K+](o)) exacerbates long QT syndrome. Recently, we demonstrated that lowering [K+](o) promotes degradation of I-Kr in rabbit ventricular myocytes and of the hERG channel stably expressed in HEK 293 cells. In this study, we investigated the degradation pathways of hERG channels under low K+ conditions. We demonstrate that under low K+ conditions, mature hERG channels and caveolin-1 (Cav1) displayed a parallel time-dependent reduction. Mature hERG channels coprecipitated with Cav1 in co-immunoprecipitation analysis, and internalized hERG channels colocalized with Cav1 in immunocytochemistry analysis. Overexpression of Cav1 accelerated internalization of mature hERG channels in 0 mM K-o(+), whereas knockdown of Cav1 impeded this process. In addition, knockdown of dynamin 2 using siRNA transfection significantly impeded hERG internalization and degradation under low K-o(+) conditions. In cultured neonatal rat ventricular myocytes, knockdown of caveolin-3 significantly impeded low K-o(+)-induced reduction of IKr. Our data indicate that a caveolin-dependent endocytic route is involved in low K-o(+)-induced degradation of mature hERG channels.	[Massaeli, Hamid; Sun, Tao; Li, Xian; Shallow, Heidi; Wu, Jimmy; Xu, Jianmin; Li, Wentao; Hanson, Christian; Guo, Jun; Zhang, Shetuan] Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Physiol, Botterell Hall,Rm 429,18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Zhang, Shetuan/0000-0002-2297-0193	Canadian Institutes of Health Research [MOP 72911]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant MOP 72911 (to S.Z.).	Aguilar RC, 2005, P NATL ACAD SCI USA, V102, P2679, DOI 10.1073/pnas.0500213102; BRADBURY NA, 1994, J BIOL CHEM, V269, P8296; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Choy AM, 1997, CIRCULATION, V96, P2149; Compton SJ, 1996, CIRCULATION, V94, P1018, DOI 10.1161/01.CIR.94.5.1018; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Garcia E, 2008, PEDIATR EMERG CARE, V24, P157, DOI 10.1097/PEC.0b013e318166868e; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Massaeli H, 2010, CIRC RES, V106, P1072, DOI 10.1161/CIRCRESAHA.109.215970; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Pierini LM, 2000, BLOOD, V95, P2471; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; RODEN DM, 1986, AM HEART J, V111, P1088, DOI 10.1016/0002-8703(86)90010-4; Rybin VO, 2003, AM J PHYSIOL-HEART C, V285, pH325, DOI 10.1152/ajpheart.00946.2002; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Smart EJ, 2002, METHOD ENZYMOL, V353, P131; Sottile J, 2005, MOL BIOL CELL, V16, P757, DOI 10.1091/mbc.e04-08-0672; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Zhang ST, 2006, AM J PHYSIOL-HEART C, V290, pH1038, DOI 10.1152/ajpheart.00679.2005	33	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27259	27264		10.1074/jbc.M110.124909	http://dx.doi.org/10.1074/jbc.M110.124909			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20605793	Green Published, hybrid			2022-12-25	WOS:000281172700079
J	Marselli, L; Thorne, J; Dahiya, S; Sgroi, DC; Sharma, A; Bonner-Weir, S; Marchetti, P; Weir, GC				Marselli, Lorella; Thorne, Jeffrey; Dahiya, Sonika; Sgroi, Dennis C.; Sharma, Arun; Bonner-Weir, Susan; Marchetti, Piero; Weir, Gordon C.			Gene Expression Profiles of Beta-Cell Enriched Tissue Obtained by Laser Capture Microdissection from Subjects with Type 2 Diabetes	PLOS ONE			English	Article							PANCREATIC-ISLETS; ENDOPLASMIC-RETICULUM; GLUCOSE-TOLERANCE; TRANSCRIPTIONAL REGULATION; INSULIN-SECRETION; GROWTH-REGULATION; PROTEIN; STRESS; APOPTOSIS; DYSFUNCTION	Background: Changes in gene expression in pancreatic beta-cells from type 2 diabetes (T2D) should provide insights into their abnormal insulin secretion and turnover. Methodology/Principal Findings: Frozen sections were obtained from cadaver pancreases of 10 control and 10 T2D human subjects. Beta-cell enriched samples were obtained by laser capture microdissection (LCM). RNA was extracted, amplified and subjected to microarray analysis. Further analysis was performed with DNA-Chip Analyzer (dChip) and Gene Set Enrichment Analysis (GSEA) software. There were changes in expression of genes linked to glucotoxicity. Evidence of oxidative stress was provided by upregulation of several metallothionein genes. There were few changes in the major genes associated with cell cycle, apoptosis or endoplasmic reticulum stress. There was differential expression of genes associated with pancreatic regeneration, most notably upregulation of members of the regenerating islet gene (REG) family and metalloproteinase 7 (MMP7). Some of the genes found in GWAS studies to be related to T2D were also found to be differentially expressed. IGF2BP2, TSPAN8, and HNF1B (TCF2) were upregulated while JAZF1 and SLC30A8 were downregulated. Conclusions/Significance: This study made possible by LCM has identified many novel changes in gene expression that enhance understanding of the pathogenesis of T2D.	[Marselli, Lorella; Thorne, Jeffrey; Sharma, Arun; Bonner-Weir, Susan; Weir, Gordon C.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Islet Transplantat & Cell Biol,Res Div, Boston, MA 02115 USA; [Marselli, Lorella; Thorne, Jeffrey; Sharma, Arun; Bonner-Weir, Susan; Weir, Gordon C.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Dahiya, Sonika; Sgroi, Dennis C.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Mol Pathol Unit, Boston, MA 02115 USA; [Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, Sect Endocrinol & Metab Organ Transplantat, Pisa, Italy	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Pisa	Marselli, L (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Islet Transplantat & Cell Biol,Res Div, Boston, MA 02115 USA.	gordon.weir@joslin.harvard.edu	Marchetti, Piero/J-7439-2013; Dahiya, Sonika/J-8359-2019; Matýsek, Dalibor/N-1737-2018; Sgroi, Dennis/AAV-2487-2021	Marchetti, Piero/0000-0003-4907-0635; Dahiya, Sonika/0000-0002-5585-0964; Matýsek, Dalibor/0000-0002-1412-1079; Marselli, Lorella/0000-0002-6698-2962; Thorne, Jeffrey/0000-0002-1937-4315; Bonner-Weir, Susan/0000-0003-4682-0656	American Diabetes Association; Juvenile Diabetes Research Foundation; National Institutes of Health, Advanced Microscopy, Bioinformatics, and Genomics Cores of Joslin Diabetes and Endocrinology Research Center [RO1 DK66056, P30 DK36836]; Diabetes Research and Wellness Foundation; European Community; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK066056] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health, Advanced Microscopy, Bioinformatics, and Genomics Cores of Joslin Diabetes and Endocrinology Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research and Wellness Foundation; European Community(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the American Diabetes Association, the Juvenile Diabetes Research Foundation, the National Institutes of Health (RO1 DK66056 and P30 DK36836 - the Advanced Microscopy, Bioinformatics, and Genomics Cores of Joslin Diabetes and Endocrinology Research Center), the Diabetes Research and Wellness Foundation and the European Community (EURODIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelli S, 2004, DIABETES, V53, P2815, DOI 10.2337/diabetes.53.11.2815; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Bottino R, 2004, DIABETES, V53, P2559, DOI 10.2337/diabetes.53.10.2559; BRUNZELL JD, 1976, J CLIN ENDOCR METAB, V42, P222, DOI 10.1210/jcem-42-2-222; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; Cnop M, 2010, DIABETOLOGIA, V53, P321, DOI 10.1007/s00125-009-1562-x; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Delghingaro-Augusto V, 2009, DIABETOLOGIA, V52, P1122, DOI 10.1007/s00125-009-1317-8; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Di Candia S, 2009, EUR J ENDOCRINOL, V160, P1019, DOI 10.1530/EJE-08-0945; Dodge R, 2009, DIFFERENTIATION, V77, P135, DOI 10.1016/j.diff.2008.09.015; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Ferrannini E, 2005, J CLIN ENDOCR METAB, V90, P493, DOI 10.1210/jc.2004-1133; Fong KW, 2009, MOL BIOL CELL, V20, P3660, DOI 10.1091/mbc.E09-01-0009; Fonseca SG, 2009, CURR OPIN PHARMACOL, V9, P763, DOI 10.1016/j.coph.2009.07.003; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Hashimoto O, 2006, BIOCHEM BIOPH RES CO, V341, P416, DOI 10.1016/j.bbrc.2005.12.205; Hemers E, 2005, CANCER RES, V65, P7363, DOI 10.1158/0008-5472.CAN-05-0157; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Igoillo-Esteve M, 2010, DIABETOLOGIA, V53, P1395, DOI 10.1007/s00125-010-1707-y; Inoue KI, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/101659; Jiang Y, 2008, DIABETES, V57, P2718, DOI 10.2337/db08-0170; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kalabis J, 2008, AM J PHYSIOL-GASTR L, V295, pG1182, DOI 10.1152/ajpgi.90294.2008; Katsuta H, 2010, DIABETOLOGIA, V53, P128, DOI 10.1007/s00125-009-1570-x; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Laybutt DR, 2002, J BIOL CHEM, V277, P10912, DOI 10.1074/jbc.M111751200; Laybutt DR, 2002, DIABETES, V51, P413, DOI 10.2337/diabetes.51.2.413; Lee SH, 2008, EXP DIABETES RES, DOI 10.1155/2008/728763; Levetan Claresa S, 2008, Endocr Pract, V14, P1075; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lieu HT, 2005, HEPATOLOGY, V42, P618, DOI 10.1002/hep.20845; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Ling C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006558; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Liu ZB, 2009, BIOCHEM BIOPH RES CO, V386, P703, DOI 10.1016/j.bbrc.2009.06.100; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; MACLEAN N, 1955, Diabetes, V4, P367; MALOY AL, 1981, HUM PATHOL, V12, P917, DOI 10.1016/S0046-8177(81)80197-9; Marchetti P, 2004, J CLIN ENDOCR METAB, V89, P5535, DOI 10.1210/jc.2004-0150; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marselli L, 2008, J CLIN ENDOCR METAB, V93, P1046, DOI 10.1210/jc.2007-0931; Marselli L, 2009, METHODS MOL BIOL, V560, P87, DOI 10.1007/978-1-59745-448-3_8; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Okamoto H, 2002, DIABETES, V51, pS462, DOI 10.2337/diabetes.51.2007.S462; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Pechhold S, 2009, NAT BIOTECHNOL, V27, P1038, DOI 10.1038/nbt.1579; Planas R, 2006, DIABETOLOGIA, V49, P2379, DOI 10.1007/s00125-006-0365-6; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Rosengren AH, 2010, SCIENCE, V327, P217, DOI 10.1126/science.1176827; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Sarkar SA, 2009, DIABETOLOGIA, V52, P1092, DOI 10.1007/s00125-009-1331-x; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Seymour PA, 2008, DEV BIOL, V323, P19, DOI 10.1016/j.ydbio.2008.07.034; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; Theys N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006110; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Unno M, 2002, DIABETES, V51, pS478, DOI 10.2337/diabetes.51.2007.S478; Wei Q, 2008, LUNG CANCER, V62, P181, DOI 10.1016/j.lungcan.2008.06.018; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; WESTERMARK P, 1978, DIABETOLOGIA, V15, P417, DOI 10.1007/BF01219652; Xu J, 2008, DIABETOLOGIA, V51, P2281, DOI 10.1007/s00125-008-1155-0; Yanagisawa N, 2005, FEMS IMMUNOL MED MIC, V44, P197, DOI 10.1016/j.femsim.2004.11.009; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhou J, 2007, J BIOL CHEM, V282, P7482, DOI 10.1074/jbc.M608289200	79	201	209	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11499	10.1371/journal.pone.0011499	http://dx.doi.org/10.1371/journal.pone.0011499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644627	Green Published, gold, Green Submitted			2022-12-25	WOS:000279822300003
J	Duncan, B; Nazarov-Stoica, C; Surls, J; Kehl, M; Bona, C; Casares, S; Brumeanu, TD				Duncan, Beverly; Nazarov-Stoica, Cristina; Surls, Jacqueline; Kehl, Margaret; Bona, Constantin; Casares, Sofia; Brumeanu, Teodor-D.			Double Negative (CD3(+)4(-)8(-)) TCR alpha beta Splenic Cells from Young NOD Mice Provide Long-Lasting Protection against Type 1 Diabetes	PLOS ONE			English	Article							REGULATORY T-CELL; INVARIANT NKT CELLS; GAMMA-DELTA; IN-VIVO; INTERFERON-GAMMA; CUTTING EDGE; RECEPTOR; MOUSE; TOLERANCE; LYMPHOCYTES	Background: Double negative CD3(+)4(-)8(-) TCR alpha beta splenic cells (DNCD3) can suppress the immune responses to allo and xenografts, infectious agents, tumors, and some autoimmune disorders. However, little is known about their role in autoimmune diabetes, a disease characterized by the reduction of insulin production subsequent to destruction of pancreatic beta-cells by a polyclonal population of self-reactive T-cells. Herein, we analyzed the function and phenotype of DNCD3 splenic cells in young NOD mice predisposed to several autoimmune disorders among which, the human-like autoimmune diabetes. Methodology/Principal Findings: DNCD3 splenic cells from young NOD mice (1) provided long-lasting protection against diabetes transfer in NOD/Scid immunodeficient mice, (2) proliferated and differentiated in the spleen and pancreas of NOD/Scid mice and pre-diabetic NOD mice into IL-10-secreting T-R-1 like cells in a Th2-like environment, and (3) their anti-diabetogenic phenotype is CD3(+)(CD4(-)CD8(-))CD28(+)CD69(+)CD25(low) Foxp3(-) iCTLA-4(-)TCR alpha beta(+) with a predominant V beta 13 gene usage. Conclusions/Significance: These findings delineate a new T regulatory component in autoimmune diabetes apart from that of NKT and CD4(+)CD25(high) Foxp3(+)T-regulatory cells. DNCD3 splenic cells could be potentially manipulated towards the development of autologous cell therapies in autoimmune diabetes.	[Duncan, Beverly] NCI, NIH, Bethesda, MD 20892 USA; [Nazarov-Stoica, Cristina; Surls, Jacqueline; Kehl, Margaret; Casares, Sofia; Brumeanu, Teodor-D.] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA; [Bona, Constantin] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Casares, Sofia] USN, Med Res Ctr, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uniformed Services University of the Health Sciences - USA; Icahn School of Medicine at Mount Sinai; United States Department of Defense; United States Navy	Duncan, B (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	tbrumeanu@usuhs.edu	è-, ä/F-9947-2012; Brumeanu, Teodor/AAB-1965-2020		National Institutes of Health [DK61927, DK61326, DK077521, JDRF-12002-1151]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK061326, R21DK077521, R01DK061927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (DK61927 & DK61326) to T.-D.B., and (DK077521 and JDRF-12002-1151) to S. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2002, NAT IMMUNOL, V3, P483, DOI 10.1038/ni779; Antonelli LRV, 2006, INFECT IMMUN, V74, P6317, DOI 10.1128/IAI.00890-06; Aoki CA, 2005, AUTOIMMUN REV, V4, P373, DOI 10.1016/j.autrev.2005.02.002; Arase H, 2001, J IMMUNOL, V167, P1141, DOI 10.4049/jimmunol.167.3.1141; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Bains I, 2009, J IMMUNOL, V183, P4329, DOI 10.4049/jimmunol.0900743; Beetz S, 2008, IMMUNOBIOLOGY, V213, P173, DOI 10.1016/j.imbio.2007.10.006; Berzins SP, 2003, DIABETES, V52, P327, DOI 10.2337/diabetes.52.2.327; Brauner H, 2010, J IMMUNOL, V184, P2272, DOI 10.4049/jimmunol.0804358; Casares S, 2002, NAT IMMUNOL, V3, P383, DOI 10.1038/ni770; Chao CC, 1999, P NATL ACAD SCI USA, V96, P9299, DOI 10.1073/pnas.96.16.9299; Chen WH, 2003, J IMMUNOL, V170, P1846, DOI 10.4049/jimmunol.170.4.1846; Chen YG, 2007, IMMUNOGENETICS, V59, P705, DOI 10.1007/s00251-007-0236-4; Chopra P, 2009, IN VIVO, V23, P195; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Dion Marie-Lise, 2007, Methods Mol Biol, V380, P197; Eggena MP, 2004, J EXP MED, V199, P1725, DOI 10.1084/jem.20040124; Fischer K, 2005, BLOOD, V105, P2828, DOI 10.1182/blood-2004-07-2583; Ford MS, 2007, EUR J IMMUNOL, V37, P2234, DOI 10.1002/eji.200636991; Ford MS, 2006, J IMMUNOL, V177, P2803, DOI 10.4049/jimmunol.177.5.2803; Ford MS, 2002, J EXP MED, V196, P261, DOI 10.1084/jem.20020029; FUNDA D, 1995, IMMUNOL LETT, V45, P179, DOI 10.1016/0165-2478(95)00003-N; Godfrey DI, 1997, J AUTOIMMUN, V10, P279, DOI 10.1006/jaut.1997.0129; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; Gonzalez A, 2001, NAT IMMUNOL, V2, P1117, DOI 10.1038/ni738; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Griseri T, 2005, J IMMUNOL, V175, P2091, DOI 10.4049/jimmunol.175.4.2091; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Johansson M, 2003, J IMMUNOL, V170, P1659, DOI 10.4049/jimmunol.170.4.1659; Johansson SE, 2004, INT IMMUNOL, V16, P1, DOI 10.1093/intimm/dxh002; Kadena T, 1997, IMMUNOLOGY, V91, P511, DOI 10.1046/j.1365-2567.1997.00303.x; KATAOKA S, 1983, DIABETES, V32, P247, DOI 10.2337/diabetes.32.3.247; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; LANG FP, 1993, J AUTOIMMUN, V6, P107, DOI 10.1006/jaut.1993.1009; LANG FP, 1991, J AUTOIMMUN, V4, P925, DOI 10.1016/0896-8411(91)90055-H; Lapolla A, 2000, ACTA DIABETOL, V37, P207, DOI 10.1007/s005920070007; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Livak F, 1999, J IMMUNOL, V162, P2575; Ma YX, 2008, XENOTRANSPLANTATION, V15, P56, DOI 10.1111/j.1399-3089.2008.00444.x; MASUDA T, 1991, J IMMUNOL, V147, P2907; Matsuda JL, 2001, P NATL ACAD SCI USA, V98, P12636, DOI 10.1073/pnas.221445298; McIntyre MSF, 2008, J IMMUNOL, V181, P2271, DOI 10.4049/jimmunol.181.4.2271; MEGAN SF, 2006, J IMMUNOL, V177, P2803; NAZAROVSTOICA C, 2009, OPEN J AUTOIMMUNITY, V1, P64; Ohga S, 2002, BRIT J HAEMATOL, V119, P535, DOI 10.1046/j.1365-2141.2002.03848.x; OHTEKI T, 1990, J EXP MED, V172, P7, DOI 10.1084/jem.172.1.7; PALATHUMPAT V, 1992, J IMMUNOL, V149, P808; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Poulton LD, 2001, INT IMMUNOL, V13, P887, DOI 10.1093/intimm/13.7.887; Priatel JJ, 2001, J IMMUNOL, V167, P6188, DOI 10.4049/jimmunol.167.11.6188; Radu DL, 1999, AUTOIMMUNITY, V30, P199, DOI 10.3109/08916939908993801; SANTAMARIA P, 1992, DIABETES, V41, P53, DOI 10.2337/diabetes.41.1.53; SANTAMARIA P, 1994, DIABETES, V43, P599, DOI 10.2337/diabetes.43.4.599; Schmidt EM, 2009, J IMMUNOL, V182, P274, DOI 10.4049/jimmunol.182.1.274; SCHWADRON RB, 1989, TRANSPLANTATION, V48, P107, DOI 10.1097/00007890-198907000-00025; STROBER S, 1989, J IMMUNOL, V143, P1118; Strober S, 1996, IMMUNOL REV, V149, P217, DOI 10.1111/j.1600-065X.1996.tb00906.x; Thomson CW, 2006, IMMUNOL RES, V35, P163, DOI 10.1385/IR:35:1:163; Utting O, 2001, J IMMUNOL, V166, P1540, DOI 10.4049/jimmunol.166.3.1540; Wang B, 1996, EUR J IMMUNOL, V26, P1762, DOI 10.1002/eji.1830260815; Wang B, 2001, J EXP MED, V194, P313, DOI 10.1084/jem.194.3.313; Wang RF, 2002, P NATL ACAD SCI USA, V99, P2181, DOI 10.1073/pnas.042692799; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415; Young KJ, 2003, CANCER RES, V63, P8014; Young KJ, 2003, J IMMUNOL, V171, P134, DOI 10.4049/jimmunol.171.1.134; Zhang L, 2010, J AUTOIMMUN, V34, P478, DOI 10.1016/j.jaut.2009.12.008; Zhang ZX, 2000, NAT MED, V6, P782, DOI 10.1038/77513	74	30	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11427	10.1371/journal.pone.0011427	http://dx.doi.org/10.1371/journal.pone.0011427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625402	Green Published, Green Submitted, gold			2022-12-25	WOS:000279465700012
J	Comeau, S; Jeffree, R; Teyssie, JL; Gattuso, JP				Comeau, Steeve; Jeffree, Ross; Teyssie, Jean-Louis; Gattuso, Jean-Pierre			Response of the Arctic Pteropod Limacina helicina to Projected Future Environmental Conditions	PLOS ONE			English	Article							OCEAN ACIDIFICATION; ARAGONITE; CO2; CALCIFICATION; IMPACT; CARBON; SEA; PHOTOSYNTHESIS; TEMPERATURE; MOLLUSKS	Thecosome pteropods (pelagic mollusks) can play a key role in the food web of various marine ecosystems. They are a food source for zooplankton or higher predators such as fishes, whales and birds that is particularly important in high latitude areas. Since they harbor a highly soluble aragonitic shell, they could be very sensitive to ocean acidification driven by the increase of anthropogenic CO2 emissions. The effect of changes in the seawater chemistry was investigated on Limacina helicina, a key species of Arctic pelagic ecosystems. Individuals were kept in the laboratory under controlled pCO(2) levels of 280, 380, 550, 760 and 1020 mu atm and at control (0 degrees C) and elevated (4 degrees C) temperatures. The respiration rate was unaffected by pCO(2) at control temperature, but significantly increased as a function of the pCO(2) level at elevated temperature. pCO(2) had no effect on the gut clearance rate at either temperature. Precipitation of CaCO3, measured as the incorporation of Ca-45, significantly declined as a function of pCO(2) at both temperatures. The decrease in calcium carbonate precipitation was highly correlated to the aragonite saturation state. Even though this study demonstrates that pteropods are able to precipitate calcium carbonate at low aragonite saturation state, the results support the current concern for the future of Arctic pteropods, as the production of their shell appears to be very sensitive to decreased pH. A decline of pteropod populations would likely cause dramatic changes to various pelagic ecosystems.	[Comeau, Steeve; Gattuso, Jean-Pierre] CNRS, Inst Natl Sci Univers, Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Comeau, Steeve; Gattuso, Jean-Pierre] Univ Paris 06, Observ Oceanol Villefranche, Villefranche Sur Mer, France; [Jeffree, Ross; Teyssie, Jean-Louis] IAEA, Marine Environm Labs, Monaco, Monaco	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Comeau, S (corresponding author), CNRS, Inst Natl Sci Univers, Lab Oceanog Villefranche, Villefranche Sur Mer, France.	comeau@obs-vlfr.fr	Gattuso, Jean-Pierre/AAG-8643-2019; Gattuso, Jean-Pierre/E-6631-2010	Gattuso, Jean-Pierre/0000-0002-4533-4114; Gattuso, Jean-Pierre/0000-0002-4533-4114	French Polar Institute (IPEV); European Community [211384]; Government of the Principality of Monaco	French Polar Institute (IPEV); European Community(European Commission); Government of the Principality of Monaco	Logistic support from the Alfred Wegener Institute for Polar and Marine Research (AWIPEV) and Kings Bay and funding from the French Polar Institute (IPEV) are gratefully acknowledged. This work is a contribution to the Svalbard 2009 experiment of the "European Project on Ocean Acidification'' (EPOCA) which received funding from the European Community's Seventh Framework Programme (FP7/2007 2013) under grant agreement n<SUP>o</SUP> 211384. The IAEA is grateful for the support provided to its Marine Environment Laboratories by the Government of the Principality of Monaco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard KS, 2009, DEEP-SEA RES PT I, V56, P582, DOI 10.1016/j.dsr.2008.11.007; BERNER RA, 1981, SCIENCE, V211, P940, DOI 10.1126/science.211.4485.940; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; CHISHOLM JRM, 1991, LIMNOL OCEANOGR, V36, P1232, DOI 10.4319/lo.1991.36.6.1232; CHRISTOFFERSEN K, 1986, J PLANKTON RES, V8, P973, DOI 10.1093/plankt/8.5.973; Collier R, 2000, DEEP-SEA RES PT II, V47, P3491, DOI 10.1016/S0967-0645(00)00076-X; Comeau S, 2009, BIOGEOSCIENCES, V6, P1877, DOI 10.5194/bg-6-1877-2009; Cottier F, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002757; DAM HG, 1988, J EXP MAR BIOL ECOL, V123, P1, DOI 10.1016/0022-0981(88)90105-0; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; FABRY VJ, 1990, J MAR RES, V48, P209, DOI 10.1357/002224090784984614; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Francois R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001722; Gangsto R, 2008, BIOGEOSCIENCES, V5, P1057, DOI 10.5194/bg-5-1057-2008; Gannefors C, 2005, MAR BIOL, V147, P169, DOI 10.1007/s00227-004-1544-y; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gehlen M, 2007, BIOGEOSCIENCES, V4, P505, DOI 10.5194/bg-4-505-2007; GILMER RW, 1991, MAR ECOL PROG SER, V77, P125, DOI 10.3354/meps077125; GILMER RW, 1986, MAR BIOL, V91, P47, DOI 10.1007/BF00397570; HUNT B, 2010, PLOS ONE, V3, pE9835; Hunt BPV, 2008, PROG OCEANOGR, V78, P193, DOI 10.1016/j.pocean.2008.06.001; IKEDA T, 1985, MAR BIOL, V85, P1, DOI 10.1007/BF00396409; Karnovsky NJ, 2008, MAR ECOL PROG SER, V357, P291, DOI 10.3354/meps07295; Lalli C.M., 1989, PELAGIC SNAILS BIOL; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Lavigne H., 2010, SEACARB SEAWATER CAR; McNeil BI, 2007, TELLUS B, V59, P191, DOI 10.1111/j.1600-0889.2006.00241.x; Moy AD, 2009, NAT GEOSCI, V2, P276, DOI 10.1038/NGEO460; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Ridgwell A, 2007, BIOGEOSCIENCES, V4, P481, DOI 10.5194/bg-4-481-2007; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; RODOLFOMETALPA R, MAR ECOL IN PRESS; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Seibel BA, 2007, INTEGR COMP BIOL, V47, P880, DOI 10.1093/icb/icm089; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Svendsen H, 2002, POLAR RES, V21, P133, DOI 10.1111/j.1751-8369.2002.tb00072.x; Weslawski Jan Marcin, 2000, Oceanologia, V42, P37; Willette TM, 2001, FISH OCEANOGR, V10, P14, DOI 10.1046/j.1054-6006.2001.00043.x; Yamamoto-Kawai M, 2009, SCIENCE, V326, P1098, DOI 10.1126/science.1174190	44	133	135	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11362	10.1371/journal.pone.0011362	http://dx.doi.org/10.1371/journal.pone.0011362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613868	gold, Green Submitted, Green Published			2022-12-25	WOS:000279369900011
J	Knight, ZA; Hannan, KS; Greenberg, ML; Friedman, JM				Knight, Zachary A.; Hannan, K. Schot; Greenberg, Matthew L.; Friedman, Jeffrey M.			Hyperleptinemia Is Required for the Development of Leptin Resistance	PLOS ONE			English	Article							DIET-INDUCED OBESITY; HIGH-FAT DIET; FEEDBACK INHIBITION; SKELETAL-MUSCLE; GENE-PRODUCT; OB/OB MICE; INSULIN; HYPOTHALAMUS; SENSITIVITY; DEFICIENCY	Leptin regulates body weight by signaling to the brain the availability of energy stored as fat. This negative feedback loop becomes disrupted in most obese individuals, resulting in a state known as leptin resistance. The physiological causes of leptin resistance remain poorly understood. Here we test the hypothesis that hyperleptinemia is required for the development of leptin resistance in diet-induced obese mice. We show that mice whose plasma leptin has been clamped to lean levels develop obesity in response to a high-fat diet, and the magnitude of this obesity is indistinguishable from wild-type controls. Yet these obese animals with constant low levels of plasma leptin remain highly sensitive to exogenous leptin even after long-term exposure to a high fat diet. This shows that dietary fats alone are insufficient to block the response to leptin. The data also suggest that hyperleptinemia itself can contribute to leptin resistance by downregulating cellular response to leptin as has been shown for other hormones.	[Knight, Zachary A.; Hannan, K. Schot; Greenberg, Matthew L.; Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Knight, ZA (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10021 USA.	friedj@rockefeller.edu	Friedman, Jeffrey M/E-5784-2011	Knight, Zachary/0000-0001-7621-1478	NIH [DK083531, DK041096]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041096, K99DK083531] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK083531 (Z.A.K.) and DK041096 (J.M.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; BJORKHOLM JE, 1998, INTEL TECHNOL J Q, V3, P1; Bjornholm M, 2007, J CLIN INVEST, V117, P1354, DOI 10.1172/JCI30688; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Ernst MB, 2009, J NEUROSCI, V29, P11582, DOI 10.1523/JNEUROSCI.5712-08.2009; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Hedbacker K, 2010, CELL METAB, V11, P11, DOI 10.1016/j.cmet.2009.11.007; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Kievit P, 2006, CELL METAB, V4, P123, DOI 10.1016/j.cmet.2006.06.010; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Knobelspies H, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-2; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; MAFFEI M, 1995, NAT MED, V1, P1; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Roth JD, 2008, P NATL ACAD SCI USA, V105, P7257, DOI 10.1073/pnas.0706473105; Scarpace P, 2005, DIABETOLOGIA, V48, P1075, DOI 10.1007/s00125-005-1763-x; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Surwit RS, 2000, DIABETES, V49, P1203, DOI 10.2337/diabetes.49.7.1203; Tanaka T, 2005, DIABETES, V54, P2365, DOI 10.2337/diabetes.54.8.2365; Thaler JP, 2010, FRONT NEUROENDOCRIN, V31, P79, DOI 10.1016/j.yfrne.2009.10.002; Townsend KL, 2008, ENDOCRINE, V33, P176, DOI 10.1007/s12020-008-9070-1; Trevaskis JL, 2010, OBESITY, V18, P21, DOI 10.1038/oby.2009.187; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; White CL, 2009, AM J PHYSIOL-ENDOC M, V296, pE291, DOI 10.1152/ajpendo.90513.2008; White MF, 2006, CAN J PHYSIOL PHARM, V84, P725, DOI 10.1139/Y06-008; Wisse BE, 2009, CELL METAB, V10, P241, DOI 10.1016/j.cmet.2009.09.003; Wolfgang MJ, 2006, ANNU REV NUTR, V26, P23, DOI 10.1146/annurev.nutr.25.050304.092532; Won JC, 2009, OBESITY, V17, P1861, DOI 10.1038/oby.2009.194; Yu X, 2008, P NATL ACAD SCI USA, V105, P14070, DOI 10.1073/pnas.0806993105; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	53	204	209	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11376	10.1371/journal.pone.0011376	http://dx.doi.org/10.1371/journal.pone.0011376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613882	Green Published, gold, Green Submitted			2022-12-25	WOS:000279369900023
J	Bochmann, L; Sarathchandra, P; Mori, F; Lara-Pezzi, E; Lazzaro, D; Rosenthal, N				Bochmann, Lars; Sarathchandra, Padmini; Mori, Federica; Lara-Pezzi, Enrique; Lazzaro, Domenico; Rosenthal, Nadia			Revealing New Mouse Epicardial Cell Markers through Transcriptomics	PLOS ONE			English	Article							RETINOIC ACID SYNTHESIS; MAMMALIAN HEART; PROTEIN; NEOVASCULARIZATION; PROGENITORS; EXPRESSION; THYMOSIN-BETA-4; IDENTIFICATION; CARDIOGENESIS; REGENERATION	Background: The epicardium has key functions during myocardial development, by contributing to the formation of coronary endothelial and smooth muscle cells, cardiac fibroblasts, and potentially cardiomyocytes. The epicardium plays a morphogenetic role by emitting signals to promote and maintain cardiomyocyte proliferation. In a regenerative context, the adult epicardium might comprise a progenitor cell population that can be induced to contribute to cardiac repair. Although some genes involved in epicardial function have been identified, a detailed molecular profile of epicardial gene expression has not been available. Methodology: Using laser capture microscopy, we isolated the epicardial layer from the adult murine heart before or after cardiac infarction in wildtype mice and mice expressing a transgenic IGF-1 propeptide (mIGF-1) that enhances cardiac repair, and analyzed the transcription profile using DNA microarrays. Principal Findings: Expression of epithelial genes such as basonuclin, dermokine, and glycoprotein M6A are highly enriched in the epicardial layer, which maintains expression of selected embryonic genes involved in epicardial development in mIGF-1 transgenic hearts. After myocardial infarct, a subset of differentially expressed genes are down-regulated in the epicardium representing an epicardium-specific signature that responds to injury. Conclusion: This study presents the description of the murine epicardial transcriptome obtained from snap frozen tissues, providing essential information for further analysis of this important cardiac cell layer.	[Bochmann, Lars; Lara-Pezzi, Enrique; Rosenthal, Nadia] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy; [Bochmann, Lars; Sarathchandra, Padmini; Rosenthal, Nadia] Univ London Imperial Coll Sci Technol & Med, Harefield Heart Sci Ctr, London, England; [Bochmann, Lars; Mori, Federica; Lazzaro, Domenico] Ist Ric Biol Mol P Angeletti SpA, Pomezia, Italy; [Lara-Pezzi, Enrique] CNIC, Cardiovasc Dev Biol Dept, Madrid, Spain	European Molecular Biology Laboratory (EMBL); Imperial College London; Merck & Company; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Bochmann, L (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy.	bochmann@embl.it	Mori, Federica/B-2944-2013; Lara-Pezzi, Enrique/E-2350-2015; Rosenthal, Nadia/O-7009-2015	Mori, Federica/0000-0002-7244-9961; Lara-Pezzi, Enrique/0000-0002-2743-1033; Rosenthal, Nadia/0000-0002-7599-7365	British Heart Foundation [PG/08/111/26226] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; Andoh A, 1996, J GASTROENTEROL, V31, P633, DOI 10.1007/BF02347609; BASSETSEGUIN N, 1992, ANN DERMATOL VENER, V119, P629; Bock-Marquette I, 2009, J MOL CELL CARDIOL, V46, P728, DOI 10.1016/j.yjmcc.2009.01.017; Brass EP, 2009, J APPL PHYSIOL, V107, P605, DOI 10.1152/japplphysiol.91347.2008; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Hatcher CJ, 2004, PHYSIOL GENOMICS, V18, P129, DOI 10.1152/physiolgenomics.00060.2004; Kang J, 2008, DEV DYNAM, V237, P692, DOI 10.1002/dvdy.21469; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Limana F, 2007, CIRC RES, V101, P1255, DOI 10.1161/CIRCRESAHA.107.150755; Limana F, 2010, J MOL CELL CARDIOL, V48, P609, DOI 10.1016/j.yjmcc.2009.11.008; Lu JR, 1998, MECH DEVELOP, V73, P23, DOI 10.1016/S0925-4773(98)00030-6; Matsui T, 2004, GENOMICS, V84, P384, DOI 10.1016/j.ygeno.2004.03.010; Moss JB, 1998, DEV BIOL, V199, P55, DOI 10.1006/dbio.1998.8911; Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5; Reese DE, 2002, CIRC RES, V91, P761, DOI 10.1161/01.RES.0000038961.53759.3C; Riley PR, 2009, BIOCHEM SOC T, V37, P1218, DOI 10.1042/BST0371218; Rosati B, 2006, J MOL CELL CARDIOL, V40, P295, DOI 10.1016/j.yjmcc.2005.11.002; Santini MP, 2007, CIRC RES, V100, P1732, DOI 10.1161/CIRCRESAHA.107.148791; Smart N, 2007, ANN NY ACAD SCI, V1112, P171, DOI 10.1196/annals.1415.000; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; van Wijk B, 2009, CIRC RES, V105, P431, DOI 10.1161/CIRCRESAHA.109.203083; Vanhoutteghem A, 2004, P NATL ACAD SCI USA, V101, P3468, DOI 10.1073/pnas.0400268101; Winter EM, 2007, CIRCULATION, V116, P917, DOI 10.1161/CIRCULATIONAHA.106.668178; Winter EM, 2007, CELL MOL LIFE SCI, V64, P692, DOI 10.1007/s00018-007-6522-3; Winter EM, 2009, CIRC-HEART FAIL, V2, P643, DOI 10.1161/CIRCHEARTFAILURE.108.843722; Xavier-Neto J, 2000, DEV BIOL, V219, P129, DOI 10.1006/dbio.1999.9588; Zhang TH, 2009, OPHTHALMIC RES, V41, P36, DOI 10.1159/000163220; Zhang XH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001087; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	35	45	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11429	10.1371/journal.pone.0011429	http://dx.doi.org/10.1371/journal.pone.0011429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596535	gold, Green Submitted, Green Published			2022-12-25	WOS:000279259900026
J	Morino, M; Natsui, S; Ono, T; Swartz, TH; Krulwich, TA; Ito, M				Morino, Masato; Natsui, Shinsuke; Ono, Tomohiro; Swartz, Talia H.; Krulwich, Terry A.; Ito, Masahiro			Single Site Mutations in the Hetero-oligomeric Mrp Antiporter from Alkaliphilic Bacillus pseudofirmus OF4 That Affect Na+/H+ Antiport Activity, Sodium Exclusion, Individual Mrp Protein Levels, or Mrp Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PH HOMEOSTASIS; ALKALOPHILIC BACILLUS; VIBRIO-PARAHAEMOLYTICUS; QUINONE OXIDOREDUCTASE; STAPHYLOCOCCUS-AUREUS; ACIDIC RESIDUES; H+ ANTIPORTER; GENE-PRODUCTS; STRAIN C-125	Mrp systems are widely distributed and structurally complex cation/proton antiporters. Antiport activity requires hetero-oligomeric complexes of all six or seven hydrophobic Mrp proteins (MrpA-MrpG). Here, a panel of site-directed mutants in conserved or proposed motif residues was made in the Mrp Na+(Li+)/H+ antiporter from an alkaliphilic Bacillus. The mutant operons were expressed in antiporter-deficient Escherichia coli KNabc and assessed for antiport properties, support of sodium resistance, membrane levels of each Mrp protein, and presence of monomeric and dimeric Mrp complexes. Antiport did not depend on a VFF motif or a conserved tyrosine pair, but a role for a conserved histidine in a potential quinone binding site of MrpA was supported. The importance of several acidic residues for antiport was confirmed, and the importance of additional residues was demonstrated (e. g. three lysine residues conserved across MrpA, MrpD, and membrane-bound respiratory Complex I subunits (NuoL/M/N)). The results extended indications that MrpE is required for normal membrane levels of other Mrp proteins and for complex formation. Moreover, mutations in several other Mrp proteins lead to greatly reduced membrane levels of MrpE. Thus, changes in either of the two Mrp modules, MrpA-MrpD and MrpE-MrpG, influence the other. Two mutants, MrpB-P37G and MrpC-Q70A, showed a normal phenotype but lacked the MrpA-MrpG monomeric complex while retaining the dimeric hetero-oligomeric complex. Finally, MrpG-P81A and MrpG-P81G mutants exhibited no antiport activity but supported sodium resistance and a low [Na+](in). Such mutants could be used to screen hypothesized but uncharacterized sodium efflux functions of Mrp apart from Na+(Li+)/H+ antiport.	[Ono, Tomohiro; Ito, Masahiro] Toyo Univ, Fac Life Sci, Itakura, Gunma 3740193, Japan; [Morino, Masato; Natsui, Shinsuke; Ito, Masahiro] Toyo Univ, Grad Sch Life Sci, Itakura, Gunma 3740193, Japan; [Ito, Masahiro] Toyo Univ, Bionano Elect Res Ctr, Itakura, Gunma 3740193, Japan; [Swartz, Talia H.; Krulwich, Terry A.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Toyo University; Toyo University; Toyo University; Icahn School of Medicine at Mount Sinai	Ito, M (corresponding author), Toyo Univ, Fac Life Sci, 1-1-1 Izumino, Itakura, Gunma 3740193, Japan.	ito1107@toyonet.toyo.ac.jp	Swartz, Talia H./AAN-8591-2020; ITO, MASAHIRO/H-1960-2013; Swartz, Talia H./AAU-2000-2020	Swartz, Talia H./0000-0003-1572-045X; ITO, MASAHIRO/0000-0002-4976-762X; Swartz, Talia H./0000-0003-1572-045X	National Institutes of Health [GM28454]; Toyo University; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Toyo University; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM28454 (to T. A. K.). This work was also supported by a special grant-in-aid from Toyo University, a grant from a High-Tech Research Center program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. I.), and a grant from the Japan Society for the Promotion of Science Research Fellowships for Young Scientists (to M. M.).	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Dzioba-Winogrodzki J, 2009, J MOL MICROB BIOTECH, V16, P176, DOI 10.1159/000119547; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; Friedrich T, 1997, J THEOR BIOL, V187, P529, DOI 10.1006/jtbi.1996.0387; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; HAMAMOTO T, 1994, MOL MICROBIOL, V14, P939, DOI 10.1111/j.1365-2958.1994.tb01329.x; Hiramatsu T, 1998, J BACTERIOL, V180, P6642, DOI 10.1128/JB.180.24.6642-6648.1998; HIROTA N, 1981, FEBS LETT, V132, P278, DOI 10.1016/0014-5793(81)81178-7; Ito M, 2004, MOL MICROBIOL, V53, P1035, DOI 10.1111/j.1365-2958.2004.04173.x; Ito M, 2004, P NATL ACAD SCI USA, V101, P10566, DOI 10.1073/pnas.0402692101; Ito M, 1999, J BACTERIOL, V181, P2394, DOI 10.1128/JB.181.8.2394-2402.1999; Ito M, 2000, J BACTERIOL, V182, P5663, DOI 10.1128/JB.182.20.5663-5670.2000; Kajiyama Y, 2007, J BACTERIOL, V189, P7511, DOI 10.1128/JB.00968-07; Kajiyama Y, 2009, MICROBIOL-SGM, V155, P2137, DOI 10.1099/mic.0.025205-0; Kashyap DR, 2006, J BACTERIOL, V188, P1577, DOI 10.1128/JB.188.4.1577-1584.2006; Kosono S, 2006, BBA-BIOMEMBRANES, V1758, P627, DOI 10.1016/j.bbamem.2006.04.012; KRULWICH TA, 1985, J BIOL CHEM, V260, P4055; Krulwich TA, 2009, MOL MICROBIOL, V74, P257, DOI 10.1111/j.1365-2958.2009.06842.x; Krulwich TA, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, P311; Kuroda T, 1997, J BACTERIOL, V179, P7600, DOI 10.1128/jb.179.23.7600-7602.1997; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACNAB RM, 1987, BIOPHYS J, V52, P637, DOI 10.1016/S0006-3495(87)83255-1; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Mathiesen C, 2003, FEBS LETT, V549, P7, DOI 10.1016/S0014-5793(03)00767-1; Mesbah NM, 2009, MOL MICROBIOL, V74, P270, DOI 10.1111/j.1365-2958.2009.06845.x; Morino M, 2008, J BACTERIOL, V190, P4162, DOI 10.1128/JB.00294-08; Nozaki K, 1998, BBA-BIOMEMBRANES, V1369, P213, DOI 10.1016/S0005-2736(97)00223-X; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SETO Y, 1995, BIOSCI BIOTECH BIOCH, V59, P1364, DOI 10.1271/bbb.59.1364; Slonczewski J. L., 2009, ADV MICROB PHYSL, V55, P317, DOI DOI 10.1016/S0065-2911(09)05501-5; Steuber J, 2001, J BIOENERG BIOMEMBR, V33, P179, DOI 10.1023/A:1010774701327; Swartz TH, 2007, J BACTERIOL, V189, P3081, DOI 10.1128/JB.00021-07; Swartz TH, 2005, EXTREMOPHILES, V9, P345, DOI 10.1007/s00792-005-0451-6; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Torres-Bacete J, 2009, J BIOL CHEM, V284, P33062, DOI 10.1074/jbc.M109.059154; Yang XD, 1998, J BIOL CHEM, V273, P31916, DOI 10.1074/jbc.273.48.31916	42	33	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30942	30950		10.1074/jbc.M110.118661	http://dx.doi.org/10.1074/jbc.M110.118661			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20624916	Green Published, hybrid			2022-12-25	WOS:000282135500059
J	Nijmeijer, S; Leurs, R; Smit, MJ; Vischer, HF				Nijmeijer, Saskia; Leurs, Rob; Smit, Martine J.; Vischer, Henry F.			The Epstein-Barr Virus-encoded G Protein-coupled Receptor BILF1 Hetero-oligomerizes with Human CXCR4, Scavenges G alpha(i) Proteins, and Constitutively Impairs CXCR4 Functioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; MU-OPIOID RECEPTORS; CHEMOKINE RECEPTOR; LIGAND-BINDING; TRANSFER BRET; CROSS-TALK; EXPRESSION; CELLS; HETERODIMERIZATION; DIMERIZATION	Cells express distinct G protein-coupled receptor (GPCR) subtypes on their surface, allowing them to react to a corresponding variety of extracellular stimuli. Cross-regulation between different ligand-GPCR pairs is essential to generate appropriate physiological responses. GPCRs can physically affect each other's functioning by forming heteromeric complexes, whereas cross-regulation between activated GPCRs also occurs through integration of shared intracellular signaling networks. Human herpesviruses utilize virally encoded GPCRs to hijack cellular signaling networks for their own benefit. Previously, we demonstrated that the Epstein-Barr virus-encoded GPCR BILF1 forms heterodimeric complexes with human chemokine receptors. Using a combination of bimolecular complementation and bioluminescence resonance energy transfer approaches, we now show the formation of hetero-oligomeric complexes between this viral GPCR and human CXCR4. BILF1 impaired CXCL12 binding to CXCR4 and, consequently, also CXCL12-induced signaling. In contrast, the G protein uncoupled mutant BILF1-K(3.50)A affected CXCL12-induced CXCR4 signaling to a much lesser extent, indicating that BILF1-mediated CXCR4 inhibition is a consequence of its constitutive activity. Co-expression of G alpha(i1) with BILF1 and CXCR4 restored CXCL12-induced signaling. Likewise, BILF1 formed heteromers with the human histamine H-4 receptor (H4R). BILF1 inhibited histamine-induced G alpha(i)-mediated signaling by H4R, however, without affecting histamine binding to this receptor. These data indicate that functional cross-regulation of G alpha(i)-coupled GPCRs by BILF1 is at the level of G proteins, even though these GPCRs are assembled in hetero-oligomeric complexes.	[Nijmeijer, Saskia; Leurs, Rob; Smit, Martine J.; Vischer, Henry F.] Vrije Univ Amsterdam, LACDR, Div Med Chem, Fac Sci, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Vischer, HF (corresponding author), Vrije Univ Amsterdam, LACDR, Div Med Chem, Fac Sci, De Boelelaan 1083, NL-1081 HV Amsterdam, Netherlands.	vischer@few.vu.nl	Leurs, Rob/AAC-8508-2022; Leurs, Rob/ABB-4299-2021	Leurs, Rob/0000-0003-1354-2848; Smit, Martine/0000-0003-2713-0238; Nijmeijer, Saskia/0000-0001-8037-4659	Netherlands Organization for Scientific Research [700.55.403, 700.54.425]; Netherlands Genomics Initiative [93518006]; COST Action [BM0806]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative; COST Action(European Cooperation in Science and Technology (COST))	This work was supported by Veni Grant 700.55.403 (to H. F. V.) and Vidi Grant 700.54.425 (to M. J. S.) from the Netherlands Organization for Scientific Research and by Breakthrough Grant 93518006 from the Netherlands Genomics Initiative (to H. F. V.) and COST Action BM0806 (to S. N. and R. L.).	Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Bakker RA, 2004, J BIOL CHEM, V279, P5152, DOI 10.1074/jbc.M309200200; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Beisser PS, 2005, J VIROL, V79, P441, DOI 10.1128/JVI.79.1.441-449.2005; Bouvier M, 1998, CURR OPIN BIOTECH, V9, P522; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Canals M, 2008, J BIOL CHEM, V283, P11424, DOI 10.1074/jbc.M710300200; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Chabre M, 2009, TRENDS PHARMACOL SCI, V30, P182, DOI 10.1016/j.tips.2009.01.003; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gandia J, 2008, FEBS LETT, V582, P2979, DOI 10.1016/j.febslet.2008.07.045; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Gupta SK, 2001, IMMUNOL LETT, V78, P29, DOI 10.1016/S0165-2478(01)00228-0; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hu JY, 2005, CLIN CANCER RES, V11, P4658, DOI 10.1158/1078-0432.CCR-04-1798; Hur EM, 2002, CELL SIGNAL, V14, P397, DOI 10.1016/S0898-6568(01)00258-3; Jordan BA, 2003, MOL PHARMACOL, V64, P1317, DOI 10.1124/mol.64.6.1317; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kniazeff J, 2002, J NEUROSCI, V22, P7352; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Laichalk LL, 2005, J VIROL, V79, P1296, DOI 10.1128/JVI.79.2.1296-1307.2005; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Maeda Y, 2004, EUR J BIOCHEM, V271, P1677, DOI 10.1111/j.1432-1033.2004.04064.x; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Park PSH, 2004, J NEUROCHEM, V90, P537, DOI 10.1111/j.1471-4159.2004.02536.x; Paulsen SJ, 2005, J VIROL, V79, P536, DOI 10.1128/JVI.79.1.536-546.2005; Piovan E, 2005, BLOOD, V105, P931, DOI 10.1182/blood-2004-03-0799; Ramsay D, 2002, BIOCHEM J, V365, P429, DOI 10.1042/BJ20020251; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Schneider EH, 2009, BIOCHEMISTRY-US, V48, P1424, DOI 10.1021/bi802050d; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; VAN RIJN RM, 2006, MOL PHARMACOL, V70, P604; Verzijl D, 2008, J PHARMACOL EXP THER, V325, P544, DOI 10.1124/jpet.107.134783; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Vischer HF, 2006, CURR TOP MICROBIOL, V303, P121, DOI 10.1007/978-3-540-33397-5_6; Vischer HF, 2008, BIOCHEM BIOPH RES CO, V377, P93, DOI 10.1016/j.bbrc.2008.09.082; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Yuan J, 2006, J VIROL, V80, P2548, DOI 10.1128/JVI.80.5.2548-2565.2006; Zuo JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000255	55	73	74	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29632	29641		10.1074/jbc.M110.115618	http://dx.doi.org/10.1074/jbc.M110.115618			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20622011	hybrid, Green Published			2022-12-25	WOS:000281740100064
J	Zykova, TA; Zhu, F; Vakorina, TI; Zhang, JS; Higgins, LA; Urusova, DV; Bode, AM; Dong, ZG				Zykova, Tatyana A.; Zhu, Feng; Vakorina, Tatyana I.; Zhang, Jishuai; Higgins, Lee Ann; Urusova, Darya V.; Bode, Ann M.; Dong, Zigang			T-LAK Cell-originated Protein Kinase (TOPK) Phosphorylation of Prx1 at Ser-32 Prevents UVB-induced Apoptosis in RPMI7951 Melanoma Cells through the Regulation of Prx1 Peroxidase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXIREDOXIN-I EXPRESSION; CYSTEINE-SULFINIC ACID; PDZ-BINDING KINASE; CIRCULAR-DICHROISM SPECTRA; MITOTIC KINASE; SECONDARY STRUCTURE; SITE CYSTEINE; LUNG-CANCER; OXIDATION; INACTIVATION	Protein kinases are potential targets for the prevention and control of UV-induced skin cancer. T-cell-originated protein kinase (TOPK) is highly expressed in skin cancer cells, but its specific function is still unknown. We investigated the role of TOPK in UVB-induced apoptosis in RPMI7951 human melanoma cells. Liquid chromatography-tandem mass spectrometry analysis was used to identify proteins that bind with TOPK. Immunofluorescence, Western blot, and flow cytometry were used to assess the effect of UVB on TOPK, peroxiredoxin 1 (Prx1), and apoptosis in RPMI7951 cells. TOPK binds with Prx1 and its phosphorylation of Prx1 at Ser-32 is important for regulation of H2O2-mediated signal transduction. Analysis of the CD spectra of Prx1 and mutant Prx1 (S32A) proteins showed that the secondary structure of Prx1 was significantly altered by phosphorylation of Prx1 at Ser-32. UVB irradiation induced phosphorylation of TOPK in RPMI7951 human melanoma cells and phosphorylated TOPK co-localized with Prx1 in the nucleus. UVB induced the peroxidase activity of Prx1 in vitro and ex vivo. Following treatment with UVB, H2O2 levels and apoptosis were increased in RPMI7951 cells stably expressing TOPK siRNA or stably mutant Prx1 (S32A). Phosphorylation of Prx1 (Ser-32) by TOPK prevents UVB-induced apoptosis in RPMI7951 melanoma cells through regulation of Prx1 peroxidase activity and blockade of intracellular H2O2 accumulation.	[Zykova, Tatyana A.; Zhu, Feng; Zhang, Jishuai; Urusova, Darya V.; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Vakorina, Tatyana I.] Russian Acad Sci, Pacific Inst Bioorgan Chem, Far E Branch, Vladivostok 690022, Russia; [Higgins, Lee Ann] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; Elyakov Pacific Institute of Bioorganic Chemistry; Russian Academy of Sciences; University of Minnesota System; University of Minnesota Twin Cities	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	ZHU, Feng/G-3567-2010; ZHU, Feng/C-1303-2010	Zhu, Feng/0000-0003-1172-0102	National Institutes of Health [CA 077646, R37 CA 081646, CA 120388, ES 016548]; Hormel Foundation; NATIONAL CANCER INSTITUTE [R01CA077646, R01CA120388, R21CA081646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 077646 (ARPA), R37 CA 081646, CA 120388, and ES 016548 and The Hormel Foundation.	Abe Y, 2000, J BIOL CHEM, V275, P21525, DOI 10.1074/jbc.M909629199; Abe Y, 2007, J MOL BIOL, V370, P231, DOI 10.1016/j.jmb.2007.04.067; Aran M, 2009, FEBS J, V276, P2478, DOI 10.1111/j.1742-4658.2009.06984.x; Ayllon V, 2007, ONCOGENE, V26, P3451, DOI 10.1038/sj.onc.1210142; Baker LMS, 2003, J BIOL CHEM, V278, P9203, DOI 10.1074/jbc.M209888200; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; BIEMANN K, 1988, BIOMED ENVIRON MASS, V16, P99, DOI 10.1002/bms.1200160119; BODE AM, 2003, SCI STKE, pRE2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butterfield LH, 1999, ANTIOXID REDOX SIGN, V1, P385, DOI 10.1089/ars.1999.1.4-385; Chang JW, 2001, BIOCHEM BIOPH RES CO, V289, P507, DOI 10.1006/bbrc.2001.5989; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chen MF, 2006, INT J RADIAT ONCOL, V64, P581, DOI 10.1016/j.ijrobp.2005.10.012; Cordray P, 2007, J BIOL CHEM, V282, P32623, DOI 10.1074/jbc.M704369200; Cote S, 2002, CYTOKINE, V20, P113, DOI 10.1006/cyto.2002.1988; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Dougherty JD, 2005, J NEUROSCI, V25, P10773, DOI 10.1523/JNEUROSCI.3207-05.2005; Gaudet S, 2000, P NATL ACAD SCI USA, V97, P5167, DOI 10.1073/pnas.090102397; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Jang HH, 2006, FEBS LETT, V580, P351, DOI 10.1016/j.febslet.2005.12.030; Kim JH, 2008, CLIN CANCER RES, V14, P2326, DOI 10.1158/1078-0432.CCR-07-4457; Kim SY, 2008, FEBS LETT, V582, P1913, DOI 10.1016/j.febslet.2008.05.015; Knoops Bernard, 2007, V44, P27; Matsumoto S, 2004, BIOCHEM BIOPH RES CO, V325, P997, DOI 10.1016/j.bbrc.2004.10.133; Nandi A, 2004, BLOOD CELL MOL DIS, V32, P240, DOI 10.1016/j.bcmd.2003.10.004; Nandi AK, 2006, LEUKEMIA RES, V30, P437, DOI 10.1016/j.leukres.2005.08.011; Nandi AK, 2007, BIOCHEM BIOPH RES CO, V358, P181, DOI 10.1016/j.bbrc.2007.04.125; Oh SM, 2007, CANCER RES, V67, P5186, DOI 10.1158/0008-5472.CAN-06-4506; Park JH, 2006, CANCER RES, V66, P9186, DOI 10.1158/0008-5472.CAN-06-1601; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Simons-Evelyn M, 2001, BLOOD CELL MOL DIS, V27, P825, DOI 10.1006/bcmd.2001.0452; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yanagawa T, 2000, CANCER LETT, V156, P27, DOI 10.1016/S0304-3835(00)00434-1; Yanagawa T, 1999, CANCER LETT, V145, P127, DOI 10.1016/S0304-3835(99)00243-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Yuryev A, 2003, GENOMICS, V81, P112, DOI 10.1016/S0888-7543(02)00008-3; Zhu F, 2007, GASTROENTEROLOGY, V133, P219, DOI 10.1053/j.gastro.2007.04.048; Zykova TA, 2005, CARCINOGENESIS, V26, P331, DOI 10.1093/carcin/bgh334; Zykova TA, 2006, CLIN CANCER RES, V12, P6884, DOI 10.1158/1078-0432.CCR-06-0410	46	65	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29138	29146		10.1074/jbc.M110.135905	http://dx.doi.org/10.1074/jbc.M110.135905			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20647304	Green Published, hybrid			2022-12-25	WOS:000281740100014
J	Benet, M; Lahoz, A; Guzman, C; Castell, JV; Jover, R				Benet, Marta; Lahoz, Agustin; Guzman, Carla; Castell, Jose V.; Jover, Ramiro			CCAAT/Enhancer-binding Protein alpha (C/EBP alpha) and Hepatocyte Nuclear Factor 4 alpha (HNF4 alpha) Synergistically Cooperate with Constitutive Androstane Receptor to Transactivate the Human Cytochrome P450 2B6 (CYP2B6) Gene APPLICATION TO THE DEVELOPMENT OF A METABOLICALLY COMPETENT HUMAN HEPATIC CELL MODEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREGNANE-X-RECEPTOR; CULTURED HUMAN HEPATOCYTES; HUMAN LIVER-MICROSOMES; QUANTITATIVE RT-PCR; IN-VITRO; INTERINDIVIDUAL VARIABILITY; TRANSCRIPTIONAL REGULATION; ORNITHINE TRANSCARBAMYLASE; BASAL EXPRESSION; N-DEMETHYLATION	The transcription of tissue-specific and inducible genes is usually subject to the dynamic control of multiple activators. Dedifferentiated hepatic cell lines lose the expression of tissue-specific activators and many characteristic hepatic genes, such as drug-metabolizing cytochrome P450. Here we demonstrate that by combining adenoviral vectors for CCAAT/enhancer-binding protein alpha (C/EBP alpha), hepatocyte nuclear factor 4 alpha (HNF4 alpha), and constitutive androstane receptor, the CYP2B6 expression and inducibility by CITCO are restored in human hepatoma HepG2 cells at levels similar to those in cultured human hepatocytes. Moreover, several other phase I and II genes are simultaneously activated, which suggests that this is an effective approach to endow dedifferentiated human hepatoma cells with a particular metabolic competence and response to inducers. In order to gain insight into the molecular mechanism, we examined the cooperation of these three transcription factors on the CYP2B6 5'-flanking region. We show new CYP2B6-responsive sequences for C/EBP alpha and HNF4 alpha and a novel synergistic regulatory mechanism whereby C/EBP alpha, HNF4 alpha, and constitutive androstane receptor bind and cooperate through proximal and distal response elements to confer a maximal level of expression. The results obtained from human liver also suggest that important differences in the expression and binding of C/EBP alpha and HNF4 alpha could account for the large interindividual variability of the hepatic CYP2B6 enzyme, which metabolizes commonly used drugs.	[Benet, Marta; Lahoz, Agustin; Guzman, Carla; Castell, Jose V.; Jover, Ramiro] Hosp Univ La Fe, Ctr Invest, Unidad Hepatol Expt, Valencia 46009, Spain; [Benet, Marta; Lahoz, Agustin; Guzman, Carla; Castell, Jose V.; Jover, Ramiro] Hosp Univ La Fe, CIBERehd, Valencia 46009, Spain; [Castell, Jose V.; Jover, Ramiro] Univ Valencia, Fac Med, Dept Bioquim & Biol Mol, Valencia 46010, Spain	Hospital Universitari i Politecnic La Fe; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitari i Politecnic La Fe; University of Valencia	Jover, R (corresponding author), Hosp La Fe, Ctr Invest, Unidad Hepatol Expt, Ave Campanar 21, E-46009 Valencia, Spain.	ramiro.jover@uv.es	Lahoz, Agustin/B-8048-2014; Jover, Ramiro/O-9796-2017; Benet, Marta/H-4168-2017; Castell, Jose V/I-9529-2016	Lahoz, Agustin/0000-0001-7232-0626; Jover, Ramiro/0000-0002-4914-5804; Castell, Jose V/0000-0003-1179-6430; Benet Gimenez, Marta/0000-0002-7910-4755	Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III) [PI 070550]; EC [PL037712]; Spanish Ministry of Science and Innovation/Instituto de Salud Carlos III Miguel Servet [CP08/00125]	Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III)(Instituto de Salud Carlos III); EC(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Science and Innovation/Instituto de Salud Carlos III Miguel Servet(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported in part by Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III) Grant PI 070550; by the EC Integrated Project, CARCINOGENOMICS, Grant PL037712; and by Spanish Ministry of Science and Innovation/Instituto de Salud Carlos III Miguel Servet Contract CP08/00125 (to A. L.).	Auerbach SS, 2007, DRUG METAB DISPOS, V35, P428, DOI 10.1124/dmd.106.012641; Bort R, 2004, ARCH BIOCHEM BIOPHYS, V426, P63, DOI 10.1016/j.abb.2004.03.032; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Castell JV, 2006, EXPERT OPIN DRUG MET, V2, P183, DOI 10.1517/17425255.2.2.183; Castell JV, 1997, GENE THER, V4, P455, DOI 10.1038/sj.gt.3300416; Chang TKH, 2003, DRUG METAB DISPOS, V31, P7, DOI 10.1124/dmd.31.1.7; Chen YP, 2005, J PHARMACOL EXP THER, V314, P1125, DOI 10.1124/jpet.105.087072; Coller JK, 2002, BRIT J CLIN PHARMACO, V54, P157, DOI 10.1046/j.1365-2125.2002.01614.x; Court MH, 2001, ANESTHESIOLOGY, V94, P110, DOI 10.1097/00000542-200101000-00021; Desta Z, 2007, PHARMACOGENOMICS, V8, P547, DOI 10.2217/14622416.8.6.547; Duret C, 2006, MOL PHARMACOL, V70, P329, DOI 10.1124/mol.105.022046; Erickson DA, 1999, DRUG METAB DISPOS, V27, P1488; Faucette SR, 2000, DRUG METAB DISPOS, V28, P1222; Faucette SR, 2006, J PHARMACOL EXP THER, V317, P1200, DOI 10.1124/jpet.105.098160; Faucette SR, 2007, J PHARMACOL EXP THER, V320, P72, DOI 10.1124/jpet.106.112136; Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996; Gerbal-Chaloin S, 2001, DRUG METAB DISPOS, V29, P242; Hidestrand M, 2001, DRUG METAB DISPOS, V29, P1480; Hodgson E, 2007, PHARMACOL THERAPEUT, V113, P420, DOI 10.1016/j.pharmthera.2006.10.002; Honkakoski P, 2004, BIOCHEM PHARMACOL, V67, P97, DOI 10.1016/j.bcp.2003.08.037; Inoue K, 2008, J BIOL CHEM, V283, P10425, DOI 10.1074/jbc.M800729200; Inoue K, 2009, FEBS LETT, V583, P2126, DOI 10.1016/j.febslet.2009.05.031; Inoue Y, 2002, J BIOL CHEM, V277, P25257, DOI 10.1074/jbc.M203126200; Ioannides C, 2004, CURR TOP MED CHEM, V4, P1767, DOI 10.2174/1568026043387188; Jover R, 1998, FEBS LETT, V431, P227, DOI 10.1016/S0014-5793(98)00746-7; Jover R, 2001, HEPATOLOGY, V33, P668, DOI 10.1053/jhep.2001.22176; Jover R, 2009, CURR DRUG METAB, V10, P508, DOI 10.2174/138920009788898000; Kamiyama Y, 2007, DRUG METAB PHARMACOK, V22, P287, DOI 10.2133/dmpk.22.287; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; KIMURA A, 1993, J BIOL CHEM, V268, P11125; Kobayashi K, 1999, DRUG METAB DISPOS, V27, P1429; Lahoz A, 2008, CURR DRUG METAB, V9, P12, DOI 10.2174/138920008783331112; Lahoz Agustin, 2008, Drug Metab Lett, V2, P205, DOI 10.2174/187231208785425845; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Li HS, 2009, DRUG METAB DISPOS, V37, P1098, DOI 10.1124/dmd.108.026005; Madan A, 2003, DRUG METAB DISPOS, V31, P421, DOI 10.1124/dmd.31.4.421; Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Martinez E, 2002, PLANT MOL BIOL, V50, P925, DOI 10.1023/A:1021258713850; Martinez-Jimenez CP, 2006, J BIOL CHEM, V281, P29840, DOI 10.1074/jbc.M604046200; Martinez-Jimenez CP, 2006, MOL PHARMACOL, V70, P1681, DOI 10.1124/mol.106.025403; Martinez-Jimenez CP, 2005, MOL PHARMACOL, V67, P2088, DOI 10.1124/mol.104.008169; Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M510713200; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Moya M, 2010, CHEM-BIOL INTERACT, V184, P376, DOI 10.1016/j.cbi.2010.01.008; Naiki T, 2004, CELL TRANSPLANT, V13, P393, DOI 10.3727/000000004783983855; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Pascual M, 2008, DRUG METAB DISPOS, V36, P1063, DOI 10.1124/dmd.107.019380; Perez G, 2003, TOXICOL IN VITRO, V17, P643, DOI 10.1016/S0887-2333(03)00109-7; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rana R, 2010, DRUG METAB DISPOS, V38, P591, DOI 10.1124/dmd.109.030387; Rodriguez-Antona C, 2000, ARCH BIOCHEM BIOPHYS, V376, P109, DOI 10.1006/abbi.2000.1697; Rodriguez-Antona C, 2003, MOL PHARMACOL, V63, P1180, DOI 10.1124/mol.63.5.1180; Roy P, 1999, DRUG METAB DISPOS, V27, P655; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Surapureddi S, 2008, MOL PHARMACOL, V74, P913, DOI 10.1124/mol.108.048983; Svensson USH, 1999, BRIT J CLIN PHARMACO, V48, P528, DOI 10.1046/j.1365-2125.1999.00044.x; Swales K, 2005, J BIOL CHEM, V280, P3458, DOI 10.1074/jbc.M411318200; Tirona RG, 2003, NAT MED, V9, P220, DOI 10.1038/nm815; Vyhlidal CA, 2006, DRUG METAB DISPOS, V34, P131, DOI 10.1124/dmd.105.005967; Wang HB, 2003, J BIOL CHEM, V278, P14146, DOI 10.1074/jbc.M212482200; Wang HB, 2008, CURR DRUG METAB, V9, P598, DOI 10.2174/138920008785821710; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wei P., 2002, Pharmacogenomics Journal, V2, P117, DOI 10.1038/sj.tpj.6500087; Wortham M, 2007, DRUG METAB DISPOS, V35, P1700, DOI 10.1124/dmd.107.016436; Yanagihara Y, 2001, DRUG METAB DISPOS, V29, P887	68	26	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28457	28471		10.1074/jbc.M110.118364	http://dx.doi.org/10.1074/jbc.M110.118364			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20622021	hybrid, Green Published			2022-12-25	WOS:000281594000009
J	Ebrahimi, S; Fraval, H; Murray, M; Saint, R; Gregory, SL				Ebrahimi, Saman; Fraval, Hamilton; Murray, Michael; Saint, Robert; Gregory, Stephen L.			Polo Kinase Interacts with RacGAP50C and Is Required to Localize the Cytokinesis Initiation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE RING; CENTRAL SPINDLE; DROSOPHILA-MELANOGASTER; BIPOLAR SPINDLE; EXCHANGE FACTOR; MITOTIC ROLES; HUMAN-CELLS; MITOSIS; GTPASE; FAMILY	The assembly and constriction of an actomyosin contractile ring in cytokinesis is dependent on the activation of Rho at the equatorial cortex by a complex, here termed the cytokinesis initiation complex, between a microtubule-associated kinesin-like protein (KLP), a member of the RacGAP family, and the RhoGEF Pebble. Recently, the activity of the mammalian Polo kinase ortholog Plk1 has been implicated in the formation of this complex. We show here that Polo kinase interacts directly with the cytokinesis initiation complex by binding RacGAP50C. We find that a new domain of Polo kinase, termed the intermediate domain, interacts directly with RacGAP50C and that Polo kinase is essential for localization of the KLP-RacGAP centralspindlin complex to the cell equator and spindle midzone. In the absence of Polo kinase, RacGAP50C and Pav-KLP fail to localize normally, instead decorating microtubules along their length. Our results indicate that Polo kinase directly binds the conserved cytokinesis initiation complex and is required to trigger centralspindlin localization as a first step in cytokinesis.	[Ebrahimi, Saman; Gregory, Stephen L.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Fraval, Hamilton; Murray, Michael; Saint, Robert] Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia	University of Adelaide; University of Melbourne	Gregory, SL (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia.	stephen.gregory@adelaide.edu.au	Gregory, Stephen L/B-9918-2008; Saint, Robert/A-4190-2008	Gregory, Stephen L/0000-0002-0046-5815; Saint, Robert/0000-0002-7989-6043; Murray, Michael/0000-0002-7427-590X	National Health and Medical Research Council of Australia; Australian Research Council; Australian National University; University of Adelaide	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Australian National University(Australian National University); University of Adelaide	This work was supported by funding from the National Health and Medical Research Council of Australia, the Australian Research Council, the Australian National University, and the University of Adelaide.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Buffin E, 2007, NAT CELL BIOL, V9, P565, DOI 10.1038/ncb1570; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Carmena M, 1998, J CELL BIOL, V143, P659, DOI 10.1083/jcb.143.3.659; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; D'Avino PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000572; Donaldson MM, 2001, J CELL SCI, V114, P2357; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; FENTON B, 1993, NATURE, V363, P637, DOI 10.1038/363637a0; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goto H, 2006, NAT CELL BIOL, V8, P180, DOI 10.1038/ncb1350; Gregory SL, 2008, CURR BIOL, V18, P25, DOI 10.1016/j.cub.2007.11.050; Herrmann S, 1998, CHROMOSOMA, V107, P440, DOI 10.1007/PL00013778; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Konig P, 2006, LAB INVEST, V86, P853, DOI 10.1038/labinvest.3700443; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Minestrini G, 2003, MOL BIOL CELL, V14, P4028, DOI 10.1091/mbc.E03-04-0214; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Prokopenko SN, 1999, GENE DEV, V13, P2301, DOI 10.1101/gad.13.17.2301; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Savoian MS, 2002, J CELL SCI, V115, P3061; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; SUNKEL CE, 1988, J CELL SCI, V89, P25; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; You X, 2006, P NATL ACAD SCI USA, V103, P18458, DOI 10.1073/pnas.0605422103; Zavortink M, 2005, J CELL SCI, V118, P5381, DOI 10.1242/jcs.02652; Zhao WM, 2005, P NATL ACAD SCI USA, V102, P13158, DOI 10.1073/pnas.0504145102	44	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28667	28673		10.1074/jbc.M110.103887	http://dx.doi.org/10.1074/jbc.M110.103887			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20628062	hybrid, Green Published			2022-12-25	WOS:000281594000031
J	Meng, J; Xia, WH; Tang, JH; Tang, BL; Liang, FY				Meng, Jun; Xia, Wenhao; Tang, Junhong; Tang, Bor Luen; Liang, Fengyi			Dephosphorylation-dependent Inhibitory Activity of Juxtanodin on Filamentous Actin Disassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; ERM PROTEINS; IN-VITRO; LATERAL ASSOCIATION; BUNDLING PROTEINS; SCHWANN-CELLS; THREONINE 558; BINDING; PHOSPHORYLATION; MYELINATION	In the vertebrate central nervous system, maturation of oligodendrocytes is accompanied by a dramatic transformation of cell morphology. Juxtanodin (JN) is an actin cytoskeleton-related oligodendroglial protein that promotes arborization of cultured oligodendrocytes. We performed in vitro and in culture experiments to further elucidate the biochemical effects, molecular interactions, and activity regulation of JN. Pulldown and co-sedimentation assays confirmed JN binding to filamentous but not globular beta-actin largely through a C-terminal domain of 14 amino acid residues. JN had much lower affinity to F-alpha-actin than to F-beta-actin. Bundling and actin polymerization assays revealed no JN influence on F-beta-actin cross-linking or G-beta-actin polymerization. Sedimentation assay, however, demonstrated that JN slowed the rate of F-beta-actin disassembly induced by dilution with F-actin depolymerization buffer. JN-S278E mutant, a mimic of phosphorylated JN at serine 278, exhibited a much diminished affinity/stabilizing effect on F-beta-actin. Immunoblotting revealed both phosphorylated and dephosphorylated native JN of the brain, with the former migrating slightly slower than the latter and becoming undetectable when brain lysate was subjected to in vitro dephosphorylation prior to being loaded for electrophoresis. In cultured OLN-93 cells, overexpression of JN promoted the formation of actin fibers and inhibited F-actin disassembly induced by latrunculin A. S278E phosphomimetic mutation resulted in loss of JN activity in cultured cells, whereas S278A, T258A, and T258E dephospho-/phosphomimetic mutations did not. These findings establish JN as an actin cytoskeleton-stabilizing protein that may play active roles in oligodendroglial differentiation and myelin formation. Specific phosphorylation of JN might serve as an important mechanism regulating JN functions.	[Meng, Jun; Xia, Wenhao; Tang, Junhong; Liang, Fengyi] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117597, Singapore; [Tang, Bor Luen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	National University of Singapore; National University of Singapore	Liang, FY (corresponding author), Block MD10,4 Med Dr, Singapore 117597, Singapore.		Tang, Bor Luen/E-4548-2012; MENG, Jun/C-8250-2012; Liang, Fengyi/A-7521-2018	Tang, Bor Luen/0000-0002-1925-636X; Liang, Fengyi/0000-0003-1162-6212	Singapore Biomedical Research Council [BMRC/04/1/21/19/305]; National Medical Research Council [0946/2005]	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Singapore Biomedical Research Council Research Grant BMRC/04/1/21/19/305 and National Medical Research Council Grant 0946/2005 (to F. L.).	ATTRI AK, 1991, J BIOL CHEM, V266, P6815; Bacon C, 2007, GLIA, V55, P844, DOI 10.1002/glia.20505; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Boggs JM, 2006, BIOCHEMISTRY-US, V45, P391, DOI 10.1021/bi0519194; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Brockschnieder D, 2006, J NEUROSCI, V26, P757, DOI 10.1523/JNEUROSCI.4317-05.2006; BROSCHAT KO, 1990, J BIOL CHEM, V265, P21323; CHANG KS, 1984, MOL CELL BIOL, V4, P2498, DOI 10.1128/MCB.4.11.2498; Coghill ID, 2003, J BIOL CHEM, V278, P24139, DOI 10.1074/jbc.M213259200; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; FernandezValle C, 1997, J NEUROSCI, V17, P241, DOI 10.1523/JNEUROSCI.17-01-00241.1997; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Gallagher SR, 2001, CURR PROTOC CELL BIO; Hashimoto Y, 2007, MOL BIOL CELL, V18, P4591, DOI 10.1091/mbc.E07-02-0157; Huang LQ, 1999, J BIOL CHEM, V274, P12803, DOI 10.1074/jbc.274.18.12803; James MF, 2001, BIOCHEM J, V356, P377, DOI 10.1042/0264-6021:3560377; Kim HJ, 2006, J NEUROSCI, V26, P5849, DOI 10.1523/JNEUROSCI.4921-05.2006; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; Lin YC, 2008, P NATL ACAD SCI USA, V105, P15791, DOI 10.1073/pnas.0804399105; Litman Pninit, 2000, BMC Cell Biology, V1, P1, DOI 10.1186/1471-2121-1-1; Martin M, 1997, MOL BIOL CELL, V8, P1543, DOI 10.1091/mbc.8.8.1543; Nakamura F, 1999, MOL BIOL CELL, V10, P2669, DOI 10.1091/mbc.10.8.2669; OTTO JJ, 1994, CURR OPIN CELL BIOL, V6, P105, DOI 10.1016/0955-0674(94)90123-6; Ramesh V, 2004, NAT REV NEUROSCI, V5, P462, DOI 10.1038/nrn1407; Richter-Landsberg C, 2000, J NEUROSCI RES, V59, P11, DOI 10.1002/(SICI)1097-4547(20000101)59:1<11::AID-JNR2>3.0.CO;2-O; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; Roy C, 1997, J BIOL CHEM, V272, P20088, DOI 10.1074/jbc.272.32.20088; ROZYCKI M, 1991, METHOD ENZYMOL, V196, P100; Rumsby M, 2003, GLIA, V42, P118, DOI 10.1002/glia.10211; Rybakova IN, 1997, J BIOL CHEM, V272, P28771, DOI 10.1074/jbc.272.45.28771; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Shu HJ, 2004, MOL CELL PROTEOMICS, V3, P279, DOI 10.1074/mcp.D300003-MCP200; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Song J, 2001, MOL CELL NEUROSCI, V17, P624, DOI 10.1006/mcne.2001.0974; Tang J, 2009, NEUROSCIENCE, V161, P249, DOI 10.1016/j.neuroscience.2009.03.051; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Webb BA, 2006, ARCH BIOCHEM BIOPHYS, V456, P183, DOI 10.1016/j.abb.2006.06.011; Winder SJ, 2003, CURR OPIN CELL BIOL, V15, P14, DOI 10.1016/S0955-0674(02)00002-9; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; YAO XB, 1995, MOL BIOL CELL, V6, P541, DOI 10.1091/mbc.6.5.541; Zhang B, 2005, P NATL ACAD SCI USA, V102, P11527, DOI 10.1073/pnas.0500952102	43	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28838	28849		10.1074/jbc.M110.117887	http://dx.doi.org/10.1074/jbc.M110.117887			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20610382	Green Published, hybrid			2022-12-25	WOS:000281594000049
J	St-Andre, O; Lemieux, C; Perreault, A; Lackner, DH; Bahler, J; Bachand, F				St-Andre, Olivier; Lemieux, Caroline; Perreault, Audrey; Lackner, Daniel H.; Baehler, Juerg; Bachand, Francois			Negative Regulation of Meiotic Gene Expression by the Nuclear Poly(a)-binding Protein in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-QUALITY-CONTROL; SMALL NUCLEOLAR RNAS; MESSENGER-RNA; POLY(A) POLYMERASE; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL PROGRAM; CAENORHABDITIS-ELEGANS; SELECTIVE ELIMINATION; EXOSOME	Meiosis is a cellular differentiation process in which hundreds of genes are temporally induced. Because the expression of meiotic genes during mitosis is detrimental to proliferation, meiotic genes must be negatively regulated in the mitotic cell cycle. Yet, little is known about mechanisms used by mitotic cells to repress meiosis-specific genes. Here we show that the poly(A)binding protein Pab2, the fission yeast homolog of mammalian PABPN1, controls the expression of several meiotic transcripts during mitotic division. Our results from chromatin immunoprecipitation and promoter-swapping experiments indicate that Pab2 controls meiotic genes post-transcriptionally. Consistently, we show that the nuclear exosome complex cooperates with Pab2 in the negative regulation of meiotic genes. We also found that Pab2 plays a role in the RNA decay pathway orchestrated by Mmi1, a previously described factor that functions in the post-transcriptional elimination of meiotic transcripts. Our results support a model in which Mmi1 selectively targets meiotic transcripts for degradation via Pab2 and the exosome. Our findings have therefore uncovered a mode of gene regulation whereby a poly(A)-binding protein promotes RNA degradation in the nucleus to prevent untimely expression.	[Bachand, Francois] Univ Sherbrooke, Fac Med, Dept Biochem, RNA Grp, Sherbrooke, PQ J1H 5N4, Canada; [Lackner, Daniel H.; Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Lackner, Daniel H.; Baehler, Juerg] UCL, Univ Coll London Canc Inst, London WC1E 6BT, England	University of Sherbrooke; University of London; University College London; University of London; University College London	Bachand, F (corresponding author), Univ Sherbrooke, Fac Med, Dept Biochem, RNA Grp, Sherbrooke, PQ J1H 5N4, Canada.	f.bachand@usherbrooke.ca	Bahler, Jurg/B-4572-2009	Bahler, Jurg/0000-0003-4036-1532	Natural Sciences and Engineering Research Council of Canada; Cancer Research UK; Canadian Institutes for Health Research (CIHR)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Cancer Research UK(Cancer Research UK); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants from Natural Sciences and Engineering Research Council of Canada (to F. B.) and Cancer Research UK (to J. B.).; The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. 1, Tables 1-3, and references.; Supported by a Scholarship from the Canadian Institutes for Health Research (CIHR).; Recipient of a New Investigator Award from the CIHR. To whom correspondence should be addressed: Faculte de Medecine, Universite de Sherbrooke, Sherbrooke, Quebec J1H 5N4, Canada. Tel.: 819-820-6868 (ext: 12733); E-mail: f.bachand@usherbrooke.ca.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Averbeck N, 2005, MOL CELL, V18, P491, DOI 10.1016/j.molcel.2005.04.007; Bachand F, 2006, MOL CELL BIOL, V26, P1731, DOI 10.1128/MCB.26.5.1731-1742.2006; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cristodero M, 2008, MOL BIOCHEM PARASIT, V159, P24, DOI 10.1016/j.molbiopara.2007.12.012; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Grzechnik P, 2008, MOL CELL, V32, P247, DOI 10.1016/j.molcel.2008.10.003; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; KEENEY JB, 1994, GENETICS, V136, P849; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lebreton A, 2008, BBA-GENE REGUL MECH, V1779, P558, DOI 10.1016/j.bbagrm.2008.02.003; Lemay JF, 2010, MOL CELL, V37, P34, DOI 10.1016/j.molcel.2009.12.019; Lemieux C, 2009, NUCLEIC ACIDS RES, V37, P3418, DOI 10.1093/nar/gkp207; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Malapeira J, 2005, MOL CELL BIOL, V25, P6330, DOI 10.1128/MCB.25.15.6330-6337.2005; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; Milligan L, 2005, MOL CELL BIOL, V25, P9996, DOI 10.1128/MCB.25.22.9996-10004.2005; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Moore MJ, 2006, MOL CELL, V24, P903, DOI 10.1016/j.molcel.2006.12.006; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Perreault A, 2007, J BIOL CHEM, V282, P7552, DOI 10.1074/jbc.M610512200; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Suh N, 2006, P NATL ACAD SCI USA, V103, P15108, DOI 10.1073/pnas.0607050103; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; van Hoof A, 2000, MOL CELL BIOL, V20, P8230, DOI 10.1128/MCB.20.21.8230-8243.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; Wang SW, 2008, MOL CELL BIOL, V28, P656, DOI 10.1128/MCB.01531-07; Watanabe T, 2001, NUCLEIC ACIDS RES, V29, P2327, DOI 10.1093/nar/29.11.2327; WATANABE Y, 1994, CELL, V78, P487, DOI 10.1016/0092-8674(94)90426-X; West S, 2006, MOL CELL, V21, P437, DOI 10.1016/j.molcel.2005.12.008; Win TZ, 2006, MOL CELL BIOL, V26, P1710, DOI 10.1128/MCB.26.5.1710-1721.2006; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Yamashita A, 1998, CELL, V95, P115, DOI 10.1016/S0092-8674(00)81787-0	57	61	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27859	27868		10.1074/jbc.M110.150748	http://dx.doi.org/10.1074/jbc.M110.150748			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20622014	Green Published, hybrid			2022-12-25	WOS:000281404100041
J	Das, PM; Thor, AD; Edgerton, SM; Barry, SK; Chen, DF; Jones, FE				Das, P. M.; Thor, A. D.; Edgerton, S. M.; Barry, S. K.; Chen, D. F.; Jones, F. E.			Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells	ONCOGENE			English	Article						breast cancer; EGFR-family; epigenetics; apoptosis; heregulin	INTRACELLULAR DOMAIN 4ICD; ESTROGEN-RECEPTOR; BH3-ONLY PROTEIN; GENE-EXPRESSION; MAMMARY-GLAND; CANCER; ERBB4; METHYLATION; HER4; DIFFERENTIATION	Experimental and clinical data support a growth inhibitory role for HER4 in breast cancer. Clinically HER4 expression is extinguished during breast tumorigenesis supporting a tumor suppressor function for HER4, however, a molecular mechanism to explain the selective loss of HER4 expression has remained elusive. Epigenetic mechanisms, for example, aberrant gene promoter hypermethylation, have been shown to ablate tumor suppressor gene expression in breast carcinomas. We identified a CpG island within the HER4 promoter and show by pyrosequencing of bisulfite-treated DNA an inverse correlation between HER4 expression and the extent of promoter methylation. Treatment of the HER4-negative BT20 cell line with the DNA demethylating agent 5-aza-2'-deoxycytidine (DAC)-enhanced HER4 expression, confirming a role for DNA methylation in suppressed HER4 expression. DAC treatment to reactive HER4 expression in combination with the HER4 ligand heregulin-beta 1 (HRG) resulted in apoptosis of BT20 cells providing a novel therapeutic strategy for triple-negative tumors. The BT20 cells were rescued from apoptosis when preincubated with HER4 small interfering RNA, thereby confirming a role for HER4 in DAC/HRG-induced apoptosis. We verified HER4 promoter methylation in primary breast carcinomas and detected a significant increase in HER4 promoter methylation in HER4-negative breast tumors (P < 0.001). Furthermore, increased levels of HER4 promoter methylation were significantly associated with worse patient prognosis (P = 0.0234). Taken together, our data support a tumor suppressor function for HER4, which is epigenetically suppressed in breast tumors through promoter hypermethylation. Oncogene (2010) 29, 5214-5219; doi:10.1038/onc.2010.271; published online 5 July 2010	[Das, P. M.; Jones, F. E.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Thor, A. D.; Edgerton, S. M.] Univ Colorado Denver, Dept Pathol, Aurora, CO USA; [Barry, S. K.; Chen, D. F.] Tulane Univ, Sch Med, New Orleans, LA 70112 USA	Tulane University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Tulane University	Jones, FE (corresponding author), Tulane Univ, Dept Cell & Mol Biol, 6400 Freret St, New Orleans, LA 70118 USA.	fjones3@tulane.edu	Das, Partha/C-6898-2012		National Cancer Institute/National Institutes of Health [RO1CA95783, RO1CA96717]; NATIONAL CANCER INSTITUTE [R01CA095783, R01CA096717] Funding Source: NIH RePORTER	National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank June Allison for excellent lab management and other members of the Jones lab for valuable input. This work is dedicated to the loving memory of June Allison who will no longer be subjected to the hardships of breast cancer. This work was supported by National Cancer Institute/National Institutes of Health Grants RO1CA95783 (FEJ) and RO1CA96717 (FEJ).	Chua YL, 2009, ONCOGENE, V28, P4041, DOI 10.1038/onc.2009.259; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fernandez SV, 2010, MUTAT RES-FUND MOL M, V688, P28, DOI 10.1016/j.mrfmmm.2010.02.007; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Jones FE, 2008, J MAMMARY GLAND BIOL, V13, P247, DOI 10.1007/s10911-008-9076-6; KREIKE B, 2009, BREAST CANC RES TREA; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Muraoka-Cook RS, 2006, MOL BIOL CELL, V17, P4118, DOI 10.1091/mbc.E06-02-0101; Muraoka-Cook RS, 2006, MOL CELL BIOL, V26, P6412, DOI 10.1128/MCB.01950-05; Muraoka-Cook RS, 2009, MOL CELL BIOL, V29, P4935, DOI 10.1128/MCB.01705-08; Naresh A, 2008, CANCER RES, V68, P6387, DOI 10.1158/0008-5472.CAN-08-0538; Naresh A, 2006, CANCER RES, V66, P6412, DOI 10.1158/0008-5472.CAN-05-2368; Nguyen C, 2001, J NATL CANCER I, V93, P1465, DOI 10.1093/jnci/93.19.1465; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rokavec M, 2007, CLIN CANCER RES, V13, P7506, DOI 10.1158/1078-0432.CCR-07-0457; Sassen A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2339; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Soung YH, 2006, INT J CANCER, V118, P1426, DOI 10.1002/ijc.21507; Strathdee G, 2004, CARCINOGENESIS, V25, P693, DOI 10.1093/carcin/bgh066; Strohecker AM, 2008, J BIOL CHEM, V283, P18269, DOI 10.1074/jbc.M802156200; Sundvall M, 2008, J MAMMARY GLAND BIOL, V13, P259, DOI 10.1007/s10911-008-9079-3; Thor AD, 2009, AM J PATHOL, V175, P1802, DOI 10.2353/ajpath.2009.090204; Tvorogov D, 2009, J BIOL CHEM, V284, P5582, DOI 10.1074/jbc.M805438200; Vidal GA, 2007, ONCOGENE, V26, P462, DOI 10.1038/sj.onc.1209794; Vidal GA, 2005, J BIOL CHEM, V280, P19777, DOI 10.1074/jbc.M412457200; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Zhu Y, 2006, CANCER RES, V66, P7991, DOI 10.1158/0008-5472.CAN-05-4397	29	35	36	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2010	29	37					5214	5219		10.1038/onc.2010.271	http://dx.doi.org/10.1038/onc.2010.271			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	650QZ	20603612	hybrid, Green Published			2022-12-25	WOS:000281867200010
J	Tang, D; Kang, R; Cheh, CW; Livesey, KM; Liang, X; Schapiro, NE; Benschop, R; Sparvero, LJ; Amoscato, AA; Tracey, KJ; Zeh, HJ; Lotze, MT				Tang, D.; Kang, R.; Cheh, C-W; Livesey, K. M.; Liang, X.; Schapiro, N. E.; Benschop, R.; Sparvero, L. J.; Amoscato, A. A.; Tracey, K. J.; Zeh, H. J.; Lotze, M. T.			HMGB1 release and redox regulates autophagy and apoptosis in cancer cells	ONCOGENE			English	Article						HMGB1; apoptosis; autophagy; Beclin 1; redox; chemotheraphy	MOBILITY GROUP BOX-1; CHROMATIN PROTEIN HMGB1; MEDIATED APOPTOSIS; TUMOR-CELLS; INFLAMMATION; RECEPTOR; DNA; HEAT-SHOCK-PROTEIN-72; MACROPHAGES; DEATH	The functional relationship and cross-regulation between autophagy and apoptosis is complex. In this study we show that the high-mobility group box 1 protein (HMGB1) is a redox-sensitive regulator of the balance between autophagy and apoptosis. In cancer cells, anticancer agents enhanced autophagy and apoptosis, as well as HMGB1 release. HMGB1 release may be a prosurvival signal for residual cells after various cytotoxic cancer treatments. Diminished HMGB1 by short hairpin RNA transfection or inhibition of HMGB1 release by ethyl pyruvate or other small molecules led predominantly to apoptosis and decreased autophagy in stressed cancer cells. In this setting, reducible HMGB1 binds to the receptor for advanced glycation end products (RAGEs), but not to Toll-like receptor 4, induces Beclin1-dependent autophagy and promotes tumor resistance to alkylators (melphalan), tubulin disrupting agents (paclitaxel), DNA crosslinkers (ultraviolet light) and DNA intercalators (oxaliplatin or adriamycin). On the contrary, oxidized HMGB1 increases the cytotoxicity of these agents and induces apoptosis mediated by the caspase-9/-3 intrinsic pathway. HMGB1 release, as well as its redox state, thus links autophagy and apoptosis, representing a suitable target when coupled with conventional tumor treatments. Oncogene (2010) 29, 5299-5310; doi:10.1038/onc.2010.261; published online 12 July 2010	[Tang, D.] Univ Pittsburgh, Sch Med, Dept Surg, DAMP Lab,Hillman Canc Ctr,Canc Inst, Pittsburgh, PA 15213 USA; [Benschop, R.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Tracey, K. J.] NYU, N Shore Univ Hosp, Sch Med, Manhasset, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Eli Lilly; New York University; Northwell Health; North Shore University Hospital	Tang, D (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, DAMP Lab,Hillman Canc Ctr,Canc Inst, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.	tangd2@upmc.edu; zehh@upmc.edu; lotzemt@upmc.edu	Kang, Rui/ABD-5291-2021; li, tao/B-2402-2008; Tang, Daolin/B-2905-2010; Tang, Daolin/ABD-5062-2021	Kang, Rui/0000-0003-2725-1574; Tang, Daolin/0000-0002-1903-6180; Amoscato, Andrew/0000-0002-1340-9150; Tracey, Kevin J/0000-0003-1884-6314	NIH [1 P01 CA 101944-04]; NATIONAL CANCER INSTITUTE [P01CA101944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062508] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was funded by a grant from the NIH 1 P01 CA 101944-04 (Michael T. Lotze) integrating NK and DC into Cancer Therapy from the National Cancer Institute. Thoughtful discussions and review of this work with Timothy Billiar and Sarah Berman at the University of Pittsburgh and with external colleagues Guido Kroemer, Douglas Green, Matthew Albert and Beth Levine are much appreciated.	Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Choi JJ, 2004, SCAND J IMMUNOL, V60, P159, DOI 10.1111/j.0300-9475.2004.01470.x; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Geft D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003238; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; Ito N, 2007, J LEUKOCYTE BIOL, V81, P75, DOI 10.1189/jlb.0306169; Kang R, 2010, LEUKEMIA, V24, P177, DOI 10.1038/leu.2009.224; Kang R, 2010, CELL DEATH DIFFER, V17, P666, DOI 10.1038/cdd.2009.149; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Ohndorf UM, 1999, NATURE, V399, P708, DOI 10.1038/21460; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Sy LK, 2008, CANCER RES, V68, P10229, DOI 10.1158/0008-5472.CAN-08-1983; Tang DL, 2008, CRIT CARE MED, V36, P291, DOI 10.1097/01.CCM.0000295316.86942.CE; Tang DL, 2007, J IMMUNOL, V179, P1236, DOI 10.4049/jimmunol.179.2.1236; Tang DL, 2007, J IMMUNOL, V178, P7376, DOI 10.4049/jimmunol.178.11.7376; Tang DL, 2007, J LEUKOCYTE BIOL, V81, P741, DOI 10.1189/jlb.0806540; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Tang DL, 2009, AM J RESP CELL MOL, V41, P651, DOI 10.1165/rcmb.2008-0119OC; Tang DL, 2005, SHOCK, V23, P434, DOI 10.1097/01.shk.0000159556.95285.df; Tesniere A, 2008, CELL DEATH DIFFER, V15, P3, DOI 10.1038/sj.cdd.4402269; Thorburn J, 2009, CELL DEATH DIFFER, V16, P175, DOI 10.1038/cdd.2008.143; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang P, 2007, P NATL ACAD SCI USA, V104, P4054, DOI 10.1073/pnas.0700020104; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	49	356	379	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	38					5299	5310		10.1038/onc.2010.261	http://dx.doi.org/10.1038/onc.2010.261			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	653KE	20622903	Green Accepted			2022-12-25	WOS:000282089100008
J	Garcia, MJ; Nunez, MC; Cox, RA				Jesus Garcia, Maria; Carmen Nunez, Maria; Cox, Robert Ashley			Measurement of the Rates of Synthesis of Three Components of Ribosomes of Mycobacterium fortuitum: A Theoretical Approach to qRT-PCR Experimentation	PLOS ONE			English	Article							ESCHERICHIA-COLI; RNA TRANSCRIPTION; PROTEIN-SYNTHESIS; GROWTH-RATES; TUBERCULOSIS; ELONGATION; OPERON; BIOSYNTHESIS; INITIATION; PROMOTER	Background: Except for the ribosomal protein L12 (rplL), ribosomal proteins are present as one copy per ribosome; L12 (rplL) is unusual because it is present as four copies per ribosome. Thus, the strategies used by Mycobacterium fortuitum to regulate ribosomal protein synthesis were investigated, including evaluations of the rates of chain elongations of 16S rRNA, rplL and ribosomal protein S12 (rpsL). Methodology: RNA was isolated from cell cultures and cDNA was prepared. The numbers of cDNA copies of 16S rRNA, precursor- 16S rRNA and transcripts of rpsL and rplL were quantified by qRT-PCR and then related to the rates of 16S rRNA, rpsL and rplL chain elongations by means of a mathematical framework for coupled transcription/translation. Principal Findings: The rates of synthesis of 16S rRNA, rpsL and rplL respectively were found to be approximately 50610 3 nucleotides h(-1), 1.6x10(3) amino acid residues h(-1) and 3.4x10(3) amino acid residues h(-1). The number of transcripts of rplL was approximately twice that of rpsL. These data account for the presence of one copy of rpsL and four copies of rplL per ribosome, and reveal that the rate of M. fortuitum ribosome synthesis was closer to that of M. tuberculosis than to E. coli. Except for rplJ, the elongation rate obtained for rpsL was inferred to be appropriate for all other proteins present as one copy per ribosome. Significance: The results obtained provide the basis for a comprehensive view of the kinetics of ribosome synthesis, and of the ways that bacterial cells utilize genes encoding ribosomal proteins. The methodology also applies to proteins involved in transcription, energy generation and to bacterial proteins in general. The method proposed for measuring the fidelity of cDNA preparations is intrinsically much more sensitive than procedures that measure the integrity of 16S rRNA.	[Jesus Garcia, Maria; Carmen Nunez, Maria] Univ Autonoma Madrid, Fac Med, Dept Prevent Med, E-28049 Madrid, Spain; [Cox, Robert Ashley] Natl Inst Med Res, Div Mycobacterial Res, London NW7 1AA, England	Autonomous University of Madrid; MRC National Institute for Medical Research	Garcia, MJ (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Prevent Med, E-28049 Madrid, Spain.	rcox@nimr.mrc.ac.uk	Garcia, Maria Jesus Garcia/B-7624-2014	Cox, Robert Ashley/0000-0002-4854-4379	Centro de Estudios de America Latina (CEAL)	Centro de Estudios de America Latina (CEAL)	This work has been funded in part by the Centro de Estudios de America Latina (CEAL) of the Autonoma University of Madrid (http://www.uam.es). This work is also part of the StopLATENT-TB network (Collaborative Project) supported by the EC under the Health Cooperation Work Programme of the 7th Framework Programme (G. A. no. 200999) (http://cordis.europa.eu/fp7/dc/index.cfm). The financial supporters had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beste DJV, 2005, J BACTERIOL, V187, P1677, DOI 10.1128/JB.187.5.1677-1684.2005; BLANCO G, 2002, BIOCHIM BIOPHYS ACTA, V1517, P243; Bremer H, 1996, ESCHERICHIA COLI SAL; Bruell CM, 2008, BIOCHEMISTRY-US, V47, P8828, DOI 10.1021/bi800527k; BYRNE R, 1964, P NATL ACAD SCI USA, V52, P140, DOI 10.1073/pnas.52.1.140; Cook GM, 2009, ADV MICROB PHYSIOL, V55, P81, DOI 10.1016/S0065-2911(09)05502-7; Cox RA, 2004, MICROBIOL-SGM, V150, P1413, DOI 10.1099/mic.0.26560-0; Cox RA, 2007, MICROBIOL-SGM, V153, P3337, DOI 10.1099/mic.0.2007/005868-0; Cox RA, 2007, CURR MOL MED, V7, P231, DOI 10.2174/156652407780598584; DOWNING WL, 1987, J MOL BIOL, V194, P609, DOI 10.1016/0022-2836(87)90238-5; EGEBJERG J, 1990, J MOL BIOL, V213, P275, DOI 10.1016/S0022-2836(05)80190-1; Falkinham JO, 2009, J APPL MICROBIOL, V107, P356, DOI 10.1111/j.1365-2672.2009.04161.x; FORCHHAMMER J, 1971, J MOL BIOL, V55, P563, DOI 10.1016/0022-2836(71)90337-8; GonzalezyMerchand JA, 1996, MICROBIOL-UK, V142, P667, DOI 10.1099/13500872-142-3-667; GonzalezyMerchand JA, 1997, J BACTERIOL, V179, P6949, DOI 10.1128/jb.179.22.6949-6958.1997; GOTTA SL, 1991, J BACTERIOL, V173, P6647, DOI 10.1128/jb.173.20.6647-6649.1991; HARSHEY RM, 1977, J BACTERIOL, V129, P616, DOI 10.1128/JB.129.2.616-622.1977; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; KEMPSELL KE, 1992, J GEN MICROBIOL, V138, P1717, DOI 10.1099/00221287-138-8-1717; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; Menendez MC, 2002, J BACTERIOL, V184, P1078, DOI 10.1128/jb.184.4.1078-1088.2002; Menendez MD, 2005, J BACTERIOL, V187, P534, DOI 10.1128/JB.187.2.534-543.2005; MILLER OL, 1970, SCIENCE, V169, P392, DOI 10.1126/science.169.3943.392; Noller HF, 1996, ESCHERICHIA COLI SAL, V1, P167; Nomura M, 1999, J BACTERIOL, V181, P6857, DOI 10.1128/JB.181.22.6857-6864.1999; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Nunez MC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-100; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; PEDERSEN S, 1984, EMBO J, V3, P2895, DOI 10.1002/j.1460-2075.1984.tb02227.x; PETERSEN C, 1990, J BACTERIOL, V172, P431, DOI 10.1128/JB.172.1.431-436.1990; Proux F, 2008, METHOD ENZYMOL, V447, P243, DOI 10.1016/S0076-6879(08)02213-1; RICHARDSON JP, 1996, ESCHERICHIA COLI SAL, V2, P822; Sambrook J, 2001, MOL CLONING LAB MANU; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; STENT GS, 1964, SCIENCE, V144, P816, DOI 10.1126/science.144.3620.816; TIMM J, 1999, MYCOBACTERIA MOL BIO, P59; ULBRICH B, 1975, EUR J BIOCHEM, V57, P49, DOI 10.1111/j.1432-1033.1975.tb02275.x; Verma I, 1999, LETT APPL MICROBIOL, V29, P113, DOI 10.1046/j.1365-2672.1999.00597.x; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994; Wahl MC, 2002, CURR PROTEIN PEPT SC, V3, P93, DOI 10.2174/1389203023380756; WAHL MC, 2002, CURR PROTEIN PEPT SC, V3, P485; Wilson DN, 2005, CRIT REV BIOCHEM MOL, V40, P243, DOI 10.1080/10409230500256523; ZENGEL JM, 1994, PROG NUCLEIC ACID RE, V47, P331, DOI 10.1016/S0079-6603(08)60256-1	45	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11575	10.1371/journal.pone.0011575	http://dx.doi.org/10.1371/journal.pone.0011575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644643	Green Submitted, Green Published, gold			2022-12-25	WOS:000279884900015
J	Mediannikov, O; Sekeyova, Z; Birg, ML; Raoult, D				Mediannikov, Oleg; Sekeyova, Zuzana; Birg, Marie-Laure; Raoult, Didier			A Novel Obligate Intracellular Gamma-Proteobacterium Associated with Ixodid Ticks, Diplorickettsia massiliensis, Gen. Nov., Sp Nov.	PLOS ONE			English	Article							RICKETTSIELLA-GRYLLI; TAXONOMIC POSITION; MOLECULAR EVIDENCE; COXIELLA-BURNETII; RIBOSOMAL-RNA; GENOMIC DNA; HUMANS; AGENT	Background: Obligate intracellular bacteria of arthropods often exhibit a significant role in either human health or arthropod ecology. Methodology/Principal Findings: An obligate intracellular gamma-proteobacterium was isolated from the actively questing hard tick Ixodes ricinus using mammalian and amphibian cell lines. Transmission electron microscopy revealed a unique morphology of the bacterium, including intravacuolar localization of bacteria grouped predominantly in pairs and internal structures composed of electron-dense crystal-like structures and regular multilayer sheath-like structures. The isolate 20B was characterized to determine its taxonomic position using a polyphasic approach. Comparative 16S rRNA gene sequence analysis showed that this strain belongs to the family Coxiellaceae, order Legionellales of Gamma-proteobacteria, and the closest relatives are different Rickettsiella spp. The level of 16S rRNA gene sequence similarity between strain 20B and other recognized species of the family was below 94.5%. Partial sequences of the rpoB, parC and ftsY genes confirmed the phylogenetic position of the new isolate. The G+C content estimated on the basis of whole genome analysis of strain 20B was 37.88%. On the basis of its phenotypic and genotypic properties, together with phylogenetic distinctiveness, we propose that strain 20B to be classified in the new genus Diplorickettsia as the type strain of a novel species named Diplorickettsia massiliensis sp. nov. Conclusions/Significance: Considering the source of its isolation (hard tick, often biting humans) the role of this bacterium in the pathology of humans, animals and ticks should be further investigated.	[Mediannikov, Oleg; Birg, Marie-Laure; Raoult, Didier] Univ La Mediterrane, Inst Rech Dev 198, Ctr Natl Rech Sci 6236, Unite Rech Malad Infect & Emergentes, Marseille, France; [Sekeyova, Zuzana] Slovak Acad Sci, Inst Virol, Bratislava, Slovakia	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Slovak Academy of Sciences	Mediannikov, O (corresponding author), Univ La Mediterrane, Inst Rech Dev 198, Ctr Natl Rech Sci 6236, Unite Rech Malad Infect & Emergentes, Marseille, France.	Didier.Raoult@gmail.com	RAOULT, Didier/A-8434-2008; Sekeyova, Zuzana/E-5956-2018; Mediannikov, Oleg/H-4018-2015	RAOULT, Didier/0000-0002-0633-5974; Mediannikov, Oleg/0000-0001-6039-2008; Sekeyova, Zuzana/0000-0002-2597-4405	VEGA [2/0016/08, 2/0065/09]; CNRS France [22525-CNRS, 2-SAS]; Slovac Academy of Sciences (SAS) [22525-CNRS, 2-SAS]	VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); CNRS France(Centre National de la Recherche Scientifique (CNRS)); Slovac Academy of Sciences (SAS)	This work was partly supported by the VEGA grant Nos. 2/0016/08, 2/0065/09 and a bilateral project between CNRS France and the Slovac Academy of Sciences (SAS) No: 22525-CNRS, 2-SAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BERGEYS MANUAL SYS B; Babudieri B., 1959, ADV VET SCI, V5, P82; Brenner J., 2005, PROBACTERIA A, P27; CROIZIER G, 1972, Annales de Recherches Veterinaires, V3, P373; EZAKI T, 1990, FEMS MICROBIOL LETT, V55, P127; Fournier PE, 2006, INT J SYST EVOL MICR, V56, P1025, DOI 10.1099/ijs.0.63903-0; FRUTOS R, 1994, J INVERTEBR PATHOL, V63, P294, DOI 10.1006/jipa.1994.1054; Gern L, 2005, Ther Umsch, V62, P707, DOI 10.1024/0040-5930.62.11.707; GIMENEZ DF, 1964, STAIN TECHNOL, V39, P135, DOI 10.3109/10520296409061219; GIROUD P, 1958, CR HEBD ACAD SCI, V247, P2499; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Jado I, 2007, EMERG INFECT DIS, V13, P1405, DOI 10.3201/eid1309.060186; KELLY PJ, 1991, T ROY SOC TROP MED H, V85, P397, DOI 10.1016/0035-9203(91)90303-G; Kurtti TJ, 2002, J MED ENTOMOL, V39, P534, DOI 10.1603/0022-2585-39.3.534; La Scola B, 2001, J CLIN MICROBIOL, V39, P365, DOI 10.1128/JCM.39.1.365-366.2001; Leclerque A, 2008, FEMS MICROBIOL LETT, V283, P117, DOI 10.1111/j.1574-6968.2008.01158.x; LOUIS C, 1977, BIOL CELLULAIRE, V29, P77; Mediannikov O, 2003, ANN NY ACAD SCI, V990, P226, DOI 10.1111/j.1749-6632.2003.tb07367.x; Mediannikov O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000654; Nielsen H, 2004, SCAND J INFECT DIS, V36, P559, DOI 10.1080/00365540410020776; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; Piesman J, 2006, INT J MED MICROBIOL, V296, P17, DOI 10.1016/j.ijmm.2005.11.007; PUDNEY M, 1973, EXPERIENTIA, V29, P466, DOI 10.1007/BF01926785; Reeves WK, 2005, ANN NY ACAD SCI, V1063, P343, DOI 10.1196/annals.1355.055; Roux V, 1997, INT J SYST BACTERIOL, V47, P1255, DOI 10.1099/00207713-47-4-1255; Spaulding AW, 2001, INSECT MOL BIOL, V10, P57, DOI 10.1046/j.1365-2583.2001.00231.x; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Waller LN, 2004, J MICROBIOL METH, V58, P23, DOI 10.1016/j.mimet.2004.02.012; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	30	55	56	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11478	10.1371/journal.pone.0011478	http://dx.doi.org/10.1371/journal.pone.0011478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644718	gold, Green Published, Green Submitted			2022-12-25	WOS:000279822300002
J	Muller, I; Boyle, S; Singer, RH; Bickmore, WA; Chubb, JR				Mueller, Iris; Boyle, Shelagh; Singer, Robert H.; Bickmore, Wendy A.; Chubb, Jonathan R.			Stable Morphology, but Dynamic Internal Reorganisation, of Interphase Human Chromosomes in Living Cells	PLOS ONE			English	Article							SCALE CHROMATIN ORGANIZATION; SMALL-MOLECULE INHIBITOR; HUMAN GENOME; NUCLEAR REORGANIZATION; TRANSCRIPTOME MAP; MAMMALIAN-CELLS; GENE-REGULATION; EARLY G1; IN-VIVO; REVEALS	Despite the distinctive structure of mitotic chromosomes, it has not been possible to visualise individual chromosomes in living interphase cells, where chromosomes spend over 90% of their time. Studies of interphase chromosome structure and dynamics use fluorescence in-situ hybridisation (FISH) on fixed cells, which potentially damages structure and loses dynamic information. We have developed a new methodology, involving photoactivation of labelled histone H3 at mitosis, to visualise individual and specific human chromosomes in living interphase cells. Our data revealed bulk chromosome volume and morphology are established rapidly after mitosis, changing only incrementally after the first hour of G1. This contrasted with the behaviour of specific loci on labelled chromosomes, which showed more progressive reorganisation, and revealed that "looping out'' of chromatin from chromosome territories is a dynamic state. We measured considerable heterogeneity in chromosome decondensation, even between sister chromatids, which may reflect local structural impediments to decondensation and could potentially amplify transcriptional noise. Chromosome structure showed tremendous resistance to inhibitors of transcription, histone deacetylation and chromatin remodelling. Together, these data indicate steric constraints determine structure, rather than innate chromosome architecture or function-driven anchoring, with interphase chromatin organisation governed primarily by opposition between needs for decondensation and the space available for this to happen.	[Mueller, Iris; Chubb, Jonathan R.] Univ Dundee, Coll Life Sci, Div Cell & Dev Biol, Dundee, Scotland; [Boyle, Shelagh; Bickmore, Wendy A.] Univ Edinburgh, Human Genet Unit, MRC, Inst Genet & Mol Med, Edinburgh EH8 9YL, Midlothian, Scotland; [Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA	University of Dundee; University of Edinburgh; Yeshiva University; Albert Einstein College of Medicine	Muller, I (corresponding author), Univ Dundee, Coll Life Sci, Div Cell & Dev Biol, Dundee, Scotland.	j.chubb@dundee.ac.uk	Bickmore, Wendy A/C-7314-2013	Bickmore, Wendy A/0000-0001-6660-7735	Medical Research Council; MRC [MC_U127527202, G0600242] Funding Source: UKRI; Medical Research Council [G0600242, MC_U127527202] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086217] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work presented here was supported by a Medical Research Council Career Development Award and Project Grant to JRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney JR, 1997, J CELL BIOL, V137, P1459, DOI 10.1083/jcb.137.7.1459; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Bin Sun H, 2000, BIOPHYS J, V79, P184, DOI 10.1016/S0006-3495(00)76282-5; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Bridger JM, 2000, CURR BIOL, V10, P149, DOI 10.1016/S0960-9822(00)00312-2; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chuang CH, 2007, SEMIN CELL DEV BIOL, V18, P698, DOI 10.1016/j.semcdb.2007.08.012; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cioce M, 2006, J CELL BIOL, V175, P401, DOI 10.1083/jcb.200604099; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Cook PR, 2002, NAT GENET, V32, P347, DOI 10.1038/ng1102-347; Cremer M, 2001, CHROMOSOME RES, V9, P541, DOI 10.1023/A:1012495201697; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Ferrai C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000270; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Gierman HJ, 2007, GENOME RES, V17, P1286, DOI 10.1101/gr.6276007; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Gilchrist Susan, 2004, Chromosome Res, V12, P505; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Hagedorn Monica, 2006, V346, P327; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Hepperger C, 2007, CHROMOSOMA, V116, P117, DOI 10.1007/s00412-006-0084-2; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Iannuccelli E, 2010, BIOINFORMATICS, V26, P696, DOI 10.1093/bioinformatics/btq013; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Kobliakova I, 2005, CHROMOSOME RES, V13, P169, DOI 10.1007/s10577-005-0308-y; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lleres D, 2009, J CELL BIOL, V187, P481, DOI 10.1083/jcb.200907029; Mahy NL, 2002, J CELL BIOL, V159, P753, DOI 10.1083/jcb.200207115; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Manders EMM, 1999, J CELL BIOL, V144, P813, DOI 10.1083/jcb.144.5.813; Manders EMM, 2003, CHROMOSOME RES, V11, P537, DOI 10.1023/A:1024995215340; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Mora-Bermudez F, 2007, METHODS, V41, P158, DOI 10.1016/j.ymeth.2006.07.035; MOREY C, 2009, GENOME RES; Morey C, 2007, DEVELOPMENT, V134, P909, DOI 10.1242/dev.02779; Muramoto T, 2008, DEVELOPMENT, V135, P1647, DOI 10.1242/dev.020115; Muramoto T, 2010, CURR BIOL, V20, P397, DOI 10.1016/j.cub.2010.01.017; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pederson T, 2000, MOL BIOL CELL, V11, P799, DOI 10.1091/mbc.11.3.799; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Platani M, 2002, NAT CELL BIOL, V4, P502, DOI 10.1038/ncb809; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; SCHEER U, 1984, J CELL BIOL, V99, P672, DOI 10.1083/jcb.99.2.672; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Stevense M, 2010, DEVELOPMENT, V137, P579, DOI 10.1242/dev.043836; Taddei A, 2005, EMBO REP, V6, P520, DOI 10.1038/sj.embor.7400441; Tanaka T, 2007, CELL CYCLE, V6, P371, DOI 10.4161/cc.6.3.3835; Thomson I, 2004, CURR BIOL, V14, P166, DOI 10.1016/j.cub.2003.12.024; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Vogt A, 1997, J BIOL CHEM, V272, P27224, DOI 10.1074/jbc.272.43.27224; Volpi EV, 2000, J CELL SCI, V113, P1565; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Wiesmeijer K, 2008, DIFFERENTIATION, V76, P83, DOI 10.1111/j.1432-0436.2007.00234.x; Williams RRE, 2002, EXP CELL RES, V272, P163, DOI 10.1006/excr.2001.5400; Zink D, 2003, METHODS, V29, P42, DOI 10.1016/S1046-2023(02)00289-X	72	45	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11560	10.1371/journal.pone.0011560	http://dx.doi.org/10.1371/journal.pone.0011560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644634	Green Published, Green Submitted, gold			2022-12-25	WOS:000279822300014
J	Burli, T; Baer, K; Ewers, H; Sidler, C; Fuhrer, C; Fritschy, JM				Buerli, Thomas; Baer, Kristin; Ewers, Helge; Sidler, Corinne; Fuhrer, Christian; Fritschy, Jean-Marc			Single Particle Tracking of alpha 7 Nicotinic AChR in Hippocampal Neurons Reveals Regulated Confinement at Glutamatergic and GABAergic Perisynaptic Sites	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR SUBUNIT; LONG-TERM PLASTICITY; BUNGAROTOXIN-BINDING; SURFACE TRAFFICKING; GLYCINE RECEPTORS; RAT HIPPOCAMPUS; AMPA RECEPTORS; NEUROTRANSMITTER RECEPTOR; POSTSYNAPTIC RECEPTORS; SYNAPTIC-TRANSMISSION	alpha 7 neuronal nicotinic acetylcholine receptors (alpha 7-nAChR) form Ca(2+)-permeable homopentameric channels modulating cortical network activity and cognitive processing. They are located pre- and postsynaptically and are highly abundant in hippocampal GABAergic interneurons. It is unclear how alpha 7-nAChRs are positioned in specific membrane microdomains, particularly in cultured neurons which are devoid of cholinergic synapses. To address this issue, we monitored by single particle tracking the lateral mobility of individual alpha 7-nAChRs labeled with alpha-bungarotoxin linked to quantum dots in live rat cultured hippocampal interneurons. Quantitative analysis revealed different modes of lateral diffusion of alpha 7-nAChR dependent on their subcellular localization. Confined receptors were found in the immediate vicinity of glutamatergic and GABAergic postsynaptic densities, as well as in extrasynaptic clusters of alpha-bungarotoxin labeling on dendrites. alpha 7-nAChRs avoided entering postsynaptic densities, but exhibited reduced mobility and long dwell times at perisynaptic locations, indicative of regulated confinement. Their diffusion coefficient was lower, on average, at glutamatergic than at GABAergic perisynaptic sites, suggesting differential, synapse-specific tethering mechanisms. Disruption of the cytoskeleton affected alpha 7-nAChR mobility and cell surface expression, but not their ability to form clusters. Finally, using tetrodotoxin to silence network activity, as well as exposure to a selective alpha 7-nAChR agonist or antagonist, we observed that alpha 7-nAChRs cell surface dynamics is modulated by chronic changes in neuronal activity. Altogether, given their high Ca(2+)-permeability, our results suggest a possible role of alpha 7-nAChR on interneurons for activating Ca(2+)-dependent signaling in the vicinity of GABAergic and glutamatergic synapses.	[Buerli, Thomas; Sidler, Corinne; Fritschy, Jean-Marc] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Baer, Kristin] Swansea Univ, Sch Med, Inst Life Sci, Swansea, W Glam, Wales; [Ewers, Helge] ETH, Phys Chem Lab, CH-8092 Zurich, Switzerland; [Fuhrer, Christian] Univ Zurich, Brain Res Inst, Dept Neurochem, Zurich, Switzerland	University of Zurich; Swansea University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Burli, T (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland.	fritschy@pharma.uzh.ch	Ewers, Helge/ABF-3629-2021; Ewers, Helge/I-3455-2012	Ewers, Helge/0000-0003-3948-4332; Fritschy, Jean-Marc/0000-0002-8552-3702	Swiss National Science Foundation; Swiss Foundation for Research on Muscle Diseases; FEBS	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Research on Muscle Diseases; FEBS	This work was supported by grants from the Swiss National Science Foundation and the Swiss Foundation for Research on Muscle Diseases and a FEBS long-term fellowship to H.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcor D, 2009, EUR J NEUROSCI, V30, P987, DOI 10.1111/j.1460-9568.2009.06927.x; Alkondon M, 1997, J PHARMACOL EXP THER, V283, P1396; Allison DW, 1998, J NEUROSCI, V18, P2423; Baer K, 2007, MOL CELL NEUROSCI, V35, P339, DOI 10.1016/j.mcn.2007.03.009; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; Bertrand D, 1993, CURR OPIN CELL BIOL, V5, P688, DOI 10.1016/0955-0674(93)90141-C; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; Charrier C, 2006, J NEUROSCI, V26, P8502, DOI 10.1523/JNEUROSCI.1758-06.2006; Chen DN, 1997, J BIOL CHEM, V272, P24024, DOI 10.1074/jbc.272.38.24024; Cincotta SL, 2008, CURR OPIN INVEST DR, V9, P47; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Ehrensperger MV, 2007, BIOPHYS J, V92, P3706, DOI 10.1529/biophysj.106.095596; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; Frazier CJ, 1998, J NEUROSCI, V18, P8228; Frazier CJ, 2003, J NEUROPHYSIOL, V89, P3018, DOI 10.1152/jn.01036.2002; FREEDMAN R, 1993, J NEUROSCI, V13, P1965; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Groc L, 2008, MOL MEMBR BIOL, V25, P344, DOI 10.1080/09687680801958364; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Jones S, 1999, TRENDS NEUROSCI, V22, P555, DOI 10.1016/S0166-2236(99)01471-X; Kawai H, 2002, J NEUROSCI, V22, P7903; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lardi-Studler B, 2007, J CELL SCI, V120, P1371, DOI 10.1242/jcs.003905; Levi S, 2008, NEURON, V59, P261, DOI 10.1016/j.neuron.2008.05.030; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; Levy RB, 2002, J NEUROSCI, V22, P5001, DOI 10.1523/JNEUROSCI.22-12-05001.2002; Li XY, 1998, J NEUROSCI, V18, P1904; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Maggi L, 2001, J PHYSIOL-LONDON, V536, P89, DOI 10.1111/j.1469-7793.2001.00089.x; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Nugent FS, 2008, J PHYSIOL-LONDON, V586, P1487, DOI 10.1113/jphysiol.2007.148098; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Renner M, 2008, CURR OPIN NEUROBIOL, V18, P532, DOI 10.1016/j.conb.2008.09.009; Rozsa B, 2008, EUR J NEUROSCI, V27, P364, DOI 10.1111/j.1460-9568.2007.05999.x; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; SEGUELA P, 1993, J NEUROSCI, V13, P596; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; van Kampen M, 2004, PSYCHOPHARMACOLOGY, V172, P375, DOI 10.1007/s00213-003-1668-7; Wanaverbecq N, 2007, J NEUROSCI, V27, P5683, DOI 10.1523/JNEUROSCI.1732-07.2007; WARD JM, 1990, FEBS LETT, V270, P45, DOI 10.1016/0014-5793(90)81231-C; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Young JW, 2007, EUR NEUROPSYCHOPHARM, V17, P145, DOI 10.1016/j.euroneuro.2006.03.008; Zhang JM, 2007, J PHYSIOL-LONDON, V579, P753, DOI 10.1113/jphysiol.2006.124578	60	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11507	10.1371/journal.pone.0011507	http://dx.doi.org/10.1371/journal.pone.0011507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634896	Green Published, Green Accepted, gold			2022-12-25	WOS:000279715300018
J	Frucht, CS; Uduman, M; Duke, JL; Kleinstein, SH; Santos-Sacchi, J; Navaratnam, DS				Frucht, Corey S.; Uduman, Mohamed; Duke, Jamie L.; Kleinstein, Steven H.; Santos-Sacchi, Joseph; Navaratnam, Dhasakumar S.			Gene Expression Analysis of Forskolin Treated Basilar Papillae Identifies MicroRNA181a as a Mediator of Proliferation	PLOS ONE			English	Article							HAIR CELL REGENERATION; FACTOR-BINDING SITES; INNER-EAR; DIRECT TRANSDIFFERENTIATION; SIGNALING PATHWAYS; TUMOR-SUPPRESSOR; ACOUSTIC TRAUMA; POCKET PROTEINS; STEM-CELLS; S-PHASE	Background: Auditory hair cells spontaneously regenerate following injury in birds but not mammals. A better understanding of the molecular events underlying hair cell regeneration in birds may allow for identification and eventually manipulation of relevant pathways in mammals to stimulate regeneration and restore hearing in deaf patients. Methodology/Principal Findings: Gene expression was profiled in forskolin treated (i.e., proliferating) and quiescent control auditory epithelia of post-hatch chicks using an Affymetrix whole-genome chicken array after 24 (n = 6), 48 (n = 6), and 72 (n = 12) hours in culture. In the forskolin-treated epithelia there was significant (p<0.05; >two-fold change) upregulation of many genes thought to be relevant to cell cycle control and inner ear development. Gene set enrichment analysis was performed on the data and identified myriad microRNAs that are likely to be upregulated in the regenerating tissue, including microRNA181a (miR181a), which is known to mediate proliferation in other systems. Functional experiments showed that miR181a overexpression is sufficient to stimulate proliferation within the basilar papilla, as assayed by BrdU incorporation. Further, some of the newly produced cells express the early hair cell marker myosin VI, suggesting that miR181a transfection can result in the production of new hair cells. Conclusions/Significance: These studies have identified a single microRNA, miR181a, that can cause proliferation in the chicken auditory epithelium with production of new hair cells.	[Frucht, Corey S.] Yale Univ, Sch Med, Med Scientist Training Program, New Haven, CT 06520 USA; [Frucht, Corey S.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA; [Uduman, Mohamed; Duke, Jamie L.; Kleinstein, Steven H.] Yale Univ, Interdept Program Computat Biol & Bioinfomat, New Haven, CT USA; [Uduman, Mohamed; Duke, Jamie L.; Kleinstein, Steven H.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Surg, Div Otolaryngol, New Haven, CT 06510 USA; [Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Santos-Sacchi, Joseph; Navaratnam, Dhasakumar S.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Navaratnam, Dhasakumar S.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Frucht, CS (corresponding author), Yale Univ, Sch Med, Med Scientist Training Program, New Haven, CT 06520 USA.	Dhasakumar.Navaratnam@Yale.edu		Duke, Jamie/0000-0002-4768-0846; Uduman, Mohamed/0000-0002-9725-0705	NIH [MSTP TG 2T32GM07205, T15 LM07056]; NIH/NIDCD [DC 007894, DC 000273, DC 008130]; National Organization for Hearing Research; National Library of Medicine; Ohse Grant for Surgical Research at Yale School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008130, R01DC007894, R01DC000273] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Organization for Hearing Research; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Ohse Grant for Surgical Research at Yale School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	CSF was supported by NIH MSTP TG 2T32GM07205 and an Ohse Grant for Surgical Research at Yale School of Medicine. CSF, JSS and DSN were supported by NIH/NIDCD grants DC 007894, DC 000273 and DC 008130. The authors would like to acknowledge the support of the National Organization for Hearing Research, which provided seed funding for this project to DSN. MU and JLD were supported by NIH Grant T15 LM07056 from the National Library of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler HJ, 1996, NEUROSCI LETT, V205, P17, DOI 10.1016/0304-3940(96)12367-3; *AFF INC, 2004, EUK SAMPL ARR PROC G; *AFF INC, 2009, GENECHIP EXPR AN TEC; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashery-Padan R, 2001, CURR OPIN CELL BIOL, V13, P706, DOI 10.1016/S0955-0674(00)00274-X; Baird RA, 1996, ANN NY ACAD SCI, V781, P59, DOI 10.1111/j.1749-6632.1996.tb15693.x; Baird RA, 2000, P NATL ACAD SCI USA, V97, P11722, DOI 10.1073/pnas.97.22.11722; BALAK KJ, 1990, J NEUROSCI, V10, P2502; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Brentani H, 2003, P NATL ACAD SCI USA, V100, P13418, DOI 10.1073/pnas.1233632100; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chen P, 1999, DEVELOPMENT, V126, P1581; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; Dalmay T, 2008, BIOCHEM SOC T, V36, P1194, DOI 10.1042/BST0361194; Dannenberg JH, 2004, GENE DEV, V18, P2952, DOI 10.1101/gad.322004; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Duncan LJ, 2006, J COMP NEUROL, V499, P691, DOI 10.1002/cne.21114; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gale JE, 2002, J NEUROBIOL, V50, P81, DOI 10.1002/neu.10002; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Hawkins RD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000525; Heanue TA, 2002, MECH DEVELOP, V111, P75, DOI 10.1016/S0925-4773(01)00611-6; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Johnson DG, 2006, CURR MOL MED, V6, P731; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; JORGENSEN JM, 1988, NATURWISSENSCHAFTEN, V75, P319, DOI 10.1007/BF00367330; Jude CD, 2008, CELL CYCLE, V7, P586, DOI 10.4161/cc.7.5.5549; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kumar JP, 2001, NAT REV GENET, V2, P846, DOI 10.1038/35098564; Lee K H, 1996, Audiol Neurootol, V1, P41; Lee YS, 2006, DEVELOPMENT, V133, P2817, DOI 10.1242/dev.02453; Li JM, 1997, P NATL ACAD SCI USA, V94, P4948, DOI 10.1073/pnas.94.10.4948; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Liu Y, 2007, PROTEOMICS, V7, P23, DOI 10.1002/pmic.200600456; Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084; Ma EY, 2009, CURR BIOL, V19, pR381, DOI 10.1016/j.cub.2009.03.057; Mangiardi DA, 2004, J COMP NEUROL, V475, P1, DOI 10.1002/cne.20129; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Montcouquiol M, 2001, J NEUROSCI, V21, P974, DOI 10.1523/JNEUROSCI.21-03-00974.2001; Narbonne P, 2008, FRONT BIOSCI-LANDMRK, V13, P995, DOI 10.2741/2738; Navaratnam DS, 1996, NAT MED, V2, P1136, DOI 10.1038/nm1096-1136; NEDZELSKI JM, 1993, AM J OTOL, V14, P278; OSHIMA K, 2010, STEM CELLS CELL, V141, P704; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Passerini AG, 2004, P NATL ACAD SCI USA, V101, P2482, DOI 10.1073/pnas.0305938101; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; RAPHAEL Y, 1992, J NEUROCYTOL, V21, P663, DOI 10.1007/BF01191727; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Roberson DW, 1996, AUDIT NEUROSCI, V2, P195; Roberson DW, 2004, J NEUROSCI RES, V78, P461, DOI 10.1002/jnr.20271; Rocha-Sanchez SMS, 2007, INT J DEV BIOL, V51, P585, DOI 10.1387/ijdb.072387sr; Roman-Gomez J, 2007, EUR J CANCER, V43, P2736, DOI 10.1016/j.ejca.2007.10.004; Rozen S, 2000, Methods Mol Biol, V132, P365; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; Sacheli R, 2009, GENE EXPR PATTERNS, V9, P364, DOI 10.1016/j.gep.2009.01.003; SAUNDERS SS, 1995, J ACOUST SOC AM, V98, P1365, DOI 10.1121/1.413472; SCHMIDT D, SCIENCE; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHUKNECHT HF, 1964, ARCHIV OTOLARYNGOL, V80, P369; SHANG J, 2010, J ASS RES OTOLARYNGO; Sienknecht UJ, 2008, J COMP NEUROL, V510, P378, DOI 10.1002/cne.21791; Sienknecht UJ, 2009, J COMP NEUROL, V517, P751, DOI 10.1002/cne.22169; Soukup GA, 2009, BRAIN RES, V1277, P104, DOI 10.1016/j.brainres.2009.02.027; Stevens CB, 2003, DEV BIOL, V261, P149, DOI 10.1016/S0012-1606(03)00297-5; Stone JS, 2007, INT J DEV BIOL, V51, P633, DOI 10.1387/ijdb.072408js; Stone JS, 1999, DEVELOPMENT, V126, P961; STONE JS, 1992, J CELL SCI, V102, P671; STONE JS, 1994, J COMP NEUROL, V341, P50, DOI 10.1002/cne.903410106; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor RR, 2005, J COMP NEUROL, V484, P105, DOI 10.1002/cne.20450; Tsonis PA, 2007, BIOCHEM BIOPH RES CO, V362, P940, DOI 10.1016/j.bbrc.2007.08.077; Vernell R, 2003, J BIOL CHEM, V278, P46124, DOI 10.1074/jbc.M304930200; Wang XN, 2009, CELL CYCLE, V8, P736, DOI 10.4161/cc.8.5.7870; Warchol ME, 1996, J NEUROSCI, V16, P5466; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; *WHO, 2005, WHO DEAFN HEAR IMP; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1	93	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11502	10.1371/journal.pone.0011502	http://dx.doi.org/10.1371/journal.pone.0011502			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634979	Green Submitted, Green Published, gold			2022-12-25	WOS:000279715300013
J	Liang, XW; Fomenko, DE; Hua, D; Kaya, A; Gladyshev, VN				Liang, Xinwen; Fomenko, Dmitri E.; Hua, Deame; Kaya, Alaattin; Gladyshev, Vadim N.			Diversity of Protein and mRNA Forms of Mammalian Methionine Sulfoxide Reductase B1 Due to Intronization and Protein Processing	PLOS ONE			English	Article							INDUCED CELL-DEATH; OXIDATIVE STRESS; INSERTION; POLYADENYLATION; OVEREXPRESSION; IDENTIFICATION; INTRONS; ROLES; SITES; ZINC	Background: Methionine sulfoxide reductases (Msrs) are repair enzymes that protect proteins from oxidative stress by catalyzing stereospecific reduction of oxidized methionine residues. MsrB1 is a selenocysteine-containing cytosolic/nuclear Msr with high expression in liver and kidney. Principal Findings: Here, we identified differences in MsrB1 gene structure among mammals. Human MsrB1 gene consists of four, whereas the corresponding mouse gene of five exons, due to occurrence of an additional intron that flanks the stop signal and covers a large part of the 3'-UTR. This intron evolved in a subset of rodents through intronization of exonic sequences, whereas the human gene structure represents the ancestral form. In mice, both splice forms were detected in liver, kidney, brain and heart with the five-exon form being the major form. We found that both mRNA forms were translated and supported efficient selenocysteine insertion into MsrB1. In addition, MsrB1 occurs in two protein forms that migrate as 14 and 5 kDa proteins. We found that each mRNA splice form generated both protein forms. The abundance of the 5 kDa form was not influenced by protease inhibitors, replacement of selenocysteine in the active site or mutation of amino acids in the cleavage site. However, mutation of cysteines that coordinate a structural zinc decreased the levels of 5 and 14 kDa forms, suggesting importance of protein structure for biosynthesis and/stability of these forms. Conclusions: This study characterized unexpected diversity of protein and mRNA forms of mammalian selenoprotein MsrB1.	[Liang, Xinwen; Fomenko, Dmitri E.; Hua, Deame; Kaya, Alaattin; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Liang, Xinwen; Fomenko, Dmitri E.; Hua, Deame; Kaya, Alaattin; Gladyshev, Vadim N.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68583 USA; [Gladyshev, Vadim N.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Liang, XW (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA.	vgladyshev@rics.bwh.harvard.edu	Kaya, Alaattin/T-6427-2017; Gladyshev, Vadim N/J-6187-2013; Gladyshev, Vadim N/A-9894-2013	Kaya, Alaattin/0000-0002-6132-5197; Gladyshev, Vadim/0000-0002-0372-7016	NIH [AG021518]; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH AG021518. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaudoing E, 2001, GENOME RES, V11, P1520, DOI 10.1101/gr.190501; Brinkman BMN, 2004, CLIN BIOCHEM, V37, P584, DOI 10.1016/j.clinbiochem.2004.05.015; Cabreiro F, 2008, J BIOL CHEM, V283, P16673, DOI 10.1074/jbc.M708580200; Cabreiro F, 2006, ANN NY ACAD SCI, V1067, P37, DOI 10.1196/annals.1354.006; Cabreiro F, 2009, ANTIOXID REDOX SIGN, V11, P215, DOI [10.1089/ars.2008.2102, 10.1089/ARS.2008.2102]; Catania F, 2008, PLOS BIOL, V6, P2354, DOI 10.1371/journal.pbio.0060283; Ding D, 2007, BIOCHEM BIOPH RES CO, V361, P629, DOI 10.1016/j.bbrc.2007.07.072; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Fomenko DE, 2009, J BIOL CHEM, V284, P5986, DOI 10.1074/jbc.M805770200; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Harvey NL, 1996, GENES CELLS, V1, P673, DOI 10.1046/j.1365-2443.1996.00255.x; Irimia M, 2008, TRENDS GENET, V24, P378, DOI 10.1016/j.tig.2008.05.007; Kim HY, 2007, BIOCHEM J, V407, P321, DOI 10.1042/BJ20070929; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Kryukov GV, 1999, J BIOL CHEM, V274, P33888, DOI 10.1074/jbc.274.48.33888; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Kumar RA, 2002, J BIOL CHEM, V277, P37527, DOI 10.1074/jbc.M203496200; Long GL, 1998, J BIOL CHEM, V273, P11521, DOI 10.1074/jbc.273.19.11521; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; Marchetti MA, 2006, EXP EYE RES, V83, P1281, DOI 10.1016/j.exer.2006.07.005; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; Novoselov SV, 2007, P NATL ACAD SCI USA, V104, P7857, DOI 10.1073/pnas.0610683104; Nurtdinov RN, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-142; OKE TT, 2009, J PARASITOL; Picot CR, 2007, EXP GERONTOL, V42, P859, DOI 10.1016/j.exger.2007.02.006; Prentice HM, 2008, BIOCHEM BIOPH RES CO, V366, P775, DOI 10.1016/j.bbrc.2007.12.043; Roy SW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-192; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; Turanov AA, 2009, SCIENCE, V323, P259, DOI 10.1126/science.1164748; Vinokur V, 2009, BIOGERONTOLOGY, V10, P43, DOI 10.1007/s10522-008-9152-8; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	34	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11497	10.1371/journal.pone.0011497	http://dx.doi.org/10.1371/journal.pone.0011497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634897	Green Published, gold			2022-12-25	WOS:000279715300010
J	Mamtani, M; Matsubara, T; Shimizu, C; Furukawa, S; Akagi, T; Onouchi, Y; Hata, A; Fujino, A; He, WJ; Ahuja, SK; Burns, JC				Mamtani, Manju; Matsubara, Tomoyo; Shimizu, Chisato; Furukawa, Susumu; Akagi, Teiji; Onouchi, Yoshihiro; Hata, Akira; Fujino, Akihiro; He, Weijing; Ahuja, Sunil K.; Burns, Jane C.			Association of CCR2-CCR5 Haplotypes and CCL3L1 Copy Number with Kawasaki Disease, Coronary Artery Lesions, and IVIG Responses in Japanese Children	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INTRAVENOUS IMMUNOGLOBULIN TREATMENT; CONTAINING SEGMENTAL DUPLICATIONS; RECEPTOR GENE POLYMORPHISMS; GAMMA-GLOBULIN THERAPY; RISK-FACTORS; SUSCEPTIBILITY; CCR5; PREDICTION; INVOLVEMENT	Background: The etiology of Kawasaki Disease (KD) is enigmatic, although an infectious cause is suspected. Polymorphisms in CC chemokine receptor 5 (CCR5) and/or its potent ligand CCL3L1 influence KD susceptibility in US, European and Korean populations. However, the influence of these variations on KD susceptibility, coronary artery lesions (CAL) and response to intravenous immunoglobulin (IVIG) in Japanese children, who have the highest incidence of KD, is unknown. Methodology/Principal Findings: We used unconditional logistic regression analyses to determine the associations of the copy number of the CCL3L1 gene-containing duplication and CCR2-CCR5 haplotypes in 133 Japanese KD cases [33 with CAL and 25 with resistance to IVIG] and 312 Japanese controls without a history of KD. We observed that the deviation from the population average of four CCL3L1 copies (i.e., or. four copies) was associated with an increased risk of KD and IVIG resistance (adjusted odds ratio (OR) = 2.25, p = 0.004 and OR = 6.26, p = 0.089, respectively). Heterozygosity for the CCR5 HHF*2 haplotype was associated with a reduced risk of both IVIG resistance (OR = 0.21, p = 0.026) and CAL development (OR = 0.44, p = 0.071). Conclusions/Significance: The CCL3L1-CCR5 axis may play an important role in KD pathogenesis. In addition to clinical and laboratory parameters, genetic markers may also predict risk of CAL and resistance to IVIG.	[Mamtani, Manju; He, Weijing; Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; [Mamtani, Manju; He, Weijing; Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Vet Adm Ctr AIDS & HIV Infect 1, San Antonio, TX 78229 USA; [Matsubara, Tomoyo] Juntendo Univ, Grad Sch Med, Dept Pediat, Chiba, Japan; [Shimizu, Chisato; Burns, Jane C.] Univ Calif San Diego, Sch Med, Rady Childrens Hosp, Dept Pediat, La Jolla, CA 92093 USA; [Furukawa, Susumu] Yamaguchi Univ, Grad Sch Med, Dept Pediat, Yamaguchi, Japan; [Akagi, Teiji] Okayama Univ Hosp, Pediat Cardiac Care Unit, Okayama, Japan; [Onouchi, Yoshihiro] RIKEN, Ctr Genom Med, Lab Cardiovasc Dis, Kanagawa, Japan; [Hata, Akira] Chiba Univ, Dept Publ Hlth, Grad Sch Med, Chiba, Japan; [Fujino, Akihiro] Natl Ctr Child Hlth & Dev, Dept Surg, Tokyo, Japan; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; Juntendo University; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Yamaguchi University; Okayama University; RIKEN; Chiba University; National Center for Child Health & Development - Japan; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Mamtani, M (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA.	ahujas@uthscsa.edu	Fujino, Akihiro/AAH-2243-2019; Burns, Jane C/J-6167-2015; Shimizu, Chisato/J-6516-2015	Fujino, Akihiro/0000-0003-2987-5081; 	National Institutes of Health, National Heart, Lung, Blood Institute [HL074864, HL69413]; Max and Minnie Tomerlin Voelcker Fund; Burroughs Wellcome Clinical Scientist Award in Translational Research; Doris Duke Distinguished Clinical Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL074864, R01HL069413] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Max and Minnie Tomerlin Voelcker Fund; Burroughs Wellcome Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the National Institutes of Health, National Heart, Lung, Blood Institute, HL074864 and HL69413 awarded to JCB. This work was also supported by the Voelcker Senior Scholar Award from The Max and Minnie Tomerlin Voelcker Fund awarded to SKA. SKA is also supported by a Burroughs Wellcome Clinical Scientist Award in Translational Research, and the Doris Duke Distinguished Clinical Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGI T, 1992, J PEDIATR-US, V121, P689, DOI 10.1016/S0022-3476(05)81894-3; Asano T, 2000, CLIN EXP IMMUNOL, V122, P514, DOI 10.1046/j.1365-2249.2000.01395.x; Asano T, 2000, SCAND J IMMUNOL, V51, P98; Aukrust P, 2008, ARTERIOSCL THROM VAS, V28, P1909, DOI 10.1161/ATVBAHA.107.161240; Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Ballow M, 2005, AM J HEALTH-SYST PH, V62, pS12, DOI 10.2146/ajhp050283; Biezeveld M, 2007, CLIN EXP IMMUNOL, V147, P106, DOI 10.1111/j.1365-2249.2006.03266.x; Breunis WB, 2007, CLIN EXP IMMUNOL, V150, P83, DOI 10.1111/j.1365-2249.2007.03457.x; Burns JC, 2005, J INFECT DIS, V192, P344, DOI 10.1086/430953; Burns JC, 2005, GENES IMMUN, V6, P438, DOI 10.1038/sj.gene.6364225; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009; Cha S, 2008, J KOREAN MED SCI, V23, P718, DOI 10.3346/jkms.2008.23.4.718; Cheung YF, 2008, PEDIATRICS, V122, pE608, DOI 10.1542/peds.2008-0646; de Zorzi A, 1998, J PEDIATR-US, V133, P254, DOI 10.1016/S0022-3476(98)70229-X; DENG XW, 2002, POLYMORPHISMS CORECE; Egami K, 2006, J PEDIATR-US, V149, P237, DOI 10.1016/j.jpeds.2006.03.050; Fietta P, 2009, RIV BIOL-BIOL FORUM, V102, P61; Fukunishi M, 2000, J PEDIATR-US, V137, P172, DOI 10.1067/mpd.2000.104815; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Guzman-Cottrill J A, 2004, Minerva Pediatr, V56, P51; Harnden A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1514; Hizawa N, 1999, AM J RESP CRIT CARE, V159, P2021, DOI 10.1164/ajrccm.159.6.9810020; Hsueh KC, 2008, J RHEUMATOL, V35, P1408; JHANG WK, 2008, J CLIN IMMUNOL; Jibiki T, 2001, ARTHRITIS RHEUM, V44, P2211, DOI 10.1002/1529-0131(200109)44:9<2211::AID-ART375>3.0.CO;2-A; Kariyazono H, 2004, PEDIATR RES, V56, P953, DOI 10.1203/01.PDR.0000145280.26284.B9; Kelchtermans H, 2008, TRENDS IMMUNOL, V29, P479, DOI 10.1016/j.it.2008.07.002; Kim T, 2007, EUR J PEDIATR, V166, P421, DOI 10.1007/s00431-006-0251-8; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; Kobayashi Tohru, 2008, Nihon Rinsho, V66, P332; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Mamtani M, 2008, ANN RHEUM DIS, V67, P1076, DOI 10.1136/ard.2007.078048; Mamtani M, 2010, GENES IMMUN, V11, P155, DOI 10.1038/gene.2009.71; McCrindle BW, 2007, CIRCULATION, V116, P174, DOI 10.1161/CIRCULATIONAHA.107.690875; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Minami T, 2005, J PEDIATR-US, V147, P78, DOI 10.1016/j.jpeds.2005.03.037; Miura M, 2004, ARCH DIS CHILD, V89, P776, DOI 10.1136/adc.2003.032748; Miyagishi R, 2003, J NEUROIMMUNOL, V145, P135, DOI 10.1016/j.jneuroim.2003.09.003; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786; Nishimura S, 2003, J PEDIATR-US, V143, P357, DOI 10.1067/S0022-3476(03)00330-5; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Park JA, 2005, J KOREAN MED SCI, V20, P607, DOI 10.3346/jkms.2005.20.4.607; Park-Min KH, 2007, IMMUNITY, V26, P67, DOI 10.1016/j.immuni.2006.11.010; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rowley AH, 2007, CURR OPIN PEDIATR, V19, P71, DOI 10.1097/MOP.0b013e328012720f; Sano T, 2007, EUR J PEDIATR, V166, P131, DOI 10.1007/s00431-006-0223-z; Sittiwangkul R., 2006, SMJ Singapore Medical Journal, V47, P780; Takahashi K, 2005, PEDIATR INT, V47, P305, DOI 10.1111/j.1442-200x.2005.02049.x; Terai M, 1999, J LEUKOCYTE BIOL, V65, P566, DOI 10.1002/jlb.65.5.566; Townson JR, 2002, EUR J IMMUNOL, V32, P3016, DOI 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D; Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021; Wong M, 1997, J RHEUMATOL, V24, P1179; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019	58	17	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11458	10.1371/journal.pone.0011458	http://dx.doi.org/10.1371/journal.pone.0011458			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628649	Green Published, Green Submitted, gold			2022-12-25	WOS:000279589300006
J	Kim, HJ; Alonzo, ES; Dorothee, G; Pollard, JW; Sant'Angelo, DB				Kim, Hye-Jung; Alonzo, Eric S.; Dorothee, Guillaume; Pollard, Jeffrey W.; Sant'Angelo, Derek B.			Selective Depletion of Eosinophils or Neutrophils in Mice Impacts the Efficiency of Apoptotic Cell Clearance in the Thymus	PLOS ONE			English	Article							IN-VIVO; RECEPTOR; MACROPHAGES; INFLAMMATION; ACTIVATION; THYMOCYTES; DEFICIENT; TOLERANCE; MONOCYTES; DELETION	Developing thymocytes undergo a rigorous selection process to ensure that the mature T cell population expresses a T cell receptor (TCR) repertoire that can functionally interact with major histocompatibility complexes (MHC). Over 90% of thymocytes fail this selection process and die. A small number of macrophages within the thymus are responsible for clearing the large number of dying thymocytes that must be continuously cleared. We studied the capacity of thymic macrophages to clear apoptotic cells under acute circumstances. This was done by synchronously inducing cell death in the thymus and then monitoring the clearance of apoptotic thymocytes. Interestingly, acute cell death was shown to recruit large numbers of CD11b(+) cells into the thymus. In the absence of a minor CSF-1 dependent population of macrophages, the recruitment of these CD11b(+) cells into the thymus was greatly reduced and the clearance of apoptotic cells was disrupted. To assess a possible role for the CD11b(+) cells in the clearance of apoptotic cells, we analyzed mice deficient for eosinophils and mice with defective trafficking of neutrophils. Failure to attract either eosinophils or neutrophils to the thymus resulted in the impaired clearance of apoptotic cells. These results suggested that there is crosstalk between cells of the innate immune system that is necessary for maximizing the efficiency of apoptotic cell removal.	[Kim, Hye-Jung; Dorothee, Guillaume; Sant'Angelo, Derek B.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; [Alonzo, Eric S.; Sant'Angelo, Derek B.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10021 USA; [Sant'Angelo, Derek B.] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA; [Pollard, Jeffrey W.] Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Yeshiva University	Kim, HJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	santangd@mskcc.org	DOROTHEE, Guillaume/O-9760-2016	DOROTHEE, Guillaume/0000-0001-5763-3632	 [NCI P30-CA 08748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant # NCI P30-CA 08748, which provides partial support for Memorial Sloan-Kettering's Monoclonal Antibody, Flow Cytometry, Glassware Washing core facilities and the Research Animal Resource Center, the May and Samuel Rudin Family Foundation and funds from MSKCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R E, 1976, Adv Immunol, V24, P215, DOI 10.1016/S0065-2776(08)60331-4; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; Esashi E, 2003, J IMMUNOL, V171, P2773, DOI 10.4049/jimmunol.171.6.2773; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Iyoda T, 2005, J IMMUNOL, V175, P3475, DOI 10.4049/jimmunol.175.6.3475; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kim SJ, 2004, IMMUNITY, V21, P643, DOI 10.1016/j.immuni.2004.09.009; Klein L, 2001, EUR J IMMUNOL, V31, P2476, DOI 10.1002/1521-4141(200108)31:8<2476::AID-IMMU2476>3.0.CO;2-T; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; MIYAZAKI T, 1993, INT IMMUNOL, V5, P1023, DOI 10.1093/intimm/5.9.1023; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; NATHAN CF, 1982, J EXP MED, V155, P1291, DOI 10.1084/jem.155.5.1291; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; SHI YF, 1991, J IMMUNOL, V146, P3340; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Throsby M, 2000, J IMMUNOL, V165, P1965, DOI 10.4049/jimmunol.165.4.1965; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Xiao YQ, 2008, J IMMUNOL, V181, P3575, DOI 10.4049/jimmunol.181.5.3575; Yamada Y, 1998, CELL MOL LIFE SCI, V54, P628, DOI 10.1007/s000180050191; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255	35	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11439	10.1371/journal.pone.0011439	http://dx.doi.org/10.1371/journal.pone.0011439			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625428	Green Published, Green Submitted, gold			2022-12-25	WOS:000279522500007
J	Ponsaerts, R; De Vuyst, E; Retamal, M; D'hondt, C; Vermeire, D; Wang, N; De Smedt, H; Zimmermann, P; Himpens, B; Vereecke, J; Leybaert, L; Bultynck, G				Ponsaerts, Raf; De Vuyst, Elke; Retamal, Mauricio; D'hondt, Catheleyne; Vermeire, Dieter; Wang, Nan; De Smedt, Humbert; Zimmermann, Pascale; Himpens, Bernard; Vereecke, Johan; Leybaert, Luc; Bultynck, Geert			Intramolecular loop/tail interactions are essential for connexin 43-hemichannel activity	FASEB JOURNAL			English	Article						intercellular communication; actomyosin contractility; intracellular calcium; purinergic signaling	GAP-JUNCTION PROTEIN; CORNEAL ENDOTHELIAL-CELLS; INTERCELLULAR CALCIUM WAVE; C6 GLIOMA-CELLS; THROMBIN-INDUCED INHIBITION; OCULODENTODIGITAL DYSPLASIA; ZONULA OCCLUDENS-1; CARBOXYL-TERMINUS; CARDIAC MYOCYTES; ATP RELEASE	Connexin-assembled gap junctions (GJs) and hemichannels coordinate intercellular signaling processes. Although the regulation of connexins in GJs has been well characterized, the molecular determinants controlling connexin-hemichannel activity are unresolved. Here we investigated the regulation of Cx43-hemichannel activity by actomyosin contractility and intracellular [Ca2+] ([Ca2+](i)) using plasma membrane-permeable TAT peptides (100 mu M) designed to interfere with interactions between the cytoplasmic loop (CL) and carboxy-terminal (CT) in primary bovine corneal endothelial cells and HeLa, C6 glioma, and Xenopus oocytes ectopically expressing Cx43. Peptides corresponding to the last 10 CT aa (TAT-Cx43CT) prevented the inhibition of Cx43-hemichannel activity by contractility/high [Ca2+](i), whereas a reverse peptide (TAT-Cx43CTrev) did not. These effects were independent of zonula occludens-1, a cytoskeletal-associated Cx43-binding protein. In contrast, peptides corresponding to CL (TAT-L2) inhibited Cx43-hemichannel responses, whereas a mutant peptide (TAT-L2(H126K/I130N)) did not inhibit. In these assays, TAT-Cx43CT acted as a scaffold for TAT-L2 and vice versa, a finding supported by surface plasmon resonance measurements. Loop/tail interactions appeared essential for Cx43-hemichannel activity, because TAT-Cx43CT restored the activity of nonfunctional hemichannels, consisting of either Cx43 lacking the C-terminal tail (Cx43(M239)) or intact Cx43 ectopically expressed in Xenopus oocytes. We conclude that intramolecular loop/tail interactions control Cx43-hemichannel activity, laying the basis for developing hemichannel-specific blockers.-Ponsaerts, R., De Vuyst, E., Retamal, M., D'hondt, C., Vermeire, D., Wang, N., De Smedt, H., Zimmermann, P., Himpens, B., Vereecke, J., Leybaert, L., Bultynck, G. Intramolecular loop/tail interactions are essential for connexin 43-hemichannel activity. FASEB J. 24, 4378-4395 (2010). www.fasebj.org	[Ponsaerts, Raf; D'hondt, Catheleyne; De Smedt, Humbert; Himpens, Bernard; Vereecke, Johan; Bultynck, Geert] Katholieke Univ Leuven, Lab Mol & Cellular Signaling, Dept Mol Cell Biol, BE-3000 Louvain, Belgium; [Vermeire, Dieter; Zimmermann, Pascale] Katholieke Univ Leuven, Dept Human Genet, Lab Signal Integrat Cell Fate Decis, BE-3000 Louvain, Belgium; [De Vuyst, Elke; Wang, Nan; Leybaert, Luc] Univ Ghent, Dept Basic Med Sci, Physiol Grp, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Retamal, Mauricio] Clin Alemana Univ Desarrollo, Lab Fisiol, Santiago, Chile	KU Leuven; KU Leuven; Ghent University; Universidad del Desarrollo	Bultynck, G (corresponding author), Katholieke Univ Leuven, Lab Mol & Cellular Signaling, Dept Mol Cell Biol, Campus Gasthuisberg O-N-1 Bus 802,Herestr 49, BE-3000 Louvain, Belgium.	geert.bultynck@med.kuleuven.be	Zimmermann, Pascale/P-4190-2017; Leybaert, Luc/F-4079-2015	Leybaert, Luc/0000-0001-6452-6982; Bultynck, Geert/0000-0002-5968-4828; Retamal, Mauricio A./0000-0003-2562-6686	Concerted Actions of the K.U. Leuven [GOA/09/012]; F.W.O. (Fund for Scientific Research Flanders) [G.0545.08, G.0354.07, G.0140.08, G.0134.09]; Interuniversity Attraction Poles Program [P6/28, P6/31]; Fondecyt de Iniciacion [11080061]	Concerted Actions of the K.U. Leuven; F.W.O. (Fund for Scientific Research Flanders)(FWO); Interuniversity Attraction Poles Program(Belgian Federal Science Policy Office); Fondecyt de Iniciacion(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The authors thank Dr. Bernd Nilius and Dr. Ludwig Missiaen for critical reading of the paper. This work was supported by Concerted Actions of the K.U. Leuven (grant GOA/09/012) to H.D.S.; by F.W.O. (Fund for Scientific Research Flanders; G.0545.08 to B.H. and J.V.; G.0354.07, G.0140.08, and G.0134.09 to L.L.); by the Interuniversity Attraction Poles Program (Belgian Science Policy; P6/28 to H.D.S. and B.H.; P6/31 to L.L.); and by the Fondecyt de Iniciacion (11080061 to M.R.). The authors do not have any commercial affiliations or conflict of interests.	Bao XY, 2004, J BIOL CHEM, V279, P9689, DOI 10.1074/jbc.M311438200; Bao XY, 2004, AM J PHYSIOL-CELL PH, V286, pC647, DOI 10.1152/ajpcell.00295.2003; Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; Bouvier D, 2008, CELL COMMUN ADHES, V15, P107, DOI 10.1080/15419060802014347; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; Butkevich E, 2004, CURR BIOL, V14, P650, DOI 10.1016/j.cub.2004.03.063; Clarke TC, 2009, EUR J PHARMACOL, V605, P9, DOI 10.1016/j.ejphar.2008.12.005; Contreras JE, 2004, BRAIN RES REV, V47, P290, DOI 10.1016/j.brainresrev.2004.08.002; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; D'hondt C, 2007, INVEST OPHTH VIS SCI, V48, P1518, DOI 10.1167/iovs.06-1062; D'hondt C, 2007, INVEST OPHTH VIS SCI, V48, P120, DOI 10.1167/iovs.06-0770; De Vuyst E, 2006, EMBO J, V25, P34, DOI 10.1038/sj.emboj.7600908; De Vuyst E, 2007, MOL BIOL CELL, V18, P34, DOI 10.1091/mbc.E06-03-0182; De Vuyst E, 2009, CELL CALCIUM, V46, P176, DOI 10.1016/j.ceca.2009.07.002; Decrock E, 2009, CELL DEATH DIFFER, V16, P524, DOI 10.1038/cdd.2008.196; Delmar M, 2004, CARDIOVASC RES, V62, P268, DOI 10.1016/j.cardiores.2003.12.030; Derangeon M, 2008, J BIOL CHEM, V283, P30754, DOI 10.1074/jbc.M801556200; Dobrowolski R, 2008, HUM MOL GENET, V17, P539, DOI 10.1093/hmg/ddm329; Dobrowolski R, 2007, J MEMBRANE BIOL, V219, P9, DOI 10.1007/s00232-007-9055-7; Duffy HS, 2004, CIRC RES, V94, P215, DOI 10.1161/01.RES.0000113924.06926.11; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; Flores CE, 2008, P NATL ACAD SCI USA, V105, P12545, DOI 10.1073/pnas.0804793105; Fu CT, 2004, J BIOL CHEM, V279, P36943, DOI 10.1074/jbc.M403952200; Gellhaus A, 2004, J BIOL CHEM, V279, P36931, DOI 10.1074/jbc.M404073200; Giepmans BNG, 2006, ADV CARDIOL, V42, P41, DOI 10.1159/000092561; Giepmans BNG, 2001, CELL COMMUN ADHES, V8, P219, DOI 10.3109/15419060109080727; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Gomes P, 2005, INVEST OPHTH VIS SCI, V46, P1208, DOI 10.1167/iovs.04-1181; Gomes P, 2005, INVEST OPHTH VIS SCI, V46, P104, DOI 10.1167/iovs.04-0846; Grootjans JJ, 2000, J BIOL CHEM, V275, P19933, DOI 10.1074/jbc.M002459200; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Hirst-Jensen BJ, 2007, J BIOL CHEM, V282, P5801, DOI 10.1074/jbc.M605233200; Homma N, 1998, CIRC RES, V83, P27, DOI 10.1161/01.RES.83.1.27; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Hunter AW, 2003, CELL COMMUN ADHES, V10, P211, DOI 10.1080/714040429; Iyer S, 2007, COMPUT METH PROG BIO, V85, P203, DOI 10.1016/j.cmpb.2006.11.004; Kalcheva N, 2007, P NATL ACAD SCI USA, V104, P20512, DOI 10.1073/pnas.0705472105; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; KONIG N, 1995, J CELL SCI, V108, P3091; Lai A, 2006, J CELL SCI, V119, P532, DOI 10.1242/jcs.02770; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lan Z, 2005, BIOCHEMISTRY-US, V44, P2385, DOI 10.1021/bi048306w; Laux-Fenton WT, 2003, CORNEA, V22, P457, DOI 10.1097/00003226-200307000-00012; Levesque SA, 2007, BRIT J PHARMACOL, V152, P141, DOI 10.1038/sj.bjp.0707361; Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Liu F, 2006, J BIOL CHEM, V281, P23207, DOI 10.1074/jbc.M605048200; Maass K, 2007, CIRC RES, V101, P1283, DOI 10.1161/CIRCRESAHA.107.162818; Moreno AP, 2002, CIRC RES, V90, P450, DOI 10.1161/hh0402.105667; Morley GE, 1996, BIOPHYS J, V70, pMP318; Omori Y, 1999, CARCINOGENESIS, V20, P1913, DOI 10.1093/carcin/20.10.1913; Orellana JA, 2009, ANTIOXID REDOX SIGN, V11, P369, DOI 10.1089/ars.2008.2130; Owens LM, 1996, CIRCULATION, V94, P10, DOI 10.1161/01.CIR.94.1.10; Ponsaerts R, 2008, INVEST OPHTH VIS SCI, V49, P4816, DOI 10.1167/iovs.07-1533; Ponsaerts R, 2010, EXTRACELLULAR ATP AND ADENOSINE AS REGULATORS OF ENDOTHELIAL CELL FUNCTION, P161, DOI 10.1007/978-90-481-3435-9_10; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Retamal MA, 2007, J MEMBRANE BIOL, V218, P49, DOI 10.1007/s00232-007-9043-y; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Retamal MA, 2009, AM J PHYSIOL-CELL PH, V296, pC1356, DOI 10.1152/ajpcell.00054.2009; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Scemes E, 2009, PFLUG ARCH EUR J PHY, V457, P1207, DOI 10.1007/s00424-008-0591-5; Seki A, 2004, CIRC RES, V95, P22, DOI 10.1161/01.RES.0000140737.62245.c5; Shibayama J, 2006, BIOPHYS J, V91, P4054, DOI 10.1529/biophysj.106.085787; Sin WC, 2008, J CELL BIOCHEM, V103, P1772, DOI 10.1002/jcb.21571; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Spray DC, 2006, GLIA, V54, P758, DOI 10.1002/glia.20429; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Thimm J, 2005, J BIOL CHEM, V280, P10646, DOI 10.1074/jbc.M412749200; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Toyofuku T, 2001, J BIOL CHEM, V276, P1780, DOI 10.1074/jbc.M005826200; Verselis VK, 2008, J GEN PHYSIOL, V132, P315, DOI 10.1085/jgp.200810029; Vitale ML, 2009, MICROSC RES TECHNIQ, V72, P856, DOI 10.1002/jemt.20771; White TW, 1999, EUR J NEUROSCI, V11, P1883, DOI 10.1046/j.1460-9568.1999.00607.x; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Yokota H, 2000, CRIT CARE MED, V28, P3275, DOI 10.1097/00003246-200009000-00025; ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883	84	123	127	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4378	4395		10.1096/fj.09-153007	http://dx.doi.org/10.1096/fj.09-153007			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20634352	Green Accepted			2022-12-25	WOS:000283861100025
J	Zadravec, D; Brolinson, A; Fisher, RM; Carneheim, C; Csikasz, RI; Bertrand-Michel, J; Boren, J; Guillou, H; Rudling, M; Jacobsson, A				Zadravec, Damir; Brolinson, Annelie; Fisher, Rachel M.; Carneheim, Claes; Csikasz, Robert I.; Bertrand-Michel, Justine; Boren, Jan; Guillou, Herve; Rudling, Mats; Jacobsson, Anders			Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity	FASEB JOURNAL			English	Article						fatty acid synthesis; gender; obesity; VLCFA	BROWN ADIPOSE-TISSUE; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; BETA-OXIDATION; DEFICIENT MICE; RAT-HEART; LIVER; METABOLISM; PROTEIN; LEPTIN	Although saturated and monounsaturated very-long-chain fatty acids (VLCFAs) have long been associated with undesirable effects on health, including obesity, heart failure, and atherosclerosis, the physiological role of endogenous synthesis is largely unknown. The fatty acid elongase ELOVL3 is involved in the synthesis of C20-C24 saturated and monounsaturated VLCFAs mainly in liver, brown and white adipose tissue, and triglyceride-rich glands such as the sebaceous and meibomian glands. Here we show that ablation of ELOVL3 leads to reduced adiponectin levels, constrained expansion of adipose tissue, and resistance against diet-induced obesity, a situation that is more exaggerated in female mice. Both female and male knockout mice show reduced hepatic lipogenic gene expression and triglyceride content, a situation that is associated with reduced de novo fatty acid synthesis and uptake. As a consequence, the VLDL-triglyceride level in serum is significantly reduced. Remarkably, despite increased energy expenditure, markedly reduced serum levels of leptin, and increased expression of orexigenic peptides in the hypothalamus, the Elovl3(-/-) mice do not compensate by increased food intake. Thus, these results reveal that C20-C22 saturated and monounsaturated VLCFAs produced by ELOVL3 are indispensable for appropriate synthesis of liver triglycerides, fatty acid uptake, and storage in adipose tissue.-Zadravec, D., Brolinson, A., Fisher, R. M., Carneheim, C., Csikasz, R. I., Bertrand-Michel, J., Boren, J., Guillou, H., Rudling, M., Jacobsson, A. Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity. FASEB J. 24, 4366-4377 (2010). www.fasebj.org	[Zadravec, Damir; Brolinson, Annelie; Carneheim, Claes; Csikasz, Robert I.; Jacobsson, Anders] Stockholm Univ, Wenner Gren Inst, Labs F3, SE-10691 Stockholm, Sweden; [Fisher, Rachel M.] Karolinska Inst, Atherosclerosis Res Unit, Dept Med Solna, Karolinska Univ Hosp, Stockholm, Sweden; [Bertrand-Michel, Justine] CHU Purpan Toulouse, IFR150, Inst Federatif Rech Biomed Toulouse, Toulouse, France; [Boren, Jan] Sahlgrens Univ Hosp, Wallenberg Lab, Sahlgrenska Ctr Cardiovasc & Metab Res, Gothenburg, Sweden; [Guillou, Herve] INRA, Lab Pharmacol & Toxicol, UR66, F-31931 Toulouse, France; [Rudling, Mats] Karolinska Inst, Dept Endocrinol Metab & Diabet, Mol Nutr Unit, Karolinska Univ Hosp Huddinge, Stockholm, Sweden	Stockholm University; Karolinska Institutet; Karolinska University Hospital; CHU de Toulouse; Sahlgrenska University Hospital; INRAE; Karolinska Institutet; Karolinska University Hospital	Jacobsson, A (corresponding author), Stockholm Univ, Wenner Gren Inst, Arrhenius Labs F3, SE-10691 Stockholm, Sweden.	anders.jacobsson@wgi.su.se	Guillou, Herve/AAG-2826-2020; Guillou, Hervé/AGL-0750-2022	Guillou, Herve/0000-0002-5363-9081; Guillou, Hervé/0000-0002-5363-9081; Fisher, Rachel/0000-0002-6031-5288	Swedish Research Council; INRA and Formas	Swedish Research Council(Swedish Research CouncilEuropean Commission); INRA and Formas	The authors thank B. Leksell, V. Roques, and S. Ixenmaier for technical assistance and Biovitrum for access to their DEXA apparatus. This work was supported by grants from the Swedish Research Council (A.J., project 15352, R.F.) and from INRA and Formas (H.G., A.J.).	ALBERTS P, 2006, CURRENT PROTOCOLS NE; Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Anzulovich A, 2006, J LIPID RES, V47, P2690, DOI 10.1194/jlr.M600230-JLR200; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; BLOMSTRAND R, 1983, LIPIDS, V18, P151, DOI 10.1007/BF02534543; Brolinson A, 2008, ENDOCRINOLOGY, V149, P3158, DOI 10.1210/en.2007-1402; Bryzgalova G, 2006, DIABETOLOGIA, V49, P588, DOI 10.1007/s00125-005-0105-3; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; CHARLTON KM, 1975, CAN J COMP MED, V39, P261; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Djouadi F, 1998, J CLIN INVEST, V102, P1083, DOI 10.1172/JCI3949; Dolezalova R, 2007, CLIN ENDOCRINOL, V67, P674, DOI 10.1111/j.1365-2265.2007.02944.x; FLATMARK T, 1983, BIOCHIM BIOPHYS ACTA, V753, P460, DOI 10.1016/0005-2760(83)90071-1; Jakobsson A, 2005, AM J PHYSIOL-ENDOC M, V289, pE517, DOI 10.1152/ajpendo.00045.2005; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jorgensen JA, 2007, AM J PHYSIOL-ENDOC M, V293, pE1159, DOI 10.1152/ajpendo.00213.2007; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kitazawa H, 2009, LIPIDS, V44, P765, DOI 10.1007/s11745-009-3320-8; Kobayashi T, 2007, FEBS LETT, V581, P3157, DOI 10.1016/j.febslet.2007.05.081; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; KRAMER JKG, 1979, J NUTR, V109, P202, DOI 10.1093/jn/109.2.202; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P4551, DOI 10.1210/en.140.10.4551; Moon YA, 2009, J LIPID RES, V50, P412, DOI 10.1194/jlr.M800383-JLR200; NORSETH J, 1983, BIOCHIM BIOPHYS ACTA, V751, P312, DOI 10.1016/0005-2760(83)90289-8; OSEI P, 1989, J BIOL CHEM, V264, P6844; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; Prieur X, 2008, ENDOCRINOLOGY, V149, P5432, DOI 10.1210/en.2008-0498; PULLEN DL, 1990, J ANIM SCI, V68, P1395; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Qiang L, 2007, MOL CELL BIOL, V27, P4698, DOI 10.1128/MCB.02279-06; Rebouissou S, 2007, J BIOL CHEM, V282, P14437, DOI 10.1074/jbc.M610725200; Tvrdik P, 1997, J BIOL CHEM, V272, P31738, DOI 10.1074/jbc.272.50.31738; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Wang Y, 2008, J LIPID RES, V49, P1538, DOI 10.1194/jlr.M800123-JLR200; Westerberg R, 2006, J BIOL CHEM, V281, P4958, DOI 10.1074/jbc.M511588200; Westerberg R, 2004, J BIOL CHEM, V279, P5621, DOI 10.1074/jbc.M310529200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	44	70	72	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4366	4377		10.1096/fj.09-152298	http://dx.doi.org/10.1096/fj.09-152298			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20605947				2022-12-25	WOS:000283861100024
J	Monje, PV; Soto, J; Bacallao, K; Wood, PM				Monje, Paula V.; Soto, Jennifer; Bacallao, Ketty; Wood, Patrick M.			Schwann Cell Dedifferentiation Is Independent of Mitogenic Signaling and Uncoupled to Proliferation ROLE OF cAMP AND JNK IN THE MAINTENANCE OF THE DIFFERENTIATED STATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL NERVOUS-SYSTEM; N-TERMINAL KINASE; CYCLIC-AMP; C-JUN; WALLERIAN DEGENERATION; REGULATED KINASE; SPINAL-CORD; MAP KINASE; MYELINATION; REGENERATION	Myelinating Schwann cells (SCs) are highly plastic cells that are able to dedifferentiate and re-enter the cell cycle. However, the molecular signals controlling dedifferentiation are not completely understood. Because a connection between mitogenic signaling and myelin loss has been suggested, we investigated the role of cAMP, a strong inducer of the myelinating phenotype, and mitogenic factors activating receptor tyrosine kinases (RTKs) on SC dedifferentiation. We herein provide evidence indicating that cAMP was required to not only initiate but also maintain a state of differentiation because SCs rapidly dedifferentiated and became competent to resume proliferation upon the removal of cAMP stimulation. Surprisingly, isolated SCs could undergo multiple cycles of differentiation and dedifferentiation upon cAMP addition and removal, respectively, in the absence of mitogenic factors and without entering the cell cycle. Conversely, the activation of RTKs and the ERK cascade by a variety of growth factors, including neuregulin, was not sufficient to initiate dedifferentiation in the presence of cAMP. Importantly, a reduction of cAMP triggered dedifferentiation through a mechanism that required JNK, rather than ERK, activity and an induction of the expression of c-Jun, a transcriptional inhibitor of myelination. In summary, the reversible transition from an undifferentiated to a myelinating state was dependent on cAMP but independent of RTK signaling and cell cycle progression, further indicating that dedifferentiation and proliferation are uncoupled and differentially regulated events in SCs.	[Monje, Paula V.; Soto, Jennifer; Bacallao, Ketty; Wood, Patrick M.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Monje, Paula V.; Wood, Patrick M.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA	University of Miami; University of Miami	Monje, PV (corresponding author), 1095 NW 14th Terrace, Miami, FL 33136 USA.	pmonje@med.miami.edu	Monje, Paula/AAB-9099-2020		National Institutes of Health, NINDS [NS009923]; Miami Project to Cure Paralysis; Buoniconti Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009923] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Miami Project to Cure Paralysis; Buoniconti Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant NS009923. This work was also supported by the Miami Project to Cure Paralysis and the Buoniconti Fund.	ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Brockes JP, 2001, J ANAT, V199, P3; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fortun J, 2009, NEUROSCI LETT, V456, P124, DOI 10.1016/j.neulet.2008.08.092; Guertin AD, 2005, J NEUROSCI, V25, P3478, DOI 10.1523/JNEUROSCI.3766-04.2005; Harada Y, 1999, BIOCHEM BIOPH RES CO, V266, P129, DOI 10.1006/bbrc.1999.1783; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; JESSEN KR, 1991, ANN NY ACAD SCI, V633, P78; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Kato H, 2003, J SURG ONCOL, V84, P24, DOI 10.1002/jso.10287; Kim HA, 2000, NEURON, V26, P405, DOI 10.1016/S0896-6273(00)81173-3; Kim HA, 2001, J NEUROSCI, V21, P1110; Martinez-Lara I, 1996, Acta Stomatol Belg, V93, P29; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; Monje PV, 2009, GLIA, V57, P947, DOI 10.1002/glia.20819; Monje PV, 2008, J BIOL CHEM, V283, P34087, DOI 10.1074/jbc.M802318200; Monje PV, 2006, GLIA, V53, P649, DOI 10.1002/glia.20330; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; MORRISSEY TK, 1991, J NEUROSCI, V11, P2433; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Parkinson DB, 2004, J CELL BIOL, V164, P385, DOI 10.1083/jcb.200307132; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; PODUSLO JF, 1995, J NEUROCHEM, V65, P149; Rao GN, 1996, J BIOL CHEM, V271, P20805, DOI 10.1074/jbc.271.34.20805; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; SALZER JL, 1980, J CELL BIOL, V84, P767, DOI 10.1083/jcb.84.3.767; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SOBUE G, 1986, BRAIN RES, V362, P23, DOI 10.1016/0006-8993(86)91394-6; Stevens B, 2004, NEURON GLIA BIOL, V1, P23, DOI 10.1017/s1740925x04000055; Straube WL, 2006, ARTIF ORGANS, V30, P743, DOI 10.1111/j.1525-1594.2006.00296.x; Strauss KI, 2004, NEUROTOX RES, V6, P333, DOI 10.1007/BF03033444; Syed N, 2010, J NEUROSCI, V30, P6122, DOI 10.1523/JNEUROSCI.1681-09.2010; Tapinos N, 2006, NAT MED, V12, P961, DOI 10.1038/nm1433; THOMAS PK, 1970, J ANAT, V106, P463; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Velloso CP, 2000, DIFFERENTIATION, V66, P239, DOI 10.1046/j.1432-0436.2000.660410.x; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323; Yang DP, 2008, MOL CELL NEUROSCI, V38, P80, DOI 10.1016/j.mcn.2008.01.017; Yoon C, 2008, J NEUROSCI, V28, P3738, DOI 10.1523/JNEUROSCI.4439-07.2008; Zanazzi G, 2001, J CELL BIOL, V152, P1289, DOI 10.1083/jcb.152.6.1289	50	60	63	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					31024	31036		10.1074/jbc.M110.116970	http://dx.doi.org/10.1074/jbc.M110.116970			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20634285	hybrid, Green Published			2022-12-25	WOS:000282135500067
J	Someya, A; Moss, J; Nagaoka, I				Someya, Akimasa; Moss, Joel; Nagaoka, Isao			The Guanine Nucleotide Exchange Protein for ADP-ribosylation Factor 6, ARF-GEP100/BRAG2, Regulates Phagocytosis of Monocytic Phagocytes in an ARF6-dependent Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; PLASMA-MEMBRANE; ACTIN CYTOSKELETON; ARF6 ACTIVATION; PHOSPHOLIPASE-D; CELL-ADHESION; GROWTH-FACTOR; MACROPHAGES; COMPONENTS; EFFECTOR	Phagocytosis is a complex multistep process requiring diverse signaling and regulatory molecules. ADP-ribosylation factor 6 (ARF6), a small GTPase, is known to regulate membrane trafficking and the actin cytoskeketon at the plasma membrane and functions as a regulatory molecule of phagocytosis. ARF activity is regulated by cycling between GDP-bound and GTP-bound forms. ARF activation is catalyzed by guanine nucleotide exchange factors (GEFs) that facilitate GTP binding. We had earlier reported a 100-kDa ARF-GEF, termed ARF-guanine nucleotide exchange protein 100, GEP100, that preferentially activates ARF6 and was also described by Dunphy et al. (Dunphy, J. L., Moravec, R., Ly, K., Lasell, T. K., Melancon, P., and Casanova, J. E. (2006) Curr. Biol. 16, 315-320) as brefeldin A-resistant ARF-GEF2 (BRAG2). We have now examined a role for GEP100 in phagocytosis. Stable depletion of GEP100 decreased phagocytosis of serum-treated zymosan and IgG-coated latex beads by human monocyte-macrophage-like U937 cells differentiated with phorbol 12-myristate 13-acetate. Decrease of phagocytic activity by RNAi was not rescued by GEP100 Delta Sec7, a deletion mutant lacking the ARF-activating domain. GEP100-depleted cells also exhibited reduced F-actin fibers around internalized particles. Attachment of these particles to cells and amounts of C3bi and Fc gamma receptors, however, were not affected by GEP100 depletion. On immunofluorescence microscopy, GEP100 and ARF6 were concentrated and partially colocalized around internalized particles. Phagocytosis by GEP100-depleted cells was not further affected by depletion of ARF6. Phagocytic activity of GEP100-depleted cells was, however, rescued by expression of the constitutively active ARF6Q67N mutant but not by the dominant-negative ARF6T27N mutant. These data are consistent with the conclusion that GEP100 functions in phago-cytosis via its role in ARF6-dependent actin remodeling.	[Someya, Akimasa] Juntendo Univ, Sch Med, Dept Host Def & Biochem Res, Bunkyo Ku, Tokyo 1138421, Japan; [Moss, Joel] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA	Juntendo University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Someya, A (corresponding author), Juntendo Univ, Sch Med, Dept Host Def & Biochem Res, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	someya@juntendo.ac.jp			National Institutes of Health, NHLBI; Ministry of Education, Culture, Sports, Science, and Technology of Japan	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in whole or in part, by the Intramural Research Program, National Institutes of Health, NHLBI. This work was also supported by the "High-Tech Research Center" Project for Private Universities (a matching fund subsidy from the Ministry of Education, Culture, Sports, Science, and Technology of Japan).	Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Braun V, 2007, MOL BIOL CELL, V18, P4921, DOI 10.1091/mbc.E07-04-0392; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Criss AK, 2001, J BIOL CHEM, V276, P48431, DOI 10.1074/jbc.M106969200; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dana RR, 2000, J BIOL CHEM, V275, P32566, DOI 10.1074/jbc.M005406200; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Dunphy JL, 2007, TRAFFIC, V8, P661, DOI 10.1111/j.1600-0854.2007.00561.x; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Greenberg S, 1999, J LEUKOCYTE BIOL, V66, P712, DOI 10.1002/jlb.66.5.712; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Hiroi T, 2006, P NATL ACAD SCI USA, V103, P10672, DOI 10.1073/pnas.0604091103; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Jovanovic OA, 2006, MOL BIOL CELL, V17, P327, DOI 10.1091/mbc.E05-06-0523; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; MASSENBURG D, 1994, P NATL ACAD SCI USA, V91, P11718, DOI 10.1073/pnas.91.24.11718; May RC, 2001, J CELL SCI, V114, P1061; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; MOSS J, 1995, J BIOL CHEM, V270, P12327, DOI 10.1074/jbc.270.21.12327; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; NAGAOKA I, 1981, BIOCHIM BIOPHYS ACTA, V678, P342, DOI 10.1016/0304-4165(81)90113-6; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Niedergang F, 2003, J CELL BIOL, V161, P1143, DOI 10.1083/jcb.200210069; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Radhakrishna H, 1999, J CELL SCI, V112, P855; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Schafer DA, 2000, TRAFFIC, V1, P892; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Someya A, 2006, J LEUKOCYTE BIOL, V80, P915, DOI 10.1189/jlb.0106059; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Togawa A, 1999, J BIOL CHEM, V274, P12308, DOI 10.1074/jbc.274.18.12308; Uchida H, 2001, J EXP MED, V193, P955, DOI 10.1084/jem.193.8.955; Vitale N, 2002, J CELL BIOL, V159, P79, DOI 10.1083/jcb.200203027; Yomogida S, 1996, INFLAMM RES, V45, P62, DOI 10.1007/BF02265117; Zhang Q, 1999, MOL CELL BIOL, V19, P8158; Zhang Q, 1998, J BIOL CHEM, V273, P19977, DOI 10.1074/jbc.273.32.19977	48	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30698	30707		10.1074/jbc.M110.107458	http://dx.doi.org/10.1074/jbc.M110.107458			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20601426	hybrid, Green Published			2022-12-25	WOS:000282135500038
J	Wimmer, P; Schreiner, S; Everett, RD; Sirma, H; Groitl, P; Dobner, T				Wimmer, P.; Schreiner, S.; Everett, R. D.; Sirma, H.; Groitl, P.; Dobner, T.			SUMO modification of E1B-55K oncoprotein regulates isoform-specific binding to the tumour suppressor protein PML	ONCOGENE			English	Article						HAdV5 E1B-55K; PML isoforms; SUMO	ACUTE PROMYELOCYTIC LEUKEMIA; E4 ORF3 PROTEIN; REGION-1B 55-KDA ONCOPROTEIN; ADENOVIRUS E4ORF6 PROTEIN; NUCLEAR-BODY FORMATION; SIMPLEX-VIRUS TYPE-1; TRANSFORMED-CELLS; RAR-ALPHA; PREMATURE SENESCENCE; DNA-DAMAGE	The E1B-55K product from human adenovirus is a substrate of the small ubiquitin-related modifier (SUMO)-conjugation system. SUMOylation of E1B-55K is required to transform primary mammalian cells in cooperation with adenovirus E1A and to repress p53 tumour suppressor functions. The biochemical consequences of SUMO1 conjugation of 55K have so far remained elusive. Here, we report that E1B-55K physically interacts with different isoforms of the tumour suppressor protein promyelocytic leukaemia (PML). We show that E1B-55K binds to PML isoforms IV and V in a SUMO1-dependent and -independent manner. Interaction with PML-IV promotes the localization of 55K to PML-containing subnuclear structures (PML-NBs). In virus-infected cells, this process is negatively regulated by other viral proteins, indicating that binding to PML is controlled through reversible SUMOylation in a timely coordinated manner. These results together with earlier work are consistent with the idea that SUMOylation regulates targeting of E1B-55K to PML-NBs, known to control transcriptional regulation, tumour suppression, DNA repair and apoptosis. Furthermore, they suggest that SUMO1-dependent modulation of p53-dependent growth suppression through E1B-55K PML-IV interaction has a key role in adenovirus-mediated cell transformation. Oncogene (2010) 29, 5511-5522; doi:10.1038/onc.2010.284; published online 19 July 2010	[Wimmer, P.; Schreiner, S.; Groitl, P.; Dobner, T.] Heinrich Pette Inst Expt Virol & Immunol, Dept Mol Virol, D-20251 Hamburg, Germany; [Sirma, H.] Univ Med Ctr, Inst Pathol, Hamburg, Germany	Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf	Dobner, T (corresponding author), Heinrich Pette Inst Expt Virol & Immunol, Dept Mol Virol, Martinistr 52, D-20251 Hamburg, Germany.	thomas.dobner@hpi.uni-hamburg.de		Schreiner, Sabrina/0000-0002-5744-7159	Studienstiftung des Deutschen Volkes e.V., Bonn, Germany [41, 53175]; Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit; Deutsche Forschungsgemeinschaft (DFG); Stiftung fur neurovirale Erkrankungen; MRC [MC_U130169966] Funding Source: UKRI; Medical Research Council [MC_U130169966] Funding Source: researchfish	Studienstiftung des Deutschen Volkes e.V., Bonn, Germany; Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Stiftung fur neurovirale Erkrankungen; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	PW was supported by grants from the 'Studienstiftung des Deutschen Volkes e.V.', Ahrstrasse 41, 53175 Bonn, Germany. We thank Philippe Gripon for providing the described HepaRG cell line and Roel van Driel/Ineke van der Kraan for the 5E10 antibody. The Heinrich-Pette-Institute is supported by the 'Freie und Hansestadt Hamburg' and the 'Bundesministerium fur Gesundheit'. This work was supported by grants from the 'Deutsche Forschungsgemeinschaft (DFG)' and by the 'Stiftung fur neurovirale Erkrankungen' to HS.	ASCOLI CA, 1991, J CELL BIOL, V112, P785, DOI 10.1083/jcb.112.5.785; Baker A, 2007, J VIROL, V81, P7034, DOI 10.1128/JVI.00029-07; Bischof O, 2001, J CELL BIOL, V153, P367, DOI 10.1083/jcb.153.2.367; Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341; Borden KLB, 2009, FRONT BIOSCI-LANDMRK, V14, P497, DOI 10.2741/3258; Carbone R, 2002, ONCOGENE, V21, P1633, DOI 10.1038/sj.onc.1205227; CARVALHO T, 1995, J CELL BIOL, V131, P45, DOI 10.1083/jcb.131.1.45; Cerec V, 2007, HEPATOLOGY, V45, P957, DOI 10.1002/hep.21536; CHANG KS, 1992, MOL CELL BIOL, V12, P800, DOI 10.1128/MCB.12.2.800; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; Dallaire F, 2009, J VIROL, V83, P5329, DOI 10.1128/JVI.00089-09; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Dobner T, 2001, CURR TOP MICROBIOL, V259, P25; Doucas V, 1996, GENE DEV, V10, P196, DOI 10.1101/gad.10.2.196; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Endter C, 2005, ONCOGENE, V24, P55, DOI 10.1038/sj.onc.1208170; Endter C, 2001, P NATL ACAD SCI USA, V98, P11312, DOI 10.1073/pnas.191361798; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Everett RD, 2008, J VIROL, V82, P2661, DOI 10.1128/JVI.02308-07; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Ferbeyre G, 2000, GENE DEV, V14, P2015; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; GODDARD AD, 1995, MAMM GENOME, V6, P732, DOI 10.1007/BF00354296; GODDARD AD, 1992, LEUKEMIA, V6, pS117; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Groitl Peter, 2007, Methods Mol Med, V130, P29; Guccione E, 2004, ONCOGENE, V23, P4662, DOI 10.1038/sj.onc.1207631; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hartl B, 2008, ONCOGENE, V27, P3673, DOI 10.1038/sj.onc.1211039; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Herrmann F, 2005, J BIOL CHEM, V280, P38005, DOI 10.1074/jbc.M502458200; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; Hoppe A, 2006, J VIROL, V80, P3042, DOI 10.1128/JVI.80.6.3042-3049.2006; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KAO CC, 1990, VIROLOGY, V179, P806, DOI 10.1016/0042-6822(90)90148-K; KASTNER P, 1992, EMBO J, V11, P629, DOI 10.1002/j.1460-2075.1992.tb05095.x; Kindsmuller K, 2007, P NATL ACAD SCI USA, V104, P6684, DOI 10.1073/pnas.0702158104; Kindsmuller K, 2009, J VIROL, V83, P9045, DOI 10.1128/JVI.00728-09; KOKEN MHM, 1995, ONCOGENE, V10, P1315; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Konig C, 1999, J VIROL, V73, P2253; Kratzer F, 2000, ONCOGENE, V19, P850, DOI 10.1038/sj.onc.1203395; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lawrence JM, 2007, STEM CELLS, V25, P2033, DOI 10.1634/stemcells.2006-0724; LEE K, 1995, SMALL SCALE PREPARAT; Leppard KN, 2009, J GEN VIROL, V90, P95, DOI 10.1099/vir.0.005512-0; Lethbridge KJ, 2003, J GEN VIROL, V84, P259, DOI 10.1099/vir.0.18820-0; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Lukashchuk V, 2010, J VIROL, V84, P4026, DOI 10.1128/JVI.02597-09; Martin MED, 1999, MOL CELL BIOL, V19, P3403; Martin MED, 1998, J VIROL, V72, P3146, DOI 10.1128/JVI.72.4.3146-3154.1998; Melnick A, 1999, LEUKEMIA, V13, P1534, DOI 10.1038/sj.leu.2401513; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; MITSUDOMI T, 1992, ONCOGENE, V7, P171; Muller S, 2008, CELL CYCLE, V7, P754, DOI 10.4161/cc.7.6.5495; Nevels M, 1997, P NATL ACAD SCI USA, V94, P1206, DOI 10.1073/pnas.94.4.1206; Nevels M, 2001, J VIROL, V75, P3089, DOI 10.1128/JVI.75.7.3089-3094.2001; ORNELLES DA, 1991, J VIROL, V65, P424, DOI 10.1128/JVI.65.1.424-429.1991; PANDOLFI PP, 1992, EMBO J, V11, P1397, DOI 10.1002/j.1460-2075.1992.tb05185.x; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; PUVIONDUTILLEUL F, 1995, EXP CELL RES, V218, P9, DOI 10.1006/excr.1995.1125; Querido E, 2001, J VIROL, V75, P699, DOI 10.1128/JVI.75.2.699-709.2001; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Salomoni P, 2009, CELL DEATH DIFFER, V16, P1083, DOI 10.1038/cdd.2009.63; Salomoni P, 2008, CELL RES, V18, P620, DOI 10.1038/cr.2008.58; SARNOW P, 1982, VIROLOGY, V120, P510, DOI 10.1016/0042-6822(82)90054-X; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Schreck KC, 2009, NAT NEUROSCI, V12, P108, DOI 10.1038/nn0209-108; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Sieber T, 2007, J VIROL, V81, P95, DOI 10.1128/JVI.01608-06; Stracker TH, 2005, J VIROL, V79, P6664, DOI 10.1128/JVI.79.11.6664-6673.2005; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; STUURMAN N, 1992, J CELL SCI, V101, P773; Takahashi Y, 2004, ONCOGENE, V23, P2819, DOI 10.1038/sj.onc.1207533; Tavalai N, 2008, BBA-MOL CELL RES, V1783, P2207, DOI 10.1016/j.bbamcr.2008.08.004; Torok D, 2009, FRONT BIOSCI-LANDMRK, V14, P1325, DOI 10.2741/3311; Ullman AJ, 2008, J VIROL, V82, P7325, DOI 10.1128/JVI.00723-08; Ullman AJ, 2007, J VIROL, V81, P4744, DOI 10.1128/JVI.02385-06; Van Damme E, 2010, INT J BIOL SCI, V6, P51, DOI 10.7150/ijbs.6.51; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; YEW PR, 1994, GENE DEV, V8, P190, DOI 10.1101/gad.8.2.190; YOUNGHUSBAND HB, 1985, CAN J BIOCHEM CELL B, V63, P654, DOI 10.1139/o85-083; ZANTEMA A, 1985, VIROLOGY, V142, P44, DOI 10.1016/0042-6822(85)90421-0; ZANTEMA A, 1985, MOL CELL BIOL, V5, P3084, DOI 10.1128/MCB.5.11.3084; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583	93	39	41	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2010	29	40					5511	5522		10.1038/onc.2010.284	http://dx.doi.org/10.1038/onc.2010.284			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664FM	20639899				2022-12-25	WOS:000282945800008
J	Dhamija, S; Doerrie, A; Winzen, R; Dittrich-Breiholz, O; Taghipour, A; Kuehne, N; Kracht, M; Holtmann, H				Dhamija, Sonam; Doerrie, Anneke; Winzen, Reinhard; Dittrich-Breiholz, Oliver; Taghipour, Azadeh; Kuehne, Nancy; Kracht, Michael; Holtmann, Helmut			IL-1-induced Post-transcriptional Mechanisms Target Overlapping Translational Silencing and Destabilizing Elements in I kappa B zeta mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; AU-RICH ELEMENT; GELATINASE-ASSOCIATED LIPOCALIN; NUCLEAR-PROTEIN; GENE-EXPRESSION; ERYTHROID-DIFFERENTIATION; DEATH DOMAIN; STABILIZATION; INDUCTION; RECEPTOR	The inflammatory cytokine IL-1 induces profound changes in gene expression. This is contributed in part by activating translation of a distinct set of mRNAs, including I kappa B zeta, as indicated by genome-wide analysis of changes in ribosomal occupancy in IL-1 alpha-treated HeLa cells. Polysome profiling of I kappa B zeta mRNA and reporter mRNAs carrying its 3' UTR indicated poor translation in unstimulated cells. 3' UTR-mediated translational silencing was confirmed by suppression of luciferase activity. Translational silencing was unaffected by replacing the poly(A) tail with a histone stem-loop, but lost under conditions of cap-independent internal initiation. IL-1 treatment of the cells caused profound shifts of endogenous and reporter mRNAs to polysome fractions and relieved suppression of luciferase activity. IL-1 also inhibited rapid mRNA degradation. Both translational activation and mRNA stabilization involved IRAK1 and -2 but occurred independently of the p38 MAPK pathway, which is known to target certain other post-transcriptional mechanisms. The translational silencing RNA element contains the destabilizing element but requires additional 5' sequences and is impaired by mutations that leave destabilization unaffected. These differences in function are associated with differential changes in protein binding in vitro. Thus, rapid degradation occurs independently of the translational silencing effect. The results provide evidence for a novel mode of post-transcriptional control by IL-1, which impinges on the time course and pattern of IL-1-induced gene expression.	[Dhamija, Sonam; Doerrie, Anneke; Winzen, Reinhard; Dittrich-Breiholz, Oliver; Taghipour, Azadeh; Kuehne, Nancy; Holtmann, Helmut] Hannover Med Sch, Inst Biochem, D-30623 Hannover, Germany; [Kracht, Michael] Univ Giessen, Rudolf Buchheim Inst Pharmacol, D-35392 Giessen, Germany	Hannover Medical School; Justus Liebig University Giessen	Holtmann, H (corresponding author), Hannover Med Sch, Inst Biochem, D-30623 Hannover, Germany.	holtmann.helmut@mh-hannover.de	Dhamija, Sonam/AAJ-2093-2020	Dhamija, Sonam/0000-0002-9569-2729; Kracht, Michael/0000-0002-8501-043X	Deutsche Forschungsgemeinschaft [SFB 566/A10, SFB 566/Z2, Ho 1116/4]; Niedersachsen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Niedersachsen Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 566/A10, SFB 566/Z2, and Ho 1116/4 and by a grant from the Niedersachsen Foundation.	Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Ben-Asouli Y, 2002, CELL, V108, P221, DOI 10.1016/S0092-8674(02)00616-5; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chen CY, 2000, GENE DEV, V14, P1236; Cohen-Chalamish S, 2009, NAT CHEM BIOL, V5, P896, DOI 10.1038/nchembio.234; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; DE BREYNE S, 2009, P NATL ACAD SCI USA, V106, P9197; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duncan KE, 2009, MOL CELL, V36, P571, DOI 10.1016/j.molcel.2009.09.042; Frevel MAE, 2003, MOL CELL BIOL, V23, P425, DOI 10.1128/MCB.23.2.425-436.2003; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gowrishankar G, 2005, BIOL CHEM, V386, P1287, DOI 10.1515/BC.2005.146; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; Hartupee J, 2008, J BIOL CHEM, V283, P15689, DOI 10.1074/jbc.M801346200; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hartupee J, 2009, J IMMUNOL, V182, P1660, DOI 10.4049/jimmunol.182.3.1660; Haruta H, 2001, J BIOL CHEM, V276, P12485, DOI 10.1074/jbc.C100075200; Hennecke M, 2001, NUCLEIC ACIDS RES, V29, P3327, DOI 10.1093/nar/29.16.3327; Hirotani T, 2005, J IMMUNOL, V174, P3650, DOI 10.4049/jimmunol.174.6.3650; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Karlsen JR, 2010, J BIOL CHEM, V285, P14088, DOI 10.1074/jbc.M109.017129; KASPAR RL, 1994, J IMMUNOL, V153, P277; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lindenblatt C, 2009, CELL CYCLE, V8, P2019, DOI 10.4161/cc.8.13.8816; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Mathews MB, 2000, COLD SPRING HARBOR M, V39, P1; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Neu-Yilik G, 2001, EMBO J, V20, P532, DOI 10.1093/emboj/20.3.532; Neumann D, 2008, J LEUKOCYTE BIOL, V84, P807, DOI 10.1189/jlb.0507290; Neumann D, 2007, BIOCHEM BIOPH RES CO, V354, P1089, DOI 10.1016/j.bbrc.2007.01.104; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Ostareck DH, 2001, CELL, V104, P281, DOI 10.1016/S0092-8674(01)00212-4; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Otkjaer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008671; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Preiss T, 2003, NAT STRUCT BIOL, V10, P1039, DOI 10.1038/nsb1015; Ridley SH, 1998, FEBS LETT, V439, P75, DOI 10.1016/S0014-5793(98)01342-8; SCHINDLER R, 1990, J BIOL CHEM, V265, P10232; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shiina T, 2004, J BIOL CHEM, V279, P55493, DOI 10.1074/jbc.M409770200; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Tebo J, 2003, J BIOL CHEM, V278, P12085, DOI 10.1074/jbc.M212992200; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Watanabe S, 2007, BIOCHEM BIOPH RES CO, V356, P785, DOI 10.1016/j.bbrc.2007.03.044; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Winzen R, 2004, MOL CELL BIOL, V24, P4835, DOI 10.1128/MCB.24.11.4835-4847.2004; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Xu NH, 1998, NUCLEIC ACIDS RES, V26, P558, DOI 10.1093/nar/26.2.558; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamasaki S, 2007, J BIOL CHEM, V282, P30070, DOI 10.1074/jbc.M706273200; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Yamazaki S, 2008, J BIOL CHEM, V283, P32404, DOI 10.1074/jbc.M802148200; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	75	27	32	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29165	29178		10.1074/jbc.M110.146365	http://dx.doi.org/10.1074/jbc.M110.146365			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20634286	hybrid, Green Published			2022-12-25	WOS:000281740100017
J	Hinz, AK; Wang, Y; Smerdon, MJ				Hinz, Angela K.; Wang, Yan; Smerdon, Michael J.			Base Excision Repair in a Glucocorticoid Response Element EFFECT OF GLUCOCORTICOID RECEPTOR BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-BETA; TRANSCRIPTION FACTOR IIIA; MAMMARY-TUMOR VIRUS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; LIGASE I; SEQUENCE; PROTEIN; COMPLEX; PROMOTER	DNA repair takes place in the context of chromatin. Previous studies showed that histones impair base excision repair (BER) of modified bases at both the excision and synthesis steps. We examined BER of uracil in a glucocorticoid response element (GRE) complexed with the glucocorticoid receptor DNA binding domain (GR-DBD). Five substrates were designed, each containing a unique C -> U substitution within the mouse mammary tumor virus promoter, one located within each GRE half-site and the others located outside the GRE. To examine distinct steps of BER, DNA cleavage by uracil-DNA glycosylase and Ape1 endonuclease was used to assess initiation, dCTP incorporation by DNA polymerase (pol) beta was used to measure repair synthesis, and DNA ligase I was used to seal the nick. For uracil sites within the GRE, there was a reduced rate of uracil-DNA glycosylase/Ape1 activity following GR-DBD binding. Cleavage in the right half-site, with higher GR-DBD binding affinity, was reduced similar to 5-fold, whereas cleavage in the left half-site was reduced similar to 3.8-fold. Conversely, uracil-directed cleavage outside the GRE was unaffected by GR-DBD binding. Surprisingly, there was no reduction in the rate of pol beta synthesis or DNA ligase activity on any of the fragments bound to GR-DBD. Indeed, we observed a small increase (similar to 1.5-2.2-fold) in the rate of pol beta synthesis at uracil residues in both the GRE and one site six nucleotides downstream. These results highlight the potential for both positive and negative impacts of DNA-transcription factor binding on the rate of BER.	[Hinz, Angela K.; Wang, Yan; Smerdon, Michael J.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Smerdon, MJ (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	smerdon@wsu.edu			NIEHS [ES004106]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004106] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES004106 from the NIEHS.	Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100; Bishop TC, 1996, PROTEINS, V24, P115; BUETTI E, 1986, J MOL BIOL, V190, P379, DOI 10.1016/0022-2836(86)90009-4; CAIRNS W, 1991, J BIOL CHEM, V266, P11221; CLEMENS KR, 1994, J MOL BIOL, V244, P23, DOI 10.1006/jmbi.1994.1701; Conconi A, 1999, EMBO J, V18, P1387, DOI 10.1093/emboj/18.5.1387; DAHLMANWRIGHT K, 1991, J BIOL CHEM, V266, P3107; DAHLMANWRIGHT K, 1990, J BIOL CHEM, V265, P14030; DAHLMANWRIGHT K, 1992, J STEROID BIOCHEM, V41, P249, DOI 10.1016/0960-0760(92)90351-I; Dianou GL, 2007, DNA REPAIR, V6, P454, DOI 10.1016/j.dnarep.2006.10.009; Dimitriadis EK, 1998, J BIOL CHEM, V273, P20540, DOI 10.1074/jbc.273.32.20540; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Ghosh R, 1999, NUCLEIC ACIDS RES, V27, P3213, DOI 10.1093/nar/27.15.3213; HAM J, 1988, NUCLEIC ACIDS RES, V16, P5263, DOI 10.1093/nar/16.12.5263; Hanawalt PC, 2007, MOL CELL, V28, P702, DOI 10.1016/j.molcel.2007.11.014; HARD T, 1990, BIOCHEMISTRY-US, V29, P5358; HARRIS LF, 1994, J BIOMOL STRUCT DYN, V12, P249, DOI 10.1080/07391102.1994.10508740; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Kwon Y, 2005, MUTAT RES-FUND MOL M, V577, P118, DOI 10.1016/j.mrfmmm.2005.02.013; Kwon YH, 2003, J BIOL CHEM, V278, P45451, DOI 10.1074/jbc.M308645200; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Memisoglu A, 2000, MUTAT RES-FUND MOL M, V451, P39, DOI 10.1016/S0027-5107(00)00039-7; Mol CD, 2000, MUTAT RES-DNA REPAIR, V460, P211, DOI 10.1016/S0921-8777(00)00028-8; Nicholl ID, 1997, BIOCHEMISTRY-US, V36, P7557, DOI 10.1021/bi962950w; Nilsen H, 2002, EMBO J, V21, P5943, DOI 10.1093/emboj/cdf581; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; PAYVAR F, 1983, CELL, V35, P381, DOI 10.1016/0092-8674(83)90171-X; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SCHEIDEREIT C, 1983, NATURE, V304, P749, DOI 10.1038/304749a0; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; TSAI SY, 1988, CELL, V55, P361, DOI 10.1016/0092-8674(88)90059-1; VERRI A, 1990, NUCLEIC ACIDS RES, V18, P5775, DOI 10.1093/nar/18.19.5775; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176	35	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28683	28690		10.1074/jbc.M110.113530	http://dx.doi.org/10.1074/jbc.M110.113530			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20628060	hybrid, Green Published			2022-12-25	WOS:000281594000033
J	Dangi-Garimella, S; Redig, AJ; Shields, MA; Siddiqui, MA; Munshi, HG				Dangi-Garimella, Surabhi; Redig, Amanda J.; Shields, Mario A.; Siddiqui, Mohammed A.; Munshi, Hidayatullah G.			Rho-ROCK-Myosin Signaling Meditates Membrane Type 1 Matrix Metalloproteinase-induced Cellular Aggregation of Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENTRAL BODY-WALL; EXTRACELLULAR-MATRIX; 1-MATRIX METALLOPROTEINASE; TERMINAL DIFFERENTIATION; CALCIUM REGULATION; TISSUE INHIBITOR; CARCINOMA-CELLS; CANCER INVASION; TUMOR-GROWTH; EXPRESSION	Membrane type 1-matrix metalloproteinase (MT1-MMP, MMP14), which is associated with extracellular matrix (ECM) breakdown in squamous cell carcinoma (SCC), promotes tumor formation and epithelial-mesenchymal transition. However, in this report we demonstrate that MT1-MMP, by cleaving the underlying ECM, causes cellular aggregation of keratinocytes and SCC cells. Treatment with an MMP inhibitor abrogated MT1-MMP-induced phenotypic changes, but decreasing E-cadherin expression did not affect MT1-MMP-induced cellular aggregation. As ROCK1/2 can regulate cell-cell and cell-ECM interaction, we examined its role in mediating MT1-MMP-induced phenotypic changes. Blocking ROCK1/2 expression or activity abrogated the cellular aggregation resulting from MT1-MMP expression. Additionally, blocking Rho and nonmuscle myosin attenuated MT1-MMP-induced phenotypic changes. Moreover, SCC cells expressing only the catalytically active MT1-MMP protein demonstrated increased cellular aggregation and increased myosin II activity in vivo when injected subcutaneously into nude mice. Together, these results demonstrate that expression of MT1-MMP may be anti-tumorigenic in keratinocytes by promoting cellular aggregation.	[Munshi, Hidayatullah G.] Northwestern Univ, Sch Med, Dept Med, Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA; [Dangi-Garimella, Surabhi; Redig, Amanda J.; Shields, Mario A.; Siddiqui, Mohammed A.; Munshi, Hidayatullah G.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Munshi, Hidayatullah G.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Munshi, HG (corresponding author), Northwestern Univ, Sch Med, Dept Med, Jesse Brown Vet Affairs Med Ctr, 303 E Super Ave,Lurie 3-117, Chicago, IL 60611 USA.	h-munshi@northwestern.edu			National Institutes of Health (NCI) [R01CA126888]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA126888, K08CA094877] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA126888 (NCI, to H. G. M.). This work was also supported by a merit grant from the Department of Veterans Affairs (to H. G. M.).	AKTORIES K, 1988, EUR J BIOCHEM, V172, P445, DOI 10.1111/j.1432-1033.1988.tb13908.x; Alexander CM, 2001, J CELL BIOL, V152, P693, DOI 10.1083/jcb.152.4.693; Baciu PC, 2003, EXP CELL RES, V291, P167, DOI 10.1016/S0014-4827(03)00387-2; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Calautti E, 2002, J CELL BIOL, V156, P137, DOI 10.1083/jcb.200105140; Cao J, 2008, J BIOL CHEM, V283, P6232, DOI 10.1074/jbc.M705759200; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Diamond ME, 2008, J CELL SCI, V121, P2197, DOI 10.1242/jcs.021782; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; GOSPODAROWICZ D, 1980, P NATL ACAD SCI-BIOL, V77, P4094, DOI 10.1073/pnas.77.7.4094; GREEN H, 1977, CELL, V11, P405, DOI 10.1016/0092-8674(77)90058-7; Grossi M, 2005, P NATL ACAD SCI USA, V102, P11313, DOI 10.1073/pnas.0505011102; Ha HY, 2001, CANCER RES, V61, P984; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Harb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003001; HENNINGS H, 1983, EXP CELL RES, V143, P127, DOI 10.1016/0014-4827(83)90115-5; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; JENSEN PKA, 1991, J CELL SCI, V100, P255; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Joseph MJ, 2009, J CELL BIOCHEM, V108, P726, DOI 10.1002/jcb.22309; Kerkela E, 2003, EXP DERMATOL, V12, P109, DOI 10.1034/j.1600-0625.2003.120201.x; KNIGHT J, 1984, ULTRASTRUCT PATHOL, V7, P133, DOI 10.3109/01913128409141470; Kurahara S, 1999, HEAD NECK-J SCI SPEC, V21, P627, DOI 10.1002/(SICI)1097-0347(199910)21:7<627::AID-HED7>3.3.CO;2-U; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Martinez-Rico C, 2010, J CELL SCI, V123, P712, DOI 10.1242/jcs.047878; McCawley LJ, 2008, AM J PATHOL, V173, P1528, DOI 10.2353/ajpath.2008.080132; McCawley LJ, 2004, CANCER RES, V64, P6965, DOI 10.1158/0008-5472.CAN-04-0910; McMullan R, 2003, CURR BIOL, V13, P2185, DOI 10.1016/S0960-9822(03)00906-0; Montel V, 2004, CANCER RES, V64, P1687, DOI 10.1158/0008-5472.CAN-03-2047; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Moss NM, 2009, J BIOL CHEM, V284, P19791, DOI 10.1074/jbc.M109.020362; Moss NM, 2009, MOL CANCER RES, V7, P809, DOI 10.1158/1541-7786.MCR-08-0571; Munshi HG, 2002, J BIOL CHEM, V277, P38159, DOI 10.1074/jbc.M202384200; Munshi HG, 2004, J BIOL CHEM, V279, P39042, DOI 10.1074/jbc.M404958200; Munshi HG, 2002, J BIOL CHEM, V277, P41480, DOI 10.1074/jbc.M207695200; Munshi HG, 2002, METHOD CELL BIOL, V69, P195, DOI 10.1016/S0091-679X(02)69013-2; Nagarajan P, 2008, CRIT REV EUKAR GENE, V18, P57; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; Ottaviano AJ, 2006, CANCER RES, V66, P7032, DOI 10.1158/0008-5472.CAN-05-4421; Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274; PILLAI S, 1988, J CELL PHYSIOL, V134, P229, DOI 10.1002/jcp.1041340208; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Rozanov DV, 2004, EXP CELL RES, V293, P81, DOI 10.1016/j.yexcr.2003.10.006; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seiki M, 2003, CANCER METAST REV, V22, P129, DOI 10.1023/A:1023087113214; Shimada T, 2000, CLIN EXP METASTAS, V18, P179, DOI 10.1023/A:1006749501682; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; Soulie P, 2005, ONCOGENE, V24, P1689, DOI 10.1038/sj.onc.1208360; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sun LM, 2008, MOL CANCER RES, V6, P10, DOI 10.1158/1541-7786.MCR-07-0208; SYMPSON CJ, 1994, J CELL BIOL, V125, P681, DOI 10.1083/jcb.125.3.681; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Villalonga P, 2006, GROWTH FACTORS, V24, P159, DOI 10.1080/08977190600560651; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; WITTY EP, 1995, MOL BIOL CELL, V6, P1287, DOI 10.1091/mbc.6.10.1287; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197; Zhu AJ, 1996, J CELL SCI, V109, P3013	77	13	13	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28363	28372		10.1074/jbc.M110.146019	http://dx.doi.org/10.1074/jbc.M110.146019			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20605790	hybrid, Green Published			2022-12-25	WOS:000281404100078
J	Cantelmo, AR; Cammarota, R; Noonan, DM; Focaccetti, C; Comoglio, PM; Prat, M; Albini, A				Cantelmo, A. R.; Cammarota, R.; Noonan, D. M.; Focaccetti, C.; Comoglio, P. M.; Prat, M.; Albini, A.			Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth	ONCOGENE			English	Article						Met; cell-penetrating peptides; Antennapedia; Tat; angiogenesis; cancer	FACTOR SCATTER FACTOR; SMALL-MOLECULE INHIBITOR; FACTOR/SCATTER FACTOR; C-MET; PENETRATING PEPTIDES; IN-VIVO; TYROSINE KINASE; INVASIVE GROWTH; FACTOR-RECEPTOR; HGF RECEPTOR	Hepatocyte growth factor (HGF) and its receptor Met are responsible for a wide variety of cellular responses, both physiologically during embryo development and tissue homeostasis, and pathologically, particularly during tumor growth and dissemination. In cancer, Met can act as an oncogene on tumor cells, as well as a pro-angiogenic factor activating endothelial cells and inducing new vessel formation. Molecules interfering with Met activity could be valuable therapeutic agents. Here we have investigated the antiangiogenic properties of a synthetic peptide mimicking the docking site of the Met carboxyl-terminal tail, which was delivered into the cells by fusion with the internalization sequences from Antennapedia or HIV-Tat. We showed that these peptides inhibit ligand-dependent endothelial cell proliferation, motility, invasiveness and morphogenesis in vitro to an even greater extent and with much less toxicity than the Met inhibitor PHA-665752, which correlated with interference of HGF-dependent downstream signaling. In vivo, the peptides inhibited HGF-induced angiogenesis in the matrigel sponge assay and impaired xenograft tumor growth and vascularization in Kaposi's sarcoma. These data show that interference with the Met receptor intracellular sequence impairs HGF-induced angiogenesis, suggesting the use of antidocking site compounds as a therapeutic strategy to counteract angiogenesis in cancer as well as in other diseases. Oncogene (2010) 29, 5286-5298; doi:10.1038/onc.2010.267; published online 5 July 2010	[Cantelmo, A. R.; Cammarota, R.; Noonan, D. M.; Focaccetti, C.; Albini, A.] Casa Cura MultiMed IRCCS, I-20138 Milan, Italy; [Noonan, D. M.] Univ Insubria, Dept Expt Med, Varese, Italy; [Comoglio, P. M.] Univ Turin, Sch Med, Inst Canc Res & Treatment IRCC, Candiolo, Italy; [Prat, M.] Univ Piemonte Orientale, Dept Med Sci, Novara, Italy	IRCCS Multimedica; University of Insubria; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; University of Eastern Piedmont Amedeo Avogadro	Albini, A (corresponding author), MultiMed Castellanza, Via Piemonte 70, I-21053 Castellanza, VA, Italy.	adriana.albini@multimedica.it	Noonan, Douglas M/A-8620-2010; Focaccetti, Chiara/AAD-9378-2019; Cantelmo, Anna Rita/G-6766-2018	Noonan, Douglas M/0000-0001-8058-0719; Focaccetti, Chiara/0000-0002-7334-3966; Cantelmo, Anna Rita/0000-0002-2748-264X; Comoglio, Paolo/0000-0002-7056-5328; Albini, Adriana/0000-0002-9624-5103	AIRC (Associazione Italiana per la Ricerca sul Cancro); ISS; Compagnia San Paolo; MIUR	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); ISS; Compagnia San Paolo(Compagnia di San Paolo); MIUR(Ministry of Education, Universities and Research (MIUR))	These studies were supported by AIRC (Associazione Italiana per la Ricerca sul Cancro), ISS, Compagnia San Paolo and the MIUR. We thank Drs Monica Morini and Raffaella Dell'Eva (Istituto Nazionale per la Ricerca sul Cancro, Genova) for preliminary observations. We are indebted to Dr Paola Corradino (CBA, Genova) for literature searches and Alessandra Panvini-Rosati (Multimedica, Milan) for assistance. ARC is a PhD student at the Department of Structural and Functional Biology, Via Dunant 5, Varese, CF is a MIUR 'Grande Progetto Strategico' fellow.	Albini A, 1997, AIDS, V11, P713, DOI 10.1097/00002030-199706000-00003; Albini A, 2001, CANCER RES, V61, P8171; ALBINI A, 1994, AIDS, V8, P1237, DOI 10.1097/00002030-199409000-00004; ALBINI A, 1987, CANCER RES, V47, P3239; Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057; Bardelli A, 1999, J BIOL CHEM, V274, P29274, DOI 10.1074/jbc.274.41.29274; Bardelli C, 2005, BIOCHEM BIOPH RES CO, V334, P1172, DOI 10.1016/j.bbrc.2005.07.020; Berthou S, 2004, ONCOGENE, V23, P5387, DOI 10.1038/sj.onc.1207691; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Cao B, 2001, P NATL ACAD SCI USA, V98, P7443, DOI 10.1073/pnas.131200498; Cao RH, 2006, BLOOD, V107, P3531, DOI 10.1182/blood-2005-06-2538; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; CHAN AML, 1991, SCIENCE, V254, P1382, DOI 10.1126/science.1720571; Christensen JG, 2003, CANCER RES, V63, P7345; Chu SH, 2009, J NEURO-ONCOL, V93, P183, DOI 10.1007/s11060-008-9772-5; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Corso S, 2008, ONCOGENE, V27, P684, DOI 10.1038/sj.onc.1210697; Deregibus MC, 2003, J BIOL CHEM, V278, P18008, DOI 10.1074/jbc.M300711200; Deshayes S, 2005, CELL MOL LIFE SCI, V62, P1839, DOI 10.1007/s00018-005-5109-0; DIRENZO MF, 1991, ONCOGENE, V6, P1997; Dong G, 2001, CANCER RES, V61, P5911; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Foged C, 2008, EXPERT OPIN DRUG DEL, V5, P105, DOI 10.1517/17425247.5.1.105; FOLKMAN J, 1985, ADV CANCER RES, V43, P175, DOI 10.1016/S0065-230X(08)60946-X; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Giordano S, 2000, FASEB J, V14, P399, DOI 10.1096/fasebj.14.2.399; Goh PP, 2007, CURR CANCER DRUG TAR, V7, P743, DOI 10.2174/156800907783220462; GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; GRAZIANI A, 1991, J BIOL CHEM, V266, P22087; Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007; Jun HT, 2007, CLIN CANCER RES, V13, P6735, DOI 10.1158/1078-0432.CCR-06-2969; Khwaja A, 1998, J BIOL CHEM, V273, P18793, DOI 10.1074/jbc.273.30.18793; Kim KJ, 2006, CLIN CANCER RES, V12, P1292, DOI 10.1158/1078-0432.CCR-05-1793; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Lock LS, 2003, J BIOL CHEM, V278, P30083, DOI 10.1074/jbc.M302675200; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; LONGATI P, 1994, ONCOGENE, V9, P49; Lou XQ, 2009, MOL CANCER THER, V8, P1126, DOI 10.1158/1535-7163.MCT-08-0904; Matsumoto K, 2003, CANCER SCI, V94, P321, DOI 10.1111/j.1349-7006.2003.tb01440.x; Mazzone M, 2004, J CLIN INVEST, V114, P1418, DOI 10.1172/JCI200422235; Michieli P, 2004, CANCER CELL, V6, P61, DOI 10.1016/j.ccr.2004.05.032; Morotti A, 2002, ONCOGENE, V21, P4885, DOI 10.1038/sj.onc.1205622; Morris MC, 2008, BIOL CELL, V100, P201, DOI 10.1042/BC20070116; NISHINO T, 1995, BLOOD, V85, P3093, DOI 10.1182/blood.V85.11.3093.bloodjournal85113093; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Paranjpe S, 2007, HEPATOLOGY, V45, P1471, DOI 10.1002/hep.21570; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; PONZETTO C, 1993, MOL CELL BIOL, V13, P4600, DOI 10.1128/MCB.13.8.4600; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; PRAT M, 1991, INT J CANCER, V49, P323, DOI 10.1002/ijc.2910490302; Prat M, 1998, J CELL SCI, V111, P237; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Sengupta S, 2003, ARTERIOSCL THROM VAS, V23, P69, DOI 10.1161/01.ATV.0000048701.86621.D0; SILVAGNO F, 1995, ARTERIOSCL THROM VAS, V15, P1857, DOI 10.1161/01.ATV.15.11.1857; Stewart KM, 2008, ORG BIOMOL CHEM, V6, P2242, DOI 10.1039/b719950c; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Vigna E, 2008, CANCER RES, V68, P9176, DOI 10.1158/0008-5472.CAN-08-1688; You WK, 2008, BMB REP, V41, P833, DOI 10.5483/BMBRep.2008.41.12.833; Zhang YW, 2003, P NATL ACAD SCI USA, V100, P12718, DOI 10.1073/pnas.2135113100; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	69	16	18	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2010	29	38					5286	5298		10.1038/onc.2010.267	http://dx.doi.org/10.1038/onc.2010.267			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	653KE	20603611	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000282089100007
J	Whitlock, BA; Hale, AM; Groff, PA				Whitlock, Barbara A.; Hale, Amanda M.; Groff, Paul A.			Intraspecific Inversions Pose a Challenge for the trnH-psbA Plant DNA Barcode	PLOS ONE			English	Article							NONCODING CHLOROPLAST DNA; LAND PLANTS; EVOLUTION; BIOGEOGRAPHY; PHYLOGENY; REGION; SEQUENCES; LACTUCEAE; DYNAMICS; IDENTIFY	Background: The chloroplast trnH-psbA spacer region has been proposed as a prime candidate for use in DNA barcoding of plants because of its high substitution rate. However, frequent inversions associated with palindromic sequences within this region have been found in multiple lineages of Angiosperms and may complicate its use as a barcode, especially if they occur within species. Methodology/Principal Findings: Here, we evaluate the implications of intraspecific inversions in the trnH-psbA region for DNA barcoding efforts. We report polymorphic inversions within six species of Gentianaceae, all narrowly circumscribed morphologically: Gentiana algida, Gentiana fremontii, Gentianopsis crinita, Gentianopsis thermalis, Gentianopsis macrantha and Frasera speciosa. We analyze these sequences together with those from 15 other species of Gentianaceae and show that typical simple methods of sequence alignment can lead to misassignment of conspecifics and incorrect assessment of relationships. Conclusions/Significance: Frequent inversions in the trnH-psbA region, if not recognized and aligned appropriately, may lead to large overestimates of the number of substitution events separating closely related lineages and to uniting more distantly related taxa that share the same form of the inversion. Thus, alignment of the trnH-psbA spacer region will need careful attention if it is used as a marker for DNA barcoding.	[Whitlock, Barbara A.; Groff, Paul A.] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA; [Hale, Amanda M.] Texas Christian Univ, Dept Biol Sci, Ft Worth, TX 76129 USA	University of Miami; Texas Christian University	Whitlock, BA (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33124 USA.	whitlock@bio.miami.edu			United States National Science Foundation [DEB 0639826]; National Geographic Society Committee on Research and Exploration [8368-07]	United States National Science Foundation(National Science Foundation (NSF)); National Geographic Society Committee on Research and Exploration(National Geographic Society)	This work was funded by the United States National Science Foundation (DEB 0639826) and the National Geographic Society Committee on Research and Exploration (8368-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catalano SA, 2009, CLADISTICS, V25, P93, DOI 10.1111/j.1096-0031.2008.00236.x; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Azuma H, 1999, J PLANT RES, V112, P291, DOI 10.1007/PL00013885; Bain JF, 2006, CAN J BOT, V84, P862, DOI 10.1139/B06-057; Borsch T, 2009, PLANT SYST EVOL, V282, P169, DOI 10.1007/s00606-009-0210-8; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; Devey DS, 2009, TAXON, V58, P7, DOI 10.1002/tax.581003; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; Erickson DL, 2008, TAXON, V57, P1304, DOI 10.1002/tax.574020; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; GOLENBERG EM, 1993, MOL PHYLOGENET EVOL, V2, P52, DOI 10.1006/mpev.1993.1006; Graham SW, 2000, CURR GENET, V37, P183, DOI 10.1007/s002940050517; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Janzen DH, 2004, PHILOS T R SOC B, V359, P731, DOI 10.1098/rstb.2003.1444; Kelchner SA, 1996, CURR GENET, V30, P259, DOI 10.1007/s002940050130; Kim CS, 1997, NUCLEIC ACIDS RES, V25, P1085, DOI 10.1093/nar/25.5.1085; Kim KJ, 2005, MOL CELLS, V19, P104; Kirschner J, 2003, PLANT SYST EVOL, V239, P231, DOI 10.1007/s00606-003-0002-5; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mast AR, 2002, AM J BOT, V89, P1311, DOI 10.3732/ajb.89.8.1311; Mes THM, 2000, GENOME, V43, P634, DOI 10.1139/gen-43-4-634; Quandt D, 2004, PLANT BIOLOGY, V6, P545, DOI 10.1055/s-2004-821144; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Scheen AC, 2004, AM J BOT, V91, P943, DOI 10.3732/ajb.91.6.943; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; STERN DB, 1987, CELL, V51, P1145, DOI 10.1016/0092-8674(87)90600-3; Storchova H, 2007, PLANT SYST EVOL, V268, P235, DOI 10.1007/s00606-007-0582-6; STRUWE L, 2002, GENTIANACEAE SYSTEMA, P21, DOI DOI 10.1017/CBO9780511541865.003; SWOFFORD DL, 2003, PAUP 4 0B10 PHYLOGEN; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tate JA, 2003, SYST BOT, V28, P723; Tsumura Y, 2000, MOL BIOL EVOL, V17, P1302, DOI 10.1093/oxfordjournals.molbev.a026414; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36	44	104	110	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11533	10.1371/journal.pone.0011533	http://dx.doi.org/10.1371/journal.pone.0011533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644717	Green Published, gold, Green Submitted			2022-12-25	WOS:000279822300007
J	Castonguay-Vanier, J; Vial, L; Tremblay, J; Deziel, E				Castonguay-Vanier, Josee; Vial, Ludovic; Tremblay, Julien; Deziel, Eric			Drosophila melanogaster as a Model Host for the Burkholderia cepacia Complex	PLOS ONE			English	Article							SURVIVAL IN-VIVO; GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; INTRACELLULAR SURVIVAL; CAENORHABDITIS-ELEGANS; III SECRETION; PATHOGEN INTERACTIONS; PULMONARY INFECTION; IMMUNE-RESPONSE	Background: Colonization with bacterial species from the Burkholderia cepacia complex (Bcc) is associated with fast health decline among individuals with cystic fibrosis. In order to investigate the virulence of the Bcc, several alternative infection models have been developed. To this end, the fruit fly is increasingly used as surrogate host, and its validity to enhance our understanding of host-pathogen relationships has been demonstrated with a variety of microorganisms. Moreover, its relevance as a suitable alternative to mammalian hosts has been confirmed with vertebrate organisms. Methodology/Principal Findings: The aim of this study was to establish Drosophila melanogaster as a surrogate host for species from the Bcc. While the feeding method proved unsuccessful at killing the flies, the pricking technique did generate mortality within the populations. Results obtained with the fruit fly model are comparable with results obtained using mammalian infection models. Furthermore, validity of the Drosophila infection model was confirmed with B. cenocepacia K56-2 mutants known to be less virulent in murine hosts or in other alternative models. Competitive index (CI) analyses were also performed using the fruit fly as host. Results of CI experiments agree with those obtained with mammalian models. Conclusions/Significance: We conclude that Drosophila is a useful alternative infection model for Bcc and that fly pricking assays and competition indices are two complementary methods for virulence testing. Moreover, CI results indicate that this method is more sensitive than mortality tests.	[Castonguay-Vanier, Josee; Vial, Ludovic; Tremblay, Julien; Deziel, Eric] Univ Quebec, Inst Armand Frappier, Inst Natl Rech Sci, Laval, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS)	Castonguay-Vanier, J (corresponding author), Univ Quebec, Inst Armand Frappier, Inst Natl Rech Sci, Laval, PQ, Canada.	eric.deziel@iaf.inrs.ca	Déziel, Eric/A-7678-2008	Déziel, Eric/0000-0002-4609-0115; Vial, ludovic/0000-0001-6021-0251; Tremblay, Julien/0000-0002-6085-3481	Canadian Institutes of Health Research (CIHR) [MOP-77642]; Fondation Armand-Frappier; Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fondation Armand-Frappier; Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)(FQRNT)	This study was supported by the Canadian Institutes of Health Research (CIHR) Operating grant MOP-77642 to ED. JCV received a master of science (M.Sc.) scholarship and LV a postdoctoral fellowship, both from the Fondation Armand-Frappier. JT was recipient of a doctor of philosophy (Ph.D.) scholarship from the Fonds quebecois de la recherche sur la nature et les technologies (FQRNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2000, AM J RESP CRIT CARE, V161, P1206, DOI 10.1164/ajrccm.161.4.9907147; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Apidianakis Y, 2005, P NATL ACAD SCI USA, V102, P2573, DOI 10.1073/pnas.0409588102; Apidianakis Y, 2004, EUKARYOT CELL, V3, P413, DOI 10.1128/EC.3.2.413-419.2004; Baldini RL, 2002, METHOD ENZYMOL, V358, P3; Bernier SP, 2003, INFECT IMMUN, V71, P5306, DOI 10.1128/IAI.71.9.5306-5313.2003; Brandt SM, 2004, PLOS BIOL, V2, P2067, DOI 10.1371/journal.pbio.0020418; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; BURKHOLDER WH, 1950, PHYTOPATHOLOGY, V40, P115; Cardona ST, 2005, FEMS MICROBIOL LETT, V250, P97, DOI 10.1016/j.femsle.2005.06.050; Chiarini L, 2006, TRENDS MICROBIOL, V14, P277, DOI 10.1016/j.tim.2006.04.006; Chu KK, 2002, INFECT IMMUN, V70, P2715, DOI 10.1128/IAI.70.5.2715-2720.2002; Chugani SA, 2001, P NATL ACAD SCI USA, V98, P2752, DOI 10.1073/pnas.051624298; Coenye T, 2001, INT J SYST EVOL MICR, V51, P1481, DOI 10.1099/00207713-51-4-1481; Coenye T, 2003, J CLIN MICROBIOL, V41, P2797, DOI 10.1128/JCM.41.6.2797-2798.2003; Coenye T, 2001, J CLIN MICROBIOL, V39, P3427, DOI 10.1128/JCM.39.10.3427-3436.2001; Corbett CR, 2003, MICROBIOL-SGM, V149, P2263, DOI 10.1099/mic.0.26243-0; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; D'Argenio DA, 2001, J BACTERIOL, V183, P1466, DOI 10.1128/JB.183.4.1466-1471.2001; Dionne MS, 2003, INFECT IMMUN, V71, P3540, DOI 10.1128/IAI.71.6.3540-3550.2003; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Fallon PG, 2001, TRENDS IMMUNOL, V22, P63, DOI 10.1016/S1471-4906(00)01800-7; Fauvarque MO, 2002, MICROB PATHOGENESIS, V32, P287, DOI 10.1006/mpat.2002.0504; Flannagan RS, 2007, INFECT IMMUN, V75, P1679, DOI 10.1128/IAI.01581-06; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Huber B, 2004, INFECT IMMUN, V72, P7220, DOI 10.1128/IAI.72.12.7220-7230.2004; Hunt TA, 2004, INFECT IMMUN, V72, P4010, DOI 10.1128/IAI.72.7.4010-4022.2004; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Kooi C, 2006, INFECT IMMUN, V74, P4083, DOI 10.1128/IAI.00297-06; Kukavica-Ibrulj I, 2008, J BACTERIOL, V190, P2804, DOI 10.1128/JB.01572-07; Lamothe J, 2007, CELL MICROBIOL, V9, P40, DOI 10.1111/j.1462-5822.2006.00766.x; Laws TR, 2005, FEMS MICROBIOL LETT, V250, P77, DOI 10.1016/j.femsle.2005.06.046; LEWENZA S, 1999, J BACTERIOL, V748, P2073; Loutet SA, 2006, J BACTERIOL, V188, P2073, DOI 10.1128/JB.188.6.2073-2080.2006; Lutter EI, 2008, INFECT IMMUN, V76, P1877, DOI 10.1128/IAI.01165-07; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P910, DOI 10.1128/JCM.38.2.910-913.2000; Mahenthiralingam E, 2001, CLIN INFECT DIS, V33, P1469, DOI 10.1086/322684; Markey KM, 2006, J MED MICROBIOL, V55, P967, DOI 10.1099/jmm.0.46618-0; Marolda CL, 1999, MICROBIOL-SGM, V145, P1509, DOI 10.1099/13500872-145-7-1509; Martin DW, 2000, INFECT IMMUN, V68, P24, DOI 10.1128/IAI.68.1.24-29.2000; McClean S, 2009, J MED MICROBIOL, V58, P1, DOI 10.1099/jmm.0.47788-0; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mylonakis E, 2005, INFECT IMMUN, V73, P3833, DOI 10.1128/IAI.73.7.3833-3841.2005; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; NELSON MJK, 1987, APPL ENVIRON MICROB, V53, P949, DOI 10.1128/AEM.53.5.949-954.1987; Nicolas E, 1998, J BIOL CHEM, V273, P10463, DOI 10.1074/jbc.273.17.10463; Riedel K, 2003, ELECTROPHORESIS, V24, P740, DOI 10.1002/elps.200390089; Roh SW, 2008, APPL ENVIRON MICROB, V74, P6171, DOI 10.1128/AEM.00301-08; Sajjan U, 2001, INFECT IMMUN, V69, P5138, DOI 10.1128/IAI.69.8.5138-5150.2001; Seed KD, 2008, INFECT IMMUN, V76, P1267, DOI 10.1128/IAI.01249-07; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sokol PA, 2003, MICROBIOL-SGM, V149, P3649, DOI 10.1099/mic.0.26540-0; Sousa SA, 2007, CELL MICROBIOL, V9, P2817, DOI 10.1111/j.1462-5822.2007.00998.x; Tomich M, 2003, INFECT IMMUN, V71, P1405, DOI 10.1128/IAI.71.3.1405-1415.2003; Tzou P, 2002, METHOD MICROBIOL, V31, P507, DOI 10.1016/S0580-9517(02)31028-6; Uehlinger S, 2009, INFECT IMMUN, V77, P4102, DOI 10.1128/IAI.00398-09; Vandamme P, 2003, RES MICROBIOL, V154, P91, DOI 10.1016/S0923-2508(03)00026-3; Vanlaere E, 2008, INT J SYST EVOL MICR, V58, P1580, DOI 10.1099/ijs.0.65634-0; Vial, 2007, J MICROBIOL BIOTECHN, V17, P1407; Vial L, 2008, J BACTERIOL, V190, P5339, DOI 10.1128/JB.00400-08; Vial L, 2008, CELL HOST MICROBE, V4, P505, DOI 10.1016/j.chom.2008.11.005; Vodovar N, 2004, TRENDS MICROBIOL, V12, P235, DOI 10.1016/j.tim.2004.03.007; Weber DJ, 2007, ANTIMICROB AGENTS CH, V51, P4217, DOI 10.1128/AAC.00138-07	66	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11467	10.1371/journal.pone.0011467	http://dx.doi.org/10.1371/journal.pone.0011467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20635002	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000279781600002
J	Ancrenaz, M; Ambu, L; Sunjoto, I; Ahmad, E; Manokaran, K; Meijaard, E; Lackman, I				Ancrenaz, Marc; Ambu, Laurentius; Sunjoto, Indra; Ahmad, Eddie; Manokaran, Kennesh; Meijaard, Erik; Lackman, Isabelle			Recent Surveys in the Forests of Ulu Segama Malua, Sabah, Malaysia, Show That Orang-utans (P. p. morio) Can Be Maintained in Slightly Logged Forests	PLOS ONE			English	Article							PONGO-PYGMAEUS; WEST KALIMANTAN; POPULATION-DENSITY; SIZE	Background: Today the majority of wild great ape populations are found outside of the network of protected areas in both Africa and Asia, therefore determining if these populations are able to survive in forests that are exploited for timber or other extractive uses and how this is managed, is paramount for their conservation. Methodology/Principal Findings: In 2007, the "Kinabatangan Orang-utan Conservation Project'' (KOCP) conducted aerial and ground surveys of orang-utan (Pongo pygmaeus morio) nests in the commercial forest reserves of Ulu Segama Malua (USM) in eastern Sabah, Malaysian Borneo. Compared with previous estimates obtained in 2002, our recent data clearly shows that orang-utan populations can be maintained in forests that have been lightly and sustainably logged. However, forests that are heavily logged or subjected to fast, successive coupes that follow conventional extraction methods, exhibit a decline in orang-utan numbers which will eventually result in localized extinction (the rapid extraction of more than 100 m(3) ha(-1) of timber led to the crash of one of the surveyed sub-populations). Nest distribution in the forests of USM indicates that orang-utans leave areas undergoing active disturbance and take momentarily refuge in surrounding forests that are free of human activity, even if these forests are located above 500 m asl. Displaced individuals will then recolonize the old-logged areas after a period of time, depending on availability of food sources in the regenerating areas. Conclusion/Significance: These results indicate that diligent planning prior to timber extraction and the implementation of reduced-impact logging practices can potentially be compatible with great ape conservation.	[Ancrenaz, Marc; Ambu, Laurentius] Sabah Wildlife Dept, Wisma Muis, Sabah, Malaysia; [Ancrenaz, Marc] Chester Zoo, N England Zool Soc, Chester, Cheshire, England; [Sunjoto, Indra] Sabah Forestry Dept, Sabah, Malaysia; [Meijaard, Erik] People & Nat Consulting Int, Kerobokan, Bali, Indonesia; [Lackman, Isabelle] Pittsburgh Zoo, Pittsburgh, PA USA	Pusat Penyelidikan Hutan; People & Nature Consulting International		marc.ancrenaz@yahoo.com	Meijaard, Erik/A-2687-2016	Meijaard, Erik/0000-0001-8685-3685	Australian Regional natural Heritage program; US Fish and Wildlife Services	Australian Regional natural Heritage program; US Fish and Wildlife Services(US Fish & Wildlife Service)	This specific study was supported by a grant from the Australian Regional natural Heritage program and from the US Fish and Wildlife Services Great Ape Conservation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; For permission to work in Sabah we are grateful to the Economic Planning Unit, to late Datuk Patrick Andau (previous Director of the Sabah Wildlife Department) for his continuous support, to staff of the Sabah Forestry and Sabah Wildlife Department who were involved in these surveys. We would also like to thank Katie King and anonymous reviewers for their useful comments on the manuscript. Long-term KOCP activities have been supported by several zoos (Apenheul, Beauval, Cleveland, Columbus, Houston, La Palmyre, Oregon, Philadelphia, Phoenix, Saint Louis, Utah Ogle, Woodland Park); foundations (Abraham, Arcus, BOS-NL, Earth Shared, Elephant Family, Ensemble, Mohamed bin Zhayed, Shining Hope, WoodTiger, World Women Work, Wildlife Conservation Network); US Fish and Wildlife Services, North England Zoological Society. Last but not least, the KOCP would not exist without the commitment of the 40 research assistants employed by the project who are dedicated to conserve the natural resources of the Kinabatangan floodplain and we are extremely grateful to all of them.	Ancrenaz M, 2005, PLOS BIOL, V3, P30, DOI 10.1371/journal.pbio.0030003; Ancrenaz M, 2004, ANIM CONSERV, V7, P375, DOI 10.1017/S136794300400157X; Ancrenaz M, 2007, PLOS BIOL, V5, P2443, DOI 10.1371/journal.pbio.0050289; BOYKO RH, 2010, PLOS ONE IN PRESS; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Cassey P, 1999, ENVIRONMETRICS, V10, P261, DOI 10.1002/(SICI)1099-095X(199905/06)10:3<261::AID-ENV351>3.0.CO;2-O; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Djojosudharmo Suharto, 1992, Tropical Biodiversity, V1, P11; Felton AM, 2003, BIOL CONSERV, V114, P91, DOI 10.1016/S0006-3207(03)00013-2; Goossens B, 2006, MOL ECOL, V15, P2577, DOI 10.1111/j.1365-294X.2006.02952.x; Goossens B, 2005, MOL ECOL, V14, P441, DOI 10.1111/j.1365-294X.02421.x; HARRISSON T, 1971, SABAH SOC J, P1; HUSSON S, 2009, GEOGRAPHIC VARIATION, P77; JOHNS AD, 1988, BIOTROPICA, V20, P31, DOI 10.2307/2388423; Johnson AE, 2005, BIOL CONSERV, V121, P495, DOI 10.1016/j.biocon.2004.06.002; Knop E, 2004, BIOL CONSERV, V120, P183, DOI 10.1016/j.biocon.2004.02.010; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Kuehl H.S., 2008, BEST PRACTICE GUIDEL; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; MacKinnon K., 1996, ECOLOGY KALIMANTAN, V3; Marsh CW., 1995, DANUM VALLEY CONSERV; MARSHALL AJ, 2009, GEOGRAPHIC VARIATION, P311; MARSHALL AJ, 2009, GEOGRAPHIC VARIATION, P97; Marshall AJ, 2007, AM J PRIMATOL, V69, P212, DOI 10.1002/ajp.20341; Marshall AJ, 2006, BIOL CONSERV, V129, P566, DOI 10.1016/j.biocon.2005.11.025; Mathewson PD, 2008, ECOL APPL, V18, P208, DOI 10.1890/07-0385.1; Meijaard E, 2008, ECOL RES, V23, P21, DOI 10.1007/s11284-007-0342-7; Meijaard Erik, 2005, pi; Morrogh-Bernard H, 2003, BIOL CONSERV, V110, P141, DOI 10.1016/S0006-3207(02)00186-6; MORROGHBERNARD H, 2009, GEOGRAPHIC VARIATION, P119; Payne J., 1988, 3759 WWF MAL INT; Pryer W.B, 1883, P ROYAL GEOGRAPHICAL, V5, P90; Rao Madhu, 1997, Tropical Biodiversity, V4, P173; RIJKSEN HD, 1978, THESIS WAGENINGEN NE; Rijksen HD, 1999, OUR VANISHING RELATI; Russon AE, 2001, BIOL CONSERV, V97, P21, DOI 10.1016/S0006-3207(00)00087-2; RUSSON AE, 2009, GEOGRAPHIC VARIATION, P135; *SAB FOR DEP, 2008, FOR MAN PLAN UL SEG; SHEIL D, 2010, BIODIVERSIT IN PRESS; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; Singleton I, 2001, INT J PRIMATOL, V22, P877, DOI 10.1023/A:1012033919441; TAYLOR AB, 2009, GEOGRAPHIC VARIATION, P15; van Kreveld A., 2009, GREAT APES LOGGING Z; vanSchaik CP, 1995, NEGLECTED APE, P129; VANSCHAIK CP, 2009, GEPGRAPHIC VARIATION, P351; Walsh RPD, 1996, J TROP ECOL, V12, P385, DOI 10.1017/S0266467400009585; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X; WILSON K, 2010, ECOL APPL IN PRESS	48	53	54	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11510	10.1371/journal.pone.0011510	http://dx.doi.org/10.1371/journal.pone.0011510			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634974	Green Submitted, Green Published, gold			2022-12-25	WOS:000279715300021
J	Ran, LA; Larsson, J; Vigil-Stenman, T; Nylander, JAA; Ininbergs, K; Zheng, WW; Lapidus, A; Lowry, S; Haselkorn, R; Bergman, B				Ran, Liang; Larsson, John; Vigil-Stenman, Theoden; Nylander, Johan A. A.; Ininbergs, Karolina; Zheng, Wei-Wen; Lapidus, Alla; Lowry, Stephen; Haselkorn, Robert; Bergman, Birgitta			Genome Erosion in a Nitrogen-Fixing Vertically Transmitted Endosymbiotic Multicellular Cyanobacterium	PLOS ONE			English	Article							AZOLLA; SEQUENCE; PROTEIN; GENES; PSEUDOGENES; APPEARANCE; EVOLUTION; THOUSANDS; SYMBIOSIS; DYNAMICS	Background: An ancient cyanobacterial incorporation into a eukaryotic organism led to the evolution of plastids (chloroplasts) and subsequently to the origin of the plant kingdom. The underlying mechanism and the identities of the partners in this monophyletic event remain elusive. Methodology/Principal Findings: To shed light on this evolutionary process, we sequenced the genome of a cyanobacterium residing extracellularly in an endosymbiosis with a plant, the water-fern Azolla filiculoides Lam. This symbiosis was selected as it has characters which make it unique among extant cyanobacterial plant symbioses: the cyanobacterium lacks autonomous growth and is vertically transmitted between plant generations. Our results reveal features of evolutionary significance. The genome is in an eroding state, evidenced by a large proportion of pseudogenes (31.2%) and a high frequency of transposable elements (similar to 600) scattered throughout the genome. Pseudogenization is found in genes such as the replication initiator dnaA and DNA repair genes, considered essential to free-living cyanobacteria. For some functional categories of genes pseudogenes are more prevalent than functional genes. Loss of function is apparent even within the 'core' gene categories of bacteria, such as genes involved in glycolysis and nutrient uptake. In contrast, serving as a critical source of nitrogen for the host, genes related to metabolic processes such as cell differentiation and nitrogen-fixation are well preserved. Conclusions/Significance: This is the first finding of genome degradation in a plant symbiont and phenotypically complex cyanobacterium and one of only a few extracellular endosymbionts described showing signs of reductive genome evolution. Our findings suggest an ongoing selective streamlining of this cyanobacterial genome which has resulted in an organism devoted to nitrogen fixation and devoid of autonomous growth. The cyanobacterial symbiont of Azolla can thus be considered at the initial phase of a transition from free-living organism to a nitrogen-fixing plant entity, a transition process which may mimic what drove the evolution of chloroplasts from a cyanobacterial ancestor.	[Ran, Liang; Larsson, John; Vigil-Stenman, Theoden; Nylander, Johan A. A.; Ininbergs, Karolina; Bergman, Birgitta] Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden; [Zheng, Wei-Wen] Fujian Agr & Forestry Univ, Biotechnol Res Ctr, Fuzhou, Peoples R China; [Lapidus, Alla; Lowry, Stephen] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Haselkorn, Robert] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Stockholm University; Fujian Agriculture & Forestry University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Chicago	Ran, LA (corresponding author), Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden.	bergmanb@botan.su.se	Lapidus, Alla L/I-4348-2013; Ininbergs, Karolina/A-8125-2013	Lapidus, Alla L/0000-0003-0427-8731; 	Swedish Energy Agency; Swedish Research Council; Knut and Alice Wallenberg Foundation; US Department of Energy's Office of Science; University of California; Lawrence Livermore National Laboratory [W-7405-Eng-48, DE-AC02-05CH11231]; Los Alamos National Laboratory [DE-AC02-06NA25396]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); US Department of Energy's Office of Science(United States Department of Energy (DOE)); University of California(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by The Swedish Energy Agency (http://www.energimyndigheten.se/en/), The Swedish Research Council Formas (http://www.formas.se/) and by the Knut and Alice Wallenberg Foundation (http://www.wallenberg.com/kaw/) (to BB). This work was performed under the auspices of the US Department of Energy's Office of Science (http://www.science.energy.gov), Biological and Environmental Research Program, and by the University of California (http://berkeley.edu/), Lawrence Livermore National Laboratory (https://www.llnl.gov/) under Contract No. W-7405-Eng-48, Lawrence Berkeley National Laboratory (www.lbl.gov/) under contract No. DE-AC02-05CH11231 and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. The work conducted by the U.S. Department of Energy Joint Genome Institute (http://www.jgi.doe.gov/) is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Andersson JO, 2001, MOL BIOL EVOL, V18, P829, DOI 10.1093/oxfordjournals.molbev.a003864; Bauer K, 2008, FEMS MICROBIOL ECOL, V63, P205, DOI 10.1111/j.1574-6941.2007.00423.x; Bergman Birgitta, 2008, P447; Bhattacharya D, 2007, BIOESSAYS, V29, P1239, DOI 10.1002/bies.20671; BRAUNHOWLAND EB, 1988, PLANTA, V176, P319, DOI 10.1007/BF00395412; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Deusch O, 2008, MOL BIOL EVOL, V25, P748, DOI 10.1093/molbev/msn022; Douglas AE, 2003, PHILOS T R SOC B, V358, P5, DOI 10.1098/rstb.2002.1188; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; HALL JW, 1968, AM J BOT, V55, P1055, DOI 10.2307/2440472; Haselkorn R, 2007, ASS ENDOPHYTIC NITRO, P233; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kikuchi Y, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-2; Kogoma T, 1997, J BACTERIOL, V179, P2109, DOI 10.1128/jb.179.7.2109-2115.1997; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Lawrence JG, 2001, TRENDS MICROBIOL, V9, P535, DOI 10.1016/S0966-842X(01)02198-9; Lechno-Yossef S, 2002, CYANOBACTERIA IN SYMBIOSIS, P153; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Mavromatis K, 2009, STAND GENOMIC SCI, V1, P63, DOI 10.4056/sigs.632; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; NIERZWICKIBAUER SA, 1986, EMBO J, V5, P29, DOI 10.1002/j.1460-2075.1986.tb04173.x; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; ORR J, 1982, J BACTERIOL, V152, P626; PETERS GA, 1989, ANNU REV PLANT PHYS, V40, P193, DOI 10.1146/annurev.pp.40.060189.001205; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; RASMUSSEN U, 1994, MOL PLANT MICROBE IN, V7, P696, DOI 10.1094/MPMI-7-0696; Richter S, 1998, J BACTERIOL, V180, P4946, DOI 10.1128/JB.180.18.4946-4949.1998; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stucken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009235; Swingley WD, 2008, MOL BIOL EVOL, V25, P643, DOI 10.1093/molbev/msn034; Usher KM, 2007, ANNU REV ECOL EVOL S, V38, P255, DOI 10.1146/annurev.ecolsys.38.091206.095641; Walker A, 2008, NAT REV MICROBIOL, V6, P878, DOI 10.1038/nrmicro2044; Wu XQ, 2004, J BACTERIOL, V186, P6422, DOI 10.1128/JB.186.19.6422-6429.2004; ZHENG SP, 2008, CHIN J AGR BIOTECHOL, V16, P508; Zheng WW, 2009, NEW PHYTOL, V181, P53, DOI 10.1111/j.1469-8137.2008.02644.x	49	114	132	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11486	10.1371/journal.pone.0011486	http://dx.doi.org/10.1371/journal.pone.0011486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628610	gold, Green Published, Green Submitted			2022-12-25	WOS:000279637100013
J	Melamed, D; Bar-Ziv, L; Truzman, Y; Arava, Y				Melamed, Daniel; Bar-Ziv, Lavi; Truzman, Yossi; Arava, Yoav			Asc1 Supports Cell-Wall Integrity Near Bud Sites by a Pkc1 Independent Mechanism	PLOS ONE			English	Article							PROTEIN-KINASE-C; SACCHAROMYCES-CEREVISIAE; BETA-SUBUNIT; SCAFFOLD PROTEIN; POLARIZED GROWTH; IN-VIVO; RACK1; RECEPTOR; YEAST; LOCALIZATION	Background: The yeast ribosomal protein Asc1 is a WD-protein family member. Its mammalian ortholog, RACK1 was initially discovered as a receptor for activated protein C kinase (PKC) that functions to maintain the active conformation of PKC and to support its movement to target sites. In the budding yeast though, a connection between Asc1p and the PKC signaling pathway has never been reported. Methodology/Principal Findings: In the present study we found that asc1-deletion mutant (asc1 Delta) presents some of the hallmarks of PKC signaling mutants. These include an increased sensitivity to staurosporine, a specific Pkc1p inhibitor, and susceptibility to cell-wall perturbing treatments such as hypotonic- and heat shock conditions and zymolase treatment. Microscopic analysis of asc1 Delta cells revealed cell-wall invaginations near bud sites after exposure to hypotonic conditions, and the dynamic of cells' survival after this stress further supports the involvement of Asc1p in maintaining the cell-wall integrity during the mid-to late stages of bud formation. Genetic interactions between asc1 and pkc1 reveal synergistic sensitivities of a double-knock out mutant (asc1 Delta/pkc1 Delta) to cell-wall stress conditions, and high basal level of PKC signaling in asc1 Delta. Furthermore, Asc1p has no effect on the cellular distribution or redistribution of Pkc1p at optimal or at cell-wall stress conditions. Conclusions/Significance: Taken together, our data support the idea that unlike its mammalian orthologs, Asc1p acts remotely from Pkc1p, to regulate the integrity of the cell-wall. We speculate that its role is exerted through translation regulation of bud-site related mRNAs during cells' growth.	[Melamed, Daniel; Bar-Ziv, Lavi; Truzman, Yossi; Arava, Yoav] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Melamed, D (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	arava@tx.technion.ac.il			Israeli Science Foundation [1096/05, 1193/09]	Israeli Science Foundation(Israel Science Foundation)	This work was supported by grants from the Israeli Science Foundation (1096/05 and 1193/09) (http://www.isf.org.il/english/default.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PD, 2000, J CELL SCI, V113, P2685; BONORA A, 1982, CURR MICROBIOL, V7, P217, DOI 10.1007/BF01568802; BORZANI W, 1958, J BACTERIOL, V76, P251, DOI 10.1128/JB.76.3.251-255.1958; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chang P-S, 1998, CARBOHYDR LETT, V3, P31; Chasse SA, 2006, EUKARYOT CELL, V5, P330, DOI 10.1128/EC.5.2.330-346.2006; Chen SH, 2004, J MOL CELL CARDIOL, V37, P399, DOI 10.1016/j.yjmcc.2004.04.019; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Csukai M, 1999, PHARMACOL RES, V39, P253, DOI 10.1006/phrs.1998.0418; Denis V, 2005, EUKARYOT CELL, V4, P36, DOI 10.1128/EC.4.1.36-45.2005; Eliyahu E, 2010, MOL CELL BIOL, V30, P284, DOI 10.1128/MCB.00651-09; Frey S, 2001, J BIOL CHEM, V276, P15905, DOI 10.1074/jbc.M009430200; Gerbasi VR, 2004, MOL CELL BIOL, V24, P8276, DOI 10.1128/MCB.24.18.8276-8287.2004; Gray JV, 1997, EMBO J, V16, P4924, DOI 10.1093/emboj/16.16.4924; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Inada T, 2002, RNA, V8, P948, DOI 10.1017/S1355838202026018; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Lee KH, 2004, NEUROCHEM RES, V29, P1405, DOI 10.1023/B:NERE.0000026404.08779.43; LEVIN DE, 1994, CELL MOL BIOL RES, V40, P229; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Liedtke CM, 2002, J BIOL CHEM, V277, P22925, DOI 10.1074/jbc.M201917200; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Loya A, 2008, RNA, V14, P1352, DOI 10.1261/rna.867208; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Mourton T, 2001, J BIOL CHEM, V276, P14896, DOI 10.1074/jbc.M010823200; Nanduri J, 2001, MOL BIOL CELL, V12, P1835, DOI 10.1091/mbc.12.6.1835; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; PARAVICINI G, 1992, MOL CELL BIOL, V12, P4896, DOI 10.1128/MCB.12.11.4896; Patterson RL, 2004, P NATL ACAD SCI USA, V101, P2328, DOI 10.1073/pnas.0308567100; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Stebbins EG, 2001, J BIOL CHEM, V276, P29644, DOI 10.1074/jbc.M101044200; Usacheva A, 2001, J BIOL CHEM, V276, P22948, DOI 10.1074/jbc.M100087200; WATANABE M, 1994, J BIOL CHEM, V269, P16829; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909; YOSHIDA S, 1992, MOL GEN GENET, V231, P337, DOI 10.1007/BF00292700; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200	43	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11389	10.1371/journal.pone.0011389	http://dx.doi.org/10.1371/journal.pone.0011389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613984	Green Published, gold, Green Submitted			2022-12-25	WOS:000279370000018
J	Barr, KL; Hearne, LB; Briesacher, S; Clark, TL; Davis, GE				Barr, Kelli L.; Hearne, Leonard B.; Briesacher, Sandra; Clark, Thomas L.; Davis, Georgia E.			Microbial Symbionts in Insects Influence Down-Regulation of Defense Genes in Maize	PLOS ONE			English	Article							WESTERN CORN-ROOTWORM; PATHOGENESIS-RELATED PROTEINS; WOLBACHIA SURFACE PROTEIN; DIABROTICA-VIRGIFERA; CHRYSOMELIDAE; COLEOPTERA; EXPRESSION; RESISTANCE; WSP; ACCUMULATION	Diabrotica virgifera virgifera larvae are root-feeding insects and significant pests to maize in North America and Europe. Little is known regarding how plants respond to insect attack of roots, thus complicating the selection for plant defense targets. Diabrotica virgifera virgifera is the most successful species in its genus and is the only Diabrotica beetle harboring an almost species-wide Wolbachia infection. Diabrotica virgifera virgifera are infected with Wolbachia and the typical gut flora found in soil-living, phytophagous insects. Diabrotica virgifera virgifera larvae cannot be reared aseptically and thus, it is not possible to observe the response of maize to effects of insect gut flora or other transient microbes. Because Wolbachia are heritable, it is possible to investigate whether Wolbachia infection affects the regulation of maize defenses. To answer if the success of Diabrotica virgifera virgifera is the result of microbial infection, Diabrotica virgifera virgifera were treated with antibiotics to eliminate Wolbachia and a microarray experiment was performed. Direct comparisons made between the response of maize root tissue to the feeding of antibiotic treated and untreated Diabrotica virgifera virgifera show down-regulation of plant defenses in the untreated insects compared to the antibiotic treated and control treatments. Results were confirmed via QRT-PCR. Biological and behavioral assays indicate that microbes have integrated into Diabrotica virgifera virgifera physiology without inducing negative effects and that antibiotic treatment did not affect the behavior or biology of the insect. The expression data and suggest that the pressure of microbes, which are most likely Wolbachia, mediate the down-regulation of many maize defenses via their insect hosts. This is the first report of a potential link between a microbial symbiont of an insect and a silencing effect in the insect host plant. This is also the first expression profile for a plant attacked by a root-feeding insect.	[Barr, Kelli L.] Florida Gulf Coast Univ, Ft Myers, FL USA; [Hearne, Leonard B.; Briesacher, Sandra; Davis, Georgia E.] Univ Missouri, Columbia, MO USA; [Clark, Thomas L.] Monsanto Co, St Louis, MO USA	State University System of Florida; Florida Gulf Coast University; University of Missouri System; University of Missouri Columbia; Monsanto	Barr, KL (corresponding author), Florida Gulf Coast Univ, Ft Myers, FL USA.	kbarr@fgcu.edu	Barr, Kelli L./I-7508-2019	Barr, Kelli L./0000-0001-7943-7181	Illinois Missouri Biotechnology Alliance, IMBA [2006-6]	Illinois Missouri Biotechnology Alliance, IMBA	This work was funded by the Illinois Missouri Biotechnology Alliance (http://www.imba.missouri.edu/), IMBA Project 2006-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Anderson CL, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-10; [Anonymous], 1986, METHODS STUDY PEST D; ASSABGUI RA, 1995, J ECON ENTOMOL, V88, P1482, DOI 10.1093/jee/88.5.1482; Balandin M, 2005, PLANT MOL BIOL, V58, P269, DOI 10.1007/s11103-005-3479-1; BALL HJ, 1962, J ECON ENTOMOL, V55, P439, DOI 10.1093/jee/55.4.439; Bazzocchi C, 2007, PARASITE IMMUNOL, V29, P73, DOI 10.1111/j.1365-3024.2006.00915.x; Bown DP, 2004, INSECT BIOCHEM MOLEC, V34, P305, DOI 10.1016/j.ibmb.2003.11.005; Carle P, 1997, INT J SYST BACTERIOL, V47, P78, DOI 10.1099/00207713-47-1-78; Clark PL, 2006, J ECON ENTOMOL, V99, P722, DOI 10.1603/0022-0493-99.3.722; Clark TL, 2001, ANN ENTOMOL SOC AM, V94, P877, DOI 10.1603/0013-8746(2001)094[0877:OOWISD]2.0.CO;2; Delp G, 2009, MOL GENET GENOMICS, V281, P233, DOI 10.1007/s00438-008-0409-3; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Farag MA, 2005, PLANTA, V220, P900, DOI 10.1007/s00425-004-1404-5; FESLOT AS, 1982, J ECON ENTOMOL, V75, P1098; Garcia-Muniz N, 1998, PLANT MOL BIOL, V38, P623, DOI 10.1023/A:1006056000957; Giordano R, 1997, P NATL ACAD SCI USA, V94, P11439, DOI 10.1073/pnas.94.21.11439; Giovanini MP, 2006, MOL PLANT MICROBE IN, V19, P1023, DOI 10.1094/MPMI-19-1023; Grandi G, 2008, J PARASITOL, V94, P1421, DOI 10.1645/GE-1575.1; Hayashi M, 2005, P NATL ACAD SCI USA, V102, P7020, DOI 10.1073/pnas.0502556102; Hibbard BE, 2007, J PLANT REGIST, V1, P151, DOI 10.3198/jpr2006.12.0774crg; Im KH, 2000, PLANT PHYSIOL, V123, P463, DOI 10.1104/pp.123.2.463; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Jiggins FM, 2001, P ROY SOC B-BIOL SCI, V268, P1123, DOI 10.1098/rspb.2001.1632; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Kawasaki T, 2006, P NATL ACAD SCI USA, V103, P230, DOI 10.1073/pnas.0509875103; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Kobayashi Y, 1997, PLANT CELL PHYSIOL, V38, P725, DOI 10.1093/oxfordjournals.pcp.a029226; Kramer L, 2005, VET PARASITOL, V133, P133, DOI 10.1016/j.vetpar.2005.04.011; Kramer LH, 2005, VET IMMUNOL IMMUNOP, V106, P303, DOI 10.1016/j.vetimm.2005.03.011; Levine E, 1996, J ECON ENTOMOL, V89, P1010, DOI 10.1093/jee/89.4.1010; LIU JJ, 2010, PLANT CELL REP  0305; MALEHORN DE, 1994, PLANT PHYSIOL, V106, P1471, DOI 10.1104/pp.106.4.1471; McKenzie CL, 2002, ARCH INSECT BIOCHEM, V49, P203, DOI 10.1002/arch.10020; MEAD LJ, 1988, APPL ENVIRON MICROB, V54, P1174, DOI 10.1128/AEM.54.5.1174-1181.1988; Moore KG, 2004, PHYTOPATHOLOGY, V94, P82, DOI 10.1094/PHYTO.2004.94.1.82; Morchon R, 2007, PARASITOL INT, V56, P71, DOI 10.1016/j.parint.2006.10.003; Ogawa J, 2002, CURR OPIN BIOTECH, V13, P367, DOI 10.1016/S0958-1669(02)00331-2; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Polidoros AN, 2001, TRANSGENIC RES, V10, P555, DOI 10.1023/A:1013027920444; Porksakorn C, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/84318; SCHALK J M, 1987, Journal of Agricultural Entomology, V4, P333; SHEN CJ, 2009, J APPL MICROBIO 0828; SIEGFRIED BD, 1989, PESTIC BIOCHEM PHYS, V35, P155, DOI 10.1016/0048-3575(89)90113-2; STINTZI A, 1993, BIOCHIMIE, V75, P687, DOI 10.1016/0300-9084(93)90100-7; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; WRIGHT RJ, 1996, COOP EXT U NEBRASKA, P45; Zhang HZ, 2004, INFECT IMMUN, V72, P498, DOI 10.1128/IAI.72.1.498-507.2004	52	94	99	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11339	10.1371/journal.pone.0011339	http://dx.doi.org/10.1371/journal.pone.0011339			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596533	Green Published, Green Submitted, gold			2022-12-25	WOS:000279259900012
J	Yi, L; Rosales, T; Rose, JJ; Chaudhury, B; Knutson, JR; Venkatesan, S				Yi, Ling; Rosales, Tilman; Rose, Jeremy J.; Chaudhury, Bhabhadeb; Knutson, Jay R.; Venkatesan, Sundararajan			HIV-1 Nef Binds a Subpopulation of MHC-I throughout Its Trafficking Itinerary and Down-regulates MHC-I by Perturbing Both Anterograde and Retrograde Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 NEF; FLUORESCENCE CORRELATION SPECTROSCOPY; ANTIGEN PRESENTATION; PHOTOBLEACHING RECOVERY; CYTOPLASMIC DOMAIN; ENDOCYTIC PATHWAY; LATERAL DIFFUSION; PLASMA-MEMBRANE; CD4 ENDOCYTOSIS; LIVING CELLS	The HIV protein Nef is thought to mediate immune evasion and promote viral persistence in part by down-regulating major histocompatibility complex class I protein (MHC-I or HLA-I) from the cell surface. Two different models have been proposed to explain this phenomenon as follows: 1) stimulation of MHC-I retrograde trafficking from and aberrant recycling to the plasma membrane, and 2) inhibition of anterograde trafficking of newly synthesized HLA-I from the endoplasmic reticulum to the plasma membrane. We show here that Nef simultaneously uses both mechanisms to down-regulate HLA-I in peripheral blood mononuclear cells or HeLa cells. Consistent with this, we found by using fluorescence correlation spectroscopy that a third of diffusing HLA-I at the endoplasmic reticulum, Golgi/trans-Golgi network, and the plasma membrane (PM) was associated with Nef. The binding of Nef was similarly avid for native HLA-I and recombinant HLA-I A2 at the PM. Nef binding to HLA-I at the PM was sensitive to specific inhibition of endocytosis. It was also attenuated by cyclodextrin disruption of PM lipid microdomain architecture, a change that also retarded lateral diffusion and induced large clusters of HLA-I. In all, our data support a model for Nef down-regulation of HLA-I that involves both major trafficking itineraries and persistent protein-protein interactions throughout the cell.	[Venkatesan, Sundararajan] NIAID, MCBU, LMI, NIH, Bethesda, MD 20892 USA; [Rosales, Tilman; Knutson, Jay R.] NHLBI, Opt Spect Sect, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Venkatesan, S (corresponding author), NIAID, MCBU, LMI, NIH, Bldg 10,Rm 6A05, Bethesda, MD 20892 USA.	sv1s@nih.gov			National Institutes of Health, Division of Intramural Research, NIAID; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006065, ZIAHL006066, ZIAHL001452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000528] Funding Source: NIH RePORTER	National Institutes of Health, Division of Intramural Research, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health grant from Division of Intramural Research, NIAID.	Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Baugh LL, 2008, J VIROL, V82, P9657, DOI 10.1128/JVI.00107-08; Benmerah A, 1999, J CELL SCI, V112, P1303; Bentham M, 2003, J GEN VIROL, V84, P2705, DOI 10.1099/vir.0.19274-0; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Burtey A, 2007, TRAFFIC, V8, P61, DOI 10.1111/j.1600-0854.2006.00512.x; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Chaudhry A, 2007, CELL HOST MICROBE, V1, P37, DOI 10.1016/j.chom.2007.01.001; Chaudhry A, 2009, J IMMUNOL, V183, P2415, DOI 10.4049/jimmunol.0804014; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Collins KL, 1999, IMMUNOL REV, V168, P65, DOI 10.1111/j.1600-065X.1999.tb01283.x; Costa LJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-33; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; DellAngelica EC, 1997, J BIOL CHEM, V272, P15078, DOI 10.1074/jbc.272.24.15078; Donaldson JG, 2009, TRAFFIC, V10, P1745, DOI 10.1111/j.1600-0854.2009.00979.x; Edidin M, 1997, IMMUNOGENETICS, V46, P41, DOI 10.1007/s002510050240; Fooksman DR, 2006, J IMMUNOL, V176, P6673, DOI 10.4049/jimmunol.176.11.6673; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Garcia-Saez AJ, 2008, METHODS, V46, P116, DOI 10.1016/j.ymeth.2008.06.011; Georgiou G, 2002, BIOPHYS J, V82, P1828, DOI 10.1016/S0006-3495(02)75533-1; Golebiewska U, 2008, MOL BIOL CELL, V19, P1663, DOI 10.1091/mbc.E07-12-1208; Greenberg ME, 1997, EMBO J, V16, P6964, DOI 10.1093/emboj/16.23.6964; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; HARRIS MPG, 1994, J MOL BIOL, V241, P136; HASUMI K, 1992, EUR J BIOCHEM, V205, P841, DOI 10.1111/j.1432-1033.1992.tb16848.x; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hiltbold EM, 2003, J IMMUNOL, V170, P1329, DOI 10.4049/jimmunol.170.3.1329; Hung CH, 2007, CELL HOST MICROBE, V1, P121, DOI 10.1016/j.chom.2007.03.004; Kasper MR, 2005, J BIOL CHEM, V280, P12840, DOI 10.1074/jbc.M413538200; Knorr R, 2009, J CELL SCI, V122, P1584, DOI 10.1242/jcs.039727; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Larson DR, 2005, J CELL BIOL, V171, P527, DOI 10.1083/jcb.200503110; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Lilley BN, 2005, IMMUNOL REV, V207, P126, DOI 10.1111/j.0105-2896.2005.00318.x; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Lubben NB, 2007, MOL BIOL CELL, V18, P3351, DOI 10.1091/mbc.E07-03-0218; Luo TC, 2001, J VIROL, V75, P2488, DOI 10.1128/JVI.75.5.2488-2492.2001; Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Marguet D, 1999, IMMUNITY, V11, P231, DOI 10.1016/S1074-7613(00)80098-9; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Noviello CM, 2008, J VIROL, V82, P1249, DOI 10.1128/JVI.00660-07; Pentcheva T, 2001, J IMMUNOL, V166, P6625, DOI 10.4049/jimmunol.166.11.6625; PETERS R, 1982, P NATL ACAD SCI-BIOL, V79, P4317, DOI 10.1073/pnas.79.14.4317; Piguet V, 1998, EMBO J, V17, P2472, DOI 10.1093/emboj/17.9.2472; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Preusser A, 2002, BIOCHEM BIOPH RES CO, V292, P734, DOI 10.1006/bbrc.2002.6700; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Rose JJ, 2005, J BIOL CHEM, V280, P7413, DOI 10.1074/jbc.M409420200; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Smith PR, 1999, BIOPHYS J, V76, P3331, DOI 10.1016/S0006-3495(99)77486-2; Sol-Foulon N, 2002, IMMUNITY, V16, P145, DOI 10.1016/S1074-7613(02)00260-1; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Su RC, 2001, J IMMUNOL, V167, P4869, DOI 10.4049/jimmunol.167.9.4869; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Tang Q, 2001, BIOPHYS J, V81, P196, DOI 10.1016/S0006-3495(01)75691-3; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Weiss M, 2003, BIOPHYS J, V84, P4043, DOI 10.1016/S0006-3495(03)75130-3; Willems PHGM, 2009, METHOD ENZYMOL, V456, P287, DOI 10.1016/S0076-6879(08)04416-9; Williams M, 2005, J VIROL, V79, P632, DOI 10.1128/JVI.79.1.632-636.2005; Wonderlich ER, 2008, J BIOL CHEM, V283, P3011, DOI 10.1074/jbc.M707760200	78	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30884	30905		10.1074/jbc.M110.135947	http://dx.doi.org/10.1074/jbc.M110.135947			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20622010	Green Published, hybrid			2022-12-25	WOS:000282135500055
J	Naula, CM; Logan, FM; Wong, PE; Barrett, MP; Burchmore, RJ				Naula, Christina M.; Logan, Flora M.; Wong, Pui Ee; Barrett, Michael P.; Burchmore, Richard J.			A Glucose Transporter Can Mediate Ribose Uptake DEFINITION OF RESIDUES THAT CONFER SUBSTRATE SPECIFICITY IN A SUGAR TRANSPORTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXOSE TRANSPORTERS; LEISHMANIA-DONOVANI; GLUT1; FRUCTOSE; MOTIF; FERMENTATION; DETERMINANT; METABOLISM; EXPRESSION; MECHANISM	Sugars, the major energy source for many organisms, must be transported across biological membranes. Glucose is the most abundant sugar in human plasma and in many other biological systems and has been the primary focus of sugar transporter studies in eukaryotes. We have previously cloned and characterized a family of glucose transporter genes from the protozoan parasite Leishmania. These transporters, called LmGT1, LmGT2, and LmGT3, are homologous to the well characterized glucose transporter (GLUT) family of mammalian glucose transporters. We have demonstrated that LmGT proteins are important for parasite viability. Here we show that one of these transporters, LmGT2, is a more effective carrier of the pentose sugar D-ribose than LmGT3, which has a 6-fold lower relative specificity (V-max/K-m) for ribose. A pair of threonine residues, located in the putative extracellular loops joining transmembrane helices 3 to 4 and 7 to 8, define a filter that limits ribose approaching the exo-facial substrate binding pocket in LmGT3. When these threonines are substituted by alanine residues, as found in LmGT2, the LmGT3 permease acquires ribose permease activity that is similar to that of LmGT2. The location of these residues in hydrophilic loops supports recent suggestions that substrate recognition is separated from substrate binding and translocation in this important group of transporters.	Univ Glasgow, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Barrett, Michael P.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow		r.burchmore@bio.gla.ac.uk	Burchmore, Richard/A-1896-2011	Burchmore, Richard/0000-0003-1663-9004; Naula, Christina/0000-0003-1165-693X; Barrett, Mike/0000-0001-9447-3519	The Wellcome Trust	The Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a project grant from The Wellcome Trust.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Arbuckle MI, 1996, BIOCHEMISTRY-US, V35, P16519, DOI 10.1021/bi962210n; Barrett MP, 1998, MOL BIOCHEM PARASIT, V91, P195, DOI 10.1016/S0166-6851(97)00192-8; BERENS RL, 1976, J PARASITOL, V62, P360, DOI 10.2307/3279142; BERENS RL, 1980, EXP PARASITOL, V49, P1, DOI 10.1016/0014-4894(80)90049-1; BISSON LF, 1993, CRIT REV BIOCHEM MOL, V28, P259, DOI 10.3109/10409239309078437; BRUN R, 1979, ACTA TROP, V36, P289; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Burchmore RJS, 1998, J BIOL CHEM, V273, P29118, DOI 10.1074/jbc.273.44.29118; Burchmore RJS, 2003, P NATL ACAD SCI USA, V100, P3901, DOI 10.1073/pnas.0630165100; Burchmore RJS, 2001, INT J PARASITOL, V31, P1311, DOI 10.1016/S0020-7519(01)00259-4; Burchmore RJS, 1995, MOL BIOCHEM PARASIT, V74, P77, DOI 10.1016/0166-6851(95)02485-9; CAMERON MM, 1995, MED VET ENTOMOL, V9, P263, DOI 10.1111/j.1365-2915.1995.tb00132.x; Cunningham P, 2006, J BIOL CHEM, V281, P5797, DOI 10.1074/jbc.M509422200; Dauterive R, 1996, J BIOL CHEM, V271, P11414, DOI 10.1074/jbc.271.19.11414; HARTZ KE, 1981, CONSERV RECYCLING, V4, P39, DOI 10.1016/0361-3658(81)90006-0; HRESKO RC, 1994, J BIOL CHEM, V269, P20482; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; IIDA A, 1984, J BACTERIOL, V158, P674, DOI 10.1128/JB.158.2.674-682.1984; Klepek YS, 2005, PLANT CELL, V17, P204, DOI 10.1105/tpc.104.026641; Lager I, 2003, FEBS LETT, V553, P85, DOI 10.1016/S0014-5793(03)00976-1; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; LEBOWITZ JH, 1990, P NATL ACAD SCI USA, V87, P9736, DOI 10.1073/pnas.87.24.9736; Manning SK, 2002, J BIOL CHEM, V277, P30942, DOI 10.1074/jbc.M204337200; Manolescu A, 2005, J BIOL CHEM, V280, P42978, DOI 10.1074/jbc.M508678200; Manolescu AR, 2007, MOL MEMBR BIOL, V24, P455, DOI 10.1080/09687680701298143; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Maugeri DA, 2003, MOL BIOCHEM PARASIT, V130, P117, DOI 10.1016/S0166-6851(03)00173-7; Molyneux D.H., 1991, Parassitologia (Rome), V33, P431; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; PASTOR GM, 1987, PROG SURF SCI, V26, P175, DOI 10.1016/0079-6816(87)90057-8; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Seatter MJ, 1998, BIOCHEMISTRY-US, V37, P1322, DOI 10.1021/bi972322u; Sedlak M, 2004, YEAST, V21, P671, DOI 10.1002/yea.1060; Snapp EL, 1997, J CELL BIOL, V139, P1775, DOI 10.1083/jcb.139.7.1775; Snapp EL, 1999, J BIOL CHEM, V274, P29543, DOI 10.1074/jbc.274.41.29543; STEIGER RF, 1980, ACTA TROP, V37, P195; YOUNG CJ, 1980, T ROY SOC TROP MED H, V74, P363, DOI 10.1016/0035-9203(80)90100-5	39	22	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29721	29728		10.1074/jbc.M110.106815	http://dx.doi.org/10.1074/jbc.M110.106815			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20601430	hybrid, Green Published			2022-12-25	WOS:000281984300007
J	Mao, ZH; Sun, W; Xu, RJ; Novgorodov, S; Szulc, ZM; Bielawski, J; Obeid, LM; Mao, CG				Mao, Zhehao; Sun, Wei; Xu, Ruijuan; Novgorodov, Sergei; Szulc, Zdzislaw M.; Bielawski, Jacek; Obeid, Lina M.; Mao, Cungui			Alkaline Ceramidase 2 (ACER2) and Its Product Dihydrosphingosine Mediate the Cytotoxicity of N-(4-Hydroxyphenyl)retinamide in Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROCERAMIDE DESATURASE; PROSTATE-CANCER; FENRETINIDE; APOPTOSIS; INDUCTION; SPHINGOSINE; ACID; PROLIFERATION; SPHINGANINE; SPECIFICITY	Increased generation of dihydrosphingosine (DHS), a bioactive sphingolipid, has been implicated in the cytotoxicity of the synthetic retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) in tumor cells. However, how 4-HPR increases DHS remains unclear. Here we demonstrate that 4-HPR increases the expression of ACER2, which catalyzes the hydrolysis of dihydroceramides to generate DHS, and that ACER2 up-regulation plays a key role in mediating the 4-HPR-induced generation of DHS as well as the cytotoxicity of 4-HPR in tumor cells. Treatment with 4-HPR induced the accumulation of dihydroceramides (DHCs) in tumor cells by inhibiting dihydroceramide desaturase (DES) activity, which catalyzes the conversion of DHCs to ceramides. Treatment with 4-HPR also increased ACER2 expression through a retinoic acid receptor-independent and caspase-dependent manner. Overexpression of ACER2 augmented the 4-HPR-induced generation of DHS as well as 4-HPR cytotoxicity, and 4-HPR-induced death in tumor cells, whereas knocking down ACER2 had the opposite effects. ACER2 overexpression, along with treatment with GT11, another DES inhibitor, markedly increased cellular DHS, leading to tumor cell death, whereas ACER2 overexpression or GT11 treatment alone failed to do so, suggesting that both ACER2 up-regulation and DES inhibition are necessary and sufficient to mediate 4-HPR-induced DHS accumulation, cytotoxicity, and death in tumor cells. Taken together, these results suggest that up-regulation of the ACER2/DHS pathway mediates the cytotoxicity of 4-HPR in tumor cells and that up-regulating or activating ACER2 may improve the anti-cancer activity of 4-HRR and other DHC-inducing agents.	[Obeid, Lina M.] Med Univ S Carolina, Dept Med, Div Gen Internal Med, Charleston, SC 29425 USA; [Szulc, Zdzislaw M.; Bielawski, Jacek; Obeid, Lina M.; Mao, Cungui] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.; Mao, Cungui] Ralph H Johnson Vet Adm Hosp, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Obeid, LM (corresponding author), Med Univ S Carolina, Dept Med, Div Gen Internal Med, 114 Doughty St,POB 250779, Charleston, SC 29425 USA.	maoc@musc.edu	xu, rui/GRX-5734-2022		National Institutes of Health [R01CA104834, P20RR017677]; Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA104834] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA104834 (to C. M.) and P20RR017677 (to L. M. O.). This work was also supported by a Veterans Affairs merit award (to L. M. O.).	Ahn EH, 2002, EXP BIOL MED, V227, P345, DOI 10.1177/153537020222700507; Ahn EH, 2006, ANTICANCER RES, V26, P121; Ahn EH, 2006, EXP BIOL MED, V231, P1664; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonanni B, 2009, RECENT RES CANCER, V181, P77; Bu PL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-236; Cheung E, 2009, CLIN GENITOURIN CANC, V7, P43, DOI 10.3816/CGC.2009.n.008; Chiesa F, 2005, INT J CANCER, V115, P625, DOI 10.1002/ijc.20923; DE PALO G, 2002, GYNECOL ONCOL, V86, P24; DiPietrantonio AM, 1998, INT J CANCER, V78, P53, DOI 10.1002/(SICI)1097-0215(19980925)78:1<53::AID-IJC10>3.0.CO;2-6; EL BAWAB S, 2002, J LIPID RES, V43, P141; Fazi B, 2008, AUTOPHAGY, V4, P435, DOI 10.4161/auto.5669; Fillet M, 2003, BIOCHEM PHARMACOL, V65, P1633, DOI 10.1016/S0006-2952(03)00125-4; Hail N, 2009, APOPTOSIS, V14, P849, DOI 10.1007/s10495-009-0356-4; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hu W, 2005, MOL BIOL CELL, V16, P1555, DOI 10.1091/mbc.E04-07-0594; Hu W, 2010, J BIOL CHEM, V285, P7964, DOI 10.1074/jbc.M109.063586; IGAWA M, 1994, PROSTATE, V24, P299, DOI 10.1002/pros.2990240605; Jiang Q, 2004, P NATL ACAD SCI USA, V101, P17825, DOI 10.1073/pnas.0408340102; Kadara H, 2008, CANCER RES, V68, P4416, DOI 10.1158/0008-5472.CAN-08-0031; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Mao CG, 2001, J BIOL CHEM, V276, P26577, DOI 10.1074/jbc.M102818200; Mao CG, 2003, J BIOL CHEM, V278, P31184, DOI 10.1074/jbc.M303875200; Maurer BJ, 1999, JNCI-J NATL CANCER I, V91, P1138, DOI 10.1093/jnci/91.13.1138; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; Mihai R, 2000, BIOCHEM BIOPH RES CO, V268, P636, DOI 10.1006/bbrc.2000.2159; MOMOI T, 1982, BIOCHEM J, V205, P419, DOI 10.1042/bj2050419; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Noda T, 2009, APOPTOSIS, V14, P287, DOI 10.1007/s10495-009-0319-9; Rath G, 2009, INT J BIOCHEM CELL B, V41, P1165, DOI 10.1016/j.biocel.2008.10.021; Reynolds CP, 2003, CANCER LETT, V197, P185, DOI 10.1016/S0304-3835(03)00108-3; Rozzo C, 1997, INT J CANCER, V70, P688, DOI 10.1002/(SICI)1097-0215(19970317)70:6<688::AID-IJC11>3.3.CO;2-V; Schiffmann S, 2009, J LIPID RES, V50, P32, DOI 10.1194/jlr.M800122-JLR200; Signorelli P, 2009, CANCER LETT, V282, P238, DOI 10.1016/j.canlet.2009.03.020; Sun W, 2008, J INVEST DERMATOL, V128, P389, DOI 10.1038/sj.jid.5701025; Sun W, 2010, J BIOL CHEM, V285, P8995, DOI 10.1074/jbc.M109.069203; Sun W, 2009, FASEB J, V23, P656, DOI 10.1096/fj.08-115634; Tamama K, 2001, BIOCHEM J, V353, P139, DOI 10.1042/bj3530139; Triola G, 2004, MOL PHARMACOL, V66, P1671, DOI 10.1124/mol.104.003681; Triola G, 2003, J ORG CHEM, V68, P9924, DOI 10.1021/jo030141u; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Wang H, 2008, MOL CANCER THER, V7, P2967, DOI 10.1158/1535-7163.MCT-08-0549; Wang HT, 2001, CANCER RES, V61, P5102; Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com; Zanardi S, 2006, ENDOCR-RELAT CANCER, V13, P51, DOI 10.1677/erc.1.00938; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	48	41	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29078	29090		10.1074/jbc.M110.105296	http://dx.doi.org/10.1074/jbc.M110.105296			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20628055	Green Published, hybrid			2022-12-25	WOS:000281740100009
J	Zhan, H; Suzuki, T; Aizawa, K; Miyagawa, K; Nagai, R				Zhan, Hong; Suzuki, Toru; Aizawa, Kenichi; Miyagawa, Kiyoshi; Nagai, Ryozo			Ataxia Telangiectasia Mutated (ATM)-mediated DNA Damage Response in Oxidative Stress-induced Vascular Endothelial Cell Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FULL ACTIVATION; ATM ACTIVATION; AKT; AUTOPHOSPHORYLATION; ATHEROSCLEROSIS; TUMORIGENESIS; CHECKPOINT; INSULIN; BARRIER; CANCER	Oxidative stress regulates dysfunction and senescence of vascular endothelial cells. The DNA damage response and its main signaling pathway involving ataxia telangiectasia mutated (ATM) have been implicated in playing a central role in mediating the actions of oxidative stress; however, the role of the ATM signaling pathway in vascular pathogenesis has largely remained unclear. Here, we identify ATM to regulate oxidative stress-induced endothelial cell dysfunction and premature senescence. Oxidative stress induced senescence in endothelial cells through activation/phosphorylation of ATM by way of an Akt/p53/p21-mediated pathway. These actions were abrogated in cells in which ATM was knocked down by RNA interference or inhibited by specific inhibitory compounds. Furthermore, the in vivo significance of this regulatory pathway was confirmed using ATM knock-out mice in which induction of senescent endothelial cells in the aorta in a diabetic mouse model of endothelial dysfunction and senescence was attenuated in contrast to pathological changes seen in wild-type mice. Collectively, our results show that ATM through an ATM/Akt/p53/p21-dependent signaling pathway mediates an instructive role in oxidative stress-induced endothelial dysfunction and premature senescence.	[Zhan, Hong; Suzuki, Toru; Aizawa, Kenichi; Nagai, Ryozo] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; [Suzuki, Toru; Aizawa, Kenichi] Univ Tokyo, Grad Sch Med, Dept Ubiquitous Prevent Med, Bunkyo Ku, Tokyo 1138655, Japan; [Miyagawa, Kiyoshi] Univ Tokyo, Grad Sch Med, Dept Radiat Biol, Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Nagai, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	nagai-tky@umin.ac.jp		Suzuki, Toru/0000-0002-8371-664X	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [21310034] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research (T. S., K. A., and R.N.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Bencokova Z, 2009, MOL CELL BIOL, V29, P526, DOI 10.1128/MCB.01301-08; Breitschopf K, 2001, FEBS LETT, V493, P21, DOI 10.1016/S0014-5793(01)02272-4; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Halaby MJ, 2008, CELL SIGNAL, V20, P1555, DOI 10.1016/j.cellsig.2008.04.011; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kang JY, 2009, MOL CELLS, V28, P489, DOI 10.1007/s10059-009-0141-9; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Ota H, 2008, ARTERIOSCL THROM VAS, V28, P1634, DOI 10.1161/ATVBAHA.108.164368; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Suzuki T, 2007, J BIOL CHEM, V282, P9895, DOI 10.1074/jbc.M608098200; SWIFT M, 1983, LANCET, V1, P1049; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; VON ZGLINICKI T, 2005, MECH AGEING DEV, V126, P111; Yokoi T, 2006, DIABETES, V55, P1660, DOI 10.2337/db05-1607; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; ZEIHER AM, 1993, J CLIN INVEST, V92, P652, DOI 10.1172/JCI116634; Zhou BBS, 2000, J BIOL CHEM, V275, P10342, DOI 10.1074/jbc.275.14.10342	31	62	69	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29662	29670		10.1074/jbc.M110.125138	http://dx.doi.org/10.1074/jbc.M110.125138			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20639198	hybrid, Green Published			2022-12-25	WOS:000281740100067
J	Al-Hashimi, AA; Caldwell, J; Gonzalez-Gronow, M; Pizzo, SV; Aboumrad, D; Pozza, L; Al-Bayati, H; Weitz, JI; Stafford, A; Chan, H; Kapoor, A; Jacobsen, DW; Dickhout, JG; Austin, RC				Al-Hashimi, Ali A.; Caldwell, Jennifer; Gonzalez-Gronow, Mario; Pizzo, Salvatore V.; Aboumrad, Danya; Pozza, Lindsay; Al-Bayati, Hiam; Weitz, Jeffrey I.; Stafford, Alan; Chan, Howard; Kapoor, Anil; Jacobsen, Donald W.; Dickhout, Jeffrey G.; Austin, Richard C.			Binding of Anti-GRP78 Autoantibodies to Cell Surface GRP78 Increases Tissue Factor Procoagulant Activity via the Release of Calcium from Endoplasmic Reticulum Stores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-ASSOCIATED THROMBOSIS; FACTOR EXPRESSION; TUMOR PROGRESSION; ENDOTHELIAL-CELLS; PROTEIN GRP78/BIP; CHAPERONE PROTEIN; FACTOR ACTIVATION; FOCAL ADHESIONS; MEMBRANE; RECEPTOR	The increased risk of venous thromboembolism in cancer patients has been attributed to enhanced tissue factor (TF) procoagulant activity (PCA) on the surface of cancer cells. Recent studies have shown that TFPCA can be modulated by GRP78, an endoplasmic reticulum (ER)-resident molecular chaperone. In this study, we investigated the role of cell surface GRP78 in modulating TF PCA in several human cancer cell lines. Although both GRP78 and TF are present on the cell surface of cancer cells, there was no evidence of a stable interaction between recombinant human GRP78 and TF, nor was there any effect of exogenously added recombinant GRP78 on cell surface TF PCA. Treatment of cells with the ER stress-inducing agent thapsigargin, an inhibitor of the sarco(endo)plasmic reticulum Ca2+ pump that causes Ca2+ efflux from ER stores, increased cytosolic [Ca2+] and induced TF PCA. Consistent with these findings, anti-GRP78 autoantibodies that were isolated from the serum of patients with prostate cancer and bind to a specific N-terminal epitope (Leu(98)-Leu(115)) on cell surface GRP78, caused a dose-dependent increase in cytosolic [Ca2+] and enhanced TF PCA. The ability to interfere with cell surface GRP78 binding, block phospholipase C activity, sequester ER Ca2+, or prevent plasma membrane phosphatidylserine exposure resulted in a significant decrease in the TF PCA induced by anti-GRP78 autoantibodies. Taken together, these findings provide evidence that engagement of the anti-GRP78 autoantibodies with cell surface GRP78 increases TFPCA through a mechanism that involves the release of Ca2+ from ER stores. Furthermore, blocking GRP78 signaling on the surface of cancer cells attenuates TF PCA and has the potential to reduce the risk of cancer-related venous thromboembolism.	[Al-Hashimi, Ali A.; Caldwell, Jennifer; Aboumrad, Danya; Pozza, Lindsay; Al-Bayati, Hiam; Austin, Richard C.] St Josephs Hosp, Dept Med, Hamilton, ON L8N 4A6, Canada; [Al-Hashimi, Ali A.; Caldwell, Jennifer; Aboumrad, Danya; Pozza, Lindsay; Al-Bayati, Hiam; Austin, Richard C.] St Josephs Hosp, Div Nephrol, Hamilton, ON L8N 4A6, Canada; [Kapoor, Anil] St Josephs Hosp, Dept Surg, Hamilton, ON L8N 4A6, Canada; [Kapoor, Anil] St Josephs Hosp, Div Urol, Hamilton, ON L8N 4A6, Canada; [Kapoor, Anil] McMaster Univ, Hamilton, ON L8N 4A6, Canada; [Weitz, Jeffrey I.; Stafford, Alan; Chan, Howard] Hamilton Gen Hosp, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8L 2X2, Canada; [Weitz, Jeffrey I.; Stafford, Alan; Chan, Howard] McMaster Univ, Hamilton, ON L8L 2X2, Canada; [Gonzalez-Gronow, Mario; Pizzo, Salvatore V.; Weitz, Jeffrey I.; Dickhout, Jeffrey G.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Jacobsen, Donald W.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Jacobsen, Donald W.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA	McGill University; McMaster University; McGill University; McMaster University; McGill University; McMaster University; McGill University; McMaster University; McMaster University; McMaster University; McMaster University; Duke University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Austin, RC (corresponding author), 50 Charlton Ave E,Rm T-3313, Hamilton, ON L8N 4A6, Canada.	austinr@taari.ca	Dickhout, Jeffrey/R-2606-2019; Kapoor, Anil/AAQ-7184-2021; Weitz, Jeffrey/AAD-1929-2019	Kapoor, Anil/0000-0001-9180-8029; Weitz, Jeffrey/0000-0002-1092-7550	Heart and Stroke Foundation of Ontario [T-6146]; Canadian Institutes of Health Research [MOP-74477, FRN-79846]; Ontario Research and Development Challenge Fund; St Joseph's Healthcare Hamilton; St Joseph's Healthcare Hamilton Division of Nephrology; Amgen Canada Research Chair in the Division of Nephrology at St Joseph's Healthcare and McMaster University; National Heart, Lung and Blood Institute of the National Institutes of Health [HL52234]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL052234, R01HL052234] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research and Development Challenge Fund(General Electric); St Joseph's Healthcare Hamilton; St Joseph's Healthcare Hamilton Division of Nephrology; Amgen Canada Research Chair in the Division of Nephrology at St Joseph's Healthcare and McMaster University; National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by research grants from the Heart and Stroke Foundation of Ontario (T-6146), the Canadian Institutes of Health Research (MOP-74477), and the Ontario Research and Development Challenge Fund (to R.C.A.). This work was also supported by St Joseph's Healthcare Hamilton and by a Canadian Institutes of Health Research Team Grant in Thromboembolism (FRN-79846).; Supported by a St Joseph's Healthcare Hamilton Division of Nephrology Junior Research Award.; A Career Investigator of the Heart and Stroke Foundation of Ontario and holder of the Amgen Canada Research Chair in the Division of Nephrology at St Joseph's Healthcare and McMaster University. To whom correspondence should be addressed: 50 Charlton Ave. East, Rm. T-3313, Hamilton, Ontario L8N 4A6, Canada. Tel.: 905-522-1155 (ext. 35175); Fax: 905-540-6589; E-mail: austinr@taari.ca.; Supported in part by the National Heart, Lung and Blood Institute of the National Institutes of Health (HL52234).	Abdulkadir SA, 2000, HUM PATHOL, V31, P443, DOI 10.1053/hp.2000.6547; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; ANDRES DA, 1991, J BIOL CHEM, V266, P14277; BACH R, 1990, P NATL ACAD SCI USA, V87, P6995, DOI 10.1073/pnas.87.18.6995; Bach RR, 2006, ARTERIOSCL THROM VAS, V26, P456, DOI 10.1161/01.ATV.0000202656.53964.04; Bach RR, 1997, BLOOD, V89, P3270, DOI 10.1182/blood.V89.9.3270; Bhattacharjee G, 2005, ARTERIOSCL THROM VAS, V25, P1737, DOI 10.1161/01.ATV.0000173419.31242.56; Boccaccio C, 2005, NATURE, V434, P396, DOI 10.1038/nature03357; Bombeli T, 1997, BLOOD, V89, P2429, DOI 10.1182/blood.V89.7.2429; Bookout AL, 2003, NUCL RECEPT SIGNAL, V1, pe012; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caldwell JA, 2010, LAB INVEST, V90, P953, DOI 10.1038/labinvest.2010.59; CARSON SD, 1994, BLOOD, V84, P526; CONSONNI R, 1995, THROMB HAEMOSTASIS, V74, P904; CONWAY EM, 1989, THROMB RES, V53, P231, DOI 10.1016/0049-3848(89)90098-4; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; Dickhout JG, 2007, ANTIOXID REDOX SIGN, V9, P1863, DOI 10.1089/ars.2007.1780; Erlich J, 1999, INFECT IMMUN, V67, P2540, DOI 10.1128/IAI.67.5.2540-2546.1999; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; GONZALEZGRONOW M, 1993, J BIOL CHEM, V268, P20791; Greeno EW, 1996, LAB INVEST, V75, P281; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hembrough TA, 2003, CANCER RES, V63, P2997; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Inesi G, 2005, J BIOENERG BIOMEMBR, V37, P365, DOI 10.1007/s10863-005-9472-1; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Kasthuri RS, 2009, J CLIN ONCOL, V27, P4834, DOI 10.1200/JCO.2009.22.6324; Kaushal V, 2008, APPL IMMUNOHISTO M M, V16, P1; Kobayashi Y, 1998, TRANSPLANTATION, V66, P708, DOI 10.1097/00007890-199809270-00004; Kunzelmann-Marche C, 2000, THROMB HAEMOSTASIS, V83, P282, DOI 10.1055/s-0037-1613800; Lentz BR, 2003, PROG LIPID RES, V42, P423, DOI 10.1016/S0163-7827(03)00025-0; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; LopezPedrera C, 1997, AM J HEMATOL, V56, P71, DOI 10.1002/(SICI)1096-8652(199710)56:2<71::AID-AJH1>3.0.CO;2-Y; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Mavropoulos JC, 2005, J RHEUMATOL, V32, P2116; Milsom C, 2007, PATHOPHYSIOL HAEMO T, V36, P160, DOI 10.1159/000175154; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Misra UK, 2005, J IMMUNOL, V174, P2092, DOI 10.4049/jimmunol.174.4.2092; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Misra UK, 2008, J CELL BIOCHEM, V104, P96, DOI 10.1002/jcb.21607; Molins B, 2010, ARTERIOSCL THROM VAS, V30, P1246, DOI 10.1161/ATVBAHA.110.205112; Okazaki Y, 2000, J BIOL CHEM, V275, P35751, DOI 10.1074/jbc.M007476200; Pozza LM, 2005, ARTERIOSCL THROM VAS, V25, P1529, DOI 10.1161/01.ATV.0000177041.47444.e2; Price NPJ, 2007, J ANTIBIOT, V60, P485, DOI 10.1038/ja.2007.62; Rak J, 2006, SEMIN THROMB HEMOST, V32, P54, DOI 10.1055/s-2006-933341; Rak J, 2008, CURR OPIN HEMATOL, V15, P522, DOI 10.1097/MOH.0b013e3283063a3e; Rak J, 2009, BEST PRACT RES CL HA, V22, P71, DOI 10.1016/j.beha.2008.12.008; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Sergeev IN, 2005, J STEROID BIOCHEM, V97, P145, DOI 10.1016/j.jsbmb.2005.06.007; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Sousou T, 2009, ARTERIOSCL THROM VAS, V29, P316, DOI 10.1161/ATVBAHA.108.182196; Sud R, 2009, THROMB RES, V123, pS18, DOI 10.1016/S0049-3848(09)70137-9; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; Triantafilou M, 2001, CYTOMETRY, V43, P279, DOI 10.1002/1097-0320(20010401)43:4<279::AID-CYTO1060>3.0.CO;2-B; van Rossum DB, 2009, CELL CALCIUM, V45, P535, DOI 10.1016/j.ceca.2009.02.008; Wang Q, 2006, J BIOL CHEM, V281, P31093, DOI 10.1074/jbc.M606392200; Wang Q, 2009, J BIOL CHEM, V284, P20763, DOI 10.1074/jbc.M808828200; Watson LM, 2003, J BIOL CHEM, V278, P17438, DOI 10.1074/jbc.M301006200; WEI JY, 1995, J BIOL CHEM, V270, P26670, DOI 10.1074/jbc.270.44.26670; Wiest DL, 1997, P NATL ACAD SCI USA, V94, P1884, DOI 10.1073/pnas.94.5.1884; Wolberg AS, 1999, BLOOD COAGUL FIBRIN, V10, P201, DOI 10.1097/00001721-199906000-00007; Xiao GQ, 1999, MOL BRAIN RES, V72, P121, DOI 10.1016/S0169-328X(99)00188-6; Yu JL, 2005, BLOOD, V105, P1734, DOI 10.1182/blood-2004-05-2042; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; ZHANG YM, 1994, J CLIN INVEST, V94, P1320, DOI 10.1172/JCI117451; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	69	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28912	28923		10.1074/jbc.M110.119107	http://dx.doi.org/10.1074/jbc.M110.119107			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20605795	Green Published, hybrid			2022-12-25	WOS:000281594000056
J	Kinne, A; Kleinau, G; Hoefig, CS; Gruters, A; Kohrle, J; Krause, G; Schweizer, U				Kinne, Anita; Kleinau, Gunnar; Hoefig, Carolin S.; Grueters, Annette; Koehrle, Josef; Krause, Gerd; Schweizer, Ulrich			Essential Molecular Determinants for Thyroid Hormone Transport and First Structural Implications for Monocarboxylate Transporter 8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERNDON-DUDLEY-SYNDROME; LIGAND-BINDING SITE; PSYCHOMOTOR RETARDATION; ESCHERICHIA-COLI; MCT8; IDENTIFICATION; MUTATIONS; GENE; METABOLISM; PHENOTYPE	Monocarboxylate transporter 8 (MCT8, SLC16A2) is a thyroid hormone (TH) transmembrane transport protein mutated in Allan-Herndon-Dudley syndrome, a severe X-linked psychomotor retardation. The neurological and endocrine phenotypes of patients deficient in MCT8 function underscore the physiological significance of carrier-mediated TH transmembrane transport. MCT8 belongs to the major facilitator superfamily of 12 transmembrane-spanning proteins and mediates energy-independent bidirectional transport of iodothyronines across the plasma membrane. Structural information is lacking for all TH transmembrane transporters. To gain insight into structure-function relations in TH transport, we chose human MCT8 as a paradigm. We systematically performed conventional and liquid chromatography-tandem mass spectrometry-based uptake measurements into MCT8-transfected cells using a large number of compounds structurally related to iodothyronines. We found that human MCT8 is specific for L-iodothyronines and requires at least one iodine atom per aromatic ring. Neither thyronamines, decarboxylated metabolites of iodothyronines, nor triiodothyroacetic acid and tetraiodothyroacetic acid, TH derivatives lacking both chiral center and amino group, are substrates for MCT8. The polyphenolic flavonoids naringenin and F21388, potent competitors for TH binding at transthyretin, did not inhibit T-3 transport, suggesting that MCT8 can discriminate its ligand better than transthyretin. Bioinformatic studies and a first molecular homology model of MCT8 suggested amino acids potentially involved in substrate interaction. Indeed, alanine mutation of either Arg(445) (helix 8) or Asp(498) (helix 10) abrogated T-3 transport activity of MCT8, supporting their predicted role in substrate recognition. The MCT8 model allows us to rationalize potential interactions of amino acids including those mutated in patients with Allan-Herndon-Dudley syndrome.	[Kinne, Anita; Hoefig, Carolin S.; Koehrle, Josef; Schweizer, Ulrich] Charite, Inst Expt Endokrinol, D-13353 Berlin, Germany; [Kleinau, Gunnar; Grueters, Annette] Charite, Inst Expt Padiatr Endokrinol, D-13353 Berlin, Germany; [Kleinau, Gunnar; Krause, Gerd] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Schweizer, U (corresponding author), Charite, Inst Expt Endokrinol, Augustenburger Pl 1, D-13353 Berlin, Germany.	ulrich.schweizer@charite.de	Kleinau, Gunnar/GPX-6330-2022; Schweizer, Ulrich/E-8105-2013; Köhrle, Josef/AAH-6438-2020	Köhrle, Josef/0000-0002-9187-9078; Schweizer, Ulrich/0000-0003-1380-4780	Deutsche Forschungsgemeinschaft (DFG) [SFB665 TP A7-2]; Charite; EnForCe	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Charite; EnForCe	This work was supported by grants from Deutsche Forschungsgemeinschaft (DFG) Project SFB665 TP A7-2, Charite, and EnForCe.	Abe T, 1998, J BIOL CHEM, V273, P22395, DOI 10.1074/jbc.273.35.22395; AUFMKOLK M, 1986, J BIOL CHEM, V261, P1623; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Biebermann H, 2005, EUR J ENDOCRINOL, V153, P359, DOI 10.1530/eje.1.01980; CAPRI Y, 2009, 2 ELA RES FDN C LUX; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Di Cosmo C, 2009, ENDOCRINOLOGY, V150, P4450, DOI 10.1210/en.2009-0209; Dumitrescu AM, 2006, ENDOCRINOLOGY, V147, P4036, DOI 10.1210/en.2006-0390; Dumitrescu AM, 2004, AM J HUM GENET, V74, P168, DOI 10.1086/380999; Fann MC, 1998, J MEMBRANE BIOL, V164, P187, DOI 10.1007/s002329900404; FRIESEMA EC, 2009, 34 ANN M EUR THYR AS; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Friesema ECH, 2001, ENDOCRINOLOGY, V142, P4339, DOI 10.1210/en.142.10.4339; Friesema ECH, 2008, MOL ENDOCRINOL, V22, P1357, DOI 10.1210/me.2007-0112; Friesema ECH, 2010, MOL CELL ENDOCRINOL, V322, P107, DOI 10.1016/j.mce.2010.01.016; Frints SGM, 2008, EUR J HUM GENET, V16, P1029, DOI 10.1038/ejhg.2008.66; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hennemann G, 2001, ENDOCR REV, V22, P451, DOI 10.1210/er.22.4.451; Heuer H, 2005, ENDOCRINOLOGY, V146, P1701, DOI 10.1210/en.2004-1179; Hildebrand PW, 2005, BIOPHYS J, V88, P1970, DOI 10.1529/biophysj.104.049585; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Ianculescu AG, 2009, ENDOCRINOLOGY, V150, P1991, DOI 10.1210/en.2008-1339; Jansen J, 2008, ENDOCRINOLOGY, V149, P2184, DOI 10.1210/en.2007-1475; Kinne A, 2009, J MOL ENDOCRINOL, V43, P263, DOI 10.1677/JME-09-0043; KOEHRLE J, 1986, J BIOL CHEM, V261, P1613; Kohrle J, 1984, Horm Metab Res Suppl, V14, P42; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Manoharan C, 2006, MOL MEMBR BIOL, V23, P486, DOI 10.1080/09687860600841967; NAMBA N, 2009, 91 ANN M END SOC WAS; Nascimento AS, 2006, J MOL BIOL, V360, P586, DOI 10.1016/j.jmb.2006.05.008; Papadimitriou A, 2008, PEDIATRICS, V121, pE199, DOI 10.1542/peds.2007-1247; Piehl S, 2008, ENDOCRINOLOGY, V149, P3037, DOI 10.1210/en.2007-1678; Piehl S, 2008, RAPID COMMUN MASS SP, V22, P3286, DOI 10.1002/rcm.3732; RAYMOND L, 2008, EUR HUM GEN C BARC S; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; Scanlan TS, 2009, ENDOCRINOLOGY, V150, P1108, DOI 10.1210/en.2008-1596; Scanlan TS, 2004, NAT MED, V10, P638, DOI 10.1038/nm1051; Schwartz CE, 2005, AM J HUM GENET, V77, P41, DOI 10.1086/431313; Schweizer U, 2008, MOL CELL ENDOCRINOL, V289, P1, DOI 10.1016/j.mce.2008.04.007; Trajkovic M, 2007, J CLIN INVEST, V117, P627, DOI 10.1172/JCI28253; Vaurs-Barriere C, 2009, ANN NEUROL, V65, P114, DOI 10.1002/ana.21579; Visser WE, 2009, ENDOCRINOLOGY, V150, P5163, DOI 10.1210/en.2009-0699; Visser WE, 2009, HUM MUTAT, V30, P29, DOI 10.1002/humu.20808; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; Wagner RL, 2001, MOL ENDOCRINOL, V15, P398, DOI 10.1210/me.15.3.398; Wilson MC, 2009, J BIOL CHEM, V284, P20011, DOI 10.1074/jbc.M109.014217; Wirth EK, 2009, J NEUROSCI, V29, P9439, DOI 10.1523/JNEUROSCI.6055-08.2009; WOOD T, 2008, EUR HUM GEN C BARC S; Wu SY, 2005, THYROID, V15, P943, DOI 10.1089/thy.2005.15.943	51	83	85	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28054	28063		10.1074/jbc.M110.129577	http://dx.doi.org/10.1074/jbc.M110.129577			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20628049	Green Published, hybrid			2022-12-25	WOS:000288742300004
J	Shu, S; Liu, XO; Kriebel, PW; Hong, MS; Daniels, MP; Parent, CA; Korn, ED				Shu, Shi; Liu, Xiong; Kriebel, Paul W.; Hong, Myoung-Soon; Daniels, Mathew P.; Parent, Carole A.; Korn, Edward D.			Expression of Y53A-Actin in Dictyostelium Disrupts the Cytoskeleton and Inhibits Intracellular and Intercellular Chemotactic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN TYROSINE PHOSPHORYLATION; COLLECTIVE CELL-MIGRATION; II-INDEPENDENT PROCESSES; HEAVY-CHAIN GENE; MYOSIN-II; ADENYLYL-CYCLASE; IN-VIVO; ACANTHAMOEBA MYOSIN; DISCOIDEUM CELLS; CLEAVAGE FURROW	We showed previously that phosphorylation of Tyr(53), or its mutation to Ala, inhibits actin polymerization in vitro with formation of aggregates of short filaments, and that expression of Y53A-actin in Dictyostelium blocks differentiation and development at the mound stage (Liu, X., Shu, S., Hong, M. S., Levine, R. L., and Korn, E. D. (2006) Proc. Natl. Acad. Sci. U.S.A. 103, 13694-13699; Liu, X., Shu, S., Hong, M. S., Yu, B., and Korn, E. D. (2010) J. Biol. Chem. 285, 9729-9739). We now show that expression of Y53A-actin, which does not affect cell growth, phagocytosis, or pinocytosis, inhibits the formation of head-to-tail cell streams during cAMP-induced aggregation, although individual amoebae chemotax normally. We show that expression of Y53A-actin causes a 50% reduction of cell surface cAMP receptors, and inhibits cAMP-induced increases in adenylyl cyclase A activity, phosphorylation of ERK2, and actin polymerization. Trafficking of vesicles containing adenylyl cyclase A to the rear of the cell and secretion of the ACA vesicles are also inhibited. The actin cytoskeleton of cells expressing Y53A-actin is characterized by numerous short filaments, and bundled and aggregated filaments similar to the structures formed by copolymerization of purified Y53A-actin and wild-type actin in vitro. This disorganized actin cytoskeleton may be responsible for the inhibition of intracellular and intercellular cAMP signaling in cells expressing F-Y53A-actin.	[Shu, Shi; Liu, Xiong; Korn, Edward D.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Kriebel, Paul W.; Parent, Carole A.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hong, Myoung-Soon; Daniels, Mathew P.] NHLBI, Electtron Microscopy Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Korn, ED (corresponding author), Bldg 50,Rm 2517,9000 Rockville Pike, Bethesda, MD 20892 USA.	edk@nih.gov	Korn, Edward D/F-9929-2012	Korn, Edward/0000-0003-3867-6295	National Institutes of Health, NHLBI; NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010418] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006035, ZIAHL000506, ZICHL005906] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Programs of the National Institute of Health, NHLBI, and NCI, Center for Cancer Research.	Baek K, 2008, P NATL ACAD SCI USA, V105, P11748, DOI 10.1073/pnas.0805852105; Breshears LM, 2010, P NATL ACAD SCI USA, V107, P6918, DOI 10.1073/pnas.0909796107; Brzostowski JA, 2006, MOL BIOL CELL, V17, P4220, DOI 10.1091/mbc.E06-05-0376; Chen LF, 2003, MOL BIOL CELL, V14, P5028, DOI 10.1091/mbc.E03-05-0339; Chisholm RL, 2004, NAT REV MOL CELL BIO, V5, P531, DOI 10.1038/nrm1427; Clow PA, 1999, MOL BIOL CELL, V10, P1309, DOI 10.1091/mbc.10.5.1309; COMBEAU C, 1992, J BIOL CHEM, V267, P14038; Comer FI, 2006, MOL BIOL CELL, V17, P357, DOI 10.1091/mbc.E05-08-0781; COOK RK, 1992, J BIOL CHEM, V267, P9430; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; DEVREOTES P, 1987, METHOD CELL BIOL, V28, P299; EGELHOFF TT, 1991, J CELL BIOL, V112, P677, DOI 10.1083/jcb.112.4.677; Faix J, 1996, CELL, V86, P631, DOI 10.1016/S0092-8674(00)80136-1; Fey P, 1999, DEV BIOL, V212, P414, DOI 10.1006/dbio.1999.9353; Garcia GL, 2008, J MICROSC-OXFORD, V231, P529, DOI 10.1111/j.1365-2818.2008.02066.x; Gauthier ML, 1997, CELL SIGNAL, V9, P79, DOI 10.1016/S0898-6568(96)00113-1; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; HOWARD PK, 1993, SCIENCE, V259, P241, DOI 10.1126/science.7678470; Ito K, 1999, BIOPHYS J, V76, P985, DOI 10.1016/S0006-3495(99)77262-0; Jung G, 2009, J CELL BIOL, V186, P555, DOI 10.1083/jcb.200810147; JUNGBLUTH A, 1994, J CELL SCI, V107, P117; JUNGBLUTH A, 1995, FEBS LETT, V375, P87, DOI 10.1016/0014-5793(95)01165-B; Kamimura Y, 2009, METHODS MOL BIOL, V571, P255, DOI 10.1007/978-1-60761-198-1_17; Kishi Y, 1998, J CELL SCI, V111, P2923; KLEIN PS, 1988, SCIENCE, V241, P1467, DOI 10.1126/science.3047871; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; Kriebel PW, 2009, METHODS MOL BIOL, V571, P111, DOI 10.1007/978-1-60761-198-1_7; Kriebel PW, 2008, J CELL BIOL, V183, P949, DOI 10.1083/jcb.200808105; Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee S, 2010, MOL BIOL CELL, V21, P1810, DOI 10.1091/mbc.E10-01-0009; Liao XH, 2009, METHODS MOL BIOL, V571, P271, DOI 10.1007/978-1-60761-198-1_18; Liu X, 2005, J BIOL CHEM, V280, P26974, DOI 10.1074/jbc.M504453200; Liu X, 2000, BIOCHEM BIOPH RES CO, V271, P75, DOI 10.1006/bbrc.2000.2582; Liu X, 2006, P NATL ACAD SCI USA, V103, P13694, DOI 10.1073/pnas.0606321103; Liu X, 2010, J BIOL CHEM, V285, P9729, DOI 10.1074/jbc.M109.073452; Maeda M, 1996, J BIOL CHEM, V271, P3351; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4; McConnell RE, 2009, J CELL BIOL, V185, P1285, DOI 10.1083/jcb.200902147; Miller CJ, 1996, BIOCHEMISTRY-US, V35, P16557, DOI 10.1021/bi962388+; Neujahr R, 1997, J CELL SCI, V110, P123; Noegel AA, 2000, J CELL SCI, V113, P759; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; PARENT CA, 1995, J BIOL CHEM, V270, P22693, DOI 10.1074/jbc.270.39.22693; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; Reichl EM, 2008, CURR BIOL, V18, P471, DOI 10.1016/j.cub.2008.02.056; Sameshima M, 2001, J STRUCT BIOL, V136, P7, DOI 10.1006/jsbi.2001.4424; SAXE CL, 1991, GENE DEV, V5, P1, DOI 10.1101/gad.5.1.1; SCHWEIGER A, 1992, J CELL SCI, V102, P601; Shu S, 2005, P NATL ACAD SCI USA, V102, P1472, DOI 10.1073/pnas.0409528102; Shu S, 2003, P NATL ACAD SCI USA, V100, P6499, DOI 10.1073/pnas.0732155100; Shu S, 2002, J CELL SCI, V115, P4237, DOI 10.1242/jcs.00112; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; SUTOH K, 1982, BIOCHEMISTRY-US, V21, P3654, DOI 10.1021/bi00258a020; SUTOH K, 1991, P NATL ACAD SCI USA, V88, P7711, DOI 10.1073/pnas.88.17.7711; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; VANHAASTERT PJM, 1983, J BIOL CHEM, V258, P9636; Vicker MG, 2008, EUR J CELL BIOL, V87, P845, DOI 10.1016/j.ejcb.2008.03.010; Wang YW, 1998, BIOCHEM BIOPH RES CO, V244, P149, DOI 10.1006/bbrc.1997.8118; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Zang JH, 1997, MOL BIOL CELL, V8, P2617, DOI 10.1091/mbc.8.12.2617	65	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27713	27725		10.1074/jbc.M110.116277	http://dx.doi.org/10.1074/jbc.M110.116277			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20610381	hybrid, Green Published			2022-12-25	WOS:000281404100027
J	Grantham, HS; Pressey, RL; Wells, JA; Beattie, AJ				Grantham, Hedley S.; Pressey, Robert L.; Wells, Jessie A.; Beattie, Andrew J.			Effectiveness of Biodiversity Surrogates for Conservation Planning: Different Measures of Effectiveness Generate a Kaleidoscope of Variation	PLOS ONE			English	Article							NEW-SOUTH-WALES; ENVIRONMENTAL CLUSTER-ANALYSIS; CAPE FLORISTIC REGION; RESERVE SELECTION; SPATIAL PATTERN; SPECIES DISTRIBUTIONS; PLANT-COMMUNITIES; INDICATOR GROUPS; PROTECTED AREAS; VULNERABILITY	Conservation planners represent many aspects of biodiversity by using surrogates with spatial distributions readily observed or quantified, but tests of their effectiveness have produced varied and conflicting results. We identified four factors likely to have a strong influence on the apparent effectiveness of surrogates: (1) the choice of surrogate; (2) differences among study regions, which might be large and unquantified (3) the test method, that is, how effectiveness is quantified, and (4) the test features that the surrogates are intended to represent. Analysis of an unusually rich dataset enabled us, for the first time, to disentangle these factors and to compare their individual and interacting influences. Using two data-rich regions, we estimated effectiveness using five alternative methods: two forms of incidental representation, two forms of species accumulation index and irreplaceability correlation, to assess the performance of 'forest ecosystems' and 'environmental units' as surrogates for six groups of threatened species-the test features-mammals, birds, reptiles, frogs, plants and all of these combined. Four methods tested the effectiveness of the surrogates by selecting areas for conservation of the surrogates then estimating how effective those areas were at representing test features. One method measured the spatial match between conservation priorities for surrogates and test features. For methods that selected conservation areas, we measured effectiveness using two analytical approaches: (1) when representation targets for the surrogates were achieved (incidental representation), or (2) progressively as areas were selected (species accumulation index). We estimated the spatial correlation of conservation priorities using an index known as summed irreplaceability. In general, the effectiveness of surrogates for our taxa (mostly threatened species) was low, although environmental units tended to be more effective than forest ecosystems. The surrogates were most effective for plants and mammals and least effective for frogs and reptiles. The five testing methods differed in their rankings of effectiveness of the two surrogates in relation to different groups of test features. There were differences between study areas in terms of the effectiveness of surrogates for different test feature groups. Overall, the effectiveness of the surrogates was sensitive to all four factors. This indicates the need for caution in generalizing surrogacy tests.	[Grantham, Hedley S.; Pressey, Robert L.; Wells, Jessie A.] Univ Queensland, Ctr Ecol, St Lucia, Qld, Australia; [Grantham, Hedley S.; Beattie, Andrew J.] Macquarie Univ, Key Ctr Biodivers & Bioresources, Sydney, NSW 2109, Australia	University of Queensland; Macquarie University	Grantham, HS (corresponding author), Univ Queensland, Ctr Ecol, St Lucia, Qld, Australia.	h.grantham@uq.edu.au	Wells, Jessie A/F-7318-2010; Pressey, Bob/C-8370-2013	Wells, Jessie A/0000-0002-3555-5108; Pressey, Bob/0000-0003-2740-0330	Australia Research Council	Australia Research Council(Australian Research Council)	Funding was provided by the Australia Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2001, ECOGRAPHY, V24, P103, DOI 10.1034/j.1600-0587.2001.240112.x; Bonn A, 2005, BIODIVERS CONSERV, V14, P1083, DOI 10.1007/s10531-004-8410-6; Brooks T, 2004, CONSERV BIOL, V18, P1682, DOI 10.1111/j.1523-1739.2004.00457.x; Brooks TM, 2004, CONSERV BIOL, V18, P616, DOI 10.1111/j.1523-1739.2004.01836.x; BURBIDGE AA, 1991, NATURE CONSERVATION, P3; Burgman MA, 2001, CONSERV BIOL, V15, P603, DOI 10.1046/j.1523-1739.2001.015003603.x; Cardillo M, 1999, LANDSCAPE ECOL, V14, P423, DOI 10.1023/A:1008088224783; Carmel Y, 2006, ISR J ECOL EVOL, V52, P11, DOI 10.1560/IJEE.52.1.11; Cowling RM, 2004, CONSERV BIOL, V18, P1674, DOI 10.1111/j.1523-1739.2004.00296.x; Cowling RM, 2003, BIOL CONSERV, V112, P191, DOI 10.1016/S0006-3207(02)00425-1; Cowling RM, 2003, BIOL CONSERV, V112, P147, DOI 10.1016/S0006-3207(02)00397-X; Dangerfield JM, 2003, AUSTRAL ECOL, V28, P227, DOI 10.1046/j.1442-9993.2003.01240.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; *ENV AUSTR, 1999, RESP DIST FOR SPEC U; Faith DP, 1996, BIODIVERS CONSERV, V5, P399, DOI 10.1007/BF00056387; Favreau JM, 2006, BIODIVERS CONSERV, V15, P3949, DOI 10.1007/s10531-005-2631-1; Ferrier S, 2002, BIODIVERS CONSERV, V11, P2309, DOI 10.1023/A:1021374009951; Ferrier S, 2002, BIODIVERS CONSERV, V11, P2275, DOI 10.1023/A:1021302930424; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Ferrier S, 2000, BIOL CONSERV, V93, P303, DOI 10.1016/S0006-3207(99)00149-4; Ferrier S, 1997, EVALUATION EFFECTIVE; FERRIER S, 1999, CONSERVATION BIODIVE, P68; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Forestry Commission of NSW, 1989, 17 FOR COMM NSW; GARSON J, 2002, J BIOSCIENCE, V27; Grantham HS, 2008, CONSERV LETT, V1, P190, DOI 10.1111/j.1755-263X.2008.00029.x; Grantham HS, 2009, ECOL LETT, V12, P293, DOI 10.1111/j.1461-0248.2009.01287.x; Hess GR, 2006, BIOL CONSERV, V132, P448, DOI 10.1016/j.biocon.2006.04.037; Hopkinson P, 2001, BIODIVERS CONSERV, V10, P271, DOI 10.1023/A:1008959829585; Joint ANZECC/MCFFA National Forest Policy Statement Implementation Sub-committee, 1997, NAT AGR CRIT EST COM; KIRKPATRICK JB, 1994, CONSERV BIOL, V8, P217, DOI 10.1046/j.1523-1739.1994.08010217.x; Lambeck RJ, 1997, CONSERV BIOL, V11, P849, DOI 10.1046/j.1523-1739.1997.96319.x; LAPIN M, 1995, CONSERV BIOL, V9, P1148, DOI 10.1046/j.1523-1739.1995.9051134.x-i1; Lawler JJ, 2003, ECOL APPL, V13, P1762, DOI 10.1890/02-5337; Lawler JJ, 2003, CONSERV BIOL, V17, P875, DOI 10.1046/j.1523-1739.2003.01638.x; Leathwick JR, 2003, CONSERV BIOL, V17, P1612, DOI 10.1111/j.1523-1739.2003.00469.x; LECHMEREOERTEL RG, 2000, J VEG SCI, V12, P75; Lombard AT, 1995, S AFR J ZOOL, V30, P145; Lombard AT, 2003, BIOL CONSERV, V112, P45, DOI 10.1016/S0006-3207(02)00422-6; LOVELL S, 2002, BIOL CONSERV, V139, P113; Mac Nally R, 2002, ECOL APPL, V12, P900, DOI 10.1890/1051-0761(2002)012[0900:HWDEBP]2.0.CO;2; Manly BFJ, 1997, RANDOMIZATION BOOTST; Manne LL, 2003, ANIM CONSERV, V6, P291, DOI 10.1017/S1367943003003354; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Moritz C, 2001, P ROY SOC B-BIOL SCI, V268, P1875, DOI 10.1098/rspb.2001.1713; Newell D., 2004, CONSERVATION AUSTR F; Noss RF, 2002, CONSERV BIOL, V16, P895, DOI 10.1046/j.1523-1739.2002.01405.x; Noss RF, 2004, NAT AREA J, V24, P223; NOSS RF, 1987, BIOL CONSERV, V41, P11, DOI 10.1016/0006-3207(87)90045-0; *NSW NAT PARKS WIL, 1999, DER FOR EC EV SURR V; Oliver I, 2004, ECOL APPL, V14, P485, DOI 10.1890/02-5181; Pharo EJ, 2001, AUST J BOT, V49, P23, DOI 10.1071/BT99063; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; Pressey R. L., 2009, SPATIAL CONSERVATION, P211; Pressey RL, 1996, FOREST ECOL MANAG, V85, P311, DOI 10.1016/S0378-1127(96)03766-8; Pressey RL, 2004, CONSERV BIOL, V18, P1677, DOI 10.1111/j.1523-1739.2004.00434.x; Pressey RL, 2002, BIOL CONSERV, V106, P57, DOI 10.1016/S0006-3207(01)00229-4; Pressey RL, 1998, ECOLOGY FOR EVERYONE, P73; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Reyers B, 2000, S AFR J SCI, V96, P406; Reyers B, 2002, AFR ZOOL, V37, P185; Rodrigues ASL, 2007, NATURE, V450, pE19, DOI 10.1038/nature06374; RODRIGUES ASL, 2007, ANN REV ECOLOGY EVOL, V38; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Sarkar S, 2005, CONSERV BIOL, V19, P815, DOI 10.1111/j.1523-1739.2005.00236.x; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Snelder TH, 2007, CONSERV BIOL, V21, P365, DOI 10.1111/j.1523-1739.2006.00632.x; Stebbins R. C., 2021, NATURAL HIST AMPHIBI; Su JC, 2004, CONSERV BIOL, V18, P167, DOI 10.1111/j.1523-1739.2004.00337.x; Trakhtenbrot A, 2005, ECOL APPL, V15, P335, DOI 10.1890/04-0077; Trakhtenbrot A, 2006, CONSERV BIOL, V20, P1087, DOI 10.1111/j.1523-1739.2006.00500.x; Warman LD, 2004, ECOL LETT, V7, P374, DOI 10.1111/j.1461-0248.2004.00590.x; Warman LD, 2004, CONSERV BIOL, V18, P655, DOI 10.1111/j.1523-1739.2004.00538.x; Wessels KJ, 1999, BIOL CONSERV, V89, P21, DOI 10.1016/S0006-3207(98)00133-5; Williams JC, 2005, ENVIRON MODEL ASSESS, V10, P163, DOI 10.1007/s10666-005-9007-5; Williams P, 2006, BIOL CONSERV, V128, P253, DOI 10.1016/j.biocon.2005.09.047	76	112	113	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11430	10.1371/journal.pone.0011430	http://dx.doi.org/10.1371/journal.pone.0011430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644726	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000279884900003
J	Langlois, B; Perrot, G; Schneider, C; Henriet, P; Emonard, H; Martiny, L; Dedieu, S				Langlois, Benoit; Perrot, Gwenn; Schneider, Christophe; Henriet, Patrick; Emonard, Herve; Martiny, Laurent; Dedieu, Stephane			LRP-1 Promotes Cancer Cell Invasion by Supporting ERK and Inhibiting JNK Signaling Pathways	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; PLASMINOGEN-ACTIVATOR INHIBITOR-1; DEPENDENT PATHWAY; SCAFFOLD PROTEINS; MIGRATION; KINASE; GROWTH; PHOSPHORYLATION; EXPRESSION; ADHESION	Background: The low-density lipoprotein receptor-related protein-1 (LRP-1) is an endocytic receptor mediating the clearance of various extracellular molecules involved in the dissemination of cancer cells. LRP-1 thus appeared as an attractive receptor for targeting the invasive behavior of malignant cells. However, recent results suggest that LRP-1 may facilitate the development and growth of cancer metastases in vivo, but the precise contribution of the receptor during cancer progression remains to be elucidated. The lack of mechanistic insights into the intracellular signaling networks downstream of LRP-1 has prevented the understanding of its contribution towards cancer. Methodology/Principal Findings: Through a short-hairpin RNA-mediated silencing approach, we identified LRP-1 as a main regulator of ERK and JNK signaling in a tumor cell context. Co-immunoprecipitation experiments revealed that LRP-1 constitutes an intracellular docking site for MAPK containing complexes. By using pharmacological agents, constitutively active and dominant-negative kinases, we demonstrated that LRP-1 maintains malignant cells in an adhesive state that is favorable for invasion by activating ERK and inhibiting JNK. We further demonstrated that the LRP-1-dependent regulation of MAPK signaling organizes the cytoskeletal architecture and mediates adhesive complex turnover in cancer cells. Moreover, we found that LRP-1 is tethered to the actin network and to focal adhesion sites and controls ERK and JNK targeting to talin-rich structures. Conclusions: We identified ERK and JNK as the main molecular relays by which LRP-1 regulates focal adhesion disassembly of malignant cells to support invasion.	[Langlois, Benoit; Perrot, Gwenn; Schneider, Christophe; Emonard, Herve; Martiny, Laurent; Dedieu, Stephane] Univ Reims, Lab SiRMa, CNRS, UMR 6237,MEDyC, Reims, France; [Henriet, Patrick] Duve Inst, Cell Biol Unit, Brussels, Belgium; [Henriet, Patrick] Catholic Univ Louvain, B-1200 Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); Universite de Reims Champagne-Ardenne; Universite Catholique Louvain	Langlois, B (corresponding author), Univ Reims, Lab SiRMa, CNRS, UMR 6237,MEDyC, Campus Moulin Housse, Reims, France.	stephane.dedieu@univ-reims.fr	Emonard, Hervé/AAD-5432-2019; Emonard, Herve/R-9718-2019; MARTINY, Laurent/ABI-5531-2020	Dedieu, Stephane/0000-0003-1447-5640; Henriet, Patrick/0000-0003-4602-8888; SCHNEIDER, Christophe/0000-0002-7867-0579	Centre National de la Recherche Scientifique (CNRS); La Ligue Nationale Contre le Cancer (Comite de la Marne); CPER (Contrat de Projets Etat-Region); Fonds National pour la Sante ACI (Action Concertee Incitative)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); La Ligue Nationale Contre le Cancer (Comite de la Marne); CPER (Contrat de Projets Etat-Region); Fonds National pour la Sante ACI (Action Concertee Incitative)	This work was supported by grants from Centre National de la Recherche Scientifique (CNRS), La Ligue Nationale Contre le Cancer (Comite de la Marne), CPER (Contrat de Projets Etat-Region) 2007-2013 and Fonds National pour la Sante ACI (Action Concertee Incitative) 2008 (Canceropole Grand-Est Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barmina OY, 1999, J BIOL CHEM, V274, P30087, DOI 10.1074/jbc.274.42.30087; Barnes H, 2001, J BIOL CHEM, V276, P19119, DOI 10.1074/jbc.M011437200; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Betts GN, 2008, J BIOL CHEM, V283, P15656, DOI 10.1074/jbc.M709514200; Boucher P, 2004, TRENDS CARDIOVAS MED, V14, P55, DOI 10.1016/j.tcm.2003.12.001; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Chazaud B, 2002, AM J PATHOL, V160, P237, DOI 10.1016/S0002-9440(10)64367-2; Chen S, 2007, J CELL SCI, V120, P4009, DOI 10.1242/jcs.013946; Cheng CF, 2008, MOL CELL BIOL, V28, P3344, DOI 10.1128/MCB.01287-07; Dedieu S, 2006, CELL SIGNAL, V18, P889, DOI 10.1016/j.cellsig.2005.08.001; Dedieu S, 2008, MOL CELL BIOL, V28, P2980, DOI 10.1128/MCB.02238-07; Dedieu S, 2008, CELL ADHES MIGR, V2, P77, DOI 10.4161/cam.2.2.6374; Degryse B, 2004, J BIOL CHEM, V279, P22595, DOI 10.1074/jbc.M313004200; Desrosiers RR, 2006, PEDIATR BLOOD CANCER, V46, P40, DOI 10.1002/pbc.20566; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Emonard H, 2005, BIOCHIMIE, V87, P369, DOI 10.1016/j.biochi.2004.11.013; Emonard H, 2004, J BIOL CHEM, V279, P54944, DOI 10.1074/jbc.M406792200; Fayard B, 2009, CANCER RES, V69, P5690, DOI 10.1158/0008-5472.CAN-08-4573; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; Gaultier A, 2006, J BIOL CHEM, V281, P7332, DOI 10.1074/jbc.M511857200; Goretzki P E, 1990, Recent Results Cancer Res, V118, P48; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Guttman M, 2009, PROTEOMICS, V9, P5016, DOI 10.1002/pmic.200900457; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hu K, 2007, J CLIN INVEST, V117, P3821, DOI 10.1172/JCI32301; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Huang SS, 2004, FASEB J, V18, P1719, DOI 10.1096/fj.04-1872fje; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; KANCHA RK, 1994, ONCOL RES, V6, P365; Lacalle RA, 2002, J CELL BIOL, V157, P277, DOI 10.1083/jcb.200109031; Langlois B, 2009, PATHOL BIOL, V57, P548, DOI 10.1016/j.patbio.2008.07.015; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Lutz C, 2002, J BIOL CHEM, V277, P43143, DOI 10.1074/jbc.M204426200; Ma Z, 2002, J CELL BIOL, V159, P1061, DOI 10.1083/jcb.200207070; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Mang GQ, 2004, J AM SOC NEPHROL, V15, P2090, DOI 10.1097/01.ASN.0000135057; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; McFarland BC, 2009, CANCER RES, V69, P5537, DOI 10.1158/0008-5472.CAN-08-4841; Montel V, 2007, CANCER RES, V67, P9817, DOI 10.1158/0008-5472.CAN-07-0683; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Orr AW, 2004, J BIOL CHEM, V279, P48983, DOI 10.1074/jbc.M404881200; Otto IM, 2000, CURR BIOL, V10, P345, DOI 10.1016/S0960-9822(00)00388-2; Pallero MA, 2008, FASEB J, V22, P3968, DOI 10.1096/fj.07-104802; Pocivavsek A, 2009, J NEUROIMMUNOL, V214, P25, DOI 10.1016/j.jneuroim.2009.06.010; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Ranganathan S, 2004, J BIOL CHEM, V279, P40536, DOI 10.1074/jbc.M407592200; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Sid B, 2008, INT J BIOCHEM CELL B, V40, P1890, DOI 10.1016/j.biocel.2008.01.023; Sid B, 2006, INT J BIOCHEM CELL B, V38, P1729, DOI 10.1016/j.biocel.2006.04.005; Smadja-Lamere N, 2008, J BIOL CHEM, V283, P34352, DOI 10.1074/jbc.M803364200; Song H, 2009, CANCER RES, V69, P879, DOI 10.1158/0008-5472.CAN-08-3379; Spijkers PPEM, 2005, BLOOD, V105, P170, DOI 10.1182/blood-2004-02-0498; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Takayama Y, 2003, J BIOL CHEM, V278, P22112, DOI 10.1074/jbc.M300894200; van der Geer P, 2002, TRENDS CARDIOVAS MED, V12, P160, DOI 10.1016/S1050-1738(02)00154-8; Webb DJ, 2000, J CELL SCI, V113, P123; Whitmarsh AJ, 2006, BIOCHEM SOC T, V34, P828, DOI 10.1042/BST0340828; Zemskov EA, 2007, J CELL SCI, V120, P3188, DOI 10.1242/jcs.010397; Zhang H, 2008, BIOCHEM J, V409, P53, DOI 10.1042/BJ20071127; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	67	65	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11584	10.1371/journal.pone.0011584	http://dx.doi.org/10.1371/journal.pone.0011584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644732	Green Submitted, Green Published, gold			2022-12-25	WOS:000279884900020
J	Li, L; Tasic, B; Micheva, KD; Ivanov, VM; Spletter, ML; Smith, SJ; Luo, LQ				Li, Ling; Tasic, Bosiljka; Micheva, Kristina D.; Ivanov, Vsevolod M.; Spletter, Maria L.; Smith, Stephen J.; Luo, Liqun			Visualizing the Distribution of Synapses from Individual Neurons in the Mouse Brain	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; CEREBELLAR CORTICAL CIRCUITRY; CULTURED HIPPOCAMPAL-NEURONS; PARALLEL FIBER SYNAPSES; 2 DISTINCT MECHANISMS; LONG-TERM DEPRESSION; EMBRYONIC STEM-CELLS; SYNAPTIC VESICLE; PURKINJE-CELLS; MEMBRANE-PROTEINS	Background: Proper function of the mammalian brain relies on the establishment of highly specific synaptic connections among billions of neurons. To understand how complex neural circuits function, it is crucial to precisely describe neuronal connectivity and the distributions of synapses to and from individual neurons. Methods and Findings: In this study, we present a new genetic synaptic labeling method that relies on expression of a presynaptic marker, synaptophysin-GFP (Syp-GFP) in individual neurons in vivo. We assess the reliability of this method and use it to analyze the spatial patterning of synapses in developing and mature cerebellar granule cells (GCs). In immature GCs, Syp-GFP is distributed in both axonal and dendritic regions. Upon maturation, it becomes strongly enriched in axons. In mature GCs, we analyzed synapses along their ascending segments and parallel fibers. We observe no differences in presynaptic distribution between GCs born at different developmental time points and thus having varied depths of projections in the molecular layer. We found that the mean densities of synapses along the parallel fiber and the ascending segment above the Purkinje cell (PC) layer are statistically indistinguishable, and higher than previous estimates. Interestingly, presynaptic terminals were also found in the ascending segments of GCs below and within the PC layer, with the mean densities two-fold lower than that above the PC layer. The difference in the density of synapses in these parts of the ascending segment likely reflects the regional differences in postsynaptic target cells of GCs. Conclusions: The ability to visualize synapses of single neurons in vivo is valuable for studying synaptogenesis and synaptic plasticity within individual neurons as well as information flow in neural circuits.	[Li, Ling; Tasic, Bosiljka; Ivanov, Vsevolod M.; Spletter, Maria L.; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA; [Micheva, Kristina D.; Smith, Stephen J.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Ivanov, Vsevolod M.] Lynbrook High Sch, San Jose, CA USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Li, L (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA.	lluo@stanford.edu	Micheva, Kristina/ABH-6913-2020; Spletter, Maria Lynn/T-5917-2018; Li, Ling/A-2008-2010	Micheva, Kristina/0000-0003-1138-3732; Spletter, Maria Lynn/0000-0002-2068-3350; Smith, Stephen/0000-0002-2290-8701; Luo, Liqun/0000-0001-5467-9264	NIH [R01-NS050835]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC008277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by an NIH grant (R01-NS050835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Bower JM, 2002, ANN NY ACAD SCI, V978, P135, DOI 10.1111/j.1749-6632.2002.tb07562.x; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; Eccles JC, 1967, CEREBELLUM NEURONAL; Espinosa JS, 2008, J NEUROSCI, V28, P2301, DOI 10.1523/JNEUROSCI.5157-07.2008; Gallia GL, 1998, ONCOGENE, V16, P1879, DOI 10.1038/sj.onc.1201706; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gundappa-Sulur G, 1999, J COMP NEUROL, V408, P580, DOI 10.1002/(SICI)1096-9861(19990614)408:4<580::AID-CNE11>3.0.CO;2-O; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; HARVEY RJ, 1988, J COMP NEUROL, V274, P151, DOI 10.1002/cne.902740202; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Huang CM, 2006, NEUROBIOL AGING, V27, P1715, DOI 10.1016/j.neurobiolaging.2005.09.025; Huang CM, 2006, EUR J NEUROSCI, V23, P1731, DOI 10.1111/j.1460-9568.2006.04690.x; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Isope P, 2002, J NEUROSCI, V22, P9668; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Javaherian A, 2005, NEURON, V45, P505, DOI 10.1016/j.neuron.2004.12.051; Joyner AL, 2000, GENE TARGETING PRACT; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kelsch W, 2008, P NATL ACAD SCI USA, V105, P16803, DOI 10.1073/pnas.0807970105; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LEUBE RE, 1987, EMBO J, V6, P3261, DOI 10.1002/j.1460-2075.1987.tb02644.x; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Llinas R.R., 2004, SYNAPTIC ORG BRAIN; Lu H, 2009, J COMP NEUROL, V514, P583, DOI 10.1002/cne.22041; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Marcaggi P, 2007, J PHYSIOL-LONDON, V578, P545, DOI 10.1113/jphysiol.2006.115014; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; Palay S. L., 1974, CEREBELLAR CORTEX CY; Pennuto M, 2002, MOL BIOL CELL, V13, P2706, DOI 10.1091/mbc.E02-01-0036; Pennuto M, 2003, MOL BIOL CELL, V14, P4909, DOI 10.1091/mbc.E03-06-0380; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; PICHITPORNCHAI C, 1994, J COMP NEUROL, V342, P206, DOI 10.1002/cne.903420205; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Siemering KR, 1996, CURR BIOL, V6, P1653, DOI 10.1016/S0960-9822(02)70789-6; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Sims RE, 2005, J NEUROSCI, V25, P3246, DOI 10.1523/JNEUROSCI.0073-05.2005; Sims RE, 2006, J NEUROSCI, V26, P5153, DOI 10.1523/JNEUROSCI.4121-05.2006; Slutsky I, 2004, NEURON, V44, P835, DOI 10.1016/j.neuron.2004.11.013; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Walter JT, 2009, J NEUROSCI, V29, P8462, DOI 10.1523/JNEUROSCI.5718-08.2009; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zeng HK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000069; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	71	69	70	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11503	10.1371/journal.pone.0011503	http://dx.doi.org/10.1371/journal.pone.0011503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634890	Green Published, gold, Green Submitted			2022-12-25	WOS:000279715300014
J	Norder, M; Becker, PD; Drexler, I; Link, C; Erfle, V; Guzman, CA				Noerder, Miriam; Becker, Pablo D.; Drexler, Ingo; Link, Claudia; Erfle, Volker; Guzman, Carlos A.			Modified Vaccinia Virus Ankara Exerts Potent Immune Modulatory Activities in a Murine Model	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; MOUSE BONE-MARROW; RECOMBINANT VIRUSES; IN-VIVO; PLASMA-CELLS; STRAIN MVA; HOST-RANGE; VACCINATION; RESPONSES; IMMUNOGENICITY	Background: Modified vaccinia virus Ankara (MVA), a highly attenuated strain of vaccinia virus, has been used as vaccine delivery vector in preclinical and clinical studies against infectious diseases and malignancies. Here, we investigated whether an MVA which does not encode any antigen (Ag) could be exploited as adjuvant per se. Methodology/Principal Findings: We showed that dendritic cells infected in vitro with non-recombinant (nr) MVA expressed maturation and activation markers and were able to efficiently present exogenously pulsed Ag to T cells. In contrast to the dominant T helper (Th) 1 biased responses elicited against Ags produced by recombinant MVA vectors, the use of nrMVA as adjuvant for the co-administered soluble Ags resulted in a long lasting mixed Th1/Th2 responses. Conclusions/Significance: These findings open new ways to potentiate and modulate the immune responses to vaccine Ags depending on whether they are co-administered with MVA or encoded by recombinant viruses.	[Noerder, Miriam; Becker, Pablo D.; Link, Claudia; Guzman, Carlos A.] Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Drexler, Ingo; Erfle, Volker] Helmholtz Ctr Munich, Munich, Germany; [Drexler, Ingo; Erfle, Volker] Tech Univ Munich, Inst Virol, Munich, Germany; [Erfle, Volker] Tech Univ Munich, Clin Cooperat Grp Antigen Specif Immunomodulat, Munich, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich	Norder, M (corresponding author), Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany.	carlos.guzman@helmholtz-hzi.de		Becker, Pablo Daniel/0000-0003-1980-1230	German Research Foundation [SFB456 TP B7]	German Research Foundation(German Research Foundation (DFG))	This study was in part supported by grants from the German Research Foundation to I.D. (SFB456 TP B7) and C.A.G. (Cluster of Excellence REBIRTH; From Regenerative Biology to Reconstructive Therapy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Becker PD, 2007, CLIN VACCINE IMMUNOL, V14, P538, DOI 10.1128/CVI.00316-06; Behboudi S, 2004, VACCINE, V22, P4326, DOI 10.1016/j.vaccine.2004.04.029; Bejon P, 2006, VACCINE, V24, P4709, DOI 10.1016/j.vaccine.2006.03.029; Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159; Brimnes MK, 2003, J EXP MED, V198, P133, DOI 10.1084/jem.20030266; Burgers WA, 2008, AIDS RES HUM RETROV, V24, P195, DOI 10.1089/aid.2007.0205; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; CATIPOVIC B, 1992, J EXP MED, V176, P1611, DOI 10.1084/jem.176.6.1611; Chahroudi A, 2006, J VIROL, V80, P8469, DOI 10.1128/JVI.02749-05; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Dorrell L, 2007, VACCINE, V25, P3277, DOI 10.1016/j.vaccine.2007.01.005; Dorrell L, 2006, J VIROL, V80, P4705, DOI 10.1128/JVI.80.10.4705-4716.2006; Drexler I, 1998, J GEN VIROL, V79, P347, DOI 10.1099/0022-1317-79-2-347; Drillien R, 2004, J GEN VIROL, V85, P2167, DOI 10.1099/vir.0.79998-0; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Gasteiger G, 2007, J VIROL, V81, P11925, DOI 10.1128/JVI.00903-07; Humrich JY, 2007, EUR J IMMUNOL, V37, P954, DOI 10.1002/eji.200636230; Hutchings CL, 2005, J IMMUNOL, V175, P599, DOI 10.4049/jimmunol.175.1.599; Hutchings CL, 2007, INFECT IMMUN, V75, P5819, DOI 10.1128/IAI.00828-07; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kastenmuller W, 2007, J EXP MED, V204, P2187, DOI 10.1084/jem.20070489; Kastenmuller W, 2006, VIROLOGY, V350, P276, DOI 10.1016/j.virol.2006.02.039; KELLY JM, 1993, EUR J IMMUNOL, V23, P3318, DOI 10.1002/eji.1830231239; LIPFORD GB, 1993, J IMMUNOL, V150, P1212; Liu L, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-15; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Manz RA, 2002, EUR J IMMUNOL, V32, P923, DOI 10.1002/1521-4141(200204)32:4<923::AID-IMMU923>3.0.CO;2-1; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; MEYER H, 1991, J GEN VIROL, V72, P1031, DOI 10.1099/0022-1317-72-5-1031; Meyer RG, 2005, CANCER IMMUNOL IMMUN, V54, P453, DOI 10.1007/s00262-004-0616-7; Molinier-Frenkel V, 2002, J VIROL, V76, P127, DOI 10.1128/JVI.76.1.127-135.2002; Moorthy VS, 2003, J INFECT DIS, V188, P1239, DOI 10.1086/378515; Moser K, 2006, CURR OPIN IMMUNOL, V18, P265, DOI 10.1016/j.coi.2006.03.004; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Rocha CD, 2004, INT MICROBIOL, V7, P83; Rock KL, 2005, SPRINGER SEMIN IMMUN, V26, P231, DOI 10.1007/s00281-004-0173-3; Samuelsson C, 2008, J CLIN INVEST, V118, P1776, DOI 10.1172/JCI33940; Schirrmacher V, 2003, TRENDS MOL MED, V9, P526, DOI 10.1016/j.molmed.2003.10.001; Shortman K, 2000, IMMUNOL CELL BIOL, V78, P161, DOI 10.1046/j.1440-1711.2000.00901.x; Slifka Mark K, 2005, Med Immunol, V4, P2, DOI 10.1186/1476-9433-4-2; Souza APD, 2005, BRAZ J MED BIOL RES, V38, P509, DOI 10.1590/S0100-879X2005000400004; Staib C, 2003, BIOTECHNIQUES, V34, P694, DOI 10.2144/03344bm02; STICKL H, 1974, DEUT MED WOCHENSCHR, V99, P2386, DOI 10.1055/s-0028-1108143; Webster DP, 2006, VACCINE, V24, P3026, DOI 10.1016/j.vaccine.2005.10.058	49	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11400	10.1371/journal.pone.0011400	http://dx.doi.org/10.1371/journal.pone.0011400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20628596	Green Submitted, gold, Green Published			2022-12-25	WOS:000279370000025
J	Bai, XD; Zhang, W; Orantes, L; Jun, TH; Mittapalli, O; Mian, MAR; Michel, AP				Bai, Xiaodong; Zhang, Wei; Orantes, Lucia; Jun, Tae-Hwan; Mittapalli, Omprakash; Mian, M. A. Rouf; Michel, Andrew P.			Combining Next-Generation Sequencing Strategies for Rapid Molecular Resource Development from an Invasive Aphid Species, Aphis glycines	PLOS ONE			English	Article							PEA APHID; SOYBEAN APHID; ACYRTHOSIPHON-PISUM; ANTIOXIDANT DEFENSE; HORIZONTAL TRANSFER; BACTERIAL SYMBIONT; GENETIC-STRUCTURE; GENOME EVOLUTION; MYZUS-PERSICAE; RESISTANCE	Background: Aphids are one of the most important insect taxa in terms of ecology, evolutionary biology, genetics and genomics, and interactions with endosymbionts. Additionally, many aphids are serious pest species of agricultural and horticultural plants. Recent genetic and genomic research has expanded molecular resources for many aphid species, including the whole genome sequencing of the pea aphid, Acrythosiphon pisum. However, the invasive soybean aphid, Aphis glycines, lacks in any significant molecular resources. Methodology/Principal Findings: Two next-generation sequencing technologies (Roche-454 and Illumina GA-II) were used in a combined approach to develop both transcriptomic and genomic resources, including expressed genes and molecular markers. Over 278 million bp were sequenced among the two methods, resulting in 19,293 transcripts and 56,688 genomic sequences. From this data set, 635 SNPs and 1,382 microsatellite markers were identified. For each sequencing method, different soybean aphid biotypes were used which revealed potential biotype specific markers. In addition, we uncovered 39,822 bp of sequence that were related to the obligatory endosymbiont, Buchnera aphidicola, as well as sequences that suggest the presence of Hamiltonella defensa, a facultative endosymbiont. Conclusions and Significance: Molecular resources for an invasive, non-model aphid species were generated. Additionally, the power of next-generation sequencing to uncover endosymbionts was demonstrated. The resources presented here will complement ongoing molecular studies within the Aphididae, including the pea aphid whole genome, lead to better understanding of aphid adaptation and evolution, and help provide novel targets for soybean aphid control.	[Bai, Xiaodong; Zhang, Wei; Orantes, Lucia; Jun, Tae-Hwan; Mittapalli, Omprakash; Michel, Andrew P.] Ohio State Univ, Dept Entomol, Ohio Agr Res & Dev Ctr, Columbus, OH 43210 USA; [Jun, Tae-Hwan; Mian, M. A. Rouf] ARS, USDA, Columbus, OH USA; [Jun, Tae-Hwan; Mian, M. A. Rouf] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; United States Department of Agriculture (USDA); University System of Ohio; Ohio State University	Bai, XD (corresponding author), Ohio State Univ, Dept Entomol, Ohio Agr Res & Dev Ctr, 1735 Neil Ave, Columbus, OH 43210 USA.	michel.70@osu.edu	Michel, Andrew P./B-5329-2012		Ohio Soybean Council [OSC 10-2-03, OSC 08-2-08]; USDA-ARS, Ohio Plant Biotechnology Consortium; The Ohio State University; The Ohio Agricultural Research and Development Center	Ohio Soybean Council; USDA-ARS, Ohio Plant Biotechnology Consortium(United States Department of Agriculture (USDA)USDA Agricultural Research Service); The Ohio State University(Ohio State University); The Ohio Agricultural Research and Development Center	Funding for this project was obtained through the Ohio Soybean Council (www.soyohio.org), #OSC 10-2-03 and #OSC 08-2-08, USDA-ARS, Ohio Plant Biotechnology Consortium and The Ohio Agricultural Research and Development Center, The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD S, 1990, PHOTOCHEM PHOTOBIOL, V51, P305, DOI 10.1111/j.1751-1097.1990.tb01715.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Blackman RL, 2000, APHIDS WORLDS CROPS, V2nd, DOI 10.1016/0261-2194(96)89825-5; Blackman RL, 2007, APHIDS AS CROP PESTS, P1, DOI 10.1079/9780851998190.0001; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; Dixon AF G, 1998, APHID ECOLOGY; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Figueroa CC, 2007, INSECT SCI, V14, P29, DOI 10.1111/j.1744-7917.2007.00123.x; FINSTON TL, 1995, INSECT BIOCHEM MOLEC, V25, P189, DOI 10.1016/0965-1748(94)00050-R; Francis F, 2010, J INSECT PHYSIOL, V56, P575, DOI 10.1016/j.jinsphys.2009.12.001; Funk DJ, 2001, GENETICS, V157, P477; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; GREGORY TR, 2006, ANIMAL GENOME SIZE D; Hales DF, 1997, EUR J ENTOMOL, V94, P1; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Haynes S, 2003, APPL ENVIRON MICROB, V69, P7216, DOI 10.1128/AEM.69.12.7216-7223.2003; Hill CB, 2004, J ECON ENTOMOL, V97, P1071, DOI 10.1603/0022-0493(2004)097[1071:ROGSAV]2.0.CO;2; Hill CB, 2006, CROP SCI, V46, P1601, DOI 10.2135/cropsci2005.11-0421; Hill CB, 2006, CROP SCI, V46, P1606, DOI 10.2135/cropsci2005.11-0438; Huerta-Cepas J, 2010, INSECT MOL BIOL, V19, P13, DOI 10.1111/j.1365-2583.2009.00947.x; Hunter WB, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.9; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Iannone MA, 2000, CYTOMETRY, V39, P131, DOI 10.1002/(SICI)1097-0320(20000201)39:2<131::AID-CYTO6>3.3.CO;2-L; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kim KS, 2008, CROP SCI, V48, P923, DOI 10.2135/cropsci2007.08.0447; Lee SH, 2004, THEOR APPL GENET, V110, P167, DOI 10.1007/s00122-004-1827-1; Legeai F, 2010, INSECT MOL BIOL, V19, P5, DOI 10.1111/j.1365-2583.2009.00930.x; McCornack BP, 2004, J ECON ENTOMOL, V97, P854, DOI 10.1603/0022-0493(2004)097[0854:DOSAHA]2.0.CO;2; Mian MAR, 2008, CROP SCI, V48, P1055, DOI 10.2135/cropsci2007.06.0357; Michel AP, 2009, ENVIRON ENTOMOL, V38, P1301, DOI 10.1603/022.038.0442; Mittapalli O, 2007, P NATL ACAD SCI USA, V104, P1889, DOI 10.1073/pnas.0604722104; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Moran NA, 1999, SYST ENTOMOL, V24, P85, DOI 10.1046/j.1365-3113.1999.00076.x; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Moran NA, 2005, J BACTERIOL, V187, P4229, DOI 10.1128/JB.187.12.4229-4237.2005; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; MORAN NA, 1992, EVOLUTION APHID LIFE, P321; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Ollivier M, 2010, INSECT MOL BIOL, V19, P33, DOI 10.1111/j.1365-2583.2009.00976.x; Osada M, 2003, INT CONGR SER, V1239, P17, DOI 10.1016/S0531-5131(02)00504-6; OSTLIE K, 2001, SOYBEAN APHID REDUCE; Peccoud J, 2008, MOL ECOL, V17, P4608, DOI 10.1111/j.1365-294X.2008.03949.x; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P16315, DOI 10.1073/pnas.0905129106; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Ragsdale DW, 2007, J ECON ENTOMOL, V100, P1258, DOI 10.1603/0022-0493(2007)100[1258:ETFSAH]2.0.CO;2; Ragsdale DW, 2004, ANN ENTOMOL SOC AM, V97, P204, DOI 10.1603/0013-8746(2004)097[0204:SABINA]2.0.CO;2; Ramsey JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-423; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Rozen S, 2000, Methods Mol Biol, V132, P365; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Sabater-Munoz B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r21; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tagu D, 2004, INSECT BIOCHEM MOLEC, V34, P809, DOI 10.1016/j.ibmb.2004.05.001; Tagu D, 2008, MOL PLANT MICROBE IN, V21, P701, DOI 10.1094/MPMI-21-6-0701; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; THURSTON MI, 2005, MSATLINDER DETECTION; van Emden H, 2007, APHIDS AS CROP PESTS, pXXI; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; VIA S, 1991, EVOLUTION, V45, P827, DOI 10.1111/j.1558-5646.1991.tb04353.x; Von Dohlen CD, 2003, ANN ENTOMOL SOC AM, V96, P107, DOI 10.1603/0013-8746(2003)096[0107:PAHBON]2.0.CO;2; Wang X. B., 1994, Plant Protection, V20, P12; Wilcox JL, 2003, MOL MICROBIOL, V48, P1491, DOI 10.1046/j.1365-2958.2003.03522.x; Wille BD, 2009, ENVIRON ENTOMOL, V38, P110, DOI 10.1603/022.038.0113; Wilson ACC, 2010, INSECT MOL BIOL, V19, P249, DOI 10.1111/j.1365-2583.2009.00942.x; Wilson ACC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-50; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang GR, 2009, THEOR APPL GENET, V118, P473, DOI 10.1007/s00122-008-0914-0; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	81	59	71	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11370	10.1371/journal.pone.0011370	http://dx.doi.org/10.1371/journal.pone.0011370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20614011	gold, Green Published, Green Submitted			2022-12-25	WOS:000279369900018
J	Kelly, HA; Mercer, GN; Fielding, JE; Dowse, GK; Glass, K; Carcione, D; Grant, KA; Effler, PV; Lester, RA				Kelly, Heath A.; Mercer, Geoff N.; Fielding, James E.; Dowse, Gary K.; Glass, Kathryn; Carcione, Dale; Grant, Kristina A.; Effler, Paul V.; Lester, Rosemary A.			Pandemic (H1N1) 2009 Influenza Community Transmission Was Established in One Australian State When the Virus Was First Identified in North America	PLOS ONE			English	Article							A H1N1; REPRODUCTION NUMBER	Background: In mid-June 2009 the State of Victoria in Australia appeared to have the highest notification rate of pandemic (H1N1) 2009 influenza in the world. We hypothesise that this was because community transmission of pandemic influenza was already well established in Victoria at the time testing for the novel virus commenced. In contrast, this was not true for the pandemic in other parts of Australia, including Western Australia (WA). Methods: We used data from detailed case follow-up of patients with confirmed infection in Victoria and WA to demonstrate the difference in the pandemic curve in two Australian states on opposite sides of the continent. We modelled the pandemic in both states, using a susceptible-infected-removed model with Bayesian inference accounting for imported cases. Results: Epidemic transmission occurred earlier in Victoria and later in WA. Only 5% of the first 100 Victorian cases were not locally acquired and three of these were brothers in one family. By contrast, 53% of the first 102 cases in WA were associated with importation from Victoria. Using plausible model input data, estimation of the effective reproductive number for the Victorian epidemic required us to invoke an earlier date for commencement of transmission to explain the observed data. This was not required in modelling the epidemic in WA. Conclusion: Strong circumstantial evidence, supported by modelling, suggests community transmission of pandemic influenza was well established in Victoria, but not in WA, at the time testing for the novel virus commenced in Australia. The virus is likely to have entered Victoria and already become established around the time it was first identified in the US and Mexico.	[Kelly, Heath A.; Fielding, James E.; Grant, Kristina A.] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Mercer, Geoff N.; Fielding, James E.; Glass, Kathryn] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Fielding, James E.; Lester, Rosemary A.] Dept Hlth, Melbourne, Vic, Australia; [Dowse, Gary K.; Carcione, Dale; Effler, Paul V.] Dept Hlth Western Australia, Perth, WA, Australia	Victorian Infectious Diseases Reference Laboratory; Australian National University	Kelly, HA (corresponding author), Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia.	heath.kelly@mh.org.au		Glass, Kathryn/0000-0001-5905-1310; Fielding, James/0000-0003-2995-9576	Victorian Government Department of Health; Victorian Infectious Diseases Reference Laboratory; Government of Western Australia Department of Health; National Centre for Epidemiology and Population Health at The Australian National University through Australian Government National Health and Medical Research Council	Victorian Government Department of Health; Victorian Infectious Diseases Reference Laboratory; Government of Western Australia Department of Health; National Centre for Epidemiology and Population Health at The Australian National University through Australian Government National Health and Medical Research Council	No specific sources of funding supported this study and all work was undertaken and written as part of salaried employment. The Victorian Government Department of Health funded the salaries of authors Fielding and Lester; the Victorian Infectious Diseases Reference Laboratory funded the salaries of authors Kelly, Fielding and Grant; the Government of Western Australia Department of Health funded the salaries of authors Dowse and Carcione and Effler. The National Centre for Epidemiology and Population Health at The Australian National University funded the salaries of authors Mercer and Glass through several Australian Government National Health and Medical Research Council grants; none of these grants were awarded for the specific purposes of undertaking or the writing of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, LANCET, V25; *AUSTR GOV DEP HLT, 2009, 1 CAS HUM SWIN INFL; *AUSTR GOV DEP HLT, 2009, NEW PAND PHAS PROT; *AUSTR GOV DEP HLT, 2009, 1 CAS SWIN FLU WA; *AUSTR GOV DEP HLT, 2009, 11 AUSTR GOV DEP HLT; Australian Government Department of Health and Ageing, 2008, AUSTR HLTH MAN PLAN; Bettencourt LMA, 2007, LECT NOTES COMPUT SC, V4506, P79; Bettencourt LMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002185; Britton T, 2009, MATH BIOSCI, V222, P109, DOI 10.1016/j.mbs.2009.10.001; Chowell G, 2008, PHYS LIFE REV, V5, P50, DOI 10.1016/j.plrev.2007.12.001; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; CIBLAK MA, 2009, EURO SURVEILL, V14; Cohen J, 2009, YET ANOTHER NEW PATI; Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Denholm JT, 2010, MED J AUSTRALIA, V192, P84, DOI 10.5694/j.1326-5377.2010.tb03424.x; Fielding JE, 2009, EURO SURVEILL, V14; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gomez J, 2009, EURO SURVEILL, V4; *HLTH PROT AG HLTH, 2009, EURO SURVEILL, V14; Kelly HA, 2009, MED J AUSTRALIA, V191, P146, DOI 10.5694/j.1326-5377.2009.tb02723.x; Lester R, 2009, VICTORIAN INFECT DIS, V12, P43; Martin RM, 2009, EUROSURVEILLANCE, V14; McBryde E, 2009, EURO SURVEILL, V14; Mccaw JM, 2007, MATH BIOSCI, V209, P336, DOI 10.1016/j.mbs.2007.02.003; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Munayco C, 2009, EURO SURVEILL, V14; Nishiura H, 2009, EUROSURVEILLANCE, V14; Nishiura H, 2009, NEW ZEAL MED J, V122, P73; Novel influenza A(H1N1) investigation team, 2009, EURO SURVEILL, V14, P19295; Pedroni E, 2010, EURO SURVEILL, V15; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; *PROMED MAIL, 2009, INFL A H1N1 WORLDW 4; PYBUS O, 2009, ORIGIN OUTBREAK HA G; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; *VICT INF DIS REF, 2009, 1 VICT INF DIS REF L; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Watts CG, 2003, AUST NZ J PUBL HEAL, V27, P409, DOI 10.1111/j.1467-842X.2003.tb00418.x; Wilson N, 2009, EUROSURVEILLANCE, V14; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	42	50	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11341	10.1371/journal.pone.0011341	http://dx.doi.org/10.1371/journal.pone.0011341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596536	Green Published, Green Submitted, gold			2022-12-25	WOS:000279259900014
J	He, LJ; Horton, W; Hristova, K				He, Lijuan; Horton, William; Hristova, Kalina			Physical Basis behind Achondroplasia, the Most Common Form of Human Dwarfism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR-3; TRANSMEMBRANE DOMAIN; TYROSINE KINASE; FGF RECEPTORS; HEPARAN-SULFATE; DOWN-REGULATION; EGF RECEPTOR; ACTIVATION; MUTATIONS; UBIQUITYLATION	Fibroblast growth factor receptor 3 (FGFR3) is a receptor tyrosine kinase that plays an important role in long bone development. The G380R mutation in FGFR3 transmembrane domain is known as the genetic cause for achondroplasia, the most common form of human dwarfism. Despite many studies, there is no consensus about the exact mechanism underlying the pathology. To gain further understanding into the physical basis behind the disorder, here we measure the activation of wild-type and mutant FGFR3 in mammalian cells using Western blots, and we analyze the activation within the frame of a physicalchemical model describing dimerization, ligand binding, and phosphorylation probabilities within the dimers. The data analysis presented here suggests that the mutation does not increase FGFR3 dimerization, as proposed previously. Instead, FGFR3 activity in achondroplasia is increased due to increased probability for phosphorylation of the unliganded mutant dimers. This finding has implications for the design of targeted molecular treatments for achondroplasia.	[Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Horton, William] Oregon Hlth & Sci Univ, Res Ctr, Shriners Hosp Children, Dept Mol & Med Genet, Portland, OR 97239 USA	Johns Hopkins University; Oregon Health & Science University	Hristova, K (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	kh@jhu.edu	Hristova, Kalina/A-3326-2010		National Institutes of Health [GM068619]; National Science Foundation [MCB 0718841]; Shriners Hospitals for Children [10-POR-007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Shriners Hospitals for Children; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM068619. This work was also supported by National Science Foundation Grant MCB 0718841 and Shriners Hospitals for Children Research Grant 10-POR-007.	Adams PD, 1996, PROTEINS, V26, P257, DOI 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B; ADAMS PD, 1995, NAT STRUCT BIOL, V2, P154, DOI 10.1038/nsb0295-154; ADAMS PD, 1997, MOL B INT U, P251; Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; Bonaventure J, 2007, FEBS J, V274, P3078, DOI 10.1111/j.1742-4658.2007.05835.x; Cho JY, 2004, P NATL ACAD SCI USA, V101, P609, DOI 10.1073/pnas.2237184100; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Harada D, 2009, J BONE MINER METAB, V27, P9, DOI 10.1007/s00774-008-0009-7; Harmer NJ, 2006, BIOCHEM SOC T, V34, P442, DOI 10.1042/BST0340442; He LJ, 2008, J MOL BIOL, V384, P1130, DOI 10.1016/j.jmb.2008.10.036; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; Li E, 2006, J MOL BIOL, V356, P600, DOI 10.1016/j.jmb.2005.11.077; Li E, 2006, BIOCHEMISTRY-US, V45, P6241, DOI 10.1021/bi060609y; Li E, 2010, CELL ADHES MIGR, V4, P249, DOI 10.4161/cam.4.2.10725; Li Y, 1997, ONCOGENE, V14, P1397, DOI 10.1038/sj.onc.1200983; Monsonego-Ornan E, 2000, MOL CELL BIOL, V20, P516, DOI 10.1128/MCB.20.2.516-522.2000; Monsonego-Ornan E, 2002, FEBS LETT, V528, P83, DOI 10.1016/S0014-5793(02)03255-6; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Olsen SK, 2004, P NATL ACAD SCI USA, V101, P935, DOI 10.1073/pnas.0307287101; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; PONSETI IV, 1970, J BONE JOINT SURG AM, VA 52, P701, DOI 10.2106/00004623-197052040-00004; Raffioni S, 1998, J BIOL CHEM, V273, P35250, DOI 10.1074/jbc.273.52.35250; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Schlessinger J, 2003, SCIENCE, V300, P750, DOI 10.1126/science.1082024; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Vajo Z, 2000, ENDOCR REV, V21, P23, DOI 10.1210/er.21.1.23; VAN RHIJN BWG, 2002, EUR J HUM GENET, V10, P819; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; Webster MK, 1997, TRENDS GENET, V13, P178, DOI 10.1016/S0168-9525(97)01131-1; You M, 2006, BIOCHEMISTRY-US, V45, P5551, DOI 10.1021/bi060113g; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411	33	33	36	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30103	30114		10.1074/jbc.M109.094086	http://dx.doi.org/10.1074/jbc.M109.094086			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20624921	Green Published, hybrid			2022-12-25	WOS:000281984300048
J	Planamente, S; Vigouroux, A; Mondy, S; Nicaise, M; Faure, D; Morera, S				Planamente, Sara; Vigouroux, Armelle; Mondy, Samuel; Nicaise, Magali; Faure, Denis; Morera, Solange			A Conserved Mechanism of GABA Binding and Antagonism Is Revealed by Structure-Function Analysis of the Periplasmic Binding Protein Atu2422 in Agrobacterium tumefaciens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURES; RHIZOBIUM-LEGUMINOSARUM; LIGAND-BINDING; SALICYLIC-ACID; RECEPTOR; LEUCINE; RECOGNITION; ARABIDOPSIS; METABOLISM; EXPRESSION	Bacterial periplasmic binding proteins (PBPs) and eukaryotic PBP-like domains (also called as Venus flytrap modules) of G-protein-coupled receptors are involved in extracellular GABA perception. We investigated the structural and functional basis of ligand specificity of the PBP Atu2422, which is implicated in virulence and transport of GABA in the plant pathogen Agrobacterium tumefaciens. Five high-resolution x-ray structures of Atu2422 liganded to GABA, Pro, Ala, and Val and of point mutant Atu2422-F77A liganded to Leu were determined. Structural analysis of the ligand-binding site revealed two essential residues, Phe77 and Tyr275, the implication of which in GABA signaling and virulence was confirmed using A. tumefaciens cells expressing corresponding Atu2422 mutants. Phe77 restricts ligand specificity to alpha-amino acids with a short lateral chain, which act as antagonists of GABA signaling in A. tumefaciens. Tyr275 specifically interacts with the GABA alpha-amino group. Conservation of these two key residues in proteins phylogenetically related to Atu2422 brought to light a subfamily of PBPs in which all members could bind GABA and short alpha-amino acids. This work led to the identification of a fingerprint sequence and structural features for defining PBPs that bind GABA and its competitors and revealed their occurrence among host-interacting proteobacteria.	[Planamente, Sara; Mondy, Samuel; Faure, Denis] CNRS, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France; [Planamente, Sara; Vigouroux, Armelle; Morera, Solange] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Nicaise, Magali] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, UMR8619, CNRS, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Faure, D (corresponding author), CNRS, Inst Sci Vegetal, Ave Terrasse, F-91198 Gif Sur Yvette, France.	faure@isv.cnrs-gif.fr; morera@lebs.cnrs-gif.fr	Mondy, Samuel/AAG-8805-2019; Planamente, Sara/ABB-4551-2020	Mondy, Samuel/0000-0002-9203-6398; Planamente, Sara/0000-0003-2778-1356	French Research Minister [ED145]; CNRS	French Research Minister; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the French Research Minister (Ecole Doctorale Sciences du Vegetal ED145, to S. P.) and by CNRS (to A.V.,S. Mondy, M.N., D.F., and S.Morera).	Acher FC, 2005, BIOPOLYMERS, V80, P357, DOI 10.1002/bip.20229; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anjard C, 2006, DEVELOPMENT, V133, P2253, DOI 10.1242/dev.02399; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Bouche N, 2003, TRENDS CELL BIOL, V13, P607, DOI 10.1016/j.tcb.2003.10.001; Cao JH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-67; Carlier A, 2004, MOL PLANT MICROBE IN, V17, P951, DOI 10.1094/MPMI.2004.17.9.951; Cha C, 1998, MOL PLANT MICROBE IN, V11, P1119, DOI 10.1094/MPMI.1998.11.11.1119; Chevrot R, 2006, P NATL ACAD SCI USA, V103, P7460, DOI 10.1073/pnas.0600313103; CHILTON MD, 1974, P NATL ACAD SCI USA, V71, P3672, DOI 10.1073/pnas.71.9.3672; Crittenden DL, 2005, J PHYS CHEM A, V109, P4195, DOI 10.1021/jp050320a; Deeken R, 2006, PLANT CELL, V18, P3617, DOI 10.1105/tpc.106.044743; Diaz C, 2005, PLANT PHYSIOL, V138, P898, DOI 10.1104/pp.105.060764; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galvez T, 1999, J BIOL CHEM, V274, P13362, DOI 10.1074/jbc.274.19.13362; Haudecoeur E, 2009, P NATL ACAD SCI USA, V106, P14587, DOI 10.1073/pnas.0808005106; Haudecoeur Elise, 2010, Commun Integr Biol, V3, P84; Haudecoeur E, 2009, MOL PLANT MICROBE IN, V22, P529, DOI 10.1094/MPMI-22-5-0529; Hosie AHF, 2002, J BACTERIOL, V184, P4071, DOI 10.1128/JB.184.15.4071-4080.2002; Huvent I, 2006, ACTA CRYSTALLOGR D, V62, P1375, DOI 10.1107/S0907444906032653; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kuang DH, 2006, P NATL ACAD SCI USA, V103, P14050, DOI 10.1073/pnas.0604717103; Kumpost J, 2008, NEUROPHARMACOLOGY, V55, P409, DOI 10.1016/j.neuropharm.2008.06.073; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Magnusson U, 2004, J BIOL CHEM, V279, P8747, DOI 10.1074/jbc.M311890200; Maurhofer M, 1998, PHYTOPATHOLOGY, V88, P678, DOI 10.1094/PHYTO.1998.88.7.678; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morera S, 2008, ACTA CRYSTALLOGR F, V64, P1153, DOI 10.1107/S1744309108036555; Prell J, 2009, J BACTERIOL, V191, P2177, DOI 10.1128/JB.01714-08; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; SACK JS, 1989, J MOL BIOL, V206, P193, DOI 10.1016/0022-2836(89)90532-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schreier B, 2009, P NATL ACAD SCI USA, V106, P18491, DOI 10.1073/pnas.0907950106; Shelp BJ, 2006, PLANT PHYSIOL, V142, P1350, DOI 10.1104/pp.106.088955; Shelp BJ, 1999, TRENDS PLANT SCI, V4, P446, DOI 10.1016/S1360-1385(99)01486-7; Solomon PS, 2002, PLANTA, V214, P414, DOI 10.1007/s004250100632; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trakhanov S, 2005, BIOCHEMISTRY-US, V44, P6597, DOI 10.1021/bi047302o; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yuan ZC, 2008, CELL MICROBIOL, V10, P2339, DOI 10.1111/j.1462-5822.2008.01215.x; ZUCKERKANDL E, 1965, GENES PROTEINS, P97	45	34	36	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30294	30303		10.1074/jbc.M110.140715	http://dx.doi.org/10.1074/jbc.M110.140715			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20630861	Green Published, hybrid			2022-12-25	WOS:000281984300065
J	Pulagam, LP; Palczewski, K				Pulagam, Lakshmi Padmavathi; Palczewski, Krzysztof			Electrostatic Compensation Restores Trafficking of the Autosomal Recessive Retinitis Pigmentosa E150K Opsin Mutant to the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR RHODOPSIN; MOLECULAR-GENETICS; POINT MUTANTS; MUTATION; ORGANIZATION; EXPRESSION; STABILITY; CLONING; DOMAIN; CONES	Rhodopsin is the rod photoreceptor G protein-coupled receptor responsible for capturing light. Mutations in the gene encoding this protein can lead to a blinding disease called retinitis pigmentosa, which is inherited frequently in an autosomal dominant manner. The E150K opsin mutant associated with rarely occurring autosomal recessive retinitis pigmentosa localizes to trans-Golgi network membranes rather than to plasma membranes of rod photoreceptor cells. We investigated the molecular mechanisms underlying opsin retention in the Golgi apparatus. Electrostatic calculations reveal that the E150K mutant features an overall accumulation of positive charges between helices H-IV and H-II. Human E150K and several other closely related opsin mutants were then expressed in HEK-293 cells. Spectral characteristics and functional biochemistry of each mutant were analyzed after reconstitution with the cis-retinoid chromophore. UV-visible spectra and rhodopsin/transducin activation assays revealed only minor differences between the purified wild type control and rhodopsin mutants. However, partial restoration of the surface electrostatic charge in the compensatory R69E/E150K double mutant rescues the plasma membrane localization of opsin. These findings emphasize the fundamental importance of electrostatic interactions for appropriate membrane trafficking of opsin and advance our understanding of the pathophysiology of autosomal recessive retinitis pigmentosa due to the E150K mutation.	[Pulagam, Lakshmi Padmavathi; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu	Pulagam, Lakshmi/E-8166-2012		National Institutes of Health [EY008061, GM079191, P30 EY11373]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R29EY008061, P30EY011373, R01EY008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY008061, GM079191, and P30 EY11373. This work was also supported by the Foundation Fighting Blindness.	Antonin W, 2000, J NEUROSCI, V20, P5724, DOI 10.1523/JNEUROSCI.20-15-05724.2000; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Azam M, 2009, MOL VIS, V15, P2526; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bereta G, 2008, BIOCHEMISTRY-US, V47, P9856, DOI 10.1021/bi800905v; Bereta G, 2010, J BIOL CHEM, V285, P1899, DOI 10.1074/jbc.M109.061713; Curcio CA, 2000, INVEST OPHTH VIS SCI, V41, P2015; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Garriga P, 1996, P NATL ACAD SCI USA, V93, P4560, DOI 10.1073/pnas.93.10.4560; Goc A, 2008, BIOCHEMISTRY-US, V47, P12409, DOI 10.1021/bi8015444; Gould DJ, 2000, GENE THER, V7, P2061, DOI 10.1038/sj.gt.3301354; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; Jastrzebska B, 2009, BIOCHEMISTRY-US, V48, P5159, DOI 10.1021/bi900284x; Jastrzebska B, 2009, FASEB J, V23, P371, DOI 10.1096/fj.07-114835; Jeon CJ, 1998, J NEUROSCI, V18, P8936; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kienle N, 2009, BIOCHEM SOC T, V37, P787, DOI 10.1042/BST0370787; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KUMARAMANICKAVEL G, 1994, NAT GENET, V8, P10, DOI 10.1038/ng0994-10; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Liu X, 1996, P NATL ACAD SCI USA, V93, P4554, DOI 10.1073/pnas.93.10.4554; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Mustafi D, 2009, PROG RETIN EYE RES, V28, P289, DOI 10.1016/j.preteyeres.2009.05.003; NATHANS J, 1992, BIOCHEMISTRY-US, V31, P4923, DOI 10.1021/bi00136a001; NATHANS J, 1992, ANNU REV GENET, V26, P403, DOI 10.1146/annurev.ge.26.120192.002155; Nichols BJ, 1998, BBA-MOL CELL RES, V1404, P9, DOI 10.1016/S0167-4889(98)00044-5; OBrien J, 1997, GENE, V193, P141, DOI 10.1016/S0378-1119(97)00079-6; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; RIDGE KD, 1995, P NATL ACAD SCI USA, V92, P3204, DOI 10.1073/pnas.92.8.3204; RODIECK RW, 1998, 1 STEPS SEEING, P36; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; Stojanovic A, 2002, RECEPTOR CHANNEL, V8, P33, DOI 10.1080/10606820212137; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Wen XH, 2009, BIOPHYS J, V96, P939, DOI 10.1016/j.bpj.2008.10.016; ZHOU NE, 1994, J MOL BIOL, V237, P500, DOI 10.1006/jmbi.1994.1250; Zhu L, 2006, J BIOL CHEM, V281, P22289, DOI 10.1074/jbc.M602664200	51	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29446	29456		10.1074/jbc.M110.151407	http://dx.doi.org/10.1074/jbc.M110.151407			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20628051	Green Published, hybrid			2022-12-25	WOS:000281740100047
J	Ng, DCH; Zhao, TT; Yeap, YYC; Ngoei, KR; Bogoyevitch, MA				Ng, Dominic C. H.; Zhao, Teresa T.; Yeap, Yvonne Y. C.; Ngoei, Kevin R.; Bogoyevitch, Marie A.			c-Jun N-terminal Kinase Phosphorylation of Stathmin Confers Protection against Cellular Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; TUMOR-NECROSIS-FACTOR; MICROTUBULE DYNAMICS; MULTISITE PHOSPHORYLATION; NH2-TERMINAL KINASE; SIGNALING PATHWAYS; PROMOTES SURVIVAL; IN-VITRO; JNK; CELLS	The cell stress response encompasses the range of intracellular events required for adaptation to stimuli detrimental to cell survival. Although the c-Jun N-terminal kinase (JNK) is a stress-activated kinase that can promote either cell survival or death in response to detrimental stimuli, the JNK-regulated mechanisms involved in survival are not fully characterized. Here we show that in response to hyperosmotic stress, JNK phosphorylates a key cytoplasmic microtubule regulatory protein, stathmin (STMN), on conserved Ser-25 and Ser-38 residues. In in vitro biochemical studies, we identified STMN Ser-38 as the critical residue required for efficient phosphorylation by JNK and identified a novel kinase interaction domain in STMN required for recognition by JNK. We revealed that JNK was required for microtubule stabilization in response to hyperosmotic stress. Importantly, we also demonstrated a novel cytoprotective function for STMN, as the knockdown of STMN levels by siRNA was sufficient to augment viability in response to hyperosmotic stress. Our findings show that JNK targeting of STMN represents a novel stress-activated cytoprotective mechanism involving microtubule network changes.	[Ng, Dominic C. H.; Zhao, Teresa T.; Yeap, Yvonne Y. C.; Ngoei, Kevin R.; Bogoyevitch, Marie A.] Univ Melbourne, Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia	University of Melbourne	Ng, DCH (corresponding author), Univ Melbourne, Inst Bio21, Dept Biochem & Mol Biol, 30 Flemington Rd, Parkville, Vic 3010, Australia.	ngd@unimelb.edu.au	Ng, Dominic/C-7291-2015	Ng, Dominic/0000-0003-4657-159X; Bogoyevitch, Marie/0000-0001-9745-3716	National Health and Medical Research Council [628335, 566804]; National Heart Foundation of Australia/National Health and Medical Research Council [404126]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia/National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of AustraliaNational Heart Foundation of Australia)	This work was supported by National Health and Medical Research Council Project Grants 628335 and 566804.; Recipient of National Heart Foundation of Australia/National Health and Medical Research Council Fellowship 404126. To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Bio21 Institute, University of Melbourne, 30 Flemington Rd., Parkville, VIC, 3010 Australia. Tel.: 61-3-8344-2543; Fax: 61-3-9348-1421; E-mail: ngd@unimelb.edu.au.	Arbour N, 2002, J EXP MED, V195, P801, DOI 10.1084/jem.20011481; Barr RK, 2004, J BIOL CHEM, V279, P36327, DOI 10.1074/jbc.M402181200; Barr RK, 2001, INT J BIOCHEM CELL B, V33, P1047, DOI 10.1016/S1357-2725(01)00093-0; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERETTA L, 1995, EUR J BIOCHEM, V227, P388, DOI 10.1111/j.1432-1033.1995.tb20401.x; BERETTA L, 1993, J BIOL CHEM, V268, P20076; Bogoyevitch MA, 2008, BBA-PROTEINS PROTEOM, V1784, P76, DOI 10.1016/j.bbapap.2007.09.013; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Cardinaux JR, 1997, MOL BRAIN RES, V51, P220, DOI 10.1016/S0169-328X(97)00241-6; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; DiPaolo G, 1996, J CELL BIOL, V133, P1383, DOI 10.1083/jcb.133.6.1383; Dougherty CJ, 2002, BIOCHEM J, V362, P561, DOI 10.1042/0264-6021:3620561; Fryer RM, 2001, AM J PHYSIOL-HEART C, V281, pH1184, DOI 10.1152/ajpheart.2001.281.3.H1184; Hayashi K, 2006, J NEUROCHEM, V99, P237, DOI 10.1111/j.1471-4159.2006.04113.x; Honnappa S, 2006, J BIOL CHEM, V281, P16078, DOI 10.1074/jbc.M513524200; Horiuchi D, 2007, CURR BIOL, V17, P1313, DOI 10.1016/j.cub.2007.06.062; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; LARSSON N, 1995, J BIOL CHEM, V270, P14175, DOI 10.1074/jbc.270.23.14175; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; LEIGHTON IA, 1993, MOL CELL BIOCHEM, V128, P151, DOI 10.1007/BF01076766; Lizundia R, 2006, CANCER RES, V66, P6105, DOI 10.1158/0008-5472.CAN-05-3861; Lovric J, 1998, J BIOL CHEM, V273, P22848; LUO XN, 1994, J BIOL CHEM, V269, P10312; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Michaelis ML, 2005, J PHARMACOL EXP THER, V312, P659, DOI 10.1124/jpet.104.074450; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; Mizumura K, 2006, J CELL PHYSIOL, V206, P363, DOI 10.1002/jcp.20465; Monnet C, 2004, FEBS LETT, V576, P114, DOI 10.1016/j.febslet.2004.08.076; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Moss DK, 2006, J CELL SCI, V119, P2362, DOI 10.1242/jcs.02959; Nakamura K, 2006, J CHROMATOGR A, V1106, P181, DOI 10.1016/j.chroma.2005.12.068; Nakamura Y, 2004, CARDIOVASC RES, V64, P322, DOI 10.1016/j.cardiores.2004.07.013; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Parker CG, 1998, BIOCHEM BIOPH RES CO, V249, P791, DOI 10.1006/bbrc.1998.9250; Podkowa M, 2010, MOL CELL BIOL, V30, P2241, DOI 10.1128/MCB.01166-09; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sellin ME, 2008, MOL BIOL CELL, V19, P2897, DOI 10.1091/mbc.E08-01-0058; Stone MC, 2010, MOL BIOL CELL, V21, P767, DOI 10.1091/mbc.E09-11-0967; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Tran TH, 2007, J BIOL CHEM, V282, P20340, DOI 10.1074/jbc.M702210200; Trushina E, 2003, P NATL ACAD SCI USA, V100, P12171, DOI 10.1073/pnas.2034961100; Vancompernolle K, 2000, J BIOL CHEM, V275, P33876, DOI 10.1074/jbc.M004785200; Ventura JJ, 2003, MOL CELL BIOL, V23, P2871, DOI 10.1128/MCB.23.8.2871-2882.2003; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001	52	20	21	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					29001	29013		10.1074/jbc.M110.128454	http://dx.doi.org/10.1074/jbc.M110.128454			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20630875	Green Published, hybrid			2022-12-25	WOS:000281594000065
J	Chen, HY; Yong, WD; Hinds, TD; Yang, ZC; Zhou, YH; Sanchez, ER; Shou, WN				Chen, Hanying; Yong, Weidong; Hinds, Terry D., Jr.; Yang, Zuocheng; Zhou, Yuhong; Sanchez, Edwin R.; Shou, Weinian			Fkbp52 Regulates Androgen Receptor Transactivation Activity and Male Urethra Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; IMMUNOPHILIN; CHAPERONES; PROTEIN; GROWTH; PENIS; MICE; FGF8	Hypospadias is a common birth defect in humans, yet its etiology and pattern of onset are largely unknown. Recent studies have shown that male mice with targeted ablation of FK506-binding protein-52 (Fkbp52) develop hypospadias, most likely due to actions of Fkbp52 as a molecular co-chaperone of the androgen receptor (AR). Here, we further dissect the developmental and molecular mechanisms that underlie hypospadias in Fkbp52-deficient mice. Scanning electron microscopy revealed a defect in the elevation of prepucial swelling that led to the onset of the ventral penile cleft. Interestingly, expression of Fkbp52 was highest in the ventral aspect of the developing penis that undergoes fusion of the urethral epithelium. Although in situ hybridization and immunohistochemical analyses suggested that Fkbp52 mutants had a normal urethral epithelium signaling center and epithelial differentiation, a reduced apoptotic cell index at ventral epithelial cells at the site of fusion and a defect of genital mesenchymal cell migration were observed. Supplementation of gestating females with excess testosterone partially rescued the hypospadic phenotype in Fkbp52 mutant males, showing that loss of Fkbp52 desensitizes AR to hormonal activation. Direct measurement of AR activity was performed in mouse embryonic fibroblast cells treated with dihydrotestosterone or synthetic agonist R1881. Reduced AR activity at genes controlling sexual dimorphism and cell growth was found in Fkbp52-deficient mouse embryonic fibroblast cells. However, chromatin immunoprecipitation analysis revealed normal occupancy of AR at gene promoters, suggesting that Fkbp52 exerts downstream effects on the transactivation function of AR. Taken together, our data show Fkbp52 to be an important molecular regulator in the androgen-mediated pathway of urethra morphogenesis.	[Chen, Hanying; Yong, Weidong; Yang, Zuocheng; Zhou, Yuhong; Shou, Weinian] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Riley Heart Res Ctr, Indianapolis, IN 46202 USA; [Hinds, Terry D., Jr.; Sanchez, Edwin R.] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA; [Yang, Zuocheng] Cent S Univ, Xiang Ya Hosp 3, Xiang Ya Sch Med, Dept Pediat, Changsha 410013, Peoples R China; [Zhou, Yuhong] Harbin Med Univ, Dept Pharmacol, Harbin 150086, Peoples R China	Indiana University System; Indiana University-Purdue University Indianapolis; University System of Ohio; University of Toledo; Central South University; Harbin Medical University	Shou, WN (corresponding author), Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Riley Heart Res Ctr, R4-302D,1044 W Walnut, Indianapolis, IN 46202 USA.	wshou@iupui.edu	Zhou, Yu/HHN-3071-2022; Hinds, Terry/B-8495-2015	Hinds, Terry/0000-0002-7599-1529	National Institutes of Health [DK73402, DK70127]; Riley Children's Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073402, F31DK084958, R01DK070127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Riley Children's Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK73402 (to W. S. and E. R. S.) and DK70127 (to E. R. S. and W. S.). This work was also supported by the Riley Children's Foundation (W. S.).	Amler LC, 2000, CANCER RES, V60, P6134; Baskin LS, 2004, ADV EXP MED BIOL, V545, P103; Baskin LS, 2001, CELL TISSUE RES, V305, P379, DOI 10.1007/s004410000345; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; Davies TH, 2005, INT J BIOCHEM CELL B, V37, P42, DOI 10.1016/j.biocel.2004.03.013; Haraguchi R, 2007, DEVELOPMENT, V134, P525, DOI 10.1242/dev.02736; Kim KS, 2002, CELL TISSUE RES, V307, P145, DOI 10.1007/s004410100464; Kurzrock EA, 1999, CELLS TISSUES ORGANS, V164, P125, DOI 10.1159/000016650; Kuslak SL, 2007, DIFFERENTIATION, V75, P638, DOI 10.1111/j.1432-0436.2006.00161.x; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Miyagawa S, 2009, DEVELOPMENT, V136, P3969, DOI 10.1242/dev.039438; Morgan EA, 2003, DEVELOPMENT, V130, P3095, DOI 10.1242/dev.00530; MURAKAMI R, 1986, J EMBRYOL EXP MORPH, V92, P133; PEATTIE DA, 1992, P NATL ACAD SCI USA, V89, P10974, DOI 10.1073/pnas.89.22.10974; Perriton CL, 2002, DEV BIOL, V247, P26, DOI 10.1006/dbio.2002.0668; Petiot A, 2005, DEVELOPMENT, V132, P2441, DOI 10.1242/dev.01778; Ratajczak T, 2003, CURR TOP MED CHEM, V3, P1348, DOI 10.2174/1568026033451934; Scott V, 2005, J BIOCHEM, V137, P671, DOI 10.1093/jb/mvi086; Seifert AW, 2009, DEVELOPMENT, V136, P2643, DOI 10.1242/dev.036830; SEIFERT AW, 2010, NAT COMMUN IN PRESS; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; Stadler HS, 2003, NAT REV GENET, V4, P478, DOI 10.1038/nrg1083; Traish AM, 2009, J ANDROL, V30, P363, DOI 10.2164/jandrol.108.006007; Vanaja DK, 2002, CELL STRESS CHAPERON, V7, P55, DOI 10.1379/1466-1268(2002)007<0055:EOGOAR>2.0.CO;2; Wang MH, 2008, J ANDROL, V29, P499, DOI 10.2164/jandrol.108.004945; Warrier M, 2010, ENDOCRINOLOGY, V151, P3225, DOI 10.1210/en.2009-1158; Yamada G, 2003, DIFFERENTIATION, V71, P445, DOI 10.1046/j.1432-0436.2003.7108001.x; Yong WD, 2007, J BIOL CHEM, V282, P5026, DOI 10.1074/jbc.M609360200	30	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27776	27784		10.1074/jbc.M110.156091	http://dx.doi.org/10.1074/jbc.M110.156091			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20605780	Green Published, hybrid			2022-12-25	WOS:000281404100033
J	Delhey, K; Burger, C; Fiedler, W; Peters, A				Delhey, Kaspar; Burger, Claudia; Fiedler, Wolfgang; Peters, Anne			Seasonal Changes in Colour: A Comparison of Structural, Melanin- and Carotenoid-Based Plumage Colours	PLOS ONE			English	Article							TITS CYANISTES-CAERULEUS; BLUE TITS; SEXUAL ATTRACTIVENESS; SPECTRAL SENSITIVITY; BREEDING-SEASON; PARENTAL EFFORT; VISUAL ECOLOGY; PARUS-MAJOR; BILL COLOR; TRADE-OFF	Background: Plumage coloration is important for bird communication, most notably in sexual signalling. Colour is often considered a good quality indicator, and the expression of exaggerated colours may depend on individual condition during moult. After moult, plumage coloration has been deemed fixed due to the fact that feathers are dead structures. Still, many plumage colours change after moult, although whether this affects signalling has not been sufficiently assessed. Methodology/Principal Findings: We studied changes in coloration after moult in four passerine birds (robin, Erithacus rubecula; blackbird, Turdus merula; blue tit, Cyanistes caeruleus; and great tit, Parus major) displaying various coloration types (melanin-, carotenoid-based and structural). Birds were caught regularly during three years to measure plumage reflectance. We used models of avian colour vision to derive two variables, one describing chromatic and the other achromatic variation over the year that can be compared in magnitude among different colour types. All studied plumage patches but one (yellow breast of the blue tit) showed significant chromatic changes over the year, although these were smaller than for a typical dynamic trait (bill colour). Overall, structural colours showed a reduction in relative reflectance at shorter wavelengths, carotenoid-based colours the opposite pattern, while no general pattern was found for melanin- based colours. Achromatic changes were also common, but there were no consistent patterns of change for the different types of colours. Conclusions/Significance: Changes of plumage coloration independent of moult are probably widespread; they should be perceivable by birds and have the potential to affect colour signalling.	[Delhey, Kaspar; Burger, Claudia; Peters, Anne] Max Planck Inst Ornithol, Behav Ecol Sexual Signals Grp, Radolfzell am Bodensee, Germany	Max Planck Society	Delhey, K (corresponding author), Max Planck Inst Ornithol, Behav Ecol Sexual Signals Grp, Radolfzell am Bodensee, Germany.	delhey@orn.mpg.de	Delhey, Kaspar/F-6515-2010; Delhey, Kaspar/AAZ-5362-2020; Fiedler, Wolfgang/AAG-4510-2021; Peters, Anne/A-1821-2010	Delhey, Kaspar/0000-0001-5190-5406; Fiedler, Wolfgang/0000-0003-1082-4161; Peters, Anne/0000-0001-8071-0560	Max Planck Society	Max Planck Society(Max Planck Society)	This study was funded by the Max Planck Society, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S., 2006, BIRD COLORATION, P76; Baeta R, 2008, P ROY SOC B-BIOL SCI, V275, P427, DOI 10.1098/rspb.2007.1383; Benites P, 2007, CONDOR, V109, P605, DOI 10.1650/8195.1; Blanco G, 2005, P ROY SOC B-BIOL SCI, V272, P1893, DOI 10.1098/rspb.2005.3157; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Bright A, 2004, BEHAV PROCESS, V65, P123, DOI 10.1016/j.beproc.2003.08.003; Burtt E.H., 1986, ORNITHOL MONOGR, V38, P1; Burtt EH, 2004, CONDOR, V106, P681, DOI 10.1650/7383; Campenhausen MV, 1998, J COMP PHYSIOL A, V183, P1; Cramp S., 1988, BIRDS W PALEARCTIC, V5; CRAMP S, 1993, BIRDS W PALEARCTIC, P225; Cuthill IC, 2006, BIRD COLORATION, V1, P3; Delhey K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001689; Delhey K, 2007, AM NAT, V169, pS145, DOI 10.1086/510095; Delhey K, 2007, BEHAV ECOL, V18, P399, DOI 10.1093/beheco/arl096; Delhey K, 2006, BEHAV ECOL, V17, P790, DOI 10.1093/beheco/arl012; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Faivre B, 2003, SCIENCE, V300, P103, DOI 10.1126/science.1081802; Faivre B, 2003, ANIM BEHAV, V65, P1125, DOI 10.1006/anbe.2003.2142; Figuerola J, 2005, IBIS, V147, P797, DOI 10.1111/j.1474-919x.2005.00461.x; Grande JM, 2004, ARDEOLA, V51, P375; Griffith SC, 2003, J EVOLUTION BIOL, V16, P1045, DOI 10.1046/j.1420-9101.2003.00550.x; Griffith SC, 2006, ANIM BEHAV, V71, P749, DOI 10.1016/j.anbehav.2005.07.016; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hadfield JD, 2006, J EVOLUTION BIOL, V19, P1104, DOI 10.1111/j.1420-9101.2006.01095.x; Hadfield JD, 2006, P ROY SOC B-BIOL SCI, V273, P1347, DOI 10.1098/rspb.2005.3459; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hegyi G, 2007, J AVIAN BIOL, V38, P698, DOI 10.1111/j.2007.0908-8857.04075.x; Hill G. E., 2006, BIRD COLORATION, V2; Hill GE., 2006, BIRD COLOURATION, P507, DOI [10.4159/9780674273788, DOI 10.4159/9780674273788]; Johnsen A, 2005, ANIM BEHAV, V70, P877, DOI 10.1016/j.anbehav.2005.01.005; JOHNSON NK, 1993, WILSON BULL, V105, P389; Kahn NW, 1998, AUK, V115, P1074; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; KNIPRATH ERNST, 1967, J ORNITHOL, V108, P1, DOI 10.1007/BF01671355; Korsten P, 2007, BEHAV ECOL SOCIOBIOL, V61, P1933, DOI 10.1007/s00265-007-0433-z; Kose M, 1999, BEHAV ECOL SOCIOBIOL, V45, P430, DOI 10.1007/s002650050581; Limbourg T, 2004, P ROY SOC B-BIOL SCI, V271, P1903, DOI 10.1098/rspb.2004.2825; Lucas A. M., 1972, AVIAN ANATOMY INTE 2; MAIER EJ, 1993, J COMP PHYSIOL A, V172, P295, DOI 10.1007/BF00216611; McGraw K.J., 2006, BIRD COLORATION, V1, P177; McGraw KJ, 2004, CAN J ZOOL, V82, P734, DOI 10.1139/Z04-043; McGraw KJ, 2004, ETHOLOGY, V110, P707, DOI 10.1111/j.1439-0310.2004.01011.x; McGraw KJ., 2006, BIRD COLORATION, P243; MOLLER AP, 1992, BEHAV ECOL SOCIOBIOL, V31, P271; MONTGOMERIE R, 2006, BIRD COLORATION, V1, P399; Montgomerie R., 2006, BIRD COLORATION, P90; Odeen A, 2003, MOL BIOL EVOL, V20, P855, DOI 10.1093/molbev/msg108; Ornborg J, 2002, BIOL J LINN SOC, V76, P237, DOI 10.1046/j.1095-8312.2002.00061.x; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Peters A, 2004, AM NAT, V164, P51, DOI 10.1086/421302; Prum RO, 2006, BIRD COLORATION, V1, P295; Roberts ML, 2009, BEHAV ECOL, V20, P535, DOI 10.1093/beheco/arp028; Schmidt-Wellenburg CA, 2008, BEHAV ECOL, V19, P1351, DOI 10.1093/beheco/arn066; Shawkey MD, 2007, AM NAT, V169, pS112, DOI 10.1086/510100; Shawkey MD, 2006, P R SOC B, V273, P2985, DOI 10.1098/rspb.2006.3675; Shawkey MD, 2005, BIOL LETTERS, V1, P121, DOI 10.1098/rsbl.2004.0289; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; Surmacki A, 2008, IBIS, V150, P335, DOI 10.1111/j.1474-919X.2007.00796.x; Svensson L., 1992, IDENTIFICATION GUIDE; TEST FREDERICK H., 1940, CONDOR, V42, P76, DOI 10.2307/1364322; Tokolyi J, 2008, BIOL J LINN SOC, V94, P711, DOI 10.1111/j.1095-8312.2008.01027.x; Tubaro PL, 2005, CONDOR, V107, P648, DOI 10.1650/0010-5422(2005)107[0648:CDASCV]2.0.CO;2; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286; Willoughby EJ, 2002, WILSON BULL, V114, P380, DOI 10.1676/0043-5643(2002)114[0380:MPAACC]2.0.CO;2; Zampiga E, 2004, ETHOL ECOL EVOL, V16, P339, DOI 10.1080/08927014.2004.9522625	67	44	44	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11582	10.1371/journal.pone.0011582	http://dx.doi.org/10.1371/journal.pone.0011582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644723	Green Published, Green Submitted, gold			2022-12-25	WOS:000279884900019
J	Steer, CD; Smith, GD; Emmett, PM; Hibbeln, JR; Golding, J				Steer, Colin D.; Smith, George Davey; Emmett, Pauline M.; Hibbeln, Joseph R.; Golding, Jean			FADS2 Polymorphisms Modify the Effect of Breastfeeding on Child IQ	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; GENETIC-VARIANTS; FISH INTAKE; PREGNANCY; N-3; CLUSTER; MILK; ASSOCIATION; CONSUMPTION; DEPRESSION	Background: Breastfeeding is important for child cognitive development. A study by Caspi et al has suggested that rs174575 within the FADS2 gene moderates this effect so that children homozygous in the minor allele (GG genotype) have similar IQs irrespective of feeding method. Methods and Principal Findings: In our study of 5934 children aged 8 years, no genetic main effect with IQ was found for rs174575. However, an interaction with this polymorphism was observed such that breastfed GG children performed better than their formula fed counterparts by an additional 5.8 points [1.4, 10.1] (interaction p = 0.0091). Interaction results were attenuated by about 10% after adjustment for 7 factors. This study also investigated rs1535, another FADS2 polymorphism in linkage disequilibrium with rs174575, together with performance and verbal IQ, finding similar results although effect sizes were generally reduced. Conclusions and Significance: This study did not replicate the findings of Caspi et al. In contrast to their study, GG children exhibited the greatest difference between feeding methods such that breastfed children performed similarly irrespective of child genotype whereas formula fed GG children performed worse than other children on formula milk. Further studies are required to replicate these findings.	[Steer, Colin D.; Emmett, Pauline M.; Golding, Jean] Univ Bristol, Dept Community Based Med, Ctr Child & Adolescent Hlth, Bristol, Avon, England; [Smith, George Davey] Univ Bristol, MRC, Ctr Causal Analyses Translat Epidemiol, Bristol, Avon, England; [Hibbeln, Joseph R.] NIAAA, NIH, Bethesda, MD USA	University of Bristol; University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Steer, CD (corresponding author), Univ Bristol, Dept Community Based Med, Ctr Child & Adolescent Hlth, Bristol, Avon, England.	Colin.Steer@bristol.ac.uk	Emmett, Pauline/AAL-6815-2021; Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Golding, Jean/0000-0003-2826-3307; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Emmett, Pauline/0000-0003-1076-4779; s, hema/0000-0002-3440-9475	National Oceanic and Atmospheric Administration; Waterloo Foundation; UK Medical Research Council; Wellcome Trust; University of Bristol; MRC [G0600705] Funding Source: UKRI; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000262, ZIAAA000235] Funding Source: NIH RePORTER; Medical Research Council [G0600705, G9815508] Funding Source: researchfish	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Waterloo Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	National Oceanic and Atmospheric Administration and the Waterloo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. The UK Medical Research Council, the Wellcome Trust and the University of Bristol currently provide core support for ALSPAC. This publication is the work of the authors and Colin Steer and Jean Golding will serve as guarantors for the contents of this paper.	[Anonymous], 2005, DIET REF INT EN CARB; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2007, P NATL ACAD SCI USA, V104, P18860, DOI 10.1073/pnas.0704292104; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Der G, 2006, BMJ-BRIT MED J, V333, P945, DOI 10.1136/bmj.38978.699583.55; Donahue SMA, 2009, PROSTAG LEUKOTR ESS, V80, P289, DOI 10.1016/j.plefa.2009.02.007; Dunstan JA, 2007, PEDIATR RES, V62, P689, DOI 10.1203/PDR.0b013e318159a93a; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; Fleith M, 2005, CRIT REV FOOD SCI, V45, P205, DOI 10.1080/10408690590956378; Gale CR, 2008, J CHILD PSYCHOL PSYC, V49, P1061, DOI 10.1111/j.1469-7610.2008.01908.x; GALE CR, 2008, J CHILD PSYCHOL PSYC; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Helland IB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e39; Helland IB, 2008, PEDIATRICS, V122, pE472, DOI 10.1542/peds.2007-2762; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; Hoddinott P, 2008, BMJ-BRIT MED J, V336, P881, DOI 10.1136/bmj.39521.566296.BE; Horta BL, 2007, EVIDENCE LONG TERM E; Innis SM, 2007, J NUTR, V137, P855, DOI 10.1093/jn/137.4.855; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Lauritzen L, 2002, LIPIDS, V37, P237, DOI 10.1007/s11745-002-0886-2; Ministry of Agriculture Fisheries and Food, 1998, FATT AC S; Oken E, 2005, ENVIRON HEALTH PERSP, V113, P1376, DOI 10.1289/ehp.8041; Oken E, 2008, AM J EPIDEMIOL, V167, P1171, DOI 10.1093/aje/kwn034; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Rzehak P, 2009, BRIT J NUTR, V101, P20, DOI 10.1017/S0007114508992564; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Wechsler D., 1992, WECHSLER INTELLIGENC; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156	36	70	71	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11570	10.1371/journal.pone.0011570	http://dx.doi.org/10.1371/journal.pone.0011570			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644632	gold, Green Submitted, Green Published			2022-12-25	WOS:000279822300020
J	Camlin, CS; Hosegood, V; Newell, ML; McGrath, N; Barnighausen, T; Snow, RC				Camlin, Carol S.; Hosegood, Victoria; Newell, Marie-Louise; McGrath, Nuala; Barnighausen, Till; Snow, Rachel C.			Gender, Migration and HIV in Rural KwaZulu-Natal, South Africa	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; RISK; LABOR; MIGRANT; PARTNERSHIPS; MORTALITY; BEHAVIOR; IMPACT	Objectives: Research on migration and HIV has largely focused on male migration, often failing to measure HIV risks associated with migration for women. We aimed to establish whether associations between migration and HIV infection differ for women and men, and identify possible mechanisms by which women's migration contributes to their high infection risk. Design: Data on socio-demographic characteristics, patterns of migration, sexual behavior and HIV infection status were obtained for a population of 11,677 women aged 15-49 and men aged 15-54, resident members of households within a demographic surveillance area participating in HIV surveillance in 2003-04. Methods: Logistic regression was conducted to examine whether sex and migration were independently associated with HIV infection in three additive effects models, using measures of recent migration, household presence and migration frequency. Multiplicative effects models were fitted to explore whether the risk of HIV associated with migration differed for males and females. Further modeling and simulations explored whether composition or behavioral differences accounted for observed associations. Results: Relative to non-migrant males, non-migrant females had higher odds of being HIV-positive (adjusted odds ratio [aOR] = 1.72; 95% confidence interval [1.49-1.99]), but odds were higher for female migrants (aOR = 2.55 [2.07-3.13]). Female migrants also had higher odds of infection relative to female non-migrants (aOR = 1.48 [1.23-1.77]). The association between number of sexual partners over the lifetime and HIV infection was modified by both sex and migrant status: For male non-migrants, each additional partner was associated with 3% higher odds of HIV infection (aOR = 1.03 [1.02-1.05]); for male migrants the association between number of partners and HIV infection was non-significant. Each additional partner increased odds of HIV infection by 22% for female non-migrants (aOR = 1.22 [1.12-1.32]) and 46% for female migrants (aOR = 1.46 [1.25-1.69]). Conclusions: Higher risk sexual behavior in the context of migration increased women's likelihood of HIV infection.	[Camlin, Carol S.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Hosegood, Victoria; McGrath, Nuala] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Hosegood, Victoria; Newell, Marie-Louise; McGrath, Nuala; Barnighausen, Till] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa; [Newell, Marie-Louise] UCL, Ctr Paediat Epidemiol & Biostat, London, England; [Newell, Marie-Louise] UCL, Inst Child Hlth, London, England; [Barnighausen, Till] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Snow, Rachel C.] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; University of London; London School of Hygiene & Tropical Medicine; University of Kwazulu Natal; University of London; University College London; University of London; University College London; Harvard University; Harvard T.H. Chan School of Public Health; University of Michigan System; University of Michigan	Camlin, CS (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.	carol.camlin@ucsf.edu	Bärnighausen, Till/Y-2388-2019; Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; Hosegood, Victoria/0000-0002-2244-2518; McGrath, Nuala/0000-0002-1039-0159	National Institute of Mental Health (NIMH) National Research Service Fellowship [T32-19105-20]; Wellcome Trust [WT082599MA]; Nuala McGrath [WT083495MA]; National Institute of Child Health and Human Development (NICHD) [1R01-HD058482-01]; University of Michigan institutions; Rackham School of Graduate Studies; Center for the Education of Women; Center for Comparative and International Studies; International Institute; Alumni/Alumnae Council; South African Initiatives Office; Global Health Research and Training Initiative; Institute for Research on Women and Gender; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482, R24HD041028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH093205] Funding Source: NIH RePORTER; ESRC [ES/G027153/1] Funding Source: UKRI	National Institute of Mental Health (NIMH) National Research Service Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission); Nuala McGrath; National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Michigan institutions; Rackham School of Graduate Studies; Center for the Education of Women; Center for Comparative and International Studies; International Institute; Alumni/Alumnae Council; South African Initiatives Office; Global Health Research and Training Initiative; Institute for Research on Women and Gender; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Carol Camlin was supported by a National Institute of Mental Health (NIMH) National Research Service Fellowship (T32-19105-20) during the preparation of this manuscript. The Africa Centre for Health and Population Studies, University of KwaZulu-Natal (UKZN) is a Wellcome Trust research centre (Grant GR082384/Z/07/Z). Victoria Hosegood was supported by the Wellcome Trust (WT082599MA), as was Nuala McGrath (WT083495MA). Till Barnighausen was supported by Grant 1R01-HD058482-01 from the National Institute of Child Health and Human Development (NICHD). The following University of Michigan institutions provided funding to Dr. Camlin for this dissertation research: The Rackham School of Graduate Studies, the Center for the Education of Women, the Center for Comparative and International Studies, the International Institute, the Alumni/Alumnae Council, the South African Initiatives Office, the Global Health Research and Training Initiative, and the Institute for Research on Women and Gender. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B.A., 2006, MIGRATION S SO AFRIC, P97; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Boerma JT, 2002, SEX TRANSM INFECT, V78, pI97, DOI 10.1136/sti.78.suppl_1.i97; Brockerhoff M, 1999, INT MIGR REV, V33, P833, DOI 10.2307/2547354; CAMLIN C, 2007, POP ASS AM 2007 ANN; Casale D, 2002, S AFR J ECON, V70, P156, DOI 10.1111/j.1813-6982.2002.tb00042.x; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Collinson M., 2006, AFRICA MOVE AFRICAN, P194; Desmond N, 2005, SOC SCI MED, V60, P1739, DOI 10.1016/j.socscimed.2004.08.027; Dodson B., 2000, BORDERS PERSPECTIVES, P119; Feinstein CH, 2005, EC HIST S AFRICA CON; GARIN B, 1993, ANN SOC BELG MED TR, V73, P143; GARNETT GP, 2002, SEX TRANSM INFECT S, V78, P14; Glynn JR, 2001, AIDS, V15, P2025, DOI 10.1097/00002030-200110190-00016; Gregson S, 2002, SEX TRANSM DIS, V29, P568, DOI 10.1097/00007435-200210000-00002; Halliday TJ, 2007, SOC SCI MED, V64, P1420, DOI 10.1016/j.socscimed.2006.11.007; HILL C, 2005, 25 INT POP C 18 23 J; Hope K R, 2001, Afr J Reprod Health, V5, P73, DOI 10.2307/3583325; Hope K R Sr, 2000, AIDS Anal Afr, V10, P6; Hosegood V, 2004, AIDS, V18, P663, DOI 10.1097/00002030-200403050-00011; Hosegood V, 2007, SOC SCI MED, V65, P1249, DOI 10.1016/j.socscimed.2007.05.002; Hosegood V, 2009, DEMOGR RES, V20, P279, DOI 10.4054/DemRes.2009.20.13; Hosegood Victoria., 2016, AFRICAN HOUSEHOLDS C, P58; Hunter M, 2007, SOC SCI MED, V64, P689, DOI 10.1016/j.socscimed.2006.09.015; Hunter Mark., 2002, AFR STUD-UK, V61, P99, DOI [DOI 10.1080/00020180220140091, 10.1080/00020180220140091]; JOCHELSON K, 1991, INT J HEALTH SERV, V21, P157, DOI 10.2190/11UE-L88J-46HN-HR0K; Kothari U., 2003, J INT DEV, V15, P645, DOI [10.1002/jid.1022, DOI 10.1002/JID.1022, DOI 10.1002/jid.1022]; Krieger N, 2003, INT J EPIDEMIOL, V32, P652, DOI 10.1093/ije/dyg156; Little R.J., 2002, STAT ANAL MISSING DA; Lurie M, 1997, S AFR MED J, V87, P908; Lurie M, 1997, HLTH TRANSITION R S3, V7, P17; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Massey D. S., 1998, WORLDS MOTION UNDERS, DOI DOI 10.1111/j.1468-2435.2010.00678.x; MASSEY DS, 2006, AFRICA MOVE AFRICAN; McGrath N, 2009, SEX TRANSM INFECT, V85, pI49, DOI 10.1136/sti.2008.033324; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; NUNN AJ, 1995, AIDS, V9, P503, DOI 10.1097/00002030-199509050-00013; Pettifor Audrey, 2004, HIV SEXUAL BEHAV YOU; Plummer ML, 2004, SEX TRANSM INFECT, V80, P49, DOI 10.1136/sti.2004.011924; Posel D, 2003, S AFR J ECON, V71, P455; Posel D., 2004, J INTERDISC ECON, V15, P277, DOI [10.1177/02601079x04001500303, DOI 10.1177/02601079X04001500303]; Robins J.M., 2000, STAT MODELS EPIDEMIO, P95, DOI DOI 10.1007/978-1-4612-1284-3_2; SABOR RH, 1979, EC DEV URBAN MIGRATI; SHISANA O, 2005, S AFRICAN NATL HIV P; Shisana O., 2002, N MANDELA HSRC STUDY; Stark Oded., 1991, MIGRATION LABOUR; StataCorp L, 2007, STAT DAT AN STAT SOF; Tanser F, 2000, TROP MED INT HEALTH, V5, P40, DOI 10.1046/j.1365-3156.2000.00513.x; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; TIENDA M, 2006, AFRICA MOVE AFRICAN; Tienda Marta, 2006, AFRICA MOVE AFRICAN; Todaro M., 1976, INTERNAL MIGRATION D; Todd J, 2009, SEX TRANSM INFECT, V85, pI72, DOI 10.1136/sti.2008.033985; UDJO E, 2001, MARITAL PATTERNS FER; *UNAIDS, 2005, FEM AIDS EP 2005 GLO; UNAIDS, 2008, REP GLOB AIDS EP; VANDERBERG S, 2002, MIGRATION CHANGING R; Vissers DCJ, 2008, SEX TRANSM DIS, V35, P714, DOI 10.1097/OLQ.0b013e3181723d93; Welaga P, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-193; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; White RG, 2008, SEX TRANSM INFECT, V84, P528, DOI 10.1136/sti.2008.032011; Yu DA., 2000, STAT METHODS CATEGOR; ZLOTNICK H, 2006, AFRICA MOVE AFRICAN; Zuberi T, 2004, INT MIGR REV, V38, P1462; Zuma K, 2005, EPIDEMIOL INFECT, V133, P421, DOI 10.1017/S0950268804003607	65	75	75	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11539	10.1371/journal.pone.0011539	http://dx.doi.org/10.1371/journal.pone.0011539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	623XV	20634965	Green Published, Green Accepted, gold			2022-12-25	WOS:000279781600018
J	Fadini, GP; Maruyama, S; Ozaki, T; Taguchi, A; Meigs, J; Dimmeler, S; Zeiher, AM; de Kreutzenberg, S; Avogaro, A; Nickenig, G; Schmidt-Lucke, C; Werner, N				Fadini, Gian Paolo; Maruyama, Shoichi; Ozaki, Takenori; Taguchi, Akihiko; Meigs, James; Dimmeler, Stefanie; Zeiher, Andreas M.; de Kreutzenberg, Saula; Avogaro, Angelo; Nickenig, Georg; Schmidt-Lucke, Caroline; Werner, Nikos			Circulating Progenitor Cell Count for Cardiovascular Risk Stratification: A Pooled Analysis	PLOS ONE			English	Article							MULTIPLE BIOMARKERS; NATURAL-HISTORY; PERIPHERAL-BLOOD; EVENTS; PREDICTION; DISEASE; POPULATION; INCREASE; NUMBER; CURVE	Background: Circulating progenitor cells (CPC) contribute to the homeostasis of the vessel wall, and a reduced CPC count predicts cardiovascular morbidity and mortality. We tested the hypothesis that CPC count improves cardiovascular risk stratification and that this is modulated by low-grade inflammation. Methodology/Principal Findings: We pooled data from 4 longitudinal studies, including a total of 1,057 patients having CPC determined and major adverse cardiovascular events (MACE) collected. We recorded cardiovascular risk factors and high-sensitive C-reactive protein (hsCRP) level. Risk estimates were derived from Cox proportional hazard analyses. CPC count and/or hsCRP level were added to a reference model including age, sex, cardiovascular risk factors, prevalent CVD, chronic renal failure (CRF) and medications. The sample was composed of high-risk individuals, as 76.3% had prevalent CVD and 31.6% had CRF. There were 331 (31.3%) incident MACE during an average 1.7 +/- 1.1 year follow-up time. CPC count was independently associated with incident MACE even after correction for hsCRP. According to C-statistics, models including CPC yielded a non-significant improvement in accuracy of MACE prediction. However, the integrated discrimination improvement index (IDI) showed better performance of models including CPC compared to the reference model and models including hsCRP in identifying MACE. CPC count also yielded significant net reclassification improvements (NRI) for CV death, non-fatal AMI and other CV events. The effect of CPC was independent of hsCRP, but there was a significant more-than-additive interaction between low CPC count and raised hsCRP level in predicting incident MACE. Conclusions/Significance: In high risk individuals, a reduced CPC count helps identifying more patients at higher risk of MACE over the short term, especially in combination with a raised hsCRP level.	[Fadini, Gian Paolo; de Kreutzenberg, Saula; Avogaro, Angelo] Univ Padua, Sch Med, Dept Clin & Expt Med, Padua, Italy; [Maruyama, Shoichi; Ozaki, Takenori] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan; [Taguchi, Akihiko] Natl Cardiovasc Ctr, Dept Cerebrovasc Dis, Osaka, Japan; [Meigs, James] Harvard Univ, Sch Med, Boston, MA USA; [Meigs, James] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Dimmeler, Stefanie; Zeiher, Andreas M.] Goethe Univ Frankfurt, Frankfurt, Germany; [Nickenig, Georg; Werner, Nikos] Univ Hosp Bonn, Dept Internal Med 2, Div Cardiol Pneumol & Angiol, Bonn, Germany; [Schmidt-Lucke, Caroline] Charite, Dept Cardiol & Pneumol, D-13353 Berlin, Germany	University of Padua; Nagoya University; National Cerebral & Cardiovascular Center - Japan; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Goethe University Frankfurt; University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Fadini, GP (corresponding author), Univ Padua, Sch Med, Dept Clin & Expt Med, Padua, Italy.	gianpaolofadini@hotmail.com	Avogaro, Angelo/S-3808-2016; Meigs, James/P-3927-2019; Fadini, Gian Paolo/M-4575-2019	Meigs, James/0000-0002-2439-2657; Fadini, Gian Paolo/0000-0002-6510-2097; Dimmeler, Stefanie/0000-0002-1045-2436; AVOGARO, ANGELO/0000-0002-1177-0516				Adams V, 2004, ARTERIOSCL THROM VAS, V24, P684, DOI 10.1161/01.ATV.0000124104.23702.a0; [Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bahlmann FH, 2005, HYPERTENSION, V45, P526, DOI 10.1161/01.HYP.0000159191.98140.89; Blankenberg S, 2006, CIRCULATION, V114, P201, DOI 10.1161/CIRCULATIONAHA.105.590927; Bogunia-Kubik K, 2009, BONE MARROW TRANSPL, V44, P273, DOI 10.1038/bmt.2009.30; Chambless LE, 2006, STAT MED, V25, P3474, DOI 10.1002/sim.2299; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Croce G, 2006, ARTERIOSCL THROM VAS, V26, pE38, DOI 10.1161/01.ATV.0000218504.71680.b5; Dimmeler S, 2004, J MOL MED, V82, P671, DOI 10.1007/s00109-004-0580-x; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI200113152; Fadini GP, 2008, ATHEROSCLEROSIS, V197, P496, DOI 10.1016/j.atherosclerosis.2007.12.039; Fadini GP, 2007, ATHEROSCLEROSIS, V194, P46, DOI 10.1016/j.atherosclerosis.2007.03.046; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fadini GP, 2010, DIABETES CARE, V33, P1097, DOI 10.2337/dc09-1999; Fadini GP, 2009, ATHEROSCLEROSIS, V207, P213, DOI 10.1016/j.atherosclerosis.2009.03.040; FADINI GP, 2009, ATHEROSCLER IN PRESS; FADINI GP, DIABETES CARE; Hackam DG, 2003, JAMA-J AM MED ASSOC, V290, P932, DOI 10.1001/jama.290.7.932; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Kondo T, 2004, ARTERIOSCL THROM VAS, V24, P1442, DOI 10.1161/01.ATV.0000135655.52088.c5; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; MARUYAMA S, 2008, KIDNEY INT; Maruyama S, 2008, KIDNEY INT, V74, P1603, DOI 10.1038/ki.2008.495; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Muller-Ehmsen J, 2008, EUR HEART J, V29, P1560, DOI 10.1093/eurheartj/ehn213; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Prokopi M, 2009, BLOOD, V114, P723, DOI 10.1182/blood-2009-02-205930; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Rosenzweig A, 2005, NEW ENGL J MED, V353, P1055, DOI 10.1056/NEJMe058134; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V103, P506, DOI 10.1093/oxfordjournals.aje.a112252; Sakurai M, 2006, EXP HEMATOL, V34, P905, DOI 10.1016/j.exphem.2006.04.011; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Shah SH, 2009, JAMA-J AM MED ASSOC, V302, P92, DOI 10.1001/jama.2009.949; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Taguchi A, 2004, CIRCULATION, V109, P2972, DOI 10.1161/01.CIR.0000133311.25587.DE; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064; Zou GY, 2008, AM J EPIDEMIOL, V168, P212, DOI 10.1093/aje/kwn104	46	87	90	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11488	10.1371/journal.pone.0011488	http://dx.doi.org/10.1371/journal.pone.0011488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634884	Green Published, Green Submitted, gold			2022-12-25	WOS:000279715300005
J	Dziedzic, R; Kiran, M; Plocinski, P; Ziolkiewicz, M; Brzostek, A; Moomey, M; Vadrevu, IS; Dziadek, J; Madiraju, M; Rajagopalan, M				Dziedzic, Renata; Kiran, Manjot; Plocinski, Przemyslaw; Ziolkiewicz, Malgorzata; Brzostek, Anna; Moomey, Meredith; Vadrevu, Indumati S.; Dziadek, Jaroslaw; Madiraju, Murty; Rajagopalan, Malini			Mycobacterium tuberculosis ClpX Interacts with FtsZ and Interferes with FtsZ Assembly	PLOS ONE			English	Article							DIVISION PROTEIN FTSZ; ESCHERICHIA-COLI FTSZ; CELL-DIVISION; BACILLUS-SUBTILIS; DYNAMICS; EXPRESSION; POLYMERIZATION; CYTOKINESIS; CAULOBACTER; DEGRADATION	FtsZ assembly at the midcell division site in the form of a Z-ring is crucial for initiation of the cell division process in eubacteria. It is largely unknown how this process is regulated in the human pathogen Mycobacterium tuberculosis. Here we show that the expression of clpX was upregulated upon macrophage infection and exposure to cephalexin antibiotic, the conditions where FtsZ-ring assembly is delayed. Independently, we show using pull-down, solid-phase binding, bacterial two-hybrid and mycobacterial protein fragment complementation assays, that M. tuberculosis FtsZ interacts with ClpX, the substrate recognition domain of the ClpXP protease. Incubation of FtsZ with ClpX increased the critical concentration of GTP-dependent polymerization of FtsZ. Immunoblotting revealed that the intracellular ratio of ClpX to FtsZ in wild type M. tuberculosis is approximately 1:2. Overproduction of ClpX increased cell length and modulated the localization of FtsZ at midcell sites; however, intracellular FtsZ levels were unaffected. A ClpX-CFP fusion protein localized to the cell poles and midcell sites and colocalized with the FtsZ-YFP protein. ClpX also interacted with FtsZ mutant proteins defective for binding to and hydrolyzing GTP and possibly for interactions with other proteins. Taken together, our results suggest that M. tuberculosis ClpX interacts stoichiometrically with FtsZ protomers, independent of its nucleotide-bound state and negatively regulates FtsZ activities, hence cell division.	[Dziedzic, Renata; Kiran, Manjot; Plocinski, Przemyslaw; Moomey, Meredith; Vadrevu, Indumati S.; Madiraju, Murty; Rajagopalan, Malini] Univ Texas Hlth Sci Ctr, Tyler, TX USA; [Ziolkiewicz, Malgorzata; Brzostek, Anna; Dziadek, Jaroslaw] Polish Acad Sci, Inst Med Biol, Lodz, Poland	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences	Dziedzic, R (corresponding author), Univ Texas Hlth Sci Ctr, Tyler, TX USA.	malini.rajagopalan@uthct.edu	Płociński, Przemysław A/S-5587-2017	Płociński, Przemysław A/0000-0002-6623-3494; Dziadek, Jaroslaw/0000-0003-1427-884X	NIH [RO1AI48417, RO1AI73966, AI084734]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI073966, R01AI084734, R01AI048417] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by NIH grants RO1AI48417 (MR) and RO1AI73966, AI084734 (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; CAMBERG JL, 2009, P NATL ACAD SCI US; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Chauhan A, 2006, MOL MICROBIOL, V62, P132, DOI 10.1111/j.1365-2958.2006.05333.x; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chien P, 2007, P NATL ACAD SCI USA, V104, P6590, DOI 10.1073/pnas.0701776104; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Corbin BD, 2007, J BACTERIOL, V189, P3026, DOI 10.1128/JB.01581-06; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; Datta P, 2002, J BIOL CHEM, V277, P24983, DOI 10.1074/jbc.M203847200; Datta P, 2006, MOL MICROBIOL, V62, P1655, DOI 10.1111/j.1365-2958.2006.05491.x; Del Sol R, 2006, J BACTERIOL, V188, P1540, DOI 10.1128/JB.188.4.1540-1550.2006; Dziadek J, 2002, MICROBIOL-SGM, V148, P961, DOI 10.1099/00221287-148-4-961; Dziadek J, 2003, MICROBIOL-SGM, V149, P1593, DOI 10.1099/mic.0.26023-0; Engels S, 2004, MOL MICROBIOL, V52, P285, DOI 10.1111/j.1365-2958.2003.03979.x; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Farrell CM, 2005, MOL MICROBIOL, V57, P1750, DOI 10.1111/j.1365-2958.2005.04798.x; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Fol M, 2006, MOL MICROBIOL, V60, P643, DOI 10.1111/j.1365-2958.2006.05137.x; Frees D, 2007, MOL MICROBIOL, V63, P1285, DOI 10.1111/j.1365-2958.2007.05598.x; Galletto R, 2007, CURR BIOL, V17, pR395, DOI 10.1016/j.cub.2007.03.009; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gerth U, 2004, J BACTERIOL, V186, P179, DOI 10.1128/JB.186.1.179-191.2004; Goley ED, 2007, J CELL SCI, V120, P3501, DOI 10.1242/jcs.005967; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Haeusser DP, 2009, J BACTERIOL, V191, P1986, DOI 10.1128/JB.01606-07; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hett EC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000001; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Kelly AJ, 1998, GENE DEV, V12, P880, DOI 10.1101/gad.12.6.880; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Margolin W, 2000, FEMS MICROBIOL REV, V24, P531, DOI 10.1016/S0168-6445(00)00038-3; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Nair N, 2009, MOL MICROBIOL, V71, P291, DOI 10.1111/j.1365-2958.2008.06523.x; Rajagopalan M, 2005, BIOCHEM BIOPH RES CO, V331, P1171, DOI 10.1016/j.bbrc.2005.03.239; Rajagopalan M, 2005, FEMS MICROBIOL LETT, V250, P9, DOI 10.1016/j.femsle.2005.06.043; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Sugimoto S, 2010, J BIOL CHEM, V285, P6648, DOI 10.1074/jbc.M109.080739; Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590; Viala J, 2002, MOL MICROBIOL, V44, P633, DOI 10.1046/j.1365-2958.2002.02907.x; Weart RB, 2005, MOL MICROBIOL, V57, P238, DOI 10.1111/j.1365-2958.2005.04673.x; White EL, 2000, J BACTERIOL, V182, P4028, DOI 10.1128/JB.182.14.4028-4034.2000	52	52	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11058	10.1371/journal.pone.0011058	http://dx.doi.org/10.1371/journal.pone.0011058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625433	Green Published, gold, Green Submitted			2022-12-25	WOS:000279522500002
J	Thaunat, O; Graff-Dubois, S; Brouard, S; Gautreau, C; Varthaman, A; Fabien, N; Field, AC; Louedec, L; Dai, JP; Joly, E; Morelon, E; Soulillou, JP; Michel, JB; Nicoletti, A				Thaunat, Olivier; Graff-Dubois, Stephanie; Brouard, Sophie; Gautreau, Chantal; Varthaman, Aditi; Fabien, Nicole; Field, Anne-Christine; Louedec, Liliane; Dai, Jianping; Joly, Etienne; Morelon, Emmanuel; Soulillou, Jean-Paul; Michel, Jean-Baptiste; Nicoletti, Antonino			Immune Responses Elicited in Tertiary Lymphoid Tissues Display Distinctive Features	PLOS ONE			English	Article							T-CELL; CHRONIC REJECTION; MEDIATED REJECTION; NEOGENESIS; ALLOGRAFT; ALLOANTIBODY; TOLERANCE; SURVIVAL; GRAFTS; RATS	During chronic inflammation, immune effectors progressively organize themselves into a functional tertiary lymphoid tissue (TLT) within the targeted organ. TLT has been observed in a wide range of chronic inflammatory conditions but its pathophysiological significance remains unknown. We used the rat aortic interposition model in which a TLT has been evidenced in the adventitia of chronically rejected allografts one month after transplantation. The immune responses elicited in adventitial TLT and those taking place in spleen and draining lymph nodes (LN) were compared in terms of antibody production, T cell activation and repertoire perturbations. The anti-MHC humoral response was more intense and more diverse in TLT. This difference was associated with an increased percentage of activated CD4+ T cells and a symmetric reduction of regulatory T cell subsets. Moreover, TCR repertoire perturbations in TLT were not only increased and different from the common pattern observed in spleen and LN but also "stochastic,'' since each recipient displayed a specific pattern. We propose that the abnormal activation of CD4+ T cells promotes the development of an exaggerated pathogenic immune humoral response in TLT. Preliminary findings suggest that this phenomenon i) is due to a defective immune regulation in this non-professional inflammatory-induced lymphoid tissue, and ii) also occurs in human chronically rejected grafts.	[Thaunat, Olivier; Fabien, Nicole; Morelon, Emmanuel] Univ Lyon 1, F-69622 Villeurbanne, France; [Thaunat, Olivier; Fabien, Nicole; Morelon, Emmanuel] INSERM, U851, F-69008 Lyon, France; [Thaunat, Olivier; Morelon, Emmanuel] Hop Edouard Herriot, Serv Transplantat Renale & Immunol Clin, Lyon, France; [Graff-Dubois, Stephanie; Varthaman, Aditi; Louedec, Liliane; Dai, Jianping; Michel, Jean-Baptiste; Nicoletti, Antonino] Hop Xavier Bichat, INSERM, U698, Paris, France; [Brouard, Sophie; Soulillou, Jean-Paul] Hop Hotel Dieu, Inst Transplantat & Rech Transplantat, Unite Mixte Rech Sante 643, Nantes, France; [Gautreau, Chantal] Hop St Louis, Lab Reg Histocompatibil IR7, AP HP, Paris, France; [Fabien, Nicole] Ctr Hosp Lyon Sud, Immunol Lab, Hosp Civils Lyon, F-69310 Pierre Benite, France; [Field, Anne-Christine] UCL, Inst Child Hlth, Mol Immunol Unit, London, England; [Joly, Etienne] Inst Pharmacol & Biol Struct, Unite Mixte Rech 5089, Toulouse, France; [Nicoletti, Antonino] Univ Paris 07, Paris, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; University of London; University College London; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Thaunat, O (corresponding author), Univ Lyon 1, F-69622 Villeurbanne, France.	olivier.thaunatpastu@free.fr	Nicoletti, Antonino/A-9460-2015; brouard, sophie c/Q-1285-2016; Joly, Etienne/A-5644-2009; Michel, Jean-Baptiste/AAH-9336-2020; Graff-Dubois, Stephanie/GQA-4845-2022; Thaunat, Olivier/M-2423-2014	Nicoletti, Antonino/0000-0002-2623-0897; Joly, Etienne/0000-0002-7264-2681; Graff-Dubois, Stephanie/0000-0001-7273-3930; Thaunat, Olivier/0000-0002-3648-8963; Field, Anne-Christine/0000-0002-4894-1964; Varthaman, Aditi/0000-0002-8703-5534	Fondation pour la Recherche Medicale; Societe de Nephrologie; Hospices Civils de Lyon; CENTAURE Transplantation Research Network	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Societe de Nephrologie; Hospices Civils de Lyon; CENTAURE Transplantation Research Network	OT is supported by the Fondation pour la Recherche Medicale, the Societe de Nephrologie, the Hospices Civils de Lyon, and the CENTAURE Transplantation Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUCHINCLOSS H, 1988, TRANSPLANTATION, V45, P1118, DOI 10.1097/00007890-198806000-00024; Baddoura FK, 2005, AM J TRANSPLANT, V5, P510, DOI 10.1111/j.1600-6143.2004.00714.x; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Brouard S, 1999, J IMMUNOL, V162, P3367; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Deteix C, 2010, J IMMUNOL, V184, P5344, DOI 10.4049/jimmunol.0902999; Douillard P, 1996, J IMMUNOL, V157, P1250; GONZALEZ AL, 1995, TRANSPLANT P, V27, P1516; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Guillet M, 2002, J IMMUNOL, V168, P5088, DOI 10.4049/jimmunol.168.10.5088; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; Miqueu P, 2007, MOL IMMUNOL, V44, P1057, DOI 10.1016/j.molimm.2006.06.026; MORTON AL, 1993, EUR J IMMUNOL, V23, P2078, DOI 10.1002/eji.1830230906; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; PANNETIER C, 1995, IMMUNOL TODAY, V16, P176, DOI 10.1016/0167-5699(95)80117-0; Pettigrew GJ, 1998, J IMMUNOL, V161, P1292; PLISSONNIER D, 1995, TRANSPLANTATION, V60, P414, DOI 10.1097/00007890-199509000-00003; PLISSONNIER D, 1991, ARTERIOSCLER THROMB, V11, P1690, DOI 10.1161/01.ATV.11.6.1690; PRINEAS JW, 1979, SCIENCE, V203, P1123, DOI 10.1126/science.424741; ROSENBERG HF, 2003, FUNDAMENTAL IMMUNOLO; RUGGIERO R, 1994, J THORAC CARDIOV SUR, V108, P253; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; Stuber E, 1996, J EXP MED, V183, P979, DOI 10.1084/jem.183.3.979; Thaunat O, 2005, P NATL ACAD SCI USA, V102, P14723, DOI 10.1073/pnas.0507223102; Thaunat O, 2008, TRANSPLANTATION, V85, P1648, DOI 10.1097/TP.0b013e3181735723; Thaunat O, 2008, CURR OPIN ORGAN TRAN, V13, P16, DOI 10.1097/MOT.0b013e3282f3df15; Thaunat O, 2006, TRENDS IMMUNOL, V27, P441, DOI 10.1016/j.it.2006.08.003; Thaunat O, 2006, CURR OPIN IMMUNOL, V18, P576, DOI 10.1016/j.coi.2006.07.006; Wildbaum G, 2002, J CLIN INVEST, V110, P701, DOI 10.1172/JCI200215176	30	36	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11398	10.1371/journal.pone.0011398	http://dx.doi.org/10.1371/journal.pone.0011398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613979	Green Published, Green Submitted, gold			2022-12-25	WOS:000279370000024
J	Gimm, T; Wiese, M; Teschemacher, B; Deggerich, A; Schodel, J; Knaup, KX; Hackenbeck, T; Hellerbrand, C; Amann, K; Wiesener, MS; Honing, S; Eckardt, KU; Warnecke, C				Gimm, Tina; Wiese, Melanie; Teschemacher, Barbara; Deggerich, Anke; Schoedel, Johannes; Knaup, Karl X.; Hackenbeck, Thomas; Hellerbrand, Claus; Amann, Kerstin; Wiesener, Michael S.; Hoening, Stefan; Eckardt, Kai-Uwe; Warnecke, Christina			Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1	FASEB JOURNAL			English	Article						renal clear-cell carcinoma; gene expression; promoter; lipid metabolism	RENAL-CELL CARCINOMA; DIFFERENTIATION-RELATED PROTEIN; FACTOR (HIF)-1-ALPHA; TRANSCRIPTION FACTORS; INSULIN-RESISTANCE; RNA INTERFERENCE; LIVER-CELLS; DNA-BINDING; FOAM CELLS; EXPRESSION	Hypoxia-inducible protein 2 (HIG2) has been implicated in canonical Wnt signaling, both as target and activator. The potential link between hypoxia and an oncogenic signaling pathway might play a pivotal role in renal clear-cell carcinoma characterized by constitutive activation of hypoxia-inducible factors (HIFs), and hence prompted us to analyze HIG2 regulation and function in detail. HIG2 was up-regulated by hypoxia and HIF inducers in all cell types and mouse organs investigated and abundantly expressed in renal clear-cell carcinomas. Promoter analyses, gel shifts, and siRNA studies revealed that HIG2 is a direct and specific target of HIF-1, but not responsive to HIF-2. Surprisingly, HIG2 was not secreted, and HIG2 overexpression neither stimulated proliferation nor activated Wnt signaling. Instead, we show that HIG2 decorates the hemimembrane of lipid droplets, whose number and size increase on hypoxic inhibition of fatty acid beta-oxidation, and colocalizes with the lipid droplet proteins adipophilin and TIP47. Normoxic overexpression of HIG2 was sufficient to increase neutral lipid deposition in HeLa cells and stimulated cytokine expression. HIG2 could be detected in atherosclerotic arteries and fatty liver disease, suggesting that this ubiquitously inducible HIF-1 target gene may play an important functional role in diseases associated with pathological lipid accumulation.-Gimm, T., Wiese, M., Teschemacher, B., Deggerich, A., Schodel, J., Knaup, K. X., Hackenbeck, T., Hellerbrand, C., Amann, K., Wiesener, M. S., Honing, S., Eckardt, K.-U., Warnecke, C. Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1. FASEB J. 24, 4443-4458 (2010). www.fasebj.org	[Warnecke, Christina] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Renal Res Labs, D-91054 Erlangen, Germany; [Knaup, Karl X.; Hackenbeck, Thomas; Wiesener, Michael S.] Univ Erlangen Nurnberg, Interdisciplinary Ctr Clin Res IZKF, D-91054 Erlangen, Germany; [Deggerich, Anke; Hoening, Stefan] Univ Cologne, Inst Biochem 1, Cologne, Germany; [Deggerich, Anke; Hoening, Stefan] Univ Cologne, Ctr Mol Med, Cologne, Germany; [Schoedel, Johannes] Univ Oxford, Oxford, England; [Hellerbrand, Claus] Univ Hosp Regensburg, Dept Internal Med 1, Regensburg, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Cologne; University of Cologne; University of Oxford; University of Regensburg	Warnecke, C (corresponding author), Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Renal Res Labs, Loschgestr 8, D-91054 Erlangen, Germany.	christina.warnecke@uk-erlangen.de		Knaup, Karl/0000-0003-1803-4463; Schodel, Johannes/0000-0002-3587-8839	Wilhelm Sander-Foundation; Roche Foundation for Anemia Research	Wilhelm Sander-Foundation; Roche Foundation for Anemia Research	This study was supported by grants of the Wilhelm Sander-Foundation and the Roche Foundation for Anemia Research to C.W. The authors thank H. Sticht (Department of Biochemistry, University of Erlangen-Nuremberg) for protein structure analysis. The authors thank M. Reutelshofer and A. Ludke for excellent technical assistance.	Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Belanger AJ, 2007, BIOCHEM BIOPH RES CO, V364, P567, DOI 10.1016/j.bbrc.2007.10.062; Belanger AJ, 2002, J MOL CELL CARDIOL, V34, P765, DOI 10.1006/jmcc.2002.2021; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bostrom P, 2006, ARTERIOSCL THROM VAS, V26, P1871, DOI 10.1161/01.ATV.0000229665.78997.0b; Bostrom P, 2009, BIOCHEM SOC T, V37, P981, DOI 10.1042/BST0370981; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Byrne CD, 2010, CLIN SCI, V118, P397, DOI 10.1042/CS20090565; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Denko N, 2000, CLIN CANCER RES, V6, P480; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Fan B, 2009, AM J PHYSIOL-ENDOC M, V297, pE112, DOI 10.1152/ajpendo.00119.2009; GORDON GB, 1977, AM J PATHOL, V88, P663; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hagist S, 2009, HEPATOLOGY, V49, P378, DOI 10.1002/hep.22677; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hull F E, 1975, Recent Adv Stud Cardiac Struct Metab, V7, P13; Imamura T, 2009, INT J CANCER, V124, P763, DOI 10.1002/ijc.24032; Jiang GJ, 2007, EUR J PHARMACOL, V562, P183, DOI 10.1016/j.ejphar.2007.01.066; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kenny PA, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-3; Krishnan J, 2009, CELL METAB, V9, P512, DOI 10.1016/j.cmet.2009.05.005; Lei L, 2008, MOL CELL BIOL, V28, P3790, DOI 10.1128/MCB.01580-07; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Maxwell P, 2003, J AM SOC NEPHROL, V14, P2712, DOI 10.1097/01.ASN.0000092792.97122.E0; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Rosenberger C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017223.49823.2A; Saarikoski ST, 2002, FEBS LETT, V530, P186, DOI 10.1016/S0014-5793(02)03475-0; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Sluimer JC, 2009, J PATHOL, V218, P7, DOI 10.1002/path.2518; Sowter HM, 2003, CANCER RES, V63, P6130; Togashi A, 2005, CANCER RES, V65, P4817, DOI 10.1158/0008-5472.CAN-05-0120; Varela GM, 2008, AM J PHYSIOL-GASTR L, V295, pG621, DOI 10.1152/ajpgi.90204.2008; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Warnecke C, 2003, FASEB J, V17, P1186, DOI 10.1096/fj.02-1062fje; Warnecke C, 2008, EXP CELL RES, V314, P2016, DOI 10.1016/j.yexcr.2008.03.003; Weidemann A, 2008, BIOCHEM J, V409, P233, DOI 10.1042/BJ20070629; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; WHITMER JT, 1978, J BIOL CHEM, V253, P4305; Wiesener MS, 2001, CANCER RES, V61, P5215; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Yao M, 2005, J PATHOL, V205, P377, DOI 10.1002/path.1693; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013	52	101	108	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4443	4458		10.1096/fj.10-159806	http://dx.doi.org/10.1096/fj.10-159806			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20624928				2022-12-25	WOS:000283861100030
J	Carvallo, L; Munoz, R; Bustos, F; Escobedo, N; Carrasco, H; Olivares, G; Larrain, J				Carvallo, Loreto; Munoz, Rosana; Bustos, Francisco; Escobedo, Noelia; Carrasco, Hector; Olivares, Gonzalo; Larrain, Juan			Non-canonical Wnt Signaling Induces Ubiquitination and Degradation of Syndecan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR CELL POLARITY; TYROSINE KINASE ROR2; GASTRULATION MOVEMENTS; MIGRATION; XENOPUS; ENDOCYTOSIS; RECEPTOR; ADHESION; INTEGRIN; PATHWAY	Dynamic regulation of cell adhesion receptors is required for proper cell migration in embryogenesis, tissue repair, and cancer. Integrins and Syndecan4 (SDC4) are the main cell adhesion receptors involved in focal adhesion formation and are required for cell migration. SDC4 interacts biochemically and functionally with components of the Wnt pathway such as Frizzled7 and Dishevelled. Non-canonical Wnt signaling, particularly components of the planar cell polarity branch, controls cell adhesion and migration in embryogenesis and metastasic events. Here, we evaluate the effect of this pathway on SDC4. We have found that Wnt5a reduces cell surface levels and promotes ubiquitination and degradation of SDC4 in cell lines and dorsal mesodermal cells from Xenopus gastrulae. Gain-and loss-of-function experiments demonstrate that Dsh plays a key role in regulating SDC4 steady-state levels. Moreover, a SDC4 deletion construct that interacts inefficiently with Dsh is resistant to Wnt5a-induced degradation. Non-canonical Wnt signaling promotes monoubiquitination of the variable region of SDC4 cytoplasmic domain. Mutation of these specific residues abrogates ubiquitination and results in increased SDC4 steady-state levels. This is the first example of a cell surface protein ubiquitinated and degraded in a Wnt/Dsh-dependent manner.	[Carvallo, Loreto; Munoz, Rosana; Bustos, Francisco; Escobedo, Noelia; Carrasco, Hector; Olivares, Gonzalo; Larrain, Juan] Pontificia Univ Catolica Chile, Ctr Aging & Regenerat, Fac Biol Sci, Santiago, Chile	Pontificia Universidad Catolica de Chile	Larrain, J (corresponding author), Pontificia Univ Catolica Chile, Ctr Aging & Regenerat, Fac Biol Sci, Alameda 340, Santiago, Chile.	jlarrain@bio.puc.cl	Carvallo, Loreto/C-2237-2019	Carvallo, Loreto/0000-0001-9943-1342; Olivares, Gonzalo/0000-0002-2784-0160; BUSTOS, FRANCISCO/0000-0001-5457-4956; Munoz Videla, Rosana/0000-0003-1957-4103				Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; Chen G, 2008, AM J PHYSIOL-RENAL, V295, pF1528, DOI 10.1152/ajprenal.90482.2008; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Davidson LA, 2006, CURR BIOL, V16, P833, DOI 10.1016/j.cub.2006.03.038; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hammerschmidt M, 2008, DEVELOPMENT, V135, P3625, DOI 10.1242/dev.015701; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Iioka H, 2007, NAT CELL BIOL, V9, P813, DOI 10.1038/ncb1607; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marsden M, 2001, DEVELOPMENT, V128, P3635; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Multhaupt HAB, 2009, J PHYSIOL PHARMACOL, V60, P31; Munoz R, 2006, NAT CELL BIOL, V8, P492, DOI 10.1038/ncb1399; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; O'Connell MP, 2009, J BIOL CHEM, V284, P28704, DOI 10.1074/jbc.M109.028498; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Tada M, 2000, DEVELOPMENT, V127, P2227; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Ulrich F, 2009, TRAFFIC, V10, P811, DOI 10.1111/j.1600-0854.2009.00929.x; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Weeraratna AT, 2005, CANCER METAST REV, V24, P237, DOI 10.1007/s10555-005-1574-z; Winklbauer R, 2001, NATURE, V413, P856, DOI 10.1038/35101621; Woods A, 2001, CURR OPIN CELL BIOL, V13, P578, DOI 10.1016/S0955-0674(00)00254-4; Yang LL, 2008, J BIOL CHEM, V283, P21703, DOI 10.1074/jbc.M800809200; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011	45	37	39	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29546	29555		10.1074/jbc.M110.155812	http://dx.doi.org/10.1074/jbc.M110.155812			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20639201	Green Published, hybrid			2022-12-25	WOS:000281740100056
J	Lontay, B; Bodoor, K; Weitzel, DH; Loiselle, D; Fortner, C; Lengyel, S; Zheng, DH; Devente, J; Hickner, R; Haystead, TAJ				Lontay, Beata; Bodoor, Khaldon; Weitzel, Douglas H.; Loiselle, David; Fortner, Christopher; Lengyel, Szabolcs; Zheng, Donghai; Devente, James; Hickner, Robert; Haystead, Timothy A. J.			Smoothelin-like 1 Protein Regulates Myosin Phosphatase-targeting Subunit 1 Expression during Sexual Development and Pregnancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE FIBERS; GENE-EXPRESSION; PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; PLASTICITY; PHOSPHORYLATION; ISOFORM; DIFFERENTIATION; SENSITIVITY; ACTIVATION	Pregnancy coordinately alters the contractile properties of both vascular and uterine smooth muscles reducing systemic blood pressure and maintaining uterine relaxation. The precise molecular mechanisms underlying these pregnancy-induced adaptations have yet to be fully defined but are likely to involve changes in the expression of proteins regulating myosin phosphorylation. Here we show that smoothelin like protein 1 (SMTNL1) is a key factor governing sexual development and pregnancy induced adaptations in smooth and striated muscle. A primary target gene of SMTNL1 in these muscles is myosin phosphatase-targeting subunit 1 (MYPT1). Deletion of SMTNL1 increases expression of MYPT1 30-40-fold in neonates and during development expression of both SMTNL1 and MYPT1 increases over 20-fold. Pregnancy also regulates SMTNL1 and MYPT1 expression, and deletion SMTNL1 greatly exaggerates expression of MYPT1 in vascular smooth muscle, producing a profound reduction in force development in response to phenylephrine as well as sensitizing the muscle to acetylcholine. We also show that MYPT1 is expressed in Type2a muscle fibers in mice and humans and its expression is regulated during pregnancy, suggesting unrecognized roles in mediating skeletal muscle plasticity in both species. Our findings define a new conserved pathway in which sexual development and pregnancy mediate smooth and striated muscle adaptations through SMTNL1 and MYPT1.	[Lontay, Beata; Bodoor, Khaldon; Weitzel, Douglas H.; Loiselle, David; Fortner, Christopher; Haystead, Timothy A. J.] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA; [Lontay, Beata] Univ Debrecen, Dept Med Chem, H-4032 Debrecen, Hungary; [Lengyel, Szabolcs] Univ Debrecen, Dept Ecol, H-4032 Debrecen, Hungary; [Zheng, Donghai; Devente, James; Hickner, Robert] E Carolina Univ, Greenville, NC 27858 USA	Duke University; University of Debrecen; University of Debrecen; University of North Carolina; East Carolina University	Haystead, TAJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol, Res Dr,LSRC,C119,Box 3, Durham, NC 27710 USA.	hayst001@mc.duke.edu	Lengyel, Szabolcs/A-3483-2011	Lengyel, Szabolcs/0000-0002-7049-0100; hickner, Robert/0000-0002-2683-1617	National Institutes of Health [R01DK065954-05]; Hungarian Academy of Science; King Hussein Institute for Biotechnology and Cancer, Amman, Jordan; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian Academy of Science(Hungarian Academy of Sciences); King Hussein Institute for Biotechnology and Cancer, Amman, Jordan; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK065954-05 (to T. A. J. H.) and a Bolyai Fellowship (Hungarian Academy of Science) (to B. L.).; Supported by a postdoctoral fellowship from the King Hussein Institute for Biotechnology and Cancer, Amman, Jordan.	Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC1311, DOI 10.1152/ajpcell.00248.2004; ARONICA SM, 1993, MOL ENDOCRINOL, V7, P743, DOI 10.1210/me.7.6.743; Borman MA, 2004, FEBS LETT, V573, P207, DOI 10.1016/j.febslet.2004.08.002; Borman MA, 2009, MOL CELL BIOCHEM, V327, P93, DOI 10.1007/s11010-009-0047-z; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; CHAMPLIN AK, 1973, BIOL REPROD, V8, P491, DOI 10.1093/biolreprod/8.4.491; Coleman KM, 2003, J BIOL CHEM, V278, P12834, DOI 10.1074/jbc.M212312200; D'Antona G, 2006, J PHYSIOL-LONDON, V570, P611, DOI 10.1113/jphysiol.2005.101642; Dirksen WP, 2000, AM J PHYSIOL-CELL PH, V278, pC589, DOI 10.1152/ajpcell.2000.278.3.C589; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Fluck M, 2005, J APPL PHYSIOL, V99, P397, DOI 10.1152/japplphysiol.00050.2005; Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7; Gonzalez B, 2002, PFLUG ARCH EUR J PHY, V443, P377, DOI 10.1007/s004240100702; Gruneberg H, 1941, P NATL ACAD SCI USA, V27, P562, DOI 10.1073/pnas.27.12.562; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Harridge SDR, 2007, EXP PHYSIOL, V92, P783, DOI 10.1113/expphysiol.2006.036525; Hoppeler H, 2007, ADV EXP MED BIOL, V618, P245; Ishida H, 2008, J BIOL CHEM, V283, P20569, DOI 10.1074/jbc.M800627200; Lontay B, 2005, CELL SIGNAL, V17, P1265, DOI 10.1016/j.cellsig.2005.01.008; Lu Y, 2008, AM J PHYSIOL-CELL PH, V294, pC564, DOI 10.1152/ajpcell.00285.2007; Machida H, 2001, BBA-GENE STRUCT EXPR, V1517, P424, DOI 10.1016/S0167-4781(00)00285-2; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; MCDONNELL DP, 1994, J STEROID BIOCHEM, V48, P425, DOI 10.1016/0960-0760(94)90190-2; Minorics R, 2009, REPRODUCTION, V138, P383, DOI 10.1530/REP-09-0116; Moorhead G, 1998, FEBS LETT, V438, P141, DOI 10.1016/S0014-5793(98)01276-9; Okamoto R, 2006, CELL SIGNAL, V18, P1408, DOI 10.1016/j.cellsig.2005.11.001; Owens Gary K, 2007, Novartis Found Symp, V283, P174; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Reggiani C, 2004, J MUSCLE RES CELL M, V25, P231, DOI 10.1023/B:JURE.0000038363.78378.1d; Rowan BG, 2000, MOL CELL BIOL, V20, P8720, DOI 10.1128/MCB.20.23.8720-8730.2000; Scotto-Lavino E, 2010, J BIOL CHEM, V285, P6419, DOI 10.1074/jbc.M109.074773; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Somlyo AV, 2007, CIRC RES, V101, P645, DOI 10.1161/CIRCRESAHA.107.161893; Thornburg KL, 2000, SEMIN PERINATOL, V24, P11, DOI 10.1016/S0146-0005(00)80047-6; Twomey E, 2010, EXP CELL RES, V316, P68, DOI 10.1016/j.yexcr.2009.09.001; Veerareddy S, 2002, AM J PHYSIOL-HEART C, V283, pH2226, DOI 10.1152/ajpheart.00593.2002; WEIGEL NL, 1995, J STEROID BIOCHEM, V53, P509, DOI 10.1016/0960-0760(95)00098-K; Wooldridge AA, 2008, J BIOL CHEM, V283, P11850, DOI 10.1074/jbc.M708628200; Wu X, 2008, J CELL MOL MED, V12, P1360, DOI 10.1111/j.1582-4934.2008.00306.x; Wu Y, 2003, J MUSCLE RES CELL M, V24, P499, DOI 10.1023/B:JURE.0000009810.36038.53; Xiao DL, 2006, AM J PHYSIOL-HEART C, V291, pH413, DOI 10.1152/ajpheart.00103.2006; Xiao DL, 2006, AM J PHYSIOL-HEART C, V290, pH2337, DOI 10.1152/ajpheart.01238.2005	43	28	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29357	29366		10.1074/jbc.M110.143966	http://dx.doi.org/10.1074/jbc.M110.143966			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20634291	hybrid, Green Published			2022-12-25	WOS:000281740100038
J	Sepramaniam, S; Armugam, A; Lim, KY; Karolina, DS; Swaminathan, P; Tan, JR; Jeyaseelan, K				Sepramaniam, Sugunavathi; Armugam, Arunmozhiarasi; Lim, Kai Ying; Karolina, Dwi Setyowati; Swaminathan, Priyadharshni; Tan, Jun Rong; Jeyaseelan, Kandiah			MicroRNA 320a Functions as a Novel Endogenous Modulator of Aquaporins 1 and 4 as Well as a Potential Therapeutic Target in Cerebral Ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIENT FOCAL ISCHEMIA; BRAIN EDEMA; MESSENGER-RNAS; EXPRESSION; GENES; ASTROCYTES; APOPTOSIS; MIGRATION; MIRNAS; GROWTH	Aquaporins facilitate efficient diffusion of water across cellular membranes, and water homeostasis is critically important in conditions such as cerebral edema. Changes in aquaporin 1 and 4 expression in the brain are associated with cerebral edema, and the lack of water channel modulators is often highlighted. Here we present evidence of an endogenous modulator of aquaporin 1 and 4. We identify miR-320a as a potential modulator of aquaporin 1 and 4 and explore the possibility of using miR-320a to alter the expression of aquaporin 1 and 4 in normal and ischemic conditions. We show that precursor miR-320a can function as an inhibitor, whereas anti-miR-320a can act as an activator of aquaporin 1 and 4 expressions. We have also shown that anti-miR-320a could bring about a reduction of infarct volume in cerebral ischemia with a concomitant increase in aquaporins 1 and 4 mRNA and protein expression.	[Sepramaniam, Sugunavathi; Armugam, Arunmozhiarasi; Lim, Kai Ying; Karolina, Dwi Setyowati; Swaminathan, Priyadharshni; Tan, Jun Rong; Jeyaseelan, Kandiah] Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Singapore 117597, Singapore	National University of Singapore	Jeyaseelan, K (corresponding author), Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, 8 Med Dr, Singapore 117597, Singapore.	bchjeya@nus.edu.sg		Armugam, Arunmozhiarasi/0000-0002-6064-1980	National Research Foundation [R-184-002-165-281]; Medical Research Council [EDG: R-183-000-230-275]; National Kidney Foundation [NKFRC/2008/10]	National Research Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Kidney Foundation	This work was supported by National Research Foundation Grant R-184-002-165-281, National Medical Research Council Grant EDG: R-183-000-230-275, and National Kidney Foundation Grant NKFRC/2008/10.	Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; Aoki K, 2003, ACTA NEUROPATHOL, V106, P121, DOI 10.1007/s00401-003-0709-y; Armugam A, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-120; Bertorelli R, 1998, NEUROSCI LETT, V246, P41, DOI 10.1016/S0304-3940(98)00221-3; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; CARBREY JM, 2009, HDB EXP PHARM, V190, P3, DOI DOI 10.1007/978-3-540-79885-9_; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chiromatzo AO, 2007, GENET MOL RES, V6, P859; Dbouk HA, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-4; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Frantseva MV, 2002, J CEREBR BLOOD F MET, V22, P453, DOI 10.1097/00004647-200204000-00009; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu XM, 2007, GLIA, V55, P935, DOI 10.1002/glia.20515; Hirt L, 2009, J CEREBR BLOOD F MET, V29, P423, DOI 10.1038/jcbfm.2008.133; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Jablonski EM, 2007, CANCER LETT, V250, P36, DOI 10.1016/j.canlet.2006.09.013; Jablonski EM, 2004, AM J PHYSIOL-CELL PH, V286, pC975, DOI 10.1152/ajpcell.00180.2003; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kong H, 2008, J CELL SCI, V121, P4029, DOI 10.1242/jcs.035758; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim SJ, 2000, ONCOGENE, V19, P6271, DOI 10.1038/sj.onc.1204014; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; MARMAROU A, 2007, FOCUS           0927, DOI DOI 10.3171/FOC.2007.22.5.2; Mosbasheri A, 2004, AM J PHYSIOL-CELL PH, V286, pC529, DOI 10.1152/ajpcell.00408.2003; Nicchia GP, 2005, FASEB J, V19, P1674, DOI 10.1096/fj.04-3281fje; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Satoh J, 2007, NEUROPATHOLOGY, V27, P245, DOI 10.1111/j.1440-1789.2007.00774.x; Schaar DG, 2009, EXP HEMATOL, V37, P245, DOI 10.1016/j.exphem.2008.10.002; Suzuki R, 2006, ACTA NEUROCHIR SUPPL, V96, P398; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Tran ND, 2010, J NEUROSURG, V112, P1095, DOI 10.3171/2009.8.JNS081704; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; VAN ROOIJ E, 2006, P NATL ACAD SCI USA, V103, P18255; Yang M, 2009, BRAIN RES, V1290, P121, DOI 10.1016/j.brainres.2009.07.018; Yin W, 2007, STROKE, V38, P1017, DOI 10.1161/01.STR.0000258102.18836.ca; Zhang B, 2009, BLOOD, V114, P4300, DOI 10.1182/blood-2008-12-193326	49	127	139	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29223	29230		10.1074/jbc.M110.144576	http://dx.doi.org/10.1074/jbc.M110.144576			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20628061	hybrid, Green Published			2022-12-25	WOS:000281740100023
J	De Jaco, A; Lin, MZ; Dubi, N; Comoletti, D; Miller, MT; Camp, S; Ellisman, M; Butko, MT; Tsien, RY; Taylor, P				De Jaco, Antonella; Lin, Michael Z.; Dubi, Noga; Comoletti, Davide; Miller, Meghan T.; Camp, Shelley; Ellisman, Mark; Butko, Margaret T.; Tsien, Roger Y.; Taylor, Palmer			Neuroligin Trafficking Deficiencies Arising from Mutations in the alpha/beta-Hydrolase Fold Protein Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROGLOBULIN GENE; DISULFIDE-ISOMERASE; CONGENITAL HYPOTHYROIDISM; STRUCTURAL VARIANTS; AUTISM REVEALS; CELL-ADHESION; NLGN4; NEUREXIN-1-BETA; DEGRADATION; SYNAPSES	Despite great functional diversity, characterization of the alpha/beta-hydrolase fold proteins that encompass a superfamily of hydrolases, heterophilic adhesion proteins, and chaperone domains reveals a common structural motif. By incorporating the R451C mutation found in neuroligin(NLGN) and associated with autism and the thyroglobulin G2320R (G221R in NLGN) mutation responsible for congenital hypothyroidism into NLGN3, we show that mutations in the alpha/beta-hydrolase fold domain influence folding and biosynthetic processing of neuroligin3 as determined by in vitro susceptibility to proteases, glycosylation processing, turnover, and processing rates. We also show altered interactions of the mutant proteins with chaperones in the endoplasmic reticulum and arrest of transport along the secretory pathway with diversion to the proteasome. Time-controlled expression of a fluorescently tagged neuroligin in hippocampal neurons shows that these mutations compromise neuronal trafficking of the protein, with the R451C mutation reducing and the G221R mutation virtually abolishing the export of NLGN3 from the soma to the dendritic spines. Although the R451C mutation causes a local folding defect, the G221R mutation appears responsible for more global misfolding of the protein, reflecting their sequence positions in the structure of the protein. Our results suggest that disease-related mutations in the alpha/beta-hydrolase fold domain share common trafficking deficiencies yet lead to discrete congenital disorders of differing severity in the endocrine and nervous systems.	[Taylor, Palmer] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmacol, La Jolla, CA 92093 USA; [Lin, Michael Z.; Butko, Margaret T.; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Lin, Michael Z.; Butko, Margaret T.; Tsien, Roger Y.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Ellisman, Mark] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [De Jaco, Antonella] Univ Roma La Sapienza, Dept Cell & Dev Biol, Daniel Bovet Neurobiol Res Ctr, I-00185 Rome, Italy; [De Jaco, Antonella] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Taylor, P (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmacol, La Jolla, CA 92093 USA.	pwtaylor@ucsd.edu		Lin, Michael/0000-0002-0492-1961; DE JACO, Antonella/0000-0002-9394-0207	United States Public Health Service [P42 ES010337, R37 GM-18360]; Compagnia San Paolo Bando Programma in Neuroscienze; Autism Speaks Grant [2617]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R37GM018360, R01GM018360] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Compagnia San Paolo Bando Programma in Neuroscienze(Compagnia di San Paolo); Autism Speaks Grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P42 ES010337 and R37 GM-18360 from the United States Public Health Service (to P. T.). This work was also supported by a grant from the Compagnia San Paolo Bando Programma in Neuroscienze 2008 (to A. D. J.) and Autism Speaks Grant 2617 (to D. C.).	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bourgeron T, 2009, B ACAD NAT MED PARIS, V193, P299, DOI 10.1016/S0001-4079(19)32583-X; Caputo M, 2007, CLIN ENDOCRINOL, V67, P351, DOI 10.1111/j.1365-2265.2007.02889.x; Caron P, 2003, J CLIN ENDOCR METAB, V88, P3546, DOI 10.1210/jc.2002-021744; Carr PD, 2009, PROTEIN PEPTIDE LETT, V16, P1137; Chen X, 2008, NAT STRUCT MOL BIOL, V15, P50, DOI 10.1038/nsmb1350; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; Cousin X, 1997, NUCLEIC ACIDS RES, V25, P143, DOI 10.1093/nar/25.1.143; De Jaco A, 2006, J BIOL CHEM, V281, P9667, DOI 10.1074/jbc.M510262200; DOLGINOVA EA, 1992, BIOCHEMISTRY-US, V31, P12248, DOI 10.1021/bi00163a039; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hishinuma A, 2000, ENDOCRINOLOGY, V141, P4050, DOI 10.1210/en.141.11.4050; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim PS, 2000, MOL ENDOCRINOL, V14, P1944, DOI 10.1210/me.14.12.1944; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Lawson-Yuen A, 2008, EUR J HUM GENET, V16, P614, DOI 10.1038/sj.ejhg.5202006; Lee J, 2008, J CLIN INVEST, V118, P2950, DOI 10.1172/JCI35164; Lin MZ, 2008, P NATL ACAD SCI USA, V105, P7744, DOI 10.1073/pnas.0803060105; Lintas C, 2009, J MED GENET, V46, P1, DOI 10.1136/jmg.2008.060871; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Menon S, 2007, J BIOL CHEM, V282, P6183, DOI 10.1074/jbc.M608863200; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Pardo V, 2008, THYROID, V18, P783, DOI 10.1089/thy.2007.0321; Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x; Scholl FG, 2003, TRENDS NEUROSCI, V26, P618, DOI 10.1016/j.tins.2003.09.004; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Talebizadeh Z, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036897; Vono-Toniolo J, 2005, THYROID, V15, P1021, DOI 10.1089/thy.2005.15.1021; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629; Yan J, 2008, NEUROSCI LETT, V438, P368, DOI 10.1016/j.neulet.2008.04.074; Yen T, 2003, CLIN CHEM, V49, P1297, DOI 10.1373/49.8.1297; Zhang C, 2009, J NEUROSCI, V29, P10843, DOI 10.1523/JNEUROSCI.1248-09.2009	48	30	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28674	28682		10.1074/jbc.M110.139519	http://dx.doi.org/10.1074/jbc.M110.139519			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20615874	Green Published, hybrid			2022-12-25	WOS:000281594000032
J	Hegde, ML; Hegde, PM; Holthauzen, LMF; Hazra, TK; Rao, KSJ; Mitra, S				Hegde, Muralidhar L.; Hegde, Pavana M.; Holthauzen, Luis M. F.; Hazra, Tapas K.; Rao, K. S. Jagannatha; Mitra, Sankar			Specific Inhibition of NEIL-initiated Repair of Oxidized Base Damage in Human Genome by Copper and Iron POTENTIAL ETIOLOGICAL LINKAGE TO NEURODEGENERATIVE DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA GLYCOSYLASE NEIL1; CARCINOGENIC METAL-COMPOUNDS; PARKINSONS-DISEASE; EXCISION-REPAIR; ALZHEIMERS-DISEASE; 8-OXOGUANINE-DNA GLYCOSYLASE; SUBSTANTIA-NIGRA; HUMAN-CELLS; CURCUMIN PROTECTS; MAMMALIAN-CELLS	Dyshomeostasis of transition metals iron and copper as well as accumulation of oxidative DNA damage have been implicated in multitude of human neurodegenerative diseases, including Alzheimer disease and Parkinson disease. These metals oxidize DNA bases by generating reactive oxygen species. Most oxidized bases in mammalian genomes are repaired via the base excision repair pathway, initiated with one of four major DNA glycosylases: NTH1 or OGG1 (of the Nth family) or NEIL1 or NEIL2 (of the Nei family). Here we show that Fe(II/III) and Cu(II) at physiological levels bind to NEIL1 and NEIL2 to alter their secondary structure and strongly inhibit repair of mutagenic 5-hydroxyuracil, a common cytosine oxidation product, both in vitro and in neuroblastoma (SH-SY5Y) cell extract by affecting the base excision and AP lyase activities of NEILs. The specificity of iron/copper inhibition of NEILs is indicated by a lack of similar inhibition of OGG1, which also indicated that the inhibition is due to metal binding to the enzymes and not DNA. Fluorescence and surface plasmon resonance studies show sub-micromolar binding of copper/iron to NEILs but not OGG1. Furthermore, Fe(II) inhibits the interaction of NEIL1 with downstream base excision repair proteins DNA polymerase beta and flap endonuclease-1 by 4-6-fold. These results indicate that iron/copper overload in the neurodegenerative diseases could act as a double-edged sword by both increasing oxidative genome damage and preventing their repair. Interestingly, specific chelators, including the natural chemopreventive compound curcumin, reverse the inhibition of NEILs both in vitro and in cells, suggesting their therapeutic potential.	[Hegde, Muralidhar L.; Hegde, Pavana M.; Holthauzen, Luis M. F.; Hazra, Tapas K.; Mitra, Sankar] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Hazra, Tapas K.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Rao, K. S. Jagannatha] Cent Food Technol Res Inst, Dept Biochem & Nutr, Mysore 570020, Karnataka, India	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI)	Mitra, S (corresponding author), 301 Univ Blvd, Galveston, TX 77555 USA.	samitra@utmb.edu	Kosagisharaf, Jagannatha Rao/N-6788-2014; Classen, Scott/AAY-8176-2020	Kosagisharaf, Jagannatha Rao/0000-0003-4290-7666; Hegde, Muralidhar/0000-0001-7333-8123; Dixit, Pavana/0000-0003-0811-3942	National Institutes of Health; American Parkinson's Disease Association; USPHS [CA81063, P01 CA092584, CA102271]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA102271, R01CA081063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Parkinson's Disease Association; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, USPHS, Grants CA81063 and P01 CA092584 (to S. M.) and CA102271 (to T. K. H.). This research was also supported by an American Parkinson's Disease Association postdoctoral fellowship award (to M. L. H.).	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Arai T, 2006, ACTA NEUROPATHOL, V112, P139, DOI 10.1007/s00401-006-0081-9; Asmuss M, 2000, CARCINOGENESIS, V21, P2097, DOI 10.1093/carcin/21.11.2097; BANAS A, 2010, J BIOL INOR IN PRESS; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Barik A, 2005, FREE RADICAL BIO MED, V39, P811, DOI 10.1016/j.freeradbiomed.2005.05.005; Barreto R, 2005, Chin J Dig Dis, V6, P31, DOI 10.1111/j.1443-9573.2005.00184.x; Baum L, 2004, J ALZHEIMERS DIS, V6, P367; Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y; Bharathi, 2007, BIOCHEM BIOPH RES CO, V359, P115, DOI 10.1016/j.bbrc.2007.05.060; Bravard A, 2010, MUTAT RES-FUND MOL M, V685, P61, DOI 10.1016/j.mrfmmm.2009.09.013; Chen J, 2006, APOPTOSIS, V11, P943, DOI 10.1007/s10495-006-6715-5; Cole GM, 2007, ADV EXP MED BIOL, V595, P197; Cuajungco MP, 2005, SUB CELL BIOCHEM, V38, P235; Dairam A, 2007, J AGR FOOD CHEM, V55, P1039, DOI 10.1021/jf063446t; Daniel S, 2004, J INORG BIOCHEM, V98, P266, DOI 10.1016/j.jinorgbio.2003.10.014; Das A, 2004, J BIOL CHEM, V279, P47132, DOI 10.1074/jbc.M406224200; Das A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703343200; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; DEXTER DT, 1990, J NEUROCHEM, V55, P16, DOI 10.1111/j.1471-4159.1990.tb08814.x; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Doublie S, 2004, P NATL ACAD SCI USA, V101, P10284, DOI 10.1073/pnas.0402051101; Englander EW, 2006, MECH AGEING DEV, V127, P64, DOI 10.1016/j.mad.2005.09.008; Farah Ibrahim O, 2010, Biomed Sci Instrum, V46, P404; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Grin IR, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1253, DOI 10.1134/S000629790911011X; Grossoehme NE, 2007, BIOCHEMISTRY-US, V46, P10506, DOI 10.1021/bi700171v; Gupta Veer Bala, 2006, Current Alzheimer Research, V3, P297; Hamann I, 2009, MUTAT RES-FUND MOL M, V669, P122, DOI 10.1016/j.mrfmmm.2009.05.011; HART RW, 1974, P NATL ACAD SCI USA, V71, P2169, DOI 10.1073/pnas.71.6.2169; Hartwig A, 2002, ENVIRON HEALTH PERSP, V110, P797, DOI 10.1289/ehp.02110s5797; Hartwig A, 2002, FOOD CHEM TOXICOL, V40, P1179, DOI 10.1016/S0278-6915(02)00043-1; Hartwig A, 2002, TOXICOL LETT, V127, P47, DOI 10.1016/S0378-4274(01)00482-9; Hazra IK, 1998, NUCLEIC ACIDS RES, V26, P5116, DOI 10.1093/nar/26.22.5116; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hegde ML, 2004, J TRACE ELEM MED BIO, V18, P163, DOI 10.1016/j.jtemb.2004.09.003; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hegde ML, 2008, J BIOL CHEM, V283, P27028, DOI 10.1074/jbc.M802712200; Hegde ML, 2007, ARCH BIOCHEM BIOPHYS, V464, P57, DOI 10.1016/j.abb.2007.03.042; Hegde ML, 2006, ARCH BIOCHEM BIOPHYS, V449, P143, DOI 10.1016/j.abb.2006.02.018; Hegde ML, 2009, J ALZHEIMERS DIS, V17, P457, DOI 10.3233/JAD-2009-1068; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; HIRSCH EC, 1991, J NEUROCHEM, V56, P446, DOI 10.1111/j.1471-4159.1991.tb08170.x; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Jalilehvand F, 2009, INORG CHEM, V48, P4219, DOI 10.1021/ic900145n; Koeppen AH, 2003, J NEUROL SCI, V207, P95, DOI 10.1016/S0022-510X(02)00429-X; Li H, 2009, J NEUROCHEM, V110, P1774, DOI 10.1111/j.1471-4159.2009.06271.x; Lipscomb DC, 1998, STROKE, V29, P487, DOI 10.1161/01.STR.29.2.487; Llanos RM, 2002, DNA CELL BIOL, V21, P259, DOI 10.1089/104454902753759681; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maiti AK, 2008, DNA REPAIR, V7, P1213, DOI 10.1016/j.dnarep.2008.03.025; Mendonca LM, 2009, MUTAT RES-GEN TOX EN, V675, P29, DOI 10.1016/j.mrgentox.2009.02.003; Molina-Holgado F, 2007, BIOMETALS, V20, P639, DOI 10.1007/s10534-006-9033-z; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; Petrat F, 2002, BIOL CHEM, V383, P489, DOI 10.1515/BC.2002.051; Podlutsky AJ, 2001, EMBO J, V20, P1477, DOI 10.1093/emboj/20.6.1477; PRASAD R, 1993, J BIOL CHEM, V268, P22746; Rao KS, 2007, NEUROSCIENCE, V145, P1330, DOI 10.1016/j.neuroscience.2006.09.032; Rao KSJ, 1999, ALZHEIMERS REP, V2, P241; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Takao M, 2002, EMBO J, V21, P3486, DOI 10.1093/emboj/cdf350; Texel SJ, 2008, BIOCHEM SOC T, V36, P1277, DOI 10.1042/BST0361277; Wang HX, 2003, J BIOL CHEM, V278, P28686, DOI 10.1074/jbc.M302844200; Wang P, 2006, TOXICOL LETT, V166, P237, DOI 10.1016/j.toxlet.2006.06.647; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yasuhara T, 2007, BRAIN RES, V1133, P49, DOI 10.1016/j.brainres.2006.11.072; Zatta P, 2003, BRAIN RES BULL, V62, P15, DOI 10.1016/S0361-9230(03)00182-5; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200; Zharkov DO, 2002, DNA REPAIR, V1, P661, DOI 10.1016/S1568-7864(02)00074-5	76	48	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28812	28825		10.1074/jbc.M110.126664	http://dx.doi.org/10.1074/jbc.M110.126664			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20622253	Green Published, hybrid			2022-12-25	WOS:000281594000047
J	Ishii, K; Hamamoto, H; Kamimura, M; Nakamura, Y; Noda, H; Imamura, K; Mita, K; Sekimizu, K				Ishii, Kenichi; Hamamoto, Hiroshi; Kamimura, Manabu; Nakamura, Yuki; Noda, Hiroaki; Imamura, Katsutoshi; Mita, Kazuei; Sekimizu, Kazuhisa			Insect Cytokine Paralytic Peptide (PP) Induces Cellular and Humoral Immune Responses in the Silkworm Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT-LIKE PROTEIN; GENOME-WIDE ANALYSIS; INNATE IMMUNITY; KINASE PATHWAY; DROSOPHILA; PHAGOCYTOSIS; GENE; EXPRESSION; HEMOLYMPH; TOLL	In the blood (hemolymph) of the silkworm Bombyx mori, the insect cytokine paralytic peptide (PP) is converted from an inactive precursor to an active form in response to the cell wall components of microorganisms and contributes to silkworm resistance to infection. To investigate the molecular mechanism underlying the up-regulation of host resistance induced by PP, we performed an oligonucleotide microarray analysis on RNA of blood cells (hemocytes) and fat body tissues of silkworm larvae injected with active PP. Expression levels of a large number of immune-related genes increased rapidly within 3 h after injecting active PP, including phagocytosis-related genes such as tetraspanin E, actin A1, and ced-6 in hemocytes, and antimicrobial peptide genes cecropin A and moricin in the fat body. Active PP promoted in vitro and in vivo phagocytosis of Staphyloccocus aureus by the hemocytes. Moreover, active PP induced in vivo phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK) in the fat body. Pretreatment of silkworm larvae with ML3403, a pharmacologic p38 MAPK inhibitor, suppressed the PP-dependent induction of cecropin A and moricin genes in the fat body. Injection of active PP delayed the killing of silkworm larvae by S. aureus, whereas its effect was abolished by preinjection of the p38 MAPK inhibitor, suggesting that p38 MAPK activation is required for PP-dependent defensive responses. These findings suggest that PP acts on multiple tissues in silkworm larvae and acutely activates cellular and humoral immune responses, leading to host protection against infection.	[Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo 1130033, Japan; [Kamimura, Manabu; Nakamura, Yuki; Noda, Hiroaki; Mita, Kazuei] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan	University of Tokyo; National Institute of Agrobiological Sciences - Japan	Sekimizu, K (corresponding author), 7-3-1 Hongo,Bunkyo ku, Tokyo 1130033, Japan.	sekimizu@mol.f.u-tokyo.ac.jp	Hamamoto, Hiroshi/G-6397-2019; Ishii, Kenichi/H-5469-2019	Hamamoto, Hiroshi/0000-0001-9315-7442; 	Japan Society for the Promotion of Science [21790063, 21-10519]; Program for Promotion of Fundamental Studies in Health Sciences of National Institute of Biomedical Innovation; Genome Pharmaceuticals Co. Ltd.	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Fundamental Studies in Health Sciences of National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Genome Pharmaceuticals Co. Ltd.	This work was supported by Grant-in-aid for Young Scientists (B) 21790063 and Grant-in-aid for Japan Society for the Promotion of Science fellows (21-10519) from Japan Society for the Promotion of Science. This study was also supported by the Program for Promotion of Fundamental Studies in Health Sciences of National Institute of Biomedical Innovation and grants from Genome Pharmaceuticals Co. Ltd.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; Aizawa T, 2002, MOL CELLS, V14, P1; BOMAN HG, 1991, EUR J BIOCHEM, V201, P23, DOI 10.1111/j.1432-1033.1991.tb16252.x; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cuttell L, 2008, CELL, V135, P524, DOI 10.1016/j.cell.2008.08.033; Davis MM, 2008, MOL CELL BIOL, V28, P4883, DOI 10.1128/MCB.02074-07; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Fujiwara Y, 2006, INSECT BIOCHEM MOLEC, V36, P47, DOI 10.1016/j.ibmb.2005.10.005; Ha SD, 1999, PEPTIDES, V20, P561, DOI 10.1016/S0196-9781(99)00008-X; Han ZQS, 1998, MOL CELL BIOL, V18, P3527, DOI 10.1128/MCB.18.6.3527; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Hussain T, 2008, AM J PHYSIOL-LUNG C, V295, pL461, DOI 10.1152/ajplung.00276.2007; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Ishii K, 2008, J BIOL CHEM, V283, P2185, DOI 10.1074/jbc.M705480200; Johansson KC, 2005, EXP CELL RES, V305, P145, DOI 10.1016/j.yexcr.2004.12.018; Kamimura M, 2001, BIOCHEM BIOPH RES CO, V286, P67, DOI 10.1006/bbrc.2001.5365; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Lagueux M, 2000, P NATL ACAD SCI USA, V97, P11427, DOI 10.1073/pnas.97.21.11427; Laufer SA, 2003, J MED CHEM, V46, P3230, DOI 10.1021/jm030766k; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; Nakahara Y, 2003, ARCH INSECT BIOCHEM, V52, P163, DOI 10.1002/arch.10080; Nakahara Y, 2009, DEV COMP IMMUNOL, V33, P439, DOI 10.1016/j.dci.2008.09.005; Natori S, 1999, DEV COMP IMMUNOL, V23, P317, DOI 10.1016/S0145-305X(99)00014-2; OKADA M, 1985, J BIOL CHEM, V260, P7174; OKADA M, 1983, BIOCHEM J, V211, P727, DOI 10.1042/bj2110727; Pujol N, 2008, CURR BIOL, V18, P481, DOI 10.1016/j.cub.2008.02.079; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Schneider DS, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030041; Shinzawa N, 2009, CELL HOST MICROBE, V6, P244, DOI 10.1016/j.chom.2009.07.010; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Strand MR, 2000, J INSECT PHYSIOL, V46, P817, DOI 10.1016/S0022-1910(99)00171-7; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Tanaka H, 2009, INSECT MOL BIOL, V18, P71, DOI 10.1111/j.1365-2583.2009.00851.x; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Wu RCC, 2007, INSECT MOL BIOL, V16, P389, DOI 10.1111/j.1365-2583.2007.00734.x; Zhuang SF, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700341200	46	67	74	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28635	28642		10.1074/jbc.M110.138446	http://dx.doi.org/10.1074/jbc.M110.138446			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20622022	Green Published, hybrid			2022-12-25	WOS:000281594000027
J	Mistafa, O; Ghalali, A; Kadekar, S; Hogberg, J; Stenius, U				Mistafa, Oras; Ghalali, Aram; Kadekar, Sandeep; Hogberg, Johan; Stenius, Ulla			Purinergic Receptor-mediated Rapid Depletion of Nuclear Phosphorylated Akt Depends on Pleckstrin Homology Domain Leucine-rich Repeat Phosphatase, Calcineurin, Protein Phosphatase 2A, and PTEN Phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; CELL-CYCLE; P53-DEFICIENT CELLS; UBIQUITIN LIGASE; LOCALIZATION; BINDING; KINASE; PCNA; DEGRADATION; D1	Akt is an important oncoprotein, and data suggest a critical role for nuclear Akt in cancer development. We have previously described a rapid (3-5 min) and P2X7-dependent depletion of nuclear phosphorylated Akt (pAkt) and effects on downstream targets, and here we studied mechanisms behind the pAkt depletion. We show that cholesterol-lowering drugs, statins, or extracellular ATP, induced a complex and coordinated response in insulin-stimulated A549 cells leading to depletion of nuclear pAkt. It involved protein/lipid phosphatases PTEN, pleckstrin homology domain leucine-rich repeat phosphatase (PHLPP1 and -2), protein phosphatase 2A (PP2A), and calcineurin. We employed immunocytology, immunoprecipitation, and proximity ligation assay techniques and show that PHLPP and calcineurin translocated to the nucleus and formed complexes with Akt within 3 min. Also PTEN translocated to the nucleus and then co-localized with pAkt close to the nuclear membrane. An inhibitor of the scaffolding immunophilin FK506-binding protein 51 (FKBP51) and calcineurin, FK506, prevented depletion of nuclear pAkt. Furthermore, okadaic acid, an inhibitor of PP2A, prevented the nuclear pAkt depletion. Chemical inhibition and siRNA indicated that PHLPP, PP2A, and PTEN were required for a robust depletion of nuclear pAkt, and in prostate cancer cells lacking PTEN, transfection of PTEN restored the statin-induced pAkt depletion. The activation of protein and lipid phosphatases was paralleled by a rapid proliferating cell nuclear antigen (PCNA) translocation to the nucleus, a PCNA-p21(cip1) complex formation, and cyclin D1 degradation. We conclude that these effects reflect a signaling pathway for rapid depletion of pAkt that may stop the cell cycle.	[Mistafa, Oras; Ghalali, Aram; Kadekar, Sandeep; Hogberg, Johan; Stenius, Ulla] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden	Karolinska Institutet	Ghalali, A (corresponding author), Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden.	aram.ghalali@ki.se			Swedish Research Council; Karolinska Insititutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Insititutet(Karolinska Institutet)	This work was supported by the Swedish Research Council for the Environment, Agriculture Science, and Spatial Planning (Formas) and funds from Karolinska Insititutet.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P9876, DOI 10.1073/pnas.0703589104; Ahn Y, 2008, BIOCHEM J, V412, P331, DOI 10.1042/BJ20071403; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Ando T, 2001, J BIOL CHEM, V276, P42971, DOI 10.1074/jbc.M106460200; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Cayrol C, 1998, ONCOGENE, V16, P311, DOI 10.1038/sj.onc.1201543; Cen XB, 2006, J NEUROSCI, V26, P3335, DOI 10.1523/JNEUROSCI.5010-05.2006; Chung JH, 2005, CANCER RES, V65, P8096, DOI 10.1158/0008-5472.CAN-05-1888; Crowell JA, 2007, MOL CANCER THER, V6, P2139, DOI 10.1158/1535-7163.MCT-07-0120; Deleris P, 2006, J CELL BIOCHEM, V98, P469, DOI 10.1002/jcb.20695; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Fukami-Kobayashi J, 1999, EXP CELL RES, V246, P338, DOI 10.1006/excr.1998.4306; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Hamilton Robert J, 2008, Curr Urol Rep, V9, P189, DOI 10.1007/s11934-008-0034-z; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Li TK, 2002, J CELL BIOCHEM, V84, P460, DOI 10.1002/jcb.10026.abs; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Lian ZL, 2005, ONCOGENE, V24, P7394, DOI 10.1038/sj.onc.1209089; Liao Y, 2010, AM J TRANSL RES, V2, P19; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marques M, 2009, P NATL ACAD SCI USA, V106, P7525, DOI 10.1073/pnas.0812000106; Martin D, 2002, J BIOL CHEM, V277, P42943, DOI 10.1074/jbc.M201070200; Mistafa O, 2008, BIOCHEM BIOPH RES CO, V365, P131, DOI 10.1016/j.bbrc.2007.10.148; Mistafa O, 2009, BIOCHEM PHARMACOL, V78, P1115, DOI 10.1016/j.bcp.2009.06.016; Morrow PW, 2004, BIOCHEM BIOPH RES CO, V323, P645, DOI 10.1016/j.bbrc.2004.08.147; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Paajarvi G, 2004, FASEB J, V18, P476, DOI 10.1096/fj.04-2745fje; Park CH, 2008, BRAIN RES, V1234, P148, DOI 10.1016/j.brainres.2008.07.082; Pawar SA, 2010, P NATL ACAD SCI USA, V107, P9210, DOI 10.1073/pnas.0913813107; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Roudier E, 2006, MOL CANCER THER, V5, P2706, DOI 10.1158/1535-7163.MCT-06-0352; Teruel T, 2001, DIABETES, V50, P2563, DOI 10.2337/diabetes.50.11.2563; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; VRIZ S, 1992, MOL CELL BIOL, V12, P3548, DOI 10.1128/MCB.12.8.3548; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zhu Q, 2008, ONCOGENE, V27, P4569, DOI 10.1038/onc.2008.91	45	39	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27900	27910		10.1074/jbc.M110.117093	http://dx.doi.org/10.1074/jbc.M110.117093			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20605778	Green Published, hybrid			2022-12-25	WOS:000281404100045
J	Wang, M; Hossain, MS; Tan, W; Coolman, B; Zhou, J; Liu, S; Casey, PJ				Wang, M.; Hossain, M. S.; Tan, W.; Coolman, B.; Zhou, J.; Liu, S.; Casey, P. J.			Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth	ONCOGENE			English	Article						isoprenylcysteine carboxylmethyltransferase (Icmt); prenylation; farnesylation; autophagy; apoptosis; cancer therapy	PROGRAMMED CELL-DEATH; SMALL-MOLECULE INHIBITOR; CARBOXYL METHYLTRANSFERASE; PROTEIN PRENYLATION; K-RAS; OVARIAN; CYTOTOXICITY; MECHANISMS; HOMOLOG; LC3	Inhibition of isoprenylcysteine carboxylmethyltransferase (Icmt), which catalyzes the final step in the post-translational C-terminal processing of prenylated proteins, suppresses tumor cell growth and induces cell death. Icmt inhibition by either a small molecule inhibitor termed as cysmethynil or inhibitory RNA induces marked autophagy leading to cell death. HepG2 cells were used to investigate the function of autophagy in tumor cell death. Suppression of autophagy, either pharmacologically or through knockdown of the autophagy essential proteins, Atg5 or Atg1, inhibits not only cysmethynil-induced autophagy, but also apoptosis in HepG2 cells. The dependence of cysmethynil-induced apoptosis on autophagy was further shown using autophagy-deficient mouse embryonic fibroblast (MEF) cells. Atg5(-/-) MEF cells were found to be resistant to cysmethynil-induced apoptosis, whereas wild-type MEFs showed high sensitivity to apoptosis induction. These data indicate that inhibition of Icmt can elicit cell death through two linked mechanisms, autophagy and apoptosis, and that autophagy can be an active player upstream of apoptosis in cell types capable of apoptotic cell death, such as HepG2 and MEFs. Further, treatment of mice-bearing HepG2-derived tumors with cysmethynil resulted in marked inhibition of tumor growth; analysis of tumor tissue from these mice revealed markers consistent with autophagy induction and cell growth arrest. Oncogene (2010) 29, 4959-4970; doi: 10.1038/onc.2010.247; published online 12 July 2010	[Wang, M.; Hossain, M. S.; Tan, W.; Zhou, J.; Liu, S.; Casey, P. J.] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore 169857, Singapore; [Coolman, B.; Casey, P. J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	National University of Singapore; Duke University	Wang, M (corresponding author), Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, 8 Coll Rd, Singapore 169857, Singapore.	mei.wang@duke-nus.edu.sg	Hossain, Mohammad Sorowar/AAX-2009-2020	Hossain, Mohammad Sorowar/0000-0001-7143-2909; Wang, Mei/0000-0001-6887-6840; Casey, Patrick/0000-0002-7366-9309	Singapore Ministry of Health; Agency for Science, Technology, and Research	Singapore Ministry of Health(Ministry of Health-Singapore); Agency for Science, Technology, and Research(Agency for Science Technology & Research (A*STAR))	We are grateful to Noboru Mizushima for the generous gift of Atg5 knockout cells. This paper is dedicated to the spirit of Block C, an aging nursing school dormitory retrofitted as the Duke-NUS interim research facility in which some of these studies were conducted. Financial support was provided by awards from the Singapore Ministry of Health and the Agency for Science, Technology, and Research.	Akar U, 2008, AUTOPHAGY, V4, P669, DOI 10.4161/auto.6083; Anderson JL, 2005, J BIOL CHEM, V280, P29454, DOI 10.1074/jbc.M504982200; Ashby MN, 1998, CURR OPIN LIPIDOL, V9, P99, DOI 10.1097/00041433-199804000-00004; Baron RA, 2007, BIOCHEMISTRY-US, V46, P554, DOI 10.1021/bi060344n; Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Blum R, 2008, RECENT PAT ANTI-CANC, V3, P31; Botti J, 2006, AUTOPHAGY, V2, P67, DOI 10.4161/auto.2.2.2458; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; CLIBY W, 1993, GYNECOL ONCOL, V50, P34, DOI 10.1006/gyno.1993.1160; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; Di X, 2009, BIOCHEM PHARMACOL, V77, P1139, DOI 10.1016/j.bcp.2008.12.016; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; ECCLES DM, 1992, ONCOGENE, V7, P2069; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; FUTREAL PA, 1992, CANCER RES, V52, P2624; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; Gewirtz DA, 2009, RADIOTHER ONCOL, V92, P323, DOI 10.1016/j.radonc.2009.05.022; Gorka M, 2005, ANTI-CANCER DRUG, V16, P777; Huang J, 2007, CELL CYCLE, V6, P1837, DOI 10.4161/cc.6.15.4511; Juhasz G, 2003, FEBS LETT, V543, P154, DOI 10.1016/S0014-5793(03)00431-9; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kramer K, 2003, MOL BIOL CELL, V14, P848, DOI 10.1091/mbc.E02-07-0390; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lambert LA, 2008, CANCER RES, V68, P7966, DOI 10.1158/0008-5472.CAN-08-1333; Levine B, 2009, CELL DEATH DIFFER, V16, P1, DOI 10.1038/cdd.2008.139; Magee T, 2005, CURR OPIN CELL BIOL, V17, P190, DOI 10.1016/j.ceb.2005.02.003; Nair U, 2005, J BIOL CHEM, V280, P41785, DOI 10.1074/jbc.R500016200; Olie RA, 1998, CURR BIOL, V8, P955, DOI 10.1016/S0960-9822(98)70395-1; Roisin-Bouffay C, 2004, J BIOL CHEM, V279, P11489, DOI 10.1074/jbc.M312741200; SAITO H, 1993, CANCER RES, V53, P3382; Scarlatti F, 2009, CELL DEATH DIFFER, V16, P12, DOI 10.1038/cdd.2008.101; SCHWARTZ LM, 1993, P NATL ACAD SCI USA, V90, P980, DOI 10.1073/pnas.90.3.980; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Sousa SF, 2008, CURR MED CHEM, V15, P1478, DOI 10.2174/092986708784638825; SPECTOR DL, 1986, EXP CELL RES, V163, P87, DOI 10.1016/0014-4827(86)90560-4; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Wahlstrom AM, 2008, BLOOD, V112, P1357, DOI 10.1182/blood-2007-06-094060; Wang M, 2008, J BIOL CHEM, V283, P18678, DOI 10.1074/jbc.M801855200; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Winter-Vann AM, 2005, P NATL ACAD SCI USA, V102, P4336, DOI 10.1073/pnas.0408107102; Wright LP, 2009, MOL CELL BIOL, V29, P1826, DOI 10.1128/MCB.01719-08; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	50	49	52	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	35					4959	4970		10.1038/onc.2010.247	http://dx.doi.org/10.1038/onc.2010.247			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	646XP	20622895				2022-12-25	WOS:000281578700010
J	Lindenmeyer, MT; Eichinger, F; Sen, K; Anders, HJ; Edenhofer, I; Mattinzoli, D; Kretzler, M; Rastaldi, MP; Cohen, CD				Lindenmeyer, Maja T.; Eichinger, Felix; Sen, Kontheari; Anders, Hans-Joachim; Edenhofer, Ilka; Mattinzoli, Deborah; Kretzler, Matthias; Rastaldi, Maria P.; Cohen, Clemens D.			Systematic Analysis of a Novel Human Renal Glomerulus-Enriched Gene Expression Dataset	PLOS ONE			English	Article							PODOCYTE-SPECIFIC DELETION; ENDOTHELIAL GROWTH-FACTOR; HUMAN KIDNEY; ACTIN CYTOSKELETON; CELL-MIGRATION; DISEASE; NEURITIN; PROTEINS; IDENTIFICATION; NEPHRIN	Glomerular diseases account for the majority of cases with chronic renal failure. Several genes have been identified with key relevance for glomerular function. Quite a few of these genes show a specific or preferential mRNA expression in the renal glomerulus. To identify additional candidate genes involved in glomerular function in humans we generated a human renal glomerulus-enriched gene expression dataset (REGGED) by comparing gene expression profiles from human glomeruli and tubulointerstitium obtained from six transplant living donors using Affymetrix HG-U133A arrays. This analysis resulted in 677 genes with prominent overrepresentation in the glomerulus. Genes with 'a priori' known prominent glomerular expression served for validation and were all found in the novel dataset (e.g. CDKN1, DAG1, DDN, EHD3, MYH9, NES, NPHS1, NPHS2, PDPN, PLA2R1, PLCE1, PODXL, PTPRO, SYNPO, TCF21, TJP1, WT1). The mRNA expression of several novel glomerulus-enriched genes in REGGED was validated by qRT-PCR. Gene ontology and pathway analysis identified biological processes previously not reported to be of relevance in glomeruli of healthy human adult kidneys including among others axon guidance. This finding was further validated by assessing the expression of the axon guidancemolecules neuritin (NRN1) and roundabout receptor ROBO1 and -2. In diabetic nephropathy, a prevalent glomerulopathy, differential regulation of glomerular ROBO2 mRNA was found. In summary, novel transcripts with predominant expression in the human glomerulus could be identified using a comparative strategy on microdissected nephrons. A systematic analysis of this glomerulus-specifc gene expression dataset allows the detection of target molecules and biological processes involved in glomerular biology and renal disease.	[Lindenmeyer, Maja T.; Edenhofer, Ilka; Cohen, Clemens D.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Lindenmeyer, Maja T.; Sen, Kontheari; Cohen, Clemens D.] Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Eichinger, Felix; Kretzler, Matthias] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Anders, Hans-Joachim] Univ Munich, Med Poliklin, D-8000 Munich, Germany; [Mattinzoli, Deborah; Rastaldi, Maria P.] Fdn IRCCS Policlin, Renal Res Lab, Milan, Italy; [Mattinzoli, Deborah; Rastaldi, Maria P.] Fdn DAmico Ric Malattie Renali, Milan, Italy	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Michigan System; University of Michigan; University of Munich; IRCCS Ca Granda Ospedale Maggiore Policlinico	Lindenmeyer, MT (corresponding author), Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland.	clemens.cohen@access.uzh.ch	Anders, Hans-Joachim/ABD-6247-2021; Mattinzoli, Deborah/AAP-9152-2021	Mattinzoli, Deborah/0000-0003-0478-022X; Anders, Hans-Joachim/0000-0003-2434-2956; Lindenmeyer, Maja/0000-0003-4162-9107	Swiss National Science Foundation [32-122439/1]; Else Kroener-Fresenius Foundation [A62/04]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079912] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Else Kroener-Fresenius Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the Swiss National Science Foundation (32-122439/1) and the Else Kroener-Fresenius Foundation (A62/04) to CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach J, 2008, NEPHROL DIAL TRANSPL, V23, P3138, DOI 10.1093/ndt/gfn235; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Beltran PJ, 2003, J COMP NEUROL, V456, P384, DOI 10.1002/cne.10532; Cappelletti G, 2007, J NEUROSCI RES, V85, P2702, DOI 10.1002/jnr.21235; Chabardes-Garonne D, 2003, P NATL ACAD SCI USA, V100, P13710, DOI 10.1073/pnas.2234604100; Cohen CD, 2006, P NATL ACAD SCI USA, V103, P5682, DOI 10.1073/pnas.0511257103; Cohen CD, 2005, J AM SOC NEPHROL, V16, P1958, DOI 10.1681/ASN.2005020204; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; Cove-Smith A, 2008, NEPHRON EXP NEPHROL, V108, pE74, DOI 10.1159/000127359; Cuellar LM, 2009, NEPHROLOGY, V14, P94, DOI 10.1111/j.1440-1797.2008.01009.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; El-Aouni C, 2006, J AM SOC NEPHROL, V17, P1334, DOI 10.1681/ASN.2005090921; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2006, J AM SOC NEPHROL, V17, P724, DOI 10.1681/ASN.2005080810; FAN KLQ, 2009, ROBO2 IS PODOCYTE PR; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Ghose A, 2002, BIOESSAYS, V24, P401, DOI 10.1002/bies.10080; Giardino L, 2009, J AM SOC NEPHROL, V20, P1929, DOI 10.1681/ASN.2008121286; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Guo JH, 2005, CYTOGENET GENOME RES, V111, P107, DOI 10.1159/000086378; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; He L, 2008, J AM SOC NEPHROL, V19, P260, DOI 10.1681/ASN.2007050588; Higgins JPT, 2004, MOL BIOL CELL, V15, P649, DOI 10.1091/mbc.E03-06-0432; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jefferson JA, 2007, NEPHROL DIAL TRANSPL, V22, P1849, DOI 10.1093/ndt/gfm098; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; KANEHISA M, 2009, NUCL ACIDS RES; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Karamoysoyli E, 2008, DIABETES, V57, P181, DOI 10.2337/db07-0895; Kobayashi Naoto, 2004, Anatomical Science International, V79, P1, DOI 10.1111/j.1447-073x.2004.00066.x; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kwoh C, 2006, ANNU REV PATHOL-MECH, V1, P349, DOI 10.1146/annurev.pathol.1.110304.100119; Le Jan S, 2006, FEBS LETT, V580, P3395, DOI 10.1016/j.febslet.2006.05.011; Legg JA, 2008, ANGIOGENESIS, V11, P13, DOI 10.1007/s10456-008-9100-x; Lu WN, 2007, AM J HUM GENET, V80, P616, DOI 10.1086/512735; Marshall CB, 2007, NEPHRON EXP NEPHROL, V106, pE51, DOI 10.1159/000101793; Marshall CB, 2006, NEPHRON EXP NEPHROL, V102, P39, DOI 10.1159/000088400; Matsui K, 1998, J AM SOC NEPHROL, V9, P2013; Meyer-Schwesinger C, 2009, J PATHOL, V217, P452, DOI 10.1002/path.2446; Miao J, 2009, NEPHROL DIAL TRANSPL, V24, P3297, DOI 10.1093/ndt/gfp338; Moeller MJ, 2004, EMBO J, V23, P3769, DOI 10.1038/sj.emboj.7600380; Morton MJ, 2004, J AM SOC NEPHROL, V15, P2981, DOI 10.1097/01.ASN.0000145046.24268.0D; Naeve GS, 1997, P NATL ACAD SCI USA, V94, P2648, DOI 10.1073/pnas.94.6.2648; Nystrom J, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-13; Patrakka J, 2007, J AM SOC NEPHROL, V18, P689, DOI 10.1681/ASN.2006060675; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Piper M, 2000, MECH DEVELOP, V94, P213, DOI 10.1016/S0925-4773(00)00313-0; Prasad A, 2007, J LEUKOCYTE BIOL, V82, P465, DOI 10.1189/jlb.1106678; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Raggo C, 2005, CANCER RES, V65, P5084, DOI 10.1158/0008-5472.CAN-04-2822; Rascle A, 2007, NEPHRON EXP NEPHROL, V106, pE60, DOI 10.1159/000101794; Rastaldi MP, 2006, FASEB J, V20, P976, DOI 10.1096/fj.05-4962fje; Rickhag M, 2007, BRAIN RES, V1151, P203, DOI 10.1016/j.brainres.2007.03.005; RONCO P, J AM SOC NEPHROL; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schmid H, 2003, J AM SOC NEPHROL, V14, P2958, DOI 10.1097/01.ASN.0000090745.85482.06; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Schmieder S, 2004, J AM SOC NEPHROL, V15, P2289, DOI 10.1097/01.ASN.0000135968.49899.E8; SCHNABEL E, 1990, J CELL BIOL, V111, P1255, DOI 10.1083/jcb.111.3.1255; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; Thorner PS, 2008, J AM SOC NEPHROL, V19, P495, DOI 10.1681/ASN.2006101115; United States Renal Data System, 2016, EXPL TRIAL EV SAF IM; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616	73	60	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11545	10.1371/journal.pone.0011545	http://dx.doi.org/10.1371/journal.pone.0011545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634963	Green Published, Green Submitted, gold			2022-12-25	WOS:000279781600022
J	Manitt, C; Labelle-Dumais, C; Eng, C; Grant, A; Mimee, A; Stroh, T; Flores, C				Manitt, Colleen; Labelle-Dumais, Cassandre; Eng, Conrad; Grant, Alanna; Mimee, Andrea; Stroh, Thomas; Flores, Cecilia			Peri-Pubertal Emergence of UNC-5 Homologue Expression by Dopamine Neurons in Rodents	PLOS ONE			English	Article							COLORECTAL-CANCER DCC; PREFRONTAL CORTEX; NETRIN RECEPTOR; POSTNATAL-DEVELOPMENT; AXON GUIDANCE; FAMILY; GROWTH; BRAIN; LOCALIZATION; AMPHETAMINE	Puberty is a critical period in mesocorticolimbic dopamine (DA) system development, particularly for the medial prefrontal cortex (mPFC) projection which achieves maturity in early adulthood. The guidance cue netrin-1 organizes neuronal networks by attracting or repelling cellular processes through DCC (deleted in colorectal cancer) and UNC-5 homologue (UNC5H) receptors, respectively. We have shown that variations in netrin-1 receptor levels lead to selective reorganization of mPFC DA circuitry, and changes in DA-related behaviors, in transgenic mice and in rats. Significantly, these effects are only observed after puberty, suggesting that netrin-1 mediated effects on DA systems vary across development. Here we report on the normal expression of DCC and UNC5H in the ventral tegmental area (VTA) by DA neurons from embryonic life to adulthood, in both mice and rats. We show a dramatic and enduring pubertal change in the ratio of DCC: UNC5H receptors, reflecting a shift toward predominant UNC5H function. This shift in DCC: UNC5H ratio coincides with the pubertal emergence of UNC5H expression by VTA DA neurons. Although the distribution of DCC and UNC5H by VTA DA neurons changes during puberty, the pattern of netrin-1 immunoreactivity in these cells does not. Together, our findings suggest that DCC: UNC5H ratios in DA neurons at critical periods may have important consequences for the organization and function of mesocorticolimbic DA systems.	[Manitt, Colleen; Labelle-Dumais, Cassandre; Eng, Conrad; Grant, Alanna; Mimee, Andrea; Flores, Cecilia] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Stroh, Thomas] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Manitt, C (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	cecilia.flores@mcgill.ca	Flores, Cecilia/N-7799-2017	Flores, Cecilia/0000-0001-8606-5910	Canadian Institutes of Health [MOP-74709]; National Science and Engineering Research Council [298226, 327327-06]; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institutes of Health (C.F., Grant Number: MOP-74709), the National Science and Engineering Research Council (C.F., Grant Number: 298226; T. S., 327327-06, A. G., student fellowship) and Fonds de la Recherche en Sante du Quebec (CF). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Adriani W, 2004, BEHAV PHARMACOL, V15, P341, DOI 10.1097/00008877-200409000-00005; Andersen SL, 2000, SYNAPSE, V37, P167, DOI 10.1002/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Andrews GL, 2008, DEVELOPMENT, V135, P3839, DOI 10.1242/dev.023739; Baker KA, 2006, CURR OPIN NEUROBIOL, V16, P529, DOI 10.1016/j.conb.2006.08.002; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Bartoe JL, 2006, J NEUROSCI, V26, P3192, DOI 10.1523/JNEUROSCI.3469-05.2006; Benes FM, 2000, CEREB CORTEX, V10, P1014, DOI 10.1093/cercor/10.10.1014; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bouchard JF, 2004, J NEUROSCI, V24, P3040, DOI 10.1523/JNEUROSCI.4934-03.2004; BOUCHARD JF, 2008, J NEUROCHEM; Cao J, 2007, NEUROPSYCHOPHARMACOL, V32, P2279, DOI 10.1038/sj.npp.1301349; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Cooper HM, 1995, ONCOGENE, V11, P2243; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Flores C, 2005, MOL PSYCHIATR, V10, P606, DOI 10.1038/sj.mp.4001607; Ford CP, 2006, J NEUROSCI, V26, P2788, DOI 10.1523/JNEUROSCI.4331-05.2006; Gad JM, 2000, EXP EYE RES, V70, P711, DOI 10.1006/exer.2000.0823; Gad JM, 1997, DEV BIOL, V192, P258, DOI 10.1006/dbio.1997.8756; Gogolla N, 2007, CURR OPIN NEUROBIOL, V17, P516, DOI 10.1016/j.conb.2007.09.002; Grant A, 2007, EUR J NEUROSCI, V26, P3215, DOI 10.1111/j.1460-9568.2007.05888.x; Grant A, 2009, EUR J NEUROSCI, V30, P1318, DOI 10.1111/j.1460-9568.2009.06919.x; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hutchins BI, 2008, J NEUROSCI, V28, P143, DOI 10.1523/JNEUROSCI.4548-07.2008; JACOBOWITZ DM, 1998, CHEMOARCHITECTONIC A; Juarez I, 2008, J COMP NEUROL, V507, P1734, DOI 10.1002/cne.21651; KALSBEEK A, 1988, J COMP NEUROL, V269, P58, DOI 10.1002/cne.902690105; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; KENNEDY TE, 1994, CELL, V78, P435; Knable MB, 1997, J PSYCHOPHARMACOL, V11, P123, DOI 10.1177/026988119701100205; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; LEMOAL M, 1991, PHYSIOL REV, V71, P155, DOI 10.1152/physrev.1991.71.1.155; Lim YS, 1999, J NEUROSCI, V19, P7048, DOI 10.1523/JNEUROSCI.19-16-07048.1999; Lin L, 2005, MOL CELL NEUROSCI, V28, P547, DOI 10.1016/j.mcn.2004.11.009; Liu GF, 2009, P NATL ACAD SCI USA, V106, P2951, DOI 10.1073/pnas.0811083106; Livesey FJ, 1997, MOL CELL NEUROSCI, V8, P417, DOI 10.1006/mcne.1997.0598; Lu WX, 2002, NEUROPSYCHOPHARMACOL, V26, P1, DOI 10.1016/S0893-133X(01)00272-X; Ly A, 2008, CELL, V133, P1241, DOI 10.1016/j.cell.2008.05.030; Manitt C, 2001, J NEUROSCI, V21, P3911, DOI 10.1523/JNEUROSCI.21-11-03911.2001; Manitt C, 2002, PROG BRAIN RES, V137, P425; Manitt C, 2004, J NEUROSCI RES, V77, P690, DOI 10.1002/jnr.20199; Manitt C, 2009, J NEUROSCI, V29, P11065, DOI 10.1523/JNEUROSCI.0947-09.2009; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; McKenna WL, 2008, J NEUROCHEM, V104, P1081, DOI 10.1111/j.1471-4159.2007.05040.x; Mueller D, 2006, NEUROSCIENCE, V137, P727, DOI 10.1016/j.neuroscience.2005.09.038; Muramatsu R, 2010, BRAIN, V133, P60, DOI 10.1093/brain/awp266; Osborne PB, 2005, NEUROSCIENCE, V131, P671, DOI 10.1016/j.neuroscience.2004.11.043; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Paxinos G., 1991, ATLAS DEV RAT BRAIN; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Rajasekharan S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-239; Riddle R, 2003, DEV BRAIN RES, V147, P3, DOI 10.1016/j.devbrainres.2003.09.010; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Schmitz Y, 2009, J NEUROSCI, V29, P11973, DOI 10.1523/JNEUROSCI.2927-09.2009; Seaman C, 2001, MECH DEVELOP, V103, P173, DOI 10.1016/S0925-4773(01)00350-1; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Sesack S R, 1998, Adv Pharmacol, V42, P171; Shu TZ, 2000, J COMP NEUROL, V416, P201, DOI 10.1002/(SICI)1096-9861(20000110)416:2<201::AID-CNE6>3.0.CO;2-Z; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Tam SY, 1997, BIOCHEM PHARMACOL, V53, P441; Tang FJ, 2005, J NEUROSCI, V25, P6702, DOI 10.1523/JNEUROSCI.0871-05.2005; Tarazi FI, 2000, INT J DEV NEUROSCI, V18, P29, DOI 10.1016/S0736-5748(99)00108-2; TEICHER MH, 1995, DEV BRAIN RES, V89, P167, DOI 10.1016/0165-3806(95)00109-Q; Tong JF, 2001, J BIOL CHEM, V276, P40917, DOI 10.1074/jbc.M103872200; Tseng KY, 2007, SYNAPSE, V61, P843, DOI 10.1002/syn.20432; Tseng KY, 2007, CEREB CORTEX, V17, P1235, DOI 10.1093/cercor/bhl034; Uesaka N, 2006, NEUROSCIENTIST, V12, P102, DOI 10.1177/1073858405281673; Van den Heuvel DMA, 2008, PROG NEUROBIOL, V85, P75, DOI 10.1016/j.pneurobio.2008.01.003; Volenec A, 1998, NEUROREPORT, V9, P3553, DOI 10.1097/00001756-199811160-00002; VOORN P, 1988, NEUROSCIENCE, V25, P857, DOI 10.1016/0306-4522(88)90041-3; Williams ME, 2003, J NEUROSCI, V23, P11279; WOLF ME, 1989, J NEUROSCI, V9, P106; Yang ZG, 2008, J COMP NEUROL, V511, P19, DOI 10.1002/cne.21819; Yetnikoff L, 2007, NEUROSCIENCE, V150, P764, DOI 10.1016/j.neuroscience.2007.09.069; Yetnikoff L, 2010, EUR J NEUROSCI, V31, P1292, DOI 10.1111/j.1460-9568.2010.07163.x	82	41	41	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11463	10.1371/journal.pone.0011463	http://dx.doi.org/10.1371/journal.pone.0011463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628609	Green Submitted, gold, Green Published			2022-12-25	WOS:000279637100003
J	Tam, CHT; Ho, JSK; Wang, Y; Lee, HM; Lam, VKL; Germer, S; Martin, M; So, WY; Ma, RCW; Chan, JCN; Ng, MCY				Tam, Claudia Ha Ting; Ho, Janice Sin Ka; Wang, Ying; Lee, Heung Man; Lam, Vincent Kwok Lim; Germer, Soren; Martin, Mitchell; So, Wing Yee; Ma, Ronald Ching Wan; Chan, Juliana Chung Ngor; Ng, Maggie Chor Yin			Common Polymorphisms in MTNR1B, G6PC2 and GCK Are Associated with Increased Fasting Plasma Glucose and Impaired Beta-Cell Function in Chinese Subjects	PLOS ONE			English	Article							INSULIN-RESISTANCE; GLUCOKINASE; DEFINITION; TOLERANCE; VARIANT; LOCI; HYPERGLYCEMIA; METAANALYSIS; HOMEOSTASIS; POPULATION	Background: Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG). We examined the associations of the reported common variants of these genes with T2D and glucose homeostasis in three independent Chinese cohorts. Methodology/Principal Findings: Five single nucleotide polymorphisms (SNPs), MTNR1B rs10830963, G6PC2 rs16856187 and rs478333, GCK rs1799884 and GCKR rs780094, were genotyped in 1644 controls (583 adults and 1061 adolescents) and 1342 T2D patients. The G-allele of MTNR1B rs10830963 and the C-alleles of both G6PC2 rs16856187 and rs478333 were associated with higher FPG (0.0034<P<6.6x10(-5)) in healthy controls. In addition to our previous report for association with FPG, the A-allele of GCK rs1799884 was also associated with reduced homeostasis model assessment of beta-cell function (HOMA-B) (P=0.0015). Together with GCKR rs780094, the risk alleles of these SNPs exhibited dosage effect in their associations with increased FPG (P=2.9x10(-9)) and reduced HOMA-B (P=1.1x10(-3)). Meta-analyses strongly supported additive effects of MTNR1B rs10830963 and G6PC2 rs16856187 on FPG. Conclusions/Significance: Common variants of MTNR1B, G6PC2 and GCK are associated with elevated FPG and impaired insulin secretion, both individually and jointly, suggesting that these risk alleles may precipitate or perpetuate hyperglycemia in predisposed individuals.	[Tam, Claudia Ha Ting; Ho, Janice Sin Ka; Wang, Ying; Lee, Heung Man; Lam, Vincent Kwok Lim; So, Wing Yee; Ma, Ronald Ching Wan; Chan, Juliana Chung Ngor; Ng, Maggie Chor Yin] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Chan, Juliana Chung Ngor] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Chan, Juliana Chung Ngor] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong Inst Diabet & Obes, Shatin, Hong Kong, Peoples R China; [Germer, Soren; Martin, Mitchell] Roche Pharmaceut, Nutley, NJ USA	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Roche Holding	Tam, CHT (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	rcwma@cuhk.edu.hk	Ma, Ronald/C-2788-2009; Chan, Juliana/B-7918-2016	Ma, Ronald/0000-0002-1227-803X; Chan, Juliana/0000-0003-1325-1194	Hong Kong Government Research Grant Committee [CUHK 1/04C, CUHK472407]; Chinese University of Hong Kong [2006.1.041]	Hong Kong Government Research Grant Committee; Chinese University of Hong Kong(Chinese University of Hong Kong)	This study was funded by the Hong Kong Government Research Grant Committee Central Allocation Scheme (CUHK 1/04C), Research Grant Committee (CUHK472407) and the Chinese University of Hong Kong Direct Grant (2006.1.041).	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; BEER NL, 2009, HUM MOL GENET; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Chen WM, 2008, J CLIN INVEST, V118, P2620, DOI 10.1172/JCI34566; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fernandez-Mejia C, 2001, ENDOCRINOLOGY, V142, P1448, DOI 10.1210/en.142.4.1448; Freeman MS, 2002, DIABETIC MED, V19, P994, DOI 10.1046/j.1464-5491.2002.00843.x; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; Hu C, 2009, DIABETOLOGIA, V52, P451, DOI 10.1007/s00125-008-1241-3; Issad T, 2008, TRENDS ENDOCRIN MET, V19, P380, DOI 10.1016/j.tem.2008.09.001; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kelliny C, 2009, DIABETES, V58, P2939, DOI 10.2337/db09-0374; Langenberg C, 2009, DIABETOLOGIA, V52, P1537, DOI 10.1007/s00125-009-1392-x; Li JKY, 2006, DIABETES-METAB RES, V22, P46, DOI 10.1002/dmrr.577; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; MATSCHINSKY F, 1993, J CLIN INVEST, V92, P2092, DOI 10.1172/JCI116809; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Newgard CB, 2002, DIABETES, V51, pS389, DOI 10.2337/diabetes.51.2007.S389; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Peschke E, 2008, J PINEAL RES, V44, P26, DOI 10.1111/j.1600-079X.2007.00519.x; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Piche ME, 2004, DIABETES CARE, V27, P2470, DOI 10.2337/diacare.27.10.2470; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi Q, 2009, DIABETOLOGIA, V52, P834, DOI 10.1007/s00125-009-1290-2; REILING E, 2009, DIABETOLOGIA; Ronn T, 2009, DIABETOLOGIA, V52, P830, DOI 10.1007/s00125-009-1297-8; Rose CS, 2009, DIABETOLOGIA, V52, P2122, DOI 10.1007/s00125-009-1463-z; Rose CS, 2005, DIABETES, V54, P3026, DOI 10.2337/diabetes.54.10.3026; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shaw JE, 2000, DIABETES CARE, V23, P34, DOI 10.2337/diacare.23.1.34; Sparso T, 2009, DIABETES, V58, P1450, DOI 10.2337/db08-1660; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Takeuchi F, 2010, DIABETOLOGIA, V53, P299, DOI 10.1007/s00125-009-1595-1; Tam CHT, 2009, DIABETES, V58, P765, DOI 10.2337/db08-1277; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; VANSCHAFTINGEN E, 1994, DIABETOLOGIA, V37, pS43, DOI 10.1007/BF00400825; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Wang Y, 2008, DIABETES, V57, P133, DOI 10.2337/db07-0092; Wuehlbauer E, 2009, EUR J PHARMACOL, V606, P61, DOI 10.1016/j.ejphar.2009.01.029; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; ZHANG S, 2009, OBESITY SILVER SPRIN	50	56	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11428	10.1371/journal.pone.0011428	http://dx.doi.org/10.1371/journal.pone.0011428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628598	Green Published, gold, Green Submitted			2022-12-25	WOS:000279637100002
J	Lawaly, YR; Sakuntabhai, A; Marrama, L; Konate, L; Phimpraphi, W; Sokhna, C; Tall, A; Sarr, FD; Peerapittayamongkol, C; Louicharoen, C; Schneider, BS; Levescot, A; Talman, A; Casademont, I; Menard, D; Trape, JF; Rogier, C; Kaewkunwal, J; Sura, T; Nuchprayoon, I; Ariey, F; Baril, L; Singhasivanon, P; Mercereau-Puijalon, O; Paul, R				Lawaly, Yaye Ramatoulaye; Sakuntabhai, Anavaj; Marrama, Laurence; Konate, Lassana; Phimpraphi, Waraphon; Sokhna, Cheikh; Tall, Adama; Sarr, Fatoumata Diene; Peerapittayamongkol, Chayanon; Louicharoen, Chalisa; Schneider, Bradley S.; Levescot, Anais; Talman, Arthur; Casademont, Isabelle; Menard, Didier; Trape, Jean-Francois; Rogier, Christophe; Kaewkunwal, Jaranit; Sura, Thanyachai; Nuchprayoon, Issarang; Ariey, Frederic; Baril, Laurence; Singhasivanon, Pratap; Mercereau-Puijalon, Odile; Paul, Rick			Heritability of the Human Infectious Reservoir of Malaria Parasites	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM GAMETOCYTES; SICKLE-CELL TRAIT; HOLOENDEMIC AREA; SEGREGATION ANALYSIS; GENETIC COMPLEXITY; ANOPHELES-GAMBIAE; SEX DETERMINATION; KAREN POPULATION; LINKAGE ANALYSIS; DRUG-TREATMENT	Background: Studies on human genetic factors associated with malaria have hitherto concentrated on their role in susceptibility to and protection from disease. In contrast, virtually no attention has been paid to the role of human genetics in eliciting the production of parasite transmission stages, the gametocytes, and thus enhancing the spread of disease. Methods and Findings: We analysed four longitudinal family-based cohort studies from Senegal and Thailand followed for 2-8 years and evaluated the relative impact of the human genetic and non-genetic factors on gametocyte production in infections of Plasmodium falciparum or P. vivax. Prevalence and density of gametocyte carriage were evaluated in asymptomatic and symptomatic infections by examination of Giemsa-stained blood smears and/or RT-PCR (for falciparum in one site). A significant human genetic contribution was found to be associated with gametocyte prevalence in asymptomatic P. falciparum infections. By contrast, there was no heritability associated with the production of gametocytes for P. falciparum or P. vivax symptomatic infections. Sickle cell mutation, HbS, was associated with increased gametocyte prevalence but its contribution was small. Conclusions: The existence of a significant human genetic contribution to gametocyte prevalence in asymptomatic infections suggests that candidate gene and genome wide association approaches may be usefully applied to explore the underlying human genetics. Prospective epidemiological studies will provide an opportunity to generate novel and perhaps more epidemiologically pertinent gametocyte data with which similar analyses can be performed and the role of human genetics in parasite transmission ascertained.	[Lawaly, Yaye Ramatoulaye; Paul, Rick] Inst Pasteur, Lab Entomol Med, Dakar, Senegal; [Sakuntabhai, Anavaj; Phimpraphi, Waraphon; Peerapittayamongkol, Chayanon; Louicharoen, Chalisa; Levescot, Anais; Casademont, Isabelle; Paul, Rick] Inst Pasteur, Lab Genet Reponse Infect Chez Homme, Paris, France; [Sakuntabhai, Anavaj; Schneider, Bradley S.; Casademont, Isabelle; Paul, Rick] Inst Pasteur, Unite Pathogenie, Paris, France; [Marrama, Laurence; Tall, Adama; Sarr, Fatoumata Diene; Baril, Laurence] Inst Pasteur, Epidemiol Unit, Dakar, Senegal; [Konate, Lassana] UCAD, Fac Sci & Tech, Dakar, Senegal; [Phimpraphi, Waraphon; Kaewkunwal, Jaranit; Singhasivanon, Pratap] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Sokhna, Cheikh; Trape, Jean-Francois] Inst Rech Dev, Lab Paludol, Dakar, Senegal; [Louicharoen, Chalisa] Chulalongkorn Univ, Interdept Program Biomed Sci, Fac Grad Sch, Bangkok, Thailand; [Talman, Arthur; Menard, Didier; Ariey, Frederic] Inst Pasteur, Unite Epidemiol Mol, Phnom Penh, Cambodia; [Rogier, Christophe] Inst Trop Med, Serv Sante Armees, Unite Rech Biol & Epidemiol Parasitaires, IFR48, Marseille, France; [Sura, Thanyachai] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok 10400, Thailand; [Nuchprayoon, Issarang] Chulalongkorn Univ, Fac Med, Dept Pediat, Bangkok 10330, Thailand; [Mercereau-Puijalon, Odile] Inst Pasteur, CNRS, Unite Immunol Mol Parasites, URA 2581, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; University Cheikh Anta Diop Dakar; Mahidol University; Institut de Recherche pour le Developpement (IRD); Chulalongkorn University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Mahidol University; Chulalongkorn University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lawaly, YR (corresponding author), Inst Pasteur, Lab Entomol Med, Dakar, Senegal.	rpaul@pasteur.fr	Talman, Arthur/GMW-9116-2022; Peerapittayamongkol, Chayanon/B-4920-2010; ROGIER, Christophe/C-2550-2008; ariey, frederic/P-1185-2017; Menard, Didier/O-3294-2013; Peerapittayamongkol, Chayanon/K-7965-2019; Mercereau-Puijalon, Odile/AAA-2242-2020	ariey, frederic/0000-0002-0680-1090; Menard, Didier/0000-0003-1357-4495; Singhasivanon, Pratap/0000-0002-9759-1702; Nuchprayoon, Issarang/0000-0002-4014-5082; Talman, Arthur/0000-0003-2584-3672; Schneider, Bradley S/0000-0001-7642-0018; Baril, Laurence/0000-0003-2346-883X	Strategic Anopheles Horizontal Research Programme, Institut Pasteur to RELP; BIOTEC [BT-B06-MG14-4507]; Thailand Research Fund [BRG/16/2544]; Mahidol University [OR-9123]; INSERM; Faculty of Medicine Siriraj Hospital; Mahidol University, Thailand; Royal Golden Jubilee Program; Thailand Research Fund; French Embassy in Thailand; Ministry of Research, France; Institut Pasteur research grant	Strategic Anopheles Horizontal Research Programme, Institut Pasteur to RELP; BIOTEC; Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Faculty of Medicine Siriraj Hospital; Mahidol University, Thailand; Royal Golden Jubilee Program; Thailand Research Fund(Thailand Research Fund (TRF)); French Embassy in Thailand; Ministry of Research, France(Ministry of Research, France); Institut Pasteur research grant	This work was funded in part by the Strategic Anopheles Horizontal Research Programme, Institut Pasteur to RELP, by grants from BIOTEC (BT-B06-MG14-4507), the Thailand Research Fund (BRG/16/2544), Mahidol University grant (OR-9123) and the Institut Pasteur to A. S. C. P. was supported by post-doctoral fellowships from INSERM and from the Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand. C. T., W. P. and C. L. were supported by the Royal Golden Jubilee Program, the Thailand Research Fund and the French Embassy in Thailand. A. Talman was supported by "Fonds Dedies'' Sanofi-Aventis, Ministry of Research, France and Institut Pasteur research grant to F. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab A, 2002, J INFECT DIS, V185, P1838, DOI 10.1086/340638; ABEL L, 1992, AM J HUM GENET, V50, P1308; Ali E, 2006, T ROY SOC TROP MED H, V100, P176, DOI 10.1016/j.trstmh.2005.04.021; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; BAIRD JK, 1991, AM J TROP MED HYG, V44, P183, DOI 10.4269/ajtmh.1991.44.183; Bonnet S, 2003, T ROY SOC TROP MED H, V97, P53, DOI 10.1016/S0035-9203(03)90022-8; BOUDIN C, 1993, AM J TROP MED HYG, V48, P700, DOI 10.4269/ajtmh.1993.48.700; Bousema JT, 2008, AM J TROP MED HYG, V78, P442, DOI 10.4269/ajtmh.2008.78.442; Bousema JT, 2006, J INFECT DIS, V193, P1151, DOI 10.1086/503051; Bousema JT, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-18; Buckling A, 1999, PARASITOLOGY, V118, P339, DOI 10.1017/S0031182099003960; Cancre N, 2000, AM J EPIDEMIOL, V152, P760, DOI 10.1093/aje/152.8.760; Carter R, 2000, NAT MED, V6, P241, DOI 10.1038/73062; Carter R, 1979, Bull World Health Organ, V57 Suppl 1, P37; CARTER R, 1988, MALARIA PRINCIPLES P, P1; Chong SS, 2000, BLOOD, V95, P360; Drakeley C, 2006, TRENDS PARASITOL, V22, P424, DOI 10.1016/j.pt.2006.07.001; Drakeley CJ, 2005, J INFECT DIS, V191, P1589, DOI 10.1086/429669; Drakeley CJ, 2000, ANN TROP MED PARASIT, V94, P399, DOI 10.1080/00034983.2000.11813555; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010020; Dyer M, 2000, PARASITOL TODAY, V16, P102, DOI 10.1016/S0169-4758(99)01608-7; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X; Fontenille D, 1997, AM J TROP MED HYG, V56, P247, DOI 10.4269/ajtmh.1997.56.247; Garcia A, 1998, AM J TROP MED HYG, V58, P480, DOI 10.4269/ajtmh.1998.58.480; Garcia A, 1998, AM J TROP MED HYG, V58, P705, DOI 10.4269/ajtmh.1998.58.705; Gilmour A. R., ASREML USER GUIDE RE; GITHEKO AK, 1992, T ROY SOC TROP MED H, V86, P355, DOI 10.1016/0035-9203(92)90216-Y; Gouagna LC, 2010, NAT GENET, V42, P328, DOI 10.1038/ng.554; GRAVES PM, 1984, AM J TROP MED HYG, V33, P1045, DOI 10.4269/ajtmh.1984.33.1045; GREENWOOD BM, 1987, PARASITOL TODAY, V3, P206, DOI 10.1016/0169-4758(87)90061-5; Haldane J.B.S., 1949, HEREDITAS, V35, P267; Hayward RE, 1999, P NATL ACAD SCI USA, V96, P4563, DOI 10.1073/pnas.96.8.4563; JEFFERY GM, 1955, AM J TROP MED HYG, V4, P781, DOI 10.4269/ajtmh.1955.4.781; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; MACDONALD G, 1951, BRIT MED BULL, V8, P33, DOI 10.1093/oxfordjournals.bmb.a074051; Mackinnon MJ, 2000, P NATL ACAD SCI USA, V97, P12661, DOI 10.1073/pnas.220267997; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; MUIRHEADTHOMSON RC, 1954, BRIT MED J, V1, P68, DOI 10.1136/bmj.1.4853.68; Nacher M, 2002, J PARASITOL, V88, P97, DOI 10.1645/0022-3395(2002)088[0097:DHCHAS]2.0.CO;2; Nassir E, 2005, INT J PARASITOL, V35, P49, DOI 10.1016/j.ijpara.2004.10.014; Oesterholt MJAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004364; Paganotti GM, 2006, PARASITOLOGY, V132, P607, DOI 10.1017/S0031182005009601; Paul REL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-39; Paul REL, 2003, ECOL LETT, V6, P866, DOI 10.1046/j.1461-0248.2003.00509.x; Paul REL, 2002, TRENDS PARASITOL, V18, P32, DOI 10.1016/S1471-4922(01)02122-5; Paul REL, 2000, SCIENCE, V287, P128, DOI 10.1126/science.287.5450.128; PERRY EL, 1914, INDIAN J MED RES, V2, P459; Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99; Phimpraphi W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003887; Piper KP, 1999, INFECT IMMUN, V67, P6369; Price R, 1999, AM J TROP MED HYG, V60, P1019, DOI 10.4269/ajtmh.1999.60.1019; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; Rihet P, 1998, GENET EPIDEMIOL, V15, P435, DOI 10.1002/(SICI)1098-2272(1998)15:5<435::AID-GEPI1>3.0.CO;2-#; Robert V, 1996, AM J TROP MED HYG, V54, P111, DOI 10.4269/ajtmh.1996.54.111; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; ROSENBERG R, 1990, T ROY SOC TROP MED H, V84, P29, DOI 10.1016/0035-9203(90)90369-P; Rozen S, 2000, Methods Mol Biol, V132, P365; Saeed M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002280; Sakuntabhai A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002000; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; Shekalaghe SA, 2007, TROP MED INT HEALTH, V12, P547, DOI 10.1111/j.1365-3156.2007.01821.x; Sinden RE, 1996, ADV PARASIT, V38, P53, DOI 10.1016/S0065-308X(08)60033-0; SMALLEY ME, 1977, PARASITOLOGY, V74, P1, DOI 10.1017/S0031182000047478; SMALLEY ME, 1981, T ROY SOC TROP MED H, V75, P316, DOI 10.1016/0035-9203(81)90348-5; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Timmann C, 2007, PLOS GENET, V3, P393, DOI 10.1371/journal.pgen.0030048; TRAGER W, 1992, J PROTOZOOL, V39, P429, DOI 10.1111/j.1550-7408.1992.tb01476.x; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; *VSN INT LTD, GENSTAT WIND; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; WEATHERALL DJ, 1987, ANN TROP MED PARASIT, V81, P539, DOI 10.1080/00034983.1987.11812155; WEATHERALL DJ, 2003, OXFORD TXB MED; Williams TN, 1996, NATURE, V383, P522, DOI 10.1038/383522a0; WILSON D. Bagster, 1936, Transactions of the Royal Society of Tropical Medicine and Hygiene, V29, P583, DOI 10.1016/S0035-9203(36)90040-8	80	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11358	10.1371/journal.pone.0011358	http://dx.doi.org/10.1371/journal.pone.0011358			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613877	Green Published, gold, Green Submitted			2022-12-25	WOS:000279369900007
J	Li, G; Elder, RT; Dubrovsky, L; Liang, D; Pushkarsky, T; Chiu, K; Fan, T; Sire, J; Bukrinsky, M; Zhao, RY				Li, Ge; Elder, Robert T.; Dubrovsky, Larisa; Liang, Dong; Pushkarsky, Tatiana; Chiu, Karen; Fan, Tao; Sire, Josephine; Bukrinsky, Michael; Zhao, Richard Y.			HIV-1 Replication through hHR23A-Mediated Interaction of Vpr with 26S Proteasome	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL-PROTEIN-R; CELL-CYCLE ARREST; DNA-REPAIR PROTEIN; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; EFFICIENT REPLICATION; NUCLEAR-ENVELOPE; HUMAN HOMOLOG; RAD23	HIV-1 Vpr is a virion-associated protein. Its activities link to viral pathogenesis and disease progression of HIV-infected patients. In vitro, Vpr moderately activates HIV-1 replication in proliferating T cells, but it is required for efficient viral infection and replication in vivo in non-dividing cells such as macrophages. How exactly Vpr contributes to viral replication remains elusive. We show here that Vpr stimulates HIV-1 replication at least in part through its interaction with hHR23A, a protein that binds to 19S subunit of the 26S proteasome and shuttles ubiquitinated proteins to the proteasome for degradation. The Vpr-proteasome interaction was initially discovered in fission yeast, where Vpr was shown to associate with Mts4 and Mts2, two 19S-associated proteins. The interaction of Vpr with the 19S subunit of the proteasome was further confirmed in mammalian cells where Vpr associates with the mammalian orthologues of fission yeast Mts4 and S5a. Consistently, depletion of hHR23A interrupts interaction of Vpr with proteasome in mammalian cells. Furthermore, Vpr promotes hHR23A-mediated protein-ubiquitination, and down-regulation of hHR23A using RNAi significantly reduced viral replication in non-proliferating MAGI-CCR5 cells and primary macrophages. These findings suggest that Vpr-proteasome interaction might counteract certain host restriction factor(s) to stimulate viral replication in non-dividing cells.	[Li, Ge; Liang, Dong; Fan, Tao; Zhao, Richard Y.] Univ Maryland, Sch Med, Dept Pathol, Dept Microbiology Immunol,Inst Human Virol, Baltimore, MD 21201 USA; [Elder, Robert T.; Chiu, Karen; Zhao, Richard Y.] Northwestern Univ, Childrens Mem Res Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Sire, Josephine] INSERM, U372, F-13258 Marseille, France; [Dubrovsky, Larisa; Pushkarsky, Tatiana; Bukrinsky, Michael] George Washington Univ, Dept Microbiol & Trop Med, Washington, DC USA	University System of Maryland; University of Maryland Baltimore; Northwestern University; Feinberg School of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); George Washington University	Li, G (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Dept Microbiology Immunol,Inst Human Virol, Baltimore, MD 21201 USA.	rzhao@som.umaryland.edu		Zhao, Richard Y./0000-0003-3424-2852	National Institutes of Health [AI40891, GM63080]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040891, R21AI033776, R21AI040891, R01AI033776, R29AI040891, R01AI040386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by National Institutes of Health Grants AI40891 and GM63080 (to R.Y.Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini I, 2000, EXP CELL RES, V259, P398, DOI 10.1006/excr.2000.4992; Apcher GS, 2003, FEBS LETT, V553, P200, DOI 10.1016/S0014-5793(03)01025-1; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, J VIROL, V84, P3320, DOI 10.1128/JVI.02590-09; Benko Z, 2004, J VIROL, V78, P11016, DOI 10.1128/JVI.78.20.11016-11029.2004; Benko Z, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-16; BUKRINSKY MI, 1997, FRONT BIOSCI, V2, P578; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Elder RT, 2002, NUCLEIC ACIDS RES, V30, P581, DOI 10.1093/nar/30.2.581; Elder RT, 2001, VIROLOGY, V287, P359, DOI 10.1006/viro.2001.1007; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Franco M, 2007, EXP CELL RES, V313, P2687, DOI 10.1016/j.yexcr.2007.04.003; Goh Teik-Khiang, 1998, Fungal Diversity, V1, P65; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Gragerov A, 1998, VIROLOGY, V245, P323, DOI 10.1006/viro.1998.9138; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Huard S, 2008, J VIROL, V82, P2904, DOI 10.1128/JVI.01098-07; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Klare N, 2007, J MOL BIOL, V373, P1, DOI 10.1016/j.jmb.2007.07.038; Le Rouzic E, 2002, J BIOL CHEM, V277, P45091, DOI 10.1074/jbc.M207439200; Li G, 2009, CURR HIV RES, V7, P178, DOI 10.2174/157016209787581436; Li TW, 2000, BIOCHEM BIOPH RES CO, V272, P270, DOI 10.1006/bbrc.2000.2767; Liang D, 2007, MOL MED, V13, P229, DOI 10.2119/2007-00004.Liang; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Mansky LM, 2001, VIROLOGY, V282, P176, DOI 10.1006/viro.2000.0791; Poon B, 1998, SCIENCE, V281, P266, DOI 10.1126/science.281.5374.266; Popov S, 1998, J BIOL CHEM, V273, P13347, DOI 10.1074/jbc.273.21.13347; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sherman MP, 2003, J VIROL, V77, P7582, DOI 10.1128/JVI.77.13.7582-7589.2003; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Stewart SA, 1997, J VIROL, V71, P5579, DOI 10.1128/JVI.71.7.5579-5592.1997; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Tatebe H, 2000, CURR BIOL, V10, P1329, DOI 10.1016/S0960-9822(00)00773-9; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Waldhuber MG, 2003, VIROLOGY, V313, P91, DOI 10.1016/S0042-6822(03)00258-7; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wilkinson CRM, 1999, PHILOS T R SOC B, V354, P1523, DOI 10.1098/rstb.1999.0496; Wilkinson CRM, 1998, EMBO J, V17, P6465, DOI 10.1093/emboj/17.22.6465; Wilkinson CRM, 1997, J BIOL CHEM, V272, P25768, DOI 10.1074/jbc.272.41.25768; WithersWard ES, 1997, J VIROL, V71, P9732, DOI 10.1128/JVI.71.12.9732-9742.1997; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhao RY, 2005, INDIAN J MED RES, V121, P270; ZHAO Y, 1998, BIOTECHNIQUES, V25, P2; Zhao YQ, 1996, J VIROL, V70, P5821, DOI 10.1128/JVI.70.9.5821-5826.1996; Zhao YQ, 1998, VIROLOGY, V246, P266, DOI 10.1006/viro.1998.9208; Zhu QZ, 2001, CANCER RES, V61, P64; [No title captured]	59	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11371	10.1371/journal.pone.0011371	http://dx.doi.org/10.1371/journal.pone.0011371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20614012	gold, Green Published, Green Submitted			2022-12-25	WOS:000279369900019
J	van Ham, TJ; Mapes, J; Kokel, D; Peterson, RT				van Ham, Tjakko J.; Mapes, James; Kokel, David; Peterson, Randall T.			Live imaging of apoptotic cells in zebrafish	FASEB JOURNAL			English	Article						neuronal cell death; in vivo microscopy; vertebrate model; neurotoxicity; p53; DNA damage response	DNA FRAGMENTATION; GENE-EXPRESSION; DEATH; EMBRYO; PHOSPHATIDYLSERINE; NEURONS; BRAIN; MODEL	Many debilitating diseases, including neurodegenerative diseases, involve apoptosis. Several methods have been developed for visualizing apoptotic cells in vitro or in fixed tissues, but few tools are available for visualizing apoptotic cells in live animals. Here we describe a genetically encoded fluorescent reporter protein that labels apoptotic cells in live zebrafish embryos. During apoptosis, the phospholipid phosphatidylserine (PS) is exposed on the outer leaflet of the plasma membrane. The calcium-dependent protein Annexin V (A5) binds PS with high affinity, and biochemically purified, fluorescently labeled A5 probes have been widely used to detect apoptosis in vitro. Here we show that secreted A5 fused to yellow fluorescent protein specifically labels apoptotic cells in living zebrafish. We use this fluorescent probe to characterize patterns of apoptosis in living zebrafish larvae and to visualize neuronal cell death at single-cell resolution in vivo.-Van Ham, T. J., Mapes, J., Kokel, D., Peterson, R. T. Live imaging of apoptotic cells in zebrafish. FASEB J. 24, 4336-4342 (2010). www.fasebj.org	[van Ham, Tjakko J.; Kokel, David; Peterson, Randall T.] Harvard Univ, Cardiovasc Res Ctr, Massachusetts Gen Hosp, Sch Med, Charlestown, MA 02129 USA; [van Ham, Tjakko J.; Kokel, David; Peterson, Randall T.] Harvard Univ, Div Cardiol, Massachusetts Gen Hosp, Sch Med,Dept Med, Charlestown, MA 02129 USA; [van Ham, Tjakko J.; Kokel, David; Peterson, Randall T.] Broad Inst, Cambridge, MA USA; [Mapes, James] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Colorado System; University of Colorado Boulder	Peterson, RT (corresponding author), Harvard Univ, Cardiovasc Res Ctr, Massachusetts Gen Hosp, Sch Med, 149 13th St, Charlestown, MA 02129 USA.	peterson@cvrc.mgh.harvard.edu	van Ham, Tjakko/I-2382-2013; van Ham, Tjakko/A-1989-2015; van Ham, Tjakko/W-8614-2019	van Ham, Tjakko/0000-0002-2175-8713; van Ham, Tjakko/0000-0002-2175-8713; kokel, david/0000-0002-1981-1511; Peterson, Randall/0000-0003-0727-3469	National Institutes of Health (NIH) [NS063733, MH086867]; NIH/National Cancer for Research Resources Centers of Biomedical Research Excellence in Obesity and Cardiovascular Disease [P20 RR021954]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH091449, R01MH086867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS063733] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Cancer for Research Resources Centers of Biomedical Research Excellence in Obesity and Cardiovascular Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the members of the R.T.P. laboratory for technical assistance and advice, Lindsay Cade for graphical expertise, Ding Xue (University of Colorado, Boulder, CO, USA) for helpful comments, David Langenau and Myron Ignatius (Massachusetts General Hospital Cancer Center, Charlestown, MA, USA) for p53 mutant animals, Chetana Satchidanandan (Institute of Genomics and Integrative Biology, Delhi, India) and Martin Distel and Reinhard Koester (Helmholtz Institute, Munich, Germany) for transgenic animals, the Koichi Kawakami laboratory (National Institute of Genetics, Mishima, Japan) for reagents, Anne Hart for use of equipment, the Michael L. Nonet laboratory (Washington University, St. Louis, MO, USA) for plasmids, and Iain Drummond (Massachusetts General Hospital, Charlestown, MA, USA) for advice on microscopy. This work was supported by National Institutes of Health (NIH) grants NS063733 and MH086867. This work was supported in part by the NIH/National Cancer for Research Resources Centers of Biomedical Research Excellence in Obesity and Cardiovascular Disease, grant P20 RR021954.	Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Burket CT, 2008, TRANSGENIC RES, V17, P265, DOI 10.1007/s11248-007-9152-5; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Collins JA, 1997, J HISTOCHEM CYTOCHEM, V45, P923, DOI 10.1177/002215549704500702; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; FADOK VA, 1992, J IMMUNOL, V148, P2207; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GORDON N, 1995, BRAIN DEV-JPN, V17, P73, DOI 10.1016/0387-7604(94)00109-B; Granato M, 1996, DEVELOPMENT, V123, P399; GRUNWALD DJ, 1988, DEV BIOL, V126, P115, DOI 10.1016/0012-1606(88)90245-X; Hale ME, 2001, J COMP NEUROL, V437, P1, DOI 10.1002/cne.1266; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KIMMEL CB, 1993, ANNU REV NEUROSCI, V16, P707, DOI 10.1146/annurev.ne.16.030193.003423; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; LAMBORGHINI JE, 1987, J COMP NEUROL, V264, P47, DOI 10.1002/cne.902640105; Lecoeur H, 2002, EXP CELL RES, V277, P1, DOI 10.1006/excr.2002.5537; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Lowery LA, 2005, DEVELOPMENT, V132, P2057, DOI 10.1242/dev.01791; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Morris EJ, 1996, J CELL BIOL, V134, P757, DOI 10.1083/jcb.134.3.757; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; ROBERTSON AMG, 1978, J PATHOL, V126, P181, DOI 10.1002/path.1711260307; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; SCHOENWOLF GC, 1981, ANAT EMBRYOL, V162, P183, DOI 10.1007/BF00306490; SOLNICAKREZEL L, 1995, BIOESSAYS, V17, P931, DOI 10.1002/bies.950171106; Song J, 2008, NEUROSCIENCE, V156, P722, DOI 10.1016/j.neuroscience.2008.07.024; van Eeden FJM, 1999, METHOD CELL BIOL, V60, P21; van Genderen H, 2006, NAT PROTOC, V1, P363, DOI 10.1038/nprot.2006.55; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	35	86	87	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4336	4342		10.1096/fj.10-161018	http://dx.doi.org/10.1096/fj.10-161018			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20601526	Green Published			2022-12-25	WOS:000283861100021
J	Lo, WY; Lagrange, AH; Hernandez, CC; Harrison, R; Dell, A; Haslam, SM; Sheehan, JH; Macdonald, RL				Lo, Wen-yi; Lagrange, Andre H.; Hernandez, Ciria C.; Harrison, Rebecca; Dell, Anne; Haslam, Stuart M.; Sheehan, Jonathan H.; Macdonald, Robert L.			Glycosylation of beta 2 Subunits Regulates GABA(A) Receptor Biogenesis and Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; SITE-DIRECTED MUTAGENESIS; N-LINKED GLYCOSYLATION; GATED ION-CHANNEL; X-SER/THR SEQUON; ALPHA-1 SUBUNIT; AMINO-ACID; EPILEPSY MUTATION; CRYSTAL-STRUCTURE; AGONIST BINDING	gamma-Aminobutyric acid type A (GABA(A)) receptors are hetero-pentameric glycoproteins. Based on consensus sequences, the GABA(A) receptor beta 2 subunit contains three potential N-linked glycosylation sites, Asn-32, Asn-104, and Asn-173. Homology modeling indicates that Asn-32 and Asn-104 are located before the alpha 1 helix and in loop L3, respectively, near the top of the subunit-subunit interface on the minus side, and that Asn-173 is located in the Cys-loop near the bottom of the subunit N-terminal domain. Using site-directed mutagenesis, we demonstrated that all predicted beta 2 subunit glycosylation sites were glycosylated in transfected HEK293T cells. Glycosylation of each site, however, produced specific changes in alpha 1 beta 2 receptor surface expression and function. Although glycosylation of Asn-173 in the Cys-loop was important for stability of beta 2 subunits when expressed alone, results obtained with flow cytometry, brefeldin A treatment, and endo-beta-N-acetylglucosaminidase H digestion suggested that glycosylation of Asn-104 was required for efficient alpha 1 beta 2 receptor assembly and/or stability in the endoplasmic reticulum. Patch clamp recording revealed that mutation of each site to prevent glycosylation decreased peak alpha 1 beta 2 receptor current amplitudes and altered the gating properties of alpha 1 beta 2 receptor channels by reducing mean open time due to a reduction in the proportion of long open states. In addition to functional heterogeneity, endo-beta-N-acetylglucosaminidase H digestion and glycomic profiling revealed that surface beta 2 subunit N-glycans at Asn-173 were high mannose forms that were different from those of Asn-32 and N104. Using a homology model of the pentameric extracellular domain of alpha 1 beta 2 channel, we propose mechanisms for regulation of GABA(A) receptors by glycosylation.	[Macdonald, Robert L.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Neurol, Nashville, TN 37232 USA; [Sheehan, Jonathan H.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Lo, Wen-yi] Vanderbilt Univ, Program Neurosci, Nashville, TN 37232 USA; [Sheehan, Jonathan H.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Harrison, Rebecca; Dell, Anne; Haslam, Stuart M.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Imperial College London	Macdonald, RL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 6140 Med Res Bldg 3,465,21st Ave, Nashville, TN 37232 USA.	robert.macdonald@vanderbilt.edu	; Lagrange, Andre/B-1227-2008	Sheehan, Jonathan/0000-0002-9641-7577; Lagrange, Andre/0000-0003-0147-7778	National Institutes of Health [R01 NS51590, K08 NS045122]; Biotechnology and Biological Sciences Research Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051590, K08NS045122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS51590 (to R. L. M.) and K08 NS045122 (to A. H. L.). This work was also supported by the Biotechnology and Biological Sciences Research Council (to A. D. and S. M. H.) and a Departmental Training Account Studentship from the Biotechnology and Biological Sciences Research Council (to R. H.).	ANGELOTTI TP, 1993, J NEUROSCI, V13, P1429; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BULLER AL, 1994, MOL PHARMACOL, V46, P858; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen DN, 1998, J NEUROCHEM, V70, P349; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; DeMarco ML, 2008, GLYCOBIOLOGY, V18, P426, DOI 10.1093/glycob/cwn026; Ehya N, 2003, J NEUROCHEM, V84, P127, DOI 10.1046/j.1471-4159.2003.01509.x; Fisher JL, 1997, J PHYSIOL-LONDON, V505, P283, DOI 10.1111/j.1469-7793.1997.283bb.x; Gallagher MJ, 2007, P NATL ACAD SCI USA, V104, P12999, DOI 10.1073/pnas.0700163104; Gallagher MJ, 2005, J BIOL CHEM, V280, P37995, DOI 10.1074/jbc.M508305200; Gorrie GH, 1997, J NEUROSCI, V17, P6587; Greenfield LJ, 1997, NEUROPHARMACOLOGY, V36, P63, DOI 10.1016/S0028-3908(96)00150-5; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kasturi L, 1997, BIOCHEM J, V323, P415, DOI 10.1042/bj3230415; KASTURI L, 1995, J BIOL CHEM, V270, P14756, DOI 10.1074/jbc.270.24.14756; Lagrange AH, 2007, J PHYSIOL-LONDON, V578, P655, DOI 10.1113/jphysiol.2006.122135; Lema GMC, 2006, J PHYSIOL-LONDON, V572, P183, DOI 10.1113/jphysiol.2005.099093; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lo WY, 2008, J BIOL CHEM, V283, P29740, DOI 10.1074/jbc.M802856200; Marklova E, 2007, CLIN CHIM ACTA, V385, P6, DOI 10.1016/j.cca.2007.07.002; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; MERLIE JP, 1982, J BIOL CHEM, V257, P2694; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Monk SA, 2004, BIOCHEM PHARMACOL, V68, P1787, DOI 10.1016/j.bcp.2004.06.034; Mortensen M, 2006, J PHYSIOL-LONDON, V577, P841, DOI 10.1113/jphysiol.2006.117952; Nishizaki T, 2003, MOL BRAIN RES, V114, P172, DOI 10.1016/S0169-328X(03)00171-2; Pang PC, 2009, J PROTEOME RES, V8, P4906, DOI 10.1021/pr9001756; PLESS DD, 1977, P NATL ACAD SCI USA, V74, P134, DOI 10.1073/pnas.74.1.134; Quirk PL, 2004, J NEUROSCI RES, V77, P498, DOI 10.1002/jnr.20185; Schofield CM, 2003, J BIOL CHEM, V278, P34079, DOI 10.1074/jbc.M302416200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shen XM, 2003, J CLIN INVEST, V111, P497, DOI 10.1172/JC1200316997; Tanaka M, 2008, AM J HUM GENET, V82, P1249, DOI 10.1016/j.ajhg.2008.04.020; Tang X, 2010, J NEUROPHYSIOL, V103, P1007, DOI 10.1152/jn.00801.2009; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9	48	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31348	31361		10.1074/jbc.M110.151449	http://dx.doi.org/10.1074/jbc.M110.151449			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20639197	hybrid, Green Published			2022-12-25	WOS:000282764600029
J	Suzuki, K; Kondo, C; Morimoto, M; Ohsumi, Y				Suzuki, Kuninori; Kondo, Chika; Morimoto, Mayumi; Ohsumi, Yoshinori			Selective Transport of alpha-Mannosidase by Autophagic Pathways IDENTIFICATION OF A NOVEL RECEPTOR, Atg34p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLE TARGETING PATHWAY; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; YEAST; CYTOPLASM; PROTEINS; MECHANISM; SYSTEM	In Saccharomyces cerevisiae, aminopeptidase I (Ape1p) and alpha-mannosidase (Ams1p) are known cargoes of selective autophagy. Atg19p has been identified as an Ape1p receptor and targets Ape1p to the preautophagosomal structure (PAS). Under nutrient-rich conditions, transport of Ams1p to the vacuole largely depends on Atg19p. Here, we show that Atg34p (Yo1083wp), a homolog of Atg19p, is a receptor for Ams1p transport during autophagy. Atg34p interacted with Ams1p, Atg11p, and Atg8p using distinct domains. Homo-oligomerized Ams1p bound to the Ams1-binding domain of Atg34p; this binding was important for the formation of a higher order complex named the Ams1 complex. In the absence of the interaction of Atg34p with Atg8p, the Ams1 complex was targeted to the preautophagosomal structure but failed to transit to the vacuole, indicating that the interaction of Atg34p with Atg8p is crucial for the Ams1 complex to be enclosed by autophagosomes. Atg34p and Atg19p have similar domain structures and are important for Ams1p transport during autophagy.	[Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology	Ohsumi, Y (corresponding author), Tokyo Inst Technol, Frontier Res Ctr, Midori Ku, 4259-S2-12 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	yohsumi@iri.titech.ac.jp	Ohsumi, Yoshinori/C-6449-2009	Ohsumi, Yoshinori/0000-0003-2384-2166	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; James P, 1996, GENETICS, V144, P1425; Kageyama T, 2009, BIOCHEM BIOPH RES CO, V378, P551, DOI 10.1016/j.bbrc.2008.11.084; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; SIKORSKI RS, 1989, GENETICS, V122, P19; Suzuki K, 2002, DEV CELL, V3, P815, DOI 10.1016/S1534-5807(02)00359-3; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; WATANABE Y, 2010, J BIOL CHEM, V285	22	89	93	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30019	30025		10.1074/jbc.M110.143511	http://dx.doi.org/10.1074/jbc.M110.143511			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20639194	Green Published, hybrid			2022-12-25	WOS:000281984300039
J	Pawelzik, SC; Uda, NR; Spahiu, L; Jegerschold, C; Stenberg, P; Hebert, H; Morgenstern, R; Jakobsson, PJ				Pawelzik, Sven-Christian; Uda, Narasimha Rao; Spahiu, Linda; Jegerschold, Caroline; Stenberg, Patric; Hebert, Hans; Morgenstern, Ralf; Jakobsson, Per-Johan			Identification of Key Residues Determining Species Differences in Inhibitor Binding of Microsomal Prostaglandin E Synthase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; CRYSTAL-STRUCTURE; HUMAN PLATELETS; PAIN; BIOSYNTHESIS; PROTEIN; MODELS; COX-2; PROSTACYCLIN; INFLAMMATION	Microsomal prostaglandin E synthase-1 (MPGES1) is induced during an inflammatory reaction from low basal levels by pro-inflammatory cytokines and subsequently involved in the production of the important mediator of inflammation, prostaglandin E-2. Nonsteroidal anti-inflammatory drugs prevent prostaglandin E-2 production by inhibiting the upstream enzymes cyclooxygenases 1 and 2. In contrast to these conventional drugs, a new generation of NSAIDs targets the terminal enzyme MPGES1. Some of these compounds potently inhibit human MPGES1 but do not have an effect on the rat orthologue. We investigated this interspecies difference in a rat/human chimeric form of the enzyme as well as in several mutants and identified key residues Thr-131, Leu-135, and Ala-138 in human MPGES1, which play a crucial role as gate keepers for the active site of MPGES1. These residues are situated in transmembrane helix 4, lining the entrance to the cleft between two subunits in the protein trimer, and regulate access of the inhibitor in the rat enzyme. Exchange toward the human residues in rat MPGES1 was accompanied with a gain of inhibitor activity, whereas exchange in human MPGES1 toward the residues found in rat abrogated inhibitor activity. Our data give evidence for the location of the active site at the interface between subunits in the homotrimeric enzyme and suggest a model of how the natural substratePGH(2), or competitive inhibitors of MPGES1, enter the active site via the phospholipid bilayer of the membrane.	[Morgenstern, Ralf] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; [Pawelzik, Sven-Christian; Uda, Narasimha Rao; Jakobsson, Per-Johan] Karolinska Inst, Dept Med, Rheumatol Unit, S-17176 Stockholm, Sweden; [Spahiu, Linda; Stenberg, Patric] Actar AB, S-17177 Solna, Sweden; [Spahiu, Linda; Stenberg, Patric] NovaSAID AB, S-17177 Solna, Sweden; [Jegerschold, Caroline; Hebert, Hans] Karolinska Inst, Dept Biosci & Nutr, S-14157 Huddinge, Sweden; [Jegerschold, Caroline; Hebert, Hans] Royal Inst Technol, Sch Technol & Hlth, Novum, S-14157 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Royal Institute of Technology	Morgenstern, R (corresponding author), Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden.	Ralf.Morgenstern@ki.se; Per-Johan.Jakobsson@ki.se	Jakobsson, Per-Johan/ABC-5594-2021; Morgenstern, Ralf/GZH-0158-2022	Uda, Narasimha Rao/0000-0001-5967-6118; Jegerschold, Caroline/0000-0003-2419-6354; Pawelzik, Sven-Christian/0000-0001-8704-6607	Swedish Research Council; Karolinska Institutet; Swedish County Council; Swedish Rheumatism Association; King Gustaf V 80-Year Fund; Marianne and Marcus Wallenberg Foundation; Borje Dahlin Fund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Swedish County Council; Swedish Rheumatism Association; King Gustaf V 80-Year Fund; Marianne and Marcus Wallenberg Foundation; Borje Dahlin Fund	This work was supported by funds from the Swedish Research Council, Karolinska Institutet, The Swedish County Council, The Swedish Rheumatism Association, the King Gustaf V 80-Year Fund, the Marianne and Marcus Wallenberg Foundation, and the Borje Dahlin Fund.	Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; BASEVICH VV, 1983, BIOORG KHIM+, V9, P658; Clark P, 2008, J PHARMACOL EXP THER, V325, P425, DOI 10.1124/jpet.107.134510; Engblom D, 2003, NAT NEUROSCI, V6, P1137, DOI 10.1038/nn1137; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Fleishman SJ, 2006, TRENDS BIOCHEM SCI, V31, P106, DOI 10.1016/j.tibs.2005.12.005; Giroux A, 2009, BIOORG MED CHEM LETT, V19, P5837, DOI 10.1016/j.bmcl.2009.08.085; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P3400, DOI 10.1073/pnas.71.9.3400; Hamza A, 2008, J PHYS CHEM B, V112, P7320, DOI 10.1021/jp8007688; Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Jania LA, 2009, PROSTAG OTH LIPID M, V88, P73, DOI 10.1016/j.prostaglandins.2008.10.003; Jegerschold C, 2008, P NATL ACAD SCI USA, V105, P11110, DOI 10.1073/pnas.0802894105; Kuwabara K, 2002, INFLAMM RES, V51, P541, DOI 10.1007/PL00012425; Lovgren AK, 2007, MOL CELL BIOL, V27, P4416, DOI 10.1128/MCB.02314-06; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Patrignani P, 1999, J PHYSIOL PHARMACOL, V50, P661; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Vermeirsch H, 2007, PHARMACOL BIOCHEM BE, V87, P349, DOI 10.1016/j.pbb.2007.05.010; Wang M, 2006, P NATL ACAD SCI USA, V103, P14507, DOI 10.1073/pnas.0606586103; Westman M, 2004, ARTHRITIS RHEUM-US, V50, P1774, DOI 10.1002/art.20286; Xing L, 2009, J COMPUT AID MOL DES, V23, P13, DOI 10.1007/s10822-008-9233-4; Xu DG, 2008, J PHARMACOL EXP THER, V326, P754, DOI 10.1124/jpet.108.138776	26	60	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29254	29261		10.1074/jbc.M110.114454	http://dx.doi.org/10.1074/jbc.M110.114454			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20605783	hybrid, Green Published			2022-12-25	WOS:000281740100027
J	Yamaguchi, M; Noda, NN; Nakatogawa, H; Kumeta, H; Ohsumi, Y; Inagaki, F				Yamaguchi, Masaya; Noda, Nobuo N.; Nakatogawa, Hitoshi; Kumeta, Hiroyuki; Ohsumi, Yoshinori; Inagaki, Fuyuhiko			Autophagy-related Protein 8 (Atg8) Family Interacting Motif in Atg3 Mediates the Atg3-Atg8 Interaction and Is Crucial for the Cytoplasm-to-Vacuole Targeting Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO RECONSTITUTION; SACCHAROMYCES-CEREVISIAE; SELECTIVE AUTOPHAGY; ATG12-ATG5 CONJUGATE; STRUCTURAL BASIS; LIPIDATION; DEGRADATION; MECHANISM; COMPLEX; SYSTEM	The autophagy-related protein 8 (Atg8) conjugation system is essential for the formation of double-membrane vesicles called autophagosomes during autophagy, a bulk degradation process conserved among most eukaryotes. It is also important in yeast for recognizing target vacuolar enzymes through the receptor protein Atg19 during the cytoplasm-to-vacuole targeting (Cvt) pathway, a selective type of autophagy. Atg3 is an E2-like enzyme that conjugates Atg8 with phosphatidylethanolamine. Here, we show that Atg3 directly interacts with Atg8 through the WEDL sequence, which is distinct from canonical interaction between E2 and ubiquitin-like modifiers. Moreover, NMR experiments suggest that the mode of interaction between Atg8 and Atg3 is quite similar to that between Atg8/LC3 and the Atg8 family interacting motif (AIM) conserved in autophagic receptors, such as Atg19 and p62. Thus, the WEDL sequence in Atg3 is a canonical AIM. In vitro analyses showed that Atg3 AIM is crucial for the transfer of Atg8 from the Atg8 similar to Atg3 thioester intermediate to phosphatidylethanolamine but not for the formation of the intermediate. Intriguingly, in vivo experiments showed that it is necessary for the Cvt pathway but not for starvation-induced autophagy. Atg3 AIM attenuated the inhibitory effect of Atg19 on Atg8 lipidation in vitro, suggesting that Atg3 AIM may be important for the lipidation of Atg19-bound Atg8 during the Cvt pathway.	[Inagaki, Fuyuhiko] Hokkaido Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Nakatogawa, Hitoshi; Ohsumi, Yoshinori] Tokyo Inst Technol, Integrated Res Inst, Yokohama, Kanagawa 2268503, Japan; [Nakatogawa, Hitoshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Hokkaido University; Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Inagaki, F (corresponding author), Hokkaido Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Kita Ku, N-12,W-6, Sapporo, Hokkaido 0600812, Japan.	finagaki@pharm.hokudai.ac.jp	Nakatogawa, Hitoshi/D-5155-2015; Ohsumi, Yoshinori/C-6449-2009; Noda, Nobuo/P-1397-2015	Nakatogawa, Hitoshi/0000-0002-5828-0741; Ohsumi, Yoshinori/0000-0003-2384-2166; Noda, Nobuo/0000-0002-6940-8069; Yamaguchi, Masaya/0000-0001-6886-8058; Kumeta, Hiroyuki/0000-0003-3713-2122	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for Scientific Research on Priority Areas and Targeted Proteins Research Program from Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Darsow T, 1997, J CELL BIOL, V138, P517, DOI 10.1083/jcb.138.3.517; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fujioka Y, 2008, J BIOL CHEM, V283, P1921, DOI 10.1074/jbc.M706214200; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Ho KH, 2009, AUTOPHAGY, V5, P461, DOI 10.4161/auto.5.4.7696; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kneller D., 1997, SPARKY 3 105; Kumeta H, 2010, J BIOMOL NMR, V47, P237, DOI 10.1007/s10858-010-9420-1; Kupce E, 1995, J MAGN RESON SER B, V109, P329, DOI 10.1006/jmrb.1995.9985; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakanishi T, 2002, J MOL BIOL, V318, P245, DOI 10.1016/S0022-2836(02)00018-9; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2008, J SYNCHROTRON RADIAT, V15, P266, DOI 10.1107/S0909049507054799; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2009, CHEM REV, V109, P1587, DOI 10.1021/cr800459r; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Oh-Oka K, 2008, J BIOL CHEM, V283, P21847, DOI 10.1074/jbc.M801836200; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; OPHEIM DJ, 1978, BIOCHIM BIOPHYS ACTA, V524, P121, DOI 10.1016/0005-2744(78)90110-9; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Scott SV, 1997, J CELL BIOL, V138, P37, DOI 10.1083/jcb.138.1.37; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200	39	82	89	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29599	29607		10.1074/jbc.M110.113670	http://dx.doi.org/10.1074/jbc.M110.113670			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20615880	Green Published, hybrid			2022-12-25	WOS:000281740100061
J	Gonzalez, DR; Treuer, AV; Castellanos, J; Dulce, RA; Hare, JM				Gonzalez, Daniel R.; Treuer, Adriana V.; Castellanos, Jorge; Dulce, Raul A.; Hare, Joshua M.			Impaired S-Nitrosylation of the Ryanodine Receptor Caused by Xanthine Oxidase Activity Contributes to Calcium Leak in Heart Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL NITRIC-OXIDE; RETICULUM CA2+ LEAK; RELEASE CHANNEL; MEDIATED DECOMPOSITION; CARDIOVASCULAR-SYSTEM; VENTRICULAR MYOCYTES; MG2+ INHIBITION; CARDIAC-MUSCLE; NADPH OXIDASE; SKELETAL	S-Nitrosylation is a ubiquitous post-translational modification that regulates diverse biologic processes. In skeletal muscle, hypernitrosylation of the ryanodine receptor (RyR) causes sarcoplasmic reticulum (SR) calcium leak, but whether abnormalities of cardiac RyR nitrosylation contribute to dysfunction of cardiac excitation-contraction coupling remains controversial. In this study, we tested the hypothesis that cardiac RyR2 is hyponitrosylated in heart failure, because of nitroso-redox imbalance. We evaluated excitation-contraction coupling and nitroso-redox balance in spontaneously hypertensive heart failure rats with dilated cardiomyopathy and age-matched Wistar-Kyoto rats. Spontaneously hypertensive heart failure myocytes were characterized by depressed contractility, increased diastolic Ca2+ leak, hyponitrosylation of RyR2, and enhanced xanthine oxidase derived superoxide. Global S-nitrosylation was decreased in failing hearts compared with nonfailing. Xanthine oxidase inhibition restored global and RyR2 nitrosylation and reversed the diastolic SR Ca2+ leak, improving Ca2+ handling and contractility. Together these findings demonstrate that nitroso-redox imbalance causes RyR2 oxidation, hyponitrosylation, and SR Ca2+ leak, a hallmark of cardiac dysfunction. The reversal of this phenotype by inhibition of xanthine oxidase has important pathophysiologic and therapeutic implications.	[Gonzalez, Daniel R.; Treuer, Adriana V.; Castellanos, Jorge; Dulce, Raul A.; Hare, Joshua M.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA	University of Miami	Hare, JM (corresponding author), Biomed Res Bldg,1501 NW 10th Ave,Rm 824,POB 01696, Miami, FL 33101 USA.	jhare@med.miami.edu		GONZALEZ, DANIEL/0000-0002-3437-8998; Treuer, Adriana V./0000-0001-7384-0228	National Institutes of Health [RO1HL 65455, HL094849-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094849, R01HL065455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1HL 65455 and HL094849-01.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Aleryani S, 1998, J BIOL CHEM, V273, P6041, DOI 10.1074/jbc.273.11.6041; Aracena P, 2003, J BIOL CHEM, V278, P42927, DOI 10.1074/jbc.M306969200; Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Bendall JK, 2004, CIRCULATION, V110, P2368, DOI 10.1161/01.CIR.0000145160.04084.AC; Bers DM, 2006, PHYSIOLOGY, V21, P380, DOI 10.1152/physiol.00019.2006; Ckless K, 2004, NITRIC OXIDE-BIOL CH, V11, P216, DOI 10.1016/j.niox.2004.06.002; Damy T, 2004, LANCET, V363, P1365, DOI 10.1016/S0140-6736(04)16048-0; Donoso P, 2000, BIOPHYS J, V79, P279, DOI 10.1016/S0006-3495(00)76290-4; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gonzalez DR, 2008, NITRIC OXIDE-BIOL CH, V18, P157, DOI 10.1016/j.niox.2007.09.086; Gonzalez DR, 2007, P NATL ACAD SCI USA, V104, P20612, DOI 10.1073/pnas.0706796104; Gow AJ, 2002, J BIOL CHEM, V277, P9637, DOI 10.1074/jbc.C100746200; Guo T, 2006, CIRC RES, V99, P398, DOI 10.1161/01.RES.0000236756.06252.13; Handy DE, 2006, ARTERIOSCL THROM VAS, V26, P1207, DOI 10.1161/01.ATV.0000217632.98717.a0; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hidalgo C, 2002, BIOL RES, V35, P183, DOI 10.4067/S0716-97602002000200009; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Janssen PML, 2003, AM J PHYSIOL-HEART C, V284, pH772, DOI 10.1152/ajpheart.01061.2001; Jourd'heuil D, 1998, BIOCHEM BIOPH RES CO, V244, P525, DOI 10.1006/bbrc.1998.8227; Kogler H, 2003, CARDIOVASC RES, V59, P582, DOI 10.1016/S0008-6363(03)00512-1; Lima B, 2009, P NATL ACAD SCI USA, V106, P6297, DOI 10.1073/pnas.0901043106; Lin J, 2009, CIRCULATION, V120, P245, DOI 10.1161/CIRCULATIONAHA.109.868729; Marengo JJ, 1998, BIOPHYS J, V74, P1263, DOI 10.1016/S0006-3495(98)77840-3; Minhas KM, 2006, CIRC RES, V98, P271, DOI 10.1161/01.RES.0000200181.59551.71; Sanchez G, 2005, J MOL CELL CARDIOL, V39, P982, DOI 10.1016/j.yjmcc.2005.08.010; Sanchez G, 2008, CARDIOVASC RES, V77, P380, DOI 10.1093/cvr/cvm011; Scriven DRL, 2008, AM J PHYSIOL-CELL PH, V294, pC1119, DOI 10.1152/ajpcell.00133.2008; Shannon TR, 2003, CIRC RES, V93, P592, DOI 10.1161/01.RES.0000093399.11734.B3; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Stoyanovsky D, 1997, CELL CALCIUM, V21, P19, DOI 10.1016/S0143-4160(97)90093-2; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Sun JH, 2008, BIOCHEMISTRY-US, V47, P13985, DOI 10.1021/bi8012627; Terentyev D, 2008, CIRC RES, V103, P1466, DOI 10.1161/CIRCRESAHA.108.184457; Trujillo M, 1998, J BIOL CHEM, V273, P7828, DOI 10.1074/jbc.273.14.7828; Wang HL, 2010, J PHYSIOL-LONDON, V588, P2905, DOI 10.1113/jphysiol.2010.192617; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Yang Y, 2005, P NATL ACAD SCI USA, V102, P117, DOI 10.1073/pnas.0405989102; Zimmet JM, 2006, CIRCULATION, V114, P1531, DOI 10.1161/CIRCULATIONAHA.105.605519; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	47	106	108	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28938	28945		10.1074/jbc.M110.154948	http://dx.doi.org/10.1074/jbc.M110.154948			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20643651	Green Published, hybrid			2022-12-25	WOS:000281594000058
J	Henry, RA; Balakrishnan, L; Ying-Lin, ST; Campbell, JL; Bambara, RA				Henry, Ryan A.; Balakrishnan, Lata; Ying-Lin, Stefanie Tan; Campbell, Judith L.; Bambara, Robert A.			Components of the Secondary Pathway Stimulate the Primary Pathway of Eukaryotic Okazaki Fragment Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION-PROTEIN-A; SINGLE-STRANDED-DNA; CELL NUCLEAR ANTIGEN; FLAP ENDONUCLEASE-1; SACCHAROMYCES-CEREVISIAE; POLYMERASE-DELTA; FEN-1 NUCLEASE; PRIMER REMOVAL; LIGATABLE NICK; IN-VIVO	Reconstitution of eukaryotic Okazaki fragment processing implicates both one- and two-nuclease pathways for processing flap intermediates. In most cases, FEN1 (flap endonuclease 1) is able to efficiently cleave short flaps as they form. However, flaps escaping cleavage bind replication protein A (RPA) inhibiting FEN1. The flaps must then be cleaved by Dna2 nuclease/helicase before FEN1 can act. Pif1 helicase aids creation of long flaps. The pathways were considered connected only in that the products of Dna2 cleavage are substrates for FEN1. However, results presented here show that Dna2, Pif1, and RPA, the unique proteins of the two-nuclease pathway from Saccharomyces cerevisiae, all stimulate FEN1 acting in the one- nuclease pathway. Stimulation is observed on RNA flaps representing the initial displacement and on short DNA flaps, subsequently displaced. Neither the RNA nor the short DNA flaps can bind the two-nuclease pathway proteins. Instead, direct interactions between FEN1 and the two-nuclease pathway proteins have been detected. These results suggest that the proteins are either part of a complex or interact successively with FEN1 because the level of stimulation would be similar either way. Proteins bound to FEN1 could be tethered to the flap base by the interaction of FEN1 with PCNA, potentially improving their availability when flaps become long. These findings also support a model in which cleavage by FEN1 alone is the preferred pathway, with the first opportunity to complete cleavage, and is stimulated by components of the backup pathway.	[Henry, Ryan A.; Balakrishnan, Lata; Ying-Lin, Stefanie Tan; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; California Institute of Technology	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu			National Institutes of Health [GM024441, GM087666]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM024441 (to R. A. B.) and GM087666 (to J. L. C.).	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Balakrishnan L, 2010, J BIOL CHEM, V285, P4398, DOI 10.1074/jbc.M109.086397; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Biswas EE, 1997, BIOCHEMISTRY-US, V36, P5955, DOI 10.1021/bi962890u; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Chai Q, 2003, BIOCHEMISTRY-US, V42, P15045, DOI 10.1021/bi035364t; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Friedrich-Heineken E, 2003, J MOL BIOL, V328, P73, DOI 10.1016/S0022-2836(03)00270-5; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hasan S, 2001, MOL CELL, V7, P1221, DOI 10.1016/S1097-2765(01)00272-6; Henneke G, 2003, ONCOGENE, V22, P4301, DOI 10.1038/sj.onc.1206606; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; Kornberg A., 1992, DNA REPLICATION, VSecond, P113; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Murante RS, 1996, J BIOL CHEM, V271, P25888, DOI 10.1074/jbc.271.42.25888; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Pike JE, 2009, J BIOL CHEM, V284, P25170, DOI 10.1074/jbc.M109.023325; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Sibenaller ZA, 1998, BIOCHEMISTRY-US, V37, P12496, DOI 10.1021/bi981110+; Stewart JA, 2008, J BIOL CHEM, V283, P31356, DOI 10.1074/jbc.M805965200; Stewart JA, 2006, J BIOL CHEM, V281, P38565, DOI 10.1074/jbc.M606884200; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	42	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28496	28505		10.1074/jbc.M110.131870	http://dx.doi.org/10.1074/jbc.M110.131870			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20628185	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000281594000013
J	Yagci, FC; Aslan, O; Gursel, M; Tincer, G; Ozdamar, Y; Karatepe, K; Akcali, KC; Gursel, I				Yagci, Fuat C.; Aslan, Ozlem; Gursel, Mayda; Tincer, Gizem; Ozdamar, Yasemin; Karatepe, Kutay; Akcali, K. Can; Gursel, Ihsan			Mammalian Telomeric DNA Suppresses Endotoxin-induced Uveitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED IMMUNE ACTIVATION; CPG OLIGONUCLEOTIDES; BACTERIAL-DNA; SYNTHETIC OLIGONUCLEOTIDES; OCULAR INFLAMMATION; INDUCED ARTHRITIS; GENE-EXPRESSION; IN-VIVO; OLIGODEOXYNUCLEOTIDES; MICE	Telomeric regions of mammalian chromosomes contain suppressive TTAGGG motifs that inhibit several proinflammatory and Th1-biased immune responses. Synthetic oligodeoxynucleotides (ODN) expressing suppressive motifs can reproduce the down-regulatory activity of mammalian telomeric repeats and have proven effective in the prevention and treatment of several autoimmune and autoinflammatory diseases. Endotoxin-induced uveitis (EIU) is an established animal model of acute ocular inflammation induced by LPS administration. Augmented expression of proinflammatory cytokines/chemokines such as TNF alpha, IL-6, and MCP1 and bactericidal nitric oxide production mediated by LPS contribute to the development of EIU. Suppressing these mediators using agents that are devoid of undesirable systemic side effects may help prevent the development of EIU. This study demonstrates the selective down-regulatory role of suppressive ODN after (i) local or (ii) systemic treatment in EIU-induced rabbits and mice. Our results indicate that suppressive ODN down-regulate at both the transcript and protein levels of several proinflammatory cytokines and chemokines as well as nitric oxide and co-stimulatory surface marker molecules when administrated prior to, simultaneously with, or even after LPS challenge, thereby significantly reducing ocular inflammation in both rabbit and mouse eyes. These findings strongly suggest that suppressive ODN is a potent candidate for the prevention of uveitis and could be applied as a novel DNA-based immunoregulatory agent to control other autoimmune or autoinflammatory diseases.	[Gursel, Ihsan] Bilkent Univ, Biotherapeut Oligonucleotide Lab, Dept Mol Biol & Genet, TR-06800 Ankara, Turkey; [Gursel, Mayda] Bilkent Univ, Merkez Lojmanlari, TR-06800 Ankara, Turkey; [Aslan, Ozlem; Ozdamar, Yasemin] Ulucanlar Eye Res & Educ Hosp, Minist Hlth, TR-06240 Ankara, Turkey	Ihsan Dogramaci Bilkent University; Ihsan Dogramaci Bilkent University; Ankara Ulucanlar Eye Training & Research Hospital; Ministry of Health - Turkey	Gursel, I (corresponding author), Bilkent Univ, Biotherapeut Oligonucleotide Lab, Dept Mol Biol & Genet, TR-06800 Ankara, Turkey.	ihsangursel@bilkent.edu.tr	Gursel, M/H-1812-2012; Gursel, Ihsan/AAT-7168-2021; Budakoğlu, Özlem/AAH-9838-2019	Gursel, M/0000-0003-0044-9054; Budakoglu, Ozlem/0000-0002-9915-1786; Yagci, Fuat Cem/0000-0001-6568-2899; Akcali, Kamil/0000-0002-7816-6938; Gursel, Ihsan/0000-0003-3761-1166	Scientific and Technological Research Council of Turkey (TUBITAK) [SBAG106S102, SBAG108S316]; EU [203953]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); EU(European Commission)	This work was supported by Scientific and Technological Research Council of Turkey (TUBITAK) Grants SBAG106S102, SBAG108S316, EU/FP6/Marie Curie, and EU/FP7 UNAM REGPOT 203953.	Adamus G, 2006, INVEST OPHTH VIS SCI, V47, P2555, DOI 10.1167/iovs.05-1242; Avunduk MC, 2004, EXP EYE RES, V79, P357, DOI 10.1016/j.exer.2004.06.001; CHAN CC, 1990, J AUTOIMMUN, V3, P247, DOI 10.1016/0896-8411(90)90144-H; Dong L, 2005, ARTHRITIS RHEUM-US, V52, P651, DOI 10.1002/art.20810; Dong L, 2004, ARTHRITIS RHEUM-US, V50, P1686, DOI 10.1002/art.20263; Dunn James P, 2004, Curr Opin Ophthalmol, V15, P293, DOI 10.1097/00055735-200408000-00003; Durrani OM, 2004, BRIT J OPHTHALMOL, V88, P1159, DOI 10.1136/bjo.2003.037226; Fujimoto C, 2009, CLIN EXP IMMUNOL, V156, P528, DOI 10.1111/j.1365-2249.2009.03918.x; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Gursel I, 2003, J IMMUNOL, V171, P1393, DOI 10.4049/jimmunol.171.3.1393; Gursel I, 2001, J IMMUNOL, V167, P3324, DOI 10.4049/jimmunol.167.6.3324; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Hafezi-Moghadam A, 2007, FASEB J, V21, P464, DOI 10.1096/fj.06-6390com; Ho PP, 2005, J IMMUNOL, V175, P6226, DOI 10.4049/jimmunol.175.9.6226; Ho PP, 2003, J IMMUNOL, V171, P4920, DOI 10.4049/jimmunol.171.9.4920; HOEKZEMA R, 1992, INVEST OPHTH VIS SCI, V33, P532; Sande PH, 2008, AM J PATHOL, V173, P1702, DOI 10.2353/ajpath.2008.080518; Hu D, 2009, MOL IMMUNOL, V46, P1387, DOI 10.1016/j.molimm.2008.12.008; Ishii KJ, 2005, INT J CANCER, V117, P517, DOI 10.1002/ijc.21402; Klinman DM, 2009, ANN NY ACAD SCI, V1175, P80, DOI 10.1111/j.1749-6632.2009.04970.x; Klinman DM, 2009, ADV DRUG DELIVER REV, V61, P248, DOI 10.1016/j.addr.2008.12.012; Klinman DM, 2003, ANN NY ACAD SCI, V1002, P112, DOI 10.1196/annals.1281.023; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; Koizumi K, 2003, INVEST OPHTH VIS SCI, V44, P2184, DOI 10.1167/iovs.02-0589; Krieg AM, 2000, CURR OPIN IMMUNOL, V12, P35, DOI 10.1016/S0952-7915(99)00048-5; Lajavardi L, 2007, INVEST OPHTH VIS SCI, V48, P3230, DOI 10.1167/iovs.06-1305; Lightman S, 1997, EYE, V11, P222, DOI 10.1038/eye.1997.56; MANDAI M, 1994, INVEST OPHTH VIS SCI, V35, P3673; Mo JS, 1999, EXP EYE RES, V68, P333, DOI 10.1006/exer.1998.0618; Moorthy RS, 1997, SURV OPHTHALMOL, V41, P361, DOI 10.1016/S0039-6257(97)00006-4; Nagai N, 2005, INVEST OPHTH VIS SCI, V46, P2925, DOI 10.1167/iovs.04-1476; Ohta K, 2005, EXP EYE RES, V80, P401, DOI 10.1016/j.exer.2004.10.011; Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sato T, 2008, J IMMUNOL, V180, P7648, DOI 10.4049/jimmunol.180.11.7648; Shirota H, 2005, J IMMUNOL, V174, P4579, DOI 10.4049/jimmunol.174.8.4579; Shirota H, 2004, J IMMUNOL, V173, P5002, DOI 10.4049/jimmunol.173.8.5002; Sobajima Satoshi, 2005, Spine J, V5, P14, DOI 10.1016/j.spinee.2004.05.251; Sparwasser T, 1998, EUR J IMMUNOL, V28, P2045, DOI 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8; Yamada H, 2002, J IMMUNOL, V169, P5590, DOI 10.4049/jimmunol.169.10.5590; YAMAMOTO S, 1992, J IMMUNOL, V148, P4072; Zeuner RA, 2003, ARTHRITIS RHEUM, V48, P1701, DOI 10.1002/art.11035; Zeuner RA, 2002, ARTHRITIS RHEUM, V46, P2219, DOI 10.1002/art.10423; Zhu FG, 2002, J LEUKOCYTE BIOL, V71, P686	44	6	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28806	28811		10.1074/jbc.M110.125948	http://dx.doi.org/10.1074/jbc.M110.125948			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20630869	Green Published, hybrid			2022-12-25	WOS:000281594000046
J	Chock, K; Allison, JMS; ElShamy, WM				Chock, K.; Allison, J. M. S.; ElShamy, W. M.			BRCA1-IRIS overexpression abrogates UV-induced p38MAPK/p53 and promotes proliferation of damaged cells	ONCOGENE			English	Article						BRCA1-IRIS; p53; p38MAPK; WIP1; UVC; etoposide; H2O2	ACTIVATED PROTEIN-KINASE; CYCLIN D1 EXPRESSION; BREAST-CANCER CELLS; NF-KAPPA-B; P38 MAPK; INDUCED PHOSPHORYLATION; FACTOR HUR; P53; WIP1; PHOSPHATASE	Cells' ability to evade cell death and to proliferate post geno-/cell-toxic stresses likely leads to formation of cancer. Activation of p38MAPK and p53 following these stresses helps protect cells against cancer development by initiating apoptosis. The duration of p38MAPK and p53 activation is regulated by the WIP1 phosphatase. BRCA1-IRIS triggers WIP1 expression in a p53-dependent and -independent manner. BRCA1-IRIS triggers the expression and cytoplasmic localization of the mRNA stabilization and translation inducer, HuR, that binds p53 and PPM1D mRNA. Hence, BRCA1-IRIS overexpression inactivates p38MAPK and/or p53 by upregulating WIP1 expression. BRCA1-IRIS abrogation of the homeostatic balance maintained by the p38MAPK-p53-WIP1 pathway suppressed cell death induced by a lethal dose of short-wavelength UV light, and high dosage of etoposide or H2O2, and allowed cells to survive and proliferate post geno-/cell-toxic stresses. This mechanism represents a new link between geno-/cell-toxic stress and aggressive breast cancer formation in p53 wild-type cells. Oncogene (2010) 29, 5274-5285; doi:10.1038/onc.2010.262; published online 12 July 2010	[ElShamy, W. M.] Univ Hawaii, Dept Pathol, John A Burns Sch Med, Honolulu, HI 96813 USA; Canc Ctr Hawaii, Honolulu, HI USA	University of Hawaii System; Cancer Research Center of Hawaii	ElShamy, WM (corresponding author), Univ Hawaii, Dept Pathol, John A Burns Sch Med, 651 Ilalo St,BSB-119A, Honolulu, HI 96813 USA.	welshamy@crch.hawaii.edu	ElShamy, Wael/AAF-2867-2019; ElShamy, Wael M./L-1090-2018		University of Hawaii; Hawaii Community Foundation	University of Hawaii; Hawaii Community Foundation	This research was supported in part by a start-up support from the University of Hawaii, and in part by a Grant from the Hawaii Community Foundation to WMeS. Wael M ElShamy is a Dr Lawrence and Mrs Bo Hing Chen Tsue American Cancer Society Scholar.	Al-Mohanna MA, 2007, NUCLEIC ACIDS RES, V35, P223, DOI 10.1093/nar/gkl1075; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Demuth T, 2007, MOL CANCER THER, V6, P1212, DOI 10.1158/1535-7163.MCT-06-0711; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ElShamy WM, 2004, NAT CELL BIOL, V6, P954, DOI 10.1038/ncb1171; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; FORNACE A, 1999, EMBO J, V18, P6845; Gorospe M, 2003, CELL CYCLE, V2, P412, DOI 10.4161/cc.2.5.491; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Hao L, 2007, INT J CANCER, V121, P39, DOI 10.1002/ijc.22597; Harrison M, 2004, TRENDS MOL MED, V10, P359, DOI 10.1016/j.molmed.2004.06.010; Hasegawa H, 2009, BRIT J CANCER, V100, P1943, DOI 10.1038/sj.bjc.6605084; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hickson JA, 2007, MOL REPROD DEV, V74, P821, DOI 10.1002/mrd.20688; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Hsieh YH, 2007, CANCER RES, V67, P4320, DOI 10.1158/0008-5472.CAN-06-2486; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; Im JS, 2008, J BIOL CHEM, V283, P25171, DOI 10.1074/jbc.M802851200; Jin SQ, 2003, ONCOGENE, V22, P8536, DOI 10.1038/sj.onc.1206907; Junttila MR, 2007, ONCOGENE, V26, P5267, DOI 10.1038/sj.onc.1210332; Kang MJ, 2008, GASTROENTEROLOGY, V135, P2030, DOI 10.1053/j.gastro.2008.08.009; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; LI I, 2007, ACTA BIOCH BIOPH SIN, V39, P181; Licata LA, 2010, BREAST CANCER RES TR, V122, P55, DOI 10.1007/s10549-009-0517-8; Lim SJ, 2009, CANCER RES TREAT, V41, P87, DOI 10.4143/crt.2009.41.2.87; Lowe JM, 2010, J BIOL CHEM, V285, P5249, DOI 10.1074/jbc.M109.034579; Lowe SW, 1999, ENDOCR-RELAT CANCER, V6, P45, DOI 10.1677/erc.0.0060045; Marechal R, 2009, EXPERT REV ANTICANC, V9, P1439, DOI [10.1586/era.09.119, 10.1586/ERA.09.119]; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167; Moll UM, 1998, CRIT REV ORAL BIOL M, V9, P23, DOI 10.1177/10454411980090010101; Nakuci E, 2006, EXP CELL RES, V312, P3120, DOI 10.1016/j.yexcr.2006.06.021; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rodriguez-Bravo V, 2007, CANCER RES, V67, P11648, DOI 10.1158/0008-5472.CAN-07-3100; Saito-Ohara F, 2003, CANCER RES, V63, P1876; Sakuma T, 2008, J NEURO-ONCOL, V88, P143, DOI 10.1007/s11060-008-9559-8; She QB, 2001, CANCER RES, V61, P1604; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sturgill TW, 2008, BIOCHEM BIOPH RES CO, V371, P1, DOI 10.1016/j.bbrc.2008.04.002; Suarez-Cuervo C, 2004, CLIN EXP METASTAS, V21, P525, DOI 10.1007/s10585-004-3503-x; Sykes SM, 2009, J BIOL CHEM, V284, P20197, DOI 10.1074/jbc.M109.026096; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Tong X, 2009, MOL CARCINOGEN, V48, P118, DOI 10.1002/mc.20460; Tran H, 2003, MOL CELL BIOL, V23, P7177, DOI 10.1128/MCB.23.20.7177-7188.2003; Wang SL, 2006, CANCER RES, V66, P6982, DOI 10.1158/0008-5472.CAN-06-0511; Yamaguchi H, 2005, BIOCHEMISTRY-US, V44, P5285, DOI 10.1021/bi0476634; YAO KM, 1993, J NEUROBIOL, V24, P723, DOI 10.1002/neu.480240604	51	24	26	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	38					5274	5285		10.1038/onc.2010.262	http://dx.doi.org/10.1038/onc.2010.262			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	653KE	20622893				2022-12-25	WOS:000282089100006
J	Yang, A; Zhu, Z; Kettenbach, A; Kapranov, P; McKeon, F; Gingeras, TR; Struhl, K				Yang, Annie; Zhu, Zhou; Kettenbach, Arminja; Kapranov, Philipp; McKeon, Frank; Gingeras, Thomas R.; Struhl, Kevin			Genome-Wide Mapping Indicates That p73 and p63 Co-Occupy Target Sites and Have Similar DNA-Binding Profiles In Vivo	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR; CHROMATIN IMMUNOPRECIPITATION; TETRAMERIZATION DOMAIN; P53; DIFFERENTIATION; IDENTIFICATION; DELTA-N-P63; EVOLUTION; FAMILY	Background: The p53 homologs, p63 and p73, share similar to 85% amino acid identity in their DNA-binding domains, but they have distinct biological functions. Principal Findings: Using chromatin immunoprecipitation and high-resolution tiling arrays covering the human genome, we identify p73 DNA binding sites on a genome-wide level in ME180 human cervical carcinoma cells. Strikingly, the p73 binding profile is indistinguishable from the previously described binding profile for p63 in the same cells. Moreover, the p73:p63 binding ratio is similar at all genomic loci tested, suggesting that there are few, if any, targets that are specific for one of these factors. As assayed by sequential chromatin immunoprecipitation, p63 and p73 co-occupy DNA target sites in vivo, suggesting that p63 and p73 bind primarily as heterotetrameric complexes in ME180 cells. Conclusions: The observation that p63 and p73 associate with the same genomic targets suggest that their distinct biological functions are due to cell-type specific expression and/or protein domains that involve functions other than DNA binding.	[Yang, Annie; Struhl, Kevin] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Zhu, Zhou] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Kettenbach, Arminja; McKeon, Frank] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Kapranov, Philipp; Gingeras, Thomas R.] Affymetrix, Santa Clara, CA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Affymetrix	Yang, A (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	kevin@hms.harvard.edu	Kutalik, Zoltan/HHZ-5697-2022	Kutalik, Zoltan/0000-0001-8285-7523; Gingeras, Thomas/0000-0001-9106-3573; Kettenbach, Arminja/0000-0003-3979-4576; Kapranov, Philipp/0000-0003-2647-4856	National Institutes of Health [GM 30186, N01-CO-12400, U01 HG003147, CA73430, CA83944]; NATIONAL CANCER INSTITUTE [R01CA083944] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG003147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083348, R37GM030186, R01GM030186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a predoctoral fellowship to A.Y. from the Department of Defense (Breast Cancer Research Program; W81XWH-04-1-0386) and by research grants from the National Institutes of Health to K.S. (GM 30186), T.R.G. (Contract N01-CO-12400 and U01 HG003147), and F.M. (CA73430 and CA83944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Belyi VA, 2009, P NATL ACAD SCI USA, V106, P17609, DOI 10.1073/pnas.0910634106; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Coutandin D, 2009, CELL DEATH DIFFER, V16, P1582, DOI 10.1038/cdd.2009.139; De Laurenzi V, 2000, BIOCHEM BIOPH RES CO, V273, P342, DOI 10.1006/bbrc.2000.2932; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; DeYoung MP, 2006, CANCER RES, V66, P9362, DOI 10.1158/0008-5472.CAN-06-1619; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Geisberg JV, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh148; Harmes DC, 2003, ONCOGENE, V22, P7607, DOI 10.1038/sj.onc.1207129; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Joerger AC, 2009, P NATL ACAD SCI USA, V106, P17705, DOI 10.1073/pnas.0905867106; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kommagani R, 2010, CELL DEATH DIFFER, V17, P398, DOI 10.1038/cdd.2009.135; Li N, 2006, ONCOGENE, V25, P2349, DOI 10.1038/sj.onc.1209270; LI W, 2010, DISTINGUISHING UNPUB; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nelson EA, 2004, J BIOL CHEM, V279, P54724, DOI 10.1074/jbc.M408464200; Rocco JW, 2006, CELL CYCLE, V5, P936, DOI 10.4161/cc.5.9.2716; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Tidow H, 2007, P NATL ACAD SCI USA, V104, P12324, DOI 10.1073/pnas.0705069104; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; van Bokhoven H, 2002, TRENDS MOL MED, V8, P133, DOI 10.1016/S1471-4914(01)02260-2; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018	33	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11572	10.1371/journal.pone.0011572	http://dx.doi.org/10.1371/journal.pone.0011572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644729	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000279884900012
J	Jang, SW; Liu, X; Chan, CB; France, SA; Sayeed, I; Tang, WX; Lin, X; Xiao, G; Andero, R; Chang, QA; Ressler, KJ; Ye, KQ				Jang, Sung-Wuk; Liu, Xia; Chan, Chi Bun; France, Stefan A.; Sayeed, Iqbal; Tang, Wenxue; Lin, Xi; Xiao, Ge; Andero, Raul; Chang, Qiang; Ressler, Kerry J.; Ye, Keqiang			Deoxygedunin, a Natural Product with Potent Neurotrophic Activity in Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CEREBRAL-ARTERY OCCLUSION; ANTIDEPRESSANT DRUGS; FUNCTIONAL RECOVERY; SIGNAL-TRANSDUCTION; NERVOUS-SYSTEM; TRK RECEPTORS; INFARCT SIZE; FACTOR BDNF; BRAIN	Gedunin, a family of natural products from the Indian neem tree, possess a variety of biological activities. Here we report the discovery of deoxygedunin, which activates the mouse TrkB receptor and its downstream signaling cascades. Deoxygedunin is orally available and activates TrkB in mouse brain in a BDNF-independent way. Strikingly, it prevents the degeneration of vestibular ganglion in BDNF -/- pups. Moreover, deoxygedunin robustly protects rat neurons from cell death in a TrkB-dependent manner. Further, administration of deoxygedunin into mice displays potent neuroprotective, anti-depressant and learning enhancement effects, all of which are mediated by the TrkB receptor. Hence, deoxygedunin imitates BDNF's biological activities through activating TrkB, providing a powerful therapeutic tool for treatment of various neurological diseases.	[Jang, Sung-Wuk; Liu, Xia; Chan, Chi Bun; Ye, Keqiang] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [France, Stefan A.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Sayeed, Iqbal] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA; [Tang, Wenxue; Lin, Xi] Emory Univ, Sch Med, Dept Otolaryngol & Cell Biol, Atlanta, GA 30322 USA; [Xiao, Ge] Ctr Dis Control & Prevent, Atlanta, GA USA; [Andero, Raul] Autonomous Univ Barcelona, Anim Physiol Unit, Inst Neurosci, Barcelona, Spain; [Chang, Qiang] Univ Wisconsin, Waisman Ctr, Dept Genet & Neurol, Madison, WI 53705 USA; [Ressler, Kerry J.] Emory Univ, Sch Med, Howard Hughes Med Inst, Atlanta, GA 30322 USA	Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; Emory University; Centers for Disease Control & Prevention - USA; Autonomous University of Barcelona; University of Wisconsin System; University of Wisconsin Madison; Emory University; Howard Hughes Medical Institute	Jang, SW (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	kye@emory.edu	Ressler, Kerry J/N-8741-2018; lin, xi/GZL-4959-2022; Andero, Raul/C-1217-2017	Ressler, Kerry J/0000-0002-5158-1103; Andero, Raul/0000-0003-3641-8903; France, Stefan/0000-0001-5998-6167; Tang, Wenxue/0000-0001-8087-0900	National Institute of Health [RO1 CA127119]; NATIONAL CANCER INSTITUTE [R01CA127119] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by grants from National Institute of Health RO1 CA127119 to K. Ye. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo JC, 2001, ONCOGENE, V20, P1229, DOI 10.1038/sj.onc.1204215; ASKANAS V, 1995, ADV NEUROL, V68, P241; Castren E, 2004, CURR OPIN PHARMACOL, V4, P58, DOI 10.1016/j.coph.2003.10.004; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chhatwal JP, 2007, GENE THER, V14, P575, DOI 10.1038/sj.gt.3302898; Chhatwal JP, 2006, NAT NEUROSCI, V9, P870, DOI 10.1038/nn1718; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Cunningham ME, 1997, J BIOL CHEM, V272, P10957; Cunningham ME, 1998, EMBO J, V17, P7282, DOI 10.1093/emboj/17.24.7282; Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biopsych.2004.02.033; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Fletcher JM, 2006, J PEPT SCI, V12, P515, DOI 10.1002/psc.760; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jang SW, 2007, P NATL ACAD SCI USA, V104, P16329, DOI 10.1073/pnas.0706662104; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Jones SV, 2007, LEARN MEMORY, V14, P816, DOI 10.1101/lm.781507; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KHALID SA, 1989, J NAT PROD, V52, P922, DOI 10.1021/np50065a002; Koda M, 2004, J NEUROTRAUM, V21, P329, DOI 10.1089/089771504322972112; KOKAIA Z, 1993, P NATL ACAD SCI USA, V90, P6711, DOI 10.1073/pnas.90.14.6711; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Leeds P, 2005, NEUROCHEM INT, V46, P61, DOI 10.1016/j.neuint.2004.07.001; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LINDHOLM D, 1993, EUR J NEUROSCI, V5, P1455, DOI 10.1111/j.1460-9568.1993.tb00213.x; Lindsay RM, 1996, PHILOS T ROY SOC B, V351, P365, DOI 10.1098/rstb.1996.0030; Maguschak KA, 2008, NAT NEUROSCI, V11, P1319, DOI 10.1038/nn.2198; Nathan SS, 2006, CHEMOSPHERE, V62, P1388, DOI 10.1016/j.chemosphere.2005.07.009; O'Leary PD, 2003, J BIOL CHEM, V278, P25738, DOI 10.1074/jbc.M303209200; Ochs G, 2000, AMYOTROPH LATERAL SC, V1, P201, DOI 10.1080/14660820050515197; Ou LC, 2006, NEUROPSYCHOPHARMACOL, V31, P287, DOI 10.1038/sj.npp.1300830; Ou LC, 2007, MOL PHARMACOL, V72, P350, DOI 10.1124/mol.107.034934; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Qian MD, 2006, J NEUROSCI, V26, P9394, DOI 10.1523/JNEUROSCI.1118-06.2006; Rattiner LM, 2004, LEARN MEMORY, V11, P727, DOI 10.1101/lm.83304; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Saarelainen T, 2003, J NEUROSCI, V23, P349; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8; Siuciak JA, 1997, PHARMACOL BIOCHEM BE, V56, P131, DOI 10.1016/S0091-3057(96)00169-4; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; Uddin SJ, 2007, PHYTOTHER RES, V21, P757, DOI 10.1002/ptr.2159	52	73	86	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11528	10.1371/journal.pone.0011528	http://dx.doi.org/10.1371/journal.pone.0011528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644624	Green Published, Green Submitted, gold			2022-12-25	WOS:000279822300006
J	Mauney, JR; Ramachandran, A; Yu, RN; Daley, GQ; Adam, RM; Estrada, CR				Mauney, Joshua R.; Ramachandran, Aruna; Yu, Richard N.; Daley, George Q.; Adam, Rosalyn M.; Estrada, Carlos R.			All-Trans Retinoic Acid Directs Urothelial Specification of Murine Embryonic Stem Cells via GATA4/6 Signaling Mechanisms	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; TRANSCRIPTION FACTOR GATA6; GENE-EXPRESSION; MOLECULAR-MECHANISMS; EXTERNAL GENITALIA; STROMAL CELLS; GUT ENDODERM; DIFFERENTIATION; BLADDER; MOUSE	The urinary bladder and associated tract are lined by the urothelium, a transitional epithelium that acts as a specialized permeability barrier that protects the underlying tissue from urine via expression of a highly specific group of proteins known as the uroplakins (UP). To date, our understanding of the developmental processes responsible for urothelial differentiation has been hampered due to the lack of suitable models. In this study, we describe a novel in vitro cell culture system for derivation of urothelial cells from murine embryonic stem cells (ESCs) following cultivation on collagen matrices in the presence all trans retinoic acid (RA). Upon stimulation with micromolar concentrations of RA, ESCs significantly downregulated the pluripotency factor OCT-4 but markedly upregulated UP1A, UP1B, UP2, UP3A, and UP3B mRNA levels in comparison to naive ESCs and spontaneously differentiating controls. Pan-UP protein expression was associated with both p63- and cytokeratin 20-positive cells in discrete aggregating populations of ESCs following 9 and 14 days of RA stimulation. Analysis of endodermal transcription factors such as GATA4 and GATA6 revealed significant upregulation and nuclear enrichment in RA-treated UP2-GFP+ populations. GATA4-/- and GATA6-/- transgenic ESC lines revealed substantial attenuation of RA-mediated UP expression in comparison to wild type controls. In addition, EMSA analysis revealed that RA treatment induced formation of transcriptional complexes containing GATA4/6 on both UP1B and UP2 promoter fragments containing putative GATA factor binding sites. Collectively, these data suggest that RA mediates ESC specification toward a urothelial lineage via GATA4/6-dependent processes.	[Mauney, Joshua R.; Ramachandran, Aruna; Yu, Richard N.; Adam, Rosalyn M.; Estrada, Carlos R.] Childrens Hosp, Urol Dis Res Ctr, Boston, MA 02115 USA; [Mauney, Joshua R.; Ramachandran, Aruna; Yu, Richard N.; Adam, Rosalyn M.; Estrada, Carlos R.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Daley, George Q.] Harvard Stem Cell Inst, Boston, MA USA; [Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Mauney, JR (corresponding author), Childrens Hosp, Urol Dis Res Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	rosalyn.adam@childrens.harvard.edu; carlos.estrada@childrens.harvard.edu	Estrada, Carlos R/H-2199-2015	Estrada, Carlos R/0000-0003-0586-9832	Children's Hospital Boston, Office of Sponsored Programs Support for Pilot Studies (Estrada); National Institutes of Health (NIH), NIDDK [P50 DK065298-06]; Harvard Catalyst/Harvard Clinical and Translational Science Center, Estrada [UL1 RR025758-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK065298] Funding Source: NIH RePORTER	Children's Hospital Boston, Office of Sponsored Programs Support for Pilot Studies (Estrada); National Institutes of Health (NIH), NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Harvard Catalyst/Harvard Clinical and Translational Science Center, Estrada; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from Children's Hospital Boston, Office of Sponsored Programs Support for Pilot Studies (Estrada) and the National Institutes of Health (NIH), NIDDK P50 DK065298-06 (Freeman). This work was also conducted with support from the Faculty Career Development Award program of the Harvard Catalyst/Harvard Clinical and Translational Science Center (Award # UL1 RR025758-01, Estrada). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the National Center for Research Resources or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboushwareb T, 2009, NEUROUROL URODYNAM, V28, P1028, DOI 10.1002/nau.20688; Adachi W, 2000, INVEST OPHTH VIS SCI, V41, P2900; ANG SL, 1993, DEVELOPMENT, V119, P1301; ARMS L, 2009, AM J PHYSL IN PRESS; Axell MZ, 2009, J NEUROSCI METH, V184, P275, DOI 10.1016/j.jneumeth.2009.08.015; Baker LA, 1998, SEMIN NEPHROL, V18, P569; Barbara PD, 2002, DEVELOPMENT, V129, P551; Batourina E, 2005, NAT GENET, V37, P1082, DOI 10.1038/ng1645; BOYLAN JF, 1995, MOL CELL BIOL, V15, P843; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Cheng W, 2006, DEVELOPMENT, V133, P4783, DOI 10.1242/dev.02621; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Darlington GJ, 1999, CURR OPIN CELL BIOL, V11, P678, DOI 10.1016/S0955-0674(99)00035-6; Erickson DR, 2008, J UROLOGY, V180, P2681, DOI 10.1016/j.juro.2008.08.007; Erman A, 2006, TISSUE CELL, V38, P293, DOI 10.1016/j.tice.2006.07.001; HICKS RM, 1965, J CELL BIOL, V26, P25, DOI 10.1083/jcb.26.1.25; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kanematsu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1093, DOI 10.1152/ajpcell.00225.2007; Keijzer R, 2001, DEVELOPMENT, V128, P503; Kinebuchi Y, 2008, CELL TISSUE RES, V331, P605, DOI 10.1007/s00441-007-0553-9; Kondo T, 1996, DEVELOPMENT, V122, P2651; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Lazarevich NL, 2000, BIOCHEMISTRY-MOSCOW+, V65, P117; Liang FX, 2005, J CELL BIOL, V171, P835, DOI 10.1083/jcb.200505035; LIN JH, 1995, P NATL ACAD SCI USA, V92, P679, DOI 10.1073/pnas.92.3.679; LIN TP, 1994, DEV BIOL, V166, P170, DOI 10.1006/dbio.1994.1305; Malpel S, 2000, DEVELOPMENT, V127, P3057; Matusik RJ, 2008, DIFFERENTIATION, V76, P682, DOI 10.1111/j.1432-0436.2008.00276.x; Mauney JR, 2004, BIOMATERIALS, V25, P3233, DOI 10.1016/j.biomaterials.2003.10.005; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301; MOLLOY CJ, 1988, EXP MOL PATHOL, V49, P128, DOI 10.1016/0014-4800(88)90027-5; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrison B, 1998, SWINE HEALTH PROD, V6, P4; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Niimi T, 2004, J BIOL CHEM, V279, P38055, DOI 10.1074/jbc.M403724200; Oottamasathien S, 2007, DEV BIOL, V304, P556, DOI 10.1016/j.ydbio.2007.01.010; Otto A, 2009, J ANAT, V215, P477, DOI 10.1111/j.1469-7580.2009.01138.x; Park JM, 1999, AM J PHYSIOL-CELL PH, V277, pC294, DOI 10.1152/ajpcell.1999.277.2.C294; Penington EC, 2003, J PEDIATR SURG, V38, P1287, DOI 10.1016/S0022-3468(03)00384-1; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Plateroti M, 1997, J CELL SCI, V110, P1227; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Schlager TA, 2004, SPINAL CORD, V42, P163, DOI 10.1038/sj.sc.3101565; Scott V, 2005, J BIOCHEM, V137, P671, DOI 10.1093/jb/mvi086; Shanks JH, 2009, HISTOPATHOLOGY, V54, P885, DOI 10.1111/j.1365-2559.2008.03167.x; Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102; Staack A, 2005, DIFFERENTIATION, V73, P121, DOI 10.1111/j.1432-0436.2005.00014.x; Stehr M, 2004, J UROLOGY, V172, P2451, DOI 10.1097/01.ju.0000138084.53577.ca; Suzuki YJ, 2003, J BIOL CHEM, V278, P17525, DOI 10.1074/jbc.M210465200; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Warot X, 1997, DEVELOPMENT, V124, P4781; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; WERT SE, 1993, DEV BIOL, V156, P426, DOI 10.1006/dbio.1993.1090; WILSON JG, 1948, AM J ANAT, V83, P357, DOI 10.1002/aja.1000830303; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Yamada G, 2006, DEV DYNAM, V235, P1738, DOI 10.1002/dvdy.20807; Yamada G, 2003, DIFFERENTIATION, V71, P445, DOI 10.1046/j.1432-0436.2003.7108001.x; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Zhuang Y, 2003, MOL CANCER RES, V1, P619	69	49	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11513	10.1371/journal.pone.0011513	http://dx.doi.org/10.1371/journal.pone.0011513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644631	gold, Green Submitted, Green Published			2022-12-25	WOS:000279822300004
J	Blanco-Kelly, F; Matesanz, F; Alcina, A; Teruel, M; Diaz-Gallo, LM; Gomez-Garcia, M; Lopez-Nevot, MA; Rodrigo, L; Nieto, A; Cardena, C; Alcain, G; Diaz-Rubio, M; de la Concha, EG; Fernandez, O; Arroyo, R; Martin, J; Urcelay, E				Blanco-Kelly, Fiona; Matesanz, Fuencisla; Alcina, Antonio; Teruel, Maria; Diaz-Gallo, Lina M.; Gomez-Garcia, Maria; Lopez-Nevot, Miguel A.; Rodrigo, Luis; Nieto, Antonio; Cardena, Carlos; Alcain, Guillermo; Diaz-Rubio, Manuel; de la Concha, Emilio G.; Fernandez, Oscar; Arroyo, Rafael; Martin, Javier; Urcelay, Elena			CD40: Novel Association with Crohn's Disease and Replication in Multiple Sclerosis Susceptibility	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GRAVES-DISEASE; T-CELLS; DENDRITIC CELLS; GENE; LIGAND; EXPRESSION; INTERLEUKIN-17; TRANSLATION	Background: A functional polymorphism located at -1 from the start codon of the CD40 gene, rs1883832, was previously reported to disrupt a Kozak sequence essential for translation. It has been consistently associated with Graves' disease risk in populations of different ethnicity and genetic proxies of this variant evaluated in genome-wide association studies have shown evidence of an effect in rheumatoid arthritis and multiple sclerosis (MS) susceptibility. However, the protective allele associated with Graves' disease or rheumatoid arthritis has shown a risk role in MS, an effect that we aimed to replicate in the present work. We hypothesized that this functional polymorphism might also show an association with other complex autoimmune condition such as inflammatory bowel disease, given the CD40 overexpression previously observed in Crohn's disease (CD) lesions. Methodology: Genotyping of rs1883832C>T was performed in 1564 MS, 1102 CD and 969 ulcerative colitis (UC) Spanish patients and in 2948 ethnically matched controls by TaqMan chemistry. Principal Findings: The observed effect of the minor allele rs1883832T was replicated in our independent Spanish MS cohort [p=0.025; OR (95% CI)=1.12 (1.01-1.23)]. The frequency of the minor allele was also significantly higher in CD patients than in controls [p=0.002; OR (95% CI)=1.19 (1.06-1.33)]. This increased predisposition was not detected in UC patients [p=0.5; OR (95% CI)=1.04 (0.93-1.17)]. Conclusion: The impact of CD40 rs1883832 on MS and CD risk points to a common signaling shared by these autoimmune conditions.	[Blanco-Kelly, Fiona; de la Concha, Emilio G.; Urcelay, Elena] Hosp Clin San Carlos, Dept Clin Immunol, Madrid, Spain; [Matesanz, Fuencisla; Alcina, Antonio; Teruel, Maria; Diaz-Gallo, Lina M.; Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Gomez-Garcia, Maria] Hosp Univ Virgen de la Nieves, Serv Digest, Granada, Spain; [Lopez-Nevot, Miguel A.] Hosp Univ Virgen de la Nieves, Serv Inmunol, Granada, Spain; [Rodrigo, Luis] Hosp Univ Cent Asturias, Serv Digest, Oviedo, Spain; [Nieto, Antonio] Hosp Puerta del Mar, Serv Inmunol, Cadiz, Spain; [Cardena, Carlos] Hosp Clin San Cecilio, Serv Digest, Granada, Spain; [Alcain, Guillermo] Hosp Virgen de la Victoria, Serv Digest, Malaga, Spain; [Diaz-Rubio, Manuel] Hosp Clin San Carlos, Digest Dept, Madrid, Spain; [Fernandez, Oscar] Hosp Carlos Haya, Inst Neurociencias Clin, Serv Neurol, Malaga, Spain; [Arroyo, Rafael] Hosp Clin San Carlos, Dept Neurol, Multiple Sclerosis Unit, Madrid, Spain	Hospital Clinico San Carlos; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen de las Nieves; Central University Hospital Asturias; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Hospital Universitario San Cecilio; Hospital Virgen de la Victoria; Hospital Clinico San Carlos; Hospital Carlos Haya; Hospital Clinico San Carlos	Blanco-Kelly, F (corresponding author), Hosp Clin San Carlos, Dept Clin Immunol, Madrid, Spain.	eurcelay.hcsc@salud.madrid.org	Teruel, Maria/V-3205-2017; Alcina, Antonio/T-1893-2017; Martin, Javier/B-8141-2008; Martín, María/HDL-9512-2022; Martín, Javier/AAV-5209-2021; Matesanz, Fuencisla/F-3715-2016; Rodrigo, Luis/A-6278-2010; Diaz-Gallo, Lina Marcela/F-1181-2018	Teruel, Maria/0000-0002-5315-2660; Alcina, Antonio/0000-0001-7294-0948; Martin, Javier/0000-0002-2202-0622; Matesanz, Fuencisla/0000-0002-9429-1819; Rodrigo, Luis/0000-0003-1717-9345; Diaz-Gallo, Lina Marcela/0000-0002-5688-0102; Lopez Nevot, Miguel Angel/0000-0002-3465-6062; Urcelay, Elena/0000-0001-8470-8396; Blanco-Kelly, Fiona/0000-0003-0052-5651	Fundacion Mutua Madrilena; Fundacion Ramon Areces; Junta de Andalucia-Feder [P07-CVI-02551]; Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Feder) [PI081636, PI0816763, PI070353, RD07/0060]; Ministerio de Ciencia e Innovacion-Feder [SAF2009-11491, SAF2006-00398]	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fundacion Ramon Areces; Junta de Andalucia-Feder(Junta de AndaluciaEuropean Commission); Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Feder)(European Commission); Ministerio de Ciencia e Innovacion-Feder(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Elena Urcelay works for the "Fundacion para la Investigacion Biomedica-Hospital Clinico San Carlos''. This work was supported by grants from: "Fundacion Mutua Madrilena'', "Fundacion Ramon Areces'', Junta de Andalucia-Feder P07-CVI-02551, Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Feder) (PI081636, PI081676, PI070353 and RETICS-REEM RD07/0060) and Ministerio de Ciencia e Innovacion-Feder (SAF2009-11491, SAF2006-00398). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Balasa B, 1997, J IMMUNOL, V159, P4620; Ban Y, 2006, THYROID, V16, P443, DOI 10.1089/thy.2006.16.443; Battaglia E, 1999, AM J GASTROENTEROL, V94, P3279, DOI 10.1111/j.1572-0241.1999.01538.x; Boon L, 2001, J IMMUNOL, V167, P2942, DOI 10.4049/jimmunol.167.5.2942; Buck D, 2006, TISSUE ANTIGENS, V68, P335, DOI 10.1111/j.1399-0039.2006.00672.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chadha S, 2006, EUR J HUM GENET, V14, P69, DOI 10.1038/sj.ejhg.5201527; Chen CR, 2006, THYROID, V16, P427, DOI 10.1089/thy.2006.16.427; Cooper JD, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-71; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gao D, 2005, GUT, V54, P70, DOI 10.1136/gut.2003.029587; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; Iezzi G, 2009, P NATL ACAD SCI USA, V106, P876, DOI 10.1073/pnas.0810769106; Jacobson EM, 2005, ENDOCRINOLOGY, V146, P2684, DOI 10.1210/en.2004-1617; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Kurylowicz A, 2005, THYROID, V15, P1119, DOI 10.1089/thy.2005.15.1119; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; MOHAN C, 1995, J IMMUNOL, V154, P1470; Murugaiyan G, 2008, J IMMUNOL, V181, P7480, DOI 10.4049/jimmunol.181.11.7480; Peters A.L., 2009, SEMIN IMMUNOL, V10, P10; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; 't Hart BA, 2008, NEURODEGENER DIS, V5, P38, DOI 10.1159/000109937; Tomer Y, 2002, THYROID, V12, P1129, DOI 10.1089/105072502321085234; Zheng J, 2010, CELL MOL IMMUNOL, V7, P44, DOI 10.1038/cmi.2009.103; Zheng J, 2009, J IMMUNOL, V183, P3742, DOI 10.4049/jimmunol.0901329	32	49	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11520	10.1371/journal.pone.0011520	http://dx.doi.org/10.1371/journal.pone.0011520			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634952	Green Published, gold, Green Submitted			2022-12-25	WOS:000279781600008
J	Chertemps, T; Mitri, C; Perrot, S; Sautereau, J; Jacques, JC; Thiery, I; Bourgouin, C; Rosinski-Chupin, I				Chertemps, Thomas; Mitri, Christian; Perrot, Sylvie; Sautereau, Jean; Jacques, Jean-Claude; Thiery, Isabelle; Bourgouin, Catherine; Rosinski-Chupin, Isabelle			Anopheles Gambiae PRS1 Modulates Plasmodium Development at Both Midgut and Salivary Gland Steps	PLOS ONE			English	Article							MALARIA PARASITE; MOLECULAR-INTERACTIONS; BERGHEI SPOROZOITES; MOSQUITO; INVASION; INFECTION; PROTEIN; VECTOR; CELLS; FALCIPARUM	Background: Invasion of the mosquito salivary glands by Plasmodium is a critical step for malaria transmission. From a SAGE analysis, we previously identified several genes whose expression in salivary glands was regulated coincident with sporozoite invasion of salivary glands. To get insights into the consequences of these salivary gland responses, here we have studied one of the genes, PRS1 (Plasmodium responsive salivary 1), whose expression was upregulated in infected glands, using immunolocalization and functional inactivation approaches. Methodology/Principal Findings: PRS1 belongs to a novel insect superfamily of genes encoding proteins with DM9 repeat motifs of uncharacterized function. We show that PRS1 is induced in response to Plasmodium, not only in the salivary glands but also in the midgut, the other epithelial barrier that Plasmodium has to cross to develop in the mosquito. Furthermore, this induction is observed using either the rodent parasite Plasmodium berghei or the human pathogen Plasmodium falciparum. In the midgut, PRS1 overexpression is associated with a relocalization of the protein at the periphery of invaded cells. We also find that sporozoite invasion of salivary gland cells occurs sequentially and induces intra-cellular modifications that include an increase in PRS1 expression and a relocalization of the corresponding protein into vesicle-like structures. Importantly, PRS1 knockdown during the onset of midgut and salivary gland invasion demonstrates that PRS1 acts as an agonist for the development of both parasite species in the two epithelia, highlighting shared vector/parasite interactions in both tissues. Conclusions/Significance: While providing insights into potential functions of DM9 proteins, our results reveal that PRS1 likely contributes to fundamental interactions between Plasmodium and mosquito epithelia, which do not depend on the specific Anopheles/P. falciparum coevolutionary history.	[Chertemps, Thomas; Perrot, Sylvie; Sautereau, Jean; Rosinski-Chupin, Isabelle] Inst Pasteur, Ctr Natl Rech Sci URA 3012, Dept Parasitol & Mycol, Unite Biochim & Biol Mol Insectes, Paris, France; [Mitri, Christian; Jacques, Jean-Claude; Thiery, Isabelle; Bourgouin, Catherine] Inst Pasteur, Dept Parasitol & Mycol, CEPIA, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Chertemps, T (corresponding author), Univ Paris 06, UMR Physiol Insecte Signalisat & Commun 1272A, Paris, France.	ichupin@pasteur.fr	Bourgouin, Catherine/F-1253-2014	Bourgouin, Catherine/0000-0002-9209-845X; Mitri, Christian/0000-0003-3882-2029	Institut Pasteur (Paris); Fonds Dedie Sanofi-Aventis/Ministere de la Recherche "Combattre les Maladies Parasitaires''	Institut Pasteur (Paris); Fonds Dedie Sanofi-Aventis/Ministere de la Recherche "Combattre les Maladies Parasitaires''(Sanofi-AventisMinistry of Research, France)	This research has received financial support from the Institut Pasteur (Paris) and the Fonds Dedie Sanofi-Aventis/Ministere de la Recherche "Combattre les Maladies Parasitaires''. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; [Anonymous], 1932, STAT METHODS RES WOR; Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Boisson B, 2006, FEBS LETT, V580, P1988, DOI 10.1016/j.febslet.2006.02.069; Danielli A, 2005, CELL MICROBIOL, V7, P181, DOI 10.1111/j.1462-5822.2004.00445.x; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gomez SM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r39; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Hillyer JF, 2007, INT J PARASITOL, V37, P673, DOI 10.1016/j.ijpara.2006.12.007; Holford KC, 2004, INSECT BIOCHEM MOLEC, V34, P785, DOI 10.1016/j.ibmb.2004.04.003; Matuschewski K, 2006, CELL MICROBIOL, V8, P1547, DOI 10.1111/j.1462-5822.2006.00778.x; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Mendes AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000069; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; Natarajan R, 2001, CELL MICROBIOL, V3, P371, DOI 10.1046/j.1462-5822.2001.00117.x; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; PIMENTA PF, 1994, J EUKARYOT MICROBIOL, V41, P608, DOI 10.1111/j.1550-7408.1994.tb01523.x; Pinto SB, 2008, CELL MICROBIOL, V10, P891, DOI 10.1111/j.1462-5822.2007.01091.x; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P242, DOI 10.1016/0035-9203(82)90289-9; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Rosinski-Chupin I, 2007, CELL MICROBIOL, V9, P708, DOI 10.1111/j.1462-5822.2006.00822.x; Shiao SH, 2006, PLOS PATHOG, V2, P1152, DOI 10.1371/journal.ppat.0020133; Sinden RE, 2002, CELL MICROBIOL, V4, P713, DOI 10.1046/j.1462-5822.2002.00229.x; STERLING CR, 1973, J PARASITOL, V59, P593, DOI 10.2307/3278847; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Tahar R, 2002, EMBO J, V21, P6673, DOI 10.1093/emboj/cdf664; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Vlachou D, 2004, CELL MICROBIOL, V6, P671, DOI 10.1111/j.1462-5822.2004.00394.x; Vlachou D, 2006, CURR OPIN GENET DEV, V16, P384, DOI 10.1016/j.gde.2006.06.012; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Zieler H, 2000, P NATL ACAD SCI USA, V97, P11516, DOI 10.1073/pnas.97.21.11516	38	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11538	10.1371/journal.pone.0011538	http://dx.doi.org/10.1371/journal.pone.0011538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634948	gold, Green Published, Green Submitted			2022-12-25	WOS:000279781600017
J	Eberle, AB; Hessle, V; Helbig, R; Dantoft, W; Gimber, N; Visa, N				Eberle, Andrea B.; Hessle, Viktoria; Helbig, Roger; Dantoft, Widad; Gimber, Niclas; Visa, Neus			Splice-Site Mutations Cause Rrp6-Mediated Nuclear Retention of the Unspliced RNAs and Transcriptional Down-Regulation of the Splicing-Defective Genes	PLOS ONE			English	Article							PRE-MESSENGER-RNA; QUALITY-CONTROL; POLYMERASE-II; IN-VIVO; EXOSOME; EXPORT; MRNP; TERMINATION; CEREVISIAE; EXPRESSION	Background: Eukaryotic cells have developed surveillance mechanisms to prevent the expression of aberrant transcripts. An early surveillance checkpoint acts at the transcription site and prevents the release of mRNAs that carry processing defects. The exosome subunit Rrp6 is required for this checkpoint in Saccharomyces cerevisiae, but it is not known whether Rrp6 also plays a role in mRNA surveillance in higher eukaryotes. Methodology/Principal Findings: We have developed an in vivo system to study nuclear mRNA surveillance in Drosophila melanogaster. We have produced S2 cells that express a human beta-globin gene with mutated splice sites in intron 2 (mut beta-globin). The transcripts encoded by the mut beta-globin gene are normally spliced at intron 1 but retain intron 2. The levels of the mut beta-globin transcripts are much lower than those of wild type (wt) beta-globin mRNAs transcribed from the same promoter. We have compared the expression of the mut and wt beta-globin genes to investigate the mechanisms that down-regulate the production of defective mRNAs. Both wt and mut beta-globin transcripts are processed at the 3', but the mut beta-globin transcripts are less efficiently cleaved than the wt transcripts. Moreover, the mut beta-globin transcripts are less efficiently released from the transcription site, as shown by FISH, and this defect is restored by depletion of Rrp6 by RNAi. Furthermore, transcription of the mut beta-globin gene is significantly impaired as revealed by ChIP experiments that measure the association of the RNA polymerase II with the transcribed genes. We have also shown that the mut beta-globin gene shows reduced levels of H3K4me3. Conclusions/Significance: Our results show that there are at least two surveillance responses that operate cotranscriptionally in insect cells and probably in all metazoans. One response requires Rrp6 and results in the inefficient release of defective mRNAs from the transcription site. The other response acts at the transcription level and reduces the synthesis of the defective transcripts through a mechanism that involves histone modifications.	[Eberle, Andrea B.; Hessle, Viktoria; Helbig, Roger; Dantoft, Widad; Gimber, Niclas; Visa, Neus] Stockholm Univ, Dept Mol Biol & Funct Genom, S-10691 Stockholm, Sweden	Stockholm University	Eberle, AB (corresponding author), Stockholm Univ, Dept Mol Biol & Funct Genom, S-10691 Stockholm, Sweden.	Neus.Visa@molbio.su.se	Visa, Neus/C-9459-2016; Visa, Neus/R-8037-2019	Visa, Neus/0000-0003-3145-3953; Visa, Neus/0000-0003-3145-3953; Gimber, Niclas/0000-0001-9456-3063	Swedish Research Council [dnr. 2006-5398]; Swedish Cancer Society [CAN 2006/1193]; European Science Foundation; Wenner-Gren Foundation; Swiss National Science Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); European Science Foundation(European Science Foundation (ESF)European Commission); Wenner-Gren Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by grants from the Swedish Research Council (dnr. 2006-5398, www.vr.se), the Swedish Cancer Society (CAN 2006/1193, www.cancerfonden.se), and the European Science Foundation, Eurocores RNA Quality Programme (VR dnr. 2007-7323, http://www.esf.org/activities/eurocores/runningprogrammes/rnaquality.html). ABE is supported by fellowships from the Wenner-Gren Foundation (http://www.swgc.org) and the Swiss National Science Foundation (www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; ALMEIDA SF, 2008, FEBS LETT, V582, P1971; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Antoniou M, 1998, NUCLEIC ACIDS RES, V26, P721, DOI 10.1093/nar/26.3.721; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Custodio N, 1999, EMBO J, V18, P2855, DOI 10.1093/emboj/18.10.2855; Custodio N, 2007, J CELL BIOL, V179, P199, DOI 10.1083/jcb.200612109; Damgaard CK, 2008, MOL CELL, V29, P271, DOI 10.1016/j.molcel.2007.11.035; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Furger A, 2002, GENE DEV, V16, P2792, DOI 10.1101/gad.983602; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Graham AC, 2009, MOL BIOL CELL, V20, P2242, DOI 10.1091/mbc.E08-08-0825; Hase ME, 2006, J BIOL CHEM, V281, P39135, DOI 10.1074/jbc.M604235200; Hessle V, 2009, MOL BIOL CELL, V20, P3459, DOI 10.1091/mbc.E09-01-0079; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Jensen TH, 2004, MOL CELL, V16, P235, DOI 10.1016/j.molcel.2004.09.019; Jensen TH, 2003, MOL CELL, V11, P1129, DOI 10.1016/S1097-2765(03)00191-6; Jensen TH, 2001, MOL CELL, V7, P887, DOI 10.1016/S1097-2765(01)00232-5; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kornblihtt AR, 2007, ADV EXP MED BIOL, V623, P175, DOI 10.1007/978-0-387-77374-2_11; Krawczak M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/humu.20400; Kurmangaliyev YZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-13; Lebreton A, 2008, BBA-GENE REGUL MECH, V1779, P558, DOI 10.1016/j.bbagrm.2008.02.003; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Minvielle-Sebastia L, 1999, CURR OPIN CELL BIOL, V11, P352, DOI 10.1016/S0955-0674(99)80049-0; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Rougemaille M, 2007, EMBO J, V26, P2317, DOI 10.1038/sj.emboj.7601669; Saguez C, 2005, CURR OPIN CELL BIOL, V17, P287, DOI 10.1016/j.ceb.2005.04.009; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schmid M, 2008, CHROMOSOMA, V117, P419, DOI 10.1007/s00412-008-0166-4; Sjolinder M, 2005, GENE DEV, V19, P1871, DOI 10.1101/gad.339405; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Vinciguerra P, 2005, EMBO J, V24, P813, DOI 10.1038/sj.emboj.7600527; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035	44	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11540	10.1371/journal.pone.0011540	http://dx.doi.org/10.1371/journal.pone.0011540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634951	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000279781600019
J	Kitahara, MV; Cairns, SD; Stolarski, J; Blair, D; Miller, DJ				Kitahara, Marcelo V.; Cairns, Stephen D.; Stolarski, Jaroslaw; Blair, David; Miller, David J.			A Comprehensive Phylogenetic Analysis of the Scleractinia (Cnidaria, Anthozoa) Based on Mitochondrial CO1 Sequence Data	PLOS ONE			English	Article							EVOLUTIONARY RELATIONSHIPS; PHYLUM CNIDARIA; CORALS; SYSTEMATICS; CLASSIFICATION; INFERENCE; ATLANTIC; PACIFIC; MRBAYES; GENOME	Background: Classical morphological taxonomy places the approximately 1400 recognized species of Scleractinia (hard corals) into 27 families, but many aspects of coral evolution remain unclear despite the application of molecular phylogenetic methods. In part, this may be a consequence of such studies focusing on the reef-building (shallow water and zooxanthellate) Scleractinia, and largely ignoring the large number of deep-sea species. To better understand broad patterns of coral evolution, we generated molecular data for a broad and representative range of deep sea scleractinians collected off New Caledonia and Australia during the last decade, and conducted the most comprehensive molecular phylogenetic analysis to date of the order Scleractinia. Methodology: Partial (595 bp) sequences of the mitochondrial cytochrome oxidase subunit 1 (CO1) gene were determined for 65 deep-sea (azooxanthellate) scleractinians and 11 shallow-water species. These new data were aligned with 158 published sequences, generating a 234 taxon dataset representing 25 of the 27 currently recognized scleractinian families. Principal Findings/Conclusions: There was a striking discrepancy between the taxonomic validity of coral families consisting predominantly of deep-sea or shallow-water species. Most families composed predominantly of deep-sea azooxanthellate species were monophyletic in both maximum likelihood and Bayesian analyses but, by contrast (and consistent with previous studies), most families composed predominantly of shallow-water zooxanthellate taxa were polyphyletic, although Acroporidae, Poritidae, Pocilloporidae, and Fungiidae were exceptions to this general pattern. One factor contributing to this inconsistency may be the greater environmental stability of deep-sea environments, effectively removing taxonomic "noise'' contributed by phenotypic plasticity. Our phylogenetic analyses imply that the most basal extant scleractinians are azooxanthellate solitary corals from deep-water, their divergence predating that of the robust and complex corals. Deep-sea corals are likely to be critical to understanding anthozoan evolution and the origins of the Scleractinia.	[Kitahara, Marcelo V.; Miller, David J.] James Cook Univ, ARC Ctr Excellence Coral Reefs Studies, Townsville, Qld 4811, Australia; [Kitahara, Marcelo V.; Miller, David J.] James Cook Univ, Coral Genom Grp, Townsville, Qld 4811, Australia; [Cairns, Stephen D.] Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA; [Stolarski, Jaroslaw] Polish Acad Sci, Inst Paleobiol, Warsaw, Poland; [Blair, David] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University; Smithsonian Institution; Smithsonian National Museum of Natural History; Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; James Cook University	Kitahara, MV (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reefs Studies, Townsville, Qld 4811, Australia.	mvkitahara@yahoo.com.br	Blair, David/O-2786-2019; Stolarski, Jaroslaw/AAF-7331-2019; Blair, David/G-6052-2011; Stolarski, Jaroslaw/V-9586-2017; Kitahara, Marcelo Visentini/D-5560-2011	Blair, David/0000-0002-4658-3251; Stolarski, Jaroslaw/0000-0003-0994-6823; Blair, David/0000-0002-4658-3251; Stolarski, Jaroslaw/0000-0003-0994-6823; Kitahara, Marcelo Visentini/0000-0003-4011-016X	Australian Research Council (through the Centre of Excellence for Coral Reef Studies); Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES); Fisheries Research and Development Corporation (FRDC); Australian Government Department of Environment, Water, Heritage and the Arts; Australian CSIRO (Commonwealth Scientific and Industrial Research Organization) Wealth [SS102005, SS022007]	Australian Research Council (through the Centre of Excellence for Coral Reef Studies)(Australian Research Council); Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fisheries Research and Development Corporation (FRDC)(Fisheries R&D Corp); Australian Government Department of Environment, Water, Heritage and the Arts(Australian Government); Australian CSIRO (Commonwealth Scientific and Industrial Research Organization) Wealth	This study was supported through funding from the Australian Research Council (through the Centre of Excellence for Coral Reef Studies) grants to DJM. MVK is a recipient of a PhD scholarship from the Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES). The Australian specimens examined in the present study were collected with funding from the Fisheries Research and Development Corporation (FRDC) and Environment Australia (now the Australian Government Department of Environment, Water, Heritage and the Arts); the 2005/2007 cruises (SS102005 and SS022007) were funded by the Australian CSIRO (Commonwealth Scientific and Industrial Research Organization) Wealth from Oceans Flagship with the assistance of the Australian Government Department of the Environment, Water, Heritage and the Arts; and the NORFANZ cruise was a collaboration between Australia's National Oceans Office (now the Australian Government Department of Environment, Water, Heritage and the Arts), Australia's CSIRO Marine and Atmospheric Research, New Zealand's Ministry of Fisheries and New Zealand's National Institute of Water and Atmospheric Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock A., 1902, TIJDSCHRIFT NEDERLAN, V7, P89; ALLOITEAU J, 1957, CONTRIBUTION SYSTEMA, V1; Baron-Szabo RC, 2006, J PALEONTOL, V80, P1033, DOI 10.1666/0022-3360(2006)80[1033:SCFTCF]2.0.CO;2; BEAUVAIS L, 1986, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V194, P1; Benzoni F, 2007, CONTRIB ZOOL, V76, P35, DOI 10.1163/18759866-07601004; Berntson EA, 1999, MOL PHYLOGENET EVOL, V13, P417, DOI 10.1006/mpev.1999.0649; BOSCHMA H, 1959, 15 INT C ZOOL SECT, V3, P1; BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750; Brugler MR, 2007, MOL PHYLOGENET EVOL, V42, P776, DOI 10.1016/j.ympev.2006.08.016; Budd AF, 2009, ACTA ZOOL-STOCKHOLM, V90, P142, DOI 10.1111/j.1463-6395.2008.00345.x; CAIRNS S D, 1984, Occasional Papers Bernice P. Bishop Museum, V25, P1; Cairns S. D., 2009, COLD WATER CORALS BI; Cairns S. D., 1982, ANTARCT RES SER, V34, P1, DOI [DOI 10.1029/AR034P0001, 10.1029/AR034p0001]; Cairns S. D., 1997, SMITHSONIAN CONTRIBU, V591, P1, DOI DOI 10.5479/SI.00810282.591; Cairns SD, 1999, MEMOIR MUS NATL HIST, V180, P31; Cairns SD., 1995, NZ OCEANOGRAPHIC I M, V103, P210, DOI DOI 10.1017/CBO9781107415324.004; CAIRNS SD, 2001, SMITHSON CONTRIB ZOO, V615, P75; Cairns Stephen D., 1999, Atoll Research Bulletin, V459, P13; CHEN CA, 1995, MOL PHYLOGENET EVOL, V4, P175, DOI 10.1006/mpev.1995.1017; Chen L, 2002, BIOORG MED CHEM LETT, V12, P137, DOI 10.1016/S0960-894X(01)00711-9; CHEVALIER JP, 1987, TRAITE ZOOLOGIE, V3; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cuif JP, 2003, ZOOL SCR, V32, P459, DOI 10.1046/j.1463-6409.2003.00133.x; Daly M, 2003, ZOOL J LINN SOC-LOND, V139, P419, DOI 10.1046/j.1096-3642.2003.00084.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Filkorn HF, 2004, J PALEONTOL, V78, P501, DOI 10.1666/0022-3360(2004)078<0501:ANECCD>2.0.CO;2; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forsman ZH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-45; Forsman ZH, 2005, CORAL REEFS, V24, P343, DOI 10.1007/s00338-005-0497-z; France SC, 1996, MOL MAR BIOL BIOTECH, V5, P15; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; George RY, 2007, B MAR SCI, V81, P309; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hoeksema BW, 1989, ZOOLOGISCHE VERHANDE, V254, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Keller N.B., 1976, T INSTITUTA OKEANOLO, V99, P31; KERBY T, 2007, SECONDARY SCI REV, V18, P14; Kerr AM, 2005, BIOL REV, V80, P543, DOI 10.1017/S1464793105006780; Kitahara MV, 2010, SYST BIODIVERS, V8, P91, DOI 10.1080/14772000903571088; Le Goff-Vitry MC, 2004, MOL PHYLOGENET EVOL, V30, P167, DOI 10.1016/S1055-7903(03)00162-3; Lindner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002429; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Nunes F, 2008, CORAL REEFS, V27, P423, DOI 10.1007/s00338-007-0349-0; Nylander JAA, 2004, MRMODELTEST 2 0 PROG; OWENS JM, 1984, GEOLOGOS, V11, P87; PANDOLFI JM, 1992, J BIOGEOGR, V19, P593, DOI 10.2307/2845703; Roberts J.M., 2009, COLD WATER CORALS BI; Romano SL, 1997, J MOL EVOL, V45, P397, DOI 10.1007/PL00006245; Romano SL, 2000, B MAR SCI, V67, P1043; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Song ZC, 1997, CRETACEOUS RES, V18, P1; SQUIRES DONALD F., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMIMIAMI BEACH FLA FRIEDRICH FRANS KOCZY MEMORIAL VOLUME, V5, P502; STANLEY GD, 1995, PALEOBIOLOGY, V21, P179, DOI 10.1017/S0094837300013191; Stolarski J, 2001, J PALEONTOL, V75, P1090, DOI 10.1666/0022-3360(2001)075<1090:TANSOE>2.0.CO;2; Stolarski J, 2000, LETHAIA, V33, P13, DOI 10.1080/00241160050150276; VAUGHAN TW, 1943, SPEC PAP GEOL SOC AM, V44, P1; VAUGHAN TW, 2007, B US NATL MUSEUM, V59, P427; Veron JEN, 1996, CORAL REEFS, V15, P1; VERON JEN, 1995, CORALS SPACE TIME BI; Veron JEN, 2000, CORALS WORLD, V3; Wallace CC, 2007, CORAL REEFS, V26, P231, DOI 10.1007/s00338-007-0203-4; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Wells J.W., 1956, TREATISE INVERTEBR F; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; YABE HISAKATSU, 1941, SCI REPTS TOHOKU IMP UNIV SER 2 GEOL SPECIAL VOL, V2, P67; ZIBROWIUS H, 1990, Scientia Marina, V54, P19	69	171	174	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11490	10.1371/journal.pone.0011490	http://dx.doi.org/10.1371/journal.pone.0011490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628613	Green Published, gold, Green Accepted			2022-12-25	WOS:000279637100015
J	Taylor, KR; Mills, RE; Costanzo, AE; Jameson, JM				Taylor, Kristen R.; Mills, Robyn E.; Costanzo, Anne E.; Jameson, Julie M.			gamma delta T Cells Are Reduced and Rendered Unresponsive by Hyperglycemia and Chronic TNF alpha in Mouse Models of Obesity and Metabolic Disease	PLOS ONE			English	Article							INSULIN-RESISTANCE; LANGERHANS CELLS; DENDRITIC CELLS; WOUND REPAIR; HUMAN SKIN; RECEPTOR; MICE; ACTIVATION; EXPRESSION; COMPLEX	Epithelial cells provide an initial line of defense against damage and pathogens in barrier tissues such as the skin; however this balance is disrupted in obesity and metabolic disease. Skin gamma delta T cells recognize epithelial damage, and release cytokines and growth factors that facilitate wound repair. We report here that hyperglycemia results in impaired skin gamma delta T cell proliferation due to altered STAT5 signaling, ultimately resulting in half the number of gamma delta T cells populating the epidermis. Skin gamma delta T cells that overcome this hyperglycemic state are unresponsive to epithelial cell damage due to chronic inflammatory mediators, including TNF alpha. Cytokine and growth factor production at the site of tissue damage was partially restored by administering neutralizing TNF alpha antibodies in vivo. Thus, metabolic disease negatively impacts homeostasis and functionality of skin gamma delta T cells, rendering host defense mechanisms vulnerable to injury and infection.	[Taylor, Kristen R.; Mills, Robyn E.; Costanzo, Anne E.; Jameson, Julie M.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Taylor, KR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	jamesonj@scripps.edu		Jameson, Julie/0000-0003-0727-4066	National Institutes of Health (NIH) [DK073098, DK080048, UL1 RR055774]; Leukemia and Lymphoma Society; Department of Immunology Institutional Training Grant [5T32 AI007244-24]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080048, R21DK073098] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Department of Immunology Institutional Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health (NIH) grant DK073098 and DK080048 (J.M.J), a Scripps Translational Science Institute Award from NIH UL1 RR055774 (J.M.J.), The Leukemia and Lymphoma Society (J.M.J.) and a Department of Immunology Institutional Training Grant 5T32 AI007244-24 (K. R. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Boismenu R, 1996, Semin Immunol, V8, P323, DOI 10.1006/smim.1996.0043; Boismenu R, 1996, J IMMUNOL, V157, P985; Born W K, 2000, Respir Res, V1, P151, DOI 10.1186/rr26; Born WK, 2007, J CLIN IMMUNOL, V27, P133, DOI 10.1007/s10875-007-9077-z; Bubici C, 2004, CELL CYCLE, V3, P1524, DOI 10.4161/cc.3.12.1321; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Cavanagh PR, 2005, LANCET, V366, P1725, DOI 10.1016/S0140-6736(05)67699-4; Cheroutre H, 2005, IMMUNOL REV, V206, P114, DOI 10.1111/j.0105-2896.2005.00284.x; Clark J, 2005, ANN RHEUM DIS, V64, P70, DOI 10.1136/ard.2005.042523; COPE AP, 1994, J CLIN INVEST, V94, P749, DOI 10.1172/JCI117394; Cope AP, 1997, J EXP MED, V185, P1573, DOI 10.1084/jem.185.9.1573; Daniel T, 2007, SHOCK, V28, P278, DOI 10.1097/shk.0b013e318034264c; DUPUY P, 1990, J INVEST DERMATOL, V94, P764, DOI 10.1111/1523-1747.ep12874626; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Fu YC, 2007, J BIOL CHEM, V282, P31525, DOI 10.1074/jbc.M701132200; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; Girardi M, 2006, J INVEST DERMATOL, V126, P808, DOI 10.1038/sj.jid.5700120; Girardi M, 2006, J INVEST DERMATOL, V126, P25, DOI 10.1038/sj.jid.5700003; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Isomaki P, 2001, J IMMUNOL, V166, P5495, DOI 10.4049/jimmunol.166.9.5495; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jameson JM, 2005, J EXP MED, V201, P1269, DOI 10.1084/jem.20042057; Jameson JM, 2004, J IMMUNOL, V172, P3573, DOI 10.4049/jimmunol.172.6.3573; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Komori H, 2006, CURR OPIN IMMUNOL, V18, P534, DOI 10.1016/j.coi.2006.06.001; Lee DF, 2008, INT J MOL MED, V22, P633, DOI 10.3892/ijmm_00000065; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Mills RE, 2008, J IMMUNOL, V181, P3974, DOI 10.4049/jimmunol.181.6.3974; Misawa M, 2008, GLYCOBIOLOGY, V18, P20, DOI 10.1093/glycob/cwm115; Nanno M, 2007, IMMUNOL REV, V215, P103, DOI 10.1111/j.1600-065X.2006.00474.x; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Raymond K, 2005, J CELL SCI, V118, P1045, DOI 10.1242/jcs.01689; Relchelt J, 2002, J CELL SCI, V115, P2639; Sharp LL, 2005, NAT IMMUNOL, V6, P73, DOI 10.1038/ni1152; Tough DF, 1998, J EXP MED, V187, P357, DOI 10.1084/jem.187.3.357; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Xiong N, 2007, IMMUNOL REV, V215, P15, DOI 10.1111/j.1600-065X.2006.00478.x; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Yoshida T, 1997, BIOCHEM BIOPH RES CO, V232, P822, DOI 10.1006/bbrc.1997.6378	57	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11422	10.1371/journal.pone.0011422	http://dx.doi.org/10.1371/journal.pone.0011422			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625397	Green Submitted, gold, Green Published			2022-12-25	WOS:000279465700009
J	Tsai, WB; Chung, YM; Zou, YY; Park, SH; Xu, ZH; Nakayama, K; Lin, SH; Hu, MCT				Tsai, Wen-Bin; Chung, Young Min; Zou, Yiyu; Park, See-Hyoung; Xu, Zhaohui; Nakayama, Keiko; Lin, Sue-Hwa; Hu, Mickey C-T.			Inhibition of FOXO3 Tumor Suppressor Function by beta TrCP1 through Ubiquitin-Mediated Degradation in a Tumor Mouse Model	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; I-KAPPA-B; BETA-TRCP; OXIDATIVE STRESS; PROTEASOME PATHWAY; DNA-DAMAGE; CELL-CYCLE; PHOSPHORYLATION; PROMOTES; PROTEIN	Background: The ubiquitin-proteasome system is the primary proteolysis machine for controlling protein stability of the majority of regulatory proteins including those that are critical for cancer development. The forkhead box transcription factor FOXO3 plays a key role in regulating tumor suppression; however, the control of FOXO3 protein stability remains to be established. It is crucial to elucidate the molecular mechanisms underlying the ubiquitin-mediated degradation of FOXO3 tumor suppressor. Methodology and Principal Findings: Here we show that beta TrCP1 oncogenic ubiquitin E3-ligase interacts with FOXO3 and induces its ubiquitin-dependent degradation in an I kappa B kinase-beta phosphorylation dependent manner. Silencing beta TrCP1 augments FOXO3 protein level, resulting in promoting cellular apoptosis in cancer cells. In animal models, increasing FOXO3 protein level by silencing beta TrCP1 suppresses tumorigenesis, whereas decreasing FOXO3 by over-expressing beta TrCP1 promotes tumorigenesis and tumor growth in vivo. Conclusions/Significance: This is a unique demonstration that the beta TrCP1-mediated FOXO3 degradation plays a crucial role in tumorigenesis. These findings significantly contribute to understanding of the control of FOXO3 stability in cancer cells and may provide opportunities for developing innovative anticancer therapeutic modalities.	[Tsai, Wen-Bin; Lin, Sue-Hwa] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Chung, Young Min; Park, See-Hyoung; Hu, Mickey C-T.] Stanford Univ, Div Gynecol Oncol, Sch Med, Stanford, CA 94305 USA; [Zou, Yiyu] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Xu, Zhaohui] Baylor Coll Med, Dept Pediat Infect Dis, Houston, TX 77030 USA; [Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res Human Dis, Div Dev Genet, Sendai, Miyagi 980, Japan	University of Texas System; UTMD Anderson Cancer Center; Stanford University; Yeshiva University; Baylor College of Medicine; Tohoku University	Tsai, WB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA.	mhu1@stanford.edu	Chung, Young Min/AAV-7656-2020		National Institutes of Health [R01CA113859];  [BCTR0504415]; NATIONAL CANCER INSTITUTE [R01CA113859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant R01CA113859 and Susan G. Komen for the Cure grant BCTR0504415 to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Arden KC, 2007, CELL, V128, P235, DOI 10.1016/j.cell.2007.01.009; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Fuchs SY, 2002, CANCER BIOL THER, V1, P337; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Nakayama K, 2003, P NATL ACAD SCI USA, V100, P8752, DOI 10.1073/pnas.1133216100; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Seo E, 2009, CELL SIGNAL, V21, P43, DOI 10.1016/j.cellsig.2008.09.009; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Tsai WB, 2008, NAT CELL BIOL, V10, P460, DOI 10.1038/ncb1709; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Xia YF, 2009, P NATL ACAD SCI USA, V106, P2629, DOI 10.1073/pnas.0812256106; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159	30	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11171	10.1371/journal.pone.0011171	http://dx.doi.org/10.1371/journal.pone.0011171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625400	gold, Green Submitted, Green Published			2022-12-25	WOS:000279465700001
J	Ballingall, KT; Rocchi, MS; McKeever, DJ; Wright, F				Ballingall, Keith T.; Rocchi, Mara S.; McKeever, Declan J.; Wright, Frank			Trans-Species Polymorphism and Selection in the MHC Class II DRA Genes of Domestic Sheep	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; POSITIVE SELECTION; EVOLUTION; DIVERSITY; CATTLE; WILD; IDENTIFICATION; NOMENCLATURE; INFERENCE; LINEAGES	Highly polymorphic genes with central roles in lymphocyte mediated immune surveillance are grouped together in the major histocompatibility complex (MHC) in higher vertebrates. Generally, across vertebrate species the class II MHC DRA gene is highly conserved with only limited allelic variation. Here however, we provide evidence of trans-species polymorphism at the DRA locus in domestic sheep (Ovis aries). We describe variation at the Ovar-DRA locus that is far in excess of anything described in other vertebrate species. The divergent DRA allele (Ovar-DRA*0201) differs from the sheep reference sequences by 20 nucleotides, 12 of which appear non-synonymous. Furthermore, DRA*0201 is paired with an equally divergent DRB1 allele (Ovar-DRB1*0901), which is consistent with an independent evolutionary history for the DR sub-region within this MHC haplotype. No recombination was observed between the divergent DRA and B genes in a range of breeds and typical levels of MHC class II DR protein expression were detected at the surface of leukocyte populations obtained from animals homozygous for the DRA*0201, DRB1*0901 haplotype. Bayesian phylogenetic analysis groups Ovar-DRA*0201 with DRA sequences derived from species within the Oryx and Alcelaphus genera rather than clustering with other ovine and caprine DRA alleles. Tests for Darwinian selection identified 10 positively selected sites on the branch leading to Ovar-DRA*0201, three of which are predicted to be associated with the binding of peptide antigen. As the Ovis, Oryx and Alcelaphus genera have not shared a common ancestor for over 30 million years, the DRA*0201 and DRB1*0901 allelic pair is likely to be of ancient origin and present in the founding population from which all contemporary domestic sheep breeds are derived. The conservation of the integrity of this unusual DR allelic pair suggests some selective advantage which is likely to be associated with the presentation of pathogen antigen to T-cells and the induction of protective immunity.	[Ballingall, Keith T.; Rocchi, Mara S.] Moredun Res Inst, Div Epidemiol & Populat Biol, Penicuik, Midlothian, Scotland; [McKeever, Declan J.] Univ London Royal Vet Coll, Dept Pathol & Infect Dis, Hatfield, Herts, England; [Wright, Frank] Scotland BIOSS, Edinburgh, Midlothian, Scotland	Moredun Research Institute; University of London; University of London Royal Veterinary College; James Hutton Institute	Ballingall, KT (corresponding author), Moredun Res Inst, Div Epidemiol & Populat Biol, Penicuik, Midlothian, Scotland.	keith.ballingall@moredun.ac.uk	Ballingall, Keith/T-1262-2019; Wright, Frank/N-3510-2013		Scottish Governments Rural and Environment Directorate (RERAD); Moredun Research Institute	Scottish Governments Rural and Environment Directorate (RERAD); Moredun Research Institute	This work was funded by the Scottish Governments Rural and Environment Directorate (RERAD) and the Moredun Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1994, BIOCHEM BIOPH RES CO, V204, P195, DOI 10.1006/bbrc.1994.2444; ANDERSSON L, 1995, IMMUNOL REV, V143, P5, DOI 10.1111/j.1600-065X.1995.tb00667.x; Anisimova M, 2007, MOL BIOL EVOL, V24, P1219, DOI 10.1093/molbev/msm042; Arrieta-Aguirre I, 2006, TISSUE ANTIGENS, V67, P222, DOI 10.1111/j.1399-0039.2006.00556.x; AYALA FJ, 1994, P NATL ACAD SCI USA, V91, P6787, DOI 10.1073/pnas.91.15.6787; Ballingall KT, 2008, IMMUNOGENETICS, V60, P95, DOI 10.1007/s00251-008-0278-2; BALLINGALL KT, 1995, ANIM GENET, V26, P79, DOI 10.1111/j.1365-2052.1995.tb02637.x; Ballingall KT, 2001, IMMUNOGENETICS, V52, P276, DOI 10.1007/s002510000276; BALLINGALL KT, 1992, ANIM GENET, V23, P347, DOI 10.1111/j.1365-2052.1992.tb00157.x; BOKONYI S, 1976, NATURE, V264, P19, DOI 10.1038/264019a0; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Chessa B, 2009, SCIENCE, V324, P532, DOI 10.1126/science.1170587; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; DEVERSON EV, 1991, ANIM GENET, V22, P211, DOI 10.1111/j.1365-2052.1991.tb00671.x; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; FABB SA, 1993, ANIM GENET, V24, P249, DOI 10.1111/j.1365-2052.1993.tb00307.x; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; FRASER DC, 1994, IMMUNOGENETICS, V40, P311, DOI 10.1007/BF00189981; Gruszczynska Joanna, 2005, Journal of Applied Genetics, V46, P311; Hiendleder S, 1998, J MOL EVOL, V47, P441, DOI 10.1007/PL00006401; Hiendleder S, 2002, P ROY SOC B-BIOL SCI, V269, P893, DOI 10.1098/rspb.2002.1975; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; KLEIN J, 1986, NATURAL HIST MAJOR H; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; MacHugh DE, 1997, GENETICS, V146, P1071; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Meyer D, 2001, ANN HUM GENET, V65, P1, DOI 10.1046/j.1469-1809.2001.6510001.x; MIKKO S, 1995, IMMUNOGENETICS, V42, P408, DOI 10.1007/BF00179403; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Ploegh H, 1998, CURR OPIN IMMUNOL, V10, P57, DOI 10.1016/S0952-7915(98)80032-0; Richman A, 2000, MOL ECOL, V9, P1953, DOI 10.1046/j.1365-294X.2000.01125.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ropiquet A, 2006, MOL PHYLOGENET EVOL, V41, P395, DOI 10.1016/j.ympev.2006.05.033; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHWAIGER FW, 1994, MOL BIOL EVOL, V11, P239; Sena L, 2003, ANIM GENET, V34, P1, DOI 10.1046/j.1365-2052.2003.00920.x; Takada T, 1998, IMMUNOGENETICS, V48, P408, DOI 10.1007/s002510050452; Uenishi H, 2004, NUCLEIC ACIDS RES, V32, pD484, DOI 10.1093/nar/gkh037; VANDERPOEL JJ, 1990, IMMUNOGENETICS, V31, P29, DOI 10.1007/BF00702486; VANEIJK MJT, 1992, ANIM GENET, V23, P483, DOI 10.1111/j.1365-2052.1992.tb00168.x; Vila C, 2005, TRENDS GENET, V21, P214, DOI 10.1016/j.tig.2005.02.004; Viret C, 1999, Rev Immunogenet, V1, P91; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhou H, 2007, J DAIRY SCI, V90, P1943, DOI 10.3168/jds.2006-578	49	26	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11402	10.1371/journal.pone.0011402	http://dx.doi.org/10.1371/journal.pone.0011402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613987	gold, Green Submitted, Green Published			2022-12-25	WOS:000279370000027
J	Davenport, LC				Davenport, Lisa C.			Aid to a Declining Matriarch in the Giant Otter (Pteronura brasiliensis)	PLOS ONE			English	Article							AFRICAN ELEPHANTS; MENOPAUSE; EVOLUTION; SURVIVAL; CULTURES; MAMMALS; MONKEYS; WHALES; DOGS	Scientists are increasingly revealing the commonalities between the intellectual, emotional and moral capacities of animals and humans. Providing assistance to elderly and ailing family members is a human trait rarely documented for wild animals, other than anecdotal accounts. Here I report observations of multiple forms of assistance to the declining matriarch of a habituated group of giant otters (Pteronura brasiliensis) in Manu National Park, Peru. The otter group had been observed annually for several years and all members were known individually. In 2007, the breeding female of the group failed to reproduce and appeared to be in physical decline. She begged from other family members 43 times over 41 contact hours and received food 11 times. Comparisons with 2004-2006 demonstrate that the family's behavior in 2007 constitutes a role-reversal, in which the majority of assistance and prey transfers accrued from young-to-old rather than from old-to-young. As in human societies, both non-adaptive and adaptive hypotheses could explain the family members' aid to their declining matriarch. I suggest that giant otter families may benefit from the knowledge and experience of an elderly matriarch and "grandparent helper,'' consistent with the "Grandmother Hypothesis'' of adaptive menopause in women.	Duke Univ, Ctr Trop Conservat, Durham, NC 27710 USA	Duke University	Davenport, LC (corresponding author), Duke Univ, Ctr Trop Conservat, Durham, NC 27710 USA.	ldavenport@parkswatch.org		Davenport, Lisa/0000-0002-2573-1622	Conservation Food and Health Foundation; Disney Worldwide Conservation Fund; Paul Hardin Dissertation Fellowship at the University of North Carolina, Chapel Hill	Conservation Food and Health Foundation; Disney Worldwide Conservation Fund; Paul Hardin Dissertation Fellowship at the University of North Carolina, Chapel Hill	This study was supported by the Conservation Food and Health Foundation, http://cfhfoundation.grantsmanagement08.com/, the Disney Worldwide Conservation Fund, http://conservation.wdwpublicaffairs.com/, and by the Paul Hardin Dissertation Fellowship at the University of North Carolina, Chapel Hill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AN BEH SOC, 2007, AN BEH SOC HDB; *AUD AUD, 2002, PERS VOIC REC SOFTW; Bates LA, 2008, J CONSCIOUSNESS STUD, V15, P204; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Carter SK, 1997, MAMMAL REV, V27, P1, DOI 10.1111/j.1365-2907.1997.tb00370.x; CORREDOR GL, COMMUNICATION; Corredor Londono G., 2006, International Zoo Yearbook, V40, P360; Davenport L. C., 2008, THESIS U N CAROLINA; de Waal Frans B. M., 1997, BONOBO FORGOTTEN APE; DEWAAL FBM, 2007, FREE ENTERPRISE VALU; Diamond Jared, 1997, WHY IS SEX FUN EVOLU; Douglas-Hamilton I, 2006, APPL ANIM BEHAV SCI, V100, P87, DOI 10.1016/j.applanim.2006.04.014; Duplaix N, 1980, REV ECOL-TERRE VIE, V34, P495, DOI DOI 10.1016/J.ENCEP.2013.04.017; Foley C, 2008, BIOL LETTERS, V4, P541, DOI 10.1098/rsbl.2008.0370; FOSSEY D, 1983, GORILLAS MIST; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; GENTRY AH, 1990, 4 NEOTROPICAL RAINFO, P542; Goodall J., 1986, CHIMPANZEES GOMBE PA; Goulding M., 2003, AMAZON HEADWATERS RI; Greve W, 2009, BIOL HYP, V2, P213; Groenendijk J, 2006, GIANTS MADRE DIOS; GROENENDIJK J, COMMUNICATION; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARRINGTON FH, 1983, BEHAV ECOL SOCIOBIOL, V13, P19, DOI 10.1007/BF00295072; Hart BL, 2008, NEUROSCI BIOBEHAV R, V32, P86, DOI 10.1016/j.neubiorev.2007.05.012; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; Hill K, 1991, Hum Nat, V2, P313, DOI 10.1007/BF02692196; Kalliola R., 1993, AMAZONIA PERUANA VEG, P9; LEE PC, 1987, ANIM BEHAV, V35, P278, DOI 10.1016/S0003-3472(87)80234-8; LORCH P, 2002, EVENT RECORDER 1 3 P; MALCOLM J, 1980, SMITHSONIAN, V11, P62; Manly BFJ, 1997, RANDOMIZATION BOOTST; Marsh H., 1986, Reports of the International Whaling Commission Special Issue, P57; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; McAuliffe K, 2005, TRENDS ECOL EVOL, V20, P650, DOI 10.1016/j.tree.2005.09.003; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; Mech L. D., 2007, WOLVES BEHAV ECOLOGY; Packer C, 1998, NATURE, V392, P807, DOI 10.1038/33910; PAVELKA MSM, 1991, YEARB PHYS ANTHROPOL, V34, P13; PIEJA GC, COMMUNICATION; Range F, 2009, P NATL ACAD SCI USA, V106, P340, DOI 10.1073/pnas.0810957105; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Richardson DS, 2007, EVOLUTION, V61, P2790, DOI 10.1111/j.1558-5646.2007.00222.x; SCHENCK C, 1999, THESIS U LUDWIGMAXIM; Sharp SP, 2010, J ANIM ECOL, V79, P176, DOI 10.1111/j.1365-2656.2009.01616.x; STAIB E, 2001, THESIS; *STAT COM LLC, 2009, RES STAT ADD EXC 200, V4; STRUHSAKER TT, 1977, BIOTROPICA, V9, P124, DOI 10.2307/2387666; Sykes-Gatz S., 2005, INT GIANT OTTER STUD; Terborgh J, 1983, 5 NEW WORLD PRIMATES; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wynne CDL, 2004, NATURE, V428, P140, DOI [10.1038/428140a, 10.1038/428140b]	54	22	23	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11385	10.1371/journal.pone.0011385	http://dx.doi.org/10.1371/journal.pone.0011385			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613978	gold, Green Published, Green Submitted			2022-12-25	WOS:000279370000014
J	Kohan, M; Muro, AF; White, ES; Berkman, N				Kohan, Martin; Muro, Andres F.; White, Eric S.; Berkman, Neville			EDA-containing cellular fibronectin induces fibroblast differentiation through binding to alpha(4)beta(7) integrin receptor and MAPK/Erk 1/2-dependent signaling	FASEB JOURNAL			English	Article						myofibroblasts; fibrosis; extracellular matrix	MONOCLONAL-ANTIBODIES; EIIIA SEGMENT; ADHESION; MYOFIBROBLAST; MATRIX; MODEL; EOSINOPHILS; EXPRESSION; MIGRATION; VCAM-1	Fibroblast differentiation is an essential step during wound healing and fibrosis. Fibronectin (FN) is a major component of the extracellular matrix and occurs in two main forms: plasma and cellular FN. The latter includes the alternatively spliced domain A (EDA). Although EDA-containing cellular fibronectin (EDA-FN) is associated with fibroblast differentiation, how EDA-FN promotes differentiation is incompletely understood. In this study, we investigate the mechanism by which EDA-FN contributes to fibroblast differentiation with emphasis on the characterization of the EDA-FN receptor. We show that EDA-FN increases alpha-SMA expression (immunofluorescence), collagen deposition, cell contractility, and focal adhesion kinase (FAK) activation (immunoblotting); whereas plasma FN, a form lacking EDA, shows no effect. Primary lung fibroblasts constitutively express alpha(4)beta(7) integrin receptor (FACS and RT-PCR). Blocking of alpha(4)beta(7) reduces fibroblast adhesion to EDA-FN and inhibits alpha-SMA expression, collagen deposition, and FAK activation induced by EDA-FN. Using recombinant EDA-containing peptides, we demonstrate that the EDA segment is sufficient to induce fibroblast differentiation via binding to alpha(4)beta(7). EDA-FN induces MAPK-Erk1/2 activation and inhibition of MEK1/2 attenuates EDA-FN-induced alpha-SMA expression. Our findings demonstrate that EDA-FN induces fibroblast differentiation by a mechanism that involves binding of EDA to alpha(4)beta(7) integrin followed by activation of FAK and MAPK-associated signaling pathways.-Kohan, M., Muro, A. F., White, E. S., Berkman, N. EDA-containing cellular fibronectin induces fibroblast differentiation through binding to alpha(4)beta(7) integrin receptor and MAPK/Erk 1/2-dependent signaling. FASEB J. 24, 4503-4512 (2010). www.fasebj.org	[Kohan, Martin; Berkman, Neville] Hadassah Hebrew Univ Med Ctr, Inst Pulmonol, Lung Cellular & Mol Biol Lab, IL-91120 Jerusalem, Israel; [Muro, Andres F.] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [White, Eric S.] Univ Michigan, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI USA	Hebrew University of Jerusalem; International Center for Genetic Engineering & Biotechnology (ICGEB); University of Michigan System; University of Michigan	Berkman, N (corresponding author), Hadassah Hebrew Univ Med Ctr, Inst Pulmonol, Lung Cellular & Mol Biol Lab, POB 12000, IL-91120 Jerusalem, Israel.	neville@hadassah.org.il	Muro, Andrés F/K-3156-2016	Muro, Andrés F/0000-0002-9628-0494; White, Eric/0000-0003-4060-8443	Israel Science Foundation [1408/08]; Chief Scientist Office of the Ministry of Health, Israel [4921]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007749, R01HL085083] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Chief Scientist Office of the Ministry of Health, Israel; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grants from the Israel Science Foundation (1408/08) and the Chief Scientist Office of the Ministry of Health, Israel (4921). The authors are grateful to Ashley M. Cornett, M. Sc., for her technical assistance in performing cell adhesion assays. The authors declare no conflict of interest.	AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; Brandt EB, 2006, CLIN EXP ALLERGY, V36, P543, DOI 10.1111/j.1365-2222.2006.02456.x; Brezinschek RI, 1996, AM J PATHOL, V149, P1651; Chauhan AK, 2004, GENE, V324, P55, DOI 10.1016/j.gene.2003.09.026; Fernandes DJ, 2006, CURR DRUG TARGETS, V7, P567, DOI 10.2174/138945006776818700; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Hynes RO, 1990, FIBRONECTINS; JARNAGIN WR, 1994, J CELL BIOL, V127, P2037, DOI 10.1083/jcb.127.6.2037; Kanayama M, 2009, J IMMUNOL, V182, P8015, DOI 10.4049/jimmunol.0900725; Kohan M, 2009, AM J RESP CELL MOL, V41, P290, DOI 10.1165/rcmb.2008-0307OC; Kornblihtt AR, 1996, FASEB J, V10, P248, DOI 10.1096/fasebj.10.2.8641558; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200; Lundahl J, 2000, ALLERGY, V55, P865, DOI 10.1034/j.1398-9995.2000.00574.x; Manabe R, 1997, J CELL BIOL, V139, P295, DOI 10.1083/jcb.139.1.295; Manabe R, 1999, J BIOL CHEM, V274, P5919, DOI 10.1074/jbc.274.9.5919; Meerschaert J, 1999, J IMMUNOL, V163, P6217; Moyano JV, 1997, J BIOL CHEM, V272, P24832, DOI 10.1074/jbc.272.40.24832; Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079; Muro AF, 1998, FEBS LETT, V437, P137, DOI 10.1016/S0014-5793(98)01201-0; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; OYAMA F, 1989, BIOCHEMISTRY-US, V28, P1428, DOI 10.1021/bi00429a072; PAGANI F, 1991, J CELL BIOL, V113, P1223, DOI 10.1083/jcb.113.5.1223; Puxeddu I, 2006, J ALLERGY CLIN IMMUN, V117, P103, DOI 10.1016/j.jaci.2005.08.057; RUEGG C, 1992, J CELL BIOL, V117, P179, DOI 10.1083/jcb.117.1.179; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Shaw S K, 1995, Semin Immunol, V7, P335, DOI 10.1016/1044-5323(95)90014-4; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Walsh GM, 1996, IMMUNOLOGY, V89, P112, DOI 10.1046/j.1365-2567.1996.d01-713.x; White ES, 2008, J PATHOL, V216, P1, DOI 10.1002/path.2388; White ES, 2003, AM J RESP CRIT CARE, V168, P436, DOI 10.1164/rccm.200301-041OC; XIA P, 1995, EXP CELL RES, V217, P517, DOI 10.1006/excr.1995.1117; Zhang Y, 2007, CELL MOL LIFE SCI, V64, P2771, DOI 10.1007/s00018-007-7012-3	39	104	106	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4503	4512		10.1096/fj.10-154435	http://dx.doi.org/10.1096/fj.10-154435			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20643910	Green Published, Green Submitted			2022-12-25	WOS:000283861100035
J	Becker, I; Lodder, J; Gieselmann, V; Eckhardt, M				Becker, Ivonne; Lodder, Julia; Gieselmann, Volkmar; Eckhardt, Matthias			Molecular Characterization of N-Acetylaspartylglutamate Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-L-ASPARTATE; METABOTROPIC GLUTAMATE-RECEPTOR; CENTRAL-NERVOUS-SYSTEM; CANAVAN-DISEASE; RAT-BRAIN; GLUTATHIONE SYNTHETASE; CARBOXYPEPTIDASE II; DENTATE GYRUS; NAAG; ACETYLASPARTATE	The dipeptide N-acetylaspartyl-glutamate (NAAG) is an abundant neuropeptide in the mammalian brain. Despite this fact, its physiological role is poorly understood. NAAG is synthesized by a NAAG synthetase catalyzing the ATP-dependent condensation of N-acetylaspartate and glutamate. In vitro NAAG synthetase activity has not been described, and the enzyme has not been purified. Using a bioinformatics approach we identified a putative dipeptide synthetase specifically expressed in the nervous system. Expression of the gene, which we named NAAGS (for NAAG synthetase) was sufficient to induce NAAG synthesis in primary astrocytes or CHO-K1 and HEK-293T cells when they coexpressed the NAA transporter NaDC3. Furthermore, coexpression of NAAGS and the recently identified N-acetylaspartate (NAA) synthase, Nat8l, in CHO-K1 or HEK-293T cells was sufficient to enable these cells to synthesize NAAG. Identity of the reaction product of NAAGS was confirmed by HPLC and electrospray ionization tandem mass spectrometry (ESI-MS). High expression levels of NAAGS were restricted to the brain, spinal cord, and testis. Taken together our results strongly suggest that the identified gene encodes a NAAG synthetase. Its identification will enable further studies to examine the role of this abundant neuropeptide in the vertebrate nervous system.	[Becker, Ivonne; Lodder, Julia; Gieselmann, Volkmar; Eckhardt, Matthias] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany	University of Bonn	Eckhardt, M (corresponding author), Univ Bonn, Inst Biochem & Mol Biol, Nussallee 11, D-53115 Bonn, Germany.	eckhardt@uni-bonn.de						ANDERSON KJ, 1987, BRAIN RES, V411, P172, DOI 10.1016/0006-8993(87)90696-2; Arun P, 2004, NEUROREPORT, V15, P1167, DOI 10.1097/00001756-200405190-00017; Arun P, 2006, J NEUROCHEM, V98, P2034, DOI 10.1111/j.1471-4159.2006.04068.x; Baslow MH, 2000, J NEUROCHEM, V75, P453, DOI 10.1046/j.1471-4159.2000.0750453.x; Becker I, 2008, HISTOCHEM CELL BIOL, V129, P233, DOI 10.1007/s00418-007-0344-0; Berger UV, 1999, J COMP NEUROL, V415, P52, DOI 10.1002/(SICI)1096-9861(19991206)415:1<52::AID-CNE4>3.0.CO;2-K; Burlina AP, 1999, EUR J PEDIATR, V158, P406, DOI 10.1007/s004310051102; BURRI R, 1991, DEV NEUROSCI-BASEL, V13, P403, DOI 10.1159/000112191; Bzdega T, 2004, J NEUROCHEM, V89, P627, DOI 10.1111/j.1471-4159.2004.02361.x; Bzdega T, 1997, J NEUROCHEM, V69, P2270; CANGRO CB, 1987, J NEUROCHEM, V49, P1579, DOI 10.1111/j.1471-4159.1987.tb01030.x; Chopra M, 2009, J PHARMACOL EXP THER, V330, P212, DOI 10.1124/jpet.109.152553; Coyle JT, 1997, NEUROBIOL DIS, V4, P231, DOI 10.1006/nbdi.1997.0153; CURATOLO A, 1965, J NEUROCHEM, V12, P339, DOI 10.1111/j.1471-4159.1965.tb06771.x; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; Eckhardt M, 2000, J BIOL CHEM, V275, P2328, DOI 10.1074/jbc.275.4.2328; Eckhardt M, 1996, P NATL ACAD SCI USA, V93, P7572, DOI 10.1073/pnas.93.15.7572; FAN C, 1995, P NATL ACAD SCI USA, V92, P1172, DOI 10.1073/pnas.92.4.1172; Fewou SN, 2007, J BIOL CHEM, V282, P16700, DOI 10.1074/jbc.M610797200; Fewou SN, 2005, J NEUROCHEM, V94, P469, DOI 10.1111/j.1471-4159.2005.03221.x; Fujita T, 2005, J NEUROCHEM, V93, P706, DOI 10.1111/j.1471-4159.2005.03067.x; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Gehl LM, 2004, J NEUROCHEM, V90, P989, DOI 10.1111/j.1471-4159.2004.02578.x; HORINISHI H, 1978, J NEUROCHEM, V31, P909, DOI 10.1111/j.1471-4159.1978.tb00127.x; Huang LQ, 1999, EUR J PHARMACOL, V366, P151, DOI 10.1016/S0014-2999(98)00918-2; Huang W, 2000, J PHARMACOL EXP THER, V295, P392; KOLLER KJ, 1984, J NEUROCHEM, V43, P1136, DOI 10.1111/j.1471-4159.1984.tb12854.x; Kumar S, 2006, MENT RETARD DEV D R, V12, P157, DOI 10.1002/mrdd.20108; Lea PM, 2001, J NEUROPHYSIOL, V85, P1097; Li H, 2003, P NATL ACAD SCI USA, V100, P9785, DOI 10.1073/pnas.1733391100; Li XQ, 2008, ACTA BIOCH BIOPH SIN, V40, P855, DOI 10.1111/j.1745-7270.2008.00468.x; Luthi-Carter R, 1998, P NATL ACAD SCI USA, V95, P3215, DOI 10.1073/pnas.95.6.3215; MIYAMOTO E, 1966, J NEUROCHEM, V13, P999, DOI 10.1111/j.1471-4159.1966.tb10297.x; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Munster AK, 1998, P NATL ACAD SCI USA, V95, P9140, DOI 10.1073/pnas.95.16.9140; Namboodiri AMA, 2006, MOL CELL ENDOCRINOL, V252, P216, DOI 10.1016/j.mce.2006.03.016; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; Sartori S, 2008, EUR J PAEDIATR NEURO, V12, P348, DOI 10.1016/j.ejpn.2007.07.011; TSAI SJ, 2005, CENTRAL MED SCI MONI, V11, P39; Urazaev AK, 2001, NEUROSCIENCE, V106, P237, DOI 10.1016/S0306-4522(01)00270-6; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Wiame E, 2010, BIOCHEM J, V425, P127, DOI 10.1042/BJ20091024; WILLIAMSON LC, 1988, BRAIN RES, V475, P151, DOI 10.1016/0006-8993(88)90209-0; Wolf NI, 2004, NEUROLOGY, V62, P1503, DOI 10.1212/01.WNL.0000123094.13406.20	45	43	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29156	29164		10.1074/jbc.M110.111765	http://dx.doi.org/10.1074/jbc.M110.111765			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20643647	Green Published, hybrid			2022-12-25	WOS:000281740100016
J	Girish, TS; Gopal, B				Girish, Tavarekere S.; Gopal, Balasubramanian			Crystal Structure of Staphylococcus aureus Metallopeptidase (Sapep) Reveals Large Domain Motions between the Manganese-bound and Apo-states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOPEPTIDASE; RESISTANCE; PEPTIDASE; CATALYSIS; BINDING; ENZYME; TOOLS	Proteases belonging to the M20 family are characterized by diverse substrate specificity and participate in several metabolic pathways. The Staphylococcus aureus metallopeptidase, Sapep, is a member of the aminoacylase-I/M20 protein family. This protein is a Mn2+-dependent dipeptidase. The crystal structure of this protein in the Mn2+-bound form and in the open, metal-free state suggests that large interdomain movements could potentially regulate the activity of this enzyme. We note that the extended inactive conformation is stabilized by a disulfide bond in the vicinity of the active site. Although these cysteines, Cys(155) and Cys(178), are not active site residues, the reduced form of this enzyme is substantially more active as a dipeptidase. These findings acquire further relevance given a recent observation that this enzyme is only active in methicillin-resistant S. aureus. The structural and biochemical features of this enzyme provide a template for the design of novel methicillin-resistant S. aureus-specific therapeutics.	[Girish, Tavarekere S.; Gopal, Balasubramanian] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Gopal, B (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	bgopal@mbu.iisc.ernet.in	Gopal, Balasubramanian/K-4566-2012; Gopal, Balasubramanian/ABG-3754-2021		Department of Science and Technology; Department of Biotechnology, Government of India	Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by grants from the Department of Science and Technology and the Department of Biotechnology, Government of India.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Biagini A, 2001, COMP BIOCHEM PHYS B, V128, P469, DOI 10.1016/S1096-4959(00)00341-9; Broder DH, 2003, J BACTERIOL, V185, P4748, DOI 10.1128/JB.185.16.4748-4754.2003; Chevrier B, 1996, EUR J BIOCHEM, V237, P393, DOI 10.1111/j.1432-1033.1996.0393k.x; Cunningham R, 1996, J MED MICROBIOL, V44, P157, DOI 10.1099/00222615-44-3-157; DOI E, 1981, ANAL BIOCHEM, V118, P173, DOI 10.1016/0003-2697(81)90175-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Greenblatt HM, 1997, J MOL BIOL, V265, P620, DOI 10.1006/jmbi.1996.0729; Hakansson K, 2002, EUR J BIOCHEM, V269, P443, DOI 10.1046/j.0014-2956.2001.02665.x; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Janssen B, 2005, DIABETES, V54, P2320, DOI 10.2337/diabetes.54.8.2320; Jozic D, 2002, STRUCTURE, V10, P1097, DOI 10.1016/S0969-2126(02)00805-5; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lindner HA, 2003, J BIOL CHEM, V278, P44496, DOI 10.1074/jbc.M304233200; Lundgren S, 2007, J BIOL CHEM, V282, P36037, DOI 10.1074/jbc.M705517200; MAKI DG, 1981, AM J MED, V70, P719, DOI 10.1016/0002-9343(81)90603-3; Mongkolrattanothai K, 2004, ANTIMICROB AGENTS CH, V48, P1823, DOI 10.1128/AAC.48.5.1823-1836.2004; Munih P, 2007, J INORG BIOCHEM, V101, P1099, DOI 10.1016/j.jinorgbio.2007.03.010; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Staub I, 2009, J AM CHEM SOC, V131, P6271, DOI 10.1021/ja901304n; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Widemann BC, 2006, ONCOLOGIST, V11, P694, DOI 10.1634/theoncologist.11-6-694; Zhou YJ, 2008, J BACTERIOL, V190, P508, DOI 10.1128/JB.01549-07	27	15	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29406	29415		10.1074/jbc.M110.147579	http://dx.doi.org/10.1074/jbc.M110.147579			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20610394	Green Published, hybrid			2022-12-25	WOS:000281740100043
J	Bartoszewski, RA; Jablonsky, M; Bartoszewska, S; Stevenson, L; Dai, Q; Kappes, J; Collawn, JF; Bebok, Z				Bartoszewski, Rafal A.; Jablonsky, Michael; Bartoszewska, Sylwia; Stevenson, Lauren; Dai, Qun; Kappes, John; Collawn, James F.; Bebok, Zsuzsa			A Synonymous Single Nucleotide Polymorphism in Delta F508 CFTR Alters the Secondary Structure of the mRNA and the Expression of the Mutant Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; SELECTIVE 2'-HYDROXYL ACYLATION; PRIMER EXTENSION SHAPE; ENDOPLASMIC-RETICULUM; IN-VITRO; CIRCULAR-DICHROISM; LENTIVIRAL VECTOR; STRUCTURE PREDICTION; ESCHERICHIA-COLI	Recent advances in our understanding of translational dynamics indicate that codon usage and mRNA secondary structure influence translation and protein folding. The most frequent cause of cystic fibrosis (CF) is the deletion of three nucleotides (CTT) from the cystic fibrosis transmembrane conductance regulator (CFTR) gene that includes the last cytosine (C) of isoleucine 507 (Ile507ATC) and the two thymidines (T) of phenylalanine 508 (Phe508TTT) codons. The consequences of the deletion are the loss of phenylalanine at the 508 position of the CFTR protein (Delta F508), a synonymous codon change for isoleucine 507 (Ile507ATT), and protein misfolding. Here we demonstrate that the Delta F508 mutation alters the secondary structure of the CFTR mRNA. Molecular modeling predicts and RNase assays support the presence of two enlarged single stranded loops in the Delta F508 CFTR mRNA in the vicinity of the mutation. The consequence of Delta F508 CFTR mRNA "misfolding" is decreased translational rate. A synonymous single nucleotide variant of the Delta F508 CFTR (Ile507ATC), that could exist naturally if Phe-508 was encoded by TTC, has wild type-like mRNA structure, and enhanced expression levels when compared with native Delta F508 CFTR. Because CFTR folding is predominantly cotranslational, changes in translational dynamics may promote Delta F508 CFTR misfolding. Therefore, we propose that mRNA "misfolding" contributes to Delta F508 CFTR protein misfolding and consequently to the severity of the human Delta F508 phenotype. Our studies suggest that in addition to modifier genes, SNPs may also contribute to the differences observed in the symptoms of various Delta F508 homozygous CF patients.	[Jablonsky, Michael] Univ Alabama, Dept Chem, Birmingham, AL 35294 USA; [Bartoszewski, Rafal A.; Bartoszewska, Sylwia; Stevenson, Lauren; Collawn, James F.; Bebok, Zsuzsa] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Dai, Qun; Kappes, John] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [Dai, Qun; Kappes, John] Univ Alabama, Dept Hematol & Oncol, Birmingham, AL 35294 USA; [Collawn, James F.; Bebok, Zsuzsa] Univ Alabama, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bebok, Z (corresponding author), Univ Alabama, Dept Cell Biol, 1918 Univ Blvd,MCLM 350, Birmingham, AL 35294 USA.	bebok@uab.edu	Bartoszewski, Rafal A/D-6311-2011; Bartoszewska, Sylwia/L-3922-2019	Bartoszewski, Rafal A/0000-0002-2864-6757; Bartoszewska, Sylwia/0000-0001-8063-1272	National Institutes of Health [R01HL076587, DK060065, R24DK64400]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064400, R01DK060065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grants R01HL076587 (to Z. B.) and DK060065 (to J. F. C.), CFF, and the Genetically Defined Microbe and Expression Core of the UAB Mucosal HIV and Immunobiology Center Grant R24DK64400 (to J. K.) from the National Institutes of Health.	Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bebok Z, 1998, J BIOL CHEM, V273, P29873, DOI 10.1074/jbc.273.45.29873; Cazzola M, 2000, BLOOD, V95, P3280, DOI 10.1182/blood.V95.11.3280.011k41_3280_3288; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Chen WY, 2000, STEM CELLS, V18, P352, DOI 10.1634/stemcells.18-5-352; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DOERFLER W, 1989, CELL BIOPHYS, V15, P21, DOI 10.1007/BF02991576; Doshi KJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-105; Dowell RD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-71; Fadiel A, 2007, CURR PROTEIN PEPT SC, V8, P29, DOI 10.2174/138920307779941532; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Gregersen N, 2006, J INHERIT METAB DIS, V29, P456, DOI 10.1007/s10545-006-0301-4; Gupta SK, 2000, BIOCHEM BIOPH RES CO, V269, P692, DOI 10.1006/bbrc.2000.2351; HOOF T, 1994, J BIOL CHEM, V269, P20575; Jurkuvenaite A, 2010, AM J RESP CELL MOL, V42, P363, DOI 10.1165/rcmb.2008-0434OC; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Knowles MR, 2006, CURR OPIN PULM MED, V12, P416, DOI 10.1097/01.mcp.0000245707.59138.40; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Marin Monica, 2008, Biotechnology Journal, V3, P1047, DOI 10.1002/biot.200800089; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Merrick WC, 2007, METHOD ENZYMOL, V429, P1, DOI 10.1016/S0076-6879(07)29001-9; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Nuzzaci M, 2009, J VIROL METHODS, V155, P118, DOI 10.1016/j.jviromet.2008.10.005; Oberdorf Jon, 2002, Methods Mol Med, V70, P295; Piazzolla P, 1998, ARCH VIROL, V143, P2305, DOI 10.1007/s007050050462; Rab A, 2007, AM J PHYSIOL-CELL PH, V292, pC756, DOI 10.1152/ajpcell.00391.2006; Ramachandiran V, 2002, FEBS LETT, V512, P209, DOI 10.1016/S0014-5793(02)02261-5; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Svoboda P, 2006, CELL MOL LIFE SCI, V63, P901, DOI 10.1007/s00018-005-5558-5; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WELLS BD, 1974, BIOCHEMISTRY-US, V13, P1311, DOI 10.1021/bi00704a001; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180; Zielenski J, 2000, RESPIRATION, V67, P117, DOI 10.1159/000029497; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999; Zuker M, 2000, CURR OPIN STRUC BIOL, V10, P303, DOI 10.1016/S0959-440X(00)00088-9; ZUKER M, 1999, ALGORITHMS THERMODYN	61	139	145	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28741	28748		10.1074/jbc.M110.154575	http://dx.doi.org/10.1074/jbc.M110.154575			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20628052	Green Published, hybrid			2022-12-25	WOS:000281594000040
J	Cassens, C; Kleene, R; Xiao, MF; Friedrich, C; Dityateva, G; Schafer-Nielsen, C; Schachner, M				Cassens, Claas; Kleene, Ralf; Xiao, Mei-Fang; Friedrich, Claudia; Dityateva, Galina; Schafer-Nielsen, Claus; Schachner, Melitta			Binding of the Receptor Tyrosine Kinase TrkB to the Neural Cell Adhesion Molecule (NCAM) Regulates Phosphorylation of NCAM and NCAM-dependent Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; POLYSIALIC ACID; PSA-NCAM; SYNAPTIC PLASTICITY; SIGNAL-TRANSDUCTION; OLFACTORY-BULB; PROTEIN-KINASE; DENTATE GYRUS; FGF RECEPTOR	Recognition molecules and neurotrophins play important roles during development and maintenance of nervous system functions. In this study, we provide evidence that the neural cell adhesion molecule (NCAM) and the neurotrophin receptor TrkB directly interact via sequences in their intracellular domains. Stimulation of TrkB by brain-derived neurotrophic factor leads to tyrosine phosphorylation of NCAM at position 734. Mutation of this tyrosine to phenylalanine completely abolishes tyrosine phosphorylation of NCAM by TrkB. Moreover, the knockdown of TrkB in hippocampal neurons leads to a reduction of NCAM-induced neurite outgrowth. Transfection of NCAM-deficient hippocampal neurons with mutated NCAM carrying an exchange of tyrosine by phenylalanine at position 734 leads to promotion of NCAM-induced neurite outgrowth in comparison with that observed after transfection with wild-type NCAM, whereas a reduction of neurite outgrowth was observed after transfection with mutated NCAM, which carries an exchange of tyrosine by glutamate that mimics the phosphorylated tyrosine. Our observations indicate a functional relationship between TrkB and NCAM.	[Cassens, Claas; Kleene, Ralf; Xiao, Mei-Fang; Friedrich, Claudia; Dityateva, Galina; Schachner, Melitta] Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Schafer-Nielsen, Claus] Schafer N ApS, DK-2100 Copenhagen, Denmark; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick	Schachner, M (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol, Martinistr 85, D-20246 Hamburg, Germany.	melitta.schachner@zmnh.uni-hamburg.de	Dityatev, Alexander/A-4034-2008	Dityatev, Alexander/0000-0002-0472-0553	Deutsche Forschungsgemeinschaft [SCHA185/17-4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHA185/17-4.	AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Brennaman LH, 2010, ADV EXP MED BIOL, V663, P299, DOI 10.1007/978-1-4419-1170-4_19; Burgess A, 2006, J NEUROCHEM, V99, P797, DOI 10.1111/j.1471-4159.2006.04110.x; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 1997, MOL CELL NEUROSCI, V8, P323, DOI 10.1006/mcne.1996.0588; Danzer SC, 2008, HIPPOCAMPUS, V18, P668, DOI 10.1002/hipo.20426; Diestel S, 2004, BIOCHEM BIOPH RES CO, V322, P186, DOI 10.1016/j.bbrc.2004.07.100; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Dityateva G, 2003, J NEUROSCI METH, V130, P65, DOI 10.1016/S0165-0270(03)00202-4; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; Gascon E, 2007, DEVELOPMENT, V134, P1181, DOI 10.1242/dev.02808; GENNARINI G, 1984, EUR J BIOCHEM, V142, P57, DOI 10.1111/j.1432-1033.1984.tb08250.x; HAYRINEN J, 1995, J INFECT DIS, V171, P1481, DOI 10.1093/infdis/171.6.1481; Hillenbrand R, 1999, EUR J NEUROSCI, V11, P813, DOI 10.1046/j.1460-9568.1999.00496.x; HONG SS, 1995, EMBO J, V14, P4714, DOI 10.1002/j.1460-2075.1995.tb00153.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Iwasaki Y, 1997, BIOCHEMISTRY-US, V36, P2694, DOI 10.1021/bi962057x; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Mackowiak M, 2005, BRAIN RES, V1055, P149, DOI 10.1016/j.brainres.2005.07.001; Makhina T, 2009, MOL CELL NEUROSCI, V41, P206, DOI 10.1016/j.mcn.2009.02.010; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Muller D, 2000, P NATL ACAD SCI USA, V97, P4315, DOI 10.1073/pnas.070022697; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Otal R, 2005, CELL TISSUE RES, V319, P349, DOI 10.1007/s00441-004-1020-5; Schachner M, 1997, CURR OPIN CELL BIOL, V9, P627, DOI 10.1016/S0955-0674(97)80115-9; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Stork O, 1999, J NEUROBIOL, V40, P343, DOI 10.1002/(SICI)1097-4695(19990905)40:3<343::AID-NEU6>3.0.CO;2-S; Stork O, 1997, EUR J NEUROSCI, V9, P1117, DOI 10.1111/j.1460-9568.1997.tb01464.x; TANNAHILL L, 1995, EUR J NEUROSCI, V7, P1424, DOI 10.1111/j.1460-9568.1995.tb01136.x; Vutskits L, 2001, EUR J NEUROSCI, V13, P1391, DOI 10.1046/j.0953-816x.2001.01516.x	43	41	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28959	28967		10.1074/jbc.M110.114835	http://dx.doi.org/10.1074/jbc.M110.114835			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20605779	Green Published, hybrid			2022-12-25	WOS:000281594000061
J	de Groot, T; Verkaart, S; Xi, Q; Bindels, RJM; Hoenderop, JGJ				de Groot, Theun; Verkaart, Sjoerd; Xi, Qi; Bindels, Rene J. M.; Hoenderop, Joost G. J.			The Identification of Histidine 712 as a Critical Residue for Constitutive TRPV5 Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL CA2+ CHANNEL; ANKYRIN REPEAT; MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE; PERMEATION; ABSORPTION; PROTEINS	The epithelial Ca2+ channel TRPV5 constitutes the apical entry gate for Ca2+ transport in renal epithelial cells. Ablation of the trpv5 gene in mice leads to a reduced Ca2+ reabsorption. TRPV5 is tightly regulated by various calciotropic hormones, associated proteins, and other factors, which mainly affect channel activity via the C terminus. To further identify the role of the C terminus in TRPV5 regulation, we expressed channels harboring C-terminal deletions and studied channel activity by measuring intracellular Ca2+ concentration ([Ca2+](i)) using fura-2 analysis. Removal of amino acid His(712) elevated the [Ca2+](v) indicating enlarged TRPV5 activity. In addition, substitution of the positively charged His(712) for a negative (H712D) or neutral (H712N) amino acid also stimulated TRPV5 activity. This critical role of His712 was confirmed by patch clamp analysis, which demonstrates increased Na+ and Ca2+ currents for TRPV5-H712D. Cell surface biotinylation studies revealed enhanced plasma membrane expression of TRPV5-H712D as compared with wild-type (WT) TRPV5. This elevated plasma membrane presence also was observed with the Ca2+-impermeable TRPV5-H712D and TRPV5-WT pore mutants, demonstrating that the elevation is not due to the increased [Ca2+](i). Finally, using an internalization assay, we demonstrated a delayed cell surface retrieval for TRPV5-H712D, likely causing the increase in plasma membrane expression. Together, these results demonstrate that His(712) plays an essential role in plasma membrane regulation of TRPV5 via a constitutive endocytotic mechanism.	[de Groot, Theun; Verkaart, Sjoerd; Xi, Qi; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.hoenderop@fysiol.umcn.nl	Bindels, René JM/B-9824-2013; Groot, Theun/A-2596-2015; Hoenderop, Joost G.J./H-8047-2014	Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544	Dutch Kidney Foundation [C03.6017, C06.2170]; Netherlands Organization for Scientific Research [NWO-ALW 814.02.001, NWO-CW 700.55.302, ZonMw 9120.6110]	Dutch Kidney Foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by grants from the Dutch Kidney Foundation (C03.6017 and C06.2170) and the Netherlands Organization for Scientific Research (NWO-ALW 814.02.001, NWO-CW 700.55.302, and ZonMw 9120.6110).	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chang Q, 2004, J BIOL CHEM, V279, P54304, DOI 10.1074/jbc.M406222200; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; de Groot T, 2008, KIDNEY INT, V74, P1241, DOI 10.1038/ki.2008.320; de Groot T, 2009, J AM SOC NEPHROL, V20, P1693, DOI 10.1681/ASN.2008080873; den Dekker E, 2003, CELL CALCIUM, V33, P497, DOI 10.1016/S0143-4160(03)00065-4; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Gkika D, 2006, EMBO J, V25, P4707, DOI 10.1038/sj.emboj.7601357; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Lambers TT, 2007, MOL CELL BIOL, V27, P1486, DOI 10.1128/MCB.01468-06; McPherson PS, 2005, MOL NEUROBIOL, V32, P73, DOI 10.1385/MN:32:1:073; Nilius B, 2003, PFLUG ARCH EUR J PHY, V445, P584, DOI 10.1007/s00424-002-0923-9; Nilius B, 2001, J BIOL CHEM, V276, P1020, DOI 10.1074/jbc.M006184200; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Schoeber JPH, 2007, BIOCHEM SOC T, V35, P115, DOI 10.1042/BST0350115; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; Stojilkovic SS, 2005, TRENDS ENDOCRIN MET, V16, P81, DOI 10.1016/j.tem.2005.02.002; Suzuki Y, 2008, ANNU REV PHYSIOL, V70, P257, DOI 10.1146/annurev.physiol.69.031905.161003; van de Graaf SFJ, 2007, REV PHYSIOL BIOCH P, V158, P77, DOI 10.1007/11220060607; van de Graaf SFJ, 2006, MOL CELL BIOL, V26, P303, DOI 10.1128/MCB.26.1.303-312.2006; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; van de Graaf SFJ, 2008, J BIOL CHEM, V283, P4077, DOI 10.1074/jbc.M706959200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Vennekens R, 2008, CURR PHARM DESIGN, V14, P18; Yeh BI, 2006, J MEMBRANE BIOL, V212, P191, DOI 10.1007/s00232-006-0023-4	30	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28481	28487		10.1074/jbc.M110.117143	http://dx.doi.org/10.1074/jbc.M110.117143			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20628046	Green Published, hybrid			2022-12-25	WOS:000281594000011
J	Hu, YL; Pan, XM; Xiang, LX; Shao, JZ				Hu, Yu-Lan; Pan, Xin-Min; Xiang, Li-Xin; Shao, Jian-Zhong			Characterization of C1q in Teleosts INSIGHT INTO THE MOLECULAR AND FUNCTIONAL EVOLUTION OF C1q FAMILY AND CLASSICAL PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARP CYPRINUS-CARPIO; JAPANESE MEDAKA FISH; COMPLEMENT-SYSTEM; MOLECULAR-CLONING; MODULAR ORGANIZATION; SEQUENCE ALIGNMENT; SUBCOMPONENT C1Q; LINKAGE ANALYSIS; INNATE IMMUNITY; C-CHAINS	C1qs are key components of the classical complement pathway. They have been well documented in human and mammals, but little is known about their molecular and functional characteristics in fish. In the present study, full-length cDNAs of c1qA, c1qB, and c1qC from zebrafish (Danio rerio) were cloned, revealing the conservation of their chromosomal synteny and organization between zebrafish and other species. For functional analysis, the globular heads of C1qA (ghA), C1qB (ghB), and C1qC (ghC) were expressed in Escherichia coli as soluble proteins. Hemolytic inhibitory assays showed that hemolytic activity in carp serum can be inhibited significantly by anti-C1qA, -C1qB, and -C1qC of zebrafish, respectively, indicating that C1qA, C1qB, and C1qC are involved in the classical pathway and are conserved functionally from fish to human. Zebrafish C1qs also could specifically bind to heat-aggregated zebrafish IgM, human IgG, and IgM. The involvement of globular head modules in the C1q-dependent classical pathway demonstrates the structural and functional conservation of these molecules in the classical pathway and their IgM or IgG binding sites during evolution. Phylogenetic analysis revealed that c1qA, c1qB, and c1qC may be formed by duplications of a single copy of c1qB and that the C1q family is, evolutionarily, closely related to the Emu family. This study improves current understanding of the evolutionary history of the C1q family and C1q-mediated immunity.	[Hu, Yu-Lan; Pan, Xin-Min; Xiang, Li-Xin; Shao, Jian-Zhong] Zhejiang Univ, Coll Life Sci, Minist Agr, Hangzhou 310058, Zhejiang, Peoples R China; [Hu, Yu-Lan; Pan, Xin-Min; Xiang, Li-Xin; Shao, Jian-Zhong] Zhejiang Univ, Minist Agr, Key Lab Cell & Gene Engn Zhejiang Prov, Hangzhou 310058, Zhejiang, Peoples R China; [Shao, Jian-Zhong] Zhejiang Univ, Minist Agr, Key Lab Anim Epidem Etiol & Immunol Prevent, Hangzhou 310058, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University	Shao, JZ (corresponding author), Zhejiang Univ, Coll Life Sci, Minist Agr, Hangzhou 310058, Zhejiang, Peoples R China.	shaojz@zju.edu.cn	胡, 瑜兰/I-8646-2014		National Basic Research Program of China (973) [2006CB101805]; Hi-Tech Research and Development Program of China (863) [2008AA09Z409]; National Natural Science Foundation of China [30871936, 30571423]; Science and Technology Foundation of Zhejiang Province [2006C12038, 2006C23045, 2006C12005, 2007C12011]	National Basic Research Program of China (973)(National Basic Research Program of China); Hi-Tech Research and Development Program of China (863)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Zhejiang Province	This work was supported by grants from the National Basic Research Program of China (973) (2006CB101805), the Hi-Tech Research and Development Program of China (863) (2008AA09Z409), the National Natural Science Foundation of China (30871936 and 30571423), and the Science and Technology Foundation of Zhejiang Province (2006C12038, 2006C23045, 2006C12005, and 2007C12011).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bag MR, 2009, FISH SHELLFISH IMMUN, V26, P275, DOI 10.1016/j.fsi.2008.11.009; Boshra H, 2006, FISH SHELLFISH IMMUN, V20, P239, DOI 10.1016/j.fsi.2005.04.004; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Cross PS, 1999, DEV COMP IMMUNOL, V23, P429, DOI 10.1016/S0145-305X(99)00022-1; Dodds AW, 2007, IMMUNOBIOLOGY, V212, P233, DOI 10.1016/j.imbio.2006.11.009; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kishore U, 1999, IMMUNOPHARMACOLOGY, V42, P15, DOI 10.1016/S0162-3109(99)00011-9; Kishore U, 2003, J IMMUNOL, V171, P812, DOI 10.4049/jimmunol.171.2.812; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kuroda N, 1996, IMMUNOGENETICS, V44, P459, DOI 10.1007/BF02602808; Kuroda N, 2000, IMMUNOGENETICS, V51, P117, DOI 10.1007/s002510050020; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leimeister C, 2002, DEV BIOL, V249, P204, DOI 10.1006/dbio.2002.0764; Liang YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004234; Matsushita M, 2004, P NATL ACAD SCI USA, V101, P10127, DOI 10.1073/pnas.0402180101; Nakao M, 1998, J IMMUNOL, V161, P4811; Nakao M, 2001, IMMUNOGENETICS, V52, P255; Nonaka M, 2000, FISH SHELLFISH IMMUN, V10, P215, DOI 10.1006/fsim.1999.0252; Nonaka M, 2000, CURR TOP MICROBIOL, V248, P37; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; SASAKI T, 1982, J IMMUNOL METHODS, V48, P121, DOI 10.1016/0022-1759(82)90216-2; SELLAR GC, 1991, BIOCHEM J, V274, P481, DOI 10.1042/bj2740481; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; SHULMAN MJ, 1987, EUR J IMMUNOL, V17, P549, DOI 10.1002/eji.1830170418; Smith LC, 1999, IMMUNOPHARMACOLOGY, V42, P107, DOI 10.1016/S0162-3109(99)00009-0; Smith SL, 1998, IMMUNOL REV, V166, P67, DOI 10.1111/j.1600-065X.1998.tb01253.x; Sunyer JO, 1998, J IMMUNOL, V161, P4106; Sunyer JO, 1998, IMMUNOL REV, V166, P39, DOI 10.1111/j.1600-065X.1998.tb01251.x; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Yu YH, 2008, J IMMUNOL, V181, P7024, DOI 10.4049/jimmunol.181.10.7024; Zou J, 2004, FISH SHELLFISH IMMUN, V17, P403, DOI 10.1016/j.fsi.2004.04.015	39	36	42	8	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28777	28786		10.1074/jbc.M110.131318	http://dx.doi.org/10.1074/jbc.M110.131318			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20615881	hybrid, Green Published			2022-12-25	WOS:000281594000043
J	Terui, Y; Tabei, Y; Akiyama, M; Higashi, K; Tomitori, H; Yamamoto, K; Ishihama, A; Igarashi, K; Kashiwagi, K				Terui, Yusuke; Tabei, Yuzuru; Akiyama, Mariko; Higashi, Kyohei; Tomitori, Hideyuki; Yamamoto, Kaneyoshi; Ishihama, Akira; Igarashi, Kazuei; Kashiwagi, Keiko			Ribosome Modulation Factor, an Important Protein for Cell Viability Encoded by the Polyamine Modulon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; STRUCTURAL-CHANGE; REQUIRING MUTANTS; RNA; ENHANCEMENT; GROWTH; STIMULATION; TRANSLATION; DECREASE; INVOLVEMENT	We searched for proteins whose synthesis is enhanced by polyamines at the stationary phase of cell growth using an Escherichia coli polyamine-requiring mutant in which cell viability is greatly decreased by polyamine deficiency. The synthesis of ribosome modulation factor (RMF) was strongly enhanced by polyamines at the level of translation at the stationary phase of cell growth. In rmf mRNA, a Shine-Dalgarno (SD) sequence is located 11 nucleotides upstream of the initiation codon AUG. When the SD sequence was moved to the more common position 8 nucleotides upstream of the initiation codon, the degree of polyamine stimulation was reduced, although the level of RMF synthesis was markedly increased. Polyamine stimulation of RMF synthesis was found to be caused by a selective structural change of the bulged-out region of the initiation site of rmf mRNA. The decrease in cell viability caused by polyamine deficiency was prevented by the addition of a modified rmf gene whose synthesis is not influenced by polyamines. The results indicate that polyamines enhance cell viability of E. coli at least in part by enhancing RMF synthesis.	[Kashiwagi, Keiko] Chiba Inst Sci, Fac Pharm, Chiba 2880025, Japan; [Higashi, Kyohei; Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; [Higashi, Kyohei; Igarashi, Kazuei] Chiba Univ, Amine Pharma Res Inst, Chuo Ku, Chiba 2600856, Japan; [Yamamoto, Kaneyoshi; Ishihama, Akira] Hosei Univ, Dept Frontier Biosci, Tokyo 1848584, Japan	Chiba University; Chiba University; Hosei University	Kashiwagi, K (corresponding author), Chiba Inst Sci, Fac Pharm, 15-8 Shiomi Cho, Chiba 2880025, Japan.	kkashiwagi@cis.ac.jp		Higashi, Kyohei/0000-0002-2622-4825; Igarashi, Kazuei/0000-0003-3751-3187	Ministry of Education, Culture, Sports, Science and Technology of Japan; Promotion and Mutual Aid Corporation for Private Schools of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	This work was supported by a grant-in aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan.	Apirakaramwong A, 1998, BIOCHEM BIOPH RES CO, V251, P482, DOI 10.1006/bbrc.1998.9494; Apirakaramwong A, 1999, BIOCHEM BIOPH RES CO, V264, P643, DOI 10.1006/bbrc.1999.1556; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; CUNNINGHAMRUNDLES S, 1975, J BACTERIOL, V124, P791, DOI 10.1128/JB.124.2.791-799.1975; ECHANDI G, 1975, BIOCHEM BIOPH RES CO, V62, P313, DOI 10.1016/S0006-291X(75)80140-9; ECHANDI G, 1975, BIOCHEM BIOPH RES CO, V67, P1185, DOI 10.1016/0006-291X(75)90798-6; EMORY SA, 1990, J BACTERIOL, V172, P4472, DOI 10.1128/jb.172.8.4472-4481.1990; HENGGEARONIS R, 1993, J BACTERIOL, V175, P259, DOI 10.1128/JB.175.1.259-265.1993; Higashi K, 2006, J BIOL CHEM, V281, P9527, DOI 10.1074/jbc.M513752200; Higashi K, 2008, J BIOL CHEM, V283, P32989, DOI 10.1074/jbc.M806027200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; IGARASHI K, 1981, EUR J BIOCHEM, V114, P127; IGARASHI K, 1986, J BACTERIOL, V166, P128, DOI 10.1128/jb.166.1.128-134.1986; IGARASHI K, 1983, BIOCHIM BIOPHYS ACTA, V755, P326, DOI 10.1016/0304-4165(83)90234-9; IGARASHI K, 1979, EUR J BIOCHEM, V93, P345, DOI 10.1111/j.1432-1033.1979.tb12829.x; Izutsu K, 2001, GENES CELLS, V6, P665, DOI 10.1046/j.1365-2443.2001.00457.x; JISHAGE M, 1995, J BACTERIOL, V177, P6832, DOI 10.1128/jb.177.23.6832-6835.1995; KASHIWAGI K, 1994, BIOCHEM BIOPH RES CO, V200, P591, DOI 10.1006/bbrc.1994.1489; KUSAMAEGUCHI K, 1991, BIOCHEM BIOPH RES CO, V177, P745, DOI 10.1016/0006-291X(91)91851-3; MAMONT PS, 1982, EUR J BIOCHEM, V123, P499; MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009; Nakano S, 2004, J AM CHEM SOC, V126, P1088, DOI 10.1021/ja037314h; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; PEGG AE, 1982, BIOCHEM J, V202, P519, DOI 10.1042/bj2020519; PHILIPSON L, 1978, CELL, V13, P189, DOI 10.1016/0092-8674(78)90149-6; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Raj VS, 2002, BIOCHEM BIOPH RES CO, V299, P252, DOI 10.1016/S0006-291X(02)02627-X; Sambrook J., 2001, MOL CLONING LAB MANU; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SHAPIRA SK, 1983, GENE, V25, P71, DOI 10.1016/0378-1119(83)90169-5; Terui Y, 2007, J BACTERIOL, V189, P2359, DOI 10.1128/JB.01562-06; Terui Y, 2009, J BACTERIOL, V191, P5348, DOI 10.1128/JB.00387-09; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167; WADA A, 1990, P NATL ACAD SCI USA, V87, P2657, DOI 10.1073/pnas.87.7.2657; WADA A, 1995, BIOCHEM BIOPH RES CO, V214, P410, DOI 10.1006/bbrc.1995.2302; WATANABE S, 1991, J BIOL CHEM, V266, P20803; Wilson K., 2001, CURR PROTOC MOL BIOL, V56, P2, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]; YAMAGISHI M, 1993, EMBO J, V12, P625, DOI 10.1002/j.1460-2075.1993.tb05695.x; Yoshida M, 2004, J BIOL CHEM, V279, P46008, DOI 10.1074/jbc.M404393200; Yoshida M, 2002, J BIOL CHEM, V277, P37139, DOI 10.1074/jbc.M206668200; Yoshida M, 2001, J BIOL CHEM, V276, P16289, DOI 10.1074/jbc.M011059200; Yoshida M, 1999, J BIOL CHEM, V274, P22723, DOI 10.1074/jbc.274.32.22723; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	24	24	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28698	28707		10.1074/jbc.M110.111195	http://dx.doi.org/10.1074/jbc.M110.111195			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20628056	hybrid, Green Published			2022-12-25	WOS:000281594000035
J	Sakurai, T; Misaka, T; Ishiguro, M; Masuda, K; Sugawara, T; Ito, K; Kobayashi, T; Matsuo, S; Ishimaru, Y; Asakura, T; Abe, K				Sakurai, Takanobu; Misaka, Takumi; Ishiguro, Masaji; Masuda, Katsuyoshi; Sugawara, Taishi; Ito, Keisuke; Kobayashi, Takuya; Matsuo, Shinji; Ishimaru, Yoshiro; Asakura, Tomiko; Abe, Keiko			Characterization of the beta-D-Glucopyranoside Binding Site of the Human Bitter Taste Receptor hTAS2R16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; MODIFYING SWEET PROTEIN; CRYSTAL-STRUCTURE; CURCULIGO-LATIFOLIA; SQUID RHODOPSIN; UMAMI TASTE; NEOCULIN; SACCHARIN; SUBUNITS; VARIETY	G-protein-coupled receptors mediate the senses of taste, smell, and vision in mammals. Humans recognize thousands of compounds as bitter, and this response is mediated by the hTAS2R family, which is one of the G-protein-coupled receptors composed of only 25 receptors. However, structural information on these receptors is limited. To address the molecular basis of bitter tastant discrimination by the hTAS2Rs, we performed ligand docking simulation and functional analysis using a series of point mutants of hTAS2R16 to identify its binding sites. The docking simulation predicted two candidate binding structures for a salicin-hTAS2R16 complex, and at least seven amino acid residues in transmembrane 3 (TM3), TM5, and TM6 were shown to be involved in ligand recognition. We also identified the probable salicin-hTAS2R16 binding mode using a mutated receptor experiment. This study characterizes the molecular interaction between hTAS2R16 and beta-D-glucopyranoside and will also facilitate rational design of bitter blockers.	[Misaka, Takumi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Matsuo, Shinji] Nissin Foods Holdings Co Ltd, Gen Res Inst Food Sci & Technol, Shiga 5250058, Japan; [Ishiguro, Masaji; Masuda, Katsuyoshi] Niigata Univ Pharm & Appl Life Sci, Niigata 9568503, Japan; [Kobayashi, Takuya] Kyoto Univ, Fac Med, Dept Med Chem, Kyoto 6068501, Japan	University of Tokyo; Niigata University; Kyoto University	Misaka, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amisaka@mail.ecc.u-tokyo.ac.jp	Ito, Keisuke/J-5926-2013; Ishimaru, Yoshiro/AAI-3049-2020	Ito, Keisuke/0000-0002-8719-9635; Misaka, Takumi/0000-0002-9547-5767	Research and Development Program for New Bio-industry Initiatives of Bio-oriented Technology Research Advancement Institution; Ministry of Education, Culture, Sports, Science, and Technology of Japan [19880008, 20780089, 18688005, 20688015, 21658046, 19300248, 20380183]	Research and Development Program for New Bio-industry Initiatives of Bio-oriented Technology Research Advancement Institution; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was performed with a grant from the Research and Development Program for New Bio-industry Initiatives of Bio-oriented Technology Research Advancement Institution. This work was also supported by Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan 19880008 and Grants 20780089 (to Y. I.), 18688005, 20688015, and 21658046 (to T. M.), 19300248 (to T. A.), and 20380183 (to K. A.).	Ammon C., 2002, Archives of Physiology and Biochemistry, V110, P137, DOI 10.1076/apab.110.1.137.908; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Behrens M, 2009, J AGR FOOD CHEM, V57, P9860, DOI 10.1021/jf9014334; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Floriano WB, 2006, J MOL MODEL, V12, P931, DOI 10.1007/s00894-006-0102-6; Ishiguro M, 2004, CHEMBIOCHEM, V5, P298, DOI 10.1002/cbic.200300668; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Koizumi A, 2007, BIOCHEM BIOPH RES CO, V358, P585, DOI 10.1016/j.bbrc.2007.04.171; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Maehashi K, 2008, BIOCHEM BIOPH RES CO, V365, P851, DOI 10.1016/j.bbrc.2007.11.070; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Miguet L, 2006, J RECEPT SIG TRANSD, V26, P611, DOI 10.1080/10799890600928210; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nakajima K, 2006, NEUROREPORT, V17, P1241, DOI 10.1097/01.wnr.0000230513.01339.3b; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; NOGUCHI M, 1975, J FOOD SCI, V40, P367, DOI 10.1111/j.1365-2621.1975.tb02203.x; Okubo S, 2008, J PLANT PHYSIOL, V165, P1964, DOI 10.1016/j.jplph.2008.04.019; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pronin AN, 2007, CURR BIOL, V17, P1403, DOI 10.1016/j.cub.2007.07.046; Pronin AN, 2004, CHEM SENSES, V29, P583, DOI 10.1093/chemse/bjh064; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Ruiz-Avila L, 2000, CHEM SENSES, V25, P361, DOI 10.1093/chemse/25.4.361; Sainz E, 2007, BIOCHEM J, V403, P537, DOI 10.1042/BJ20061744; Sakurai T, 2009, J AGR FOOD CHEM, V57, P2508, DOI 10.1021/jf8040148; Shimamura T, 2008, J BIOL CHEM, V283, P17753, DOI 10.1074/jbc.C800040200; Shirasuka Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1403, DOI 10.1271/bbb.68.1403; Ueda T, 2003, J NEUROSCI, V23, P7376; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Winnig M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-66; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Zhang F, 2008, P NATL ACAD SCI USA, V105, P20930, DOI 10.1073/pnas.0810174106	39	69	70	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28373	28378		10.1074/jbc.M110.144444	http://dx.doi.org/10.1074/jbc.M110.144444			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20605788	hybrid, Green Published			2022-12-25	WOS:000281404100079
J	Teissier, S; Pang, CL; Thierry, F				Teissier, S.; Pang, C. L.; Thierry, F.			The E2F5 repressor is an activator of E6/E7 transcription and of the S-phase entry in HPV18-associated cells	ONCOGENE			English	Article						papillomavirus; transcription; HPV; E2F; cell cycle	MITOTIC PATHWAY; PROTEIN; CYCLE; IDENTIFICATION; ENHANCEOSOME; REPLICATION; EXPRESSION; HMG-I(Y); FAMILY; E6	High-risk papillomavirus type 18 (HPV18) is one of the less represented HPV types in low-grade lesions of the anogenital tract, whereas it occupies the second place in cervical cancer, where it can be found in 16% of the cases worldwide, after HPV16 present in 54% of them. These epidemiological data indicate that HPV18 infection is more prone to carcinogenic progression. The main oncogenic proteins, E6 and E7 of HPV18, are functionally comparable to the homologous proteins of the other high-risk viruses, including HPV16. In this work, we investigated the possibility that the higher oncogenic potential of HPV18 might be due to transcriptional regulation of the E6/E7 oncogenes. By comparing the E6/E7 promoter and enhancer sequences of the mucosal HPV genomes, we identified E2F binding sites specific for HPV18. The E2F family of transcription factors contains activators (E2F1-3) and repressors (E2F4-8) that regulate the transcription of S-phase and mitotic genes and thereby have a crucial role in cell-cycle progression. Surprisingly, we identified E2F5 as a direct activator of HPV18 E6/E7 transcription by sequential silencing of E2F members in HeLa cells. In addition, we could show that E2F5 positively regulates S-phase entry in HeLa cells and that this activation of the cell cycle by a member of the E2F repressor family is specific for HPV18-expressing cells. Diverting the function of E2F5 from a cell-cycle repressor into an activator might contribute to the higher oncogenic potential of HPV18 when compared with other high-risk HPV types. Oncogene (2010) 29, 5061-5070; doi:10.1038/onc.2010.246; published online 19 July 2010	[Teissier, S.; Thierry, F.] ASTAR, Inst Med Biol, Singapore 138648, Singapore; [Pang, C. L.] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore	Thierry, F (corresponding author), ASTAR, Inst Med Biol, Immunos 06-05,8A Biomed Grove, Singapore 138648, Singapore.	francoise.thierry@imb.a-star.edu.sg						Apostolova MD, 2002, J BIOL CHEM, V277, P34471, DOI 10.1074/jbc.M205827200; BERNARD BA, 1989, J VIROL, V63, P4317, DOI 10.1128/JVI.63.10.4317-4324.1989; Bouallaga I, 2000, EMBO REP, V1, P422, DOI 10.1093/embo-reports/kvd091; Bouallaga I, 2003, MOL CELL BIOL, V23, P2329, DOI 10.1128/MCB.23.7.2329-2340.2003; Caracciolo V, 2007, J CELL PHYSIOL, V212, P96, DOI 10.1002/jcp.21005; CASTELLSAGUE X, 2007, VACCINE, V25; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Grinstein E, 2002, J EXP MED, V196, P1067, DOI 10.1084/jem.20011053; Heino P, 2000, VIROLOGY, V276, P304, DOI 10.1006/viro.2000.0342; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Kong LJ, 2007, ONCOGENE, V26, P321, DOI 10.1038/sj.onc.1209817; Kuner R, 2007, J MOL MED, V85, P1253, DOI 10.1007/s00109-007-0230-1; Linhart C, 2005, CELL CYCLE, V4, P1788, DOI 10.4161/cc.4.12.2173; McLaughlin-Drubin ME, 2008, J VIROL, V82, P8695, DOI 10.1128/JVI.00579-08; MUDRYJ M, 1991, CELL, V65, P1243, DOI 10.1016/0092-8674(91)90019-U; Polager S, 2003, J BIOL CHEM, V278, P1443, DOI 10.1074/jbc.M210327200; Reed SA, 2007, J CELL BIOCHEM, V101, P1394, DOI 10.1002/jcb.21256; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Teissier S, 2007, J VIROL, V81, P9368, DOI 10.1128/JVI.00427-07; Thierry F, 2004, CANCER RES, V64, P895, DOI 10.1158/0008-5472.CAN-03-2349; THIERRY F, 1991, NEW BIOL, V3, P90; THIERRY F, 1987, EMBO J, V6, P3391, DOI 10.1002/j.1460-2075.1987.tb02662.x; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; VILLA LL, 1991, VIROLOGY, V181, P374; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Zhang BY, 2006, P NATL ACAD SCI USA, V103, P437, DOI 10.1073/pnas.0510012103; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	31	15	15	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	36					5061	5070		10.1038/onc.2010.246	http://dx.doi.org/10.1038/onc.2010.246			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	647LN	20639900				2022-12-25	WOS:000281620100006
J	Zimmer, SM; Crevar, CJ; Carter, DM; Stark, JH; Giles, BM; Zimmerman, RK; Ostroff, SM; Lee, BY; Burke, DS; Ross, TM				Zimmer, Shanta M.; Crevar, Corey J.; Carter, Donald M.; Stark, James H.; Giles, Brendan M.; Zimmerman, Richard K.; Ostroff, Stephen M.; Lee, Bruce Y.; Burke, Donald S.; Ross, Ted M.			Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza in Pittsburgh, PA, USA	PLOS ONE			English	Article							ORIGINAL ANTIGENIC SIN; IMMUNE-RESPONSES; VIRUS; ANTIBODIES; HUMANS	Background: In April 2009, a new pandemic strain of influenza infected thousands of persons in Mexico and the United States and spread rapidly worldwide. During the ensuing summer months, cases ebbed in the Northern Hemisphere while the Southern Hemisphere experienced a typical influenza season dominated by the novel strain. In the fall, a second wave of pandemic H1N1 swept through the United States, peaking in most parts of the country by mid October and returning to baseline levels by early December. The objective was to determine the seroprevalence of antibodies against the pandemic 2009 H1N1 influenza strain by decade of birth among Pittsburgh-area residents. Methods and Findings: Anonymous blood samples were obtained from clinical laboratories and categorized by decade of birth from 1920-2009. Using hemagglutination-inhibition assays, approximately 100 samples per decade (n = 846) were tested from blood samples drawn on hospital and clinic patients in mid-November and early December 2009. Age specific seroprevalences against pandemic H1N1 (A/California/7/2009) were measured and compared to seroprevalences against H1N1 strains that had previously circulated in the population in 2007, 1957, and 1918. (A/Brisbane/59/2007, A/Denver/1/1957, and A/South Carolina/1/1918). Stored serum samples from healthy, young adults from 2008 were used as a control group (n = 100). Seroprevalences against pandemic 2009 H1N1 influenza varied by age group, with children age 10-19 years having the highest seroprevalence (45%), and persons age 70-79 years having the lowest (5%). The baseline seroprevalence among control samples from 18-24 year-olds was 6%. Overall seroprevalence against pandemic H1N1 across all age groups was approximately 21%. Conclusions: After the peak of the second wave of 2009 H1N1, HAI seroprevalence results suggest that 21% of persons in the Pittsburgh area had become infected and developed immunity. Extrapolating to the entire US population, we estimate that at least 63 million persons became infected in 2009. As was observed among clinical cases, this sero-epidemiological study revealed highest infection rates among school-age children.	[Zimmer, Shanta M.; Zimmerman, Richard K.; Lee, Bruce Y.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA; [Crevar, Corey J.; Carter, Donald M.; Giles, Brendan M.; Burke, Donald S.; Ross, Ted M.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA; [Stark, James H.; Lee, Bruce Y.; Burke, Donald S.; Ross, Ted M.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Ostroff, Stephen M.] Penn Dept Hlth, Pittsburgh, PA USA; [Ross, Ted M.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zimmer, SM (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA.	tmr15@pitt.edu	Stark, James/A-2895-2019	Stark, James/0000-0002-0728-876X; Zimmerman, Richard/0000-0001-5941-6092; /0000-0002-5704-8094	NIH/NIAID supplemental A.R.R.A. [U01AI077771]; University of Pittsburgh, Graduate School of Public Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077771] Funding Source: NIH RePORTER	NIH/NIAID supplemental A.R.R.A.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh, Graduate School of Public Health(University of Pittsburgh); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by NIH/NIAID supplemental A.R.R.A. to U01AI077771 to T. M. R. and a research pilot award from the University of Pittsburgh, Graduate School of Public Health (D. S. B. and S. M.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Control CfD Prevention, 1998, MMWR-MORBID MORTAL W, V47, pi, DOI DOI 10.1001/jamahealthforum.2021.0325; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; FRANCIS T, 1955, ANN INTERN MED, V43, P534, DOI 10.7326/0003-4819-43-3-534; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; HANCOCK K, 2009, N ENGL J MED; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; JENSEN KE, 1956, J EXP MED, V104, P199, DOI 10.1084/jem.104.2.199; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; Langmuir A D, 1976, Hosp Pract, V11, P49; MILLER E, 2010, LANCET; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Rao BL, 2003, NATL MED J INDIA, V16, P143; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Shope RE, 1936, J EXP MED, V63, P669, DOI 10.1084/jem.63.5.669; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; *US BUR CENS, 2000, 1 US CENS BUR; Webster R G, 1972, Curr Top Microbiol Immunol, V59, P75; WEBSTER RG, 1966, J IMMUNOL, V97, P177; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	32	74	74	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11601	10.1371/journal.pone.0011601	http://dx.doi.org/10.1371/journal.pone.0011601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644650	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000279884900029
J	Khurana, S; Verma, S; Verma, N; Crevar, CJ; Carter, DM; Manischewitz, J; King, LR; Ross, TM; Golding, H				Khurana, Surender; Verma, Swati; Verma, Nitin; Crevar, Corey J.; Carter, Donald M.; Manischewitz, Jody; King, Lisa R.; Ross, Ted M.; Golding, Hana			Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus	PLOS ONE			English	Article							INSECT CELLS; TRANSPORT; RESPONSES; EFFICACY; SITES	Background: In the face of impending influenza pandemic, a rapid vaccine production and mass vaccination is the most effective approach to prevent the large scale mortality and morbidity that was associated with the 1918 "Spanish Flu''. The traditional process of influenza vaccine production in eggs is time consuming and may not meet the demands of rapid global vaccination required to curtail influenza pandemic. Methodology/Principal Findings: Recombinant technology can be used to express the hemagglutinin (HA) of the emerging new influenza strain in a variety of systems including mammalian, insect, and bacterial cells. In this study, two forms of HA proteins derived from the currently circulating novel H1N1 A/California/07/2009 virus, HA1 (1-330) and HA (1-480), were expressed and purified from E. coli under controlled redox refolding conditions that favoured proper protein folding. However, only the recombinant HA1 (1-330) protein formed oligomers, including functional trimers that bound receptor and caused agglutination of human red blood cells. These proteins were used to vaccinate ferrets prior to challenge with the A/California/07/2009 virus. Both proteins induced neutralizing antibodies, and reduced viral loads in nasal washes. However, the HA1 (1-330) protein that had higher content of multimeric forms provided better protection from fever and weight loss at a lower vaccine dose compared with HA (1-480). Protein yield for the HA1 (1-330) ranged around 40 mg/Liter, while the HA (1-480) yield was 0.4-0.8 mg/Liter. Conclusions/Significance: This is the first study that describes production in bacterial system of properly folded functional globular HA1 domain trimers, lacking the HA2 transmembrane protein, that elicit potent neutralizing antibody responses following vaccination and protect ferrets from in vivo challenge. The combination of bacterial expression system with established quality control methods could provide a mechanism for rapid large scale production of influenza vaccines in the face of influenza pandemic threat.	[Khurana, Surender; Verma, Swati; Verma, Nitin; Manischewitz, Jody; King, Lisa R.; Golding, Hana] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Crevar, Corey J.; Carter, Donald M.; Ross, Ted M.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA	US Food & Drug Administration (FDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Khurana, S (corresponding author), US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	hana.golding@fda.hhs.gov			American Recovery and Reinvestment Act supplement [UO1-AI077771]; DMID, NIH [IAA 224-10-1006]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077771] Funding Source: NIH RePORTER	American Recovery and Reinvestment Act supplement; DMID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by an American Recovery and Reinvestment Act supplement to NIH/NIAID grant UO1-AI077771 to TMR. This study was also partly supported by IAA 224-10-1006 from DMID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Biesova Z, 2009, VACCINE, V27, P6234, DOI 10.1016/j.vaccine.2009.07.107; CERIOTTI A, 1990, J CELL BIOL, V111, P409, DOI 10.1083/jcb.111.2.409; Cheng X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004436; Chiu FF, 2009, BIOCHEM BIOPH RES CO, V383, P27, DOI 10.1016/j.bbrc.2009.03.106; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; Curtis-Fisk J, 2008, PROTEIN EXPRES PURIF, V61, P212, DOI 10.1016/j.pep.2008.06.009; Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Kobinger GP, 2010, J INFECT DIS, V201, P1000, DOI 10.1086/651171; Matrosovich M, 2003, REV MED VIROL, V13, P85, DOI 10.1002/rmv.372; Monto AS, 2006, EMERG INFECT DIS, V12, P55, DOI 10.3201/eid1201.051068; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; Pascua PNQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008431; ROBERTS PC, 1993, J VIROL, V67, P3048, DOI 10.1128/JVI.67.6.3048-3060.1993; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Shen S, 2008, J MED VIROL, V80, P1972, DOI 10.1002/jmv.21298; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Song LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002257; Treanor JJ, 2006, J INFECT DIS, V193, P1223, DOI 10.1086/503050; Treanor JJ, 1996, J INFECT DIS, V173, P1467, DOI 10.1093/infdis/173.6.1467; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Xie QM, 2009, POULTRY SCI, V88, P1608, DOI 10.3382/ps.2009-00092; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	29	75	82	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11548	10.1371/journal.pone.0011548	http://dx.doi.org/10.1371/journal.pone.0011548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634959	Green Accepted, Green Published, gold			2022-12-25	WOS:000279781600025
J	Maronde, E; Schilling, AF; Seitz, S; Schinke, T; Schmutz, I; van der Horst, G; Amling, M; Albrecht, U				Maronde, Erik; Schilling, Arndt F.; Seitz, Sebastian; Schinke, Thorsten; Schmutz, Isabelle; van der Horst, Gijsbertus; Amling, Michael; Albrecht, Urs			The Clock Genes Period 2 and Cryptochrome 2 Differentially Balance Bone Formation	PLOS ONE			English	Article							CIRCADIAN-CLOCK; STEM-CELLS; EXPRESSION; RESORPTION; PHENOTYPE; PATHWAY; MURINE; TIME	Background: Clock genes and their protein products regulate circadian rhythms in mammals but have also been implicated in various physiological processes, including bone formation. Osteoblasts build new mineralized bone whereas osteoclasts degrade it thereby balancing bone formation. To evaluate the contribution of clock components in this process, we investigated mice mutant in clock genes for a bone volume phenotype. Methodology/Principal Findings: We found that Per2(Brdm1) mutant mice as well as mice lacking Cry2(-/-) displayed significantly increased bone volume at 12 weeks of age, when bone turnover is high. Per2(Brdm1) mutant mice showed alterations in parameters specific for osteoblasts whereas mice lacking Cry2(-/-) displayed changes in osteoclast specific parameters. Interestingly, inactivation of both Per2 and Cry2 genes leads to normal bone volume as observed in wild type animals. Importantly, osteoclast parameters affected due to the lack of Cry2, remained at the level seen in the Cry2(-/-) mutants despite the simultaneous inactivation of Per2. Conclusions/Significance: This indicates that Cry2 and Per2 affect distinct pathways in the regulation of bone volume with Cry2 influencing mostly the osteoclastic cellular component of bone and Per2 acting on osteoblast parameters.	[Maronde, Erik] Goethe Univ Frankfurt, Inst Anat 3, Frankfurt, Germany; [Schilling, Arndt F.; Seitz, Sebastian; Schinke, Thorsten; Amling, Michael] Univ Hamburg, Dept Osteol & Biomech, Hamburg, Germany; [Schmutz, Isabelle; Albrecht, Urs] Univ Fribourg, Dept Med, Biochem Unit, CH-1700 Fribourg, Switzerland; [van der Horst, Gijsbertus] Erasmus MC, Ctr Biomed Genet, Dept Genet, Rotterdam, Netherlands	Goethe University Frankfurt; University of Hamburg; University of Fribourg; Erasmus University Rotterdam; Erasmus MC	Maronde, E (corresponding author), Goethe Univ Frankfurt, Inst Anat 3, Frankfurt, Germany.	E.Maronde@em.uni-frankfurt.de; urs.albrecht@unifr.ch	van der Horst, Gijsbertus TJ/E-3661-2015; Albrecht, Urs/A-9831-2011; Maronde, Erik/J-1915-2019	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Albrecht, Urs/0000-0002-0663-8676; Maronde, Erik/0000-0002-5574-6323	Swiss National Science Foundation; European Union; Kurt-Eberhard-Bode-Trust; Stifterverband fur die Deutsche Wissenschaft, Essen, Germany	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); Kurt-Eberhard-Bode-Trust; Stifterverband fur die Deutsche Wissenschaft, Essen, Germany	This research was supported by the Swiss National Science Foundation and the European Union Framework 6 Integrated Project EUCLOCK (UA and GvdH). AFS is supported by an unrestricted grant of the Kurt-Eberhard-Bode-Trust, Stifterverband fur die Deutsche Wissenschaft, Essen, Germany. In the past five years AFS has provided consulting services to Biomet, Curasan, Eucro, Heraeus and IPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 2007, COLD SPRING HARB SYM, V72, P95, DOI 10.1101/sqb.2007.72.001; Amling M, 1999, ENDOCRINOLOGY, V140, P4982, DOI 10.1210/en.140.11.4982; Bae K, 2006, MOL CELLS, V22, P275; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; Dallmann R, 2006, J COMP PHYSIOL A, V192, P769, DOI 10.1007/s00359-006-0114-9; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Gimble JM, 2009, J CELL BIOCHEM, V107, P569, DOI 10.1002/jcb.22153; Grundberg E, 2008, PHYSIOL GENOMICS, V33, P301, DOI 10.1152/physiolgenomics.00028.2008; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Hastings MH, 2008, CURR BIOL, V18, pR805, DOI 10.1016/j.cub.2008.07.021; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; Hoffman AE, 2009, CANCER RES, V69, P3605, DOI 10.1158/0008-5472.CAN-08-4572; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; Merrow M, 2007, CURR BIOL, V17, pR636, DOI 10.1016/j.cub.2007.06.041; Neutzsky-Wulff AV, 2008, CALCIFIED TISSUE INT, V83, P425, DOI 10.1007/s00223-008-9185-7; Oster H, 2002, GENE DEV, V16, P2633, DOI 10.1101/gad.233702; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pilorz V, 2008, REPRODUCTION, V135, P559, DOI 10.1530/REP-07-0434; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosen CJ, 2008, CELL METAB, V7, P7, DOI 10.1016/j.cmet.2007.12.004; Rucinski M, 2008, INT J MOL MED, V22, P363, DOI 10.3892/ijmm_00000031; Sato S, 2007, NAT MED, V13, P1234, DOI 10.1038/nm1640; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shidara K, 2008, CALCIFIED TISSUE INT, V82, P278, DOI 10.1007/s00223-008-9127-4; Spanagel R, 2005, NAT MED, V11, P35, DOI 10.1038/nm1163; Stephan S, 2007, EUR J MED RES, V12, P13; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Viswambharan H, 2007, CIRCULATION, V115, P2188, DOI 10.1161/CIRCULATIONAHA.106.653303; Wu XY, 2008, BONE, V42, P861, DOI 10.1016/j.bone.2007.12.226; Wu XY, 2007, OBESITY, V15, P2560, DOI 10.1038/oby.2007.308; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zvonic S, 2007, J BONE MINER RES, V22, P357, DOI 10.1359/jbmr.061114	37	80	84	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11527	10.1371/journal.pone.0011527	http://dx.doi.org/10.1371/journal.pone.0011527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634945	Green Published, gold, Green Submitted			2022-12-25	WOS:000279781600012
J	Klee, SR; Brzuszkiewicz, EB; Nattermann, H; Bruggemann, H; Dupke, S; Wollherr, A; Franz, T; Pauli, G; Appel, B; Liebl, W; Couacy-Hymann, E; Boesch, C; Meyer, FD; Leendertz, FH; Ellerbrok, H; Gottschalk, G; Grunow, R; Liesegang, H				Klee, Silke R.; Brzuszkiewicz, Elzbieta B.; Nattermann, Herbert; Brueggemann, Holger; Dupke, Susann; Wollherr, Antje; Franz, Tatjana; Pauli, Georg; Appel, Bernd; Liebl, Wolfgang; Couacy-Hymann, Emmanuel; Boesch, Christophe; Meyer, Frauke-Dorothee; Leendertz, Fabian H.; Ellerbrok, Heinz; Gottschalk, Gerhard; Grunow, Roland; Liesegang, Heiko			The Genome of a Bacillus Isolate Causing Anthrax in Chimpanzees Combines Chromosomal Properties of B. cereus with B. anthracis Virulence Plasmids	PLOS ONE			English	Article							SEQUENCE CONSERVATION; GENETIC-RELATIONSHIPS; POPULATION-STRUCTURE; THURINGIENSIS; IDENTIFICATION; BACTERIA; PLCR; SPORULATION; SECRETION; REVEALS	Anthrax is a fatal disease caused by strains of Bacillus anthracis. Members of this monophyletic species are non motile and are all characterized by the presence of four prophages and a nonsense mutation in the plcR regulator gene. Here we report the complete genome sequence of a Bacillus strain isolated from a chimpanzee that had died with clinical symptoms of anthrax. Unlike classic B. anthracis, this strain was motile and lacked the four prohages and the nonsense mutation. Four replicons were identified, a chromosome and three plasmids. Comparative genome analysis revealed that the chromosome resembles those of non-B. anthracis members of the Bacillus cereus group, whereas two plasmids were identical to the anthrax virulence plasmids pXO1 and pXO2. The function of the newly discovered third plasmid with a length of 14 kbp is unknown. A detailed comparison of genomic loci encoding key features confirmed a higher similarity to B. thuringiensis serovar konkukian strain 97-27 and B. cereus E33L than to B. anthracis strains. For the first time we describe the sequence of an anthrax causing bacterium possessing both anthrax plasmids that apparently does not belong to the monophyletic group of all so far known B. anthracis strains and that differs in important diagnostic features. The data suggest that this bacterium has evolved from a B. cereus strain independently from the classic B. anthracis strains and established a B. anthracis lifestyle. Therefore we suggest to designate this isolate as "B. cereus variety (var.) anthracis''.	[Klee, Silke R.; Nattermann, Herbert; Dupke, Susann; Franz, Tatjana; Pauli, Georg; Appel, Bernd; Ellerbrok, Heinz; Grunow, Roland] Robert Koch Inst, Ctr Biol Secur ZBS, D-1000 Berlin, Germany; [Leendertz, Fabian H.] Robert Koch Inst, Res Grp Emerging Zoonoses NG2, D-1000 Berlin, Germany; [Brzuszkiewicz, Elzbieta B.; Brueggemann, Holger; Wollherr, Antje; Liebl, Wolfgang; Meyer, Frauke-Dorothee; Gottschalk, Gerhard; Liesegang, Heiko] Univ Gottingen, Inst Microbiol & Genet, Goettingen Genom Lab, Gottingen, Germany; [Couacy-Hymann, Emmanuel] LANADA Lab Cent Pathol Anim, Bingerville, Cote Ivoire; [Boesch, Christophe] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany	Robert Koch Institute; Robert Koch Institute; University of Gottingen; Max Planck Society	Klee, SR (corresponding author), Robert Koch Inst, Ctr Biol Secur ZBS, D-1000 Berlin, Germany.	klees@rki.de	Liebl, Wolfgang/D-3766-2014; Leendertz, Fabian Hubertus/H-8902-2019	Liebl, Wolfgang/0000-0002-8421-2478; Bruggemann, Holger/0000-0001-7433-0190; Liesegang, Heiko/0000-0003-1792-2047	Federal Ministry of Health [Foko 1-121-42261]; Ministry for Science and Culture of Lower Saxony	Federal Ministry of Health; Ministry for Science and Culture of Lower Saxony	This work was supported in part by grants from the Federal Ministry of Health (grant Foko 1-121-42261) and the Ministry for Science and Culture of Lower Saxony. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen GL, 1996, J BACTERIOL, V178, P377, DOI 10.1128/jb.178.2.377-384.1996; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; BATTISTI L, 1985, J BACTERIOL, V162, P543, DOI 10.1128/JB.162.2.543-550.1985; Berry C, 2002, APPL ENVIRON MICROB, V68, P5082, DOI 10.1128/AEM.68.10.5082-5095.2002; Bouillaut L, 2008, NUCLEIC ACIDS RES, V36, P3791, DOI 10.1093/nar/gkn149; Bourgogne A, 2003, INFECT IMMUN, V71, P2736, DOI 10.1128/IAI.71.5.2736-2743.2003; Brunsing RL, 2005, J BACTERIOL, V187, P6972, DOI 10.1128/JB.187.20.6972-6981.2005; Brzuszkiewicz E, 2009, GENOME DYNAM, V6, P110, DOI 10.1159/000235766; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Challacombe JF, 2007, J BACTERIOL, V189, P3680, DOI 10.1128/JB.00241-07; Daffonchio D, 2000, APPL ENVIRON MICROB, V66, P5460, DOI 10.1128/AEM.66.12.5460-5468.2000; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Didelot X, 2009, SYST APPL MICROBIOL, V32, P81, DOI 10.1016/j.syapm.2009.01.001; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Ehling-Schulz M, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-20; Ellerbrok H, 2002, FEMS MICROBIOL LETT, V214, P51, DOI 10.1016/S0378-1097(02)00837-6; Ellis RJ, 2004, J MICROBIOL METH, V56, P287, DOI 10.1016/j.mimet.2003.10.005; Fagerlund A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-43; Fedhila S, 2006, MOL MICROBIOL, V62, P339, DOI 10.1111/j.1365-2958.2006.05362.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fouet A, 2002, CURR TOP MICROBIOL, V271, P87; Gohar M, 2002, PROTEOMICS, V2, P784, DOI 10.1002/1615-9861(200206)2:6<784::AID-PROT784>3.0.CO;2-R; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Guinebretiere MH, 2008, ENVIRON MICROBIOL, V10, P851, DOI 10.1111/j.1462-2920.2007.01495.x; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Haraldsen JD, 2003, MOL MICROBIOL, V48, P811, DOI 10.1046/j.1365-2958.2003.03471.x; Harwood CR, 2008, TRENDS MICROBIOL, V16, P73, DOI 10.1016/j.tim.2007.12.001; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Helgason E, 2004, APPL ENVIRON MICROB, V70, P191, DOI 10.1128/AEM.70.1.191-201.2004; Hernandez E, 1999, FEMS IMMUNOL MED MIC, V24, P43, DOI 10.1111/j.1574-695X.1999.tb01263.x; Hernandez E, 1998, J CLIN MICROBIOL, V36, P2138, DOI 10.1128/JCM.36.7.2138-2139.1998; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Hoffmaster AR, 1999, J APPL MICROBIOL, V87, P279, DOI 10.1046/j.1365-2672.1999.00887.x; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Hotopp JCD, 2006, MICROBIOL-SGM, V152, P3733, DOI 10.1099/mic.0.29261-0; Hu XM, 2009, APPL ENVIRON MICROB, V75, P3016, DOI 10.1128/AEM.02709-08; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Kern JW, 2008, MOL MICROBIOL, V68, P504, DOI 10.1111/j.1365-2958.2008.06169.x; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; Klee SR, 2006, J APPL MICROBIOL, V100, P673, DOI 10.1111/j.1365-2672.2006.02809.x; Koch R, 1876, BEITR BIOL PFLANZ, V2, P277; Kozel TR, 2007, INFECT IMMUN, V75, P152, DOI 10.1128/IAI.01133-06; KUNKEL B, 1990, GENE DEV, V4, P525, DOI 10.1101/gad.4.4.525; Kurtz S, 2006, INFECT IMMUN, V74, P6855, DOI 10.1128/IAI.01022-06; Leendertz FH, 2006, PLOS PATHOG, V2, P632, DOI 10.1371/journal.ppat.0020008; Leendertz FH, 2006, AM J PRIMATOL, V68, P928, DOI 10.1002/ajp.20298; Leendertz FH, 2004, NATURE, V430, P451, DOI 10.1038/nature02722; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; MAKINO S, 1989, J BACTERIOL, V171, P722, DOI 10.1128/jb.171.2.722-730.1989; Mignot T, 2003, MOL MICROBIOL, V47, P917, DOI 10.1046/j.1365-2958.2003.03345.x; Mignot T, 2001, MOL MICROBIOL, V42, P1189, DOI 10.1046/j.1365-2958.2001.02692.x; Mock M, 2003, CELL MICROBIOL, V5, P15, DOI 10.1046/j.1462-5822.2003.00253.x; Okinaka R, 1999, J APPL MICROBIOL, V87, P261, DOI 10.1046/j.1365-2672.1999.00883.x; Okinaka R, 2006, PLOS PATHOG, V2, P1025, DOI 10.1371/journal.ppat.0020122; Overbeek R, 2003, NUCLEIC ACIDS RES, V31, P164, DOI 10.1093/nar/gkg148; Pannucci J, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-34; Pannucci J, 2002, J BACTERIOL, V184, P134, DOI 10.1128/JB.184.1.134-141.2002; Perego M, 2008, TRENDS MICROBIOL, V16, P215, DOI 10.1016/j.tim.2008.01.010; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Radnedge L, 2003, APPL ENVIRON MICROB, V69, P2755, DOI 10.1128/AEM.69.5.2755-2764.2003; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Rasko DA, 2007, J BACTERIOL, V189, P52, DOI 10.1128/JB.01313-06; Ravel J, 2009, J BACTERIOL, V191, P445, DOI 10.1128/JB.01347-08; Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837; REDDY A, 1987, J BACTERIOL, V169, P5263, DOI 10.1128/jb.169.11.5263-5270.1987; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Roh JY, 2007, J MICROBIOL BIOTECHN, V17, P547; Sacchi CT, 2002, EMERG INFECT DIS, V8, P1117, DOI 10.3201/eid0810.020391; Saile E, 2006, APPL ENVIRON MICROB, V72, P3168, DOI 10.1128/AEM.72.5.3168-3174.2006; SATO T, 1990, J BACTERIOL, V172, P1092, DOI 10.1128/jb.172.2.1092-1098.1990; Schmeisser C, 2009, APPL ENVIRON MICROB, V75, P4035, DOI 10.1128/AEM.00515-09; Slamti L, 2002, EMBO J, V21, P4550, DOI 10.1093/emboj/cdf450; STRAGIER P, 1989, SCIENCE, V243, P507, DOI 10.1126/science.2536191; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tech Maike, 2003, In Silico Biology, V3, P441; Turner KME, 2007, INT J ANTIMICROB AG, V29, P129, DOI 10.1016/j.ijantimicag.2006.11.002; UCHIDA I, 1993, J BACTERIOL, V175, P5329, DOI 10.1128/JB.175.17.5329-5338.1993; Van der Auwera GA, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-103; Van der Auwera GA, 2008, PLASMID, V59, P134, DOI 10.1016/j.plasmid.2007.11.007; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Vilain S, 2006, APPL ENVIRON MICROB, V72, P4970, DOI 10.1128/AEM.03076-05	87	112	119	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e10986	10.1371/journal.pone.0010986	http://dx.doi.org/10.1371/journal.pone.0010986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634886	Green Published, gold, Green Submitted			2022-12-25	WOS:000279715300001
J	Oleksyk, TK; Nelson, GW; An, P; Kopp, JB; Winkler, CA				Oleksyk, Taras K.; Nelson, George W.; An, Ping; Kopp, Jeffrey B.; Winkler, Cheryl A.			Worldwide Distribution of the MYH9 Kidney Disease Susceptibility Alleles and Haplotypes: Evidence of Historical Selection in Africa	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; NATURAL-SELECTION; LINKAGE DISEQUILIBRIUM; POPULATION; GENETICS; SOFTWARE; GENOTYPE; GENOME; NEPHROPATHY; PREVALENCE	MYH9 was recently identified as renal susceptibility gene (OR 3-8, p<10(-8)) for major forms of kidney disease disproportionately affecting individuals of African descent. The risk haplotype (E-1) occurs at much higher frequencies in African Americans (>= 60%) than in European Americans (<4%), revealing a genetic basis for a major health disparity. The population distributions of MYH9 risk alleles and the E-1 risk haplotype and the demographic and selective forces acting on the MYH9 region are not well explored. We reconstructed MYH9 haplotypes from 4 tagging single nucleotide polymorphisms (SNPs) spanning introns 12-23 using available data from HapMap Phase II, and by genotyping 938 DNAs from the Human Genome Diversity Panel (HGDP). The E-1 risk haplotype followed a cline, being most frequent within sub-Saharan African populations (range 50-80%), less frequent in populations from the Middle East (9-27%) and Europe (0- 9%), and rare or absent in Asia, the Americas, and Oceania. The fixation indexes (F-ST) for pairwise comparisons between the risk haplotypes for continental populations were calculated for MYH9 haplotypes; F-ST ranged from 0.27-0.40 for Africa compared to other continental populations, possibly due to selection. Uniquely in Africa, the Yoruba population showed high frequency extended haplotype length around the core risk allele (C) compared to the alternative allele (T) at the same locus (rs4821481, iHs = 2.67), as well as high population differentiation (F-ST(CEU vs. YRI) = 0.51) in HapMap Phase II data, also observable only in the Yoruba population from HGDP (F-ST = 0.49), pointing to an instance of recent selection in the genomic region. The population-specific divergence in MYH9 risk allele frequencies among the world's populations may prove important in risk assessment and public health policies to mitigate the burden of kidney disease in vulnerable populations.	[Oleksyk, Taras K.] Univ Puerto Rico, Dept Biol, Mayaguez, PR USA; [Nelson, George W.; An, Ping; Winkler, Cheryl A.] SAIC Frederick, Lab Genom Divers, Frederick, MD USA; [Kopp, Jeffrey B.] NIDDK, Kidney Dis Sect, NIH, Bethesda, MD USA	University of Puerto Rico; University of Puerto Rico Mayaguez; Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Oleksyk, TK (corresponding author), Univ Puerto Rico, Dept Biol, Mayaguez, PR USA.	winklerc@mail.nih.gov	Rinaldi2, Carlos/D-4479-2011; Kopp, Jeffrey B/O-2681-2015; Taras, Oleksyk/J-8805-2013	Kopp, Jeffrey B/0000-0001-9052-186X; Taras, Oleksyk/0000-0002-8148-3918; An, Ping/0000-0002-5322-3510	National Cancer Institute; National Institutes of Health [HHSN261200800001E, RO1 DK 070941, RO1 RFA-CA-09-003]; National Institute for Diabetes, Digestive, and Kidney Diseases [ZO-1 DK043308]; NATIONAL CANCER INSTITUTE [ZIABC010022, ZIABC010297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070941, ZIADK043308, Z01DK043308] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Diabetes, Digestive, and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E, the Intramural Research Programs of the National Institute for Diabetes, Digestive, and Kidney Diseases (ZO-1 DK043308), and by a grant from the NIH (RO1 DK 070941 (BIF)) and (RO1 RFA-CA-09-003 (CAW)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amato R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007927; BANDELT HJ, 1995, GENETICS, V141, P743; Behar DM, 2006, AM J KIDNEY DIS, V47, P88, DOI 10.1053/j.ajkd.2005.09.023; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Chen Z, 2007, BLOOD, V110, P171, DOI 10.1182/blood-2007-02-071589; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Eck R.V., 1966, ATLAS PROTEIN SEQUEN; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fabian J, 2009, NAT REV NEPHROL, V5, P591, DOI 10.1038/nrneph.2009.141; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FREEDMAN BI, 1995, AM J KIDNEY DIS, V25, P710, DOI 10.1016/0272-6386(95)90546-4; FREEDMAN BI, 2009, NEPHROL DIAL TRANSPL; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; KOPP JB, 2003, KIDNEY INT S, pS46; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LEWONTIN RC, 1973, GENETICS, V74, P175; Lohmueller KE, 2006, AM J HUM GENET, V78, P130, DOI 10.1086/499287; NEEL JV, 1962, AM J HUM GENET, V14, P353; Neel JV, 1998, PERSPECT BIOL MED, V42, P44; Nelson GW, 2010, HUM MOL GENET, V19, P1805, DOI 10.1093/hmg/ddq039; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; PAYS E, 2009, CURR OPIN IMMUNOL; Pemberton TJ, 2008, ANN HUM GENET, V72, P535, DOI 10.1111/j.1469-1809.2008.00457.x; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Shrestha S, 2006, J INFECT DIS, V193, P16, DOI 10.1086/498532; Sumaili EK, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-18; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; *USRDS, 1999, US REN DAT SYST 1999; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Yu FL, 2009, HUM MOL GENET, V18, P4853, DOI 10.1093/hmg/ddp457; Zakharia F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r141	44	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11474	10.1371/journal.pone.0011474	http://dx.doi.org/10.1371/journal.pone.0011474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634883	Green Published, Green Submitted, gold			2022-12-25	WOS:000279715300002
J	Villa-Cuesta, E; Sage, BT; Tatar, M				Villa-Cuesta, Eugenia; Sage, Brian T.; Tatar, Marc			A Role for Drosophila dFoxO and dFoxO 5 ' UTR Internal Ribosomal Entry Sites during Fasting	PLOS ONE			English	Article							CAP-INDEPENDENT TRANSLATION; INSULIN-RECEPTOR; MESSENGER-RNA; PROTEIN-SYNTHESIS; STARVATION; STRESS; FOXO; DIFFERENTIATION; TRANSCRIPTION; HOMEOSTASIS	One way animals may cope with nutrient deprivation is to broadly repress translation by inhibiting 5'-cap initiation. However, under these conditions specific proteins remain essential to survival during fasting. Such peptides may be translated through initiation at 5'UTR Internal Ribosome Entry Sites (IRES). Here we show that the Drosophila melanogaster Forkhead box type O (dFoxO) transcription factor is required for adult survival during fasting, and that the 5'UTR of dfoxO has the ability to initiate IRES-mediated translation in cell culture. Previous work has shown that insulin negatively regulates dFoxO through AKT-mediated phosphorylation while dFoxO itself induces transcription of the insulin receptor dInR, which also harbors IRES. Here we report that IRES-mediated translation of both dFoxO and dInR is activated in fasted Drosophila S2 cells at a time when cap-dependent translation is reduced. IRES mediated translation of dFoxO and dInR may be essential to ensure function and sensitivity of the insulin signaling pathway during fasting.	[Villa-Cuesta, Eugenia; Sage, Brian T.; Tatar, Marc] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Brown University	Villa-Cuesta, E (corresponding author), Brown Univ, Dept Pediat, Providence, RI 02912 USA.	eugenia_villa-cuesta@brown.edu		Villa-Cuesta, Eugenia/0000-0002-8919-6788; Tatar, Marc/0000-0003-3232-6884	National Institutes of Health [RO1 AGO21953]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by the National Institutes of Health grant RO1 AGO21953. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; BAILLIE AGS, 1991, AM J PHYSIOL, V260, pE891, DOI 10.1152/ajpendo.1991.260.6.E891; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Dyer JR, 2003, NAT NEUROSCI, V6, P219, DOI 10.1038/nn1018; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Gershman B, 2007, PHYSIOL GENOMICS, V29, P24, DOI 10.1152/physiolgenomics.00061.2006; Giannakou ME, 2008, AGING CELL, V7, P187, DOI 10.1111/j.1474-9726.2007.00362.x; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Graber TE, 2007, MOL BIOSYST, V3, P825, DOI 10.1039/b708867a; HATADA EN, 1989, J BIOL CHEM, V264, P6741; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; JANG S, 2007, J VIROL, V62, P2636; Jefferson LS, 2003, J NUTR, V133, p2046S, DOI 10.1093/jn/133.6.2046S; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kramer JM, 2008, GENOME, V51, P668, DOI 10.1139/G08-047; Kramer Jamie M, 2003, BMC Dev Biol, V3, P5, DOI 10.1186/1471-213X-3-5; Lasko P, 2007, GENE DEV, V21, P235, DOI 10.1101/gad.1524707; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marr MT, 2007, GENE DEV, V21, P175, DOI 10.1101/gad.1506407; MCNURLAN MA, 1979, BIOCHEM J, V178, P373, DOI 10.1042/bj1780373; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Parmer MKB, 1995, SURVIVAL ANAL PRACTI; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Sonenberg N, 2000, TRANSLATIONAL CONTRO; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Weber K, 2005, GENETICS, V169, P1461, DOI 10.1534/genetics.104.027748	33	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11521	10.1371/journal.pone.0011521	http://dx.doi.org/10.1371/journal.pone.0011521			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634900	Green Published, gold, Green Submitted			2022-12-25	WOS:000279715300025
J	Virk, J; Li, J; Vestergaard, M; Obel, C; Lu, M; Olsen, J				Virk, Jasveer; Li, Jiong; Vestergaard, Mogens; Obel, Carsten; Lu, Michael; Olsen, Jorn			Early Life Disease Programming during the Preconception and Prenatal Period: Making the Link between Stressful Life Events and Type-1 Diabetes	PLOS ONE			English	Article							MELLITUS; RISK; SYSTEM	Background: To assess the risk of developing Type-1 diabetes among children who were exposed to maternal bereavement during the prenatal or 1-year preconception period. Methods: We identified N = 1,548,746 singleton births born in Denmark between January 1(st) 1979 through December 31(st) 2004, and their next of kin. Altogether, 39,857 children were exposed to bereavement during their prenatal life. The main outcome of interest was hospitalization for type-1 diabetes (ICD 8: 249; ICD 10: E10). Results: We found the strongest association for type-1 diabetes among children exposed to traumatic father or sibling deaths (aIRR: 2.03, 1.22-3.38); the association was mainly seen for girls (aIRR: 2.91, 1.61-5.26). Conclusions: We found evidence to suggest that female fetuses exposed to severe prenatal stress are at increased risk for developing type-1 diabetes.	[Virk, Jasveer; Lu, Michael; Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Li, Jiong; Olsen, Jorn] Aarhus Univ, Danish Epidemiol Sci Ctr, Inst Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Res Unit Gen Practice, Aarhus, Denmark; [Vestergaard, Mogens; Obel, Carsten] Aarhus Univ, Inst Publ Hlth, Dept Gen Practice, Aarhus, Denmark; [Lu, Michael] Univ Calif Los Angeles, Dept Obstet & Gynecol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; Aarhus University; Aarhus University; Aarhus University; University of California System; University of California Los Angeles	Virk, J (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA.	jasvirk@ucla.edu	Vestergaard, Mogens/M-9333-2014; Olsen, Jørn/F-8801-2015; li, jiong/L-6534-2014; Obel, Carsten/H-9605-2016	Vestergaard, Mogens/0000-0001-8830-2174; Olsen, Jørn/0000-0001-7462-5140; li, jiong/0000-0002-1716-8067; Obel, Carsten/0000-0001-5004-1933; Huicho, Luis/0000-0002-5272-5885; li, jiong/0000-0003-1125-026X	Danish Medical Research Council [271-05-0616, 271-07-0437]; NordForsk [070331]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NordForsk	The study was supported by the Danish Medical Research Council (projects no. 271-05-0616 and 271-07-0437) and NordForsk (070331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; Concannon P, 2009, NEW ENGL J MED, V360, P1646, DOI 10.1056/NEJMra0808284; Dahlquist G, 2002, DIABETES CARE, V25, P1755; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Entringer S, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.006; Gale EAM, 2002, DIABETOLOGIA, V45, P588, DOI 10.1007/s00125-002-0801-1; Harder T, 2009, AM J EPIDEMIOL, V169, P1428, DOI 10.1093/aje/kwp065; Krupnick J.L., 1984, BEREAVEMENT REACTION, P99; McKinney PA, 2000, DIABETIC MED, V17, P236, DOI 10.1046/j.1464-5491.2000.00220.x; Nielsen G L, 1996, J Med Syst, V20, P1, DOI 10.1007/BF02260869; O'Regan D, 2004, AM J PHYSIOL-ENDOC M, V287, pE863, DOI 10.1152/ajpendo.00137.2004; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Pedersen CB, 2006, DAN MED BULL, V53, P441; Rubin S.S., 2001, HDB BEREAVEMENT RES, P219, DOI DOI 10.1037/10436-009; Rubin Simon Shimshon, 1993, P285, DOI 10.1017/CBO9780511664076.020; Svensson J, 2002, DIABETES CARE, V25, P2197, DOI 10.2337/diacare.25.12.2197; WAREHAM NJ, 2002, MED INT, V30, P11; WEINSTOCK M, 1992, BRAIN RES, V595, P195, DOI 10.1016/0006-8993(92)91049-K	18	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11523	10.1371/journal.pone.0011523	http://dx.doi.org/10.1371/journal.pone.0011523			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634978	Green Submitted, gold, Green Published			2022-12-25	WOS:000279715300026
J	van Kampen, JJA; Reedijk, ML; Burgers, PC; Dekker, LJM; Hartwig, NG; van der Ende, IE; de Groot, R; Osterhaus, ADME; Burger, DM; Luider, TM; Gruters, RA				van Kampen, Jeroen J. A.; Reedijk, Mariska L.; Burgers, Peter C.; Dekker, Lennard J. M.; Hartwig, Nico G.; van der Ende, Ineke E.; de Groot, Ronald; Osterhaus, Albert D. M. E.; Burger, David M.; Luider, Theo M.; Gruters, Rob A.			Ultra-Fast Analysis of Plasma and Intracellular Levels of HIV Protease Inhibitors in Children: A Clinical Application of MALDI Mass Spectrometry	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; ASSISTED-LASER-DESORPTION/IONIZATION; REVERSE-TRANSCRIPTASE INHIBITORS; IMMUNODEFICIENCY-VIRUS TYPE-1; STEADY-STATE PHARMACOKINETICS; P-GLYCOPROTEIN EXPRESSION; INFECTED PATIENTS; LIQUID-CHROMATOGRAPHY; QUANTITATIVE-ANALYSIS; ANTIRETROVIRAL DRUGS	HIV protease inhibitors must penetrate into cells to exert their action. Differences in the intracellular pharmacokinetics of these drugs may explain why some patients fail on therapy or suffer from drug toxicity. Yet, there is no information available on the intracellular levels of HIV protease inhibitors in HIV infected children, which is in part due to the large amount of sample that is normally required to measure the intracellular concentrations of these drugs. Therefore, we developed an ultra-fast and sensitive assay to measure the intracellular concentrations of HIV protease inhibitors in small amounts of peripheral blood mononuclear cells (PBMCs), and determined the intracellular concentrations of lopinavir and ritonavir in HIV infected children. An assay based on matrix-assisted laser desorption/ionization (MALDI) - triple quadrupole mass spectrometry was developed to determine the concentrations of HIV protease inhibitors in 10 mu L plasma and 1 x 10(6) PBMCs. Precisions and accuracies were within the values set by the FDA for bioanalytical method validation. Lopinavir and ritonavir did not accumulate in PBMCs of HIV infected children. In addition, the intracellular concentrations of lopinavir and ritonavir correlated poorly to the plasma concentrations of these drugs. MALDI-triple quadrupole mass spectrometry is a new tool for ultra-fast and sensitive determination of drug concentrations which can be used, for example, to assess the intracellular pharmacokinetics of HIV protease inhibitors in HIV infected children.	[van Kampen, Jeroen J. A.; Burgers, Peter C.; Dekker, Lennard J. M.; Luider, Theo M.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [van Kampen, Jeroen J. A.; Hartwig, Nico G.] Erasmus MC Sophia, Dept Paediat, Rotterdam, Netherlands; [van Kampen, Jeroen J. A.; Reedijk, Mariska L.; Osterhaus, Albert D. M. E.; Gruters, Rob A.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [van der Ende, Ineke E.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [de Groot, Ronald] Univ Med Ctr Nijmegen, Dept Paediat, Nijmegen, Netherlands; [Burger, David M.] Univ Med Ctr Nijmegen, Dept Clin Pharm, Nijmegen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Radboud University Nijmegen	van Kampen, JJA (corresponding author), Erasmus MC, Dept Neurol, Rotterdam, Netherlands.	t.luider@erasmusmc.nl	Gruters, Rob/AAM-2362-2020; Burger, David/C-9929-2013; Hartwig, Nico/ABI-5467-2020; de Groot, R./H-8039-2014	Osterhaus, Albert/0000-0002-6074-1172; Gruters, Rob/0000-0002-8486-5903; van Kampen, Jeroen/0000-0002-7625-8230	Top Institute Pharma [T4-212]; Aids Fonds, the Netherlands [2004051]; VIRGO	Top Institute Pharma; Aids Fonds, the Netherlands; VIRGO	This work was supported by a grant from Top Institute Pharma (project T4-212). The consortium of project T4-212 consists of the departments of Neurology and Virology of the Erasmus MC (Rotterdam, the Netherlands), the departments of Pediatrics and Clinical Pharmacy of the UMC St. Radboud (Nijmegen, the Netherlands), TNO Quality-of-Life (Zeist, the Netherlands), and GlaxoSmithKline (Zeist, the Netherlands). Jeroen van Kampen is supported by a grant from Aids Fonds, the Netherlands (project 2004051), and Rob Gruters is supported by VIRGO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergshoeff AS, 2003, ANTIVIR THER, V8, P215; Bilello JA, 1996, ANTIMICROB AGENTS CH, V40, P1491, DOI 10.1128/AAC.40.6.1491; Breilh D, 2004, AIDS, V18, P1305, DOI 10.1097/00002030-200406180-00009; Colombo S, 2005, J CHROMATOGR B, V819, P259, DOI 10.1016/j.jchromb.2005.02.010; Colombo S, 2006, THER DRUG MONIT, V28, P332, DOI 10.1097/01.ftd.0000211807.74192.62; Corr JJ, 2006, J AM SOC MASS SPECTR, V17, P1129, DOI 10.1016/j.jasms.2006.04.026; Crommentuyn KML, 2004, ANTIVIR THER, V9, P779; Cvetkovic RS, 2003, DRUGS, V63, P769, DOI 10.2165/00003495-200363080-00004; Denissen JF, 1997, DRUG METAB DISPOS, V25, P489; Droste JAH, 2003, THER DRUG MONIT, V25, P393, DOI 10.1097/00007691-200306000-00023; Ehrhardt M, 2007, J CHROMATOGR B, V850, P249, DOI 10.1016/j.jchromb.2006.11.037; Ford J, 2004, J ANTIMICROB CHEMOTH, V54, P982, DOI 10.1093/jac/dkh487; Ford J, 2004, ANTIVIR THER, V9, P77; Ford J, 2004, ANTIMICROB AGENTS CH, V48, P2388, DOI 10.1128/AAC.48.7.2388-2393.2004; Ford J, 2006, J ANTIMICROB CHEMOTH, V58, P1009, DOI 10.1093/jac/dkl379; Fraaij PLA, 2005, CLIN PHARMACOKINET, V44, P935, DOI 10.2165/00003088-200544090-00004; Fraaij PLA, 2004, THER DRUG MONIT, V26, P122, DOI 10.1097/00007691-200404000-00006; Fraaij PLA, 2003, J ANTIMICROB CHEMOTH, V52, P727, DOI 10.1093/jac/dkg391; Gobey J, 2005, ANAL CHEM, V77, P5643, DOI 10.1021/ac0506130; Hatsis P, 2003, RAPID COMMUN MASS SP, V17, P2303, DOI 10.1002/rcm.1192; Hennessy M, 2004, ANTIVIR THER, V9, P115; Hennessy M, 2003, ANTIVIR THER, V8, P191; Hoggard PG, 2003, J ANTIMICROB CHEMOTH, V51, P493, DOI 10.1093/jac/dkg137; Jones K, 2001, BRIT J CLIN PHARMACO, V51, P99, DOI 10.1046/j.1365-2125.2001.01324.x; Khoo SH, 2002, ANTIMICROB AGENTS CH, V46, P3228, DOI 10.1128/AAC.46.10.3228-3235.2002; Koal T, 2005, RAPID COMMUN MASS SP, V19, P2995, DOI 10.1002/rcm.2158; Kumar GN, 2004, PHARM RES-DORDR, V21, P1622, DOI 10.1023/B:PHAM.0000041457.64638.8d; Pelerin H, 2005, J CHROMATOGR B, V819, P47, DOI 10.1016/j.jchromb.2005.01.024; Ribera E, 2004, ANTIMICROB AGENTS CH, V48, P4256, DOI 10.1128/AAC.48.11.4256-4262.2004; Sleno L, 2005, RAPID COMMUN MASS SP, V19, P1928, DOI 10.1002/rcm.2006; Sleno L, 2005, ANAL CHEM, V77, P1509, DOI 10.1021/ac0486600; ter Heine R, 2009, J CHROMATOGR B, V877, P575, DOI 10.1016/j.jchromb.2009.01.011; U.S. FDA, 1998, GUIDANCE IND BIOANAL; van Kampen JJA, 2008, ANAL CHEM, V80, P4969, DOI 10.1021/ac800218a; van Kampen JJA, 2007, J CHROMATOGR B, V847, P38, DOI 10.1016/j.jchromb.2006.10.001; van Kampen JJA, 2011, MASS SPECTROM REV, V30, P101, DOI 10.1002/mas.20268; VANBUEREN J, 1994, J HOSP INFECT, V28, P137, DOI 10.1016/0195-6701(94)90140-6; Volmer DA, 2007, ANAL CHEM, V79, P9000, DOI 10.1021/ac7016234; Wagner M, 2008, J CHROMATOGR B, V872, P68, DOI 10.1016/j.jchromb.2008.07.009; Yang Yong, 2007, J Biomol Tech, V18, P226	40	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2010	5	7							e11409	10.1371/journal.pone.0011409	http://dx.doi.org/10.1371/journal.pone.0011409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YF	20625386	Green Submitted, Green Published, gold			2022-12-25	WOS:000279465500002
J	Chano, T; Ikebuchi, K; Ochi, Y; Tameno, H; Tomita, Y; Jin, YF; Inaji, H; Ishitobi, M; Teramoto, K; Nishimura, I; Minami, K; Inoue, H; Isono, T; Saitoh, M; Shimada, T; Hisa, Y; Okabe, H				Chano, Tokuhiro; Ikebuchi, Kaichiro; Ochi, Yasuko; Tameno, Hitosuke; Tomita, Yasuhiko; Jin, Yufen; Inaji, Hideo; Ishitobi, Makoto; Teramoto, Koji; Nishimura, Ichiro; Minami, Kahori; Inoue, Hirokazu; Isono, Takahiro; Saitoh, Masao; Shimada, Taketoshi; Hisa, Yasuo; Okabe, Hidetoshi			RB1CC1 Activates RB1 Pathway and Inhibits Proliferation and Cologenic Survival in Human Cancer	PLOS ONE			English	Article							HUMAN BREAST-CANCER; TUMOR-CELLS; COMPLEX; FIP200; AUTOPHAGY; GENE; PHOSPHORYLATION; TRANSCRIPTION; SENESCENCE; MUTATIONS	RB1-inducible coiled-coil 1 (RB1CC1, also known as FIP200) plays a role in the enhancement of the RB1 pathway through the direct binding to a GC-rich region 201bp upstream (from the initiation ATG) of the RB1 promoter. Here, we identified hSNF5 and p53 as the binding partners of RB1CC1 by immunoprecipitation and immunofluorescence assays. Interaction between these molecules and the RB1 pathway was analyzed by the assays of chromatin immunoprecipitation, luciferase-reporter, reverse transcription-polymerase chain reaction and immunoblot. The tumor growth suppression by RB1CC1 was evaluated by flow cytometry or by a cell growth assay. The nuclear RB1CC1 complex involving hSNF5 and/or p53 activated transcription of RB1, p16 and p21, and suppressed tumor cell growth. Furthermore, nuclear RB1CC1 expression significantly correlated with those of RB1 and p16 in breast cancer tissue in vivo, and the Ki-67 proliferation index was dependent on p53 as well as RB1CC1. The present study indicates that RB1CC1 together with hSNF5 and/or p53 enhances the RB1 pathway through transcriptional activation of RB1, p16 and p21. Evaluation of RB1CC1 expression combined with RB1 and p53 status is expected to provide useful information in clinical practice and future therapeutic strategies in breast cancer.	[Chano, Tokuhiro; Ikebuchi, Kaichiro; Ochi, Yasuko; Tameno, Hitosuke; Nishimura, Ichiro; Minami, Kahori; Okabe, Hidetoshi] Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan; [Ikebuchi, Kaichiro; Ochi, Yasuko; Tameno, Hitosuke; Shimada, Taketoshi; Hisa, Yasuo] Kyoto Prefectural Univ Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan; [Tomita, Yasuhiko; Jin, Yufen] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Osaka, Japan; [Inaji, Hideo; Ishitobi, Makoto] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Breast & Endocrine Surg, Osaka, Japan; [Teramoto, Koji] Shiga Univ Med Sci, Dept Thorac Surg, Otsu, Shiga 52021, Japan; [Inoue, Hirokazu] Shiga Univ Med Sci, Dept Microbiol, Otsu, Shiga 52021, Japan; [Isono, Takahiro] Shiga Univ Med Sci, Cent Res Lab, Otsu, Shiga 52021, Japan; [Saitoh, Masao] Tokyo Med & Dent Univ, Tokyo, Japan	Shiga University of Medical Science; Kyoto Prefectural University of Medicine; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases; Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Tokyo Medical & Dental University (TMDU)	Chano, T (corresponding author), Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan.	chano@belle.shiga-med.ac.jp	Chano, Tokuhiro/F-5816-2018	Chano, Tokuhiro/0000-0002-9959-1183	Ministry of Education, Culture, Sports, Science, and Technology, Japan [20012025]; Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research	This study was supported in part by KAKENHI (Grant-in-Aid for Scientific Research on Priority Areas; No. 20012025) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; and the Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research. These funding sources had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript.	Betz BL, 2002, ONCOGENE, V21, P5193, DOI 10.1038/sj.onc.1205706; Chai JJ, 2005, CANCER RES, V65, P10192, DOI 10.1158/0008-5472.CAN-05-1896; Chano T, 2002, NAT GENET, V31, P285, DOI 10.1038/ng911; Chano T, 2002, ONCOGENE, V21, P1295, DOI 10.1038/sj.onc.1205178; Chano T, 2006, INT J MOL MED, V18, P425; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gresh L, 2005, EMBO J, V24, P3313, DOI 10.1038/sj.emboj.7600802; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2009, AUTOPHAGY, V5, P85, DOI 10.4161/auto.5.1.7180; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Ikebuchi K, 2009, INT J CANCER, V125, P861, DOI 10.1002/ijc.24466; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Martin N, 2008, MOL CELL BIOL, V28, P2771, DOI 10.1128/MCB.01210-07; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; SAKAI T, 1991, NATURE, V353, P83, DOI 10.1038/353083a0; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Yagi A, 2003, J CELL BIOCHEM, V90, P1242, DOI 10.1002/jcb.10711; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709	19	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11404	10.1371/journal.pone.0011404	http://dx.doi.org/10.1371/journal.pone.0011404			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614030	Green Submitted, Green Published, gold			2022-12-25	WOS:000279370000029
J	Madsen, L; Pedersen, LM; Lillefosse, HH; Fjaere, E; Bronstad, I; Hao, Q; Petersen, RK; Hallenborg, P; Ma, T; De Matteis, R; Araujo, P; Mercader, J; Bonet, ML; Hansen, JB; Cannon, B; Nedergaard, J; Wang, J; Cinti, S; Voshol, P; Doskeland, SO; Kristiansen, K				Madsen, Lise; Pedersen, Lone M.; Lillefosse, Haldis Haukaas; Fjaere, Even; Bronstad, Ingeborg; Hao, Qin; Petersen, Rasmus K.; Hallenborg, Philip; Ma, Tao; De Matteis, Rita; Araujo, Pedro; Mercader, Josep; Luisa Bonet, M.; Hansen, Jacob B.; Cannon, Barbara; Nedergaard, Jan; Wang, Jun; Cinti, Saverio; Voshol, Peter; Doskeland, Stein Ove; Kristiansen, Karsten			UCP1 Induction during Recruitment of Brown Adipocytes in White Adipose Tissue Is Dependent on Cyclooxygenase Activity	PLOS ONE			English	Article							DIET-INDUCED OBESITY; MITOCHONDRIAL UNCOUPLING PROTEIN; PROSTANOID RECEPTORS; INSULIN-RESISTANCE; LEAN PHENOTYPE; C57BL/6J MICE; GENE; FAT; EXPRESSION; DEFICIENT	Background: The uncoupling protein 1 (UCP1) is a hallmark of brown adipocytes and pivotal for cold- and diet-induced thermogenesis. Methodology/Principal Findings: Here we report that cyclooxygenase (COX) activity and prostaglandin E-2 (PGE(2)) are crucially involved in induction of UCP1 expression in inguinal white adipocytes, but not in classic interscapular brown adipocytes. Cold-induced expression of UCP1 in inguinal white adipocytes was repressed in COX2 knockout (KO) mice and by administration of the COX inhibitor indomethacin in wild-type mice. Indomethacin repressed beta-adrenergic induction of UCP1 expression in primary inguinal adipocytes. The use of PGE(2) receptor antagonists implicated EP4 as a main PGE(2) receptor, and injection of the stable PGE(2) analog (EP3/4 agonist) 16,16 dm PGE(2) induced UCP1 expression in inguinal white adipose tissue. Inhibition of COX activity attenuated diet-induced UCP1 expression and increased energy efficiency and adipose tissue mass in obesity-resistant mice kept at thermoneutrality. Conclusions/Significance: Our findings provide evidence that induction of UCP1 expression in white adipose tissue, but not in classic interscapular brown adipose tissue is dependent on cyclooxygenase activity. Our results indicate that cyclooxygenase-dependent induction of UCP1 expression in white adipose tissues is important for diet-induced thermogenesis providing support for a surprising role of COX activity in the control of energy balance and obesity development.	[Madsen, Lise; Lillefosse, Haldis Haukaas; Fjaere, Even; Hao, Qin; Petersen, Rasmus K.; Hallenborg, Philip; Ma, Tao; Wang, Jun; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Pedersen, Lone M.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Madsen, Lise; Lillefosse, Haldis Haukaas; Fjaere, Even; Araujo, Pedro] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Bronstad, Ingeborg; Doskeland, Stein Ove] Univ Bergen, Dept Biomed, Bergen, Norway; [De Matteis, Rita] Univ Urbino, Dept Biomol Sci, I-61029 Urbino, Italy; [Mercader, Josep; Luisa Bonet, M.] Univ Illes Balears, Lab Mol Biol Nutr & Biotechnol, Palma de Mallorca, Spain; [Mercader, Josep; Luisa Bonet, M.] CIBERobn, Palma de Mallorca, Spain; [Hansen, Jacob B.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Cannon, Barbara; Nedergaard, Jan] Stockholm Univ, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Wang, Jun; Kristiansen, Karsten] BGI Shenzhen, Shenzhen, Peoples R China; [Cinti, Saverio] Univ Ancona, Dept Mol Pathol & Innovat Therapies, Ancona, Italy; [Voshol, Peter] Univ Cambridge, Metab Res Labs, Cambridge, England	University of Copenhagen; University of Southern Denmark; University of Bergen; University of Urbino; Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Copenhagen; Stockholm University; Beijing Genomics Institute (BGI); Marche Polytechnic University; University of Cambridge	Madsen, L (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	lise.madsen@nifes.no; kk@bio.ku.dk	Mercader, J/I-1867-2017; Hansen, Jacob B/F-3775-2010; Madsen, Lise/C-6246-2012; De+Matteis, Rita/AAG-6904-2019; Nedergaard, Jan/Q-8286-2019; Nedergaard, Jan/A-1706-2010; Kristiansen, Karsten/J-5148-2014; Bonet, M.Luisa/H-6722-2015; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016; Cannon, Barbara/B-3089-2016	Hansen, Jacob B/0000-0001-5249-2586; Madsen, Lise/0000-0003-4468-1947; Kristiansen, Karsten/0000-0002-6024-0917; Bonet, M.Luisa/0000-0002-8698-0630; Wang, Jun/0000-0002-8540-8931; Nedergaard, Jan/0000-0003-2070-1587; DE MATTEIS, Rita/0000-0003-4665-4547; Wang, Jun/0000-0002-2113-5874; CINTI, Saverio/0000-0003-0362-5017; Mercader Barcelo, Josep/0000-0002-5293-2809; Cannon, Barbara/0000-0001-6594-2363; Araujo, Pedro/0000-0002-1962-6084; Hao, Qin/0000-0002-6775-2181; Doskeland, Stein Ove/0000-0002-4009-4756	Danish Natural Science Research Council; Novo Nordisk Foundation; Carlsberg Foundation; Danish Council [2101 06 0005]	Danish Natural Science Research Council(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); Danish Council(Danish Medical Research Council)	This work was supported by the Danish Natural Science Research Council, the Novo Nordisk Foundation and the Carlsberg Foundation. Part of the work was carried out as a part of the research program of the Danish Obesity Research Centre (DanORC). DanORC is supported by The Danish Council for Strategic Research (Grant No 2101 06 0005). CIBER de Fisiopatologia de la Obesidad y Nutricion is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz M, 2000, BBA-MOL CELL BIOL L, V1483, P285, DOI 10.1016/S1388-1981(99)00164-X; Bauer AK, 2000, CARCINOGENESIS, V21, P543, DOI 10.1093/carcin/21.4.543; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; CINTI S, 2009, AM J PHYSIOL-ENDOC M; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dali-Youcef N, 2007, P NATL ACAD SCI USA, V104, P10703, DOI 10.1073/pnas.0611568104; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fain JN, 2001, PROSTAG OTH LIPID M, V65, P199, DOI 10.1016/S0090-6980(01)00136-8; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; GARRUTI G, 1992, INT J OBESITY, V16, P383; GASKINS HR, 1989, J NUTR, V119, P458, DOI 10.1093/jn/119.3.458; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Granneman JG, 2003, AM J PHYSIOL-ENDOC M, V285, pE1230, DOI 10.1152/ajpendo.00197.2003; Grujic D, 1997, J BIOL CHEM, V272, P17686, DOI 10.1074/jbc.272.28.17686; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Hetu PO, 2007, OBESITY, V15, P60, DOI 10.1038/oby.2007.514; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; HYMAN BT, 1982, BIOCHIM BIOPHYS ACTA, V713, P375, DOI 10.1016/0005-2760(82)90256-9; Jimenez M, 2003, EUR J BIOCHEM, V270, P699, DOI 10.1046/j.1432-1033.2003.03422.x; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE768, DOI 10.1152/ajpendo.1996.270.5.E768; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE776, DOI 10.1152/ajpendo.1996.270.5.E776; Koza RA, 2000, J BIOL CHEM, V275, P34486, DOI 10.1074/jbc.M002136200; Kunikata T, 2002, DIGEST DIS SCI, V47, P894, DOI 10.1023/A:1014725024519; LEAN MEJ, 1986, INT J OBESITY, V10, P219; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503; Madsen L, 2008, J BIOL CHEM, V283, P7196, DOI 10.1074/jbc.M707775200; Mercader J, 2009, AM J PHYSIOL-ENDOC M, V297, pE184, DOI 10.1152/ajpendo.00163.2009; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Muller-Decker K, 2002, J INVEST DERMATOL, V119, P1189, DOI 10.1046/j.1523-1747.2002.19501.x; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Nolan MA, 2004, MOL ENDOCRINOL, V18, P2302, DOI 10.1210/me.2004-0194; Oberkofler H, 1997, J LIPID RES, V38, P2125; Petersen RK, 2003, J LIPID RES, V44, P2320, DOI 10.1194/jlr.M300192-JLR200; PETROVIC N, 2009, J BIOL CHEM      DEC; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sakuma Y, 2000, INFECT IMMUN, V68, P6819, DOI 10.1128/IAI.68.12.6819-6825.2000; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Semple RK, 2004, INT J OBESITY, V28, P176, DOI 10.1038/sj.ijo.0802482; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; Strom K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001793; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; USHIKUBI F, 1995, J LIPID MEDIAT CELL, V12, P343, DOI 10.1016/0929-7855(95)00022-I; VASSAUX G, 1992, ENDOCRINOLOGY, V131, P2393, DOI 10.1210/en.131.5.2393; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Watson PM, 2000, AM J PHYSIOL-ENDOC M, V279, pE356, DOI 10.1152/ajpendo.2000.279.2.E356; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	60	155	164	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11391	10.1371/journal.pone.0011391	http://dx.doi.org/10.1371/journal.pone.0011391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613988	Green Submitted, Green Published, gold			2022-12-25	WOS:000279370000020
J	Rogers, C; Guo, ZH; Stiller, JW				Rogers, Carlyle; Guo, Zhenhua; Stiller, John W.			Connecting Mutations of the RNA Polymerase II C-Terminal Domain to Complex Phenotypic Changes Using Combined Gene Expression and Network Analyses	PLOS ONE			English	Article							GDP-MANNOSE PYROPHOSPHORYLASE; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; CHROMOSOME SEGREGATION; LARGEST SUBUNIT; YEAST MEDIATOR; DNA-REPAIR; PROTEINS; CTD; RECOMBINATION	The C-terminal domain (CTD) of the largest subunit in DNA-dependent RNA polymerase II (RNAP II) is essential for mRNA synthesis and processing, through coordination of an astounding array of protein-protein interactions. Not surprisingly, CTD mutations can have complex, pleiotropic impacts on phenotype. For example, insertions of five alanine residues between CTD diheptads in yeast, which alter the CTD's overall tandem structure and physically separate core functional units, dramatically reduce growth rate and result in abnormally large cells that accumulate increased DNA content over time. Patterns by which specific CTD-protein interactions are disrupted by changes in CTD structure, as well as how downstream metabolic pathways are impacted, are difficult to target for direct experimental analyses. In an effort to connect an altered CTD to complex but quantifiable phenotypic changes, we applied network analyses of genes that are differentially expressed in our five alanine CTD mutant, combined with established genetic interactions from the Saccharomyces cerevisiae Genome Database (SGD). We were able to identify candidate genetic pathways, and several key genes, that could explain how this change in CTD structure leads to the specific phenotypic changes observed. These hypothetical networks identify links between CTD-associated proteins and mitotic function, control of cell cycle checkpoint mechanisms, and expression of cell wall and membrane components. Such results can help to direct future genetic and biochemical investigations that tie together the complex impacts of the CTD on global cellular metabolism.	[Rogers, Carlyle; Stiller, John W.] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Guo, Zhenhua] Chinese Acad Sci, Kunming Inst Bot, Kunming, Peoples R China	University of North Carolina; East Carolina University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Rogers, C (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	acr1002@ecu.edu		Stiller, John/0000-0002-0668-8243	National Science Foundation [MCB0133295]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grant MCB0133295. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON LA, 1988, MOL CELL BIOL, V8, P321, DOI 10.1128/MCB.8.1.321; Ashkenazi M, 2008, BIOINFORMATICS, V24, P1465, DOI 10.1093/bioinformatics/btn208; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; BARTOLOMEI MS, 1988, MOL CELL BIOL, V8, P330, DOI 10.1128/MCB.8.1.330; Bennett CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001448; Bertuch AA, 2003, GENE DEV, V17, P2347, DOI 10.1101/gad.1146603; Biddick R, 2005, CR BIOL, V328, P773, DOI 10.1016/j.crvi.2005.03.004; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; BROWN MT, 1993, J CELL BIOL, V123, P387, DOI 10.1083/jcb.123.2.387; CHEN J, 1989, P NATL ACAD SCI USA, V86, P7961, DOI 10.1073/pnas.86.20.7961; CORDEN JL, 1990, TRENDS BIOCHEM SCI, V15, P383, DOI 10.1016/0968-0004(90)90236-5; de Almeida SF, 2008, FEBS LETT, V582, P1971, DOI 10.1016/j.febslet.2008.04.019; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; Euskirchen GM, 2002, EUKARYOT CELL, V1, P229, DOI 10.1128/EC.1.2.229-240.2002; Farr KA, 1998, MOL CELL BIOL, V18, P2738, DOI 10.1128/MCB.18.5.2738; Guo ZH, 2005, MOL BIOL EVOL, V22, P2166, DOI 10.1093/molbev/msi215; Han SJ, 1999, MOL CELL BIOL, V19, P979; Hashimoto H, 1997, J BIOL CHEM, V272, P16308, DOI 10.1074/jbc.272.26.16308; Howe KJ, 2002, BBA-GENE STRUCT EXPR, V1577, P308, DOI 10.1016/S0167-4781(02)00460-8; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KATO R, 1994, NUCLEIC ACIDS RES, V22, P3104, DOI 10.1093/nar/22.15.3104; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Liu PD, 2008, MOL BIOL EVOL, V25, P719, DOI 10.1093/molbev/msn017; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marquez MG, 2000, CYTOMETRY, V41, P115, DOI 10.1002/1097-0320(20001001)41:2<115::AID-CYTO6>3.3.CO;2-X; Milne DM, 2001, EXP CELL RES, V263, P43, DOI 10.1006/excr.2000.5100; Nair D, 2005, J BIOL CHEM, V280, P33739, DOI 10.1074/jbc.M506067200; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Ren Q, 2008, COMP FUNCT GENOM, DOI 10.1155/2008/634283; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stiller JW, 2004, EUKARYOT CELL, V3, P735, DOI 10.1128/EC.3.3.735-740.2004; Stiller JW, 2002, P NATL ACAD SCI USA, V99, P6091, DOI 10.1073/pnas.082646199; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; STUART D, 1995, GENE DEV, V9, P2780, DOI 10.1101/gad.9.22.2780; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tanaka TU, 2005, NAT REV MOL CELL BIO, V6, P929, DOI 10.1038/nrm1764; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; VANBAKEL H, 2007, TUTORIAL DNA MICROAR; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; WEST ML, 1995, GENETICS, V140, P1223; Wolfger H, 2004, J BIOL CHEM, V279, P11593, DOI 10.1074/jbc.M311282200; XIAO ZX, 1993, MOL CELL BIOL, V13, P4691, DOI 10.1128/MCB.13.8.4691; Xu YX, 2007, GENE DEV, V21, P2950, DOI 10.1101/gad.1592807; Xu YX, 2007, MOL CELL, V26, P287, DOI 10.1016/j.molcel.2007.03.020; Yoda K, 2000, BIOSCI BIOTECH BIOCH, V64, P1937, DOI 10.1271/bbb.64.1937; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zhu Y, 2004, NUCLEIC ACIDS RES, V32, P5066, DOI 10.1093/nar/gkh838	53	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11386	10.1371/journal.pone.0011386	http://dx.doi.org/10.1371/journal.pone.0011386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613981	gold, Green Published, Green Submitted			2022-12-25	WOS:000279370000015
J	Woodard, LE; Keravala, A; Jung, WE; Wapinski, OL; Yang, QW; Felsher, DW; Calos, MP				Woodard, Lauren E.; Keravala, Annahita; Jung, W. Edward; Wapinski, Orly L.; Yang, Qiwei; Felsher, Dean W.; Calos, Michele P.			Impact of Hydrodynamic Injection and phiC31 Integrase on Tumor Latency in a Mouse Model of MYC-Induced Hepatocellular Carcinoma	PLOS ONE			English	Article							PHAGE PHI-C31 INTEGRASE; GENE-THERAPY; CHROMOSOMAL REARRANGEMENTS; INDUCED TUMORIGENESIS; GENOMIC INTEGRATION; VECTOR INTEGRATION; MAMMALIAN-CELLS; PLASMID DNA; C-MYC; DELIVERY	Background: Hydrodynamic injection is an effective method for DNA delivery in mouse liver and is being translated to larger animals for possible clinical use. Similarly, phi C31 integrase has proven effective in mediating long-term gene therapy in mice when delivered by hydrodynamic injection and is being considered for clinical gene therapy applications. However, chromosomal aberrations have been associated with phi C31 integrase expression in tissue culture, leading to questions about safety. Methodology/Principal Findings: To study whether hydrodynamic delivery alone, or in conjunction with delivery of phi C31 integrase for long-term transgene expression, could facilitate tumor formation, we used a transgenic mouse model in which sustained induction of the human C-MYC oncogene in the liver was followed by hydrodynamic injection. Without injection, mice had a median tumor latency of 154 days. With hydrodynamic injection of saline alone, the median tumor latency was significantly reduced, to 105 days. The median tumor latency was similar, 106 days, when a luciferase donor plasmid and backbone plasmid without integrase were administered. In contrast, when active or inactive phi C31 integrase and donor plasmid were supplied to the mouse liver, the median tumor latency was 153 days, similar to mice receiving no injection. Conclusions/Significance: Our data suggest that phi C31 integrase does not facilitate tumor formation in this C-MYC transgenic mouse model. However, in groups lacking phi C31 integrase, hydrodynamic injection appeared to contribute to C-MYC-induced hepatocellular carcinoma in adult mice. Although it remains to be seen to what extent these findings may be extrapolated to catheter-mediated hydrodynamic delivery in larger species, they suggest that caution should be used during translation of hydrodynamic injection to clinical applications.	[Woodard, Lauren E.; Keravala, Annahita; Jung, W. Edward; Wapinski, Orly L.; Calos, Michele P.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Yang, Qiwei; Felsher, Dean W.] Stanford Univ, Dept Med, Sch Med, Div Oncol, Stanford, CA 94305 USA	Stanford University; Stanford University	Woodard, LE (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	calos@stanford.edu			PHS [CA09302]; National Cancer Institute, DHHS; NIH [HL068112, CA89305-01A1, CA034233]; NATIONAL CANCER INSTITUTE [T32CA009302, P01CA034233, R01CA089305] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL068112, R01HL068112] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	PHS Grant Number CA09302, awarded by the National Cancer Institute, DHHS, www.cancer.gov. Amgen Scholars Program through the Stanford Summer Research Program, www.amgenscholars.eu. NIH grant HL068112 to MPC, www.nih.gov. NIH grants CA89305-01A1 and CA034233 to DWF, www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouElella A, 1996, MODERN PATHOL, V9, P95; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; Beer S, 2010, MOL THER, V18, P161, DOI 10.1038/mt.2009.222; Beer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002493; Bertoni C, 2006, P NATL ACAD SCI USA, V103, P419, DOI 10.1073/pnas.0504505102; Calos MP, 2006, CURR GENE THER, V6, P633, DOI 10.2174/156652306779010642; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; Chavez CL, 2010, HUM GENE THER, V21, P1287, DOI 10.1089/hum.2010.049; Chen JZ, 2006, NUCLEIC ACIDS RES, V34, P6298, DOI 10.1093/nar/gkl890; Donaldson TD, 2004, CURR BIOL, V14, pR425, DOI 10.1016/j.cub.2004.05.035; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Ehrhardt A, 2005, MOL THER, V11, P695, DOI 10.1016/j.ymthe.2005.01.010; Ehrhardt A, 2006, HUM GENE THER, V17, P1077, DOI 10.1089/hum.2006.17.1077; Fabre JW, 2008, GENE THER, V15, P452, DOI 10.1038/sj.gt.3303079; Felsher Dean W., 2008, Lymphatic Research and Biology, V6, P149, DOI 10.1089/lrb.2008.63403; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Held PK, 2005, MOL THER, V11, P399, DOI 10.1016/j.ymthe.2004.11.001; Kamimura K, 2009, MOL THER, V17, P491, DOI 10.1038/mt.2008.294; Kawate S, 1999, ONCOLOGY-BASEL, V57, P157, DOI 10.1159/000012024; Keravala A, 2009, MOL THER, V17, P112, DOI 10.1038/mt.2008.241; Khorsandi SE, 2008, CANCER GENE THER, V15, P225, DOI 10.1038/sj.cgt.7701119; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu J, 2006, GENE THER, V13, P1188, DOI 10.1038/sj.gt.3302789; Liu J, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-31; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; Portlock JL, 2006, HUM GENE THER, V17, P871, DOI 10.1089/hum.2006.17.871; Ryu BY, 2008, BLOOD, V111, P1866, DOI 10.1182/blood-2007-04-085506; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Shou Y, 2006, P NATL ACAD SCI USA, V103, P11730, DOI 10.1073/pnas.0603635103; Sivalingam J, 2010, MOL THER, V18, P1346, DOI 10.1038/mt.2010.61; Suda T, 2008, MOL THER, V16, P1098, DOI 10.1038/mt.2008.66; Suda T, 2009, HEPATOL RES, V39, P325, DOI 10.1111/j.1872-034X.2008.00479.x; Themis M, 2005, MOL THER, V12, P763, DOI 10.1016/j.ymthe.2005.07.358; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Thyagarajan Haskar, 2005, V308, P99; Tward AD, 2007, P NATL ACAD SCI USA, V104, P14771, DOI 10.1073/pnas.0706578104; Wang BY, 2010, MOL BIOL REP, V37, P2809, DOI 10.1007/s11033-009-9829-3; Woodard LE, 2010, GENE THER, V17, P217, DOI 10.1038/gt.2009.136; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	42	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11367	10.1371/journal.pone.0011367	http://dx.doi.org/10.1371/journal.pone.0011367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20614008	Green Submitted, Green Published, gold			2022-12-25	WOS:000279369900016
J	Bhardwaj, A; Leelavathi, S; Mazumdar-Leighton, S; Ghosh, A; Ramakumar, S; Reddy, VS				Bhardwaj, Amit; Leelavathi, Sadhu; Mazumdar-Leighton, Sudeshna; Ghosh, Amit; Ramakumar, Suryanarayanarao; Reddy, Vanga S.			The Critical Role of N- and C-Terminal Contact in Protein Stability and Folding of a Family 10 Xylanase under Extreme Conditions	PLOS ONE			English	Article							ALKALI-THERMOSTABLE XYLANASE; CATION-PI INTERACTIONS; STRUCTURAL BASIS; STABILIZATION CENTERS; HYDROPHOBIC RESIDUES; THERMAL-STABILITY; SEQUENCE-ANALYSIS; BARREL PROTEINS; SWISS-MODEL; CLONING	Background: Stabilization strategies adopted by proteins under extreme conditions are very complex and involve various kinds of interactions. Recent studies have shown that a large proportion of proteins have their N- and C-terminal elements in close contact and suggested they play a role in protein folding and stability. However, the biological significance of this contact remains elusive. Methodology: In the present study, we investigate the role of N- and C-terminal residue interaction using a family 10 xylanase (BSX) with a TIM-barrel structure that shows stability under high temperature, alkali pH, and protease and SDS treatment. Based on crystal structure, an aromatic cluster was identified that involves Phe4, Trp6 and Tyr343 holding the Nand C-terminus together; this is a unique and important feature of this protein that might be crucial for folding and stability under poly-extreme conditions. Conclusion: A series of mutants was created to disrupt this aromatic cluster formation and study the loss of stability and function under given conditions. While the deletions of Phe4 resulted in loss of stability, removal of Trp6 and Tyr343 affected in vivo folding and activity. Alanine substitution with Phe4, Trp6 and Tyr343 drastically decreased stability under all parameters studied. Importantly, substitution of Phe4 with Trp increased stability in SDS treatment. Mass spectrometry results of limited proteolysis further demonstrated that the Arg344 residue is highly susceptible to trypsin digestion in sensitive mutants such as DF4, W6A and Y343A, suggesting again that disruption of the Phe4-Trp6-Tyr343 (F-W-Y) cluster destabilizes the N- and C-terminal interaction. Our results underscore the importance of N- and C-terminal contact through aromatic interactions in protein folding and stability under extreme conditions, and these results may be useful to improve the stability of other proteins under suboptimal conditions.	[Bhardwaj, Amit; Leelavathi, Sadhu; Reddy, Vanga S.] Int Ctr Genet Engn & Biotechnol, New Delhi, India; [Bhardwaj, Amit; Mazumdar-Leighton, Sudeshna] Univ Delhi, Dept Bot, Delhi 110007, India; [Ghosh, Amit] Natl Inst Cholera & Enter Dis, Kolkata, India; [Ramakumar, Suryanarayanarao] Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India; [Ramakumar, Suryanarayanarao] Indian Inst Sci, Bioinformat Ctr, Bangalore 560012, Karnataka, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Bhardwaj, A (corresponding author), Int Ctr Genet Engn & Biotechnol, New Delhi, India.	vsreddy@icgeb.res.in	Ghosh, Amit/AAB-3140-2019; Bhardwaj, Amit/AAZ-7110-2020; Bhardwaj, Amit/AAC-5393-2020	Bhardwaj, Amit/0000-0002-0172-2027; Bhardwaj, Amit/0000-0002-0172-2027	International Centre for Genetic Engineering and Biotechnology, New Delhi; Department of Biotechnology (DBT), Government of India	International Centre for Genetic Engineering and Biotechnology, New Delhi; Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This work was supported by funds from the International Centre for Genetic Engineering and Biotechnology, New Delhi and the Department of Biotechnology (DBT), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharadwaj A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003063; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang PC, 2004, BIOCHEM BIOPH RES CO, V319, P1017, DOI 10.1016/j.bbrc.2004.05.078; CHOU KC, 1991, PROTEINS, V9, P280, DOI 10.1002/prot.340090406; Dosztanyi Z, 1997, J MOL BIOL, V272, P597, DOI 10.1006/jmbi.1997.1242; Dosztanyi Z, 2003, BIOINFORMATICS, V19, P899, DOI 10.1093/bioinformatics/btg110; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Funahashi J, 2000, BIOCHEMISTRY-US, V39, P14448, DOI 10.1021/bi0015717; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Georis J, 2000, PROTEIN SCI, V9, P466; Gromiha MM, 2004, PROTEINS, V55, P316, DOI 10.1002/prot.20052; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta N, 2000, APPL ENVIRON MICROB, V66, P2631, DOI 10.1128/AEM.66.6.2631-2635.2000; Harris GW, 1997, PROTEINS, V29, P77, DOI 10.1002/(SICI)1097-0134(199709)29:1<77::AID-PROT6>3.3.CO;2-K; Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2; HUGHSON FM, 1990, SCIENCE, V249, P1544, DOI 10.1126/science.2218495; Ihsanawati, 2005, PROTEINS, V61, P999, DOI 10.1002/prot.20700; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753; Kay MS, 1999, P NATL ACAD SCI USA, V96, P2007, DOI 10.1073/pnas.96.5.2007; Knochel T, 2002, J BIOL CHEM, V277, P8626, DOI 10.1074/jbc.M109517200; Krishna MMG, 2005, P NATL ACAD SCI USA, V102, P1053, DOI 10.1073/pnas.0409114102; LESK AM, 1989, PROTEINS, V5, P139, DOI 10.1002/prot.340050208; LUGER K, 1989, SCIENCE, V243, P206, DOI 10.1126/science.2643160; Machius M, 2003, J BIOL CHEM, V278, P11546, DOI 10.1074/jbc.M212618200; Mamo G, 2006, MOL BIOTECHNOL, V33, P149; Manikandan K, 2005, ACTA CRYSTALLOGR F, V61, P747, DOI 10.1107/S1744309105020518; Manikandan K, 2006, PROTEIN SCI, V15, P1951, DOI 10.1110/ps.062220206; Meyer EL, 2003, J BIOL CHEM, V278, P23786, DOI 10.1074/jbc.M301360200; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; PAKULA AA, 1990, NATURE, V344, P363, DOI 10.1038/344363a0; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Peng BH, 2003, J BIOL CHEM, V278, P49644, DOI 10.1074/jbc.M302782200; Perl D, 2000, NAT STRUCT BIOL, V7, P380; Prajapati RS, 2006, BIOCHEMISTRY-US, V45, P15000, DOI 10.1021/bi061275f; Puchkaev AV, 2003, ARCH BIOCHEM BIOPHYS, V409, P52, DOI 10.1016/S0003-9861(02)00402-2; Rodriguez HM, 2000, PROTEIN SCI, V9, P1993, DOI 10.1110/ps.9.10.1993; Rodriguez J, 2008, J PROTEOME RES, V7, P300, DOI 10.1021/pr0705035; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schindler T, 1998, PROTEINS, V30, P401, DOI 10.1002/(SICI)1097-0134(19980301)30:4<401::AID-PROT7>3.3.CO;2-G; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Selvaraj S, 1998, J PROTEIN CHEM, V17, P407, DOI 10.1023/A:1022514400583; TABERNERO C, 1995, APPL ENVIRON MICROB, V61, P2420, DOI 10.1128/AEM.61.6.2420-2424.1995; Tanford C., 1991, HYDROPHOBIC EFFECT F, V2nd; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Wang L, 1998, PROTEIN SCI, V7, P2460, DOI 10.1002/pro.5560071124; Watanabe K, 1997, J MOL BIOL, V269, P142, DOI 10.1006/jmbi.1997.1018; WILMANNS M, 1992, J MOL BIOL, V223, P477, DOI 10.1016/0022-2836(92)90665-7; Xie HF, 2006, J MOL BIOL, V360, P157, DOI 10.1016/j.jmb.2006.05.002; Yamaguchi A, 2005, J BIOCHEM, V137, P587, DOI 10.1093/jb/mvi078	50	40	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11347	10.1371/journal.pone.0011347	http://dx.doi.org/10.1371/journal.pone.0011347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596542	Green Submitted, Green Published, gold			2022-12-25	WOS:000279259900018
J	Balogh, Z; Lautner, G; Bardoczy, V; Komorowska, B; Gyurcsanyi, RE; Meszaros, T				Balogh, Zsofia; Lautner, Gergely; Bardoczy, Viola; Komorowska, Beata; Gyurcsanyi, Robert. E.; Meszaros, Tamas			Selection and versatile application of virus-specific aptamers	FASEB JOURNAL			English	Article						DOS-ELONA; SELEX; immunoblot; virus coat protein	QUADRUPLEX STRUCTURE; DNA APTAMERS; PROTEIN; EVOLUTION; ANTIGEN	Although the significance of molecular diagnostics in routine plant virus detection is rapidly growing, the preferred methods are still antibody-based enzyme immunoassays. In the past decade, aptamers have been demonstrated to be viable alternatives of antibodies in many applications. We set out to select apple stem pitting virus (ASPV)-specific aptamers and to apply them as antibody substitutes in various immunoassay methods. The applied systematic evolution of ligands by exponential enrichment (SELEX) procedure resulted in highly discriminative aptamers selectively binding to the target virus coat protein even in complex protein matrixes. We developed protocols for exploitation of aptamers in diverse plant virus diagnosis methods, such as dot and Western blot analyses and enzyme-linked oligonucleotide assay (ELONA). Our selected aptamers proved to be superior to the available antibody in all aspects. In contrast to the antibody, the aptamers decorate both native and denaturated proteins, and ELONA produces higher signal intensity than traditional enzyme-linked immunosorbent assay (ELISA) with virus-infected plant extract. Summarily, our results present the selection and practical utilization of first plant virus-specific aptamers. Most important, the first application of ELONA for virus detection is demonstrated, which proposes a novel, more flexible, and cost-effective means of virus diagnostics.-Balogh, Z., Lautner, G., Bardoczy, V., Komorowska, B., Gyurcsanyi, R. E., Meszaros, T. Selection and versatile application of virus-specific aptamers. FASEB J. 24, 4187-4195 (2010). www.fasebj.org	[Balogh, Zsofia; Meszaros, Tamas] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1094 Budapest, Hungary; [Lautner, Gergely; Gyurcsanyi, Robert. E.] Budapest Univ Technol & Econ, Dept Inorgan & Analyt Chem, H-1117 Budapest, Hungary; [Bardoczy, Viola] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, H-1117 Budapest, Hungary; [Komorowska, Beata] Res Inst Pomol & Floriculture, Skierniewice, Poland; [Gyurcsanyi, Robert. E.; Meszaros, Tamas] Hungarian Acad Sci, Res Grp Tech Analyt Chem, Budapest, Hungary	Semmelweis University; Budapest University of Technology & Economics; Budapest University of Technology & Economics; Hungarian Academy of Sciences	Meszaros, T (corresponding author), Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Tuzolto U 37-47, H-1094 Budapest, Hungary.	tamas.meszaros@eok.sote.hu	Lautner, Gergely/F-7150-2010; Meszaros, Tamas/A-9647-2014; Komorowska, Beata/U-9022-2018; Gyurcsányi, Róbert E./ABD-6643-2021; Gyurcsanyi, Robert/F-5865-2010	Meszaros, Tamas/0000-0002-7396-9678; Komorowska, Beata/0000-0002-0093-3842; Gyurcsanyi, Robert/0000-0002-9929-7865	Hungarian Scientific Fund OTKA [NF 69262]; NKTH-OTKA [K68161]; Bolyai Janos Fellowship	Hungarian Scientific Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NKTH-OTKA(National Office for Research and TechnologyOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Janos Fellowship(Hungarian Academy of Sciences)	The authors thank Wilhelm Jelkmann (Julius Kuehn Institute-Federal Research Center for Cultivated Plants, Institute for Plant Protection in Fruit Crops and Viticulture, Dossenheim, Germany) for kindly providing PSA-H-infected plants. This work was supported by the Hungarian Scientific Fund OTKA (NF 69262) and NKTH-OTKA (K68161). T.M. gratefully acknowledges the support of the Bolyai Janos Fellowship.	Ahn DG, 2009, ANALYST, V134, P1896, DOI 10.1039/b906788d; Balamurugan S, 2008, ANAL CHEM, V80, P9630, DOI 10.1021/ac8009559; Baldrich E, 2004, ANAL CHEM, V76, P7053, DOI 10.1021/ac049258o; Bonhoeffer S, 2002, NATURE, V420, P367, DOI 10.1038/420367a; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; CAMERON HR, 1989, VIRUS VIRUSLIKE DIS, P175; Charlton B, 2009, COMP IMMUNOL MICROB, V32, P341, DOI 10.1016/j.cimid.2008.01.009; Chen F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006830; Croft H, 2008, J VIROL METHODS, V153, P203, DOI 10.1016/j.jviromet.2008.07.016; Dausse E, 2009, CURR OPIN PHARMACOL, V9, P602, DOI 10.1016/j.coph.2009.07.006; Dougan H, 2000, NUCL MED BIOL, V27, P289, DOI 10.1016/S0969-8051(99)00103-1; Drolet DW, 1996, NAT BIOTECHNOL, V14, P1021, DOI 10.1038/nbt0896-1021; Ferreira CSM, 2008, ANAL BIOANAL CHEM, V390, P1039, DOI 10.1007/s00216-007-1470-1; Gatto B, 2009, CURR MED CHEM, V16, P1248, DOI 10.2174/092986709787846640; Gopinath SCB, 2006, J GEN VIROL, V87, P479, DOI 10.1099/vir.0.81508-0; Gopinath SCB, 2007, ANAL BIOANAL CHEM, V387, P171, DOI 10.1007/s00216-006-0826-2; Gugerli P, 2004, ACTA HORTIC, P59, DOI 10.17660/ActaHortic.2004.657.6; Hudson PJ, 2003, NAT MED, V9, P129, DOI 10.1038/nm0103-129; Ikebukuro K, 2004, ANAL LETT, V37, P2901, DOI 10.1081/AL-200035778; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Jones LA, 2006, ANTIMICROB AGENTS CH, V50, P3019, DOI 10.1128/AAC.01603-05; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Klerks MM, 2001, PHYTOPATHOLOGY, V91, P1085, DOI 10.1094/PHYTO.2001.91.11.1085; Komorowska B, 2010, J VIROL METHODS, V168, P242, DOI 10.1016/j.jviromet.2010.04.024; KUMMERT J, 2004, ACTA HORT ISHS, V657, P541; KUMMERT J, 1998, ACTA HORTIC, V472, P97; Lautner G, 2010, ANALYST, V135, P918, DOI 10.1039/b922829b; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; MacKenzie DJ, 1997, PLANT DIS, V81, P222, DOI 10.1094/PDIS.1997.81.2.222; Mairal T, 2008, ANAL BIOANAL CHEM, V390, P989, DOI 10.1007/s00216-007-1346-4; Martelli GP, 1998, ARCH VIROL, V143, P1245, DOI 10.1007/s007050050372; Murphy MB, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng110; Nadala ECB, 2000, J VIROL METHODS, V84, P175, DOI 10.1016/S0166-0934(99)00140-8; NEMETH M, 1986, VIRUS MYCOPLASMA RIC, P216; NIVISON T, 1987, PLANT MOL BIOL REP, V5, P295; Papamichael KI, 2007, SENSOR ACTUAT B-CHEM, V121, P178, DOI 10.1016/j.snb.2006.09.024; Reina J, 2002, J CLIN MICROBIOL, V40, P3515, DOI 10.1128/JCM.40.9.3515-3517.2002; ROSENTHAL A, 1993, NUCLEIC ACIDS RES, V21, P173, DOI 10.1093/nar/21.1.173; Skottrup PD, 2008, BIOSENS BIOELECTRON, V24, P339, DOI 10.1016/j.bios.2008.06.045; Takahashi M, 2005, J CLIN MICROBIOL, V43, P186, DOI 10.1128/JCM.43.1.186-191.2005; Thompson RL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000352; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vivekananda J, 2006, LAB INVEST, V86, P610, DOI 10.1038/labinvest.3700417; YOSHIKAWA N, 2001, ACTA HORTIC ISHS, V1, P285	44	33	37	0	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4187	4195		10.1096/fj.09-144246	http://dx.doi.org/10.1096/fj.09-144246			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20624933				2022-12-25	WOS:000283861100007
J	Tago, K; Funakoshi-Tago, M; Sakinawa, M; Mizuno, N; Itoh, H				Tago, Kenji; Funakoshi-Tago, Megumi; Sakinawa, Masaki; Mizuno, Norikazu; Itoh, Hiroshi			kappa B-Ras Is a Nuclear-Cytoplasmic Small GTPase That Inhibits NF-kappa B Activation through the Suppression of Transcriptional Activation of p65/RelA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-1 MSK1; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; MOLECULAR SWITCH; ARF6 RECRUITS; BINDING; P65; STIMULATION; ONCOGENES; SUBUNIT	NF-kappa B is an important transcription factor involved in various biological responses, including inflammation, cell differentiation, and tumorigenesis. kappa B-Ras was identified as an I kappa B-interacting small GTPase and is reported to disturb cytokine-induced NF-kappa B activation. In this study, we established that kappa B-Ras is a novel type of nuclear-cytoplasmic small GTPase that mainly binds to GTP, and its localization seemed to be regulated by its GTP/GDP-binding state. Unexpectedly, the GDP-binding form of the kappa B-Ras mutant exhibited a more potent inhibitory effect on NF-kappa B activation, and this inhibitory effect seemed to be due to suppression of the transactivation of a p65/RelA NF-kappa B subunit. kappa B-Ras suppressed phosphorylation at serine 276 on the p65/RelA subunit, resulting in decreased interaction between p65/RelA and the transcriptional coactivator p300. Interestingly, the GDP-bound kappa B-Ras mutant exhibited higher interactive affinity with p65/RelA and inhibited the phosphorylation of p65/RelA more potently than wild-type kappa B-Ras. Taken together, these findings suggest that the GDP-bound form of kappa B-Ras in cytoplasm suppresses NF-kappa B activation by inhibiting its transcriptional activation.	[Tago, Kenji; Sakinawa, Masaki; Mizuno, Norikazu; Itoh, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Cell Biol, Lab Signal Transduct, Nara 6300192, Japan; [Funakoshi-Tago, Megumi] Keio Univ, Fac Pharm, Dept Biochem, Minato Ku, Tokyo 1058512, Japan	Nara Institute of Science & Technology; Keio University	Tago, K (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Cell Biol, Lab Signal Transduct, 8916-5 Takayama, Nara 6300192, Japan.	ktago@bs.naist.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [20770103]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research 20770103 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	BOS JL, 1989, CANCER RES, V49, P4682; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Chen Y, 2004, MOL CELL BIOL, V24, P3048, DOI 10.1128/MCB.24.7.3048-3056.2004; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cox AD, 2002, CANCER BIOL THER, V1, P599, DOI 10.4161/cbt.306; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; DOBRZANSKI P, 1993, MOL CELL BIOL, V13, P1572, DOI 10.1128/MCB.13.3.1572; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Fenwick C, 2000, SCIENCE, V287, P869, DOI 10.1126/science.287.5454.869; Funakoshi-Tago M, 2008, BIOCHEM PHARMACOL, V76, P662, DOI 10.1016/j.bcp.2008.06.015; Furusawa JI, 2009, CELL SIGNAL, V21, P778, DOI 10.1016/j.cellsig.2009.01.021; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gao N, 2008, J BIOL CHEM, V283, P7834, DOI 10.1074/jbc.M710285200; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; GIBBS JB, 1990, J BIOL CHEM, V265, P20437; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; JOHN J, 1993, J BIOL CHEM, V268, P923; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; Koo TH, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-29; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; NEUMANN M, 1995, EMBO J, V14, P1991, DOI 10.1002/j.1460-2075.1995.tb07191.x; Pacifico F, 2006, BIOCHEM PHARMACOL, V72, P1142, DOI 10.1016/j.bcp.2006.07.032; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; QIU MS, 1991, NEURON, V7, P937, DOI 10.1016/0896-6273(91)90339-2; SATOH T, 1992, J BIOL CHEM, V267, P25423; SATOH T, 1992, J BIOL CHEM, V267, P24149; SATOH T, 1990, P NATL ACAD SCI USA, V87, P7926, DOI 10.1073/pnas.87.20.7926; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Sonoda Y, 1997, J BIOL CHEM, V272, P15366, DOI 10.1074/jbc.272.24.15366; Takahashi N, 2002, EUR J BIOCHEM, V269, P4559, DOI 10.1046/j.1432-1033.2002.03157.x; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; TORTI M, 1992, J BIOL CHEM, V267, P8293; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Weih DS, 2001, J IMMUNOL, V167, P1909, DOI 10.4049/jimmunol.167.4.1909; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	45	17	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30622	30633		10.1074/jbc.M110.117028	http://dx.doi.org/10.1074/jbc.M110.117028			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20639196	Green Published, hybrid			2022-12-25	WOS:000282135500031
J	Crespo, PM; Demichelis, VT; Daniotti, JL				Crespo, Pilar M.; Torres Demichelis, Vanina; Daniotti, Jose L.			Neobiosynthesis of Glycosphingolipids by Plasma Membrane-associated Glycosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR PHOSPHORYLATION; TRANS-GOLGI NETWORK; ANCHORED PROTEINS; APICAL SURFACE; GANGLIOSIDE; CELLS; GD3; MODULATION; SYNTHASE; MOUSE	Gangliosides, complex glycosphingolipids containing sialic acids, are synthesized in the endoplasmic reticulum and in the Golgi complex. These neobiosynthesized gangliosides move via vesicular transport to the plasma membrane, becoming components of the external leaflet. Gangliosides can undergo endocytosis followed by recycling to the cell surface or sorting to the Golgi complex or lysosomes for remodeling and catabolism. Recently, glycosphingolipid catabolic enzymes (glycohydrolases) have been found to be associated with the plasma membrane, where they display activity on the membrane components. In this work, we demonstrated that ecto-ganglioside glycosyltransferases may catalyze ganglioside synthesis outside the Golgi compartment, particularly at the cell surface. Specifically, we report the first direct evidence of expression and activity of CMP-NeuAc: GM3 sialyltransferase (Sial-T2) at the cell surface of epithelial and melanoma cells, with membrane-integrated ecto-Sial-T2 being able to sialylate endogenously synthesized GM3 ganglioside as well as exogenously incorporated substrate. Interestingly, we also showed that ecto-Sial-T2 was able to synthesize GD3 ganglioside at the cell surface using the endogenously synthesized cytidine monophospho-N-acetylneuraminic acid (CMP-NeuAc) available at the extracellular milieu. In addition, the expression of UDP-GalNAc: LacCer/GM3/GD3 N-acetylgalactosaminyltransferase (GalNAc-T) was also detected at the cell surface of epithelial cells, whose catalytic activity was only observed after feeding the cells with exogenous GM3 substrate. Thus, the relative interplay between the plasma membrane-associated glycosyltransferase and glycohydrolase activities, even when acting on a common substrate, emerges as a potential level of regulation of the local glycosphingolipid composition in response to different external and internal stimuli.	[Crespo, Pilar M.; Torres Demichelis, Vanina; Daniotti, Jose L.] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba, CONICET,CIQUIBIC,Dept Quim Biol, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Daniotti, JL (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba, CONICET,CIQUIBIC,Dept Quim Biol, Ciudad Univ,X5000HUA, RA-5000 Cordoba, Argentina.	daniotti@dqb.fcq.unc.edu.ar			Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina; CONICET (Argentina)	Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part by Grants from Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), and Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina.; <SUP>2</SUP>Recipient of CONICET (Argentina) Fellowships.; <SUP>3</SUP>Recipient of ANPCyT Fellowships.	Aureli M, 2009, FEBS LETT, V583, P2469, DOI 10.1016/j.febslet.2009.06.048; BEGOVAC PC, 1994, J BIOL CHEM, V269, P31793; COATES SW, 1980, J BIOL CHEM, V255, P9225; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Crespo PM, 2004, J BIOL CHEM, V279, P47610, DOI 10.1074/jbc.M407181200; Crespo PM, 2004, BIOCHEM J, V377, P561, DOI 10.1042/BJ20031016; Crespo PM, 2002, J BIOL CHEM, V277, P44731, DOI 10.1074/jbc.M204604200; Daniotti JL, 2000, J NEUROCHEM, V74, P1711, DOI 10.1046/j.1471-4159.2000.0741711.x; Daniotti JL, 2006, J CELL BIOCHEM, V99, P1442, DOI 10.1002/jcb.21034; DE MATTEIS MA, 2008, NAT REV MOL CELL BIO, V9, P273; DURRIE R, 1988, BIOCHEMISTRY-US, V27, P3759, DOI 10.1021/bi00410a036; Giraudo CG, 1999, BIOCHEM J, V342, P633, DOI 10.1042/0264-6021:3420633; Giraudo CG, 2001, P NATL ACAD SCI USA, V98, P1625, DOI 10.1073/pnas.031458398; Gross HJ, 1996, BLOOD, V87, P5113, DOI 10.1182/blood.V87.12.5113.bloodjournal87125113; Hakomori S, 1998, GLYCOBIOLOGY, V8, pXI; Iglesias-Bartolome R, 2006, FEBS J, V273, P1744, DOI 10.1111/j.1742-4658.2006.05194.x; Iglesias-Bartolome R, 2009, BBA-BIOMEMBRANES, V1788, P2526, DOI 10.1016/j.bbamem.2009.09.018; Iwamori M, 2005, GLYCOCONJUGATE J, V22, P119, DOI 10.1007/s10719-005-0363-9; Kean EL, 2004, BBA-GEN SUBJECTS, V1673, P56, DOI 10.1016/j.bbagen.2004.04.006; KOPITZ J, 1994, BIOCHEM BIOPH RES CO, V199, P1188, DOI 10.1006/bbrc.1994.1356; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Li RX, 2000, J BIOL CHEM, V275, P34213, DOI 10.1074/jbc.M906368199; Maccioni HJF, 1999, BBA-MOL CELL BIOL L, V1437, P101, DOI 10.1016/S1388-1981(99)00002-5; MARTIN OC, 1987, J BIOL CHEM, V262, P5890; Martina JA, 1998, J BIOL CHEM, V273, P3725, DOI 10.1074/jbc.273.6.3725; MATSUI Y, 1986, J NEUROCHEM, V46, P144, DOI 10.1111/j.1471-4159.1986.tb12937.x; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mencarelli S, 2005, FEBS LETT, V579, P5501, DOI 10.1016/j.febslet.2005.08.081; MILJAN EA, 2002, SCI STKE, pRE15; MILLER DJ, 1992, NATURE, V357, P589, DOI 10.1038/357589a0; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; PARSONS NJ, 1993, MICROB PATHOGENESIS, V14, P329, DOI 10.1006/mpat.1993.1032; PODBILEWICZ B, 1990, EMBO J, V9, P3477, DOI 10.1002/j.1460-2075.1990.tb07556.x; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; PRETI A, 1980, J NEUROCHEM, V35, P281, DOI 10.1111/j.1471-4159.1980.tb06263.x; Prinetti A, 2007, J NEUROCHEM, V103, P113, DOI 10.1111/j.1471-4159.2007.04714.x; Proia RL, 2003, PHILOS T R SOC B, V358, P879, DOI 10.1098/rstb.2003.1268; PUKEL CS, 1982, J EXP MED, V155, P1133, DOI 10.1084/jem.155.4.1133; Raychoudhury SS, 1997, BIOL REPROD, V56, P1268, DOI 10.1095/biolreprod56.5.1268; Saraste J, 2009, FEBS LETT, V583, P3804, DOI 10.1016/j.febslet.2009.10.084; Smalley KSM, 2001, BRIT J PHARMACOL, V132, P1102, DOI 10.1038/sj.bjp.0703896; Smith H, 1995, MICROB PATHOGENESIS, V19, P365, DOI 10.1006/mpat.1995.0071; Tettamanti G, 2003, GLYCOCONJUGATE J, V20, P301, DOI 10.1023/B:GLYC.0000033627.02765.cc; Troyanovsky RB, 2006, MOL BIOL CELL, V17, P3484, DOI 10.1091/mbc.E06-03-0190; Tveit H, 2009, TRAFFIC, V10, P1685, DOI 10.1111/j.1600-0854.2009.00984.x; Valaperta R, 2006, FASEB J, V20, P1227, DOI 10.1096/fj.05-5077fje; VAN MEER G, 2002, J BIOL CHEM, V277, P25855; VAN MEER G, 2000, BBA-MOL CELL BIOL L, V1486, P145; Yu RK, 2004, J LIPID RES, V45, P783, DOI 10.1194/jlr.R3000020-JLR200; Zhao W, 2006, J BIOL CHEM, V281, P31106, DOI 10.1074/jbc.M605564200; Zurita AR, 2001, BIOCHEM J, V355, P465, DOI 10.1042/0264-6021:3550465; Zurita AR, 2004, EUR J BIOCHEM, V271, P2428, DOI 10.1111/j.1432-1033.2004.04165.x	53	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29179	29190		10.1074/jbc.M110.123422	http://dx.doi.org/10.1074/jbc.M110.123422			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20639193	hybrid, Green Published			2022-12-25	WOS:000281740100018
J	Li, C; Tan, TW; Zhang, HY; Feng, W				Li, Cong; Tan, Tianwei; Zhang, Haiyang; Feng, Wei			Analysis of the Conformational Stability and Activity of Candida antarctica Lipase B in Organic Solvents INSIGHT FROM MOLECULAR DYNAMICS AND QUANTUM MECHANICS/SIMULATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNDAMENTAL PHYSICAL CONSTANTS; CODATA RECOMMENDED VALUES; SUBSTRATE-SPECIFICITY; SECONDARY ALCOHOLS; ENZYME; ENANTIOSELECTIVITY; MEDIA; WATER	The conformational stability and activity of Candida antarctica lipase B (CALB) in the polar and nonpolar organic solvents were investigated by molecular dynamics and quantum mechanics/molecular mechanics simulations. The conformation change of CALB in the polar and nonpolar solvents was examined in two aspects: the overall conformation change of CALB and the conformation change of the active site. The simulation results show that the overall conformation of CALB is stable in the organic solvents. In the nonpolar solvents, the conformation of the active site keeps stable, whereas in the polar solvents, the solvent molecules reach into the active site and interact intensively with the active site. This interaction destroys the hydrogen bonding between Ser(105) and His(224). In the solvents, the activation energy of CALB and that of the active site region were further simulated by quantum mechanics/molecular mechanics simulation. The results indicate that the conformation change in the region of active sites is the main factor that influences the activity of CALB.	[Li, Cong; Tan, Tianwei; Zhang, Haiyang; Feng, Wei] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing 100029, Peoples R China	Beijing University of Chemical Technology	Tan, TW (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing 100029, Peoples R China.	twtan@mail.buct.edu.cn; fengwei@mail.buct.edu.cn	Zhang, Haiyang/A-8413-2011; li, cong/X-4978-2019	Zhang, Haiyang/0000-0002-2410-7078	National Science Foundation of China [20636010]; National Basic Research Program of China [2007CB714304]; 863 Program [2009AA033001]; Program for New Century Excellent Talents in University	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Science Foundation of China Grant 20636010, National Basic Research Program of China Grant 2007CB714304, 863 Program Grant 2009AA033001, and the Program for New Century Excellent Talents in University.	[Anonymous], 2008, AMBER 10; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Carlqvist P, 2003, J MOL MODEL, V9, P164, DOI 10.1007/s00894-003-0128-y; Cherukuvada SL, 2005, PLOS COMPUT BIOL, V1, P182, DOI 10.1371/journal.pcbi.0010028; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Frisch G.W., 2016, GAUSSIAN 16 REVISION; Kirk O, 2002, ORG PROCESS RES DEV, V6, P446, DOI 10.1021/op0200165; LAANE C, 1987, BIOTECHNOL BIOENG, V30, P81, DOI 10.1002/bit.260300112; Lee J, 2000, J BIOMOL STRUCT DYN, V18, P297, DOI 10.1080/07391102.2000.10506667; Magnusson AO, 2005, CHEMBIOCHEM, V6, P1051, DOI 10.1002/cbic.200400410; Mohr PJ, 2000, REV MOD PHYS, V72, P351, DOI 10.1103/RevModPhys.72.351; Mohr PJ, 1999, J PHYS CHEM REF DATA, V28, P1713, DOI 10.1063/1.556049; NORIN M, 1994, BIOPHYS J, V67, P548, DOI 10.1016/S0006-3495(94)80515-6; OTTOSSON J, 2001, ENTHALPY ENTROPY ENZ, pP12; Pleiss J, 1998, CHEM PHYS LIPIDS, V93, P67, DOI 10.1016/S0009-3084(98)00030-9; Rotticci D, 2001, CHEMBIOCHEM, V2, P766, DOI 10.1002/1439-7633(20011001)2:10<766::AID-CBIC766>3.0.CO;2-K; RUSSELL AJ, 1989, BIOCHEM SOC T, V17, P1145, DOI 10.1042/bst0171145; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Speight J.G., 2004, LANGES HDB CHEM, V16th; STAHL M, 1991, J AM CHEM SOC, V113, P9366; STORER JW, 1995, J COMPUT AID MOL DES, V9, P87, DOI 10.1007/BF00117280; TAWAKI S, 1992, J AM CHEM SOC, V114, P1882, DOI 10.1021/ja00031a054; Tejo BA, 2004, J MOL MODEL, V10, P358, DOI 10.1007/s00894-004-0203-z; UPPENBERG J, 1994, STRUCTURE, V2, P293, DOI 10.1016/S0969-2126(00)00031-9; Uppenberg J, 1995, BIOCHEMISTRY-US, V34, P16838, DOI 10.1021/bi00051a035; WARSHEL A, 1989, BIOCHEMISTRY-US, V28, P3629, DOI 10.1021/bi00435a001; WESCOTT CR, 1994, BBA-PROTEIN STRUCT M, V1206, P1, DOI 10.1016/0167-4838(94)90065-5; Wescott CR, 1997, BIOTECHNOL BIOENG, V56, P340, DOI 10.1002/(SICI)1097-0290(19971105)56:3<340::AID-BIT12>3.0.CO;2-K; WESCOTT CR, 1993, J AM CHEM SOC, V115, P1629, DOI 10.1021/ja00058a002; ZAKS A, 1986, J AM CHEM SOC, V108, P2767, DOI 10.1021/ja00270a053; ZAKS A, 1985, P NATL ACAD SCI USA, V82, P3192, DOI 10.1073/pnas.82.10.3192	32	118	119	3	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28434	28441		10.1074/jbc.M110.136200	http://dx.doi.org/10.1074/jbc.M110.136200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20601697	Green Published, hybrid			2022-12-25	WOS:000281594000006
J	Volpicelli-Daley, LA; Lucast, L; Gong, LW; Liu, LJ; Sasaki, J; Sasaki, T; Abrams, CS; Kanaho, Y; De Camilli, P				Volpicelli-Daley, Laura A.; Lucast, Louise; Gong, Liang-Wei; Liu, Lijuan; Sasaki, Junko; Sasaki, Takehiko; Abrams, Charles S.; Kanaho, Yasunori; De Camilli, Pietro			Phosphatidylinositol-4-Phosphate 5-Kinases and Phosphatidylinositol 4,5-Bisphosphate Synthesis in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE-METABOLIZING ENZYMES; LIPID KINASE FAMILY; 4-PHOSPHATE 5-KINASE; INOSITOL POLYPHOSPHATE-5-PHOSPHATASE; PTDINS(4,5)P-2 SYNTHESIS; PSYCHIATRIC-DISORDERS; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; CANDIDATE GENE; HUMAN-DISEASE	The predominant pathway for phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P-2) synthesis is thought to be phosphorylation of phosphatidylinositol 4-phosphate at the 5 position of the inositol ring by type I phosphatidylinositol phosphate kinases (PIPK): PIPKI alpha, PIPKI beta, and PIPKI gamma. PIPKI gamma has been shown to play a role in PI(4,5)P-2 synthesis in brain, and the absence of PIPKI gamma is incompatible with postnatal life. Conversely, mice lacking PIPKI alpha or PIPKI beta (isoforms are referred to according to the nomenclature of human PIPKIs) live to adulthood, although functional effects in specific cell types are observed. To determine the contribution of PIPKI alpha and PIPKI beta to PI(4,5)P-2 synthesis in brain, we investigated the impact of disrupting multiple PIPKI genes. Our results show that a single allele of PIPKI gamma, in the absence of both PIPKI alpha and PIPKI beta, can support life to adulthood. In addition, PIPKI alpha alone, but not PIPKI beta alone, can support prenatal development, indicating an essential and partially overlapping function of PIPKI alpha and PIPKI gamma during embryogenesis. This is consistent with early embryonic expression of PIPKI alpha and PIPKI gamma but not of PIPKI beta. PIPKI beta expression in brain correlates with neuronal differentiation. The absence of PIPKI beta does not impact embryonic development in the PIPKI gamma knock-out (KO) background but worsens the early postnatal phenotype of the PIPKI gamma KO (death occurs within minutes rather than hours). Analysis of PIP2 in brain reveals that only the absence of PIPKI gamma significantly impacts its levels. Collectively, our results provide new evidence for the dominant importance of PIPKI gamma in mammals and imply that PIPKI alpha and PIPKI beta function in the generation of specific PI(4,5)P-2 pools that, at least in brain, do not have a major impact on overall PI(4,5)P-2 levels.	[De Camilli, Pietro] Howard Hughes Med Inst, Dept Cell Biol, Program Cellular Neurosci Neurodegenerat & Repair, Chevy Chase, MD USA; [De Camilli, Pietro] Howard Hughes Med Inst, Dept Neurobiol, Program Cellular Neurosci Neurodegenerat & Repair, Chevy Chase, MD USA; [De Camilli, Pietro] Yale Univ, Kavli Inst Neurosci, Sch Med, New Haven, CT 06510 USA; [Kanaho, Yasunori] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Physiol Chem, Tsukuba, Ibaraki, Japan; [Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 305, Japan; [Abrams, Charles S.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Sasaki, Junko; Sasaki, Takehiko] Akita Univ, Dept Med Biol, Grad Sch Med, Akita 010, Japan	Howard Hughes Medical Institute; Howard Hughes Medical Institute; Yale University; University of Tsukuba; University of Tsukuba; University of Pennsylvania; Akita University	De Camilli, P (corresponding author), 295 Congress Ave,BCMM 236, New Haven, CT 06510 USA.	pietro.decamilli@yale.edu		Sasaki, Takehiko/0000-0003-1837-3748	National Institutes of Health [NS36251, DK45735, DA018343]; Yale Center for Genomics and Proteomics; National Alliance for Research on Schizophrenia and Depression distinguished Neuroscience; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036251, R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Center for Genomics and Proteomics; National Alliance for Research on Schizophrenia and Depression distinguished Neuroscience; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS36251, DK45735, and DA018343 (to P. D. C.). This work was also supported by the Yale Center for Genomics and Proteomics and by a National Alliance for Research on Schizophrenia and Depression distinguished Neuroscience Award (to P. D. C.).	Lacalle RA, 2007, J CELL BIOL, V179, P1539, DOI 10.1083/jcb.200705044; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; Bairstow SF, 2006, J BIOL CHEM, V281, P20632, DOI 10.1074/jbc.M601465200; Barlow CA, 2010, TRENDS CELL BIOL, V20, P25, DOI 10.1016/j.tcb.2009.09.009; Berman DE, 2008, NAT NEUROSCI, V11, P547, DOI 10.1038/nn.2100; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Chang JD, 2004, J BIOL CHEM, V279, P11672, DOI 10.1074/jbc.M309721200; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Davis JN, 1997, MOL CELL BIOL, V17, P7398, DOI 10.1128/MCB.17.12.7398; Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Hernandez-Deviez DJ, 2004, MOL BIOL CELL, V15, P111, DOI 10.1091/mbc.E03-06-0410; HOKIN MR, 1953, J BIOL CHEM, V203, P967; Ishihara H, 1996, J BIOL CHEM, V271, P23611, DOI 10.1074/jbc.271.39.23611; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Marion E, 2002, DIABETES, V51, P2012, DOI 10.2337/diabetes.51.7.2012; McCrea HJ, 2009, PHYSIOLOGY, V24, P8, DOI 10.1152/physiol.00035.2008; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Mellman DL, 2008, NATURE, V451, P1013, DOI 10.1038/nature06666; Min Sang H, 2009, Biochem J, V423, pe5, DOI 10.1042/BJ20091274; Nakano-Kobayashi A, 2007, EMBO J, V26, P1105, DOI 10.1038/sj.emboj.7601573; Narkis G, 2007, AM J HUM GENET, V81, P530, DOI 10.1086/520771; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Padron D, 2003, J CELL BIOL, V162, P693, DOI 10.1083/jcb.200302051; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Paquet M, 2006, J COMP NEUROL, V494, P752, DOI 10.1002/cne.20854; Parker G J, 1998, Methods Mol Biol, V105, P127; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Saito T, 2003, AM J MED GENET B, V116B, P77, DOI 10.1002/ajmg.b.10042; Sasaki J, 2005, J EXP MED, V201, P859, DOI 10.1084/jem.20041891; Schurman SJ, 2009, NAT REV NEPHROL, V5, P529, DOI 10.1038/nrneph.2009.124; Soares JC, 2001, NEUROSCI LETT, V299, P150, DOI 10.1016/S0304-3940(00)01775-4; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Stopkova P, 2003, AM J MED GENET B, V123B, P50, DOI 10.1002/ajmg.b.20012; Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854; Thieman JR, 2009, J BIOL CHEM, V284, P13924, DOI 10.1074/jbc.M901017200; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Vasudevan L, 2009, J CELL SCI, V122, P2567, DOI 10.1242/jcs.048124; Voronov SV, 2008, P NATL ACAD SCI USA, V105, P9415, DOI 10.1073/pnas.0803756105; Wang YF, 2008, P NATL ACAD SCI USA, V105, P14064, DOI 10.1073/pnas.0804139105; Wang YF, 2007, P NATL ACAD SCI USA, V104, P11748, DOI 10.1073/pnas.0700019104; Wang YJ, 2004, J CELL BIOL, V167, P1005, DOI 10.1083/jcb.200408008; Wenk MR, 2003, NAT BIOTECHNOL, V21, P813, DOI 10.1038/nbt837; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Yamazaki M, 2002, J BIOL CHEM, V277, P17226, DOI 10.1074/jbc.M109795200; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	63	40	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28708	28714		10.1074/jbc.M110.132191	http://dx.doi.org/10.1074/jbc.M110.132191			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20622009	Green Published, hybrid			2022-12-25	WOS:000281594000036
J	Yang, LK; Manithody, C; Qureshi, SH; Rezaie, AR				Yang, Likui; Manithody, Chandrashekhara; Qureshi, Shabir H.; Rezaie, Alireza R.			Role of the Residues of the 39-Loop in Determining the Substrate and Inhibitor Specificity of Factor IXa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR IXA; HEPARIN-BINDING EXOSITE; ACTIVATED PROTEIN-C; FACTOR-XA; BLOOD-COAGULATION; BASIC RESIDUES; MOLECULAR-BASIS; PLASMINOGEN-ACTIVATOR; AUTOLYSIS LOOP; ALPHA-THROMBIN	The activation of antithrombin (AT) by heparin facilitates the exosite-dependent interaction of the serpin with factors IXa (FIXa) and Xa (FXa), thereby improving the rate of reactions by 300- to 500-fold. Relative to FXa, AT inhibits FIXa with similar to 40-fold slower rate constant. Structural data suggest that differences in the residues of the 39-loop (residues 31-41) may partly be responsible for the differential reactivity of the two proteases with AT. This loop is highly acidic in FXa, containing three Glu residues at positions 36, 37, and 39. By contrast, the loop is shorter by one residue in FIXa (residue 37 is missing), and it contains a Lys and an Asp at positions 36 and 39, respectively. To determine whether differences in the residues of this loop contribute to the slower reactivity of FIXa with AT, we prepared an FIXa/FXa chimera in which the 39-loop of the protease was replaced with the corresponding loop of FXa. The chimeric mutant cleaved a FIXa- specific chromogenic substrate with normal catalytic efficiency, however, the mutant exhibited similar to 5-fold enhanced reactivity with AT specifically in the absence of the cofactor, heparin. Further studies revealed that the FIXa mutant activates factor X with similar to 4-fold decreased k(cat) and similar to 2-fold decreased K-m, although the mutant interacted normally with factor VIIIa. Based on these results we conclude that residues of the 39-loop regulate the cofactor-independent interaction of FIXa with its physiological inhibitor AT and substrate factor X.	[Yang, Likui; Manithody, Chandrashekhara; Qureshi, Shabir H.; Rezaie, Alireza R.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Rezaie, AR (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, 1100 S Grand Blvd, St Louis, MO 63104 USA.	rezaiear@slu.edu	Qureshi, Shabir H/B-3610-2014		NHLBI, National Institutes of Health [HL68571, HL62565]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068571, R01HL062565] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL68571 and HL62565 (to A. R. R.) from NHLBI.	Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BRANDSTETTER H, 1995, P NATL ACAD SCI USA, V92, P9796, DOI 10.1073/pnas.92.21.9796; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; FURIE B, 1982, J BIOL CHEM, V257, P3875; Gettins PGW, 2009, FEBS LETT, V583, P3397, DOI 10.1016/j.febslet.2009.10.005; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hopfner KP, 1997, EMBO J, V16, P6626, DOI 10.1093/emboj/16.22.6626; Hopfner KP, 1999, STRUCTURE, V7, P989, DOI 10.1016/S0969-2126(99)80125-7; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Jenkins PV, 2004, J THROMB HAEMOST, V2, P452, DOI 10.1111/j.1538-7933.2004.00625.x; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson DJD, 2010, P NATL ACAD SCI USA, V107, P645, DOI 10.1073/pnas.0910144107; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; MADISON EL, 1989, NATURE, V339, P721, DOI 10.1038/339721a0; Manithody C, 2002, BIOCHEMISTRY-US, V41, P6780, DOI 10.1021/bi0255367; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MARCUM JA, 1984, BIOCHEMISTRY-US, V23, P1730, DOI 10.1021/bi00303a023; Mertens K, 1999, THROMB HAEMOSTASIS, V82, P209; Neuenschwander PF, 2006, J BIOL CHEM, V281, P23066, DOI 10.1074/jbc.M603743200; OLSON ST, 1982, J BIOL CHEM, V257, P4891; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; OLSON ST, 1992, THROMBIN STRUCTURE F, P159; Quinsey NS, 2004, INT J BIOCHEM CELL B, V36, P386, DOI 10.1016/S1357-2725(03)00244-9; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; Rezaie AR, 2000, BIOCHEMISTRY-US, V39, P12083, DOI 10.1021/bi0011126; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Rezaie AR, 2006, BIOCHEMISTRY-US, V45, P5324, DOI 10.1021/bi060056r; Rezaie AR, 2005, J BIOL CHEM, V280, P32722, DOI 10.1074/jbc.M505517200; Rezaie AR, 1998, BIOCHEMISTRY-US, V37, P13138, DOI 10.1021/bi9808518; Rezaie AR, 1996, J BIOL CHEM, V271, P23807, DOI 10.1074/jbc.271.39.23807; Rezaie AR, 2002, J BIOL CHEM, V277, P1235, DOI 10.1074/jbc.M108544200; Rezaie AR, 2001, BBA-GEN SUBJECTS, V1528, P167, DOI 10.1016/S0304-4165(01)00189-1; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SMIRNOV MD, 1994, J BIOL CHEM, V269, P816; Sturzebecher J, 1997, FEBS LETT, V412, P295, DOI 10.1016/S0014-5793(97)00811-9; THOMPSON AR, 1986, BLOOD, V67, P565; Wiebe EM, 2003, J BIOL CHEM, V278, P35767, DOI 10.1074/jbc.M304803200; Yang LK, 2006, PROTEIN EXPRES PURIF, V50, P196, DOI 10.1016/j.pep.2006.05.012; Yang LK, 2003, J BIOL CHEM, V278, P25032, DOI 10.1074/jbc.M302174200; Yang LK, 2002, J BIOL CHEM, V277, P50756, DOI 10.1074/jbc.M208485200; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049	46	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28488	28495		10.1074/jbc.M110.143321	http://dx.doi.org/10.1074/jbc.M110.143321			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20628058	Green Published, hybrid			2022-12-25	WOS:000281594000012
J	Yuan, XQ; Yin, P; Hao, Q; Yan, CY; Wang, JW; Yan, NE				Yuan, Xiaoqiu; Yin, Ping; Hao, Qi; Yan, Chuangye; Wang, Jiawei; Yan, Nieng			Single Amino Acid Alteration between Valine and Isoleucine Determines the Distinct Pyrabactin Selectivity by PYL1 and PYL2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM; START	Abscisic acid (ABA) is one of the most important phytohormones in plant. PYL proteins were identified to be ABA receptors in Arabidopsis thaliana. Despite the remarkably high degree of sequence similarity, PYL1 and PYL2 exhibit distinct responses toward pyrabactin, an ABA agonist. PYL1 inhibits protein phosphatase type 2C upon binding of pyrabactin. In contrast, PYL2 appears relatively insensitive to this compound. The crystal structure of pyrabactin-bound PYL1 revealed that most of the PYL1 residues involved in pyrabactin binding are conserved, hence failing to explain the selectivity of pyrabactin for PYL1 over PYL2. To understand the molecular basis of pyrabactin selectivity, we determined the crystal structure of PYL2 in complex with pyrabactin at 1.64 angstrom resolution. Structural comparison and biochemical analyses demonstrated that one single amino acid alteration between a corresponding valine and isoleucine determines the distinct pyrabactin selectivity by PYL1 and PYL2. These characterizations provide an important clue to dissecting the redundancy of PYL proteins.	[Yan, Nieng] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Struct Biol Ctr, Sch Med, Beijing 100084, Peoples R China; Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Yan, NE (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Struct Biol Ctr, Sch Med, Rm C329,Med Sci Bldg, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021; Wang, Jiawei/D-1144-2010	Wang, Jiawei/0000-0001-9893-8539; Yan, Chuangye/0000-0001-9338-8048	Ministry of Science and Technology [2009CB918802]; Tsinghua University; Yuyuan Foundation; Li Foundation	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tsinghua University; Yuyuan Foundation; Li Foundation	This work was supported by Ministry of Science and Technology Grant 2009CB918802, Tsinghua University 985 Phase II funds, Yuyuan Foundation, and the Li Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Hao Q, 2010, J BIOL CHEM, V285, P28946, DOI 10.1074/jbc.M110.149005; Klingler JP, 2010, J EXP BOT, V61, P3199, DOI 10.1093/jxb/erq151; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Zhao Y, 2007, NAT CHEM BIOL, V3, P716, DOI 10.1038/nchembio.2007.32	19	41	48	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28953	28958		10.1074/jbc.M110.160192	http://dx.doi.org/10.1074/jbc.M110.160192			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20630864	Green Published, hybrid			2022-12-25	WOS:000281594000060
J	Chen, YJ; Chen, YH; Chow, LP; Tsai, YH; Chen, PH; Huang, CYF; Chen, WT; Hwang, LH				Chen, Yin-Ju; Chen, Yu-Hsuan; Chow, Lu-Ping; Tsai, Ya-Hui; Chen, Pei-Hong; Huang, Chi-Ying F.; Chen, Wei-Tzu; Hwang, Lih-Hwa			Heat Shock Protein 72 Is Associated with the Hepatitis C Virus Replicase Complex and Enhances Viral RNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTRUCTURAL 5A PROTEIN; NS5A PROTEIN; CELL-CULTURE; ANTIVIRAL ACTIVITY; HSP70 CHAPERONES; INTERFERON; EXPRESSION; KINASE; IDENTIFICATION; MUTATIONS	The NS5A protein of the hepatitis C virus (HCV) is an integral component of the viral replicase. It also modulates cellular signaling and perturbs host interferon responses. The multifunctional characteristics of NS5A are mostly attributed to its ability to interact with various cellular proteins. This study aimed to identify the novel cellular factors that interact with NS5A and decipher the significance of this interaction in viral replication. The NS5A-interacting proteins were purified by the tandem affinity purification (TAP) procedure from cells expressing NS5A and identified by mass spectrometry. The chaperone protein Hsp72 was identified herein. In vivo protein-protein interaction was verified by co-immunoprecipitation and an in situ proximity ligation assay. In addition to NS5A, Hsp72 was also associated with other members of the replicase complex, NS3 and NS5B, suggesting that it might be directly involved in the HCV replication complex. Hsp72 plays a positive regulatory role in HCV RNA replication by increasing levels of the replicase complex, which was attributed either to the increased stability of the viral proteins in the replicase complex or to the enhanced translational activity of the internal ribosome entry site of HCV. The fact that the host chaperone protein Hsp72 is involved in HCV RNA replication may represent a therapeutic target for controlling virus production.	[Hwang, Lih-Hwa] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chow, Lu-Ping] Natl Taiwan Univ, Coll Med, Grad Inst Biochem & Mol Biol, Taipei 100, Taiwan; [Chen, Wei-Tzu] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 100, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University	Hwang, LH (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	lhhwang@ym.edu.tw	Huang, Chi-Ying/AAG-7672-2022; Huang, Chi-Ying/AFL-7729-2022	Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937; CHOW, LU-PING/0000-0002-4420-211X; TSAI, YA-HUI/0000-0002-7913-6415	National Science Council of the Republic of China [NSC 97-2320-B-010-031-MY3]; Ministry of Education, Aim for the Top University Plan	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This work was supported by Grant NSC 97-2320-B-010-031-MY3 from the National Science Council of the Republic of China and in part by a grant from Ministry of Education, Aim for the Top University Plan.	Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Bartenschlager R, 2003, ANTIVIR RES, V60, P91, DOI 10.1016/j.antiviral.2003.08.016; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Brass Volker, 2006, Int J Med Sci, V3, P29; Burckstummer T, 2006, FEBS LETT, V580, P575, DOI 10.1016/j.febslet.2005.12.071; Choi Yook-Wah, 2004, Biochemical and Biophysical Research Communications, V318, P514, DOI 10.1016/j.bbrc.2004.04.052; Choukhi A, 1998, J VIROL, V72, P3851, DOI 10.1128/JVI.72.5.3851-3858.1998; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; El-Hage N, 2003, J GEN VIROL, V84, P2761, DOI 10.1099/vir.0.19305-0; Elazar M, 2003, J VIROL, V77, P6055, DOI 10.1128/JVI.77.10.6055-6061.2003; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Gale M, 1999, J VIROL, V73, P6506, DOI 10.1128/JVI.73.8.6506-6516.1999; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Georgopoulou U, 2006, BIOCHIMIE, V88, P651, DOI 10.1016/j.biochi.2005.12.003; Ghosh AK, 2003, VIROLOGY, V306, P51, DOI 10.1016/S0042-6822(02)00029-6; Gong GZ, 2007, WORLD J GASTROENTERO, V13, P4080, DOI 10.3748/wjg.v13.i30.4080; Gonzalez O, 2009, HEPATOLOGY, V50, P1756, DOI 10.1002/hep.23232; He YP, 2003, J GEN VIROL, V84, P535, DOI 10.1099/vir.0.18658-0; Inubushi S, 2008, J GEN VIROL, V89, P1231, DOI 10.1099/vir.0.83510-0; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu Z, 2009, J VIROL, V83, P6554, DOI 10.1128/JVI.02550-08; Lohmann V, 2001, J VIROL, V75, P1437, DOI 10.1128/JVI.75.3.1437-1449.2001; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Macdonald A, 2005, J GEN VIROL, V86, P1027, DOI 10.1099/vir.0.80724-0; Majumder M, 2001, J VIROL, V75, P1401, DOI 10.1128/JVI.75.3.1401-1407.2001; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Mayer MP, 2005, REV PHYSIOL BIOCH P, V153, P1, DOI 10.1007/s10254-004-0025-5; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MILNER CM, 1990, IMMUNOGENETICS, V32, P242; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Parent R, 2009, HEPATOLOGY, V49, P1798, DOI 10.1002/hep.22852; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Pflugheber J, 2002, P NATL ACAD SCI USA, V99, P4650, DOI 10.1073/pnas.062055699; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Shimakami T, 2004, J VIROL, V78, P2738, DOI 10.1128/JVI.78.6.2738-2748.2004; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song J, 1999, J GEN VIROL, V80, P879, DOI 10.1099/0022-1317-80-4-879; Taguchi T, 2004, J GEN VIROL, V85, P959, DOI 10.1099/vir.0.19513-0; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Thomson BJ, 2005, CLIN MICROBIOL INFEC, V11, P86, DOI 10.1111/j.1469-0691.2004.01061.x; Tsai YH, 2008, J HEPATOL, V49, P899, DOI 10.1016/j.jhep.2008.06.030; Ujino S, 2009, J BIOL CHEM, V284, P6841, DOI 10.1074/jbc.M806452200; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; WU B, 1985, MOL CELL BIOL, V5, P330, DOI 10.1128/MCB.5.2.330; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zhang ZB, 2008, J VIROL, V82, P5761, DOI 10.1128/JVI.00064-08	53	49	54	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28183	28190		10.1074/jbc.M110.118323	http://dx.doi.org/10.1074/jbc.M110.118323			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20601427	Green Published, hybrid			2022-12-25	WOS:000281404100061
J	Ye, X; Li, Y; Stawicki, S; Couto, S; Eastham-Anderson, J; Kallop, D; Weimer, R; Wu, Y; Pei, L				Ye, X.; Li, Y.; Stawicki, S.; Couto, S.; Eastham-Anderson, J.; Kallop, D.; Weimer, R.; Wu, Y.; Pei, L.			An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies	ONCOGENE			English	Article						monoclonal antibody; tumor stroma; combination therapies	RECEPTOR TYROSINE KINASE; CELL LUNG-CANCER; BREAST-CANCER; THERAPEUTIC TARGET; PROLONGS SURVIVAL; MYELOID-LEUKEMIA; EXPRESSION; INFLAMMATION; PROGRESSION; METASTASIS	Axl is expressed in various types of cancer and is involved in multiple processes of tumorigenesis, including promoting tumor cell growth, migration, invasion, metastasis as well as angiogenesis. To evaluate further the mechanisms involved in the expression/activation of Axl in various aspects of tumorigenesis, especially its roles in modulating tumor stromal functions, we have developed a phage-derived mAb (YW327.6S2) that recognizes both human and murine Axl. YW327.6S2 binds to both human and murine Axl with high affinity. It blocks the ligand Gas6 binding to the receptor, downregulates receptor expression, inhibits receptor activation and downstream signaling. In A549 non-small-cell lung cancer (NSCLC) and MDA-MB-231 breast cancer models, YW327.6S2 attenuates xenograft tumor growth and potentiates the effect of anti-VEGF treatment. In NSCLC models, YW327.6S2 also enhances the effect of erlotinib and chemotherapy in reducing tumor growth. Furthermore, YW327.6S2 reduces the metastasis of MDA-MB-231 breast cancer cells to distant organs. YW327.6S2 induces tumor cell apoptosis in NSCLC, reduces tumor-associated vascular density and inhibits the secretion of inflammatory cytokines and chemokines from tumor-associated macrophages in the breast cancer model. In conclusion, anti-Axl mAb can enhance the therapeutic efficacy of anti-VEGF, EGFR small-molecule inhibitors as well as chemotherapy. Axl mAb affects not only tumor cells but also tumor stroma through its modulation of tumor-associated vasculature and immune cell functions. Oncogene (2010) 29, 5254-5264; doi:10.1038/onc.2010.268; published online 5 July 2010	[Ye, X.; Li, Y.; Pei, L.] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; [Stawicki, S.; Wu, Y.] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Couto, S.; Eastham-Anderson, J.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Kallop, D.; Weimer, R.] Genentech Inc, Dept Biomed Imaging, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Pei, L (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	lpei@gene.com						Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Berclaz G, 2001, ANN ONCOL, V12, P819, DOI 10.1023/A:1011126330233; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Chung BI, 2003, DNA CELL BIOL, V22, P533, DOI 10.1089/10445490360708946; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; CRAVEN RJ, 1995, INT J CANCER, V60, P791, DOI 10.1002/ijc.2910600611; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Giaccone G, 2005, J CLIN ONCOL, V23, P3235, DOI 10.1200/JCO.2005.08.409; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Haghnegahdar H, 2000, J LEUKOCYTE BIOL, V67, P53, DOI 10.1002/jlb.67.1.53; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Holland SJ, 2005, CANCER RES, V65, P9294, DOI 10.1158/0008-5472.CAN-05-0993; Hong CC, 2008, CANCER LETT, V268, P314, DOI 10.1016/j.canlet.2008.04.017; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Ito T, 1999, THYROID, V9, P563, DOI 10.1089/thy.1999.9.563; JANSSEN JWG, 1991, ONCOGENE, V6, P2113; Koorstra JBM, 2009, CANCER BIOL THER, V8, P618, DOI 10.4161/cbt.8.7.7923; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Loges S, 2010, BLOOD, V115, P2264, DOI 10.1182/blood-2009-06-228684; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Meric F, 2002, CLIN CANCER RES, V8, P361; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; Sun WS, 2004, ONCOLOGY-BASEL, V66, P450, DOI 10.1159/000079499; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; Wu CW, 2002, ANTICANCER RES, V22, P1071; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661	44	155	179	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2010	29	38					5254	5264		10.1038/onc.2010.268	http://dx.doi.org/10.1038/onc.2010.268			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	653KE	20603615				2022-12-25	WOS:000282089100004
J	Forsberg, K; Jonsson, PA; Andersen, PM; Bergemalm, D; Graffmo, KS; Hultdin, M; Jacobsson, J; Rosquist, R; Marklund, SL; Brannstrom, T				Forsberg, Karin; Jonsson, P. Andreas; Andersen, Peter M.; Bergemalm, Daniel; Graffmo, Karin S.; Hultdin, Magnus; Jacobsson, Johan; Rosquist, Roland; Marklund, Stefan L.; Brannstrom, Thomas			Novel Antibodies Reveal Inclusions Containing Non-Native SOD1 in Sporadic ALS Patients	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN SUPEROXIDE-DISMUTASE; MOTOR-NEURON DEGENERATION; MOLECULAR PATHOLOGY; GENE MUTATION; LINKED SOD1; MUTANT SOD1; MICE; DISEASE; IMMUNOREACTIVITY	Mutations in CuZn-superoxide dismutase (SOD1) cause amyotrophic lateral sclerosis (ALS) and are found in 6% of ALS patients. Non-native and aggregation-prone forms of mutant SOD1s are thought to trigger the disease. Two sets of novel antibodies, raised in rabbits and chicken, against peptides spaced along the human SOD1 sequence, were by enzyme-linked immunosorbent assay and an immunocapture method shown to be specific for denatured SOD1. These were used to examine SOD1 in spinal cords of ALS patients lacking mutations in the enzyme. Small granular SOD1-immunoreactive inclusions were found in spinal motoneurons of all 37 sporadic and familial ALS patients studied, but only sparsely in 3 of 28 neurodegenerative and 2 of 19 non-neurological control patients. The granular inclusions were by confocal microscopy found to partly colocalize with markers for lysosomes but not with inclusions containing TAR DNA binding protein-43, ubiquitin or markers for endoplasmic reticulum, autophagosomes or mitochondria. Granular inclusions were also found in carriers of SOD1 mutations and in spinobulbar muscular atrophy (SBMA) patients and they were the major type of inclusion detected in ALS patients homozygous for the wild type-like D90A mutation. The findings suggest that SOD1 may be involved in ALS pathogenesis in patients lacking mutations in the enzyme.	[Forsberg, Karin; Jonsson, P. Andreas; Bergemalm, Daniel; Graffmo, Karin S.; Hultdin, Magnus; Marklund, Stefan L.; Brannstrom, Thomas] Umea Univ, Dept Med Biosci, Umea, Sweden; [Forsberg, Karin; Graffmo, Karin S.; Hultdin, Magnus; Brannstrom, Thomas] Umea Univ, Dept Pathol, S-90187 Umea, Sweden; [Jonsson, P. Andreas; Bergemalm, Daniel; Marklund, Stefan L.] Umea Univ, Dept Clin Chem, Umea, Sweden; [Andersen, Peter M.; Jacobsson, Johan] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Rosquist, Roland] Umea Univ, Dept Mol Biol, Umea, Sweden	Umea University; Umea University; Umea University; Umea University; Umea University	Forsberg, K (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	thomas.brannstrom@medbio.umu.se		Jonsson, Andreas/0000-0002-1938-0707	Swedish Science Council	Swedish Science Council	This work was supported by the Swedish Science Council (Grants no: 2008: 2786; 2009: 3548; 2009-4942), the Swedish Brain Fund/Hallsten Fund, the Swedish Medical Society/Bjorklund Fund for ALS Research, King Gustaf and Queen Victoria Fund, the Swedish Association for Individuals with Neurological Disabilities, the Torsten and Ragnar Soderbergs Foundations, the Vasterbotten County Council, and the Research Fund of the Medical Faculty, Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; ANDERSEN PM, 1995, NAT GENET, V10, P61, DOI 10.1038/ng0595-61; BOWLING AC, 1995, J NEUROCHEM, V64, P2366; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Feeney SJ, 2001, MUSCLE NERVE, V24, P1510, DOI 10.1002/mus.1176; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Hirano A, 1998, NEUROPATHOLOGY, V18, P363, DOI 10.1111/j.1440-1789.1998.tb00132.x; Ince PG, 1998, J NEUROPATH EXP NEUR, V57, P895, DOI 10.1097/00005072-199810000-00002; Ince PG, 1996, ACTA NEUROPATHOL, V92, P395, DOI 10.1007/s004010050535; Jaarsma D, 2000, NEUROBIOL DIS, V7, P623, DOI 10.1006/nbdi.2000.0299; Jacobsson J, 2001, BRAIN, V124, P1461, DOI 10.1093/brain/124.7.1461; Jonsson PA, 2006, J NEUROPATH EXP NEUR, V65, P1126, DOI 10.1097/01.jnen.0000248545.36046.3c; Jonsson PA, 2009, NEUROBIOL DIS, V36, P421, DOI 10.1016/j.nbd.2009.08.006; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Liu HN, 2009, ANN NEUROL, V66, P75, DOI 10.1002/ana.21704; Liu Y, 1998, ACTA NEUROPATHOL, V95, P63, DOI 10.1007/s004010050766; MARKLUND SL, 1984, J CLIN INVEST, V74, P1398, DOI 10.1172/JCI111550; Marklund SL, 1997, J NEUROCHEM, V69, P675; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sato T, 2005, NEUROLOGY, V65, P1954, DOI 10.1212/01.wnl.0000188760.53922.05; Shaw CE, 1997, NEUROLOGY, V49, P1612, DOI 10.1212/WNL.49.6.1612; Shaw PJ, 1997, J NEUROL SCI, V147, P115, DOI 10.1016/S0022-510X(96)05316-6; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Stewart HG, 2006, MUSCLE NERVE, V33, P701, DOI 10.1002/mus.20495; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang J, 2005, NEUROBIOL DIS, V20, P943, DOI 10.1016/j.nbd.2005.06.005; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Wooley CM, 2005, MUSCLE NERVE, V32, P43, DOI 10.1002/mus.20228; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104; 1994, J NEUROL SCI S, V124, P1	44	233	237	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11552	10.1371/journal.pone.0011552	http://dx.doi.org/10.1371/journal.pone.0011552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644736	gold, Green Published, Green Submitted			2022-12-25	WOS:000279884900009
J	Werth, N; Beerlage, C; Rosenberger, C; Yazdi, AS; Edelmann, M; Amr, A; Bernhardt, W; von Eiff, C; Becker, K; Schafer, A; Peschel, A; Kempf, VAJ				Werth, Nadine; Beerlage, Christiane; Rosenberger, Christian; Yazdi, Amir S.; Edelmann, Markus; Amr, Amro; Bernhardt, Wanja; von Eiff, Christof; Becker, Karsten; Schaefer, Andrea; Peschel, Andreas; Kempf, Volkhard A. J.			Activation of Hypoxia Inducible Factor 1 Is a General Phenomenon in Infections with Human Pathogens	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SMALL COLONY VARIANTS; FACTOR-I; BARTONELLA ADHESIN; HIF-ALPHA; HIF-1-ALPHA; LIPOPOLYSACCHARIDE; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; STABILIZATION; EXPRESSION	Background: Hypoxia inducible factor (HIF)-1 is the key transcriptional factor involved in the adaptation process of cells and organisms to hypoxia. Recent findings suggest that HIF-1 plays also a crucial role in inflammatory and infectious diseases. Methodology/Principal Findings: Using patient skin biopsies, cell culture and murine infection models, HIF-1 activation was determined by immunohistochemistry, immunoblotting and reporter gene assays and was linked to cellular oxygen consumption. The course of a S. aureus peritonitis was determined upon pharmacological HIF-1 inhibition. Activation of HIF-1 was detectable (i) in all ex vivo in biopsies of patients suffering from skin infections, (ii) in vitro using cell culture infection models and (iii) in vivo using murine intravenous and peritoneal S. aureus infection models. HIF-1 activation by human pathogens was induced by oxygen-dependent mechanisms. Small colony variants (SCVs) of S. aureus known to cause chronic infections did not result in cellular hypoxia nor in HIF-1 activation. Pharmaceutical inhibition of HIF-1 activation resulted in increased survival rates of mice suffering from a S. aureus peritonitis. Conclusions/Significance: Activation of HIF-1 is a general phenomenon in infections with human pathogenic bacteria, viruses, fungi and protozoa. HIF-1-regulated pathways might be an attractive target to modulate the course of life-threatening infections.	[Werth, Nadine; Edelmann, Markus; Amr, Amro; Schaefer, Andrea; Peschel, Andreas] Univ Klinikum Tubingen, Inst Med Mikrobiol & Hyg, Tubingen, Germany; [Beerlage, Christiane; Kempf, Volkhard A. J.] Klinikum Johann Wolfgang Goethe Univ, Inst Med Mikrobiol & Krankenhaushyg, Frankfurt, Germany; [Rosenberger, Christian] Charite, Med Klin Schwerpunkt Nephrol & Internist Intens M, Berlin, Germany; [Yazdi, Amir S.] Univ Lausanne, Dept Biochim, CH-1066 Epalinges, Switzerland; [Yazdi, Amir S.] Univ Tubingen, Univ Hautklin, Tubingen, Germany; [Bernhardt, Wanja] Univ Erlangen Nurnberg, Med Klin Nephrol & Hypertensiol 4, Erlangen, Germany; [von Eiff, Christof; Becker, Karsten] Univ Klinikum Munster, Inst Med Mikrobiol, Munster, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lausanne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster	Werth, N (corresponding author), Univ Klinikum Tubingen, Inst Med Mikrobiol & Hyg, Tubingen, Germany.	volkhard.kempf@kgu.de	Becker, Karsten/O-2302-2018	Becker, Karsten/0000-0002-6391-1341	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft to V.A.J.K. and K.B. (Priority Program 1316) and to A.S.Y. and A.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt WM, 2006, KIDNEY INT, V69, P114, DOI 10.1038/sj.ki.5000062; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Chavakis T, 2002, NAT MED, V8, P687, DOI 10.1038/nm728; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209; Doege K, 2005, BLOOD, V106, P2311, DOI 10.1182/blood-2005-03-1138; ENKHBAATAR P, 2008, YB INTENSIVE CARE EM, P404; Essin K, 2007, AM J PHYSIOL-CELL PH, V293, pC45, DOI 10.1152/ajpcell.00450.2006; Fedtke I, 2007, MOL MICROBIOL, V65, P1078, DOI 10.1111/j.1365-2958.2007.05854.x; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Haeberle HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003352; Hartmann H, 2008, GASTROENTEROLOGY, V134, P756, DOI 10.1053/j.gastro.2007.12.008; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hussain M, 2002, INFECT IMMUN, V70, P2933, DOI 10.1128/IAI.70.6.2933-2940.2002; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Kaiser PO, 2008, CELL MICROBIOL, V10, P2223, DOI 10.1111/j.1462-5822.2008.01201.x; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; Kempf VAJ, 2002, TRENDS MICROBIOL, V10, P269, DOI 10.1016/S0966-842X(02)02372-7; Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x; KERL H, 2003, HISTOPATHOLOGIE HAUT, P3; Lang SA, 2007, CLIN CANCER RES, V13, P6459, DOI 10.1158/1078-0432.CCR-07-1104; Lannergard J, 2008, ANTIMICROB AGENTS CH, V52, P4017, DOI 10.1128/AAC.00668-08; Mazure NM, 2004, BIOCHEM PHARMACOL, V68, P971, DOI 10.1016/j.bcp.2004.04.022; Meyer-Hoffert U, 2008, GUT, V57, P764, DOI 10.1136/gut.2007.141481; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Pickkers P, 2005, SHOCK, V24, P508, DOI 10.1097/01.shk.0000190827.36406.6e; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; RALEIGH JA, 1990, BIOCHEM PHARMACOL, V40, P2457, DOI 10.1016/0006-2952(90)90086-Z; Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500; Rupp J, 2007, CELL MICROBIOL, V9, P2181, DOI 10.1111/j.1462-5822.2007.00948.x; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Sheta EA, 2001, ONCOGENE, V20, P7624, DOI 10.1038/sj.onc.1204972; Shimoda LA, 2001, AM J PHYSIOL-LUNG C, V281, pL202, DOI 10.1152/ajplung.2001.281.1.L202; Sifri CD, 2006, INFECT IMMUN, V74, P1091, DOI 10.1128/IAI.74.2.1091-1096.2006; van der Flier M, 2005, SHOCK, V23, P35, DOI 10.1097/01.shk.0000150728.91155.41; van der Flier M, 2001, J INFECT DIS, V183, P149, DOI 10.1086/317643; von Eiff C, 2008, INT J ANTIMICROB AG, V31, P507, DOI 10.1016/j.ijantimicag.2007.10.026; vonEiff C, 1997, J BACTERIOL, V179, P4706, DOI 10.1128/jb.179.15.4706-4712.1997; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Yeo M, 2006, GUT, V55, P26, DOI 10.1136/gut.2005.067454	48	127	134	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11576	10.1371/journal.pone.0011576	http://dx.doi.org/10.1371/journal.pone.0011576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644645	Green Published, gold, Green Submitted			2022-12-25	WOS:000279884900016
J	Autore, F; Bergeron, JRC; Malim, MH; Fraternali, F; Huthoff, H				Autore, Flavia; Bergeron, Julien R. C.; Malim, Michael H.; Fraternali, Franca; Huthoff, Hendrik			Rationalisation of the Differences between APOBEC3G Structures from Crystallography and NMR Studies by Molecular Dynamics Simulations	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SINGLE-STRANDED-DNA; CYTIDINE DEAMINATION; CATALYTIC DOMAIN; RETROVIRAL INFECTION; CRYSTAL-STRUCTURE; MODEL STRUCTURE; HIV-1 VIF; PROTEINS; RNA	The human APOBEC3G (A3G) protein is a cellular polynucleotide cytidine deaminase that acts as a host restriction factor of retroviruses, including HIV-1 and various transposable elements. Recently, three NMR and two crystal structures of the catalytic deaminase domain of A3G have been reported, but these are in disagreement over the conformation of a terminal beta-strand, beta 2, as well as the identification of a putative DNA binding site. We here report molecular dynamics simulations with all of the solved A3G catalytic domain structures, taking into account solubility enhancing mutations that were introduced during derivation of three out of the five structures. In the course of these simulations, we observed a general trend towards increased definition of the beta 2 strand for those structures that have a distorted starting conformation of beta 2. Solvent density maps around the protein as calculated from MD simulations indicated that this distortion is dependent on preferential hydration of residues within the beta 2 strand. We also demonstrate that the identification of a pre-defined DNA binding site is prevented by the inherent flexibility of loops that determine access to the deaminase catalytic core. We discuss the implications of our analyses for the as yet unresolved structure of the full-length A3G protein and its biological functions with regard to hypermutation of DNA.	[Autore, Flavia; Bergeron, Julien R. C.; Fraternali, Franca] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Bergeron, Julien R. C.; Malim, Michael H.; Huthoff, Hendrik] Kings Coll London, Dept Infect Dis, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Autore, F (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	franca.fraternalli@kc.ac.uk; hendrik.huthoff@kcl.ac.uk	Bergeron, Julien/AGY-1707-2022; Fraternali, Franca/C-8912-2009; Fraternali, Franca/D-4410-2011	Fraternali, Franca/0000-0002-3143-6574; Malim, Michael/0000-0002-7699-2064	Medical Research Council [G0401570]; Guy's & St Thomas' Charity [R041069]; Wellcome Trust [084280/Z/07/Z]; BHF Centre of Excellence; Wellcome Trust; European Molecular Biology Organisation; Guy's & St Thomas' Charity; MRC [G1000196, G0401570] Funding Source: UKRI; Medical Research Council [G1000196] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Guy's & St Thomas' Charity; Wellcome Trust(Wellcome Trust); BHF Centre of Excellence; Wellcome Trust(Wellcome Trust); European Molecular Biology Organisation; Guy's & St Thomas' Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (G0401570), the Guy's & St Thomas' Charity (R041069), the Wellcome Trust (084280/Z/07/Z) and the BHF Centre of Excellence. HH is a Wellcome Trust fellow, FA is supported by a short-term fellowship of the European Molecular Biology Organisation, JB is supported by a grant from the Guy's & St Thomas' Charity, and FF is supported by a priming grant from the BHF Centre of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman K, 2008, BARIAT NURS SURG PAT, V3, P7, DOI 10.1089/bar.2008.9997; Bennett RP, 2008, J BIOL CHEM, V283, P33329, DOI 10.1074/jbc.M803726200; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bransteitter R, 2009, CELL MOL LIFE SCI, V66, P3137, DOI 10.1007/s00018-009-0070-y; Bulliard Y, 2009, J VIROL, V83, P12611, DOI 10.1128/JVI.01491-09; Burnett A, 2007, J VIROL, V81, P5000, DOI 10.1128/JVI.02237-06; CARPENTER MA, 2010, DNA REPAIR, V579, P3; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chelico L, 2009, NAT STRUCT MOL BIOL, V16, P454, DOI 10.1038/nsmb0509-454; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Daura X, 1998, J COMPUT CHEM, V19, P535, DOI 10.1002/(SICI)1096-987X(19980415)19:5<535::AID-JCC6>3.0.CO;2-N; De Simone A, 2005, P NATL ACAD SCI USA, V102, P7535, DOI 10.1073/pnas.0501748102; ESPINOSA R, 1994, GENOMICS, V24, P414, DOI 10.1006/geno.1994.1645; Friew YN, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-56; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huthoff H, 2005, VIROLOGY, V334, P147, DOI 10.1016/j.virol.2005.01.038; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Lavens D, 2010, NUCLEIC ACIDS RES, V38, P1902, DOI 10.1093/nar/gkp1154; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; SIMON JHM, 1995, J VIROL, V69, P4166, DOI 10.1128/JVI.69.7.4166-4172.1995; Stauch B, 2009, P NATL ACAD SCI USA, V106, P12079, DOI 10.1073/pnas.0900979106; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000378; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	55	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11515	10.1371/journal.pone.0011515	http://dx.doi.org/10.1371/journal.pone.0011515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20635000	Green Submitted, gold, Green Published			2022-12-25	WOS:000279781600004
J	Chen, F; Lee, Y; Jiang, YL; Wang, SL; Peatman, E; Abernathy, J; Liu, H; Liu, SK; Kucuktas, H; Ke, CH; Liu, ZJ				Chen, Fei; Lee, Yoona; Jiang, Yanliang; Wang, Shaolin; Peatman, Eric; Abernathy, Jason; Liu, Hong; Liu, Shikai; Kucuktas, Huseyin; Ke, Caihuan; Liu, Zhanjiang			Identification and Characterization of Full-Length cDNAs in Channel Catfish (Ictalurus punctatus) and Blue Catfish (Ictalurus furcatus)	PLOS ONE			English	Article							POLYADENYLATION SIGNAL; GENE-EXPRESSION; SEQUENCES; SELENIUM; TOOL	Background: Genome annotation projects, gene functional studies, and phylogenetic analyses for a given organism all greatly benefit from access to a validated full-length cDNA resource. While increasingly common in model species, full-length cDNA resources in aquaculture species are scarce. Methodology and Principal Findings: Through in silico analysis of catfish (Ictalurus spp.) ESTs, a total of 10,037 channel catfish and 7,382 blue catfish cDNA clones were identified as potentially encoding full-length cDNAs. Of this set, a total of 1,169 channel catfish and 933 blue catfish full-length cDNA clones were selected for re-sequencing to provide additional coverage and ensure sequence accuracy. A total of 1,745 unique gene transcripts were identified from the full-length cDNA set, including 1,064 gene transcripts from channel catfish and 681gene transcripts from blue catfish, with 416 transcripts shared between the two closely related species. Full-length sequence characteristics (ortholog conservation, UTR length, Kozak sequence, and conserved motifs) of the channel and blue catfish were examined in detail. Comparison of gene ontology composition between full-length cDNAs and all catfish ESTs revealed that the full-length cDNA set is representative of the gene diversity encoded in the catfish transcriptome. Conclusions: This study describes the first catfish full-length cDNA set constructed from several cDNA libraries. The catfish full-length cDNA sequences, and data gleaned from sequence characteristics analysis, will be a valuable resource for ongoing catfish whole-genome sequencing and future gene-based studies of function and evolution in teleost fishes.	[Chen, Fei; Lee, Yoona; Jiang, Yanliang; Wang, Shaolin; Peatman, Eric; Abernathy, Jason; Liu, Hong; Liu, Shikai; Kucuktas, Huseyin; Liu, Zhanjiang] Auburn Univ, Dept Fisheries & Allied Aquacultures, Aquat Genom Unit, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA; [Chen, Fei; Lee, Yoona; Jiang, Yanliang; Wang, Shaolin; Peatman, Eric; Abernathy, Jason; Liu, Hong; Liu, Shikai; Kucuktas, Huseyin; Liu, Zhanjiang] Auburn Univ, Program Cell & Mol Biosci, Auburn, AL 36849 USA; [Chen, Fei; Ke, Caihuan] Xiamen Univ, Coll Oceanog & Environm Sci, State Key Lab Marine Environm Sci, Xiamen, Peoples R China	Auburn University System; Auburn University; Auburn University System; Auburn University; Xiamen University	Chen, F (corresponding author), Auburn Univ, Dept Fisheries & Allied Aquacultures, Aquat Genom Unit, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA.	liuzhan@auburn.edu	Liu, Shikai/AAO-2247-2021; Liu, Zhanjiang/R-9633-2019; Liu, Shikai/D-4664-2013; Wang, Shaolin/M-2282-2013; Wang, Shaolin/FDL-8163-2022; Ke, CH/G-4635-2010	Liu, Shikai/0000-0001-5777-489X; Liu, Shikai/0000-0001-5777-489X; Wang, Shaolin/0000-0003-0866-4584; Wang, Shaolin/0000-0003-0866-4584; Abernathy, Jason/0000-0001-6084-8239	United States Department of Agriculture National Institute for Food and Agriculture Animal Genome Basic Genome Reagents and Tools Program [2009-35205-05101]; Korean Government (MOEHRD) [KRF-2008-357-F00035]	United States Department of Agriculture National Institute for Food and Agriculture Animal Genome Basic Genome Reagents and Tools Program; Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This project was supported in part by a grant from the United States Department of Agriculture National Institute for Food and Agriculture Animal Genome Basic Genome Reagents and Tools Program (USDA/NRICGP award# 2009-35205-05101) and in part by a Korea Research Foundation Grant funded by the Korean Government (MOEHRD), KRF-2008-357-F00035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-502; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Bjornstedt M, 1997, BIOMED ENVIRON SCI, V10, P271; Castelli V, 2004, GENOME RES, V14, P406, DOI 10.1101/gr.1515604; Chapman BA, 2004, BIOINFORMATICS, V20, P180, DOI 10.1093/bioinformatics/bth022; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fagegaltier D, 2000, NUCLEIC ACIDS RES, V28, P2679, DOI 10.1093/nar/28.14.2679; Fischer A, 2001, BIOCHEM BIOPH RES CO, V285, P470, DOI 10.1006/bbrc.2001.5171; Harhay GP, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-166; Hayashizaki Y, 2003, CR BIOL, V326, P923, DOI 10.1016/j.crvi.2003.09.018; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hurowitz EH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000460; Kaldy P, 1999, EMBO J, V18, P6073, DOI 10.1093/emboj/18.21.6073; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Li P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-177; Liu H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-592; MacDonald CC, 2002, MOL CELL ENDOCRINOL, V190, P1, DOI 10.1016/S0303-7207(02)00044-8; Mignone F, 2005, NUCLEIC ACIDS RES, V33, pD141, DOI 10.1093/nar/gki021; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW669, DOI 10.1093/nar/gki436; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; Satoh K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001235; Soderlund C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000740; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomson AM, 1999, INT J BIOCHEM CELL B, V31, P1139, DOI 10.1016/S1357-2725(99)00080-1; Walczak R, 1996, RNA, V2, P367; WANG S, GENOME, V11, pR8; Wang Y, 2007, PHYSIOL GENOMICS, V28, P141, DOI 10.1152/physiolgenomics.00097.2006; Xin DD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002377	31	28	30	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11546	10.1371/journal.pone.0011546	http://dx.doi.org/10.1371/journal.pone.0011546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634964	Green Published, Green Submitted, gold			2022-12-25	WOS:000279781600023
J	Kuka, M; Baronio, R; Valentini, S; Monaci, E; Muzzi, A; Aprea, S; De Gregorio, E; D'Oro, U				Kuka, Mirela; Baronio, Roberta; Valentini, Sara; Monaci, Elisabetta; Muzzi, Alessandro; Aprea, Susanna; De Gregorio, Ennio; D'Oro, Ugo			Src Kinases Are Required for a Balanced Production of IL-12/IL-23 in Human Dendritic Cells Activated by Toll-Like Receptor Agonists	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; T-HELPER-CELLS; TYROSINE KINASES; C-REL; DIFFERENTIATION; INTERLEUKIN-23; PROTEIN; INFLAMMATION; CYTOKINE; TLR	Background: Pathogen recognition by dendritic cells (DC) is crucial for the initiation of both innate and adaptive immune responses. Activation of Toll-like Receptors (TLRs) by microbial molecular patterns leads to the maturation of DC, which present the antigen and activate T cells in secondary lymphoid tissues. Cytokine production by DC is critical for shaping the adaptive immune response by regulating T helper cell differentiation. It was previously shown by our group that Src kinases play a key role in cytokines production during TLR4 activation in human DC. Principal Findings: In this work we investigated the role of Src kinases during different TLRs triggering in human monocyte-derived DC (MoDC). We found that Src family kinases are important for a balanced production of inflammatory cytokines by human MoDC upon stimulation of TLR3 and 8 with their respective agonists. Disruption of this equilibrium through pharmacological inhibition of Src kinases alters the DC maturation pattern. In particular, while expression of IL-12 and other inflammatory cytokines depend on Src kinases, the induction of IL-23 and co-stimulatory molecules do not. Accordingly, DC treated with Src inhibitors are not compromised in their ability to induce CD4 T cell proliferation and to promote the Th17 subset survival but are less efficient in inducing Th1 differentiation. Conclusions: We suggest that the pharmacological modulation of DC maturation has the potential to shape the quality of the adaptive immune response and could be exploited for the treatment of inflammation-related diseases.	[Kuka, Mirela; Baronio, Roberta; Valentini, Sara; Monaci, Elisabetta; Muzzi, Alessandro; Aprea, Susanna; De Gregorio, Ennio; D'Oro, Ugo] Novartis Vaccines, Siena, Italy	Novartis	Kuka, M (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	ugo.doro@novartis.com	KUKA, MIRELA/G-6410-2018; KUKA, MIRELA/M-5336-2019; De Gregorio, Ennio/J-8073-2012	KUKA, MIRELA/0000-0001-9418-1559; KUKA, MIRELA/0000-0001-9418-1559; 	European Network of Excellence DC-THERA [LSHB-CT-2004-512074]; Novartis Vaccines and Diagnostics; DC-THERA	European Network of Excellence DC-THERA; Novartis Vaccines and Diagnostics; DC-THERA	This work was partially supported by the European Network of Excellence DC-THERA (contract number LSHB-CT-2004-512074). Mirela Kuka was supported by a Fellowship from the DC-THERA network. The DC-THERA Network had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Novartis Vaccines and Diagnostics partially funded this work, and approved all the author's decision about study design, data collection and analysis, and decision to publish.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boniface K, 2008, IMMUNOL REV, V226, P132, DOI 10.1111/j.1600-065X.2008.00714.x; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; CHAN SH, 1992, J IMMUNOL, V148, P92; Chan VWF, 1998, J EXP MED, V188, P93, DOI 10.1084/jem.188.1.93; Coffman RL, 2006, NAT IMMUNOL, V7, P539, DOI 10.1038/ni0606-539; Cornelissen F, 2009, CURR OPIN INVEST DR, V10, P452; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Masumi A, 2002, FEBS LETT, V531, P348, DOI 10.1016/S0014-5793(02)03556-1; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Napolitani G, 2003, EUR J IMMUNOL, V33, P2832, DOI 10.1002/eji.200324073; OCONNOR W, 2009, NAT IMMUNOL; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Otani K, 2009, BIOCHEM BIOPH RES CO, V382, P252, DOI 10.1016/j.bbrc.2009.02.107; Page TH, 2009, CURR MOL MED, V9, P69, DOI 10.2174/156652409787314507; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; ROMAGNANI S, 2009, MOL IMMUNOL; Smolinska MJ, 2008, MOL IMMUNOL, V45, P990, DOI 10.1016/j.molimm.2007.07.026; STEFANOVA I, 1993, J BIOL CHEM, V268, P20725; Trinchieri Giorgio, 1992, Progress in Growth Factor Research, V4, P355, DOI 10.1016/0955-2235(92)90016-B; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	37	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11491	10.1371/journal.pone.0011491	http://dx.doi.org/10.1371/journal.pone.0011491			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634889	Green Published, gold, Green Submitted			2022-12-25	WOS:000279715300006
J	Tsurui, K; Honma, A; Nishida, T				Tsurui, Kaori; Honma, Atsushi; Nishida, Takayoshi			Camouflage Effects of Various Colour-Marking Morphs against Different Microhabitat Backgrounds in a Polymorphic Pygmy Grasshopper Tetrix japonica	PLOS ONE			English	Article							DISRUPTIVE COLORATION; CRYPTIC COLORATION; EVOLUTION; PATTERN; SELECTION; TESTS; SIZE	Background: Colour-marking polymorphism is widely distributed among cryptic species. To account for the adaptive significance of such polymorphisms, several hypotheses have been proposed to date. Although these hypotheses argue over the degree of camouflage effects of marking morphs (and the interactions between morphs and their microhabitat backgrounds), as far as we know, most empirical evidence has been provided under unnatural conditions (i.e., using artificial prey). Methodology/Principal Findings: Tetrix japonica, a pygmy grasshopper, is highly polymorphic in colour-markings and occurs in both sand and grass microhabitats. Even within a microhabitat, T. japonica is highly polymorphic. Using humans as dummy predators and printed photographs in which various morphs of grasshoppers were placed against different backgrounds, we addressed three questions to test the neutral, background heterogeneity, and differential crypsis hypotheses in four marking-type morphs: 1) do the morphs differ in the degree of crypsis in each microhabitat, 2) are different morphs most cryptic in specific backgrounds of the microhabitats, and 3) does the morph frequency reflect the degree of crypsis? Conclusions/Significance: The degree of camouflage differed among the four morphs; therefore, the neutral hypothesis was rejected. Furthermore, the order of camouflage advantage among morphs differed depending on the two types of backgrounds (sand and grass), although the grass background consistently provided greater camouflage effects. Thus, based on our results, we could not reject the background heterogeneity hypothesis. Under field conditions, the more cryptic morphs comprised a minority of the population. Overall, our results demonstrate that the different morphs were not equivalent in the degree of crypsis, but the degree of camouflage of the morphs was not consistent with the morph frequency. These findings suggest that trade-offs exist between the camouflage benefit of body colouration and other fitness components, providing a better understanding of the adaptive significance of colour-markings and presumably supporting the differential crypsis hypothesis.	[Tsurui, Kaori; Honma, Atsushi; Nishida, Takayoshi] Kyoto Univ, Grad Sch Agr, Lab Insect Ecol, Sakyo Ku, Kyoto, Japan	Kyoto University	Tsurui, K (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Insect Ecol, Sakyo Ku, Kyoto, Japan.	tsurik@kais.kyoto-u.ac.jp			MEXT [16657008, K18]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a Grant-in-aid for Exploratory Research (16657008) from MEXT to T.N. (http://kaken.nii.ac.jp/ja/p/16657008) and the 21st Century COE Program for Innovative Food and Environmental Studies pioneered by Entomomimetic Sciences (K18) from MEXT (http://www.jsps.go.jp/english/e-21coe/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnesjo J, 2003, J EVOLUTION BIOL, V16, P1308, DOI 10.1046/j.1420-9101.2003.00610.x; Alan BB, 2007, ANNU REV ECOL EVOL S, V38, P489, DOI [10.1146/annurev.ecolsys.38.091206.095728, DOI 10.1146/ANNUREV.ECOLSYS.38.091206.095728]; Arnqvist Goran, 2005, pUnpaginated; Beatty CD, 2004, NATURE, V431, P63, DOI 10.1038/nature02818; Bond AB, 2006, P NATL ACAD SCI USA, V103, P3214, DOI 10.1073/pnas.0509963103; Cott H.B., 1940, ADAPTIVE COLORATION; COX DR, 1972, J R STAT SOC B, V187, P220; Cuthill IC, 2000, ADV STUD BEHAV, V29, P159, DOI 10.1016/S0065-3454(08)60105-9; Cuthill IC, 2005, NATURE, V434, P72, DOI 10.1038/nature03312; Cuthill IC, 2006, P ROY SOC B-BIOL SCI, V273, P1267, DOI 10.1098/rspb.2005.3438; Endler J.A., 1991, P169; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; Forsman A, 1998, BEHAV ECOL, V9, P409, DOI 10.1093/beheco/9.4.409; Forsman A, 2001, OECOLOGIA, V129, P357, DOI 10.1007/s004420100743; Forsman A, 1997, ANN ZOOL FENN, V34, P145; Forsman A, 2000, EVOL ECOL, V14, P25, DOI 10.1023/A:1011024320725; Fraser S, 2007, P ROY SOC B-BIOL SCI, V274, P1325, DOI 10.1098/rspb.2007.0153; Hancock JL, 1902, TETTIGIDAE N AM; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Hochkirch A, 2000, ENTOMOL GEN, V25, P39; Holst K.T., 1986, Fauna Entomologica Scandinavica, V16, P1; Ichikawa A, 2006, ORTHOPTERA JAPANESE; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Majerus M, 1998, MELANISM EVOLUTION A; Merilaita S, 1999, BIOL J LINN SOC, V67, P151, DOI 10.1111/j.1095-8312.1999.tb01858.x; Merilaita S, 2001, P ROY SOC B-BIOL SCI, V268, P1925, DOI 10.1098/rspb.2001.1747; R Development Core Team, 2009, R FDN STAT COMP; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stevens M, 2006, P R SOC B, V273, P2433, DOI 10.1098/rspb.2006.3614; Stevens M, 2009, PHILOS T R SOC B, V364, P481, DOI 10.1098/rstb.2008.0216; Thayer GH., 1909, CONCEALING COLORATIO; Therneau TM, 2000, MODELING SURVIVAL DA; TINBERGEN L., 1960, ARCH NEERLAND ZOOL, V13, P265; Tsurui Kaori, 2010, Bulletin of the Osaka Museum of Natural History, P19; Webster RJ, 2009, PHILOS T R SOC B, V364, P503, DOI 10.1098/rstb.2008.0215	37	26	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11446	10.1371/journal.pone.0011446	http://dx.doi.org/10.1371/journal.pone.0011446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625405	Green Published, gold, Green Submitted			2022-12-25	WOS:000279522500013
J	Meachen-Samuels, JA; Van Valkenburgh, B				Meachen-Samuels, Julie A.; Van Valkenburgh, Blaire			Radiographs Reveal Exceptional Forelimb Strength in the Sabertooth Cat, Smilodon fatalis	PLOS ONE			English	Article							PREDATORY BEHAVIOR; BODY-SIZE; POSTCRANIAL ROBUSTICITY; LATE PLEISTOCENE; TOOTHED CATS; LATE MIOCENE; BITE FORCE; BONE; PATTERNS; MACHAIRODONTINAE	Background: The sabertooth cat, Smilodon fatalis, was an enigmatic predator without a true living analog. Their elongate canine teeth were more vulnerable to fracture than those of modern felids, making it imperative for them to immobilize prey with their forelimbs when making a kill. As a result, their need for heavily muscled forelimbs likely exceeded that of modern felids and thus should be reflected in their skeletons. Previous studies on forelimb bones of S. fatalis found them to be relatively robust but did not quantify their ability to withstand loading. Methodology/Principal Findings: Using radiographs of the sabertooth cat, Smilodon fatalis, 28 extant felid species, and the larger, extinct American lion Panthera atrox, we measured cross-sectional properties of the humerus and femur to provide the first estimates of limb bone strength in bending and torsion. We found that the humeri of Smilodon were reinforced by cortical thickening to a greater degree than those observed in any living felid, or the much larger P. atrox. The femur of Smilodon also was thickened but not beyond the normal variation found in any other felid measured. Conclusions/Significance: Based on the cross-sectional properties of its humerus, we interpret that Smilodon was a powerful predator that differed from extant felids in its greater ability to subdue prey using the forelimbs. This enhanced forelimb strength was part of an adaptive complex driven by the need to minimize the struggles of prey in order to protect the elongate canines from fracture and position the bite for a quick kill.	[Meachen-Samuels, Julie A.; Van Valkenburgh, Blaire] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	University of California System; University of California Los Angeles	Meachen-Samuels, JA (corresponding author), Natl Evolutionary Synth Ctr, Durham, NC 27705 USA.	meachensamuels@nescent.org			University of California Los Angeles (UCLA); National Science Foundation (NSF) [EF-0423641]	University of California Los Angeles (UCLA)(University of California System); National Science Foundation (NSF)(National Science Foundation (NSF))	JMS was partially funded by a University of California Los Angeles (UCLA) Graduate Assistance in Areas of National Need (GAANN) fellowship for collection of data at the Smithsonian Institution and by National Science Foundation (NSF) grant # EF-0423641 to the National Evolutionary Synthesis Center (NESCent) during the writing of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akersten W.A, 1985, CONTRIB SCI NAT HIST, V356, P1; Alexander R., 1983, ANIMAL MECH; Anton M, 2005, QUATERNARY SCI REV, V24, P1287, DOI 10.1016/j.quascirev.2004.09.008; Anton M, 1998, ZOOL J LINN SOC-LOND, V124, P369, DOI 10.1111/j.1096-3642.1998.tb00582.x; Anton M, 1999, J VERTEBR PALEONTOL, V19, P771, DOI 10.1080/02724634.1999.10011190; ANYONGE W, 1993, J ZOOL, V231, P339, DOI 10.1111/j.1469-7998.1993.tb01922.x; Anyonge W, 1996, J ZOOL, V238, P395, DOI 10.1111/j.1469-7998.1996.tb05402.x; Barnett R, 2009, MOL ECOL, V18, P1668, DOI 10.1111/j.1365-294X.2009.04134.x; Beisiegel Beatriz de Mello, 2005, Mammalian Species, P1, DOI 10.1644/783.1; BERTRAM JEA, 1988, J THEOR BIOL, V131, P75, DOI 10.1016/S0022-5193(88)80122-X; BIKNEVICIUS AR, 1993, J MAMMAL, V74, P95, DOI 10.2307/1381908; Bryant Harold N., 1996, P283; Christiansen P, 2006, J MORPHOL, V267, P1186, DOI 10.1002/jmor.10468; Coltrain JB, 2004, PALAEOGEOGR PALAEOCL, V205, P199, DOI 10.1016/j.palaeo.2003.12.008; COTGREAVE P, 1994, OIKOS, V71, P89, DOI 10.2307/3546175; DEMES B, 1991, AM J PHYS ANTHROPOL, V86, P537, DOI 10.1002/ajpa.1330860409; Demes B, 2001, AM J PHYS ANTHROPOL, V116, P257, DOI 10.1002/ajpa.1122.abs; Demes B, 1998, AM J PHYS ANTHROPOL, V106, P87, DOI 10.1002/(SICI)1096-8644(199805)106:1<87::AID-AJPA6>3.0.CO;2-A; Doube M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004742; Ewer, 1998, CARNIVORES; Felidae Martin L.D., 1998, EVOLUTION TERTIARY M, P236; GONYEA W J, 1976, Paleobiology, V2, P332; Heinrich RE, 1998, J MORPHOL, V235, P121, DOI 10.1002/(SICI)1097-4687(199802)235:2<121::AID-JMOR3>3.0.CO;2-C; Lieberman DE, 2004, AM J PHYS ANTHROPOL, V123, P156, DOI 10.1002/ajpa.10316; MacDonald DW, 1996, J ZOOL, V239, P525, DOI 10.1111/j.1469-7998.1996.tb05941.x; Martin RB, 1998, SKELETAL TISSUE MECH; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Meachen-Samuels J, 2009, J MORPHOL, V270, P729, DOI 10.1002/jmor.10712; Meachen-Samuels J, 2008, J VERTEBR PALEONTOL, V28, p115A; MEACHENSAMUELS JA, 2010, J MAMMAL EV IN PRESS; Polk JD, 2000, J HUM EVOL, V39, P297, DOI 10.1006/jhev.2000.0420; RASBAND W, 2007, IMAGEJ; Robling AG, 2002, J BONE MINER RES, V17, P1545, DOI 10.1359/jbmr.2002.17.8.1545; RUBIN CT, 1995, J BONE MINER RES, V10, P488; RUBIN CT, 1982, J EXP BIOL, V101, P187; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Ruff CB, 2000, J HUM EVOL, V38, P269, DOI 10.1006/jhev.1999.0322; RUFF CB, 1993, AM J PHYS ANTHROPOL, V91, P21, DOI 10.1002/ajpa.1330910103; RUFF CB, 1983, AM J PHYS ANTHROPOL, V60, P359, DOI 10.1002/ajpa.1330600308; Runestad JA, 1997, J ZOOL, V242, P261; Salesa MJ, 2010, J ANAT, V216, P381, DOI 10.1111/j.1469-7580.2009.01178.x; Salesa MJ, 2005, ZOOL J LINN SOC-LOND, V144, P363, DOI 10.1111/j.1096-3642.2005.00174.x; Sasaki M, 2005, ANN ANAT, V187, P153, DOI 10.1016/j.aanat.2004.10.001; Schaller G. B., 1972, SERENGETI LION STUDY; Schaller GB., 1967, DEER TIGER; SCHULTZ C B, 1970, Bulletin of the University of Nebraska State Museum, V9, P33; Sorkin B, 2008, LETHAIA, V41, P333, DOI 10.1111/j.1502-3931.2007.00091.x; Therrien F, 2005, ZOOL J LINN SOC-LOND, V145, P393, DOI 10.1111/j.1096-3642.2005.00194.x; TRINKAUS E, 1994, AM J PHYS ANTHROPOL, V93, P1, DOI 10.1002/ajpa.1330930102; Turner A., 1997, BIG CATS THEIR FOSSI; van Valkenburgh B., 1987, Journal of Vertebrate Paleontology, V7, P162; Van Valkenburgh Blaire, 1998, Illinois State Museum Scientific Papers, V27, P357; VANVALKENBURGH B, 1987, J ZOOL, V212, P379; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2008, ZOOLOGY, V111, P196, DOI 10.1016/j.zool.2007.07.008	55	44	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11412	10.1371/journal.pone.0011412	http://dx.doi.org/10.1371/journal.pone.0011412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625398	Green Published, gold			2022-12-25	WOS:000279465700004
J	Hess, D; Chisholm, JW; Igal, RA				Hess, Daniel; Chisholm, Jeffrey W.; Igal, R. Ariel			Inhibition of StearoylCoA Desaturase Activity Blocks Cell Cycle Progression and Induces Programmed Cell Death in Lung Cancer Cells	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; FATTY-ACID SYNTHASE; GROWTH-FACTOR RECEPTOR; MEMBRANE-FLUIDITY; ACTIVATION; PROLIFERATION; PATHWAY; ENZYMES; PROTEIN; BIOSYNTHESIS	Lung cancer is the most frequent form of cancer. The survival rate for patients with metastatic lung cancer is similar to 5%, hence alternative therapeutic strategies to treat this disease are critically needed. Recent studies suggest that lipid biosynthetic pathways, particularly fatty acid synthesis and desaturation, are promising molecular targets for cancer therapy. We have previously reported that inhibition of stearoylCoA desaturase-1 (SCD1), the enzyme that produces monounsaturated fatty acids (MUFA), impairs lung cancer cell proliferation, survival and invasiveness, and dramatically reduces tumor formation in mice. In this report, we show that inhibition of SCD activity in human lung cancer cells with the small molecule SCD inhibitor CVT-11127 reduced lipid synthesis and impaired proliferation by blocking the progression of cell cycle through the G(1)/S boundary and by triggering programmed cell death. These alterations resulting from SCD blockade were fully reversed by either oleic (18: 1n-9), palmitoleic acid (16: 1n-7) or cis-vaccenic acid (18: 1n-7) demonstrating that cis-MUFA are key molecules for cancer cell proliferation. Additionally, co-treatment of cells with CVT-11127 and CP-640186, a specific acetylCoA carboxylase (ACC) inhibitor, did not potentiate the growth inhibitory effect of these compounds, suggesting that inhibition of ACC or SCD1 affects a similar target critical for cell proliferation, likely MUFA, the common fatty acid product in the pathway. This hypothesis was further reinforced by the observation that exogenous oleic acid reverses the anti-growth effect of SCD and ACC inhibitors. Finally, exogenous oleic acid restored the globally decreased levels of cell lipids in cells undergoing a blockade of SCD activity, indicating that active lipid synthesis is required for the fatty acid-mediated restoration of proliferation in SCD1-inhibited cells. Altogether, these observations suggest that SCD1 controls cell cycle progression and apoptosis and, consequently, the overall rate of proliferation in cancer cells through MUFA-mediated activation of lipid synthesis.	[Hess, Daniel; Igal, R. Ariel] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08903 USA; [Hess, Daniel; Igal, R. Ariel] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08903 USA; [Chisholm, Jeffrey W.] Gilead Sci Inc, Biol, Palo Alto, CA USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Gilead Sciences	Hess, D (corresponding author), Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08903 USA.	igal@aesop.rutgers.edu			Pfizer [CP-480186]; School of Environmental and Biological Sciences; Johanna and Charles Busch Foundation, Rutgers University; US Department of Agriculture; Gilead Sciences Inc. [CVT-11127]	Pfizer(Pfizer); School of Environmental and Biological Sciences; Johanna and Charles Busch Foundation, Rutgers University; US Department of Agriculture(United States Department of Agriculture (USDA)); Gilead Sciences Inc.(Gilead Sciences)	We are indebted to Dr Donnie Owens, Pfizer, for the generous donation of CP-480186.; This work was supported in part by funds from the School of Environmental and Biological Sciences and the Johanna and Charles Busch Foundation, Rutgers University, and a Hatch grant from the US Department of Agriculture. Gilead Sciences Inc. provided CVT-11127 in support of the studies and JWC contributed scientifically to the interpretation of the data and writing of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Chang YS, 2005, J LIPID RES, V46, P2624, DOI 10.1194/jlr.M500154-JLR200; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Demoulin JB, 2004, J BIOL CHEM, V279, P35392, DOI 10.1074/jbc.M405924200; Dubey S, 2006, LANCET ONCOL, V7, P416, DOI 10.1016/S1470-2045(06)70693-3; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Falvella FS, 2002, CARCINOGENESIS, V23, P1933, DOI 10.1093/carcin/23.11.1933; Ge GX, 2001, BIOCHEM BIOPH RES CO, V282, P511, DOI 10.1006/bbrc.2001.4600; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Harwood HJ, 2003, J BIOL CHEM, V278, P37099, DOI 10.1074/jbc.M304481200; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; Knowles LM, 2004, J BIOL CHEM, V279, P30540, DOI 10.1074/jbc.M405061200; Koltun DO, 2009, BIOORG MED CHEM LETT, V19, P2048, DOI 10.1016/j.bmcl.2009.02.019; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; LI LO, BIOCH BIOPHYS ACTA, V1801, P246; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; McDonnel AC, 2003, EXP BIOL MED, V228, P308, DOI 10.1177/153537020322800310; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Scaglia N, 2005, J BIOL CHEM, V280, P25339, DOI 10.1074/jbc.M501159200; Scaglia N, 2005, BBA-MOL CELL BIOL L, V1687, P141, DOI 10.1016/j.bbalip.2004.11.015; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Scaglia N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006812; Sok M, 2002, ANN THORAC SURG, V73, P1567, DOI 10.1016/S0003-4975(02)03458-6; Sok M, 1999, CANCER LETT, V139, P215, DOI 10.1016/S0304-3835(99)00044-0; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Vacaresse N, 1999, CIRC RES, V85, P892; Wang J, 2005, BIOCHEM BIOPH RES CO, V332, P735, DOI 10.1016/j.bbrc.2005.05.013; Yahagi N, 2005, EUR J CANCER, V41, P1316, DOI 10.1016/j.ejca.2004.12.037; Zhang L, 1999, BIOCHEM J, V340, P255, DOI 10.1042/0264-6021:3400255	37	131	143	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11394	10.1371/journal.pone.0011394	http://dx.doi.org/10.1371/journal.pone.0011394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613975	Green Published, Green Submitted, gold			2022-12-25	WOS:000279370000022
J	Baker, PJ				Baker, Phillip J.			Chronic Lyme disease: in defense of the scientific enterprise	FASEB JOURNAL			English	Article						evidence-based research; antibiotic therapy	NEUROPROTECTION; GUIDELINES; HISTORY	There is no better example of a relentless attack on evidence-based biomedical research and the integrity of outstanding scientists than that associated with the treatment of a poorly defined condition called "chronic Lyme disease." Here, a scientifically naive general population, the lay press, and legislators, who in most instances are unable to evaluate and judge scientific evidence properly, have been misled by patient advocate groups to believe that extended antibiotic therapy is the best and only solution to this condition. This has resulted in the unprecedented intrusion of government and the legal systems into the practice of medicine and scientific research. Because there is no clinical evidence that this condition is due to a persistent infection, advocating extended antibiotic therapy is not justified and has been shown to be harmful and of no benefit.-Baker, P. J. Chronic Lyme disease: in defense of the scientific enterprise. FASEB J. 24, 4175-4177 (2010). www.fasebj.org	Amer Lyme Dis Fdn, Lyme, CT 06371 USA		Baker, PJ (corresponding author), Amer Lyme Dis Fdn, POB 466, Lyme, CT 06371 USA.	executivedir@aldf.com						Baker PJ, 2008, AM J MED, V121, P562, DOI 10.1016/j.amjmed.2008.02.013; Chandra A, 2010, BRAIN BEHAV IMMUN, V24, P1018, DOI 10.1016/j.bbi.2010.03.002; Domercq M, 2004, TRENDS PHARMACOL SCI, V25, P609, DOI 10.1016/j.tips.2004.10.001; Fallon BA, 2008, NEUROLOGY, V70, P992, DOI 10.1212/01.WNL.0000284604.61160.2d; Halperin JJ, 2007, NEUROLOGY, V69, P91, DOI 10.1212/01.wnl.0000265517.66976.28; HASSETT A, 2009, ARTHRITIS RHEUM, V59, P1742; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Kraemer JD, 2009, JAMA-J AM MED ASSOC, V301, P665, DOI 10.1001/jama.301.6.665; Krupp LB, 2003, NEUROLOGY, V60, P1923, DOI 10.1212/01.WNL.0000071227.23769.9E; Kuschak T, 2007, CAN J INFECT DIS MED, V18, P145; Lantos PM, 2010, CLIN INFECT DIS, V51, P1, DOI 10.1086/654809; Mygland A, 2010, EUR J NEUROL, V17, P8, DOI 10.1111/j.1468-1331.2009.02862.x; Nau R, 2009, DTSCH ARZTEBL INT, V106, P72, DOI 10.3238/arztebl.2009.0072; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sigal L, 2007, ANN INTERN MED, V120, pS4; Weissenbacher S, 2005, DERMATOLOGY, V211, P123, DOI 10.1159/000086441; Weissmann G, 2007, FASEB J, V21, P299, DOI 10.1096/fj.07-0201ufm; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; EUROPEAN UNION CONCE	19	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4175	4177		10.1096/fj.10-167247	http://dx.doi.org/10.1096/fj.10-167247			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20631327				2022-12-25	WOS:000283861100005
J	Lalevee, S; Bour, G; Quinternet, M; Samarut, E; Kessler, P; Vitorino, M; Bruck, N; Delsuc, MA; Vonesch, JL; Kieffer, B; Rochette-Egly, C				Lalevee, Sebastien; Bour, Gaetan; Quinternet, Marc; Samarut, Eric; Kessler, Pascal; Vitorino, Marc; Bruck, Nathalie; Delsuc, Marc-Andre; Vonesch, Jean-Luc; Kieffer, Bruno; Rochette-Egly, Cecile			Vinexin beta, an atypical "sensor" of retinoic acid receptor gamma signaling: union and sequestration, separation, and phosphorylation	FASEB JOURNAL			English	Article						nuclear receptors; coregulators; retinoic acid; transcription	PROLINE-RICH MOTIFS; RAR-GAMMA; OF-PHARMACOLOGY; TRANSCRIPTION; DOMAIN; ALPHA; RECRUITMENT; INTERACTS; PROTEINS; DIFFERENTIATION	The transcriptional activity of nuclear retinoic acid receptors (RARs) relies on the association/dissociation of coregulators at the ligand-binding domain. However, we determined that the N-terminal domain (NTD) also plays a role through its phosphorylation, and we isolated vinexin beta, a cytoskeleton protein with three SH3 domains, as a new partner of the RAR gamma NTD. Here we deciphered the mechanism of the interaction and its role in RAR gamma-mediated transcription. By combining molecular and biophysical (surface plasmon resonance, NMR, and fluorescence resonance energy transfer) approaches, we demonstrated that the third SH3 domain of vinexin beta interacts with a proline-rich domain (PRD) located in RAR gamma NTD and that phosphorylation at a serine located in the PRD abrogates the interaction. The affinity of the interaction was also evaluated. In vivo, vinexin beta represses RAR gamma-mediated transcription and we dissected the underlying mechanism in chromatin immunoprecipitation experiments performed with F9 cells expressing RAR gamma wild type or mutated at the phosphorylation site. In the absence of retinoic acid (RA), vinexin beta does not occupy RAR gamma target gene promoters and sequesters non-phosphorylated RAR gamma out of promoters. In response to RA, RAR gamma becomes phosphorylated and dissociates from vinexin beta. This separation allows RAR gamma to occupy promoters. This is the first report of an RAR corepressor association/dissociation out of promoters and regulated by phosphorylation.-Lalevee, S., Bour, G., Quinternet, M., Samarut, E., Kessler, P., Vitorino, M., Bruck, N., Delsuc, M.-A., Vonesch, J.-L., Kieffer, B., Rochette-Egly, C. Vinexin beta, an atypical "sensor" of retinoic acid receptor gamma signaling: union and sequestration, separation, and phosphorylation. FASEB J. 24, 4523-4534 (2010). www.fasebj.org	[Rochette-Egly, Cecile] Univ Strasbourg, INSERM, IGBMC, U596, F-67404 Illkirch Graffenstaden, France; Univ Strasbourg, CNRS, UMR 7104, F-67404 Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Rochette-Egly, C (corresponding author), Univ Strasbourg, INSERM, IGBMC, U596, 1 Rue Laurent Fries,BP 10142, F-67404 Illkirch Graffenstaden, France.	cegly@igbmc.fr	Kessler, Pascal/ABF-6615-2021; Kieffer, Bruno/AAE-8999-2019; Delsuc, Marc-André/ABI-5400-2020	Delsuc, Marc-André/0000-0002-1400-5326; SAMARUT, ERIC/0000-0001-7818-2009; QUINTERNET, Marc/0000-0002-8299-7136; Kieffer, Bruno/0000-0002-2033-4679	Centre National de la Recherche Scientifique, INSERM; Agence Nationale pour la Recherche [ANR-05-BLAN- 0390-02, ANR-09-BLAN-0297-01]; Association pour la Recherche sur le Cancer [ARC-07-1-3169]; Foundation pour la Recherche Medicale (FRM) [DEQ 20090515423]; Institut National du Cancer [INCa-PL06-095, PL07-96099]; Ministere de l'Enseignement Superieur et de la Recherche; ARC	Centre National de la Recherche Scientifique, INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Foundation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National du Cancer(Institut National du Cancer (INCA) France); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); ARC(Australian Research Council)	The authors thank Dr. N. Kioka (Kyoto University, Kyoto, Japan) for the gift of the vinexin beta vector, M. Oulad Abdelghani (IGBMC) for the mouse monoclonal antibodies, and P. Eberling (IGBMC) for the synthetic peptides. The authors are also grateful to D. Altschuh and the Biacore platform (UMR 7100 Illkirch). The authors warmly acknowledge Regis Lutzing, Julie Goepp, Hussein Raad, Xiaojun Gao, Anne Chapelle, and members of the cell culture facilities for help. We give special thanks to Christine Ferry and Ali Hamiche for fruitful discussions and suggestions. This work was supported by funds from Centre National de la Recherche Scientifique, INSERM, the Agence Nationale pour la Recherche (ANR-05-BLAN- 0390-02 and ANR-09-BLAN-0297-01), the Association pour la Recherche sur le Cancer (ARC-07-1-3169), the Foundation pour la Recherche Medicale (FRM; DEQ 20090515423), and the Institut National du Cancer (INCa-PL06-095 and PL07-96099). S.L. was supported by the Ministere de l'Enseignement Superieur et de la Recherche and ARC.	Altschuh D, 2006, J MOL RECOGNIT, V19, P459, DOI 10.1002/jmr.807; Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Bastien J, 2000, J BIOL CHEM, V275, P21896, DOI 10.1074/jbc.M001985200; Bour G, 2005, J BIOL CHEM, V280, P17027, DOI 10.1074/jbc.M501344200; Bour G, 2006, AD DEV BIOL, V16, P211, DOI 10.1016/S1574-3349(06)16007-X; Bruck N, 2009, EMBO J, V28, P34, DOI 10.1038/emboj.2008.256; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Farboud B, 2003, MOL CELL BIOL, V23, P2844, DOI 10.1128/MCB.23.8.2844-2858.2003; Gaillard E, 2006, P NATL ACAD SCI USA, V103, P9548, DOI 10.1073/pnas.0509717103; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Gianni M, 2002, EMBO J, V21, P3760, DOI 10.1093/emboj/cdf374; Gillespie RF, 2007, J BIOL CHEM, V282, P33421, DOI 10.1074/jbc.M704845200; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Hauksdottir H, 2003, MOL ENDOCRINOL, V17, P373, DOI 10.1210/me.2002-0340; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kioka N, 2002, CELL STRUCT FUNCT, V27, P1, DOI 10.1247/csf.27.1; Lavery DN, 2005, BIOCHEM J, V391, P449, DOI 10.1042/BJ20050872; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Mitsushima M, 2006, GENES CELLS, V11, P281, DOI 10.1111/j.1365-2443.2006.00932.x; Mitsushima M, 2006, FEBS LETT, V580, P4288, DOI 10.1016/j.febslet.2006.06.072; Ouararhni K, 2006, GENE DEV, V20, P3324, DOI 10.1101/gad.396106; Plassat JL, 2000, J CELL SCI, V113, P2887; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Taneja R, 1997, EMBO J, V16, P6452, DOI 10.1093/emboj/16.21.6452; Townson SM, 2003, J BIOL CHEM, V278, P20059, DOI 10.1074/jbc.M212988200; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; Zhang JH, 2007, BIOCHEM BIOPH RES CO, V357, P931, DOI 10.1016/j.bbrc.2007.04.029; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x	30	22	22	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4523	4534		10.1096/fj.10-160572	http://dx.doi.org/10.1096/fj.10-160572			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20634350				2022-12-25	WOS:000283861100037
J	Van Goietsenoven, G; Hutton, J; Becker, JP; Lallemand, B; Robert, F; Lefranc, F; Pirker, C; Vandenbussche, G; Van Antwerpen, P; Evidente, A; Berger, W; Prevost, M; Pelletier, J; Kiss, R; Kinzy, TG; Kornienko, A; Mathieu, V				Van Goietsenoven, Gwendoline; Hutton, Jenna; Becker, Jean-Paul; Lallemand, Benjamin; Robert, Francis; Lefranc, Florence; Pirker, Christine; Vandenbussche, Guy; Van Antwerpen, Pierre; Evidente, Antonio; Berger, Walter; Prevost, Martine; Pelletier, Jerry; Kiss, Robert; Kinzy, Terri Goss; Kornienko, Alexander; Mathieu, Veronique			Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas	FASEB JOURNAL			English	Article						narciclasine; growth inhibition; apoptosis resistance; actin	ACTIN-BINDING PROTEIN; ELONGATION-FACTOR 1A; CANCER-CELLS; TRANSLATION ELONGATION; APOPTOSIS; NARCICLASINE; CYTOSKELETON; MITOCHONDRIA; RESISTANCE; LYCORINE	Melanomas display poor response rates to adjuvant therapies because of their intrinsic resistance to proapoptotic stimuli. This study indicates that such resistance can be overcome, at least partly, through the targeting of eEF1A elongation factor with narciclasine, an Amaryllidaceae isocarbostyril controlling plant growth. Narciclasine displays IC50 growth inhibitory values between 30-100 nM in melanoma cell lines, irrespective of their levels of resistance to proapoptotic stimuli. Normal noncancerous cell lines are much less affected. At nontoxic doses, narciclasine also significantly improves (P=0.004) the survival of mice bearing metastatic apoptosis-resistant melanoma xeno-grafts in their brain. The eEF1A targeting with narciclasine (50 nM) leads to 1) marked actin cytoskeleton disorganization, resulting in cytokinesis impairment, and 2) protein synthesis impairment (elongation and initiation steps), whereas apoptosis is induced at higher doses only (>= 200 nM). In addition to molecular docking validation and identification of potential binding sites, we biochemically confirmed that narciclasine directly binds to human recombinant and yeast-purified eEF1A in a nanomolar range, but not to actin or elongation factor 2, and that 5 nM narciclasine is sufficient to impair eEF1A-related actin bundling activity. eEF1A is thus a potential target to combat melanomas regardless of their apoptosis-sensitivity, and this finding reconciles the pleiotropic cytostatic of narciclasine.-Van Goietsenoven, G., Hutton, J., Becker, J.-P., Lallemand, B., Robert, F., Lefranc, F., Pirker, C., Vandenbussche, G., Van Antwerpen, P., Evidente, A., Berger, W., Prevost, M., Pelletier, J., Kiss, R., Goss Kinzy, T., Kornienko, A., Mathieu, V. Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas. FASEB J. 24, 4575-4584 (2010). www.fasebj.org	[Kiss, Robert] Univ Libre Bruxelles, Inst Pharm, Toxicol Lab, B-1050 Brussels, Belgium; [Lallemand, Benjamin] Univ Libre Bruxelles, Lab Bioanalyt Chem Toxicol & Appl Chem, B-1050 Brussels, Belgium; [Van Antwerpen, Pierre] Univ Libre Bruxelles, Inst Pharm, Lab Pharmaceut Chem, B-1050 Brussels, Belgium; [Becker, Jean-Paul; Vandenbussche, Guy; Prevost, Martine] Univ Libre Bruxelles, Lab Struct & Funct Biol Membranes, Ctr Struct Biol & Bioinformat, B-1050 Brussels, Belgium; [Hutton, Jenna; Kinzy, Terri Goss] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA; [Robert, Francis; Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Lefranc, Florence] Erasme Univ Hosp, Dept Neurosurg, B-1070 Brussels, Belgium; [Pirker, Christine; Berger, Walter] Med Univ Vienna, Inst Canc Res, Dept Med 1, Vienna, Austria; [Evidente, Antonio] Univ Naples Federico II, Dipartimento Sci Suolo Pianta Ambiente & Prod Ani, Portici, Italy; [Kornienko, Alexander] New Mexico Inst Min & Technol, Dept Chem, Socorro, NM 87801 USA	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Rutgers State University New Brunswick; Rutgers State University Medical Center; McGill University; Universite Libre de Bruxelles; Medical University of Vienna; University of Naples Federico II; New Mexico Institute of Mining Technology	Kiss, R (corresponding author), Univ Libre Bruxelles, Inst Pharm, Toxicol Lab, Campus Plaine,Blvd Triomphe, B-1050 Brussels, Belgium.	rkiss@ulb.ac.be	Kornienko, Alexander/AAE-1870-2020; Evidente, Antonio/N-9357-2013	Kornienko, Alexander/0000-0003-2041-7367; Evidente, Antonio/0000-0001-9110-1656; Van Antwerpen, Pierre/0000-0002-4934-8863; Kinzy, Terri/0000-0003-1394-9226; Pirker, Christine/0000-0001-7104-4404; Berger, Walter/0000-0003-0014-1658; Vandenbussche, Guy/0000-0001-9592-2304	Fonds Yvonne Boel (Brussels, Belgium); Fonds National de la Recherche Scientifique (FNRS; Brussels, Belgium); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057483] Funding Source: NIH RePORTER	Fonds Yvonne Boel (Brussels, Belgium); Fonds National de la Recherche Scientifique (FNRS; Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Jean-Francois Gaussin and Sebastien Sauvage for the in vivo experiment. The present work has been supported partly by grants awarded by the Fonds Yvonne Boel (Brussels, Belgium) and by the Fonds National de la Recherche Scientifique (FNRS; Brussels, Belgium). F.L. is a clinical research fellow, V.M. is a senior research assistant, and R.K. is a director of research with the FNRS.	Atallah Ehab, 2005, Curr Treat Options Oncol, V6, P185; Berger W, 1997, INT J CANCER, V71, P108, DOI 10.1002/(SICI)1097-0215(19970328)71:1<108::AID-IJC18>3.0.CO;2-E; Bi YR, 2003, J PLANT PHYSIOL, V160, P1041, DOI 10.1078/0176-1617-00911; Boldogh IR, 2006, BBA-MOL CELL RES, V1763, P450, DOI 10.1016/j.bbamcr.2006.02.014; CARRASCO L, 1975, FEBS LETT, V52, P236, DOI 10.1016/0014-5793(75)80813-1; CERIOTTI G, 1967, NATURE, V213, P595, DOI 10.1038/213595a0; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; de Heredia ML, 2004, CURR OPIN CELL BIOL, V16, P80, DOI 10.1016/j.ceb.2003.11.002; Dumont P, 2007, NEOPLASIA, V9, P766, DOI 10.1593/neo.07535; Duttaroy A, 1998, EXP CELL RES, V238, P168, DOI 10.1006/excr.1997.3819; Eberle J, 2007, DRUG RESIST UPDATE, V10, P218, DOI 10.1016/j.drup.2007.09.001; Edmonds BT, 1996, J CELL SCI, V109, P2705; EVIDENTE A, 1991, PLANTA MED, V57, P293, DOI 10.1055/s-2006-960098; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gerweck LE, 1996, CANCER RES, V56, P1194; GHEORGHUI A, 1962, ANN PHARM FR, V20, P531; Grassi G, 2007, BIOCHIMIE, V89, P1544, DOI 10.1016/j.biochi.2007.07.007; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Hamm C, 2008, CANCER TREAT REV, V34, P145, DOI 10.1016/j.ctrv.2007.10.003; Hayot C, 2006, TOXICOL APPL PHARM, V211, P30, DOI 10.1016/j.taap.2005.06.006; Ingrassia L, 2009, J MED CHEM, V52, P1100, DOI 10.1021/jm8013585; Ivanov VN, 2003, ONCOGENE, V22, P3152, DOI 10.1038/sj.onc.1206456; Jansen RP, 1999, FASEB J, V13, P455, DOI 10.1096/fasebj.13.3.455; JIMENEZ A, 1976, BIOCHIM BIOPHYS ACTA, V425, P342, DOI 10.1016/0005-2787(76)90261-6; Kornienko A, 2008, CHEM REV, V108, P1982, DOI 10.1021/cr078198u; La Porta CAM, 2007, CURR MED CHEM, V14, P387; Lamoral-Theys D, 2009, J MED CHEM, V52, P6244, DOI 10.1021/jm901031h; Lefranc F, 2009, MOL CANCER THER, V8, P1739, DOI 10.1158/1535-7163.MCT-08-0932; Li R, 2006, ONCOGENE, V25, P2628, DOI 10.1038/sj.onc.1209289; Liu G, 1996, J CELL BIOL, V135, P953, DOI 10.1083/jcb.135.4.953; Liu J, 2007, BIOMED PHARMACOTHER, V61, P229, DOI 10.1016/j.biopha.2007.01.003; Liu XS, 2009, CANCER LETT, V274, P16, DOI 10.1016/j.canlet.2008.08.029; Mathieu V, 2009, J CELL MOL MED, V13, P3960, DOI 10.1111/j.1582-4934.2009.00708.x; McLachlan A, 2005, APOPTOSIS, V10, P619, DOI 10.1007/s10495-005-1896-x; Murray JW, 1996, J CELL BIOL, V135, P1309, DOI 10.1083/jcb.135.5.1309; Noble CG, 2008, CELL MOL LIFE SCI, V65, P1335, DOI 10.1007/s00018-008-7495-6; Pelletier CL, 2007, CANCER RES, V67, P1609, DOI 10.1158/0008-5472.CAN-06-2875; Pettit GR, 2009, J NAT PROD, V72, P1279, DOI 10.1021/np9001948; PETTIT GR, 1986, J NAT PROD, V49, P995, DOI 10.1021/np50048a005; Pinke DE, 2008, GYNECOL ONCOL, V108, P561, DOI 10.1016/j.ygyno.2007.11.019; Pittman YR, 2009, J BIOL CHEM, V284, P4739, DOI 10.1074/jbc.M807945200; SADOWSKI J, 1993, CHEM REV, V93, P2567, DOI 10.1021/cr00023a012; Siedlakowski P, 2008, CANCER BIOL THER, V7, P376, DOI 10.4161/cbt.7.3.5364; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Wang CH, 2008, J CELL SCI, V121, P2913, DOI 10.1242/jcs.023911; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0	48	99	99	0	36	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4575	4584		10.1096/fj.10-162263	http://dx.doi.org/10.1096/fj.10-162263			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20643906	Green Published			2022-12-25	WOS:000283861100042
J	Poillot, C; Dridi, K; Bichraoui, H; Pecher, J; Alphonse, S; Douzi, B; Ronjat, M; Darbon, H; De Waard, M				Poillot, Cathy; Dridi, Kaouthar; Bichraoui, Hicham; Pecher, Julien; Alphonse, Sebastien; Douzi, Badreddine; Ronjat, Michel; Darbon, Herve; De Waard, Michel			D-Maurocalcine, a Pharmacologically Inert Efficient Cell-penetrating Peptide Analogue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-AMINO-ACID; SKELETAL RYANODINE RECEPTOR; TORSION ANGLE DYNAMICS; SCORPION TOXIN; EXCITATORY PEPTIDE; PROTEIN STRUCTURES; IN-VITRO; NMR; MECHANISM; DELIVERY	Maurocalcine has been the first demonstrated animal toxin acting as a cell-penetrating peptide. Although it possesses competitive advantages, its use as a cell-penetrating peptide (CPP) requires that analogues be developed that lack its characteristic pharmacological activity on ryanodine-sensitive calcium channels without affecting its cell-penetrating and vector efficiencies. Here, we present the synthesis, three-dimensional (HNMR)-H-1 structure, and activity of D-maurocalcine. We demonstrate that it possesses all of the desired features for an excellent CPP: preserved structure, lack of pharmacological action, conserved vector properties, and absence of cell toxicity. This is the first report of a folded/oxidized animal toxin in its D-diastereomer conformation for use as a CPP. The protease resistance of this new peptide analogue, combined with its efficient cell penetration at concentrations devoid of cell toxicity, suggests that D-maurocalcine should be an excellent vector for in vivo applications.	[Ronjat, Michel; De Waard, Michel] INSERM, U836, Grenoble Inst Neurosci, F-38042 Grenoble 9, France; [Dridi, Kaouthar; Alphonse, Sebastien; Douzi, Badreddine; Darbon, Herve] Architecture & Funct Macromol Biol CNRS, UMR 6098, F-13288 Marseille 9, France; [Pecher, Julien; De Waard, Michel] Smartox Biotechnol, Floralis, Biopolis, F-38700 La Tronche, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	De Waard, M (corresponding author), INSERM, U836, Grenoble Inst Neurosci, BP170, F-38042 Grenoble 9, France.	michel.dewaard@ujf-grenoble.fr	douzi, Badreddine/Z-5707-2019; De Waard, Michel/G-7406-2014; Douzi, Badreddine/ABA-4540-2021	De Waard, Michel/0000-0002-2782-9615; Douzi, Badreddine/0000-0003-3140-4713; Alphonse, Sebastien/0000-0002-2054-2005; Ronjat, Michel/0000-0002-9728-6425	Technology pour la Sante; Agence Nationale de la Recherche; Association Francaise contre les Myopathies	Technology pour la Sante; Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by grants from Technology pour la Sante (Program TIMOMA2 of the Commissariat a l'Energie Atomique) and from Agence Nationale de la Recherche PNANO (Programs SYNERGIE and NanoFret).; Supported by a grant of the Association Francaise contre les Myopathies.	Altafaj X, 2005, J BIOL CHEM, V280, P4013, DOI 10.1074/jbc.C400433200; Beeton C, 2008, J BIOL CHEM, V283, P988, DOI 10.1074/jbc.M706008200; Boisseau S, 2006, BBA-BIOMEMBRANES, V1758, P308, DOI 10.1016/j.bbamem.2006.02.007; Buczek O, 2005, J BIOL CHEM, V280, P4247, DOI 10.1074/jbc.M405835200; Buczek O, 2008, TOXICON, V51, P218, DOI 10.1016/j.toxicon.2007.09.006; Chen L, 2003, J BIOL CHEM, V278, P16095, DOI 10.1074/jbc.M209501200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; di Luccio E, 2001, BIOCHEM J, V358, P681, DOI 10.1042/0264-6021:3580681; Dutertre S, 2006, FEBS LETT, V580, P3860, DOI 10.1016/j.febslet.2006.06.011; Esteve E, 2005, J BIOL CHEM, V280, P12833, DOI 10.1074/jbc.M412521200; Esteve E, 2003, J BIOL CHEM, V278, P37822, DOI 10.1074/jbc.M305798200; Fajloun Z, 2000, FEBS LETT, V469, P179, DOI 10.1016/S0014-5793(00)01239-4; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Huang FJ, 2009, TOXICON, V54, P153, DOI 10.1016/j.toxicon.2009.03.033; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KIM DH, 1983, J BIOL CHEM, V258, P9662; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lukacs B, 2008, BIOPHYS J, V95, P3497, DOI 10.1529/biophysj.107.120840; Mabrouk K, 2007, BBA-BIOMEMBRANES, V1768, P2528, DOI 10.1016/j.bbamem.2007.06.030; Mae M, 2006, CURR OPIN PHARMACOL, V6, P509, DOI 10.1016/j.coph.2006.04.004; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; MERRIFIELD RB, 1969, ADV ENZYMOL RAMB, V32, P221; Mosbah A, 2000, PROTEINS, V40, P436, DOI 10.1002/1097-0134(20000815)40:3&lt;436::AID-PROT90&gt;3.0.CO;2-9; Nabuurs SB, 2004, PROTEINS, V55, P483, DOI 10.1002/prot.20118; Oehlke J, 1998, BBA-BIOMEMBRANES, V1414, P127, DOI 10.1016/S0005-2736(98)00161-8; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Patel LN, 2007, PHARM RES, V24, P1977, DOI 10.1007/s11095-007-9303-7; Pooga M, 1998, FASEB J, V12, P67, DOI 10.1096/fasebj.12.1.67; Pooga M, 1998, NAT BIOTECHNOL, V16, P857, DOI 10.1038/nbt0998-857; Ram N, 2008, J BIOL CHEM, V283, P27048, DOI 10.1074/jbc.M804727200; Ram N, 2008, J BIOL CHEM, V283, P24274, DOI 10.1074/jbc.M709971200; Rhee M, 2006, J BIOL CHEM, V281, P1233, DOI 10.1074/jbc.M509813200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P1; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	44	20	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34168	34180		10.1074/jbc.M110.104919	http://dx.doi.org/10.1074/jbc.M110.104919			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20610396	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-25	WOS:000283354000062
J	Aachmann, FL; Sal, LS; Kim, HY; Marino, SM; Gladyshev, VN; Dikiy, A				Aachmann, Finn L.; Sal, Lena S.; Kim, Hwa-Young; Marino, Stefano M.; Gladyshev, Vadim N.; Dikiy, Alexander			Insights into Function, Catalytic Mechanism, and Fold Evolution of Selenoprotein Methionine Sulfoxide Reductase B1 through Structural Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							R-SULFOXIDE; NEISSERIA-MENINGITIDIS; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; CHEMICAL-SHIFT; PROTEIN; CYSTEINE; ZINC; SELENOCYSTEINE; THIOREDOXIN	Methionine sulfoxide reductases protect cells by repairing oxidatively damaged methionine residues in proteins. Here, we report the first three-dimensional structure of the mammalian selenoprotein methionine sulfoxide reductase B1 (MsrB1), determined by high resolution NMR spectroscopy. Heteronuclear multidimensional spectra yielded NMR spectral assignments for the reduced form of MsrB1 in which catalytic selenocysteine (Sec) was replaced with cysteine (Cys). MsrB1 consists of a central structured core of two beta-sheets and a highly flexible, disordered N-terminal region. Analysis of pH dependence of NMR signals of catalytically relevant residues, comparison with the data for bacterial MsrBs, and NMR-based structural analysis of methionine sulfoxide (substrate) and methionine sulfone (inhibitor) binding to MsrB1 at the atomic level reveal a mechanism involving catalytic Sec(95) and resolving Cys(4) residues in catalysis. The MsrB1 structure differs from the structures of Cys-containing MsrBs in the use of distal selenenylsulfide, residues needed for catalysis, and the mode in which the active form of the enzyme is regenerated. In addition, this is the first structure of a eukaryotic zinc-containing MsrB, which highlights the structural role of this metal ion bound to four conserved Cys. We integrated this information into a structural model of evolution of MsrB superfamily.	[Aachmann, Finn L.; Sal, Lena S.; Dikiy, Alexander] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway; [Kim, Hwa-Young] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu 705717, South Korea; [Marino, Stefano M.; Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Marino, Stefano M.; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Norwegian University of Science & Technology (NTNU); Yeungnam University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Dikiy, A (corresponding author), Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway.	alex.dikiy@biotech.ntnu.no	Gladyshev, Vadim N/A-9894-2013; Aachmann, Finn/G-4136-2015; Gladyshev, Vadim N/J-6187-2013	Aachmann, Finn/0000-0003-1613-4663; Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health [AG021518]; Faculty of Natural Sciences and Technology at the Norwegian University of Science and Technology; National Research Foundation of Korea [2010-0001240]; EUNMR [RII3-026145]; Norwegian Research Council Kompetenseprogjekt Med Brukermedvizkning (KMB) [182695/I40]; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Faculty of Natural Sciences and Technology at the Norwegian University of Science and Technology; National Research Foundation of Korea(National Research Foundation of Korea); EUNMR; Norwegian Research Council Kompetenseprogjekt Med Brukermedvizkning (KMB); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG021518 (to V. N. G.). This work was also supported by the Faculty of Natural Sciences and Technology at the Norwegian University of Science and Technology (A. D.) and National Research Foundation of Korea Grant 2010-0001240 (to H.-Y. K.). Access to the 800-MHz NMR spectrometer at the NMR center at the University of Florence was within the EUNMR project Contract RII3-026145.; Supported by the Norwegian Research Council Kompetenseprogjekt Med Brukermedvizkning (182695/I40) (KMB) project.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chantalat L, 1999, EMBO J, V18, P2930, DOI 10.1093/emboj/18.11.2930; CHEIGHTON TE, 1996, PROTEIN STRUCTURE MO; COLONNACESARI F, 1986, J BIOL CHEM, V261, P5273; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DeLano WL, 2002, PYMOL USERS MANUAL; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Kauffmann B, 2005, BBA-PROTEINS PROTEOM, V1703, P249, DOI 10.1016/j.bbapap.2004.09.008; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keller RLJ., 2004, OPTIMIZING PROCESS N; Kim HY, 2008, BIOCHEM BIOPH RES CO, V371, P490, DOI 10.1016/j.bbrc.2008.04.101; Kim HY, 2007, BIOCHEM J, V407, P321, DOI 10.1042/BJ20070929; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Kim YK, 2009, MOL MICROBIOL, V72, P699, DOI 10.1111/j.1365-2958.2009.06680.x; Kornhaber GJ, 2006, J BIOMOL NMR, V34, P259, DOI 10.1007/s10858-006-0027-5; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Kumar RA, 2002, J BIOL CHEM, V277, P37527, DOI 10.1074/jbc.M203496200; Lee BC, 2008, J BIOL CHEM, V283, P28361, DOI 10.1074/jbc.M805059200; Lee SR, 2000, P NATL ACAD SCI USA, V97, P2521, DOI 10.1073/pnas.050579797; Lee TH, 2008, ARCH BIOCHEM BIOPHYS, V478, P175, DOI 10.1016/j.abb.2008.07.028; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Mechulam Y, 1999, J MOL BIOL, V294, P1287, DOI 10.1006/jmbi.1999.3339; Neiers F, 2004, J BIOL CHEM, V279, P42462, DOI 10.1074/jbc.M407464200; Neiers F, 2007, J BIOL CHEM, V282, P32397, DOI 10.1074/jbc.M704730200; Olry A, 2005, PROTEIN SCI, V14, P2828, DOI 10.1110/ps.051711105; Olry A, 2004, BIOCHEMISTRY-US, V43, P11616, DOI 10.1021/bi049306z; Ranaivoson FM, 2009, J MOL BIOL, V394, P83, DOI 10.1016/j.jmb.2009.08.073; Sal LS, 2007, BIOMOL NMR ASSIGM, V1, P131, DOI 10.1007/s12104-007-9039-7; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664	36	21	24	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33315	33323		10.1074/jbc.M110.132308	http://dx.doi.org/10.1074/jbc.M110.132308			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20605785	hybrid, Green Published			2022-12-25	WOS:000283048200067
J	Maloverjan, A; Piirsoo, M; Kasak, L; Peil, L; Osterlund, T; Kogerman, P				Maloverjan, Alla; Piirsoo, Marko; Kasak, Lagle; Peil, Lauri; Osterlund, Torben; Kogerman, Priit			Dual Function of UNC-51-like Kinase 3 (Ulk3) in the Sonic Hedgehog Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-THREONINE KINASE; PROTEIN-KINASE; CUBITUS-INTERRUPTUS; GENETIC DISSECTION; NEGATIVE REGULATOR; FUSED GENE; SUPPRESSOR; GLI; DROSOPHILA; POLARITY	The Sonic hedgehog (Shh) signaling pathway controls a variety of developmental processes and is implicated in tissue homeostasis maintenance and neurogenesis in adults. Recently, we identified Ulk3 as an active kinase able to positively regulate Gli proteins, mediators of the Shh signaling in mammals. Here, we provide several lines of evidence that Ulk3 participates in the transduction of the Shh signal also independently of its kinase activity. We demonstrate that Ulk3 through its kinase domain interacts with Suppressor of Fused (Sufu), a protein required for negative regulation of Gli proteins. Sufu blocks Ulk3 autophosphorylation and abolishes its ability to phosphorylate and positively regulate Gli proteins. We show that Shh signaling destabilizes the Sufu-Ulk3 complex and induces the release of Ulk3. We demonstrate that the Sufu-Ulk3 complex, when co-expressed with Gli2, promotes generation of the Gli2 repressor form, and that reduction of the Ulk3 mRNA level in Shh-responsive cells results in higher potency of the cells to transmit the Shh signal. Our data suggests a dual function of Ulk3 in the Shh signal transduction pathway and propose an additional way of regulating Gli proteins by Sufu, through binding to and suppression of Ulk3.	Tallinn Univ Technol, Dept Gene Technol, Inst Clin Med, EE-12618 Tallinn, Estonia; [Kogerman, Priit] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia	Tallinn University of Technology; University of Tartu		alla.maloverjan@ttu.ee	Piirsoo, Alla/G-5890-2017; Peil, Lauri/G-9944-2012	Peil, Lauri/0000-0001-6906-7113; Osterlund, Torben/0000-0002-2047-767X	Estonian Science Foundation [7279, 8116]; Center of Excellence in Chemical Biology (Institute of Technology, University of Tartu)	Estonian Science Foundation; Center of Excellence in Chemical Biology (Institute of Technology, University of Tartu)	This work was supported in part by Estonian Science Foundation Grants 7279 (to T. O.) and 8116 (to P. K.). Mass spectrometric analyses were supported in part by the European Regional Development Fund through the Center of Excellence in Chemical Biology (Institute of Technology, University of Tartu).	Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Alves G, 1998, MECH DEVELOP, V78, P17, DOI 10.1016/S0925-4773(98)00130-0; Ascano M, 2004, MOL CELL BIOL, V24, P10397, DOI 10.1128/MCB.24.23.10397-10405.2004; Ascano M, 2002, MOL CELL BIOL, V22, P1555, DOI 10.1128/MCB.22.5.1555-1566.2002; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Chen MH, 2005, MOL CELL BIOL, V25, P7042, DOI 10.1128/MCB.25.16.7042-7053.2005; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chen Y, 1998, P NATL ACAD SCI USA, V95, P2349, DOI 10.1073/pnas.95.5.2349; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Claret S, 2007, CURR BIOL, V17, P1326, DOI 10.1016/j.cub.2007.06.059; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Dussillol-Godar F, 2006, DEV BIOL, V291, P53, DOI 10.1016/j.ydbio.2005.12.004; Evangelista M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162925; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hellman U, 2000, EXS, V88, P43; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jacob J, 2003, EMBO REP, V4, P761, DOI 10.1038/sj.embor.embor896; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lefers MA, 2001, DEV BIOL, V236, P411, DOI 10.1006/dbio.2001.0345; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Maloverjan A, 2010, EXP CELL RES, V316, P627, DOI 10.1016/j.yexcr.2009.10.018; Maloveryan A, 2007, J CELL COMMUN SIGNAL, V1, P165, DOI 10.1007/s12079-007-0014-y; Merchant M, 2005, MOL CELL BIOL, V25, P7054, DOI 10.1128/MCB.25.16.7054-7068.2005; Monnier V, 1998, CURR BIOL, V8, P583, DOI 10.1016/S0960-9822(98)70227-1; Murone M, 2000, NAT CELL BIOL, V2, P310, DOI 10.1038/35010610; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Nybakken KE, 2002, J BIOL CHEM, V277, P24638, DOI 10.1074/jbc.M110730200; Paces-Fessy M, 2004, BIOCHEM J, V378, P353, DOI 10.1042/BJ20030786; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pan Y, 2009, DEV BIOL, V326, P177, DOI 10.1016/j.ydbio.2008.11.009; Pearse RV, 1999, DEV BIOL, V212, P323, DOI 10.1006/dbio.1999.9335; PHAM A, 1995, GENETICS, V140, P587; PREAT T, 1992, GENETICS, V132, P725; PREAT T, 1993, GENETICS, V135, P1047; PREAT T, 1990, NATURE, V347, P87, DOI 10.1038/347087a0; Rieff HI, 1999, J NEUROSCI, V19, P10757, DOI 10.1523/JNEUROSCI.19-24-10757.1999; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; RUIZ I ALTABA A, 2007, TRENDS CELL BIOL, V17, P438; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Stegman MA, 2000, J BIOL CHEM, V275, P21809, DOI 10.1074/jbc.C000043200; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Therond P, 1996, GENETICS, V142, P1181; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; Tsanev R, 2009, FEBS LETT, V583, P224, DOI 10.1016/j.febslet.2008.12.010; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103	58	39	42	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30079	30090		10.1074/jbc.M110.133991	http://dx.doi.org/10.1074/jbc.M110.133991			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20643644	Green Published, hybrid			2022-12-25	WOS:000281984300046
J	Kamath, P; Huntington, JA; Krishnaswamy, S				Kamath, Parvathi; Huntington, James A.; Krishnaswamy, Sriram			Ligand Binding Shuttles Thrombin along a Continuum of Zymogen-and Proteinase-like States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ALLOSTERIC LINKAGE; 2 CONFORMATIONS; EXOSITE-I; PROTHROMBIN; NA+; SUBSTRATE; COMPENSATION; SPECIFICITY; ACTIVATION	The critical and multiple roles of thrombin in blood coagulation are regulated by ligands and cofactors. Zymogen activation imparts proteolytic activity to thrombin and also affects the binding of ligands to its two principal exosites. We have used the activation peptide fragment 1.2 (F12), a ligand for anion-binding exosite 2, to probe the zymogenicity of thrombin by isothermal titration calorimetry. We show that F12 binding is sensitive to subtle aspects of proteinase formation beyond simply reporting on zymogen cleavage. Large thermodynamic differences in F12 binding distinguish between a series of thrombin species poised along the transition of zymogen to proteinase. Active-site ligands transitioned a zymogen-like state to a proteinase-like state. Conversely, removal of Na+ converted proteinase-like thrombin to a more zymogen-like form. Thrombin mutants, with deformed x-ray structures, previously considered to be emblematic of specific regulated states of the enzyme, are instead shown to be variously zymogen-like and can be made proteinase-like by active-site ligation. Thermodynamic linkage between anion-binding exosite 2, the Na+-binding site, and the active site arises from interconversions of thrombin between a continuum of zymogen-and proteinase-like states. These interconversions, reciprocally regulated by different ligands, cast new light on the problem of thrombin allostery and provide a thermodynamic framework to explain the regulation of thrombin by different ligands.	[Krishnaswamy, Sriram] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Kamath, Parvathi; Krishnaswamy, Sriram] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Huntington, James A.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Cambridge	Krishnaswamy, S (corresponding author), Childrens Hosp Philadelphia, Res Inst, 310 Abramson,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	skrishna@mail.med.upenn.edu	Krishnaswamy, Sriram/Z-4380-2019		National Institutes of Health [HL-74124]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074124] Funding Source: NIH RePORTER; MRC [G0601596] Funding Source: UKRI; Medical Research Council [G0601596] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported, in whole or in part, by National Institutes of Health Grant HL-74124 (to S. K.).	Adams TE, 2009, J THROMB HAEMOST, V7, P1688, DOI 10.1111/j.1538-7836.2009.03563.x; ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; Bah A, 2009, J BIOL CHEM, V284, P20034, DOI 10.1074/jbc.M109.012344; Bevington PR., 2002, DATA REDUCTION ERROR; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bode W, 2006, SEMIN THROMB HEMOST, V32, P16, DOI 10.1055/s-2006-939551; Bush-Pelc LA, 2007, J BIOL CHEM, V282, P27165, DOI 10.1074/jbc.M703202200; Carter WJ, 2004, J BIOL CHEM, V279, P26387, DOI 10.1074/jbc.M402364200; Davie EW, 2006, SEMIN THROMB HEMOST, V32, P3, DOI 10.1055/s-2006-939550; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; EFTINK MR, 1983, BIOCHEMISTRY-US, V22, P3884, DOI 10.1021/bi00285a025; Esmon CT, 2006, SEMIN THROMB HEMOST, V32, P49, DOI 10.1055/s-2006-939554; FERSHT AR, 1971, J MOL BIOL, V60, P279, DOI 10.1016/0022-2836(71)90294-4; Gandhi PS, 2009, J BIOL CHEM, V284, P24098, DOI 10.1074/jbc.M109.025403; Higashi S, 1996, J BIOL CHEM, V271, P26569, DOI 10.1074/jbc.271.43.26569; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Huntington JA, 2009, J THROMB HAEMOST, V7, P159, DOI 10.1111/j.1538-7836.2009.03365.x; Johnson DJD, 2005, BIOCHEM J, V392, P21, DOI 10.1042/BJ20051217; Kamath P, 2008, J BIOL CHEM, V283, P30164, DOI 10.1074/jbc.M806158200; Khan AR, 1998, PROTEIN SCI, V7, P815; Kroh HK, 2007, J BIOL CHEM, V282, P16095, DOI 10.1074/jbc.M610577200; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; LECHTENBERG B, 2010, P NATL ACAD IN PRESS; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; Lumry R, 1995, METHOD ENZYMOL, V259, P628; Lundblad R L, 1976, Methods Enzymol, V45, P156; MANN KG, 1981, METHOD ENZYMOL, V80, P286; Mann M, 2003, CHEST, V124, P70, DOI 10.1378/chest.124.1.70; NESHEIM ME, 1979, BIOCHEMISTRY-US, V18, P996, DOI 10.1021/bi00573a010; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Petrera NS, 2009, J BIOL CHEM, V284, P25620, DOI 10.1074/jbc.M109.000042; Pineda AO, 2006, J BIOL CHEM, V281, P32922, DOI 10.1074/jbc.M605530200; Pineda AO, 2004, J BIOL CHEM, V279, P39824, DOI 10.1074/jbc.M407272200; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Sharp K, 2001, PROTEIN SCI, V10, P661, DOI 10.1110/ps.37801; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; Vindigni A, 1997, BIOCHEMISTRY-US, V36, P6674, DOI 10.1021/bi962766a; WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008	43	42	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28651	28658		10.1074/jbc.M110.154914	http://dx.doi.org/10.1074/jbc.M110.154914			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20639195	Green Published, hybrid			2022-12-25	WOS:000281594000029
J	Ong, YC; Reese, ML; Boothroyd, JC				Ong, Yi-Ching; Reese, Michael L.; Boothroyd, John C.			Toxoplasma Rhoptry Protein 16 (ROP16) Subverts Host Function by Direct Tyrosine Phosphorylation of STAT6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; GAMMA-INTERFERON; TARGET GENES; GONDII; CELLS; PATHWAYS; REVEALS; IDENTIFICATION; TRANSFORMATION; TRANSCRIPTION	The obligate intracellular parasite, Toxoplasma gondii, modulates host immunity in a variety of highly specific ways. Previous work revealed a polymorphic, injected parasite factor, ROP16, to be a key virulence determinant and regulator of host cell transcription. These properties were shown to be partially mediated by dysregulation of the host transcription factors STAT3 and STAT6, but the molecular mechanisms underlying this phenotype were unclear. Here, we use a Type I Toxoplasma strain deficient in ROP16 to show that ROP16 induces not only sustained activation but also an extremely rapid (within 1 min) initial activation of STAT6. Using recombinant wild-type and kinase-deficient ROP16, we demonstrate in vitro that ROP16 has intrinsic tyrosine kinase activity and is capable of directly phosphorylating the key tyrosine residue for STAT6 activation, Tyr(641). Furthermore, ROP16 co-immunoprecipitates with STAT6 from infected cells. Taken together, these data strongly suggest that STAT6 is a direct substrate for ROP16 in vivo.	[Ong, Yi-Ching; Reese, Michael L.; Boothroyd, John C.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University	Boothroyd, JC (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Fairchild Bldg D305,300 Pasteur Dr, Stanford, CA 94305 USA.	jboothr@stanford.edu		Reese, Michael/0000-0001-9401-9594; Boothroyd, John C./0000-0001-9719-745X	National Institutes of Health [AI21423, AI73756]; National Science Foundation; Smith Stanford Graduate Fellowship; American Cancer Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021423, R01AI021423, R01AI073756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Smith Stanford Graduate Fellowship; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI21423 and AI73756 (to J. C. B.). This work was also supported by a National Science Foundation Graduate Research Fellowship and Smith Stanford Graduate Fellowship (to Y.-C.O.) and an American Cancer Society fellowship (to M. L. R.).	Ahn HJ, 2009, PARASITOL RES, V105, P1445, DOI 10.1007/s00436-009-1577-8; Ahn HJ, 2009, KOREAN J PARASITOL, V47, P117, DOI 10.3347/kjp.2009.47.2.117; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Bradley PJ, 2002, MOL BIOCHEM PARASIT, V125, P189, DOI 10.1016/S0166-6851(02)00162-7; Carme B, 2009, EMERG INFECT DIS, V15, P656, DOI 10.3201/eid1504.081306; Carmen JC, 2007, MOL MICROBIOL, V64, P904, DOI 10.1111/j.1365-2958.2007.05714.x; Chen HC, 2010, J IMMUNOL, V185, P64, DOI 10.4049/jimmunol.0903323; Chen Z, 2003, J IMMUNOL, V171, P3627, DOI 10.4049/jimmunol.171.7.3627; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Daines MO, 2003, J BIOL CHEM, V278, P30971, DOI 10.1074/jbc.M301094200; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; ENDO T, 1990, J PROTOZOOL, V37, P133, DOI 10.1111/j.1550-7408.1990.tb05883.x; Gaddi PJ, 2007, IMMUNOL CELL BIOL, V85, P155, DOI 10.1038/sj.icb.7100038; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hayakawa F, 2006, ANN NY ACAD SCI, V1086, P213, DOI 10.1196/annals.1377.002; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoeck J, 2001, J IMMUNOL, V167, P3216, DOI 10.4049/jimmunol.167.6.3216; Hsiao WLW, 1996, CARCINOGENESIS, V17, P2771, DOI 10.1093/carcin/17.12.2771; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson SH, 2004, J IMMUNOL, V172, P2307, DOI 10.4049/jimmunol.172.4.2307; Kafsack BFC, 2004, MOL BIOCHEM PARASIT, V136, P309, DOI 10.1016/j.molbiopara.2004.04.004; Kim SK, 2007, J IMMUNOL, V178, P5154, DOI 10.4049/jimmunol.178.8.5154; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; Lodoen MB, 2010, CELL MICROBIOL, V12, P55, DOI 10.1111/j.1462-5822.2009.01378.x; McKee AS, 2004, J IMMUNOL, V173, P2632, DOI 10.4049/jimmunol.173.4.2632; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; Montag DT, 2006, CLIN IMMUNOL, V121, P215, DOI 10.1016/j.clim.2006.06.013; Ohmori Y, 2000, J BIOL CHEM, V275, P38095, DOI 10.1074/jbc.M006227200; OSSORIO PN, 1992, MOL BIOCHEM PARASIT, V50, P1, DOI 10.1016/0166-6851(92)90239-G; Qiu W, 2009, EMBO J, V28, P969, DOI 10.1038/emboj.2009.24; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Schnyder B, 2002, BIOCHEM BIOPH RES CO, V292, P841, DOI 10.1006/bbrc.2002.6754; Soldati D, 1995, MOL BIOCHEM PARASIT, V74, P87, DOI 10.1016/0166-6851(95)02487-5; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; Tomkinson A, 1999, AM J RESP CRIT CARE, V160, P1283, DOI 10.1164/ajrccm.160.4.9809065; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Xu D, 2008, FRONT BIOSCI-LANDMRK, V13, P4925, DOI 10.2741/3051; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Zhang WJ, 2008, CYTOKINE, V42, P39, DOI 10.1016/j.cyto.2008.01.016; Zimmermann N, 2004, J IMMUNOL, V172, P1815, DOI 10.4049/jimmunol.172.3.1815	50	154	178	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28731	28740		10.1074/jbc.M110.112359	http://dx.doi.org/10.1074/jbc.M110.112359			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20624917	hybrid, Green Published			2022-12-25	WOS:000281594000039
J	Cao, HN; Pauff, JM; Hille, R				Cao, Hongnan; Pauff, James M.; Hille, Russ			Substrate Orientation and Catalytic Specificity in the Action of Xanthine Oxidase THE SEQUENTIAL HYDROXYLATION OF HYPOXANTHINE TO URIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR STRUCTURES; MOLYBDENUM; MECHANISM; DEHYDROGENASE; REFINEMENT; RESIDUES; ENZYME; SITE	Xanthine oxidase is a molybdenum-containing enzyme catalyzing the hydroxylation of a sp(2)-hybridized carbon in a broad range of aromatic heterocycles and aldehydes. Crystal structures of the bovine enzyme in complex with the physiological substrate hypoxanthine at 1.8A resolution and the chemotherapeutic agent 6-mercaptopurine at 2.6A resolution have been determined, showing in each case two alternate orientations of substrate in the two active sites of the crystallographic asymmetric unit. One orientation is such that it is expected to yield hydroxylation at C-2 of substrate, yielding xanthine. The other suggests hydroxylation at C-8 to give 6,8-dihydroxypurine, a putative product not previously thought to be generated by the enzyme. Kinetic experiments demonstrate that > 98% of hypoxanthine is hydroxylated at C-2 rather than C-8, indicating that the second crystallographically observed orientation is significantly less catalytically effective than the former. Theoretical calculations suggest that enzyme selectivity for the C-2 over C-8 of hypoxanthine is largely due to differences in the intrinsic reactivity of the two sites. For the orientation of hypoxanthine with C-2 proximal to the molybdenum center, the disposition of substrate in the active site is such that Arg(880) and Glu(802), previous shown to be catalytically important for the conversion of xanthine to uric acid, play similar roles in hydroxylation at C-2 as at C-8. Contrary to the literature, we find that 6,8-dihydroxypurine is effectively converted to uric acid by xanthine oxidase.	[Cao, Hongnan; Pauff, James M.; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Pauff, James M.] Ohio State Univ, Med Scientist Program, Columbus, OH 43210 USA	University of California System; University of California Riverside; University System of Ohio; Ohio State University	Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, 1463 Boyce Hall, Riverside, CA 92521 USA.	russ.hille@ucr.edu	Cao, Hongnan/M-2047-2014	Cao, Hongnan/0000-0002-9808-3240; Cao, Hongnan/0000-0003-2496-1298	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Eli Lilly Company	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Eli Lilly Company(Eli Lilly)	This work was supported in part by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences Contract DE-AC02-06CH11357 and by Eli Lilly & Company.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cultrone A, 2005, MOL MICROBIOL, V57, P276, DOI 10.1111/j.1365-2958.2005.04686.x; de la Riva L, 2008, J BACTERIOL, V190, P7892, DOI 10.1128/JB.01022-08; Dietzel U, 2009, J BIOL CHEM, V284, P8759, DOI 10.1074/jbc.M808114200; EDMONDSON D, 1973, J BIOL CHEM, V248, P6135; EDMONDSON D, 1972, J BIOL CHEM, V247, P1597; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Hille R, 2005, ARCH BIOCHEM BIOPHYS, V433, P107, DOI 10.1016/j.abb.2004.08.012; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; HILLE R, 1995, FASEB J, V9, P995, DOI 10.1096/fasebj.9.11.7649415; Huber R, 1996, P NATL ACAD SCI USA, V93, P8846, DOI 10.1073/pnas.93.17.8846; Ilich P, 1997, INORG CHIM ACTA, V263, P87, DOI 10.1016/S0020-1693(97)05654-5; JEZEWSKA MM, 1973, EUR J BIOCHEM, V36, P385, DOI 10.1111/j.1432-1033.1973.tb02923.x; Kim JH, 1996, J BIOL CHEM, V271, P6771, DOI 10.1074/jbc.271.12.6771; Kulikowska E, 2004, ACTA BIOCHIM POL, V51, P493; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leimkuhler S, 2004, J BIOL CHEM, V279, P40437, DOI 10.1074/jbc.M405778200; MASSEY V, 1969, J BIOL CHEM, V244, P1682; Montero-Moran GM, 2007, BIOCHEMISTRY-US, V46, P5293, DOI 10.1021/bi700065h; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Murshudov GN, 1996, P CCP4 STUDY WEEKEND, P93; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Pauff JM, 2008, J BIOL CHEM, V283, P4818, DOI 10.1074/jbc.M707918200; Pauff JM, 2007, J BIOL CHEM, V282, P12785, DOI 10.1074/jbc.M700364200; Pauff JM, 2009, J BIOL CHEM, V284, P8751, DOI 10.1074/jbc.M804517200; Pope SD, 2009, J BACTERIOL, V191, P1006, DOI 10.1128/JB.01281-08; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Stewart J. J. P, 2008, MOPAC2009; Stockert AL, 2002, J AM CHEM SOC, V124, P14554, DOI 10.1021/ja027388d; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamaguchi Y, 2007, J BIOCHEM, V141, P513, DOI 10.1093/jb/mvm053	35	73	74	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28044	28053		10.1074/jbc.M110.128561	http://dx.doi.org/10.1074/jbc.M110.128561			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20615869	Green Published, hybrid			2022-12-25	WOS:000288742300003
J	Draheim, KM; Chen, HB; Tao, Q; Moore, N; Roche, M; Lyle, S				Draheim, K. M.; Chen, H-B; Tao, Q.; Moore, N.; Roche, M.; Lyle, S.			ARRDC3 suppresses breast cancer progression by negatively regulating integrin beta 4	ONCOGENE			English	Article						ARRDC3; breast cancer; integrin beta 4; TLIMP	ALPHA-6-BETA-4 INTEGRIN; CARCINOMA-CELLS; SIGNALING PATHWAYS; EPIDERMAL-GROWTH; MIGRATING CELLS; TUMOR-GROWTH; RECEPTOR; ENDOCYTOSIS; INVASION; PROTEIN	Large-scale genetic analyses of human tumor samples have been used to identify novel oncogenes, tumor suppressors and prognostic factors, but the functions and molecular interactions of many individual genes have not been determined. In this study we examined the cellular effects and molecular mechanism of the arrestin family member, ARRDC3, a gene preferentially lost in a subset of breast cancers. Oncomine data revealed that the expression of ARRDC3 decreases with tumor grade, metastases and recurrences. ARRDC3 overexpression represses cancer cell proliferation, migration, invasion, growth in soft agar and in vivo tumorigenicity, whereas downregulation of ARRCD3 has the opposite effects. Mechanistic studies showed that ARRDC3 functions in a novel regulatory pathway that controls the cell surface adhesion molecule, beta-4 integrin (ITG beta 4), a protein associated with aggressive tumor behavior. Our data indicates ARRDC3 directly binds to a phosphorylated form of ITG beta 4 leading to its internalization, ubiquitination and ultimate degradation. The results identify the ARRCD3-ITG beta 4 pathway as a new therapeutic target in breast cancer and show the importance of connecting genetic arrays with mechanistic studies in the search for new treatments. Oncogene (2010) 29, 5032-5047; doi:10.1038/onc.2010.250; published online 5 July 2010	[Draheim, K. M.; Chen, H-B; Moore, N.; Roche, M.; Lyle, S.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Tao, Q.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Beth Israel Deaconess Medical Center	Lyle, S (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, 364 Plantat St,LRB 411, Worcester, MA 01605 USA.	stephen.lyle@umassmed.edu		Roche, Michael/0000-0001-8064-3556	National Cancer Institute of the National Institutes of Health [CA118916]; Worcester Foundation for Biotechnology Research; NATIONAL CANCER INSTITUTE [R01CA118916] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Worcester Foundation for Biotechnology Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: this work was supported by the National Cancer Institute of the National Institutes of Health (grant number CA118916) and The Worcester Foundation for Biotechnology Research (SRL).	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Aubry L, 2009, CURR GENOMICS, V10, P133, DOI 10.2174/138920209787847014; Baril P, 2007, ONCOGENE, V26, P2082, DOI 10.1038/sj.onc.1210009; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chen M, 2009, J BIOL CHEM, V284, P1484, DOI 10.1074/jbc.M803997200; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Diaz LK, 2005, MODERN PATHOL, V18, P1165, DOI 10.1038/modpathol.3800411; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Dutta U, 2008, CANCER RES, V68, P8779, DOI 10.1158/0008-5472.CAN-08-2125; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; FALCIONI R, 1989, MOL CARCINOGEN, V2, P361, DOI 10.1002/mc.2940020611; Fuchs E, 1997, CURR OPIN GENET DEV, V7, P672, DOI 10.1016/S0959-437X(97)80016-0; Gagnoux-Palacios L, 2003, J CELL BIOL, V162, P1189, DOI 10.1083/jcb.200305006; Germain EC, 2009, MOL BIOL CELL, V20, P56, DOI 10.1091/mbc.E08-06-0646; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Hemler ME, 2001, DEV CELL, V1, P728, DOI 10.1016/S1534-5807(01)00102-2; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kendall RT, 2009, CELL MOL LIFE SCI, V66, P2953, DOI 10.1007/s00018-009-0088-1; LEE EC, 1992, J CELL BIOL, V117, P671, DOI 10.1083/jcb.117.3.671; Li TT, 2009, MOL CANCER RES, V7, P1064, DOI 10.1158/1541-7786.MCR-08-0578; Lipscomb EA, 2005, CANCER RES, V65, P10970, DOI 10.1158/0008-5472.CAN-05-2327; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Lipscomb EA, 2003, CLIN EXP METASTAS, V20, P569, DOI 10.1023/A:1025819521707; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; Luttrell LM, 2002, J CELL SCI, V115, P455; Mercurio AM, 2001, CURR OPIN CELL BIOL, V13, P541, DOI 10.1016/S0955-0674(00)00249-0; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Nikolopoulos SN, 2004, CANCER CELL, V6, P471, DOI 10.1016/j.ccr.2004.09.029; O'Connor KL, 1998, J CELL BIOL, V143, P1749, DOI 10.1083/jcb.143.6.1749; Oka S, 2006, ENDOCRINOLOGY, V147, P733, DOI 10.1210/en.2005-0679; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; Rabinovitz I, 1996, BIOCHEM CELL BIOL, V74, P811, DOI 10.1139/o96-087; Raghuwanshi SK, 2008, J IMMUNOL, V180, P5699, DOI 10.4049/jimmunol.180.8.5699; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Rakha EA, 2009, PATHOLOGY, V41, P40, DOI 10.1080/00313020802563510; Raymond K, 2007, MOL BIOL CELL, V18, P4210, DOI 10.1091/mbc.E06-08-0720; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Voduc D, 2008, CLIN BREAST CANCER, V8, pS171, DOI 10.3816/CBC.2008.s.014; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wilhelmsen K, 2006, MOL CELL BIOL, V26, P2877, DOI 10.1128/MCB.26.8.2877-2886.2006; Wilhelmsen K, 2007, MOL BIOL CELL, V18, P3512, DOI 10.1091/mbc.E07-04-0306; Yoon SO, 2005, CANCER RES, V65, P2761, DOI 10.1158/0008-5472.CAN-04-4122; Zhang ZP, 2009, CELL SIGNAL, V21, P1195, DOI 10.1016/j.cellsig.2009.03.010	56	82	85	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	36					5032	5047		10.1038/onc.2010.250	http://dx.doi.org/10.1038/onc.2010.250			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	647LN	20603614	hybrid, Green Published			2022-12-25	WOS:000281620100004
J	Lovric, MM; Hawkins, CJ				Lovric, M. M.; Hawkins, C. J.			TRAIL treatment provokes mutations in surviving cells	ONCOGENE			English	Article						late effects; second malignancies; Apo-2L; DNA damage; mutagenesis; HPRT	APOPTOSIS-INDUCING LIGAND; CASPASE-ACTIVATED DNASE; DOUBLE-STRAND BREAKS; IN-VIVO; CONVERTING-ENZYME; HUMAN HEPATOCYTES; MAMMALIAN-CELLS; TUMOR-GROWTH; CANCER; DEATH	Chemotherapy and radiotherapy commonly damage DNA and trigger p53-dependent apoptosis through intrinsic apoptotic pathways. Two unfortunate consequences of this mechanism are resistance due to blockade of p53 or intrinsic apoptosis pathways, and mutagenesis of nonmalignant surviving cells which can impair cellular function or provoke second malignancies. Death ligand-based drugs, such as tumor necrosis factor-related apoptosis inducing ligand (TRAIL), stimulate extrinsic apoptotic signaling, and may overcome resistance to treatments that induce intrinsic apoptosis. As death receptor ligation does not damage DNA as a primary mechanism of pro-apoptotic action, we hypothesized that surviving cells would remain genetically unscathed, suggesting that death ligand-based therapies may avoid some of the adverse effects associated with traditional cancer treatments. Surprisingly, however, treatment with sub-lethal concentrations of TRAIL or FasL was mutagenic. Mutations arose in viable cells that contained active caspases, and overexpression of the caspase-8 inhibitor crmA or silencing of caspase-8 abolished TRAIL-mediated mutagenesis. Downregulation of the apoptotic nuclease caspase-activated DNAse (CAD)/DNA fragmentation factor 40 (DFF40) prevented the DNA damage associated with TRAIL treatment. Although death ligands do not need to damage DNA in order to induce apoptosis, surviving cells nevertheless incur DNA damage after treatment with these agents. Oncogene (2010) 29, 5048-5060; doi:10.1038/onc.2010.242; published online 19 July 2010	[Lovric, M. M.; Hawkins, C. J.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Bundoora, Vic 3083, Australia; [Hawkins, C. J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Childrens Canc Ctr, Parkville, Vic 3052, Australia	La Trobe University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Hawkins, CJ (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Kingsbury Dr, Bundoora, Vic 3083, Australia.	c.hawkins@latrobe.edu.au	Hawkins, Christine/B-8769-2011	Hawkins, Christine/0000-0001-8120-1071; Green, Maja/0000-0002-7982-2503	Cancer Council Victoria [384400]; La Trobe University; National Health and Medical Research Council [541930]; Australian Research Council [FT0991464]	Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); La Trobe University; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This study was funded by a Cancer Council Victoria Grant-in-Aid (#384400), a La Trobe University Postgraduate scholarship to MML, a National Health and Medical Research Council Career Development Award (#541930) and Australian Research Council Future Fellowship (#FT0991464) to CJH. We are grateful to Anissa Jabbour for the MEF cells and advice, to Rebecca Bilardi for assistance in establishing the gamma H2AX assay and to Lahiru Gangoda for help with fluorescence microscopy. We thank Tanja Kitevska for proofreading, Delara Pantaki, Sarah Roberts, Sunil Kumar and Livleen Kaur for technical assistance and members of the Hawkins laboratory and Children's Cancer Centre for advice and suggestions.	Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Ashley DM, 2008, BRIT J CANCER, V99, P294, DOI 10.1038/sj.bjc.6604459; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Chuntharapai A, 2001, J IMMUNOL, V166, P4891, DOI 10.4049/jimmunol.166.8.4891; Coultas L, 2003, SEMIN CANCER BIOL, V13, P115, DOI 10.1016/S1044-579X(02)00129-3; DEMARS R, 1971, FED PROC, V30, P944; Dickerman JD, 2007, PEDIATRICS, V119, P554, DOI 10.1542/peds.2006-2826; Ekert PG, 1999, EMBO J, V18, P330, DOI 10.1093/emboj/18.2.330; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Evens AM, 2008, NAT CLIN PRACT ONCOL, V5, P543, DOI 10.1038/ncponc1186; Frankenberg-Schwager M, 2005, TOXICOLOGY, V212, P175, DOI 10.1016/j.tox.2005.04.015; Ganten TM, 2006, CLIN CANCER RES, V12, P2640, DOI 10.1158/1078-0432.CCR-05-2635; Gocke E, 2009, TOXICOL LETT, V190, P254, DOI 10.1016/j.toxlet.2009.03.016; Hao CH, 2004, CANCER RES, V64, P8502, DOI 10.1158/0008-5472.CAN-04-2599; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Hawkins CJ, 1996, P NATL ACAD SCI USA, V93, P13786, DOI 10.1073/pnas.93.24.13786; Holoch PA, 2009, EUR J PHARMACOL, V625, P63, DOI 10.1016/j.ejphar.2009.06.066; Jabbour AM, 2009, CELL DEATH DIFFER, V16, P555, DOI 10.1038/cdd.2008.179; Jeha S, 2009, SEMIN HEMATOL, V46, P76, DOI 10.1053/j.seminhematol.2008.09.009; Jo M, 2000, NAT MED, V6, P564, DOI 10.1038/75045; Kelley SK, 2001, J PHARMACOL EXP THER, V299, P31; Knight MJ, 2004, MOL CARCINOGEN, V39, P173, DOI 10.1002/mc.20011; KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331; Kuo LJ, 2008, IN VIVO, V22, P305; Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397; Leverkus M, 2000, CANCER RES, V60, P553; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; Mahalingam D, 2009, CANCER TREAT REV, V35, P280, DOI 10.1016/j.ctrv.2008.11.006; Meadows AT, 2009, J CLIN ONCOL, V27, P2356, DOI 10.1200/JCO.2008.21.1920; Meulmeester E, 2008, CURR CANCER DRUG TAR, V8, P87, DOI 10.2174/156800908783769337; Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nitsch R, 2000, LANCET, V356, P827, DOI 10.1016/S0140-6736(00)02659-3; Olive PL, 2009, CYTOM PART B-CLIN CY, V76B, P79, DOI 10.1002/cyto.b.20450; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Rice SC, 2004, CANCER RES, V64, P4464, DOI 10.1158/0008-5472.CAN-03-3940; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Vaughan ATM, 2002, APOPTOSIS, V7, P173, DOI 10.1023/A:1014374717773; Veld CWOH, 1997, MUTAGENESIS, V12, P417, DOI 10.1093/mutage/12.6.417; Vogler M, 2008, CANCER RES, V68, P7956, DOI 10.1158/0008-5472.CAN-08-1296; Watters GP, 2009, MUTAT RES-GEN TOX EN, V679, P50, DOI 10.1016/j.mrgentox.2009.07.007; Widlak P, 2005, J CELL BIOCHEM, V94, P1078, DOI 10.1002/jcb.20409; Widlak P, 2000, J BIOL CHEM, V275, P8226, DOI 10.1074/jbc.275.11.8226; Widlak P, 2000, ACTA BIOCHIM POL, V47, P1037; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Winer E, 2009, J CLIN ONCOL, V27, P812, DOI 10.1200/JCO.2008.21.2134; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45	53	61	62	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2010	29	36					5048	5060		10.1038/onc.2010.242	http://dx.doi.org/10.1038/onc.2010.242			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	647LN	20639907	hybrid, Green Published			2022-12-25	WOS:000281620100005
J	Wilson, MR; O'Dea, KP; Dorr, AD; Yamamoto, H; Goddard, ME; Takata, M				Wilson, Michael R.; O'Dea, Kieran P.; Dorr, Anthony D.; Yamamoto, Hirotoshi; Goddard, Michael E.; Takata, Masao			Efficacy and Safety of Inhaled Carbon Monoxide during Pulmonary Inflammation in Mice	PLOS ONE			English	Article							ACUTE LUNG INJURY; HEME OXYGENASE-1/CARBON MONOXIDE; NEUTROPHIL RECRUITMENT; ENDOTOXIC-SHOCK; PROTECTION; MECHANISM; LAVAGE; MODEL	Background: Pulmonary inflammation is a major contributor to morbidity in a variety of respiratory disorders, but treatment options are limited. Here we investigate the efficacy, safety and mechanism of action of low dose inhaled carbon monoxide (CO) using a mouse model of lipopolysaccharide (LPS)-induced pulmonary inflammation. Methodology: Mice were exposed to 0-500 ppm inhaled CO for periods of up to 24 hours prior to and following intratracheal instillation of 10 ng LPS. Animals were sacrificed and assessed for intraalveolar neutrophil influx and cytokine levels, flow cytometric determination of neutrophil number and activation in blood, lung and lavage fluid samples, or neutrophil mobilisation from bone marrow. Principal Findings: When administered for 24 hours both before and after LPS, inhaled CO of 100 ppm or more reduced intraalveolar neutrophil infiltration by 40-50%, although doses above 100 ppm were associated with either high carboxyhemoglobin, weight loss or reduced physical activity. This anti-inflammatory effect of CO did not require pre-exposure before induction of injury. 100 ppm CO exposure attenuated neutrophil sequestration within the pulmonary vasculature as well as LPS-induced neutrophilia at 6 hours after LPS, likely due to abrogation of neutrophil mobilisation from bone marrow. In contrast to such apparently beneficial effects, 100 ppm inhaled CO induced an increase in pulmonary barrier permeability as determined by lavage fluid protein content and translocation of labelled albumin from blood to the alveolar space. Conclusions: Overall, these data confirm some protective role for inhaled CO during pulmonary inflammation, although this required a dose that produced carboxyhemoglobin values close to potentially toxic levels for humans, and increased lung permeability.	[Wilson, Michael R.; O'Dea, Kieran P.; Dorr, Anthony D.; Yamamoto, Hirotoshi; Goddard, Michael E.; Takata, Masao] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, London, England	Imperial College London	Wilson, MR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, London, England.	michael.wilson@imperial.ac.uk			Carburos Metalicos, Madrid, Spain; Medical Research Council, London, United Kingdom [G0000101]; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom [BB/D01820X/1]; Biotechnology and Biological Sciences Research Council [BB/D01820X/1] Funding Source: researchfish; Medical Research Council [G0000101] Funding Source: researchfish; BBSRC [BB/D01820X/1] Funding Source: UKRI; MRC [G0000101] Funding Source: UKRI	Carburos Metalicos, Madrid, Spain; Medical Research Council, London, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by grants from Carburos Metalicos, Madrid, Spain; Medical Research Council, London, United Kingdom (G0000101: URL www.mrc.ac.uk/index.htm); and Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom (BB/D01820X/1: URL www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg AM, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-13; Althaus M, 2009, AM J RESP CELL MOL, V41, P639, DOI 10.1165/rcmb.2008-0458OC; Bathoorn E, 2007, EUR RESPIR J, V30, P1131, DOI 10.1183/09031936.00163206; Chapman JT, 2001, AM J PHYSIOL-LUNG C, V281, pL209, DOI 10.1152/ajplung.2001.281.1.L209; Choudhury S, 2004, AM J PHYSIOL-LUNG C, V287, pL902, DOI 10.1152/ajplung.00187.2004; Clayton CE, 2001, AM J PHYSIOL-LUNG C, V281, pL949, DOI 10.1152/ajplung.2001.281.4.L949; Dolinay T, 2004, AM J RESP CRIT CARE, V170, P613, DOI 10.1164/rccm.200401-023OC; Foresti R, 2008, INTENS CARE MED, V34, P649, DOI 10.1007/s00134-008-1011-1; FREVERT CW, 1995, J IMMUNOL, V154, P335; Fujita T, 2001, NAT MED, V7, P598, DOI 10.1038/87929; Ghio AJ, 2008, AM J RESP CELL MOL, V38, P715, DOI 10.1165/rcmb.2007-0179OC; Ghosh S, 2005, AM J PHYSIOL-LUNG C, V288, pL1003, DOI 10.1152/ajplung.00451.2004; Hoetzel A, 2007, ANTIOXID REDOX SIGN, V9, P2013, DOI 10.1089/ars.2007.1762; Kohmotoa J, 2007, AM J TRANSPLANT, V7, P2279, DOI 10.1111/j.1600-6143.2007.01940.x; Leite JHP, 2008, CRIT CARE MED, V36, P2621, DOI 10.1097/CCM.0b013e3181847b43; Mayr FB, 2005, AM J RESP CRIT CARE, V171, P354, DOI 10.1164/rccm.200404-446OC; Mazzola S, 2005, FASEB J, V19, P2045, DOI 10.1096/fj.05-3782fje; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Nemzek JA, 2008, AM J PHYSIOL-LUNG C, V294, pL644, DOI 10.1152/ajplung.00324.2007; O'Dea KP, 2009, J IMMUNOL, V182, P1155, DOI 10.4049/jimmunol.182.2.1155; Otterbein LE, 1999, AM J PHYSIOL-LUNG C, V276, pL688; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Otterbein LE, 2003, AM J PATHOL, V163, P2555, DOI 10.1016/S0002-9440(10)63610-3; Perkins GD, 2006, CRIT CARE MED, V34, P57, DOI 10.1097/01.CCM.0000190197.69945.C5; Piantadosi CA, 2002, ANTIOXID REDOX SIGN, V4, P259, DOI 10.1089/152308602753666316; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Ritter C, 2006, CRIT CARE MED, V34, P471, DOI 10.1097/01.CCM.0000199069.19193.89; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P2157, DOI 10.1089/ars.2007.1811; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sarady JK, 2004, FASEB J, V18, P854, DOI 10.1096/fj.03-0643fje; Sarady JK, 2002, AM J RESP CELL MOL, V27, P739, DOI 10.1165/rcmb.4816; Spoelstra EN, 2007, LAB ANIM-UK, V41, P128, DOI 10.1258/002367707779399400; Thom SR, 2005, AM J RESP CRIT CARE, V171, P1318, DOI 10.1164/ajrccm.171.11.952; Wang S, 2009, P NATL ACAD SCI USA, V106, P2957, DOI 10.1073/pnas.0809100106; Wang XM, 2009, J IMMUNOL, V182, P3809, DOI 10.4049/jimmunol.0712437; WATSON ES, 1987, J ANAL TOXICOL, V11, P19, DOI 10.1093/jat/11.1.19; Wilson MR, 2007, AM J PHYSIOL-LUNG C, V293, pL60, DOI 10.1152/ajplung.00284.2006; Wilson MR, 2003, J APPL PHYSIOL, V95, P1385, DOI 10.1152/japplphysiol.00213.2003; Zhou ZH, 2005, AM J PATHOL, V166, P27, DOI 10.1016/S0002-9440(10)62229-8	39	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11565	10.1371/journal.pone.0011565	http://dx.doi.org/10.1371/journal.pone.0011565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644637	Green Submitted, Green Published, gold			2022-12-25	WOS:000279822300016
J	Marathe, SA; Ray, S; Chakravortty, D				Marathe, Sandhya A.; Ray, Seemun; Chakravortty, Dipshikha			Curcumin Increases the Pathogenicity of Salmonella enterica Serovar Typhimurium in Murine Model	PLOS ONE			English	Article							ESCHERICHIA-COLI; OXIDATIVE STRESS; INVASION GENES; TRANSCRIPTIONAL REGULATOR; INTRACELLULAR SALMONELLA; ANTIMICROBIAL PEPTIDES; RESISTANCE; PATHOGENESIS; TRANSPORT; VIRULENCE	Curcumin has gained immense importance for its vast therapeutic and prophylactic applications. Contrary to this, our study reveals that it regulates the defense pathways of Salmonella enterica serovar Typhimurium ( S. Typhimurium) to enhance its pathogenicity. In a murine model of typhoid fever, we observed higher bacterial load in Peyer's patches, mesenteric lymph node, spleen and liver, when infected with curcumin-treated Salmonella. Curcumin increased the resistance of S. Typhimurium against antimicrobial agents like antimicrobial peptides, reactive oxygen and nitrogen species. This increased tolerance might be attributed to the up-regulation of genes involved in resistance against antimicrobial peptides - pmrD and pmrHFIJKLM and genes with antioxidant function - mntH, sodA and sitA. We implicate that iron chelation property of curcumin have a role in regulating mntH and sitA. Interestingly, we see that the curcumin-mediated modulation of pmr genes is through the PhoPQ regulatory system. Curcumin downregulates SPI1 genes, required for entry into epithelial cells and upregulates SPI2 genes required to intracellular survival. Since it is known that the SPI1 and SPI2 system can be regulated by the PhoPQ system, this common regulator could explain curcumin's mode of action. This data urges us to rethink the indiscriminate use of curcumin especially during Salmonella outbreaks.	[Marathe, Sandhya A.] Indian Inst Sci, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India; Indian Inst Sci, Biosafety Labs, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Marathe, SA (corresponding author), Indian Inst Sci, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India.	dipa@mcbl.iisc.ernet.in	Chakravortty, Dipshikha/AAI-4448-2020; chakravortty, dipshikha/A-9492-2009	Chakravortty, Dipshikha/0000-0002-7838-5145	Director of Indian Institute of Science, Bangalore, India [191/MCB]; Department of Biotechnology [DBT 197, DBT 172]; ICMR (Center for Advanced Study in Molecular Medicine); DST (FIST); UGC; C.S.I.R.	Director of Indian Institute of Science, Bangalore, India; Department of Biotechnology; ICMR (Center for Advanced Study in Molecular Medicine)(Indian Council of Medical Research (ICMR)); DST (FIST)(Department of Science & Technology (India)); UGC(University Grants Commission, India); C.S.I.R.(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the grant, Provision (2A) Tenth Plan (191/MCB) from the Director of Indian Institute of Science, Bangalore, India, and the Department of Biotechnology (DBT 197 and DBT 172) to D. C. Infrastructure support from ICMR (Center for Advanced Study in Molecular Medicine), DST (FIST) and UGC (special assistance) is acknowledged. S.M. acknowledges C.S.I.R. for the fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams GL, 2006, CELL MICROBIOL, V8, P728, DOI 10.1111/j.1462-5822.2006.00706.x; AGGARWAL BB, 2007, ADV EXP MED BIOL, V1, P75; Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; BEHLAU I, 1993, J BACTERIOL, V175, P4475, DOI 10.1128/JB.175.14.4475-4484.1993; Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; BUNTON CA, 1955, NATURE, V175, P83, DOI 10.1038/175083b0; Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; DAHL TA, 1989, ARCH MICROBIOL, V151, P183, DOI 10.1007/BF00414437; Dairam A, 2008, J AGR FOOD CHEM, V56, P3350, DOI 10.1021/jf0734931; Das P, 2009, MICROBIOL-SGM, V155, P2476, DOI 10.1099/mic.0.029611-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De R, 2009, ANTIMICROB AGENTS CH, V53, P1592, DOI 10.1128/AAC.01242-08; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Eswarappa SM, 2008, MICROBIOL-SGM, V154, P666, DOI 10.1099/mic.0.2007/011114-0; Fang FC, 1999, P NATL ACAD SCI USA, V96, P7502, DOI 10.1073/pnas.96.13.7502; FIELDS PI, 1989, SCIENCE, V243, P1059, DOI 10.1126/science.2646710; Freeman JA, 2002, J BACTERIOL, V184, P4971, DOI 10.1128/JB.184.18.4971-4980.2002; Fujisawa S, 2004, ANTICANCER RES, V24, P563; GROISMAN EA, 1992, P NATL ACAD SCI USA, V89, P11939, DOI 10.1073/pnas.89.24.11939; Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Han C, 2006, FEBS J, V273, P4682, DOI 10.1111/j.1742-4658.2006.05469.x; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; HASSETT DJ, 1989, FASEB J, V3, P2574, DOI 10.1096/fasebj.3.14.2556311; Hensel M, 2000, MOL MICROBIOL, V36, P1015, DOI 10.1046/j.1365-2958.2000.01935.x; Horsburgh MJ, 2002, TRENDS MICROBIOL, V10, P496, DOI 10.1016/S0966-842X(02)02462-9; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Ingolfsson HI, 2007, BIOCHEMISTRY-US, V46, P10384, DOI 10.1021/bi701013n; Jiao Y, 2006, FREE RADICAL BIO MED, V40, P1152, DOI 10.1016/j.freeradbiomed.2005.11.003; Kehres DG, 2000, MOL MICROBIOL, V36, P1085, DOI 10.1046/j.1365-2958.2000.01922.x; Kehres DG, 2002, J BACTERIOL, V184, P3151, DOI 10.1128/JB.184.12.3151-3158.2002; Lahiri A, 2008, MICROBIOL-SGM, V154, P2837, DOI 10.1099/mic.0.2008/017574-0; MILLER JH, 1997, EXPT MOL GENETICS; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Murray RA, 2000, INFECT IMMUN, V68, P5050, DOI 10.1128/IAI.68.9.5050-5055.2000; ODA Y, 1995, MUTAT RES LETT, V348, P67, DOI 10.1016/0165-7992(95)00048-8; PEGUES DA, 1995, MOL MICROBIOL, V17, P169, DOI 10.1111/j.1365-2958.1995.mmi_17010169.x; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; Rai D, 2008, BIOCHEM J, V410, P147, DOI 10.1042/BJ20070891; Sabri M, 2006, MICROBIOL-SGM, V152, P745, DOI 10.1099/mic.0.28682-0; SHANK JL, 1962, APPL MICROBIOL, V10, P185, DOI 10.1128/AEM.10.3.185-189.1962; Sharma A, 2000, J AGR FOOD CHEM, V48, P1340, DOI 10.1021/jf990851u; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Shiloh MU, 2000, CURR OPIN MICROBIOL, V3, P35, DOI 10.1016/S1369-5274(99)00048-X; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; TSOLIS RM, 1995, INFECT IMMUN, V63, P1739, DOI 10.1128/IAI.63.5.1739-1744.1995; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Zaharik ML, 2004, INFECT IMMUN, V72, P5522, DOI 10.1128/IAI.72.9.5522-5525.2004; Zaharik ML, 2002, P NATL ACAD SCI USA, V99, P15705, DOI 10.1073/pnas.252415599; Zhou DG, 1999, INFECT IMMUN, V67, P1974	58	20	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11511	10.1371/journal.pone.0011511	http://dx.doi.org/10.1371/journal.pone.0011511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634977	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000279715300022
J	D'Antonio, JM; Griend, DJV; Antony, L; Ndikuyeze, G; Dalrymple, SL; Koochekpour, S; Isaacs, JT				D'Antonio, Jason M.; Griend, Donald J. Vander; Antony, Lizamma; Ndikuyeze, George; Dalrymple, Susan L.; Koochekpour, Shahriar; Isaacs, John T.			Loss of Androgen Receptor-Dependent Growth Suppression by Prostate Cancer Cells Can Occur Independently from Acquiring Oncogenic Addiction to Androgen Receptor Signaling	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; TUMOR-SUPPRESSOR; IN-VITRO; DIFFERENTIATION; EXPRESSION; PROLIFERATION; MECHANISM; DISRUPTION; THERAPY; BINDING	The conversion of androgen receptor (AR) signaling as a mechanism of growth suppression of normal prostate epithelial cells to that of growth stimulation in prostate cancer cells is often associated with AR mutation, amplification and overexpression. Thus, down-regulation of AR signaling is commonly therapeutic for prostate cancer. The E006AA cell line was established from a hormone naive, localized prostate cancer. E006AA cells are genetically aneuploid and grow equally well when xenografted into either intact or castrated male NOG but not nude mice. These cells exhibit: 1) X chromosome duplication and AR gene amplification, although paradoxically not coupled with increased AR expression, and 2) somatic, dominant-negative Serine-599-Glycine loss-of-function mutation within the dimerization surface of the DNA binding domain of the AR gene. No effect on the growth of E006AA cells is observed using targeted knockdown of endogenous mutant AR, ectopic expression of wild-type AR, or treatment with androgens or anti-androgens. E006AA cells represent a prototype for a newly identified subtype of prostate cancer cells that exhibit a dominant-negative AR loss-of-function in a hormonally naive patient. Such loss-of-function eliminates AR-mediated growth suppression normally induced by normal physiological levels of androgens, thus producing a selective growth advantage for these malignant cells in hormonally naive patients. These data highlight that loss of AR-mediated growth suppression is an independent process, and that, without additional changes, is insufficient for acquiring oncogene addiction to AR signaling. Thus, patients with prostate cancer cells harboring such AR loss-of-function mutations will not benefit from aggressive hormone or anti-AR therapies even though they express AR protein.	[D'Antonio, Jason M.; Griend, Donald J. Vander; Antony, Lizamma; Ndikuyeze, George; Dalrymple, Susan L.; Isaacs, John T.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [D'Antonio, Jason M.; Griend, Donald J. Vander; Isaacs, John T.] Johns Hopkins Univ, Sch Med, Brady Urol Inst, Dept Urol, Baltimore, MD 21205 USA; [Koochekpour, Shahriar] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Dept Biochem & Mol Biol, New Orleans, LA USA; [Koochekpour, Shahriar] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Dept Urol, New Orleans, LA USA; [Griend, Donald J. Vander] Univ Chicago, Dept Surg, Chicago, IL 60637 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Chicago	D'Antonio, JM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA.	jdanton1@jhmi.edu; isaacjo@jhmi.edu	Griend, Donald J Vander/H-7532-2019	Griend, Donald J Vander/0000-0003-4421-5698; D'Antonio, Jason/0000-0001-8522-7009	NIH [R01DK52645, T32DK07552, T32DK07552-21A1]; Maryland Stem Cell Research Fund [MSCRF-II-0428]; DOD [PC060843]; NIH/NCRR-Center of Biomedical Research Excellence (COBRE) [1P20 RR021970];  [R21CA149137]; NATIONAL CANCER INSTITUTE [R21CA149137, R21CA143589] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052645, T32DK007552] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD005824] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Fund; DOD(United States Department of Defense); NIH/NCRR-Center of Biomedical Research Excellence (COBRE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	NIH Grant R01DK52645 and the Maryland Stem Cell Research Fund MSCRF-II-0428 generously supported this research. Donald Vander Griend was supported by a Urology Training Grant (NIH T32DK07552), and by a DOD Post-Doctoral Training Award (PC060843). Jason DAntonio is supported by a Urology Training Grant (NIH T32DK07552-21A1). Dr. Koochekpour was supported by a grant from the NIH/NCRR-Center of Biomedical Research Excellence (COBRE; 1P20 RR021970) and grant R21CA149137. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir AL, 2003, J BIOL CHEM, V278, P30828, DOI 10.1074/jbc.M301208200; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; Denmeade SR, 2003, PROSTATE, V56, P45, DOI 10.1002/pros.10213; Denmeade SR, 2003, PROSTATE, V54, P249, DOI 10.1002/pros.10199; Denmeade SR, 2002, NAT REV CANCER, V2, P389, DOI 10.1038/nrc801; Gao J, 2001, CANCER RES, V61, P5038; HANNA N, 1980, INT J CANCER, V26, P675, DOI 10.1002/ijc.2910260521; Huang YC, 2006, J CELL PHYSIOL, V209, P363, DOI 10.1002/jcp.20741; Hudson DL, 2001, J HISTOCHEM CYTOCHEM, V49, P271, DOI 10.1177/002215540104900214; Isaacs JT, 2000, JNCI-J NATL CANCER I, V92, P1367, DOI 10.1093/jnci/92.17.1367; Isaacs JT, 2004, NAT MED, V10, P26, DOI 10.1038/nm0104-26; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; JENSEN EV, 1968, P NATL ACAD SCI USA, V59, P632, DOI 10.1073/pnas.59.2.632; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Khalili M, 2010, AM J PATHOL, V176, P2259, DOI 10.2353/ajpath.2010.080747; Koochekpour S, 2004, PROSTATE, V60, P141, DOI 10.1002/pros.20053; Leversha MA, 2009, CLIN CANCER RES, V15, P2091, DOI 10.1158/1078-0432.CCR-08-2036; Li TH, 2007, NUCLEIC ACIDS RES, V35, P2767, DOI 10.1093/nar/gkm198; Ling MT, 2001, J ENDOCRINOL, V170, P287, DOI 10.1677/joe.0.1700287; Litvinov IV, 2004, PROSTATE, V61, P299, DOI 10.1002/pros.20187; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Litvinov IV, 2006, PROSTATE, V66, P1329, DOI 10.1002/pros.20483; Liu WN, 2008, NEOPLASIA, V10, P897, DOI 10.1593/neo.08428; Long RM, 2005, CLIN SCI, V108, P1, DOI 10.1042/CS20040241; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Shaffer LG, 2005, ISCN 2005 INT SYSTEM; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Simanainen U, 2007, ENDOCRINOLOGY, V148, P2264, DOI 10.1210/en.2006-1223; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Sultan C, 2001, HUM REPROD UPDATE, V7, P314, DOI 10.1093/humupd/7.3.314; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; van der Poel HG, 2001, CANCER GENE THER, V8, P927, DOI 10.1038/sj.cgt.7700385; Vander Griend DJ, 2007, CELL CYCLE, V6, P647, DOI 10.4161/cc.6.6.4028; Verrijdt G, 2003, MOL GENET METAB, V78, P175, DOI 10.1016/S1096-7192(03)00003-9; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2008, CANCER RES, V68, P3086; Whitacre DC, 2002, CELL GROWTH DIFFER, V13, P1; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Yang Q, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-8; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; ZOPPI S, 1992, MOL ENDOCRINOL, V6, P409, DOI 10.1210/me.6.3.409	46	30	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11475	10.1371/journal.pone.0011475	http://dx.doi.org/10.1371/journal.pone.0011475			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628607	Green Published, Green Submitted, gold			2022-12-25	WOS:000279637100006
J	Apicella, MA; Post, DMB; Fowler, AC; Jones, BD; Rasmussen, JA; Hunt, JR; Imagawa, S; Choudhury, B; Inzana, TJ; Maier, TM; Frank, DW; Zahrt, TC; Chaloner, K; Jennings, MP; McLendon, MK; Gibson, BW				Apicella, Michael A.; Post, Deborah M. B.; Fowler, Andrew C.; Jones, Bradley D.; Rasmussen, Jed A.; Hunt, Jason R.; Imagawa, Sayaka; Choudhury, Biswa; Inzana, Thomas J.; Maier, Tamara M.; Frank, Dara W.; Zahrt, Thomas C.; Chaloner, Kathryn; Jennings, Michael P.; McLendon, Molly K.; Gibson, Bradford W.			Identification, Characterization and Immunogenicity of an O-Antigen Capsular Polysaccharide of Francisella tularensis	PLOS ONE			English	Article							STRUCTURAL-ANALYSIS; TULAREMIA VACCINE; ESCHERICHIA-COLI; DEFICIENT MUTANT; LIPID-A; LVS; BACTERIUM; VIRULENCE; BIOSYNTHESIS; DISEASE	Capsular polysaccharides are important factors in bacterial pathogenesis and have been the target of a number of successful vaccines. Francisella tularensis has been considered to express a capsular antigen but none has been isolated or characterized. We have developed a monoclonal antibody, 11B7, which recognizes the capsular polysaccharide of F. tularensis migrating on Western blot as a diffuse band between 100 kDa and 250 kDa. The capsule stains poorly on SDS-PAGE with silver stain but can be visualized using ProQ Emerald glycoprotein stain. The capsule appears to be highly conserved among strains of F. tularensis as antibody 11B7 bound to the capsule of 14 of 14 F. tularensis type A and B strains on Western blot. The capsular material can be isolated essentially free of LPS, is phenol and proteinase K resistant, ethanol precipitable and does not dissociate in sodium dodecyl sulfate. Immunoelectron microscopy with colloidal gold demonstrates 11B7 circumferentially staining the surface of F. tularensis which is typical of a polysaccharide capsule. Mass spectrometry, compositional analysis and NMR indicate that the capsule is composed of a polymer of the tetrasaccharide repeat, 4)-alpha-D-GalNAcAN-(1->4)-alpha-D-GalNAcAN-(1->3)-beta-D-QuiNAc-(1->2)-beta-D-Qui4NFm-(1-, which is identical to the previously described F. tularensis O-antigen subunit. This indicates that the F. tularensis capsule can be classified as an O-antigen capsular polysaccharide. Our studies indicate that F. tularensis O-antigen glycosyltransferase mutants do not make a capsule. An F. tularensis acyltransferase and an O-antigen polymerase mutant had no evidence of an O-antigen but expressed a capsular antigen. Passive immunization of BALB/c mice with 75 mu g of 11B7 protected against a 150 fold lethal challenge of F. tularensis LVS. Active immunization of BALB/c mice with 10 mu g of capsule showed a similar level of protection. These studies demonstrate that F. tularensis produces an O-antigen capsule that may be the basis of a future vaccine.	[Apicella, Michael A.; Fowler, Andrew C.; Jones, Bradley D.; Rasmussen, Jed A.; Hunt, Jason R.; McLendon, Molly K.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Post, Deborah M. B.; Gibson, Bradford W.] Buck Inst Age Res, Novato, CA USA; [Imagawa, Sayaka; Choudhury, Biswa] Univ Calif San Diego, San Diego, CA 92103 USA; [Inzana, Thomas J.] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA 24061 USA; [Maier, Tamara M.; Frank, Dara W.; Zahrt, Thomas C.] Med Coll Wisconsin, Ctr Biopreparedness & Infect Dis, Milwaukee, WI 53226 USA; [Chaloner, Kathryn] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA 52242 USA; [Jennings, Michael P.] Griffith Univ, Inst Glyc, Gold Coast, Australia	University of Iowa; Buck Institute for Research on Aging; University of California System; University of California San Diego; Virginia Polytechnic Institute & State University; Medical College of Wisconsin; University of Iowa; Griffith University	Apicella, MA (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	michael-apicella@uiowa.edu	Jennings, Michael P/G-4822-2013; Chaloner, Kathryn/B-5090-2013	Jennings, Michael P/0000-0002-1027-4684; Fowler, Andrew/0000-0001-5646-5307; Jones, Brad/0000-0002-2698-8251	National Institutes of Allergy and Infectious Diseases [P01AI44642, AI057160, R01 AI063441]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044642, R01AI063441] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Public Health Service grant P01AI44642 (MAA), AI057160 (MAA and BDJ), AI057160 (BDJ) and R01 AI063441 (DWF) from the National Institutes of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamkiewicz TV, 2008, PEDIATRICS, V121, P562, DOI 10.1542/peds.2007-0018; Allen S, 2005, INFECT IMMUN, V73, P5291, DOI 10.1128/IAI.73.9.5291-5300.2005; ARTENSTEIN MS, 1976, NEW ENGL J MED, V282, P417; Barak JD, 2007, MOL PLANT MICROBE IN, V20, P1083, DOI 10.1094/MPMI-20-9-1083; Buchan BW, 2008, APPL ENVIRON MICROB, V74, P2637, DOI 10.1128/AEM.02882-07; CARLISLE HN, 1962, J IMMUNOL, V89, P638; Chen YS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-20; CHERWONOGRODZKY JW, 1994, VACCINE, V12, P773, DOI 10.1016/0264-410X(94)90284-4; Ciucanu I, 2006, ANAL CHIM ACTA, V576, P147, DOI 10.1016/j.aca.2006.06.009; Conlan JW, 2002, VACCINE, V20, P3465, DOI 10.1016/S0264-410X(02)00345-6; Cross AS, 2007, CLIN INFECT DIS, V45, pS61, DOI 10.1086/518150; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Dodgson C, 1996, J BACTERIOL, V178, P1895, DOI 10.1128/jb.178.7.1895-1902.1996; Elkins KL, 2002, INFECT IMMUN, V70, P1936, DOI 10.1128/IAI.70.4.1936-1948.2002; Goddard T.D., 2008, SPARKY NMR ASSIGNMEN; GOLDMAN RC, 1983, EUR J BIOCHEM, V131, P473, DOI 10.1111/j.1432-1033.1983.tb07286.x; GOLDMAN RC, 1982, J BACTERIOL, V151, P1210, DOI 10.1128/JB.151.3.1210-1221.1982; HOOD AM, 1977, J HYG-CAMBRIDGE, V79, P47, DOI 10.1017/S0022172400052840; Joklik WK, 1992, ZINSSER MICROBIOLOGY; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kaufmann AF, 1997, EMERG INFECT DIS, V3, P83, DOI 10.3201/eid0302.970201; Le Pihive E, 2009, PLASMID, V62, P147, DOI 10.1016/j.plasmid.2009.07.001; Li J, 2007, MICROBIOL-SGM, V153, P3141, DOI 10.1099/mic.0.2007/006460-0; Maier TA, 2007, INFECT IMMUN, V75, P5376, DOI 10.1128/IAI.00238-07; Maier TM, 2006, APPL ENVIRON MICROB, V72, P1878, DOI 10.1128/AEM.72.3.1878-1885.2006; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; McCoy G, 1912, J INFECT DIS, V10, P61, DOI 10.1093/infdis/10.1.61; McLendon MK, 2007, INFECT IMMUN, V75, P5518, DOI 10.1128/IAI.01288-06; Nakhamchik A, 2007, INFECT IMMUN, V75, P5550, DOI 10.1128/IAI.00932-07; NIERENGARTEN MB, 2002, MEDSCAPE INFECT DIS, V4; Phillips NJ, 2004, INFECT IMMUN, V72, P5340, DOI 10.1128/IAI.72.9.5340-5348.2004; Post DMB, 2003, INFECT IMMUN, V71, P647, DOI 10.1128/IAI.71.2.647-655.2003; R Development Core Team, 2009, R FDN STAT COMP; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; SANDSTROM G, 1988, INFECT IMMUN, V56, P1194; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006; Schilling B, 2007, ANAL CHEM, V79, P1034, DOI 10.1021/ac061654e; Sorokin VM, 1996, FEMS IMMUNOL MED MIC, V13, P249, DOI 10.1111/j.1574-695X.1996.tb00246.x; Steeghs L, 1998, NATURE, V392, P449, DOI 10.1038/33046; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; TARNVIK A, 1989, EUR J CLIN MICROBIOL, V8, P146, DOI 10.1007/BF01963900; Therneau T, 2009, SURVIVAL SURVIVAL AN; Thirumalapura NR, 2005, J MED MICROBIOL, V54, P693, DOI 10.1099/jmm.0.45931-0; VINOGRADOV EV, 1991, CARBOHYD RES, V214, P289, DOI 10.1016/0008-6215(91)80036-M; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Zhang F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-152; 2002, MMWR, V51, P181	50	66	70	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11060	10.1371/journal.pone.0011060	http://dx.doi.org/10.1371/journal.pone.0011060			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625403	gold, Green Published, Green Submitted			2022-12-25	WOS:000279522500003
J	Song, J; Chang, I; Chen, Z; Kang, M; Wang, CY				Song, Jun; Chang, Insoon; Chen, Zhuo; Kang, Mo; Wang, Cun-Yu			Characterization of Side Populations in HNSCC: Highly Invasive, Chemoresistant and Abnormal Wnt Signaling	PLOS ONE			English	Article							CANCER STEM-CELLS; CARCINOMA-CELLS; APOPTOSIS; SUBPOPULATION; TRANSCRIPTION; PHENOTYPE; MODEL; HEAD; LINE	Side Population (SP) cells, a subset of Hoechst-low cells, are enriched with stem cells. Originally, SP cells were isolated from bone marrow but recently have been found in various solid tumors and cancer cell lines that are clonogenic in vitro and tumorigenic in vivo. In this study, SP cells from lymph node metastatic head and neck squamous cell carcinoma (HNSCC) cell lines were examined using flow cytometry and Hoechst 3342 efflux assay. We found that highly metastatic HNSCC cell lines M3a2 and M4e contained more SP cells compared to the low metastatic parental HNSCC cell line 686LN. SP cells in HNSCC were highly invasive in vitro and tumorigenic in vivo compared to non-SP cells. Furthermore, SP cells highly expressed ABCG2 and were chemoresistant to Bortezomib and etoposide. Importantly, we found that SP cells in HNSCC had abnormal activation of Wnt/beta-catenin signaling as compared to non-SP cells. Together, these findings indicate that SP cells might be a major driving force of head and neck tumor formation and metastasis. The Wnt/b-catenin signaling pathway may be an important target for eliminating cancer stem cells in HNSCC.	[Song, Jun; Chang, Insoon; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Lab Mol Signaling, Los Angeles, CA 90024 USA; [Song, Jun; Wang, Cun-Yu] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Chen, Zhuo] Emory Univ, Winship Canc Inst, Dept Hematol & Oncol, Atlanta, GA 30322 USA; [Kang, Mo] Univ Calif Los Angeles, Sch Dent, Div Associated Clin Specialty, Sect Endodont, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Emory University; University of California System; University of California Los Angeles	Song, J (corresponding author), Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Lab Mol Signaling, Los Angeles, CA 90024 USA.	cwang@dentistry.ucla.edu			U.S. National Institutes of Dental and Craniofacial Research [R37DE13848, DE15964]; National Institutes of Health [CA-16042, AI-28697]; JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015964, R37DE013848] Funding Source: NIH RePORTER	U.S. National Institutes of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by U.S. National Institutes of Dental and Craniofacial Research grants R37DE13848 and DE15964. Flow cytometry was performed in the UCLA Jonsson Comprehensive Cancer Center (JCCC) and Center for AIDS Research Flow Cytometry Core Facility that is supported by National Institutes of Health awards CA-16042 and AI-28697, and by the JCCC, the UCLA AIDS Institute, and the David Geffen School of Medicine at UCLA. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Bunting KD, 2002, STEM CELLS, V20, P11, DOI 10.1002/stem.200011; Burkert J, 2006, J PATHOL, V209, P287, DOI 10.1002/path.2016; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dingli D, 2006, STEM CELLS, V24, P2603, DOI 10.1634/stemcells.2006-0136; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Haraguchi Naotsugu, 2006, Hum Cell, V19, P24, DOI 10.1111/j.1749-0774.2005.00004.x; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Kopper L, 2004, PATHOL ONCOL RES, V10, P69, DOI 10.1007/BF02893458; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pisani P, 2002, INT J CANCER, V97, P72, DOI 10.1002/ijc.1571; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Rehman AO, 2009, INT J ORAL SCI, V1, P105, DOI 10.4248/IJOS.09059; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Tan BT, 2006, LAB INVEST, V86, P1203, DOI 10.1038/labinvest.3700488; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Yang F, 2006, CELL SIGNAL, V18, P679, DOI 10.1016/j.cellsig.2005.06.015; Zhang X, 2002, CANCER-AM CANCER SOC, V95, P1663, DOI 10.1002/cncr.10837; Zhang X, 2006, CLIN EXP METASTAS, V23, P209, DOI 10.1007/s10585-006-9031-0; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	31	106	118	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11456	10.1371/journal.pone.0011456	http://dx.doi.org/10.1371/journal.pone.0011456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625515	Green Submitted, Green Published, gold			2022-12-25	WOS:000279522500021
J	Radhakrishnan, VM; Martinez, JD				Radhakrishnan, Vijayababu M.; Martinez, Jesse D.			14-3-3 gamma Induces Oncogenic Transformation by Stimulating MAP Kinase and PI3K Signaling	PLOS ONE			English	Article							LUNG-CANCER; TUBEROUS SCLEROSIS; PROTEINS; RAS; PHOSPHORYLATION; 14-3-3-SIGMA; ACTIVATION; RAF-1; TSC2; AKT	The 14-3-3 proteins are a set of highly conserved scaffolding proteins that have been implicated in the regulation of a variety of important cellular processes such as the cell cycle, apoptosis and mitogenic signaling. Recent evidence indicates that the expression of some of the family members is elevated in human cancers suggesting that they may play a role in tumorigenesis. In the present study, the oncogenic potential of 14-3-3 gamma was shown by focus formation and tumor formation in SCID mice using 14-3-3 gamma transfected NIH3T3 mouse fibroblast cells. In contrast, 14-3-3 sigma, a putative tumor suppressor, inhibited NIH3T3 transformation by H-ras and c-myc. We also report that activation of both MAP kinase and PI3K signaling pathways are essential for transformation by 14-3-3 gamma. In addition, we found that 14-3-3 gamma interacts with phosphatidylinositol 3-kinase (PI3K) and TSC2 proteins indicating that it could stimulate PI3K signaling by acting at two points in the signaling pathway. Overall, our studies establish 14-3-3 gamma as an oncogene and implicate MAPK and PI3K signaling as important for 14-3-3 gamma induced transformation.	[Radhakrishnan, Vijayababu M.; Martinez, Jesse D.] Univ Arizona, Arizona Canc Ctr, Dept Cell Biol & Anat, Tucson, AZ 85721 USA	Arizona Center Cancer Care; University of Arizona	Radhakrishnan, VM (corresponding author), Univ Arizona, Arizona Canc Ctr, Dept Cell Biol & Anat, Tucson, AZ 85721 USA.	jmartinez@azcc.arizona.edu			National Institutes of Health (NIH) [RO1 CA107510]; Cancer Center Support [P30 CA023074]; NATIONAL CANCER INSTITUTE [P30CA023074, R01CA107510] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a grant to JDM from the National Institutes of Health (NIH) (RO1 CA107510) and a Cancer Center Support Grant to the Arizona Cancer Center (P30 CA023074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballare E, 2001, J CLIN ENDOCR METAB, V86, P3809, DOI 10.1210/jc.86.8.3809; BONDY GP, 1985, CANCER RES, V45, P6005; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Fan T, 2007, CANCER RES, V67, P7901, DOI 10.1158/0008-5472.CAN-07-0090; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Guweidhi A, 2004, CARCINOGENESIS, V25, P1575, DOI 10.1093/carcin/bgh159; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Higaki M, 1996, J BIOL CHEM, V271, P29342, DOI 10.1074/jbc.271.46.29342; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Iwata N, 2000, ONCOGENE, V19, P5298, DOI 10.1038/sj.onc.1203898; Jin YH, 2008, BIOCHEM BIOPH RES CO, V368, P690, DOI 10.1016/j.bbrc.2008.01.114; LI SF, 1995, EMBO J, V14, P685, DOI 10.1002/j.1460-2075.1995.tb07047.x; Li WQ, 2004, J BIOL CHEM, V279, P37398, DOI 10.1074/jbc.M405730200; Li Y, 2002, J BIOL CHEM, V277, P44593, DOI 10.1074/jbc.C200510200; Liu Y, 2002, CHEM MATER, V14, P3, DOI 10.1021/cm0109544; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MICHAUD NR, 1995, MOL CELL BIOL, V15, P3390; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; MORRISON DK, 1995, METHOD ENZYMOL, V255, P301; Munday AD, 2000, BLOOD, V96, P577; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Olson MF, 2000, SEMIN IMMUNOL, V12, P63, DOI 10.1006/smim.2000.0208; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Qi WQ, 2007, MOL CARCINOGEN, V46, P847, DOI 10.1002/mc.20314; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; RAY RB, 1995, CANCER RES, V55, P3747; Samuel T, 2001, J BIOL CHEM, V276, P45201, DOI 10.1074/jbc.M106427200; Su TT, 2001, J CELL SCI, V114, P3445; Takihara Y, 2000, CARCINOGENESIS, V21, P2073, DOI 10.1093/carcin/21.11.2073; TUCK SP, 1989, ONCOGENE RES, V4, P81; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Yang HL, 2006, CANCER RES, V66, P3096, DOI 10.1158/0008-5472.CAN-05-3620; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	41	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11433	10.1371/journal.pone.0011433	http://dx.doi.org/10.1371/journal.pone.0011433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20628654	Green Published, gold, Green Submitted			2022-12-25	WOS:000279465700015
J	Ajslev, TA; Andersen, CS; Ingstrup, KG; Nohr, EA; Sorensen, TIA				Ajslev, Teresa A.; Andersen, Camilla S.; Ingstrup, Katja G.; Nohr, Ellen A.; Sorensen, Thorkild I. A.			Maternal Postpartum Distress and Childhood Overweight	PLOS ONE			English	Article							BODY-MASS INDEX; POSTTRAUMATIC-STRESS-DISORDER; GESTATIONAL WEIGHT-GAIN; INTERNATIONAL SURVEY; OBESITY; RISK; DEPRESSION; CHILDREN; PREGNANCY; MALTREATMENT	Objective: We investigated associations between maternal postpartum distress covering anxiety, depression and stress and childhood overweight. Methods: We performed a prospective cohort study, including 21 121 mother-child-dyads from the Danish National Birth Cohort (DNBC). Maternal distress was measured 6 months postpartum by 9 items covering anxiety, depression and stress. Outcome was childhood overweight at 7-years-of age. Multiple logistic regression analyses were performed and information on maternal age, socioeconomic status, pre-pregnancy BMI, gestational weight gain, parity, smoking during pregnancy, paternal BMI, birth weight, gestational age at birth, sex, breastfeeding and finally infant weight at 5 and 12 month were included in the analyses. Results: We found, that postpartum distress was not associated with childhood risk of overweight, OR 1.00, 95% Cl [0.98-1.02]. Neither was anxiety, depression, or stress exposure, separately. There were no significant differences between the genders. Adjustment for potential confounders did not alter the results. Conclusion: Maternal postpartum distress is apparently not an independent risk factor for childhood overweight at 7-years-of-age. However, we can confirm previous findings of perinatal determinants as high maternal pre-pregnancy BMI, and smoking during pregnancy being risk factors for childhood overweight.	[Ajslev, Teresa A.; Andersen, Camilla S.; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Ingstrup, Katja G.; Nohr, Ellen A.] Univ Aarhus, Inst Publ Hlth, Dept Epidemiol, Aarhus, Denmark	University of Copenhagen; Aarhus University	Ajslev, TA (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark.	ta@ipm.regionh.dk		Ingstrup, Katja Glejsted/0000-0001-7288-5336	Pharmacy Foundation; Egmont Foundation; March of Dimes Birth Defects Foundation; Augustinus Foundation; Health Foundation; Lundbeck Foundation [195/04]; Danish Medical Research Council [SSVF 0646]	Pharmacy Foundation; Egmont Foundation; March of Dimes Birth Defects Foundation(March of Dimes); Augustinus Foundation; Health Foundation; Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Additional support for the Danish National Birth Cohort was obtained from the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Augustinus Foundation, and the Health Foundation. The 7-year follow-up study within the DNBC has received financial support from the Lundbeck Foundation (195/04) and the Danish Medical Research Council (SSVF 0646). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 2007, OBES REV, V8, P45, DOI 10.1111/j.1467-789X.2007.00317.x; Brockington I, 2004, LANCET, V363, P303, DOI 10.1016/S0140-6736(03)15390-1; Charmandari E, 2003, HORM RES, V59, P161, DOI 10.1159/000069325; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Forman DR, 2007, DEV PSYCHOPATHOL, V19, P585, DOI 10.1017/S0954579407070289; Grilo CM, 2005, OBES RES, V13, P123, DOI 10.1038/oby.2005.16; Gustafson T B, 2004, Obes Rev, V5, P129, DOI 10.1111/j.1467-789X.2004.00145.x; KNUTSON JF, 2009, J PEDIAT PSYCHOL; LISSAU I, 1994, LANCET, V343, P324, DOI 10.1016/S0140-6736(94)91163-0; Lobstein T, 2003, Obes Rev, V4, P195, DOI 10.1046/j.1467-789X.2003.00116.x; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Monasta L, 2010, OBES REV; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Navarro P, 2007, GEN HOSP PSYCHIAT, V29, P1, DOI 10.1016/j.genhosppsych.2006.10.004; Nemeroff CB, 2008, NEURON, V59, P185, DOI 10.1016/j.neuron.2008.07.015; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; O'Hara MW, 2009, J CLIN PSYCHOL, V65, P1258, DOI 10.1002/jclp.20644; Oberlander TF, 2008, EARLY HUM DEV, V84, P689, DOI 10.1016/j.earlhumdev.2008.06.008; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Oken E, 2008, INT J OBESITY, V32, P201, DOI 10.1038/sj.ijo.0803760; Oken E, 2008, OBSTET GYNECOL, V112, P999, DOI 10.1097/AOG.0b013e31818a5d50; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Ong KK, 2006, HORM RES, V65, P65, DOI 10.1159/000091508; Padez C, 2005, ACTA PAEDIATR, V94, P1550, DOI 10.1080/08035250510042924; Pederson CL, 2009, PSYCHOL REP, V105, P111, DOI 10.2466/PR0.105.1.111-126; Perkonigg A, 2009, AM J PREV MED, V36, P1, DOI 10.1016/j.amepre.2008.09.026; Plagemann Andreas, 2005, Metabolic Syndrome and Related Disorders, V3, P222, DOI 10.1089/met.2005.3.222; Schmitz N, 2001, COMPR PSYCHIAT, V42, P166, DOI 10.1053/comp.2001.19751; Sorensen TIA, 2009, P NUTR SOC, V68, P43, DOI 10.1017/S0029665108008847; STENHAMMAR C, 2010, ACTA PAEDIAT; Surkan PJ, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.065664; Trombini E, 2003, PERCEPT MOTOR SKILL, V97, P613, DOI 10.2466/PMS.97.5.613-620; Vohr BR, 2008, J MATERN-FETAL NEO M, V21, P149, DOI 10.1080/14767050801929430; Whitaker RC, 2007, CHILD ABUSE NEGLECT, V31, P1187, DOI 10.1016/j.chiabu.2007.04.008; Wisner KL, 2009, AM J PSYCHIAT, V166, P557, DOI 10.1176/appi.ajp.2008.08081170; Wisner KL, 2002, NEW ENGL J MED, V347, P194, DOI 10.1056/NEJMcp011542; Zeller MH, 2007, OBESITY, V15, P126, DOI 10.1038/oby.2007.517; 2010, DANISH NATL BIRTH CO	42	31	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11136	10.1371/journal.pone.0011136	http://dx.doi.org/10.1371/journal.pone.0011136			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	618QE	20614031	Green Published, gold, Green Submitted			2022-12-25	WOS:000279370000001
J	Saikkonen, K; Wali, PR; Helander, M				Saikkonen, Kari; Wali, Piippa R.; Helander, Marjo			Genetic Compatibility Determines Endophyte-Grass Combinations	PLOS ONE			English	Article							FUNGAL ENDOPHYTES; MUTUALISM; EVOLUTION; FESCUE; INFECTION; ECOLOGY; SYSTEMS; LOLIUM	Even highly mutually beneficial microbial-plant interactions, such as mycorrhizal- and rhizobial-plant exchanges, involve selfishness, cheating and power-struggles between the partners, which depending on prevailing selective pressures, lead to a continuum of interactions from antagonistic to mutualistic. Using manipulated grass-endophyte combinations in a five year common garden experiment, we show that grass genotypes and genetic mismatches constrain genetic combinations between the vertically (via host seeds) transmitted endophytes and the out-crossing host, thereby reducing infections in established grass populations. Infections were lost in both grass tillers and seedlings in F-1 and F-2 generations, respectively. Experimental plants were collected as seeds from two different environments, i.e., meadows and nearby riverbanks. Endophyte-related benefits to the host included an increased number of inflorescences, but only in meadow plants and not until the last growing season of the experiment. Our results illustrate the importance of genetic host specificity and transgenerational maternal effects on the genetic structure of a host population, which act as destabilizing forces in endophyte-grass symbioses. We propose that (1) genetic mismatches may act as a buffering mechanism against highly competitive endophyte-grass genotype combinations threatening the biodiversity of grassland communities and (2) these mismatches should be acknowledged, particularly in breeding programmes aimed at harnessing systemic and heritable endophytes to improve the agriculturally valuable characteristics of cultivars.	[Saikkonen, Kari] MTT Agrifood Res Finland, Plant Prod Res, Jokioinen, Finland; [Wali, Piippa R.] Univ Oulu, Dept Biol, Oulu, Finland; [Helander, Marjo] Univ Turku, Dept Biol, SF-20500 Turku, Finland	Natural Resources Institute Finland (Luke); University of Oulu; University of Turku	Saikkonen, K (corresponding author), MTT Agrifood Res Finland, Plant Prod Res, Jokioinen, Finland.	kari.saikkonen@mtt.fi	; Wali, Piippa/H-8562-2017	Helander, Marjo/0000-0002-9759-4321; Wali, Piippa/0000-0002-2484-7455	Academy of Finland [110658]	Academy of Finland(Academy of Finland)	This study was funded by the Academy of Finland (Project no. 110658, www.aka.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlholm JU, 2002, OIKOS, V99, P173, DOI 10.1034/j.1600-0706.2002.990118.x; [Anonymous], 1998, RETKEILYKASVIO; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BRONSTEIN JL, 1994, Q REV BIOL, V69, P31, DOI 10.1086/418432; Cheplick GP, 2009, ECOLOGY EVOLUTION GR; Clay K, 1999, SCIENCE, V285, P1742, DOI 10.1126/science.285.5434.1742; Clay K, 2002, AM NAT, V160, pS99, DOI 10.1086/342161; Faeth SH, 2003, AM NAT, V161, P310, DOI 10.1086/345937; Gould F.W., 1983, GRASS SYSTEMATICS, V2; GWINN KD, 1991, PHYTOPATHOLOGY, V81, P747, DOI 10.1094/Phyto-81-747; HARBERD D. J., 1961, NEW PHYTOL, V60, P184, DOI 10.1111/j.1469-8137.1961.tb06251.x; HERRE EA, 1998, ANNU REV ECOL SYST, V39, P439; Jensen AMD, 2004, AGR ECOSYST ENVIRON, V104, P419, DOI 10.1016/j.agee.2004.01.044; Kiers ET, 2008, ANNU REV ECOL EVOL S, V39, P215, DOI 10.1146/annurev.ecolsys.39.110707.173423; LATCH GCM, 1984, MYCOTAXON, V20, P535; LATCH GCM, 1985, ANN APPL BIOL, V107, P17, DOI 10.1111/j.1744-7348.1985.tb01543.x; Lehtonen P, 2005, ECOL LETT, V8, P1256, DOI 10.1111/j.1461-0248.2005.00834.x; MOSSEAU TA, 1998, MATERNAL EFFECTS AAD; Omacini M, 2001, NATURE, V409, P78, DOI 10.1038/35051070; PELLMYR O, 1994, NATURE, V372, P257, DOI 10.1038/372257a0; Rudgers JA, 2008, ECOL LETT, V11, P831, DOI 10.1111/j.1461-0248.2008.01201.x; Saari S, 2009, GRASS FORAGE SCI, V64, P169, DOI 10.1111/j.1365-2494.2009.00680.x; Saari S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009845; Sachs JL, 2006, TRENDS ECOL EVOL, V21, P585, DOI 10.1016/j.tree.2006.06.018; SAHA DC, 1988, PHYTOPATHOLOGY, V78, P237, DOI 10.1094/Phyto-78-237; Saikkonen K, 2000, ECOGRAPHY, V23, P360, DOI 10.1034/j.1600-0587.2000.d01-1645.x; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Saikkonen K, 2004, TRENDS PLANT SCI, V9, P275, DOI 10.1016/j.tplants.2004.04.005; Saikkonen K, 2006, TRENDS PLANT SCI, V11, P428, DOI 10.1016/j.tplants.2006.07.001; Saikkonen K, 2010, FUNGAL DIVERS, V41, P101, DOI 10.1007/s13225-010-0023-7; Schardl CL, 2004, ANNU REV PLANT BIOL, V55, P315, DOI 10.1146/annurev.arplant.55.031903.141735; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; Stadler B, 2005, ANNU REV ECOL EVOL S, V36, P345, DOI 10.1146/annurev.ecolsys.36.091704.175531; Thompson J. N., 2005, INTERSPEC INTERACT; Wali PR, 2007, MICROB ECOL, V53, P20, DOI 10.1007/s00248-006-9076-2; Wali P, 2009, OECOLOGIA, V159, P49, DOI 10.1007/s00442-008-1202-z; Wei YK, 2006, GRASS FORAGE SCI, V61, P422, DOI 10.1111/j.1365-2494.2006.00551.x; WILLIAMS MJ, 1984, PLANT DIS, V68, P49, DOI 10.1094/PD-69-49; Zar JH., 2010, BIOSTAT ANAL	39	64	66	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11395	10.1371/journal.pone.0011395	http://dx.doi.org/10.1371/journal.pone.0011395			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614034	Green Submitted, Green Published, gold			2022-12-25	WOS:000279370000023
J	Schimizzi, GV; Currie, JD; Rogers, SL				Schimizzi, Gregory V.; Currie, Joshua D.; Rogers, Stephen L.			Expression Levels of a Kinesin-13 Microtubule Depolymerase Modulates the Effectiveness of Anti-Microtubule Agents	PLOS ONE			English	Article							DYNAMICS; CELLS; COOPERATE; BINDING; TUBULIN; TARGET; DRUGS	Background: Chemotheraputic drugs often target the microtubule cytoskeleton as a means to disrupt cancer cell mitosis and proliferation. Anti-microtubule drugs inhibit microtubule dynamics, thereby triggering apoptosis when dividing cells activate the mitotic checkpoint. Microtubule dynamics are regulated by microtubule-associated proteins (MAPs); however, we lack a comprehensive understanding about how anti-microtubule agents functionally interact with MAPs. In this report, we test the hypothesis that the cellular levels of microtubule depolymerases, in this case kinesin-13 s, modulate the effectiveness of the microtubule disrupting drug colchicine. Methodology/Principal Findings: We used a combination of RNA interference (RNAi), high-throughput microscopy, and time-lapse video microscopy in Drosophila S2 cells to identify a specific MAP, kinesin-like protein 10A (KLP10A), that contributes to the efficacy of the anti-microtubule drug colchicine. KLP10A is an essential microtubule depolymerase throughout the cell cycle. We find that depletion of KLP10A in S2 cells confers resistance to colchicine-induced microtubule depolymerization to a much greater extent than depletion of several other destabilizing MAPs. Using image-based assays, we determined that control cells retained 58% (+/- 2% SEM) of microtubule polymer when after treatment with 2 mu M colchicine for 1 hour, while cells depleted of KLP10A by RNAi retained 74% (+/- 1% SEM). Likewise, overexpression of KLP10A-GFP results in increased susceptibility to microtubule depolymerization by colchicine. Conclusions/Significance: Our results demonstrate that the efficacy of microtubule destabilization by a pharmacological agent is dependent upon the cellular expression of a microtubule depolymerase. These findings suggest that expression levels of Kif2A, the human kinesin-13 family member, may be an attractive biomarker to assess the effectiveness of anti-microtubule chemotherapies. Knowledge of how MAP expression levels affect the action of anti-microtubule drugs may prove useful for evaluating possible modes of cancer treatment.	[Schimizzi, Gregory V.; Currie, Joshua D.; Rogers, Stephen L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Rogers, Stephen L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Rogers, Stephen L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Schimizzi, GV (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	srogers@bio.unc.edu		Schimizzi, Gregory/0000-0001-8744-3434; Currie, Josh/0000-0001-7402-4265	National Institutes of Health (NIH) [RO1GM081645]; Arnold and Mabel Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081645] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (NIH) (RO1GM081645) and the Beckman Young Investigator Award from the Arnold and Mabel Beckman Foundation (http://www.beckman-foundation.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Bolanos-Garcia VM, 2009, CURR CANCER DRUG TAR, V9, P131, DOI 10.2174/156800909787580980; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Hedrick DG, 2008, CELL CYCLE, V7, P2146, DOI 10.4161/cc.7.14.6239; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Jordan MA, 1998, METHOD ENZYMOL, V298, P252, DOI 10.1016/S0076-6879(98)98024-7; Mennella V, 2005, NAT CELL BIOL, V7, P235, DOI 10.1038/ncb1222; Mulder AM, 2009, J CELL BIOL, V185, P51, DOI 10.1083/jcb.200812052; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Rogers SL, 2008, NAT PROTOC, V3, P606, DOI 10.1038/nprot.2008.18; UPPULURI S, 1993, P NATL ACAD SCI USA, V90, P11598, DOI 10.1073/pnas.90.24.11598; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; Wood Kenneth W., 2001, Current Opinion in Pharmacology, V1, P370, DOI 10.1016/S1471-4892(01)00064-9	17	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11381	10.1371/journal.pone.0011381	http://dx.doi.org/10.1371/journal.pone.0011381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614032	Green Published, Green Submitted, gold			2022-12-25	WOS:000279370000011
J	Kallio, J; Myllymaki, H; Gronholm, J; Armstrong, M; Vanha-aho, LM; Makinen, L; Silvennoinen, O; Valanne, S; Ramet, M				Kallio, Jenni; Myllymaki, Henna; Gronholm, Juha; Armstrong, Morag; Vanha-aho, Leena-Maija; Makinen, Leena; Silvennoinen, Olli; Valanne, Susanna; Ramet, Mika			Eye transformer is a negative regulator of Drosophila JAK/STAT signaling	FASEB JOURNAL			English	Article						RNAi screen; cytokine signaling; stress response; Domeless; unpaired	JANUS KINASE/SIGNAL TRANSDUCER; HUMORAL STRESS-RESPONSE; WIDE RNAI ANALYSIS; PATHWAY; RECEPTOR; PROTEIN; GENES; IDENTIFICATION; EXPRESSION; COMPONENTS	JAK/STAT signaling pathway is evolutionarily conserved and tightly regulated. We carried out a reporter-based genome-wide RNAi in vitro screen to identify genes that regulate Drosophila JAK/STAT pathway and found 5 novel regulators. Of these, CG14225 is a negative regulator structurally related to the Drosophila JAK/STAT pathway receptor Domeless, especially in the extracellular domain, and to the mammalian IL-6 receptor and the signal transducer gp130. CG14225 coimmunoprecipitates with Domeless and its associated kinase hopscotch in S2 cells. CG14225 RNAi caused hyperphosphorylation of the transcription factor Stat92E in S2 cells on stimulation with the Drosophila JAK/STAT pathway ligand unpaired. CG14225 RNAi in vivo hyperactivated JAK/STAT target genes on septic injury and enhanced unpaired-induced eye overgrowth, and was thus named the eye transformer (ET). In the gastrointestinal infection model, where JAK/STAT signaling is important for stem cell renewal, CG14225/ET RNAi was protective in vivo. In conclusion, we have identified ET as a novel negative regulator of the Drosophila JAK/STAT pathway both in vitro and in vivo, and it functions in regulating Stat92E phosphorylation.-Kallio, J., Myllymaki, H., Gronholm, J., Armstrong, M., Vanha-aho, L.-M., Makinen, L., Silvennoinen, O., Valanne, S., Ramet, M. Eye transformer is a negative regulator of Drosophila JAK/STAT signaling. FASEB J. 24, 4467-4479 (2010). www.fasebj.org	[Kallio, Jenni; Myllymaki, Henna; Armstrong, Morag; Vanha-aho, Leena-Maija; Makinen, Leena; Valanne, Susanna; Ramet, Mika] Tampere Univ, Inst Med Technol, Expt Immunol Lab, FIN-33014 Tampere, Finland; [Gronholm, Juha; Silvennoinen, Olli] Tampere Univ, Inst Med Technol, Lab Mol Immunol & Cytokine Receptor Signaling, FIN-33014 Tampere, Finland; [Ramet, Mika] Tampere Univ Hosp, Dept Pediat, Tampere, Finland	Tampere University; Tampere University; Tampere University; Tampere University Hospital	Ramet, M (corresponding author), Tampere Univ, Inst Med Technol, Expt Immunol Lab, FIN-33014 Tampere, Finland.	mika.ramet@uta.fi	Valanne, Susanna/GZK-2381-2022; Grönholm, Juha/Q-4078-2017	Valanne, Susanna/0000-0003-0898-8423; Grönholm, Juha/0000-0002-4190-0000; Myllymaki, Henna/0000-0002-6936-4879; Vanha-aho, Leena-Maija/0000-0001-7933-7711	Academy of Finland; Foundation for Pediatric Research; Sigrid Juselius Foundation; Emil Aaltonen Foundation; Pirkanmaa Hospital District; Tampere Tuberculosis Foundation	Academy of Finland(Academy of Finland); Foundation for Pediatric Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Emil Aaltonen Foundation; Pirkanmaa Hospital District; Tampere Tuberculosis Foundation	The authors thank Prof. Bruno Lemaitre (Centre de Genetique Moleculaire, Gif-sur-Yvette, France) for C564-GAL4 fly stock and Prof. Howard Jacobs (University of Tampere, Tampere, France) for GeneSwitch-GAL4 fly stock. The authors thank Prof. Jean-Luc Imler (Universite Louis Pasteur, Strasbourg, France) for TotM-luciferase and hop<SUP>Tum-l</SUP> constructs, Prof. Michael Boutros (German Cancer Research Center, Heidelberg, Germany) for GMR-upd Delta 3' and ey-GAL4 fly stocks and pMT-upd and 3 x 2-Draf-luc constructs, and Erica Bach (New York University Langone Medical Center, New York, NY, USA) for 10xStat92E-luc reporter. The authors also thank Prof. Jussi Taipale, Dr. Minna Taipale, and Dr. Mikael Bjorklund (University of Helsinki, Helsinki, Finland) for their help in generating our dsRNA library. This research was supported by grants from the Academy of Finland, the Foundation for Pediatric Research, the Sigrid Juselius Foundation, the Emil Aaltonen Foundation (to M.R.), the Competitive Research Funding of the Pirkanmaa Hospital District, and the Tampere Tuberculosis Foundation (to M.R. and S.V.). The authors declare they have no conflicts of interest. All authors approved the final version of the text.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; Arbouzova NI, 2006, CURR BIOL, V16, P80, DOI 10.1016/j.cub.2005.11.033; Bach EA, 2003, GENETICS, V165, P1149; Baeg GH, 2005, GENE DEV, V19, P1861, DOI 10.1101/gad.1320705; BAUMANN H, 1994, MOL CELL BIOL, V14, P138, DOI 10.1128/MCB.14.1.138; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Betz A, 2001, P NATL ACAD SCI USA, V98, P9563, DOI 10.1073/pnas.171302098; BINARI R, 1994, GENE DEV, V8, P300, DOI 10.1101/gad.8.3.300; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Brown S, 2003, DEVELOPMENT, V130, P3077, DOI 10.1242/dev.00535; Brown S, 2001, CURR BIOL, V11, pR43, DOI 10.1016/S0960-9822(01)00007-0; Brun S, 2006, GENES CELLS, V11, P397, DOI 10.1111/j.1365-2443.2006.00953.x; Callus BA, 2002, ONCOGENE, V21, P4812, DOI 10.1038/sj.onc.1205618; Chen HW, 2002, GENE DEV, V16, P388, DOI 10.1101/gad.955202; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Ekengren S, 2001, CURR BIOL, V11, P714, DOI 10.1016/S0960-9822(01)00203-2; Gilbert MM, 2005, MECH DEVELOP, V122, P939, DOI 10.1016/j.mod.2005.03.004; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Hirano Toshio, 1997, Cytokine and Growth Factor Reviews, V8, P241, DOI 10.1016/S1359-6101(98)80005-1; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; Hombria JCG, 2002, CURR BIOL, V12, pR569, DOI 10.1016/S0960-9822(02)01057-6; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Kallio J, 2005, MICROBES INFECT, V7, P811, DOI 10.1016/j.micinf.2005.03.014; Karsten P, 2002, MECH DEVELOP, V117, P343, DOI 10.1016/S0925-4773(02)00216-2; Kleino A, 2005, EMBO J, V24, P3423, DOI 10.1038/sj.emboj.7600807; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Luo H, 1997, MOL CELL BIOL, V17, P1562, DOI 10.1128/MCB.17.3.1562; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Mukherjee T, 2006, GENETICS, V172, P1683, DOI 10.1534/genetics.105.046904; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Pernis AB, 2002, J CLIN INVEST, V109, P1279, DOI 10.1172/JCI200215786; PERRIMON N, 1986, DEV BIOL, V118, P28, DOI 10.1016/0012-1606(86)90070-9; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Singh SR, 2005, CELL RES, V15, P1, DOI 10.1038/sj.cr.7290255; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Ungureanu D, 2003, BLOOD, V102, P3311, DOI 10.1182/blood-2002-12-3816; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Zeidler MP, 1999, GENE DEV, V13, P1342, DOI 10.1101/gad.13.10.1342; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	56	36	36	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4467	4479		10.1096/fj.10-162784	http://dx.doi.org/10.1096/fj.10-162784			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20624926				2022-12-25	WOS:000283861100032
J	Klimacek, M; Nidetzky, B				Klimacek, Mario; Nidetzky, Bernd			From Alcohol Dehydrogenase to a "One-way" Carbonyl Reductase by Active-site Redesign A MECHANISTIC STUDY OF MANNITOL 2-DEHYDROGENASE FROM PSEUDOMONAS FLUORESCENS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENS MANNITOL 2-DEHYDROGENASE; PSEUDOMONAS-FLUORESCENS; CRYSTAL-STRUCTURE; CATALYTIC MECHANISM; TERNARY COMPLEXES; 5-BETA-REDUCTASE AKR1D1; RATE CONSTANTS; OXYANION HOLE; SPECIFICITY; BINDING	Directional preference in catalysis is often used to distinguish alcohol dehydrogenases from carbonyl reductases. However, the mechanistic basis underpinning this discrimination is weak. In mannitol 2-dehydrogenase from Pseudomonas fluorescens, stabilization of (partial) negative charge on the substrate oxyanion by the side chains of Asn-191 and Asn-300 is a key feature of catalysis in the direction of alcohol oxidation. We have disrupted this ability through individual and combined substitutions of the two asparagines by aspartic acid. Kinetic data and their thermodynamic analysis show that the internal equilibrium of enzyme-NADH-fructose and enzyme-NAD(+)-mannitol (K-int) was altered dramatically (10(4)-to 10(5)-fold) from being balanced in the wild-type enzyme (K-int approximate to 3) to favoring enzyme-NAD(+)-mannitol in the single site mutants, N191D and N300D. The change in K-int reflects a selective slowing down of the mannitol oxidation rate, resulting because Asn -> Asp replacement (i) disfavors partial abstraction of alcohol proton by Lys-295 in a step preceding catalytic hydride transfer, and (ii) causes stabilization of a nonproductive enzyme-NAD(+)-mannitol complex. N191D and N300D appear to lose fructose binding affinity due to deprotonation of the respective Asp above apparent pK values of 5.3 +/- 0.1 and 6.3 +/- 0.2, respectively. The mutant incorporating both Asn -> Asp substitutions behaved as a slow "fructose reductase" at pH 5.2, lacking measurable activity for mannitol oxidation in the pH range 6.8-10. A mechanism is suggested in which polarization of the substrate carbonyl by a doubly protonated diad of Asp and Lys-295 facilitates NADH-dependent reduction of fructose by N191D and N300D under optimum pH conditions. Creation of an effectively "one-way" reductase by active-site redesign of a parent dehydrogenase has not been previously reported and holds promise in the development of carbonyl reductases for application in organic synthesis.	[Klimacek, Mario; Nidetzky, Bernd] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria; [Nidetzky, Bernd] ACIB GmbH, A-8010 Graz, Austria	Graz University of Technology; Austrian Centre of Industrial Biotechnology	Nidetzky, B (corresponding author), Graz Univ Technol, Inst Biotechnol & Biochem Engn, Petersgasse 12-1, A-8010 Graz, Austria.	bernd.nidetzky@tugraz.at		Nidetzky, Bernd/0000-0002-5030-2643				Bobofchak KM, 2005, J BIOL CHEM, V280, P25644, DOI 10.1074/jbc.M503499200; BRYAN P, 1986, P NATL ACAD SCI USA, V83, P3743, DOI 10.1073/pnas.83.11.3743; Chakravorty DK, 2009, BIOCHEMISTRY-US, V48, P10608, DOI 10.1021/bi901353v; CLARKE AR, 1988, BIOCHEMISTRY-US, V27, P1617, DOI 10.1021/bi00405a034; Collins P. C., 1995, MONOSACCHARIDES THEI; Cook PF, 1991, ENZYME MECH ISOTOPE; Di Costanzo L, 2008, J BIOL CHEM, V283, P16830, DOI 10.1074/jbc.M801778200; Di Costanzo L, 2009, MOL CELL ENDOCRINOL, V301, P191, DOI 10.1016/j.mce.2008.09.013; Di Costanzo L, 2009, CHEM-BIOL INTERACT, V178, P127, DOI 10.1016/j.cbi.2008.10.046; Eschenburg S, 1998, EUR J BIOCHEM, V257, P309, DOI 10.1046/j.1432-1327.1998.2570309.x; Faucher F, 2008, BIOCHEMISTRY-US, V47, P8261, DOI 10.1021/bi800572s; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; GRIMSHAW CE, 1995, BIOCHEMISTRY-US, V34, P14356, DOI 10.1021/bi00044a012; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; Kavanagh KL, 2002, J BIOL CHEM, V277, P43433, DOI 10.1074/jbc.M206914200; Klimacek M, 2003, CHEM-BIOL INTERACT, V143, P559, DOI 10.1016/S0009-2797(02)00219-3; Klimacek M, 2003, BIOCHEM J, V375, P141, DOI 10.1042/BJ20030733; Klimacek M, 2002, BIOCHEM J, V367, P13, DOI 10.1042/BJ20020932; Klimacek M, 2002, BIOCHEMISTRY-US, V41, P10158, DOI 10.1021/bi025517x; Klimacek M, 2010, BIOCHEM J, V425, P455, DOI 10.1042/BJ20091441; NIDETZKY B, 2007, ENZYMOLOGY MOL BIOL, V13; Northrop D. B., 1977, ISOTOPE EFFECTS ENZY; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Segel IH., 1993, ENZYME KINETICS BEHA; SEKHAR VC, 1990, BIOCHEMISTRY-US, V29, P4289, DOI 10.1021/bi00470a005; Slatner M, 1999, BIOCHEMISTRY-US, V38, P10489, DOI 10.1021/bi990327g	29	5	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30644	30653		10.1074/jbc.M110.108993	http://dx.doi.org/10.1074/jbc.M110.108993			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20639204	hybrid, Green Published			2022-12-25	WOS:000282135500033
J	Radchenko, MV; Thornton, J; Merrick, M				Radchenko, Martha V.; Thornton, Jeremy; Merrick, Mike			Control of AmtB-GlnK Complex Formation by Intracellular Levels of ATP, ADP, and 2-Oxoglutarate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PROTEIN; AMMONIUM TRANSPORTER AMTB; ADENYLATE ENERGY-CHARGE; ESCHERICHIA-COLI; P-II; RHODOSPIRILLUM-RUBRUM; GLUTAMINE-SYNTHETASE; CRYSTAL-STRUCTURE; ACETYLGLUTAMATE-KINASE; RNA-POLYMERASE	P-II proteins are one of the most widespread families of signal transduction proteins in nature, being ubiquitous throughout bacteria, archaea, and plants. They play a major role in coordinating nitrogen metabolism by interacting with, and regulating the activities of, a variety of enzymes, transcription factors, and membrane transport proteins. The regulatory properties of P-II proteins derive from their ability to bind three effectors: ATP, ADP, and 2-oxoglutarate. However, a clear model to integrate physiological changes with the consequential structural changes that mediate P-II interaction with a target protein has so far not been developed. In this study, we analyzed the fluctuations in intracellular effector pools in Escherichia coli during association and dissociation of the P-II protein GlnK with the ammonia channel AmtB. We determined that key features promoting AmtB-GlnK complex formation are the rapid drop in the 2-oxoglutarate pool upon ammonium influx and a simultaneous, but transient, change in the ATP/ADP ratio. We were also able to replicate AmtB-GlnK interactions in vitro using the same effector combinations that we observed in vivo. This comprehensive data set allows us to propose a model that explains the way in which interactions between GlnK and its effectors influence the conformation of GlnK and thereby regulate its interaction with AmtB.	[Radchenko, Martha V.; Thornton, Jeremy; Merrick, Mike] John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Merrick, M (corresponding author), John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England.	mike.merrick@bbsrc.ac.uk			Biotechnology and Biological Sciences Research Council (United Kingdom)	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (United Kingdom).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; CHAPMAN AG, 1971, J BACTERIOL, V108, P1072, DOI 10.1128/JB.108.3.1072-1086.1971; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Durand A, 2006, J BIOL CHEM, V281, P29558, DOI 10.1074/jbc.M602477200; Forchhammer K, 1999, MOL MICROBIOL, V33, P338, DOI 10.1046/j.1365-2958.1999.01477.x; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; Gruswitz F, 2007, P NATL ACAD SCI USA, V104, P42, DOI 10.1073/pnas.0609796104; Huergo LF, 2007, MOL MICROBIOL, V66, P1523, DOI 10.1111/j.1365-2958.2007.06016.x; Javelle A, 2005, BIOCHEM J, V390, P215, DOI 10.1042/BJ20042094; Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200; Javelle A, 2008, P NATL ACAD SCI USA, V105, P5040, DOI 10.1073/pnas.0711742105; Javelle A, 2006, J BIOL CHEM, V281, P39492, DOI 10.1074/jbc.M608325200; Jiang P, 1999, J BACTERIOL, V181, P1906, DOI 10.1128/JB.181.6.1906-1911.1999; Jiang P, 2007, BIOCHEMISTRY-US, V46, P12979, DOI 10.1021/bi701062t; Jiang P, 2009, BIOCHEMISTRY-US, V48, P11522, DOI 10.1021/bi9011594; KAMBEROV ES, 1995, J BIOL CHEM, V270, P17797, DOI 10.1074/jbc.270.30.17797; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; KUSTU S, 1984, MOL GEN GENET, V197, P309, DOI 10.1007/BF00330979; Liu Z, 2001, J BIOL CHEM, V276, P1424, DOI 10.1074/jbc.M007528200; Llacer JL, 2007, P NATL ACAD SCI USA, V104, P17644, DOI 10.1073/pnas.0705987104; MACNEIL D, 1981, J BACTERIOL, V146, P260, DOI 10.1128/JB.146.1.260-268.1981; Merrick M, 2006, TRANSFUS CLIN BIOL, V13, P97, DOI 10.1016/j.tracli.2006.02.015; Mizuno Y, 2007, J BIOL CHEM, V282, P35733, DOI 10.1074/jbc.M707127200; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Reyes-Ramirez F, 2001, J BACTERIOL, V183, P3076, DOI 10.1128/JB.183.10.3076-3082.2001; Sant'Anna F, 2009, J MOL EVOL, V68, P322, DOI 10.1007/s00239-009-9209-6; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; SCHUTT H, 1972, EUR J BIOCHEM, V26, P68, DOI 10.1111/j.1432-1033.1972.tb01740.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Teixeira PF, 2008, MICROBIOL-SGM, V154, P2336, DOI 10.1099/mic.0.2008/017533-0; Thomas G, 2000, TRENDS GENET, V16, P11, DOI 10.1016/S0168-9525(99)01887-9; Thornton J, 2006, FEMS MICROBIOL LETT, V258, P114, DOI 10.1111/j.1574-6968.2006.00202.x; Truan D, 2010, J MOL BIOL, V400, P531, DOI 10.1016/j.jmb.2010.05.036; von Wiren N, 2004, TOP CURR GENET, V9, P95; Wolfe DM, 2007, J BACTERIOL, V189, P6861, DOI 10.1128/JB.00759-07; Xu YB, 1998, J MOL BIOL, V282, P149, DOI 10.1006/jmbi.1998.1979; Yildiz O, 2007, EMBO J, V26, P589, DOI 10.1038/sj.emboj.7601492; Yuan J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.60; Zhang YP, 2006, MICROBIOL-SGM, V152, P2075, DOI 10.1099/mic.0.28903-0; Zhang YP, 2009, J BACTERIOL, V191, P5526, DOI 10.1128/JB.00585-09; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	46	64	67	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					31037	31045		10.1074/jbc.M110.153908	http://dx.doi.org/10.1074/jbc.M110.153908			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20639578	Green Published, hybrid			2022-12-25	WOS:000282135500068
J	Holz-Schietinger, C; Reich, NO				Holz-Schietinger, Celeste; Reich, Norbert O.			The Inherent Processivity of the Human de Novo Methyltransferase 3A (DNMT3A) Is Enhanced by DNMT3L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION PATTERNS; ENZYMATIC-PROPERTIES; MOUSE; BINDING; DOMAIN; CPG; MAINTENANCE; ESTABLISHMENT; MECHANISM; SEQUENCES	Human DNMT3A is responsible for de novo DNA cytosine methylation patterning during development. Here we show that DNMT3A methylates 5-8 CpG sites on human promoters before 50% of the initially bound enzyme dissociates from the DNA. Processive methylation is enhanced 3-fold in the presence of DNMT3L, an inactive homolog of DNMT3A, therefore providing a mechanism for the previously described DNMT3L activation of DNMT3A. DNMT3A processivity on human promoters is also regulated by DNA topology, where a 2-fold decrease in processivity was observed on supercoiled DNA in comparison with linear DNA. These results are the first observation that DNMT3A utilizes this mechanism of increasing catalytic efficiency. Processive de novo DNA methylation provides a mechanism that ensures that multiple CpG sites undergo methylation for transcriptional regulation and silencing of newly integrated viral DNA.	[Holz-Schietinger, Celeste; Reich, Norbert O.] Univ Calif Santa Barbara, Interdept Program Biomol Sci & Engn, Santa Barbara, CA 93106 USA; [Reich, Norbert O.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Reich, NO (corresponding author), Univ Calif Santa Barbara, Interdept Program Biomol Sci & Engn, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu			Cancer Research Coordinating Committee (University of California)	Cancer Research Coordinating Committee (University of California)(University of California System)	This work was supported by funds from the Cancer Research Coordinating Committee (University of California).	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Aoki A, 2001, NUCLEIC ACIDS RES, V29, P3506, DOI 10.1093/nar/29.17.3506; Athanasiadou R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009937; Berezuk MA, 2007, TRAFFIC, V8, P124, DOI 10.1111/j.1600-0854.2006.00517.x; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bloom LB, 2006, CRIT REV BIOCHEM MOL, V41, P179, DOI 10.1080/10409230600648751; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen ZX, 2005, BIOCHEM CELL BIOL, V83, P438, DOI 10.1139/O05-138; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Freitag M, 2004, MOL CELL, V13, P427, DOI 10.1016/S1097-2765(04)00024-3; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gowher H, 2005, BIOCHEMISTRY-US, V44, P9899, DOI 10.1021/bi047634t; Gowher H, 2002, J BIOL CHEM, V277, P20409, DOI 10.1074/jbc.M202148200; Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710; Grunau C, 2000, HUM MOL GENET, V9, P2651, DOI 10.1093/hmg/9.18.2651; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Howell CY, 1998, MOL CELL BIOL, V18, P4149, DOI 10.1128/MCB.18.7.4149; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; Jeruzalmi D, 2002, CURR OPIN STRUC BIOL, V12, P217, DOI 10.1016/S0959-440X(02)00313-5; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; KATO H, 1992, GENE DEV, V6, P655, DOI 10.1101/gad.6.4.655; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Morris KV, 2008, CURR TOP MICROBIOL, V320, P211; Myant K, 2008, MOL CELL BIOL, V28, P215, DOI 10.1128/MCB.01073-07; Okuwaki M, 2004, J BIOL CHEM, V279, P2904, DOI 10.1074/jbc.M310111200; OREND G, 1991, J VIROL, V65, P4301, DOI 10.1128/JVI.65.8.4301-4308.1991; Peterson SN, 2006, J MOL BIOL, V355, P459, DOI 10.1016/j.jmb.2005.11.003; Porter DJT, 1998, J BIOL CHEM, V273, P18906, DOI 10.1074/jbc.273.30.18906; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Purdy MM, 2010, ARCH BIOCHEM BIOPHYS, V498, P13, DOI 10.1016/j.abb.2010.03.007; Qiu C, 2002, NAT STRUCT BIOL, V9, P217, DOI 10.1038/nsb759; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; RENBAUM P, 1992, FEBS LETT, V313, P243, DOI 10.1016/0014-5793(92)81201-V; RICKWOOD D, 1993, DNA TOPOLOGY, P17; Robertson AK, 2004, BIOCHEM BIOPH RES CO, V322, P110, DOI 10.1016/j.bbrc.2004.07.083; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Strichman-Almashanu LZ, 2002, GENOME RES, V12, P543, DOI 10.1101/gr.224102; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Suetake I, 2003, J BIOCHEM, V133, P737, DOI 10.1093/jb/mvg095; Surby MA, 1996, BIOCHEMISTRY-US, V35, P2201, DOI 10.1021/bi951883n; Svedruzic ZM, 2005, BIOCHEMISTRY-US, V44, P14977, DOI 10.1021/bi050988f; Takeshima H, 2006, J BIOCHEM, V139, P503, DOI 10.1093/jb/mvj044; TOTH M, 1990, J MOL BIOL, V214, P673, DOI 10.1016/0022-2836(90)90285-T; Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147	54	64	65	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29091	29100		10.1074/jbc.M110.142513	http://dx.doi.org/10.1074/jbc.M110.142513			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20630873	Green Published, hybrid			2022-12-25	WOS:000281740100010
J	Saiepour, L; Fuchs, C; Patrizi, A; Sassoe-Pognetto, M; Harvey, RJ; Harvey, K				Saiepour, Leila; Fuchs, Celine; Patrizi, Annarita; Sassoe-Pognetto, Marco; Harvey, Robert J.; Harvey, Kirsten			Complex Role of Collybistin and Gephyrin in GABA(A) Receptor Clustering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABAERGIC SYNAPSES; INHIBITORY SYNAPSES; ALPHA-5 SUBUNIT; BINDING; BRAIN; MOTIF; IDENTIFICATION; MAINTENANCE; DISRUPTION; ARHGEF9	Gephyrin and collybistin are key components of GABA(A) receptor (GABA(A)R) clustering. Nonetheless, resolving the molecular interactions between the plethora of GABA(A)R subunits and these clustering proteins is a significant challenge. We report a direct interaction of GABA(A)R alpha 2 and alpha 3 subunit intracellular M3-M4 domain (but not alpha 1, alpha 4, alpha 5, alpha 6, beta 1-3, or gamma 1-3) with gephyrin. Curiously, GABA(A)R alpha 2, but not alpha 3, binds to both gephyrin and collybistin using overlapping sites. The reciprocal binding sites on gephyrin for collybistin and GABA(A)R alpha 2 also overlap at the start of the gephyrin E domain. This suggests that although GABA(A)R alpha 3 interacts with gephyrin, GABA(A)R alpha 2, collybistin, and gephyrin form a trimeric complex. In support of this proposal, tri-hybrid interactions between GABA(A)R alpha 2 and collybistin or GABA(A)R alpha 2 and gephyrin are strengthened in the presence of gephyrin or collybistin, respectively. Collybistin and gephyrin also compete for binding to GABA(A)R alpha 2 in co-immuno-precipitation experiments and co-localize in transfected cells in both intracellular and submembrane aggregates. Interestingly, GABA(A)R alpha 2 is capable of "activating" collybistin isoforms harboring the regulatory SH3 domain, enabling targeting of gephyrin to the submembrane aggregates. The GABA(A)R alpha 2-collybistin interaction was disrupted by a pathogenic mutation in the collybistin SH3 domain (p.G55A) that causes X-linked intellectual disability and seizures by disrupting GABA(A)R and gephyrin clustering. Because immunohistochemistry in retina revealed a preferential co-localization of collybistin with alpha 2 subunit containing GABA(A)Rs, but not GlyRs or other GABA(A)R subtypes, we propose that the collybistin-gephyrin complex has an intimate role in the clustering of GABA(A)Rs containing the alpha 2 subunit.	[Harvey, Kirsten] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Patrizi, Annarita; Sassoe-Pognetto, Marco] Univ Turin, Dept Anat Pharmacol & Forens Med, Natl Inst Neurosci Italy, I-10126 Turin, Italy	University of London; University College London; University of London School of Pharmacy; University of Turin	Harvey, K (corresponding author), Univ London, Sch Pharm, Dept Pharmacol, 29-39 Brunswick Sq, London WC1N 1AX, England.	kirsten.harvey@pharmacy.ac.uk	Harvey, Robert/D-3994-2016; Sassoe-Pognetto, Marco/AAE-3536-2022	Harvey, Robert/0000-0001-5956-6664; Sassoe-Pognetto, Marco/0000-0001-8906-0613	Medical Research Council [G0501258]; Compagnia di San Paolo; Regione Piemonte Ricerca Sanitaria Finalizzata; Medical Research Council [G0800498] Funding Source: researchfish; MRC [G0501258, G0800498] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Compagnia di San Paolo(Compagnia di San Paolo); Regione Piemonte Ricerca Sanitaria Finalizzata(Regione Piemonte); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council New Investigator Award G0501258 (to K. H.) and by a Compagnia di San Paolo and Regione Piemonte Ricerca Sanitaria Finalizzata 2008 grant (to M. S.-P.).	Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699; Dixon CI, 2008, PHARMACOL BIOCHEM BE, V90, P1, DOI 10.1016/j.pbb.2008.01.015; Douangamath A, 2002, MOL CELL, V10, P1007, DOI 10.1016/S1097-2765(02)00749-9; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fischer F, 2000, J COMP NEUROL, V427, P634, DOI 10.1002/1096-9861(20001127)427:4<634::AID-CNE10>3.0.CO;2-X; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Fuller KJ, 1998, BIOTECHNIQUES, V25, P85, DOI 10.2144/98251st04; Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Hoon M, 2009, J NEUROSCI, V29, P8039, DOI 10.1523/JNEUROSCI.0534-09.2009; Jedlicka P, 2009, MOL CELL NEUROSCI, V41, P94, DOI 10.1016/j.mcn.2009.02.005; Kalscheuer VM, 2009, HUM MUTAT, V30, P61, DOI 10.1002/humu.20814; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; Kneussel M, 2000, P NATL ACAD SCI USA, V97, P8594, DOI 10.1073/pnas.97.15.8594; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 2001, MOL CELL NEUROSCI, V17, P973, DOI 10.1006/mcne.2001.0983; Kneussel M, 1999, J NEUROCHEM, V72, P1323, DOI 10.1046/j.1471-4159.1999.0721323.x; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Liu Q, 2003, MOL CELL, V11, P471, DOI 10.1016/S1097-2765(03)00046-7; Loebrich S, 2006, EMBO J, V25, P987, DOI 10.1038/sj.emboj.7600995; Marco EJ, 2008, J MED GENET, V45, P100, DOI 10.1136/jmg.2007.052324; Meier J, 2004, J PHYSIOL-LONDON, V559, P355, DOI 10.1113/jphysiol.2004.066233; Melzer N, 2010, J BIOL CHEM, V285, P3730, DOI 10.1074/jbc.M109.030460; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Mohler H, 2009, BIOCHEM SOC T, V37, P1328, DOI 10.1042/BST0371328; Nymann-Andersen J, 2002, J NEUROCHEM, V83, P1164, DOI 10.1046/j.1471-4159.2002.01222.x; Papadopoulos T, 2008, MOL CELL NEUROSCI, V39, P161, DOI 10.1016/j.mcn.2008.06.006; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Patrizi A, 2008, P NATL ACAD SCI USA, V105, P13151, DOI 10.1073/pnas.0802390105; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Reid T, 1999, J BIOL CHEM, V274, P33587, DOI 10.1074/jbc.274.47.33587; Sancho RM, 2009, HUM MOL GENET, V18, P3955, DOI 10.1093/hmg/ddp337; SASSOEPOGNETTO M, 1994, J NEUROSCI, V14, P5131; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Serwanski DR, 2006, J COMP NEUROL, V499, P458, DOI 10.1002/cne.21115; Studer R, 2006, EUR J NEUROSCI, V24, P1307, DOI 10.1111/j.1460-9568.2006.05006.x; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Wassle H, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.006.2009; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; WISDEN W, 1992, J NEUROSCI, V12, P1040; Xiang S, 2006, J MOL BIOL, V359, P35, DOI 10.1016/j.jmb.2006.03.019; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008	49	101	101	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29623	29631		10.1074/jbc.M110.121368	http://dx.doi.org/10.1074/jbc.M110.121368			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20622020	hybrid, Green Published			2022-12-25	WOS:000281740100063
J	Nilsson, A; Fehniger, TE; Gustavsson, L; Andersson, M; Kenne, K; Marko-Varga, G; Andren, PE				Nilsson, Anna; Fehniger, Thomas E.; Gustavsson, Lena; Andersson, Malin; Kenne, Kerstin; Marko-Varga, Gyoergy; Andren, Per E.			Fine Mapping the Spatial Distribution and Concentration of Unlabeled Drugs within Tissue Micro-Compartments Using Imaging Mass Spectrometry	PLOS ONE			English	Article							MALDI-MS; SECTIONS; PROTEINS; METABOLITES; TECHNOLOGY; DISCOVERY; PEPTIDES; SPECTRA; TIME; RAT	Readouts that define the physiological distributions of drugs in tissues are an unmet challenge and at best imprecise, but are needed in order to understand both the pharmacokinetic and pharmacodynamic properties associated with efficacy. Here we demonstrate that it is feasible to follow the in vivo transport of unlabeled drugs within specific organ and tissue compartments on a platform that applies MALDI imaging mass spectrometry to tissue sections characterized with high definition histology. We have tracked and quantified the distribution of an inhaled reference compound, tiotropium, within the lungs of dosed rats, using systematic point by point MS and MS/MS sampling at 200 mu m intervals. By comparing drug ion distribution patterns in adjacent tissue sections, we observed that within 15 min following exposure, tiotropium parent MS ions (mass-to-charge; m/z 392.1) and fragmented daughter MS/MS ions (m/z 170.1 and 152.1) were dispersed in a concentration gradient (80 fmol-5 pmol) away from the central airways into the lung parenchyma and pleura. These drug levels agreed well with amounts detected in lung compartments by chemical extraction. Moreover, the simultaneous global definition of molecular ion signatures localized within 2-D tissue space provides accurate assignment of ion identities within histological landmarks, providing context to dynamic biological processes occurring at sites of drug presence. Our results highlight an important emerging technology allowing specific high resolution identification of unlabeled drugs at sites of in vivo uptake and retention.	[Nilsson, Anna; Andersson, Malin; Andren, Per E.] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Fehniger, Thomas E.] Tallinn Univ Technol, Inst Clin Med, Tallinn, Estonia; [Fehniger, Thomas E.; Gustavsson, Lena; Marko-Varga, Gyoergy] AstraZeneca R&D, Lund, Sweden; [Kenne, Kerstin] AstraZeneca R&D, Sodertalje, Sweden; [Marko-Varga, Gyoergy] Lund Univ, Dept Measurement Technol & Ind Elect Engn, Lund, Sweden	Uppsala University; Tallinn University of Technology; AstraZeneca; AstraZeneca; Lund University	Nilsson, A (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden.	per.andren@bmms.uu.se	Andersson, Malin/A-9930-2009	Andersson, Malin/0000-0002-1450-8046; Andren, Per/0000-0002-4062-7743	Swedish Research Council [2004-3417, 621-2007-4686, 521-2007-3017]; K&A Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); K&A Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This study was sponsored by the Swedish Research Council (http://www.vr.se), grant no. 2004-3417, 621-2007-4686, 521-2007-3017, and the K&A Wallenberg Foundation (http://www.wallenberg.com/kaw/). The study has been conducted as a fully shared collaboration between an academic laboratory at the Uppsala University, Sweden and AstraZeneca R&D, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann BL, 2006, CURR DRUG METAB, V7, P525; Andersson M, 2008, NAT METHODS, V5, P101, DOI [10.1038/nmeth1145, 10.1038/NMETH1145]; Atkinson SJ, 2007, RAPID COMMUN MASS SP, V21, P1271, DOI 10.1002/rcm.2952; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Chaurand P, 2007, J MASS SPECTROM, V42, P476, DOI 10.1002/jms.1180; DAHLBACK M, 1994, ANN OCCUP HYG, P127; Dickerson BC, 2007, NEUROTHERAPEUTICS, V4, P360, DOI 10.1016/j.nurt.2007.05.007; Drexler Dieter M., 2007, Journal of Pharmacological and Toxicological Methods, V55, P279, DOI 10.1016/j.vascn.2006.11.004; Hilario M, 2006, MASS SPECTROM REV, V25, P409, DOI 10.1002/mas.20072; Hsieh Yunsheng, 2007, Journal of Pharmacological and Toxicological Methods, V55, P193, DOI 10.1016/j.vascn.2006.06.004; Jackson SN, 2005, J AM SOC MASS SPECTR, V16, P2052, DOI 10.1016/j.jasms.2005.08.014; Jain S, 2004, FRONT BIOSCI-LANDMRK, V9, P3167, DOI 10.2741/1470; Jansen FP, 2007, NUCL MED BIOL, V34, P733, DOI 10.1016/j.nucmedbio.2007.06.013; Khatib-Shahidi S, 2006, ANAL CHEM, V78, P6448, DOI 10.1021/ac060788p; Leusch A, 2001, BIOPHARM DRUG DISPOS, V22, P199, DOI 10.1002/bdd.280; Norris JL, 2007, INT J MASS SPECTROM, V260, P212, DOI 10.1016/j.ijms.2006.10.005; Reyzer ML, 2007, CURR OPIN CHEM BIOL, V11, P29, DOI 10.1016/j.cbpa.2006.11.035; Reyzer ML, 2003, J MASS SPECTROM, V38, P1081, DOI 10.1002/jms.525; Rohner TC, 2005, MECH AGEING DEV, V126, P177, DOI 10.1016/j.mad.2004.09.032; Signor L, 2007, J MASS SPECTROM, V42, P900, DOI 10.1002/jms.1225; Solon EG, 2010, AAPS J, V12, P11, DOI 10.1208/s12248-009-9158-4; Spengler B, 2002, J AM SOC MASS SPECTR, V13, P735, DOI 10.1016/S1044-0305(02)00376-8; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0	24	176	176	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11411	10.1371/journal.pone.0011411	http://dx.doi.org/10.1371/journal.pone.0011411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644728	gold, Green Published, Green Submitted			2022-12-25	WOS:000279884900002
J	Peirce, MJ; Brook, M; Morrice, N; Snelgrove, R; Begum, S; Lanfrancotti, A; Notley, C; Hussell, T; Cope, AP; Wait, R				Peirce, Matthew J.; Brook, Matthew; Morrice, Nicholas; Snelgrove, Robert; Begum, Shajna; Lanfrancotti, Alessandra; Notley, Clare; Hussell, Tracy; Cope, Andrew P.; Wait, Robin			Themis2/ICB1 Is a Signaling Scaffold That Selectively Regulates Macrophage Toll-Like Receptor Signaling and Cytokine Production	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ACTIVATED PROTEIN-KINASE; BRUTONS TYROSINE KINASE; MESSENGER-RNA STABILITY; TNF-ALPHA PRODUCTION; CANCER CELL-LINES; NF-KAPPA-B; RICH ELEMENT; POSITIVE SELECTION; MEMBRANE-PROTEINS	Background: Thymocyte expressed molecule involved in selection 1 (Themis1, SwissProt accession number Q8BGW0) is the recently characterised founder member of a novel family of proteins. A second member of this family, Themis2 (Q91YX0), also known as ICB1 (Induced on contact with basement membrane 1), remains unreported at the protein level despite microarray and EST databases reporting Themis2 mRNA expression in B cells and macrophages. Methodology/Principal Findings: Here we characterise Themis2 protein for the first time and show that it acts as a macrophage signalling scaffold, exerting a receptor-, mediator- and signalling pathway-specific effect on TLR responses in RAW 264.7 macrophages. Themis2 over-expression enhanced the LPS-induced production of TNF but not IL-6 or Cox-2, nor TNF production induced by ligands for TLR2 (PAM3) or TLR3 (poly I: C). Moreover, LPS-induced activation of the MAP kinases ERK and p38 was enhanced in cells over-expressing Themis2 whereas the activation of JNK, IRF3 or NF-kappa B p65, was unaffected. Depletion of Themis2 protein by RNA inteference inhibited LPS-induced TNF production in primary human macrophages demonstrating a requirement for Themis2 in this event. Themis2 was inducibly tyrosine phosphorylated upon LPS challenge and interacted with Lyn kinase (P25911), the Rho guanine nucleotide exchange factor, Vav (P27870), and the adaptor protein Grb2 (Q60631). Mutation of either tyrosine 660 or a proline-rich sequence (PPPRPPK) simultaneously interrupted this complex and reduced by approximately 50% the capacity of Themis2 to promote LPS-induced TNF production. Finally, Themis2 protein expression was induced during macrophage development from murine bone marrow precursors and was regulated by inflammatory stimuli both in vitro and in vivo. Conclusions/Significance: We hypothesise that Themis2 may constitute a novel, physiological control point in macrophage inflammatory responses.	[Peirce, Matthew J.; Brook, Matthew; Snelgrove, Robert; Begum, Shajna; Lanfrancotti, Alessandra; Notley, Clare; Hussell, Tracy; Cope, Andrew P.; Wait, Robin] Univ London Imperial Coll Sci Technol & Med, Div Rheumatol, Kennedy Inst, London, England; [Morrice, Nicholas] Univ Dundee, MRC, Prot Phosphorylat Unit, Dundee, Scotland	Imperial College London; University of Oxford; University of Dundee	Peirce, MJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Rheumatol, Kennedy Inst, London, England.	m.pierce@imperial.ac.uk	Hussell, Tracy/O-4630-2014; Brook, Matthew/I-5828-2019; Peirce, Matthew/ABB-9577-2021	Hussell, Tracy/0000-0001-7186-6141; Brook, Matthew/0000-0003-1245-7385; Peirce, Matthew/0000-0003-3648-5639; Cope, Andrew/0000-0001-6735-5496	Arthritis Research Campaign, UK; MRC [G0400795, G0802752, G9900166] Funding Source: UKRI; Medical Research Council [G9900166, G0400795, G0802752] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	Arthritis Research Campaign, UK(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by a core grant to the Kennedy Institute provided by the Arthritis Research Campaign, UK (http://www.arc.org.uk/) and by the Trustees of the Kennedy Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Bollmann J, 2008, J STEROID BIOCHEM, V109, P16, DOI 10.1016/j.jsbmb.2007.12.007; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Chen QZ, 2009, J LEUKOCYTE BIOL, V85, P539, DOI 10.1189/jlb.0308219; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; de Miranda MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001654; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Denys A, 2002, J IMMUNOL, V168, P4837, DOI 10.4049/jimmunol.168.10.4837; Doyle SL, 2007, J BIOL CHEM, V282, P36953, DOI 10.1074/jbc.M707682200; DUNHAM DM, 1990, J LEUKOCYTE BIOL, V48, P473, DOI 10.1002/jlb.48.6.473; English BK, 1997, J LEUKOCYTE BIOL, V62, P859, DOI 10.1002/jlb.62.6.859; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Herskowitz JH, 2008, J VIROL, V82, P3295, DOI 10.1128/JVI.02234-07; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Horwood NJ, 2003, J EXP MED, V197, P1603, DOI 10.1084/jem.20021845; Inglis JJ, 2008, NAT PROTOC, V3, P612, DOI 10.1038/nprot.2008.19; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Johnson AL, 2009, NAT IMMUNOL, V10, P831, DOI 10.1038/ni.1769; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Lock LS, 2000, J BIOL CHEM, V275, P31536, DOI 10.1074/jbc.M003597200; Manukyan M, 2009, J IMMUNOL, V182, P3522, DOI 10.4049/jimmunol.0802280; Miletic AV, 2007, BLOOD, V109, P3360, DOI 10.1182/blood-2006-07-033662; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Patrick MS, 2009, P NATL ACAD SCI USA, V106, P16345, DOI 10.1073/pnas.0908593106; Peirce MJ, 2005, PROTEOMICS, V5, P2417, DOI 10.1002/pmic.200401176; Peirce MJ, 2004, MOL CELL PROTEOMICS, V3, P56, DOI 10.1074/mcp.M300064-MCP200; Raabe T, 1998, J BIOL CHEM, V273, P974, DOI 10.1074/jbc.273.2.974; Rutault K, 2001, J BIOL CHEM, V276, P6666, DOI 10.1074/jbc.M005486200; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Shi L, 2002, AM J PHYSIOL-CELL PH, V282, pC1205, DOI 10.1152/ajpcell.00511.2001; Shibolet O, 2007, J BIOL CHEM, V282, P35308, DOI 10.1074/jbc.M704426200; Siegel AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000039; Smolinska MJ, 2008, MOL IMMUNOL, V45, P990, DOI 10.1016/j.molimm.2007.07.026; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; STEFANOVA I, 1993, J BIOL CHEM, V268, P20725; Treeck O, 2005, CYTOKINE, V32, P137, DOI 10.1016/j.cyto.2005.08.008; Treeck O, 2002, LEUKEMIA RES, V26, P765, DOI 10.1016/S0145-2126(02)00005-X; Treeck O, 1998, FEBS LETT, V425, P426, DOI 10.1016/S0014-5793(98)00278-6; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	48	24	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11465	10.1371/journal.pone.0011465	http://dx.doi.org/10.1371/journal.pone.0011465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644716	Green Submitted, gold, Green Published			2022-12-25	WOS:000279822300001
J	Meier-Stiegen, F; Schwanbeck, R; Bernoth, K; Martini, S; Hieronymus, T; Ruau, D; Zenke, M; Just, U				Meier-Stiegen, Franziska; Schwanbeck, Ralf; Bernoth, Kristina; Martini, Simone; Hieronymus, Thomas; Ruau, David; Zenke, Martin; Just, Ursula			Activated Notch1 Target Genes during Embryonic Cell Differentiation Depend on the Cellular Context and Include Lineage Determinants and Inhibitors	PLOS ONE			English	Article							STEM-CELLS; PROGENITOR CELLS; SKELETAL-MUSCLE; DOWN-REGULATION; ENDOTHELIAL-CELLS; EXPRESSION; FATE; BINDING; MODEL; HES	Background: Notch receptor signaling controls developmental cell fates in a cell-context dependent manner. Although Notch signaling directly regulates transcription via the RBP-J/CSL DNA binding protein, little is known about the target genes that are directly activated by Notch in the respective tissues. Methodology/Principal Findings: To analyze how Notch signaling mediates its context dependent function(s), we utilized a Tamoxifen-inducible system to activate Notch1 in murine embryonic stem cells at different stages of mesodermal differentiation and performed global transcriptional analyses. We find that the majority of genes regulated by Notch1 are unique for the cell type and vary widely dependent on other signals. We further show that Notch1 signaling regulates expression of genes playing key roles in cell differentiation, cell cycle control and apoptosis in a context dependent manner. In addition to the known Notch1 targets of the Hes and Hey families of transcriptional repressors, Notch1 activates the expression of regulatory transcription factors such as Sox9, Pax6, Runx1, Myf5 and Id proteins that are critically involved in lineage decisions in the absence of protein synthesis. Conclusion/Significance: We suggest that Notch signaling determines lineage decisions and expansion of stem cells by directly activating both key lineage specific transcription factors and their repressors (Id and Hes/Hey proteins) and propose a model by which Notch signaling regulates cell fate commitment and self renewal in dependence of the intrinsic and extrinsic cellular context.	[Meier-Stiegen, Franziska; Schwanbeck, Ralf; Bernoth, Kristina; Martini, Simone; Just, Ursula] Univ Kiel, Dept Biochem, Kiel, Germany; [Hieronymus, Thomas; Ruau, David; Zenke, Martin] Rhein Westfal TH Aachen, Univ Med Sch, Inst Biomed Engn, Dept Cell Biol, Aachen, Germany	University of Kiel; RWTH Aachen University; RWTH Aachen University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Meier-Stiegen, F (corresponding author), Tech Univ Munich, Univ Hosp Rechts Isar, Res Grp Diabet, Munich, Germany.	rschwanbeck@biochem.uni-kiel.de; ujust@biochem.uni-kiel.de	Hieronymus, Thomas/AAU-1995-2020; Schwanbeck, Ralf/A-2648-2008; Just, Ursula/E-6992-2010	Hieronymus, Thomas/0000-0002-7879-6518; Schwanbeck, Ralf/0000-0003-0925-929X; 	Deutsche Forschungsgemeinschaft [DFG SPP1109, SFB 415, SPP1356]; Hensel Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hensel Stiftung	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG SPP1109 to UJ (Ju197/5-1, 5-2), and TH and MZ (Ze432/2), SFB 415 project B8 to UJ and partially by DFG SPP1356 to MZ) and partially by Hensel Stiftung to UJ. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold HH, 2000, CURR TOP DEV BIOL, V48, P129; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asakura A, 2007, P NATL ACAD SCI USA, V104, P16552, DOI 10.1073/pnas.0708145104; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Baonza A, 2000, DEVELOPMENT, V127, P2383; Braun T, 1996, EMBO J, V15, P310, DOI 10.1002/j.1460-2075.1996.tb00361.x; Buas MF, 2009, J CELL PHYSIOL, V218, P84, DOI 10.1002/jcp.21571; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Cormier S, 2004, GENE EXPR PATTERNS, V4, P713, DOI 10.1016/j.modgep.2004.04.003; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Gensch N, 2008, DEVELOPMENT, V135, P1597, DOI 10.1242/dev.019331; Haldar M, 2008, DEV CELL, V14, P437, DOI 10.1016/j.devcel.2008.01.002; Henning K, 2007, EXP HEMATOL, V35, P1321, DOI 10.1016/j.exphem.2007.05.014; Hirai H, 2005, BLOOD, V106, P1948, DOI 10.1182/blood-2004-12-4872; Hirashima M, 1999, BLOOD, V93, P1253, DOI 10.1182/blood.V93.4.1253.404k31_1253_1263; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; King IN, 2006, BIOCHEM BIOPH RES CO, V345, P446, DOI 10.1016/j.bbrc.2006.04.097; KODAMA H, 1994, EXP HEMATOL, V22, P979; Kopan R, 1997, TRENDS GENET, V13, P465, DOI 10.1016/S0168-9525(97)01318-8; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Krejci A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000140; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Kurokawa M, 2006, INT J HEMATOL, V84, P136, DOI 10.1532/IJH97.06070; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Main H, 2010, EXP CELL RES, V316, P1610, DOI 10.1016/j.yexcr.2009.12.012; Muto A, 2009, EXP EYE RES, V89, P549, DOI 10.1016/j.exer.2009.05.006; Nakagawa M, 2006, BLOOD, V108, P3329, DOI 10.1182/blood-2006-04-019570; Nemir M, 2006, CIRC RES, V98, P1471, DOI 10.1161/01.RES.0000226497.52052.2a; OKA C, 1995, DEVELOPMENT, V121, P3291; Ong CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002823; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Onuma Y, 2002, P NATL ACAD SCI USA, V99, P2020, DOI 10.1073/pnas.022626999; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Poellinger L, 2008, CURR OPIN GENET DEV, V18, P449, DOI 10.1016/j.gde.2008.07.013; Reynaud-Deonauth S, 2002, DIFFERENTIATION, V69, P198, DOI 10.1046/j.1432-0436.2002.690413.x; Ruau D, 2006, CELL IMMUNOL, V244, P116, DOI 10.1016/j.cellimm.2007.01.011; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Schroeder T, 2003, J IMMUNOL, V170, P5538, DOI 10.4049/jimmunol.170.11.5538; Schroeder T, 2006, MECH DEVELOP, V123, P570, DOI 10.1016/j.mod.2006.05.002; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Schwanbeck R, 2008, CELLS TISSUES ORGANS, V188, P91, DOI 10.1159/000113531; Suter DM, 2009, STEM CELLS, V27, P49, DOI 10.1634/stemcells.2008-0319; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Taylor MK, 2007, DEVELOPMENT, V134, P2435, DOI 10.1242/dev.005520; Thatcher EJ, 2007, DEV DYNAM, V236, P2172, DOI 10.1002/dvdy.21211; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Ustanina S, 2007, STEM CELLS, V25, P2006, DOI 10.1634/stemcells.2006-0736; Vasyutina E, 2007, CELL CYCLE, V6, P1451; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Wobus A M, 2002, Methods Mol Biol, V185, P127; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; Yoo AS, 2005, SCIENCE, V310, P1330, DOI 10.1126/science.1119481; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	68	75	81	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11481	10.1371/journal.pone.0011481	http://dx.doi.org/10.1371/journal.pone.0011481			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628604	Green Published, gold, Green Submitted			2022-12-25	WOS:000279637100011
J	Hedskog, C; Mild, M; Jernberg, J; Sherwood, E; Bratt, G; Leitner, T; Lundeberg, J; Andersson, B; Albert, J				Hedskog, Charlotte; Mild, Mattias; Jernberg, Johanna; Sherwood, Ellen; Bratt, Goran; Leitner, Thomas; Lundeberg, Joakim; Andersson, Bjorn; Albert, Jan			Dynamics of HIV-1 Quasispecies during Antiviral Treatment Dissected Using Ultra-Deep Pyrosequencing	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; DRUG-RESISTANCE; IN-VIVO; ANTIRETROVIRAL-NAIVE; TYPE-1 VIREMIA; VARIANTS; MUTATION; FIDELITY; THERAPY	Background: Ultra-deep pyrosequencing (UDPS) allows identification of rare HIV-1 variants and minority drug resistance mutations, which are not detectable by standard sequencing. Principal Findings: Here, UDPS was used to analyze the dynamics of HIV-1 genetic variation in reverse transcriptase (RT) (amino acids 180-220) in six individuals consecutively sampled before, during and after failing 3TC and AZT containing antiretroviral treatment. Optimized UDPS protocols and bioinformatic software were developed to generate, clean and analyze the data. The data cleaning strategy reduced the error rate of UDPS to an average of 0.05%, which is lower than previously reported. Consequently, the cut-off for detection of resistance mutations was very low. A median of 16,016 (range 2,406-35,401) sequence reads were obtained per sample, which allowed detection and quantification of minority resistance mutations at amino acid position 181, 184, 188, 190, 210, 215 and 219 in RT. In four of five pre-treatment samples low levels (0.07-0.09%) of the M184I mutation were observed. Other resistance mutations, except T215A and T215I were below the detection limit. During treatment failure, M184V replaced M184I and dominated the population in combination with T215Y, while wild-type variants were rarely detected. Resistant virus disappeared rapidly after treatment interruption and was undetectable as early as after 3 months. In most patients, drug resistant variants were replaced by wild-type variants identical to those present before treatment, suggesting rebound from latent reservoirs. Conclusions: With this highly sensitive UDPS protocol preexisting drug resistance was infrequently observed; only M184I, T215A and T215I were detected at very low levels. Similarly, drug resistant variants in plasma quickly decreased to undetectable levels after treatment interruption. The study gives important insights into the dynamics of the HIV-1 quasispecies and is of relevance for future research and clinical use of the UDPS technology.	[Hedskog, Charlotte; Mild, Mattias; Jernberg, Johanna; Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Hedskog, Charlotte; Mild, Mattias; Jernberg, Johanna; Albert, Jan] Swedish Inst Infect Dis Control, Dept Virol, Stockholm, Sweden; [Sherwood, Ellen] Sci Life Lab Stockholm, Solna, Sweden; [Bratt, Goran] Stockholm S Gen Hosp, Stockholm, Sweden; [Bratt, Goran] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Leitner, Thomas] Los Alamos Natl Lab, Los Alamos, NM USA; [Lundeberg, Joakim] AlbaNova Univ Ctr, Royal Inst Technol, Sch Biotechnol, Div Gene Technol, Stockholm, Sweden; [Andersson, Bjorn] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet; Swedish Institute for Infectious Disease Control; Karolinska Institutet; United States Department of Energy (DOE); Los Alamos National Laboratory; Royal Institute of Technology; Karolinska Institutet	Hedskog, C (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	jan.albert@smi.se	Andersson, Bjorn/G-9832-2013	Andersson, Bjorn/0000-0002-4624-0259; Hedskog, Charlotte/0000-0003-0512-7767	Swedish Research Council [2007-1131-49460-36]; Swedish International Development Cooperation Agency [SWE-2006-018]; Europe HIV Resistance (EHR) [LSHP-CT-2006-518211]; CHAIN [223131]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency; Europe HIV Resistance (EHR); CHAIN	M. Mild was funded by a post doctoral fellowship grant from The Swedish Research Council. The research leading to these results has received funding from the Swedish Research Council (grant no. 2007-1131-49460-36); Swedish International Development Cooperation Agency (grant no. SWE-2006-018), a non-commercial organization working according to directives of the Swedish Parliament and Government (http://www.sida.se/English/); Europe HIV Resistance (EHR) (LSHP-CT-2006-518211) and CHAIN (FP7/2007-2013) "Collaborative HIV and Anti-HIV Drug Resistance Network" grant agreement no 223131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers K, 2007, JAIDS-J ACQ IMM DEF, V44, P377, DOI 10.1097/QAI.0b013e31803104c0; Back NKT, 1996, EMBO J, V15, P4040, DOI 10.1002/j.1460-2075.1996.tb00777.x; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Barbour Jason D., 2004, Curr Infect Dis Rep, V6, P151, DOI 10.1007/s11908-996-0012-x; Brennan TP, 2009, J VIROL, V83, P8470, DOI 10.1128/JVI.02568-08; Brenner BG, 2002, J VIROL, V76, P1753, DOI 10.1128/JVI.76.4.1753-1761.2002; BRINCHMANN JE, 1991, J VIROL, V65, P2019, DOI 10.1128/JVI.65.4.2019-2023.1991; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Cong ME, 2007, J VIROL, V81, P3037, DOI 10.1128/JVI.02712-06; Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2; Diallo K, 2003, ANTIMICROB AGENTS CH, V47, P3377, DOI 10.1128/AAC.47.11.3377-3383.2003; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; Frost SDW, 2000, J VIROL, V74, P6262, DOI 10.1128/JVI.74.14.6262-6268.2000; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; JI JP, 1994, VIROLOGY, V199, P323, DOI 10.1006/viro.1994.1130; Johnson JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000638; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Johnson NP, 2007, OPTO-ELECTRON REV, V15, P125, DOI 10.2478/s11772-007-0009-5; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Keulen W, 1997, J VIROL, V71, P3346, DOI 10.1128/JVI.71.4.3346-3350.1997; King MS, 2005, J INFECT DIS, V191, P2046, DOI 10.1086/430387; Kitchen CMR, 2006, AIDS RES HUM RETROV, V22, P1260, DOI 10.1089/aid.2006.22.1260; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Lindstrom A, 2006, ANTIVIR THER, V11, P1031; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez-Picado J, 2000, P NATL ACAD SCI USA, V97, P10948, DOI 10.1073/pnas.97.20.10948; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; Mitsuya Y, 2008, J VIROL, V82, P10747, DOI 10.1128/JVI.01827-07; Monie D, 2005, J VIROL, V79, P5185, DOI 10.1128/JVI.79.8.5185-5202.2005; Neher RA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000660; Paredes R, 2009, J VIROL, V83, P2038, DOI 10.1128/JVI.02154-08; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Preston BD, 1997, SCIENCE, V275, P228, DOI 10.1126/science.275.5297.228; Shafer RW, 2009, J INFECT DIS, V199, P610, DOI 10.1086/596737; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; SRINIVASAN A, 1989, P NATL ACAD SCI USA, V86, P6388, DOI 10.1073/pnas.86.16.6388; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Varghese V, 2009, JAIDS-J ACQ IMM DEF, V52, P309, DOI 10.1097/QAI.0b013e3181bca669; WAINBERG MA, 1995, AIDS, V9, P351, DOI 10.1097/00002030-199509040-00006; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0	47	94	126	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11345	10.1371/journal.pone.0011345	http://dx.doi.org/10.1371/journal.pone.0011345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628644	Green Submitted, Green Published, gold			2022-12-25	WOS:000279589300001
J	Vanderwert, RE; Marshall, PJ; Nelson, CA; Zeanah, CH; Fox, NA				Vanderwert, Ross E.; Marshall, Peter J.; Nelson, Charles A., III; Zeanah, Charles H.; Fox, Nathan A.			Timing of Intervention Affects Brain Electrical Activity in Children Exposed to Severe Psychosocial Neglect	PLOS ONE			English	Article							INTERNATIONAL RESEARCH COLLABORATION; ETHICAL CONSIDERATIONS; FOLLOW-UP; EEG; PROJECT; DEPRIVATION; PERFORMANCE; ROMANIA; AGE	Background: Early psychosocial deprivation has profound effects on brain activity in the young child. Previous reports have shown increased power in slow frequencies of the electroencephalogram (EEG), primarily in the theta band, and decreased power in higher alpha and beta band frequencies in infants and children who have experienced institutional care. Methodology/Principal Findings: We assessed the consequences of removing infants from institutions and placing them into a foster care intervention on brain electrical activity when children were 8 years of age. We found the intervention was successful for increasing high frequency EEG alpha power, with effects being most pronounced for children placed into foster care before 24 months of age. Conclusions/Significance: The dependence on age of placement for the effects observed on high frequency EEG alpha power suggests a sensitive period after which brain activity in the face of severe psychosocial deprivation is less amenable to recovery.	[Vanderwert, Ross E.; Fox, Nathan A.] Univ Maryland, Dept Human Dev, College Pk, MD 20742 USA; [Marshall, Peter J.] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA; [Nelson, Charles A., III] Childrens Hosp, Div Dev Med, Boston, MA 02115 USA; [Nelson, Charles A., III] Harvard Univ, Sch Med, Boston, MA USA; [Zeanah, Charles H.] Tulane Univ, Dept Psychiat & Neurol, New Orleans, LA 70118 USA	University System of Maryland; University of Maryland College Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Tulane University	Vanderwert, RE (corresponding author), Univ Maryland, Dept Human Dev, College Pk, MD 20742 USA.	fox@umd.edu	Zeanah, Charles H/AAO-3756-2020	Zeanah, Charles/0000-0002-7004-6819; Vanderwert, Ross/0000-0002-2280-8401	John D. and Catherine T. MacArthur Foundation	John D. and Catherine T. MacArthur Foundation	This work was funded by the John D. and Catherine T. MacArthur Foundation through their support of the Early Experience and Brain Development network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P171, DOI 10.1016/S1388-2457(02)00362-0; Bauer PM, 2009, BIOL PSYCHIAT, V66, P1100, DOI 10.1016/j.biopsych.2009.06.014; Beckett C, 2006, CHILD DEV, V77, P696, DOI 10.1111/j.1467-8624.2006.00898.x; Bell M. A., 1998, NEUROIMAGING CHILD N, P97, DOI DOI 10.1007/978-3-642-95848-9; Bell MA, 2001, INFANCY, V2, P311, DOI 10.1207/S15327078IN0203_2; Chugani HT, 2001, NEUROIMAGE, V14, P1290, DOI 10.1006/nimg.2001.0917; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Fernandez T, 2000, NEUROREPORT, V11, P2663, DOI 10.1097/00001756-200008210-00012; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Marshall PJ, 2008, DEV PSYCHOPATHOL, V20, P861, DOI 10.1017/S0954579408000412; Marshall PJ, 2002, CLIN NEUROPHYSIOL, V113, P1199, DOI 10.1016/S1388-2457(02)00163-3; Marshall PJ, 2004, J COGNITIVE NEUROSCI, V16, P1327, DOI 10.1162/0898929042304723; Millum J, 2007, SCIENCE, V318, P1874, DOI 10.1126/science.1153822; Miskovic V, 2009, CLIN NEUROPHYSIOL, V120, P231, DOI 10.1016/j.clinph.2008.11.004; Nelson CA, 2007, SCIENCE, V318, P1937, DOI 10.1126/science.1143921; O'Connor TG, 2000, CHILD DEV, V71, P376, DOI 10.1111/1467-8624.00151; Otero G A, 1994, Int J Neurosci, V79, P213; Otero GA, 2003, CLIN NEUROPHYSIOL, V114, P1918, DOI 10.1016/S1388-2457(03)00173-1; Raine A, 2001, PSYCHOPHYSIOLOGY, V38, P254, DOI 10.1111/1469-8986.3820254; Wassenaar DR, 2006, INF MENTAL HLTH J, V27, P577, DOI 10.1002/imhj.20108; Zeanah CH, 2003, DEV PSYCHOPATHOL, V15, P885, DOI 10.1017/S0954579403000452; Zeanah CH, 2006, INF MENTAL HLTH J, V27, P559, DOI 10.1002/imhj.20107	22	104	104	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2010	5	7							e11415	10.1371/journal.pone.0011415	http://dx.doi.org/10.1371/journal.pone.0011415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	619YF	20617175	Green Accepted, Green Published, gold			2022-12-25	WOS:000279465500004
J	Xu, FH; Yan, QA; Wang, H; Niu, JJ; Li, LA; Zhu, FC; He, SZ; Zhang, SY; Weng, ZX; Cheng, T; Cai, YJ; He, DL; Chen, YX; Ge, SX; Yeo, AET; Zhang, J; Ng, MH; Xia, NS				Xu, Feihai; Yan, Qiang; Wang, Hua; Niu, Jianjun; Li, Liang; Zhu, Fengcai; He, Shuizhen; Zhang, Shiyin; Weng, Zuxing; Cheng, Tong; Cai, Yijun; He, Delei; Chen, Yixin; Ge, Shengxiang; Yeo, Anthony E. T.; Zhang, Jun; Ng, Mun-Hon; Xia, Ningshao			Performance of Detecting IgM Antibodies against Enterovirus 71 for Early Diagnosis	PLOS ONE			English	Article							CLINICAL SPECIMENS; RAPID DETECTION; INFECTION; OUTBREAK; VIRUSES; DISEASE	Enterovirus 71 (EV71) infection is more likely to induce severe complications and mortality than other enteroviruses. Methods for detection of IgM antibody against EV71 had been established for years, however, the performance of the methods in the very early diagnosis of EV71 infection had not been fully evaluated, which is especially meaningful because of the short incubation period of EV71 infection. In this report, the performance of an IgM anti-EV71 assay was evaluated using acute sera collected from 165 EV71 infected patients, 165 patients infected with other enteroviruses, and more than 2,000 sera from healthy children or children with other infected diseases. The results showed a 90% sensitivity in 20 patients who were in their first illness day, and similar sensitivity remained till 4 days after onset. After then the sensitivity increased to 95% to 100% for more than one month. The specificity of the assay in non-HFMD children is 99.1% (95% Cl: 98.6-99.4), similar as the 99.9% specificity in healthy adults. The cross-reaction rate in patients infected with other non-EV71 enteroviruses was 11.4%. In conclusion, the data here presented show that the detection of IgM anti-EV71 by ELISA affords a reliable, convenient, and prompt diagnosis of EV71 infection.	[Xu, Feihai; Yan, Qiang; Zhang, Shiyin; Weng, Zuxing; Cheng, Tong; Cai, Yijun; He, Delei; Chen, Yixin; Ge, Shengxiang; Yeo, Anthony E. T.; Zhang, Jun; Ng, Mun-Hon; Xia, Ningshao] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China; [Wang, Hua; Li, Liang; Zhu, Fengcai] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Peoples R China; [Niu, Jianjun; He, Shuizhen] Xiamen Ctr Dis Control & Prevent, Xiamen, Peoples R China	Xiamen University; Jiangsu Provincial Center for Disease Control & Prevention	Xu, FH (corresponding author), Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China.	nsxia@xmu.edu.cn	Ge, Shengxiang/Q-2256-2019; Zhang, Jun/G-4598-2010; Ge, SX/G-4693-2010; Chen, YX/G-3937-2010; Yeo, Anthony/AHD-9194-2022; Xia, NS/G-4647-2010	Ge, Shengxiang/0000-0002-7165-3004; Zhang, Jun/0000-0002-6601-9180; Niu, Jianjun/0000-0003-1960-654X; Xia, Ningshao/0000-0003-0179-5266; Cheng, Tong/0000-0002-1638-6214	National Key Technology Research and Development program of China [2008BAI70B00]; Science and Technology Plan Program of Xiamen City [3502Z20093010]; National Natural Science Foundation of China [30972826]	National Key Technology Research and Development program of China(National Key Technology R&D ProgramNational High Technology Research and Development Program of China); Science and Technology Plan Program of Xiamen City; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Key Technology Research and Development program of China (No. 2008BAI70B00), the Science and Technology Plan Program of Xiamen City (No. 3502Z20093010), and National Natural Science Foundation of China (No. 30972826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Brown BA, 2000, J CLIN VIROL, V16, P107, DOI 10.1016/S1386-6532(00)00065-2; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Grandien M, 1995, DIAGNOSTIC PROCEDURE, P279; Jin Q, 2001, MED MOL VIROLOGY; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; LIM KA, 1960, J IMMUNOL, V84, P309; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Ooi EE, 2002, EMERG INFECT DIS, V8, P995, DOI 10.3201/eid0809.010397; Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; SCHNURR D, 1992, P351; Shih SR, 2003, J VIROL METHODS, V111, P55, DOI 10.1016/S0166-0934(03)00151-4; Tan EL, 2006, MOL CELL PROBE, V20, P135, DOI 10.1016/j.mcp.2005.11.003; Tan EL, 2008, J CLIN VIROL, V42, P203, DOI 10.1016/j.jcv.2008.01.001; Tee KK, 2009, INT J INFECT DIS, V13, P307, DOI 10.1016/j.ijid.2008.09.005; Tsao KC, 2002, J MED VIROL, V68, P574, DOI 10.1002/jmv.10233; Wang SY, 2004, J VIROL METHODS, V119, P37, DOI 10.1016/j.jviromet.2004.02.017; Yan JJ, 2000, J CLIN VIROL, V17, P13, DOI 10.1016/S1386-6532(00)00067-6; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09	20	40	43	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11388	10.1371/journal.pone.0011388	http://dx.doi.org/10.1371/journal.pone.0011388			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613983	Green Submitted, Green Published, gold			2022-12-25	WOS:000279370000017
J	Li, MZ; Xia, YL; Gu, YR; Zhang, K; Lang, QL; Chen, L; Guan, JQ; Luo, ZG; Chen, HS; Li, Y; Li, QH; Li, XA; Jiang, AA; Shuai, SR; Wang, JY; Zhu, Q; Zhou, XC; Gao, XL; Li, XW				Li, Mingzhou; Xia, Youlin; Gu, Yiren; Zhang, Kai; Lang, Qiulei; Chen, Lei; Guan, Jiuqiang; Luo, Zonggang; Chen, Haosi; Li, Yang; Li, Qinghai; Li, Xiang; Jiang, An-an; Shuai, Surong; Wang, Jinyong; Zhu, Qi; Zhou, Xiaochuan; Gao, Xiaolian; Li, Xuewei			MicroRNAome of Porcine Pre- and Postnatal Development	PLOS ONE			English	Article							RAPID EVOLUTION; SWINE GENOME; EXPRESSION; TRANSCRIPTOME; DISCOVERY; PATHWAYS; MIR-122; TARGETS; CLONING; MIRNAS	The domestic pig is of enormous agricultural significance and valuable models for many human diseases. Information concerning the pig microRNAome (miRNAome) has been long overdue and elucidation of this information will permit an atlas of microRNA (miRNA) regulation functions and networks to be constructed. Here we performed a comprehensive search for porcine miRNAs on ten small RNA sequencing libraries prepared from a mixture of tissues obtained during the entire pig lifetime, from the fetal period through adulthood. The sequencing results were analyzed using mammalian miRNAs, the precursor hairpins (pre-miRNAs) and the first release of the high-coverage porcine genome assembly (Sscrofa9, April 2009) and the available expressed sequence tag (EST) sequences. Our results extend the repertoire of pig miRNAome to 867 pre-miRNAs (623 with genomic coordinates) encoding for 1,004 miRNAs, of which 777 are unique. We preformed real-time quantitative PCR (q-PCR) experiments for selected 30 miRNAs in 47 tissue-specific samples and found agreement between the sequencing and q-PCR data. This broad survey provides detailed information about multiple variants of mature sequences, precursors, chromosomal organization, development-specific expression, and conservation patterns. Our data mining produced a broad view of the pig miRNAome, consisting of miRNAs and isomiRs and a wealth of information of pig miRNA characteristics. These results are prelude to the advancement in pig biology as well the use of pigs as model organism for human biological and biomedical studies.	[Li, Mingzhou; Gu, Yiren; Zhang, Kai; Guan, Jiuqiang; Luo, Zonggang; Li, Yang; Li, Qinghai; Li, Xiang; Jiang, An-an; Shuai, Surong; Li, Xuewei] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China; [Xia, Youlin; Chen, Haosi; Gao, Xiaolian] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Lang, Qiulei] Zhejiang Univ, Dept Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Lang, Qiulei; Zhou, Xiaochuan] LC Sci, Houston, TX USA; [Chen, Lei; Wang, Jinyong] Chongqing Acad Anim Sci, Chongqing, Peoples R China; [Gao, Xiaolian] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Sichuan Agricultural University; University of Houston System; University of Houston; Zhejiang University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Li, MZ (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China.	xgao@uh.edu; xuewei.li@sicau.edu.cn		Li, Mingzhou/0000-0001-8681-7684; Su, Erzheng/0000-0002-3868-567X	National Special Foundation for Transgenic Species of China [2009ZX08009-155B, 2008ZX08006-003]; National Natural Science Foundation of China [30901024, 30771534]; Department Public Benefit Research Foundation of China [NYHYZX07-034]; NIH [R41 DA029063]	National Special Foundation for Transgenic Species of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department Public Benefit Research Foundation of China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Special Foundation for Transgenic Species of China (2009ZX08009-155B and 2008ZX08006-003), the National Natural Science Foundation of China (30901024 and 30771534), the Department Public Benefit Research Foundation of China (NYHYZX07-034) to X. L. and M.L., and the NIH (R41 DA029063) to X.Z. and X.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bashir A, 2005, GENOME RES, V15, P998, DOI 10.1101/gr.3493405; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Glazov EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006349; Green RD, 2007, INT J BIOL SCI, V3, P185; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-97; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Jiang ZH, 2007, INT J BIOL SCI, V3, P129; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim HJ, 2006, GENOME, V49, P1283, DOI 10.1139/G06-120; Kim J, 2008, MAMM GENOME, V19, P570, DOI 10.1007/s00335-008-9111-3; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Rocha D, 2006, DRUG DISCOV TODAY, V11, P475, DOI 10.1016/j.drudis.2006.04.009; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schook LB, 2005, COMP FUNCT GENOM, V6, P251, DOI 10.1002/cfg.479; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sharbati-Tehrani S, 2008, BIOCHEM BIOPH RES CO, V375, P484, DOI 10.1016/j.bbrc.2008.08.048; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Xie SS, 2010, ANIM GENET, V41, P179, DOI 10.1111/j.1365-2052.2009.01991.x; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507	51	103	111	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11541	10.1371/journal.pone.0011541	http://dx.doi.org/10.1371/journal.pone.0011541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	21179198	Green Published, Green Submitted, gold			2022-12-25	WOS:000279781600020
J	Hunt, ME; Scherrer, MP; Ferrari, FD; Matz, MV				Hunt, Marguerite E.; Scherrer, Michael P.; Ferrari, Frank D.; Matz, Mikhail V.			Very Bright Green Fluorescent Proteins from the Pontellid Copepod Pontella mimocerami	PLOS ONE			English	Article							CORAL; REPORTER; RED; GFP; AMPHIOXUS; DIVERSITY; EVOLUTION; MUTANTS; EMBRYOS; MARKER	Background: Fluorescent proteins (FP) homologous to the green fluorescent protein (GFP) from the jellyfish Aequorea victoria have revolutionized biomedical research due to their usefulness as genetically encoded fluorescent labels. Fluorescent proteins from copepods are particularly promising due to their high brightness and rapid fluorescence development. Results: Here we report two novel FPs from Pontella mimocerami (Copepoda, Calanoida, Pontellidae), which were identified via fluorescence screening of a bacterial cDNA expression library prepared from the whole-body total RNA of the animal. The proteins are very similar in sequence and spectroscopic properties. They possess high molar extinction coefficients (79,000 M(-1) cm(-)) and quantum yields (0.92), which make them more than two-fold brighter than the most common FP marker, EGFP. Both proteins form oligomers, which we were able to counteract to some extent by mutagenesis of the N-terminal region; however, this particular modification resulted in substantial drop in brightness. Conclusions: The spectroscopic characteristics of the two P. mimocerami proteins place them among the brightest green FPs ever described. These proteins may therefore become valuable additions to the in vivo imaging toolkit.	[Hunt, Marguerite E.; Scherrer, Michael P.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Ferrari, Frank D.] Smithsonian Inst, Dept Invertebrate Zool, Natl Museum Nat Hist, Suitland, MD USA; [Matz, Mikhail V.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Texas System; University of Texas Austin	Hunt, ME (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	matz@mail.utexas.edu	Matz, Mikhail V/K-4392-2017	Matz, Mikhail V/0000-0001-5453-9819; Janga, Sarath Chandra/0000-0001-7351-6268	National Institutes of Health [R01 GM078247]; Ocean Exploration program of the National Oceanic and Atmospheric Administration; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ocean Exploration program of the National Oceanic and Atmospheric Administration; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Ocean Exploration program of the National Oceanic and Atmospheric Administration ("Operation Deep Scope 2007''), and the National Institutes of Health grant R01 GM078247 to M. V. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMSTERDAM A, 1995, DEV BIOL, V171, P123, DOI 10.1006/dbio.1995.1265; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Bomati EK, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-77; Bryan B., 2001, United States Patent, Patent No. 6232107; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHUDAKOV DM, FLUORESCENT IN PRESS; Cormack B, 1998, CURR OPIN MICROBIOL, V1, P406, DOI 10.1016/S1369-5274(98)80057-X; Deheyn DD, 2007, BIOL BULL-US, V213, P95, DOI 10.2307/25066625; DRUMMOND AJ, 2009, GENEIOUS V4 8; Evdokimov AG, 2006, EMBO REP, V7, P1006, DOI 10.1038/sj.embor.7400787; Fleminger A., 1957, Tulane Studies in Zoology, V5, P19; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Gurskaya NG, 2003, BIOCHEM J, V373, P403, DOI 10.1042/BJ20021966; Harvey E.N., 1952, BIOLUMINESCENCE; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HERRING PJ, 1988, HYDROBIOLOGIA, V167, P183, DOI 10.1007/BF00026304; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; LAND MF, 1988, J EXP BIOL, V140, P381; Masuda H, 2006, GENE, V372, P18, DOI 10.1016/j.gene.2005.11.031; Matz MV, 2006, METHOD BIOCHEM ANAL, V47, P139; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Matz MV, 1999, NAT BIOTECHNOL, V17, P1227; Ohtsuka S, 2001, HYDROBIOLOGIA, V453, P441, DOI 10.1023/A:1013162605809; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shagin DA, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.18.e23; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHEEN J, 1995, PLANT J, V8, P777, DOI 10.1046/j.1365-313X.1995.08050777.x; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Yanushevich YG, 2002, FEBS LETT, V511, P11, DOI 10.1016/S0014-5793(01)03263-X	35	87	90	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11517	10.1371/journal.pone.0011517	http://dx.doi.org/10.1371/journal.pone.0011517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644720	gold, Green Published			2022-12-25	WOS:000279884900005
J	Padayatty, SJ; Sun, AY; Chen, Q; Espey, MG; Drisko, J; Levine, M				Padayatty, Sebastian J.; Sun, Andrew Y.; Chen, Qi; Espey, Michael Graham; Drisko, Jeanne; Levine, Mark			Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; RECOMMENDED DIETARY ALLOWANCE; ACUTE OXALATE NEPHROPATHY; ACID-INDUCED HEMOLYSIS; TERMINAL HUMAN CANCER; ASCORBIC-ACID; EXPERIMENTAL POLIOMYELITIS; SUPPLEMENTAL ASCORBATE; SUPPORTIVE TREATMENT; HYDROGEN-PEROXIDE	Background: Anecdotal information and case reports suggest that intravenously administered vitamin C is used by Complementary and Alternate Medicine (CAM) practitioners. The scale of such use in the U. S. and associated side effects are unknown. Methods and Findings: We surveyed attendees at annual CAM Conferences in 2006 and 2008, and determined sales of intravenous vitamin C by major U. S. manufacturers/distributors. We also queried practitioners for side effects, compiled published cases, and analyzed FDA's Adverse Events Database. Of 199 survey respondents (out of 550), 172 practitioners administered IV vitamin C to 11,233 patients in 2006 and 8876 patients in 2008. Average dose was 28 grams every 4 days, with 22 total treatments per patient. Estimated yearly doses used (as 25g/50ml vials) were 318,539 in 2006 and 354,647 in 2008. Manufacturers' yearly sales were 750,000 and 855,000 vials, respectively. Common reasons for treatment included infection, cancer, and fatigue. Of 9,328 patients for whom data is available, 101 had side effects, mostly minor, including lethargy/fatigue in 59 patients, change in mental status in 21 patients and vein irritation/phlebitis in 6 patients. Publications documented serious adverse events, including 2 deaths in patients known to be at risk for IV vitamin C. Due to confounding causes, the FDA Adverse Events Database was uninformative. Total numbers of patients treated in the US with high dose vitamin C cannot be accurately estimated from this study. Conclusions: High dose IV vitamin C is in unexpectedly wide use by CAM practitioners. Other than the known complications of IV vitamin C in those with renal impairment or glucose 6 phosphate dehydrogenase deficiency, high dose intravenous vitamin C appears to be remarkably safe. Physicians should inquire about IV vitamin C use in patients with cancer, chronic, untreatable, or intractable conditions and be observant of unexpected harm, drug interactions, or benefit.	[Padayatty, Sebastian J.; Sun, Andrew Y.; Espey, Michael Graham; Levine, Mark] NIDDK, Mol & Clin Nutr Sect, NIH, Bethesda, MD 20892 USA; [Chen, Qi; Drisko, Jeanne] Univ Kansas, Med Ctr, Program Integrat Med, Kansas City, KS 66103 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Kansas; University of Kansas Medical Center	Padayatty, SJ (corresponding author), NIDDK, Mol & Clin Nutr Sect, NIH, Bethesda, MD 20892 USA.	MarkL@intra.niddk.nih.gov	Padayatty, Sebastian J/A-8581-2012; Ganapathy, Suthakar/C-1266-2013; Chen, Qi/D-8278-2015	Padayatty, Sebastian J/0000-0001-8758-3170; Ganapathy, Suthakar/0000-0003-3828-5382; Chen, Qi/0000-0002-7173-8411; Sun, Andrew/0000-0002-7925-6580	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2009, J ALTERN COMPLEM MED, V15, P247, DOI 10.1089/acm.2008.0410; Barnes Patricia M, 2004, Adv Data, P1; Bromley J, 2005, ANN PHARMACOTHER, V39, P1566, DOI 10.1345/aph.1E634; CALLEJA H B, 1960, Ohio State Med J, V56, P821; CAMERON E, 1976, P NATL ACAD SCI USA, V73, P3685, DOI 10.1073/pnas.73.10.3685; CAMERON E, 1972, LANCET, V1, P542; CAMERON E, 1978, P NATL ACAD SCI USA, V75, P4538, DOI 10.1073/pnas.75.9.4538; CAMPBELL GD, 1975, ANN INTERN MED, V82, P810, DOI 10.7326/0003-4819-82-6-810_1; Canavese C, 2005, AM J KIDNEY DIS, V45, P540, DOI 10.1053/j.ajkd.2004.10.025; CATHCART RF, 1981, MED HYPOTHESES, V7, P1359, DOI 10.1016/0306-9877(81)90126-2; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; CREAGAN ET, 1979, NEW ENGL J MED, V301, P687, DOI 10.1056/NEJM197909273011303; DL VP, 2004, JPEN J PARENTER ENTE, V28, P435; Gaby Alan R, 2002, Altern Med Rev, V7, P389; Gonzalez Michael J, 2005, Integr Cancer Ther, V4, P32, DOI 10.1177/1534735404273861; Heaney ML, 2008, CANCER RES, V68, P8031, DOI 10.1158/0008-5472.CAN-08-1490; Hoffer LJ, 2008, ANN ONCOL, V19, P1969, DOI 10.1093/annonc/mdn377; IWAMOTO N, 1994, AM J HEMATOL, V47, P337, DOI 10.1002/ajh.2830470426; IWAMOTO N, 1994, LANCET, V343, P357, DOI 10.1016/S0140-6736(94)91195-9; Jungeblut CW, 1937, J EXP MED, V66, P459, DOI 10.1084/jem.66.4.459; Jungeblut CW, 1939, J EXP MED, V70, P315, DOI 10.1084/jem.70.3.315; Jungeblut CW, 1935, J EXP MED, V62, P517, DOI 10.1084/jem.62.4.517; KLENNER F R, 1949, South Med Surg, V111, P209; KLENNER F R, 1951, South Med Surg, V113, P101; KLENNER FR, 1971, J APPL NUTR, V23, P61; LAWTON JM, 1985, ARCH INTERN MED, V145, P950, DOI 10.1001/archinte.145.5.950; Levine M, 2001, P NATL ACAD SCI USA, V98, P9842, DOI 10.1073/pnas.171318198; Levine M, 1996, P NATL ACAD SCI USA, V93, P3704, DOI 10.1073/pnas.93.8.3704; Levine M, 1999, JAMA-J AM MED ASSOC, V281, P1415, DOI 10.1001/jama.281.15.1415; Levine M, 2009, FREE RADICAL BIO MED, V47, P27, DOI 10.1016/j.freeradbiomed.2009.04.001; Levy T E, 2002, VITAMIN C INFECT DIS; MCALLISTER CJ, 1984, JAMA-J AM MED ASSOC, V252, P1684, DOI 10.1001/jama.1984.03350130016019; McCORMICK W J, 1954, Arch Pediatr, V71, P313; MOERTEL CG, 1985, NEW ENGL J MED, V312, P137, DOI 10.1056/NEJM198501173120301; Padayatty SJ, 2006, NEW ENGL J MED, V355, P1065; Padayatty SJ, 2000, J AM COLL NUTR, V19, P423, DOI 10.1080/07315724.2000.10718941; Padayatty SJ, 2004, ANN INTERN MED, V140, P533, DOI 10.7326/0003-4819-140-7-200404060-00010; PATTERSON JW, 1951, AM J PHYSIOL, V165, P61, DOI 10.1152/ajplegacy.1951.165.1.61; PATTERSON JW, 1950, J BIOL CHEM, V183, P81; Pauling L., 1976, VITAMIN C COMMON COL; REES DC, 1993, BRIT MED J, V306, P841, DOI 10.1136/bmj.306.6881.841; Riordan HD, 1990, J ORTHOMOL MED, V5, P5; RIORDAN NH, 1995, MED HYPOTHESES, V44, P207, DOI 10.1016/0306-9877(95)90137-X; Riordan NH, 2000, J ORTHOMOL MED, V15, P201; Sabin AB, 1939, J EXP MED, V69, P507, DOI 10.1084/jem.69.4.507; Verrax J, 2009, FREE RADICAL BIO MED, V47, P32, DOI 10.1016/j.freeradbiomed.2009.02.016; WITTES RE, 1985, NEW ENGL J MED, V312, P178, DOI 10.1056/NEJM198501173120310; WONG K, 1994, AUST NZ J MED, V24, P410, DOI 10.1111/j.1445-5994.1994.tb01477.x; 2008, NUTR BUSINESS J	51	231	241	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11414	10.1371/journal.pone.0011414	http://dx.doi.org/10.1371/journal.pone.0011414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628650	Green Published, gold, Green Submitted			2022-12-25	WOS:000279589300002
